PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Genovese, G; Handsaker, RE; Li, H; Altemose, N; Lindgren, AM; Chambert, K; Pasaniuc, B; Price, AL; Reich, D; Morton, CC; Pollak, MR; Wilson, JG; McCarroll, SA				Genovese, Giulio; Handsaker, Robert E.; Li, Heng; Altemose, Nicolas; Lindgren, Amelia M.; Chambert, Kimberly; Pasaniuc, Bogdan; Price, Alkes L.; Reich, David; Morton, Cynthia C.; Pollak, Martin R.; Wilson, James G.; McCarroll, Steven A.			Using population admixture to help complete maps of the human genome	NATURE GENETICS			English	Article							GENETIC-LINKAGE MAP; SEGMENTAL DUPLICATIONS; COPY-NUMBER; CHROMOSOME 1Q21.1; SEQUENCE; RECOMBINATION; EVOLUTION; DIVERSITY; MUTATION; IMPACT	Tens of millions of base pairs of euchromatic human genome sequence, including many protein-coding genes, have no known location in the human genome. We describe an approach for localizing the human genome's missing pieces using the patterns of genome sequence variation created by population admixture. We mapped the locations of 70 scaffolds spanning 4 million base pairs of the human genome's unplaced euchromatic sequence, including more than a dozen protein-coding genes, and identified 8 new large interchromosomal segmental duplications. We find that most of these sequences are hidden in the genome's heterochromatin, particularly its pericentromeric regions. Many cryptic, pericentromeric genes are expressed at the RNA level and have been maintained intact for millions of years while their expression patterns diverged from those of paralogous genes elsewhere in the genome. We describe how knowledge of the locations of these sequences can inform disease association and genome biology studies.	[Genovese, Giulio; Handsaker, Robert E.; Li, Heng; Chambert, Kimberly; Price, Alkes L.; Morton, Cynthia C.; Pollak, Martin R.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Genovese, Giulio; Handsaker, Robert E.; Li, Heng; Altemose, Nicolas; Reich, David; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Genovese, Giulio; Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Genovese, Giulio; Morton, Cynthia C.; Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA USA; [Genovese, Giulio; Handsaker, Robert E.; Chambert, Kimberly; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Lindgren, Amelia M.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Pasaniuc, Bogdan; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of Mississippi; University of Mississippi Medical Center	Genovese, G (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.	giulio.genovese@gmail.com; mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021; Altemose, Nicolas/O-7539-2019; Li, Heng/D-9344-2011; Altemose, Nicolas/EIR-2712-2022	Handsaker, Bob/0000-0002-3128-3547; Altemose, Nicolas/0000-0002-7231-6026; Li, Heng/0000-0003-4874-2874; Altemose, Nicolas/0000-0002-7231-6026; Genovese, Giulio/0000-0003-3066-5575; McCarroll, Steven/0000-0002-6954-8184; Pasaniuc, Bogdan/0000-0002-0227-2056	US National Institutes of Health [RC1 GM091332-01, R01 HG006855, R01DK54931]; Smith Family Foundation Award for Excellence in Biomedical Research; Jackson State University [N01-HC-95170]; University of Mississippi Medical Center [N01-HC-95171]; Touglaoo College [N0I-HC-95172]; National Heart, Lung, and Blood Institute (NHLBI); National Institute for Minority Health and Health Disparities (NIMHD); National Institute on Biomedical Imaging and Bioengineering (NIBIB); NHLBI [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HH5N268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI in collaboration with the University of Alabama at Birmingham [N01-HC95095, N01-HC48047]; University of Minnesota [N01-HC48048]; Northwestern University [N01-HC48049]; Kaiser Foundation Research Institute [N01-HC48050]; MESA; NHLBI in collaboration with the MESA investigators; MESA [N0I-HC-95159, N01-HC-95169, RR-024156, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL071258, R01-HL-071259]; US Environmental Protection Agency (EPA)-Science.to Achieve Results (STAR) [RD831697];  [NO2-HL-6-4278];  [NO1-HC-65226]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095, N01HC048048, N01HC095170, N01HC095169, N01HC095171, N01HC048050, N01HC095159, N01HC048049, N01HC095172, N01HC048047] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071252, R44HL095169, R01HL048049, R01HL071051, R01HL048048, R01HL048050, R01HL065226, R01HL071250, R43HL095169, R01HL071251, R41HL095172, R01HL071258, R01HL071205, R01HL071259, R01HL064278, R29HL048048] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855, R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233, RC1GM091332] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007092] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation Award for Excellence in Biomedical Research; Jackson State University; University of Mississippi Medical Center; Touglaoo College; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Biomedical Imaging and Bioengineering (NIBIB); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI in collaboration with the University of Alabama at Birmingham; University of Minnesota(University of Minnesota System); Northwestern University; Kaiser Foundation Research Institute; MESA; NHLBI in collaboration with the MESA investigators; MESA; US Environmental Protection Agency (EPA)-Science.to Achieve Results (STAR)(United States Environmental Protection Agency); ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants RC1 GM091332-01 (S.A.M. and J.G.W.), R01 HG006855 (S.A.M.) and R01DK54931 (G.G. and M.R.P.) from the US National Institutes of Health and by a Smith Family Foundation Award for Excellence in Biomedical Research (S.A.M.). The Jackson Heart Study is supported and conducted in collaboration with Jackson State University (N01-HC-95170), University of Mississippi Medical Center (N01-HC-95171) and Touglaoo College (N0I-HC-95172) contracts from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute for Minority Health and Health Disparities (NIMHD), with additional support from the National Institute on Biomedical Imaging and Bioengineering (NIBIB). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by NHLBI contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HH5N268201100010C, HHSN268201100011C and HHSN268201100012C). The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the NHLBI in collaboration with the University of Alabama at Birmingham (N01-HC95095 and N01-HC48047), the University of Minnesota (N01-HC48048), Northwestern University (N01-HC48049) and the Kaiser Foundation Research Institute (N01-HC48050). MESA, MESA Family and the MESA SHARe project are conducted and supported by the NHLBI in collaboration with the MESA investigators. Support for MESA is provided by contracts N0I-HC-95159, through N01-HC-95169, and RR-024156. Funding for MESA Family is provided by grants R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL071258 and R01-HL-071259. MESA Air is funded by the US Environmental Protection Agency (EPA)-Science.to Achieve Results (STAR) Program Grant RD831697. Funding for genotyping was provided by NHLBI contracts NO2-HL-6-4278 and NO1-HC-65226. This manuscript does not necessarily reflect the opinions or views of ARIC, CARDIA, JHS, MESA or the NHLBI.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Doggett NA, 2006, GENOMICS, V88, P762, DOI 10.1016/j.ygeno.2006.07.012; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Golfier G, 2003, GENE, V312, P51, DOI 10.1016/S0378-1119(03)00673-5; Guipponi H, 2000, HUM GENET, V107, P127, DOI 10.1007/s004390000343; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Kim Jong-Il, 2009, Genomics & Informatics, V7, P159; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Lyle R, 2007, GENOME RES, V17, P1690, DOI 10.1101/gr.6675307; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Ruault M, 2003, GENOMICS, V81, P391, DOI 10.1016/S0888-7543(03)00025-9; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Sirmaci A, 2010, AM J HUM GENET, V86, P797, DOI 10.1016/j.ajhg.2010.04.004; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wegmann D, 2011, NAT GENET, V43, P847, DOI 10.1038/ng.894; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	56	50	51	0	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					406	414		10.1038/ng.2565	http://dx.doi.org/10.1038/ng.2565			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435088	Green Accepted, Green Submitted			2022-12-25	WOS:000316840600011
J	Desai, R; Sarpal, R; Ishiyama, N; Pellikka, M; Ikura, M; Tepass, U				Desai, Ridhdhi; Sarpal, Ritu; Ishiyama, Noboru; Pellikka, Milena; Ikura, Mitsuhiko; Tepass, Ulrich			Monomeric alpha-catenin links cadherin to the actin cytoskeleton	NATURE CELL BIOLOGY			English	Article							MEDIATED CELL-ADHESION; ADHERENS JUNCTIONS; BETA-CATENIN; DE-CADHERIN; F-ACTIN; IN-VITRO; DROSOPHILA; COMPLEX; MORPHOGENESIS; VINCULIN	The linkage of adherens junctions to the actin cytoskeleton is essential for cell adhesion. The contribution of the cadherin-catenin complex to the interaction between actin and the adherens junction remains an intensely investigated subject that centres on the function of alpha-catenin, which binds to cadherin through beta-catenin and can bind F-actin directly or indirectly. Here, we delineate regions within Drosophila alpha-Catenin (alpha-Cat) that are important for adherens junction performance in static epithelia and dynamic morphogenetic processes. Moreover, we address whether persistent alpha-catenin-mediated physical linkage between cadherin and F-actin is crucial for cell adhesion and characterize the functions of alpha-catenin monomers and dimers at adherens junctions. Our data support the view that monomeric alpha-catenin acts as an essential physical linker between the cadherin beta-catenin complex and the actin cytoskeleton, whereas alpha-catenin dimers are cytoplasmic and form an equilibrium with monomeric junctional alpha-catenin.	[Desai, Ridhdhi; Sarpal, Ritu; Pellikka, Milena; Tepass, Ulrich] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Ishiyama, Noboru; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Ishiyama, Noboru; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Tepass, U (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	u.tepass@utoronto.ca	Desai, Ridhdhi/U-5949-2019; Pellikka, Milena/L-8930-2015	Ishiyama, Noboru/0000-0002-1426-6083	Ontario Graduate Scholarship; Canadian Cancer Society Research Institute	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	We are grateful to M. Takeichi (Riken, Center for Developmental Biology, Japan), A. Nagafuchi (Nara Medical University, Japan), L. Nilson (McGill University, Canada), P. Rorth (Institute of Molecular and Cell Biology, Singapore), G. Thomas (Penn State University, USA), the Vienna Drosophila Research Center, the Developmental Studies Hybridoma Bank, and the Bloomington Drosophila Stock Center for supplying reagents. We thank C. Arana for technical assistance and A. McKinley for help with live-cell imaging. We are grateful to J. Nelson and B. Weis for valuable discussion, and T. Harris and D. Godt for critical reading of the manuscript. This work was supported by an Ontario Graduate Scholarship (to R.D.) and operating grants from the Canadian Cancer Society Research Institute (to M.I. and U.T.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; ABERLE H, 1994, J CELL SCI, V107, P3655; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Feng W, 2007, EMBO J, V26, P2786, DOI 10.1038/sj.emboj.7601702; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Huber O, 1997, J CELL SCI, V110, P1759; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Islam R, 2003, DEVELOPMENT, V130, P2051, DOI 10.1242/dev.00415; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Mirkovic I, 2011, NAT STRUCT MOL BIOL, V18, P665, DOI 10.1038/nsmb.2049; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nieset JE, 1997, J CELL SCI, V110, P1013; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Obama H, 1997, J BIOL CHEM, V272, P11017; Ozawa M, 1998, J BIOL CHEM, V273, P29524, DOI 10.1074/jbc.273.45.29524; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	55	126	128	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					261	273		10.1038/ncb2685	http://dx.doi.org/10.1038/ncb2685			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23417122				2022-12-25	WOS:000315844900007
J	Theofilopoulos, S; Wang, YQ; Kitambi, SS; Sacchetti, P; Sousa, KM; Bodin, K; Kirk, J; Salto, C; Gustafsson, M; Toledo, EM; Karu, K; Gustafsson, JA; Steffensen, KR; Ernfors, P; Sjovall, J; Griffiths, WJ; Arenas, E				Theofilopoulos, Spyridon; Wang, Yuqin; Kitambi, Satish Srinivas; Sacchetti, Paola; Sousa, Kyle M.; Bodin, Karl; Kirk, Jayne; Salto, Carmen; Gustafsson, Magnus; Toledo, Enrique M.; Karu, Kersti; Gustafsson, Jan-Ake; Steffensen, Knut R.; Ernfors, Patrik; Sjovall, Jan; Griffiths, William J.; Arenas, Ernest			Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATED NUCLEAR RECEPTORS; CENTRAL-NERVOUS-SYSTEM; BILE-ACIDS; LXR-ALPHA; CHOLESTEROL-METABOLISM; LIPID HOMEOSTASIS; STEM-CELLS; OXYSTEROLS; BETA; MICE	Liver X receptors (Lxr alpha and Lxr beta) are ligand-dependent nuclear receptors critical for ventral midbrain neurogenesis in vivo. However, no endogenous midbrain Lxr ligand has so far been identified. Here we used LC/MS and functional assays to identify cholic acid as a new Lxr ligand. Moreover, 24(S),25-epoxycholesterol (24,25-EC) was found to be the most potent and abundant Lxr ligand in the developing mouse midbrain. Both Lxr ligands promoted neural development in an Lxr-dependent manner in zebrafish in vivo. Notably, each ligand selectively regulated the development of distinct midbrain neuronal populations. Whereas cholic acid increased survival and neurogenesis of Brn3a-positive red nucleus neurons, 24,25-EC promoted dopaminergic neurogenesis. These results identify an entirely new class of highly selective and cell type-specific regulators of neurogenesis and neuronal survival. Moreover, 24,25-EC promoted dopaminergic differentiation of embryonic stem cells, suggesting that Lxr ligands may thus contribute to the development of cell replacement and regenerative therapies for Parkinson's disease.	[Theofilopoulos, Spyridon; Kitambi, Satish Srinivas; Sacchetti, Paola; Sousa, Kyle M.; Bodin, Karl; Salto, Carmen; Gustafsson, Magnus; Toledo, Enrique M.; Ernfors, Patrik; Sjovall, Jan; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden; [Wang, Yuqin; Griffiths, William J.] Swansea Univ, Inst Mass Spectrometry, Coll Med, Swansea, W Glam, Wales; [Kirk, Jayne] Waters UK Ltd, Manchester, Lancs, England; [Karu, Kersti] Univ London, Sch Pharm, London WC1N 1AX, England; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Steffensen, Knut R.] Ctr Biosci, Dept Biosci & Nutr, Stockholm, Sweden	Karolinska Institutet; Swansea University; Waters UK; University of London; University College London; University of London School of Pharmacy; University of Houston System; University of Houston	Arenas, E (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden.	ernest.arenas@ki.se	Theofilopoulos, Spyridon/E-1508-2011; Theofilopoulos, Spyridon/B-2075-2015; Arenas, Ernest/AAO-5231-2020; Sacchetti, Paola/ABC-8884-2021; Toledo, Enrique/E-8860-2010; griffiths, william/N-4641-2016	Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Sacchetti, Paola/0000-0002-6390-2744; Ernfors, Patrik/0000-0002-1140-3986; Steffensen, Knut/0000-0001-6093-2801; wang, yuqin/0000-0002-3063-3066; Toledo, Enrique/0000-0002-1460-4708; griffiths, william/0000-0002-4129-6616	Hjarnfonden; European Union; Swedish Foundation for Strategic Research; Karolinska Institutet; Karolinska Institutet (Thematic Center in Stem Cells and Regenerative Medicine); Swedish Research Council (DBRM) [2008:2811, 2011-3116, 3318]; UK Research Councils Biotechnology and Biological Sciences Research Council [BB/C515771/2, BB/C511356/1, BB/I001735/1, BB/H001018/1]; Swedish Medical Research Council; Onassis Foundation; BBSRC [BB/I001735/1, BB/H001018/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001018/1, BB/I001735/1, BB/C515771/2, BB/C511356/1] Funding Source: researchfish	Hjarnfonden; European Union(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institutet(Karolinska Institutet); Karolinska Institutet (Thematic Center in Stem Cells and Regenerative Medicine); Swedish Research Council (DBRM)(Swedish Research Council); UK Research Councils Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Onassis Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in Karolinska was supported by Hjarnfonden, European Union (Strokemap and NeuroStemCell projects), Swedish Foundation for Strategic Research (SRL Program), Karolinska Institutet (Strategic Research Program and Thematic Center in Stem Cells and Regenerative Medicine) and the Swedish Research Council (DBRM, 2008:2811, 2011-3116 and 3318). The authors are grateful to L. Jansson-Sjostrand and J. Soderlund for technical assistance, A. Nanni for secretarial help and S. Yang for help with artwork. Work in Swansea was supported by funding from the UK Research Councils Biotechnology and Biological Sciences Research Council (BB/C515771/2, BB/C511356/1 and BB/I001735/1 to W.J.G. and BB/H001018/1 to Y.W.). S.T. was supported by the Swedish Medical Research Council and the Onassis Foundation.	Alberti S, 2000, GENE, V243, P93, DOI 10.1016/S0378-1119(99)00555-7; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berrodin TJ, 2010, MOL PHARMACOL, V78, P1046, DOI 10.1124/mol.110.065193; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; CLARE K, 1995, ATHEROSCLEROSIS, V118, P67, DOI 10.1016/0021-9150(95)05594-M; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Goodwin BJ, 2008, CURR TOP MED CHEM, V8, P781, DOI 10.2174/156802608784535075; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mano N, 2004, J LIPID RES, V45, P295, DOI 10.1194/jlr.M300369-JLR200; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Song C, 2000, ENDOCRINOLOGY, V141, P4180, DOI 10.1210/en.141.11.4180; Song C, 2000, STEROIDS, V65, P423, DOI 10.1016/S0039-128X(00)00127-6; Tint GS, 2006, J LIPID RES, V47, P1535, DOI 10.1194/jlr.M600141-JLR200; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Wang YQ, 2009, MOL BIOSYST, V5, P529, DOI 10.1039/b819502a; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	49	91	94	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					126	133		10.1038/NCHEMBIO.1156	http://dx.doi.org/10.1038/NCHEMBIO.1156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23292650				2022-12-25	WOS:000314083200012
J	Werner, A; Disanza, A; Reifenberger, N; Habeck, G; Becker, J; Calabrese, M; Urlaub, H; Lorenz, H; Schulman, B; Scita, G; Melchior, F				Werner, Achim; Disanza, Andrea; Reifenberger, Nina; Habeck, Gregor; Becker, Janina; Calabrese, Matthew; Urlaub, Henning; Lorenz, Holger; Schulman, Brenda; Scita, Giorgio; Melchior, Frauke			SCFFbxw5 mediates transient degradation of actin remodeller Eps8 to allow proper mitotic progression	NATURE CELL BIOLOGY			English	Article							SCF UBIQUITIN LIGASES; CENTROSOME DUPLICATION; STRUCTURAL BASIS; CAPPING PROTEIN; CELL-MIGRATION; ACTIVATION; SUBSTRATE; COMPLEX; MITOSIS; CANCER	Eps8, a bi-functional actin cytoskeleton remodeller, is a positive regulator of cell proliferation and motility. Here, we describe an unrecognized mechanism regulating Eps8 that is required for proper mitotic progression: whereas Eps8 is stable in G1 and S phase, its half-life drops sharply in G2. This requires G2-specific proteasomal degradation mediated by the ubiquitin E3 ligase SCFFbxw5. Consistent with a short window of degradation, Eps8 disappears from the cell cortex early in mitosis, but reappears at the midzone of dividing cells. Failure to reduce Eps8 levels in G2 prolongs its localization at the cell cortex and markedly delays cell rounding and prometaphase duration. However, during late stages of mitosis and cytokinesis, Eps8 capping activity is required to prevent membrane blebbing and cell-shape deformations. Our findings identify SCFFbxw5-driven fluctuation of Eps8 levels as an important mechanism that contributes to cell-shape changes during entry into-and exit from-mitosis.	[Werner, Achim; Reifenberger, Nina; Habeck, Gregor; Becker, Janina; Lorenz, Holger; Melchior, Frauke] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Disanza, Andrea; Scita, Giorgio] Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Calabrese, Matthew; Schulman, Brenda] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Urlaub, Henning] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr, Dept Clin Chem, D-37075 Gottingen, Germany; [Scita, Giorgio] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; IFOM - FIRC Institute of Molecular Oncology; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Max Planck Society; University of Gottingen; University of Milan	Werner, A (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany.	a.werner@berkeley.edu; f.melchior@zmbh.uni-heidelberg.de	Scita, Giorgio/J-9670-2012; Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797; Habeck, Gregor/0000-0002-8327-7691; Scita, Giorgio/0000-0001-7984-1889; Disanza, Andrea/0000-0001-5101-2907	Deutsche Forschungsgemeinschaft [SPP136, ME2279/3-1]; NoE RUBICON; ALSAC; NIH [2R01GM069530]; Associazione Italiana per la Ricerca sin Cancro (AIRC); Italian Ministries of Education-University-Research (MIUR-PRIN); International Association For Cancer Research; European Research Council; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NoE RUBICON; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sin Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministries of Education-University-Research (MIUR-PRIN)(Ministry of Education, Universities and Research (MIUR)); International Association For Cancer Research; European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge J. Ellenberg (EMBL, Heidelberg, Germany), B. Baum (MRC-LMCB, England) and D. Gerlich (IMBA, Austria) for their gifts of stable HeLa cell lines. P. Di Fiore, O. Gruss, B. Mardin and A. Maccario are acknowledged for helpful discussions, F. Milanesi for Eps8 purification, R. Geiss-Friedlander for Fbxw5 construct generation, U. Gern for excellent technical assistance, and B. Mardin, S. Barysch, A. Flotho and U. Winter for critical manuscript reading. This work was supported by the Deutsche Forschungsgemeinschaft (SPP136, ME2279/3-1; F.M and A.W.) and NoE RUBICON, by ALSAC and NIH (2R01GM069530) to B.A.S., by the Associazione Italiana per la Ricerca sin Cancro (AIRC) to G.S and A.D.; by the Italian Ministries of Education-University-Research (MIUR-PRIN), the International Association For Cancer Research, and the European Research Council to G.S.; B.A.S. is an Investigator of the Howard Hughes Medical Institute. M.F.C. is an HHMI fellow of the Damon Runyon Cancer Research Foundation.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Bear JE, 2008, CELL, V133, P765, DOI 10.1016/j.cell.2008.05.012; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen YJ, 2008, MOL CANCER THER, V7, P1376, DOI 10.1158/1535-7163.MCT-07-2388; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Frittoli E, 2011, IMMUNITY, V35, P388, DOI 10.1016/j.immuni.2011.07.007; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hertzog M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000387; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Maa MC, 2001, ONCOGENE, V20, P106, DOI 10.1038/sj.onc.1204069; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Matthews HK, 2012, DEV CELL, V23, P371, DOI 10.1016/j.devcel.2012.06.003; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pagan J, 2011, NAT CELL BIOL, V13, P888, DOI 10.1038/ncb2312; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Provenzano C, 1998, EXP CELL RES, V242, P186, DOI 10.1006/excr.1998.4095; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skaar JR, 2009, CELL, V137; Song L, 2011, CELL CYCLE, V10, P52, DOI 10.4161/cc.10.1.14387; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Swaminathan S, 2004, J CELL BIOL, V164, P965, DOI 10.1083/jcb.200309126; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Wang HX, 2009, CARCINOGENESIS, V30, P165, DOI 10.1093/carcin/bgn252; Welsch T, 2007, CANCER LETT, V255, P205, DOI 10.1016/j.canlet.2007.04.008; Welsch T, 2010, EXP CELL RES, V316, P1914, DOI 10.1016/j.yexcr.2010.02.020; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xu M, 2009, ENDOCRINOLOGY, V150, P2064, DOI 10.1210/en.2008-1265; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yap LF, 2009, ONCOGENE, V28, P2524, DOI 10.1038/onc.2009.105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	57	27	30	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2013	15	2					179	188		10.1038/ncb2661	http://dx.doi.org/10.1038/ncb2661			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	088SF	23314863	Green Accepted			2022-12-25	WOS:000314856700009
J	Relman, DA				Relman, David A.			Restoration of the gut microbial habitat as a disease therapy	NATURE BIOTECHNOLOGY			English	Editorial Material							INFECTION; MICE		[Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000964] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Pray L, 2012, HUMAN MICROBIOME DIE, P99	10	8	8	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					35	37		10.1038/nbt.2475	http://dx.doi.org/10.1038/nbt.2475			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302933				2022-12-25	WOS:000313563600019
J	Broxmeyer, HE; Hoggatt, J; O'Leary, HA; Mantel, C; Chitteti, BR; Cooper, S; Messina-Graham, S; Hangoc, G; Farag, S; Rohrabaugh, SL; Ou, X; Speth, J; Pelus, LM; Srour, EF; Campbell, TB				Broxmeyer, Hal E.; Hoggatt, Jonathan; O'Leary, Heather A.; Mantel, Charlie; Chitteti, Brahmananda R.; Cooper, Scott; Messina-Graham, Steven; Hangoc, Giao; Farag, Sherif; Rohrabaugh, Sara L.; Ou, Xuan; Speth, Jennifer; Pelus, Louis M.; Srour, Edward F.; Campbell, Timothy B.			Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis	NATURE MEDICINE			English	Article							RECOMBINANT MURINE INTERLEUKIN-3; PROGENITOR CELLS; STEM-CELLS; CD26 INHIBITION; GM-CSF; ENHANCES ENGRAFTMENT; REPLATING CAPACITY; CD34(+) CELLS; IN-VITRO; MICE	Enhancement of hematopoietic recovery after radiation, chemotherapy, or hematopoietic stem cell (HSC) transplantation is clinically relevant. Dipeptidylpeptidase (DPP4) cleaves a wide variety of substrates, including the chemokine stromal cell-derived factor-1 (SDF-1). In the course of experiments showing that inhibition of DPP4 enhances SDF-1-mediated progenitor cell survival, ex vivo cytokine expansion and replating frequency, we unexpectedly found that DPP4 has a more general role in regulating colony-stimulating factor (CSF) activity. DPP4 cleaved within the N-termini of the CSFs granulocyte-macrophage (GM)-CSF, G-CSF, interleukin-3 (IL-3) and erythropoietin and decreased their activity. Dpp4 knockout or DPP4 inhibition enhanced CSF activities both in vitro and in vivo. The reduced activity of DPP4-truncated versus full-length human GM-CSF was mechanistically linked to effects on receptor-binding affinity, induction of GM-CSF receptor oligomerization and signaling capacity. Hematopoiesis in mice after radiation or chemotherapy was enhanced in Dpp4(-/-) mice or mice receiving an orally active DPP4 inhibitor. DPP4 inhibition enhanced engraftment in mice without compromising HSC function, suggesting the potential clinical utility of this approach.	[Broxmeyer, Hal E.; Hoggatt, Jonathan; O'Leary, Heather A.; Mantel, Charlie; Cooper, Scott; Messina-Graham, Steven; Hangoc, Giao; Rohrabaugh, Sara L.; Ou, Xuan; Speth, Jennifer; Pelus, Louis M.; Srour, Edward F.; Campbell, Timothy B.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Chitteti, Brahmananda R.; Farag, Sherif; Srour, Edward F.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Srour, Edward F.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu		O'Leary, Heather/0000-0003-1321-1520; Speth, Jennifer/0000-0002-7724-6995	US Health Service National Institutes of Health (NIH) [R01 HL056416, R01 HL067284, R01 HL112669]; Center of Excellence in Hematology [P01 DK090948, HL69669, HL96305]; NIH [T32 DK07519, T32 HL07910, R25 GM079657, T32 CA111198]; NATIONAL CANCER INSTITUTE [T32CA111198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067284, R01HL096305, R01HL112669, T32HL007910, R01HL067384, R01HL056416, R01HL069669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519, P30DK090948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079657] Funding Source: NIH RePORTER	US Health Service National Institutes of Health (NIH); Center of Excellence in Hematology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by US Health Service National Institutes of Health (NIH) grants R01 HL056416, R01 HL067284 and R01 HL112669 and a Center of Excellence in Hematology grant P01 DK090948 to H.E.B., and HL69669 and HL96305 to L.M.P.J.H. was supported as a doctoral candidate on NIH T32 DK07519 (to H.E.B.) and as a postdoc on NIH T32 HL07910 (to H.E.B.); H.A.O. was supported as a postdoc on NIH T32 DK07519; S.M.-G. was supported as a doctoral candidate on NIH R25 GM079657 (to H.E.B.); and T.B.C. was supported as a doctoral candidate on NIH T32 DK07519. S.L.R. was supported by NIH T32 CA111198 for parts of this study. We thank Y.-R. Zhou, The Feinstein Insitute for Medical Research, for the Cre<SUP>+</SUP> Cxcr4<SUP>F1/F1</SUP> mice.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Broxmeyer H.E., 2009, THOMAS HEMATOPOIETIC, P559; Broxmeyer HE, 2007, STEM CELLS DEV, V16, P589, DOI 10.1089/scd.2007.0044; Broxmeyer HE, 2011, BLOOD, V117, P4773, DOI 10.1182/blood-2011-01-330514; BROXMEYER HE, 1978, BLOOD, V51, P889; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; BROXMEYER HE, 1987, J CLIN INVEST, V79, P721, DOI 10.1172/JCI112877; BROXMEYER HE, 1987, P NATL ACAD SCI USA, V84, P3871, DOI 10.1073/pnas.84.11.3871; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; BROXMEYER HE, 1991, INT J HEMATOL, V54, P447; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Campbell TB, 2008, FRONT BIOSCI-LANDMRK, V13, P1795, DOI 10.2741/2800; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; CAROW CE, 1993, BLOOD, V81, P942; Chitteti B. R., 2011, CORD BLOOD BIOL TRAN, P75; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Cho SY, 2010, CANCER RES, V70, P3402, DOI 10.1158/0008-5472.CAN-09-3977; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Christopherson KW, 2007, STEM CELLS DEV, V16, P355, DOI 10.1089/scd.2007.9996; Christopherson KW, 2006, EXP HEMATOL, V34, P1060, DOI 10.1016/j.exphem.2006.03.012; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Gotoh A, 1996, BLOOD, V88, P138; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Haman A, 1999, J BIOL CHEM, V274, P34155, DOI 10.1074/jbc.274.48.34155; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Kajiyama H, 2002, CANCER RES, V62, P2753; Kawai T, 2007, STEM CELLS DEV, V16, P361, DOI 10.1089/scd.2007.9997; Kidd S, 2011, EXP HEMATOL, V39, P580, DOI 10.1016/j.exphem.2011.01.012; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Lee Y, 2002, BLOOD, V99, P4307, DOI 10.1182/blood.V99.12.4307; Lopez AF, 2010, IUBMB LIFE, V62, P509, DOI 10.1002/iub.350; Mantel C, 2008, CELL CYCLE, V7, P484, DOI 10.4161/cc.7.4.5316; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Niu LH, 1999, BLOOD, V94, P3748, DOI 10.1182/blood.V94.11.3748.423k16_3748_3753; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peranteau WH, 2006, BLOOD, V108, P4268, DOI 10.1182/blood-2006-04-018986; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Shaheen MA, 2009, HEMATOLOGY BASIC PRI, P253; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Tian C, 2006, GENE THER, V13, P652, DOI 10.1038/sj.gt.3302695; Waterstrat A, 2010, BLOOD, V115, P408, DOI 10.1182/blood-2008-03-143370; Woodcock JM, 1999, INT J BIOCHEM CELL B, V31, P1017, DOI 10.1016/S1357-2725(99)00084-9; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Woodcock JM, 1997, BAILLIERE CLIN HAEM, V10, P507, DOI 10.1016/S0950-3536(97)80023-6; Wyss BK, 2009, EXP HEMATOL, V37, P814, DOI 10.1016/j.exphem.2009.03.005; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	55	165	169	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1786	+		10.1038/nm.2991	http://dx.doi.org/10.1038/nm.2991			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160239	Green Accepted			2022-12-25	WOS:000311999800026
J	Ebbers, HC; Crow, SA; Vulto, AG; Schellekens, H				Ebbers, Hans C.; Crow, Stacy A.; Vulto, Arnold G.; Schellekens, Huub			Interchangeability, immunogenicity and biosimilars	NATURE BIOTECHNOLOGY			English	Editorial Material							GENERIC SUBSTITUTION; EPOETIN-ALPHA; RENAL ANEMIA; SAFETY; NEED		[Ebbers, Hans C.] Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Crow, Stacy A.; Vulto, Arnold G.] Erasmus Univ, Dept Hosp Pharm, Med Ctr, Rotterdam, Netherlands; [Schellekens, Huub] Univ Utrecht, Copernicus Inst, Dept Innovat & Environm Studies, Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University	Ebbers, HC (corresponding author), Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	h.ebbers@uu.nl						Brinks V, 2011, PHARM RES-DORDR, V28, P386, DOI 10.1007/s11095-010-0288-2; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Covic A, 2008, NEPHROL DIAL TRANSPL, V23, P3731, DOI 10.1093/ndt/gfn519; Declerck PJ, 2010, CURR MED RES OPIN, V26, P1219, DOI 10.1185/03007991003719642; Dellanna F, 2011, INT J CLIN PRACT, V65, P64, DOI 10.1111/j.1742-1241.2010.02551.x; Directive, 2001, OFFICIAL J EUROPEA L; Duerden MG, 2010, BRIT J CLIN PHARMACO, V70, P335, DOI 10.1111/j.1365-2125.2010.03718.x; Ebbers HC, 2012, EXPERT OPIN BIOL TH, V12, P1473, DOI 10.1517/14712598.2012.711308; European Commission, 2004, OFF J EUR UNION, V136, P34; European Medicines Agency, 2007, GUID IMM ASS BIOT DE; European Medicines Agency, SCI GUID DOC BIOS ME; European Medicines Agency, EPARS AUTH MED PROD; European Medicines Agency, 2008, RUL GOV MED PROD E A; European Medicines Agency, 2006, GUID SIM BIOL MED PR; Frau S, 2010, EUR J CLIN PHARMACOL, V66, P785, DOI 10.1007/s00228-010-0848-8; Gascon P, 2010, ANN ONCOL, V21, P1419, DOI 10.1093/annonc/mdp574; Haag-Weber M, 2012, CLIN NEPHROL, V77, P8, DOI 10.5414/CN107304; Health I.M.S, 2011, SHAP BIOS OPP GLOB P; Jiang YJ, 2009, J PHARM SCI-US, V98, P4695, DOI 10.1002/jps.21778; Kresse GB, 2009, EUR J PHARM BIOPHARM, V72, P479, DOI 10.1016/j.ejpb.2009.02.014; Macdougall IC, 2009, NEW ENGL J MED, V361, P1848, DOI 10.1056/NEJMoa074037; Meredith PA, 2009, CURR MED RES OPIN, V25, P2179, DOI 10.1185/03007990903116867; Minghetti P, 2011, NEPHRON CLIN PRACT, V117, pC1, DOI 10.1159/000319640; Niederwieser D, 2011, EUR J HAEMATOL, V86, P277, DOI 10.1111/j.1600-0609.2010.01566.x; Peterson G.M., 2011, BR J CLIN PHARM, V71, P968; Peterson GM, 2011, BRIT J CLIN PHARMACO, V71, P966, DOI 10.1111/j.1365-2125.2010.03872.x; Praditpornsilpa K, 2011, KIDNEY INT, V80, P88, DOI 10.1038/ki.2011.68; Rovira J., 2011, IMPACK BIOSIMILARS E; Schiestl M, 2011, NAT BIOTECHNOL, V29, P310, DOI 10.1038/nbt.1839; Seidl A, 2012, PHARM RES-DORDR, V29, P1454, DOI 10.1007/s11095-011-0621-4; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Storring PL, 1998, BRIT J HAEMATOL, V100, P79; Vanrenterghem Y, 2002, KIDNEY INT, V62, P2167, DOI 10.1046/j.1523-1755.2002.00657.x; Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009	34	82	87	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1186	1190		10.1038/nbt.2438	http://dx.doi.org/10.1038/nbt.2438			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222784				2022-12-25	WOS:000312092400017
J	Mercier, PP; Lysaght, AC; Bandyopadhyay, S; Chandrakasan, AP; Stankovic, KM				Mercier, Patrick P.; Lysaght, Andrew C.; Bandyopadhyay, Saurav; Chandrakasan, Anantha P.; Stankovic, Konstantina M.			Energy extraction from the biologic battery in the inner ear	NATURE BIOTECHNOLOGY			English	Article							BIOFUEL CELL; ELECTRICITY; CIRCUIT; HEARING	Endocochlear potential (EP) is a battery-like electrochemical gradient found in and actively maintained by the inner ear(1,2). Here we demonstrate that the mammalian EP can be used as a power source for electronic devices. We achieved this by designing an anatomically sized, ultra-low quiescent-power energy harvester chip integrated with a wireless sensor capable of monitoring the EP itself. Although other forms of in vivo energy harvesting have been described in lower organisms(3-5), and thermoelectric(6), piezoelectric(7) and biofuel(8,9) devices are promising for mammalian applications, there have been few, if any, in vivo demonstrations in the vicinity of the ear, eye and brain. In this work, the chip extracted a minimum of 1.12 nW from the EP of a guinea pig for up to 5 h, enabling a 2.4 GHz radio to transmit measurement of the EP every 40-360 s. With future optimization of electrode design, we envision using the biologic battery in the inner ear to power chemical and molecular sensors, or drug-delivery actuators for diagnosis and therapy of hearing loss and other disorders.	[Mercier, Patrick P.; Bandyopadhyay, Saurav; Chandrakasan, Anantha P.] MIT, Microsyst Technol Labs, Cambridge, MA 02139 USA; [Lysaght, Andrew C.; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Lysaght, Andrew C.; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Lysaght, Andrew C.; Stankovic, Konstantina M.] Harvard Massachusetts Inst Technol, Program Speech & Hearing Biosci & Technol, Joint Div Hlth Sci & Technol, Cambridge, MA USA; [Stankovic, Konstantina M.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard University; Harvard Medical School	Chandrakasan, AP (corresponding author), MIT, Microsyst Technol Labs, Cambridge, MA 02139 USA.	anantha@mtl.mit.edu; konstantina_stankovich@meei.harvard.edu		Mercier, Patrick/0000-0003-1488-5076	C2S2 Focus Center; Interconnect Focus Center; Focus Center Research Program (FCRP); Semiconductor Research Corporation entity; US National Institutes of Health [K08 DC010419, T32 DC00038]; Bertarelli Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC010419, T32DC000038] Funding Source: NIH RePORTER	C2S2 Focus Center; Interconnect Focus Center; Focus Center Research Program (FCRP); Semiconductor Research Corporation entity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bertarelli Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We acknowledge support from the C2S2 Focus Center and the Interconnect Focus Center, two of six research centers funded under the Focus Center Research Program (FCRP), a Semiconductor Research Corporation entity (A. P. C., P. P. M., S. B.), and from US National Institutes of Health grants K08 DC010419 (K. M. S.) and T32 DC00038 (A. C. L.) and the Bertarelli Foundation (K. M. S.). We thank J.J. Guinan Jr. for experimental assistance and advice, and B. Zhu for preliminary studies.	Bullen RA, 2006, BIOSENS BIOELECTRON, V21, P2015, DOI 10.1016/j.bios.2006.01.030; Chen G., 2011, 2011 IEEE International Solid-State Circuits Conference (ISSCC 2011), P310, DOI 10.1109/ISSCC.2011.5746332; Chen P., 2011, 2011 IEEE International Solid-State Circuits Conference (ISSCC 2011), P216, DOI 10.1109/ISSCC.2011.5746290; Chow EY, 2010, IEEE T BIOMED CIRC S, V4, P340, DOI 10.1109/TBCAS.2010.2081364; DALLOS P, 1983, HEARING RES, V12, P89, DOI 10.1016/0378-5955(83)90120-X; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Fayad JN, 2009, OTOL NEUROTOL, V30, P1122, DOI 10.1097/MAO.0b013e3181be645d; FERNANDEZ C, 1952, J ACOUST SOC AM, V24, P519, DOI 10.1121/1.1906929; Gao YL, 2012, PROC IEEE INT SYMP, P298, DOI 10.1109/ISIE.2012.6237101; Halamkova L, 2012, J AM CHEM SOC, V134, P5040, DOI 10.1021/ja211714w; Hibino H, 2010, PFLUG ARCH EUR J PHY, V459, P521, DOI 10.1007/s00424-009-0754-z; Himes C, 2010, IEEE T NANOTECHNOL, V9, P2, DOI 10.1109/TNANO.2009.2032293; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Lang H, 2002, HEARING RES, V172, P118, DOI 10.1016/S0378-5955(02)00552-X; Mason MJ, 2001, J ZOOL, V255, P467; MILLS DM, 1993, J ACOUST SOC AM, V94, P2108, DOI 10.1121/1.407483; Mowry SE, 2012, OTOLARYNG CLIN N AM, V45, P187, DOI 10.1016/j.otc.2011.09.001; Qin Y, 2008, NATURE, V451, P809, DOI [10.1038/nature06601, 10.1038/nature066O1]; Ramadass YK, 2011, IEEE J SOLID-ST CIRC, V46, P333, DOI 10.1109/JSSC.2010.2074090; Rapoport BI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038436; Rasmussen M, 2012, J AM CHEM SOC, V134, P1458, DOI 10.1021/ja210794c; Roy K, 2003, P IEEE, V91, P305, DOI 10.1109/JPROC.2002.808156; Shimamura T., 2010, IEEE ISSCC, P540; Starner T, 2004, LOW POWER ELECT DESI, V45, P1, DOI DOI 10.1201/9781420039559.CH45; Swanson R.M., 1972, IEEE ISSCC, P192; Takeuchi S, 2000, BIOPHYS J, V79, P2572, DOI 10.1016/S0006-3495(00)76497-6; VONBEKESY G, 1952, NATURE, V169, P241; VONBEKESY G, 1952, J ACOUST SOC AM, V24, P72; Wieckowski M, 2009, SYMP VLSI CIRCUITS, P166; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8	31	141	150	7	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1240	+		10.1038/nbt.2394	http://dx.doi.org/10.1038/nbt.2394			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23138225	Green Accepted			2022-12-25	WOS:000312092400028
J	Barcia, G; Fleming, MR; Deligniere, A; Gazula, VR; Brown, MR; Langouet, M; Chen, HJ; Kronengold, J; Abhyankar, A; Cilio, R; Nitschke, P; Kaminska, A; Boddaert, N; Casanova, JL; Desguerre, I; Munnich, A; Dulac, O; Kaczmarek, LK; Colleaux, L; Nabbout, R				Barcia, Giulia; Fleming, Matthew R.; Deligniere, Aline; Gazula, Valeswara-Rao; Brown, Maile R.; Langouet, Maeva; Chen, Haijun; Kronengold, Jack; Abhyankar, Avinash; Cilio, Roberta; Nitschke, Patrick; Kaminska, Anna; Boddaert, Nathalie; Casanova, Jean-Laurent; Desguerre, Isabelle; Munnich, Arnold; Dulac, Olivier; Kaczmarek, Leonard K.; Colleaux, Laurence; Nabbout, Rima			De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy	NATURE GENETICS			English	Article							ACTIVATED POTASSIUM CHANNEL; AUTISM SPECTRUM DISORDERS; SCN1A MUTATIONS; FOCAL SEIZURES; K+ CHANNELS; SLACK; EPILEPSY; SODIUM; LEVETIRACETAM; PHENOTYPE	Malignant migrating partial seizures of infancy (MMPSI) is a rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay(1). We performed exome sequencing in three probands with MMPSI and identified de novo gain-of-function mutations affecting the C-terminal domain of the KCNT1 potassium channel. We sequenced KCNT1 in 9 additional individuals with MMPSI and identified mutations in 4 of them, in total identifying mutations in 6 out of 12 unrelated affected individuals. Functional studies showed that the mutations led to constitutive activation of the channel, mimicking the effects of phosphorylation of the C-terminal domain by protein kinase C. In addition to regulating ion flux, KCNT1 has a non-conducting function, as its C terminus interacts with cytoplasmic proteins involved in developmental signaling pathways. These results provide a focus for future diagnostic approaches and research for this devastating condition.	[Barcia, Giulia; Deligniere, Aline; Desguerre, Isabelle; Dulac, Olivier; Nabbout, Rima] Hop Necker Enfants Malad, AP HP, Ctr Reference Epilepsies Rares, Dept Pediat Neurol, Paris, France; [Barcia, Giulia; Dulac, Olivier; Nabbout, Rima] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U663, Paris, France; [Fleming, Matthew R.; Gazula, Valeswara-Rao; Brown, Maile R.; Kronengold, Jack; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Fleming, Matthew R.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Langouet, Maeva; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781,Inst Imagine, Paris, France; [Chen, Haijun] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Abhyankar, Avinash; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Cilio, Roberta] Bambino Gesu Pediat Hosp, Div Neurol, Rome, Italy; [Nitschke, Patrick] Hop Necker Enfants Malad, Dept Biostat, Paris, France; [Kaminska, Anna] Hop Necker Enfants Malad, AP HP, Clin Electrophysiol Unit, Paris, France; [Boddaert, Nathalie] Hop Necker Enfants Malad, AP HP, Dept Paediat Radiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Yale University; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rockefeller University; IRCCS Bambino Gesu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Nabbout, R (corresponding author), Hop Necker Enfants Malad, AP HP, Ctr Reference Epilepsies Rares, Dept Pediat Neurol, Paris, France.	rimanabbout@yahoo.com	Casanova, Jean-Laurent/I-3418-2017; COLLEAUX, Laurence/H-6455-2017; boddaert, nathalie/GWV-2865-2022; COLLEAUX, LAURENCE/AAA-8144-2022; Barcia, Giulia/H-7907-2017	COLLEAUX, LAURENCE/0000-0002-0987-7648; Barcia, Giulia/0000-0001-6657-5040; Casanova, Jean-Laurent/0000-0002-7782-4169; boddaert, nathalie/0000-0003-0991-7774; Kaminska, Anna/0000-0003-3805-6651	Centre National de la Recherche Scientifique; French National Research Agency [ANR-08-MNP-010]; US National Institutes of Health (NIH) [HD067517, DC01919, NS073943]; FRAXA foundation; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science [5UL1RR024143]; Rockefeller University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA foundation; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science; Rockefeller University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to the affected individuals and their families for their participation in the study. The team of L.C. was supported in part by the Centre National de la Recherche Scientifique and the French National Research Agency (ANR-08-MNP-010). Work by the team of L.K.K. is supported by the US National Institutes of Health (NIH) grants HD067517, DC01919 and NS073943 and a grant from the FRAXA foundation. The Laboratory of Human Genetics of Infectious Diseases is supported in part by grants from the St. Giles Foundation, the Rockefeller University Center for Clinical and Translational Science grant 5UL1RR024143 and the Rockefeller University.	Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Caraballo RH, 2008, J CHILD NEUROL, V23, P497, DOI 10.1177/0883073807309771; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Coppola G, 2006, BRAIN DEV-JPN, V28, P76, DOI 10.1016/j.braindev.2005.05.002; COPPOLA G, 1995, EPILEPSIA, V36, P1017, DOI 10.1111/j.1528-1157.1995.tb00961.x; Djuric M, 2011, EPILEPTIC DISORD, V13, P22, DOI 10.1684/epd.2011.0402; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fleming MR, 2009, J RECEPT SIG TRANSD, V29, P173, DOI 10.1080/10799890903056883; Freilich ER, 2011, ARCH NEUROL-CHICAGO, V68, P665, DOI 10.1001/archneurol.2011.98; Friocourt G, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00004; Gerard F, 1999, EPILEPTIC DISORD, V1, P135; Gilhuis HJ, 2011, EPILEPTIC DISORD, V13, P185, DOI 10.1684/epd.2011.0424; Gross-Tsur V, 2004, PEDIATR NEUROL, V31, P287, DOI 10.1016/j.pediatrneurol.2004.05.001; Hamdan FF, 2011, EUR J HUM GENET, V19, P607, DOI 10.1038/ejhg.2010.183; Hmaimess G, 2006, PEDIATR NEUROL, V34, P55, DOI 10.1016/j.pediatrneurol.2005.06.011; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Lee EH, 2012, BRAIN DEV-JPN, V34, P768, DOI 10.1016/j.braindev.2011.11.011; Marsh E, 2005, EPILEPSIA, V46, P568, DOI 10.1111/j.0013-9580.2005.34104.x; Nabbout R, 2003, NEUROLOGY, V60, P1961, DOI 10.1212/01.WNL.0000069463.41870.2F; Nabbout R, 2008, CURR OPIN NEUROL, V21, P161, DOI 10.1097/WCO.0b013e3282f7007e; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Okuda K, 2000, BRAIN DEV-JPN, V22, P56, DOI 10.1016/S0387-7604(99)00108-4; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Rojo DC, 2011, NEUROLOGY, V77, P380, DOI 10.1212/WNL.0b013e318227046d; Ruffin VA, 2008, NEUROSCIENCE, V151, P410, DOI 10.1016/j.neuroscience.2007.10.031; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Steinlein OK, 2007, EPILEPSY RES, V73, P245, DOI 10.1016/j.eplepsyres.2006.10.010; Vendrame M, 2011, EPILEPTIC DISORD, V13, P18, DOI 10.1684/epd.2011.0406; Veneselli E, 2001, EPILEPSY RES, V46, P27, DOI 10.1016/S0920-1211(01)00197-8; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wilmshurst JM, 2000, J CHILD NEUROL, V15, P717, DOI 10.1177/088307380001501102; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zamponi N, 2008, NEUROSURG REV, V31, P291, DOI 10.1007/s10143-008-0134-8	39	305	320	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1255	1259		10.1038/ng.2441	http://dx.doi.org/10.1038/ng.2441			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23086397	Green Accepted			2022-12-25	WOS:000310495800019
J	Doyle, AJ; Doyle, JJ; Bessling, SL; Maragh, S; Lindsay, ME; Schepers, D; Gillis, E; Mortier, G; Homfray, T; Sauls, K; Norris, RA; Huso, ND; Leahy, D; Mohr, DW; Caulfield, MJ; Scott, AF; Destree, A; Hennekam, RC; Arn, PH; Curry, CJ; Van Laer, L; McCallion, AS; Loeys, BL; Dietz, HC				Doyle, Alexander J.; Doyle, Jefferson J.; Bessling, Seneca L.; Maragh, Samantha; Lindsay, Mark E.; Schepers, Dorien; Gillis, Elisabeth; Mortier, Geert; Homfray, Tessa; Sauls, Kimberly; Norris, Russell A.; Huso, Nicholas D.; Leahy, Dan; Mohr, David W.; Caulfield, Mark J.; Scott, Alan F.; Destree, Anne; Hennekam, Raoul C.; Arn, Pamela H.; Curry, Cynthia J.; Van Laer, Lut; McCallion, Andrew S.; Loeys, Bart L.; Dietz, Harry C.			Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm	NATURE GENETICS			English	Article							ONCOPROTEIN INTERACTS; SMAD PROTEINS; MOUSE MODEL; C-SKI; PATHOGENESIS; PROTOONCOGENE; CONTRIBUTES; ANTAGONIST; ACTIVATION; PATHWAYS	Elevated transforming growth factor (TGF)-beta signaling has been implicated in the pathogenesis of syndromic presentations of aortic aneurysm, including Marfan syndrome (MFS) and Loeys-Dietz syndrome (LDS)(1-4). However, the location and character of many of the causal mutations in LDS intuitively imply diminished TGF-beta signaling(5). Taken together, these data have engendered controversy regarding the specific role of TGF-beta in disease pathogenesis. Shprintzen-Goldberg syndrome (SGS) has considerable phenotypic overlap with MFS and LDS, including aortic aneurysm(6-8). We identified causative variation in ten individuals with SGS in the proto-oncogene SKI, a known repressor of TGF-beta activity(9,10). Cultured dermal fibroblasts from affected individuals showed enhanced activation of TGF-beta signaling cascades and higher expression of TGF-beta-responsive genes relative to control cells. Morpholino-induced silencing of SKI paralogs in zebrafish recapitulated abnormalities seen in humans with SGS. These data support the conclusions that increased TGF-beta signaling is the mechanism underlying SGS and that high signaling contributes to multiple syndromic presentations of aortic aneurysm.	[Maragh, Samantha; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Predoctoral Training Program Human Genet, Baltimore, MD 21218 USA; [Doyle, Alexander J.; Leahy, Dan; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Doyle, Alexander J.; Caulfield, Mark J.] Queen Mary Univ London, Baits & London Sch Med, William Harvey Res Inst, London, England; [Maragh, Samantha] US Natl Inst Stand & Technol, Biochem Sci Div, Gaithersburg, MD USA; [Lindsay, Mark E.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Schepers, Dorien; Gillis, Elisabeth; Mortier, Geert; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp Hosp, Fac Med & Hlth Sci, Ctr Med Genet, Antwerp, Belgium; [Schepers, Dorien; Gillis, Elisabeth; Mortier, Geert; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp, B-2020 Antwerp, Belgium; [Homfray, Tessa] St Georges Healthcare Natl Hlth Serv NHS Trust, Dept Med Genet, London, England; [Sauls, Kimberly; Norris, Russell A.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Leahy, Dan] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Destree, Anne] Inst Pathol & Genet, Gosselies, Belgium; [Curry, Cynthia J.] Univ Calif San Francisco, Fresno, CA USA; [Arn, Pamela H.] Nemours Childrens Clin, Jacksonville, FL USA; [McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Loeys, Bart L.] Univ Ghent, Dept Pediat & Genet, B-9000 Ghent, Belgium	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of London; Queen Mary University London; National Institute of Standards & Technology (NIST) - USA; Johns Hopkins University; University of Antwerp; University of Antwerp; Medical University of South Carolina; Johns Hopkins University; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Johns Hopkins University; Ghent University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Predoctoral Training Program Human Genet, Baltimore, MD 21218 USA.	hdietz@jhmi.edu	Mortier, Geert/D-2542-2012; Doyle, Jefferson/C-3156-2013; Loeys, Bart/B-3236-2017	Mortier, Geert/0000-0001-9871-4578; Loeys, Bart/0000-0003-3703-9518; Schepers, Dorien/0000-0003-4225-6621; Caulfield, Mark/0000-0001-9295-3594; Arn, Pamela/0000-0002-8441-7764	US National Institutes of Health [RO1-AR41135, PO1-AR049698]; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute; Baylor-Hopkins Center for Mendelian Genetics [1U54HG006542]; NHLBI [HL107738-01, 1R01HL111267]; National Institute for Health Research (NIHR) through Barts NIHR Cardiovascular Biomedical Research Unit; Fund for Scientific Research, Flanders (Belgium) [G.0458.09, G.0221.12]; European Grant Fighting Aneurysmal Disease (EC-FP7); Ghent University [BOF10/GOA/005]; Agency for Innovation by Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107738, R01HL111267] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, R01GM099321] Funding Source: NIH RePORTER; Medical Research Council [G9521010, G0600237] Funding Source: researchfish; MRC [G0600237, G9521010] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Baylor-Hopkins Center for Mendelian Genetics; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Health Research (NIHR) through Barts NIHR Cardiovascular Biomedical Research Unit(National Institute for Health Research (NIHR)); Fund for Scientific Research, Flanders (Belgium)(FWO); European Grant Fighting Aneurysmal Disease (EC-FP7); Ghent University(Ghent University); Agency for Innovation by Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank E. Gerber and H. Bjornsson for their contributions to the cell culture experiments. This work was funded by grants to H.C.D. from the US National Institutes of Health (RO1-AR41135 and PO1-AR049698), the Bloomberg Fund of the National Marfan Foundation, the Smilow Center for Marfan Syndrome Research, the Howard Hughes Medical Institute and the Baylor-Hopkins Center for Mendelian Genetics (1U54HG006542). A.J.D. was supported as a Research Associate by the Howard Hughes Medical Institute. J.J.D. was supported by a Victor A. McKusick Fellowship from the National Marfan Foundation. M.E.L. was supported by an NHLBI K08 Award (HL107738-01) and by a Fellow-to-Faculty Award from the National Marfan Foundation. A.S.M. was supported in part by the NHLBI (1R01HL111267). M.J.C. was supported by the National Institute for Health Research (NIHR) through Barts NIHR Cardiovascular Biomedical Research Unit. This study was also supported in part by funding from the Fund for Scientific Research, Flanders (Belgium) (G.0458.09 and G.0221.12), a European Grant Fighting Aneurysmal Disease (EC-FP7) and the Special Research Fund of Ghent University (BOF10/GOA/005). B.L.L. is a Senior Clinical Investigator of the Fund for Scientific Research, Flanders (FWO, Belgium). D.S. was supported by a Ph.D. grant from the Agency for Innovation by Science and Technology.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Chen WJ, 2007, J BIOL CHEM, V282, P11365, DOI 10.1074/jbc.M700186200; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Greally MT, 1998, AM J MED GENET, V76, P202, DOI 10.1002/(SICI)1096-8628(19980319)76:3<202::AID-AJMG2>3.0.CO;2-S; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Kosaki K, 2006, AM J MED GENET A, V140A, P104, DOI 10.1002/ajmg.a.31006; Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; LYONS GE, 1994, DEV DYNAM, V201, P354, DOI 10.1002/aja.1002010407; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; Reed JA, 2001, CANCER RES, V61, P8074; Robinson PN, 2005, AM J MED GENET A, V135A, P251, DOI 10.1002/ajmg.a.30431; SHPRINTZEN RJ, 1982, J CRAN GENET DEV BIO, V2, P65; Sood S, 1996, NAT GENET, V12, P209, DOI 10.1038/ng0296-209; Ueki N, 2003, J BIOL CHEM, V278, P32489, DOI 10.1074/jbc.C300276200; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Wang LH, 2007, CLIN CANCER RES, V13, P102, DOI 10.1158/1078-0432.CCR-06-1467; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	172	175	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1249	1254		10.1038/ng.2421	http://dx.doi.org/10.1038/ng.2421			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23023332	Green Accepted			2022-12-25	WOS:000310495800018
J	Fan, Y; Arif, A; Gong, YQ; Jia, J; Eswarappa, SM; Willard, B; Horowitz, A; Graham, LM; Penn, MS; Fox, PL				Fan, Yi; Arif, Abul; Gong, Yanqing; Jia, Jie; Eswarappa, Sandeepa M.; Willard, Belinda; Horowitz, Arie; Graham, Linda M.; Penn, Marc S.; Fox, Paul L.			Stimulus-dependent phosphorylation of profilin-1 in angiogenesis	NATURE CELL BIOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION; ACTIN POLYMERIZATION; VEGF; MOTILITY; 3-KINASE; PATHWAY; LIGAND; POLARIZATION; COMPLEXES	Angiogenesis, the formation of new blood vessels, is fundamental to development and post-injury tissue repair. Vascular endothelial growth factor (VEGF)-A guides and enhances endothelial cell migration to initiate angiogenesis. Profilin-1 (Pin-1) is an actin-binding protein that enhances actin filament formation and cell migration, but stimulus-dependent regulation of Pfn-1 has not been observed. Here, we show that VEGF-A-inducible phosphorylation of Pfn-1 at Tyr 129 is critical for endothelial cell migration and angiogenesis. Chemotactic activation of VEGF receptor kinase-2 (VEGFR2) and Src induces Pfn-1 phosphorylation in the cell leading edge, promoting Pin-1 binding to actin and actin polymerization. Conditional endothelial knock-in of phosphorylation-deficient Pfn1(Y129F) in mice reveals that Pfn-1 phosphorylation is critical for angiogenesis in response to wounding and ischaemic injury, but not for developmental angiogenesis. Thus, VEGFR2/Src-mediated phosphorylation of Pfn-1 bypasses canonical, multistep intracellular signalling events to initiate endothelial cell migration and angiogenesis, and might serve as a selective therapeutic target for anti-angiogenic therapy.	[Fan, Yi; Arif, Abul; Jia, Jie; Eswarappa, Sandeepa M.; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Gong, Yanqing; Horowitz, Arie] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Graham, Linda M.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Penn, Marc S.] NE Ohio Med Univ, Dept Integrated Med Sci, Rootstown, OH 44272 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Northeast Ohio Medical University (NEOMED)	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org	Eswarappa, Sandeep/AFG-1997-2022; Horowitz, Arie/AAT-9482-2021; Horowitz, Arie/F-4628-2015	Jia, Jie/0000-0002-9583-1055; Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354; Horowitz, Arie/0000-0001-6239-1287; Eswarappa, Sandeep/0000-0002-7903-5198	National Institutes of Health [P01 HL029582, P01 HL076491, R21 HL094841]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094841, P01HL076491, P01HL029582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to A. Levine and T. Egelhoff for helpful suggestions, X. West, A. Vasanji and J. Boerckel for technical assistance in punch-wound and microCT studies, and J. Drazba for image analysis. Cdh5-Cre/ERT2 mice were provided by R. Adams, Max Planck Institute, Germany. This work was supported by National Institutes of Health grants P01 HL029582, P01 HL076491 and R21 HL094841 (to P.L.F.).	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Fan Y, 2009, DEV CELL, V16, P661, DOI 10.1016/j.devcel.2009.03.009; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghosh PK, 2002, NAT CELL BIOL, V4, P894, DOI 10.1038/ncb873; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Hoffman M, 2006, BLOOD, V108, P3053, DOI 10.1182/blood-2006-05-020495; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; Huttenlocher A, 2005, NAT CELL BIOL, V7, P336, DOI 10.1038/ncb0405-336; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Joukov V, 1996, EMBO J, V15, P290; Kang F, 1999, J BIOL CHEM, V274, P36963, DOI 10.1074/jbc.274.52.36963; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Korenbaum E, 1998, BIOCHEMISTRY-US, V37, P9274, DOI 10.1021/bi9803675; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Luttun A, 2002, ANN NY ACAD SCI, V979, P80, DOI 10.1111/j.1749-6632.2002.tb04870.x; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palmer SM, 2009, J BIOL CHEM, V284, P7223, DOI 10.1074/jbc.M807842200; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schluter K, 1998, J CELL SCI, V111, P3261; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; TSENG PCH, 1984, J CELL BIOL, V98, P214, DOI 10.1083/jcb.98.1.214; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Ware JA, 1997, NAT MED, V3, P158, DOI 10.1038/nm0297-158; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001	65	41	41	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1046	+		10.1038/ncb2580	http://dx.doi.org/10.1038/ncb2580			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	23000962	Green Accepted			2022-12-25	WOS:000309543800013
J	Baker, RP; Urban, S				Baker, Rosanna P.; Urban, Sinisa			Architectural and thermodynamic principles underlying intramembrane protease function	NATURE CHEMICAL BIOLOGY			English	Article							HELICAL MEMBRANE-PROTEINS; UNFOLDING FREE-ENERGY; TRANSMEMBRANE HELIX; ASPARTYL PROTEASES; RHOMBOID PROTEASE; GAMMA-SECRETASE; PROTEOLYSIS; STABILITY; ASSOCIATION; REVEALS	Intramembrane proteases hydrolyze peptide bonds within the membrane as a signaling paradigm universal to all life forms and with implications in disease. Deciphering the architectural strategies supporting intramembrane proteolysis is an essential but unattained goal. We integrated new, quantitative and high-throughput thermal light-scattering technology, reversible equilibrium unfolding and refolding and quantitative protease assays to interrogate rhomboid architecture with 151 purified variants. Rhomboid proteases maintain low intrinsic thermodynamic stability (Delta G = 2.1-4.5 kcal mol(-1)) resulting from a multitude of generally weak transmembrane packing interactions, making them highly responsive to their environment. Stability is consolidated by two buried glycines and several packing leucines, with a few multifaceted hydrogen bonds strategically deployed to two peripheral regions. Opposite these regions lie transmembrane segment 5 and connected loops that are notably exempt of structural responsibility, suggesting intramembrane proteolysis involves considerable but localized protein dynamics. Our analyses provide a comprehensive 'heat map' of the physiochemical anatomy underlying membrane-immersed enzyme function at, what is to our knowledge, unprecedented resolution.	[Baker, Rosanna P.; Urban, Sinisa] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21218 USA	Howard Hughes Medical Institute; Johns Hopkins University	Baker, RP (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21218 USA.	surban@jhmi.edu		Baker, Rosanna/0000-0002-9970-6278	Howard Hughes Medical Institute; David and Lucile Packard Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We are grateful to all members of the Urban lab and to D. Otzen for stimulating scientific discussions and to the Malaria Research Institute Biophysics Core for use of their CD spectropolarimeter. This work was supported by the Howard Hughes Medical Institute and the David and Lucile Packard Foundation.	Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; Curnow P, 2010, J MOL BIOL, V403, P630, DOI 10.1016/j.jmb.2010.09.003; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Joh NH, 2009, J AM CHEM SOC, V131, P10846, DOI 10.1021/ja904711k; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Senisterra GA, 2010, J BIOMOL SCREEN, V15, P314, DOI 10.1177/1087057109357117; Tastan O, 2009, BIOPHYS J, V96, P2299, DOI 10.1016/j.bpj.2008.12.3894; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Veerappan A, 2011, BIOCHEMISTRY-US, V50, P10223, DOI 10.1021/bi201266m; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	43	76	78	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					759	768		10.1038/NCHEMBIO.1021	http://dx.doi.org/10.1038/NCHEMBIO.1021			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22797666	Green Accepted			2022-12-25	WOS:000308077600007
J	Bianco, A; Townsley, FM; Greiss, S; Lang, K; Chin, JW				Bianco, Ambra; Townsley, Fiona M.; Greiss, Sebastian; Lang, Kathrin; Chin, Jason W.			Expanding the genetic code of Drosophila melanogaster	NATURE CHEMICAL BIOLOGY			English	Article							MAMMALIAN-CELLS; RECOMBINANT PROTEINS; AMINO-ACIDS; TRANSFORMATION; EXPRESSION	Genetic code expansion for unnatural amino acid mutagenesis has, until recently, been limited to cell culture. We demonstrate the site-specific incorporation of unnatural amino acids into proteins in Drosophila melanogaster at different developmental stages, in specific tissues and in a subset of cells within a tissue. This approach provides a foundation for probing and controlling processes in this established metazoan model organism with a new level of molecular precision.	[Bianco, Ambra; Townsley, Fiona M.; Greiss, Sebastian; Lang, Kathrin; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bianco, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	chin@mrc-lmb.cam.ac.uk	Greiss, Sebastian/B-2395-2015; Lang, Kathrin/AAD-2559-2020; Lang, Kathrin/M-6472-2015	Greiss, Sebastian/0000-0001-9130-0831; Lang, Kathrin/0000-0002-1318-6567	UK Medical Research Council (MRC) [U105181009, UD99999908]; Louis-Jeantet Foundation Young Investigator Career Award; MRC [MC_UP_A024_1008] Funding Source: UKRI; Medical Research Council [MC_UP_A024_1008] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Louis-Jeantet Foundation Young Investigator Career Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (MRC) (grants U105181009 and UD99999908) and the Louis-Jeantet Foundation Young Investigator Career Award (both to J.W.C.). We are grateful to S. Bullock (MRC Laboratory of Molecular Biology) for providing initial plasmids and for extensive help and advice with this project; to S. Peak-Chew and M. Skehel in the MRC Laboratory of Molecular Biology Mass Spectrometry Facility for MS; S. Brunner for assistance with statistical analysis; and J. Schmitz and R. Pisa for experimental assistance.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; GARZA D, 1990, GENETICS, V126, P625; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Isogai Y, 2007, EMBO J, V26, P76, DOI 10.1038/sj.emboj.7601448; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; LASKI FA, 1989, P NATL ACAD SCI USA, V86, P6696, DOI 10.1073/pnas.86.17.6696; Lemke EA, 2007, NAT CHEM BIOL, V3, P769, DOI 10.1038/nchembio.2007.44; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Mukai T, 2010, PROTEIN SCI, V19, P440, DOI 10.1002/pro.322; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nguyen D.P., 2012, THESIS U CAMBRIDGE; Nguyen DP, 2009, J AM CHEM SOC, V131, P14194, DOI 10.1021/ja906603s; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Pignoni F, 1997, DEVELOPMENT, V124, P271; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Van Doren M, 1998, CURR BIOL, V8, P243; WASHBURN T, 1992, GENETICS, V130, P585	25	145	150	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					748	750		10.1038/NCHEMBIO.1043	http://dx.doi.org/10.1038/NCHEMBIO.1043			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22864544				2022-12-25	WOS:000308077600005
J	Wegmann, F; Gartlan, KH; Harandi, AM; Brinckmann, SA; Coccia, M; Hillson, WR; Kok, WL; Cole, S; Ho, LP; Lambe, T; Puthia, M; Svanborg, C; Scherer, EM; Krashias, G; Williams, A; Blattman, JN; Greenberg, PD; Flavell, RA; Moghaddam, AE; Sheppard, NC; Sattentau, QJ				Wegmann, Frank; Gartlan, Kate H.; Harandi, Ali M.; Brinckmann, Sarah A.; Coccia, Margherita; Hillson, William R.; Kok, Wai Ling; Cole, Suzanne; Ho, Ling-Pei; Lambe, Teresa; Puthia, Manoj; Svanborg, Catharina; Scherer, Erin M.; Krashias, George; Williams, Adam; Blattman, Joseph N.; Greenberg, Philip D.; Flavell, Richard A.; Moghaddam, Amin E.; Sheppard, Neil C.; Sattentau, Quentin J.			Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens	NATURE BIOTECHNOLOGY			English	Article							INTRANASAL DELIVERY; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; NALP3 INFLAMMASOME; DENDRITIC CELLS; GENE DELIVERY; BELLS-PALSY; VACCINE; INNATE; MUTANT	Protection against mucosally transmitted infections probably requires immunity at the site of pathogen entry(1), yet there are no mucosal adjuvant formulations licensed for human use. Polyethyleneimine (PEI) represents a family of organic polycations used as nucleic acid transfection reagents in vitro and DNA vaccine delivery vehicles in vivo(2,3). Here we show that diverse PEI forms have potent mucosal adjuvant activity for viral subunit glycoprotein antigens. A single intranasal administration of influenza hemagglutinin or herpes simplex virus type-2 (HSV-2) glycoprotein D with PEI elicited robust antibody-mediated protection from an otherwise lethal infection, and was superior to existing experimental mucosal adjuvants. PEI formed nanoscale complexes with antigen, which were taken up by antigen-presenting cells in vitro and in vivo, promoted dendritic cell trafficking to draining lymph nodes and induced non-proinflammatory cytokine responses. PEI adjuvanticity required release of host double-stranded DNA that triggered Irf3-dependent signaling. PEI therefore merits further investigation as a mucosal adjuvant for human use.	[Wegmann, Frank; Gartlan, Kate H.; Brinckmann, Sarah A.; Coccia, Margherita; Hillson, William R.; Krashias, George; Moghaddam, Amin E.; Sheppard, Neil C.; Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Harandi, Ali M.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Kok, Wai Ling; Cole, Suzanne; Ho, Ling-Pei] John Radcliffe Hosp, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Lambe, Teresa] Univ Oxford, Jenner Inst, Oxford, England; [Puthia, Manoj; Svanborg, Catharina] Lund Univ, Div Microbiol Immunol & Glycobiol, Lund, Sweden; [Scherer, Erin M.; Blattman, Joseph N.; Greenberg, Philip D.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Williams, Adam; Flavell, Richard A.] Yale Univ, Sch Med, New Haven, CT USA	University of Oxford; University of Gothenburg; University of Oxford; University of Oxford; Jenner Institute; Lund University; University of Washington; University of Washington Seattle; Yale University	Sattentau, QJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	quentin.sattentau@path.ox.ac.uk	Ho, Ling-Pei/AAL-4776-2021; Lambe, Teresa/E-5733-2016; Brinckmann, Steffen/G-7075-2011; Gartlan, Kate/C-5315-2009; Moghaddam, Amin/N-2300-2014; Gartlan, Kate H/B-7279-2012; Gartlan, Kate/S-7187-2019	Lambe, Teresa/0000-0001-7711-897X; Brinckmann, Steffen/0000-0003-0930-082X; Gartlan, Kate/0000-0002-0343-1274; Moghaddam, Amin/0000-0001-8668-1609; Sheppard, Neil/0000-0002-9551-9491; Coccia, Margherita/0000-0003-1947-4735; Ho, Ling Pei/0000-0001-8319-301X; Wegmann, Frank/0000-0002-9821-1492; Puthia, Manoj/0000-0001-6048-7234	MRC UK; EU Network of Excellence 'Europrise'; International AIDS Vaccine Initiative Neutralizing Antibody Consortium (IAVI); Bill and Melinda Gates Foundation Collaboration for Vaccine Design (CAVD); Dormeur Investment Service Ltd.; FP7; EuroNanoMed-European Commission; Medical Research Council [G0600371, G0000635] Funding Source: researchfish; National Institute for Health Research [DHCS/04/G121/68] Funding Source: researchfish; MRC [G0000635, G0600371] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Network of Excellence 'Europrise'; International AIDS Vaccine Initiative Neutralizing Antibody Consortium (IAVI); Bill and Melinda Gates Foundation Collaboration for Vaccine Design (CAVD); Dormeur Investment Service Ltd.; FP7; EuroNanoMed-European Commission; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from The MRC UK, The EU Network of Excellence 'Europrise', The International AIDS Vaccine Initiative Neutralizing Antibody Consortium (IAVI), The Bill and Melinda Gates Foundation Collaboration for Vaccine Design (CAVD), Dormeur Investment Service Ltd., the FP7-funded High Impact Project Advanced Immunization Technologies (ADITEC) and The EuroNanoMed-European Commission funded iNanoDCs. Q.J.S. is a Jenner Institute Investigator and a James Martin Senior Fellow.	Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Chen JA, 2011, INT J NANOMED, V6, P77, DOI 10.2147/IJN.S15457; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Del Campo J, 2010, VACCINE, V28, P1193, DOI 10.1016/j.vaccine.2009.11.035; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gunther M, 2011, EUR J PHARM BIOPHARM, V77, P438, DOI 10.1016/j.ejpb.2010.11.007; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu K, 2011, VACCINE, V29, P1455, DOI 10.1016/j.vaccine.2010.12.031; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Krashias G, 2010, VACCINE, V28, P2482, DOI 10.1016/j.vaccine.2010.01.046; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Lindqvist M, 2009, J IMMUNOL, V182, P6435, DOI 10.4049/jimmunol.0900136; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Ma YF, 2010, EUR J PHARM SCI, V40, P75, DOI 10.1016/j.ejps.2010.02.009; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Orr G, 2009, TOXICOL APPL PHARM, V236, P210, DOI 10.1016/j.taap.2009.01.022; Park K, 2009, J CONTROL RELEASE, V141, P109; Roman VRG, 2010, J IMMUNOL METHODS, V363, P29, DOI 10.1016/j.jim.2010.09.030; Rudolph C, 2005, J GENE MED, V7, P59, DOI 10.1002/jgm.646; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Torrieri-Dramard L, 2011, MOL THER, V19, P602, DOI 10.1038/mt.2010.222; Wegmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015861; Wegrowski Y, 2006, CLIN EXP IMMUNOL, V144, P485, DOI 10.1111/j.1365-2249.2006.03059.x; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267	39	157	170	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					883	U116		10.1038/nbt.2344	http://dx.doi.org/10.1038/nbt.2344			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22922673	Green Accepted			2022-12-25	WOS:000308705700023
J	Ishii, T; Numaguchi, K; Miura, K; Yoshida, K; Thanh, PT; Htun, TM; Yamasaki, M; Komeda, N; Matsumoto, T; Terauchi, R; Ishikawa, R; Ashikari, M				Ishii, Takashige; Numaguchi, Koji; Miura, Kotaro; Yoshida, Kentaro; Pham Thien Thanh; Than Myint Htun; Yamasaki, Masanori; Komeda, Norio; Matsumoto, Takashi; Terauchi, Ryohei; Ishikawa, Ryo; Ashikari, Motoyuki			OsLG1 regulates a closed panicle trait in domesticated rice	NATURE GENETICS			English	Article							SHATTERING LOCI; AGRICULTURE; EVOLUTION; ORIGINS; WILD	Reduction in seed shattering was an important phenotypic change during cereal domestication(1,2). Here we show that a simple morphological change in rice panicle shape, controlled by the SPR3 locus, has a large impact on seed-shedding and pollinating behaviors. In the wild genetic background of rice, we found that plants with a cultivated-like type of closed panicle had significantly reduced seed shedding through seed retention. In addition, the long awns in closed panicles disturbed the free exposure of anthers and stigmas on the flowering spikelets, resulting in a significant reduction of the outcrossing rate. We localized the SPR3 locus to a 9.3-kb genomic region, and our complementation tests suggest that this region regulates the liguleless gene (OsLG1). Sequencing analysis identified reduced nucleotide diversity and a selective sweep at the SPR3 locus in cultivated rice. Our results suggest that a closed panicle was a selected trait during rice domestication.	[Ishii, Takashige; Numaguchi, Koji; Pham Thien Thanh; Than Myint Htun; Yamasaki, Masanori; Ishikawa, Ryo] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan; [Miura, Kotaro; Komeda, Norio; Ashikari, Motoyuki] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Miura, Kotaro] Fukui Prefectural Univ, Fac Biotechnol, Yoshida, Japan; [Yoshida, Kentaro; Terauchi, Ryohei] Iwate Biotechnol Inst, Kitakami, Iwate, Japan; [Yoshida, Kentaro] Norwich Res Pk, Sainsbury Lab, Norwich, Norfolk, England; [Matsumoto, Takashi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Kobe University; Nagoya University; Fukui Prefectural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; National Institute of Agrobiological Sciences - Japan	Ishii, T (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan.	tishii@kobe-u.ac.jp	Ishii, Takashige/AAG-1486-2021; Yamasaki, Masanori/C-5193-2018; Terauchi, Ryohei/Y-2992-2019	Yamasaki, Masanori/0000-0001-7759-3965; Terauchi, Ryohei/0000-0002-0095-4651; Numaguchi, Koji/0000-0001-5679-352X; Ishii, Takashige/0000-0001-9604-9877; Ishikawa, Ryo/0000-0003-1848-2493	Japanese Society for Promotion of Science [20580005, 23580006, 2301390]; Japan Science and Technology Agency-Japan International Cooperation Agency within the framework of the Science and Technology Research Partnership for Sustainable Development; Grants-in-Aid for Scientific Research [23580473, 23580006] Funding Source: KAKEN	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency-Japan International Cooperation Agency within the framework of the Science and Technology Research Partnership for Sustainable Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the National Institute of Genetics (National Bioresource Project), Japan, and the National Institute of Agrobiological Sciences, Japan, for providing the seeds of wild and cultivated rice, Y. Takezalci and Ram Phuong for helping with field experiments and H. Fukaki for supporting expression analysis. This work was supported in part by a Grant-in-Aid from Japanese Society for Promotion of Science to T.I. (20580005, 23580006, 2301390) and by the Japan Science and Technology Agency-Japan International Cooperation Agency within the framework of the Science and Technology Research Partnership for Sustainable Development to M.A.	Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Eiguchi M., 1990, RICE GENET NEWSL, V7, P105; FLANNERY KV, 1973, ANNU REV ANTHROPOL, V2, P271, DOI 10.1146/annurev.an.02.100173.001415; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Ishikawa R, 2010, GENES GENET SYST, V85, P265, DOI 10.1266/ggs.85.265; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Lee J, 2007, PLANT MOL BIOL, V65, P487, DOI 10.1007/s11103-007-9196-1; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Luo JJ, 2008, MOL PLANT, V1, P830, DOI 10.1093/mp/ssn045; Mannion AM, 1999, PROG PHYS GEOG, V23, P37, DOI 10.1191/030913399677315626; Oka H. I., 1988, Origin of cultivated rice.; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x	15	118	133	8	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2013	45	4					462	465		10.1038/ng.2567	http://dx.doi.org/10.1038/ng.2567			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435087				2022-12-25	WOS:000316840600020
J	Petrova, E; Rios-Esteves, J; Ouerfelli, O; Glickman, JF; Resh, MD				Petrova, Elissaveta; Rios-Esteves, Jessica; Ouerfelli, Ouathek; Glickman, J. Fraser; Resh, Marilyn D.			Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE; FATTY-ACIDS; PALMITOYLATION; ACTIVATION; PROTEINS; CELLS	Inhibition of Sonic hedgehog (Shh) signaling is of great clinical interest. Here we exploit Hedgehog acyltransferase (Hhat)-mediated Shh palmitoylation, a modification critical for Shh signaling, as a new target for Shh pathway inhibition. A target-oriented high-throughput screen was used to identify small-molecule inhibitors of Hhat. In cells, these Hhat inhibitors specifically block Shh palmitoylation and inhibit autocrine and paracrine Shh signaling.	[Petrova, Elissaveta; Rios-Esteves, Jessica; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Petrova, Elissaveta] Cornell Univ, Grad Program Pharmacol, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Rios-Esteves, Jessica; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10021 USA; [Ouerfelli, Ouathek] Mem Sloan Kettering Canc Ctr, Pharmacol Program, New York, NY 10021 USA; [Glickman, J. Fraser] Rockefeller Univ, High Throughput Screening Resource Ctr, New York, NY 10021 USA; [Resh, Marilyn D.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Cell Biol, New York, NY 10021 USA; [Resh, Marilyn D.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Biochem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	reshm@mskcc.org	Glickman, Joseph/H-3021-2013	Glickman, Joseph/0000-0002-6706-4039; Resh, Marilyn/0000-0001-6118-9466; Ouerfelli, Ouathek/0000-0002-7038-0219	US National Institutes of Health [GM57966, CA158474]; Cycle for Survival; Geoffrey Beene Cancer Research Foundation; Sarcoma Foundation of America; W.H. Goodwin and A. Goodwin; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center;  [NCI P30 CA008748-43]; NATIONAL CANCER INSTITUTE [R21CA158474, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966, F31GM100691] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cycle for Survival; Geoffrey Beene Cancer Research Foundation; Sarcoma Foundation of America; W.H. Goodwin and A. Goodwin; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Louft-Nisenbaum, K. Anderson, D. Tan, E. Legue and A. Joyner for helpful input. This work was supported by US National Institutes of Health grants GM57966 and CA158474, Cycle for Survival, the Geoffrey Beene Cancer Research Foundation, the Sarcoma Foundation of America, W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center. The Organic Synthesis Core is partially supported by NCI P30 CA008748-43.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Peukert S, 2010, CHEMMEDCHEM, V5, P500, DOI 10.1002/cmdc.201000011; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393	23	115	120	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					247	249		10.1038/NCHEMBIO.1184	http://dx.doi.org/10.1038/NCHEMBIO.1184			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23416332	Green Accepted			2022-12-25	WOS:000317025800014
J	Cibulskis, K; Lawrence, MS; Carter, SL; Sivachenko, A; Jaffe, D; Sougnez, C; Gabriel, S; Meyerson, M; Lander, ES; Getz, G				Cibulskis, Kristian; Lawrence, Michael S.; Carter, Scott L.; Sivachenko, Andrey; Jaffe, David; Sougnez, Carrie; Gabriel, Stacey; Meyerson, Matthew; Lander, Eric S.; Getz, Gad			Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples	NATURE BIOTECHNOLOGY			English	Article							EVOLUTION; LANDSCAPE; DISCOVERY; CATALOG; GENOMES	Detection of somatic point substitutions is a key step in characterizing the cancer genome. However, existing methods typically miss low-allelic-fraction mutations that occur in only a subset of the sequenced cells owing to either tumor heterogeneity or contamination by normal cells. Here we present MuTect, a method that applies a Bayesian classifier to detect somatic mutations with very low allele fractions, requiring only a few supporting reads, followed by carefully tuned filters that ensure high specificity. We also describe benchmarking approaches that use real, rather than simulated, sequencing data to evaluate the sensitivity and specificity as a function of sequencing depth, base quality and allelic fraction. Compared with other methods, MuTect has higher sensitivity with similar specificity, especially for mutations with allelic fractions as low as 0.1 and below, making MuTect particularly useful for studying cancer subclones and their evolution in standard exome and genome sequencing data.	[Cibulskis, Kristian; Lawrence, Michael S.; Carter, Scott L.; Sivachenko, Andrey; Jaffe, David; Sougnez, Carrie; Gabriel, Stacey; Meyerson, Matthew; Lander, Eric S.; Getz, Gad] Broad Inst Harvard, Cambridge, MA USA; [Cibulskis, Kristian; Lawrence, Michael S.; Carter, Scott L.; Sivachenko, Andrey; Jaffe, David; Sougnez, Carrie; Gabriel, Stacey; Meyerson, Matthew; Lander, Eric S.; Getz, Gad] MIT, Cambridge, MA 02139 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Div Canc Biol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst Harvard, Cambridge, MA USA.	gadgetz@broadinstitute.org	Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Meyerson, Matthew/0000-0002-9133-8108; Cibulskis, Kristian/0000-0003-1343-1582	US National Institutes of Health [U54HG003067, U24CA143845]; NATIONAL CANCER INSTITUTE [U24CA143845] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by US National Institutes of Health grants U54HG003067 and U24CA143845. We thank the Genome Analysis ToolKit (GATK) group, and our beta test users for their valuable feedback.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	44	2781	2837	4	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					213	219		10.1038/nbt.2514	http://dx.doi.org/10.1038/nbt.2514			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23396013	Green Submitted, Green Accepted, Bronze			2022-12-25	WOS:000316439500014
J	Huard, DJE; Kane, KM; Tezcan, FA				Huard, Dustin J. E.; Kane, Kathleen M.; Tezcan, F. Akif			Re-engineering protein interfaces yields copper-inducible ferritin cage assembly	NATURE CHEMICAL BIOLOGY			English	Article							DIMERIZATION IN-VIVO; SMALL MOLECULES; HORSE SPLEEN; SIGNAL-TRANSDUCTION; CHEMICAL INDUCER; IRON RELEASE; DESIGN; METAL; MECHANISM; APOFERRITIN	The ability to chemically control protein-protein interactions would allow the interrogation of dynamic cellular processes and lead to a better understanding and exploitation of self-assembling protein architectures. Here we introduce a new engineering strategy reverse metal-templated interface redesign (rMeTIR)-that transforms a natural protein-protein interface into one that only engages in selective response to a metal ion. We have applied rMeTIR to render the self-assembly of the cage-like protein ferritin controllable by divalent copper binding, which has allowed the study of the structure and stability of the isolated ferritin monomer, the demonstration of the primary role of conserved hydrogen-bonding interactions in providing geometric specificity for cage assembly and the uniform chemical modification of the cage interior under physiological conditions. Notably, copper acts as a structural template for ferritin assembly in a manner that is highly reminiscent of RNA sequences that template virus capsid formation.	[Huard, Dustin J. E.; Kane, Kathleen M.; Tezcan, F. Akif] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Tezcan, FA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tezcan@ucsd.edu			US Department of Energy (Division of Materials Sciences, Office of Basic Energy Sciences) [DE-FG02-10ER46677]; Beckman Foundation; Sloan Foundation; National Science Foundation [CHE-0908115]	US Department of Energy (Division of Materials Sciences, Office of Basic Energy Sciences)(United States Department of Energy (DOE)); Beckman Foundation; Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by the US Department of Energy (Division of Materials Sciences, Office of Basic Energy Sciences, Award DE-FG02-10ER46677 to F.A.T.). F.A.T. was additionally supported by the Beckman Foundation, the Sloan Foundation and the National Science Foundation (CHE-0908115). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, operated by Stanford University on behalf of the Department of Energy. We thank J. Brodin for experimental assistance with TEM measurements and J. Faraone Mennella for illustrations.	Abe S, 2009, J AM CHEM SOC, V131, P6958, DOI 10.1021/ja901234j; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; BANCROFT J B, 1970, P99, DOI 10.1016/S0065-3527(08)60022-6; Brodin JD, 2010, J AM CHEM SOC, V132, P8610, DOI 10.1021/ja910844n; Butler P.J.G., 1979, INT REV BIOCHEM, V25, P205; Butts CA, 2008, BIOCHEMISTRY-US, V47, P12729, DOI 10.1021/bi8016735; Comellas-Aragones M, 2007, NAT NANOTECHNOL, V2, P635, DOI 10.1038/nnano.2007.299; Corson TW, 2008, ACS CHEM BIOL, V3, P677, DOI 10.1021/cb8001792; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Dalmau M, 2009, NANO LETT, V9, P160, DOI 10.1021/nl8027069; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; GERL M, 1988, BIOCHEMISTRY-US, V27, P4089, DOI 10.1021/bi00411a027; Guo ZH, 2000, SCIENCE, V288, P2042, DOI 10.1126/science.288.5473.2042; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hussey SL, 2003, J AM CHEM SOC, V125, P3692, DOI 10.1021/ja0293305; Johnson E, 2005, STRUCTURE, V13, P637, DOI 10.1016/j.str.2005.01.019; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Laganowsky A, 2011, PROTEIN SCI, V20, P1876, DOI 10.1002/pro.727; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Lin HN, 2000, J AM CHEM SOC, V122, P4247, DOI 10.1021/ja9941532; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Mines GA, 1996, CHEM BIOL, V3, P491, DOI 10.1016/S1074-5521(96)90097-6; Salgado EN, 2008, J AM CHEM SOC, V130, P6082, DOI 10.1021/ja8012177; Salgado EN, 2007, J AM CHEM SOC, V129, P13374, DOI 10.1021/ja075261o; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Salgado EN, 2009, INORG CHEM, V48, P2726, DOI 10.1021/ic9001237; Santambrogio P, 1997, BIOCHEM J, V322, P461, DOI 10.1042/bj3220461; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; STEFANINI S, 1987, BIOCHEMISTRY-US, V26, P1831, DOI 10.1021/bi00381a007; Swift J, 2006, J AM CHEM SOC, V128, P6611, DOI 10.1021/ja057069x; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Treffry A, 1996, J BIOL INORG CHEM, V1, P49, DOI 10.1007/s007750050022; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; WEBB B, 1994, ARCH BIOCHEM BIOPHYS, V309, P178, DOI 10.1006/abbi.1994.1100; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Wong KKW, 1998, CHEM MATER, V10, P279, DOI 10.1021/cm970421o; YANG DW, 1995, BIOCHEM J, V307, P253, DOI 10.1042/bj3070253; Zhang Y, 2011, INT J MOL SCI, V12, P5406, DOI 10.3390/ijms12085406; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	50	139	142	0	159	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					169	176		10.1038/NCHEMBIO.1163	http://dx.doi.org/10.1038/NCHEMBIO.1163			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23340339				2022-12-25	WOS:000315132900012
J	Maliga, Z; Junqueira, M; Toyoda, Y; Ettinger, A; Mora-Bermudez, F; Klemm, RW; Vasilj, A; Guhr, E; Ibarlucea-Benitez, I; Poser, I; Bonifacio, E; Huttner, WB; Shevchenko, A; Hyman, AA				Maliga, Zoltan; Junqueira, Magno; Toyoda, Yusuke; Ettinger, Andreas; Mora-Bermudez, Felipe; Klemm, Robin W.; Vasilj, Andrej; Guhr, Elaine; Ibarlucea-Benitez, Itziar; Poser, Ina; Bonifacio, Ezio; Huttner, Wieland B.; Shevchenko, Andrej; Hyman, Anthony A.			A genomic toolkit to investigate kinesin and myosin motor function in cells	NATURE CELL BIOLOGY			English	Article							BAC TRANSGENEOMICS; RNA INTERFERENCE; GLOBAL ANALYSIS; PROTEINS; SUPERFAMILY; SEGREGATION; PROTEOMICS; TRANSPORT; SPINDLE; POLO-LIKE-KINASE-1	Coordination of multiple kinesin and myosin motors is required for intracellular transport, cell motility and mitosis. However, comprehensive resources that allow systems analysis of the localization and interplay between motors in living cells do not exist. Here, we generated a library of 243 amino- and carboxy-terminally tagged mouse and human bacterial artificial chromosome transgenes to establish 227 stably transfected HeLa cell lines, 15 mouse embryonic stem cell lines and 1 transgenic mouse line. The cells were characterized by expression and localization analyses and further investigated by affinity-purification mass spectrometry, identifying 191 candidate protein-protein interactions. We illustrate the power of this resource in two ways. First, by characterizing a network of interactions that targets CEP170 to centrosomes, and second, by showing that kinesin light-chain heterodimers bind conventional kinesin in cells. Our work provides a set of validated resources and candidate molecular pathways to investigate motor protein function across cell lineages.	[Maliga, Zoltan; Toyoda, Yusuke; Mora-Bermudez, Felipe; Vasilj, Andrej; Guhr, Elaine; Poser, Ina; Huttner, Wieland B.; Shevchenko, Andrej; Hyman, Anthony A.] Max Planck Inst Cell Biol & Genet CBG, D-01307 Dresden, Germany; [Junqueira, Magno] Univ Brasilia, Dept Cell Biol, Brazilian Ctr Prot Res, BR-70910900 Brasilia, DF, Brazil; [Ettinger, Andreas] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Klemm, Robin W.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA; [Ibarlucea-Benitez, Itziar] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany	Max Planck Society; Universidade de Brasilia; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Technische Universitat Dresden	Maliga, Z (corresponding author), Max Planck Inst Cell Biol & Genet CBG, D-01307 Dresden, Germany.	maliga@mpi-cbg.de	Hyman, Tony/F-1923-2011; Klemm, Robin/C-5463-2014; Bonifacio, Ezio/E-7700-2010; Huttner, Wieland B./P-4080-2018; Klemm, Robin/ABA-2252-2020; Hyman, Anthony A/B-3917-2017; Junqueira, Magno/A-7495-2012; Ibarlucea, Itziar/GLS-1578-2022	Klemm, Robin/0000-0003-2313-8240; Bonifacio, Ezio/0000-0002-8704-4713; Klemm, Robin/0000-0003-2313-8240; Hyman, Anthony A/0000-0003-3664-154X; Junqueira, Magno/0000-0002-7036-0728; Ettinger, Andreas/0000-0001-6436-010X; Toyoda, Yusuke/0000-0003-0534-6898	European Commission [LSHG-CT-2004-503464]; Max Planck Society; Bundesministerium fuer Bildung und Forschung [01GR0402, 01GS0859]; Japan Society for the Promotion of Science; EMBO [ALTF 1080-2007]; DFG [SFB 655, A2, TRR 83, Tp6]; ERC [250197]; DFG; Fonds der Chemischen Industrie; DFG Research Center; Cluster of Excellence-Center for Regenerative Therapies Dresden [FZ 111]	European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fuer Bildung und Forschung; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DFG Research Center(German Research Foundation (DFG)); Cluster of Excellence-Center for Regenerative Therapies Dresden	Most of this project was funded by the European Commission through the Sixth Framework Programme Integrated Project MitoCheck (LSHG-CT-2004-503464). A.A.H. received support from the Max Planck Society and from Bundesministerium fuer Bildung und Forschung grants NGFN-2 SMP-RNAi (01GR0402) and NGFN-Plus (01GS0859). Y.T. was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science. F.M-B. was supported by EMBO (ALTF 1080-2007). A.E. was a member of the International Max Planck Research School for Molecular Cell Biology and Bioengineering and a Technische Universitat Dresden doctoral student. W.B.H. was supported by grants from the DFG (SFB 655, A2; TRR 83, Tp6) and the ERC (250197), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie. E.B. and E.G. were supported by the DFG Research Center and Cluster of Excellence-Center for Regenerative Therapies Dresden (FZ 111). We thank J. Jarrells and B. Schilling (MPI-CBG Microarray Facility) for processing microarray samples. M. Biesold, M. Augsburg, A. Ssykor, S. Bastidas and N. Berger provided assistance with cell culture and transfection. I. Nuesslein (MPI-CBG FACS Facility) performed FACS of transgenic HeLa pools. M. Theis and F. Buchholz helped produce esiRNAs. The Trangsgenic Core Facility and Biomedical Services at the MPI-CBG provided technical assistance in generating and maintaining the KIF23 transgenic mouse strain.	Anko ML, 2010, NAT STRUCT MOL BIOL, V17, P962, DOI 10.1038/nsmb.1862; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Cox RT, 2006, DEVELOPMENT, V133, P3371, DOI 10.1242/dev.02514; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Ettinger AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1511; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi049288l; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Jones W. M., J CELL SCI, V123, P2179; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kotzamanis G, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-1; Levy S, 2001, BIOINFORMATICS, V17, P871, DOI 10.1093/bioinformatics/17.10.871; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Maffini S, 2009, CURR BIOL, V19, P1566, DOI 10.1016/j.cub.2009.07.059; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Mollinari C, 2005, MOL BIOL CELL, V16, P1043, DOI 10.1091/mbc.E04-04-0346; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Patino-Lopez G., J BIOL CHEM, V285, P8675; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Yu WQ, 1997, J CELL BIOL, V136, P659, DOI 10.1083/jcb.136.3.659; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	46	76	76	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					325	334		10.1038/ncb2689	http://dx.doi.org/10.1038/ncb2689			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23417121				2022-12-25	WOS:000315844900014
J	Kornblum, C; Nicholls, TJ; Haack, TB; Scholer, S; Peeva, V; Danhauser, K; Hallmann, K; Zsurka, G; Rorbach, J; Iuso, A; Wieland, T; Sciacco, M; Ronchi, D; Comi, GP; Moggio, M; Quinzii, CM; DiMauro, S; Calvo, SE; Mootha, VK; Klopstock, T; Strom, TM; Meitinger, T; Minczuk, M; Kunz, WS; Prokisch, H				Kornblum, Cornelia; Nicholls, Thomas J.; Haack, Tobias B.; Schoeler, Susanne; Peeva, Viktoriya; Danhauser, Katharina; Hallmann, Kerstin; Zsurka, Gabor; Rorbach, Joanna; Iuso, Arcangela; Wieland, Thomas; Sciacco, Monica; Ronchi, Dario; Comi, Giacomo P.; Moggio, Maurizio; Quinzii, Catarina M.; DiMauro, Salvatore; Calvo, Sarah E.; Mootha, Vamsi K.; Klopstock, Thomas; Strom, Tim M.; Meitinger, Thomas; Minczuk, Michal; Kunz, Wolfram S.; Prokisch, Holger			Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease	NATURE GENETICS			English	Article							HUMAN DNA2; DEFICIENCY; DEPLETION; PROTEIN; GENE; POLG; TWINKLE; KINASE; REPAIR	Known disease mechanisms in mitochondria! DNA (mtDNA) maintenance disorders alter either the mitochondrial replication machinery (POLG, POLG2 and C10orf2)(1-3) or the biosynthesis pathways of deoxyribonucleoside 5'-triphosphates for mtDNA synthesis(4-11). However, in many of these disorders, the underlying genetic defect has yet to be discovered. Here, we identify homozygous nonsense and missense mutations in the orphan gene C20orf72 in three families with a mitochondrial syndrome characterized by external ophthalmoplegia, emaciation and respiratory failure. Muscle biopsies showed mtDNA depletion and multiple mtDNA deletions. C20orf72, hereafter MGME1 (mitochondrial genome maintenance exonuclease 1), encodes a mitochondria! RecB-type exonuclease belonging to the PD-(D/E)XK nuclease superfamily. We show that MGME1 cleaves single-stranded DNA and processes DNA flap substrates. Fibroblasts from affected individuals do not repopulate after chemically induced mtDNA depletion. They also accumulate intermediates of stalled replication and show increased levels of 7S DNA, as do MGME1-depleted cells. Thus, we show that MGME1-mediated mtDNA processing is essential for mitochondrial genome maintenance.	[Kornblum, Cornelia] Univ Bonn, Dept Neurol, Med Ctr, Bonn, Germany; [Nicholls, Thomas J.; Rorbach, Joanna; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge, England; [Haack, Tobias B.; Danhauser, Katharina; Iuso, Arcangela; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Haack, Tobias B.; Danhauser, Katharina; Iuso, Arcangela; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Munich, Germany; [Schoeler, Susanne; Peeva, Viktoriya; Hallmann, Kerstin; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany; [Schoeler, Susanne; Peeva, Viktoriya; Hallmann, Kerstin; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Med Ctr, Life & Brain Ctr, Bonn, Germany; [Sciacco, Monica; Moggio, Maurizio] Univ Milan, Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Neuromuscular Unit, Osped Maggiore Policlin,Ctr Dino Ferrari, Milan, Italy; [Ronchi, Dario; Comi, Giacomo P.] Univ Milan, Fdn IRCCS Ca Granda, Neurol Unit, Osped Maggiore Policlin,Ctr Dino Ferrari, Milan, Italy; [Quinzii, Catarina M.; DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol & Med, Boston, MA 02114 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA; [Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany	University of Bonn; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Bonn; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Munich	Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge, England.	michal.minczuk@mrc-mbu.cam.ac.uk; wolfram.kunz@ukb.uni-bonn.de	Kunz, Wolfram/K-1232-2019; Prokisch, Holger/N-8964-2013; rorbach, Joanna/AAM-5683-2021; Sciacco, Monica/AAC-6500-2022; Comi, Giacomo P/K-5702-2016; Ronchi, Dario/K-8011-2016; Ronchi, Dario/O-4138-2019; Meitinger, Thomas/O-1318-2015; Minczuk, Michal/G-1638-2014	Kunz, Wolfram/0000-0003-1113-3493; rorbach, Joanna/0000-0002-2891-2840; Sciacco, Monica/0000-0003-4593-4977; Comi, Giacomo P/0000-0002-1383-5248; Ronchi, Dario/0000-0002-6093-9816; Ronchi, Dario/0000-0002-6093-9816; Zsurka, Gabor/0000-0002-6379-849X; Prokisch, Holger/0000-0003-2379-6286; Nicholls, Thomas/0000-0002-3034-4109; Minczuk, Michal/0000-0001-8242-1420; Meitinger, Thomas/0000-0002-8838-8403	Medical Research Council UK; German Bundesministerium fur Bildung und Forschung (BMBF) [SysMBo 0315494A]; E-Rare project GENOMIT [01GM1207]; German Network for mitochondrial disorders (mitoNET) [mitoNET 01GM0862, 01GM1113A, mitoNET 01GM0867, 01GM1113C, mitoNET 01GM0868]; Deutsche Forschungsgemeinschaft [SFB TR3 All, D12]; US National Institutes of Health [GM077465, GM097136]; Associazione Amici del Centro Dino Ferrari; University of Milan; Telethon project [GTB07001ER]; Eurobiobank project [QLTR-2001-02769]; Criobanca Automatizzata di Materiale Biologico [R.F.02.187]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD065871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465, R01GM097136] Funding Source: NIH RePORTER; Medical Research Council [MC_U105697135] Funding Source: researchfish; MRC [MC_U105697135] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; German Network for mitochondrial disorders (mitoNET); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Amici del Centro Dino Ferrari; University of Milan; Telethon project(Fondazione Telethon); Eurobiobank project; Criobanca Automatizzata di Materiale Biologico; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	T.J.N. and M. Minczuk are grateful to S. Wood and I. Holt for stimulating discussions during the course of this work We are grateful to S. Beyer, K. Kappes-Horn, M. Stepien-Mering, E. Botz and R. Hellinger for technical assistance. We thank R. Wiesner (University of Cologne) for providing the TFAM antibody. This work was supported by the Medical Research Council UK (T.J.N., J.R. and M. Minczuk) and the German Bundesministerium fur Bildung und Forschung (BMBF) through funding of the Systems Biology of Metabotypes grant (SysMBo 0315494A), the E-Rare project GENOMIT (01GM1207) and the German Network for mitochondrial disorders (mitoNET), including C.K., T.K. (mitoNET 01GM0862 and 01GM1113A), T.M., H.P. (mitoNET 01GM0867 and 01GM1113C) and W.S.K. (mitoNET 01GM0868). W.S.K. was funded by the Deutsche Forschungsgemeinschaft (SFB TR3 All and D12). V.K.M. was supported by grants from the US National Institutes of Health (GM077465 and GM097136). The financial support of Associazione Amici del Centro Dino Ferrari, University of Milan, the Telethon project GTB07001ER, the Eurobiobank project QLTR-2001-02769 and R.F.02.187 Criobanca Automatizzata di Materiale Biologico to M.M. and M.S. are gratefully acknowledged.	Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	28	148	151	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					214	219		10.1038/ng.2501	http://dx.doi.org/10.1038/ng.2501			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313956	Green Accepted			2022-12-25	WOS:000314333000019
J	Liew, CW; Boucher, J; Cheong, JK; Vernochet, C; Koh, HJ; Mallol, C; Townsend, K; Langin, D; Kawamori, D; Hu, J; Tseng, YH; Hellerstein, MK; Farmer, SR; Goodyear, L; Doria, A; Bluher, M; Hsu, SIH; Kulkarni, RN				Liew, Chong Wee; Boucher, Jeremie; Cheong, Jit Kong; Vernochet, Cecile; Koh, Ho-Jin; Mallol, Cristina; Townsend, Kristy; Langin, Dominique; Kawamori, Dan; Hu, Jiang; Tseng, Yu-Hua; Hellerstein, Marc K.; Farmer, Stephen R.; Goodyear, Laurie; Doria, Alessandro; Blueher, Matthias; Hsu, Stephen I-Hong; Kulkarni, Rohit N.			Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance	NATURE MEDICINE			English	Article							HORMONE-SENSITIVE LIPASE; WHITE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; BR FAMILY; MICE; OVEREXPRESSION; TRANSCRIPTION; INFLAMMATION; COREGULATORS; HOMEOSTASIS	Obesity develops as a result of altered energy homeostasis favoring fat storage. Here we describe a new transcription co-regulator for adiposity and energy metabolism, SERTA domain containing 2 (TRIP-Br2, also called SERTAD2). TRIP-Br2 null mice are resistant to obesity and obesity-related insulin resistance. Adipocytes of these knockout mice showed greater stimulated lipolysis secondary to enhanced expression of hormone sensitive lipase (HSL) and beta 3-adrenergic (Adrb3) receptors. The knockout mice also have higher energy expenditure because of increased adipocyte thermogenesis and oxidative metabolism caused by upregulating key enzymes in their respective processes. Our data show that a cell-cycle transcriptional co-regulator, TRIP-Br2, modulates fat storage through simultaneous regulation of lipolysis, thermogenesis and oxidative metabolism. These data, together with the observation that TRIP-Br2 expression is selectively elevated in visceral fat in obese humans, suggests that this transcriptional co-regulator is a new therapeutic target for counteracting the development of obesity, insulin resistance and hyperlipidemia.	[Liew, Chong Wee; Boucher, Jeremie; Vernochet, Cecile; Koh, Ho-Jin; Townsend, Kristy; Kawamori, Dan; Hu, Jiang; Tseng, Yu-Hua; Goodyear, Laurie; Doria, Alessandro; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Cheong, Jit Kong] Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Vernochet, Cecile; Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Mallol, Cristina] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, E-08193 Barcelona, Spain; [Langin, Dominique] Inst Metab & Cardiovasc Dis, Obes Res Lab, INSERM, U1048, Toulouse, France; [Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Hsu, Stephen I-Hong] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Hsu, Stephen I-Hong] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Liew, Chong Wee] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; National University of Singapore; Boston University; Autonomous University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Berkeley; Leipzig University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kulkarni, RN (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA.	clipcap2148@gmail.com; rohit.kulkarni@joslin.harvard.edu	Boucher, Jeremie/G-6602-2015; Doria, Alessandro/H-9157-2018; Tseng, Yu-Hua/AAE-6471-2021	Doria, Alessandro/0000-0002-3830-4304; Tseng, Yu-Hua/0000-0003-2053-9559; Farmer, Stephen/0000-0003-2483-2795; Mallol, Cristina/0000-0002-2920-9612; Langin, Dominique/0000-0002-2669-7825; Liew, Chong Wee/0000-0001-9904-0958	US National Institutes of Health (NIH) [RO1 DK 67536]; Joslin Graetz Bridge Funds; Joslin Diabetes and Endocrinology Research Center Specialized Assay and Advanced Microscopy Cores [NIH P30 DK36836]; Deutsche Forschungsgemeinschaft Clinical Research group 'Atherobesity' [KFO152, BL 833/1-1]; US National Institutes of Health Interdisciplinary training grant [1RL9EB008539-01]; Manpei Suzuki Diabetes Foundation, Japan; Juvenile Diabetes Research Foundation; Dialysis Center, Inc.; University of Florida, Division of Nephrology Gatorade Fund; NIH [K99 DK090210, R01 HL073168, DK51586, DK58825]; Clinical Translational Science Institute at the University of Florida;  [R00 DK090210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [RL9EB008539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK067536, K99DK090210, R01DK058825, P30DK036836, R56DK051586, R00DK090210, R56DK058825, R01DK051586] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Graetz Bridge Funds; Joslin Diabetes and Endocrinology Research Center Specialized Assay and Advanced Microscopy Cores; Deutsche Forschungsgemeinschaft Clinical Research group 'Atherobesity'; US National Institutes of Health Interdisciplinary training grant; Manpei Suzuki Diabetes Foundation, Japan; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Dialysis Center, Inc.; University of Florida, Division of Nephrology Gatorade Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Translational Science Institute at the University of Florida; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank C.R. Kahn (Joslin Diabetes Center) for providing reagents and discussions, E. Rosen for discussions, E. Morgan and K. Parlee for excellent assistance in the preparation of this manuscript, H. Li for assistance with hormone assays, O.P. McGuinness for mouse metabolic phenotyping, L. Fajas (INSERM) for providing reagents, M. Mori (Joslin Diabetes Center) for providing samples and R. Zechner for providing the protocol for triglyceride hydrolase activities. Funds to generate some reagents used in this research were supported by US National Institutes of Health (NIH) grant RO1 DK 67536 (R.N.K.) and the Joslin Graetz Bridge Funds (R.N.K.), NIH grants R01 HL073168 (A.D.), K99 DK090210 (C.W.L.), DK51586 and DK58825 (S.R.F.) and the Joslin Diabetes and Endocrinology Research Center Specialized Assay and Advanced Microscopy Cores (NIH P30 DK36836). The human studies were supported by a grant of the Deutsche Forschungsgemeinschaft Clinical Research group 'Atherobesity' (KFO152; BL 833/1-1). C.W.L. was supported by a US National Institutes of Health Interdisciplinary training grant (1RL9EB008539-01) (SysCODE), K99 DK090210 and R00 DK090210. D.K. is the recipient of a research fellowship (Manpei Suzuki Diabetes Foundation, Japan) and a Juvenile Diabetes Research Foundation postdoctoral Fellowship. S.I.-H.H. and J.K.C. were supported by the R. Glenn Davis (Dialysis Center, Inc.) Endowed Professorship in Clinical and Translational Medicine and by the University of Florida, Division of Nephrology Gatorade Fund. S.I.-H.H. was supported as a Scholar of the Clinical Translational Science Institute at the University of Florida.	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Blanchet E, 2009, CELL CYCLE, V8, P4029, DOI 10.4161/cc.8.24.10110; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheong JK, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-8; Darwish H, 2007, ONCOGENE, V26, P4319, DOI 10.1038/sj.onc.1210195; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Hirose T, 2003, INT J MOL MED, V11, P705; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE776, DOI 10.1152/ajpendo.1996.270.5.E776; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lai IL, 2007, GENE, V388, P102, DOI 10.1016/j.gene.2006.10.008; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Lucas S, 2003, J LIPID RES, V44, P154, DOI 10.1194/jlr.M200250-JLR200; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosenbaum M, 1999, NEW ENGL J MED, V341, P913, DOI 10.1056/NEJM199909163411211; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sim KG, 2006, CELL CYCLE, V5, P1111, DOI 10.4161/cc.5.10.2797; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	49	55	60	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					217	226		10.1038/nm.3056	http://dx.doi.org/10.1038/nm.3056			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23291629	Green Accepted, Green Submitted			2022-12-25	WOS:000314675900030
J	Liu, Y; Aryee, MJ; Padyukov, L; Fallin, MD; Hesselberg, E; Runarsson, A; Reinius, L; Acevedo, N; Taub, M; Ronninger, M; Shchetynsky, K; Scheynius, A; Kere, J; Alfredsson, L; Klareskog, L; Ekstrom, TJ; Feinberg, AP				Liu, Yun; Aryee, Martin J.; Padyukov, Leonid; Fallin, M. Daniele; Hesselberg, Espen; Runarsson, Arni; Reinius, Lovisa; Acevedo, Nathalie; Taub, Margaret; Ronninger, Marcus; Shchetynsky, Klementy; Scheynius, Annika; Kere, Juha; Alfredsson, Lars; Klareskog, Lars; Ekstrom, Tomas J.; Feinberg, Andrew P.			Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis	NATURE BIOTECHNOLOGY			English	Article							GLUTATHIONE-S-TRANSFERASE; POLYMORPHISMS; EXPRESSION; SMOKING; PROTEINS; ETIOLOGY; MHC; M1; T1; P1	Epigenetic mechanisms integrate genetic and environmental causes of disease, but comprehensive genome-wide analyses of epigenetic modifications have not yet demonstrated robust association with common diseases. Using II lumina HumanMethylation450 arrays on 354 anti-citrullinated protein antibody-associated rheumatoid arthritis cases and 337 controls, we identified two clusters within the major histocompatibility complex (MHC) region whose differential methylation potentially mediates genetic risk for rheumatoid arthritis. To reduce confounding factors that have hampered previous epigenome-wide studies, we corrected for cellular heterogeneity by estimating and adjusting for cell-type proportions in our blood-derived DNA samples and used mediation analysis to filter out associations likely to be a consequence of disease. Four CpGs also showed an association between genotype and variance of methylation. The associations for both clusters replicated at least one CpG (P < 0.01), with the rest showing suggestive association, in monocyte cell fractions in an independent cohort of 12 cases and 12 controls. Thus, DNA methylation is a potential mediator of genetic risk.	[Liu, Yun; Aryee, Martin J.; Fallin, M. Daniele; Runarsson, Arni; Taub, Margaret; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Liu, Yun; Runarsson, Arni; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Aryee, Martin J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Padyukov, Leonid; Hesselberg, Espen; Ronninger, Marcus; Shchetynsky, Klementy; Klareskog, Lars] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Padyukov, Leonid; Hesselberg, Espen; Ronninger, Marcus; Shchetynsky, Klementy; Klareskog, Lars; Ekstrom, Tomas J.] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Fallin, M. Daniele; Taub, Margaret; Feinberg, Andrew P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Fallin, M. Daniele] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Reinius, Lovisa; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Acevedo, Nathalie; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Ekstrom, Tomas J.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Karolinska Institutet; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Klareskog, L (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	lars.klareskog@ki.se; tomas.ekstrom@ki.se; afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020; Aryee, Martin/AAC-8113-2020; Kere, Juha/AAX-9117-2021; Alfredsson, Lars/AAC-9007-2019; Ekström, Tomas/B-7764-2013; Reinius, Lovisa/C-4555-2014; Kere, Juha/A-9179-2008; Padyukov, Leonid/A-4890-2009	Kere, Juha/0000-0003-1974-0271; Alfredsson, Lars/0000-0003-1688-6697; Reinius, Lovisa/0000-0001-5029-0120; Kere, Juha/0000-0003-1974-0271; Acevedo, Nathalie/0000-0002-5154-2964; Padyukov, Leonid/0000-0003-2950-5670; Shchetynsky, Klementy/0000-0003-4578-5588; Feinberg, Andrew/0000-0002-8364-1991; Klareskog, Lars/0000-0001-9601-6186; Liu, Yun/0000-0001-5753-1265	US National Institutes of Health Centers of Excellence in Genomic Science [5P50HG003233]; Swedish Research Council; Swedish Combine project; Swedish Strategic Foundations; AFA Insurance; European Research Council (ERC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER	US National Institutes of Health Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Combine project; Swedish Strategic Foundations; AFA Insurance; European Research Council (ERC)(European Research Council (ERC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Rosenblum for helpful discussions on the application of statistical mediation methodology. We thank R.A. Irizarry for his contributions to the concepts in this work, his statistical insights on batch effects and helpful comments. We thank E.A. Houseman for codes used for estimating cell proportions. We also thank the EIRA study group<SUP>18</SUP> for contributing invaluable clinical information and biological samples. This work was supported by the US National Institutes of Health Centers of Excellence in Genomic Science, 5P50HG003233 to A.P.F., and by the Swedish Research Council, the Swedish Combine project, the Swedish Strategic Foundations, the AFA Insurance and the European Research Council (ERC).	Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Grabar PB, 2009, CLIN EXP RHEUMATOL, V27, P229; Hao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008695; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kang EY, 2010, J COMPUT BIOL, V17, P533, DOI 10.1089/cmb.2009.0176; Keenan BT, 2010, ARTHRITIS RHEUM-US, V62, P3196, DOI 10.1002/art.27639; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lundstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017880; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Mueller RB, 2007, RHEUMATOLOGY, V46, P931, DOI 10.1093/rheumatology/kem025; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; van der Laan M.J., 2004, STAT APPL GENET MOL, V3, DOI [DOI 10.2202/1544-6115.1041, 10.2202/1544-6115.1041]; Yun BR, 2005, J RHEUMATOL, V32, P992	41	648	661	3	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					142	147		10.1038/nbt.2487	http://dx.doi.org/10.1038/nbt.2487			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23334450	Green Accepted			2022-12-25	WOS:000315322100025
J	Nakanishi, Y; Seno, H; Fukuoka, A; Ueo, T; Yamaga, Y; Maruno, T; Nakanishi, N; Kanda, K; Komekado, H; Kawada, M; Isomura, A; Kawada, K; Sakai, Y; Yanagita, M; Kageyama, R; Kawaguchi, Y; Taketo, MM; Yonehara, S; Chiba, T				Nakanishi, Yuki; Seno, Hiroshi; Fukuoka, Ayumi; Ueo, Taro; Yamaga, Yuichi; Maruno, Takahisa; Nakanishi, Naoko; Kanda, Keitaro; Komekado, Hideyuki; Kawada, Mayumi; Isomura, Akihiro; Kawada, Kenji; Sakai, Yoshiharu; Yanagita, Motoko; Kageyama, Ryoichiro; Kawaguchi, Yoshiya; Taketo, Makoto M.; Yonehara, Shin; Chiba, Tsutomu			Dclk1 distinguishes between tumor and normal stem cells in the intestine	NATURE GENETICS			English	Article							DOUBLECORTIN-LIKE; MYELOID-LEUKEMIA; CANCER; IDENTIFICATION; COLON; MICE; POLYPOSIS; ABLATION; ORIGIN; MARKER	There is great interest in tumor stem cells (TSCs) as potential therapeutic targets; however, cancer therapies targeting TSCs are limited. A drawback is that TSC markers are often shared by normal stem cells (NSCs)(1-4); thus, therapies that target these markers may cause severe injury to normal tissues. To identify a potential TSC-specific marker, we focused on doublecortin-like kinase 1 (Dclk1). Dclk1 was reported as a candidate NSC marker in the gut(5,6), but recent reports have implicated it as a marker of differentiated cells (for example, Tuft cells)(7,8). Using lineage-tracing experiments, we show here that Dclk1 does not mark NSCs in the intestine but instead marks TSCs that continuously produce tumor progeny in the polyps of Apc(Min/+) mice. Specific ablation of Dclk1-positive TSCs resulted in a marked regression of polyps without apparent damage to the normal intestine. Our data suggest the potential for developing a therapy for colorectal cancer based on targeting Dclk1-positive TSCs.	[Nakanishi, Yuki; Seno, Hiroshi; Ueo, Taro; Yamaga, Yuichi; Maruno, Takahisa; Nakanishi, Naoko; Kanda, Keitaro; Komekado, Hideyuki; Kawada, Mayumi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Fukuoka, Ayumi; Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Kyoto, Japan; [Isomura, Akihiro; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; [Kawada, Kenji; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Kawaguchi, Yoshiya] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Seno, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	seno@kuhp.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021	Fukuoka, Ayumi/0000-0002-6752-7814; Nakanishi, Naoko/0000-0003-0092-2593; Yanagita, Motoko/0000-0002-0339-9008; Seno, Hiroshi/0000-0002-8509-8128	Japan Society for the Promotion of Science (JSPS) KAKENHI [10J02434, 21229009, 23590937, 24229005, 24659363, 24590914, 24590916]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Science, Sports and Technology of Japan [LS075]; Princess Takamatsu Cancer Research Fund [10-24212]; Grants-in-Aid for Scientific Research [23590937, 13J02261] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kohno (Nara Institute of Science and Technology) for kindly providing diphtheria toxin. We also thank Y. Kimura, S. Ishizu, M. Nakatsuji, R. Akitake-Kawano, K. Furuyama and T. S. Stappenbeck for technical assistance and helpful suggestions. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI 10J02434, 21229009, 23590937, 24229005, 24659363, 24590914 and 24590916; the Research Program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants for Research on Intractable Diseases, Hepatitis, and Innovative Development and Practical Application of New Drugs for Hepatitis B from the Ministry of Health, Labour and Welfare, Japan; the Funding Program for Next-Generation World-leading Researchers (LS075) and Grants-in Aid from the Ministry of Education, Culture, Science, Sports and Technology of Japan; and the Princess Takamatsu Cancer Research Fund 10-24212.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cocciadiferro L, 2009, ANN NY ACAD SCI, V1155, P257, DOI 10.1111/j.1749-6632.2009.03696.x; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Davies EJ, 2011, MOL CARCINOGEN, V50, P254, DOI 10.1002/mc.20631; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Saqui-Salces M, 2011, HISTOCHEM CELL BIOL, V136, P191, DOI 10.1007/s00418-011-0831-1; SAUER B, 1990, New Biologist, V2, P441; Singh SK, 2003, CANCER RES, V63, P5821; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	32	277	288	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2013	45	1					98	U143		10.1038/ng.2481	http://dx.doi.org/10.1038/ng.2481			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202126	Green Published, Green Submitted			2022-12-25	WOS:000312838800020
J	Heron, SE; Smith, KR; Bahlo, M; Nobili, L; Kahana, E; Licchetta, L; Oliver, KL; Mazarib, A; Afawi, Z; Korczyn, A; Plazzi, G; Petrou, S; Berkovic, SF; Scheffer, IE; Dibbens, LM				Heron, Sarah E.; Smith, Katherine R.; Bahlo, Melanie; Nobili, Lino; Kahana, Esther; Licchetta, Laura; Oliver, Karen L.; Mazarib, Aziz; Afawi, Zaid; Korczyn, Amos; Plazzi, Giuseppe; Petrou, Steven; Berkovic, Samuel F.; Scheffer, Ingrid E.; Dibbens, Leanne M.			Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy	NATURE GENETICS			English	Article								We performed genomic mapping of a family with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and intellectual and psychiatric problems, identifying a disease-associated region on chromosome 9q34.3. Whole-exome sequencing identified a mutation in KCNT1, encoding a sodium-gated potassium channel subunit. KCNT1 mutations were identified in two additional families and a sporadic case with severe ADNFLE and psychiatric features. These findings implicate the sodium-gated potassium channel complex in ADNFLE and, more broadly, in the pathogenesis of focal epilepsies.	[Licchetta, Laura; Oliver, Karen L.; Berkovic, Samuel F.; Scheffer, Ingrid E.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Melbourne, Vic, Australia; [Heron, Sarah E.; Dibbens, Leanne M.] Univ S Australia, Sch Pharm & Med Sci, Epilepsy Res Program, Adelaide, SA 5001, Australia; [Heron, Sarah E.; Dibbens, Leanne M.] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Smith, Katherine R.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Smith, Katherine R.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Nobili, Lino] Osped Niguarda Ca Granda, Sleep Med Ctr, Epilepsy Surg Ctr, Milan, Italy; [Kahana, Esther] Ben Gurion Univ Negev, Sch Hlth Sci, Barzilai Med Ctr, Dept Neurol, IL-84105 Beer Sheva, Israel; [Afawi, Zaid] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Mazarib, Aziz] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Korczyn, Amos] Tel Aviv Univ, Sch Med, Sieratzki Chair Neurol, Ramat Aviv, Israel; [Plazzi, Giuseppe] Univ Bologna, Dept Neurol Sci, Bologna, Italy; [Petrou, Steven; Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Petrou, Steven] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Petrou, Steven] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia	University of Melbourne; University of South Australia; University of South Australia; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Ben Gurion University; Barzilai Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; University of Bologna; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Berkovic, SF (corresponding author), Univ Melbourne, Dept Med, Epilepsy Res Ctr, Melbourne, Vic, Australia.	s.berkovic@unimelb.edu.au	Licchetta, Laura/ACB-8249-2022; Oliver, Karen Louise/O-6159-2018; Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022; Korczyn, Amos D/C-3461-2017; Afawi, Zaid/AAE-7848-2022; Nobili, Lino/AAB-6398-2020; Heron, Sarah/F-4222-2013; Plazzi, Giuseppe/AAB-9627-2020; Petrou, Steven/M-8332-2013	Oliver, Karen Louise/0000-0001-5188-6153; Scheffer, Ingrid E/0000-0002-2311-2174; Korczyn, Amos D/0000-0003-0125-2579; Nobili, Lino/0000-0001-9317-5405; Heron, Sarah/0000-0001-8759-6748; Kahana, Esther/0000-0002-3863-3271; Bahlo, Melanie/0000-0001-5132-0774; Petrou, Steven/0000-0002-4960-6375; Dibbens, Leanne/0000-0002-5824-3342; Plazzi, Giuseppe/0000-0002-1051-0472; Berkovic, Samuel/0000-0003-4580-841X	National Health and Medical Research Council of Australia [628952, 490037, 1016715, 1005050, 466671, 1006110, 1032603]; Victorian State government; Pratt Foundation; Australian Research Council [FT100100764]; Australian Government National Health and Medical Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State government; Pratt Foundation; Australian Research Council(Australian Research Council); Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank the affected individuals and their families for their participation in this study, and B. Johns and R. Schultz for technical assistance. This work was supported by the National Health and Medical Research Council of Australia (Program Grant 628952 to S.F.B., I.E.S., S.P. and L.M.D., Program Grant 490037 to M.B., Training Fellowship 1016715 to S.E.H., Senior Research Fellowship 1005050 to S.P., Australia Fellowship 466671 to S.F.B., Practitioner Fellowship 1006110 to I.E.S. and Career Development Fellowship 1032603 to L.M.D.). The Florey Institute of Neuroscience and Mental Health is supported by Victorian State government infrastructure funds. K.R.S. is supported by a PhD scholarship funded by the Pratt Foundation. M.B. is supported by Australian Research Council Future Fellowship FT100100764. Work by K.R.S. and M.B. was also supported by Victorian State Government Operational Infrastructure and Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme (IRIISS) funding. The study was approved by the Human Research Ethics Committees of Austin Health and the University of South Australia. Informed consent was obtained from all participants or their parents or guardians.	Aridon P, 2006, AM J HUM GENET, V79, P342, DOI 10.1086/506459; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Derry CP, 2008, EPILEPSIA, V49, P2125, DOI 10.1111/j.1528-1167.2008.01652.x; Heron SE, 2007, NEUROTHERAPEUTICS, V4, P295, DOI 10.1016/j.nurt.2007.01.009; Hoda JC, 2008, MOL PHARMACOL, V74, P379, DOI 10.1124/mol.107.044545; Khatami R, 1998, J NEUROL, V245, P809, DOI 10.1007/s004150050291; Magnusson A, 2003, PSYCHIAT GENET, V13, P91, DOI 10.1097/01.ypg.0000056173.32550.b0; PLAZZI G, 1995, SLEEP, V18, P749, DOI 10.1093/sleep/18.9.749; Reid CA, 2009, PROG NEUROBIOL, V87, P41, DOI 10.1016/j.pneurobio.2008.09.016; Rodrigues-Pinguet N, 2003, J PHYSIOL-LONDON, V550, P11, DOI 10.1113/jphysiol.2003.036681; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009	14	244	254	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1188	1190		10.1038/ng.2440	http://dx.doi.org/10.1038/ng.2440			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23086396	Green Accepted			2022-12-25	WOS:000310495800008
J	Coelho, D; Kim, JC; Miousse, IR; Fung, S; du Moulin, M; Buers, I; Suormala, T; Burda, P; Frapolli, M; Stucki, M; Nurnberg, P; Thiele, H; Robenek, H; Hohne, W; Longo, N; Pasquali, M; Mengel, E; Watkins, D; Shoubridge, EA; Majewski, J; Rosenblatt, DS; Fowler, B; Rutsch, F; Baumgartner, MR				Coelho, David; Kim, Jaeseung C.; Miousse, Isabelle R.; Fung, Stephen; du Moulin, Marcel; Buers, Insa; Suormala, Terttu; Burda, Patricie; Frapolli, Michele; Stucki, Martin; Nuernberg, Peter; Thiele, Holger; Robenek, Horst; Hoehne, Wolfgang; Longo, Nicola; Pasquali, Marzia; Mengel, Eugen; Watkins, David; Shoubridge, Eric A.; Majewski, Jacek; Rosenblatt, David S.; Fowler, Brian; Rutsch, Frank; Baumgartner, Matthias R.			Mutations in ABCD4 cause a new inborn error of vitamin B-12 metabolism	NATURE GENETICS			English	Article							C-OXIDASE DEFICIENCY; CBLD DEFECT; METHYLMALONIC ACIDURIA; PEROXISOMAL MEMBRANE; COBALAMIN METABOLISM; MASS-SPECTROMETRY; LEIGH-SYNDROME; IDENTIFICATION; PROTEIN; TRANSPORTER	Inherited disorders of vitamin B-12 (cobalamin) have provided important clues to how this vitamin, which is essential for hematological and neurological function, is transported and metabolized. We describe a new disease that results in failure to release vitamin B-12 from lysosomes, which mimics the cblF defect caused by LMBRD1 mutations. Using microcell-mediated chromosome transfer and exome sequencing, we identified causal mutations in ABCD4, a gene that codes for an ABC transporter, which was previously thought to have peroxisomal localization and function. Our results show that ABCD4 colocalizes with the lysosomal proteins LAMP1 and LMBD1, the latter of which is deficient in the cblF defect. Furthermore, we show that mutations altering the putative ATPase domain of ABCD4 affect its function, suggesting that the ATPase activity of ABCD4 may be involved in intracellular processing of vitamin B-12.	[Coelho, David; Suormala, Terttu; Burda, Patricie; Frapolli, Michele; Stucki, Martin; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, Zurich, Switzerland; [Coelho, David; Suormala, Terttu; Burda, Patricie; Frapolli, Michele; Stucki, Martin; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, CRC, Zurich, Switzerland; [Coelho, David; Suormala, Terttu; Fowler, Brian] Univ Childrens Hosp, Metab Unit, Basel, Switzerland; [Kim, Jaeseung C.; Miousse, Isabelle R.; Fung, Stephen; Watkins, David; Shoubridge, Eric A.; Majewski, Jacek; Rosenblatt, David S.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [du Moulin, Marcel; Buers, Insa; Rutsch, Frank] Univ Childrens Hosp, Dept Gen Pediat, Munster, Germany; [Stucki, Martin; Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Nuernberg, Peter; Thiele, Holger] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Robenek, Horst] Univ Munster, Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Hoehne, Wolfgang] Charite, Dept Biochem, D-13353 Berlin, Germany; [Longo, Nicola] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Longo, Nicola; Pasquali, Marzia] Associated Reg & Univ Pathologists ARUP Labs, Salt Lake City, UT USA; [Pasquali, Marzia] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Mengel, Eugen] Univ Childrens Hosp, Metab Unit, Mainz, Germany; [Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	University Children's Hospital Zurich; University Children's Hospital Zurich; McGill University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Cologne; University of Cologne; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fowler, B (corresponding author), Univ Childrens Hosp, Div Metab, Zurich, Switzerland.	david.rosenblatt@mcgill.ca; brian.fowler@kispi.uzh.ch	Miousse, Isabelle R./K-3512-2013; Coelho, David/F-6680-2011; Thiele, Holger/ABE-6792-2020; Coelho, David/AAE-9547-2020; Baumgartner, Matthias R/Q-2855-2017	Miousse, Isabelle R./0000-0001-6543-3219; Coelho, David/0000-0001-7010-5789; Thiele, Holger/0000-0002-0169-998X; Baumgartner, Matthias R/0000-0002-9270-0826	Swiss National Science Foundation [320000_122568, 31003A_138521]; Deutsche Forschungsgemeinschaft [RU816/5-1]; Canadian Institutes for Health Research [15078]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank S. Lutz for technical assistance in carrying out enzyme assays and K. Locher for fruitful discussions. We thank J. Gartner (University of Gottingen) for providing cell lines with peroxisomal defects and R. Newbold (Brunel University) for providing the mouse-human monochromosomal hybrid cell lines used for microcell-mediated chromosome transfer. This work was supported by the Swiss National Science Foundation (320000_122568 and 31003A_138521) and by the Deutsche Forschungsgemeinschaft (RU816/5-1). D.S.R. is supported by the Canadian Institutes for Health Research (15078).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Alfares A, 2011, J MED GENET, V48, P602, DOI 10.1136/jmedgenet-2011-100230; Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Fowler B, 1997, PEDIATR RES, V41, P145, DOI 10.1203/00006450-199701000-00023; Fowler B, 1998, EUR J PEDIATR, V157, pS88, DOI 10.1007/PL00014311; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Hunt JD, 1996, ANAL BIOCHEM, V238, P107, DOI 10.1006/abio.1996.0263; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LITZKAS P, 1984, MOL CELL BIOL, V4, P2549, DOI 10.1128/MCB.4.11.2549; Matsukawa T, 2011, NEUROGENETICS, V12, P41, DOI 10.1007/s10048-010-0253-6; Miousse IR, 2009, J PEDIATR-US, V154, P551, DOI 10.1016/j.jpeds.2008.10.043; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Shani N, 1997, HUM MOL GENET, V6, P1925, DOI 10.1093/hmg/6.11.1925; Stucki M, 2012, HUM MOL GENET, V21, P1410, DOI 10.1093/hmg/ddr579; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Watkins D, 1998, CLIN INVEST MED, V21, P151; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541	35	144	153	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2012	44	10					1152	+		10.1038/ng.2386	http://dx.doi.org/10.1038/ng.2386			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922874	Green Accepted			2022-12-25	WOS:000309550200018
J	Silvius, JR				Silvius, John R.			MEMBRANES First steps to rafts?	NATURE CHEMICAL BIOLOGY			English	News Item							CELL-MEMBRANES; LIPID RAFTS; ORGANIZATION; MOLECULES		McGill Univ, Dept Chem, Montreal, PQ, Canada	McGill University	Silvius, JR (corresponding author), McGill Univ, Dept Chem, Montreal, PQ, Canada.	john.silvius@mcgill.ca						Chen Y, 2009, J CELL SCI, V122, P3966, DOI 10.1242/jcs.049346; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]	9	4	4	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					743	744		10.1038/nchembio.1045	http://dx.doi.org/10.1038/nchembio.1045			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22907090				2022-12-25	WOS:000308077600003
J	Stachowiak, JC; Schmid, EM; Ryan, CJ; Ann, HS; Sasaki, DY; Sherman, MB; Geissler, PL; Fletcher, DA; Hayden, CC				Stachowiak, Jeanne C.; Schmid, Eva M.; Ryan, Christopher J.; Ann, Hyoung Sook; Sasaki, Darryl Y.; Sherman, Michael B.; Geissler, Phillip L.; Fletcher, Daniel A.; Hayden, Carl C.			Membrane bending by protein-protein crowding	NATURE CELL BIOLOGY			English	Article							CLATHRIN-COATED PITS; CURVATURE GENERATION; BAR DOMAINS; VESICLE; EPSIN; ENDOCYTOSIS; ADSORPTION; TUBULATION; MECHANISM; BINDING	Curved membranes are an essential feature of dynamic cellular structures, including endocytic pits, filopodia protrusions and most organelles(1,2). It has been proposed that specialized proteins induce curvature by binding to membranes through two primary mechanisms: membrane scaffolding by curved proteins or complexes(3,4); and insertion of wedge-like amphipathic helices into the membrane(5,6). Recent computational studies have raised questions about the efficiency of the helix-insertion mechanism, predicting that proteins must cover nearly 100% of the membrane surface to generate high curvature(7-9), an improbable physiological situation. Thus, at present, we lack a sufficient physical explanation of how protein attachment bends membranes efficiently. On the basis of studies of epsin1 and AP180, proteins involved in clathrin-mediated endocytosis, we propose a third general mechanism for bending fluid cellular membranes: protein-protein crowding. By correlating membrane tubulation with measurements of protein densities on membrane surfaces, we demonstrate that lateral pressure generated by collisions between bound proteins drives bending. Whether proteins attach by inserting a helix or by binding lipid heads with an engineered tag, protein coverage above similar to 20% is sufficient to bend membranes. Consistent with this crowding mechanism, we find that even proteins unrelated to membrane curvature, such as green fluorescent protein (GFP), can bend membranes when sufficiently concentrated. These findings demonstrate a highly efficient mechanism by which the crowded protein environment on the surface of cellular membranes can contribute to membrane shape change.	[Stachowiak, Jeanne C.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Stachowiak, Jeanne C.; Sasaki, Darryl Y.; Hayden, Carl C.] Sandia Natl Labs, Livermore, CA 94551 USA; [Schmid, Eva M.; Ann, Hyoung Sook; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Ryan, Christopher J.; Geissler, Phillip L.; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Gradate Grp, Berkeley, CA 94720 USA; [Sherman, Michael B.] Univ Texas Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Geissler, Phillip L.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Geissler, Phillip L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Stachowiak, JC (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	jcstach@austin.utexas.edu; evaschmid@berkeley.edu; fletch@berkeley.edu; cchayde@sandia.gov			US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering (membrane studies and development) [DEAC02-05CH11231]; Division of Chemical Sciences, Geosciences, and Biosciences (fluorescence imaging and analysis); Laboratory Directed Research and Development program at Sandia National Laboratories (engineered vesicle design); NIH NIGMS and Nanomedicine Development Centers (protein membrane interactions); Sealy and Smith Foundation; Miller Institute for Basic Research in Science; Sandia Corporation; Lockheed Martin Company, for the United States Department of Energy's National Nuclear Security Administration under contract [DE-AC04-94AL85000]	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering (membrane studies and development); Division of Chemical Sciences, Geosciences, and Biosciences (fluorescence imaging and analysis); Laboratory Directed Research and Development program at Sandia National Laboratories (engineered vesicle design); NIH NIGMS and Nanomedicine Development Centers (protein membrane interactions); Sealy and Smith Foundation; Miller Institute for Basic Research in Science; Sandia Corporation(United States Department of Energy (DOE)); Lockheed Martin Company, for the United States Department of Energy's National Nuclear Security Administration under contract	We acknowledge H. McMahon (LMB, Cambridge, UK) and M. Ford (UC Davis, USA) for discussions on this work and contribution of reagents. This work was supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering (membrane studies and development, J.C.S., D.Y.S., Sandia), DEAC02-05CH11231 (membrane modelling, P.L.G., C.J.R.) and Division of Chemical Sciences, Geosciences, and Biosciences (fluorescence imaging and analysis, C.C.H., Sandia); as well as the Laboratory Directed Research and Development program at Sandia National Laboratories (engineered vesicle design, J.C.S., D.Y.S., C.C.H., D.A.F.); the NIH NIGMS and Nanomedicine Development Centers (protein membrane interactions, D.A.F., E.M.S., H.S.A.); a Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics (cryo-electron microscopy facility, M.B.S.); and the Miller Institute for Basic Research in Science (E.M.S.). Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000.	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Blood PD, 2008, BIOPHYS J, V95, P1866, DOI 10.1529/biophysj.107.121160; Brady RJ, 2008, J CELL SCI, V121, P3433, DOI 10.1242/jcs.032573; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; CARNAHAN NF, 1969, J CHEM PHYS, V51, P635, DOI 10.1063/1.1672048; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Dibble CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011740; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; FEDER J, 1980, J THEOR BIOL, V87, P237, DOI 10.1016/0022-5193(80)90358-6; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gizeli E, 2004, ANAL CHEM, V76, P3995, DOI 10.1021/ac034855g; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HARRISON SC, 1983, CELL, V33, P650, DOI 10.1016/0092-8674(83)90007-7; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Kent MS, 2004, LANGMUIR, V20, P2819, DOI 10.1021/la036207y; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Pack DW, 1997, CHEM PHYS LIPIDS, V86, P135, DOI 10.1016/S0009-3084(97)02662-5; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Sherman MB, 2006, J VIROL, V80, P10395, DOI 10.1128/JVI.01137-06; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Tsafrir I, 2001, PHYS REV LETT, V86, P1138, DOI 10.1103/PhysRevLett.86.1138; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Xie XH, 2012, DEV BIOL, V363, P399, DOI 10.1016/j.ydbio.2012.01.004; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; YUSTE SB, 1993, J CHEM PHYS, V99, P2020, DOI 10.1063/1.465264	39	347	349	3	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2012	14	9					944	+		10.1038/ncb2561	http://dx.doi.org/10.1038/ncb2561			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	004GJ	22902598				2022-12-25	WOS:000308668600010
J	Kamada, N; Chen, G; Nunez, G				Kamada, Nobuhiko; Chen, Grace; Nunez, Gabriel			Harnessing pathogen-commensal relations	NATURE MEDICINE			English	Editorial Material							HEMOLYTIC-UREMIC SYNDROME; VIRULENCE		[Kamada, Nobuhiko; Nunez, Gabriel] Univ Michigan, Dept Pathol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chen, Grace] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kamada, N (corresponding author), Univ Michigan, Dept Pathol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014; Kamada, Nobuhiko/AAW-3299-2020	Kamada, Nobuhiko/0000-0002-1980-4178				Badger VO, 2012, JPEN-PARENTER ENTER, V36, P645, DOI 10.1177/0148607112446703; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	13	17	18	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1190	1191		10.1038/nm.2900	http://dx.doi.org/10.1038/nm.2900			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869189				2022-12-25	WOS:000307469300023
J	Oh, E; Zhu, JY; Wang, ZY				Oh, Eunkyoo; Zhu, Jia-Ying; Wang, Zhi-Yong			Interaction between BZR1 and PIF4 integrates brassinosteroid and environmental responses	NATURE CELL BIOLOGY			English	Article							REGULATE CHLOROPLAST DEVELOPMENT; GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; PLANT-GROWTH; CELL ELONGATION; GENE-EXPRESSION; LIGHT; NETWORK; AUXIN	plant growth is coordinately regulated by environmental and hormonal signals. Brassinosteroid (BR) plays essential roles in growth regulation by light and temperature, but the interactions between BR and these environmental signals remain poorly understood at the molecular level. Here, we show that direct interaction between the dark- and heat-activated transcription factor phytochrome-interacting factor4 (PIF4) and the BR-activated transcription factor BZR1 integrates the hormonal and environmental signals. BZR1 and PIF4 interact with each other in vitro and in vivo, bind to nearly 2,000 common target genes, and synergistically regulate many of these target genes, including the PRE family helix-loop-helix factors required for promoting cell elongation. Genetic analysis indicates that BZR1 and PIFs are interdependent in promoting cell elongation in response to BR, darkness or heat. These results show that the BZR1-PIF4 interaction controls a core transcription network, enabling plant growth co-regulation by the steroid and environmental signals.	[Oh, Eunkyoo; Zhu, Jia-Ying; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Wang, ZY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390	NIH [R01GM066258]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Center for Genomics and Personalized Medicine (SCGPM) service centre led by M. Snyder and A. Sidow for the sequencing service, Z. Wen for carrying out the sequencing, Y. Bai for help with genomic data analysis and Y. Hao for experimental assistance. Research was primarily supported by a grant from the NIH (R01GM066258).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fan XY, 2012, MOL PLANT, V5, P591, DOI 10.1093/mp/sss041; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Hao YQ, 2012, MOL PLANT, V5, P688, DOI 10.1093/mp/sss011; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Ji H., 2011, CURR PROTOC BIOINFOR, V33; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kozuka T, 2010, PLANT PHYSIOL, V153, P1608, DOI 10.1104/pp.110.156802; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lorrain S, 2009, PLANT J, V60, P449, DOI 10.1111/j.1365-313X.2009.03971.x; Luo XM, 2010, DEV CELL, V19, P872, DOI 10.1016/j.devcel.2010.10.023; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Muino JM, 2011, NUCLEIC ACIDS RES, V39, pW524, DOI 10.1093/nar/gkr373; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nozue K, 2011, PLANT PHYSIOL, V156, P357, DOI 10.1104/pp.111.172684; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Richter R, 2010, GENE DEV, V24, P2093, DOI 10.1101/gad.594910; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Song L, 2009, MOL PLANT, V2, P755, DOI 10.1093/mp/ssp039; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vert G, 2011, DEV CELL, V21, P985, DOI 10.1016/j.devcel.2011.11.006; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Waters MT, 2008, PLANT J, V56, P432, DOI 10.1111/j.1365-313X.2008.03616.x; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yu XF, 2011, PLANT J, V65, P634, DOI 10.1111/j.1365-313X.2010.04449.x; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441	51	546	588	22	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					802	U64		10.1038/ncb2545	http://dx.doi.org/10.1038/ncb2545			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22820378	Green Accepted, Green Submitted			2022-12-25	WOS:000307115900009
J	Zhu, Q; Talton, J; Zhang, GF; Cunningham, T; Wang, ZJ; Waters, RC; Kirk, J; Eppler, B; Klinman, DM; Sui, YJ; Gagnon, S; Belyakov, IM; Mumper, RJ; Berzofsky, JA				Zhu, Qing; Talton, James; Zhang, Guofeng; Cunningham, Tshaka; Wang, Zijian; Waters, Robert C.; Kirk, James; Eppler, Baerbel; Klinman, Dennis M.; Sui, Yongjun; Gagnon, Susan; Belyakov, Igor M.; Mumper, Russell J.; Berzofsky, Jay A.			Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection	NATURE MEDICINE			English	Article							IN-VIVO EVALUATION; T-CELL RESPONSES; DRUG-DELIVERY; PROTECTS MICE; RECTAL MUCOSA; IMMUNIZATION; COMPARTMENTALIZATION; TRANSMISSION; TECHNOLOGIES; PROTEINS	Both rectal and vaginal mucosal surfaces serve as transmission routes for pathogenic microorganisms. Vaccination through large intestinal mucosa, previously proven protective for both of these mucosal sites in animal studies, can be achieved successfully by direct intracolorectal (i.c.r.) administration, but this route is clinically impractical. Oral vaccine delivery seems preferable but runs the risk of the vaccine's destruction in the upper gastrointestinal tract. Therefore, we designed a large intestine-targeted oral delivery with pH-dependent microparticles containing vaccine nanoparticles, which induced colorectal immunity in mice comparably to colorectal vaccination and protected against rectal and vaginal viral challenge. Conversely, vaccine targeted to the small intestine induced only small intestinal immunity and provided no rectal or vaginal protection, demonstrating functional compartmentalization within the gut mucosal immune system. Therefore, using this oral vaccine delivery system to target the large intestine, but not the small intestine, may represent a feasible new strategy for immune protection of rectal and vaginal mucosa.	[Zhu, Qing; Cunningham, Tshaka; Sui, Yongjun; Gagnon, Susan; Belyakov, Igor M.; Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Zhu, Qing] AF Gen Hosp, Dept Oncol, Beijing, Peoples R China; [Zhang, Guofeng] Natl Inst Biomed Imaging & Bioengn, Lab Bioengn & Phys Sci, US Natl Inst Hlth, Bethesda, MD USA; [Wang, Zijian] Jingmeng Res Ctr, Beijing, Peoples R China; [Klinman, Dennis M.] NCI, Expt Immunol Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Belyakov, Igor M.] Univ Michigan, Sch Med, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI USA; [Belyakov, Igor M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Mumper, Russell J.] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill	Zhu, Q (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA.	qing20892@gmail.com; berzofsj@mail.nih.gov	Sui, Yongjun/AAA-3228-2019	Talton, James/0000-0002-4310-661X; Sui, Yongjun/0000-0002-1568-4607	Intramural Research Program of NIH; National Cancer Institute; Center for Cancer Research; Intramural AIDS Targeted Antiviral Program; National Natural Science Foundation of China [31170872]; Collaborative Research and Development Agreement with Nanotherapeutics Inc; NATIONAL CANCER INSTITUTE [ZIASC004020, ZIABC010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000080] Funding Source: NIH RePORTER	Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Research and Development Agreement with Nanotherapeutics Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank B. Moss and P. Earl (US National Institutes of Health (NIH)) for generously providing vPE16, G. Cohen (University of Pennsylvania) for vaccinia antibodies, the NIH Tetramer Facility for tetramer P18-I10 and BEI Resources for vaccinia recombinant proteins. We also thank J. Hooper, D. Johnson, M. Dobrovolskaia, B. Zolnik, J. Gao and X. Liu for professional comments and help, and J. FitzGerald for electron microscopy. We appreciate Z. Xia, D. Pendleton, D. Li and L. Smith for their technical and secretarial assistance. This research was supported by the Intramural Research Program of NIH, the National Cancer Institute, the Center for Cancer Research and the Intramural AIDS Targeted Antiviral Program, a grant from the National Natural Science Foundation of China (31170872), and a Collaborative Research and Development Agreement with Nanotherapeutics Inc.	Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Belyakov IM, 1998, J CLIN INVEST, V102, P2072, DOI 10.1172/JCI5102; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; Bott C, 2004, ALIMENT PHARM THER, V20, P347, DOI 10.1111/j.1365-2036.2004.02033.x; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Cole ET, 2002, INT J PHARMACEUT, V231, P83, DOI 10.1016/S0378-5173(01)00871-7; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Cronkhite RI, 2004, VACCINE, V22, P2106, DOI 10.1016/j.vaccine.2003.12.012; Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Fogg C, 2004, J VIROL, V78, P10230, DOI 10.1128/JVI.78.19.10230-10237.2004; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Han M, 2009, J PHARM SCI-US, V98, P2626, DOI 10.1002/jps.21627; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Lehner T, 1996, NAT MED, V2, P767, DOI 10.1038/nm0796-767; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; McConnell EL, 2008, VACCINE, V26, P639, DOI 10.1016/j.vaccine.2007.11.071; Miller CJ, 1996, NAT MED, V2, P751, DOI 10.1038/nm0796-751; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Schellekens RCA, 2008, J CONTROL RELEASE, V132, P91, DOI 10.1016/j.jconrel.2008.08.008; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Shang LM, 2008, GASTROENTEROLOGY, V135, P529, DOI 10.1053/j.gastro.2008.04.020; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Zhu Q, 2008, MUCOSAL IMMUNOL, V1, P78, DOI 10.1038/mi.2007.3; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293	32	126	131	11	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1291	+		10.1038/nm.2866	http://dx.doi.org/10.1038/nm.2866			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22797811	Green Submitted, Green Accepted			2022-12-25	WOS:000307469300037
J	Senter, PD; Sievers, EL				Senter, Peter D.; Sievers, Eric L.			The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma	NATURE BIOTECHNOLOGY			English	Article							ANTIBODY-DRUG CONJUGATE; METASTATIC BREAST-CANCER; POTENT ANTITUMOR-ACTIVITY; ACUTE MYELOID-LEUKEMIA; MONOCLONAL-ANTIBODY; PHASE-II; HEMATOLOGIC MALIGNANCIES; GEMTUZUMAB OZOGAMICIN; ANTINEOPLASTIC AGENTS; ANTICANCER DRUGS	Progress has been made recently in developing antibody-drug conjugates (ADCs) that can selectively deliver cancer drugs to tumor cells. In principle, the idea is simple: by attaching drugs to tumor-seeking antibodies, target cells will be killed and nontarget cells will be spared. In practice, many parameters needed to be addressed to develop safe and effective ADCs, including the expression profiles of tumor versus normal tissues, the potency of the drug, the linker attaching the drug and placement of the drug on the antibody, and the pharmacokinetic and stability profiles of the resulting ADC. All these issues had been taken into account in developing brentuximab vedotin (Adcetris), an ADC that recently received accelerated approval by the US Food and Drug Administration for the treatment of relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL). Research is under way to extend the applications of brentuximab vedotin and to advance the field by developing other ADCs with new linker and conjugation strategies.	[Senter, Peter D.; Sievers, Eric L.] Seattle Genet, Bothell, WA USA	Seattle Genetics	Senter, PD (corresponding author), Seattle Genet, Bothell, WA USA.	psenter@seagen.com		Sievers, Eric/0000-0002-0794-9441				Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Andersen DC, 2004, CURR OPIN BIOTECH, V15, P456, DOI 10.1016/j.copbio.2004.08.002; Ansell SM, 2007, J CLIN ONCOL, V25, P2764, DOI 10.1200/JCO.2006.07.8972; ARNON R, 1982, IMMUNOL REV, V62, P5, DOI 10.1111/j.1600-065X.1982.tb00387.x; Baselga J, 2005, J CLIN ONCOL, V23, P2162, DOI 10.1200/JCO.2005.01.014; Beck A, 2011, MABS-AUSTIN, V3, P331, DOI 10.4161/mabs.3.4.16612; Bernardes GJL, 2012, ANGEW CHEM INT EDIT, V51, P941, DOI 10.1002/anie.201106527; Boghaert ER, 2008, CANCER CHEMOTH PHARM, V61, P1027, DOI 10.1007/s00280-007-0560-2; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Connors JM, 2005, J CLIN ONCOL, V23, P6400, DOI 10.1200/JCO.2005.05.016; Deutsch YE, 2011, LEUKEMIA LYMPHOMA, V52, P1641, DOI 10.3109/10428194.2011.574761; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dubowchik GM, 1998, BIOORG MED CHEM LETT, V8, P3347, DOI 10.1016/S0960-894X(98)00610-6; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Fanale MA, 2012, CLIN CANCER RES, V18, P248, DOI 10.1158/1078-0432.CCR-11-1425; Forero-Torres A, 2009, BRIT J HAEMATOL, V146, P171, DOI 10.1111/j.1365-2141.2009.07740.x; Friedman M, 2009, BIOTECHNOL APPL BIOC, V53, P1, DOI 10.1042/BA20080287; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hartley JA, 2010, CANCER RES, V70, P6849, DOI 10.1158/0008-5472.CAN-10-0790; Hollander I, 2008, BIOCONJUGATE CHEM, V19, P358, DOI 10.1021/bc700321z; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; JAIN RK, 1990, FRONT RADIAT THER ON, V24, P32; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kantarjian H, 2012, LANCET ONCOL, V13, P403, DOI 10.1016/S1470-2045(11)70386-2; Keir CH, 2012, EXPERT OPIN BIOL TH, V12, P259, DOI 10.1517/14712598.2012.642357; Kim KM, 2008, MOL CANCER THER, V7, P2486, DOI 10.1158/1535-7163.MCT-08-0388; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krop IE, 2012, J CLIN ONCOL, V30, P3234, DOI 10.1200/JCO.2011.40.5902; Krop IE, 2010, J CLIN ONCOL, V28, P2698, DOI 10.1200/JCO.2009.26.2071; Leonard JP, 2003, J CLIN ONCOL, V21, P3051, DOI 10.1200/JCO.2003.01.082; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Lyon RP, 2012, METHOD ENZYMOL, V502, P123, DOI 10.1016/B978-0-12-416039-2.00006-9; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Moldenhauer G, 2012, JNCI-J NATL CANCER I, V104, P622, DOI 10.1093/jnci/djs140; Oflazoglu E, 2008, BRIT J HAEMATOL, V142, P69, DOI 10.1111/j.1365-2141.2008.07146.x; Perez EA, 2005, INVEST NEW DRUG, V23, P257, DOI 10.1007/s10637-005-6735-y; Petersdorf S, 2009, BLOOD, V114; PETERSEN BH, 1991, CANCER RES, V51, P2286; PETTIT GR, 1987, J AM CHEM SOC, V109, P6883, DOI 10.1021/ja00256a070; Pettit GR, 1998, ANTI-CANCER DRUG DES, V13, P243; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Ravandi F, 2011, J CLIN ONCOL, V29, P349, DOI 10.1200/JCO.2010.32.2693; Schnell R, 2002, CLIN CANCER RES, V8, P1779; Schwartz RS, 2004, NEW ENGL J MED, V350, P1079, DOI 10.1056/NEJMp048021; Senter PD, 2009, CURR OPIN CHEM BIOL, V13, P235, DOI 10.1016/j.cbpa.2009.03.023; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sievers EL, 2001, CURR OPIN ONCOL, V13, P522, DOI 10.1097/00001622-200111000-00016; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Tolcher AW, 1999, J CLIN ONCOL, V17, P478, DOI 10.1200/JCO.1999.17.2.478; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wahl AF, 2002, CANCER RES, V62, P3736; Walter R.B., 2012, BLOOD           0127, DOI DOI 10.1182/BLOOD-2011-11-325050; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965	65	524	553	15	260	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					631	637		10.1038/nbt.2289	http://dx.doi.org/10.1038/nbt.2289			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781692				2022-12-25	WOS:000306293400022
J	Golden, SA; Christoffel, DJ; Heshmati, M; Hodes, GE; Magida, J; Davis, K; Cahill, ME; Dias, C; Ribeiro, E; Ables, JL; Kennedy, PJ; Robison, AJ; Gonzalez-Maeso, J; Neve, RL; Turecki, G; Ghose, S; Tamminga, CA; Russo, SJ				Golden, Sam A.; Christoffel, Daniel J.; Heshmati, Mitra; Hodes, Georgia E.; Magida, Jane; Davis, Keithara; Cahill, Michael E.; Dias, Caroline; Ribeiro, Efrain; Ables, Jessica L.; Kennedy, Pamela J.; Robison, Alfred J.; Gonzalez-Maeso, Javier; Neve, Rachael L.; Turecki, Gustavo; Ghose, Subroto; Tamminga, Carol A.; Russo, Scott J.			Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression	NATURE MEDICINE			English	Article							SOCIAL DEFEAT STRESS; NUCLEUS-ACCUMBENS; SPINE PLASTICITY; DENDRITIC SPINES; RHO; GTPASE; KINASE; MODULATION; CHROMATIN; GLUTAMATE	Depression induces structural and functional synaptic plasticity in brain reward circuits, although the mechanisms promoting these changes and their relevance to behavioral outcomes are unknown. Transcriptional profiling of the nucleus accumbens (NAc) for Rho GTPase related genes, which are known regulators of synaptic structure, revealed a sustained reduction in RAS-related C3 botulinum toxin substrate 1 (Rac1) expression after chronic social defeat stress. This was associated with a repressive chromatin state surrounding the proximal promoter of Rac1. Inhibition of class 1 histone deacetylases (HDACs) with MS-275 rescued both the decrease in Rac1 transcription after social defeat stress and depression-related behavior, such as social avoidance. We found a similar repressive chromatin state surrounding the RAC1 promoter in the NAc of subjects with depression, which corresponded with reduced RAC1 transcription. Viral-mediated reduction of Rac1 expression or inhibition of Rac1 activity in the NAc increases social defeat induced social avoidance and anhedonia in mice. Chronic social defeat stress induces the formation of stubby excitatory spines through a Rac1-dependent mechanism involving the redistribution of synaptic cofilin, an actin-severing protein downstream of Rac1. Overexpression of constitutively active Rac1 in the NAc of mice after chronic social defeat stress reverses depression-related behaviors and prunes stubby spines. Taken together, our data identify epigenetic regulation of RAC1 in the NAc as a disease mechanism in depression and reveal a functional role for Rac1 in rodents in regulating stress-related behaviors.	[Golden, Sam A.; Christoffel, Daniel J.; Heshmati, Mitra; Hodes, Georgia E.; Magida, Jane; Davis, Keithara; Cahill, Michael E.; Dias, Caroline; Ribeiro, Efrain; Kennedy, Pamela J.; Robison, Alfred J.; Gonzalez-Maeso, Javier; Russo, Scott J.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Fishberg Dept Neurosci, New York, NY USA; [Golden, Sam A.; Christoffel, Daniel J.; Heshmati, Mitra; Hodes, Georgia E.; Magida, Jane; Davis, Keithara; Cahill, Michael E.; Dias, Caroline; Ribeiro, Efrain; Kennedy, Pamela J.; Robison, Alfred J.; Gonzalez-Maeso, Javier; Russo, Scott J.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Friedman Brain Inst, New York, NY USA; [Ables, Jessica L.] Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, McGovern Inst, Cambridge, MA 02139 USA; [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, Depress Disorders Program, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Montreal, PQ, Canada; [Ghose, Subroto; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Massachusetts Institute of Technology (MIT); McGill University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Fishberg Dept Neurosci, New York, NY USA.	scott.russo@mssm.edu	Hodes, Georgia/L-8022-2016; Ghose, Subroto/J-6732-2016; Turecki, Gustavo/K-5100-2015; Russo, Scott/R-7107-2019; Robison, Alfred J/P-8521-2018	Hodes, Georgia/0000-0002-1551-2178; Russo, Scott/0000-0002-6470-1805; Robison, Alfred J/0000-0002-4150-9570; Christoffel, Dan/0000-0002-6303-5134; Cahill, Michael/0000-0003-0574-2655; Ables, Jessica L./0000-0003-1818-3506; Turecki, Gustavo/0000-0003-4075-2736; Golden, Sam/0000-0002-2104-2272	US National Institute of Mental Health [R01 MH090264, P50 MH66172, P50MH096890]; Johnson and Johnson International Mental Health Research Organization Rising Star Award; US National Institutes of Health [T32 GM062754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090264, T32MH087004, P50MH096890, R01MH084894, P50MH066172] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson and Johnson International Mental Health Research Organization Rising Star Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Y. Zeng (University of Cincinnati) for providing Rac1<SUP>flox/flox</SUP> mice. This research was supported by US National Institute of Mental Health grant R01 MH090264, the Johnson and Johnson International Mental Health Research Organization Rising Star Award (S.J.R.), US National Institute of Mental Health grants P50 MH66172 and P50MH096890 (C.A.T.) and US National Institutes of Health grant T32 GM062754 (K.D.).	Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bongmba OYN, 2011, BRAIN RES, V1399, P79, DOI 10.1016/j.brainres.2011.05.020; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Chen LY, 2010, J NEUROSCI, V30, P10977, DOI 10.1523/JNEUROSCI.1077-10.2010; Christoffel DJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2615, DOI 10.1038/npp.2012.121; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dubos A, 2012, J NEUROSCI, V32, P519, DOI 10.1523/JNEUROSCI.3252-11.2012; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Fang J, 2012, SOC NEUR ABSTR, V458, p12/T7; Golden SA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011957; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kiraly DD, 2010, ACS CHEM NEUROSCI, V1, P348, DOI 10.1021/cn100012x; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; Martinez LA, 2011, NEUROPHARMACOLOGY, V61, P305, DOI 10.1016/j.neuropharm.2011.04.017; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Palucha A, 2005, DRUG NEWS PERSPECT, V18, P262, DOI 10.1358/dnp.2005.18.4.908661; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Stolzenburg S, 2010, METHODS MOL BIOL, V649, P117, DOI 10.1007/978-1-60761-753-2_7; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; TISSOT R, 1975, Neuropsychobiology, V1, P243, DOI 10.1159/000117498; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Vidal R, 2011, CURR PHARM DESIGN, V17, P521, DOI 10.2174/138161211795164086; Wei Q, 2012, BIOL PSYCHIAT, V71, P224, DOI 10.1016/j.biopsych.2011.07.009; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013	50	204	212	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					337	344		10.1038/nm.3090	http://dx.doi.org/10.1038/nm.3090			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23416703	Green Accepted			2022-12-25	WOS:000316040700027
J	Kirby, A; Gnirke, A; Jaffe, DB; Baresova, V; Pochet, N; Blumenstiel, B; Ye, C; Aird, D; Stevens, C; Robinson, JT; Cabili, MN; Gat-Viks, I; Kelliher, E; Daza, R; DeFelice, M; Hulkova, H; Sovova, J; Vylet'al, P; Antignac, C; Guttman, M; Handsaker, RE; Perrin, D; Steelman, S; Sigurdsson, S; Scheinman, SJ; Sougnez, C; Cibulskis, K; Parkin, M; Green, T; Rossin, E; Zody, MC; Xavier, RJ; Pollak, MR; Alper, SL; Lindblad-Toh, K; Gabriel, S; Hart, PS; Regev, A; Nusbaum, C; Kmoch, S; Bleyer, AJ; Lander, ES; Daly, MJ				Kirby, Andrew; Gnirke, Andreas; Jaffe, David B.; Baresova, Veronika; Pochet, Nathalie; Blumenstiel, Brendan; Ye, Chun; Aird, Daniel; Stevens, Christine; Robinson, James T.; Cabili, Moran N.; Gat-Viks, Irit; Kelliher, Edward; Daza, Riza; DeFelice, Matthew; Hulkova, Helena; Sovova, Jana; Vylet'al, Petr; Antignac, Corinne; Guttman, Mitchell; Handsaker, Robert E.; Perrin, Danielle; Steelman, Scott; Sigurdsson, Snaevar; Scheinman, Steven J.; Sougnez, Carrie; Cibulskis, Kristian; Parkin, Melissa; Green, Todd; Rossin, Elizabeth; Zody, Michael C.; Xavier, Ramnik J.; Pollak, Martin R.; Alper, Seth L.; Lindblad-Toh, Kerstin; Gabriel, Stacey; Hart, P. Suzanne; Regev, Aviv; Nusbaum, Chad; Kmoch, Stanislav; Bleyer, Anthony J.; Lander, Eric S.; Daly, Mark J.			Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing	NATURE GENETICS			English	Article							GENETIC DIAGNOSIS; CHROMOSOME 1Q21; REFINEMENT; LINKAGE; LOCUS; MCKD1; MAP	Although genetic lesions responsible for some mendelian disorders can be rapidly discovered through massively parallel sequencing of whole genomes or exomes, not all diseases readily yield to such efforts. We describe the illustrative case of the simple mendelian disorder medullary cystic kidney disease type 1 (MCKD1), mapped more than a decade ago to a 2-Mb region on chromosome 1. Ultimately, only by cloning, capillary sequencing and de novo assembly did we find that each of six families with MCKD1 harbors an equivalent but apparently independently arising mutation in sequence markedly under-represented in massively parallel sequencing data: the insertion of a single cytosine in one copy (but a different copy in each family) of the repeat unit comprising the extremely long (similar to 1.5-5 kb), GC-rich (>80%) coding variable-number tandem repeat (VNTR) sequence in the MUC1 gene encoding mucin 1. These results provide a cautionary tale about the challenges in identifying the genes responsible for mendelian, let alone more complex, disorders through massively parallel sequencing.	[Kirby, Andrew; Gnirke, Andreas; Jaffe, David B.; Pochet, Nathalie; Blumenstiel, Brendan; Ye, Chun; Aird, Daniel; Stevens, Christine; Robinson, James T.; Cabili, Moran N.; Gat-Viks, Irit; Daza, Riza; DeFelice, Matthew; Guttman, Mitchell; Handsaker, Robert E.; Perrin, Danielle; Steelman, Scott; Sigurdsson, Snaevar; Sougnez, Carrie; Cibulskis, Kristian; Parkin, Melissa; Green, Todd; Rossin, Elizabeth; Zody, Michael C.; Xavier, Ramnik J.; Lindblad-Toh, Kerstin; Gabriel, Stacey; Regev, Aviv; Nusbaum, Chad; Lander, Eric S.; Daly, Mark J.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Kirby, Andrew; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Baresova, Veronika; Hulkova, Helena; Sovova, Jana; Vylet'al, Petr; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic; [Pochet, Nathalie] Univ Ghent VIB, Dept Plant Syst Biol, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Cabili, Moran N.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Gat-Viks, Irit] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Antignac, Corinne] INSERM, U983, Paris, France; [Antignac, Corinne] Univ Paris 05, Inst Imagine, Paris, France; [Antignac, Corinne] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Dept Genet, Paris, France; [Handsaker, Robert E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Scheinman, Steven J.] Commonwealth Med Coll, Scranton, PA USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Ctr Study Inflammatory Bowe, Boston, MA USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA; [Pollak, Martin R.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Pollak, Martin R.; Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, Uppsala, Sweden; [Hart, P. Suzanne] NHGRI, Off Clin Director, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Bleyer, Anthony J.] Wake Forest Sch Med, Sect Nephrol, Winston Salem, NC 27106 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Charles University Prague; Flanders Institute for Biotechnology (VIB); Ghent University; Harvard University; Harvard Medical School; Tel Aviv University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Harvard University; Harvard Medical School; Geisinger Commonwealth School of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Uppsala University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wake Forest University	Bleyer, AJ (corresponding author), Wake Forest Sch Med, Sect Nephrol, Winston Salem, NC 27106 USA.	ableyer@wfubmc.edu; lander@broadinstitute.org; mjdaly@atgu.mgh.harvard.edu	Vyleťal, Petr/F-4771-2017; Handsaker, Bob/AAX-9095-2021; Kmoch, Stanislav/C-1575-2010; Baresova, Veronika/H-4931-2017; Daly, Mark J/B-2453-2017; Pochet, Nathalie/Q-1322-2017; Hůlková, Helena/O-2268-2017; Ye, Chun/AAK-4868-2021; Vyleťal, Petr/AAC-3468-2021; Daza, Riza M./HCH-4047-2022; Vyleťal, Petr/AHE-7903-2022; ANTIGNAC, Corinne/H-8945-2017; Cibulskis, Kristian/AAC-7380-2019	Vyleťal, Petr/0000-0002-9357-1237; Handsaker, Bob/0000-0002-3128-3547; Kmoch, Stanislav/0000-0002-6239-707X; Baresova, Veronika/0000-0001-8989-6090; Daly, Mark J/0000-0002-0949-8752; Pochet, Nathalie/0000-0003-1820-5656; Hůlková, Helena/0000-0002-7441-6610; Ye, Chun/0000-0001-6560-3783; ANTIGNAC, Corinne/0000-0002-9934-4940; Stevens, Christine/0000-0002-2621-2234; Cibulskis, Kristian/0000-0003-1343-1582; Sigurdsson, Snaevar/0000-0003-4860-6311	Carlos Slim Health Institute; Intramural Research Program of the US NIH, National Human Genome Research Institute (NHGRI); Charles University [PRVOUK-P24/LF1/3, UNCE 204011]; Ministry of Education [LH12015, NT13116-4/2012]; US NIH grant [DK34854]; Human Frontier Science Program, Alon; Israeli Centers of Research Excellence (I-CORE); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Ministry of Health of the Czech Republic; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Carlos Slim Health Institute; Intramural Research Program of the US NIH, National Human Genome Research Institute (NHGRI); Charles University; Ministry of Education; US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program, Alon; Israeli Centers of Research Excellence (I-CORE); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T.L. Hatte for reagent use. We thank D. Altshuler, T. Carter and J. Schlondorff for useful discussions and M. Cortes, M. Ilzarbe and M. Betancourt for helpful project management. We also thank F. Letendre, M. Coole, R.P. Frere, C. Bonnet, L. Mulrain, N. Norbui and H. Arachchi for Sanger sequencing. This work was conducted as part of the Slim Initiative for Genomic Medicine, a joint United States-Mexico project funded by the Carlos Slim Health Institute. This research was supported in part by the Intramural Research Program of the US NIH, National Human Genome Research Institute (NHGRI). S.K., H.H., J.S. and V.B. were funded by Charles University programs PRVOUK-P24/LF1/3 and UNCE 204011, and their work was supported by grants LH12015 and NT13116-4/2012 from the Ministry of Education and the Ministry of Health of the Czech Republic. S.L.A. was supported by US NIH grant DK34854 (The Harvard Digestive Diseases Center). N.P. is a Broad Fellow of the Broad Institute and a postdoctoral research fellow of the Fund for Scientific Research-Flanders (FWO Vlaanderen, Belgium). I.G.-V. was supported by the Human Frontier Science Program, Alon, the Israeli Centers of Research Excellence (I-CORE) and the Edmond J. Safra Center for Bioinformatics at Tel Aviv University.	Al-Romaih KI, 2011, AM J KIDNEY DIS, V58, P186, DOI 10.1053/j.ajkd.2011.01.025; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auranen M, 2001, KIDNEY INT, V60, P1225, DOI 10.1046/j.1523-1755.2001.00931.x; Bleyer AJ, 2010, SEMIN NEPHROL, V30, P366, DOI 10.1016/j.semnephrol.2010.06.003; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; Castro AF, 2009, AM J KIDNEY DIS, V53, pS46, DOI 10.1053/j.ajkd.2008.07.054; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Christodoulou K, 1998, HUM MOL GENET, V7, P905, DOI 10.1093/hmg/7.5.905; Fowler JC, 2003, HUM GENET, V113, P473, DOI 10.1007/s00439-003-1011-8; Fuchshuber A, 2001, GENOMICS, V72, P278, DOI 10.1006/geno.2000.6486; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Horne AW, 2001, LANCET, V357, P1336, DOI 10.1016/S0140-6736(00)04502-5; Kiser RL, 2004, AM J KIDNEY DIS, V44, P611, DOI 10.1053/j.ajkd.2004.06.027; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Wolf MTF, 2006, HUM GENET, V119, P649, DOI 10.1007/s00439-006-0176-3; Wolf MTF, 2004, KIDNEY INT, V66, P580, DOI 10.1111/j.1523-1755.2004.00799.x	19	167	177	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					299	303		10.1038/ng.2543	http://dx.doi.org/10.1038/ng.2543			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23396133	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000315664800015
J	Lentz, JJ; Jodelka, FM; Hinrich, AJ; McCaffrey, KE; Farris, HE; Spalitta, MJ; Bazan, NG; Duelli, DM; Rigo, F; Hastings, ML				Lentz, Jennifer J.; Jodelka, Francine M.; Hinrich, Anthony J.; McCaffrey, Kate E.; Farris, Hamilton E.; Spalitta, Matthew J.; Bazan, Nicolas G.; Duelli, Dominik M.; Rigo, Frank; Hastings, Michelle L.			Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness	NATURE MEDICINE			English	Article							USHER-SYNDROME; HAIR-BUNDLE; GENE-THERAPY; USH1C; CELL; MECHANISMS; FREQUENCY; HARMONIN; MUTATIONS; COHESION	Hearing impairment is the most common sensory disorder, with congenital hearing impairment present in approximately 1 in 1,000 newborns(1). Hereditary deafness is often mediated by the improper development or degeneration of cochlear hair cells(2). Until now, it was not known whether such congenital failures could be mitigated by therapeutic intervention(3-5). Here we show that hearing and vestibular function can be rescued in a mouse model of human hereditary deafness. An antisense oligonucleotide (ASO) was used to correct defective pre-mRNA splicing of transcripts from the USH1C gene with the c.216G>A mutation, which causes human Usher syndrome, the leading genetic cause of combined deafness and blindness(6,7). Treatment of neonatal mice with a single systemic dose of ASO partially corrects Ush1c c.216G>A splicing, increases protein expression, improves stereocilia organization in the cochlea, and rescues cochlear hair cells, vestibular function and low-frequency hearing in mice. These effects were sustained for several months, providing evidence that congenital deafness can be effectively overcome by treatment early in development to correct gene expression and demonstrating the therapeutic potential of ASOs in the treatment of deafness.	[Lentz, Jennifer J.; Farris, Hamilton E.; Spalitta, Matthew J.; Bazan, Nicolas G.] LSUHSC, Ctr Neurosci, New Orleans, LA USA; [Lentz, Jennifer J.; Farris, Hamilton E.; Spalitta, Matthew J.] LSUHSC, Dept Otorhinolaryngol & Biocommun, New Orleans, LA USA; [Jodelka, Francine M.; Hinrich, Anthony J.; McCaffrey, Kate E.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA; [Bazan, Nicolas G.] LSUHSC, Dept Ophthalmol, New Orleans, LA USA; [Duelli, Dominik M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL USA; [Rigo, Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Chicago Medical School; Rosalind Franklin University Medical & Science; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Chicago Medical School; Rosalind Franklin University Medical & Science; Isis Pharmaceuticals Inc	Hastings, ML (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA.	jlentz@lsuhsc.edu; michelle.hastings@rosalindfranklin.edu	Bazan, Nicolas/AAN-4121-2020; Hastings, MICHELLE L./AAK-6627-2021	Bazan, Nicolas/0000-0002-9243-5444; Jodelka, Francine/0000-0001-9374-8437; Hastings, Michelle L./0000-0002-4253-9261	Hearing Health Foundation; Midwest Eye-Banks; National Organization for Hearing Research Foundation; Capita Foundation; US National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012596] Funding Source: NIH RePORTER	Hearing Health Foundation; Midwest Eye-Banks; National Organization for Hearing Research Foundation; Capita Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We gratefully acknowledge support from the Hearing Health Foundation, Midwest Eye-Banks, the National Organization for Hearing Research Foundation, Capita Foundation and the US National Institutes of Health. We thank D. Cunningham and E. Rubel for assistance with scanning electron microscopy analysis; A. Rosenkranz, R. Marr and M. Oblinger for use of equipment; J. Huang for assistance with open-field analysis, L. Ochoa for assistance with ABR analysis computer support, G. MacDonald for assistance with confocal imaging and deconvolution analysis, U. Wolfrum (Johannes Gutenberg University of Mainz) for harmonin b-specific antibodies, H. Thompson for statistical analysis, and A. Case, B. Keats and M. Havens for discussions and comments on the manuscript.	Bermingham-McDonogh O, 2011, NEURON, V71, P389, DOI 10.1016/j.neuron.2011.07.015; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; de Felipe MMC, 2011, HISTOL HISTOPATHOL, V26, P923, DOI 10.14670/HH-26.923; Di Domenico M, 2011, J CELL PHYSIOL, V226, P2494, DOI 10.1002/jcp.22617; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Ebermann I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r47; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hall J, 2000, TLS-TIMES LIT SUPPL, P20; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lentz J, 2005, HUM GENET, V116, P225, DOI 10.1007/s00439-004-1217-4; Lentz J, 2007, MUTAT RES-FUND MOL M, V616, P139, DOI 10.1016/j.mrfmmm.2006.11.006; Lentz JJ, 2010, DEV NEUROBIOL, V70, P253, DOI 10.1002/dneu.20771; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Ouyang XM, 2003, CLIN GENET, V63, P150, DOI 10.1046/j.0009-9163.2002.00004.x; Peng AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1533; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Uhlmann RA, 2010, CURR OPIN OBSTET GYN, V22, P155, DOI 10.1097/GCO.0b013e32833723b5; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362	28	140	149	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					345	350		10.1038/nm.3106	http://dx.doi.org/10.1038/nm.3106			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23380860	Green Accepted			2022-12-25	WOS:000316040700028
J	Na, D; Yoo, SM; Chung, H; Park, H; Park, JH; Lee, SY				Na, Dokyun; Yoo, Seung Min; Chung, Hannah; Park, Hyegwon; Park, Jin Hwan; Lee, Sang Yup			Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs	NATURE BIOTECHNOLOGY			English	Article							MESSENGER-RNA; EXPRESSION; MODEL	Small regulatory RNAs (sRNAs) regulate gene expression in bacteria. We designed synthetic sRNAs to identify and modulate the expression of target genes for metabolic engineering in Escherichia coli. Using synthetic sRNAs for the combinatorial knockdown of four candidate genes in 14 different strains, we isolated an engineered E. coli strain (tyrR- and csrA-repressed S17-1) capable of producing 2 g per liter of tyrosine. Using a library of 130 synthetic sRNAs, we also identified chromosomal gene targets that enabled substantial increases in cadaverine production. Repression of murE led to a 55% increase in cadaverine production compared to the reported engineered strain (XQ56 harboring the plasmid p15CadA)(1). The design principles and the engineering strategy using synthetic sRNAs reported here are generalizable to other bacteria and applicable in developing superior producer strains. The ability to fine-tune target genes with designed sRNAs provides substantial advantages over gene-knockout strategies and other large-scale target identification strategies owing to its easy implementation, ability to modulate chromosomal gene expression without modifying those genes and because it does not require construction of strain libraries.	[Na, Dokyun; Yoo, Seung Min; Chung, Hannah; Park, Hyegwon; Park, Jin Hwan; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Metab & Biomol Engn Natl Res Lab, Program BK21, Taejon 305701, South Korea; [Na, Dokyun; Yoo, Seung Min; Park, Jin Hwan; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Inst BioCentury, Ctr Syst & Synthet Biotechnol, BioProc Engn Res Ctr,Bioinformat Res Ctr, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Metab & Biomol Engn Natl Res Lab, Program BK21, Taejon 305701, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; Na, Dokyun/0000-0002-9107-7040	Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries [NRF-2012-C1AAA001-2012M1A2A2026556]; Intelligent Synthetic Biology Center through the Global Frontier Project of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea [2011-0031963]; World Class University program of MEST [R32-2008-000-10142-0]	Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries; Intelligent Synthetic Biology Center through the Global Frontier Project of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); World Class University program of MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We would like to thank M.-H. Lee for measuring tyrosine and cadaverine concentrations using high-performance liquid chromatography, Y.H. Lee for 2D-PAGE experiments, J.A. Im for large-scale cloning of synthetic sRNAs and cultivation experiments, and S.J. Choi for fermentation experiments. This work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries (NRF-2012-C1AAA001-2012M1A2A2026556); the Intelligent Synthetic Biology Center through the Global Frontier Project (2011-0031963) of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea; and the World Class University program (R32-2008-000-10142-0) of MEST.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Culver GM, 2001, STRUCTURE, V9, P751, DOI 10.1016/S0969-2126(01)00649-9; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Desai SK, 2004, J AM CHEM SOC, V126, P13247, DOI 10.1021/ja048634j; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hua Q, 2003, J BACTERIOL, V185, P7053, DOI 10.1128/JB.185.24.7053-7067.2003; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Juminaga D, 2012, APPL ENVIRON MICROB, V78, P89, DOI 10.1128/AEM.06017-11; Kadir TAA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-88; Kang Z, 2012, BIOTECHNOL LETT, V34, P527, DOI 10.1007/s10529-011-0794-2; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; LEE SY, 1994, BIOTECHNOL BIOENG, V44, P1337, DOI 10.1002/bit.260441110; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Luetke-Eversloh T, 2008, METAB ENG, V10, P69, DOI 10.1016/j.ymben.2007.12.001; Lutke-Eversloh T, 2007, APPL MICROBIOL BIOT, V75, P103, DOI 10.1007/s00253-006-0792-9; Man SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr034; Na D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-71; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pichon C, 2012, NUCLEIC ACIDS RES, V40, P2846, DOI 10.1093/nar/gkr1141; Qian ZG, 2011, BIOTECHNOL BIOENG, V108, P93, DOI 10.1002/bit.22918; Saito H, 2009, INT J BIOCHEM CELL B, V41, P398, DOI 10.1016/j.biocel.2008.08.017; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sharma V, 2012, ACS SYNTH BIOL, V1, P6, DOI 10.1021/sb200001q; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311	30	409	450	19	311	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					170	174		10.1038/nbt.2461	http://dx.doi.org/10.1038/nbt.2461			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23334451				2022-12-25	WOS:000315322100030
J	Kozik, P; Hodson, NA; Sahlender, DA; Simecek, N; Soromani, C; Wu, JH; Collinson, LM; Robinson, MS				Kozik, Patrycja; Hodson, Nicola A.; Sahlender, Daniela A.; Simecek, Nikol; Soromani, Christina; Wu, Jiahua; Collinson, Lucy M.; Robinson, Margaret S.			A human genome-wide screen for regulators of clathrin-coated vesicle formation reveals an unexpected role for the V-ATPase	NATURE CELL BIOLOGY			English	Article							PICK TYPE-C; TRANS-GOLGI NETWORK; MEDIATED ENDOCYTOSIS; LYSOSOMAL CHOLESTEROL; RECEPTOR TRAFFICKING; ACCESSORY PROTEINS; H+-ATPASE; ACIDIFICATION; REQUIREMENT; DEPLETION	Clathrin-mediated endocytosis is essential for a wide range of cellular functions. We used a multi-step siRNA-based screening strategy to identify regulators of the first step in clathrin-mediated endocytosis, formation of clathrin-coated vesicles (CCVs) at the plasma membrane. A primary genome-wide screen identified 334 hits that caused accumulation of CCV cargo on the cell surface. A secondary screen identified 92 hits that inhibited cargo uptake and/or altered the morphology of clathrin-coated structures. The hits include components of four functional complexes: coat proteins, V-ATPase subunits, spliceosome-associated proteins and acetyltransferase subunits. Electron microscopy revealed that V-ATPase depletion caused the cell to form aberrant non-constricted clathrin-coated structures at the plasma membrane. The V-ATPase-knockdown phenotype was rescued by addition of exogenous cholesterol, indicating that the knockdown blocks clathrin-mediated endocytosis by preventing cholesterol from recycling from endosomes back to the plasma membrane.	[Kozik, Patrycja; Hodson, Nicola A.; Sahlender, Daniela A.; Simecek, Nikol; Soromani, Christina; Wu, Jiahua; Robinson, Margaret S.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Collinson, Lucy M.] Lincolns Inn Fields Labs, London Res Inst, London WC2A 3LY, England	University of Cambridge	Kozik, P (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	pk275@cam.ac.uk; msr12@mole.bio.cam.ac.uk		Sahlender, Daniela Andrea/0000-0002-0510-9529; Collinson, Lucy/0000-0003-0260-613X; Kozik, Patrycja/0000-0001-8596-843X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank M. Boutros (DKFZ) for providing the siRNA reannotation data, S. Arden (CIMR) for mRNA isolation, J. Bauer (Centre for Microarray Resources, Department of Pathology, Cambridge) for analysis of the microarray data, S. Grinstein (University of Toronto) for the pH sensor plasmids and helpful suggestions, J. Skepper (Multi-Imaging Centre, Department of Anatomy, University of Cambridge) for help with the critical-point drying, all members of the Robinson laboratory, in particular G. Borner, for invaluable discussions, and P. Luzio and J. Kilmartin for reading the manuscript and helpful suggestions. This work was financially supported by the Wellcome Trust.	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BALL CL, 1995, J CELL SCI, V108, P2865; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Bruckner RJ, 2009, BIOPHYS J, V97, P3113, DOI 10.1016/j.bpj.2009.09.025; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; COSSON P, 1989, J CELL BIOL, V108, P377, DOI 10.1083/jcb.108.2.377; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fielding AB, 2012, P NATL ACAD SCI USA, V109, P6572, DOI 10.1073/pnas.1117401109; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hirst J, 2008, TRAFFIC, V9, P1354, DOI 10.1111/j.1600-0854.2008.00764.x; Hofmann JC, 2010, NUCLEUS-PHILA, V1, P447, DOI 10.4161/nucl.1.6.13328; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2002, J LIPID RES, V43, P198; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liscum L, 2000, TRAFFIC, V1, P218, DOI 10.1034/j.1600-0854.2000.010304.x; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Shepard BD, 2012, HEPATOLOGY, V55, P1260, DOI 10.1002/hep.24785; Sigala B, 2005, EXP CELL RES, V310, P357, DOI 10.1016/j.yexcr.2005.07.030; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Straud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011629; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; TIWARI RK, 1987, EMBO J, V6, P3373, DOI 10.1002/j.1460-2075.1987.tb02659.x; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062	67	83	83	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					50	U105		10.1038/ncb2652	http://dx.doi.org/10.1038/ncb2652			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23263279	Green Accepted			2022-12-25	WOS:000312841300009
J	Liu, H; Rankin, S; Yu, HT				Liu, Hong; Rankin, Susannah; Yu, Hongtao			Phosphorylation-enabled binding of SGO1-PP2A to cohesin protects sororin and centromeric cohesion during mitosis	NATURE CELL BIOLOGY			English	Article							SISTER-CHROMATID COHESION; DNA-REPLICATION; PHOSPHATASE 2A; CHROMOSOME; SHUGOSHIN; ACETYLATION; COMPLEX; ESTABLISHMENT; RESOLUTION; SMC3	Timely dissolution of sister-chromatid cohesion in mitosis ensures accurate chromosome segregation to guard against aneuploidy and tumorigenesis. The complex of shugoshin and protein phosphatase 2A (SGO1-PP2A) protects cohesin at centromeres from premature removal by mitotic kinases and WAPL in prophase. Here we address the regulation and mechanism of human SGO1 in centromeric cohesion protection, and show that cyclin-dependent kinase (CDK)-mediated, mitosis-specific phosphorylation of SGO1 activates its cohesion-protection function and enables its direct binding to cohesin. The phospho-SGO1-bound cohesin complex contains PP2A, PDS5 and hypophosphorylated sororin, but lacks WAPL. Expression of non-phosphorylatable sororin bypasses the requirement for SGO1-PP2A in centromeric cohesion. Thus, mitotic phosphorylation of SGO1 targets SGO1-PP2A to cohesin, promotes dephosphorylation of PDS5-bound sororin and protects centromeric cohesin from WAPL. PP2A-orchestrated, site-selective dephosphorylation of cohesin and its regulators underlies centromeric cohesion protection.	[Liu, Hong; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA; [Rankin, Susannah] Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, Oklahoma City, OK 73104 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Oklahoma Medical Research Foundation	Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu		Rankin, Susannah/0000-0002-4056-6610; Yu, Hongtao/0000-0002-8861-049X	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [RR016478]; Welch Foundation [I-1441]; Cancer Prevention Research Institute of Texas [RP110465]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076481] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Li and the Protein Chemistry Core at UT Southwestern Medical Center for mass spectrometry analysis of phospho-SGO1. We also thank J. Chen (Oklahoma Medical Research Foundation, USA) for making the sororin antibody and J-M. Peters (Research Institute of Molecular Pathology, Vienna, Austria) for providing the phospho-S1224-SA2 antibody. S.R. was financially supported by grant RR016478 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and is a Pew Scholar in the Biomedical Sciences. H.Y. is an Investigator with the Howard Hughes Medical Institute and is supported by grants from the Welch Foundation (I-1441) and the Cancer Prevention Research Institute of Texas (RP110465).	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Domingo-Sananes MR, 2011, PHILOS T R SOC B, V366, P3584, DOI 10.1098/rstb.2011.0087; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Karamysheva Z, 2009, J BIOL CHEM, V284, P1772, DOI 10.1074/jbc.M807083200; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Orth M, 2011, EMBO J, V30, P2868, DOI 10.1038/emboj.2011.187; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tanno Y, 2010, GENE DEV, V24, P2169, DOI 10.1101/gad.1945310; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Wu FM, 2011, J BIOL CHEM, V286, P3579, DOI 10.1074/jbc.M110.196758; Wu N, 2012, GENE DEV, V26, P1473, DOI 10.1101/gad.193615.112; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2011, J BIOL CHEM, V286, P41826, DOI 10.1074/jbc.M111.305888	35	131	133	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					40	U82		10.1038/ncb2637	http://dx.doi.org/10.1038/ncb2637			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23242214	Green Accepted			2022-12-25	WOS:000312841300008
J	Spitale, RC; Crisalli, P; Flynn, RA; Torre, EA; Kool, ET; Chang, HY				Spitale, Robert C.; Crisalli, Pete; Flynn, Ryan A.; Torre, Eduardo A.; Kool, Eric T.; Chang, Howard Y.			RNA SHAPE analysis in living cells	NATURE CHEMICAL BIOLOGY			English	Article							5S RIBOSOMAL-RNA; SECONDARY STRUCTURE; IN-VIVO; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; NONCODING RNAS; PREDICTION; GENOME; MODEL	RNA structure has important roles in practically every facet of gene regulation, but the paucity of in vivo structural probes limits current understanding. Here we design, synthesize and demonstrate two new chemical probes that enable selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) in living cells. RNA structures in human, mouse, fly, yeast and bacterial cells are read out at single-nucleotide resolution, revealing tertiary contacts and RNA-protein interactions.	[Spitale, Robert C.; Flynn, Ryan A.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Spitale, Robert C.; Flynn, Ryan A.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Crisalli, Pete; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Spitale, RC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kool@stanford.edu; howchang@stanford.edu		Kool, Eric/0000-0002-7310-2935; Flynn, Ryan/0000-0001-5013-0442	US National Institutes of Health [R01 GM072705, R01-HG004361]; A.P. Giannini Foundation; Stanford MedScholars Program; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.P. Giannini Foundation; Stanford MedScholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Wan, G. Zheng and R. Das for comments. This work is supported by the US National Institutes of Health (R01 GM072705 to E.T.K. and R01-HG004361 to H.Y.C.), the A.P. Giannini Foundation (R.C.S.) and the Stanford MedScholars Program (R.A.F.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; BRUNEL C, 1991, J MOL BIOL, V221, P293; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; David L, 2001, METHOD ENZYMOL, V341, P518, DOI 10.1016/S0076-6879(01)41174-8; Gherghe CM, 2008, J AM CHEM SOC, V130, P12244, DOI 10.1021/ja804541s; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Kladwang W, 2011, NAT CHEM, V3, P954, DOI [10.1038/nchem.1176, 10.1038/NCHEM.1176]; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; Luo D, 1998, NUCLEIC ACIDS RES, V26, P5379, DOI 10.1093/nar/26.23.5379; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mattick JS, 2009, ANN NY ACAD SCI, V1178, P29, DOI 10.1111/j.1749-6632.2009.04991.x; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Pan T, 2001, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0603s00; Schroeder R, 2002, CURR OPIN STRUC BIOL, V12, P296, DOI 10.1016/S0959-440X(02)00325-1; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Trang P, 1999, NUCLEIC ACIDS RES, V27, P4590, DOI 10.1093/nar/27.23.4590; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weeks KM, 2011, ACCOUNTS CHEM RES, V44, P1280, DOI 10.1021/ar200051h; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; ZAUG AJ, 1995, RNA, V1, P363; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	277	282	6	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					18	+		10.1038/NCHEMBIO.1131	http://dx.doi.org/10.1038/NCHEMBIO.1131			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23178934	Green Accepted			2022-12-25	WOS:000312484200007
J	Hong, GS; Lee, JC; Robinson, JT; Raaz, U; Xie, LM; Huang, NF; Cooke, JP; Dai, HJ				Hong, Guosong; Lee, Jerry C.; Robinson, Joshua T.; Raaz, Uwe; Xie, Liming; Huang, Ngan F.; Cooke, John P.; Dai, Hongjie			Multifunctional in vivo vascular imaging using near-infrared II fluorescence	NATURE MEDICINE			English	Article							WALLED CARBON NANOTUBES; QUANTUM DOTS; CELLS; MICE; THICKNESS; TUMORS; MEDIA; CT	In vivo real-time epifluorescence imaging of mouse hind limb vasculatures in the second near-infrared region (NIR-II) is performed using single-walled carbon nanotubes as fluorophores. Both high spatial (similar to 30 mu m) and temporal (<200 ms per frame) resolution for small-vessel imaging are achieved at 1-3 mm deep in the hind limb owing to the beneficial NIR-II optical window that affords deep anatomical penetration and low scattering. This spatial resolution is unattainable by traditional NIR imaging (NIR-I) or microscopic computed tomography, and the temporal resolution far exceeds scanning microscopic imaging techniques. Arterial and venous vessels are unambiguously differentiated using a dynamic contrast-enhanced NIR-II imaging technique on the basis of their distinct hemodynamics. Further, the deep tissue penetration and high spatial and temporal resolution of NIR-II imaging allow for precise quantifications of blood velocity in both normal and ischemic femoral arteries, which are beyond the capabilities of ultrasonography at lower blood velocities.	[Hong, Guosong; Robinson, Joshua T.; Xie, Liming; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Lee, Jerry C.; Raaz, Uwe; Huang, Ngan F.; Cooke, John P.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	ngantina@stanford.edu; jcooke@stanford.edu; hdai@stanford.edu	Xie, Liming/AAL-9554-2020; Hong, Guosong/A-7551-2013; Dai, Hongjie/ABC-4574-2021; Xie, Liming/C-4639-2011	Hong, Guosong/0000-0002-8858-4471; Xie, Liming/0000-0001-8190-8325; Huang, Ngan/0000-0003-2298-6790; Lee, Jerry/0000-0002-0354-5247; Cooke, John/0000-0003-0033-9138	National Cancer Institute of the US National Institutes of Health [5R01CA135109-02]; National Heart, Lung and Blood Institute of the US National Institutes of Health [U01HL100397, RC2HL103400, K99HL098688]; Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA135109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103400, U01HL100397, K99HL098688, R00HL098688] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford Graduate Fellowship(Stanford University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Cancer Institute of the US National Institutes of Health to H.D. (5R01CA135109-02), the National Heart, Lung and Blood Institute of the US National Institutes of Health to J.P.C. (U01HL100397, RC2HL103400) and N.F.H. (K99HL098688) and a Stanford Graduate Fellowship to G.H.	Adams JY, 2002, NAT MED, V8, P891, DOI 10.1038/nm743; Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707; BURSTEIN P, 1984, NUCL INSTRUM METH A, V221, P207, DOI 10.1016/0167-5087(84)90201-1; Du YP, 2010, J AM CHEM SOC, V132, P1470, DOI 10.1021/ja909490r; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; GORDON R, 1974, INT REV CYTOL, V38, P111, DOI 10.1016/S0074-7696(08)60925-0; Greco A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/519238; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hong GS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1698; Hong GS, 2011, ANGEW CHEM INT EDIT, V50, P4644, DOI 10.1002/anie.201100934; Huang NF, 2010, ARTERIOSCL THROM VAS, V30, P984, DOI 10.1161/ATVBAHA.110.202796; InternationalAA Commission onAA Non-Ionizing RadiationAA Protection, 2000, HEALTH PHYS, V79, P431; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4; Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146; Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pizzoferrato R, 2000, J LUMIN, V87-9, P748, DOI 10.1016/S0022-2313(99)00384-1; Ritman EL, 2011, ANNU REV BIOMED ENG, V13, P531, DOI 10.1146/annurev-bioeng-071910-124717; Robinson JT, 2010, NANO RES, V3, P779, DOI 10.1007/s12274-010-0045-1; Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938; Saba L, 2010, NEURORADIOLOGY, V52, P75, DOI 10.1007/s00234-009-0589-5; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Singh J, 2008, J NUCL MED TECHNOL, V36, P69, DOI 10.2967/jnmt.107.047621; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Tabakman SM, 2010, J PHYS CHEM C, V114, P19569, DOI 10.1021/jp106453v; Terentyuk GS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3122371; Toussaint JF, 1996, CIRCULATION, V94, P932, DOI 10.1161/01.CIR.94.5.932; Wang CH, 2011, J VASC SURG, V53, P1350, DOI 10.1016/j.jvs.2010.10.128; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108; Welsher K, 2009, NAT NANOTECHNOL, V4, P773, DOI [10.1038/nnano.2009.294, 10.1038/NNANO.2009.294]; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148; Zhang Y, 2012, ACS NANO, V6, P3695, DOI 10.1021/nn301218z; Zhao LL, 2010, ENERG FUEL, V24, P5844, DOI 10.1021/ef100846r	40	667	675	37	689	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1841	+		10.1038/nm.2995	http://dx.doi.org/10.1038/nm.2995			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160236	Green Accepted, Green Submitted			2022-12-25	WOS:000311999800033
J	Rinkevich, Y; Mori, T; Sahoo, D; Xu, PX; Bermingham, JR; Weissman, IL				Rinkevich, Yuval; Mori, Taisuke; Sahoo, Debashis; Xu, Pin-Xian; Bermingham, John R., Jr.; Weissman, Irving L.			Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM; PROGENITOR CELLS; FATE; POPULATION; CONTRIBUTE; HEART; TBX18; DIFFERENTIATION; TRANSPLANTATION; EPICARDIUM	Fibroblasts and smooth muscle cells (FSMCs) are principal cell types of connective and adventitial tissues that participate in the development, physiology and pathology of internal organs, with incompletely defined cellular origins. Here, we identify and prospectively isolate from the mesothelium a mouse cell lineage that is committed to FSMCs. The mesothelium is an epithelial monolayer covering the vertebrate thoracic and abdominal cavities and internal organs. Time-lapse imaging and transplantation experiments reveal robust generation of FSMCs from the mesothelium. By targeting mesothelin (MSLN), a surface marker expressed on mesothelial cells, we identify and isolate precursors capable of clonally generating FSMCs. Using a genetic lineage tracing approach, we show that embryonic and adult mesothelium represents a common lineage to trunk FSMCs, and trunk vasculature, with minimal contributions from neural crest, or circulating cells. The isolation of FSMC precursors enables the examination of multiple aspects of smooth muscle and fibroblast biology as well as the prospective isolation of these precursors for potential regenerative medicine purposes.	[Rinkevich, Yuval; Mori, Taisuke; Sahoo, Debashis; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Rinkevich, Yuval; Mori, Taisuke; Sahoo, Debashis; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Mori, Taisuke] Natl Inst Canc Res, Div Mol Pathol, Tokyo 1040045, Japan; [Xu, Pin-Xian] NYU, Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Bermingham, John R., Jr.] McLaughlin Res Inst, Great Falls, MT 59405 USA	Stanford University; Stanford University; National Cancer Center - Japan; Icahn School of Medicine at Mount Sinai; New York University; McLaughlin Research Institute for Biomedical Sciences, Inc.	Rinkevich, Y (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA.	ryuval@stanford.edu	Rinkevich, Yuval/B-7854-2018; Rinkevich, Yuval/B-7647-2018	Rinkevich, Yuval/0000-0001-6290-7271; Rinkevich, Yuval/0000-0002-9022-7668	California Institute of Regenerative Medicine [RC1 00354]; Smith Family Trust; National Institutes of Health [RO1 DK064640]; Human Frontier Science Program (HFSP) Long Term Fellowship; Machiah Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040751] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Smith Family Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP) Long Term Fellowship; Machiah Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Mosley for assisting with generating the transgenic Msln<SUP>CLN</SUP> mice, and R. Kopito, M. Brandeis and K. Bersuker for usage and their assistance with the time-lapse video. We thank T. Violante for her assistance with sectioning, D. Hunter for his assistance with histochemical staining and G. Paz and D. Montoro for their assistance with figure preparation. The CreER<SUP>T2</SUP>IRES-lacZ-PGK-neo cassette was a gift from R. J. Gilbertson (St. Jude Children's Research Hospital, USA). This work was supported in part by a grant from the California Institute of Regenerative Medicine (RC1 00354 to I.L.W.), the Smith Family Trust (to I.L.W.) and from the National Institutes of Health (RO1 DK064640 to P.X.X.). Y.R. is supported by the Human Frontier Science Program (HFSP) Long Term Fellowship, and the Machiah Foundation Fellowship.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Bochaton-Piallat ML, 2006, CIRC RES, V98, P448, DOI 10.1161/01.RES.0000214330.15785.46; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Choudhary B, 2006, DEV BIOL, V289, P420, DOI 10.1016/j.ydbio.2005.11.008; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Elmadbouh I, 2007, INT J ARTIF ORGANS, V30, P541, DOI 10.1177/039139880703000612; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Jiang X., 2002, SCIENCE, V297, P2256; Jiang XB, 2000, DEVELOPMENT, V127, P1607; KENNEDY LJ, 1971, NEW ENGL J MED, V285, P884, DOI 10.1056/NEJM197110142851603; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Manner J, 1999, ANAT RECORD, V255, P212; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Mutsaers S, 2007, INT J ARTIF ORGANS, V30, P557, DOI 10.1177/039139880703000614; Mutsaers S E, 2007, Cancer Treat Res, V134, P1; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Olivera-Martinez I, 2002, DEVELOPMENT, V129, P4763; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Sahoo D, 2010, P NATL ACAD SCI USA, V107, P5732, DOI 10.1073/pnas.0913635107; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Tran TH, 2010, DEVELOPMENT, V137, P3973, DOI 10.1242/dev.056473; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21; Zeng B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-67; Zhang N, 2006, STEM CELLS DEV, V15, P17, DOI 10.1089/scd.2006.15.17; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	46	124	130	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1251	+		10.1038/ncb2610	http://dx.doi.org/10.1038/ncb2610			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23143399	Green Accepted			2022-12-25	WOS:000311890300007
J	Tumaneng, K; Schlegelmilch, K; Russell, RC; Yimlamai, D; Basnet, H; Mahadevan, N; Fitamant, J; Bardeesy, N; Camargo, FD; Guan, KL				Tumaneng, Karen; Schlegelmilch, Karin; Russell, Ryan C.; Yimlamai, Dean; Basnet, Harihar; Mahadevan, Navin; Fitamant, Julien; Bardeesy, Nabeel; Camargo, Fernando D.; Guan, Kun-Liang			YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29	NATURE CELL BIOLOGY			English	Article							CELL-PROLIFERATION; TUMOR-SUPPRESSOR; BANTAM MICRORNA; GROWTH-CONTROL; DROSOPHILA; APOPTOSIS; KINASE; LATS1; SIZE; INACTIVATION	Organ development is a complex process governed by the interplay of several signalling pathways that have critical functions in the regulation of cell growth and proliferation. Over the past years, the Hippo pathway has emerged as a key regulator of organ size. Perturbation of this pathway has been shown to play important roles in tumorigenesis. YAP, the main downstream target of the mammalian Hippo pathway, promotes organ growth, yet the underlying molecular mechanism of this regulation remains unclear. Here we provide evidence that YAP activates the mammalian target of rapamycin (mTOR), a major regulator of cell growth. We have identified the tumour suppressor PTEN, an upstream negative regulator of mTOR, as a critical mediator of YAP in mTOR regulation. We demonstrate that YAP downregulates PTEN by inducing miR-29 to inhibit PTEN translation. Last, we show that PI(3)K-mTOR is a pathway modulated by YAP to regulate cell size, tissue growth and hyperplasia. Our studies reveal a functional link between Hippo and PI(3)K-mTOR, providing a molecular basis for the coordination of these two pathways in organ size regulation.	[Tumaneng, Karen; Russell, Ryan C.; Guan, Kun-Liang] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Tumaneng, Karen; Russell, Ryan C.; Guan, Kun-Liang] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Tumaneng, Karen; Basnet, Harihar; Mahadevan, Navin] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Schlegelmilch, Karin; Yimlamai, Dean; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Fitamant, Julien; Bardeesy, Nabeel] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Schlegelmilch, Karin] FU Berlin, Inst Chem Biochem, D-14195 Berlin, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard University; Harvard Medical School; Free University of Berlin	Guan, KL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Yimlamai, Dean/AAA-6607-2020	Yimlamai, Dean/0000-0002-7936-7168; Schlegelmilch, Karin/0000-0003-3173-0914; Russell, Ryan/0000-0003-3364-8869	UCSD Graduate Training Program in Cellular and Molecular Pharmacology; NIH; NATIONAL CANCER INSTITUTE [R01CA136567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK105351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	UCSD Graduate Training Program in Cellular and Molecular Pharmacology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Furnari and M. Wicha for reagents. We thank J. Zhao for technical help, and J. Kim and B. Zhao for thoughtful discussions. The deep-sequencing service was provided by LC Sciences. K.T. was supported in part by the UCSD Graduate Training Program in Cellular and Molecular Pharmacology. K-L.G. is supported by grants from the NIH.	Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Ye X, 2012, DEV BIOL, V369, P115, DOI 10.1016/j.ydbio.2012.06.014; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	33	337	350	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1322	+		10.1038/ncb2615	http://dx.doi.org/10.1038/ncb2615			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23143395	Green Accepted			2022-12-25	WOS:000311890300014
J	Busque, L; Patel, JP; Figueroa, ME; Vasanthakumar, A; Provost, S; Hamilou, Z; Mollica, L; Li, J; Viale, A; Heguy, A; Hassimi, M; Socci, N; Bhatt, PK; Gonen, M; Mason, CE; Melnick, A; Godley, LA; Brennan, CW; Abdel-Wahab, O; Levine, RL				Busque, Lambert; Patel, Jay P.; Figueroa, Maria E.; Vasanthakumar, Aparna; Provost, Sylvie; Hamilou, Zineb; Mollica, Luigina; Li, Juan; Viale, Agnes; Heguy, Adriana; Hassimi, Maryam; Socci, Nicholas; Bhatt, Parva K.; Gonen, Mithat; Mason, Christopher E.; Melnick, Ari; Godley, Lucy A.; Brennan, Cameron W.; Abdel-Wahab, Omar; Levine, Ross L.			Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis	NATURE GENETICS			English	Article							STEM-CELLS; INACTIVATION PATTERNS; LEADS	Aging is characterized by clonal expansion of myeloid-biased hematopoietic stem cells and by increased risk of myeloid malignancies. Exome sequencing of three elderly females with clonal hematopoiesis, demonstrated by X-inactivation analysis, identified somatic TET2 mutations. Recurrence testing identified TET2 mutations in 10 out of 182 individuals with X-inactivation skewing. TET2 mutations were specific to individuals with clonal hematopoiesis without hematological malignancies and were associated with alterations in DNA methylation.	[Busque, Lambert; Mollica, Luigina] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Busque, Lambert; Hamilou, Zineb; Mollica, Luigina] Maisonneuve Rosemont Hosp, Dept Hematol, Montreal, PQ, Canada; [Provost, Sylvie] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Patel, Jay P.; Heguy, Adriana; Bhatt, Parva K.; Brennan, Cameron W.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Figueroa, Maria E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Vasanthakumar, Aparna; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Li, Juan; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Hassimi, Maryam; Socci, Nicholas] Mem Sloan Kettering Canc Ctr, Bioinformat Core, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Mason, Christopher E.] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA; [Mason, Christopher E.] Cornell Univ, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, Weill Med Coll, New York, NY 10021 USA; [Mason, Christopher E.; Melnick, Ari; Levine, Ross L.] Cornell Univ, Weill Med Coll, Grad Sch Biomed Sci, New York, NY 10021 USA; [Melnick, Ari] Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY 10021 USA; [Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10021 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Chicago; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Busque, L (corresponding author), Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	lbusque.hmr@ssss.gouv.qc.ca; leviner@mskcc.org	Patel, Jay/HDM-6251-2022; Heguy, Adriana/GPP-3907-2022; Figueroa, Maria/AAE-8662-2019; Gonen, Mithat/E-4826-2012; Brennan, Cameron/R-7082-2019; Melnick, Ari/AAA-5763-2020; Mason, Christopher/HCH-3977-2022; levine, ross/AAE-7658-2019	Gonen, Mithat/0000-0001-8683-8477; Brennan, Cameron/0000-0003-4064-8891; Figueroa, Maria Eugenia/0000-0003-4887-4981; Abdel-Wahab, Omar/0000-0002-3907-6171	National Cancer Institute Physical Sciences Oncology Center [U54CA143798-01]; National Cancer Institute [1R01CA129831, 1R01CA129831-03S1]; US National Institutes of Health; Leukemia and Lymphoma Society; Doris Duke Charitable Foundation; Sackler Center for Biomedical and Physical Sciences; Howard Hughes Medical Institute;  [1R01CA138234-01]; NATIONAL CANCER INSTITUTE [R01CA138234, U54CA143798, R01CA129831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK092030] Funding Source: NIH RePORTER	National Cancer Institute Physical Sciences Oncology Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Sackler Center for Biomedical and Physical Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Levine and Busque laboratories for helpful comments and discussion. This work was supported by a grant from the National Cancer Institute Physical Sciences Oncology Center (U54CA143798-01) to R.L.L. and A.M., by grant 1R01CA138234-01 to R.L.L. and by grants 1R01CA129831 and 1R01CA129831-03S1 to L.A.G. from the National Cancer Institute. A. Vasanthakumar is supported by a US National Institutes of Health F32 award. M.E.F. is supported by a Leukemia and Lymphoma Society Special Fellow award and a Doris Duke Charitable Foundation Clinical Scientist Development Award. O.A.-W. is an American Society of Hematology Basic Research Fellow. A.M. is a Burroughs Wellcome Clinical Translational Scholar and is also supported by the Sackler Center for Biomedical and Physical Sciences. R.L.L. is an Early Career Award Recipient of the Howard Hughes Medical Institute. R.L.L. and A.M. are funded by Leukemia and Lymphoma Society Scholar Awards. All subjects answered a medical questionnaire and gave informed consent. The study was approved by the Maisonneuve-Rosemont Hospital's Ethics Committee in 1998 and is reapproved yearly in accordance with institutional bylaws.	Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Busque L, 1996, BLOOD, V88, P59; Busque L, 1998, LEUKEMIA, V12, P128, DOI 10.1038/sj.leu.2400936; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47	13	558	571	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1179	1181		10.1038/ng.2413	http://dx.doi.org/10.1038/ng.2413			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23001125	Green Accepted			2022-12-25	WOS:000310495800005
J	Liu, JZ; Almarri, MA; Gaffney, DJ; Mells, GF; Jostins, L; Cordell, HJ; Ducker, SJ; Day, DB; Heneghan, MA; Neuberger, JM; Donaldson, PT; Bathgate, AJ; Burroughs, A; Davies, MH; Jones, DE; Alexander, GJ; Barrett, JC; Sandford, RN; Anderson, CA				Liu, Jimmy Z.; Almarri, Mohamed A.; Gaffney, Daniel J.; Mells, George F.; Jostins, Luke; Cordell, Heather J.; Ducker, Samantha J.; Day, Darren B.; Heneghan, Michael A.; Neuberger, James M.; Donaldson, Peter T.; Bathgate, Andrew J.; Burroughs, Andrew; Davies, Mervyn H.; Jones, David E.; Alexander, Graeme J.; Barrett, Jeffrey C.; Sandford, Richard N.; Anderson, Carl A.		UK Primary Biliary Cirrhosis PBC C; Wellcome Trust Case Control Consor	Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE-CALLING ALGORITHM; CLASSICAL HLA ALLELES; CLASS-II ALLELES; COMMON; RISK; RARE; POLYMORPHISMS; VARIANTS; CELLS	We genotyped 2,861 cases of primary biliary cirrhosis (PBC) from the UK PBC Consortium and 8,514 UK population controls across 196,524 variants within 186 known autoimmune risk loci. We identified 3 loci newly associated with PBC (at P < 5 x 10(-8)), increasing the number of known susceptibility loci to 25. The most associated variant at 19p12 is a low-frequency nonsynonymous SNP in TYK2, further implicating JAK-STAT and cytokine signaling in disease pathogenesis. An additional five loci contained nonsynonymous variants in high linkage disequilibrium (LD; r(2) > 0.8) with the most associated variant at the locus. We found multiple independent common, low-frequency and rare variant association signals at five loci. Of the 26 independent non-human leukocyte antigen (HLA) signals tagged on the Immunochip, 15 have SNPs in B-lymphoblastoid open chromatin regions in high LD (r(2) > 0.8) with the most associated variant. This study shows how data from dense fine-mapping arrays coupled with functional genomic data can be used to identify candidate causal variants for functional follow-up.	[Liu, Jimmy Z.; Almarri, Mohamed A.; Gaffney, Daniel J.; Jostins, Luke; Barrett, Jeffrey C.; Anderson, Carl A.] Wellcome Trust Sanger Inst, Cambridge, England; [Mells, George F.; Day, Darren B.; Sandford, Richard N.] Univ Cambridge, Acad Dept Med Genet, Cambridge, England; [Mells, George F.; Alexander, Graeme J.] Natl Hlth Serv NHS Fdn Trust, Cambridge Univ Hosp, Dept Hepatol, Cambridge, England; [Cordell, Heather J.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ducker, Samantha J.; Donaldson, Peter T.; Jones, David E.] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Heneghan, Michael A.] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England; [Neuberger, James M.] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England; [Bathgate, Andrew J.] Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, Edinburgh, Midlothian, Scotland; [Burroughs, Andrew] UCL, Sch Med, Hepatol Dept, London W1N 8AA, England; [Davies, Mervyn H.] St James Univ Hosp, Liver Unit, Leeds, W Yorkshire, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Newcastle University - UK; Newcastle University - UK; King's College Hospital NHS Foundation Trust; University of London; King's College London; University of Birmingham; Royal Infirmary of Edinburgh; University of Edinburgh; University of London; University College London; UCL Medical School; Saint James's University Hospital	Anderson, CA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	carl.anderson@sanger.ac.uk	Burroughs, Andrew K/C-5645-2009; Dominiczak, Anna F/P-9390-2017; Anderson, Carl A/B-8327-2013; Dolwani, Sunil/C-9187-2013; Neuberger, James/ABG-3010-2020; Dolwani, Sunil/M-4241-2016; Ramage, John/ABG-4603-2020	Burroughs, Andrew K/0000-0001-6527-457X; Dominiczak, Anna F/0000-0003-4913-3608; Anderson, Carl A/0000-0003-1719-7009; Ramage, John/0000-0003-4824-6600; Lord, Graham/0000-0003-2069-4743; Maxwell, Alexander P./0000-0002-6110-7253; Almarri, Mohamed/0000-0003-1255-0918; Ouwehand, Willem/0000-0002-7744-1790; Cordell, Heather/0000-0002-1879-5572; Das, Debasish/0000-0003-2340-1301; Barrett, Jeffrey/0000-0002-1152-370X; Gaffney, Daniel/0000-0002-1529-1862; Bulik, Cynthia/0000-0001-7772-3264; ALA, AFTAB/0000-0001-6257-3160; Hoeroldt, Barbara/0000-0001-8154-8155	Isaac Newton Trust; PBC Foundation; Addenborooke's Charitable Trust; Wellcome Trust [085925/Z/08/Z, WT090355/A/09/Z, WT090355/B/09/Z, 098051, 068545/Z/02, 076113/C/04/Z]; US National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International; US National Institutes of Health [U01-DK-062418]; UK Medical Research Council; MRC [G0000934]; UK Blood Services collection of Common Controls; Wellcome Trust/Juvenile Diabetes Research Foundation [061858]; National Institute of Health Research of England; Medical Research Council [G0800460]; Raymond and Beverly Sackler Studentship; MRC [G0500020, G0800460, G0802068] Funding Source: UKRI; Medical Research Council [G0500020, G0802068, G0000934] Funding Source: researchfish; National Institute for Health Research [IS-BRC-0211-10046] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH121729] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	Isaac Newton Trust; PBC Foundation; Addenborooke's Charitable Trust; Wellcome Trust(Wellcome Trust); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Blood Services collection of Common Controls; Wellcome Trust/Juvenile Diabetes Research Foundation(Juvenile Diabetes Research FoundationWellcome Trust); National Institute of Health Research of England(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Raymond and Beverly Sackler Studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to the PBC Foundation for helping us to establish the PBC Genetics Study, for endorsing it and for encouraging members of the Foundation to contribute samples. We thank all of the research nurses who assisted with participant recruitment in collaborating centers. We thank the staff in the UK National Institute for Health Research Clinical Research Network (NIHR CRN) and Clinical Research Collaboration (CRC) Cymru for providing invaluable support. We are grateful to K. Chittock and his colleagues at Source Bioscience for performing DNA extraction. We thank O. Burren for designing the participant database and for providing information technology support. We are grateful to A. Dilthey for providing support regarding HLA*IMP. We thank J. Stone for coordinating Immunochip design and production at Illumina. We also thank the members of each disease consortium who initiated and sustained the cross-disease Immunochip project and shared control genotypes. Finally, we thank the individuals who contributed the DNA samples used in this study. The PBC sample collection was funded by the Isaac Newton Trust, the PBC Foundation, The Addenborooke's Charitable Trust and the Wellcome Trust (085925/Z/08/Z). The PBC Genetics Study is a portfolio study of the UK NIHR CRN (portfolio reference 5630). The project is also supported by the Wellcome Trust (WT090355/A/09/Z, WT090355/B/09/Z and 098051). Genotyping of samples at the University of Virginia used resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the US National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, the National Human Genome Research Institute, the National Institute of Child Health and Human Development and the Juvenile Diabetes Research Foundation International and is supported by U01-DK-062418 from the US National Institutes of Health. We would like to thank the UK Medical Research Council and Wellcome Trust for funding the collection of DNA for the British 1958 Birth Cohort (MRC grant G0000934, Wellcome Trust grant 068545/Z/02). We acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS collection), funded by Wellcome Trust grant 076113/C/04/Z, by Wellcome Trust/Juvenile Diabetes Research Foundation grant 061858 and by the National Institute of Health Research of England. The collection was established as part of the Wellcome Trust Case Control Consortium. G. F. M. is a Clinical Research Training Fellow of the Medical Research Council (G0800460). G. F. M. is also supported by a Raymond and Beverly Sackler Studentship.	Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Couturier N, 2011, BRAIN, V134, P693, DOI 10.1093/brain/awr010; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Falconer D.S., 1996, INTRO QUANTITATIVE G, P464; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; James OFW, 1999, HEPATOLOGY, V30, P390, DOI 10.1002/hep.510300213; Jones DEJ, 1999, J HEPATOL, V30, P402, DOI 10.1016/S0168-8278(99)80097-X; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Mullarkey ME, 2005, TISSUE ANTIGENS, V65, P199, DOI 10.1111/j.1399-0039.2005.00351.x; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rong G, 2009, CLIN EXP IMMUNOL, V156, P217, DOI 10.1111/j.1365-2249.2009.03898.x; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang DD, 2010, CELL MOL IMMUNOL, V7, P485, DOI 10.1038/cmi.2010.40; Wassmuth R, 2002, TISSUE ANTIGENS, V59, P381, DOI 10.1034/j.1399-0039.2002.590504.x; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	40	195	201	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1137	+		10.1038/ng.2395	http://dx.doi.org/10.1038/ng.2395			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22961000	Green Accepted, Green Submitted			2022-12-25	WOS:000309550200015
J	Minamiyama, M; Katsuno, M; Adachi, H; Doi, H; Kondo, N; Iida, M; Ishigaki, S; Fujioka, Y; Matsumoto, S; Miyazaki, Y; Tanaka, F; Kurihara, H; Sobue, G				Minamiyama, Makoto; Katsuno, Masahisa; Adachi, Hiroaki; Doi, Hideki; Kondo, Naohide; Iida, Madoka; Ishigaki, Shinsuke; Fujioka, Yusuke; Matsumoto, Shinjiro; Miyazaki, Yu; Tanaka, Fumiaki; Kurihara, Hiroki; Sobue, Gen			Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract	NATURE MEDICINE			English	Article							BULBAR MUSCULAR-ATROPHY; GENE-RELATED PEPTIDE; TRANSGENIC MOUSE MODEL; HISTONE DEACETYLASE INHIBITORS; MUTANT ANDROGEN RECEPTOR; HUNTINGTONS-DISEASE; DEPENDENT NEURODEGENERATION; PHENOTYPIC-EXPRESSION; AXONAL-TRANSPORT; PROTEIN-KINASE	Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by the expansion of the CAG triplet repeat within the androgen receptor (AR) gene. Here, we demonstrated that pathogenic AR upregulates the gene encoding calcitonin gene-related peptide alpha (CGRP1). In neuronal cells, overexpression of CGRP1 induced cellular damage via the activation of the c-Jun N-terminal kinase (JNK) pathway, whereas pharmacological suppression of CGRP1 or JNK attenuated the neurotoxic effects of pathogenic AR. The depletion of CGRP1 inactivated JNK and suppressed neurodegeneration in a mouse model of SBMA. Naratriptan, a serotonin 1B/1D (5-hydroxytryptamine 1B/1D, or 5-HT1B/1D) receptor agonist, decreased CGRP1 expression via the induction of dual-specificity protein phosphatase 1 (DUSP1), attenuated JNK activity and mitigated pathogenic AR-mediated neuronal damage in cellular and mouse SBMA models. These observations suggest that pharmacological activation of the 5-HT1B/1D receptor may be used therapeutically to treat SBMA and other polyglutamine-related neurodegenerative diseases.	[Minamiyama, Makoto; Katsuno, Masahisa; Adachi, Hiroaki; Doi, Hideki; Kondo, Naohide; Iida, Madoka; Ishigaki, Shinsuke; Fujioka, Yusuke; Matsumoto, Shinjiro; Miyazaki, Yu; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Tokyo, Japan	Nagoya University; University of Tokyo	Katsuno, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan.	ka2no@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/I-2669-2012; iida, madoka/AAB-7707-2020; ISHIGAKI, Shinsuke/I-7305-2014; KATSUNO, MASAHISA/I-7502-2014; Adachi, Hiroaki/AAM-7812-2020	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311; Adachi, Hiroaki/0000-0002-9302-4663; Kurihara, Hiroki/0000-0002-6476-5593; Ishigaki, Shinsuke/0000-0002-9555-0659	Center-of-Excellence, Ministry of Education, Culture, Sports, Science and Technology, Japan [22110005, 21229011, 21689024, 23390230]; Ministry of Health, Labor and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST); Kennedy Disease Association; Grants-in-Aid for Scientific Research [23659107, 23013007, 23390230] Funding Source: KAKEN	Center-of-Excellence, Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Kennedy Disease Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Center-of-Excellence grant, a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology" (No. 22110005) and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Nos. 21229011, 21689024 and 23390230); grants from the Ministry of Health, Labor and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST); and a grant from the Kennedy Disease Association.	Adachi H, 2005, BRAIN, V128, P659, DOI 10.1093/brain/awh381; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; Benemei S, 2007, NEUROL SCI, V28, pS89, DOI 10.1007/s10072-007-0757-5; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Di Angelantonio S, 2003, BRIT J PHARMACOL, V139, P1061, DOI 10.1038/sj.bjp.0705337; Disa J, 2000, NEUROPEPTIDES, V34, P229, DOI 10.1054/npep.2000.0810; Durham PL, 1998, MOL ENDOCRINOL, V12, P1002, DOI 10.1210/me.12.7.1002; Durham PL, 2002, PHARMACOL THERAPEUT, V94, P77, DOI 10.1016/S0163-7258(02)00173-0; EDVINSSON L, 1994, CEPHALALGIA, V14, P320, DOI 10.1046/j.1468-2982.1994.1405320.x; Fernandez-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5; Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Jhee SS, 2001, CLIN PHARMACOKINET, V40, P189, DOI 10.2165/00003088-200140030-00004; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; Katsuno M, 2006, EXP NEUROL, V200, P8, DOI 10.1016/j.expneurol.2006.01.021; Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Ma W, 2003, NEUROSCIENCE, V120, P677, DOI 10.1016/S0306-4522(03)00159-3; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obrietan K, 2004, J NEUROSCI, V24, P791, DOI 10.1523/JNEUROSCI.3493-03.2004; Oh-hashi Y, 2001, CIRC RES, V89, P983, DOI 10.1161/hh2301.100812; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; POPPER P, 1989, NEUROENDOCRINOLOGY, V50, P338, DOI 10.1159/000125243; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Ringer C, 2012, NEUROBIOL DIS, V45, P547, DOI 10.1016/j.nbd.2011.09.011; Ringer C, 2009, NEUROBIOL DIS, V35, P286, DOI 10.1016/j.nbd.2009.05.011; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Zheng LF, 2008, BRAIN RES, V1187, P20, DOI 10.1016/j.brainres.2007.10.044	52	28	29	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1531	U131		10.1038/nm.2932	http://dx.doi.org/10.1038/nm.2932			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23023499				2022-12-25	WOS:000309587500032
J	Talukdar, S; Oh, DY; Bandyopadhyay, G; Li, DM; Xu, JF; McNelis, J; Lu, M; Li, PP; Yan, QY; Zhu, YM; Ofrecio, J; Lin, M; Brenner, MB; Olefsky, JM				Talukdar, Saswata; Oh, Da Young; Bandyopadhyay, Gautam; Li, Dongmei; Xu, Jianfeng; McNelis, Joanne; Lu, Min; Li, Pingping; Yan, Qingyun; Zhu, Yimin; Ofrecio, Jachelle; Lin, Michael; Brenner, Martin B.; Olefsky, Jerrold M.			Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase	NATURE MEDICINE			English	Article							T-CELLS; TUMOR-GROWTH; OBESITY; INFLAMMATION; INTERLEUKIN-8; MACROPHAGES; ACTIVATION; MECHANISMS; IMMUNITY	Chronic low-grade adipose tissue and liver inflammation is a major cause of systemic insulin resistance and is a key component of the low degree of insulin sensitivity that exists in obesity and type 2 diabetes(1,2). Immune cells, such as macrophages, T cells, B cells, mast cells and eosinophils, have all been implicated as having a role in this process(3-8). Neutrophils are typically the first immune cells to respond to inflammation and can exacerbate the chronic inflammatory state by helping to recruit macrophages and by interacting with antigen-presenting cells(9-11). Neutrophils secrete several proteases, one of which is neutrophil elastase, which can promote inflammatory responses in several disease models(12). Here we show that treatment of hepatocytes with neutrophil elastase causes cellular insulin resistance and that deletion of neutrophil elastase in high-fat-diet-induced obese (DIO) mice leads to less tissue inflammation that is associated with lower adipose tissue neutrophil and macrophage content. These changes are accompanied by improved glucose tolerance and increased insulin sensitivity. Taken together, we show that neutrophils can be added to the extensive repertoire of immune cells that participate in inflammation-induced metabolic disease.	[Talukdar, Saswata; Oh, Da Young; Bandyopadhyay, Gautam; Xu, Jianfeng; McNelis, Joanne; Lu, Min; Li, Pingping; Ofrecio, Jachelle; Lin, Michael; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Dongmei; Yan, Qingyun; Zhu, Yimin; Brenner, Martin B.] Pfizer Cardiovasc Metab & Endocrine Dis CVMED Dia, Cambridge, MA USA	University of California System; University of California San Diego; Pfizer	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Li, Pingping/F-1109-2019	Li, Pingping/0000-0003-0679-270X; Talukdar, Saswata/0000-0003-3042-0025	US National Institutes of Health (NIH) [DK033651, DK074868, T32 DK 007494, DK 090962, DK063491]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007494, R01DK033651, P30DK063491, P01DK074868, R37DK033651, R24DK090962] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to J.M.O. from the US National Institutes of Health (NIH): DK033651, DK074868, T32 DK 007494, DK 090962 and DK063491. This work was also supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH through cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. We wish to thank S. Shapiro (University of Pittsburgh) for helpful comments over the course of the project, C. Pham (Washington University, St. Louis) for providing cathepsin G and neutrophil elastase double knockout mice, S. Nalbandian at University of California San Diego for breeding and caring for the NEKO mice and P. Bansal (Pfizer), B. Ghosh (Pfizer) and J. Wellen (Pfizer) for the neutrophil elastase activity imaging studies.	Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Houghton AM, 2010, CELL CYCLE, V9, P1732, DOI 10.4161/cc.9.9.11297; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Kalupov T, 2009, J BIOL CHEM, V284, P34084, DOI 10.1074/jbc.M109.042903; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mcdonold SJF, 2001, BIOORG MED CHEM LETT, V11, P895, DOI 10.1016/S0960-894X(01)00078-6; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	25	606	627	3	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1407	+		10.1038/nm.2885	http://dx.doi.org/10.1038/nm.2885			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22863787	Green Accepted			2022-12-25	WOS:000308472300037
J	Boileau, C; Guo, DC; Hanna, N; Regalado, ES; Detaint, D; Gong, LM; Varret, M; Prakash, SK; Li, AH; d'Indy, H; Braverman, AC; Grandchamp, B; Kwartler, CS; Gouya, L; Santos-Cortez, RLP; Abifadel, M; Leal, SM; Muti, C; Shendure, J; Gross, MS; Rieder, MJ; Vahanian, A; Nickerson, DA; Michel, JB; Jondeau, G; Milewicz, DM				Boileau, Catherine; Guo, Dong-Chuan; Hanna, Nadine; Regalado, Ellen S.; Detaint, Delphine; Gong, Limin; Varret, Mathilde; Prakash, Siddharth K.; Li, Alexander H.; d'Indy, Hyacintha; Braverman, Alan C.; Grandchamp, Bernard; Kwartler, Callie S.; Gouya, Laurent; Santos-Cortez, Regie Lyn P.; Abifadel, Marianne; Leal, Suzanne M.; Muti, Christine; Shendure, Jay; Gross, Marie-Sylvie; Rieder, Mark J.; Vahanian, Alec; Nickerson, Deborah A.; Michel, Jean Baptiste; Jondeau, Guillaume; Milewicz, Dianna M.		Natl Heart Lung Blood Inst NHLBI G	TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome	NATURE GENETICS			English	Article							SMOOTH-MUSCLE; FBN1 MUTATIONS; OSTEOARTHRITIS; PHENOTYPES; SPECTRUM; PATHWAY; CELLS; MICE	A predisposition for thoracic aortic aneurysms leading to acute aortic dissections can be inherited in families in an autosomal dominant manner. Genome-wide linkage analysis of two large unrelated families with thoracic aortic disease followed by whole-exome sequencing of affected relatives identified causative mutations in TGFB2. These mutations-a frameshift mutation in exon 6 and a nonsense mutation in exon 4-segregated with disease with a combined logarithm of odds (LOD) score of 7.7. Sanger sequencing of 276 probands from families with inherited thoracic aortic disease identified 2 additional TGFB2 mutations. TGFB2 encodes transforming growth factor (TGF)-beta 2, and the mutations are predicted to cause haploinsufficiency for TGFB2; however, aortic tissue from cases paradoxically shows increased TGF-beta 2 expression and immunostaining. Thus, haploinsufficiency for TGFB2 predisposes to thoracic aortic disease, suggesting that the initial pathway driving disease is decreased cellular TGF-beta 2 levels leading to a secondary increase in TGF-beta 2 production in the diseased aorta.	[Guo, Dong-Chuan; Regalado, Ellen S.; Gong, Limin; Prakash, Siddharth K.; Li, Alexander H.; Kwartler, Callie S.; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA; [Boileau, Catherine; Hanna, Nadine; Detaint, Delphine; Varret, Mathilde; d'Indy, Hyacintha; Abifadel, Marianne; Gross, Marie-Sylvie; Michel, Jean Baptiste; Jondeau, Guillaume] Hop Bichat Claude Bernard, INSERM, U698, F-75877 Paris, France; [Boileau, Catherine; Hanna, Nadine; Detaint, Delphine; Grandchamp, Bernard; Gouya, Laurent; Muti, Christine; Jondeau, Guillaume] Hop Bichat Claude Bernard, AP HP, Ctr Natl Reference Syndromes Marfan & Apparentes, Serv Cardiologie, F-75877 Paris, France; [Boileau, Catherine; Hanna, Nadine; d'Indy, Hyacintha] Hop Ambroise Pare, AP HP, Serv Biochim Hormonologie & Genet Mol, Boulogne, France; [Boileau, Catherine; Gouya, Laurent] Univ Versailles St Quentin En Yvelines, Unite Format & Rech UFR Sci Sante, Guyancourt, France; [Prakash, Siddharth K.; Milewicz, Dianna M.] Mem Hermann Heart & Vasc Inst, Houston, TX USA; [Braverman, Alan C.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Grandchamp, Bernard; Vahanian, Alec; Jondeau, Guillaume] Univ Paris 07, Unite Format & Rech UFR Med, Paris, France; [Santos-Cortez, Regie Lyn P.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shendure, Jay; Rieder, Mark J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Milewicz, Dianna M.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL); UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; University of Washington; University of Washington Seattle; Saint Lukes Episcopal Hospital; Texas Heart Institute	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA.	catherine.boileau@inserm.fr; Dianna.M.Milewicz@uth.tmc.edu	boileau, catherine/M-4482-2017; Kwartler, Callie/AGB-4204-2022; Altshuler, David M/A-4476-2009; Singleton, Andrew B/C-3010-2009; VARRET, Mathilde/C-2279-2016; Michel, Jean-Baptiste/AAH-9336-2020; Abifadel, Marianne/ABH-5370-2020; Shendure, Jay/AAU-3684-2021; de Bakker, Paul IW/B-8730-2009	boileau, catherine/0000-0002-0371-7539; Kwartler, Callie/0000-0002-3722-9939; Altshuler, David M/0000-0002-7250-4107; VARRET, Mathilde/0000-0001-9261-1551; de Bakker, Paul IW/0000-0001-7735-7858; Seshadri, Sudha/0000-0001-6135-2622; Regalado, Ellen/0000-0002-5859-218X; Ballantyne, Christie/0000-0002-6432-1730; Shendure, Jay/0000-0002-1516-1865; Gouya, Laurent/0000-0002-1326-7025; Caan, Bette/0000-0002-5803-310X; HANNA, Nadine/0000-0001-5434-3111; ABIFADEL, Marianne/0000-0001-7645-8323; Akey, Joshua/0000-0002-4411-1330; Turner, Emily/0000-0001-9040-9229	Lung Cohorts Sequencing Project [HL-102923]; NHLBI Women's Health Initiative Sequencing Project [HL-102924]; Heart Cohorts Sequencing Project [HL103010]; Broad Institute Sequencing Project [HL-102925]; Northwest Genomics Center Sequencing Project [HL-102926]; Family Studies Project Team; US National Institutes of Health (NIH) [RO1 HL62594]; NIH [P50HL083794-01]; NIH (Centers for Clinical and Translational Sciences) [UL1 RR024148]; Vivian L. Smith Foundation; TexGen Foundation; Richard T. Pasani Funds; Groupement d'Interet Scientifique (GIS)-Maladies Rares; Projet Hospitalier de Recherche Clinique (PHRC) [AOM09093]; PHRC [AOM 10108]; Agence Nationale de Recherche (ANR) BLAN 1129 from the French National Research Agency; European Union Framework Programme 7-integrated project Fighting Aneurysmal Disease (FAD, see URLs); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102925, RC2HL103010, RC2HL102924, P50HL083794, RC2HL102923, UC2HL103010, R01HL062594, R01HL109942, UC2HL102925, UC2HL102923, UC2HL102924, RC2HL102926, UC2HL102926] Funding Source: NIH RePORTER	Lung Cohorts Sequencing Project; NHLBI Women's Health Initiative Sequencing Project; Heart Cohorts Sequencing Project; Broad Institute Sequencing Project; Northwest Genomics Center Sequencing Project; Family Studies Project Team; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Centers for Clinical and Translational Sciences); Vivian L. Smith Foundation; TexGen Foundation; Richard T. Pasani Funds; Groupement d'Interet Scientifique (GIS)-Maladies Rares; Projet Hospitalier de Recherche Clinique (PHRC); PHRC; Agence Nationale de Recherche (ANR) BLAN 1129 from the French National Research Agency(French National Research Agency (ANR)); European Union Framework Programme 7-integrated project Fighting Aneurysmal Disease (FAD, see URLs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are extremely grateful to the families involved in this study and to the medical professionals who aided in the collection of clinical data from the families. We would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison: the Lung Cohorts Sequencing Project (HL-102923), the NHLBI Women's Health Initiative Sequencing Project (HL-102924), the Heart Cohorts Sequencing Project (HL103010), the Broad Institute Sequencing Project (HL-102925), the Northwest Genomics Center Sequencing Project (HL-102926 to D.A.N., M.J.R. and J.S.) and the Family Studies Project Team. We thank J. M. Serfaty for providing vascular imaging and L. Louedec and Z. Ren for technical assistance.; The following sources provided funding for these studies: the US National Institutes of Health (NIH) RO1 HL62594 (D.M.M.), NIH P50HL083794-01 (D.M.M.), NIH UL1 RR024148 (Centers for Clinical and Translational Sciences), the Vivian L. Smith Foundation ( D. M. M.), the TexGen Foundation (D.M.M.), Richard T. Pasani Funds (D.M.M.), Groupement d'Interet Scientifique (GIS)-Maladies Rares (C.B.), Projet Hospitalier de Recherche Clinique (PHRC) AOM09093 (G.J.), PHRC AOM 10108 (C.B.), Agence Nationale de Recherche (ANR) 2010 BLAN 1129 from the French National Research Agency (G.J.) and the European Union Framework Programme 7-integrated project Fighting Aneurysmal Disease (FAD, see URLs) (J.B.M.).	Attias D, 2009, CIRCULATION, V120, P2541, DOI 10.1161/CIRCULATIONAHA.109.887042; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Faivre L, 2009, AM J MED GENET A, V149A, P854, DOI 10.1002/ajmg.a.32809; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gomez D, 2011, CARDIOVASC RES, V89, P446, DOI 10.1093/cvr/cvq291; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Guo DC, 2003, BIOTECHNOL LETT, V25, P2079, DOI 10.1023/B:BILE.0000007075.24434.5e; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Inamoto S, 2010, CARDIOVASC RES, V88, P520, DOI 10.1093/cvr/cvq230; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Regalado E, 2011, AM J MED GENET A, V155A, P2125, DOI 10.1002/ajmg.a.34050; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Stheneur C, 2008, HUM MUTAT, V29, pE284, DOI 10.1002/humu.20871; van de Laar IMBH, 2012, J MED GENET, V49, P47, DOI 10.1136/jmedgenet-2011-100382; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; WEEKS DE, 1995, AM J HUM GENET, V56, P1506	34	233	247	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					916	+		10.1038/ng.2348	http://dx.doi.org/10.1038/ng.2348			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22772371	Green Accepted			2022-12-25	WOS:000306854700018
J	Schmidt, EP; Yang, YM; Janssen, WJ; Gandjeva, A; Perez, MJ; Barthel, L; Zemans, RL; Bowman, JC; Koyanagi, DE; Yunt, ZX; Smith, LP; Cheng, SS; Overdier, KH; Thompson, KR; Geraci, MW; Douglas, IS; Pearse, DB; Tuder, RM				Schmidt, Eric P.; Yang, Yimu; Janssen, William J.; Gandjeva, Aneta; Perez, Mario J.; Barthel, Lea; Zemans, Rachel L.; Bowman, Joel C.; Koyanagi, Dan E.; Yunt, Zulma X.; Smith, Lynelle P.; Cheng, Sara S.; Overdier, Katherine H.; Thompson, Kathy R.; Geraci, Mark W.; Douglas, Ivor S.; Pearse, David B.; Tuder, Rubin M.			The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis	NATURE MEDICINE			English	Article							HEPARAN-SULFATE; PROTEIN-KINASE; UNFRACTIONATED HEPARIN; IN-VIVO; CELL; ACTIVATION; LEUKOCYTES; MOLECULES; ICAM-1; MODEL	Sepsis, a systemic inflammatory response to infection, commonly progresses to acute lung injury (ALI), an inflammatory lung disease with high morbidity. We postulated that sepsis-associated ALI is initiated by degradation of the pulmonary endothelial glycocalyx, leading to neutrophil adherence and inflammation. Using intravital microscopy, we found that endotoxemia in mice rapidly induced pulmonary microvascular glycocalyx degradation via tumor necrosis factor-alpha (TNF-alpha)-dependent mechanisms. Glycocalyx degradation involved the specific loss of heparan sulfate and coincided with activation of endothelial heparanase, a TNF-alpha-responsive, heparan sulfate-specific glucuronidase. Glycocalyx degradation increased the availability of endothelial surface adhesion molecules to circulating microspheres and contributed to neutrophil adhesion. Heparanase inhibition prevented endotoxemia-associated glycocalyx loss and neutrophil adhesion and, accordingly, attenuated sepsis-induced ALI and mortality in mice. These findings are potentially relevant to human disease, as sepsis-associated respiratory failure in humans was associated with higher plasma heparan sulfate degradation activity; moreover, heparanase content was higher in human lung biopsies showing diffuse alveolar damage than in normal human lung tissue.	[Schmidt, Eric P.; Yang, Yimu; Gandjeva, Aneta; Perez, Mario J.; Bowman, Joel C.; Koyanagi, Dan E.; Smith, Lynelle P.; Geraci, Mark W.; Douglas, Ivor S.; Tuder, Rubin M.] Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med,Dept Med, Aurora, CO USA; [Schmidt, Eric P.; Overdier, Katherine H.; Thompson, Kathy R.; Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO USA; [Janssen, William J.; Barthel, Lea; Zemans, Rachel L.; Yunt, Zulma X.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Cheng, Sara S.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO USA; [Pearse, David B.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University	Schmidt, EP (corresponding author), Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med,Dept Med, Aurora, CO USA.	eric.schmidt@ucdenver.edu	Douglas, Ivor S/AAC-6245-2021	Douglas, Ivor S/0000-0002-4541-1431; Schmidt, Eric/0000-0002-7360-0504	US National Institutes of Health (NIH) /National Heart, Lung and Blood Institute (NHLBI) [P30 HL101295, K08 HL105538]; Chronic Obstructive Pulmonary Disease Specialized Centers of Clinically Oriented Research [P01-NHLBI 085609, R01 ES016285]; Flight Attendant Medical Research Institute; Colorado Clinical and Translational Sciences Institute [UL1 RR025780]; NATIONAL CANCER INSTITUTE [R01CA164780] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105538, K08HL103772, R01HL109517, P30HL101295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016285] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) /National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Chronic Obstructive Pulmonary Disease Specialized Centers of Clinically Oriented Research; Flight Attendant Medical Research Institute; Colorado Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J.P. Li (Uppsula University) for providing Hpse<SUP>-/-</SUP> mice, C. Silliman (University of Colorado) for providing human donor plasma samples and R. Coffman (DNAX Research Institute) for donation of a Gr-1-specific monoclonal antibody (RB6-8C5) hybridoma. MLE-15 cells were kindly provided by J. Whitsett (Children's Hospital Cincinnati). pHTS nuclear factor-kappa B reporter vector and pRL-TK vector were kindly provided by S. Biswal (Johns Hopkins University). We additionally thank W. Kuebler and A. Tabuchi for instruction on mouse lung IVM techniques, K. Queensland for instruction regarding cecal ligation and puncture, P. Henson and G. Downey for manuscript review and the Tuder lab for support and discussions of experimental design. This work was supported by the US National Institutes of Health (NIH) /National Heart, Lung and Blood Institute (NHLBI) grants P30 HL101295 (to E.P.S. and R.M.T.); K08 HL105538 (to E.P.S.); Chronic Obstructive Pulmonary Disease Specialized Centers of Clinically Oriented Research P01-NHLBI 085609 (to R.M.T.); and R01 ES016285 (to R.M.T.). Additional funding was provided by the Flight Attendant Medical Research Institute (to R.M.T.) and the Colorado Clinical and Translational Sciences Institute UL1 RR025780 (to E.P.S.).	ADAMSON RH, 1990, J PHYSIOL-LONDON, V428, P1; Aggarwal NR, 2010, AM J PHYSIOL-LUNG C, V298, pL371, DOI 10.1152/ajplung.00308.2009; Alvira CM, 2007, AM J RESP CRIT CARE, V175, P805, DOI 10.1164/rccm.200608-1162OC; Bagher P, 2011, JOVE-J VIS EXP, DOI 10.3791/2874; Bashenko Y, 2007, SHOCK, V28, P207, DOI 10.1097/shk.0b013e3180311d84; Berger G, 2011, AM J PHYSIOL-LUNG C, V301, pL23, DOI 10.1152/ajplung.00010.2010; Chappell D, 2008, BIOL CHEM, V389, P79, DOI 10.1515/BC.2008.005; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Doerschuk CM, 1999, CHEST, V116, p37S, DOI 10.1378/chest.116.suppl_1.37S-a; EVANS TJ, 1994, J EXP MED, V180, P2173, DOI 10.1084/jem.180.6.2173; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; Henninger DD, 1997, J IMMUNOL, V158, P1825; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hostettler N, 2007, FASEB J, V21, P3562, DOI 10.1096/fj.07-8450com; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0; Jacob M, 2009, TRANSPLANTATION, V87, P956, DOI 10.1097/TP.0b013e31819c83b5; Javaid K, 2003, CIRC RES, V92, P1089, DOI 10.1161/01.RES.0000072971.88704.CB; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Lever R, 2000, BRIT J PHARMACOL, V129, P533, DOI 10.1038/sj.bjp.0703099; Marechal X, 2008, SHOCK, V29, P572, DOI 10.1097/SHK.0b013e318157e926; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Pries A. R., 2006, V176, P1; Rao G, 2011, DIABETOLOGIA, V54, P1527, DOI 10.1007/s00125-011-2110-z; Raschke R, 2003, ANN INTERN MED, V138, P720, DOI 10.7326/0003-4819-138-9-200305060-00008; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Schmidt EP, 2008, AM J PHYSIOL-LUNG C, V295, pL1056, DOI 10.1152/ajplung.90329.2008; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; Stephens RS, 2010, AM J PHYSIOL-LUNG C, V299, pL323, DOI 10.1152/ajplung.00442.2009; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Stevens AP, 2007, AM J PHYSIOL-LUNG C, V293, pL328, DOI 10.1152/ajplung.00390.2006; Tabuchi A, 2008, J APPL PHYSIOL, V104, P338, DOI 10.1152/japplphysiol.00348.2007; Takahashi H, 2005, BRIT J PHARMACOL, V146, P333, DOI 10.1038/sj.bjp.0706344; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Wang JH, 1997, SHOCK, V8, P357, DOI 10.1097/00024382-199711000-00007; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wu XY, 2009, AM J PHYSIOL-RENAL, V297, pF316, DOI 10.1152/ajprenal.00089.2009; Yang YM, 2007, COMP BIOCHEM PHYS A, V147, P84, DOI 10.1016/j.cbpa.2006.11.019; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	59	461	489	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1217	+		10.1038/nm.2843	http://dx.doi.org/10.1038/nm.2843			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820644	Green Accepted			2022-12-25	WOS:000307469300027
J	Brastianos, PK; Horowitz, PM; Santagata, S; Jones, RT; McKenna, A; Getz, G; Ligon, KL; Palescandolo, E; Van Hummelen, P; Ducar, MD; Raza, A; Sunkavalli, A; MacConaill, LE; Stemmer-Rachamimov, AO; Louis, DN; Hahn, WC; Dunn, IF; Beroukhim, R				Brastianos, Priscilla K.; Horowitz, Peleg M.; Santagata, Sandro; Jones, Robert T.; McKenna, Aaron; Getz, Gad; Ligon, Keith L.; Palescandolo, Emanuele; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Stemmer-Rachamimov, Anat O.; Louis, David N.; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen			Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations	NATURE GENETICS			English	Article							BASAL-CELL CARCINOMAS; NF2; PATHWAY; CANCER; MEDULLOBLASTOMA; COMPLEXITY; LANDSCAPE; PATTERNS; TUMORS	Meningiomas are the most common primary nervous system tumor. The tumor suppressor NF2 is disrupted in approximately half of all meningiomas(1), but the complete spectrum of genetic changes remains undefined. We performed whole-genome or whole-exome sequencing on 17 meningiomas and focused sequencing on an additional 48 tumors to identify and validate somatic genetic alterations. Most meningiomas had simple genomes, with fewer mutations, rearrangements and copy-number alterations than reported in other tumors in adults. However, several meningiomas harbored more complex patterns of copy-number changes and rearrangements, including one tumor with chromothripsis. We confirmed focal NF2 inactivation in 43% of tumors and found alterations in epigenetic modifiers in an additional 8% of tumors. A subset of meningiomas lacking NF2 alterations harbored recurrent oncogenic mutations in AKT1 (p.Glu17Lys) and SMO (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways. These mutations were present in therapeutically challenging tumors of the skull base and higher grade. These results begin to define the spectrum of genetic alterations in meningiomas and identify potential therapeutic targets.	[Brastianos, Priscilla K.; Jones, Robert T.; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Hahn, William C.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Brastianos, Priscilla K.] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Brastianos, Priscilla K.; Horowitz, Peleg M.; Santagata, Sandro; Ligon, Keith L.; Stemmer-Rachamimov, Anat O.; Louis, David N.; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen] Harvard Univ, Sch Med, Boston, MA USA; [Brastianos, Priscilla K.; Horowitz, Peleg M.; McKenna, Aaron; Getz, Gad; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen] Broad Inst MIT & Harvard, Boston, MA USA; [Horowitz, Peleg M.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Horowitz, Peleg M.; Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Santagata, Sandro; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jones, Robert T.; Palescandolo, Emanuele; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Hahn, William C.; Beroukhim, Rameen] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Stemmer-Rachamimov, Anat O.; Louis, David N.] Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02114 USA; [Louis, David N.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu; idunn@partners.org; rameen@broadinstitute.org		Jones, Robert/0000-0001-8007-4023; van hummelen, paul/0000-0002-4801-8600; Brastianos, Priscilla/0000-0003-4470-8425; Sunkavalli, Ashwini/0000-0002-5561-3694; Horowitz, Peleg/0000-0002-5177-1783; Santagata, Sandro/0000-0002-7528-9668	Brain Science Foundation; Pediatric Low-Grade Astrocytoma Foundation; American Brain Tumor Association; Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (NIH) [K08 CA122833, K08 NS064168, K12 CA090354-11]; US Department of Defense grant [W81XWE-12-1-0136]; NATIONAL CANCER INSTITUTE [K08CA122833, K12CA090354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Brain Science Foundation; Pediatric Low-Grade Astrocytoma Foundation; American Brain Tumor Association; Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank M. Lawrence, N. Stransky, M. Imielinski, K. Cibulskis, S. Carter, C. Stewart, C.-Z. Zhang, Y. Drier, S. Schumacher and B. Tabak for their assistance with genomic analyses; P. Wen, O. Al-Mefty, T. Batchelor, B. Reisler, M. Johnson, W. Richards and J. Kim for their assistance with tissue acquisition; and A. Pisarek-Horowitz, S.A. Horowitz, G. Bergthold and C.H. Brastianos for critical review of the manuscript. This work was supported by the Brain Science Foundation (I.F.D., P.K.B., R.B. and S.S.), the Pediatric Low-Grade Astrocytoma Foundation (R.B. and W.C.H.), the American Brain Tumor Association (P.K.B.), a Conquer Cancer Foundation Young Investigator Award (P.K.B.), US National Institutes of Health (NIH) grants K08 CA122833 (R.B.), K08 NS064168 (S.S.) and K12 CA090354-11 (P.K.B.), and US Department of Defense grant W81XWE-12-1-0136 (P.M.H.).	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Choy W, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1116; Durand A, 2009, J NEURO-ONCOL, V95, P367, DOI 10.1007/s11060-009-9934-0; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Goutagny S, 2010, CLIN CANCER RES, V16, P4155, DOI 10.1158/1078-0432.CCR-10-0891; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Karst AM, 2011, GYNECOL ONCOL, V123, P5, DOI 10.1016/j.ygyno.2011.05.021; Ketter R, 2007, J NEURO-ONCOL, V83, P213, DOI 10.1007/s11060-006-9318-7; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Krayenbuhl N, 2007, NEUROSURGERY, V61, P495, DOI 10.1227/01.NEU.0000280009.79813.DE; Laurendeau I, 2010, MOL MED, V16, P262, DOI 10.2119/molmed.2010.00005; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mathiesen T, 1996, NEUROSURGERY, V39, P2, DOI 10.1097/00006123-199607000-00002; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Nunes F, 2005, CANCER GENET CYTOGEN, V162, P135, DOI 10.1016/j.cancergencyto.2005.04.003; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reifenberger J, 1998, CANCER RES, V58, P1798; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Santos DCC, 2011, INT J DERMATOL, V50, P838, DOI 10.1111/j.1365-4632.2010.04866.x; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van Alkemade H, 2012, NEURO-ONCOLOGY, V14, P658, DOI 10.1093/neuonc/nos013; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; WELLENREUTHER R, 1995, AM J PATHOL, V146, P827; Wen PY, 2010, J NEURO-ONCOL, V99, P365, DOI 10.1007/s11060-010-0349-8; Yang HW, 2012, NEOPLASIA, V14, P20, DOI 10.1593/neo.111574	40	384	390	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					285	289		10.1038/ng.2526	http://dx.doi.org/10.1038/ng.2526			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23334667	Green Submitted, Green Accepted			2022-12-25	WOS:000315664800012
J	Carter, CS; Vogel, TW; Zhang, QH; Seo, S; Swiderski, RE; Moninger, TO; Cassell, MD; Thedens, DR; Keppler-Noreuil, KM; Nopoulos, P; Nishimura, DY; Searby, CC; Bugge, K; Sheffield, VC				Carter, Calvin S.; Vogel, Timothy W.; Zhang, Qihong; Seo, Seongjin; Swiderski, Ruth E.; Moninger, Thomas O.; Cassell, Martin D.; Thedens, Daniel R.; Keppler-Noreuil, Kim M.; Nopoulos, Peggy; Nishimura, Darryl Y.; Searby, Charles C.; Bugge, Kevin; Sheffield, Val C.			Abnormal development of NG2(+)PDGFR-alpha(+) neural progenitor cells leads to neonatal hydrocephalus in a ciliopathy mouse model	NATURE MEDICINE			English	Article							BIEDL-SYNDROME PROTEINS; UNITED-STATES; PRIMARY CILIA; CONGENITAL HYDROCEPHALUS; GLIA GENERATE; STEM-CELLS; DEFECTS; OLIGODENDROCYTES; PROLIFERATION; MUTATIONS	Hydrocephalus is a common neurological disorder that leads to expansion of the cerebral ventricles and is associated with a high rate of morbidity and mortality. Most neonatal cases are of unknown etiology and are likely to have complex inheritance involving multiple genes and environmental factors. Identifying molecular mechanisms for neonatal hydrocephalus and developing noninvasive treatment modalities are high priorities. Here we use a hydrocephalic mouse model of the human ciliopathy Bardet-Biedl Syndrome (BBS) and identify a role for neural progenitors in the pathogenesis of neonatal hydrocephalus. We found that hydrocephalus in this mouse model is caused by aberrant platelet-derived growth factor receptor alpha (PDGFR-alpha) signaling, resulting in increased apoptosis and impaired proliferation of chondroitin sulfate proteoglycan 4 (also known as neuron-glial antigen 2 or NG2)(+)PDGFR-alpha(+) neural progenitors. Targeting this pathway with lithium treatment rescued NG2(+)PDGFR-alpha(+) progenitor cell proliferation in BBS mutant mice, reducing their ventricular volume. Our findings demonstrate that neural progenitors are crucial in the pathogenesis of neonatal hydrocephalus, and we identify new therapeutic targets for this common neurological disorder.	[Zhang, Qihong; Swiderski, Ruth E.; Keppler-Noreuil, Kim M.; Nishimura, Darryl Y.; Searby, Charles C.; Bugge, Kevin; Sheffield, Val C.] Univ Iowa, Dept Pediat, Div Med Genet, Carver Coll Med, Iowa City, IA 52242 USA; [Carter, Calvin S.] Univ Iowa, Grad Program Neurosci, Carver Coll Med, Iowa City, IA 52242 USA; [Vogel, Timothy W.] Univ Iowa, Dept Neurosurg, Carver Coll Med, Iowa City, IA 52242 USA; [Zhang, Qihong; Seo, Seongjin; Swiderski, Ruth E.; Searby, Charles C.; Bugge, Kevin; Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Seo, Seongjin] Univ Iowa, Dept Ophthalmol, Carver Coll Med, Iowa City, IA 52242 USA; [Moninger, Thomas O.] Univ Iowa, Cent Microscopy Res Facil, Carver Coll Med, Iowa City, IA 52242 USA; [Cassell, Martin D.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; [Nopoulos, Peggy] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Div Med Genet, Carver Coll Med, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu		Searby, Charles/0000-0002-8108-8782; Sheffield, Val/0000-0002-6282-0835; Nopoulos, Peggy/0000-0001-8810-1903; Seo, Seongjin/0000-0002-7908-3210	US National Institutes of Health [R01EY110298, R01EY017168, R01EY022616]; Knight Templar Eye Foundation; Neurosurgery Research and Education Foundation; NATIONAL EYE INSTITUTE [R01EY011298, R01EY022616, R01EY017168] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knight Templar Eye Foundation; Neurosurgery Research and Education Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank L. Biesecker for help obtaining the human MRI scans. We thank K. Rahmouni and D.-F. Guo for help with quantitative RT-PCR and infusion experiments. We thank K. Agassandian for help with dye injection and CSF collection. We thank V. Buffard and L. Qian for their excellent technical assistance. We also appreciate valuable assistance from the University of Iowa Central Microscopy Research Facility. This work was supported in part by US National Institutes of Health grants R01EY110298 and R01EY017168 (to V.C.S.), R01EY022616 (to S.S.), the Knight Templar Eye Foundation (to S.S.) and the Neurosurgery Research and Education Foundation (to T.W.V.). C.S.C. is a National Science Foundation graduate research fellow, and V.C.S. is an Investigator of the Howard Hughes Medical Institute.	Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Baker K, 2011, AM J MED GENET A, V155A, P1, DOI 10.1002/ajmg.a.33773; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chi JH, 2005, J NEUROSURG, V103, P113, DOI 10.3171/ped.2005.103.2.0113; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Drake JM, 2008, NEUROSURGERY, V62, P633, DOI [10.1227/01.NEU.0000296952.38148.49, 10.1227/01.neu.0000316268.05338.5b]; Drake JM, 2000, CHILD NERV SYST, V16, P800, DOI 10.1007/s003810000351; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Keppler-Noreuil KM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-101; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Li HF, 2011, J CEREBR BLOOD F MET, V31, P2106, DOI 10.1038/jcbfm.2011.75; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shannon CN, 2011, J NEUROSURG-PEDIATR, V8, P593, DOI 10.3171/2011.9.PEDS11192; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Su HX, 2007, EXP NEUROL, V206, P296, DOI 10.1016/j.expneurol.2007.05.018; Talos F, 2010, CELL DEATH DIFFER, V17, P1816, DOI 10.1038/cdd.2010.131; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; VANCAMP G, 1993, NAT GENET, V4, P421; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Vogel TW, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS12222; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004	54	73	75	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1797	+		10.1038/nm.2996	http://dx.doi.org/10.1038/nm.2996			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160237	Green Accepted			2022-12-25	WOS:000311999800027
J	Junttila, IS; Creusot, RJ; Moraga, I; Bates, DL; Wong, MT; Alonso, MN; Suhoski, MM; Lupardus, P; Meier-Schellersheim, M; Engleman, EG; Utz, PJ; Fathman, CG; Paul, WE; Garcia, KC				Junttila, Ilkka S.; Creusot, Remi J.; Moraga, Ignacio; Bates, Darren L.; Wong, Michael T.; Alonso, Michael N.; Suhoski, Megan M.; Lupardus, Patrick; Meier-Schellersheim, Martin; Engleman, Edgar G.; Utz, Paul J.; Fathman, C. Garrison; Paul, William E.; Garcia, K. Christopher			Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines	NATURE CHEMICAL BIOLOGY			English	Article							IL-4 RECEPTOR; NOD MICE; BINDING; EXPRESSION; COMPLEX; DIFFERENTIATION; MECHANISMS; INTERFACE; SYSTEM; ALLOWS	Cytokines dimerize their receptors, with the binding of the 'second chain' triggering signaling. In the interleukin (IL)-4 and IL-13 system, different cell types express varying numbers of alternative second receptor chains (gamma c or IL-13R alpha 1), forming functionally distinct type I or type II complexes. We manipulated the affinity and specificity of second chain recruitment by human IL-4. A type I receptor-selective IL-4 'superkine' with 3,700-fold higher affinity for gamma c was three- to ten-fold more potent than wild-type IL-4. Conversely, a variant with high affinity for IL-13R alpha 1 more potently activated cells expressing the type II receptor and induced differentiation of dendritic cells from monocytes, implicating the type II receptor in this process. Superkines showed signaling advantages on cells with lower second chain numbers. Comparative transcriptional analysis reveals that the superkines induce largely redundant gene expression profiles. Variable second chain numbers can be exploited to redirect cytokines toward distinct cell subsets and elicit new actions, potentially improving the selectivity of cytokine therapy.	[Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Junttila, Ilkka S.; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Junttila, Ilkka S.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Junttila, Ilkka S.] Fimlab Labs, Tampere, Finland; [Creusot, Remi J.; Wong, Michael T.; Utz, Paul J.; Fathman, C. Garrison] Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Moraga, Ignacio; Bates, Darren L.; Lupardus, Patrick; Garcia, K. Christopher] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Alonso, Michael N.; Suhoski, Megan M.; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Meier-Schellersheim, Martin] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tampere University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Creusot, Remi/M-2642-2019	Junttila, Ilkka/0000-0002-9830-0823; Moraga, Ignacio/0000-0001-9909-0701; Creusot, Remi/0000-0002-8328-8155	US National Institute of Allergy and Infectious Diseases Division of Intramural Research; Finnish Medical Foundation; Sigrid Juselius Foundation; Howard Hughes Medical Institute; US National Institutes of Health (NIH) [RO1-AI51321]; NIH [UO1-DK078123]; Stanford Immunology Program Training Grant; NATIONAL CANCER INSTITUTE [R01CA065237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051321, ZIAAI001076, R01AI051321, T32AI007290, ZIAAI000493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases Division of Intramural Research; Finnish Medical Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Immunology Program Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank J. Gregorio and K. Weiskopf for assistance and the Stanford Human Immune Monitoring Center. This work was supported by US National Institute of Allergy and Infectious Diseases Division of Intramural Research (I. S. J. and W. E. P.), the Finnish Medical Foundation, the Sigrid Juselius Foundation (I. S. J.), the Howard Hughes Medical Institute (K. C. G.), the US National Institutes of Health (NIH) RO1-AI51321 (K. C. G.) and NIH UO1-DK078123 (C. G. F.) and the Stanford Immunology Program Training Grant (D.L.B.).	Andrews AL, 2002, J BIOL CHEM, V277, P46073, DOI 10.1074/jbc.M209560200; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CONRAD DH, 1987, J IMMUNOL, V139, P2290; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Creusot RJ, 2010, MOL THER, V18, P2112, DOI 10.1038/mt.2010.146; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ito T, 2009, J BIOL CHEM, V284, P24289, DOI 10.1074/jbc.M109.007286; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kraich M, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-13; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pillet AH, 2010, J MOL BIOL, V403, P671, DOI 10.1016/j.jmb.2010.08.056; SIEGEL JP, 1990, J IMMUNOL METHODS, V132, P287, DOI 10.1016/0022-1759(90)90040-3; SOSMAN JA, 1994, ANN ONCOL, V5, P447, DOI 10.1093/oxfordjournals.annonc.a058878; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53	31	58	62	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					990	998		10.1038/NCHEMBIO.1096	http://dx.doi.org/10.1038/NCHEMBIO.1096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103943	Green Accepted			2022-12-25	WOS:000311491200014
J	Wang, LK; Perera, BGK; Hari, SB; Bhhatarai, B; Backes, BJ; Seeliger, MA; Schurer, SC; Oakes, SA; Papa, FR; Maly, DJ				Wang, Likun; Perera, B. Gayani K.; Hari, Sanjay B.; Bhhatarai, Barun; Backes, Bradley J.; Seeliger, Markus A.; Schuerer, Stephan C.; Oakes, Scott A.; Papa, Feroz R.; Maly, Dustin J.			Divergent allosteric control of the IRE1 alpha endoribonuclease using kinase inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; CELL FATE; IRE1; PATHWAY; ACTIVATION; MECHANISM; APOPTOSIS; REVEALS	Under endoplasmic reticulum stress, unfolded protein accumulation leads to activation of the endoplasmic reticulum transmembrane kinase/endoRNase (RNase) IRE1 alpha. IRE1 alpha oligomerizes, autophosphorylates and initiates splicing of XBP1 mRNA, thus triggering the unfolded protein response (UPR). Here we show that IRE1 alpha's kinase-controlled RNase can be regulated in two distinct modes with kinase inhibitors: one class of ligands occupies IRE1 alpha's kinase ATP-binding site to activate RNase-mediated XBP1 mRNA splicing even without upstream endoplasmic reticulum stress, whereas a second class can inhibit the RNase through the same ATP-binding site, even under endoplasmic reticulum stress. Thus, alternative kinase conformations stabilized by distinct classes of ATP-competitive inhibitors can cause allosteric switching of IRE1 alpha's RNase-either on or off. As dysregulation of the UPR has been implicated in a variety of cell degenerative and neoplastic disorders, small-molecule control over IRE1 alpha should advance efforts to understand the UPR's role in pathophysiology and to develop drugs for endoplasmic reticulum stress-related diseases.	[Wang, Likun; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Wang, Likun; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Wang, Likun; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wang, Likun; Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Perera, B. Gayani K.; Hari, Sanjay B.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Seeliger, Markus A.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Bhhatarai, Barun; Schuerer, Stephan C.] Univ Miami, Ctr Computat Sci, Coral Gables, FL 33124 USA; [Schuerer, Stephan C.] Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, Coral Gables, FL 33124 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Miami; University of Miami	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu; maly@chem.washington.edu	Seeliger, Markus A/D-6409-2013	Seeliger, Markus/0000-0003-0990-1756; /0000-0003-0606-9896; Bhhatarai, Barun/0000-0002-0109-7487; Papa, Feroz/0000-0002-3684-9108	US National Institutes of Health Director's New Innovator Award [DP2 OD001925, RO1 DK080955, RO1 CA136577, R00 GM080097, R01 GM086858]; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Juvenile Diabetes Research Foundation; Sloan Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA136577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080097, R01GM086858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	US National Institutes of Health Director's New Innovator Award; American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Sloan Foundation(Alfred P. Sloan Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Institutes of Health Director's New Innovator Award DP2 OD001925 (F. R. P.), RO1 DK080955 (F. R. P.), RO1 CA136577 (S.A.O.), R00 GM080097 (M. A. S.) and R01 GM086858 (D.J.M.), an American Cancer Society Research Scholar Award (S.A.O.) and the Burroughs Wellcome (F. R. P.), Juvenile Diabetes Research (F. R. P.) and Sloan (D.J.M.) Foundations. S. B. H. was supported by a predoctoral fellowship from the American Heart Association.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-48; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Ranjitkar P, 2010, CHEM BIOL, V17, P195, DOI 10.1016/j.chembiol.2010.01.008; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tu BP, 1999, P NATL ACAD SCI USA, V96, P4862, DOI 10.1073/pnas.96.9.4862; Underbakke ES, 2008, ANGEW CHEM INT EDIT, V47, P9677, DOI 10.1002/anie.200803378; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	34	150	168	4	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					982	989		10.1038/NCHEMBIO.1094	http://dx.doi.org/10.1038/NCHEMBIO.1094			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23086298	Green Submitted, Green Accepted			2022-12-25	WOS:000311491200013
J	Cowper-Sal-lari, R; Zhang, XY; Wright, JB; Bailey, SD; Cole, MD; Eeckhoute, J; Moore, JH; Lupien, M				Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Wright, Jason B.; Bailey, Swneke D.; Cole, Michael D.; Eeckhoute, Jerome; Moore, Jason H.; Lupien, Mathieu			Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EPIGENETIC SIGNATURES; SUSCEPTIBILITY; ENHANCERS; DISTINCT; DEFINES; PROMOTERS; RS6983267; PROTEINS; DYNAMICS	Genome-wide association studies (GWAS) have identified thousands of SNPs that are associated with human traits and diseases. But, because the vast majority of these SNPs are located in non-coding regions of the genome, the mechanisms by which they promote disease risk have remained elusive. Employing a new methodology that combines cistromics, epigenomics and genotype imputation, we annotate the non-coding regions of the genome in breast cancer cells and systematically identify the functional nature of SNPs associated with breast cancer risk. Our results show that breast cancer risk-associated SNPs are enriched in the cistromes of FOXA1 and ESR1 and the epigenome of histone H3 lysine 4 monomethylation (H3K4me1) in a cancer- and cell type-specific manner. Furthermore, the majority of the risk-associated SNPs modulate the affinity of chromatin for FOXA1 at distal regulatory elements, thereby resulting in allele-specific gene expression, which is exemplified by the effect of the rs4784227 SNP on the TOX3 gene within the 16q12.1 risk locus.	[Bailey, Swneke D.; Lupien, Mathieu] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Wright, Jason B.; Cole, Michael D.; Moore, Jason H.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Lebanon, NH USA; [Cowper-Sal-lari, Richard; Zhang, Xiaoyang; Moore, Jason H.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Inst Quantitat Biomed Sci, Lebanon, NH USA; [Bailey, Swneke D.; Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Eeckhoute, Jerome] Univ Lille Nord France, UMR 1011, INSERM, Lille, France; [Eeckhoute, Jerome] Inst Pasteur, F-59019 Lille, France	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Lupien, M (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada.	jason.h.moore@dartmouth.edu; mlupien@uhnres.utoronto.ca	Eeckhoute, Jerome/AAN-8219-2021; Moore, Jason H./AAV-9645-2021	Eeckhoute, Jerome/0000-0002-7222-9264; Moore, Jason H./0000-0002-5015-1099; Lupien, Mathieu/0000-0003-0929-9478	US National Cancer Institute (NCI) [2P30CA023108-32]; American Cancer Society (ACS) [1RG-82-003-27]; US National Institutes of Health (NIH) [R01LM009012, R01CA155004]; Princess Margaret Hospital Foundation; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA155004, R01CA080320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK096822] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012] Funding Source: NIH RePORTER; Direct For Biological Sciences [0923008] Funding Source: National Science Foundation	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society (ACS)(American Cancer Society); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Princess Margaret Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Brown, M.L. Freedman and M. Lemaire for discussions, as well as B.G. Neel and R. Marcotte for technical assistance. We acknowledge support from the US National Cancer Institute (NCI; 2P30CA023108-32), the American Cancer Society (ACS; 1RG-82-003-27 to M.L.), the US National Institutes of Health (NIH; R01LM009012 to J.H.M. and R01CA155004 to M.L.) and the Princess Margaret Hospital Foundation (M.L.).	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Grant SFA, 2008, CLIN CHEM, V54, P1116, DOI 10.1373/clinchem.2008.105395; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Udler MS, 2010, HUM MOL GENET, V19, P2507, DOI 10.1093/hmg/ddq122; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111	47	274	277	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1191	1198		10.1038/ng.2416	http://dx.doi.org/10.1038/ng.2416			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23001124	Green Accepted			2022-12-25	WOS:000310495800009
J	Hirota, T; Takahashi, A; Kubo, M; Tsunoda, T; Tomita, K; Sakashita, M; Yamada, T; Fujieda, S; Tanaka, S; Doi, S; Miyatake, A; Enomoto, T; Nishiyama, C; Nakano, N; Maeda, K; Okumura, K; Ogawa, H; Ikeda, S; Noguchi, E; Sakamoto, T; Hizawa, N; Ebe, K; Saeki, H; Sasaki, T; Ebihara, T; Amagai, M; Takeuchi, S; Furue, M; Nakamura, Y; Tamari, M				Hirota, Tomomitsu; Takahashi, Atsushi; Kubo, Michiaki; Tsunoda, Tatsuhiko; Tomita, Kaori; Sakashita, Masafumi; Yamada, Takechiyo; Fujieda, Shigeharu; Tanaka, Shota; Doi, Satoru; Miyatake, Akihiko; Enomoto, Tadao; Nishiyama, Chiharu; Nakano, Nobuhiro; Maeda, Keiko; Okumura, Ko; Ogawa, Hideoki; Ikeda, Shigaku; Noguchi, Emiko; Sakamoto, Tohru; Hizawa, Nobuyuki; Ebe, Koji; Saeki, Hidehisa; Sasaki, Takashi; Ebihara, Tamotsu; Amagai, Masayuki; Takeuchi, Satoshi; Furue, Masutaka; Nakamura, Yusuke; Tamari, Mayumi			Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population	NATURE GENETICS			English	Article							DISEASE; KERATINOCYTES; METAANALYSIS; MODULATION; MECHANISMS; EXPRESSION; FILAGGRIN; VARIANTS; CARMA1; ASTHMA	Atopic dermatitis is a common inflammatory skin disease caused by interaction of genetic and environmental factors. On the basis of data from a genome-wide association study (GWAS) and a validation study comprising a total of 3,328 subjects with atopic dermatitis and 14,992 controls in the Japanese population, we report here 8 new susceptibility loci: IL1RL1-IL18R1-IL18RAP (P-combined = 8.36 x 10(-18)), the major histocompatibility complex (MHC) region (P = 8.38 x 10(-20)), OR10A3-NLRP10 (P = 1.54 x 10(-22)), GLB1 (P = 2.77 x 10(-16)), CCDC80 (P = 1.56 x 10(-19)), CARD11 (P = 7.83 x ZNF365 (P = 5.85 x 10(-20)) and CYP24A1-PFDN4 (P = 1.65 x 10(-8)). We also replicated the associations of the FLG, C11orf30, TMEM232-SLC25A46, TNFRSF6B-ZGPAT, OVOL1, ACTL9 and KIF3A-IL13 loci that were previously reported in GWAS of European and Chinese individuals and a meta-analysis of GWAS for atopic dermatitis. These findings advance the understanding of the genetic basis of atopic dermatitis.	[Hirota, Tomomitsu; Tanaka, Shota; Tamari, Mayumi] RIKEN, Ctr Genom Med, Lab Resp Dis, Yokohama, Kanagawa, Japan; [Takahashi, Atsushi] RIKEN, Ctr Genom Med, Lab Stat Anal, Minato Ku, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa, Japan; [Tomita, Kaori; Sakashita, Masafumi; Yamada, Takechiyo; Fujieda, Shigeharu] Fukui Med Univ, Dept Otorhinolaryngol, Matsuoka, Fukui, Japan; [Tanaka, Shota] Univ Yamanashi, Fac Med, Dept Otolaryngol Head & Neck Surg, Chuo Ku, Tamaho, Yamanashi, Japan; [Doi, Satoru] Osaka Prefectural Med Ctr Resp & Allerg Dis, Habikino, Japan; [Miyatake, Akihiko] Miyatake Asthma Clin, Osaka, Japan; [Enomoto, Tadao] Japan Hlth Promot Supporting Network, Nonprofit Org NPO, Wakayama, Japan; [Nishiyama, Chiharu; Nakano, Nobuhiro; Maeda, Keiko; Okumura, Ko; Ogawa, Hideoki] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo, Japan; [Ikeda, Shigaku] Juntendo Univ, Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo, Japan; [Noguchi, Emiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Med Genet, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Sakamoto, Tohru; Hizawa, Nobuyuki] Univ Tsukuba, Inst Clin Med, Div Resp Med, Tsukuba, Ibaraki 305, Japan; [Saeki, Hidehisa] Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo, Japan; [Ebe, Koji] Takao Hosp, Dept Dermatol, Kyoto, Japan; [Takeuchi, Satoshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1138654, Japan; [Sasaki, Takashi; Ebihara, Tamotsu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, Tokyo 108, Japan	RIKEN; RIKEN; RIKEN; RIKEN; University of Fukui; University of Yamanashi; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; Juntendo University; Juntendo University; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; Jikei University; Kyushu University; University of Tokyo; Keio University	Tamari, M (corresponding author), RIKEN, Ctr Genom Med, Lab Resp Dis, Yokohama, Kanagawa, Japan.	tamari@src.riken.jp	Nishiyama, Chiharu/GPW-9372-2022; Tamari, Mayumi/N-5378-2015; Sasaki, Takashi/AAD-1461-2019; Amagai, Masayuki/K-5325-2013; Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014	Amagai, Masayuki/0000-0003-3314-7052; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sasaki, Takashi/0000-0002-6275-046X; Sakamoto, Tohru/0000-0002-8876-1466; Nakano, Nobuhiro/0000-0002-5317-5950	Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	We thank all the individuals who participated in the study and also thank the collaborating physicians for helping with sample collection. We are grateful to the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. We thank M.T. Shimizu, H. Sekiguchi, A.I. Jodo, N. Kawaraichi and the technical staff of the Center for Genomic Medicine for providing technical assistance and K. Barrymore for proofreading this manuscript. This work was conducted as part of the BioBank Japan Project, which is supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also partly supported by grants from the Ministry of Health, Labour and Welfare, Japan.	Altrichter S, 2008, J INVEST DERMATOL, V128, P2232, DOI 10.1038/jid.2008.80; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Blonska M, 2012, J IMMUNOL, V188, P3160, DOI 10.4049/jimmunol.1102943; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Jung K, 2011, J ALLERGY CLIN IMMUN, V127, P420, DOI 10.1016/j.jaci.2010.10.043; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Magalhaes JG, 2011, CURR OPIN IMMUNOL, V23, P29, DOI 10.1016/j.coi.2010.12.003; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Peroni DG, 2011, BRIT J DERMATOL, V164, P1078, DOI 10.1111/j.1365-2133.2010.10147.x; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tremblay F, 2009, J BIOL CHEM, V284, P8136, DOI 10.1074/jbc.M809535200; Vestergaard C, 2000, J INVEST DERMATOL, V115, P640, DOI 10.1046/j.1523-1747.2000.00115.x; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106	30	225	244	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1222	1226		10.1038/ng.2438	http://dx.doi.org/10.1038/ng.2438			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23042114				2022-12-25	WOS:000310495800013
J	Orr, N; Lemnrau, A; Cooke, R; Fletcher, O; Tomczyk, K; Jones, M; Johnson, N; Lord, CJ; Mitsopoulos, C; Zvelebil, M; McDade, SS; Buck, G; Blancher, C; Trainer, AH; James, PA; Bojesen, SE; Bokmand, S; Nevanlinna, H; Mattson, J; Friedman, E; Laitman, Y; Palli, D; Masala, G; Zanna, I; Ottini, L; Giannini, G; Hollestelle, A; van den Ouweland, AMW; Novakovic, S; Krajc, M; Gago-Dominguez, M; Castelao, JE; Olsson, H; Hedenfalk, I; Easton, DF; Pharoah, PDP; Dunning, AM; Bishop, DT; Neuhausen, SL; Steele, L; Houlston, RS; Garcia-Closas, M; Ashworth, A; Swerdlow, AJ				Orr, Nick; Lemnrau, Alina; Cooke, Rosie; Fletcher, Olivia; Tomczyk, Katarzyna; Jones, Michael; Johnson, Nichola; Lord, Christopher J.; Mitsopoulos, Costas; Zvelebil, Marketa; McDade, Simon S.; Buck, Gemma; Blancher, Christine; Trainer, Alison H.; James, Paul A.; Bojesen, Stig E.; Bokmand, Susanne; Nevanlinna, Heli; Mattson, Johanna; Friedman, Eitan; Laitman, Yael; Palli, Domenico; Masala, Giovanna; Zanna, Ines; Ottini, Laura; Giannini, Giuseppe; Hollestelle, Antoinette; van den Ouweland, Ans M. W.; Novakovic, Srdjan; Krajc, Mateja; Gago-Dominguez, Manuela; Castelao, Jose Esteban; Olsson, Hakan; Hedenfalk, Ingrid; Easton, Douglas F.; Pharoah, Paul D. P.; Dunning, Alison M.; Bishop, D. Timothy; Neuhausen, Susan L.; Steele, Linda; Houlston, Richard S.; Garcia-Closas, Montserrat; Ashworth, Alan; Swerdlow, Anthony J.		KConFab Consortium	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; CONFER SUSCEPTIBILITY; LOCUS; BRCA1	We conducted a genome-wide association study of male breast cancer comprising 823 cases and 2,795 controls of European ancestry, with validation in independent sample sets totaling 438 cases and 474 controls. A SNP in RAD51B at 14q24.1 was significantly associated with male breast cancer risk (P = 3.02 x 10(-13); odds ratio (OR) = 1.57). We also refine association at 16q12.1 to a SNP within TOX3 (P = 3.87 x 10(-15); OR = 1.50).	[Orr, Nick; Lemnrau, Alina; Fletcher, Olivia; Tomczyk, Katarzyna; Johnson, Nichola; Lord, Christopher J.; Mitsopoulos, Costas; Zvelebil, Marketa; Garcia-Closas, Montserrat; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Orr, Nick; Lemnrau, Alina; Cooke, Rosie; Fletcher, Olivia; Tomczyk, Katarzyna; Jones, Michael; Johnson, Nichola; Lord, Christopher J.; Mitsopoulos, Costas; Zvelebil, Marketa; Garcia-Closas, Montserrat; Ashworth, Alan; Swerdlow, Anthony J.] Inst Canc Res, Div Breast Canc Res, Sutton, Surrey, England; [Cooke, Rosie; Jones, Michael; Houlston, Richard S.; Garcia-Closas, Montserrat; Swerdlow, Anthony J.] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [McDade, Simon S.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Buck, Gemma; Blancher, Christine] Wellcome Trust Ctr Human Genet, High Throughput Genom Grp, Oxford, England; [KConFab Consortium] Peter MacCallum Canc Ctr, Res Dept, Kathleen Cuningham Consortium Res Familial Breast, Melbourne, Vic, Australia; [Trainer, Alison H.; James, Paul A.] Peter MacCallum Canc Ctr, Familial Canc Clin, Melbourne, Vic, Australia; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Bokmand, Susanne] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Herlev, Denmark; [Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Mattson, Johanna] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Friedman, Eitan; Laitman, Yael] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Tel Aviv, Israel; [Friedman, Eitan; Laitman, Yael] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Palli, Domenico; Masala, Giovanna; Zanna, Ines] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Ottini, Laura; Giannini, Giuseppe] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Hollestelle, Antoinette] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; [van den Ouweland, Ans M. W.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Novakovic, Srdjan] Inst Oncol Ljubljana, Dept Mol Diagnost, Ljubljana, Slovenia; [Krajc, Mateja] Inst Oncol Ljubljana, Canc Genet Clin, Epidemiol & Canc Registry, Ljubljana, Slovenia; [Gago-Dominguez, Manuela] CHUS, Galician Fdn Genom Med, Serv Galego Saude SERGAS, Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain; [Castelao, Jose Esteban] Complexo Hosp Univ Vigo CHUVI, SERGAS, Genet Oncol Unit, Vigo, Spain; [Olsson, Hakan; Hedenfalk, Ingrid] Lund Univ, Dept Oncol, Lund, Sweden; [Easton, Douglas F.; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Easton, Douglas F.; Pharoah, Paul D. P.; Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Bishop, D. Timothy] Univ Leeds, Leeds Inst Mol Med, Div Canc Studies & Pathol, Sect Epidemiol & Biostat, Leeds, W Yorkshire, England; [Neuhausen, Susan L.; Steele, Linda] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Queens University Belfast; University of Oxford; Wellcome Centre for Human Genetics; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Sapienza University Rome; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Institute of Oncology - Slovenia; Institute of Oncology - Slovenia; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo; Lund University; University of Cambridge; University of Cambridge; University of Leeds; City of Hope; Beckman Research Institute of City of Hope	Orr, N (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	nicholas.orr@icr.ac.uk	James, Paul/G-2943-2014; Pharoah, Paul/V-6658-2019; Giannini, Giuseppe/B-5672-2013; Zanna, Ines/AAC-5596-2022; Garcia-Closas, Montserrat/AAZ-6930-2021; McDade, Simon S/E-5730-2017; Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012; Garcia-Closas, Montserrat/F-3871-2015; McDade, Simon/AAE-5031-2020; Gago-Dominguez, Manuela/AAP-6611-2021; Masala, Giovanna/AAC-5474-2022	Pharoah, Paul/0000-0001-8494-732X; Giannini, Giuseppe/0000-0003-0299-4056; Zanna, Ines/0000-0002-5710-6506; Garcia-Closas, Montserrat/0000-0003-1033-2650; McDade, Simon S/0000-0002-3024-4773; Lord, Christopher J/0000-0002-3226-0515; Garcia-Closas, Montserrat/0000-0003-1033-2650; McDade, Simon/0000-0002-3024-4773; Masala, Giovanna/0000-0002-5758-9069; Nevanlinna, Heli/0000-0002-0916-2976; Hollestelle, Antoinette/0000-0003-1166-1966; Fletcher, Olivia/0000-0001-9387-7116; tumino, rosario/0000-0003-2666-414X; OTTINI, LAURA/0000-0001-8030-0449; Buck, Gemma/0000-0001-5289-1050; Houlston, Richard/0000-0002-5268-0242; Hedenfalk, Ingrid/0000-0002-6840-3397; PALLI, Domenico/0000-0002-5558-2437; Olsson, Hakan/0000-0002-8794-9635; Castelao, Jose E/0000-0001-7110-1376; Thorne, Heather/0000-0003-3610-2511; James, Paul/0000-0002-4361-4657; Mitsopoulos, Costas/0000-0002-9116-5921; Dunning, Alison Margaret/0000-0001-6651-7166; Novakovic, Srdjan/0000-0002-8888-4810; Jones, Michael/0000-0001-7479-3451; Zvelebil, Marketa/0000-0001-8018-5591; Swerdlow, Anthony/0000-0001-5550-4159; Bojesen, Stig/0000-0002-4061-4133; Bishop, Tim/0000-0002-8752-8785; Gago, Manuela/0000-0001-6713-4351	Australian National Health & Medical Research Council (NHMRC); National Breast Cancer Foundation; Cancer Australia [628333]; Breakthrough Breast Cancer, Movember; Institute of Cancer Research; Wellcome Trust [090532/Z/09/Z, 068545/Z/02]; UK Medical Research Council (MRC) [G0900747 91070]; UK MRC [G0000934]; Finnish Breast Cancer Group; Finnish Oncology Association; Salonoja Foundation; Italian Association for Cancer Research (AIRC) [IG 8713]; Istituto Toscano Tumori, Florence, Italy; Cancer Research UK [C490/A10124, CA8197/A10865, C588/A10589]; University of Cambridge NIHR Biomedical Research Centre; Joseph Mitchell Fund; Department of Pathology of the CHUS Santiago Hospital; Galician Foundation of Genomic Medicine; Program Grupos Emergentes, Cancer Genetics Unit of CHUVI, Instituto de Salud Carlos III; Swedish Cancer Society; Swedish Medical Research Council; US ARMY [DAMD-17-96-I-6266]; US National Institutes of Health (NIH) [R01CA74415]; City of Hope; MRC [G0000934] Funding Source: UKRI; Cancer Research UK [10118, 10589, 11022] Funding Source: researchfish; Medical Research Council [G0000934] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA074415] Funding Source: NIH RePORTER	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Cancer Australia; Breakthrough Breast Cancer, Movember; Institute of Cancer Research; Wellcome Trust(Wellcome Trust); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Finnish Breast Cancer Group; Finnish Oncology Association; Salonoja Foundation; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori, Florence, Italy; Cancer Research UK(Cancer Research UK); University of Cambridge NIHR Biomedical Research Centre; Joseph Mitchell Fund; Department of Pathology of the CHUS Santiago Hospital; Galician Foundation of Genomic Medicine; Program Grupos Emergentes, Cancer Genetics Unit of CHUVI, Instituto de Salud Carlos III; Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); US ARMY(United States Department of DefenseUnited States Army); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of Hope; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the men who participated in the study. For ICR sample collection, we are grateful to B. Smith, D. Hogben, R. McCann, J. Melia, S. Squires, M. Snigorska, J. Micic and K. Sibley for administrative help and advice; to the research nurses A. Butlin, M. Pelerin, J. Wood and T. Gardener for collection of blood samples and questionnaire data from participants; to D. Thomas and her team front the Breakthrough Generations Study for coordinating collection of controls; and to the cancer registries of England and Wales for providing information on eligible participants. The Study of Epidemiology and Risk Factors in Cancer Heredity (SEARCH) thanks the SEARCH team. We wish to thank H. Thorne, E. Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics and the Clinical Follow Up Study (funded from 2001-2009 by the Australian National Health & Medical Research Council (NHMRC) and currently by the National Breast Cancer Foundation and Cancer Australia; 628333) for their contributions to this resource and the many families who contribute to kConFab. We thank G. Wilhoite for preparing the US samples for this study. We thank A. Jukkola-Vuorinen, V. Kataja and P. Auvinen, as well as S. Hallamies and S. Rants, for their contributions to the Finnish Male Breast Cancer Study. We thank J. Forteza, M. Fraga, C. Celeiro and the staff of the Department of Pathology of CHUS Santiago and A. Carracedo and C.M. Redondo for their contributions to the Spanish study. Finally, we thank the consultants who cared for the study participants for their advice and help. The Breakthrough Male Breast Cancer Study was approved by the South Eastern Research Ethics Committee. Participants gave informed consent for all aspects of the study.; This work was supported by Breakthrough Breast Cancer, Movember and the Institute of Cancer Research who acknowledge National Health Service (NHS) funding to the National Institute for Health Research (NIHR) Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics is funded by Wellcome Trust grant 090532/Z/09/Z and UK Medical Research Council (MRC) Hub grant G0900747 91070. This work made use of data and samples generated by the 1958 British Birth Cohort under grant G0000934 from the UK MRC and grant 068545/Z/02 from the Wellcome Trust. The Finnish Male Breast Cancer Study acknowledges funding from the Finnish Breast Cancer Group, the Finnish Oncology Association and the Salonoja Foundation. L.O. acknowledges funding from the Italian Association for Cancer Research (AIRC, IG 8713). D.P. acknowledges funding from the Istituto Toscano Tumori, Florence, Italy. SEARCH is funded by a grant from Cancer Research UK (C490/A10124) and is supported by the University of Cambridge NIHR Biomedical Research Centre. A.M.D. has been funded by Cancer Research UK grant CA8197/A10865 and by the Joseph Mitchell Fund. D.T.B. acknowledges funding by Cancer Research UK (Programme Award C588/A10589). M.G.-D. and J.E.C. acknowledge the support of the Department of Pathology of the CHUS Santiago Hospital, the Galician Foundation of Genomic Medicine and the Program Grupos Emergentes, Cancer Genetics Unit of CHUVI, Instituto de Salud Carlos III. H.O. and I.H. acknowledge funding from the Swedish Cancer Society and The Swedish Medical Research Council. The collection of samples and epidemiological data for the US cases was supported by US ARMY Grant DAMD-17-96-I-6266 and US National Institutes of Health (NIH) grant R01CA74415. S.L.N. was partially supported by the Morris and Horowitz Families Endowed Professorship at the City of Hope.	Basham VM, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr419; Bevier M, 2012, BREAST CANCER RES TR, V132, P723, DOI 10.1007/s10549-011-1915-2; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Orr N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002290; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037	15	76	77	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1182	1184		10.1038/ng.2417	http://dx.doi.org/10.1038/ng.2417			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23001122	Green Submitted, Green Accepted			2022-12-25	WOS:000310495800006
J	Schiel, JA; Simon, GC; Zaharris, C; Weisz, J; Castle, D; Wu, CC; Prekeris, R				Schiel, John A.; Simon, Glenn C.; Zaharris, Chelsey; Weisz, Julie; Castle, David; Wu, Christine C.; Prekeris, Rytis			FIP3-endosome-dependent formation of the secondary ingression mediates ESCRT-III recruitment during cytokinesis	NATURE CELL BIOLOGY			English	Article							CLEAVAGE FURROW; ABSCISSION CHECKPOINT; PROTEIN; DOMAIN; FUSION; ARF6; IDENTIFICATION; REQUIREMENTS; TRAFFICKING; RAB11-FIP3	The final cytokinesis event involves severing of the connecting intercellular bridge (ICB) between daughter cells. FIP3-positive recycling endosomes (FIP3 endosomes) and ESCRT complexes have been implicated in mediating the final stages of cytokinesis. Here we analyse the spatiotemporal dynamics of the actin cytoskeleton, FIP3-endosome fusion and ESCRT-II I localization during cytokinesis to show that the ICB narrows by a FIP3-endosome-mediated secondary ingression, whereas the ESCRT-III complex is needed only for the last scission step of cytokinesis. We characterize the role of FIP3 endosomes during cytokinesis to demonstrate that FIP3 endosomes deliver SCAMP2/3 and p50RhoGAP to the ICB during late telophase, proteins required for the formation of the secondary ingression. We also show that the FIP3-endosome-induced secondary ingression is required for the recruitment of the ESCRT-II I complex to the abscission site. Finally, we characterize a FIP3-endosome-dependent regulation of the ICB cortical actin network through the delivery of p50RhoGAP. These results provide a framework for the coordinated efforts of actin, FIP3 endosomes and the ESCRTs to regulate cytokinesis and abscission.	[Schiel, John A.; Simon, Glenn C.; Prekeris, Rytis] Univ Colorado Denver, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Zaharris, Chelsey] Univ Colorado Denver, Sch Med, Dept Struct Biol & Biophys, Aurora, CO 80045 USA; [Weisz, Julie; Wu, Christine C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Castle, David] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia	Prekeris, R (corresponding author), Univ Colorado Denver, Sch Med, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO 80045 USA.	Rytis.Prekeris@ucdenver.edu			NIH-NIDDK [DK064380]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064380] Funding Source: NIH RePORTER	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Pearson and C. Willenborg (University of Colorado Denver, USA) for critically reading the manuscript. We also thank J. Martin-Serrano (King's College London, UK) for mCherry-CEP55, mCherry-TSG101 and YFP-CHMP4B; M. Geiszt (Semmelweis University, Hungary) for GFP-p50RhoGAP; C. Westlake (NCI-Frederick, USA) for RAB8 complementary DNA; A. Bresnick (Albert Einstein College of Medicine, USA) for myosin-IIA-GFP; and W. Bement (University of Wisconsin Madison, USA) for utrophin-GFP and utrophin-RFP. This work was supported in part by a grant from NIH-NIDDK (DK064380 to R.P.).	Aoh QL, 2009, MOL BIOL CELL, V20, P1816, DOI 10.1091/mbc.E08-09-0894; Baluska F, 2006, DEV BIOL, V294, P1, DOI 10.1016/j.ydbio.2006.02.047; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; BYERS B, 1968, PROTOPLASMA, V66, P413, DOI 10.1007/BF01255868; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; COCIORVA D, 2007, CURR PROTOC BIOINFOR; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Falguieres T, 2012, TRAFFIC, V13, P131, DOI 10.1111/j.1600-0854.2011.01291.x; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Horgan CP, 2004, BIOCHEM BIOPH RES CO, V319, P83, DOI 10.1016/j.bbrc.2004.04.157; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Liao H, 2008, AM J PHYSIOL-CELL PH, V294, pC797, DOI 10.1152/ajpcell.00493.2007; Liao H, 2007, BIOCHEMISTRY-US, V46, P10909, DOI 10.1021/bi701121j; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Liu LX, 2005, MOL BIOL CELL, V16, P4463, DOI 10.1091/mbc.E05-03-0231; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Lowenthal Mark S., 2008, V432, P37, DOI 10.1007/978-1-59745-028-7_3; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Robinson DN, 1996, TRENDS CELL BIOL, V6, P474, DOI 10.1016/0962-8924(96)84945-2; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Simon GC, 2008, EMBO J, V27, P1791, DOI 10.1038/emboj.2008.112; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Thomas DDH, 2010, BIOCHEM BIOPH RES CO, V402, P583, DOI 10.1016/j.bbrc.2010.10.041; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Zhang J, 2011, TRAFFIC, V12, P600, DOI 10.1111/j.1600-0854.2011.01170.x; Zhou YT, 2010, MOL BIOL CELL, V21, P3232, DOI 10.1091/mbc.E09-05-0408	52	96	97	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1068	+		10.1038/ncb2577	http://dx.doi.org/10.1038/ncb2577			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	23000966	Green Accepted			2022-12-25	WOS:000309543800015
J	Wei, Q; Zhang, YX; Li, YJ; Zhang, Q; Ling, K; Hu, JH				Wei, Qing; Zhang, Yuxia; Li, Yujie; Zhang, Qing; Ling, Kun; Hu, Jinghua			The BBSome controls IFT assembly and turnaround in cilia	NATURE CELL BIOLOGY			English	Article							BARDET-BIEDL-SYNDROME; RETROGRADE INTRAFLAGELLAR TRANSPORT; C-ELEGANS; CAENORHABDITIS-ELEGANS; SYNDROME PROTEINS; KINESIN-II; PARTICLES; DEFECTS; DYNEIN; MICE	The bidirectional movement of intraflagellar transport (IFT) particles,which are composed of motors, IFT-A and IFT-B subcomplexes,and cargoes,is required for the biogenesis and signalling of cilia(1,2). A successful IFT cycle depends on the proper assembly of the massive IFT particle at the ciliary base and its turnaround from anterograde to retrograde transport at the ciliary tip. However,how IFT assembly and turnaround are regulated in vivo remains elusive. From a whole-genome mutagenesis screen in Caenorhabditis elegans, we identified two hypomorphic mutations in dyf-2 and bbs-1 as the only mutants showing normal anterograde IFT transport but defective IFT turnaround at the ciliary tip. Further analyses revealed that the BBSome (refs3,4), agroup of conserved proteins affected in human Bardet-Biedl syndrome(5) (BBS), assembles IFT complexes at the ciliary base, then binds to the anterograde IFT particleina DYF-2- (an orthologue of human WDR19) and BBS-1-dependent manner, and lastly reaches the ciliary tip to regulate proper IFT recycling. Our results identify the BBSome as the key player regulating IFT assembly and turnaround in cilia.	[Wei, Qing; Zhang, Yuxia; Li, Yujie; Zhang, Qing; Hu, Jinghua] Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Ling, Kun; Hu, Jinghua] Mayo Translat PKD Ctr, Rochester, MN 55905 USA; [Ling, Kun; Hu, Jinghua] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Hu, JH (corresponding author), Div Nephrol & Hypertens, Rochester, MN 55905 USA.	hu.jinghua@mayo.edu	Wei, Qing/G-5523-2014; Li, yu/HHZ-5236-2022; Zhang, Yong/H-1774-2012; Li, YuJie/HGT-8657-2022; Zhang, Yuxia/J-3449-2013; Zhang, Yufeng/GZL-1973-2022; Zhang, Yiming/HGB-7344-2022; wang, meng/GWZ-9558-2022	Zhang, Yong/0000-0002-5831-637X; Wei, Qing/0000-0001-7803-1139	National Institutes of Health [1R01DK090038]; P30 center grant [P30DK90728]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; PKD Foundation Young Investigator Award [04YI09a]; FULK Career Development Award; Zell PKD Research Award; Upjohn PKD Research Fund; National Cancer Institute (NCI) [1R01CA149039-0 1A1]; Susan G. Komen for the Cure [KG100902]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK90728]; NATIONAL CANCER INSTITUTE [R01CA149039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, P30DK090728, R01DK090038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P30 center grant; Mayo Clinic Center for Cell Signaling in Gastroenterology; PKD Foundation Young Investigator Award; FULK Career Development Award; Zell PKD Research Award; Upjohn PKD Research Fund; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Caenorhabditis Genetics Center, the Japanese Bioresource Project, J. Scholey (University of California, Davis, USA), M. Leroux (Simon Fraser University, Canada) and M. Barr (Rutgers University, USA) forstrains; and A. Fire (Stanford University, USA) for GFP vectors. J.H. and co-workers were supported by the National Institutes of Health research grant 1R01DK090038 and P30 center grant P30DK90728, a Pilot and Feasibility Award from the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567) and the PKD Foundation Young Investigator Award 04YI09a. J.H. was also supported by a FULK Career Development Award, a Zell PKD Research Award and the Upjohn PKD Research Fund. K.L. was supported by the National Cancer Institute (NCI; 1R01CA149039-0 1A1), Susan G. Komen for the Cure (KG100902) and the National Institute of Diabetes and Digestive and Kidney Diseases (P30DK90728).	Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; BRENNER S, 1974, GENETICS, V77, P71; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Efimenko E, 2006, MOL BIOL CELL, V17, P4801, DOI 10.1091/mbc.E06-04-0260; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pedersen LB, 2006, CURR BIOL, V16, P450, DOI 10.1016/j.cub.2006.02.020; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Tayeh MK, 2008, HUM MOL GENET, V17, P1956, DOI 10.1093/hmg/ddn093; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	44	146	161	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2012	14	9					950	+		10.1038/ncb2560	http://dx.doi.org/10.1038/ncb2560			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	004GJ	22922713	Green Accepted			2022-12-25	WOS:000308668600011
J	June, C; Rosenberg, SA; Sadelain, M; Weber, JS				June, Carl; Rosenberg, Steven A.; Sadelain, Michel; Weber, Jeffrey S.			T-cell therapy at the threshold	NATURE BIOTECHNOLOGY			English	Article								Despite impressive clinical activity in B-cell lymphoma and melanoma, questions remain about the immunobiology of adoptive T-cell therapies.	[June, Carl] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [Weber, Jeffrey S.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Donald A Adam Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	June, C (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu; sar@nih.gov; m-sadelain@ski.mskcc.org; jeffrey.weber@moffitt.org			Intramural NIH HHS [Z01 BC010984-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010984, ZIABC010985] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		2010, BLOOD, V116, P4099; 2011, J CLIN ONCOLOGY, V29, P917	2	45	47	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					611	614		10.1038/nbt.2305	http://dx.doi.org/10.1038/nbt.2305			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781680	Green Accepted			2022-12-25	WOS:000306293400016
J	Follis, AV; Chipuk, JE; Fisher, JC; Yun, MK; Grace, CR; Nourse, A; Baran, K; Ou, L; Min, L; White, SW; Green, DR; Kriwacki, RW				Follis, Ariele Viacava; Chipuk, Jerry E.; Fisher, John C.; Yun, Mi-Kyung; Grace, Christy R.; Nourse, Amanda; Baran, Katherine; Ou, Li; Min, Lie; White, Stephen W.; Green, Douglas R.; Kriwacki, Richard W.			PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis	NATURE CHEMICAL BIOLOGY			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; BH3-ONLY PROTEINS; BH3 DOMAINS; COMPLEX; ACTIVATION; BIM; BAX; RECOGNITION; NMR; DIMERIZATION	Following DNA damage, nuclear p53 induces the expression of PUMA, a BH3-only protein that binds and inhibits the antiapoptotic BCL-2 repertoire, including BCL-xL. PUMA, unique among BH3-only proteins, disrupts the interaction between cytosolic p53 and BCL-xL, allowing p53 to promote apoptosis via direct activation of the BCL-2 effector molecules BAX and BAK. Structural investigations using NMR spectroscopy and X-ray crystallography revealed that PUMA binding induced partial unfolding of two alpha-helices within BCL-xL. Wild-type PUMA or a PUMA mutant incapable of causing binding-induced unfolding of BCL-xL equivalently inhibited the antiapoptotic BCL-2 repertoire to sensitize for death receptor-activated apoptosis, but only wild-type PUMA promoted p53-dependent, DNA damage-induced apoptosis. Our data suggest that PUMA-induced partial unfolding of BCL-xL disrupts interactions between cytosolic p53 and BCL-xL, releasing the bound p53 to initiate apoptosis. We propose that regulated unfolding of BCL-xL provides a mechanism to promote PUMA-dependent signaling within the apoptotic pathways.	[Follis, Ariele Viacava; Fisher, John C.; Yun, Mi-Kyung; Grace, Christy R.; Ou, Li; Min, Lie; White, Stephen W.; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Chipuk, Jerry E.; Baran, Katherine; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Fisher, John C.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA; [Nourse, Amanda] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [White, Stephen W.; Kriwacki, Richard W.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org; richard.kriwacki@stjude.org	White, Stephen W/N-8164-2018; Viacava Follis, Ariele/J-1720-2014; Green, Douglas R/N-8083-2018; Kriwacki, Richard/N-8154-2018	Viacava Follis, Ariele/0000-0002-2934-788X; Green, Douglas R/0000-0002-7332-1417; Kriwacki, Richard/0000-0002-9798-6018; Chipuk, Jerry Edward/0000-0002-1337-842X; Nourse, Amanda/0000-0003-4595-5321	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NIH [R01CA082491, 1R01GM083159, R01GM52735, R01GM96208, R01 CA157740]; JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; National Cancer Institute Cancer Center [P30CA21765]; March of Dimes Foundation [5-FY11-74]; American Lebanese Syrian Associated Charities; University of Tennessee Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA157740, P30CA021765, R01CA082491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM083159, R01GM096208, R01GM052735] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes Foundation(March of Dimes); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); University of Tennessee Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.T. Opferman and S.W.G. Tait (St. Jude Children's Research Hospital) for the Mx-Cre bak<SUP>-/-</SUP> bax<SUP>f/-</SUP> animals and MCF7 SMAC-GFP cells, respectively. The prokaryotic expression vectors for PUMA beta and BCL-xL Delta L Delta C were kindly provided by E. Eldering (Academic Medical Center, Amsterdam) and G. Wagner (Harvard University), respectively. We would like to acknowledge D. Miller (St. Jude Children's Research Hospital) for help with synchrotron data collection. Southeast Regional Collaborative Access Team (SER-CAT) supporting institutions may be found at http://www.ser.aps.anl.gov. Use of the SER-CAT Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. We would like to thank Bruker BioSpin and R. Weismann and W Bermel for access to a 950-MHz NMR spectrometer. We also thank M. Madan Babu and A. Venkatakrishnan (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for stimulating discussions and comments on the manuscript. This work was supported by NIH R01CA082491 and 1R01GM083159 (to R.W.K.), NIH R01GM52735 and R01GM96208 (to D.R.G.), NIH R01 CA157740 (to J.E.C.), the JJR Foundation (to J.E.C.), the William A. Spivak Fund (to J.E.C.), the Fridolin Charitable Trust (to J.E.C.), a National Cancer Institute Cancer Center Support Grant P30CA21765 (at St. Jude Children's Research Hospital), research grant no. 5-FY11-74 from the March of Dimes Foundation (to J.E.C.) and the American Lebanese Syrian Associated Charities. J.C.F. is a recipient of the Alma and Hal Reagan Cancer Research fellowship provided by the University of Tennessee Health Sciences Center.	Berjanskii M, 2006, NAT PROTOC, V1, P683, DOI 10.1038/nprot.2006.108; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Denisov AY, 2007, BIOCHEMISTRY-US, V46, P734, DOI 10.1021/bi062080a; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	37	119	124	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					163	168		10.1038/NCHEMBIO.1166	http://dx.doi.org/10.1038/NCHEMBIO.1166			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23340338	Green Accepted			2022-12-25	WOS:000315132900011
J	DeKosky, BJ; Ippolito, GC; Deschner, RP; Lavinder, JJ; Wine, Y; Rawlings, BM; Varadarajan, N; Giesecke, C; Dorner, T; Andrews, SF; Wilson, PC; Hunicke-Smith, SP; Willson, CG; Ellington, AD; Georgiou, G				DeKosky, Brandon J.; Ippolito, Gregory C.; Deschner, Ryan P.; Lavinder, Jason J.; Wine, Yariv; Rawlings, Brandon M.; Varadarajan, Navin; Giesecke, Claudia; Doerner, Thomas; Andrews, Sarah F.; Wilson, Patrick C.; Hunicke-Smith, Scott P.; Willson, C. Grant; Ellington, Andrew D.; Georgiou, George			High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire	NATURE BIOTECHNOLOGY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; PLASMA-CELLS; NEXT-GENERATION; CLONING; ANTIGEN	Each B-cell receptor consists of a pair of heavy and light chains. High-throughput sequencing can identify large numbers of heavy- and light-chain variable regions (V-H and V-L) in a given B-cell repertoire, but information about endogenous pairing of heavy and light chains is lost after bulk lysis of B-cell populations. Here we describe a way to retain this pairing information. In our approach, single B cells (>5 x 10(4) capacity per experiment) are deposited in a high-density microwell plate (125 pl/well) and lysed in situ. mRNA is then captured on magnetic beads, reverse transcribed and amplified by emulsion V-H:V-L linkage PCR. The linked transcripts are analyzed by Illumina high-throughput sequencing. We validated the fidelity of V-H:V-L pairs identified by this approach and used the method to sequence the repertoire of three human cell subsets-peripheral blood IgG(+) B cells, peripheral plasmablasts isolated after tetanus toxoid immunization and memory B cells isolated after seasonal influenza vaccination.	[DeKosky, Brandon J.; Deschner, Ryan P.; Wine, Yariv; Rawlings, Brandon M.; Willson, C. Grant; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Lavinder, Jason J.; Hunicke-Smith, Scott P.; Ellington, Andrew D.; Georgiou, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Varadarajan, Navin] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA; [Giesecke, Claudia; Doerner, Thomas] Charite, Dept Med Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Giesecke, Claudia; Doerner, Thomas] German Rheumatism Res Ctr DRFZ, Berlin, Germany; [Andrews, Sarah F.; Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Willson, C. Grant; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Houston System; University of Houston; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Chicago; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	Wilson, Patrick/HGC-3157-2022; Ippolito, Gregory C./AAR-2930-2021	Ippolito, Gregory C./0000-0002-7565-7002; Giesecke-Thiel, Claudia/0000-0002-5927-7018; Varadarajan, Navin/0000-0001-7524-8228	Hertz Foundation; University of Texas Donald D. Harrington Foundation; National Science Foundation; US National Institutes of Health [U19AI057234-09, U54AI057156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, U19AI057234] Funding Source: NIH RePORTER	Hertz Foundation; University of Texas Donald D. Harrington Foundation; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Iverson and M. Pogson for insightful discussions and thoughtful advice, C. Das for assistance with antibody expression, and S. Reddy for help with initial studies. This work was funded by fellowships to B.J.D. from the Hertz Foundation, the University of Texas Donald D. Harrington Foundation and the National Science Foundation, and also by the US National Institutes of Health U19AI057234-09 (P.C.W.), U19AI057234-09 (G.G.), and U54AI057156 (G.G. and A.E.D.).	Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Frolich D, 2010, J IMMUNOL, V185, P3103, DOI 10.4049/jimmunol.1000911; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Reddy ST, 2011, CURR OPIN BIOTECH, V22, P584, DOI 10.1016/j.copbio.2011.04.015; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Sato S, 2012, NAT BIOTECHNOL, V30, P1039, DOI 10.1038/nbt.2406; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Tanaka Y, 2010, CANCER RES, V70, P6181, DOI 10.1158/0008-5472.CAN-10-0678; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	23	317	373	5	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					166	169		10.1038/nbt.2492	http://dx.doi.org/10.1038/nbt.2492			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23334449	Green Accepted			2022-12-25	WOS:000315322100029
J	Fakiola, M; Strange, A; Cordell, HJ; Miller, EN; Pirinen, M; Su, Z; Mishra, A; Mehrotra, S; Monteiro, GR; Band, G; Bellenguez, C; Dronov, S; Edkins, S; Freeman, C; Giannoulatou, E; Gray, E; Hunt, SE; Lacerda, HG; Langford, C; Pearson, R; Pontes, NN; Rai, M; Singh, SP; Smith, L; Sousa, O; Vukcevic, D; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Duncanson, A; Jankowski, J; Markus, HS; Mathew, CG; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Trembath, RC; Viswanathan, AC; Wood, NW; Wilson, ME; Deloukas, P; Peltonen, L; Christiansen, F; Witt, C; Jeronimo, SMB; Sundar, S; Spencer, CCA; Blackwell, JM; Donnelly, P				Fakiola, Michaela; Strange, Amy; Cordell, Heather J.; Miller, E. Nancy; Pirinen, Matti; Su, Zhan; Mishra, Anshuman; Mehrotra, Sanjana; Monteiro, Gloria R.; Band, Gavin; Bellenguez, Celine; Dronov, Serge; Edkins, Sarah; Freeman, Colin; Giannoulatou, Eleni; Gray, Emma; Hunt, Sarah E.; Lacerda, Henio G.; Langford, Cordelia; Pearson, Richard; Pontes, Nubia N.; Rai, Madhukar; Singh, Shri P.; Smith, Linda; Sousa, Olivia; Vukcevic, Damjan; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S.; Mathew, Christopher G.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas W.; Wilson, Mary E.; Deloukas, Panos; Peltonen, Leena; Christiansen, Frank; Witt, Campbell; Jeronimo, Selma M. B.; Sundar, Shyam; Spencer, Chris C. A.; Blackwell, Jenefer M.; Donnelly, Peter		LeishGEN Consortium; Wellcome Trust Case Control	Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFECTION; POLYMORPHISM; CHAGASI; GENES; MODEL	To identify susceptibility loci for visceral leishmaniasis, we undertook genome-wide association studies in two populations: 989 cases and 1,089 controls from India and 357 cases in 308 Brazilian families (1,970 individuals). The HLA-DRB1-HLA-DQA1 locus was the only region to show strong evidence of association in both populations. Replication at this region was undertaken in a second Indian population comprising 941 cases and 990 controls, and combined analysis across the three cohorts for rs9271858 at this locus showed P-combined = 2.76 x 10(-17) and odds ratio (OR) = 1.41, 95% confidence interval (Cl) = 1.30-1.52. A conditional analysis provided evidence for multiple associations within the HLA-DRB1-HLA-DQA1 region, and a model in which risk differed between three groups of haplotypes better explained the signal and was significant in the Indian discovery and replication cohorts. In conclusion, the HLA-DRB1-HLA-DQA1 HLA class II region contributes to visceral leishmaniasis susceptibility in India and Brazil, suggesting shared genetic risk factors for visceral leishmaniasis that cross the epidemiological divides of geography and parasite species.	[Fakiola, Michaela; Miller, E. Nancy; Blackwell, Jenefer M.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Sch Clin Med, Cambridge CB2 2QQ, England; [Pirinen, Matti; Su, Zhan; Band, Gavin; Bellenguez, Celine; Freeman, Colin; Giannoulatou, Eleni; Pearson, Richard; Vukcevic, Damjan; Rautanen, Anna; Spencer, Chris C. A.; Donnelly, Peter; LeishGEN Consortium] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Cordell, Heather J.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mishra, Anshuman; Mehrotra, Sanjana; Rai, Madhukar; Singh, Shri P.; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Monteiro, Gloria R.; Pontes, Nubia N.; Sousa, Olivia; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Ctr Biosci, BR-59072970 Natal, RN, Brazil; [Dronov, Serge; Edkins, Sarah; Gray, Emma; Hunt, Sarah E.; Langford, Cordelia; Deloukas, Panos; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Lacerda, Henio G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil; [Smith, Linda; Christiansen, Frank; Witt, Campbell] Royal Perth Hosp, Dept Clin Immunol, Perth, WA 6001, Australia; [Bramon, Elvira] S London & Maudsley Natl Hlth Serv NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Ctr Mental Hlt, London, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Inst Mol Med, Dublin, Ireland; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Jankowski, Janusz] Univ Oxford, Dept Oncol, Oxford, England; [Markus, Hugh S.] St Georges Univ London, Stroke & Dementia Res Grp, London, England; [Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, London WC2R 2LS, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Trembath, Richard C.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab ICDEM, Oxford OX3 7LJ, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Ctr Ophthalmol, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wilson, Mary E.] Vet Affairs VA Med Ctr, Iowa City, IA USA; [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA, Australia; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Newcastle University - UK; Banaras Hindu University (BHU); Universidade Federal do Rio Grande do Norte; Wellcome Trust Sanger Institute; Universidade Federal do Rio Grande do Norte; Royal Perth Hospital; University of Western Australia; South London & Maudsley NHS Trust; University of London; King's College London; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; Trinity College Dublin; University of Oxford; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Telethon Kids Institute; University of Western Australia; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	jblackwell@ichr.uwa.edu.au; donnelly@well.ox.ac.uk	Bellenguez, Céline/X-4004-2019; Wood, Nicholas W/C-2505-2009; Jeronimo, Selma/AAY-4033-2020; Blackwell, Jenefer M/H-3015-2015; Bramon, Elvira/A-9463-2011; Mathew, Christopher G/G-3434-2015; Jeronimo, Selma M.B./M-8672-2014; Palmer, Colin NA/C-7053-2008; Deloukas, Panos/B-2922-2013; Jankowski, Janusz/H-2706-2012; Bramon, Elvira/HHC-3809-2022; Brown, Matthew A/E-5749-2010; Belllenguez, Céline/Y-3183-2018	Bellenguez, Céline/0000-0002-1240-7874; Wood, Nicholas W/0000-0002-9500-3348; Jeronimo, Selma/0000-0002-4784-9904; Mathew, Christopher G/0000-0003-4178-1838; Jeronimo, Selma M.B./0000-0002-4784-9904; Palmer, Colin NA/0000-0002-6415-6560; Deloukas, Panos/0000-0001-9251-070X; Jankowski, Janusz/0000-0003-2130-9181; Bramon, Elvira/0000-0003-1369-5983; Brown, Matthew A/0000-0003-0538-8211; Belllenguez, Céline/0000-0002-1240-7874; Fakiola, Michaela/0000-0001-9071-4709; Cordell, Heather/0000-0002-1879-5572; Wilson, Mary/0000-0001-8680-7275; Plomin, Robert/0000-0002-0756-3629; Mishra, Anshuman/0000-0002-9390-9971; Vukcevic, Damjan/0000-0001-7780-9586; Giannoulatou, Eleni/0000-0002-7084-6736; Walters, James/0000-0002-6980-4053; Pirinen, Matti/0000-0002-1664-1350; Trembath, Richard/0000-0003-0550-3400; Corvin, Aiden/0000-0001-6717-4089; Hunt, Sarah/0000-0002-8350-1235	Wellcome Trust, WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; Wellcome Senior Fellowship in Basic Biomedical Science [087436/Z/10/Z]; Royal Society Wolfson Merit Award; Wellcome Trust Centre for Human Genetics core grants [090532/Z/09/Z, 075491/Z/04/B]; Wellcome Trust [085475/Z/08/Z, 074196/Z/04/Z]; US National Institutes of Health (Tropical Medicine Research Center) in Brazil [P50AI074321, P50 AI-30639, 1201 AI076233, R01 AI048822]; Medical Research Council [G9817803B, MC_G1000735] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321, R01AI048822, R01AI076233, P50AI030639] Funding Source: NIH RePORTER	Wellcome Trust, WTCCC2 project; Wellcome Senior Fellowship in Basic Biomedical Science; Royal Society Wolfson Merit Award(Royal Society of London); Wellcome Trust Centre for Human Genetics core grants; Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health (Tropical Medicine Research Center) in Brazil(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The principal funding for this study was provided by the Wellcome Trust, as part of the WTCCC2 project (085475/B/08/Z and 085475/Z/08/Z). We thank S. Bertrand, J. Bryant, S.L. Clark, J.S. Conquer, T. Dibling, J.C. Eldred, S. Gamble, C. Hind, M.L. Perez, C.R. Stribling, S. Taylor and A. Wilk of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We thank D. Davison for making available his Shellfish program for calculating principal components in large genetic data sets. C.C.A.S. is supported by a Wellcome Trust Fellowship (097364/Z/11/Z). H.J.C. is supported by a Wellcome Senior Fellowship in Basic Biomedical Science (087436/Z/10/Z). P. Donnelly is supported in part by a Royal Society Wolfson Merit Award, and work was supported in part by Wellcome Trust Centre for Human Genetics core grants 090532/Z/09/Z and 075491/Z/04/B. Collection of samples and epidemiological data, sample preparation and sequence-based HLA typing were supported by grants from the Wellcome Trust (074196/Z/04/Z and 085475/Z/08/Z to J.M.B., S.S., S.M.B.J. and M.E.W.) and the US National Institutes of Health (Tropical Medicine Research Center award P50AI074321 to S.S. in India; Tropical Medicine Research Center award P50 AI-30639 to E.M. Carvalho and S.M.B.J. in Brazil; and 1201 AI076233 to M.E.W. and J.M.B.; R01 AI048822 to MEW, S.M.B.J. and J.M.B.). We give special thanks to all subjects who contributed samples and to clinicians and field staff in India and Brazil who helped with the recruitment of study subjects.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x; Fakiola M, 2011, J INFECT DIS, V204, P467, DOI 10.1093/infdis/jir284; HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3; Mehrotra S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-162; Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089; Olivo-Diaz A, 2004, HUM IMMUNOL, V65, P255, DOI 10.1016/j.humimm.2003.12.008; Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8; PETZLERLER ML, 1991, HUM IMMUNOL, V32, P254, DOI 10.1016/0198-8859(91)90088-Q; SACKS DL, 1987, J IMMUNOL, V138, P908; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	36	76	77	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					208	213		10.1038/ng.2518	http://dx.doi.org/10.1038/ng.2518			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23291585	Green Submitted, Green Accepted			2022-12-25	WOS:000314333000018
J	Diana, J; Simoni, Y; Furio, L; Beaudoin, L; Agerberth, B; Barrat, F; Lehuen, A				Diana, Julien; Simoni, Yannick; Furio, Laetitia; Beaudoin, Lucie; Agerberth, Birgitta; Barrat, Franck; Lehuen, Agnes			Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes	NATURE MEDICINE			English	Article							INTERFERON-ALPHA; T-CELLS; APOPTOTIC CELLS; VIRAL-INFECTION; B-CELLS; MELLITUS; ONSET; ACTIVATION; ACID; MICE	Type 1 diabetes develops over many years and is characterized ultimately by the destruction of insulin-producing pancreatic beta cells by autoreactive T cells. Nonetheless, the role of innate cells in the initiation of this disease remains poorly understood. Here, we show that in young female nonobese diabetic mice, physiological beta cell death induces the recruitment and activation of B-la cells, neutrophils and plasmacytoid dendritic cells (pDCs) to the pancreas. Activated B-1a cells secrete IgGs specific for double-stranded DNA. IgGs activate neutrophils to release DNA-binding cathelicidin-related antimicrobial peptide (CRAMP), which binds self DNA. Then, self DNA, DNA-specific IgG and CRAMP peptide activate pDCs through the Toll-like receptor 9-myeloid differentiation factor 88 pathway, leading to interferon-alpha production in pancreatic islets. We further demonstrate through the use of depleting treatments that B-1a cells, neutrophils and IFN-alpha-producing pDCs are required for the initiation of the diabetogenic T cell response and type 1 diabetes development. These findings reveal that an innate immune cell crosstalk takes place in the pancreas of young NOD mice and leads to the initiation of T1D.	[Diana, Julien; Simoni, Yannick; Beaudoin, Lucie; Lehuen, Agnes] INSERM, U986, Paris, France; [Diana, Julien; Simoni, Yannick; Furio, Laetitia; Beaudoin, Lucie; Lehuen, Agnes] Univ Paris Descartes Sorbonne Paris Cite, Lab Excellence Inflamex, Paris, France; [Furio, Laetitia] Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Barrat, Franck] Dynavax Technol Corp, Berkeley, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Lehuen, A (corresponding author), INSERM, U986, Paris, France.	julien.diana@inserm.fr; agnes.lehuen@inserm.fr	DIANA, Julien/A-2873-2014	DIANA, Julien/0000-0001-7542-042X; SIMONI, Yannick/0000-0002-9086-3680; Lehuen, Agnes/0000-0002-0450-3321	INSERM, Centre National de la Recherche Scientifique [ANR-05-PCOD009-01, ANR-09-GENO-023]; Labex INFLAMEX; APHP-CNRS Contrat Hospitalier de Recherche Translationelle	INSERM, Centre National de la Recherche Scientifique(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Labex INFLAMEX; APHP-CNRS Contrat Hospitalier de Recherche Translationelle	We thank N. Charles (INSERM UMR-S 699, Paris Diderot University) for dsDNA-specific immunoglobulin ELISA, M. Colonna (Department of Pathology and Immunology, Washington University School of Medicine) for m927 mAb, S. Mecheri (Biology of Host Parasite Interactions Unit, Pasteur Institute) for NIMP-14 mAb, S. Muller (CNRS, Institut de Biologie Moleculaire et Cellulaire, UPR9021) for serum from NZB/W F1 mice, J. Ravetch (Laboratory of Molecular Genetics and Immunology, Rockefeller University) for Fc gamma RIV-specific mAb, N. Thieblemont (CNRS UMR 8147, Paris Descartes University) for Myd88<SUP>-/-</SUP> NOD mice and all for their expertise. We thank F. Boutillon for technical assistance and the staff of the INSERM U986 mouse facility for help in animal care. Y.S. is supported by a doctoral fellowship from the Region Ile de France. This work was supported by funds from INSERM, Centre National de la Recherche Scientifique, ANR-05-PCOD009-01, ANR-09-GENO-023 and Labex INFLAMEX to A.L. A.L. is recipient of an APHP-CNRS Contrat Hospitalier de Recherche Translationelle.	Alba A, 2004, J IMMUNOL, V173, P6667, DOI 10.4049/jimmunol.173.11.6667; Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; AUNE TM, 1982, P NATL ACAD SCI-BIOL, V79, P3808, DOI 10.1073/pnas.79.12.3808; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bock T, 2003, J ENDOCRINOL, V179, P245, DOI 10.1677/joe.0.1790245; Brod SA, 1998, DIABETOLOGIA, V41, P1227, DOI 10.1007/s001250051056; BURASTERO SE, 1988, J EXP MED, V168, P1979, DOI 10.1084/jem.168.6.1979; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; De Filippo G, 1997, ACTA DIABETOL, V34, P271, DOI 10.1007/s005920050087; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; EWEL CH, 1992, DIABETES, V41, P1016, DOI 10.2337/diabetes.41.8.1016; Fabris P, 1998, J HEPATOL, V28, P514, DOI 10.1016/S0168-8278(98)80328-0; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; GUERCI AP, 1994, LANCET, V343, P1167, DOI 10.1016/S0140-6736(94)90276-3; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Habib T, 2012, J IMMUNOL, V188, P487, DOI 10.4049/jimmunol.1102176; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HUANG XJ, 1994, IMMUNITY, V1, P469, DOI 10.1016/1074-7613(94)90089-2; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kendall PL, 2004, EUR J IMMUNOL, V34, P2387, DOI 10.1002/eji.200324744; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Li Q, 2011, CLIN IMMUNOL, V140, P3, DOI 10.1016/j.clim.2011.04.010; Mallone R, 2011, DIABETES, V60, P2020, DOI 10.2337/db11-0700; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mujtaba MG, 1997, J NEUROIMMUNOL, V75, P35, DOI 10.1016/S0165-5728(96)00231-7; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Peng RH, 2006, ANN NY ACAD SCI, V1079, P99, DOI 10.1196/annals.1375.013; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; SHIRAI T, 1992, ANN NY ACAD SCI, V651, P509; Sobel DO, 1998, J AUTOIMMUN, V11, P343, DOI 10.1006/jaut.1998.0203; Sobel DO, 1998, DIABETES, V47, P1867, DOI 10.2337/diabetes.47.12.1867; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tanaka-Kataoka M, 1999, J INTERF CYTOK RES, V19, P877, DOI 10.1089/107999099313398; Teige I, 2006, J IMMUNOL, V177, P3542, DOI 10.4049/jimmunol.177.6.3542; Theofilopoulos AN, 2011, J INTERF CYTOK RES, V31, P867, DOI 10.1089/jir.2011.0092; Thomas JW, 2002, J IMMUNOL, V169, P6617, DOI 10.4049/jimmunol.169.11.6617; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Winkler C, 2011, DIABETES, V60, P685, DOI 10.2337/db10-1269; Zhou RB, 2007, J IMMUNOL, V178, P2141, DOI 10.4049/jimmunol.178.4.2141	55	309	318	4	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					65	73		10.1038/nm.3042	http://dx.doi.org/10.1038/nm.3042			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23242473				2022-12-25	WOS:000313230300027
J	Gkountela, S; Li, ZW; Vincent, JJ; Zhang, KX; Chen, A; Pellegrini, M; Clark, AT				Gkountela, Sofia; Li, Ziwei; Vincent, John J.; Zhang, Kelvin X.; Chen, Angela; Pellegrini, Matteo; Clark, Amander T.			The ontogeny of cKIT(+) human primordial germ cells proves to be a resource for human germ line reprogramming, imprint erasure and in vitro differentiation	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; C-KIT; FETAL; PLURIPOTENT; EXPRESSION; SPECIFICATION; 5-HYDROXYMETHYLCYTOSINE; METHYLATION; DERIVATION; PROTEINS	The generation of research-quality, clinically relevant cell types in vitro from human pluripotent stem cells requires a detailed understanding of the equivalent human cell types. Here we analysed 134 human embryonic and fetal samples from 6 to 20 developmental weeks and identified the stages at which cKIT(+) primordial germ cells (PGCs), the precursors of gametes, undergo whole-genome epigenetic reprogramming with global depletion of 5mC, H3K27me3 and H2A.Z, and the time at which imprint erasure is initiated and 5hmC is present. Using five alternative in vitro differentiation strategies combined with single-cell microfluidic analysis and a bona fide human cKIT(+) PGC signature, we show the stage of cKIT(+) PGC formation in the first 16 days of differentiation. Taken together, our study creates a resource of human germ line ontogeny that is essential for future studies aimed at in vitro differentiation and unveiling the mechanisms necessary to pass human DNA from one generation to the next.	[Gkountela, Sofia; Li, Ziwei; Vincent, John J.; Pellegrini, Matteo; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Gkountela, Sofia; Li, Ziwei; Vincent, John J.; Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Zhang, Kelvin X.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Chen, Angela] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Clark, Amander T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Clark, AT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu		Chen, Angela/0000-0002-2697-0385; Pellegrini, Matteo/0000-0001-9355-9564	Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD058047]; Iris Cantor-UCLA Women's Health Pilot Project; NIGMS [1P01GM081621]; NIH from the NICHD [5R24HD000836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047, R24HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Iris Cantor-UCLA Women's Health Pilot Project; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH from the NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the UCLA Translational Pathology Core Laboratory and the UCLA Gene and Cellular Core Laboratory for some of the gonadal samples used in this study. We also thank J. Hargan-Calvopina, M. Oliveros-Etter and S. Diaz-Perez for critical reading of the manuscript, F. Codrea and J. Scholes for FACS and S. Peckman from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research for critical assistance with human subject and embryonic stem cell review. This work was supported primarily by fund number 1R01HD058047 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD; ATC), as well as the Iris Cantor-UCLA Women's Health Pilot Project (ATC) and 1P01GM081621 from NIGMS. The Laboratory of Developmental Biology, University of Washington, Seattle is supported by NIH Award Number 5R24HD000836 from the NICHD. Human fetal tissue requests can be made to: bdrl@u.washington.edu.	Aflatoonian B, 2009, HUM REPROD, V24, P3150, DOI 10.1093/humrep/dep334; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Bao SQ, 2012, CELL STEM CELL, V11, P110, DOI 10.1016/j.stem.2012.02.023; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; BRIDDELL RA, 1992, BLOOD, V79, P3159; Chuang CY, 2012, J BIOL CHEM, V287, P14389, DOI 10.1074/jbc.M111.338434; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; Geuns E, 2007, J MED GENET, V44, P144, DOI 10.1136/jmg.2006.044149; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kamei KI, 2010, LAB CHIP, V10, P1113, DOI 10.1039/b922884e; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Medrano JV, 2012, STEM CELLS, V30, P441, DOI 10.1002/stem.1012; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Pauls K, 2006, HUM REPROD, V21, P397, DOI 10.1093/humrep/dei325; Perez SVD, 2012, HUM MOL GENET, V21, P751, DOI 10.1093/hmg/ddr506; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Robinson LLL, 2001, MOL HUM REPROD, V7, P845, DOI 10.1093/molehr/7.9.845; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tilgner K, 2010, STEM CELLS, V28, P84, DOI 10.1002/stem.263; Vincent JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028960; Warthemann R, 2012, MOL HUM REPROD, V18, P605, DOI 10.1093/molehr/gas032; Zechner U, 2010, MOL HUM REPROD, V16, P704, DOI 10.1093/molehr/gap107; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	48	138	145	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					113	U247		10.1038/ncb2638	http://dx.doi.org/10.1038/ncb2638			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23242216	Green Accepted			2022-12-25	WOS:000312841300016
J	Zhang, YN; Zhou, LJ; Rouge, L; Phillips, AH; Lam, C; Liu, P; Sandoval, W; Helgason, E; Murray, JM; Wertz, IE; Corn, JE				Zhang, Yingnan; Zhou, Lijuan; Rouge, Lionel; Phillips, Aaron H.; Lam, Cynthia; Liu, Peter; Sandoval, Wendy; Helgason, Elizabeth; Murray, Jeremy M.; Wertz, Ingrid E.; Corn, Jacob E.			Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN GROWTH-HORMONE; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; PROTEIN; RECOGNITION; DYNAMICS; CHAINS; IDENTIFICATION; RELAXATION; ACTIVATION	Protein conformation and function are often inextricably linked, such that the states a protein adopts define its enzymatic activity or its affinity for various partners. Here we combine computational design with macromolecular display to isolate functional conformations of ubiquitin that tightly bind the catalytic core of the oncogenic ubiquitin-specific protease 7 (USP7) deubiquitinase. Structural and biochemical characterization of these ubiquitin variants suggest that remodeled backbone conformations and core packing poise these molecules for stronger interactions, leading to potent and specific inhibition of enzymatic activity. A ubiquitin variant expressed in human tumor cell lines binds and inhibits endogenous USP7, thereby enhancing Mdm2 proteasomal turnover and stabilizing p53. In sum, we have developed an approach to rationally target macromolecular libraries toward the remodeling of protein conformation, shown that engineering of ubiquitin conformation can greatly increase its interaction with deubiquitinases and developed powerful tools to probe the cellular role of USP7.	[Zhang, Yingnan; Zhou, Lijuan; Phillips, Aaron H.; Lam, Cynthia; Helgason, Elizabeth; Wertz, Ingrid E.; Corn, Jacob E.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Rouge, Lionel; Murray, Jeremy M.] Genentech Inc, Struct Biol, San Francisco, CA 94080 USA; [Liu, Peter; Sandoval, Wendy] Genentech Inc, Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Zhang, YN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	cornj@gene.com	Zhou, Li/GSE-4531-2022	Helgason, Elizabeth/0000-0002-0397-9125; Corn, Jacob/0000-0002-7798-5309				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Friedland GD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000393; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; GIEBEL LB, 1995, BIOCHEMISTRY-US, V34, P15430, DOI 10.1021/bi00047a006; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hansen DF, 2007, J AM CHEM SOC, V129, P11468, DOI 10.1021/ja072717t; Hansen DF, 2009, J AM CHEM SOC, V131, P16257, DOI 10.1021/ja906842s; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Lazar GA, 1999, PROTEIN SCI, V8, P2598; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Newton K, 2012, METHODS MOL BIOL, V832, P185, DOI 10.1007/978-1-61779-474-2_13; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rizk S.S., 2011, NAT STRUCT MOL BIOL; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; ULTSCH MH, 1994, J MOL BIOL, V236, P286, DOI 10.1006/jmbi.1994.1135; Wermuth C.G., 2003, PRACTICE MED CHEM, V2nd; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	52	74	76	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					51	+		10.1038/NCHEMBIO.1134	http://dx.doi.org/10.1038/NCHEMBIO.1134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23178935				2022-12-25	WOS:000312484200012
J	[Anonymous]				[Anonymous]			Unlocking the mysterious mechanisms of Myc	NATURE MEDICINE			English	Editorial Material														Dang, Chi/0000-0002-4031-2522					0	10	10	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					26	27						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296005				2022-12-25	WOS:000313230300017
J	Chen, L; Reiss, AL; Sudhof, TC; Neul, JL; Murphy, DG; Ecker, C				Chen, Lu; Reiss, Allan L.; Sudhof, Thomas C.; Neul, Jeffrey L.; Murphy, Declan G.; Ecker, Christine			Trialing targeted therapies for autism	NATURE MEDICINE			English	Editorial Material								Researchers are beginning to decipher the genetics underlying and create better animal models for autism spectrum disorders (ASDs), but the development of new drugs for these conditions has been considerably slower. Two recent studies describing the effects of the GABA(B) receptor agonist STX209 (arbaclofen) in fragile X syndrome (FXS) illustrate some of the complexities of designing targeted therapies in this field. Henderson et al.(1) tested this treatment in a mouse model of fragile X and found that it led to improvements in synaptic dysfunction and behavior in this model. In a phase 2 trial, Berry-Kravis et al.(2) tested arbaclofen in 63 people aged 6 to 39 who carry a full FMR1 mutation. Although the authors did not detect a significant improvement compared with placebo for the primary endpoint of the trial, they did see improvements in the treated subjects in other analyses. We asked experts to comment on these studies and their implications for the development of new therapies to treat ASDs.					Ecker, Christine/E-5194-2010; Neul, Jeffrey/AAF-5324-2020	Ecker, Christine/0000-0002-1003-5931; Murphy, Declan/0000-0002-6664-7451; Neul, Jeffrey/0000-0002-5628-5872	Department of Health [RP-PG-0606-1045] Funding Source: Medline	Department of Health		Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Ecker C, 2013, MOL PSYCHIATR, V18, P435, DOI 10.1038/mp.2012.102; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hall SS, 2012, J INTELL DISABIL RES, V56, P947, DOI 10.1111/j.1365-2788.2012.01560.x; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Mendez MA, 2013, NEUROPHARMACOLOGY, V68, P195, DOI 10.1016/j.neuropharm.2012.04.008; Soden ME, 2010, J NEUROSCI, V30, P16910, DOI 10.1523/JNEUROSCI.3660-10.2010	12	0	0	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1746	1747		10.1038/nm.3027	http://dx.doi.org/10.1038/nm.3027			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223062				2022-12-25	WOS:000311999800017
J	Mallilankaraman, K; Cardenas, C; Doonan, PJ; Chandramoorthy, HC; Irrinki, KM; Golenar, T; Csordas, G; Madireddi, P; Yang, J; Muller, M; Miller, R; Kolesar, JE; Molgo, J; Kaufman, B; Hajnoczky, G; Foskett, JK; Madesh, M				Mallilankaraman, Karthik; Cardenas, Cesar; Doonan, Patrick J.; Chandramoorthy, Harish C.; Irrinki, Krishna M.; Golenar, Tuende; Csordas, Gyoergy; Madireddi, Priyanka; Yang, Jun; Mueller, Marioly; Miller, Russell; Kolesar, Jill E.; Molgo, Jordi; Kaufman, Brett; Hajnoczky, Gyoergy; Foskett, J. Kevin; Madesh, Muniswamy			MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism	NATURE CELL BIOLOGY			English	Article							CALCIUM UNIPORTER; INNER MEMBRANE; CYTOCHROME-C; IN-VIVO; APOPTOSIS; TRANSPORT; PROTEIN; CELLS; SUPEROXIDE; CONTACTS	Ca2+ flux across the mitochondrial inner membrane regulates bioenergetics, cytoplasmic Ca2+ signals and activation of cell death pathways(1-11). Mitochondrial Ca2+ uptake occurs at regions of close apposition with intracellular Ca2+ release sites(12-14), driven by the inner membrane voltage generated by oxidative phosphorylation and mediated by a Ca2+ selective ion channel (MiCa; ref. 15) called the uniporter(16-18) whose complete molecular identity remains unknown. Mitochondrial calcium uniporter (MCU) was recently identified as the likely ion-conducting pore(19,20). In addition, MICUl was identified as a mitochondrial regulator of uniporter-mediated Ca2+ uptake in HeLa CellS(21,22). Here we identified CCDC90A, hereafter referred to as MCUR1 (mitochondrial calcium uniporter regulator 1), an integral membrane protein required for MCU-dependent mitochondrial Ca2+ uptake. MCUR1 binds to MCU and regulates ruthenium-red-sensitive MCU-dependent Ca2+ uptake. MCUR1 knockdown does not alter MCU localization, but abrogates Ca2+ uptake by energized mitochondria in intact and permeabilized cells. Ablation of MCUR1 disrupts oxidative phosphorylation, lowers cellular ATP and activates AMP kinase-dependent pro-survival autophagy. Thus, MCUR1 is a critical component of a mitochondrial uniporter channel complex required for mitochondrial Ca2+ uptake and maintenance of normal cellular bioenergetics.	[Cardenas, Cesar; Yang, Jun; Mueller, Marioly; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Mallilankaraman, Karthik; Doonan, Patrick J.; Chandramoorthy, Harish C.; Irrinki, Krishna M.; Madireddi, Priyanka; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Golenar, Tuende; Csordas, Gyoergy; Hajnoczky, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Miller, Russell] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Kolesar, Jill E.; Kaufman, Brett] Univ Penn, Dept Anim Biol, Sch Vet Med, Philadelphia, PA 19104 USA; [Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol & Dev,UPR 3294, F-91198 Gif Sur Yvette, France; [Mallilankaraman, Karthik; Doonan, Patrick J.; Chandramoorthy, Harish C.; Irrinki, Krishna M.; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; University of Pennsylvania; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu; madeshm@temple.edu	Kolesar, Jill/AAA-9727-2020; Cardenas, Julio C/I-3221-2013; Foskett, Kevin/R-2549-2019; Irrinki, Krishna/AAH-9975-2019; Chandramoorthy, Harish C/A-6533-2019; Muller, Marioly/J-5420-2014	Kolesar, Jill/0000-0003-1802-6439; Irrinki, Krishna/0000-0002-4835-3206; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050; Foskett, J. Kevin/0000-0002-8854-0268; Csordas, Gyorgy/0000-0003-3156-1460; Chinna Konda Chandramoorthy, Harish/0000-0002-8780-8971; Madireddi, Priyanka/0000-0002-5702-1262	National Institutes of Health [R01 HL086699, HL086699-01A2S1, 1S10RR027327-01, GM56328]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699, R01HL119306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056328, R01GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health grants R01 HL086699, HL086699-01A2S1 and 1S10RR027327-01 to M.M., and GM56328 to J.K.F. C.C. was supported by an award from the American Heart Association.	Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Csordas G, 2003, J BIOL CHEM, V278, P42273, DOI 10.1074/jbc.M305248200; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Greenawalt J W, 1974, Methods Enzymol, V31, P310; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HANSFORD RG, 1994, J BIOENERG BIOMEMBR, V26, P495, DOI 10.1007/BF00762734; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349	35	354	367	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1336	+		10.1038/ncb2622	http://dx.doi.org/10.1038/ncb2622			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23178883	Green Accepted			2022-12-25	WOS:000311890300016
J	Schimpl, M; Zheng, XW; Borodkin, VS; Blair, DE; Ferenbach, AT; Schuttelkopf, AW; Navratilova, I; Aristotelous, T; Albarbarawi, O; Robinson, DA; Macnaughtan, MA; van Aalten, DMF				Schimpl, Marianne; Zheng, Xiaowei; Borodkin, Vladimir S.; Blair, David E.; Ferenbach, Andrew T.; Schuettelkopf, Alexander W.; Navratilova, Iva; Aristotelous, Tonia; Albarbarawi, Osama; Robinson, David A.; Macnaughtan, Megan A.; van Aalten, Daan M. F.			O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; GLCNACYLATION; SUBSTRATE; ROLES; MECHANISM	Protein O-GlcNAcylation is an essential post-translational modification on hundreds of intracellular proteins in metazoa, catalyzed by O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT) using unknown mechanisms of transfer and substrate recognition. Through crystallographic snapshots and mechanism-inspired chemical probes, we define how human OGT recognizes the sugar donor and acceptor peptide and uses a new catalytic mechanism of glycosyl transfer, involving the sugar donor a-phosphate as the catalytic base as well as an essential lysine. This mechanism seems to be a unique evolutionary solution to the spatial constraints imposed by a bulky protein acceptor substrate and explains the unexpected specificity of a recently reported metabolic OGT inhibitor.	[Schimpl, Marianne; Zheng, Xiaowei; Borodkin, Vladimir S.; Blair, David E.; Ferenbach, Andrew T.; Schuettelkopf, Alexander W.; Navratilova, Iva; Aristotelous, Tonia; Albarbarawi, Osama; Robinson, David A.; van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Macnaughtan, Megan A.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA	University of Dundee; Louisiana State University System; Louisiana State University	van Aalten, DMF (corresponding author), Univ Dundee, Coll Life Sci, Dundee, Scotland.	dmfvanaalten@dundee.ac.uk	Albarbarawi, Osama/P-7632-2018	Albarbarawi, Osama/0000-0002-0165-778X; Ferenbach, Andrew/0000-0002-1562-7987; Macnaughtan, Megan/0000-0003-4626-0062; Robinson, David/0000-0003-1979-5918; Schimpl, Marianne/0000-0003-2284-5250; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust [WT087590MA]; MRC [G0900138] Funding Source: UKRI; Medical Research Council [G0900138] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Senior Research Fellowship (WT087590MA) to D.M.F.v.A.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gold H, 2008, J ORG CHEM, V73, P9458, DOI 10.1021/jo802021t; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; MEYNIAL I, 1995, ANAL CHEM, V67, P1627, DOI 10.1021/ac00105a024; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Sala RF, 1998, CARBOHYD RES, V306, P127, DOI 10.1016/S0008-6215(97)10033-7; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	30	98	99	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					969	974		10.1038/NCHEMBIO.1108	http://dx.doi.org/10.1038/NCHEMBIO.1108			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103942	Green Accepted, Green Submitted			2022-12-25	WOS:000311491200011
J	Whitcomb, DC; LaRusch, J; Krasinskas, AM; Klei, L; Smith, JP; Brand, RE; Neoptolemos, JP; Lerch, MM; Tector, M; Sandhu, BS; Guda, NM; Orlichenko, L; Alkaade, S; Amann, ST; Anderson, MA; Baillie, J; Banks, PA; Conwell, D; Cote, GA; Cotton, PB; DiSario, J; Farrer, LA; Forsmark, CE; Johnstone, M; Gardner, TB; Gelrud, A; Greenhalf, W; Haines, JL; Hartman, DJ; Hawes, RA; Lawrence, C; Lewis, M; Mayerle, J; Mayeux, R; Melhem, NM; Money, ME; Muniraj, T; Papachristou, GI; Pericak-Vance, MA; Romagnuolo, J; Schellenberg, GD; Sherman, S; Simon, P; Singh, VP; Slivka, A; Stolz, D; Sutton, R; Weiss, FU; Wilcox, CM; Zarnescu, NO; Wisniewski, SR; O'Connell, MR; Kienholz, ML; Roeder, K; Barmada, MM; Yadav, D; Devlin, B; Albert, MS; Albin, RL; Apostolova, LG; Arnold, SE; Baldwin, CT; Barber, R; Barnes, LL; Beach, TG; Beecham, GW; Beekly, D; Bennett, DA; Bigio, EH; Bird, TD; Blacker, D; Boxer, A; Burke, JR; Buxbaum, JD; Cairns, NJ; Cantwell, LB; Cao, CH; Carney, RM; Carroll, SL; Chui, HC; Clark, DG; Cribbs, DH; Crocco, EA; Cruchaga, C; DeCarli, C; Demirci, FY; Dick, M; Dickson, DW; Duara, R; Ertekin-Taner, N; Faber, KM; Fallon, KB; Farlow, MR; Ferris, S; Foroud, TM; Frosch, MP; Galasko, DR; Ganguli, M; Gearing, M; Geschwind, DH; Ghetti, B; Gilbert, JR; Gilman, S; Glass, JD; Goate, AM; Graff-Radford, NR; Green, RC; Growdon, JH; Hakonarson, H; Hamilton-Nelson, KL; Hamilton, RL; Harrell, LE; Head, E; Honig, LS; Hulette, CM; Hyman, BT; Jicha, GA; Jin, LW; Jun, G; Kamboh, MI; Karydas, A; Kaye, JA; Kim, R; Koo, EH; Kowall, NW; Kramer, JH; Kramer, P; Kukull, WA; LaFerla, FM; Lah, JJ; Leverenz, JB; Levey, AI; Li, G; Lin, CF; Lieberman, AP; Lopez, OL; Lunetta, KL; Lyketsos, CG; Mack, WJ; Marson, DC; Martin, ER; Martiniuk, F; Mash, DC; Masliah, E; Mckee, AC; Mesulam, M; Miller, BL; Miller, CA; Miller, JW; Montine, TJ; Morris, JC; Murrell, JR; Naj, AC; Olichney, JM; Parisi, JE; Peskind, E; Petersen, RC; Pierce, A; Poon, WW; Potter, H; Quinn, JF; Raj, A; Raskind, M; Reiman, EM; Reisberg, B; Reitz, C; Ringman, JM; Roberson, ED; Rosen, HJ; Rosenberg, RN; Sano, M; Saykin, AJ; Schneider, JA; Schneider, LS; Seeley, WW; Smith, AG; Sonnen, JA; Spina, S; Stern, RA; Tanzi, RE; Trojanowski, JQ; Troncoso, JC; Tsuang, DW; Valladares, O; Van Deerlin, VM; Van Eldik, LJ; Vardarajan, BN; Vinters, HV; Vonsattel, JP; Wang, LS; Weintraub, S; Welsh-Bohmer, KA; Williamson, J; Woltjer, RL; Wright, CB; Younkin, SG; Yu, CE; Yu, L				Whitcomb, David C.; LaRusch, Jessica; Krasinskas, Alyssa M.; Klei, Lambertus; Smith, Jill P.; Brand, Randall E.; Neoptolemos, John P.; Lerch, Markus M.; Tector, Matt; Sandhu, Bimaljit S.; Guda, Nalini M.; Orlichenko, Lidiya; Alkaade, Samer; Amann, Stephen T.; Anderson, Michelle A.; Baillie, John; Banks, Peter A.; Conwell, Darwin; Cote, Gregory A.; Cotton, Peter B.; DiSario, James; Farrer, Lindsay A.; Forsmark, Chris E.; Johnstone, Marianne; Gardner, Timothy B.; Gelrud, Andres; Greenhalf, William; Haines, Jonathan L.; Hartman, Douglas J.; Hawes, Robert A.; Lawrence, Christopher; Lewis, Michele; Mayerle, Julia; Mayeux, Richard; Melhem, Nadine M.; Money, Mary E.; Muniraj, Thiruvengadam; Papachristou, Georgios I.; Pericak-Vance, Margaret A.; Romagnuolo, Joseph; Schellenberg, Gerard D.; Sherman, Stuart; Simon, Peter; Singh, Vijay P.; Slivka, Adam; Stolz, Donna; Sutton, Robert; Weiss, Frank Ulrich; Wilcox, C. Mel; Zarnescu, Narcis Octavian; Wisniewski, Stephen R.; O'Connell, Michael R.; Kienholz, Michelle L.; Roeder, Kathryn; Barmada, M. Michael; Yadav, Dhiraj; Devlin, Bernie; Albert, Marilyn S.; Albin, Roger L.; Apostolova, Liana G.; Arnold, Steven E.; Baldwin, Clinton T.; Barber, Robert; Barnes, Lisa L.; Beach, Thomas G.; Beecham, Gary W.; Beekly, Duane; Bennett, David A.; Bigio, Eileen H.; Bird, Thomas D.; Blacker, Deborah; Boxer, Adam; Burke, James R.; Buxbaum, Joseph D.; Cairns, Nigel J.; Cantwell, Laura B.; Cao, Chuanhai; Carney, Regina M.; Carroll, Steven L.; Chui, Helena C.; Clark, David G.; Cribbs, David H.; Crocco, Elizabeth A.; Cruchaga, Carlos; DeCarli, Charles; Demirci, F. Yesim; Dick, Malcolm; Dickson, Dennis W.; Duara, Ranjan; Ertekin-Taner, Nilufer; Faber, Kelley M.; Fallon, Kenneth B.; Farlow, Martin R.; Ferris, Steven; Foroud, Tatiana M.; Frosch, Matthew P.; Galasko, Douglas R.; Ganguli, Mary; Gearing, Marla; Geschwind, Daniel H.; Ghetti, Bernardino; Gilbert, John R.; Gilman, Sid; Glass, Jonathan D.; Goate, Alison M.; Graff-Radford, Neill R.; Green, Robert C.; Growdon, John H.; Hakonarson, Hakon; Hamilton-Nelson, Kara L.; Hamilton, Ronald L.; Harrell, Lindy E.; Head, Elizabeth; Honig, Lawrence S.; Hulette, Christine M.; Hyman, Bradley T.; Jicha, Gregory A.; Jin, Lee-Way; Jun, Gyungah; Kamboh, M. Ilyas; Karydas, Anna; Kaye, Jeffrey A.; Kim, Ronald; Koo, Edward H.; Kowall, Neil W.; Kramer, Joel H.; Kramer, Patricia; Kukull, Walter A.; LaFerla, Frank M.; Lah, James J.; Leverenz, James B.; Levey, Allan I.; Li, Ge; Lin, Chiao-Feng; Lieberman, Andrew P.; Lopez, Oscar L.; Lunetta, Kathryn L.; Lyketsos, Constantine G.; Mack, Wendy J.; Marson, Daniel C.; Martin, Eden R.; Martiniuk, Frank; Mash, Deborah C.; Masliah, Eliezer; McKee, Ann C.; Mesulam, Marsel; Miller, Bruce L.; Miller, Carol A.; Miller, Joshua W.; Montine, Thomas J.; Morris, John C.; Murrell, Jill R.; Naj, Adam C.; Olichney, John M.; Parisi, Joseph E.; Peskind, Elaine; Petersen, Ronald C.; Pierce, Aimee; Poon, Wayne W.; Potter, Huntington; Quinn, Joseph F.; Raj, Ashok; Raskind, Murray; Reiman, Eric M.; Reisberg, Barry; Reitz, Christiane; Ringman, John M.; Roberson, Erik D.; Rosen, Howard J.; Rosenberg, Roger N.; Sano, Mary; Saykin, Andrew J.; Schneider, Julie A.; Schneider, Lon S.; Seeley, William W.; Smith, Amanda G.; Sonnen, Joshua A.; Spina, Salvatore; Stern, Robert A.; Tanzi, Rudolph E.; Trojanowski, John Q.; Troncoso, Juan C.; Tsuang, Debby W.; Valladares, Otto; Van Deerlin, Vivianna M.; Van Eldik, Linda J.; Vardarajan, Badri N.; Vinters, Harry V.; Vonsattel, Jean Paul; Wang, Li-San; Weintraub, Sandra; Welsh-Bohmer, Kathleen A.; Williamson, Jennifer; Woltjer, Randall L.; Wright, Clinton B.; Younkin, Steven G.; Yu, Chang-En; Yu, Lei		Alzheimer's Dis Genetics Consortiu	Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis	NATURE GENETICS			English	Article							HEREDITARY PANCREATITIS; CLAUDIN-2 EXPRESSION; RECURRENT ACUTE; ACTIVATION; DIAGNOSIS; PROMOTER	Pancreatitis is a complex, progressively destructive inflammatory disorder. Alcohol was long thought to be the primary causative agent, but genetic contributions have been of interest since the discovery that rare PRSS1, CFTR and SPINK1 variants were associated with pancreatitis risk. We now report two associations at genome-wide significance identified and replicated at PRSS1-PRSS2 (P < 1 x 10(-12)) and X-linked CLDN2 (P < 1 x 10(-21)) through a two-stage genome-wide study (stage 1: 676 cases and 4,507 controls; stage 2: 910 cases and 4,170 controls). The PRSS1 variant likely affects disease susceptibility by altering expression of the primary trypsinogen gene. The CLDN2 risk allele is associated with atypical localization of claudin-2 in pancreatic acinar cells. The homozygous (or hemizygous in males) CLDN2 genotype confers the greatest risk, and its alleles interact with alcohol consumption to amplify risk. These results could partially explain the high frequency of alcohol-related pancreatitis in men (male hemizygote frequency is 0.26, whereas female homozygote frequency is 0.07).	[Whitcomb, David C.; LaRusch, Jessica; Brand, Randall E.; Orlichenko, Lidiya; Gelrud, Andres; Papachristou, Georgios I.; Singh, Vijay P.; Slivka, Adam; Zarnescu, Narcis Octavian; O'Connell, Michael R.; Kienholz, Michelle L.; Yadav, Dhiraj] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Whitcomb, David C.; Stolz, Donna] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA; [Whitcomb, David C.; Barmada, M. Michael; Devlin, Bernie; Demirci, F. Yesim] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Krasinskas, Alyssa M.; Hartman, Douglas J.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Klei, Lambertus; Melhem, Nadine M.; Devlin, Bernie; Ganguli, Mary] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Smith, Jill P.] Penn State Univ, Div Gastroenterol & Liver Dis, Hershey, PA USA; [Neoptolemos, John P.; Johnstone, Marianne; Greenhalf, William; Sutton, Robert] Univ Liverpool, Inst Translat Med, Natl Inst Hlth Res Liverpool Pancreas Biomed Res, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England; [Tector, Matt; Guda, Nalini M.] St Lukes Med Ctr, Aurora Hlth Care Syst, Milwaukee, WI USA; [Lerch, Markus M.; Mayerle, Julia; Simon, Peter; Weiss, Frank Ulrich] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Sandhu, Bimaljit S.] Virginia Commonwealth Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA; [Alkaade, Samer] St Louis Univ, Dept Med, St Louis, MO USA; [Amann, Stephen T.] N Mississippi Med Ctr, Tupelo, MS USA; [Anderson, Michelle A.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Baillie, John; Burke, James R.; Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Conwell, Darwin] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Cote, Gregory A.; Sherman, Stuart] Indiana Univ, Med Ctr, Dept Med, Indianapolis, IN USA; [Cotton, Peter B.; Hawes, Robert A.; Lawrence, Christopher; Romagnuolo, Joseph] Med Univ S Carolina, Ctr Digest Dis, Charleston, SC 29425 USA; [DiSario, James] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med, Biomed Genet Sect, Boston, MA 02118 USA; [Forsmark, Chris E.] Univ Florida, Dept Med, Gainesville, FL USA; [Gardner, Timothy B.] Dartmouth Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Dept Med, Hanover, NH USA; [Haines, Jonathan L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Haines, Jonathan L.] Vanderbilt Univ, Vanderbilt Ctr Human Genet Res, Nashville, TN USA; [Lewis, Michele] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA; [Mayeux, Richard; Reitz, Christiane; Vardarajan, Badri N.] Columbia Univ, Dept Neurol, Gertrude H Sergievsky Ctr, New York, NY USA; [Mayeux, Richard; Honig, Lawrence S.; Reitz, Christiane; Vardarajan, Badri N.; Vonsattel, Jean Paul; Williamson, Jennifer] Columbia Univ, Dept Neurol, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; [Money, Mary E.] Meritus Med Ctr, Hagerstown, MD USA; [Muniraj, Thiruvengadam] Yale Univ, Dept Internal Med, Derby, CT USA; [Muniraj, Thiruvengadam] Griffin Hosp, Derby, CT USA; [Pericak-Vance, Margaret A.; Beecham, Gary W.; Gilbert, John R.; Hamilton-Nelson, Kara L.; Martin, Eden R.; Naj, Adam C.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Pericak-Vance, Margaret A.; Beecham, Gary W.; Gilbert, John R.; Hamilton-Nelson, Kara L.; Naj, Adam C.] Univ Miami, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL USA; [Schellenberg, Gerard D.; Cantwell, Laura B.; Lin, Chiao-Feng; Trojanowski, John Q.; Valladares, Otto; Van Deerlin, Vivianna M.; Wang, Li-San] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA; [Wilcox, C. Mel] Univ Alabama Birmingham, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Epidemiol Data Ctr, Pittsburgh, PA USA; [Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Albert, Marilyn S.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Albin, Roger L.; Gilman, Sid] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Albin, Roger L.] VA Ann Arbor Healthcare Syst VAAAHS, GRECC, Ann Arbor, MI USA; [Apostolova, Liana G.; Ringman, John M.; Vinters, Harry V.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Arnold, Steven E.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Baldwin, Clinton T.; Jun, Gyungah] Boston Univ, Genet Program, Dept Med, Boston, MA USA; [Barber, Robert] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Barnes, Lisa L.; Bennett, David A.; Schneider, Julie A.; Yu, Lei] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL USA; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Phoenix, AZ USA; [Beekly, Duane] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL USA; [Bigio, Eileen H.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bird, Thomas D.] Univ Washington, Dept Neurol, Seattle, WA USA; [Blacker, Deborah] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Blacker, Deborah] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA USA; [Boxer, Adam; Karydas, Anna; Miller, Bruce L.; Rosen, Howard J.; Seeley, William W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.; Sano, Mary] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Cairns, Nigel J.; Morris, John C.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Cao, Chuanhai; Potter, Huntington; Raj, Ashok; Smith, Amanda G.] Univ S Florida, Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Carney, Regina M.] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA; [Carroll, Steven L.; Fallon, Kenneth B.] Univ Alabama, Dept Pathol, Birmingham, TN USA; [Chui, Helena C.; Schneider, Lon S.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Clark, David G.; Harrell, Lindy E.; Marson, Daniel C.; Roberson, Erik D.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Cribbs, David H.; Pierce, Aimee] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Crocco, Elizabeth A.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [DeCarli, Charles; Olichney, John M.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Dick, Malcolm; Poon, Wayne W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA; [Dickson, Dennis W.; Ertekin-Taner, Nilufer; Graff-Radford, Neill R.; Younkin, Steven G.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Duara, Ranjan] Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Memory Disorders, Miami Beach, FL 33140 USA; [Ertekin-Taner, Nilufer; Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Faber, Kelley M.; Foroud, Tatiana M.; Murrell, Jill R.; Saykin, Andrew J.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN USA; [Farlow, Martin R.; Reisberg, Barry] Indiana Univ, Dept Neurol, Indianapolis, IN USA; [Ferris, Steven] NYU, Dept Psychiat, New York, NY 10016 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Charlestown, MA USA; [Galasko, Douglas R.; Koo, Edward H.; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Gearing, Marla] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Emory Alzheimers Dis Ctr, Atlanta, GA 30322 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Neurogenet Program, Los Angeles, CA USA; [Ghetti, Bernardino; Murrell, Jill R.; Spina, Salvatore] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA; [Glass, Jonathan D.; Lah, James J.; Levey, Allan I.] Emory Univ, Dept Neurol, Atlanta, GA USA; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Green, Robert C.] Brigham & Womens Hosp, Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Growdon, John H.; Hyman, Bradley T.; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Dept Pathol Neuropathol, Pittsburgh, PA USA; [Head, Elizabeth] Univ Kentucky, Dept Mol & Biomed Pharmacol, Sanders Brown Ctr Aging, Lexington, KY USA; [Hulette, Christine M.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Jicha, Gregory A.] Univ Kentucky, Dept Neurol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Jin, Lee-Way; Miller, Joshua W.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Farrer, Lindsay A.; Jun, Gyungah] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Farrer, Lindsay A.; Jun, Gyungah; Lunetta, Kathryn L.] Boston Univ, Dept Ophthalmol, Boston, MA USA; [Kamboh, M. Ilyas; Lopez, Oscar L.] Univ Pittsburgh, Alzheimers Dis Res Ctr, Pittsburgh, PA USA; [Kaye, Jeffrey A.; Kramer, Patricia; Quinn, Joseph F.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Kaye, Jeffrey A.] Portland VA Med Ctr, Dept Neurol, Portland, OR USA; [Kim, Ronald] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Farrer, Lindsay A.; Kowall, Neil W.; McKee, Ann C.; Stern, Robert A.] Boston Univ, Dept Neurol, Boston, MA USA; [Kowall, Neil W.; McKee, Ann C.] Boston Univ, Dept Pathol, Boston, MA USA; [Kramer, Joel H.] Univ Calif San Francisco, Dept Neuropsychol, San Francisco, CA 94143 USA; [Kramer, Patricia] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Kukull, Walter A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Leverenz, James B.; Montine, Thomas J.; Sonnen, Joshua A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Li, Ge; Peskind, Elaine; Raskind, Murray; Tsuang, Debby W.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lyketsos, Constantine G.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA; [Mack, Wendy J.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Martiniuk, Frank] NYU, Dept Med Pulm, New York, NY USA; [Mash, Deborah C.] Univ Miami, Dept Neurol, Miami, FL USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Mesulam, Marsel; Weintraub, Sandra] Northwestern Univ, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Miller, Carol A.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Morris, John C.] Washington Univ, Dept Neurol, St Louis, MO USA; [Parisi, Joseph E.] Mayo Clin, Dept Anat Pathol, Rochester, MN USA; [Parisi, Joseph E.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Reiman, Eric M.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Reisberg, Barry] NYU, Alzheimers Dis Ctr, New York, NY USA; [Rosenberg, Roger N.] Univ Texas SW, Dept Neurol, Dallas, TX USA; [Saykin, Andrew J.] Indiana Univ, Dept Radiol & Imaging Sci, Indianapolis, IN 46204 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol Neuropathol, Chicago, IL USA; [Schneider, Lon S.] Univ So Calif, Dept Psychiat, Los Angeles, CA USA; [Troncoso, Juan C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Vinters, Harry V.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Wright, Clinton B.] Univ Miami, Miller Sch Med, Dept Neurol, Evelyn F McKnight Brain Inst, Miami, FL 33136 USA; [Yu, Chang-En] Univ Washington, Dept Med, Seattle, WA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Liverpool; Greifswald Medical School; Virginia Commonwealth University; Saint Louis University; University of Michigan System; University of Michigan; Duke University; Harvard University; Brigham & Women's Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Medical University of South Carolina; Utah System of Higher Education; University of Utah; Boston University; State University System of Florida; University of Florida; Dartmouth College; Vanderbilt University; Vanderbilt University; Mayo Clinic; Columbia University; Columbia University; Yale University; University of Miami; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Johns Hopkins University; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; Boston University; University of North Texas System; University of North Texas Health Science Center; Rush University; Rush University; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Washington; University of Washington Seattle; Rush University; Northwestern University; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); State University System of Florida; University of South Florida; Vanderbilt University; University of Southern California; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Irvine; University of Miami; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; University of California System; University of California Irvine; Mayo Clinic; Mount Sinai Medical Center; Mayo Clinic; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; New York University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; Emory University; Emory University; University of California System; University of California Los Angeles; Indiana University System; Indiana University-Purdue University Indianapolis; Emory University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kentucky; Duke University; University of Kentucky; University of California System; University of California Davis; Boston University; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of California System; University of California Irvine; Boston University; Boston University; University of California System; University of California San Francisco; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Johns Hopkins University; University of Southern California; New York University; University of Miami; University of California System; University of California San Diego; Northwestern University; University of Southern California; Washington University (WUSTL); Mayo Clinic; Mayo Clinic; Mayo Clinic; Banner Research; Banner Health; Banner Alzheimer's Institute; Translational Genomics Research Institute; New York University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; Rush University; University of Southern California; Johns Hopkins University; University of Kentucky; University of California System; University of California Los Angeles; Duke University; Oregon Health & Science University; University of Miami; University of Washington; University of Washington Seattle	Whitcomb, DC (corresponding author), Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA.	whitcomb@pitt.du; devlinbj@upmc.edu	Lerch, Markus M./E-2206-2016; Baillie, Kenneth/AEK-6650-2022; Cairns, Nigel/AAB-9713-2020; Levey, Allan/F-2104-2011; Neoptolemos, John/HGU-7742-2022; , Bob/ABA-8507-2020; DeCarli, Charles/B-5541-2009; Spina, Salvatore/M-4463-2019; Papachristou, Georgios/AAN-7619-2021; Sutton, Robert/I-3587-2016; Tsuang, Debby/L-7234-2016; Kowall, Neil/M-5378-2019; Tanzi, Rudolph/AAE-9622-2019; Reitz, Christiane/GNP-0257-2022; Cruchaga, Carlos/ABF-4065-2020; Johnstone, Marianne/K-8887-2012; Yu, Lei/AAT-3685-2020; Farrer, Lindsay/AAS-1035-2020; Melhem, Nadine M/G-1510-2013; Greenhalf, William/A-2680-2013; Weiss, Frank Ulrich/A-6386-2009; Buxbaum, Joseph D/G-6001-2010; Baillie, John Kenneth/F-3124-2011; MORAN, CATHERINE L/C-9539-2015; Frosch, Matthew P/ABD-7456-2021; Welsh-Bohmer, Kathleen/AAA-3178-2020; Mayeux, Richard/E-9788-2013; Burke, James R/E-4245-2016; Zarnescu, Narcis/J-4196-2015; Sonnen, Joshua/AAT-5788-2021; Mayerle, Julia/W-7907-2019; Saykin, Andrew/A-1318-2007; Hollyman, Marianne/J-8362-2016; Roberson, Erik/A-5718-2009	Lerch, Markus M./0000-0002-9643-8263; Baillie, Kenneth/0000-0001-5258-793X; Cairns, Nigel/0000-0001-9858-3344; Levey, Allan/0000-0002-3153-502X; Sutton, Robert/0000-0001-6600-562X; Tsuang, Debby/0000-0002-4716-1894; Kowall, Neil/0000-0002-6624-0213; Tanzi, Rudolph/0000-0002-7032-1454; Cruchaga, Carlos/0000-0002-0276-2899; Johnstone, Marianne/0000-0001-7785-4213; Weiss, Frank Ulrich/0000-0003-3369-6369; Baillie, John Kenneth/0000-0001-5258-793X; Frosch, Matthew P/0000-0002-3940-9861; Mayeux, Richard/0000-0001-6519-9696; Burke, James R/0000-0002-3408-7787; Zarnescu, Narcis/0000-0003-3973-6309; Neoptolemos, John/0000-0002-6201-7399; Carroll, Steven/0000-0001-6714-4373; Leverenz, James/0000-0002-0896-0749; Dickson, Dennis W/0000-0001-7189-7917; Baldwin, Clinton/0000-0002-3275-9463; Poon, Wayne/0000-0003-0625-3968; Roeder, Kathryn/0000-0002-8869-6254; Demirci, F. Yesim/0000-0001-6907-9843; Mayerle, Julia/0000-0002-3666-6459; Jun, Gyungah/0000-0002-3230-8697; Reisberg, Barry/0000-0002-9104-7423; Saykin, Andrew/0000-0002-1376-8532; Barmada, M Michael/0000-0002-3604-6460; Lin, Chiao-Feng/0000-0002-6177-8807; Singh, Vijay/0000-0001-6611-1908; Kaye, Jeffrey/0000-0002-9971-3478; Quinn, Joseph/0000-0001-7305-2256; Goate, Alison/0000-0002-0576-2472; Stern, Robert/0000-0002-5008-077X; Lunetta, Kathryn/0000-0002-9268-810X; Hollyman, Marianne/0000-0002-5972-0454; Wisniewski, Stephen/0000-0002-3877-9860; Cao, Chuanhai/0000-0002-5765-6401; Farrer, Lindsay/0000-0001-5533-4225; Kukull, Walter/0000-0001-8761-9014; Ferris, Steven/0000-0001-8641-6223; Lewis, Michele/0000-0001-5465-5211; Kamboh, M. Ilyas/0000-0002-3453-1438; Buxbaum, Joseph/0000-0001-8898-8313; Romagnuolo, Joseph/0000-0002-5630-3022; Amann, Stephen/0000-0002-1487-6965; Roberson, Erik/0000-0002-1810-9763	US National Institutes of Health (NIH) [R56DK061451, R01DK054709, T32DK063922, R01MH057881, R01CA117926, R01DK077906, UL1RR024153, UL1TR000005]; Digestive Disease Training Program [T32DK063922]; American Gastroenterology Association; National Institute for Health Research (NIHR) Biomedical Research Unit award; National Pancreas Foundation; Frieda G. and Saul E Shapira BRCA-Associated Cancer Research Program; Wayne Fusaro Pancreatic Cancer Research Fund; Gift of Life Foundation; Alzheimer's Disease Genetics Consortium (ADGC): The NIH-National Institute on Aging (NIH-NIA) [U01AG032984, RC2AG036528]; National Alzheimer's Coordinating Center (NACC) [U01AG016976]; National Cell Repository for Alzheimer's Disease (NCRAD) [U24AG021886]; Banner Sun Health Research Institute [P30AG019610]; Boston University [P30AG013846, U01AG10483, R01CA129769, R01MH080295, R01AG017173, R01AG025259, R01AG33193]; Columbia University [P50AG008702, R37AG015473]; Duke University [P30AG028377, AG05128]; Emory University [AG025688]; Indiana University [P30AG10133]; Johns Hopkins University [P50AG005146, R01AG020688]; Massachusetts General Hospital [P50AG005134]; Mayo Clinic [P50AG016574]; Mount Sinai School of Medicine [P50AG005138, P01AG002219]; New York University [P30AG08051, MO1RR00096, UL1RR029893]; Northwestern University [P30AG013854]; Oregon Health & Science University [P30AG008017, R01AG026916]; Rush University [P30AG010161, R01AG019085, R01AG15819, R01AG17917, R01AG30146]; University of Alabama at Birmingham [P50AG016582, UL1RR02777]; University of Arizona [R01AG031581]; University of California, Davis [P30AG010129]; University of California, Irvine [P50AG016573, P50AG016575, P50AG016576, P50AG016577]; University of California, Los Angeles [P50AG016570]; University of California, San Diego [P50AG005131]; University of California, San Francisco [P50AG023501, P01AG019724]; University of Kentucky [P30AG028383, AG05144]; University of Michigan [P50AG008671]; University of Pennsylvania [P30AG010124]; University of Pittsburgh [P50AG005133, AG030653]; University of Southern California [P50AG005142]; University of Texas Southwestern [P30AG012300]; University of Miami [R01AG027944, AG010491, AG027944, AG021547, AG019757]; University of Washington [P50AG005136]; Vanderbilt University [R01AG019085]; Washington University [P50AG005681, P01AG03991]; National Institute of Neurological Disorders and Stroke (NINDS) [NS39764]; National Institute of Mental Health (NIMH) [MH60451]; GlaxoSmithKline; NATIONAL CANCER INSTITUTE [R01CA129769, P30CA047904, R01CA117926] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, M01RR000096, UL1RR025741, UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061451, T32DK063922, R01DK077906, R01DK054709, R01DK061451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451, R37MH057881, R01MH057881, R01MH080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036960, P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028377, U01AG016976, R01AG020688, P30AG013846, P50AG005128, P30AG008017, P50AG005131, P50AG005138, R01AG019757, RC2AG036528, R01AG027944, P01AG010491, R01AG026916, P01AG003991, P50AG008702, P50AG005146, P50AG016570, P50AG005144, P50AG005681, P50AG016582, P30AG010161, P30AG019610, P50AG005133, P01AG019724, P30AG012300, K23AG034550, R01AG040770, P50AG023501, P50AG008671, R01AG025259, P30AG010133, P50AG005142, R01AG032990, P01AG002219, P30AG028383, R01AG017173, U01AG010483, P30AG010129, R01AG019085, P30AG008051, P50AG016574, R01AG031581, R01AG030146, P30AG010124, P50AG025688, R01AG022018, P50AG005134, R01AG017917, R01AG021547, P50AG016573, U01AG032984, R01AG033193, R01AG015819, R01AG030653, U24AG021886, P50AG005136, R37AG015473, P30AG013854] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0510-10126, PB-PG-0407-13363] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Training Program; American Gastroenterology Association; National Institute for Health Research (NIHR) Biomedical Research Unit award(National Institute for Health Research (NIHR)); National Pancreas Foundation; Frieda G. and Saul E Shapira BRCA-Associated Cancer Research Program; Wayne Fusaro Pancreatic Cancer Research Fund; Gift of Life Foundation; Alzheimer's Disease Genetics Consortium (ADGC): The NIH-National Institute on Aging (NIH-NIA); National Alzheimer's Coordinating Center (NACC); National Cell Repository for Alzheimer's Disease (NCRAD); Banner Sun Health Research Institute; Boston University; Columbia University; Duke University; Emory University; Indiana University; Johns Hopkins University(Johns Hopkins University); Massachusetts General Hospital(General Electric); Mayo Clinic; Mount Sinai School of Medicine; New York University; Northwestern University; Oregon Health & Science University; Rush University; University of Alabama at Birmingham; University of Arizona; University of California, Davis(University of California System); University of California, Irvine(University of California System); University of California, Los Angeles(University of California System); University of California, San Diego(University of California System); University of California, San Francisco(University of California System); University of Kentucky; University of Michigan(University of Michigan System); University of Pennsylvania; University of Pittsburgh(University of Pittsburgh); University of Southern California; University of Texas Southwestern; University of Miami; University of Washington(University of Washington); Vanderbilt University; Washington University; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Health Research(National Institute for Health Research (NIHR))	Technical support was provided by K. Stello, S. Das, D. Dwyer, A. Rowland, P.A. Blake, M. Ross, C. McGovern, L. Kish, H. Nawaz, S. Solomon, S. Boggiano, R. Ostroff, M. Goss and J. Timm. Data management was provided by L. Silfies and D. Protivnak. Clinical support was provided by S. Boggaino, M. Hendricks, B. Elinoff, L. McHenry, G. Lehman,). Watkins, E. Fogel and L. Lazzell-Pannell. Additional samples were provided by F. Burton (deceased; St. Louis University School of Medicine); S. Lo (Cedars-Sinai Medical Center, University of California, Los Angeles); M.T. DeMeo (Rush University Medical Center); W.M. Steinberg (Washington Hospital Center); M.L. Kochman (University of Pennsylvania); B. Etemad (Ochsner Medical Center); and H. Zeh, A.). Moser and K.K. Lee (University of Pittsburgh). This publication was made possible by grants R56DK061451 (D.C.W.), R01DK054709 (D.C.W), T32DK063922 (D.C.W.), R01MH057881 (B.D. and K.R.), R01CA117926 (J.P.S.), R01DK077906 (D.C.W. and D.Y.), UL1RR024153 and UL1TR000005 from the US National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH. This project used the University of Pittsburgh Genomics and Proteomics Core laboratories (UL1RR024153, UL1RR024153 and UL1TR000005) and the University of Pittsburgh Cancer Institute (UPCI) Clinical Genomics Immunoproteomics and Sequencing Facility (NIH P30CA047904). J.L. was supported by Digestive Disease Training Program T32DK063922 (D.C.W.). N.O.Z. was supported by the American Gastroenterology Association John I Isenberg International Scholar Award. The Liverpool cohort was supported by the National Institute for Health Research (NIHR) Biomedical Research Unit award. Additional support was provided by the National Pancreas Foundation (D.C.W.), the Frieda G. and Saul E Shapira BRCA-Associated Cancer Research Program (D.C.W.) and the Wayne Fusaro Pancreatic Cancer Research Fund (D.C.W.) and Gift of Life Foundation (J.P.S.).; Alzheimer's Disease Genetics Consortium (ADGC): The NIH-National Institute on Aging (NIH-NIA) supported this work through the following grants: ADGC, U01AG032984 and RC2AG036528; National Alzheimer's Coordinating Center (NACC), U01AG016976; National Cell Repository for Alzheimer's Disease (NCRAD), U24AG021886; Banner Sun Health Research Institute, P30AG019610; Boston University P30AG013846, U01AG10483, R01CA129769, R01MH080295, R01AG017173, R01AG025259 and R01AG33193; Columbia University, P50AG008702 and R37AG015473; Duke University, P30AG028377 and AG05128; Emory University, AG025688; Indiana University, P30AG10133; Johns Hopkins University, P50AG005146 and R01AG020688; Massachusetts General Hospital, P50AG005134; Mayo Clinic, P50AG016574; Mount Sinai School of Medicine, P50AG005138 and P01AG002219; New York University, P30AG08051, MO1RR00096 and UL1RR029893; Northwestern University, P30AG013854; Oregon Health & Science University, P30AG008017 and R01AG026916; Rush University, P30AG010161, R01AG019085, R01AG15819, R01AG17917 and R01AG30146; University of Alabama at Birmingham, P50AG016582 and UL1RR02777; University of Arizona, R01AG031581; University of California, Davis, P30AG010129; University of California, Irvine, P50AG016573, P50AG016575, P50AG016576 and P50AG016577; University of California, Los Angeles, P50AG016570; University of California, San Diego, P50AG005131; University of California, San Francisco, P50AG023501 and P01AG019724; University of Kentucky, P30AG028383 and AG05144; University of Michigan, P50AG008671; University of Pennsylvania, P30AG010124; University of Pittsburgh, P50AG005133 and AG030653; University of Southern California, P50AG005142; University of Texas Southwestern, P30AG012300; University of Miami, R01AG027944, AG010491, AG027944, AG021547 and AG019757; University of Washington, P50AG005136; Vanderbilt University, R01AG019085; and Washington University, P50AG005681 and P01AG03991. The Kathleen Price Bryan Brain Bank at the Duke University Medical Center is funded by National Institute of Neurological Disorders and Stroke (NINDS) grant NS39764 and National Institute of Mental Health (NIMH) grant MH60451 and by GlaxoSmithKline. We thank D.S. Snyder and M. Miller who are ex officio ADGC members.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; AMMANN RW, 1984, GASTROENTEROLOGY, V86, P820; Aung PP, 2006, VIRCHOWS ARCH, V448, P428, DOI 10.1007/s00428-005-0120-2; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Irving HM, 2009, J PANCREAS, V10, P387; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; LaRusch J, 2012, J PANCREAS, V13, P258; Lee JH, 2011, ONCOL REP, V25, P971, DOI 10.3892/or.2011.1132; Liggins AP, 2007, BRIT J HAEMATOL, V138, P479, DOI 10.1111/j.1365-2141.2007.06680.x; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; MARKS IN, 1973, DIGESTION, V9, P447, DOI 10.1159/000197473; Masson E, 2008, CLIN GASTROENTEROL H, V6, P82, DOI 10.1016/j.cgh.2007.10.004; Merilainen S, 2008, SCAND J GASTROENTERO, V43, P1259, DOI 10.1080/00365520802158580; ROBLESDIAZ G, 1990, PANCREAS, V5, P479, DOI 10.1097/00006676-199007000-00017; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Van den Bossche J, 2012, SCAND J IMMUNOL, V75, P588, DOI 10.1111/j.1365-3083.2012.02689.x; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Whitcomb DC, 2008, PANCREATOLOGY, V8, P520, DOI 10.1159/000152001; Whitcomb DC, 2012, NAT REV GASTRO HEPAT, V9, P418, DOI 10.1038/nrgastro.2012.100; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Yadav D, 2007, PANCREAS, V34, P390, DOI 10.1097/mpa.0b013e318040b332; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125	31	206	210	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1349	1354		10.1038/ng.2466	http://dx.doi.org/10.1038/ng.2466			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143602	Green Submitted, Green Accepted			2022-12-25	WOS:000311713200014
J	Ebrahimi, KH; Bill, E; Hagedoorn, PL; Hagen, WR				Ebrahimi, Kourosh Honarmand; Bill, Eckhard; Hagedoorn, Peter-Leon; Hagen, Wilfred R.			The catalytic center of ferritin regulates iron storage via Fe(II)-Fe(III) displacement	NATURE CHEMICAL BIOLOGY			English	Article							H-CHAIN FERRITIN; ANAEROBE PYROCOCCUS-FURIOSUS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; REDUCTION POTENTIALS; FERROXIDASE CENTER; CORE FORMATION; TRANSIT SITE; BACTERIOFERRITIN	A conserved iron-binding site, the ferroxidase center, regulates the vital iron storage role of the ubiquitous protein ferritin in iron metabolism. It is commonly thought that two Fe(II) simultaneously bind the ferroxidase center and that the oxidized Fe(III)-O(H)-Fe(III) product spontaneously enters the cavity of ferritin as a unit. In contrast, in some bacterioferritins and in archaeal ferritins a persistent di-iron prosthetic group in this center is believed to mediate catalysis of core formation. Using a combination of binding experiments and isotopically labeled Fe-57(II), we studied two systems in comparison: the ferritin from the hyperthermophilic archaeal anaerobe Pyrococcus furiosus (PfFtn) and the eukaryotic human H ferritin (HuHF). The results do not support either of the two paradigmatic models; instead they suggest a unifying mechanism in which the Fe(III)-O-Fe(III) unit resides in the ferroxidase center until it is sequentially displaced by Fe(II).	[Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands; [Bill, Eckhard] Max Planck Inst Bioanorgan Chem, Mulheim, Germany	Delft University of Technology; Max Planck Society	Ebrahimi, KH (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Ebrahimi, Kourosh Honarmand/X-4579-2019; Hagedoorn, Peter-Leon/C-8535-2014; Hagen, Wilfred R./H-8918-2017	Ebrahimi, Kourosh Honarmand/0000-0001-6628-944X; Hagedoorn, Peter-Leon/0000-0001-6342-2022; Hagen, Wilfred R./0000-0002-1609-6671	Dutch National Research School Combination-Catalysis	Dutch National Research School Combination-Catalysis	The construct for production of recombinant HuHF was kindly provided by P. Arosio (University of Brescia). We thank L. van der Weel for assistance with expression of ferritin, M.J.F. Strampraad for technical assistance, D. Sordi for her assistance with the E129R mutation, M. M. Kabir for assistance with kinetic measurements and B. Mienert for Mossbauer measurements. This work was financially supported by a research grant from the Dutch National Research School Combination-Catalysis Controlled by Chemical Design (NRSC-C).	Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Bauminger ER, 1999, BIOCHEMISTRY-US, V38, P7791, DOI 10.1021/bi990377l; BAUMINGER ER, 1993, BIOCHEM J, V296, P709, DOI 10.1042/bj2960709; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Bou-Abdallah F, 2002, BIOCHEM J, V364, P57, DOI 10.1042/bj3640057; CHASTEEN ND, 1985, J BIOL CHEM, V260, P2926; CHEESMAN MR, 1990, NATURE, V346, P771, DOI 10.1038/346771a0; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hagen W. R., 2009, BIOMOLECULAR EPR SPE; Hagen WR, 2006, DALTON T, P4415, DOI 10.1039/b608163k; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; LEVI S, 1989, BIOCHEMISTRY-US, V28, P5179, DOI 10.1021/bi00438a040; LEVI S, 1988, J BIOL CHEM, V263, P18086; MANN S, 1987, J MOL BIOL, V198, P405, DOI 10.1016/0022-2836(87)90290-7; Masuda T, 2010, BIOCHEM BIOPH RES CO, V400, P94, DOI 10.1016/j.bbrc.2010.08.017; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mathevon C, 2007, P NATL ACAD SCI USA, V104, P13295, DOI 10.1073/pnas.0704338104; PAULSEN KE, 1994, BIOCHEMISTRY-US, V33, P713, DOI 10.1021/bi00169a013; Pereira AS, 1998, BIOCHEMISTRY-US, V37, P9871, DOI 10.1021/bi980847w; Rucker P, 1996, J BIOL CHEM, V271, P33352, DOI 10.1074/jbc.271.52.33352; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; STPIERRE TG, 1986, BIOCHIM BIOPHYS ACTA, V870, P127, DOI 10.1016/0167-4838(86)90015-4; Tatur J, 2006, EXTREMOPHILES, V10, P139, DOI 10.1007/s00792-005-0484-x; Tatur J, 2005, FEBS LETT, V579, P4729, DOI 10.1016/j.febslet.2005.07.045; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; TREFFRY A, 1992, FEBS LETT, V302, P108, DOI 10.1016/0014-5793(92)80417-F; TREFFRY A, 1987, J INORG BIOCHEM, V31, P1, DOI 10.1016/0162-0134(87)85001-8; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119	43	95	98	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					941	948		10.1038/NCHEMBIO.1071	http://dx.doi.org/10.1038/NCHEMBIO.1071			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23001032				2022-12-25	WOS:000310052100014
J	Pohler, E; Mamai, O; Hirst, J; Zamiri, M; Horn, H; Nomura, T; Irvine, AD; Moran, B; Wilson, NJ; Smith, FJD; Goh, CSM; Sandilands, A; Cole, C; Barton, GJ; Evans, AT; Shimizu, H; Akiyama, M; Suehiro, M; Konohana, I; Shboul, M; Teissier, S; Boussofara, L; Denguezli, M; Saad, A; Gribaa, M; Dopping-Hepenstal, PJ; McGrath, JA; Brown, SJ; Goudie, DR; Reversade, B; Munro, CS; McLean, WHI				Pohler, Elizabeth; Mamai, Ons; Hirst, Jennifer; Zamiri, Mozheh; Horn, Helen; Nomura, Toshifumi; Irvine, Alan D.; Moran, Benvon; Wilson, Neil J.; Smith, Frances J. D.; Goh, Christabelle S. M.; Sandilands, Aileen; Cole, Christian; Barton, Geoffrey J.; Evans, Alan T.; Shimizu, Hiroshi; Akiyama, Masashi; Suehiro, Mitsuhiro; Konohana, Izumi; Shboul, Mohammad; Teissier, Sebastien; Boussofara, Lobna; Denguezli, Mohamed; Saad, Ali; Gribaa, Moez; Dopping-Hepenstal, Patricia J.; McGrath, John A.; Brown, Sara J.; Goudie, David R.; Reversade, Bruno; Munro, Colin S.; McLean, W. H. Irwin			Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma	NATURE GENETICS			English	Article							ENDOCYTIC TRAFFICKING; MUTATIONS; EGFR; IDENTIFICATION; PROTEIN; OCCURS; LOCUS; GENE	Palmoplantar keratodermas (PPKs) are a group of disorders that are diagnostically and therapeutically problematic in dermatogenetics(1-3). Punctate PPKs are characterized by circumscribed hyperkeratotic lesions on the palms and soles with considerable heterogeneity. In 18 families with autosomal dominant punctate PPK, we report heterozygous loss-of-function mutations in AAGAB, encoding alpha- and gamma-adaptin binding protein p34, located at a previously linked locus at 15q22. alpha- and gamma-adaptin binding protein p34, a cytosolic protein with a Rab-like GTPase domain, was shown to bind both clathrin adaptor protein complexes, indicating a role in membrane trafficking. Ultrastructurally, lesional epidermis showed abnormalities in intracellular vesicle biology. Immunohistochemistry showed hyperproliferation within the punctate lesions. Knockdown of AAGAB in keratinocytes led to increased cell division, which was linked to greatly elevated epidermal growth factor receptor (EGFR) protein expression and tyrosine phosphorylation. We hypothesize that p34 deficiency may impair endocytic recycling of growth factor receptors such as EGFR, leading to increased signaling and cellular proliferation.	[Pohler, Elizabeth; Wilson, Neil J.; Smith, Frances J. D.; Goh, Christabelle S. M.; Sandilands, Aileen; Cole, Christian; Brown, Sara J.; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Ctr Dermatol & Genet Med, Dundee, Scotland; [Pohler, Elizabeth; Wilson, Neil J.; Smith, Frances J. D.; Goh, Christabelle S. M.; Sandilands, Aileen; Cole, Christian; Brown, Sara J.; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland; [Mamai, Ons; Saad, Ali; Gribaa, Moez] Farhat Hached Univ Hosp, Lab Human Cytogenet Mol Genet & Reprod Biol, Sousse, Tunisia; [Mamai, Ons; Shboul, Mohammad; Teissier, Sebastien; Reversade, Bruno] ASTAR, Inst Med Biol, Singapore, Singapore; [Hirst, Jennifer] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Zamiri, Mozheh] Univ Hosp Crosshouse, Dept Dermatol, Kilmarnock, Scotland; [Horn, Helen] Royal Infirm Edinburgh NHS Trust, Dept Dermatol, Edinburgh, Midlothian, Scotland; [Nomura, Toshifumi; Shimizu, Hiroshi] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Irvine, Alan D.; Moran, Benvon] Our Ladys Childrens Hosp, Dept Paediat Dermatol, Dublin, Ireland; [Irvine, Alan D.] Univ Dublin Trinity Coll, Inst Mol Med, Dublin 2, Ireland; [Cole, Christian; Barton, Geoffrey J.] Univ Dundee, Coll Life Sci, Div Biochem & Drug Discovery, Bioinformat Res Grp, Dundee, Scotland; [Evans, Alan T.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Pathol, Dundee DD1 9SY, Scotland; [Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Suehiro, Mitsuhiro] Otsu Municipal Hosp, Dept Dermatol, Otsu, Shiga, Japan; [Konohana, Izumi] Hiratsuka Municipal Hosp, Dept Dermatol, Hiratsuka, Kanagawa, Japan; [Boussofara, Lobna; Denguezli, Mohamed] Farhat Hached Univ Hosp, Dept Dermatol & Venerol, Sousse, Tunisia; [Dopping-Hepenstal, Patricia J.] St Thomas Hosp, Guys & St Thomas GSTS Pathol, London, England; [McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Goudie, David R.] Univ Dundee, Ninewells Hosp & Med Sch, Human Genet Unit, Dundee DD1 9SY, Scotland; [Reversade, Bruno] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Munro, Colin S.] So Gen Hosp, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland	University of Dundee; University of Dundee; Universite de Sousse; Hopital Farhat Hached; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Cambridge; Royal Infirmary of Edinburgh; University of Edinburgh; Hokkaido University; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Dundee; University of Dundee; Nagoya University; Universite de Sousse; Hopital Farhat Hached; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; National University of Singapore; University of Glasgow	McLean, WHI (corresponding author), Univ Dundee, Coll Life Sci, Ctr Dermatol & Genet Med, Dundee, Scotland.	w.h.i.mclean@dundee.ac.uk	McGrath, John/N-3529-2019; Irvine, Alan D/A-3982-2008; Barton, Geoffrey/N-1037-2019; Nomura, Toshifumi/A-5454-2012; Brown, Sara J/AAF-7095-2019; Boussofara, Lobna/K-6428-2019; Barton, Geoffrey J/C-6267-2011; Akiyama, Masashi/I-1122-2012; McGrath, John/D-6824-2012	Irvine, Alan D/0000-0002-9048-2044; Barton, Geoffrey/0000-0002-9014-5355; Nomura, Toshifumi/0000-0002-9954-6446; Brown, Sara J/0000-0002-3232-5251; Boussofara, Lobna/0000-0003-0041-8741; McLean, William Henry Irwin/0000-0001-5539-5757; MAMAI, ons/0000-0003-4392-0037; Denguezli, Mohamed/0000-0002-4176-2744; REVERSADE, Bruno/0000-0002-4070-7997; Cole, Christian/0000-0002-2560-2484; McGrath, John/0000-0002-3708-9964	National Institute for Health Research; Cambridge Biomedical Research Centre; Wellcome Trust [092530/Z/10/Z, 098439/Z/12/Z]; Pachyonychia Congenita Project; AstarSTAR; AstarSTAR Research Attachment Program (ARAP); MRC [G0802780, G0900756] Funding Source: UKRI; Medical Research Council [G0900756, G0802780] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome Trust); Pachyonychia Congenita Project; AstarSTAR(Agency for Science Technology & Research (A*STAR)); AstarSTAR Research Attachment Program (ARAP); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors dedicate this paper to their erstwhile colleague, the late dermatologist and cell biologist Susan M. Morley, who treated some of the individuals studied here, We thank M. Robinson and C. Watts for insightful discussions, I. Nathke and I. Newton for their help with protein blot quantification and Tayside Tissue Bank, Dundee for providing skin samples. Specialist Sequencing and Bioinformatics Services were provided by The Eastern Sequence and Informatics Hub (EASIH) at the University of Cambridge, which is supported by the National Institute for Health Research and the Cambridge Biomedical Research Centre. This work was supported by a Wellcome Trust Programme Grant (092530/Z/10/Z) to W.H.I.M., A.D.I. and G.J.B., a Wellcome Trust Strategic Award (098439/Z/12/Z) to W.H.I.M., G.J.B. and J.A.M., a project grant from the Pachyonychia Congenita Project to F.J.D.S. and a strategic positioning fund for Genetic Orphan Diseases from A<SUP>star</SUP>STAR. O.M. was funded by an A<SUP>star</SUP>STAR Research Attachment Program (ARAP), and B.R. is a fellow of the Branco Weiss Foundation.	BENNION SD, 1984, J AM ACAD DERMATOL, V10, P587, DOI 10.1016/S0190-9622(84)80262-5; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Ceresa BP, 2006, HISTOL HISTOPATHOL, V21, P987, DOI 10.14670/HH-21.987; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; El Amri I, 2010, ANN DERMATOL VENER, V137, P269, DOI 10.1016/j.annder.2010.02.002; Emmert S, 2003, EUR J DERMATOL, V13, P16; Gao M, 2005, BRIT J DERMATOL, V152, P874, DOI 10.1111/j.1365-2133.2005.06488.x; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Horgan CP, 2011, BIOCHEM SOC T, V39, P1202, DOI 10.1042/BST0391202; Itin PH, 2005, CLIN DERMATOL, V23, P15, DOI 10.1016/j.clindermatol.2004.09.005; JUNG EG, 1973, HUMANGENETIK, V17, P357; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Kelsell DP, 1999, MOL MED TODAY, V5, P107, DOI 10.1016/S1357-4310(98)01428-2; Martinez-Mir A, 2003, J MED GENET, V40, P872, DOI 10.1136/jmg.40.12.872; McLean WHI, 2003, J ANAT, V202, P133, DOI 10.1046/j.1469-7580.2003.00141.x; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Rappoport JZ, 2009, J CELL SCI, V122, P1301, DOI 10.1242/jcs.040030; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Stevens HP, 1996, ARCH DERMATOL, V132, P640, DOI 10.1001/archderm.132.6.640; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Wan H, 2004, BRIT J DERMATOL, V150, P878, DOI 10.1111/j.1365-2133.2004.05996.x; Zhang XJ, 2004, J INVEST DERMATOL, V122, P1121, DOI 10.1111/j.0022-202X.2004.22507.x	28	54	57	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1272	1276		10.1038/ng.2444	http://dx.doi.org/10.1038/ng.2444			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23064416	Green Accepted			2022-12-25	WOS:000310495800022
J	Zhang, S; Liu, XB; Bawa-Khalfe, T; Lu, LS; Lyu, YL; Liu, LF; Yeh, ETH				Zhang, Sui; Liu, Xiaobing; Bawa-Khalfe, Tasneem; Lu, Long-Sheng; Lyu, Yi Lisa; Liu, Leroy F.; Yeh, Edward T. H.			Identification of the molecular basis of doxorubicin-induced cardiotoxicity	NATURE MEDICINE			English	Article							TOPOISOMERASE-II-BETA; INDUCED CARDIOMYOPATHY; HEART; GENE; TRANSCRIPTION; EXPRESSION; PREVENTION; PGC-1-BETA; APOPTOSIS; ADULT	Doxorubicin is believed to cause dose-dependent cardiotoxicity through redox cycling and the generation of reactive oxygen species (ROS). Here we show that cardiomyocyte-specific deletion of Top2b (encoding topoisomerase-II beta) protects cardiomyocytes from doxorubicin-induced DNA double-strand breaks and transcriptome changes that are responsible for defective mitochondrial biogenesis and ROS formation. Furthermore, cardiomyocyte-specific deletion of Top2b protects mice from the development of doxorubicin-induced progressive heart failure, suggesting that doxorubicin-induced cardiotoxicity is mediated by topoisomerase-II beta in cardiomyocytes.	[Zhang, Sui; Bawa-Khalfe, Tasneem; Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Liu, Xiaobing; Lu, Long-Sheng; Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA; [Liu, Xiaobing] Shanghai Jiao Tong Univ, Dept Vasc Surg, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Lyu, Yi Lisa; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yeh, ETH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA.	etyeh@mdanderson.org		Liu, Leroy/0000-0001-9396-763X	Cancer Prevention Research Institute of Texas; McNair Medical Institute; US National Institutes of Health [CA102463]; New Jersey Commission on Cancer Research [06-2419-CCR-EO]; US Department of Defense [W81XWH-07-1-0407, W81XWH06-1-0514]; NATIONAL CANCER INSTITUTE [R01CA102463] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; McNair Medical Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. H. Ren for expert technical assistance and F. M. Lin and H. Dou for conducting studies on mitochondria DNA. W. C. Claycomb (Louisiana State University Health Science Center) provided HL-1 cells. This study is supported by the Cancer Prevention Research Institute of Texas and McNair Medical Institute (E.T.H.Y.), US National Institutes of Health grant CA102463 (to L. F. L.), the New Jersey Commission on Cancer Research Grant 06-2419-CCR-EO, US Department of Defense Idea Award W81XWH-07-1-0407 and Concept Award W81XWH06-1-0514 (to Y.L.L.).	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Liao Ronglih, 2007, V139, P251; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Martin E, 2009, TOXICOLOGY, V255, P72, DOI 10.1016/j.tox.2008.10.011; MYERS C, 1983, SEMIN ONCOL, V10, P53; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Plesca D, 2008, METHOD ENZYMOL, V446, P107, DOI 10.1016/S0076-6879(08)01606-6; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wang JX, 2010, CIRC RES, V106, P1904, DOI 10.1161/CIRCRESAHA.110.221762; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	24	1104	1143	13	244	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1639	+		10.1038/nm.2919	http://dx.doi.org/10.1038/nm.2919			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23104132				2022-12-25	WOS:000310837000023
J	Creixell, P; Schoof, EM; Erler, JT; Linding, R				Creixell, Pau; Schoof, Erwin M.; Erler, Janine T.; Linding, Rune			Navigating cancer network attractors for tumor-specific therapy	NATURE BIOTECHNOLOGY			English	Review							EDGETIC PERTURBATION; SOMATIC MUTATION; MOUSE MODELS; PROTEIN; PHOSPHORYLATION; EVOLUTION; PREDICTION; ONCOGENE; PATHWAY; GROWTH	Cells employ highly dynamic signaling networks to drive biological decision processes. Perturbations to these signaling networks may attract cells to new malignant signaling and phenotypic states, termed cancer network attractors, that result in cancer development. As different cancer cells reach these malignant states by accumulating different molecular alterations, uncovering these mechanisms represents a grand challenge in cancer biology. Addressing this challenge will require new systems-based strategies that capture the intrinsic properties of cancer signaling networks and provide deeper understanding of the processes by which genetic lesions perturb these networks and lead to disease phenotypes. Network biology will help circumvent fundamental obstacles in cancer treatment, such as drug resistance and metastasis, empowering personalized and tumor-specific cancer therapies.	[Erler, Janine T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Creixell, Pau; Schoof, Erwin M.; Linding, Rune] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal CBS, C SIG, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Erler, JT (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	janine.erler@bric.ku.dk; linding@cbs.dtu.dk		Schoof, Erwin Marten/0000-0002-3117-7832; Erler, Janine/0000-0001-8675-6527; Linding, Rune/0000-0003-0420-4839	Danish Council for Independent Research; Career Development Award from Human Frontier Science Program; Novo Nordisk Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Career Development Award from Human Frontier Science Program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We apologize to our colleagues whose work could not be cited due to space limitations. We thank all members of the C-SIG (DTU), the ErlerLab (BRIC), M. Yaffe (MIT) and N. Brunner (KU) for critical input on this manuscript. R. L. is a Lundbeck Foundation Fellow and is supported by a Sapere Aude Starting Grant from The Danish Council for Independent Research and a Career Development Award from Human Frontier Science Program. J.T.E. is supported by a Hallas Moller Stipend from the Novo Nordisk Foundation. Visit http://www.networkbio.org/, http://www.lindinglab.org/ and http://www.erlerlab.org/ for more information on cancer-related network biology.	Abreu-Martin MT, 1999, AM J PHYSIOL-GASTR L, V276, pG599, DOI 10.1152/ajpgi.1999.276.3.G599; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Blumenthal RD, 2007, MOL BIOTECHNOL, V35, P185, DOI 10.1007/BF02686104; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Dreze M, 2009, NAT METHODS, V6, P843, DOI [10.1038/NMETH.1394, 10.1038/nmeth.1394]; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Erler JT, 2012, CELL, V149, P731, DOI 10.1016/j.cell.2012.04.014; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoffman RM, 2010, EXPERT OPIN DRUG DIS, V5, P851, DOI 10.1517/17460441.2010.510129; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Hunter KW, 2012, NAT REV CANCER, V12, P144, DOI 10.1038/nrc3206; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; KAUFFMAN SA, 1989, J THEOR BIOL, V141, P211, DOI 10.1016/S0022-5193(89)80019-0; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Ledford H, 2010, NATURE, V464, P972, DOI 10.1038/464972a; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Meyer P, 2011, NAT BIOTECHNOL, V29, P811, DOI 10.1038/nbt.1968; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Pazos F, 2006, CURR BIOINFORM, V1, P15, DOI 10.2174/157489306775330633; Pe'er D, 2011, CELL, V144, P864, DOI 10.1016/j.cell.2011.03.001; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Turk BE, 2008, CURR OPIN CHEM BIOL, V12, P4, DOI 10.1016/j.cbpa.2008.01.018; Uribesalgo I, 2012, CELL CYCLE, V11, P1757, DOI 10.4161/cc.19883; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Waddington C H, 1957, STRATEGY GENES DISCU; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; WHO, 2012, WHO FACT SHEET 297; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	81	104	104	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					842	848		10.1038/nbt.2345	http://dx.doi.org/10.1038/nbt.2345			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965061	Bronze			2022-12-25	WOS:000308705700018
J	Puri, AW; Broz, P; Shen, A; Monack, DM; Bogyo, M				Puri, Aaron W.; Broz, Petr; Shen, Aimee; Monack, Denise M.; Bogyo, Matthew			Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection	NATURE CHEMICAL BIOLOGY			English	Article							CELL-DEATH; ACTIVATION; PYROPTOSIS; NECROSIS; PROTEIN; MECHANISM; SUBSTRATE; RELEASE	Here we report AWP28, an activity-based probe that can be used to biochemically monitor caspase-1 activation in response to proinflammatory stimuli. Using AWP28, we show that apoptosis is triggered upon Salmonella enterica var. Typhimurium infection in primary mouse bone marrow macrophages lacking caspase-1. Furthermore, we report that upon Salmonella infection, inflammasome-mediated caspase-1 activity is required to bypass apoptosis in favor of proinflammatory pyroptotic cell death.	[Puri, Aaron W.; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Broz, Petr; Monack, Denise M.; Bogyo, Matthew] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Shen, Aimee; Bogyo, Matthew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mbogyo@stanford.edu	Broz, Petr/AAC-7940-2019	Broz, Petr/0000-0002-2334-7790; Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412; Monack, Denise/0000-0003-3804-2209	US National Institutes of Health (NIH) grants [R01EB005011, R01AI088541]; US National Science Foundation Graduate Research Fellowship; Stanford Institute for Immunity, Transplantation and Infection Young Investigator Award; Swiss National Science Foundation and the Human Frontiers in Science Program; NIH grant [K99 GM092934]; Burroughs Wellcome Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088541, R01AI078947, R01AI095396, R01AI089722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092934] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Institute for Immunity, Transplantation and Infection Young Investigator Award; Swiss National Science Foundation and the Human Frontiers in Science Program; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bogyo and Monack labs for useful discussions and help with macrophage harvesting. We thank S. Lynch for help with NMR. We thank B. Van Raam for apoptosis marker protocols and S. Snipas and E. Deu for helpful discussions about kinetics. Caspases 3, 4, 6, 7 and 8 and substrates were provided by the Salvesen lab (Sanford Burnham Medical Research Institute); granzyme B and substrate was provided by the Craik lab (University of California-San Francisco), caspase-1-specific antibody was provided by P. Vandenabeele (VIB, Ghent University). This work was supported by US National Institutes of Health (NIH) grants R01EB005011 and R01AI088541 to M.B. A.W.P. was supported by an US National Science Foundation Graduate Research Fellowship. P.B. is supported by a Stanford Institute for Immunity, Transplantation and Infection Young Investigator Award and was supported by the Swiss National Science Foundation and the Human Frontiers in Science Program. A.S. is supported by the NIH grant K99 GM092934. M.B. and D.M.M. are supported by the Burroughs Wellcome Foundation.	Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Darzynkiewicz Z, 2007, CYTOM PART A, V71A, P536, DOI 10.1002/cyto.a.20425; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Motani K, 2011, J BIOL CHEM, V286, P33963, DOI 10.1074/jbc.M111.286823; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Puri AW, 2009, ACS CHEM BIOL, V4, P603, DOI 10.1021/cb9001409; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Wannamaker W, 2007, J PHARMACOL EXP THER, V321, P509, DOI 10.1124/jpet.106.111344; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	25	47	48	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					745	747		10.1038/NCHEMBIO.1023	http://dx.doi.org/10.1038/NCHEMBIO.1023			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22797665	Green Accepted			2022-12-25	WOS:000308077600004
J	Van Hoecke, A; Schoonaert, L; Lemmens, R; Timmers, M; Staats, KA; Laird, AS; Peeters, E; Philips, T; Goris, A; Dubois, B; Andersen, PM; Al-Chalabi, A; Thijs, V; Turnley, AM; van Vught, PW; Veldink, JH; Hardiman, O; Van Den Bosch, L; Gonzalez-Perez, P; Van Damme, P; Brown, RH; van den Berg, LH; Robberecht, W				Van Hoecke, Annelies; Schoonaert, Lies; Lemmens, Robin; Timmers, Mieke; Staats, Kim A.; Laird, Angela S.; Peeters, Elke; Philips, Thomas; Goris, An; Dubois, Benedicte; Andersen, Peter M.; Al-Chalabi, Ammar; Thijs, Vincent; Turnley, Ann M.; van Vught, Paul W.; Veldink, Jan H.; Hardiman, Orla; Van Den Bosch, Ludo; Gonzalez-Perez, Paloma; Van Damme, Philip; Brown, Robert H., Jr.; van den Berg, Leonard H.; Robberecht, Wim			EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans	NATURE MEDICINE			English	Article							GENE-EXPRESSION PROFILES; RECEPTOR TYROSINE KINASE; SPINAL-CORD; CORTICOSPINAL TRACT; SELECTIVE LOSS; MOTONEURON; ZEBRAFISH; BLOOD; SCHIZOPHRENIA; TDP-43	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons. Disease onset and progression are variable, with survival ranging from months to decades. Factors underlying this variability may represent targets for therapeutic intervention. Here, we have screened a zebrafish model of ALS and identified Epha4, a receptor in the ephrin axonal repellent system, as a modifier of the disease phenotype in fish, rodents and humans. Genetic as well as pharmacological inhibition of Epha4 signaling rescues the mutant SOD1 phenotype in zebrafish and increases survival in mouse and rat models of ALS. Motor neurons that are most vulnerable to degeneration in ALS express higher levels of Epha4, and neuromuscular re-innervation by axotomized motor neurons is inhibited by the presence of Epha4. In humans with ALS, EPHA4 expression inversely correlates with disease onset and survival, and loss-of-function mutations in EPHA4 are associated with long survival. Furthermore, we found that knockdown of Epha4 also rescues the axonopathy induced by expression of mutant TAR DNA-binding protein 43 (TDP-43), another protein causing familial ALS, and the axonopathy induced by knockdown of survival of motor neuron 1, a model for spinomuscular atrophy. This suggests that Epha4 generically modulates the vulnerability of (motor) neurons to axonal degeneration and may represent a new target for therapeutic intervention.	[Van Hoecke, Annelies; Schoonaert, Lies; Lemmens, Robin; Timmers, Mieke; Staats, Kim A.; Philips, Thomas; Thijs, Vincent; Van Den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] VIB, Vesalius Res Ctr, Neurobiol Lab, Louvain, Belgium; [Van Hoecke, Annelies; Schoonaert, Lies; Lemmens, Robin; Timmers, Mieke; Staats, Kim A.; Philips, Thomas; Thijs, Vincent; Van Den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] Univ Leuven KU Leuven, Expt Neurol & Leuven Res Inst Neurodegenerat Dis, Louvain, Belgium; [Lemmens, Robin; Peeters, Elke; Dubois, Benedicte; Thijs, Vincent; Van Damme, Philip; Robberecht, Wim] Katholieke Univ Leuven Hosp, Dept Neurol, Louvain, Belgium; [Laird, Angela S.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2006, Australia; [Goris, An; Dubois, Benedicte] Katholieke Univ Leuven, Lab Neuroimmunol, Expt Neurol, Louvain, Belgium; [Andersen, Peter M.] Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden; [Al-Chalabi, Ammar] Kings Coll London, Dept Clin Neurosci, MRC, Ctr Neurodegenerat Res, London WC2R 2LS, England; [Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [van Vught, Paul W.; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Hardiman, Orla] Trinity Coll Dublin, Sch Med, Sect Neurol, Dublin, Ireland; [Gonzalez-Perez, Paloma; Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; KU Leuven; Umea University; University of London; King's College London; University of Melbourne; Utrecht University; Utrecht University Medical Center; Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester	Robberecht, W (corresponding author), VIB, Vesalius Res Ctr, Neurobiol Lab, Louvain, Belgium.	wim.robberecht@vib-kuleuven.be	Thijs, Vincent/C-3647-2009; Hardiman, Orla/Y-3441-2019; Al-Chalabi, Ammar/E-5361-2010; Research Institute, ANZAC/CAE-9030-2022; Phillips, Thomas/AAG-3230-2021; Van Damme, Philip/A-6464-2009; Goris, An/L-5852-2019; Goris, An/F-2943-2010; Dubois, Benedicte/A-4338-2019	Thijs, Vincent/0000-0002-6614-8417; Hardiman, Orla/0000-0003-2610-1291; Al-Chalabi, Ammar/0000-0002-4924-7712; Phillips, Thomas/0000-0001-8936-6575; Van Damme, Philip/0000-0002-4010-2357; Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682; Veldink, Jan/0000-0001-5572-9657; Turnley, Ann/0000-0002-8442-127X; Dubois, Benedicte/0000-0003-0604-8702; Staats, Kim/0000-0001-8392-7992; Van Den Bosch, Ludo/0000-0003-0104-4067; Laird, Angela/0000-0002-6860-9192; Lemmens, Robin/0000-0002-4948-5956	Flanders Institute for Biotechnology (VIB); University of Leuven [GOA 11/014]; Life Sciences Research Partners, Research Foundation Flanders (FWO-Vlaanderen) [G.0695.10]; Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office [P7/16]; Robert Packard Center for ALS Research; Association Belge contre les Maladies Musculaires; ALS League Belgium; Thierry Latran Foundation; European Community [259867]; E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders at the University of Leuven; Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen); Research Fund KU Leuven; Alfonso Martin Escudero Foundation; UK National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London; King's College London; US National Institute for Neurological Disease and Stroke (NINDS) [5RO1-NS050557-05]; Angel Fund; ALS Association; Pierre L. de Bourgknecht ALS Research Foundation; ALS Therapy Alliance; Maudsley National Health Service (NHS) Foundation Trust; NINDS American Recovery and Reinvestment Act Award [RC2-NS070-342]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050557, RC2NS070342, R01NS079836] Funding Source: NIH RePORTER	Flanders Institute for Biotechnology (VIB); University of Leuven(KU Leuven); Life Sciences Research Partners, Research Foundation Flanders (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office; Robert Packard Center for ALS Research; Association Belge contre les Maladies Musculaires; ALS League Belgium; Thierry Latran Foundation; European Community(European Commission); E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders at the University of Leuven; Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Fund KU Leuven(KU Leuven); Alfonso Martin Escudero Foundation; UK National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London; King's College London(General Electric); US National Institute for Neurological Disease and Stroke (NINDS); Angel Fund; ALS Association; Pierre L. de Bourgknecht ALS Research Foundation; ALS Therapy Alliance; Maudsley National Health Service (NHS) Foundation Trust; NINDS American Recovery and Reinvestment Act Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by grants from the Flanders Institute for Biotechnology (VIB), the University of Leuven (GOA 11/014), Life Sciences Research Partners, Research Foundation Flanders (FWO-Vlaanderen; G.0695.10), the Interuniversity Attraction Poles program P7/16 of the Belgian Federal Science Policy Office, the Robert Packard Center for ALS Research, the Association Belge contre les Maladies Musculaires, the ALS League Belgium and the Thierry Latran Foundation. The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement number 259867. W.R. is supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders at the University of Leuven. A.V.H. is supported by the Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen). R.L., P.V.D., V.T. and B.D. hold a clinical investigatorship of FWO-Vlaanderen. R. L. is supported by Research Fund KU Leuven. P.G.-P. is supported by the Alfonso Martin Escudero Foundation. A.A.-C. receives salary support from the UK National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. R.H.B. Jr. is supported by the US National Institute for Neurological Disease and Stroke (NINDS) (5RO1-NS050557-05) and NINDS American Recovery and Reinvestment Act Award RC2-NS070-342 and acknowledges generous support from the Angel Fund, the ALS Association, P2ALS, Project ALS, the Pierre L. de Bourgknecht ALS Research Foundation and the ALS Therapy Alliance.	BAKELS R, 1993, J PHYSIOL-LONDON, V463, P307, DOI 10.1113/jphysiol.1993.sp019596; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; DeJesus Hernandez M., 2011, NEURON, V72, P245; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fogh I, 2007, NEUROGENETICS, V8, P235, DOI 10.1007/s10048-007-0092-2; Frey D, 2000, J NEUROSCI, V20, P2534; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; GARDINER PF, 1993, J NEUROPHYSIOL, V69, P1160, DOI 10.1152/jn.1993.69.4.1160; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Kim W, 2007, J CLIN NEUROL, V3, P38, DOI 10.3988/jcn.2007.3.1.38; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Penco S, 2011, J MOL NEUROSCI, V44, P25, DOI 10.1007/s12031-010-9480-4; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Xu QL, 1995, DEVELOPMENT, V121, P4005	38	200	208	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1418	+		10.1038/nm.2901	http://dx.doi.org/10.1038/nm.2901			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922411				2022-12-25	WOS:000308472300039
J	Saitsu, H; Nishimura, T; Muramatsu, K; Kodera, H; Kumada, S; Sugai, K; Kasai-Yoshida, E; Sawaura, N; Nishida, H; Hoshino, A; Ryujin, F; Yoshioka, S; Nishiyama, K; Kondo, Y; Tsurusaki, Y; Nakashima, M; Miyake, N; Arakawa, H; Kato, M; Mizushima, N; Matsumoto, N				Saitsu, Hirotomo; Nishimura, Taki; Muramatsu, Kazuhiro; Kodera, Hirofumi; Kumada, Satoko; Sugai, Kenji; Kasai-Yoshida, Emi; Sawaura, Noriko; Nishida, Hiroya; Hoshino, Ai; Ryujin, Fukiko; Yoshioka, Seiichiro; Nishiyama, Kiyomi; Kondo, Yukiko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Arakawa, Hirokazu; Kato, Mitsuhiro; Mizushima, Noboru; Matsumoto, Naomichi			De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood	NATURE GENETICS			English	Article							BRAIN IRON ACCUMULATION; PROTEIN FAMILY; BINDING-SITES; ATG PROTEINS; MICE; MECHANISMS; MITOPHAGY; PROPPINS; DISTINCT; DISEASE	Static encephalopathy of childhood with neurodegeneration in adulthood (SENDA) is a recently established subtype of neurodegeneration with brain iron accumulation (NBIA)(1-3). By exome sequencing, we found de novo heterozygous mutations in WDR45 at Xp11.23 in two individuals with SENDA, and three additional WDR45 mutations were identified in three other subjects by Sanger sequencing. Using lymphoblastoid cell lines (LCLs) derived from the subjects, aberrant splicing was confirmed in two, and protein expression was observed to be severely impaired in all five. WDR45 encodes WD-repeat domain 45 (WDR45). WDR45 (also known as WIP14) is one of the four mammalian homologs of yeast Atgl 8, which has an important role in autophagy(4,5). Lower autophagic activity and accumulation of aberrant early autophagic structures were demonstrated in the LCLs of the affected subjects. These findings provide direct evidence that an autophagy defect is indeed associated with a neurodegenerative disorder in humans.	[Saitsu, Hirotomo; Kodera, Hirofumi; Nishiyama, Kiyomi; Kondo, Yukiko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Nishimura, Taki; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Grad Sch, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Muramatsu, Kazuhiro; Sawaura, Noriko; Arakawa, Hirokazu] Gunma Univ, Dept Pediat, Grad Sch Med, Gunma, Japan; [Kumada, Satoko; Kasai-Yoshida, Emi] Tokyo Metropolitan Neurol Hosp, Dept Neuropediat, Tokyo, Japan; [Sugai, Kenji] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Nishida, Hiroya; Hoshino, Ai] Natl Rehabil Ctr Children Disabil, Dept Pediat, Tokyo, Japan; [Ryujin, Fukiko; Yoshioka, Seiichiro] Shiga Univ Med Sci, Dept Pediat, Shiga, Japan; [Kato, Mitsuhiro] Yamagata Univ, Dept Pediat, Fac Med, Yamagata 990, Japan	Yokohama City University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Gunma University; Tokyo Metropolitan Institute for Neuroscience; National Center for Neurology & Psychiatry - Japan; Shiga University of Medical Science; Yamagata University	Saitsu, H (corresponding author), Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	hsaitsu@yokohama-cu.ac.jp; nmizu@m.u-tokyo.ac.jp; naomat@yokohama-cu.ac.jp	Muramatsu, Kazuhiro/AAA-6350-2021; NISHIMURA, TAKI/I-6616-2018; Saitsu, Hirotomo/AAM-7131-2021; Mizushima, Noboru/C-3635-2009	Muramatsu, Kazuhiro/0000-0001-9256-5591; NISHIMURA, TAKI/0000-0003-4019-5984; Mizushima, Noboru/0000-0002-6258-6444; Tsurusaki, Yoshinori/0000-0002-7240-6355; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553				Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Kasai-Yoshida E, 2013, MOVEMENT DISORD, V28, P397, DOI 10.1002/mds.25158; Kimura Y, 2013, BRAIN DEV-JPN, V35, P458, DOI 10.1016/j.braindev.2012.07.008; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lu Q, 2011, DEV CELL, V21, P343, DOI 10.1016/j.devcel.2011.06.024; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schneider SA, 2012, SEMIN PEDIATR NEUROL, V19, P57, DOI 10.1016/j.spen.2012.03.005; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Watanabe Y, 2012, J BIOL CHEM, V287, P31681, DOI 10.1074/jbc.M112.397570; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	34	325	332	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2013	45	4					445	449		10.1038/ng.2562	http://dx.doi.org/10.1038/ng.2562			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435086				2022-12-25	WOS:000316840600017
J	Qiao, YL; Liu, L; Xiong, Q; Flores, C; Wong, J; Shi, JX; Wang, XB; Liu, XG; Xiang, QJ; Jiang, SS; Zhang, FC; Wang, YC; Judelson, HS; Chen, XM; Ma, WB				Qiao, Yongli; Liu, Lin; Xiong, Qin; Flores, Cristina; Wong, James; Shi, Jinxia; Wang, Xianbing; Liu, Xigang; Xiang, Qijun; Jiang, Shushu; Zhang, Fuchun; Wang, Yuanchao; Judelson, Howard S.; Chen, Xuemei; Ma, Wenbo			Oomycete pathogens encode RNA silencing suppressors	NATURE GENETICS			English	Article							EFFECTOR PROTEINS; PLANT; ARABIDOPSIS; GENOME; BIOGENESIS; MECHANISMS; MICRORNAS; SEQUENCES; DEFENSE; CELLS	Effectors are essential virulence proteins produced by a broad range of parasites, including viruses, bacteria, fungi, oomycetes, protozoa, insects and nematodes. Upon entry into host cells, pathogen effectors manipulate specific physiological processes or signaling pathways to subvert host immunity. Most effectors, especially those of eukaryotic pathogens, remain functionally uncharacterized. Here, we show that two effectors from the oomycete plant pathogen Phytophthora sojae suppress RNA silencing in plants by inhibiting the biogenesis of small RNAs. Ectopic expression of these Phytophthora suppressors of RNA silencing enhances plant susceptibility to both a virus and Phytophthora, showing that some eukaryotic pathogens have evolved virulence proteins that target host RNA silencing processes to promote infection. These findings identify RNA silencing suppression as a common strategy used by pathogens across kingdoms to cause disease and are consistent with RNA silencing having key roles in host defense.	[Qiao, Yongli; Flores, Cristina; Wong, James; Shi, Jinxia; Wang, Xianbing; Xiang, Qijun; Jiang, Shushu; Judelson, Howard S.; Ma, Wenbo] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Qiao, Yongli; Wong, James; Judelson, Howard S.; Chen, Xuemei; Ma, Wenbo] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Liu, Lin; Liu, Xigang; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Liu, Lin; Zhang, Fuchun] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Peoples R China; [Xiong, Qin; Wang, Yuanchao] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Chen, Xuemei] Univ Calif Riverside, Howard Hughes Med Inst, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Xinjiang University; Nanjing Agricultural University; Howard Hughes Medical Institute; University of California System; University of California Riverside	Ma, WB (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	wenbo.ma@ucr.edu	Wang, Xianbing/E-4831-2013; Xiong, Qin/AAH-8836-2020; wang, yuanchao/G-9667-2011	Xiong, Qin/0000-0003-2033-5062; wang, yuanchao/0000-0001-5803-5343; Chen, Xuemei/0000-0002-5209-1157; Wang, Xian-Bing/0000-0003-3082-2462	University of California, Riverside; National Science Foundation (NSF) grant [IOS-0847870]; US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2010-04209, 2008-00694]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	University of California, Riverside(University of California System); National Science Foundation (NSF) grant(National Science Foundation (NSF)); US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Tyler (Oregon State University) for providing soybean seeds and ten effector clones. S. Kamoun (The Sainsbury Laboratory) and M. Coffey (University of California, Riverside) kindly provided pGR106 and P. sojae strain P6497, respectively. We are indebted to S.-W Ding for sharing viral suppressor constructs and thoughtful input. This work was supported by funds from the University of California, Riverside, to W.M. and X.C., National Science Foundation (NSF) grant IOS-0847870 to W.M. and US Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) grants 2010-04209 and 2008-00694 to X.C. and H.S.J., respectively. L.L. was supported by a fellowship from the China Scholarship Council.	Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brosnan CA, 2011, CURR OPIN PLANT BIOL, V14, P580, DOI 10.1016/j.pbi.2011.07.011; Chen XM, 2002, DEVELOPMENT, V129, P1085; Chen XM, 2010, PLANT J, V61, P941, DOI 10.1111/j.1365-313X.2009.04089.x; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haldar K, 2006, NAT REV MICROBIOL, V4, P922, DOI 10.1038/nrmicro1549; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Ren GD, 2012, P NATL ACAD SCI USA, V109, P12817, DOI 10.1073/pnas.1204915109; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	25	168	183	5	224	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					330	333		10.1038/ng.2525	http://dx.doi.org/10.1038/ng.2525			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23377181	Green Accepted			2022-12-25	WOS:000315664800021
J	Twigg, SRF; Vorgia, E; McGowan, SJ; Peraki, I; Fenwick, AL; Sharma, VP; Allegra, M; Zaragkoulias, A; Akha, ES; Knight, SJL; Lord, H; Lester, T; Izatt, L; Lampe, AK; Mohammed, SN; Stewart, FJ; Verloes, A; Wilson, LC; Healy, C; Sharpe, PT; Hammond, P; Hughes, J; Taylor, S; Johnson, D; Wall, SA; Mavrothalassitis, G; Wilkie, AOM				Twigg, Stephen R. F.; Vorgia, Elena; McGowan, Simon J.; Peraki, Ioanna; Fenwick, Aimee L.; Sharma, Vikram P.; Allegra, Maryline; Zaragkoulias, Andreas; Akha, Elham Sadighi; Knight, Samantha J. L.; Lord, Helen; Lester, Tracy; Izatt, Louise; Lampe, Anne K.; Mohammed, Shehla N.; Stewart, Fiona J.; Verloes, Alain; Wilson, Louise C.; Healy, Chris; Sharpe, Paul T.; Hammond, Peter; Hughes, Jim; Taylor, Stephen; Johnson, David; Wall, Steven A.; Mavrothalassitis, George; Wilkie, Andrew O. M.			Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REPRESSOR ERF; CLEIDOCRANIAL DYSPLASIA; CANCER CELLS; SKULL VAULT; MOUSE MODEL; DIFFERENTIATION; PROLIFERATION; INHIBITION; MUTATIONS; PROTEIN	The extracellular signal related kinases 1 and 2 (ERK1/2) are key proteins mediating mitogen-activated protein kinase signaling downstream of RAS: phosphorylation of ERK1/2 leads to nuclear uptake and modulation of multiple targets(1). Here, we show that reduced dosage of ERF, which encodes an inhibitory ETS transcription factor directly bound by ERK1/2 (refs. 2-7), causes complex craniosynostosis (premature fusion of the cranial sutures) in humans and mice. Features of this newly recognized clinical disorder include multiple-suture synostosis, craniofacial dysmorphism, Chiari malformation and language delay. Mice with functional Erf levels reduced to similar to 30% of normal exhibit postnatal multiple-suture synostosis; by contrast, embryonic calvarial development appears mildly delayed. Using chromatin immunoprecipitation in mouse embryonic fibroblasts and high-throughput sequencing, we find that ERF binds preferentially to elements away from promoters that contain RUNX or AP-1 motifs. This work identifies ERF as a novel regulator of osteogenic stimulation by RAS-ERK signaling, potentially by competing with activating ETS factors in multifactor transcriptional complexes.	[Twigg, Stephen R. F.; Fenwick, Aimee L.; Sharma, Vikram P.; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford, England; [Vorgia, Elena; Peraki, Ioanna; Allegra, Maryline; Mavrothalassitis, George] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Vorgia, Elena; Peraki, Ioanna; Zaragkoulias, Andreas; Mavrothalassitis, George] Univ Crete, Sch Med, Iraklion, Greece; [McGowan, Simon J.; Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England; [Sharma, Vikram P.; Johnson, David; Wall, Steven A.; Wilkie, Andrew O. M.] Oxford Univ Hosp Natl Hlth Serv NHS Trust, Craniofacial Unit, Oxford, England; [Akha, Elham Sadighi; Knight, Samantha J. L.] NIHR, Biomed Res Ctr, Oxford, England; [Akha, Elham Sadighi; Knight, Samantha J. L.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lord, Helen; Lester, Tracy] Oxford Univ Hosp NHS Trust, Mol Genet Lab, Oxford, England; [Izatt, Louise; Mohammed, Shehla N.] Guys & St Thomas NHS Fdn Trust, London, England; [Lampe, Anne K.] NHS Lothian, South East Scotland Clin Genet Serv, Edinburgh, Midlothian, Scotland; [Stewart, Fiona J.] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast BT9 7AD, Antrim, North Ireland; [Verloes, Alain] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France; [Wilson, Louise C.] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Healy, Chris; Sharpe, Paul T.] Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [Hammond, Peter] UCL, Inst Child Hlth, Mol Med Unit, London, England; [Hughes, Jim] Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford, England	University of Oxford; Foundation for Research & Technology - Hellas (FORTH); University of Crete; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Belfast City Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of Oxford	Mavrothalassitis, G (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.	mavro@imbb.forth.gr; awilkie@hammer.imm.ox.ac.uk	/AAK-8500-2021; Wilkie, Andrew/AAC-3820-2020; Twigg, Stephen/AAU-1135-2021; VERLOES, Alain/E-7287-2014	Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X; VERLOES, Alain/0000-0003-4819-0264; Zaragkoulias, Andreas/0000-0002-2290-0128; Jones, Aimee/0000-0003-0279-1814; McGowan, Simon/0000-0001-9720-1914; Knight, Samantha/0000-0002-6047-3462; Sharpe, Paul/0000-0003-2116-9561	Greek Ministry of Education [PYTHAGORAS II KA2092, PENED 03ED626, HERAKLEITOS II KA 3396, SYNERGASIA 09SYN-11-902]; NIHR Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres funding scheme; Oxford Craniofacial Unit Charitable Fund; Department of Health, UK, Quality, Improvement, Development and Initiative Scheme (QIDIS) (YES); Wellcome Trust [090532, 093329]; MRC [G0901599] Funding Source: UKRI; Medical Research Council [G0901599, MR/J006742/1] Funding Source: researchfish	Greek Ministry of Education(Greek Ministry of Development-GSRT); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Oxford Craniofacial Unit Charitable Fund; Department of Health, UK, Quality, Improvement, Development and Initiative Scheme (QIDIS) (YES); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Boehm, H. Care, C. Langman, J. Phipps and E. Sweeney for clinical assistance, L. Gregory, P. Piazza and staff at the High-Throughput Genomics facility at the Wellcome Trust Centre for Human Genetics for exome sequencing, C. Babbs, S. Butler, J. Frankland, C. Rode and T. Rostron for technical help, K. Kourouniotis for blastocyst injections and expert animal support, E. Giannoulatou for bioinformatics assistance, and B. Graves and P. Hollenhorst for discussions. We thank J. Heath (University of Birmingham), G. Schwabe (Charite University Hospital) and D. Rice (University of Helsinki) for the gifts of the Spp1, Runx2 and Bglap2 probes, respectively. This work was funded by the Greek Ministry of Education grants PYTHAGORAS II KA2092, PENED 03ED626, HERAKLEITOS II KA 3396 and SYNERGASIA 09SYN-11-902 to G.M., the NIHR Biomedical Research Centre, with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme (S.J.L.K. and A.O.M.W.), the Oxford Craniofacial Unit Charitable Fund (V.P.S.), the Department of Health, UK, Quality, Improvement, Development and Initiative Scheme (QIDIS) (YES.) and the Wellcome Trust (090532, S.J.L.K.; 093329, S.R.F.T. and A.O.M.W.). The views expressed in this publication are those of the authors and not necessarily those of the Department of Health, UK.	Allegra M, 2012, MOL BIOL CELL, V23, P3873, DOI 10.1091/mbc.E12-04-0276; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Hammond P, 2012, HUM MUTAT, V33, P817, DOI 10.1002/humu.22054; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Iseki S, 1999, DEVELOPMENT, V126, P5611; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Lajeunie E, 2006, EUR J HUM GENET, V14, P289, DOI 10.1038/sj.ejhg.5201558; Le Gallic L, 2004, MOL CELL BIOL, V24, P1206, DOI 10.1128/MCB.24.3.1206-1218.2004; Le Gallic L, 1999, MOL CELL BIOL, V19, P4121; Little GH, 2012, NUCLEIC ACIDS RES, V40, P3538, DOI 10.1093/nar/gkr1219; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; MAVROTHALASSITIS GJ, 1991, CELL GROWTH DIFFER, V2, P215; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Papadaki C, 2007, MOL CELL BIOL, V27, P5201, DOI 10.1128/MCB.02237-06; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Polychronopoulos S, 2006, J BIOL CHEM, V281, P25601, DOI 10.1074/jbc.M605185200; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Sumarsono SH, 1996, NATURE, V379, P534, DOI 10.1038/379534a0; Varvagiannis K, 2013, AM J MED GENET A, V161A, P343, DOI 10.1002/ajmg.a.35727; Vary CPH, 2000, EXP CELL RES, V257, P213, DOI 10.1006/excr.2000.4879; Verykokakis M, 2007, J BIOL CHEM, V282, P30285, DOI 10.1074/jbc.M704428200; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491	42	102	107	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					308	313		10.1038/ng.2539	http://dx.doi.org/10.1038/ng.2539			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23354439	Green Accepted			2022-12-25	WOS:000315664800017
J	Birsoy, K; Wang, T; Possemato, R; Yilmaz, OH; Koch, CE; Chen, WW; Hutchins, AW; Gultekin, Y; Peterson, TR; Carette, JE; Brummelkamp, TR; Clish, CB; Sabatini, DM				Birsoy, Kivanc; Wang, Tim; Possemato, Richard; Yilmaz, Omer H.; Koch, Catherine E.; Chen, Walter W.; Hutchins, Amanda W.; Gultekin, Yetis; Peterson, Tim R.; Carette, Jan E.; Brummelkamp, Thijn R.; Clish, Clary B.; Sabatini, David M.			MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors	NATURE GENETICS			English	Article							ENERGY BLOCKER 3-BROMOPYRUVATE; SITE-DIRECTED REAGENT; ANTICANCER AGENT; PYRUVATE-KINASE; CANCER-CELLS; MONOCARBOXYLATE TRANSPORTERS; METABOLISM; BROMOPYRUVATE; INACTIVATION; INHIBITION	There is increasing evidence that oncogenic transformation modifies the metabolic program of cells. A common alteration is the upregulation of glycolysis, and efforts to target glycolytic enzymes for anticancer therapy are under way. Here, we performed a genome-wide haploid genetic screen to identify resistance mechanisms to 3-bromopyruvate (3-BrPA), a drug candidate that inhibits glycolysis in a poorly understood fashion. We identified the SLC16A1 gene product, MCT1, as the main determinant of 3-BrPA sensitivity. MCT1 is necessary and sufficient for 3-BrPA uptake by cancer cells. Additionally, SLC16A1 mRNA levels are the best predictor of 3-BrPA sensitivity and are most elevated in glycolytic cancer cells. Furthermore, forced MCT1 expression in 3-BrPA-resistant cancer cells sensitizes tumor xenografts to 3-BrPA treatment in vivo. Our results identify a potential biomarker for 3-BrPA sensitivity and provide proof of concept that the selectivity of cancer-expressed transporters can be exploited for delivering toxic molecules to tumors.	[Birsoy, Kivanc; Wang, Tim; Possemato, Richard; Yilmaz, Omer H.; Koch, Catherine E.; Chen, Walter W.; Hutchins, Amanda W.; Gultekin, Yetis; Peterson, Tim R.; Carette, Jan E.; Brummelkamp, Thijn R.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Wang, Tim; Possemato, Richard; Yilmaz, Omer H.; Koch, Catherine E.; Chen, Walter W.; Hutchins, Amanda W.; Gultekin, Yetis; Peterson, Tim R.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA USA; [Birsoy, Kivanc; Wang, Tim; Possemato, Richard; Yilmaz, Omer H.; Chen, Walter W.; Hutchins, Amanda W.; Gultekin, Yetis; Peterson, Tim R.; Clish, Clary B.; Sabatini, David M.] Broad Inst, Cambridge, MA USA; [Birsoy, Kivanc; Wang, Tim; Possemato, Richard; Yilmaz, Omer H.; Chen, Walter W.; Hutchins, Amanda W.; Gultekin, Yetis; Peterson, Tim R.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Clish, Clary B/ABB-9374-2021; Gultekin, Yetis/H-4194-2013; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Chen, Walter/0000-0002-7752-9581; /0000-0002-1446-7256; Carette, Jan/0000-0002-5187-8070; Gultekin, Yetis/0000-0003-0103-351X; Wang, Timothy/0000-0001-5730-3019; Possemato, Richard/0000-0002-2401-0030	US National Institutes of Health (NIH) [CA103866]; David H. Koch Institute for Integrative Cancer Research; Jane Coffin Childs Memorial Fund; US National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG045144] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David H. Koch Institute for Integrative Cancer Research; Jane Coffin Childs Memorial Fund; US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Sabatini laboratory and F. Reinhardt for advice and assistance. This work was supported by grants from the US National Institutes of Health (NIH; CA103866) and the David H. Koch Institute for Integrative Cancer Research to D. M. S. and fellowships from the Jane Coffin Childs Memorial Fund to K. B. and US National Science Foundation to T. W. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Acan NL, 2001, J ENZYM INHIB, V16, P457, DOI 10.1080/14756360109162395; ARENDT T, 1990, J NEUROCHEM, V55, P1474, DOI 10.1111/j.1471-4159.1990.tb04928.x; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; BLESSINGER KJ, 1992, BIOCHEM CELL BIOL, V70, P716, DOI 10.1139/o92-109; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dell'Antone P, 2006, LIFE SCI, V79, P2049, DOI 10.1016/j.lfs.2006.06.043; Dell'Antone P, 2009, MED CHEM, V5, P491, DOI 10.2174/157340609790170551; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Ganapathy-Kanniappan S, 2009, ANTICANCER RES, V29, P4909; GOTHE PO, 1972, FEBS LETT, V21, P159, DOI 10.1016/0014-5793(72)80127-3; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Gupta N, 2005, BBA-MOL BASIS DIS, V1741, P215, DOI 10.1016/j.bbadis.2005.04.002; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Jardim-Messeder D, 2012, INT J BIOCHEM CELL B, V44, P801, DOI 10.1016/j.biocel.2012.02.002; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Ko YH, 2012, J BIOENERG BIOMEMBR, V44, P163, DOI 10.1007/s10863-012-9417-4; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; Layton Judith E., 2009, V546, P31, DOI 10.1007/978-1-60327-977-2_3; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Lis P, 2012, J BIOENERG BIOMEMBR, V44, P155, DOI 10.1007/s10863-012-9421-8; Mathupala SP, 2004, NEUROSURGERY, V55, P1410, DOI 10.1227/01.NEU.0000143034.62913.59; MELOCHE HP, 1972, J BIOL CHEM, V247, P4186; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; Pedersen PL, 2012, J BIOENERG BIOMEMBR, V44, P1, DOI 10.1007/s10863-012-9425-4; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; da Silva APP, 2009, BIOCHEM J, V417, P717, DOI 10.1042/BJ20080805; Pinheiro C, 2008, VIRCHOWS ARCH, V452, P139, DOI 10.1007/s00428-007-0558-5; Pinheiro C, 2010, HISTOPATHOLOGY, V56, P860, DOI 10.1111/j.1365-2559.2010.03560.x; Pinheiro C, 2009, DIS MARKERS, V26, P97, DOI [10.3233/DMA-2009-0596, 10.1155/2009/169678]; Poole RC, 1997, J BIOL CHEM, V272, P14624, DOI 10.1074/jbc.272.23.14624; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Queiros O, 2012, J BIOENERG BIOMEMBR, V44, P141, DOI 10.1007/s10863-012-9418-3; Rodrigues-Ferreira C, 2012, J BIOENERG BIOMEMBR, V44, P39, DOI 10.1007/s10863-012-9413-8; SANBORN BM, 1971, BIOCHIM BIOPHYS ACTA, V227, P219, DOI 10.1016/0005-2744(71)90055-6; Shoshan MC, 2012, J BIOENERG BIOMEMBR, V44, P7, DOI 10.1007/s10863-012-9419-2; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thangaraju M, 2009, CANCER, V115, P4655, DOI 10.1002/cncr.24532; Thompson CB, 2011, COLD SH Q B, V76, P23, DOI 10.1101/sqb.2012.76.010496; TUNNICLIFF G, 1978, INT J BIOCHEM, V9, P249, DOI 10.1016/0020-711X(78)90006-X; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; WARBURG O, 1956, SCIENCE, V124, P269; Wood TE, 2008, MOL CANCER THER, V7, P3546, DOI 10.1158/1535-7163.MCT-08-0569; Xu RH, 2005, CANCER RES, V65, P613; YUN SL, 1979, J BIOL CHEM, V254, P1811	57	180	190	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2013	45	1					104	U149		10.1038/ng.2471	http://dx.doi.org/10.1038/ng.2471			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202129	Green Accepted, Green Submitted			2022-12-25	WOS:000312838800021
J	Love, C; Sun, Z; Jima, D; Li, GJ; Zhang, J; Miles, R; Richards, KL; Dunphy, CH; Choi, WWL; Srivastava, G; Lugar, PL; Rizzieri, DA; Lagoo, AS; Bernal-Mizrachi, L; Mann, KP; Flowers, CR; Naresh, KN; Evens, AM; Chadburn, A; Gordon, LI; Czader, MB; Gill, JI; Hsi, ED; Greenough, A; Moffitt, AB; McKinney, M; Banerjee, A; Grubor, V; Levy, S; Dunson, DB; Dave, SS				Love, Cassandra; Sun, Zhen; Jima, Dereje; Li, Guojie; Zhang, Jenny; Miles, Rodney; Richards, Kristy L.; Dunphy, Cherie H.; Choi, William W. L.; Srivastava, Gopesh; Lugar, Patricia L.; Rizzieri, David A.; Lagoo, Anand S.; Bernal-Mizrachi, Leon; Mann, Karen P.; Flowers, Christopher R.; Naresh, Kikkeri N.; Evens, Andrew M.; Chadburn, Amy; Gordon, Leo I.; Czader, Magdalena B.; Gill, Javed I.; Hsi, Eric D.; Greenough, Adrienne; Moffitt, Andrea B.; McKinney, Matthew; Banerjee, Anjishnu; Grubor, Vladimir; Levy, Shawn; Dunson, David B.; Dave, Sandeep S.			The genetic landscape of mutations in Burkitt lymphoma	NATURE GENETICS			English	Article							C-MYC ONCOGENE; SOMATIC MUTATIONS; GENOME; CANCER; EXPRESSION; AMPLIFICATION; FREQUENT; REVEALS	Burkitt lymphoma is characterized by deregulation of MYC, but the contribution of other genetic mutations to the disease is largely unknown. Here, we describe the first completely sequenced genome from a Burkitt lymphoma tumor and germline DNA from the same affected individual. We further sequenced the exomes of 59 Burkitt lymphoma tumors and compared them to sequenced exomes from 94 diffuse large B-cell lymphoma (DLBCL) tumors. We identified 70 genes that were recurrently mutated in Burkitt lymphomas, including ID3, GNA13, RET, PIK3R1 and the SWI/SNF genes ARID1A and SMARCA4. Our data implicate a number of genes in cancer for the first time, including CCT6B, SALL3, FTCD and PC. ID3 mutations occurred in 34% of Burkitt lymphomas and not in DLBCLs. We show experimentally that ID3 mutations promote cell cycle progression and proliferation. Our work thus elucidates commonly occurring gene-coding mutations in Burkitt lymphoma and implicates ID3 as a new tumor suppressor gene.	[Love, Cassandra; Sun, Zhen; Jima, Dereje; Li, Guojie; Zhang, Jenny; Greenough, Adrienne; Moffitt, Andrea B.; McKinney, Matthew; Grubor, Vladimir; Dave, Sandeep S.] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA; [Miles, Rodney] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Richards, Kristy L.; Dunphy, Cherie H.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Choi, William W. L.; Srivastava, Gopesh] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lugar, Patricia L.; Rizzieri, David A.; Lagoo, Anand S.; McKinney, Matthew; Dave, Sandeep S.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Lugar, Patricia L.; Rizzieri, David A.; Lagoo, Anand S.; McKinney, Matthew; Dave, Sandeep S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Bernal-Mizrachi, Leon; Mann, Karen P.; Flowers, Christopher R.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Naresh, Kikkeri N.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Evens, Andrew M.] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; [Chadburn, Amy; Gordon, Leo I.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Czader, Magdalena B.] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46204 USA; [Gill, Javed I.] Baylor Univ, Med Ctr, Dept Hematol, Dallas, TX USA; [Hsi, Eric D.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Banerjee, Anjishnu; Dunson, David B.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Levy, Shawn] Hudson Alpha Inst Biotechnol, Huntsville, AL USA	Duke University; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; University of Hong Kong; Duke University; Duke University; Emory University; Imperial College London; University of Massachusetts System; University of Massachusetts Worcester; Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Baylor University; Baylor University Medical Center; Cleveland Clinic Foundation; Duke University	Dave, SS (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA.	sandeep.dave@duke.edu	Zhang, Jenny/GXV-4980-2022; Flowers, Christopher R/F-1953-2010	Flowers, Christopher R/0000-0002-9524-3990; Naresh, Kikkeri N/0000-0003-3807-3638; Gordon, Leo/0000-0003-1666-7064; Evens, Andrew/0000-0002-6900-1824; Jima, Dereje/0000-0002-7784-1612; Levy, Shawn/0000-0002-1369-5740; Nugent, Adrienne/0000-0002-1818-2098; Moffitt, Andrea/0000-0001-5964-7851	Hertz Foundation; National Cancer Institute [R21CA1561686, R01CA136895]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA136895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	Hertz Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Sunay and the Georgia Cancer Coalition for support in sample collection. A.B.M. was supported by the Hertz Foundation. This work was supported through grants R21CA1561686 and R01CA136895 from the National Cancer Institute (S.S.D.). S.S.D. was also supported by the American Cancer Society. We gratefully acknowledge the generous support of C. Stiefel and D. Stiefel.	Augenlicht LH, 1997, CANCER RES, V57, P1769; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; MUNZEL P, 1991, J CANCER RES CLIN, V117, P603, DOI 10.1007/BF01613296; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Schiffman JD, 2011, BRIT J HAEMATOL, V155, P477, DOI 10.1111/j.1365-2141.2011.08883.x; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow E., 2008, WHO CLASSIFICATION T; Wang ZR, 1999, EXP MOL PATHOL, V66, P140, DOI 10.1006/exmp.1999.2259; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	26	395	406	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1321	1325		10.1038/ng.2468	http://dx.doi.org/10.1038/ng.2468			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143597	Green Accepted, Green Submitted			2022-12-25	WOS:000311713200009
J	Jwa, M; Chang, P				Jwa, Miri; Chang, Paul			PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1 alpha-mediated unfolded protein response	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; MAMMALIAN-CELLS; ER MEMBRANE; POLY(ADP-RIBOSE); KINASE; DNA	Poly(ADP-ribose) polymerases (PARPs; also known as ADP-ribosyl transferase D proteins) modify acceptor proteins with ADP-ribose modifications of varying length (reviewed in refs 1-3). PARPs regulate key stress response pathways, including DNA damage repair and the cytoplasmic stress response(2-6). Here, we show that PARPs also regulate the unfolded protein response (UPR) of the endoplasmic reticulum (ER). Human PARP16 (also known as ARTD15) is a tail-anchored ER transmembrane protein required for activation of the functionally related ER stress sensors PERK and IRE1 alpha during the UPR. The third identified ER stress sensor, ATF6, is not regulated by PARP16. As is the case for other PARPs that function during stress, the enzymatic activity of PARP16 is upregulated during ER stress when it ADP-ribosylates itself, PERK and IRE1 alpha. ADP-ribosylation by PARP16 is sufficient for activating PERK and IRE1 alpha in the absence of ER stress, and is required for PERK and IRE1 alpha activation during the UPR. Modification of PERK and IRE1 alpha by PARP16 increases their kinase activities and the endonuclease activity of IRE1 alpha. Interestingly, the carboxy-terminal luminal tail of PARP16 is required for PARP16 function during ER stress, suggesting that it transduces stress signals to the cytoplasmic PARP catalytic domain.	[Jwa, Miri; Chang, Paul] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chang, Paul] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chang, P (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pchang2@mit.edu			Cancer Center Support [P30-CA14051]; National Institutes of Health [5R01GM087465-02]; Curt and Kathy Marble; Jeptha H. and Emily V. Wade Fund; Ludwig fund for Cancer Research fellowship; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087465] Funding Source: NIH RePORTER	Cancer Center Support; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Curt and Kathy Marble; Jeptha H. and Emily V. Wade Fund; Ludwig fund for Cancer Research fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Borgese (University of Milan, Italy) for sharing reagents; T. Sangpo for technical assistance; and T. Jacks, H. Lodish, H. Ploegh, U. L. RajBhandary and M. Chesarone-Cataldo for comments on the manuscript. P.C. is a Rita Allen Foundation Scholar, a Kimmel Foundation for Cancer Research Scholar, and was a Howard S. and Linda B. Stern Career Development assistant professor. This work is partially financially supported by Cancer Center Support (core grant P30-CA14051), grant 5R01GM087465-02 from the National Institutes of Health (P.C.), Curt and Kathy Marble, the Jeptha H. and Emily V. Wade Fund (P.C.) and the Ludwig fund for Cancer Research fellowship (M.J.).	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; MENISSIERDEMURCIA J, 1989, J MOL BIOL, V210, P229, DOI 10.1016/0022-2836(89)90302-1; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	27	142	152	4	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1223	+		10.1038/ncb2593	http://dx.doi.org/10.1038/ncb2593			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23103912	Green Submitted, Green Accepted			2022-12-25	WOS:000310778100015
J	Mack, NA; Porter, AP; Whalley, HJ; Schwarz, JP; Jones, RC; Khaja, ASS; Bjartell, A; Anderson, KI; Malliri, A				Mack, Natalie A.; Porter, Andrew P.; Whalley, Helen J.; Schwarz, Juliane P.; Jones, Richard C.; Khaja, Azharuddin Sajid Syed; Bjartell, Anders; Anderson, Kurt I.; Malliri, Angeliki			beta 2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RHO-FAMILY GTPASES; ACTIVATOR TIAM1; EPITHELIAL-CELLS; TIGHT JUNCTIONS; PDZ DOMAIN; PROSTATE-CANCER; PROGNOSTIC RELEVANCE; POLARITY COMPLEX; GENE-EXPRESSION	Although Rac and its activator Tiam1 are known to stimulate cell-cell adhesion, the mechanisms regulating their activity in cell-cell junction formation are poorly understood. Here, we identify beta 2-syntrophin as a Tiam1 interactor required for optimal cell-cell adhesion. We show that during tight-junction (TJ) assembly beta 2-syntrophin promotes Tiam1-Rac activity, in contrast to the function of the apical determinant Par-3 whose inhibition of Tiam1-Rac activity is necessary for TJ assembly. We further demonstrate that beta 2-syntrophin localizes more basally than Par-3 at cell-cell junctions, thus generating an apicobasal Rac activity gradient at developing cell-cell junctions. Targeting active Rac to TJs shows that this gradient is required for optimal TJ assembly and apical lumen formation. Consistently, beta 2-syntrophin depletion perturbs Tiam1 and Rac localization at cell-cell junctions and causes defects in apical lumen formation. We conclude that beta 2-syntrophin and Par-3 fine-tune Rac activity along cell-cell junctions controlling TJ assembly and the establishment of apicobasal polariy.	[Mack, Natalie A.; Porter, Andrew P.; Whalley, Helen J.; Malliri, Angeliki] Univ Manchester, Canc Res UK Paterson Inst Canc Res, Cell Signalling Grp, Manchester M20 4BX, Lancs, England; [Schwarz, Juliane P.; Anderson, Kurt I.] Canc Res UK Beatson Inst Canc Res, Tumour Cell Migrat Grp, Glasgow G61 1BD, Lanark, Scotland; [Jones, Richard C.] MS Bioworks, Ann Arbor, MI 48108 USA; [Khaja, Azharuddin Sajid Syed; Bjartell, Anders] Lund Univ, Skane Univ Hosp, Div Urol Canc, Dept Clin Sci, SE-20502 Malmo, Sweden	Cancer Research UK; University of Manchester; Beatson Institute; Lund University; Skane University Hospital	Malliri, A (corresponding author), Univ Manchester, Canc Res UK Paterson Inst Canc Res, Cell Signalling Grp, Manchester M20 4BX, Lancs, England.	amalliri@picr.man.ac.uk	Syed Khaja, Azharuddin Sajid/AAF-2693-2021; Porter, Andrew/GWU-8628-2022	Syed Khaja, Azharuddin Sajid/0000-0003-1594-1826; Porter, Andrew/0000-0002-3353-7002; Anderson, Kurt/0000-0002-9324-9598	Cancer Research UK [C147/A6058]; Medical Research Council [MR/J00104X/1]; MRC [MR/J00104X/1] Funding Source: UKRI; Cancer Research UK [12937, 15565] Funding Source: researchfish; Worldwide Cancer Research [12-0037] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by Cancer Research UK grant number C147/A6058 and Medical Research Council grant number MR/J00104X/1.We thank colleagues mentioned in the Methods for providing reagents; E. Nilsson for immunohistochemical stainings; S. Bagley and A. Dunne for help with microscopy and image analysis; C. O'Neill, M. Balda, S. Ohno and V. Braga for technical advice; A. Hurlstone, I. Hagan, D. Garrod, J. Brognardand members of the Cell Signalling Group for helpful discussions and critical reading of the manuscript.	Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Bertazzi DT, 2011, J CELL BIOL, V193, P1033, DOI 10.1083/jcb.201101056; Brennan K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/460607; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Dahlman A, 2011, MODERN PATHOL, V24, P708, DOI 10.1038/modpathol.2010.238; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Ding Y, 2009, INT J CANCER, V124, P653, DOI 10.1002/ijc.23954; Engers R, 2007, ENDOCR-RELAT CANCER, V14, P245, DOI 10.1677/ERC-06-0036; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Feigin ME, 2009, CURR OPIN CELL BIOL, V21, P694, DOI 10.1016/j.ceb.2009.07.003; Ferrari A, 2008, J CELL SCI, V121, P3649, DOI 10.1242/jcs.018648; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Gee SH, 1998, J BIOL CHEM, V273, P21980, DOI 10.1074/jbc.273.34.21980; Georgiou M, 2010, J CELL SCI, V123, P1089, DOI 10.1242/jcs.060772; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Hamelers IHL, 2005, J CELL BIOL, V171, P871, DOI 10.1083/jcb.200509172; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Khaja ASS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026539; Kobayashi T, 2010, MOL ENDOCRINOL, V24, P722, DOI 10.1210/me.2009-0326; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lane Jane, 2008, Int Semin Surg Oncol, V5, P23, DOI 10.1186/1477-7800-5-23; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Li Y, 2007, ONCOGENE, V26, P6220, DOI 10.1038/sj.onc.1210432; Liu L, 2005, WORLD J GASTROENTERO, V11, P705, DOI 10.3748/wjg.v11.i5.705; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Masuda-Hirata M, 2009, GENES CELLS, V14, P835, DOI 10.1111/j.1365-2443.2009.01315.x; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Otsuki Y, 2003, J BIOL CHEM, V278, P5132, DOI 10.1074/jbc.M206733200; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Qi HW, 2001, CELL GROWTH DIFFER, V12, P603; Qi Y, 2009, ORL-J OTO-RHIN-LARYN, V71, P163, DOI 10.1159/000223440; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Schluter MA, 2009, J AM SOC NEPHROL, V20, P1444, DOI 10.1681/ASN.2008090949; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Stafford RL, 2011, J MOL BIOL, V412, P3, DOI 10.1016/j.jmb.2011.07.005; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Tassidis H, 2010, INT J CANCER, V126, P2296, DOI 10.1002/ijc.24917; Timpson P, 2011, CANCER RES, V71, P747, DOI 10.1158/0008-5472.CAN-10-2267; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Woodcock SA, 2010, CURR BIOL, V20, P669, DOI 10.1016/j.cub.2010.02.033; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Yagi S., 2012, EMBO REP; Yang W., 2010, JPN J CLIN ONCOL; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhao L., 2010, J CANC RES CLIN ONCO; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	68	40	41	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1169	+		10.1038/ncb2608	http://dx.doi.org/10.1038/ncb2608			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23103911	Green Accepted			2022-12-25	WOS:000310778100010
J	Okoro, CK; Kingsley, RA; Connor, TR; Harris, SR; Parry, CM; Al-Mashhadani, MN; Kariuki, S; Msefula, CL; Gordon, MA; de Pinna, E; Wain, J; Heyderman, RS; Obaro, S; Alonso, PL; Mandomando, I; MacLennan, CA; Tapia, MD; Levine, MM; Tennant, SM; Parkhill, J; Dougan, G				Okoro, Chinyere K.; Kingsley, Robert A.; Connor, Thomas R.; Harris, Simon R.; Parry, Christopher M.; Al-Mashhadani, Manar N.; Kariuki, Samuel; Msefula, Chisomo L.; Gordon, Melita A.; de Pinna, Elizabeth; Wain, John; Heyderman, Robert S.; Obaro, Stephen; Alonso, Pedro L.; Mandomando, Inacio; MacLennan, Calman A.; Tapia, Milagritos D.; Levine, Myron M.; Tennant, Sharon M.; Parkhill, Julian; Dougan, Gordon			Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa	NATURE GENETICS			English	Article							NON-TYPHOIDAL SALMONELLA; NONTYPHOIDAL SALMONELLA; POPULATION-GENETICS; INFECTION; CHILDREN; BACTEREMIA; EVOLUTION; SEROVARS; HIV-1; ADULTS	A highly invasive form of non-typhoidal Salmonella (iNTS) disease has recently been documented in many countries in sub-Saharan Africa. The most common Salmonella enterica serovar causing this disease is Typhimurium (Salmonella Typhimurium). We applied whole-genome sequence-based phylogenetic methods to define the population structure of sub-Saharan African invasive Salmonella Typhimurium isolates and compared these to global Salmonella Typhimurium populations. Notably, the vast majority of sub-Saharan invasive Salmonella Typhimurium isolates fell within two closely related, highly clustered phylogenetic lineages that we estimate emerged independently similar to 52 and similar to 35 years ago in close temporal association with the current HIV pandemic. Clonal replacement of isolates from lineage I by those from lineage II was potentially influenced by the use of chloramphenicol for the treatment of iNTS disease. Our analysis suggests that iNTS disease is in part an epidemic in sub-Saharan Africa caused by highly related Salmonella Typhimurium lineages that may have occupied new niches associated with a compromised human population and antibiotic treatment.	[Okoro, Chinyere K.; Kingsley, Robert A.; Connor, Thomas R.; Harris, Simon R.; Parkhill, Julian; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Parry, Christopher M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Parry, Christopher M.; Al-Mashhadani, Manar N.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Kariuki, Samuel] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Msefula, Chisomo L.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Msefula, Chisomo L.] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Gordon, Melita A.] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [de Pinna, Elizabeth; Wain, John] Ctr Infect, Lab Gastrointestinal Infect, Hlth Protect Agcy, London, England; [Wain, John] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Heyderman, Robert S.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Obaro, Stephen] Michigan State Univ, Dept Paediat & Human Dev, Div Paediat Infect Dis, E Lansing, MI 48824 USA; [Obaro, Stephen] Natl Hosp Abuja, Dept Pediat, Garki Abuja, Nigeria; [Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Alonso, Pedro L.; Mandomando, Inacio] CISM, Manhica, Mozambique; [Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth NVGH, Siena, Italy; [MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Ctr Immune Regulat,MRC, Birmingham, W Midlands, England; [Tapia, Milagritos D.; Levine, Myron M.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Levine, Myron M.; Tennant, Sharon M.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA	Wellcome Trust Sanger Institute; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Liverpool; Kenya Medical Research Institute; University of Malawi; University of Malawi; University of Liverpool; Health Protection Agency; University of East Anglia; University of Bristol; Michigan State University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; University of Birmingham; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Dougan, G (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	gd1@sanger.ac.uk	Wain, John/B-3446-2013; Mandomando, Inacio/ABD-8007-2020; MacLennan, Calman A/L-9343-2014; Alonso, Pedro L/AAZ-3645-2020; Harris, Simon R/K-1318-2013; Parkhill, Julian/G-4703-2011; Msefula, Chisomo/AAY-9107-2020; Connor, Thomas/ABD-6533-2021; Connor, Thomas/ABE-5989-2020; Gordon, Melita/F-5563-2012	Wain, John/0000-0002-1257-1148; Mandomando, Inacio/0000-0002-1078-2187; MacLennan, Calman A/0000-0001-9694-0846; Alonso, Pedro L/0000-0003-3292-3443; Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; Connor, Thomas/0000-0003-2394-6504; Gordon, Melita/0000-0002-0629-0884; Kingsley, Robert/0000-0002-0194-6485; Heyderman, Robert/0000-0003-4573-449X; Okoro, Chinyere/0000-0002-2466-304X; Msefula, Chisomo/0000-0003-2304-886X	Wellcome Trust [098051]; Wellcome Trust; GlaxoSmithKline; Medical Research Council [G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Cheesborough for providing the DRC isolates, M. Okong, N. French and the Medical Research Council, Uganda, for providing the Uganda isolates, S. Nair for providing the Health Protection Agency (HPA) isolates, L. Barquist for modeling the pre-1990 HIV prevalence data and the Sequencing team at the Wellcome Trust Sanger Institute. This work was funded by a Wellcome Trust grant (098051). C.A.M. was supported by a Tropical Research Fellowship from the Wellcome Trust and a Clinical Research Fellowship from GlaxoSmithKline.	BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Beyene G, 2011, J INFECT DEV COUNTR, V5, P23, DOI 10.3855/jidc.906; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Cheesbrough JS, 1997, PEDIATR INFECT DIS J, V16, P277, DOI 10.1097/00006454-199703000-00005; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; den Bakker HC, 2010, APPL ENVIRON MICROB, V76, P6085, DOI 10.1128/AEM.00447-10; Dione MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001148; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; GANGAROSA EJ, 1972, J INFECT DIS, V126, P215, DOI 10.1093/infdis/126.2.215; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Keddy KH, 2009, J INFECT DEV COUNTR, V3, P585, DOI 10.3855/jidc.549; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Langridge GC, 2009, J INFECT DIS, V199, P602, DOI 10.1086/596208; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; LEVINE WC, 1991, J INFECT DIS, V164, P81, DOI 10.1093/infdis/164.1.81; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; NAHMIAS AJ, 1986, LANCET, V1, P1279; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Rosanova Maria Teresa, 2002, International Journal of Infectious Diseases, V6, P187, DOI 10.1016/S1201-9712(02)90109-8; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Sharp ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021135; Sibhat B, 2011, ZOONOSES PUBLIC HLTH, V58, P102, DOI 10.1111/j.1863-2378.2009.01305.x; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SMITH PD, 1985, ANN INTERN MED, V102, P207, DOI 10.7326/0003-4819-102-2-207; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	51	260	263	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1215	1221		10.1038/ng.2423	http://dx.doi.org/10.1038/ng.2423			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23023330	Bronze, Green Accepted			2022-12-25	WOS:000310495800012
J	Shen, BZ; Sun, XG; Zuo, X; Shilling, T; Apgar, J; Ross, M; Bougri, O; Samoylov, V; Parker, M; Hancock, E; Lucero, H; Gray, B; Ekborg, NA; Zhang, DC; Johnson, JCS; Lazar, G; Raab, RM				Shen, Binzhang; Sun, Xueguang; Zuo, Xiao; Shilling, Taran; Apgar, James; Ross, Mary; Bougri, Oleg; Samoylov, Vladimir; Parker, Matthew; Hancock, Elaina; Lucero, Hector; Gray, Benjamin; Ekborg, Nathan A.; Zhang, Dongcheng; Johnson, Jeremy C. Schley; Lazar, Gabor; Raab, R. Michael			Engineering a thermoregulated intein-modified xylanase into maize for consolidated lignocellulosic biomass processing	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-STRUCTURE; TRANSGENIC MAIZE; SWISS-MODEL; IN-VITRO; ZEA-MAYS; MYCOBACTERIUM-TUBERCULOSIS; AGROBACTERIUM-TUMEFACIENS; STRUCTURE PREDICTION; SCREENING SYSTEM; RECA INTEIN	Plant cellulosic biomass is an abundant, low-cost feedstock for producing biofuels and chemicals. Expressing cell wall-degrading (CWD) enzymes (e.g. xylanases) in plant feedstocks could reduce the amount of enzymes required for feedstock pretreatment and hydrolysis during bioprocessing to release soluble sugars. However, in planta expression of xylanases can reduce biomass yield and plant fertility. To overcome this problem, we engineered a thermostable xylanase (XynB) with a thermostable self-splicing bacterial intein to control the xylanase activity. Intein-modified XynB (iXynB) variants were selected that have < 10% wild-type enzymatic activity but recover > 60% enzymatic activity upon intein self-splicing at temperatures > 59 degrees C. Greenhouse-grown xynB maize expressing XynB has shriveled seeds and low fertility, but ixynB maize had normal seeds and fertility. Processing dried ixynB maize stover by temperature-regulated xylanase activation and hydrolysis in a cocktail of commercial CWD enzymes produced > 90% theoretical glucose and > 63% theoretical xylose yields.	[Shen, Binzhang; Sun, Xueguang; Zuo, Xiao; Shilling, Taran; Apgar, James; Ross, Mary; Bougri, Oleg; Samoylov, Vladimir; Parker, Matthew; Hancock, Elaina; Lucero, Hector; Gray, Benjamin; Ekborg, Nathan A.; Zhang, Dongcheng; Johnson, Jeremy C. Schley; Lazar, Gabor; Raab, R. Michael] Agrivida Inc, Medford, MA USA		Raab, RM (corresponding author), Agrivida Inc, Medford, MA USA.	rmraab@agrivida.com		Apgar, James/0000-0002-4669-0188				Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berrondo M, 2008, STRUCTURE, V16, P513, DOI 10.1016/j.str.2008.01.012; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Chin HG, 2003, P NATL ACAD SCI USA, V100, P4510, DOI 10.1073/pnas.0736538100; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; Evanko D, 2007, NAT METHODS, V4, P112, DOI 10.1038/nmeth0207-112a; Gangopadhyay JP, 2003, ANAL CHEM, V75, P2456, DOI 10.1021/ac020756b; Gangopadhyay JP, 2003, BBA-GEN SUBJECTS, V1619, P193, DOI 10.1016/S0304-4165(02)00495-6; Gils M, 2008, PLANT BIOTECHNOL J, V6, P226, DOI 10.1111/j.1467-7652.2007.00318.x; Gray BN, 2011, PLANT BIOTECHNOL J, V9, P1100, DOI 10.1111/j.1467-7652.2011.00632.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harholt J, 2010, PLANT BIOTECHNOL J, V8, P351, DOI 10.1111/j.1467-7652.2009.00490.x; Harrison MD, 2011, PLANT BIOTECHNOL J, V9, P884, DOI 10.1111/j.1467-7652.2011.00597.x; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hood EE, 2003, PLANT BIOTECHNOL J, V1, P129, DOI 10.1046/j.1467-7652.2003.00014.x; Hood EE, 2007, PLANT BIOTECHNOL J, V5, P709, DOI 10.1111/j.1467-7652.2007.00275.x; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Jensen LG, 1996, P NATL ACAD SCI USA, V93, P3487, DOI 10.1073/pnas.93.8.3487; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Kempe Katja, 2009, Plant Biotechnol J, V7, P283, DOI 10.1111/j.1467-7652.2008.00399.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Krause P. F., 1997, TEC0099 US ARM CORPS; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leber J., 2010, NY TIMES; Lew BM, 2002, GENE, V282, P169, DOI 10.1016/S0378-1119(01)00836-8; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; McCarthy AA, 2000, ACTA CRYSTALLOGR D, V56, P1367, DOI 10.1107/S0907444900009896; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; ROGERS JC, 1985, J BIOL CHEM, V260, P3731; Rohl CA, 2005, METHOD ENZYMOL, V394, P244, DOI 10.1016/S0076-6879(05)94009-3; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; Sivamani E, 2006, PLANT MOL BIOL, V60, P225, DOI 10.1007/s11103-005-3853-z; Southworth MW, 1996, P NATL ACAD SCI USA, V93, P5281, DOI 10.1073/pnas.93.11.5281; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zhang D, 2011, BIOENERG RES, V4, P276, DOI 10.1007/s12155-011-9138-2	59	60	65	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1131	+		10.1038/nbt.2402	http://dx.doi.org/10.1038/nbt.2402			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23086202				2022-12-25	WOS:000311087500033
J	Idris, NM; Gnanasammandhan, MK; Zhang, J; Ho, PC; Mahendran, R; Zhang, Y				Idris, Niagara Muhammad; Gnanasammandhan, Muthu Kumara; Zhang, Jing; Ho, Paul C.; Mahendran, Ratha; Zhang, Yong			In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers	NATURE MEDICINE			English	Article							PHOTOSENSITIZERS; DELIVERY; CELLS; VITRO; DRUG	Conventional photodynamic therapy (PDT) is limited by the penetration depth of visible light needed for its activation. Here we used mesoporous-silica-coated upconversion fluorescent nanoparticles (UCNs) as a nanotransducer to convert deeply penetrating near-infrared light to visible wavelengths and a carrier of photosensitizers. We also used the multicolor-emission capability of the UCNs at a single excitation wavelength for simultaneous activation of two photosensitizers for enhanced PDT. We showed a greater PDT efficacy with the dual-photosensitizer approach compared to approaches using a single photosensitizer, as determined by enhanced generation of singlet oxygen and reduced cell viability. In vivo studies also showed tumor growth inhibition in PDT-treated mice by direct injection of UCNs into melanoma tumors or intravenous injection of UCNs conjugated with a tumor-targeting agent into tumor-bearing mice. As the first demonstration, to the best of our knowledge, of the photosensitizer-loaded UCN as an in vivo-targeted PDT agent, this finding may serve as a platform for future noninvasive deep-cancer therapy.	[Idris, Niagara Muhammad; Gnanasammandhan, Muthu Kumara; Zhang, Yong] Natl Univ Singapore, Fac Engn, Dept Bioengn, Singapore 117548, Singapore; [Zhang, Jing; Ho, Paul C.] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore; [Mahendran, Ratha] Natl Univ Singapore, Fac Med, Dept Surg, Singapore 117548, Singapore; [Zhang, Yong] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore; [Zhang, Yong] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Zhang, Y (corresponding author), Natl Univ Singapore, Fac Engn, Dept Bioengn, Singapore 117548, Singapore.	biezy@nus.edu.sg	Mahendran, Ratha/B-3827-2012; Jayakumar, Muthu kumara Gnanasammandhan/G-4965-2016; Ho, Paul C/O-9652-2014; Zhang, Yong/F-2803-2010	Jayakumar, Muthu kumara Gnanasammandhan/0000-0003-2524-9104; Ho, Paul C/0000-0001-9213-7116; Zhang, Yong/0000-0002-1303-0458; Muhammad Idris, Niagara/0000-0002-9722-1410	Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) Biomedical Research Council [R-397-000-062-305, R-397-000-119-305]; National University of Singapore	Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) Biomedical Research Council; National University of Singapore(National University of Singapore)	We thank Z.Q. Li, A. Priyam and C. X. Li (Department of Bioengineering, Faculty of Engineering, National University of Singapore) for synthesis of the nanoparticles and S. Rajan for technical support in preparing the schematic illustration. We also acknowledge financial support from the Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) Biomedical Research Council (grants R-397-000-062-305 and R-397-000-119-305) and National University of Singapore.	Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g; Chatteriee DK, 2008, BIOMATERIALS, V29, P937, DOI 10.1016/j.biomaterials.2007.10.051; Chatterjee DK, 2008, NANOMEDICINE-UK, V3, P73, DOI 10.2217/17435889.3.1.73; Cheng LA, 2011, J PHYS CHEM C, V115, P2686, DOI 10.1021/jp111006z; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gao D, 2006, NANO LETT, V6, P2383, DOI 10.1021/nl0617179; Guo H, 2009, OPT MATER, V31, P583, DOI 10.1016/j.optmat.2008.06.011; Guo HC, 2010, NANOMED-NANOTECHNOL, V6, P486, DOI 10.1016/j.nano.2009.11.004; Heer S, 2004, ADV MATER, V16, P2102, DOI 10.1002/adma.200400772; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; Joensen J, 2011, PHOTOMED LASER SURG, V29, P145, DOI 10.1089/pho.2010.2793; Kim S, 2007, J AM CHEM SOC, V129, P2669, DOI 10.1021/ja0680257; Konan YN, 2002, J PHOTOCH PHOTOBIO B, V66, P89, DOI 10.1016/S1011-1344(01)00267-6; Kuznetsova NA, 2001, RUSS J GEN CHEM+, V71, P36, DOI 10.1023/A:1012369120376; Laser Institute of America, 2000, Z13612000 ANSI LAS I; Li X, 2011, INT J NANOMED, V6, P1167, DOI 10.2147/IJN.S21445; Li ZQ, 2006, ANGEW CHEM INT EDIT, V45, P7732, DOI 10.1002/anie.200602975; Li ZQ, 2008, ADV MATER, V20, P4765, DOI 10.1002/adma.200801056; Mohapatra S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/38/385102; Nyk M, 2008, NANO LETT, V8, P3834, DOI 10.1021/nl802223f; Prasad P. N., 2003, INTRO BIOPHOTONICS; Qian HS, 2009, SMALL, V5, P2285, DOI 10.1002/smll.200900692; Wang C, 2011, BIOMATERIALS, V32, P1110, DOI 10.1016/j.biomaterials.2010.09.069; Wang M, 2009, J PHYS CHEM C, V113, P19021, DOI 10.1021/jp906394z; Xiong LQ, 2009, BIOMATERIALS, V30, P5592, DOI 10.1016/j.biomaterials.2009.06.015; Xiong LQ, 2009, ANAL CHEM, V81, P8687, DOI 10.1021/ac901960d; Zhang P, 2007, J AM CHEM SOC, V129, P4526, DOI 10.1021/ja0700707	27	1102	1139	32	1316	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1580	U190		10.1038/nm.2933	http://dx.doi.org/10.1038/nm.2933			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22983397				2022-12-25	WOS:000309587500038
J	Wolgemuth, DJ; Griswold, MD; Grimes, DA				Wolgemuth, Debra J.; Griswold, Michael D.; Grimes, David A.			Parsing the potential of a new male contraceptive	NATURE MEDICINE			English	Editorial Material							ACID RECEPTOR-ALPHA; 1ST BROMODOMAIN; SPERMATOGENESIS; TESTIS; EXPRESSION; BRDT; MICE	In contrast to the range of contraceptives available to women, contraceptive options for men are limited to condoms or a vasectomy-thus, a pharmacological, reversible method of male contraception has been a long-standing quest in medicine. Spermatogenic-specific proteins have been pursued as potential targets, and the bromodomain and extraterminal (BET) family member BRDT has come to attention in two recent studies(1,2). Matzuk et al.(2) have now described the effects of a small-molecule inhibitor of the BET family, JQ1, as a contraceptive in male mice. They showed that JQ1 can inhibit BRDT and is also able to cross the blood-testis barrier. JQ1 treatment had a complete contraceptive effect, and importantly, when JQ1 administration was stopped, the mice could recover spermatogenesis with no obvious effects on their testes or on their offspring. We asked three experts to comment on the results of this study and their implications.							NICHD NIH HHS [U01 HD060479] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060479] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Berkovits BD, 2011, DEV BIOL, V360, P358, DOI 10.1016/j.ydbio.2011.10.005; Chung SSW, 2011, ENDOCRINOLOGY, V152, P2492, DOI 10.1210/en.2010-0941; Chung SSW, 2009, DEVELOPMENT, V136, P2091, DOI 10.1242/dev.020040; Fox M., 2012, NBC NEWS        0816; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Goodman A., 2008, TIME; Grimes DA, 2012, COCHRANE DB SYST REV, V3; Lopez LM, 2005, OBSTET GYNECOL SURV, V60, P746, DOI 10.1097/01.ogx.0000182905.71077.13; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Skoogh J, 2011, INT J ANDROL, V34, P183, DOI 10.1111/j.1365-2605.2010.01073.x	15	2	3	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1466	1467		10.1038/nm.2970	http://dx.doi.org/10.1038/nm.2970			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042348				2022-12-25	WOS:000309587500017
J	Ban, L; Pettit, N; Li, L; Stuparu, AD; Cai, L; Chen, WL; Guan, WY; Han, WQ; Wang, PG; Mrksich, M				Ban, Lan; Pettit, Nicholas; Li, Lei; Stuparu, Andreea D.; Cai, Li; Chen, Wenlan; Guan, Wanyi; Han, Weiqing; Wang, Peng George; Mrksich, Milan			Discovery of glycosyltransferases using carbohydrate arrays and mass spectrometry	NATURE CHEMICAL BIOLOGY			English	Article							SELF-ASSEMBLED MONOLAYERS; GLYCAN MICROARRAYS; ESCHERICHIA-COLI; ENZYME-ACTIVITY; GALACTOSYLTRANSFERASE; SIALYLTRANSFERASE; GLYCOSYLATION; MECHANISMS; EXPRESSION; LIBRARIES	Glycosyltransferases catalyze the reaction between an activated sugar donor and an acceptor to form a new glycosidic linkage. Glycosyltransferases are responsible for the assembly of oligosaccharides in vivo and are also important for the in vitro synthesis of these biomolecules. However, the functional identification and characterization of new glycosyltransferases is difficult and tedious. This paper describes an approach that combines arrays of reactions on an immobilized array of acceptors with an analysis by mass spectrometry to screen putative glycosyltransferases. A total of 14,280 combinations of a glycosyltransferase, an acceptor and a donor in four buffer conditions were screened, leading to the identification and characterization of four new glycosyltransferases. This work is notable because it provides a label-free method for the rapid functional annotation of putative enzymes.	[Ban, Lan; Stuparu, Andreea D.; Mrksich, Milan] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Ban, Lan; Stuparu, Andreea D.; Mrksich, Milan] Northwestern Univ, Dept Chem, Evanston, IL USA; [Pettit, Nicholas; Cai, Li; Chen, Wenlan; Guan, Wanyi] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Pettit, Nicholas; Cai, Li; Chen, Wenlan; Guan, Wanyi] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Li, Lei; Guan, Wanyi] Shandong Univ, Natl Glycoengn Res Ctr, Jinan, Shandong, Peoples R China; [Li, Lei; Guan, Wanyi] Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China; [Li, Lei; Han, Weiqing; Wang, Peng George] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Han, Weiqing; Wang, Peng George] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Mrksich, Milan] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Shandong University; Shandong University; Nankai University; Nankai University; Northwestern University	Wang, PG (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	pwang@nankai.edu; milan.mrksich@northwestern.edu	Mrksich, Milan/G-2469-2011; Cai, Li/A-2214-2012; Guan, Wanyi/D-8421-2014; WANG, Peng/GSN-5263-2022	Cai, Li/0000-0002-6098-1168; Guan, Wanyi/0000-0002-5982-5512; Mrksich, Milan/0000-0002-4964-796X	National Science Foundation [EEC-01180205]; US National Institutes of Health [P50 GM086145]; Defense Advanced Research Projects Agency [FA 9550-08-1-0221]; National Basic Research Program of China (973 Program) [2012CB822100, 2012CB910300]; China Scholarship Council [2007102057]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM086145, R01GM085267] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.M. acknowledges the National Science Foundation (EEC-01180205), US National Institutes of Health (P50 GM086145) and Defense Advanced Research Projects Agency (FA 9550-08-1-0221), and P.G.W. acknowledges the National Basic Research Program of China (973 Program, no. 2012CB822100 and no. 2012CB910300) for financial support. L.L. acknowledges support from the China Scholarship Council (2007102057). We thank J. Modica for assistance with synthesis. We thank Z.-J. Liu (Institute of Biophysics of the Chinese Academy of Sciences) for providing the vector pMCSG7.	Aharoni A, 2006, NAT METHODS, V3, P609, DOI 10.1038/NMETH899; Ban L, 2008, ANGEW CHEM INT EDIT, V47, P3396, DOI 10.1002/anie.200704998; BELLA A, 1977, BIOCHEM J, V167, P621, DOI 10.1042/bj1670621; Blixt O, 1999, GLYCOBIOLOGY, V9, P1061, DOI 10.1093/glycob/9.10.1061; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chang SH, 2010, J AM CHEM SOC, V132, P13371, DOI 10.1021/ja1046523; Cleland W W, 1979, Methods Enzymol, V63, P103; Fang JW, 1998, J AM CHEM SOC, V120, P6635, DOI 10.1021/ja9808898; Guan WY, 2011, BIOORG MED CHEM LETT, V21, P5025, DOI 10.1016/j.bmcl.2011.04.100; Gurard-Levin ZA, 2011, ACS COMB SCI, V13, P347, DOI 10.1021/co2000373; Houseman BT, 2002, CHEM BIOL, V9, P443, DOI 10.1016/S1074-5521(02)00124-2; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Kosik O, 2010, GLYCOCONJUGATE J, V27, P79, DOI 10.1007/s10719-009-9271-8; Laurent N, 2008, CHEMBIOCHEM, V9, P883, DOI 10.1002/cbic.200700692; Leskovac, 2003, COMPREHENSIVE ENZYME; Li M, 2008, BIOCHEMISTRY-US, V47, P378, DOI 10.1021/bi701345v; Min DH, 2004, ANGEW CHEM INT EDIT, V43, P5973, DOI 10.1002/anie.200461061; Min DH, 2004, ANAL CHEM, V76, P3923, DOI 10.1021/ac049816z; Mrksich M, 2008, ACS NANO, V2, P7, DOI 10.1021/nn7004156; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PALCIC M M, 1991, Glycobiology, V1, P205, DOI 10.1093/glycob/1.2.205; Park S, 2007, ORG LETT, V9, P1675, DOI 10.1021/ol070250l; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sanchez-Ruiz A, 2011, ANGEW CHEM INT EDIT, V50, P1801, DOI 10.1002/anie.201006304; Su J, 2002, ANGEW CHEM INT EDIT, V41, P4715, DOI 10.1002/anie.200290026; Yi W, 2008, J AM CHEM SOC, V130, P14420, DOI 10.1021/ja805844y; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690	31	91	96	2	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					769	773		10.1038/NCHEMBIO.1022	http://dx.doi.org/10.1038/NCHEMBIO.1022			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22820418	Green Accepted			2022-12-25	WOS:000308077600008
J	Chan, MM; Smith, ZD; Egli, D; Regev, A; Meissner, A				Chan, Michelle M.; Smith, Zachary D.; Egli, Dieter; Regev, Aviv; Meissner, Alexander			Mouse ooplasm confers context-specific reprogramming capacity	NATURE GENETICS			English	Article							MAMMALIAN DEVELOPMENT; DNA METHYLATION; 5-HYDROXYMETHYLCYTOSINE; OOCYTES; ZYGOTES; GENOME	Enucleated oocytes have the distinctive ability to reprogram somatic nuclei back to totipotency. Here, we investigate genome-scale DNA methylation patterns after nuclear transfer and compare them to the dynamics at fertilization. We identify specific targets for DNA demethylation after nuclear transfer, such as germline-associated promoters, as well as unique limitations that include certain repetitive element classes.	[Chan, Michelle M.; Smith, Zachary D.; Regev, Aviv; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chan, Michelle M.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Egli, Dieter] New York Stem Cell Fdn Lab, New York, NY USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; The New York Stem Cell Foundation; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu			New York Stem Cell Foundation (NYSCF); US National Institutes of Health (NIH) Pioneer Award [5DP1OD003958]; National Human Genome Research Institute (NHGRI) Centers of Excellence in Genomic Science (CEGS) grant [1P50HG006193]; Burroughs Wellcome Career Award at the Scientific Interface; Howard Hughes Medical Institute (HHMI); Pew Charitable Trusts; Human Frontiers Science Program; NIH [1P50HG006193, U01ES017155, P01GM099117]; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	New York Stem Cell Foundation (NYSCF); US National Institutes of Health (NIH) Pioneer Award; National Human Genome Research Institute (NHGRI) Centers of Excellence in Genomic Science (CEGS) grant; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Pew Charitable Trusts; Human Frontiers Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank all the members of the Meissner and Regev laboratories. We thank M. Garber, N. Yosef, J. Ye, R. Koche, H. Gu, A. Gnirke and T. Mikkelsen for technical advice and discussion and all members of the Broad Sequencing Platform, in particular, F. Kelley, J. Meldrim, T. Fennel, K. Tibbetts and J. Fostel. We also thank S. Levine, M. Gravina and K. Thai from the MIT BioMicro Center. D.E. is supported by the New York Stem Cell Foundation (NYSCF). A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute and is supported by a US National Institutes of Health (NIH) Pioneer Award (5DP1OD003958), a National Human Genome Research Institute (NHGRI) Centers of Excellence in Genomic Science (CEGS) grant (1P50HG006193), the Burroughs Wellcome Career Award at the Scientific Interface and the Howard Hughes Medical Institute (HHMI). A.M. is supported by the Pew Charitable Trusts, the Human Frontiers Science Program and the NIH (U01ES017155, P01GM099117 and 1P50HG006193).	Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Polanski Z, 2008, INT J DEV BIOL, V52, P295, DOI 10.1387/ijdb.072347zp; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80	15	52	60	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					978	980		10.1038/ng.2382	http://dx.doi.org/10.1038/ng.2382			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22902786	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000308491200008
J	Nabel, CS; Jia, HJ; Ye, Y; Shen, L; Goldschmidt, HL; Stivers, JT; Zhang, Y; Kohli, RM				Nabel, Christopher S.; Jia, Huijue; Ye, Yu; Shen, Li; Goldschmidt, Hana L.; Stivers, James T.; Zhang, Yi; Kohli, Rahul M.			AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation	NATURE CHEMICAL BIOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; THYMINE DNA; TET PROTEINS; SOMATIC HYPERMUTATION; MAMMALIAN DNA; GLYCOSYLASE; AID; 5-METHYLCYTOSINE; METHYLATION	Activation-induced deaminase (AID)/APOBEC-family cytosine deaminases, known to function in diverse cellular processes from antibody diversification to mRNA editing, have also been implicated in DNA demethylation, a major process for transcriptional activation. Although oxidation-dependent pathways for demethylation have been described, pathways involving deamination of either 5-methylcytosine (5mC) or 5-hydroxymethylcytosine (5hmC) have emerged as alternatives. Here we address the biochemical plausibility of deamination-coupled demethylation. We found that purified AID/APOBECs have substantially reduced activity on 5mC relative to cytosine, their canonical substrate, and no detectable deamination of 5hmC. This finding was explained by the reactivity of a series of modified substrates, where steric bulk was increasingly detrimental to deamination. Further, upon AID/APOBEC overexpression, the deamination product of 5hmC was undetectable in genomic DNA, whereas oxidation intermediates remained detectable. Our results indicate that the steric requirements for cytosine deamination are one intrinsic barrier to the proposed function of deaminases in DNA demethylation.	[Nabel, Christopher S.; Kohli, Rahul M.] Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Nabel, Christopher S.; Kohli, Rahul M.] Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Jia, Huijue; Shen, Li; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC USA; [Ye, Yu; Goldschmidt, Hana L.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Kohli, RM (corresponding author), Univ Penn, Raymond & Ruth Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	yi_zhang@med.unc.edu; rkohli@upenn.edu	Jia, Huijue/M-3991-2015	Jia, Huijue/0000-0002-3592-126X; Goldschmidt, Hana L./0000-0002-5676-366X; Kohli, Rahul/0000-0002-7689-5678; Zhang, Yi/0000-0002-2789-0811	Rita Allen Foundation; W.W. Smith Charitable Trust; US National Institutes of Health [K08-AI089242, GM056834, U01DK089565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER	Rita Allen Foundation; W.W. Smith Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Bartolomei, M. Weitzman and M. Lazar for helpful discussions, K. Gajula and S. Manning for technical assistance and the University of North Carolina Biomarker Mass Spectrometry Facility for guidance. We are also grateful for A. Drohat (University of Maryland), A. Guminski (Johns Hopkins University) and J. Guo and H. Song (Johns Hopkins University) for providing reagents. This work was supported in part by the Rita Allen Foundation (to R.M.K.), the W.W. Smith Charitable Trust (to R.M.K.) and US National Institutes of Health grants K08-AI089242 (to R.M.K.), GM056834 (to J.T.S.) and U01DK089565 (to Y.Z.). Y.Z. is an investigator of the Howard Hughes Medical Institute.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Grogan BC, 2011, BIOCHEMISTRY-US, V50, P618, DOI 10.1021/bi102046h; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2011, PHILOS T R SOC B, V366, P2266, DOI 10.1098/rstb.2011.0042; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Larijani M, 2005, IMMUNOGENETICS, V56, P840, DOI 10.1007/s00251-004-0748-0; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teperek-Tkacz M, 2011, REPRODUCTION, V142, P621, DOI 10.1530/REP-11-0148; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]	45	232	238	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					751	758		10.1038/NCHEMBIO.1042	http://dx.doi.org/10.1038/NCHEMBIO.1042			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22772155	Green Accepted, Green Submitted			2022-12-25	WOS:000308077600006
J	Dolgin, E				Dolgin, Elie			First therapy targeting Parkinson's proteins enters clinical trials	NATURE MEDICINE			English	News Item																		2005, NEURON, V46, P857	1	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					992	993		10.1038/nm0712-992b	http://dx.doi.org/10.1038/nm0712-992b			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772533				2022-12-25	WOS:000306121600006
J	Avalos, JL; Fink, GR; Stephanopoulos, G				Avalos, Jose L.; Fink, Gerald R.; Stephanopoulos, Gregory			Compartmentalization of metabolic pathways in yeast mitochondria improves the production of branched-chain alcohols	NATURE BIOTECHNOLOGY			English	Article							INCREASED ISOBUTANOL PRODUCTION; SACCHAROMYCES-CEREVISIAE; EHRLICH PATHWAY; ACID SYNTHESIS; COENZYME-Q; GENE; BIOGENESIS; BIOSYNTHESIS; LOCALIZATION; SYNTHASE	Efforts to improve the production of a compound of interest in Saccharomyces cerevisiae have mainly involved engineering or overexpression of cytoplasmic enzymes. We show that targeting metabolic pathways to mitochondria can increase production compared with overexpression of the enzymes involved in the same pathways in the cytoplasm. Compartmentalization of the Ehrlich pathway into mitochondria increased isobutanol production by 260%, whereas overexpression of the same pathway in the cytoplasm only improved yields by 10%, compared with a strain overproducing enzymes involved in only the first three steps of the biosynthetic pathway. Subcellular fractionation of engineered strains revealed that targeting the enzymes of the Ehrlich pathway to the mitochondria achieves greater local enzyme concentrations. Other benefits of compartmentalization may include increased availability of intermediates, removing the need to transport intermediates out of the mitochondrion and reducing the loss of intermediates to competing pathways.	[Avalos, Jose L.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Avalos, Jose L.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; gregstep@mit.edu		Avalos, Jose L./0000-0002-7209-4208	US National Institutes of Health under Ruth L. Kirchstein National Research Service Award [1F32GM098022-01A1]; National Institutes of Health [GM040266]; Shell Global Solutions (US) Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085323, R01GM035010, F32GM098022, R01GM040266] Funding Source: NIH RePORTER	US National Institutes of Health under Ruth L. Kirchstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shell Global Solutions (US) Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K.L. Jones Prather and T.D. Fox for helpful discussions, T.J. Helbig for working on GFP subcellular localization experiments, T. DiCesare for preparing figures, S. Lindquist (Whitehead Institute) for strain Y3929, and members of the Stephanopoulos, Fink and Prather laboratories for discussions and advice. J.L.A. is supported by US National Institutes of Health under Ruth L. Kirchstein National Research Service Award 1F32GM098022-01A1. G.R.F. is supported by National Institutes of Health grant GM040266. This work was supported by Shell Global Solutions (US) Inc.	Anthony LC, 2010, US Patent, Patent No. [2010/0129886, 20100129886, US 2010/0129886 A1]; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Blombach Bastian, 2011, Bioeng Bugs, V2, P346, DOI 10.4161/bbug.2.6.17845; Brat D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-65; Buelter T., 2010, World patent, Patent No. [WO 2010/075504A2, 2010075504]; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Feldman R.M.R., 2011, US patent, Patent No. [US 2011/8017375 B2, 20118017375]; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; Gregg C, 2009, JOVE-J VIS EXP, V24, P1417, DOI DOI 10.3791/1417; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Jia XQ, 2012, APPL BIOCHEM BIOTECH, V168, P1, DOI 10.1007/s12010-011-9268-1; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kondo T, 2012, J BIOTECHNOL, V159, P32, DOI 10.1016/j.jbiotec.2012.01.022; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Larroy C, 2002, EUR J BIOCHEM, V269, P5738, DOI 10.1046/j.1432-1033.2002.03296.x; Lee WH, 2012, BIOPROC BIOSYST ENG, V35, P1467, DOI 10.1007/s00449-012-0736-y; Li SS, 2011, APPL MICROBIOL BIOT, V91, P577, DOI 10.1007/s00253-011-3280-9; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; MAARSE AC, 1984, EMBO J, V3, P2831, DOI 10.1002/j.1460-2075.1984.tb02216.x; Marquet A, 2001, VITAM HORM, V61, P51; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Paltauf F., 1992, MOL CELLULAR BIOL YE, P415, DOI DOI 10.1101/087969365.21B.415; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; SULO P, 1993, J BIOL CHEM, V268, P17634; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Urano J., 2011, US patent, Patent No. [US 2011/0076733 A1, 20110076733]; URBANGRIMAL D, 1986, EUR J BIOCHEM, V156, P511, DOI 10.1111/j.1432-1033.1986.tb09610.x; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Xu XM, 2008, CHEMBIOCHEM, V9, P2355, DOI 10.1002/cbic.200800384; ZHANG SG, 1994, ARCH BIOCHEM BIOPHYS, V309, P29, DOI 10.1006/abbi.1994.1079	49	306	338	20	326	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					335	+		10.1038/nbt.2509	http://dx.doi.org/10.1038/nbt.2509			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23417095	Green Accepted, Green Submitted			2022-12-25	WOS:000317195500027
J	Januschke, J; Reina, J; Llamazares, S; Bertran, T; Rossi, F; Roig, J; Gonzalez, C				Januschke, J.; Reina, J.; Llamazares, S.; Bertran, T.; Rossi, F.; Roig, J.; Gonzalez, C.			Centrobin controls mother-daughter centriole asymmetry in Drosophila neuroblasts	NATURE CELL BIOLOGY			English	Article							CELL-DIVISION; CENTROSOME INHERITANCE; SELF-RENEWAL; PROTEIN; CYCLE; PHOSPHORYLATION; DUPLICATION; ORIENTATION; MECHANISMS; DYNAMICS	During interphase in Drosophila neuroblasts, the Centrobin (CNB)-positive daughter centriole retains pericentriolar material (PCM) and organizes an aster that is a key determinant of the orientation of cell division. Here we show that daughter centrioles depleted of CNB cannot fulfil this function whereas mother centrioles that carry ectopic CNB can. CNB co-precipitates with a set of centrosomal proteins that include gamma-TUB, ANA2, CNN, SAS-4, ASL, DGRIP71, POLO and SAS-6. Following chemical inhibition of POLO or removal of three POLO phosphorylation sites present in CNB, the interphase microtubule aster is lost. These results demonstrate that centriolar CNB localization is both necessary and sufficient to enable centrioles to retain PCM and organize the interphase aster in Drosophila neuroblasts. They also reveal an interphase function for POLO in this process that seems to have co-opted part of the protein network involved in mitotic centrosome maturation.	[Januschke, J.; Reina, J.; Llamazares, S.; Bertran, T.; Rossi, F.; Roig, J.; Gonzalez, C.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Gonzalez, C.] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Gonzalez, C (corresponding author), Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.	gonzalez@irbbarcelona.org	Gonzalez, Cayetano/K-3933-2019; Gonzalez, Cayetano/K-3055-2019; Bertran, M. Teresa/C-4169-2019; Roig, Joan/E-2836-2017	Gonzalez, Cayetano/0000-0002-5259-3608; Bertran, M. Teresa/0000-0002-8336-0903; Llamazares, Salud/0000-0002-8771-2312; Januschke, Jens/0000-0001-8985-2717; Roig, Joan/0000-0002-3872-4712; Reina, Jose/0000-0003-3789-4514	Spanish MICINN MIMECO [BFU2009-07975/BMC, BFU2012-32522, CENIT ONCOLOGICA-20091016, Consolider-Ingenio C3D CSD2006-23]; CDTI; Generalitat de Catalunya [SGR Agaur 2009 CG041413]; ICREA Funding Source: Custom	Spanish MICINN MIMECO(Ministry of Science and Innovation, Spain (MICINN)); CDTI; Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	We thank W. Chia (Temasek Life Sciences Laboratory, Singapore), C. Doe (University of Oregon, USA)., T. Kaufman (Indiana University, USA), B. Lange (Max-Planck Institute for Molecular Genetics, Germany), M. Peifer (University of North Carolina at Chapel Hill, USA), the Bloomington stock centre, DGRC, DSHB, Harvard Exelixis and VDRC for providing flies and reagents; A. Olza for transgenesis; and J. Colombelli and L. Bardia from the IRB Advanced Microscopy Facility for technical assistance. Work in our laboratory is supported by grants BFU2009-07975/BMC, BFU2012-32522, CENIT ONCOLOGICA-20091016 and Consolider-Ingenio C3D CSD2006-23, from the Spanish MICINN MIMECO, and CDTI, and SGR Agaur 2009 CG041413, from Generalitat de Catalunya.	Azimzadeh J, 2012, SCIENCE, V335, P461, DOI 10.1126/science.1214457; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Callaini G, 1997, EXP CELL RES, V234, P183, DOI 10.1006/excr.1997.3618; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Conduit PT, 2010, CURR BIOL, V20, P2187, DOI 10.1016/j.cub.2010.11.055; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Debec A, 1999, BIOL CELL, V91, P379, DOI 10.1016/S0248-4900(99)80098-7; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Gillingham AK, 2000, EMBO REP, V1, P524; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135; Hegemann B, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001993; Izumi H, 2012, P NATL ACAD SCI USA, V109, P18048, DOI 10.1073/pnas.1205525109; Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Januschke J, 2010, J CELL BIOL, V188, P693, DOI 10.1083/jcb.200905024; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lange BMH, 1996, TRENDS CELL BIOL, V6, P348, DOI 10.1016/0962-8924(96)10033-7; Lee J, 2010, J BIOL CHEM, V285, P25476, DOI 10.1074/jbc.M109.099127; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rebollo E, 2009, DEVELOPMENT, V136, P3393, DOI 10.1242/dev.041822; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Wang H, 2012, BREAST CANCER RES TR, V136, P241, DOI 10.1007/s10549-012-2244-9; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	40	86	86	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					241	248		10.1038/ncb2671	http://dx.doi.org/10.1038/ncb2671			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23354166				2022-12-25	WOS:000315844900005
J	Ramel, D; Wang, XB; Laflamme, C; Montell, DJ; Emery, G				Ramel, Damien; Wang, Xiaobo; Laflamme, Carl; Montell, Denise J.; Emery, Gregory			Rab11 regulates cell-cell communication during collective cell movements	NATURE CELL BIOLOGY			English	Article							BORDER CELLS; DROSOPHILA-MELANOGASTER; SPATIAL RESTRICTION; MIGRATION; RAC; OOGENESIS; GUIDANCE; RECEPTOR; ACTIVATION; MECHANISMS	Collective cell movements contribute to development and metastasis. The small GTPase Rac is a key regulator of actin dynamics and cell migration but the mechanisms that restrict Rac activation and localization in a group of collectively migrating cells are unknown. Here, we demonstrate that the small GTPases Rab5 and Rab11 regulate Rac activity and polarization during collective cell migration. We use photoactivatable forms of Rac to demonstrate that Rab11 acts on the entire group to ensure that Rac activity is properly restricted to the leading cell through regulation of cell-cell communication. In addition, we show that Rab11 binds to the actin cytoskeleton regulator Moesin and regulates its activation in vivo during migration. Accordingly, reducing the level of Moesin activity also affects cell-cell communication, whereas expressing active Moesin rescues loss of Rab11 function. Our model suggests that Rab11 controls the sensing of the relative levels of Rac activity in a group of cells, leading to the organization of individual cells in a coherent multicellular motile structure.	[Ramel, Damien; Laflamme, Carl; Emery, Gregory] Univ Montreal, Fac Med, Inst Res Immunol & Canc IRIC, Montreal, PQ H3C 3J7, Canada; [Ramel, Damien; Laflamme, Carl; Emery, Gregory] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Wang, Xiaobo; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, Baltimore, MD 21205 USA	Universite de Montreal; Universite de Montreal; Johns Hopkins University; Johns Hopkins Medicine	Emery, G (corresponding author), Univ Montreal, Fac Med, Inst Res Immunol & Canc IRIC, Montreal, PQ H3C 3J7, Canada.	gregory.emery@umontreal.ca		Wang, Xiaobo/0000-0002-3311-1378; Laflamme, Carl/0000-0001-5906-025X; Emery, Gregory/0000-0002-6874-6875; RAMEL, Damien/0000-0002-9089-1497	Canadian Institute for Health Research (CIHR) [MOP-114899]; Fonds de Recherche Quebec Sante (FRQS); Atip-Avenir programme; Centre National de la Recherche Scientifique (CNRS); Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche du Quebec en Sante (FRQS);  [R01GM46425];  [R01GM73164]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046425, R01GM073164] Funding Source: NIH RePORTER	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Quebec Sante (FRQS); Atip-Avenir programme; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche du Quebec en Sante (FRQS); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Stock Collection and the Vienna Drosophila RNAi Center for fly stocks. We thank G. Assaker, C. Iampietro and C. Charbonneau for technical assistance and helpful discussions. We also thank S. Carreno for providing important insights on Moesin experiments. This work was supported by grants from the Canadian Institute for Health Research (CIHR) to G.E. (MOP-114899). G.E. holds a Canada Research Chair (Tier II) in Vesicular Trafficking and Cell Signalling. D.R. and C.L. are supported by Fonds de Recherche Quebec Sante (FRQS). X.W. is supported by the Atip-Avenir programme and the Centre National de la Recherche Scientifique (CNRS). D.M. is supported by grants R01GM46425 and R01GM73164. IRIC is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation (CFI) and by the Fonds de Recherche du Quebec en Sante (FRQS). This paper is dedicated to the memory of A. Ruffe.	Assaker G, 2010, P NATL ACAD SCI USA, V107, P22558, DOI 10.1073/pnas.1010795108; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Cao J, 2008, J CELL BIOL, V182, P301, DOI 10.1083/jcb.200712036; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Laflamme C, 2012, J CELL BIOL, V198, P57, DOI 10.1083/jcb.201112114; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Prasad M, 2011, METHODS MOL BIOL, V769, P277, DOI 10.1007/978-1-61779-207-6_19; Riggs B, 2007, MOL BIOL CELL, V18, P3313, DOI 10.1091/mbc.E07-02-0146; Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Roubinet C, 2011, J CELL BIOL, V195, P99, DOI 10.1083/jcb.201106048; Thiery JP, 2009, CURR BIOL, V19, pR1121, DOI 10.1016/j.cub.2009.11.001; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wu YI, 2011, METHOD ENZYMOL, V497, P393, DOI 10.1016/B978-0-12-385075-1.00016-0; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139	28	99	101	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					317	324		10.1038/ncb2681	http://dx.doi.org/10.1038/ncb2681			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23376974	Green Accepted			2022-12-25	WOS:000315844900013
J	Smith, MJ; O'Sullivan, J; Bhaskar, SS; Hadfield, KD; Poke, G; Caird, J; Sharif, S; Eccles, D; Fitzpatrick, D; Rawluk, D; du Plessis, D; Newman, WG; Evans, DG				Smith, Miriam J.; O'Sullivan, James; Bhaskar, Sanjeev S.; Hadfield, Kristen D.; Poke, Gemma; Caird, John; Sharif, Saba; Eccles, Diana; Fitzpatrick, David; Rawluk, Daniel; du Plessis, Daniel; Newman, William G.; Evans, D. Gareth			Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas	NATURE GENETICS			English	Article							COFFIN-SIRIS SYNDROME; FAMILIAL MULTIPLE; CANCER-CELLS; NF2 GENE; BAF57; COMPLEXES; IDENTIFICATION; SCHWANNOMAS; EXPRESSION; CARCINOMA	One-third of all primary central nervous system tumors in adults are meningiomas(1). Rarely, meningiomas occur at multiple sites, usually occurring in individuals with type 2 neurofibromatosis (NF2). We sequenced the exomes of three unrelated individuals with familial multiple spinal meningiomas without NF2 mutations. We identified two individuals with heterozygous loss-of-function mutations in the SWI/SNF chromatin-remodeling complex subunit gene SMARCE1. Sequencing of SMARCE1 in six further individuals with spinal meningiomas identified two additional heterozygous loss-of-function mutations. Tumors from individuals with SMARCE1 mutations were of clear-cell histological subtype, and all had loss of SMARCE1 protein, consistent with a tumor suppressor mechanism. Our findings identify multiple-spinal-meningioma disease as a new discrete entity and establish a key role for the SWI/SNF complex in the pathogenesis of both meningiomas and tumors with clear-cell histology.	[Smith, Miriam J.; O'Sullivan, James; Bhaskar, Sanjeev S.; Hadfield, Kristen D.; Newman, William G.; Evans, D. Gareth] Univ Manchester, St Marys Hosp, MAHSC, Manchester M13 0JH, Lancs, England; [Poke, Gemma] Western Gen Hosp, South East Scotland Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Caird, John; Rawluk, Daniel] Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland; [Sharif, Saba] West Midlands Reg Genet Unit, Dept Clin Genet, Birmingham, W Midlands, England; [Eccles, Diana] Univ Southampton, Fac Med, Southampton Univ Hosp Natl Hlth Serv NHS Trust, Southampton SO9 5NH, Hants, England; [Fitzpatrick, David] Univ Edinburgh, Western Gen Hosp, MRC, Human Genet Unit,IGMM, Edinburgh, Midlothian, Scotland; [du Plessis, Daniel] Salford Royal Hosp NHS Fdn Trust, Dept Cellular Pathol, Salford, Lancs, England; [du Plessis, Daniel] Salford Royal Hosp NHS Fdn Trust, Greater Manchester Neurosci Ctr, Salford, Lancs, England	University of Manchester; University of Edinburgh; University of Southampton; University of Edinburgh; Salford Royal NHS Foundation Trust; Salford Royal Hospital; Salford Royal NHS Foundation Trust; Salford Royal Hospital	Evans, DG (corresponding author), Univ Manchester, St Marys Hosp, MAHSC, Manchester M13 0JH, Lancs, England.	william.newman@manchester.ac.uk; gareth.evans@cmft.nhs.uk	Eccles, Diana/K-6327-2019; Smith, Miriam/J-4001-2015; Evans, D Gareth/AAB-4308-2022	Eccles, Diana/0000-0002-9935-3169; Smith, Miriam/0000-0002-3184-0817; Evans, D Gareth/0000-0002-8482-5784; FitzPatrick, David R./0000-0003-4861-969X; Poke, Gemma/0000-0002-8748-4866; Newman, William/0000-0002-6382-4678	Young Investigator Award from the Children's Tumor Foundation [2011-01-006]; Association for International Cancer Research [12-0275]; Manchester Biomedical Research Centre; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Worldwide Cancer Research [12-0275] Funding Source: researchfish	Young Investigator Award from the Children's Tumor Foundation; Association for International Cancer Research; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Lung GO Sequencing Project; Women's Health Initiative (WHI) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Worldwide Cancer Research	We thank the families for their contributions to this study. We also thank N. Bowers and A. Wallace for NF2 mutation screening and T. Gledhill for immunohistochemistry images. M.J.S. is supported by a Young Investigator Award (2011-01-006) from the Children's Tumor Foundation. We also acknowledge support from the Association for International Cancer Research (12-0275) and the Manchester Biomedical Research Centre. D.G.E. is a National Institute for Health Research (NIHR) Senior Clinical Investigator. Finally, we thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Villaronga MA, 2011, BREAST CANCER RES TR, V128, P891, DOI 10.1007/s10549-011-1492-4; Antinheimo J, 2000, NEUROLOGY, V54, P71, DOI 10.1212/WNL.54.1.71; Bacci C, 2010, NEUROGENETICS, V11, P73, DOI 10.1007/s10048-009-0204-2; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; CBTRUS, 2012, CBTRUS STAT REP PRIM; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Christiaans I, 2011, J MED GENET, V48, P93, DOI 10.1136/jmg.2010.082420; Dobbins SE, 2011, NAT GENET, V43, P825, DOI 10.1038/ng.879; Evans DGR, 2005, J MED GENET, V42, P45, DOI 10.1136/jmg.2004.023705; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Hadfield KD, 2010, J MED GENET, V47, P567, DOI 10.1136/jmg.2009.075721; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P1137; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; Kiskinis E, 2006, BREAST CANCER RES TR, V98, P191, DOI 10.1007/s10549-005-9149-9; Kuratsu J, 2000, J NEUROSURG, V92, P766, DOI 10.3171/jns.2000.92.5.0766; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mitchell RJ, 2002, AM J EPIDEMIOL, V156, P885, DOI 10.1093/aje/kwf139; Rieske P, 2003, J CLIN PATHOL-MOL PA, V56, P299, DOI 10.1136/mp.56.5.299; RUTTLEDGE MH, 1994, NAT GENET, V6, P180, DOI 10.1038/ng0294-180; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Shen YP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-42; Smith MJ, 2011, J MED GENET, V48, P261, DOI 10.1136/jmg.2010.085241; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van den Munckhof P, 2012, NEUROGENETICS, V13, P1, DOI 10.1007/s10048-011-0300-y; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong DR, 2009, LARYNGOSCOPE, V119, pS129, DOI 10.1002/lary.20430	34	162	165	0	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					295	298		10.1038/ng.2552	http://dx.doi.org/10.1038/ng.2552			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23377182				2022-12-25	WOS:000315664800014
J	Tang, WX; van der Donk, WA				Tang, Weixin; van der Donk, Wilfred A.			The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry	NATURE CHEMICAL BIOLOGY			English	Article							FAECALIS CYTOLYSIN; GENETIC-ANALYSIS; HEMOLYSIN BACTERIOCIN; PROKARYOTIC CELLS; BIOSYNTHESIS; LANTIBIOTICS; TOXIN; DISCOVERY; SYSTEM; MODE	The enterococcal cytolysin is a two-component lantibiotic of unknown structure with hemolytic activity that is important for virulence. We prepared cytolysin by coexpression of each precursor peptide with the synthetase CylM in Escherichia con and characterized its structure. Unexpectedly, cytolysin is to our knowledge the first example of a lantibiotic containing lanthionine and methyllanthionine structures with different stereochemistries in the same peptide. The stereochemistry is determined by the sequence of the substrate peptide.	[Tang, Weixin; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Tang, Weixin; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	van der Donk, WA (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.	vddonk@illinois.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071; Tang, Weixin/0000-0002-5739-5416	US National Institutes of Health [GM58822]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058822, R37GM058822] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Yang (University of Illinois) for providing the modified HaIA2 and Hal beta 3 peptides. This work was supported by the US National Institutes of Health (GM58822).	Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Cox CR, 2005, CURR PROTEIN PEPT SC, V6, P77, DOI 10.2174/1389203053027557; Garg N, 2012, P NATL ACAD SCI USA, V109, P5241, DOI 10.1073/pnas.1116815109; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; GILMORE MS, 1990, INFECT IMMUN, V58, P3914, DOI 10.1128/IAI.58.12.3914-3923.1990; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Haas W, 1999, MED MICROBIOL IMMUN, V187, P183, DOI 10.1007/s004300050091; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; Hyink O, 2005, FEMS MICROBIOL LETT, V252, P235, DOI 10.1016/j.femsle.2005.09.003; IKE Y, 1990, J BACTERIOL, V172, P155, DOI 10.1128/JB.172.1.155-163.1990; IKE Y, 1984, J BACTERIOL, V158, P777, DOI 10.1128/JB.158.3.777-783.1984; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Liu W, 2011, J AM CHEM SOC, V133, P14216, DOI 10.1021/ja206017p; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; Ross AC, 2011, J ANTIBIOT, V64, P27, DOI 10.1038/ja.2010.136; SEGARRA RA, 1991, INFECT IMMUN, V59, P1239, DOI 10.1128/IAI.59.4.1239-1246.1991; Shi YX, 2011, J AM CHEM SOC, V133, P2338, DOI 10.1021/ja109044r; Tang WX, 2012, BIOCHEMISTRY-US, V51, P4271, DOI 10.1021/bi300255s; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005	25	71	75	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					157	159		10.1038/NCHEMBIO.1162	http://dx.doi.org/10.1038/NCHEMBIO.1162			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23314913	Green Accepted			2022-12-25	WOS:000315132900009
J	Yoshikawa, K; Nakagawa, H; Mori, N; Watanabe, H; Touhara, K				Yoshikawa, Keiichi; Nakagawa, Hiroaki; Mori, Naoki; Watanabe, Hidenori; Touhara, Kazushige			An unsaturated aliphatic alcohol as a natural ligand for a mouse odorant receptor	NATURE CHEMICAL BIOLOGY			English	Article							VERTEBRATE OLFACTORY RECEPTORS; FUNCTIONAL EXPRESSION; RESPONSE ASSAYS; MICE; BULB; AGGRESSION; PHEROMONES	We report the identification of a physiological receptor-volatile pair in the mouse olfactory system. By activity-guided fractionation of exocrine gland extracts and subsequent chemical analysis, (Z)-5-tetradecen-1-ol was identified as a natural ligand for a mouse odorant receptor. (Z)-5-tetradecen-1-ol is excreted into male mouse urine under androgen control and enhances urine attractiveness to female mice. This report is to our knowledge the first to describe natural product-based deorphanization of an odorant receptor.	[Yoshikawa, Keiichi; Nakagawa, Hiroaki; Mori, Naoki; Watanabe, Hidenori; Touhara, Kazushige] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan	University of Tokyo	Touhara, K (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp		Yoshikawa, Keiichi/0000-0003-4790-4114	Ministry of Education, Culture, Sports, Science and Technology Japan [24227003]; Japan Society for the Promotion of Science (JSPS) [18077001]; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology Japan (grant 24227003), a Grant-in-Aid for Scientific Research on Priority Areas from the Japan Society for the Promotion of Science (JSPS) (grant 18077001) and a research grant from the Astellas Foundation for Research on Metabolic Disorders to K.T K.Y. was supported by a Grant-in-Aid for JSPS fellows. We thank T. Ando for Z8-14:OH (Tokyo University of Agriculture and Technology), and T. Kikusui and T. Hattori for advice on behavioral experiments.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Bartell J.R., 1983, J CHEM ECOL, V9, P1343; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Civelli O, 1998, FEBS LETT, V430, P55, DOI 10.1016/S0014-5793(98)00524-9; EVANS CM, 1978, PHYSIOL BEHAV, V21, P19, DOI 10.1016/0031-9384(78)90270-6; JEMIOLO B, 1985, ANIM BEHAV, V33, P1114, DOI 10.1016/S0003-3472(85)80170-6; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; MUGFORD RA, 1972, HORM BEHAV, V3, P39, DOI 10.1016/0018-506X(72)90005-0; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Touhara K, 2007, NEUROCHEM INT, V51, P132, DOI 10.1016/j.neuint.2007.05.020; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	23	37	38	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					160	162		10.1038/NCHEMBIO.1164	http://dx.doi.org/10.1038/NCHEMBIO.1164			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23314914				2022-12-25	WOS:000315132900010
J	Chen, LL; Li, Y; Lin, CH; Chan, THM; Chow, RKK; Song, YY; Liu, M; Yuan, YF; Fu, L; Kong, KL; Qi, LH; Li, Y; Zhang, N; Tong, AHY; Kwong, DLW; Man, K; Lo, CM; Lok, S; Tenen, DG; Guan, XY				Chen, Lei Lei; Li, Yan; Lin, Chi Ho; Chan, Tim Hon Man; Chow, Raymond Kwok Kei; Song, Yangyang; Liu, Ming; Yuan, Yun-Fei; Fu, Li; Kong, Kar Lok; Qi, Lihua; Li, Yan; Zhang, Na; Tong, Amy Hin Yan; Kwong, Dora Lai-Wan; Man, Kwan; Lo, Chung Mau; Lok, Si; Tenen, Daniel G.; Guan, Xin-Yuan			Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma	NATURE MEDICINE			English	Article							ANTIZYME INHIBITOR; GLUR-B; DEGRADATION; EVOLUTION; CANCER; PATHOGENESIS; EXPRESSION; ENTRY	A better understanding of human hepatocellular carcinoma (HCC) pathogenesis at the molecular level will facilitate the discovery of tumor-initiating events. Transcriptome sequencing revealed that adenosine-to-inosine (A -> I) RNA editing of AZIN1 (encoding antizyme inhibitor 1) is increased in HCC specimens. A -> I editing of AZIN1 transcripts, specifically regulated by ADAR1 (encoding adenosine deaminase acting on RNA-1), results in a serine-to-glycine substitution at residue 367 of AZIN1, located in beta-strand 15 (beta 15) and predicted to cause a conformational change, induced a cytoplasmic-to-nuclear translocation and conferred gain-of-function phenotypes that were manifested by augmented tumor-initiating potential and more aggressive behavior. Compared with wild-type AZIN1 protein, the edited form has a stronger affinity to antizyme, and the resultant higher AZIN1 protein stability promotes cell proliferation through the neutralization of antizyme-mediated degradation of ornithine decarboxylase (ODC) and cyclin D1 (CCND1). Collectively, A -> I RNA editing of AZIN1 may be a potential driver in the pathogenesis of human cancers, particularly HCC.	[Chen, Lei Lei; Li, Yan; Chan, Tim Hon Man; Chow, Raymond Kwok Kei; Song, Yangyang; Liu, Ming; Fu, Li; Kong, Kar Lok; Kwong, Dora Lai-Wan; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chen, Lei Lei; Chan, Tim Hon Man; Qi, Lihua; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Chen, Lei Lei; Li, Yan; Chan, Tim Hon Man; Song, Yangyang; Liu, Ming; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Lin, Chi Ho; Zhang, Na; Lok, Si] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Yuan, Yun-Fei; Li, Yan; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Amy Hin Yan] Chinese Univ Hong Kong, Li Ka Shing Inst Med Sci, Hong Kong, Hong Kong, Peoples R China; [Man, Kwan; Lo, Chung Mau] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National University of Singapore; University of Hong Kong; University of Hong Kong; Sun Yat Sen University; Chinese University of Hong Kong; University of Hong Kong	Guan, XY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.	csidgt@nus.edu.sg; xyguan@hkucc.hku.hk	Fu, Li/F-7182-2010; Qi, LI/AAF-3389-2019; Song, Yang/HGU-4953-2022; Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Fu, Li/0000-0003-2643-6278; Chen, Polly Leilei/0000-0002-1987-3878; Yuan, Yunfei/0000-0003-2467-3683; Guan, Xin-Yuan/0000-0002-4485-6017; Tenen, Daniel/0000-0002-6423-3888; LIU, MING/0000-0003-3222-8715; /0000-0003-1874-9805	Hong Kong Research Grant Council [T12-403/11, HKBU5/CRF/10, HKU7/CRG/09, HKU3/CRF/11R]; General Research Fund [HKU/766811M]; China National Basic Research Program [2012CB967001]; Sun Yat-Sen University [85000-3171311]; China National Key Science-Technology Special Project of Infectious Diseases [2008ZX10002-022]; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE [R01CA118316, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719, R01HL056745] Funding Source: NIH RePORTER	Hong Kong Research Grant Council(Hong Kong Research Grants Council); General Research Fund; China National Basic Research Program(National Basic Research Program of China); Sun Yat-Sen University; China National Key Science-Technology Special Project of Infectious Diseases; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank and acknowledge the patients for tumor tissue donation to our tissue bank and M. Fullwood (Cancer Science Institute of Singapore, National University of Singapore, Singapore) for providing complementary DNA (cDNA) samples of normal tissues. We thank K. Man and C.M. Lo (Department of Surgery, The University of Hong Kong) for providing healthy human liver tissues. This work was supported by Hong Kong Research Grant Council grants, including the Theme-based Research Scheme Fund (T12-403/11) (X.-Y.G.), Collaborative Research Funds (HKBU5/CRF/10, HKU7/CRG/09 and HKU3/CRF/11R) (X.-Y.G.), the General Research Fund (HKU/766811M) (X.-Y.G.), the China National Basic Research Program (2012CB967001) (X.-Y.G.), the 'Hundred Talents Program' at Sun Yat-Sen University (85000-3171311) (X.-Y.G.), the China National Key Science-Technology Special Project of Infectious Diseases (2008ZX10002-022) (X.-Y.G.) and the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (D.G.T.).	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gommans WM, 2009, BIOESSAYS, V31, P1137, DOI 10.1002/bies.200900045; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mangold U, 2008, ONCOGENE, V27, P604, DOI 10.1038/sj.onc.1210685; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Mattick JS, 2008, TRENDS NEUROSCI, V31, P227, DOI 10.1016/j.tins.2008.02.003; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Olsen RR, 2011, MOL CANCER RES, V9, P1285, DOI 10.1158/1541-7786.MCR-11-0178; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Young M, 1999, PROTEIN SCI, V8, P1752, DOI 10.1110/ps.8.9.1752	37	316	330	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					209	216		10.1038/nm.3043	http://dx.doi.org/10.1038/nm.3043			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23291631	Green Accepted			2022-12-25	WOS:000314675900029
J	Chmielecki, J; Crago, AM; Rosenberg, M; O'Connor, R; Walker, SR; Ambrogio, L; Auclair, D; McKenna, A; Heinrich, MC; Frank, DA; Meyerson, M				Chmielecki, Juliann; Crago, Aimee M.; Rosenberg, Mara; O'Connor, Rachael; Walker, Sarah R.; Ambrogio, Lauren; Auclair, Daniel; McKenna, Aaron; Heinrich, Michael C.; Frank, David A.; Meyerson, Matthew			Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors	NATURE GENETICS			English	Article							EXPRESSION; NAB2; COREPRESSOR; ACTIVATION; MUTATIONS	Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs.	[Chmielecki, Juliann; Walker, Sarah R.; Frank, David A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chmielecki, Juliann; Rosenberg, Mara; Ambrogio, Lauren; Auclair, Daniel; McKenna, Aaron; Meyerson, Matthew] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA; [Crago, Aimee M.; O'Connor, Rachael] Mem Sloan Kettering Canc Ctr, Dept Surg, Sarcoma Biol Lab, New York, NY 10021 USA; [Walker, Sarah R.; Frank, David A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Walker, Sarah R.; Frank, David A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Heinrich, Michael C.] Portland Vet Affairs VA Med Ctr, Div Hematol & Med Oncol, Portland, OR USA; [Heinrich, Michael C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Oregon Health & Science University; Harvard University; Harvard Medical School	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Heinrich, Michael/AAC-6745-2019	Heinrich, Michael/0000-0003-3790-0478; O'Connor, Rachael/0000-0002-6869-7954; Crago, Aimee/0000-0002-2965-752X; Meyerson, Matthew/0000-0002-9133-8108; Rosenberg, Mara/0000-0001-6400-3161	Carlos Slim Health Institute in Mexico; Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma [P50 CA140146]; MSKCC [P01CA47179]; American Cancer Society AstraZeneca; Kristen Ann Carr Foundation; NATIONAL CANCER INSTITUTE [P50CA140146, P01CA047179] Funding Source: NIH RePORTER	Carlos Slim Health Institute in Mexico; Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma; MSKCC; American Cancer Society AstraZeneca; Kristen Ann Carr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the individuals with SFT who contributed material for this study. We thank members of the Genomics Platform at the Broad Institute for their technical expertise and M. Abazeed and A. Dulak for critically reviewing the manuscript. This work was conducted as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA), a project funded by the Carlos Slim Health Institute in Mexico. This work was supported by a Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma (P50 CA140146) and a P01 grant (P01CA47179) to S. Singer (MSKCC). J.C. is supported by an American Cancer Society AstraZeneca Postdoctoral Fellowship. A.M.C. is supported by a grant from the Kristen Ann Carr Foundation. M.M. is supported by generous donations from M.B. Zuckerman and Team Dragonfly of the Pan-Mass Challenge. Material was collected under institutional review board (IRB)-approved protocols at the Memorial Sloan-Kettering Cancer Center and the Oregon Health & Science University Biolibrary. All patients provided informed consent.	Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bhattacharyya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007620; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; He HJ, 2006, J BIOL CHEM, V281, P31369, DOI 10.1074/jbc.M603762200; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Merk BC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-184; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Nelson EA, 2011, ONCOTARGET, V2, P518; Pal NR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-5; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Shimoyamada H, 2010, AM J PATHOL, V177, P70, DOI 10.2353/ajpath.2010.091164; Svaren J, 1996, MOL CELL BIOL, V16, P3545	15	357	380	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					131	132		10.1038/ng.2522	http://dx.doi.org/10.1038/ng.2522			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313954	Green Accepted, Green Submitted			2022-12-25	WOS:000314333000006
J	Alvarez-Breckenridge, CA; Yu, JH; Price, R; Wojton, J; Pradarelli, J; Mao, HY; Wei, M; Wang, Y; He, S; Hardcastle, J; Fernandez, SA; Kaur, B; Lawler, SE; Vivier, E; Mandelboim, O; Moretta, A; Caligiuri, MA; Chiocca, EA				Alvarez-Breckenridge, Christopher A.; Yu, Jianhua; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Mao, Hsiaoyin; Wei, Min; Wang, Yan; He, Shun; Hardcastle, Jayson; Fernandez, Soledad A.; Kaur, Balveen; Lawler, Sean E.; Vivier, Eric; Mandelboim, Ofer; Moretta, Alessandro; Caligiuri, Michael A.; Chiocca, E. Antonio			NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors	NATURE MEDICINE			English	Article							HERPES-SIMPLEX-VIRUS; VESICULAR STOMATITIS-VIRUS; HUMAN DENDRITIC CELLS; KILLER-CELLS; TUMOR MICROENVIRONMENT; DEPENDENT MECHANISMS; TRIGGERING RECEPTOR; GLIOMA VIROTHERAPY; ONCOLYTIC VIRUSES; IMMUNE-RESPONSES	The role of the immune response to oncolytic Herpes simplex viral (oHSV) therapy for glioblastoma is controversial because it might enhance or inhibit efficacy. We found that within hours of oHSV infection of glioblastomas in mice, activated natural killer (NK) cells are recruited to the site of infection. This response substantially diminished the efficacy of glioblastoma virotherapy. oHSV-activated NK cells coordinated macrophage and microglia activation within tumors. In vitro, human NK cells preferentially lysed oHSV-infected human glioblastoma cell lines. This enhanced killing depended on the NK cell natural cytotoxicity receptors (NCRs) NKp30 and NKp46, whose ligands are upregulated in oHSV-infected glioblastoma cells. We found that HSV titers and oHSV efficacy are increased in Ncr1(-/-) mice and a Ncr1(-/-) NK cell adoptive transfer model of glioma, respectively. These results demonstrate that glioblastoma virotherapy is limited partially by an antiviral NK cell response involving specific NCRs, uncovering new potential targets to enhance cancer virotherapy.	[Alvarez-Breckenridge, Christopher A.; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Wang, Yan; Hardcastle, Jayson; Kaur, Balveen; Lawler, Sean E.; Chiocca, E. Antonio] Ohio State Univ, Med Ctr, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA; [Alvarez-Breckenridge, Christopher A.; Yu, Jianhua; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Mao, Hsiaoyin; Wei, Min; Wang, Yan; He, Shun; Hardcastle, Jayson; Fernandez, Soledad A.; Kaur, Balveen; Lawler, Sean E.; Caligiuri, Michael A.; Chiocca, E. Antonio] James Canc Hosp, Columbus, OH USA; [Alvarez-Breckenridge, Christopher A.; Yu, Jianhua; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Mao, Hsiaoyin; Wei, Min; Wang, Yan; He, Shun; Hardcastle, Jayson; Fernandez, Soledad A.; Kaur, Balveen; Lawler, Sean E.; Caligiuri, Michael A.; Chiocca, E. Antonio] Solove Res Inst, Columbus, OH USA; [Alvarez-Breckenridge, Christopher A.; Price, Richard] Ohio State Univ, Med Ctr, Med Scientist Training Program, Columbus, OH 43210 USA; [Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Med Ctr, Div Hematol, Columbus, OH 43210 USA; [Yu, Jianhua; Mao, Hsiaoyin; Wei, Min; He, Shun; Fernandez, Soledad A.; Kaur, Balveen; Caligiuri, Michael A.; Chiocca, E. Antonio] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Fernandez, Soledad A.] Ohio State Univ, Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Vivier, Eric] Univ Aix Marseille 2, INSERM, U631, Ctr Immunol Marseille Luminy, Marseille, France; [Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Moretta, Alessandro] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy; [Moretta, Alessandro] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy; [Chiocca, E. Antonio] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Sch Med,Dept Neurosurg, Boston, MA 02115 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Hebrew University of Jerusalem; University of Genoa; University of Genoa; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Chiocca, EA (corresponding author), Ohio State Univ, Med Ctr, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA.	michael.caligiuri@osumc.edu; eachiocca@partners.org	kaur, Balveen/E-3355-2011; He, Shun/K-7448-2014; Vivier, Eric/F-8939-2010; Wei, Min/GSI-8510-2022	Vivier, Eric/0000-0001-7022-8287; Mandelboim, Ofer/0000-0002-9354-1855	US National Institutes of Health [7U01NS061811, CA069246, CA068458, CA095426, TL1RR025753, CA163205]; American Medical Association Foundation Seed Grant; Dardinger Neuro-oncology Laboratory; NATIONAL CANCER INSTITUTE [R01CA068458, P01CA163205, R01CA150153, R37CA068458, R01CA098472, P01CA095426, P30CA016058, P01CA069246, R01CA155521] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS061811, R01NS064607] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Medical Association Foundation Seed Grant; Dardinger Neuro-oncology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants 7U01NS061811 (to E.A.C.), CA069246 (to E.A.C.), CA068458 (to M.A.C.), CA095426 (to M.A.C.), TL1RR025753 (to C.A.A.-B.) and CA163205 (to E.A.C., M.A.C. and B.K.). C.A.A.-B. was supported by an American Medical Association Foundation Seed Grant. This work was also supported by the Dardinger Neuro-oncology Laboratory.	Aghi M, 2008, ONCOGENE, V27, P4249, DOI 10.1038/onc.2008.53; Altomonte J, 2009, CANCER GENE THER, V16, P266, DOI 10.1038/cgt.2008.74; Altomonte J, 2008, MOL THER, V16, P146, DOI 10.1038/sj.mt.6300343; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Chiocca EA, 2008, CURR OPIN MOL THER, V10, P38; Chiocca EA, 2002, NAT REV CANCER, V2, P938, DOI 10.1038/nrc948; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; DeRubertis BG, 2007, CANCER GENE THER, V14, P590, DOI 10.1038/sj.cgt.7701053; Errington F, 2008, J IMMUNOL, V180, P6018, DOI 10.4049/jimmunol.180.9.6018; Farrell CJ, 2008, CLIN CANCER RES, V14, P7711, DOI 10.1158/1078-0432.CCR-08-1364; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Friedman A, 2006, CANCER RES, V66, P2314, DOI 10.1158/0008-5472.CAN-05-2661; Fulci G, 2007, CANCER RES, V67, P9398, DOI 10.1158/0008-5472.CAN-07-1063; Fulci G, 2006, P NATL ACAD SCI USA, V103, P12873, DOI 10.1073/pnas.0605496103; Galivo F, 2010, GENE THER, V17, P158, DOI 10.1038/gt.2009.161; Galivo F, 2010, HUM GENE THER, V21, P439, DOI 10.1089/hum.2009.143; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Ghiasi H, 2000, ANTIVIR RES, V45, P33, DOI 10.1016/S0166-3542(99)00075-3; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Ikeda K, 1999, NAT MED, V5, P881, DOI 10.1038/11320; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kottke T, 2008, MOL THER, V16, P1910, DOI 10.1038/mt.2008.212; Kottke T, 2009, CLIN CANCER RES, V15, P561, DOI 10.1158/1078-0432.CCR-08-1688; Kurozumi K, 2007, JNCI-J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Prestwich RJ, 2009, J IMMUNOL, V183, P4312, DOI 10.4049/jimmunol.0901074; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Taylor MA, 2002, EUR J IMMUNOL, V32, P793, DOI 10.1002/1521-4141(200203)32:3<793::AID-IMMU793>3.0.CO;2-M; Todo T, 2001, P NATL ACAD SCI USA, V98, P6396, DOI 10.1073/pnas.101136398; Trotta R, 1998, J IMMUNOL, V161, P6648; Varghese S, 2006, CLIN CANCER RES, V12, P2919, DOI 10.1158/1078-0432.CCR-05-1187; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wakimoto H, 2004, GENE THER, V11, P214, DOI 10.1038/sj.gt.3302143; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Weiner NE, 1999, J NEUROPATH EXP NEUR, V58, P54, DOI 10.1097/00005072-199901000-00007; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Yoshino H, 2000, BONE MARROW TRANSPL, V26, P1211, DOI 10.1038/sj.bmt.1702702; Yu JH, 2011, J CLIN INVEST, V121, P1456, DOI 10.1172/JCI43242; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491	59	138	141	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2012	18	12					1827	+		10.1038/nm.3013	http://dx.doi.org/10.1038/nm.3013			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23178246	Green Accepted			2022-12-25	WOS:000311999800031
J	Giambra, V; Jenkins, CR; Wang, HF; Lam, SH; Shevchuk, OO; Nemirovsky, O; Wai, C; Gusscott, S; Chiang, MY; Aster, JC; Humphries, RK; Eaves, C; Weng, AP				Giambra, Vincenzo; Jenkins, Christopher R.; Wang, Hongfang; Lam, Sonya H.; Shevchuk, Olena O.; Nemirovsky, Oksana; Wai, Carol; Gusscott, Sam; Chiang, Mark Y.; Aster, Jon C.; Humphries, R. Keith; Eaves, Connie; Weng, Andrew P.			NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-theta and reactive oxygen species	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; KINASE-C-THETA; HEMATOPOIETIC STEM-CELLS; GAMMA-SECRETASE INHIBITORS; CENTRAL DNA FLAP; TUMOR-SUPPRESSOR; LENTIVIRUS VECTOR; NUCLEAR IMPORT; GENE DELIVERY; IN-VIVO	Reactive oxygen species (ROS), a byproduct of cellular metabolism, damage intracellular macromolecules and, when present in excess, can promote normal hematopoietic stem cell differentiation and exhaustion(1-3). However, mechanisms that regulate the amount of ROS in leukemia-initiating cells (LICs) and the biological role of ROS in these cells are largely unknown. We show here that the ROSlow subset of CD44(+) cells in T cell acute lymphoblastic leukemia (T-ALL), a malignancy of immature T cell progenitors, is highly enriched in the most aggressive LICs and that ROS accumulation is restrained by downregulation of protein kinase C theta (PKC-theta). Notably, primary mouse T-ALLs lacking PKC-theta show improved LIC activity, whereas enforced PKC-theta expression in both mouse and human primary T-ALLs compromised LIC activity. We also show that PKC-theta is regulated by a new pathway in which NOTCH1 induces runt-related transcription factor 3 (RUNX3), RUNX3 represses RUNX1 and RUNX1 induces PKC-theta. NOTCH1, which is frequently activated by mutation in T-ALL4-6 and required for LIC activity in both mouse and human models(7,8), thus acts to repress PKC-theta. These results reveal key functional roles for PKC-theta and ROS in T-ALL and suggest that aggressive biological behavior in vivo could be limited by therapeutic strategies that promote PKC-theta expression or activity, or the accumulation of ROS.	[Giambra, Vincenzo; Jenkins, Christopher R.; Lam, Sonya H.; Shevchuk, Olena O.; Nemirovsky, Oksana; Wai, Carol; Gusscott, Sam; Humphries, R. Keith; Eaves, Connie; Weng, Andrew P.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Wang, Hongfang; Aster, Jon C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Chiang, Mark Y.] Univ Michigan, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA	British Columbia Cancer Agency; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan	Weng, AP (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	aweng@bccrc.ca	Weng, Andrew P/I-5015-2014; Giambra, Vincenzo/H-8296-2012; Giambra, Vincenzo/ABG-8306-2021	Giambra, Vincenzo/0000-0003-2607-2080; Giambra, Vincenzo/0000-0003-2607-2080; Chiang, Mark/0000-0003-2099-0956; Humphries, Richard/0000-0003-0540-7005; Eaves, Connie/0000-0002-3452-1926	Canadian Institutes of Health Research/Terry Fox Foundation; Leukemia and Lymphoma Society of Canada; Cancer Research Society; Lymphoma Foundation Canada; US National Cancer Institute [P01CA119070, K08CA120544]; NATIONAL CANCER INSTITUTE [K08CA120544, K22CA112538, P01CA119070] Funding Source: NIH RePORTER	Canadian Institutes of Health Research/Terry Fox Foundation(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada; Cancer Research Society; Lymphoma Foundation Canada; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Z. Sun (City of Hope, Duarte, California) for providing PKC-theta knockout mice, J. Fletcher and W. Ou (Brigham and Women's Hospital, Boston, Massachusetts) for PKC-theta shRNA lentivectors, E. Kieff (Brigham and Women's Hospital, Boston, Massachusetts) for CSL antibody, I. Bernstein (Fred Hutchinson Cancer Research Center, Seattle, Washington) for Ig-DL1 ligand, F. Pflumio (Commissariat a l'Energie Atomique Fontenay-aux-Roses, France) for the MS5-DL1 cell line and E. Martignani for help with immunofluorescence. We would also like to thank P. Ballerini (Hopital Armand Trousseau, Paris, France), T. Leblanc (Hopital Saint-Louis, Paris, France), L. Matherly (Karmanos Cancer Institute, Detroit, Michigan) and M. J. You (MD Anderson Cancer Center, Houston, Texas) for providing patient T-ALL samples. This work was supported by grants from the Canadian Institutes of Health Research/Terry Fox Foundation, the Leukemia and Lymphoma Society of Canada, the Cancer Research Society, the Lymphoma Foundation Canada (to A. P. W.) and the US National Cancer Institute (P01CA119070 to J. C. A.). M.Y.C. was supported by a career development award from the US National Cancer Institute (K08CA120544). A.P.W. was a Michael Smith Foundation for Health Research Scholar.	Adly A.M., 2010, J IMMUNOL, V3, P129; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Cox CV, 2007, BLOOD, V109, P674, DOI 10.1182/blood-2006-06-030445; Dallas MH, 2007, BLOOD, V109, P3579, DOI 10.1182/blood-2006-08-039842; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Felli MP, 2005, ONCOGENE, V24, P992, DOI 10.1038/sj.onc.1208302; Gerby B, 2011, LEUKEMIA, V25, P1249, DOI 10.1038/leu.2011.93; Grossmann V, 2011, HAEMATOL-HEMATOL J, V96, P1874, DOI 10.3324/haematol.2011.043919; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Medyouf H, 2010, BLOOD, V115, P1175, DOI 10.1182/blood-2009-04-214718; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ou WB, 2008, ONCOGENE, V27, P5624, DOI 10.1038/onc.2008.177; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robbins PB, 1998, P NATL ACAD SCI USA, V95, P10182, DOI 10.1073/pnas.95.17.10182; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sirven A, 2000, BLOOD, V96, P4103; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tatarek J, 2011, BLOOD, V118, P1579, DOI 10.1182/blood-2010-08-300343; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tremblay M, 2010, GENE DEV, V24, P1093, DOI 10.1101/gad.1897910; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Winter SS, 2007, BLOOD, V110, P1429, DOI 10.1182/blood-2006-12-059790; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	59	63	67	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1693	+		10.1038/nm.2960	http://dx.doi.org/10.1038/nm.2960			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086478	Green Submitted, Green Accepted			2022-12-25	WOS:000310837000031
J	Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S; Turner, SD; Pileri, S; Piccaluga, PP; Valent, P; Messana, K; Landra, I; Weichhart, T; Knapp, S; Shehata, M; Todaro, M; Sexl, V; Hofler, G; Piva, R; Medico, E; Ruggeri, BA; Cheng, MG; Eferl, R; Egger, G; Penninger, JM; Jaeger, U; Moriggl, R; Inghirami, G; Kenner, L				Laimer, Daniela; Dolznig, Helmut; Kollmann, Karoline; Vesely, Paul W.; Schlederer, Michaela; Merkel, Olaf; Schiefer, Ana-Iris; Hassler, Melanie R.; Heider, Susi; Amenitsch, Lena; Thallinger, Christiane; Staber, Philipp B.; Simonitsch-Klupp, Ingrid; Artaker, Matthias; Lagger, Sabine; Turner, Suzanne D.; Pileri, Stefano; Piccaluga, Pier Paolo; Valent, Peter; Messana, Katia; Landra, Indira; Weichhart, Thomas; Knapp, Sylvia; Shehata, Medhat; Todaro, Maria; Sexl, Veronika; Hoefler, Gerald; Piva, Roberto; Medico, Enzo; Ruggeri, Bruce A.; Cheng, Mangeng; Eferl, Robert; Egger, Gerda; Penninger, Josef M.; Jaeger, Ulrich; Moriggl, Richard; Inghirami, Giorgio; Kenner, Lukas			PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas	NATURE MEDICINE			English	Article							LARGE-CELL LYMPHOMA; ACTIVATING MUTATIONS; C-JUN; KINASE; GENE; INHIBITION; FUSION; PROLIFERATION; TRANSCRIPTION; IMATINIB	Anaplastic large cell lymphoma (ALCL) is an aggressive non-Hodgkin's lymphoma found in children and young adults. ALCLs frequently carry a chromosomal translocation that results in expression of the oncoprotein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK). The key molecular downstream events required for NPM-ALK-triggered lymphoma growth have been only partly unveiled. Here we show that the activator protein 1 family members JUN and JUNB promote lymphoma development and tumor dissemination through transcriptional regulation of platelet-derived growth factor receptor-beta (PDGFRB) in a mouse model of NPM-ALK-triggered lymphomagenesis. Therapeutic inhibition of PDGFRB markedly prolonged survival of NPM-ALK transgenic mice and increased the efficacy of an ALK-specific inhibitor in transplanted NPM-ALK tumors. Notably, inhibition of PDGFRA and PDGFRB in a patient with refractory late-stage NPM-ALK+ ALCL resulted in rapid, complete and sustained remission. Together, our data identify PDGFRB as a previously unknown JUN and JUNB target that could be a highly effective therapy for ALCL.	[Laimer, Daniela; Schiefer, Ana-Iris; Hassler, Melanie R.; Heider, Susi; Amenitsch, Lena; Simonitsch-Klupp, Ingrid; Egger, Gerda; Kenner, Lukas] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Dolznig, Helmut; Weichhart, Thomas] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Kollmann, Karoline; Sexl, Veronika] Vet Univ Vienna, Inst Pharmacol & Toxicol, A-1030 Vienna, Austria; [Vesely, Paul W.; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Schlederer, Michaela; Moriggl, Richard; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Merkel, Olaf] Paracelsus Med Univ, Dept Med 3, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Hassler, Melanie R.; Thallinger, Christiane] Med Univ Vienna, Dept Internal Med 1, Div Oncol, Vienna, Austria; [Staber, Philipp B.] Med Univ Graz, Div Hematol, Graz, Austria; [Staber, Philipp B.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA; [Artaker, Matthias; Lagger, Sabine] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Med Biochem, Vienna, Austria; [Turner, Suzanne D.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Mol Histopathol, Cambridge CB2 2QQ, England; [Pileri, Stefano; Piccaluga, Pier Paolo] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol & Oncol L&A Seragnoli, Pathol & Hematopathol Unit, Bologna, Italy; [Valent, Peter; Shehata, Medhat; Jaeger, Ulrich] Med Univ Vienna, Ctr Comprehens Canc, Dept Internal Med 1,Drug & Target Screening Unit, Div Hematol & Hemostaseol, Vienna, Austria; [Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Messana, Katia; Landra, Indira; Todaro, Maria; Piva, Roberto; Inghirami, Giorgio] Univ Turin, Ctr Expt Res & Med Studies, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Knapp, Sylvia] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Knapp, Sylvia] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Piva, Roberto] NYU, Sch Med, Dept Pathol, New York, NY USA; [Piva, Roberto] NYU, Sch Med, Ctr Canc, New York, NY USA; [Medico, Enzo; Inghirami, Giorgio] Univ Turin, Dept Oncol Sci, Turin, Italy; [Medico, Enzo] Inst Canc Res & Treatment, Lab Oncogenom, Candiolo, Italy; [Ruggeri, Bruce A.; Cheng, Mangeng] Cephalon Inc, Worldwide Discovery Res, W Chester, PA USA; [Eferl, Robert] Med Univ Vienna, Ctr Comprehens Canc, Inst Canc Res, Dept Internal Med 1, Vienna, Austria; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Graz; Ludwig Boltzmann Institute; Paracelsus Private Medical University; Medical University of Vienna; Medical University of Graz; Harvard University; Harvard Medical School; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Medical University of Vienna; Ludwig Boltzmann Institute; University of Turin; Austrian Academy of Sciences; Medical University of Vienna; New York University; New York University; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Teva Pharmaceutical Industries; Cephalon Inc.; Medical University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Kenner, L (corresponding author), Med Univ Vienna, Clin Inst Pathol, Vienna, Austria.	lukas.kenner@meduniwien.ac.at	Weichhart, Thomas/J-3531-2014; Staber, Philipp Bernhard/ADK-1536-2022; Valent, Peter/B-8533-2016; Schiefer, Ana-Iris/AAX-8123-2020; Test, PV/U-9451-2019; Medico, Enzo/AAC-3185-2021; Gamperl, Susi/V-2715-2019; Test, Test/Y-7921-2019; Piccaluga, Pier Paolo/H-7132-2019; Dolznig, Helmut/L-7005-2015; Piva, Roberto/H-7315-2013; Egger, Gerda/B-7177-2013; Knapp, Sylvia/J-3973-2013; Vesely, Paul/AAO-1286-2020; Penninger, Josef M/I-6860-2013; Turner, Suzanne Dawn/K-4405-2013; Moriggl, Richard/H-8118-2019; Lagger, Sabine/GQP-6676-2022; Sexl, Veronika/B-8657-2016; Piva, Roberto/B-9580-2018	Weichhart, Thomas/0000-0002-4349-0797; Staber, Philipp Bernhard/0000-0001-6729-7708; Valent, Peter/0000-0003-0456-5095; Medico, Enzo/0000-0002-3917-2438; Gamperl, Susi/0000-0003-0456-5095; Piccaluga, Pier Paolo/0000-0002-9432-0595; Dolznig, Helmut/0000-0002-6063-3585; Knapp, Sylvia/0000-0001-9016-5244; Penninger, Josef M/0000-0002-8194-3777; Turner, Suzanne Dawn/0000-0002-8439-4507; Moriggl, Richard/0000-0003-0918-9463; Kollmann, Karoline/0000-0002-7937-4245; Shehata, Medhat/0000-0001-6891-646X; Kenner, Lukas/0000-0003-2184-1338; Egger, Gerda/0000-0003-2489-155X; Eferl, Robert/0000-0002-6074-7144; Vesely, Paul Willibald/0000-0003-3608-1060; Sexl, Veronika/0000-0001-9363-0412; Merkel, Olaf/0000-0001-5089-344X; Piva, Roberto/0000-0002-2273-3470; Lagger, Sabine/0000-0002-3032-9910; Amenitsch, Lena/0000-0003-4873-1155	Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P-18478-B12]; Genome Research in Austria InflammoBiota project; FWF [SFB-F28, 19723]; Elise Richter Fellowship [FWF V102-B12]; FP7 Marie Curie International Reintegration Grant [IRG 230984]; Herzfelder Family Foundation; Niederosterreichische Forschungs- und Bildungsges.m.b.H.P.W.V.; Jubil umsfonds of the sterreichische Nationalbank [P-12147]; Else-Kroner Fresenius Stiftung; Italian Association for Cancer Research (AIRC) Special Program in Clinical Molecular Oncology, Milan [10007]; Regione Piemonte (ONCOPROT) [CIPE 25/2005]; ImmOnc ('Innovative approaches to bust the immune responses', Programma Operativo Regionale, Piattaforme Innovative BIO) [LR 34/2004];  [J 2922]	Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Genome Research in Austria InflammoBiota project; FWF(Austrian Science Fund (FWF)); Elise Richter Fellowship; FP7 Marie Curie International Reintegration Grant; Herzfelder Family Foundation; Niederosterreichische Forschungs- und Bildungsges.m.b.H.P.W.V.; Jubil umsfonds of the sterreichische Nationalbank; Else-Kroner Fresenius Stiftung; Italian Association for Cancer Research (AIRC) Special Program in Clinical Molecular Oncology, Milan(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte (ONCOPROT)(Regione Piemonte); ImmOnc ('Innovative approaches to bust the immune responses', Programma Operativo Regionale, Piattaforme Innovative BIO); 	We thank E. F. Wagner for providing the JUNB<SUP>flox/flox</SUP> and JUN<SUP>flox/flox</SUP> mice, A. Ostman for helpful discussions and technical help with PDGFRB analysis, and S. Reichmann for technical help with soluble-CD30 and PDGFB assays. L. K. is supported by the Fonds zur Forderung der wissenschaftlichen Forschung (FWF, P-18478-B12) and the Genome Research in Austria InflammoBiota project. R. M., V. S. and R. E. are supported by the FWF (SFB-F28) and V. S. is supported by FWF project 19723. G. E. is supported by an Elise Richter Fellowship (FWF V102-B12) and an FP7 Marie Curie International Reintegration Grant (IRG 230984). H. D. is supported by the Herzfelder Family Foundation and the Niederosterreichische Forschungs- und Bildungsges.m.b.H.P.W.V. and P. B. S. were supported by Jubil umsfonds of the sterreichische Nationalbank (P-12147), and P. W. V. was awarded an E. Schroedinger Grant (J 2922). T. W. is supported by the Else-Kroner Fresenius Stiftung. S. P. and G. I. are supported by Italian Association for Cancer Research (AIRC) Special Program in Clinical Molecular Oncology, Milan (5x1000 No. 10007). G. I. is supported by Regione Piemonte (ONCOPROT, CIPE 25/2005); ImmOnc ('Innovative approaches to bust the immune responses', Programma Operativo Regionale, Piattaforme Innovative BIO F. E. S. R. 2007/13, Asse 1 'Ricerca e innovazione' della LR 34/2004) and the Oncology Program of Compagnia di San Paolo, Torino. R. P. is supported by AIRC grant IG-8675. R. E. is supported by the FWF Doktoratskolleg-plus Inflammation and Immunity grant, the Comprehensive Cancer Center Vienna Research Grant and the Austrian Federal Ministry of Science and Research GENAU Austromouse grant. J. M. P. is supported by the Austrian Academy of Sciences and an Advanced Grant from the European Research Council. This study was performed on behalf of the European Research Initiative on ALCL (ERIA).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheng MG, 2012, MOL CANCER THER, V11, P670, DOI 10.1158/1535-7163.MCT-11-0776; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Claesson-Welsh Lena, 1994, Progress in Growth Factor Research, V5, P37, DOI 10.1016/0955-2235(94)90016-7; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Ergin M, 2001, EXP HEMATOL, V29, P1082, DOI 10.1016/S0301-472X(01)00688-9; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gunby RH, 2006, J MED CHEM, V49, P5759, DOI 10.1021/jm060380k; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; KADIN ME, 1994, J CLIN ONCOL, V12, P884, DOI 10.1200/JCO.1994.12.5.884; KADIN ME, 1994, ANN ONCOL, V5, pS25, DOI 10.1093/annonc/5.suppl_1.S25; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pardanani A, 2004, BLOOD, V104, P1931, DOI 10.1182/blood-2004-01-0246; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pietras K, 2002, CANCER RES, V62, P5476; Piva R, 2010, J CLIN ONCOL, V28, P1583, DOI 10.1200/JCO.2008.20.9759; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Stein H, 2000, BLOOD, V96, P3681; Stover EH, 2005, BLOOD, V106, P3206, DOI 10.1182/blood-2005-05-1932; Sumida T, 2011, INT J CANCER, V128, P2050, DOI 10.1002/ijc.25812; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	38	92	93	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1699	+		10.1038/nm.2966	http://dx.doi.org/10.1038/nm.2966			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23064464	Green Submitted			2022-12-25	WOS:000310837000032
J	Rudin, CM; Durinck, S; Stawiski, EW; Poirier, JT; Modrusan, Z; Shames, DS; Bergbower, EA; Guan, YH; Shin, J; Guillory, J; Rivers, CS; Foo, CK; Bhatt, D; Stinson, J; Gnad, F; Haverty, PM; Gentleman, R; Chaudhuri, S; Janakiraman, V; Jaiswal, BS; Parikh, C; Yuan, WL; Zhang, ZM; Koeppen, H; Wu, TD; Stern, HM; Yauch, RL; Huffman, KE; Paskulin, DD; Illei, PB; Varella-Garcia, M; Gazdar, AF; de Sauvage, FJ; Bourgon, R; Minna, JD; Brock, MV; Seshagiri, S				Rudin, Charles M.; Durinck, Steffen; Stawiski, Eric W.; Poirier, John T.; Modrusan, Zora; Shames, David S.; Bergbower, Emily A.; Guan, Yinghui; Shin, James; Guillory, Joseph; Rivers, Celina Sanchez; Foo, Catherine K.; Bhatt, Deepali; Stinson, Jeremy; Gnad, Florian; Haverty, Peter M.; Gentleman, Robert; Chaudhuri, Subhra; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Parikh, Chaitali; Yuan, Wenlin; Zhang, Zemin; Koeppen, Hartmut; Wu, Thomas D.; Stern, Howard M.; Yauch, Robert L.; Huffman, Kenneth E.; Paskulin, Diego D.; Illei, Peter B.; Varella-Garcia, Marileila; Gazdar, Adi F.; de Sauvage, Frederic J.; Bourgon, Richard; Minna, John D.; Brock, Malcolm V.; Seshagiri, Somasekar			Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer	NATURE GENETICS			English	Article							NONSMALL CELL; MUTATIONS; CARCINOMA; KINASE; TARGET; GROWTH; DIFFERENTIATION; REARRANGEMENTS; PATHWAY; COMPLEX	Small-cell lung cancer (SCLC) is an exceptionally aggressive disease with poor prognosis. Here, we obtained exome, transcriptome and copy-number alteration data from approximately 53 samples consisting of 36 primary human SCLC and normal tissue pairs and 17 matched SCLC and lymphoblastoid cell lines. We also obtained data for 4 primary tumors and 23 SCLC cell lines. We identified 22 significantly mutated genes in SCLC, including genes encoding kinases, G protein-coupled receptors and chromatin-modifying proteins. We found that several members of the SOX family of genes were mutated in SCLC. We also found SOX2 amplification in similar to 27% of the samples. Suppression of SOX2 using shRNAs blocked proliferation of SOX2-amplified SCLC lines. RNA sequencing identified multiple fusion transcripts and a recurrent RLF-MYCL1 fusion. Silencing of MYCL1 in SCLC cell lines that had the RLF-MYCL1 fusion decreased cell proliferation. These data provide an in-depth view of the spectrum of genomic alterations in SCLC and identify several potential targets for therapeutic intervention.	[Rudin, Charles M.; Poirier, John T.; Bergbower, Emily A.; Shin, James; Illei, Peter B.; Brock, Malcolm V.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Durinck, Steffen; Stawiski, Eric W.; Modrusan, Zora; Guan, Yinghui; Guillory, Joseph; Rivers, Celina Sanchez; Foo, Catherine K.; Bhatt, Deepali; Stinson, Jeremy; Chaudhuri, Subhra; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Parikh, Chaitali; Yuan, Wenlin; de Sauvage, Frederic J.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Durinck, Steffen; Stawiski, Eric W.; Gnad, Florian; Haverty, Peter M.; Gentleman, Robert; Zhang, Zemin; Wu, Thomas D.; Bourgon, Richard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Shames, David S.; Yauch, Robert L.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Koeppen, Hartmut; Stern, Howard M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Huffman, Kenneth E.; Gazdar, Adi F.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Paskulin, Diego D.; Varella-Garcia, Marileila] Univ Colorado, Ctr Canc, Div Med Oncol, Aurora, CO USA	Johns Hopkins University; Johns Hopkins Medicine; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus	Rudin, CM (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	rudin@jhmi.edu; sekar@gene.com	Rudin, Charles/R-2530-2019; de Sauvage, Frederic/ABE-8400-2020	Rudin, Charles/0000-0001-5204-3465; de Sauvage, Frederic/0000-0002-5275-2584; Gnad, Florian/0000-0002-2287-2251; Bourgon, Richard/0000-0002-5890-4374; Poirier, John/0000-0001-9795-5644; Bergbower, Emily/0000-0002-7937-2661	Burroughs Wellcome Fund; Flight Attendant Medical Research Institute; Johns Hopkins Specialized Programs of Research Excellence (SPORE) NCI [P50CA058184]; Colorado SPORE NCI [P50 CA058187]; University of Texas SPORE NCI [P50CA70907]; Coordenacao de Aperfeicoamento de Passoal de Nivel Superior (CAPES) Foundation; Ministry of Education of Brazil; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA070907, P50CA058184, P30CA046934, P50CA058187] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Flight Attendant Medical Research Institute; Johns Hopkins Specialized Programs of Research Excellence (SPORE) NCI; Colorado SPORE NCI; University of Texas SPORE NCI; Coordenacao de Aperfeicoamento de Passoal de Nivel Superior (CAPES) Foundation; Ministry of Education of Brazil; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank Genentech DNA Sequencing and Oligo groups for their help with the project. We thank M.A. Huntley and J. Degenhardt for bioinformatics support and the Pathology Core Labs for providing histology, IHC and tissue management support. This work was also supported by grants from the Burroughs Wellcome Fund, the Flight Attendant Medical Research Institute, the Johns Hopkins Specialized Programs of Research Excellence (SPORE) NCI P50CA058184 (M.V.B. and C.M.R.), the Colorado SPORE NCI P50 CA058187 (M.V.-G) and the University of Texas SPORE NCI P50CA70907 (J.D.M., A.F.G. and K.E.H.). D.D.P. is supported by the Coordenacao de Aperfeicoamento de Passoal de Nivel Superior (CAPES) Foundation and the Ministry of Education of Brazil.	Arriola E, 2008, CLIN TRANSL ONCOL, V10, P189, DOI 10.1007/s12094-008-0181-1; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; CARNEY DN, 1985, RECENT RESULTS CANC, V99, P157; D'Angelo SP, 2010, CANCER BIOL THER, V10, P1, DOI 10.4161/cbt.10.1.12045; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Hann CL, 2007, TRENDS MOL MED, V13, P150, DOI 10.1016/j.molmed.2007.02.003; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; MAKELA TP, 1991, EMBO J, V10, P1331, DOI 10.1002/j.1460-2075.1991.tb07652.x; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Molderings GJ, 2007, SCAND J GASTROENTERO, V42, P1045, DOI 10.1080/00365520701245744; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; MORI N, 1990, ONCOGENE, V5, P1713; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Onuki N, 1999, CANCER, V85, P600, DOI 10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W; Phelps RM, 1996, J CELL BIOCHEM, P32; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shibata T, 2009, CANCER LETT, V283, P203, DOI 10.1016/j.canlet.2009.03.038; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SIMMS E, 1980, CANCER RES, V40, P4356; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tatematsu A, 2008, CLIN CANCER RES, V14, P6092, DOI 10.1158/1078-0432.CCR-08-0332; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Wegner M, 2011, GENE DEV, V25, P2423, DOI 10.1101/gad.181487.111; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956	48	709	733	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1111	+		10.1038/ng.2405	http://dx.doi.org/10.1038/ng.2405			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22941189	Green Accepted			2022-12-25	WOS:000309550200010
J	Holt, KE; Baker, S; Weill, FX; Holmes, EC; Kitchen, A; Yu, J; Sangal, V; Brown, DJ; Coia, JE; Kim, DW; Choi, SY; Kim, SH; da Silveira, WD; Pickard, DJ; Farrar, JJ; Parkhill, J; Dougan, G; Thomson, NR				Holt, Kathryn E.; Baker, Stephen; Weill, Francois-Xavier; Holmes, Edward C.; Kitchen, Andrew; Yu, Jun; Sangal, Vartul; Brown, Derek J.; Coia, John E.; Kim, Dong Wook; Choi, Seon Young; Kim, Su Hee; da Silveira, Wanderley D.; Pickard, Derek J.; Farrar, Jeremy J.; Parkhill, Julian; Dougan, Gordon; Thomson, Nicholas R.			Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe	NATURE GENETICS			English	Article							FREE-LIVING AMEBAS; ESCHERICHIA-COLI; PLESIOMONAS-SHIGELLOIDES; VIETNAMESE CHILDREN; BACILLARY DYSENTERY; TRANSMISSION; EVOLUTION; PLASMID; DIVERSITY; PATTERNS	Shigella are human-adapted Escherichia coli that have gained the ability to invade the human gut mucosa and cause dysentery(1,2), spreading efficiently via low-dose fecal-oral transmission(3,4). Historically, S. sonnei has been predominantly responsible for dysentery in developed countries but is now emerging as a problem in the developing world, seeming to replace the more diverse Shigella flexneri in areas undergoing economic development and improvements in water quality(4-6). Classical approaches have shown that S. sonnei is genetically conserved and clonal(7). We report here whole-genome sequencing of 132 globally distributed isolates. Our phylogenetic analysis shows that the current S. sonnei population descends from a common ancestor that existed less than 500 years ago and that diversified into several distinct lineages with unique characteristics. Our analysis suggests that the majority of this diversification occurred in Europe and was followed by more recent establishment of local pathogen populations on other continents, predominantly due to the pandemic spread of a single, rapidly evolving, multidrug-resistant lineage.	[Holt, Kathryn E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Baker, Stephen; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Holmes, Edward C.; Kitchen, Andrew] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Holmes, Edward C.] US Natl Inst Hlth, Fogarty Int Ctr, Bethesda, MD USA; [Yu, Jun; Sangal, Vartul] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Brown, Derek J.; Coia, John E.] Stobhill Hosp, Scottish Salmonella Shigella & Clostridium Diffic, Glasgow, Lanark, Scotland; [Kim, Dong Wook; Choi, Seon Young; Kim, Su Hee] IVI, Mol Biol Lab, Seoul, South Korea; [Kim, Dong Wook] Hanyang Univ Ansan, Coll Pharm, Dept Pharm, Kyeonggi Do, South Korea; [da Silveira, Wanderley D.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil; [Pickard, Derek J.; Parkhill, Julian; Dougan, Gordon; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Cambridge, England	University of Melbourne; University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Strathclyde; International Vaccine Institute; Hanyang University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Wellcome Trust Sanger Institute	Holt, KE (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	kholt@unimelb.edu.au; nrt@sanger.ac.uk	Parkhill, Julian/G-4703-2011; Farrar, Jeremy J./HGA-7610-2022; Holt, Kathryn E/A-8108-2012; Kim, Dong Wook/H-8253-2015; Brown, Derek/AAE-5597-2020; Holmes, Edward/GVR-9499-2022; Sangal, Vartul/AAB-5426-2020; Coia, John/AAP-5379-2020; Holmes, Edward/Y-2789-2019; Dias da Silveira, Wanderley/C-6420-2012; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Holt, Kathryn E/0000-0003-3949-2471; Kim, Dong Wook/0000-0001-5351-7597; Brown, Derek/0000-0003-3742-8257; Sangal, Vartul/0000-0002-7405-8446; Coia, John/0000-0002-4966-8453; Holmes, Edward/0000-0001-9596-3552; Thomson, Nicholas/0000-0002-4432-8505; Farrar, Jeremy/0000-0002-2700-623X; Weill, Francois-Xavier/0000-0001-9941-5799; Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [0689]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0082]; National Health & Medical Research Council (NHMRC) of Australia [628930]; Oak Foundation Fellowship through Oxford University [OAKF9]; Li Ka Shing foundation [LG13]; Institut de Veille Sanitaire; UK Medical Research Council (MRC) [G0800173]; Korean Ministry of Knowledge and Economy (MKE) [RTI05-01-01]; MRC [G0800173] Funding Source: UKRI; Medical Research Council [G0800173] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Victorian Life Sciences Computation Initiative (VLSCI); National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Oak Foundation Fellowship through Oxford University; Li Ka Shing foundation; Institut de Veille Sanitaire; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Korean Ministry of Knowledge and Economy (MKE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Levine (University of Maryland School of Medicine) and C. Tang (University of Oxford) for their kind gift of S. sonnei strain 53G. This work was supported by the Wellcome Trust (0689) and a Victorian Life Sciences Computation Initiative (VLSCI) grant (VR0082) on its Peak Computing Facility at the University of Melbourne (an initiative of the Victorian Government, Australia). K.E.H. was supported by a Fellowship from the National Health & Medical Research Council (NHMRC) of Australia (628930); S.B. is supported by an Oak Foundation Fellowship through Oxford University (OAKF9) and by the Li Ka Shing foundation (LG13); F.X.W. was partially funded by the Institut de Veille Sanitaire; J.Y. was supported by a UK Medical Research Council (MRC) grant (G0800173); and D.W.K. was partially supported by grant RTI05-01-01 from the Korean Ministry of Knowledge and Economy (MKE).	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Christopher PRH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006784.pub4; COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Genobile Dania, 2004, Commun Dis Intell Q Rep, V28, P225; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Vinh H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001264; Ha V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-204; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Jeong HJ, 2007, EXP PARASITOL, V115, P181, DOI 10.1016/j.exppara.2006.08.002; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; KARAOLIS DKR, 1994, J CLIN MICROBIOL, V32, P796, DOI 10.1128/JCM.32.3.796-802.1994; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lewis HC, 2009, EPIDEMIOL INFECT, V137, P326, DOI 10.1017/S0950268808001829; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; NASTASI A, 1993, EPIDEMIOL INFECT, V110, P23, DOI 10.1017/S0950268800050640; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Ranjbar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-62; SACK DA, 1994, LANCET, V343, P1413, DOI 10.1016/S0140-6736(94)92531-3; Saeed A, 2009, ARCH MICROBIOL, V191, P83, DOI 10.1007/s00203-008-0422-2; SANSONETTI PJ, 1981, INFECT IMMUN, V34, P75, DOI 10.1128/IAI.34.1.75-83.1981; Shepherd JG, 2000, INFECT IMMUN, V68, P6056, DOI 10.1128/IAI.68.10.6056-6061.2000; SHIMADA T, 1978, JPN J MED SCI BIOL, V31, P135, DOI 10.7883/yoken1952.31.135; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000455; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; VANDEVERG LL, 1992, J INFECT DIS, V166, P158, DOI 10.1093/infdis/166.1.158; Vinh H, 2000, T ROY SOC TROP MED H, V94, P323, DOI 10.1016/S0035-9203(00)90343-2; Winiecka-Krusnell J, 1999, SCAND J INFECT DIS, V31, P383, DOI 10.1080/00365549950163833; World Health Organization, 2005, GUIDELINES CONTROL S; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	40	188	193	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1056	+		10.1038/ng.2369	http://dx.doi.org/10.1038/ng.2369			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22863732	Green Accepted			2022-12-25	WOS:000308491200020
J	Ito, K; Carracedo, A; Weiss, D; Arai, F; Ala, U; Avigan, DE; Schafer, ZT; Evans, RM; Suda, T; Lee, CH; Pandolfi, PP				Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Arai, Fumio; Ala, Ugo; Avigan, David E.; Schafer, Zachary T.; Evans, Ronald M.; Suda, Toshio; Lee, Chih-Hao; Pandolfi, Pier Paolo			A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-DELTA; ENERGY-METABOLISM; MAMMALIAN TARGET; LIPID-METABOLISM; SKELETAL-MUSCLE; INHIBITION; BETA; DIFFERENTIATION; MODULATION; QUIESCENCE	Stem-cell function is an exquisitely regulated process. Thus far, the contribution of metabolic cues to stem-cell function has not been well understood. Here we identify a previously unknown promyelocytic leukemia (PML)-peroxisome proliferator-activated receptor delta (PPAR-delta)-fatty-acid oxidation (FAO) pathway for the maintenance of hematopoietic stem cells (HSCs). We have found that loss of PPAR-delta or inhibition of mitochondrial FAO induces loss of HSC maintenance, whereas treatment with PPAR-delta agonists improved HSC maintenance. PML exerts its essential role in HSC maintenance through regulation of PPAR signaling and FAO. Mechanistically, the PML-PPAR-delta-FAO pathway controls the asymmetric division of HSCs. Deletion of Ppard or Pml as well as inhibition of FAO results in the symmetric commitment of HSC daughter cells, whereas PPAR-delta activation increased asymmetric cell division. Thus, our findings identify a metabolic switch for the control of HSC cell fate with potential therapeutic implications.	[Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Genet, Boston, MA 02215 USA; [Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Canc Genet Program, Boston, MA 02215 USA; [Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Dept Med, Boston, MA 02215 USA; [Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Dept Pathol, Boston, MA 02215 USA; [Arai, Fumio; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Tokyo, Japan; [Avigan, David E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, Boston, MA 02215 USA; [Schafer, Zachary T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard University; Keio University; Harvard University; Beth Israel Deaconess Medical Center; University of Notre Dame; Howard Hughes Medical Institute; Salk Institute; Harvard University; Harvard T.H. Chan School of Public Health	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Genet, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Evans, Ronald/AAF-4001-2019; Ala, Ugo/K-2029-2016; Suda, Toshio/H-6761-2013; Arai, Fumio/J-5241-2013; Carracedo, Arkaitz/F-7029-2011	Evans, Ronald/0000-0002-9986-5965; Ala, Ugo/0000-0001-5408-6397; Suda, Toshio/0000-0001-7540-1771; Arai, Fumio/0000-0003-1936-4907; Carracedo, Arkaitz/0000-0001-5957-1260; Pandolfi, Pier Paolo/0000-0002-5352-5295	K99 US National Institutes of Health (NIH); EMBO; Ramon y Cajal award (Spanish Ministry of Education); Instituto de Salud Carlos III [PI10/01484]; Marie Curie Reintegration grant [277043]; Basque Government [PI2012-03]; NIH; NATIONAL CANCER INSTITUTE [R00CA139009, R01CA142780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER	K99 US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Ramon y Cajal award (Spanish Ministry of Education); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Marie Curie Reintegration grant(European Commission); Basque Government(Basque Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the members of the Pandolfi laboratory for comments and discussion. We especially thank K. Hosokawa for technical advice on asymmetric division, M. Alberich-Jorda and A.M. Zubiaga for technical help and critical discussions, and P. Puigserver and M.C. Haigis for technical support with the metabolic analysis. K.I. was supported by a K99 US National Institutes of Health (NIH) grant. The work of A.C. was supported by EMBO, the Ramon y Cajal award (Spanish Ministry of Education), Instituto de Salud Carlos III (PI10/01484), the Marie Curie Reintegration grant (277043) and the Basque Government (PI2012-03). This work was supported by NIH grants to P.P.P.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Clapham JC, 2007, DIABETES OBES METAB, V9, P259, DOI 10.1111/j.1463-1326.2006.00608.x; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Ergen AV, 2010, EXP GERONTOL, V45, P286, DOI 10.1016/j.exger.2009.12.010; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lansdorp P M, 1997, Biol Blood Marrow Transplant, V3, P171; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lemischka IR, 2003, NATURE, V425, P778, DOI 10.1038/425778a; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Metcalf D, 1998, IMMUNOL CELL BIOL, V76, P441, DOI 10.1046/j.1440-1711.1998.00761.x; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ogawa M, 1999, INT J HEMATOL, V69, P2; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Takahashi S, 2007, ENDOCR J, V54, P347, DOI 10.1507/endocrj.KR-99; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; TUTWILER GF, 1985, P SOC EXP BIOL MED, V178, P288; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wang ZG, 1998, SCIENCE, V279, P1547; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; WOLF HPO, 1992, HORM METAB RES, V26, P62; WOLF NS, 1974, CELL TISSUE KINET, V7, P89, DOI 10.1111/j.1365-2184.1974.tb00402.x; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Wurch T, 2002, N-S ARCH PHARMACOL, V365, P133, DOI 10.1007/s00210-001-0504-z	58	469	485	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1350	+		10.1038/nm.2882	http://dx.doi.org/10.1038/nm.2882			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22902876	Green Accepted			2022-12-25	WOS:000308472300030
J	Krauthammer, M; Kong, Y; Ha, BH; Evans, P; Bacchiocchi, A; McCusker, JP; Cheng, E; Davis, MJ; Goh, G; Choi, M; Ariyan, S; Narayan, D; Dutton-Regester, K; Capatana, A; Holman, EC; Bosenberg, M; Sznol, M; Kluger, HM; Brash, DE; Stern, DF; Materin, MA; Lo, RS; Mane, S; Ma, SG; Kidd, KK; Hayward, NK; Lifton, RP; Schlessinger, J; Boggon, TJ; Halaban, R				Krauthammer, Michael; Kong, Yong; Ha, Byung Hak; Evans, Perry; Bacchiocchi, Antonella; McCusker, James P.; Cheng, Elaine; Davis, Matthew J.; Goh, Gerald; Choi, Murim; Ariyan, Stephan; Narayan, Deepak; Dutton-Regester, Ken; Capatana, Ana; Holman, Edna C.; Bosenberg, Marcus; Sznol, Mario; Kluger, Harriet M.; Brash, Douglas E.; Stern, David F.; Materin, Miguel A.; Lo, Roger S.; Mane, Shrikant; Ma, Shuangge; Kidd, Kenneth K.; Hayward, Nicholas K.; Lifton, Richard P.; Schlessinger, Joseph; Boggon, Titus J.; Halaban, Ruth			Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma	NATURE GENETICS			English	Article							KINASE INHIBITOR; BRAF MUTATIONS; MORPHOLOGIC FEATURES; MOLECULAR-GRAPHICS; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; AURORA KINASE; IN-VIVO; PROTEIN; CELLS	We characterized the mutational landscape of melanoma, the form of skin cancer with the highest mortality rate, by sequencing the exomes of 147 melanomas. Sun-exposed melanomas had markedly more ultraviolet ( UV)-like C> T somatic mutations compared to sun-shielded acral, mucosal and uveal melanomas. Among the newly identified cancer genes was PPP6C, encoding a serine/threonine phosphatase, which harbored mutations that clustered in the active site in 12% of sun-exposed melanomas, exclusively in tumors with mutations in BRAF or NRAS. Notably, we identified a recurrent UV-signature, an activating mutation in RAC1 in 9.2% of sun-exposed melanomas. This activating mutation, the third most frequent in our cohort of sun-exposed melanoma after those of BRAF and NRAS, changes Pro29 to serine ( RAC1(P29S)) in the highly conserved switch I domain. Crystal structures, and biochemical and functional studies of RAC1(P29S) showed that the alteration releases the conformational restraint conferred by the conserved proline, causes an increased binding of the protein to downstream effectors, and promotes melanocyte proliferation and migration. These findings raise the possibility that pharmacological inhibition of downstream effectors of RAC1 signaling could be of therapeutic benefit.	[Bacchiocchi, Antonella; Cheng, Elaine; Holman, Edna C.; Bosenberg, Marcus; Brash, Douglas E.; Halaban, Ruth] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Krauthammer, Michael; Evans, Perry; McCusker, James P.; Capatana, Ana; Stern, David F.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kong, Yong] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Kong, Yong] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT USA; [Ha, Byung Hak; Davis, Matthew J.; Schlessinger, Joseph; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Goh, Gerald; Choi, Murim; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Ariyan, Stephan; Narayan, Deepak] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Dutton-Regester, Ken] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia; [Dutton-Regester, Ken; Hayward, Nicholas K.] Queensland Inst Med Res, Dept Genet & Computat Biol, Brisbane, Qld 4006, Australia; [Sznol, Mario; Kluger, Harriet M.] Yale Univ, Sch Med, Ctr Comprehens Canc, Sect Med Oncol, New Haven, CT 06510 USA; [Brash, Douglas E.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Materin, Miguel A.] Yale Univ, Sch Med, Dept Ophthalmol, New Haven, CT USA; [Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Dermatol, Dept Med, Los Angeles, CA 90024 USA; [Mane, Shrikant] Yale Univ, Sch Med, Ctr Human Genet & Genom, New Haven, CT USA; [Mane, Shrikant] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT USA; [Ma, Shuangge] Yale Univ, Sch Med, Sch Publ Hlth, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Yale University; Yale University; Yale University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Yale University; Yale University; Yale University	Halaban, R (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	ruth.halaban@yale.edu	Kong, Yong/B-5105-2014; Choi, Murim/AAP-9120-2021; Goh, Gerald/E-9158-2014; hayward, nick/AAV-8802-2020; Materin, Miguel A./S-4933-2019; Goh, Gerald/N-1684-2015; Holman, Edna/D-1536-2011; hayward, nicholas k/C-1367-2015	Kong, Yong/0000-0002-2881-5274; Goh, Gerald/0000-0002-3832-6466; Goh, Gerald/0000-0002-3832-6466; Holman, Edna/0000-0001-6949-5003; hayward, nicholas k/0000-0003-4760-1033; Sznol, Mario/0000-0002-4359-8749; Krauthammer, Michael/0000-0002-4808-1845; McCusker, Jamie/0000-0003-1085-6059; Dutton-Regester, Ken/0000-0002-8884-6355	Yale SPORE in Skin Cancer; National Cancer Institute grant [1 P50 CA121974]; Melanoma Research Alliance; National Library of Medicine Training grant [5T15LM007056]; Department of Dermatology; Yale Comprehensive Cancer Center; National Health and Medical Research Council of Australia; Gilead Sciences, Inc.; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	Yale SPORE in Skin Cancer; National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance; National Library of Medicine Training grant; Department of Dermatology; Yale Comprehensive Cancer Center; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Gilead Sciences, Inc.(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Yale SPORE in Skin Cancer funded by the National Cancer Institute grant number 1 P50 CA121974 (principal investigator, R.H.), the Melanoma Research Alliance (a Team award to R.H., M.B., M.K. and D.F.S.), The National Library of Medicine Training grant 5T15LM007056 (P.E.), the Department of Dermatology (R.H.), Yale Comprehensive Cancer Center (M.K.), the National Health and Medical Research Council of Australia (N.K.H. and K.D.-R.), Gilead Sciences, Inc. (J.S., M.K., R H. and T.J.B.) and a generous gift from Roz and Jerry Meyer (R.H., M.S. and H.M.K.). We thank C. Truini, W. Meng, B. Speed, E. Straka, A. Raefski, M. Scallion and S. Levin for technical support, P. Parsons, C. Schmidt and colleagues at the Queensland Institute of Medical Research for generously providing many of the melanoma cell lines, the Yale Center for Genome Analysis and the Northeastern Collaborative Access Team (NE-CAT) facility at the Advanced Photon Source at Argonne National Laboratory.	Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Bauer J, 2011, PIGM CELL MELANOMA R, V24, P345, DOI 10.1111/j.1755-148X.2011.00837.x; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bernet A, 2008, EXPERT OPIN THER TAR, V12, P995, DOI [10.1517/14728222.12.8.995, 10.1517/14728222.12.8.995 ]; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BRASH DE, 1982, NATURE, V298, P189, DOI 10.1038/298189a0; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Castets M, 2012, NATURE, V482, P534, DOI 10.1038/nature10708; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Donnelly MP, 2010, AM J HUM GENET, V86, P161, DOI 10.1016/j.ajhg.2010.01.007; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fears TR, 2002, CANCER RES, V62, P3992; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; Furney SJ, 2012, PIGM CELL MELANOMA R, V25, P488, DOI 10.1111/j.1755-148X.2012.01016.x; Garla V, 2011, BIOINFORMATICS, V27, P416, DOI 10.1093/bioinformatics/btq658; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Jensen JSRE, 2012, PLANTA MED, V78, P448, DOI 10.1055/s-0031-1298230; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Li A, 2011, DEV CELL, V21, P722, DOI 10.1016/j.devcel.2011.07.008; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Macarulla T, 2010, MOL CANCER THER, V9, P2844, DOI 10.1158/1535-7163.MCT-10-0299; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MENARD L, 1993, BIOCHEMISTRY-US, V32, P13357, DOI 10.1021/bi00211a050; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; Onken MD, 2007, CLIN CANCER RES, V13, P2923, DOI 10.1158/1078-0432.CCR-06-2383; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sehdev V, 2012, MOL CANCER THER, V11, P763, DOI 10.1158/1535-7163.MCT-11-0623; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Tworkoski K, 2011, MOL CANCER RES, V9, P801, DOI 10.1158/1541-7786.MCR-10-0512; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	81	812	826	4	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1006	+		10.1038/ng.2359	http://dx.doi.org/10.1038/ng.2359			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22842228	Green Accepted			2022-12-25	WOS:000308491200011
J	O'Connell, RJ; Thon, MR; Hacquard, S; Amyotte, SG; Kleemann, J; Torres, MF; Damm, U; Buiate, EA; Epstein, L; Alkan, N; Altmuller, J; Alvarado-Balderrama, L; Bauser, CA; Becker, C; Birren, BW; Chen, ZH; Choi, J; Crouch, JA; Duvick, JP; Farman, MA; Gan, P; Heiman, D; Henrissat, B; Howard, RJ; Kabbage, M; Koch, C; Kracher, B; Kubo, Y; Law, AD; Lebrun, MH; Lee, YH; Miyara, I; Moore, N; Neumann, U; Nordstrom, K; Panaccione, DG; Panstruga, R; Place, M; Proctor, RH; Prusky, D; Rech, G; Reinhardt, R; Rollins, JA; Rounsley, S; Schardl, CL; Schwartz, DC; Shenoy, N; Shirasu, K; Sikhakolli, UR; Stuber, K; Sukno, SA; Sweigard, JA; Takano, Y; Takahara, H; Trail, F; van der Does, HC; Voll, LM; Will, I; Young, S; Zeng, QD; Zhang, JZ; Zhou, SG; Dickman, MB; Schulze-Lefert, P; van Themaat, EVL; Ma, LJ; Vaillancourt, LJ				O'Connell, Richard J.; Thon, Michael R.; Hacquard, Stephane; Amyotte, Stefan G.; Kleemann, Jochen; Torres, Maria F.; Damm, Ulrike; Buiate, Ester A.; Epstein, Lynn; Alkan, Noam; Altmueller, Janine; Alvarado-Balderrama, Lucia; Bauser, Christopher A.; Becker, Christian; Birren, Bruce W.; Chen, Zehua; Choi, Jaeyoung; Crouch, Jo Anne; Duvick, Jonathan P.; Farman, Mark A.; Gan, Pamela; Heiman, David; Henrissat, Bernard; Howard, Richard J.; Kabbage, Mehdi; Koch, Christian; Kracher, Barbara; Kubo, Yasuyuki; Law, Audrey D.; Lebrun, Marc-Henri; Lee, Yong-Hwan; Miyara, Itay; Moore, Neil; Neumann, Ulla; Nordstroem, Karl; Panaccione, Daniel G.; Panstruga, Ralph; Place, Michael; Proctor, Robert H.; Prusky, Dov; Rech, Gabriel; Reinhardt, Richard; Rollins, Jeffrey A.; Rounsley, Steve; Schardl, Christopher L.; Schwartz, David C.; Shenoy, Narmada; Shirasu, Ken; Sikhakolli, Usha R.; Stueber, Kurt; Sukno, Serenella A.; Sweigard, James A.; Takano, Yoshitaka; Takahara, Hiroyuki; Trail, Frances; van der Does, H. Charlotte; Voll, Lars M.; Will, Isa; Young, Sarah; Zeng, Qiandong; Zhang, Jingze; Zhou, Shiguo; Dickman, Martin B.; Schulze-Lefert, Paul; van Themaat, Emiel Ver Loren; Ma, Li-Jun; Vaillancourt, Lisa J.			Lifestyle transitions in plant pathogenic Colletotrichum fungi deciphered by genome and transcriptome analyses	NATURE GENETICS			English	Article							BLAST FUNGUS; SECRETED PROTEINS; GENE-EXPRESSION; HIGGINSIANUM; GRAMINICOLA; SEQUENCE; DEGRADATION; ANTHRACNOSE; DIVERGENCE; CELLULOSE	Colletotrichum species are fungal pathogens that devastate crop plants worldwide. Host infection involves the differentiation of specialized cell types that are associated with penetration, growth inside living host cells (biotrophy) and tissue destruction (necrotrophy). We report here genome and transcriptome analyses of Colletotrichum higginsianum infecting Arabidopsis thaliana and Colletotrichum graminicola infecting maize. Comparative genomics showed that both fungi have large sets of pathogenicity-related genes, but families of genes encoding secreted effectors, pectin-degrading enzymes, secondary metabolism enzymes, transporters and peptidases are expanded in C. higginsianum. Genome-wide expression profiling revealed that these genes are transcribed in successive waves that are linked to pathogenic transitions: effectors and secondary metabolism enzymes are induced before penetration and during biotrophy, whereas most hydrolases and transporters are upregulated later, at the switch to necrotrophy. Our findings show that preinvasion perception of plant-derived signals substantially reprograms fungal gene expression and indicate previously unknown functions for particular fungal cell types.	[O'Connell, Richard J.; Hacquard, Stephane; Kleemann, Jochen; Kracher, Barbara; Panstruga, Ralph; Takahara, Hiroyuki; van der Does, H. Charlotte; Will, Isa; Schulze-Lefert, Paul; van Themaat, Emiel Ver Loren] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Thon, Michael R.; Rech, Gabriel; Sukno, Serenella A.] Univ Salamanca, Dept Microbiol & Genet, Ctr Hispano Luso Invest Agr, Villamayor, Spain; [Amyotte, Stefan G.; Torres, Maria F.; Buiate, Ester A.; Farman, Mark A.; Law, Audrey D.; Schardl, Christopher L.; Vaillancourt, Lisa J.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; [Damm, Ulrike] Koninklijke Nederlandse Akad Wetenschappen, Fungal Biodivers Ctr, Cent Bur Schimmelcultures, Utrecht, Netherlands; [Epstein, Lynn] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Alkan, Noam; Miyara, Itay; Prusky, Dov] Agr Res Org, Volcani Ctr, Dept Postharvest Sci Fresh Produce, IL-50250 Bet Dagan, Israel; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Alvarado-Balderrama, Lucia; Birren, Bruce W.; Chen, Zehua; Heiman, David; Rounsley, Steve; Shenoy, Narmada; Young, Sarah; Zeng, Qiandong; Zhang, Jingze; Ma, Li-Jun] Broad Inst, Cambridge, MA USA; [Bauser, Christopher A.] GATC Biotech AG, Constance, Germany; [Choi, Jaeyoung; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Dept Agr Biotechnol, Seoul, South Korea; [Crouch, Jo Anne] ARS, Systemat Mycol & Microbiol Lab, USDA, Beltsville, MD USA; [Duvick, Jonathan P.; Howard, Richard J.; Sweigard, James A.] DuPont Agr Biotechnol, Pioneer Hibred Int, Wilmington, DE USA; [Gan, Pamela; Shirasu, Ken] RIKEN Plant Sci Ctr, Plant Immun Res Grp, Yokohama, Kanagawa, Japan; [Henrissat, Bernard] Univ Aix Marseille, CNRS, UMR 7257, Lab Architecture & Fonct Macromol Biol, Marseille, France; [Kabbage, Mehdi; Dickman, Martin B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, Inst Plant Genom & Biotechnol, Borlaug Genom & Bioinformat Ctr, College Stn, TX 77843 USA; [Koch, Christian; Voll, Lars M.] Univ Erlangen Nurnberg, Div Biochem, Dept Biol, D-91054 Erlangen, Germany; [Kubo, Yasuyuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Plant Pathol Lab, Kyoto 606, Japan; [Lebrun, Marc-Henri] INRA, Biol & Gest Risques Agr, Champignons Pathogenes Plantes, F-78850 Thiverval Grignon, France; [Moore, Neil] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Nordstroem, Karl] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Panaccione, Daniel G.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Panstruga, Ralph] Rhein Westfal TH Aachen Univ, Unit Plant Mol Cell Biol, Inst Biol 1, Aachen, Germany; [Place, Michael; Schwartz, David C.; Zhou, Shiguo] Univ Wisconsin Madison, Lab Mol & Computat Genom, Madison, WI USA; [Proctor, Robert H.] ARS, USDA, Natl Ctr Agr Utilizat Res, Peoria, IL USA; [Reinhardt, Richard; Stueber, Kurt] Max Planck Genome Ctr Cologne, Cologne, Germany; [Rollins, Jeffrey A.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Sikhakolli, Usha R.; Trail, Frances] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Takano, Yoshitaka] Kyoto Univ, Grad Sch Agr, Plant Pathol Lab, Kyoto, Japan	Max Planck Society; University of Salamanca; University of Kentucky; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of California System; University of California Davis; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; University of Cologne; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Seoul National University (SNU); United States Department of Agriculture (USDA); DuPont; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Texas A&M University System; Texas A&M University College Station; University of Erlangen Nuremberg; Kyoto Prefectural University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Kentucky; Max Planck Society; West Virginia University; RWTH Aachen University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Max Planck Society; State University System of Florida; University of Florida; Michigan State University; Kyoto University	O'Connell, RJ (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany.	oconnel@mpipz.mpg.de; vaillan@uky.edu	Ma, Li-Jun/AAG-2359-2020; Choi, Jaeyoung/T-5932-2019; Zhou, Shiguo/B-3832-2011; Panstruga, Ralph/F-3340-2011; Damm, Ulrike/C-9539-2013; Torres, Maria/GVU-3391-2022; Koch, Christian/J-5716-2013; Shirasu, Ken/ABF-5306-2020; Schardl, Christopher L/P-5655-2014; Sukno, Serenella A/K-1449-2014; Rech, Gabriel E/F-5499-2016; Schulze-Lefert, Paul/B-6707-2011; Sukno, Serenella/T-5919-2019; Choi, Jaeyoung/H-8665-2013; Alkan, Noam/GRJ-3904-2022; Henrissat, Bernard/J-2475-2012; Shirasu, Ken/A-4455-2010; Zeng, Qiandong/AAF-3305-2019; Thon, Michael/M-9463-2014; Chen, Zehua/E-6356-2011; Koch, Christian/W-5731-2019	Choi, Jaeyoung/0000-0003-2206-4593; Zhou, Shiguo/0000-0001-7421-2506; Panstruga, Ralph/0000-0002-3756-8957; Shirasu, Ken/0000-0002-0349-3870; Schardl, Christopher L/0000-0003-2197-0842; Sukno, Serenella A/0000-0003-3248-6490; Rech, Gabriel E/0000-0002-7979-8654; Sukno, Serenella/0000-0003-3248-6490; Choi, Jaeyoung/0000-0003-2206-4593; Henrissat, Bernard/0000-0002-3434-8588; Shirasu, Ken/0000-0002-0349-3870; Thon, Michael/0000-0002-7225-7003; Koch, Christian/0000-0001-8407-4952; Nordstrom, Karl/0000-0001-6231-4417; Rollins, Jeffrey/0000-0002-9897-6292; Crouch, Jo Anne/0000-0001-6886-8090; Heiman, David/0000-0001-7895-4259; LEBRUN, marc-henri/0000-0003-1562-1902; Gan, Pamela/0000-0002-3949-7793; Reinhardt, Richard/0000-0001-9376-2132; Ma, Li-Jun/0000-0002-2733-3708; Altmuller, Janine/0000-0003-4372-1521	US Department of Agriculture (USDA)-Cooperative State Research, Education and Extension Service (CSREES) [2007-35600-17829]; Max Planck Society; Deutsche Forschungsgemeinschaft [SPP1212, OC 104/1-3]; USDA-CSREES [2009-34457-20125]; University of Kentucky College of Agriculture Research Office; Ministerio de Ciencia e Innovacion (MICINN) of Spain [AGL2008-03177/AGR, AGL2011-29446/AGR]; Programme for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry	US Department of Agriculture (USDA)-Cooperative State Research, Education and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of Kentucky College of Agriculture Research Office; Ministerio de Ciencia e Innovacion (MICINN) of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programme for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry	This manuscript is dedicated to the memory of Robert Hanau. This work was primarily supported by US Department of Agriculture (USDA)-Cooperative State Research, Education and Extension Service (CSREES) grant 2007-35600-17829 (L.J.V., M.B.D., S.R. and M.R.T.), the Max Planck Society (R.J.O.) and Deutsche Forschungsgemeinschaft (SPP1212) grant OC 104/1-3 (R.J.O.). Other funding sources included USDA-CSREES grant 2009-34457-20125 (L.J.V.), the University of Kentucky College of Agriculture Research Office (L.J.V.), Ministerio de Ciencia e Innovacion (MICINN) of Spain grants AGL2008-03177/AGR and AGL2011-29446/AGR (M.R.T.) and the Programme for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (P.G. and K. Shirasu). This is manuscript number 12-12-011, published with the approval of the Director of the University of Kentucky Agricultural Experiment Station. See the Supplementary Note for a full list of acknowledgments.	Alkan N, 2008, MOL PLANT MICROBE IN, V21, P1058, DOI 10.1094/MPMI-21-8-1058; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Collemare J, 2011, EFFECTORS PLANT MICR, P377, DOI DOI 10.1002/9781119949138.CH15; Collemare J, 2008, MYCOL RES, V112, P207, DOI 10.1016/j.mycres.2007.08.003; Crouch JA, 2009, FUNGAL DIVERS, V39, P19; Crous PW, 2004, STUD MYCOL, P19; Engels R, 2006, BIOINFORMATICS, V22, P1782, DOI 10.1093/bioinformatics/btl193; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Farman ML, 2007, FEMS MICROBIOL LETT, V273, P125, DOI 10.1111/j.1574-6968.2007.00812.x; Frank B., 1883, BER DEUT BOT GES, V1, P29; Frey TJ, 2011, CROP SCI, V51, P1551, DOI 10.2135/cropsci2010.10.0613; Haas Brian J, 2011, Mycology, V2, P118; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; King BC, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-4; Kleemann J, 2008, MICROBIOL-SGM, V154, P1204, DOI 10.1099/mic.0.2007/014944-0; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Mims CW, 2002, PHYTOPATHOLOGY, V92, P803, DOI 10.1094/PHYTO.2002.92.7.803; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; O'Connell R, 2004, MOL PLANT MICROBE IN, V17, P272, DOI 10.1094/MPMI.2004.17.3.272; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Takahara H, 2009, PLANT J, V59, P672, DOI 10.1111/j.1365-313X.2009.03896.x; Thon MR, 2000, MOL PLANT MICROBE IN, V13, P1356, DOI 10.1094/MPMI.2000.13.12.1356; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ushimaru T, 2010, MOL GENET GENOMICS, V284, P357, DOI 10.1007/s00438-010-0572-1; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Voegele RT, 2011, EUPHYTICA, V179, P41, DOI 10.1007/s10681-011-0358-5; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711	62	586	656	23	350	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1060	+		10.1038/ng.2372	http://dx.doi.org/10.1038/ng.2372			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22885923	Green Published			2022-12-25	WOS:000308491200021
J	Suzuki, KGN; Kasai, RS; Hirosawa, KM; Nemoto, YL; Ishibashi, M; Miwa, Y; Fujiwara, TK; Kusumi, A				Suzuki, Kenichi G. N.; Kasai, Rinshi S.; Hirosawa, Koichiro M.; Nemoto, Yuri L.; Ishibashi, Munenori; Miwa, Yoshihiro; Fujiwara, Takahiro K.; Kusumi, Akihiro			Transient GPI-anchored protein homodimers are units for raft organization and function	NATURE CHEMICAL BIOLOGY			English	Article							SINGLE-MOLECULE TRACKING; PLASMA-MEMBRANE; LIVING CELLS; LIVE CELLS; H-RAS; K-RAS; ACTIVATION; RECEPTOR; MICRODOMAINS; CHOLESTEROL	Advanced single-molecule fluorescent imaging was applied to study the dynamic organization of raft-associated glycosylphosphatidylinositol- anchored proteins (GPI-APs) in the plasma membrane and their stimulation-induced changes. In resting cells, virtually all of the GPI-APs are mobile and continually form transient (similar to 200 ms) homodimers (termed homodimer rafts) through ectodomain protein interactions, stabilized by the presence of the GPI-anchoring chain and cholesterol. Heterodimers do not form, suggesting a fundamental role for the specific ectodomain protein interaction. Under higher physiological expression conditions, homodimers coalesce to form hetero- and homo-GPI-AP oligomer rafts through raft-based lipid interactions. When CD59 was ligated, it formed stable oligomer rafts containing up to four CD59 molecules, which triggered intracellular Ca2+ responses that were dependent on GPI anchorage and cholesterol, suggesting a key part played by transient homodimer rafts. Transient homodimer rafts are most likely one of the basic units for the organization and function of raft domains containing GPI-APs.	[Suzuki, Kenichi G. N.; Hirosawa, Koichiro M.; Nemoto, Yuri L.; Ishibashi, Munenori; Fujiwara, Takahiro K.; Kusumi, Akihiro] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Kasai, Rinshi S.; Kusumi, Akihiro] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Suzuki, Kenichi G. N.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Miwa, Yoshihiro] Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Ibaraki, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of Tsukuba	Kusumi, A (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan.	akusumi@frontier.kyoto-u.ac.jp	Fujiwara, Takahiro/G-2755-2012; Kasai, Rinshi S./ABA-7656-2021	Fujiwara, Takahiro/0000-0001-5576-759X; Kasai, Rinshi S./0000-0002-9234-3283; Nemoto, Yuri/0000-0001-6159-3709; Ishibashi, Munenori/0000-0002-6922-573X; Suzuki, Kenichi/0000-0002-8436-5757	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government [A12020366, 23110002, 233306]; Development of Systems and Technology for Advanced Measurement and Analysis program of the Japan Science and Technology Agency [10101506]; Grants-in-Aid for Scientific Research [24115511] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Development of Systems and Technology for Advanced Measurement and Analysis program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank V. Horejsi (Institute of Molecular Genetics, Academy of Sciences of the Czech Republic), M. Tone (University of Oxford) and M. Maio (Istituto Nazionale di Ricovero e Cura a Carattere Scientifico) for the hybridoma lines that produce the CD59- and DAF-specific antibodies, the cDNA construct for human CD59, and that for CD59TM, respectively. This work was supported in part by Grants-in-Aid for Scientific Research (A12020366) and Specific Research on Innovative Areas (23110002, 233306) from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government and by the Development of Systems and Technology for Advanced Measurement and Analysis program of the Japan Science and Technology Agency (10101506).	Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Catino MA, 2008, TRAFFIC, V9, P2141, DOI 10.1111/j.1600-0854.2008.00826.x; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; De Nardo C, 2002, J CELL PHYSIOL, V190, P200, DOI 10.1002/JCP.10050; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang YX, 2007, ACTA CRYSTALLOGR D, V63, P714, DOI 10.1107/S0907444907015557; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; KEUNING S, 1985, J BACTERIOL, V163, P635, DOI 10.1128/JB.163.2.635-639.1985; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Omidvar N, 2006, J IMMUNOL, V176, P2915, DOI 10.4049/jimmunol.176.5.2915; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rivier AS, 2010, TRAFFIC, V11, P1017, DOI 10.1111/j.1600-0854.2010.01081.x; ROCK CO, 1979, J BIOL CHEM, V254, P9778; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	170	174	0	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					774	783		10.1038/NCHEMBIO.1028	http://dx.doi.org/10.1038/NCHEMBIO.1028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22820419				2022-12-25	WOS:000308077600009
J	Nawroth, JC; Lee, H; Feinberg, AW; Ripplinger, CM; McCain, ML; Grosberg, A; Dabiri, JO; Parker, KK				Nawroth, Janna C.; Lee, Hyungsuk; Feinberg, Adam W.; Ripplinger, Crystal M.; McCain, Megan L.; Grosberg, Anna; Dabiri, John O.; Parker, Kevin Kit			A tissue-engineered jellyfish with biomimetic propulsion	NATURE BIOTECHNOLOGY			English	Article							THIN-FILMS; PATTERNS; CNIDARIA; MEDUSAE; MUSCLE; FLOW	Reverse engineering of biological form and function requires hierarchical design over several orders of space and time. Recent advances in the mechanistic understanding of biosynthetic compound materials(1-3), computer-aided design approaches in molecular synthetic biology(4,5) and traditional soft robotics(6,7), and increasing aptitude in generating structural and chemical microenvironments that promote cellular self-organization(8-10) have enhanced the ability to recapitulate such hierarchical architecture in engineered biological systems. Here we combined these capabilities in a systematic design strategy to reverse engineer a muscular pump. We report the construction of a freely swimming jellyfish from chemically dissociated rat tissue and silicone polymer as a proof of concept. The constructs, termed 'medusoids', were designed with computer simulations and experiments to match key determinants of jellyfish propulsion and feeding performance by quantitatively mimicking structural design, stroke kinematics and animal-fluid interactions. The combination of the engineering design algorithm with quantitative benchmarks of physiological performance suggests that our strategy is broadly applicable to reverse engineering of muscular organs or simple life forms that pump to survive.	[Lee, Hyungsuk; Feinberg, Adam W.; Ripplinger, Crystal M.; McCain, Megan L.; Grosberg, Anna; Parker, Kevin Kit] Harvard Univ, Dis Biophys Grp, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Lee, Hyungsuk; Feinberg, Adam W.; Ripplinger, Crystal M.; McCain, Megan L.; Grosberg, Anna; Parker, Kevin Kit] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Nawroth, Janna C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dabiri, John O.] CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA	Harvard University; Harvard University; California Institute of Technology; California Institute of Technology	Parker, KK (corresponding author), Harvard Univ, Dis Biophys Grp, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	jodabiri@caltech.edu; kkparker@seas.harvard.edu	Feinberg, Adam W/A-7103-2009; Grosberg, Anna/B-3017-2014; Feinberg, Adam W/AAM-8547-2020	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; Nawroth, Janna/0000-0003-1898-3968; Ripplinger, Crystal/0000-0002-9908-4106; Grosberg, Anna/0000-0002-8878-0843	Wyss Institute for Biologically Inspired Engineering at Harvard; Harvard Materials Research Science and Engineering Center under National Science Foundation [DMR-0213805]; US National Institutes of Health [1 R01 HL079126]; office of Naval Research; National Science Foundation Program in Fluid Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100408, R01HL079126] Funding Source: NIH RePORTER	Wyss Institute for Biologically Inspired Engineering at Harvard; Harvard Materials Research Science and Engineering Center under National Science Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); office of Naval Research(Office of Naval Research); National Science Foundation Program in Fluid Dynamics(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge financial support from the Wyss Institute for Biologically Inspired Engineering at Harvard, the Harvard Materials Research Science and Engineering Center under National Science Foundation award number DMR-0213805, US National Institutes of Health grant 1 R01 HL079126 (K.K.P.), and from the office of Naval Research and National Science Foundation Program in Fluid Dynamics (J.O.D.). We acknowledge the Harvard Center for Nanoscale Science for use of facilities and the New England Aquarium for supplying jellyfish. We thank J. Goss, P.W. Alford, K.R. Sutherland, K. Balachandran, C. Regan, P. Campbell, S. Spina and A. Agarwal for comments and technical support.	Alford PW, 2010, BIOMATERIALS, V31, P3613, DOI 10.1016/j.biomaterials.2010.01.079; ANDERSON PAV, 1981, J MORPHOL, V170, P383, DOI 10.1002/jmor.1051700309; Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Bar-Cohen Y, 2004, P SOC PHOTO-OPT INS, V5385, P10, DOI 10.1117/12.538698; Bar-Cohen Y, 2006, BIOINSPIR BIOMIM, V1, pP1, DOI 10.1088/1748-3182/1/1/P01; BLANQUET RS, 1981, T AM MICROSC SOC, V100, P109, DOI 10.2307/3225794; Bol M, 2009, COMPUT MECH, V43, P535, DOI 10.1007/s00466-008-0328-5; Chapman DM, 1999, CAN J ZOOL, V77, P34, DOI 10.1139/cjz-77-1-34; Costello JH, 1995, MAR BIOL, V124, P399, DOI 10.1007/BF00363913; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Feitl KE, 2009, BIOL BULL-US, V217, P283, DOI 10.1086/BBLv217n3p283; Fu Pengcheng, 2006, Biotechnology Journal, V1, P690, DOI 10.1002/biot.200600019; GLADFELTER WB, 1972, MAR BIOL, V14, P150, DOI 10.1007/BF00373214; GLADFELTER WG, 1973, HELGOLAND WISS MEER, V25, P228, DOI 10.1007/BF01611199; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Grosberg A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001088; Hayward R.T., 2007, THESIS UNCW; Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018; Kaznessis YN, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-47; Koehl MAR, 2004, J BIOMECH, V37, P789, DOI 10.1016/j.jbiomech.2003.06.001; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Marder M, 2007, PHYS TODAY, V60, P33, DOI 10.1063/1.2711634; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Nawroth JC, 2010, BIOL LETTERS, V6, P389, DOI 10.1098/rsbl.2010.0068; PASSANO LM, 1965, AM ZOOL, V5, P465; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Satterlie RA, 2002, CAN J ZOOL, V80, P1654, DOI 10.1139/Z02-132; Shim J, 2012, J BIOMECH, V45, P832, DOI 10.1016/j.jbiomech.2011.11.024; Vogel S, 2020, LIFE MOVING FLUIDS P; von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5; Widmer CL, 2008, KEEP JELLYFISH AQUAR	32	416	432	21	402	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					792	797		10.1038/nbt.2269	http://dx.doi.org/10.1038/nbt.2269			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22820316	Green Published, Green Accepted			2022-12-25	WOS:000307416900023
J	Siuti, P; Yazbek, J; Lu, TK				Siuti, Piro; Yazbek, John; Lu, Timothy K.			Synthetic circuits integrating logic and memory in living cells	NATURE BIOTECHNOLOGY			English	Article							GENE NETWORKS; MAMMALIAN-CELLS; BIOLOGY; DESIGN; CONSTRUCTION; COMMUNICATION; PROMOTERS; SWITCH	Logic and memory are essential functions of circuits that generate complex, state-dependent responses. Here we describe a strategy for efficiently assembling synthetic genetic circuits that use recombinases to implement Boolean logic functions with stable DNA-encoded memory of events. Application of this strategy allowed us to create all 16 two-input Boolean logic functions in living Escherichia coli cells without requiring cascades comprising multiple logic gates. We demonstrate long-term maintenance of memory for at least 90 cell generations and the ability to interrogate the states of these synthetic devices with fluorescent reporters and PCR. Using this approach we created two-bit digital-to-analog converters, which should be useful in biotechnology applications for encoding multiple stable gene expression outputs using transient inputs of inducers. We envision that this integrated logic and memory system will enable the implementation of complex cellular state machines, behaviors and pathways for therapeutic, diagnostic and basic science applications.	[Siuti, Piro; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Siuti, Piro; Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yazbek, John] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	timlu@mit.edu		Lu, Timothy/0000-0002-3918-8923	Office of Naval Research Multidisciplinary University Research Initiative (MURI); Defense Advanced Research Projects Agency (DARPA)	Office of Naval Research Multidisciplinary University Research Initiative (MURI)(MURI); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The bxb1 gene was a generous gift from G. F. Hatfull (Department of Biological Sciences, University of Pittsburgh), and the riboregulator plasmids were donated by J. J. Collins (Biomedical Engineering, Boston University). The authors thank R. Danial and A. A. Cheng for careful comments on the manuscript. This work was supported by an Office of Naval Research Multidisciplinary University Research Initiative (MURI) grant and the Defense Advanced Research Projects Agency (DARPA).	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bacchus W, 2012, NAT BIOTECHNOL, V30, P991, DOI 10.1038/nbt.2351; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghosh P, 2005, J MOL BIOL, V349, P331, DOI 10.1016/j.jmb.2005.03.043; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gordley RM, 2009, P NATL ACAD SCI USA, V106, P5053, DOI 10.1073/pnas.0812502106; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Lux MW, 2012, TRENDS BIOTECHNOL, V30, P120, DOI 10.1016/j.tibtech.2011.09.001; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Mijakovic I, 2005, CURR OPIN BIOTECH, V16, P329, DOI 10.1016/j.copbio.2005.04.003; Ortiz ME, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-16; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Sambrook J, 1989, MOL CLONING LAB MANU, VII; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	321	344	10	296	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					448	+		10.1038/nbt.2510	http://dx.doi.org/10.1038/nbt.2510			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23396014				2022-12-25	WOS:000318589600025
J	Cho, SW; Kim, S; Kim, JM; Kim, JS				Cho, Seung Woo; Kim, Sojung; Kim, Jong Min; Kim, Jin-Soo			Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES	We employ the CRISPR-Cas system of Streptococcus pyogenes as programmable RNA-guided endonucleases (RGENs) to cleave DNA in a targeted manner for genome editing in human cells. We show that complexes of the Cas9 protein and artificial chimeric RNAs efficiently cleave two genomic sites and induce indels with frequencies of up to 33%.	[Cho, Seung Woo; Kim, Sojung; Kim, Jong Min; Kim, Jin-Soo] Seoul Natl Univ, Natl Creat Res Initiat Ctr Genome Engn, Seoul, South Korea; [Cho, Seung Woo; Kim, Sojung; Kim, Jong Min; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Genome Engn, Seoul, South Korea.	jskim01@snu.ac.kr	Wilson, Matthew H/K-3193-2013; KIM, Jin-Soo/M-6918-2013; Cho, Seung Woo/B-2441-2019	KIM, Jin-Soo/0000-0003-4847-1306; Cho, Seung Woo/0000-0001-9091-0937; Kim, Sojung/0000-0002-2690-875X	National Research Foundation of Korea [2012-0001225]; ToolGen, Inc.	National Research Foundation of Korea(National Research Foundation of Korea); ToolGen, Inc.	This work was supported by the National Research Foundation of Korea (2012-0001225) and ToolGen, Inc. We thank Jae Kyung Chon for bioinformatic analysis.	Cohen J, 2011, SCIENCE, V332, P784, DOI 10.1126/science.332.6031.784; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim JS, 2010, NAT METHODS, V7, P91, DOI 10.1038/nmeth0210-91a; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	17	1279	1589	16	516	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					230	232		10.1038/nbt.2507	http://dx.doi.org/10.1038/nbt.2507			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23360966				2022-12-25	WOS:000316439500017
J	Esch, D; Vahokoski, J; Groves, MR; Pogenberg, V; Cojocaru, V; vom Bruch, H; Han, D; Drexler, HCA; Arauzo-Bravo, MJ; Ng, CKL; Jauch, R; Wilmanns, M; Scholer, HR				Esch, Daniel; Vahokoski, Juha; Groves, Matthew R.; Pogenberg, Vivian; Cojocaru, Vlad; vom Bruch, Hermann; Han, Dong; Drexler, Hannes C. A.; Arauzo-Bravo, Marcos J.; Ng, Calista K. L.; Jauch, Ralf; Wilmanns, Matthias; Schoeler, Hans R.			A unique Oct4 interface is crucial for reprogramming to pluripotency	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; INTERACTION NETWORK; CRYSTAL-STRUCTURE; BINDING; MOUSE; FIBROBLASTS; SOX2	Terminally differentiated cells can be reprogrammed to pluripotency by the forced expression of Oct4, Sox2, Klf4 and c-Myc(1,2). However, it remains unknown how this leads to the multitude of epigenetic changes observed during the reprogramming process. Interestingly, Oct4 is the only factor that cannot be replaced by other members of the same family to induce pluripotency(3-5). To understand the unique role of Oct4 in reprogramming, we determined the structure of its POU domain bound to DNA. We show that the linker between the two DNA-binding domains is structured as an alpha-helix and exposed to the protein's surface, in contrast to the unstructured linker of Oct1. Point mutations in this a-helix alter or abolish the reprogramming activity of Oct4, but do not affect its other fundamental properties. On the basis of mass spectrometry studies of the interactome of wild-type and mutant Oct4, we propose that the linker functions as a protein-protein interaction interface and plays a crucial role during reprogramming by recruiting key epigenetic players to Oct4 target genes. Thus, we provide molecular insights to explain how Oct4 contributes to the reprogramming process.	[Esch, Daniel; Cojocaru, Vlad; vom Bruch, Hermann; Han, Dong; Drexler, Hannes C. A.; Arauzo-Bravo, Marcos J.; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Vahokoski, Juha; Groves, Matthew R.; Pogenberg, Vivian; Wilmanns, Matthias] EMBL Hamburg, D-22603 Hamburg, Germany; [Ng, Calista K. L.; Jauch, Ralf] Genome Inst Singapore, Lab Struct Biochem, Singapore 138672, Singapore; [Ng, Calista K. L.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Max Planck Society; European Molecular Biology Laboratory (EMBL); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Wilmanns, M (corresponding author), EMBL Hamburg, Notkestr 85, D-22603 Hamburg, Germany.	wilmanns@embl-hamburg.de; office@mpi-muenster.mpg.de	Pogenberg, Vivian/A-3463-2012; Marcos, Arauzo-Bravo/A-1706-2011; , HS/AAB-4434-2019; Jauch, Ralf/C-5631-2011; Drexler, Hannes/AAI-3449-2020; Cojocaru, Vlad/GZA-7475-2022	Pogenberg, Vivian/0000-0002-1021-6804; Marcos, Arauzo-Bravo/0000-0002-3264-464X; , HS/0000-0003-2643-5136; Jauch, Ralf/0000-0002-6590-9579; Cojocaru, Vlad/0000-0003-0886-3401; Wilmanns, Matthias/0000-0002-4643-5435; Groves, Matthew/0000-0001-9859-5177	DFG [SPP1356]; AJ DFG [SI 1695/1-2, CO 975/1]	DFG(German Research Foundation (DFG)); AJ DFG(German Research Foundation (DFG))	X-ray diffraction experiments were performed on the ID23-1 beamline at the European Synchrotron Radiation Facility (ESRF), Grenoble, and X12 and X13 at EMBL Hamburg, DESY. We are grateful to E. Fioravanti of the ESRF for providing assistance in using beamline ID23-1. We thank G. Bourenkov for invaluable assistance in crystallographic problem resolution and data collection. We thank A. Nolte for help with mass spectrometry measurements. We also thank R. Grindberg for critically reading, and A. Malapetsas and J. Bruder for editing the manuscript. We acknowledge the financial support from DFG (SPP1356 Pluripotency and Cellular Reprogramming priority program) AJ DFG SI 1695/1-2 and AJ DFG CO 975/1.	Adachi K, 2012, CURR OPIN GENET DEV, V22, P416, DOI 10.1016/j.gde.2012.07.001; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Jauch R, 2011, PROTEINS, V79, P674, DOI 10.1002/prot.22916; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	109	111	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					295	301		10.1038/ncb2680	http://dx.doi.org/10.1038/ncb2680			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23376973				2022-12-25	WOS:000315844900010
J	James, LI; Barsyte-Lovejoy, D; Zhong, N; Krichevsky, L; Korboukh, VK; Herold, JM; MacNevin, CJ; Norris, JL; Sagum, CA; Tempel, W; Marcon, E; Guo, HB; Gao, C; Huang, XP; Duan, SL; Emili, A; Greenblatt, JF; Kireev, DB; Jin, J; Janzen, WP; Brown, PJ; Bedford, MT; Arrowsmith, CH; Frye, SV				James, Lindsey I.; Barsyte-Lovejoy, Dalia; Zhong, Nan; Krichevsky, Liubov; Korboukh, Victoria K.; Herold, J. Martin; MacNevin, Christopher J.; Norris, Jacqueline L.; Sagum, Cari A.; Tempel, Wolfram; Marcon, Edyta; Guo, Hongbo; Gao, Cen; Huang, Xi-Ping; Duan, Shili; Emili, Andrew; Greenblatt, Jack F.; Kireev, Dmitri B.; Jin, Jian; Janzen, William P.; Brown, Peter J.; Bedford, Mark T.; Arrowsmith, Cheryl H.; Frye, Stephen V.			Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain	NATURE CHEMICAL BIOLOGY			English	Article							LYSINE BINDING-PROTEINS; POLYCOMB PROTEIN; STRUCTURAL BASIS; DNA-REPAIR; PHD FINGER; METHYLATION; RECOGNITION; CHROMATIN; INHIBITION; MBT	We describe the discovery of UNC1215, a potent and selective chemical probe for the methyllysine (Kme) reading function of L3MBTL3, a member of the malignant brain tumor (MBT) family of chromatin-interacting transcriptional repressors. UNC1215 binds L3MBTL3 with a K-d of 120 nM, competitively displacing mono- or dimethyllysine-containing peptides, and is greater than 50-fold more potent toward L3MBTL3 than other members of the MBT family while also demonstrating selectivity against more than 200 other reader domains examined. X-ray crystallography identified a unique 2:2 polyvalent mode of interaction between UNC1215 and L3MBTL3. In cells, UNC1215 is nontoxic and directly binds L3MBTL3 via the Kme-binding pocket of the MBT domains. UNC1215 increases the cellular mobility of GFP-L3MBTL3 fusion proteins, and point mutants that disrupt the Kme-binding function of GFP-L3MBTL3 phenocopy the effects of UNC1215 on localization. Finally, UNC1215 was used to reveal a new Kme-dependent interaction of L3MBTL3 with BCLAF1, a protein implicated in DNA damage repair and apoptosis.	[James, Lindsey I.; Korboukh, Victoria K.; Herold, J. Martin; MacNevin, Christopher J.; Norris, Jacqueline L.; Gao, Cen; Kireev, Dmitri B.; Jin, Jian; Janzen, William P.; Frye, Stephen V.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Barsyte-Lovejoy, Dalia; Zhong, Nan; Krichevsky, Liubov; Tempel, Wolfram; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Krichevsky, Liubov; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Krichevsky, Liubov; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [MacNevin, Christopher J.; Huang, Xi-Ping] Univ N Carolina, Dept Pharmacol, Chapel Hill Med Sch, Chapel Hill, NC USA; [Sagum, Cari A.; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA; [Marcon, Edyta; Guo, Hongbo; Emili, Andrew; Greenblatt, Jack F.] Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON, Canada; [Huang, Xi-Ping] Univ N Carolina, Chapel Hill Med Sch, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill	Frye, SV (corresponding author), Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.	carrow@uhnres.utoronto.ca; svfrye@email.unc.edu	Kireev, Dmitri/B-7225-2012	Kireev, Dmitri/0000-0001-8479-8555; Arrowsmith, Cheryl/0000-0002-4971-3250; Brown, Peter/0000-0002-8454-0367	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; US National Institute of General Medical Sciences; US National Institutes of Health [RC1GM090732, R01GM100919]; Carolina Partnership; University Cancer Research Fund; University of North Carolina at Chapel Hill; Center for Environmental and Molecular Carcinogenesis at the M.D. Anderson Cancer Center; National Institute of Mental Health Psychoactive Drug Screening Program; Ontario Research Fund [ORF-GL2]; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Health and Long-Term Care; American Cancer Society [119169-PF-10-183-01-TBE]; Structural Genomics Consortium; Canadian Institutes of Health Research [1097737]; Eli Lilly Canada; Genome Canada; GlaxoSmithKline; Ontario Ministry of Economic Development and Innovation; Novartis Research Foundation; Pfizer; Abbott; Takeda; Wellcome Trust; US National Institute of Environmental Health Sciences [ES007784]; Cancer Prevention Research Institute of Texas [RP110471]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100919, RC1GM090732] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carolina Partnership; University Cancer Research Fund; University of North Carolina at Chapel Hill; Center for Environmental and Molecular Carcinogenesis at the M.D. Anderson Cancer Center; National Institute of Mental Health Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); American Cancer Society(American Cancer Society); Structural Genomics Consortium(University of Toronto); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Eli Lilly Canada(Eli Lilly); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Ontario Ministry of Economic Development and Innovation; Novartis Research Foundation; Pfizer(Pfizer); Abbott(Abbott Laboratories); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Vedadi, G. Wasney and F. Li for support with the protein lysine methyltransferase selectivity screening; O. Fedorov for support with the bromodomain selectivity screening; A. Tumber for support with the lysine demethylase selectivity screening; E. Hull-Ryde for support with the CellTiter-Glo cell viability assay; K. Hahn (University of North Carolina (UNC)) for providing mero76; B. Roth for helpful discussion regarding the GPCR selectivity studies; and G. Wang (UNC) for providing PHF23 and JARID1 proteins. Results shown in this report are derived from work performed at the Structural Biology Center at the Advanced Photon Source at Argonne National Laboratory. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. The research described here was supported by the US National Institute of General Medical Sciences; US National Institutes of Health (grant RC1GM090732 and R01GM100919); the Carolina Partnership and the University Cancer Research Fund; University of North Carolina at Chapel Hill; the Center for Environmental and Molecular Carcinogenesis at the M.D. Anderson Cancer Center; the National Institute of Mental Health Psychoactive Drug Screening Program; the Ontario Research Fund (grant ORF-GL2); the Natural Sciences and Engineering Research Council of Canada; the Ontario Ministry of Health and Long-Term Care; the American Cancer Society (C.J.M.; 119169-PF-10-183-01-TBE); and the Structural Genomics Consortium, which is a registered charity (number 1097737) that receives funds from Canadian Institutes of Health Research; Eli Lilly Canada; Genome Canada; GlaxoSmithKline; the Ontario Ministry of Economic Development and Innovation; the Novartis Research Foundation; Pfizer; Abbott; Takeda; and the Wellcome Trust. M.T.B. is supported by an institutional grant from the US National Institute of Environmental Health Sciences (ES007784) and Cancer Prevention Research Institute of Texas funding (RP110471). C.H.A. holds a Canada Research Chair in Structural Genomics.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Addou-Klouche L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-213; Arai S, 2005, EMBO J, V24, P1863, DOI 10.1038/sj.emboj.7600654; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gao C, 2011, J AM CHEM SOC, V133, P5357, DOI 10.1021/ja110432e; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Herold JM, 2012, MEDCHEMCOMM, V3, P45, DOI 10.1039/c1md00195g; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Honda H, 2011, P NATL ACAD SCI USA, V108, P2468, DOI 10.1073/pnas.1003403108; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Perna F, 2010, BLOOD, V116, P2812, DOI 10.1182/blood-2010-02-270611; Santiago C, 2011, J COMPUT AID MOL DES, V25, P1171, DOI 10.1007/s10822-011-9505-2; Takada Y, 2007, DEVELOPMENT, V134, P579, DOI 10.1242/dev.02747; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wigle TJ, 2010, J BIOMOL SCREEN, V15, P62, DOI 10.1177/1087057109352902; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	38	124	129	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					184	191		10.1038/NCHEMBIO.1157	http://dx.doi.org/10.1038/NCHEMBIO.1157			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23292653	Green Accepted, Green Submitted			2022-12-25	WOS:000315132900014
J	Morris, LGT; Kaufman, AM; Gong, YX; Ramaswami, D; Walsh, LA; Turcan, S; Eng, S; Kannan, K; Zou, YL; Peng, LK; Banuchi, VE; Paty, P; Zeng, ZS; Vakiani, E; Solit, D; Singh, B; Ganly, I; Liau, L; Cloughesy, TC; Mischel, PS; Mellinghoff, IK; Chan, TA				Morris, Luc G. T.; Kaufman, Andrew M.; Gong, Yongxing; Ramaswami, Deepa; Walsh, Logan A.; Turcan, Sevin; Eng, Stephanie; Kannan, Kasthuri; Zou, Yilong; Peng, Luke; Banuchi, Victoria E.; Paty, Phillip; Zeng, Zhaoshi; Vakiani, Efsevia; Solit, David; Singh, Bhuvanesh; Ganly, Ian; Liau, Linda; Cloughesy, Timothy C.; Mischel, Paul S.; Mellinghoff, Ingo K.; Chan, Timothy A.			Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; FREQUENT EPIGENETIC INACTIVATION; INTEGRATED GENOMIC ANALYSIS; BETA-CATENIN; E-CADHERIN; CELL-PROLIFERATION; SIGNALING PATHWAY; COLON-CANCER; SFRP GENES; IDENTIFICATION	Aberrant Wnt signaling can drive cancer development. In many cancer types, the genetic basis of Wnt pathway activation remains incompletely understood. Here, we report recurrent somatic mutations of the Drosophila melanogaster tumor suppressor-related gene FAT1 in glioblastoma (20.5%), colorectal cancer (7.7%), and head and neck cancer (6.7%). FAT1 encodes a cadherin-like protein, which we found is able to potently suppress cancer cell growth in vitro and in vivo by binding beta-catenin and antagonizing its nuclear localization. Inactivation of FAT1 via mutation therefore promotes Wnt signaling and tumorigenesis and affects patient survival. Taken together, these data strongly point to FAT1 as a tumor suppressor gene driving loss of chromosome 4q35, a prevalent region of deletion in cancer. Loss of FAT1 function is a frequent event during oncogenesis. These findings address two outstanding issues in cancer biology: the basis of Wnt activation in non-colorectal tumors and the identity of a 4q35 tumor suppressor.	[Morris, Luc G. T.; Kaufman, Andrew M.; Gong, Yongxing; Ramaswami, Deepa; Walsh, Logan A.; Turcan, Sevin; Eng, Stephanie; Kannan, Kasthuri; Zou, Yilong; Peng, Luke; Solit, David; Mellinghoff, Ingo K.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Morris, Luc G. T.; Banuchi, Victoria E.; Singh, Bhuvanesh; Ganly, Ian] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA; [Paty, Phillip; Zeng, Zhaoshi] Mem Sloan Kettering Canc Ctr, Dept Surg, Colorectal Serv, New York, NY 10021 USA; [Vakiani, Efsevia] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Solit, David] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Liau, Linda; Cloughesy, Timothy C.; Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Mellinghoff, Ingo K.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Chan, Timothy A/ABD-5850-2021; Turcan, Sevin/AAF-1095-2019; Cloughesy, Timothy Francis/AGV-1013-2022; Solit, David B./AAC-5309-2019	Turcan, Sevin/0000-0002-0885-5607; Zou, Yilong/0000-0001-8198-6067; Gong, Yongxing/0000-0003-1071-0375; Liau, Linda/0000-0002-4053-0052; Ganly, Ian/0000-0001-7636-5426; Walsh, Logan/0000-0001-8771-2577; Banuchi, Victoria/0000-0001-5456-7318; Kannan, Kasthuri/0000-0002-8479-0657	US National Institutes of Health (NIH) [NIH T32 CA009685, NIH R01CA154767-01]; Memorial Sloan-Kettering Cancer Center, Department of Surgery Junior Faculty Award; Louis Gerstner Foundation; STARR Cancer Consortium; Geoffrey Beene Cancer Center; Doris Duke Charitable Foundation; AVON Foundation; Flight Attendant Medical Research Institute; Sontag Foundation; NATIONAL CANCER INSTITUTE [T32CA160001, R01CA154767, P30CA008748, T32CA009685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080944] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan-Kettering Cancer Center, Department of Surgery Junior Faculty Award; Louis Gerstner Foundation; STARR Cancer Consortium; Geoffrey Beene Cancer Center; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); AVON Foundation; Flight Attendant Medical Research Institute; Sontag Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Heguy, A. Viale, K. Huberman, I. Dolgalev, S. Thomas, A. Kayserian and R. Spektor for excellent technical assistance. We are grateful to N. Sibinga (Albert Einstein College of Medicine) for providing an antibody to FAT1. This work was supported in part by US National Institutes of Health (NIH) grants NIH T32 CA009685 (L.G.T.M.) and NIH R01CA154767-01 (T.A.C.), the Memorial Sloan-Kettering Cancer Center, Department of Surgery Junior Faculty Award (L.G.T.M.), the Louis Gerstner Foundation (T.A.C.), the STARR Cancer Consortium (T.A.C.), The Geoffrey Beene Cancer Center (T.A.C.), the Doris Duke Charitable Foundation (T.A.C. and I.K.M.), the AVON Foundation (T.A.C.), the Flight Attendant Medical Research Institute (T.A.C.) and the Sontag Foundation (T.A.C.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Borkosky SS, 2009, J CANCER RES CLIN, V135, P703, DOI 10.1007/s00432-008-0507-y; Brosens RPM, 2010, ANAL CELL PATHOL, V33, P95, DOI [10.1155/2010/161608, 10.3233/ACP-CLO-2010-0531]; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Candidus S, 1996, CANCER RES, V56, P49; Castillejo-Lopez C, 2004, J BIOL CHEM, V279, P24034, DOI 10.1074/jbc.M313878200; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jung HC, 2005, LIFE SCI, V77, P1249, DOI 10.1016/j.lfs.2005.02.009; Katoh Y, 2006, INT J MOL MED, V18, P523; Katz BZ, 1998, EXP CELL RES, V243, P415, DOI 10.1006/excr.1998.4194; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rock R, 2005, DEV DYNAM, V234, P747, DOI 10.1002/dvdy.20515; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Saburi S, 2012, DEVELOPMENT, V139, P1806, DOI 10.1242/dev.077461; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Simcha I, 2001, MOL BIOL CELL, V12, P1177, DOI 10.1091/mbc.12.4.1177; Singh RK, 2007, HUM GENET, V122, P71, DOI 10.1007/s00439-007-0375-6; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Sonoda Y, 2001, CANCER RES, V61, P4956; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vistejnova L, 2009, NEUROENDOCRINOL LETT, V30, P121; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070	81	231	245	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					253	261		10.1038/ng.2538	http://dx.doi.org/10.1038/ng.2538			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23354438	Green Submitted, Green Accepted			2022-12-25	WOS:000315664800008
J	Brynildsen, MP; Winkler, JA; Spina, CS; MacDonald, IC; Collins, JJ				Brynildsen, Mark P.; Winkler, Jonathan A.; Spina, Catherine S.; MacDonald, I. Cody; Collins, James J.			Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production	NATURE BIOTECHNOLOGY			English	Article							HYDROGEN-PEROXIDE FORMATION; ESCHERICHIA-COLI; METABOLIC CAPABILITIES; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ANTIBIOTICS; OXIDATIVE DAMAGE; HIGH-THROUGHPUT; CELL-DEATH; SUPEROXIDE; MUTANTS	The ever-increasing incidence of antibiotic-resistant infections combined with a weak pipeline of new antibiotics has created a global public health crisis(1). Accordingly, novel strategies for enhancing our antibiotic arsenal are needed. As antibiotics kill bacteria in part by inducing reactive oxygen species (ROS)(2-4), we reasoned that targeting microbial ROS production might potentiate antibiotic activity. Here we show that ROS production can be predictably enhanced in Escherichia coli, increasing the bacteria's susceptibility to oxidative attack. We developed an ensemble approach of genome-scale, metabolic models capable of predicting ROS production in E. coli. The metabolic network was systematically perturbed and its flux distribution analyzed to identify targets predicted to increase ROS production. Targets that were predicted in silico were experimentally validated and further shown to confer increased susceptibility to oxidants. Validated targets also increased susceptibility to killing by antibiotics. This work establishes a systems-based method to tune ROS production in bacteria and demonstrates that increased microbial ROS production can potentiate killing by oxidants and antibiotics.	[Brynildsen, Mark P.; Winkler, Jonathan A.; Spina, Catherine S.; MacDonald, I. Cody; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Brynildsen, Mark P.; Winkler, Jonathan A.; Spina, Catherine S.; MacDonald, I. Cody; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Winkler, Jonathan A.; Collins, James J.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Spina, Catherine S.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Spina, Catherine S.; Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu		Spina, Catherine/0000-0001-6067-5024	National Institutes of Health; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Director's Pioneer Award Program and the Howard Hughes Medical Institute.	AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; JENSEN PR, 1992, J BACTERIOL, V174, P7635, DOI 10.1128/JB.174.23.7635-7641.1992; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Korshunov S, 2010, MOL MICROBIOL, V75, P1389, DOI 10.1111/j.1365-2958.2010.07059.x; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; LOEWEN PC, 1984, J BACTERIOL, V157, P622, DOI 10.1128/JB.157.2.622-626.1984; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024	29	270	282	15	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					160	165		10.1038/nbt.2458	http://dx.doi.org/10.1038/nbt.2458			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23292609	Green Accepted, Green Submitted			2022-12-25	WOS:000315322100028
J	Kolotuev, I; Hyenne, V; Schwab, Y; Rodriguez, D; Labouesse, M				Kolotuev, Irina; Hyenne, Vincent; Schwab, Yannick; Rodriguez, David; Labouesse, Michel			A pathway for unicellular tube extension depending on the lymphatic vessel determinant Prox1 and on osmoregulation	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; EXCRETORY CELL; TRANSCRIPTION FACTOR; PROSPERO; HOMOLOG; MORPHOGENESIS; SYSTEM	The mechanisms regulating the extension of small unicellular tubes remain poorly defined. Here we identify several steps in Caenorhabditis elegans excretory canal growth, and propose a model for lumen extension. Our results suggest that the basal and apical excretory membranes grow sequentially: the former extends first like an axon growth cone; the latter extends next as a result of an osmoregulatory activity triggering pen-apical vesicles (a membrane reservoir) to fuse with the lumen. An apical cytoskeletal web including intermediate filaments and actin crosslinking proteins ensures straight regular lumen growth. Expression of several genes encoding proteins mediating excretory lumen extension, such as the osmoregulatory STE20-like kinase GCK-3 and the intermediate filament IFB-1, is regulated by ceh-26 (here referred to as pros-1), which we found essential for excretory canal formation. Interestingly, PROS-1 is homologous to vertebrate Prox1, a transcription factor controlling lymphatic vessel growth. Our findings have potential evolutionary implications for the origin of fluid-collecting organs, and provide a reference for lymphangiogenesis.	[Kolotuev, Irina; Hyenne, Vincent; Rodriguez, David; Labouesse, Michel] Univ Strasbourg, Dev & Stem Cells Program, CNRS, UMR7104,INSERM,U964,IGBMC, F-67400 Illkirch Graffenstaden, France; [Schwab, Yannick] Univ Strasbourg, Imaging Ctr, CNRS, UMR7104,INSERM,U964,IGBMC, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Labouesse, M (corresponding author), Univ Strasbourg, Dev & Stem Cells Program, CNRS, UMR7104,INSERM,U964,IGBMC, 1 Rue Laurent Fries,BP 10142, F-67400 Illkirch Graffenstaden, France.	lmichel@igbmc.fr	Hyenne, Vincent/AAW-8244-2020; Hyenne, Vincent/F-7716-2013	Hyenne, Vincent/0000-0002-1254-2814; Kolotuev, Irina/0000-0003-1433-8048; Schwab, Yannick/0000-0001-8027-1836	Institut National du Cancer; Fondation pour la Recherche Medicale	Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank M. Buechner (University of Kansas, USA), J. Culotti (Mt. Sinai Hospital, Toronto, Canada), I. Hope (University of Leeds, UK), V. Gobel (Massachusetts General Hospital, Boston, USA), K. Strange (Mount Desert Island Biological Laboratory, Salisbury Cove, USA), C. Eckmann (MPI-CBG, Dresden, Germany) and the CGC for strains, the Sanger Center for cosmids; P. Schultz for access to his EMPACT2 high-pressure system and Technai microscope for electron microscope tomography; L. Bianchetti, F. Klein and G. Garber for help with bioinformatics; M. Koch, P. Kessler and D. Hentsch for imaging advice; C. Spiegelhalter for assistance with electron microscopy; E. Troesch and D. Busso for directed mutagenesis; and M. Diem for technical assistance. We thank L. Broday, O. Pourquie, C. Gaily and S. Quintin for critical reading of the manuscript; and L. Broday, C. Gaily, I. Biryukova and G. Volohonsky for useful suggestions during the course of this work. This work was supported by grants from the Institut National du Cancer to M.L., and by a fellowship from the Fondation pour la Recherche Medicale to I.K. We wish to dedicate this work to R. Kolotueva.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Armstrong KR, 2010, MOL GENET GENOMICS, V283, P73, DOI 10.1007/s00438-009-0497-8; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; BURGLIN TR, 1994, TRENDS BIOCHEM SCI, V19, P70, DOI 10.1016/0968-0004(94)90035-3; Burglin TR, 2001, DEVELOPMENT, V128, P779; Cheshire AM, 2008, DEV DYNAM, V237, P2874, DOI 10.1002/dvdy.21709; Choe KP, 2007, FEBS J, V274, P5782, DOI 10.1111/j.1742-4658.2007.06098.x; Choe KP, 2007, AM J PHYSIOL-CELL PH, V293, pC915, DOI 10.1152/ajpcell.00126.2007; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Gao JT, 2001, HUM MOL GENET, V10, P3049, DOI 10.1093/hmg/10.26.3049; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; Gobel V, 2012, NAT CELL BIOL; Hahn-Windgassen A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000553; Hassan B, 1997, P NATL ACAD SCI USA, V94, P10991, DOI 10.1073/pnas.94.20.10991; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; Hisamoto N, 2008, EMBO REP, V9, P70, DOI 10.1038/sj.embor.7401128; Husken K, 2008, DIFFERENTIATION, V76, P881, DOI 10.1111/j.1432-0436.2008.00264.x; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kerman BE, 2006, DIFFERENTIATION, V74, P326, DOI 10.1111/j.1432-0436.2006.00095.x; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; Mah AK, 2007, J BIOL CHEM, V282, P28074, DOI 10.1074/jbc.M703305200; Mattingly BC, 2011, DEV BIOL, V359, P59, DOI 10.1016/j.ydbio.2011.08.011; McKeown C, 1998, DEVELOPMENT, V125, P2087; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Oka T, 1997, J BIOL CHEM, V272, P24387, DOI 10.1074/jbc.272.39.24387; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Ryter JM, 2002, STRUCTURE, V10, P1541, DOI 10.1016/S0969-2126(02)00883-3; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schmidt-Rhaesa A., 2007, EVOLUTION ORGAN SYST, P169, DOI DOI 10.1093/ACPROF:OSO/9780198566687.003.0009; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Suzuki N, 2001, EMBO REP, V2, P530, DOI 10.1093/embo-reports/kve110; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; van Furden D, 2004, DEV BIOL, V272, P262, DOI 10.1016/j.ydbio.2004.05.012; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Yousef M, 2005, STRUCTURE, V13, P601, DOI 10.1016/j.str.2005.01.023	43	52	57	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2013	15	2					157	168		10.1038/ncb2662	http://dx.doi.org/10.1038/ncb2662			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	088SF	23334499				2022-12-25	WOS:000314856700007
J	Mauldin, RV; Sauer, RT				Mauldin, Randall V.; Sauer, Robert T.			Allosteric regulation of DegS protease subunits through a shared energy landscape	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI SIGMA(E); ENVELOPE-STRESS-RESPONSE; SERINE-PROTEASE; CRYSTAL-STRUCTURE; DOMAIN; SENSOR; MODULATION; ACTIVATION; CLEAVAGE; SIGNALS	The PDZ domains of the trimeric DegS protease bind unassembled outer-membrane proteins (OMPs) that accumulate in the Escherichia coli periplasm. This cooperative binding reaction triggers a proteolytic cascade that activates a transcriptional stress response. To dissect the mechanism of allosteric activation, we generated hybrid DegS trimers with different numbers of PDZ domains and/or protease-domain mutations. By studying the chemical reactivity and enzymatic properties of these hybrids, we show that all subunits experience a strongly coupled energetic landscape. For example, OMP peptide binding to a single PDZ domain stimulates active site chemical modification and proteolytic cleavage in the attached and neighboring protease domains. OMP peptide binding relieves inhibitory PDZ interactions, whereas the interfaces between protease domains in the trimeric DegS core mediate positively cooperative activation driven by both substrate binding and inhibition relief.	[Mauldin, Randall V.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, Cambridge, MA USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	US National Institutes of Health (NIH) [AI-16892]; NIH [GM097972]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097972] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grant AI-16892 (R.T.S.). R.V.M. was supported by an NIH postdoctoral fellowship (GM097972). We thank B. Stinson, A. Olivares, J. Sohn, A. Nager, A. de Regt and S. Kim for helpful discussions.	Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Bowden MA, 2010, MOL CELL ENDOCRINOL, V327, P13, DOI 10.1016/j.mce.2010.06.001; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Creighton T. E., 1993, PROTEINS STRUCTURES; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; De Las Penas A, 1997, MOL MICROBIOL, V24, P373; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; EIGEN M, 1967, Nobel Symposium, V5, P333; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; HAMMES GG, 1971, SCIENCE, V172, P1205, DOI 10.1126/science.172.3989.1205; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kimmel JL, 2001, BIOCHEMISTRY-US, V40, P11623, DOI 10.1021/bi010844a; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Milner JM, 2008, ARTHRITIS RHEUM-US, V58, P3644, DOI 10.1002/art.24046; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Waller PRH, 1996, J BACTERIOL, V178, P1146, DOI 10.1128/jb.178.4.1146-1153.1996; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Zeth K, 2004, FEBS LETT, V569, P351, DOI 10.1016/j.febslet.2004.06.012	38	12	12	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					90	96		10.1038/NCHEMBIO.1135	http://dx.doi.org/10.1038/NCHEMBIO.1135			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23201899	Green Accepted, Green Submitted			2022-12-25	WOS:000314083200007
J	Parpaleix, A; Houssen, YG; Charpak, S				Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge			Imaging local neuronal activity by monitoring PO2 transients in capillaries	NATURE MEDICINE			English	Article							CEREBRAL-BLOOD-FLOW; TISSUE OXYGENATION; INTRINSIC SIGNALS; OLFACTORY-BULB; BARREL CORTEX; RAT MESENTERY; ACTIVATION; SPECTROSCOPY; CONSUMPTION; MICROSCOPY	Two-photon phosphorescence lifetime microscopy (2PLM) has been used recently for depth measurements of oxygen partial pressure (PO2) in the rodent brain. In capillaries of olfactory bulb glomeruli, 2PLM has also allowed simultaneous measurements of PO2 and blood flow and revealed the presence of erythrocyte-associated transients (EATs), which are PO2 gradients that are associated with individual erythrocytes. We investigated the extent to which EAT properties in capillaries report local neuronal activity. We find that at rest, PO2 at EAT peaks overestimates the mean PO2 by 35 mm Hg. PO2 between two EAT peaks is at equilibrium with, and thus reports, PO2 in the neuropil. During odor stimulation, there is a small PO2 decrease before functional hyperemia, showing that the initial dip in PO2 is present at the level of capillaries. We conclude that imaging oxygen dynamics in capillaries provides a unique and noninvasive approach to map neuronal activity.	[Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge] INSERM, U603, Paris, France; [Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge] CNRS, UMR 8154, Paris, France; [Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge] Univ Paris 05, Lab Neurophysiol & New Microscopies, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Charpak, S (corresponding author), INSERM, U603, Paris, France.	serge.charpak@parisdescartes.fr	Charpak, Serge/M-9412-2017	GOULAM HOUSSEN, Yannick/0000-0002-1220-5105; PARPALEIX, Alexandre/0000-0001-9007-3155	INSERM; CNRS; Leducq Foundation; Human Frontier Science Program Organization (HSFPO); Agence Nationale de la Recherche; Fondation pour la Recherche Medicale	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Leducq Foundation(Leducq Foundation); Human Frontier Science Program Organization (HSFPO); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank S. Vinogradov (Department of Biochemistry and Biophysics, University of Pennsylvania) for providing PtP-C343 through the intermediate of Oxygen Enterprises. We also thank G. Bouchery and A. Virolle for help in animal surgery, S. Sasnouski for software improvements and M. Ducros, B. Weber and U. Lindauer for critical comments. Support was provided by INSERM, CNRS, the Leducq Foundation, the Human Frontier Science Program Organization (HSFPO), the Agence Nationale de la Recherche and the Fondation pour la Recherche Medicale.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Devor A, 2011, J NEUROSCI, V31, P13676, DOI 10.1523/JNEUROSCI.1968-11.2011; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; FEDERSPIEL WJ, 1986, MICROVASC RES, V32, P164, DOI 10.1016/0026-2862(86)90052-X; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Golub AS, 2008, AM J PHYSIOL-HEART C, V294, pH2905, DOI 10.1152/ajpheart.01347.2007; Golub AS, 2005, AM J PHYSIOL-HEART C, V288, pH2735, DOI 10.1152/ajpheart.00711.2004; Groebe K, 1989, Adv Exp Med Biol, V248, P175; HELLUMS JD, 1977, MICROVASC RES, V13, P131, DOI 10.1016/0026-2862(77)90122-4; HOMER LD, 1981, MICROVASC RES, V22, P308, DOI 10.1016/0026-2862(81)90099-6; Hudetz AG, 1997, MICROCIRCULATION, V4, P233, DOI 10.3109/10739689709146787; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Lecoq J, 2011, NAT MED, V17, P893, DOI 10.1038/nm.2394; Lecoq J, 2009, J NEUROSCI, V29, P1424, DOI 10.1523/JNEUROSCI.4817-08.2009; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Lindauer U, 2010, J CEREBR BLOOD F MET, V30, P757, DOI 10.1038/jcbfm.2009.259; Livneh Y, 2012, NAT NEUROSCI, V15, P26, DOI 10.1038/nn.2980; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Shepherd GM, 2008, NEURON, V58, P827, DOI 10.1016/j.neuron.2008.06.005; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Thompson JK, 2004, NAT NEUROSCI, V7, P919, DOI 10.1038/nn1308; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tsai AG, 2005, AM J PHYSIOL-HEART C, V289, pH1777, DOI 10.1152/ajpheart.00503.2005; WANG CH, 1993, MATH BIOSCI, V116, P89, DOI 10.1016/0025-5564(93)90062-F; Weber B, 2004, EUR J NEUROSCI, V20, P2664, DOI 10.1111/j.1460-9568.2004.03735.x	34	87	88	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					241	246		10.1038/nm.3059	http://dx.doi.org/10.1038/nm.3059			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23314058				2022-12-25	WOS:000314675900034
J	Rouaux, C; Arlotta, P				Rouaux, Caroline; Arlotta, Paola			Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo	NATURE CELL BIOLOGY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PLURIPOTENT STEM-CELLS; SUBTYPE-SPECIFIC GENES; REGULATORY SUBUNIT; PYRAMIDAL NEURONS; DOUBLECORTIN; EXPRESSION; DIFFERENTIATION; SPECIFICATION; MECHANISMS	Once programmed to acquire a specific identity and function, cells rarely change in vivo(1). Neurons of the mammalian central nervous system (CNS) in particular are a classic example of a stable, terminally differentiated cell type. With the exception of the adult neurogenic niches, where a limited set of neuronal subtypes continue to be generated throughout life(2,3), CNS neurons are born only during embryonic and early postnatal development. Once generated, neurons become permanently post-mitotic and do not change their identity for the lifespan of the organism. Here, we have investigated whether excitatory neurons of the neocortex can be instructed to directly reprogram their identity post-mitotically from one subtype into another, in vivo. We show that embryonic and early postnatal callosal projection neurons of layer II/III can be post-mitotically lineage reprogrammed into layer-V/VI corticofugal projection neurons following expression of the transcription factor encoded by Fezf2. Reprogrammed callosal neurons acquire molecular properties of corticofugal projection neurons and change their axonal connectivity from interhemispheric, intracortical projections to corticofugal projections directed below the cortex. The data indicate that during a window of post-mitotic development neurons can change their identity, acquiring critical features of alternative neuronal lineages.	[Rouaux, Caroline; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Sherman Fairchild Bldg,7 Divin Ave, Cambridge, MA 02138 USA.	paola_arlotta@harvard.edu	Rouaux, Caroline/O-1712-2017	Rouaux, Caroline/0000-0002-5724-2903	US National Institute of Health [NS062849]; Spastic Paraplegia Foundation; Harvard Stem Cell Institute; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849, R01NS073124] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spastic Paraplegia Foundation; Harvard Stem Cell Institute; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Melton, A. McMahon, J. Macklis, B. Molyneaux and E. Stronge for their advice and comments on the manuscript; C. Cepko (Harvard Medical School, USA), S. Arber (University of Basel, Switzerland), F. Zhang (MIT, USA) and Q. Lu (Beckman Research Institute, USA) for sharing of antibodies and expression vectors; M. M. Radji for help with data analysis; A. Merlino and Z. Trayes-Gibson for technical support; and C. Mare for schematic drawings. This work was supported by the US National Institute of Health (NS062849), the Spastic Paraplegia Foundation and the Harvard Stem Cell Institute to P.A.; C.R. was partially supported by a Milton-Safenowitz postdoctoral fellowship from the ALS Association.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bayer S. A., 1991, J NEOCORTICAL DEV; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fishell G, 2008, NEURON, V57, P333, DOI 10.1016/j.neuron.2008.01.018; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Matsuo N, 1998, BIOCHEM BIOPH RES CO, V252, P571, DOI 10.1006/bbrc.1998.9698; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Ozaki HS, 1998, J COMP NEUROL, V400, P197, DOI 10.1002/(SICI)1096-9861(19981019)400:2<197::AID-CNE3>3.0.CO;2-4; Rouaux C, 2012, DEV NEUROBIOL, V72, P1085, DOI 10.1002/dneu.22018; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Selvaraj V, 2010, TRENDS BIOTECHNOL, V28, P214, DOI 10.1016/j.tibtech.2010.01.002; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Waddington C H, 1957, STRATEGY GENES DISCU; Wang X, 2007, J NEUROSCI RES, V85, P3567, DOI 10.1002/jnr.21440; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	36	147	155	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2013	15	2					214	221		10.1038/ncb2660	http://dx.doi.org/10.1038/ncb2660			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	088SF	23334497	Green Accepted			2022-12-25	WOS:000314856700012
J	Abou Hamdan, A; Burlat, B; Gutierrez-Sanz, O; Liebgott, PP; Baffert, C; De Lacey, AL; Rousset, M; Guigliarelli, B; Leger, C; Dementin, S				Abou Hamdan, Abbas; Burlat, Benedicte; Gutierrez-Sanz, Oscar; Liebgott, Pierre-Pol; Baffert, Carole; De Lacey, Antonio L.; Rousset, Marc; Guigliarelli, Bruno; Leger, Christophe; Dementin, Sebastien			O-2-independent formation of the inactive states of NiFe hydrogenase	NATURE CHEMICAL BIOLOGY			English	Article							DESULFOVIBRIO-GIGAS HYDROGENASE; ALLOCHROMATIUM-VINOSUM; CHROMATIUM-VINOSUM; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; CATALYTIC CYCLE; ACTIVE-SITE; ACTIVATION; NICKEL; UNREADY	We studied the mechanism of aerobic inactivation of Desulfovibrio fructosovorans nickel-iron (NiFe) hydrogenase by quantitatively examining the results of electrochemistry, EPR and FTIR experiments. They suggest that, contrary to the commonly accepted mechanism, the attacking O-2 is not incorporated as an active site ligand but, rather, acts as an electron acceptor. Our findings offer new ways toward the understanding of O-2 inactivation and O-2 tolerance in NiFe hydrogenases.	[Abou Hamdan, Abbas; Burlat, Benedicte; Liebgott, Pierre-Pol; Baffert, Carole; Rousset, Marc; Guigliarelli, Bruno; Leger, Christophe; Dementin, Sebastien] Aix Marseille Univ, CNRS, Lab Bioenerget & Ingn Prot, Unite Mixte Rech 7281,Inst Microbiol Mediterranee, Marseille, France; [Gutierrez-Sanz, Oscar; De Lacey, Antonio L.] CSIC, ICP, Lab Bioelectrocatalisis, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Abou Hamdan, A (corresponding author), Aix Marseille Univ, CNRS, Lab Bioenerget & Ingn Prot, Unite Mixte Rech 7281,Inst Microbiol Mediterranee, Marseille, France.	dementin@imm.cnrs.fr	Baffert, Carole/C-4638-2018; De Lacey, Antonio L/H-3311-2015; LIEBGOTT, Pierre-Pol/K-1045-2016; Léger, Christophe/C-7230-2016; HAMDAN, Abbas ABOU/N-6783-2014	Baffert, Carole/0000-0003-3993-3089; De Lacey, Antonio L/0000-0002-9347-0452; LIEBGOTT, Pierre-Pol/0000-0002-2559-1738; Léger, Christophe/0000-0002-8871-6059; HAMDAN, Abbas ABOU/0000-0001-6703-772X; Gutierrez-Sanz, Oscar/0000-0001-7559-9204; Dementin, Sebastien/0000-0001-6168-5371	CNRS; Agence Nationale de la Recherche; Aix-Marseille Universite; City of Marseilles; Spanish Ministerio de Ciencia e Innovacion (MICINN) [CTQ2009-12649]; Pole de Competitivite Capenergies; Region Provence-Alpes Cote d'Azur; MICINN	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Aix-Marseille Universite; City of Marseilles(Region Provence-Alpes-Cote d'Azur); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pole de Competitivite Capenergies; Region Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	We thank J. Hadj-Said for performing preliminary electrochemical experiments and P. Bertrand, V. Fourmond and V. Fernandez for helpful discussions. This work was funded by the CNRS, the Agence Nationale de la Recherche, the Aix-Marseille Universite, the City of Marseilles and the Spanish Ministerio de Ciencia e Innovacion (MICINN) (project CTQ2009-12649) and was supported by the Pole de Competitivite Capenergies. A.A.H. thanks the CNRS and the Region Provence-Alpes Cote d'Azur for financial support. O.G.-S. thanks the MICINN for a Formacion de Personal Investigador (FPI) grant.	Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; Carepo M, 2002, J AM CHEM SOC, V124, P281, DOI 10.1021/ja010204v; Chohan BS, 2004, INORG CHEM, V43, P7726, DOI 10.1021/ic049110n; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; FERNANDEZ VM, 1986, BIOCHIM BIOPHYS ACTA, V883, P145, DOI 10.1016/0304-4165(86)90145-5; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; KUMAR M, 1989, J AM CHEM SOC, V111, P8323, DOI 10.1021/ja00203a068; Lamle SE, 2004, J AM CHEM SOC, V126, P14899, DOI 10.1021/ja047939v; Leger C, 2004, J AM CHEM SOC, V126, P12162, DOI 10.1021/ja046548d; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2011, J AM CHEM SOC, V133, P986, DOI 10.1021/ja108787s; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Millo D, 2009, J PHYS CHEM B, V113, P15344, DOI 10.1021/jp906575r; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Pandelia ME, 2010, J AM CHEM SOC, V132, P6991, DOI 10.1021/ja910838d; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rudiger O, 2005, J AM CHEM SOC, V127, P16008, DOI 10.1021/ja0554312; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; van Gastel M, 2010, APPL MAGN RESON, V37, P207, DOI 10.1007/s00723-009-0044-0; VANDERZWAAN JW, 1985, FEBS LETT, V179, P271, DOI 10.1016/0014-5793(85)80533-0; VANDERZWAAN JW, 1990, BIOCHIM BIOPHYS ACTA, V1041, P101, DOI 10.1016/0167-4838(90)90051-G; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109	29	61	61	0	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					15	+		10.1038/NCHEMBIO.1110	http://dx.doi.org/10.1038/NCHEMBIO.1110			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143415				2022-12-25	WOS:000312484200006
J	Ito, N; Ruegg, UT; Kudo, A; Miyagoe-Suzuki, Y; Takeda, S				Ito, Naoki; Ruegg, Urs T.; Kudo, Akira; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi			Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; UP-REGULATION; IN-VIVO; ATROPHY; MTOR; PGC-1-ALPHA; PHYSIOLOGY; MECHANISM; PATHWAY	Skeletal muscle atrophy occurs in aging and pathological conditions, including cancer, diabetes and AIDS(1). Treatment of atrophy is based on either preventing protein-degradation pathways, which are activated during atrophy, or activating protein-synthesis pathways, which induce muscle hypertrophy(2). Here we show that neuronal nitric oxide synthase (nNOS) regulates load-induced hypertrophy by activating transient receptor potential cation channel, subfamily V, member 1 (TRPV1). The overload-induced hypertrophy was prevented in nNOS-null mice. nNOS was transiently activated within 3 min after overload. This activation promoted formation of peroxynitrite, a reaction product of nitric oxide with superoxide(3), which was derived from NADPH oxidase 4 (Nox4). Nitric oxide and peroxynitrite then activated Trpv1, resulting in an increase of intracellular Ca2+ concentration ([Ca2+](i)) that subsequently triggered activation of mammalian target of rapamycin (mTOR). Notably, administration of the TRPV1 agonist capsaicin induced hypertrophy without overload and alleviated unloading- or denervation-induced atrophy. These findings identify nitric oxide, peroxynitrite and [Ca2+](i) as the crucial mediators that convert a mechanical load into an intracellular signaling pathway and lead us to suggest that TRPV1 could be a new therapeutic target for treating muscle atrophy.	[Ito, Naoki; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1870031, Japan; [Ito, Naoki; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Ruegg, Urs T.] Univ Geneva, Geneva Lausanne Sch Pharmaceut Sci, Geneva, Switzerland	National Center for Neurology & Psychiatry - Japan; Tokyo Institute of Technology; University of Geneva	Takeda, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1870031, Japan.	takeda@ncnp.go.jp	Ito, Naoki/K-9327-2018; Kudo, Akira/C-7340-2015	Ito, Naoki/0000-0002-1884-8494; Kudo, Akira/0000-0001-6289-3391; RUEGG, Urs/0000-0001-6078-8280	Association Francaise contre les Myopathies (AFM, France)	Association Francaise contre les Myopathies (AFM, France)(Association Francaise contre les Myopathies)	We thank M. Kotlikoff (Department of Biomedical Science, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA) for providing pCAGGS-GCaMP2 mice, K.-H. Krause (Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland) for Nox4-null mice, Y. Ono for the technical support to isolate satellite cells and GenKyoTex (Geneva, Switzerland) for supplying GKT136901. We also thank D. Glass, I. Kii, V. Ullrich, B. Gahwiler and Y. Aoki for reading the manuscript and contributing to valuable discussions. This work was supported by a Grant-in-Aid for Scientific Research (B), a Grant-in-Aid for Japan Society for the Promotion of Science Fellows and a grant from the Association Francaise contre les Myopathies (AFM, France).	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Heck DE, 2001, ANTIOXID REDOX SIGN, V3, P249, DOI 10.1089/152308601300185205; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Kemp-Harper B, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19pe12; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Luo ZD, 2012, CELL RES, V22, P551, DOI 10.1038/cr.2011.205; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Pietri-Rouxel F, 2010, EMBO J, V29, P643, DOI 10.1038/emboj.2009.366; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sellman JE, 2006, J APPL PHYSIOL, V100, P258, DOI 10.1152/japplphysiol.00936.2005; Soltow QA, 2006, MED SCI SPORT EXER, V38, P840, DOI 10.1249/01.mss.0000218142.98704.66; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Wozniak AC, 2007, DEV DYNAM, V236, P240, DOI 10.1002/dvdy.21012; Xin H, 2005, BIOCHEM BIOPH RES CO, V332, P756, DOI 10.1016/j.bbrc.2005.05.016; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	199	209	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2013	19	1					101	106		10.1038/nm.3019	http://dx.doi.org/10.1038/nm.3019			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202294				2022-12-25	WOS:000313230300031
J	Le Gallo, M; O'Hara, AJ; Rudd, ML; Urick, ME; Hansen, NF; O'Neil, NJ; Price, JC; Zhang, S; England, BM; Godwin, AK; Sgroi, DC; Hieter, P; Mullikin, JC; Merino, MJ; Bell, DW				Le Gallo, Matthieu; O'Hara, Andrea J.; Rudd, Meghan L.; Urick, Mary Ellen; Hansen, Nancy F.; O'Neil, Nigel J.; Price, Jessica C.; Zhang, Suiyuan; England, Bryant M.; Godwin, Andrew K.; Sgroi, Dennis C.; Hieter, Philip; Mullikin, James C.; Merino, Maria J.; Bell, Daphne W.		NIH Intramural Sequencing Ctr NISC	Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes	NATURE GENETICS			English	Article							HISTONE DEACETYLASE; FREQUENT MUTATIONS; CARCINOMA; ARID1A; NURD; SUPPRESSOR; OVARIAN; AMPLIFICATION; SENSITIVITY; EXPRESSION	Endometrial cancer is the sixth most commonly diagnosed cancer in women worldwide, causing similar to 74,000 deaths annually(1). Serous endometrial cancers are a clinically aggressive subtype with a poorly defined genetic etiology(2-4). We used whole-exome sequencing to comprehensively search for somatic mutations within similar to 22,000 protein-encoding genes in 13 primary serous endometrial tumors. We subsequently resequenced 18 genes, which were mutated in more than 1 tumor and/or were components of an enriched functional grouping, from 40 additional serous tumors. We identified high frequencies of somatic mutations in CHD4 (17%), EP300 (8%), ARID1A (6%), TSPYL2 (6%), FBXW7 (29%), SPOP (8%), MAP3K4 (6%) and ABCC9 (6%). Overall, 36.5% of serous tumors had a mutated chromatin-remodeling gene, and 35% had a mutated ubiquitin ligase complex gene, implicating frequent mutational disruption of these processes in the molecular pathogenesis of one of the deadliest forms of endometrial cancer.	[Le Gallo, Matthieu; O'Hara, Andrea J.; Rudd, Meghan L.; Urick, Mary Ellen; Price, Jessica C.; England, Bryant M.; Bell, Daphne W.] NHGRI, Canc Genet Branch, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA; [Hansen, Nancy F.; Zhang, Suiyuan; Mullikin, James C.] NHGRI, Genome Technol Branch, US NIH, Bethesda, MD 20892 USA; [O'Neil, Nigel J.; Hieter, Philip] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Mullikin, James C.; NIH Intramural Sequencing Ctr NISC] NISC, US NIH, Bethesda, MD USA; [Merino, Maria J.] NCI, US NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of British Columbia; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bell, DW (corresponding author), NHGRI, Canc Genet Branch, US Natl Inst Hlth NIH, Bethesda, MD 20892 USA.	belldaph@mail.nih.gov	O'Neil, Nigel/J-4012-2014; Le Gallo, Matthieu/T-4181-2019; Sgroi, Dennis/AAV-2487-2021; Le Gallo, Matthieu/F-7188-2012	O'Neil, Nigel/0000-0002-1992-6976; Le Gallo, Matthieu/0000-0001-9085-8155	National Human Genome Research Institute, US NIH; NIH [R01CA112021, R01CA140323, CA016519]; Avon Foundation; Ovarian Cancer Fund; Canadian Institutes for Health Research [MOP-38096]; NATIONAL CANCER INSTITUTE [R01CA112021, ZIESC000853, R01CA140323, R01CA158162, P01CA016519] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338, ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER	National Human Genome Research Institute, US NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; Ovarian Cancer Fund; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded in part by the Intramural Program of the National Human Genome Research Institute, US NIH (D.W.B., J.C.M. and M.J.M.); NIH grant R01CA112021 (D.C.S.); the Avon Foundation (D.C.S.); NIH grant R01CA140323 (A.K.G.); and the Ovarian Cancer Fund (A.K.G.). P.H. is supported by grants from the NIH (CA016519) and by the Canadian Institutes for Health Research (MOP-38096).	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Cassia R, 2003, J PATHOL, V201, P589, DOI 10.1002/path.1474; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Glaeser M, 2001, HORM METAB RES, V33, P121, DOI 10.1055/s-2001-14938; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hayes MP, 2009, GYNECOL ONCOL, V113, P370, DOI 10.1016/j.ygyno.2008.12.021; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Li CP, 2011, EUR PHYS J-SPEC TOP, V193, P1, DOI 10.1140/epjst/e2011-01377-3; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; National Cancer Institute, 2007, SEER SURVIVAL MONOGR; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Sherman ME, 2000, MODERN PATHOL, V13, P295, DOI 10.1038/modpathol.3880051; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Spruck CH, 2002, CANCER RES, V62, P4535; Suehiro Y, 2008, CLIN CANCER RES, V14, P3354, DOI 10.1158/1078-0432.CCR-07-4609; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	59	302	305	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1310	1315		10.1038/ng.2455	http://dx.doi.org/10.1038/ng.2455			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23104009	Green Accepted			2022-12-25	WOS:000311713200007
J	Schneider, CK; Vleminckx, C; Gravanis, I; Ehmann, F; Trouvin, JH; Weise, M; Thirstrup, S				Schneider, Christian K.; Vleminckx, Camille; Gravanis, Iordanis; Ehmann, Falk; Trouvin, Jean-Hugues; Weise, Martina; Thirstrup, Steffen			Setting the stage for biosimilar monoclonal antibodies	NATURE BIOTECHNOLOGY			English	Editorial Material							PRODUCTS		[Schneider, Christian K.; Thirstrup, Steffen] Danish Hlth & Med Author, Copenhagen, Denmark; [Schneider, Christian K.; Vleminckx, Camille; Gravanis, Iordanis; Ehmann, Falk; Trouvin, Jean-Hugues; Weise, Martina] EMA, London, England; [Schneider, Christian K.] Twincore Ctr Expt & Clin Infect Res, Hannover, Germany; [Trouvin, Jean-Hugues] Paris Descartes Univ, Sch Pharm, Paris, France; [Weise, Martina] Bundesinst Arzneimittel & Med Prod, Bonn, Germany; [Thirstrup, Steffen] Univ Copenhagen, European Commiss Project Grp Access & Uptake Bios, DK-1168 Copenhagen, Denmark; [Thirstrup, Steffen] Univ Copenhagen, Fac Pharmaceut Sci, DK-1168 Copenhagen, Denmark	Helmholtz Association; Helmholtz-Center for Infection Research; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; University of Copenhagen	Schneider, CK (corresponding author), Danish Hlth & Med Author, Copenhagen, Denmark.	c_schneid@web.de						[Anonymous], 2012, EMACHMPBMWP403543201; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; English V, 2007, RAJ PHARM MARKETS, V2007, P173; *EUR MED AG, 2006, EMEACHMPBMWP32775200; European Medicines Agency, 2008, EUR PUBL ASS REP FIL; European Medicines Agency, 2006, EMEACHMPBMWP42832200; European Medicines Agency, 2010, EMACHMPBMWP403543201; European Medicines Agency, 2006, EMEACHMPBMWP31329200; European Medicines Agency, 2012, EMA2058862012; European Medicines Agency, 2012, APPL NEW HUM MED EV; European Medicines Agency, 2009, EMEA WORKSH MON ANT; European Medicines Agency, 2012, MULT GUID BIOS; European Medicines Agency, 2012, EUR PUBL ASS REP; European Medicines Agency, 2009, EMEACHMPBMWP63261320; European Medicines Agency, 2011, EUR MED AG WORKSH BI; European Medicines Agency, 2009, EMEACHMPBMWP11826420; European Parliament and Council, 2010, OFF J EUROPEAN UNION, V3L348, P74; Schiestl M, 2011, NAT BIOTECHNOL, V29, P310, DOI 10.1038/nbt.1839; Schneider CK, 2008, NAT REV DRUG DISCOV, V7, P893, DOI 10.1038/nrd2728; Schneider CK, 2008, NAT BIOTECHNOL, V26, P985, DOI 10.1038/nbt0908-985; Schneider CK, 2012, NAT BIOTECHNOL, V30, P745, DOI 10.1038/nbt.2322; Weise M, 2012, BLOOD, V120, P5111, DOI 10.1182/blood-2012-04-425744; Weise M, 2011, NAT BIOTECHNOL, V29, P690, DOI 10.1038/nbt.1936	23	59	61	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1179	1185		10.1038/nbt.2447	http://dx.doi.org/10.1038/nbt.2447			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222783	Green Submitted			2022-12-25	WOS:000312092400016
J	Mak, HC; Baker, S; Joecker, A; Church, G; Snyder, M; West, J; Salzberg, S; Worthey, E; Smith, T; Wang, J; Reid, JG				Mak, H. Craig; Baker, Shawn; Joecker, Anika; Church, George; Snyder, Michael; West, John; Salzberg, Steven; Worthey, Elizabeth; Smith, Todd; Wang, Jun; Reid, Jeffrey G.			Genome interpretation and assembly-recent progress and next steps	NATURE BIOTECHNOLOGY			English	Editorial Material													Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; church, george/0000-0001-6232-9969; Snyder, Michael/0000-0003-0784-7987					0	7	9	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1081	1083		10.1038/nbt.2425	http://dx.doi.org/10.1038/nbt.2425			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138307	Bronze			2022-12-25	WOS:000311087500027
J	Mennella, V; Keszthelyi, B; McDonald, KL; Chhun, B; Kan, F; Rogers, GC; Huang, B; Agard, DA				Mennella, V.; Keszthelyi, B.; McDonald, K. L.; Chhun, B.; Kan, F.; Rogers, G. C.; Huang, B.; Agard, D. A.			Subdiffraction-resolution fluorescence microscopy reveals a domain of the centrosome critical for pericentriolar material organization	NATURE CELL BIOLOGY			English	Article							TUBULIN RING COMPLEX; MICROTUBULE NUCLEATION; BASAL BODY; 3-DIMENSIONAL STRUCTURE; 9-FOLD SYMMETRY; PROTEIN; CENTRIOLES; CYCLE; DUPLICATION; BIOGENESIS	As the main microtubule-organizing centre in animal cells, the centrosome has a fundamental role in cell function. Surrounding the centrioles, the pericentriolar material (PCM) provides a dynamic platform for nucleating microtubules. Although the importance of the PCM is established, its amorphous electron-dense nature has made it refractory to structural investigation. By using SIM and STORM subdiffraction-resolution microscopies to visualize proteins critical for centrosome maturation, we demonstrate that the PCM is organized into two main structural domains: a layer juxtaposed to the centriole wall, and proteins extending farther away from the centriole organized in a matrix. Analysis of Pericentrin-like protein (PLP) reveals that its carboxy terminus is positioned at the centriole wall, it radiates outwards into the matrix and is organized in clusters having quasi-nine-fold symmetry. By RNA-mediated interference (RNAi), we show that PLP fibrils are required for interphase recruitment and proper mitotica ssembly of the PCM matrix.	[Mennella, V.; Keszthelyi, B.; Chhun, B.; Kan, F.; Huang, B.; Agard, D. A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Mennella, V.; Keszthelyi, B.; Kan, F.; Agard, D. A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [McDonald, K. L.] Univ Calif Berkeley, Electron Microscope Lab, Berkeley, CA 94720 USA; [Chhun, B.; Huang, B.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Rogers, G. C.] Univ Arizona, Arizona Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85724 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Arizona Center Cancer Care; University of Arizona	Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	david@agardlab.ucsf.edu	Mennella, Vito/GZL-7765-2022	Chhun, Bryant/0000-0002-3539-2396; Mennella, Vito/0000-0002-4842-9012	HHMI; NIH [GM310627]; Searle Scholarship; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031627] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008479] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholarship; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We especially thank J. Sedat, L. Winoto and C. Weisiger for invaluable assistance with the OMX, S. Li for advice and help with the 3D alignment strategy, and D. Buster and K. Model for comments and editing on the manuscript. We also would like to thank T. Avidor-reiss (Harvard University, USA), J. Raff (University of Oxford, UK), M. Bettencourt-Dias (Instituto Gulbenkian de Ciencia, Portugal), M. Gatti (Universita ~ La Sapienza di Roma, Italy), T. Megraw (Florida State University, USA), M. Takahashi (Teikyo Heisei University, Japan), Y. Zheng (Carnegie Institution of Washington) and Howard Hughes Medical Institute, T. Davis (University of Washington) and T. Kaufman (University of Indiana, USA) for generously sharing their antibodies. This work was financially supported by HHMI and NIH grant GM310627. B.H. is a recipient of the Searle Scholarship and the Packard Fellowship for Science and Engineering.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; ANDERSON RG, 1972, J CELL BIOL, V54, P246, DOI 10.1083/jcb.54.2.246; Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Gillingham AK, 2000, EMBO REP, V1, P524; Gogendeau D, 2010, SEMIN CELL DEV BIOL, V21, P163, DOI 10.1016/j.semcdb.2009.07.001; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Ibrahim R, 2009, MICROSC RES TECHNIQ, V72, P42, DOI 10.1002/jemt.20637; Kawaguchi S, 2004, MOL BIOL CELL, V15, P37, DOI 10.1091/mbc.E03-03-0191; Keating TJ, 2000, NAT CELL BIOL, V2, P352, DOI 10.1038/35014045; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Lau L, 2012, BIOPHYS J, V102, P2926, DOI 10.1016/j.bpj.2012.05.015; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Mahen R, 2012, CURR OPIN CELL BIOL, V24, P14, DOI 10.1016/j.ceb.2011.12.012; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; MCDONALD KL, 1994, METHOD CELL BIOL, V44, P411, DOI 10.1016/S0091-679X(08)60926-7; Mennella V, 2009, J CELL BIOL, V186, P481, DOI 10.1083/jcb.200902113; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Mogensen MM, 2000, J CELL SCI, V113, P3013; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; Ou Y, 2004, CELL MOTIL CYTOSKEL, V57, P1, DOI 10.1002/cm.10154; Ou YC, 2000, CELL MOTIL CYTOSKEL, V47, P13, DOI 10.1002/1097-0169(200009)47:1<13::AID-CM2>3.0.CO;2-C; Ou YY, 2003, CELL MOTIL CYTOSKEL, V55, P125, DOI 10.1002/cm.10115; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; RIEDER CL, 1982, BIOL CELL, V44, P117; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schnackenberg BJ, 2000, J CELL SCI, V113, P943; Sonnen K. F., 2012, BIOL OPEN, V000, P1; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]	72	263	268	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1159	+		10.1038/ncb2597	http://dx.doi.org/10.1038/ncb2597			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23086239	Green Accepted			2022-12-25	WOS:000310778100009
J	Min, LH; Ji, Y; Bakiri, L; Qiu, ZX; Cen, J; Chen, XT; Chen, LL; Scheuch, H; Zheng, H; Qin, LX; Zatloukal, K; Hui, LJ; Wagner, EF				Min, Lihua; Ji, Yuan; Bakiri, Latifa; Qiu, Zhixin; Cen, Jin; Chen, Xiaotao; Chen, Lingli; Scheuch, Harald; Zheng, Hai; Qin, Lunxiu; Zatloukal, Kurt; Hui, Lijian; Wagner, Erwin F.			Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin	NATURE CELL BIOLOGY			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR SUPPRESSION; GENE-EXPRESSION; PROLIFERATION; SIRT6; FOS; INFLAMMATION; ACTIVATION; PREVENTION; OPINION	Understanding stage-dependent oncogenic mechanisms is critical to develop not only targeted therapies, but also diagnostic markers and preventive strategies. The mechanisms acting during cancer initiation remain elusive, largely owing to a lack of suitable animal models and limited availability of human precancerous lesions. Here we show using genetic mouse models specific for liver cancer initiation, that survival of initiated cancer cells is controlled by c-Jun, independently of p53, through suppressing c-Fos-mediated apoptosis. Mechanistically, c-Fos induces SIRT6 transcription, which represses survivin by reducing histone H3K9 acetylation and NF-kappa B activation. Importantly, increasing the level of SIRT6 or targeting the anti-apoptotic activity of survivin at the initiation stage markedly impairs cancer development. Moreover, in human dysplastic liver nodules, but not in malignant tumours, a special expression pattern with increased c-Jun-survivin and attenuated c-Fos-SIRT6 levels was identified. These results reveal a regulatory network connecting stress response and histone modification in liver tumour initiation, which could be targeted to prevent liver tumorigenesis.	[Min, Lihua; Qiu, Zhixin; Cen, Jin; Chen, Xiaotao; Zheng, Hai; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Ji, Yuan; Chen, Lingli] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China; [Bakiri, Latifa; Wagner, Erwin F.] Spanish Natl Canc Res Ctr, F BBVA CNIO Canc Cell Biol Programme, Genes Dev & Dis Grp, Madrid 28029, Spain; [Scheuch, Harald] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Qin, Lunxiu] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China; [Zatloukal, Kurt] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Centro Nacional de Investigaciones Oncologicas (CNIO); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Fudan University; Medical University of Graz	Hui, LJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Yueyang Rd 320, Shanghai 200031, Peoples R China.	ljhui@sibs.ac.cn; ewagner@cnio.es	Bakiri, Latifa/AAP-1674-2020; Qiu, Zhixin/CAG-1575-2022; Bakiri, Latifa/N-5780-2014	Qiu, Zhixin/0000-0001-7103-8004; Wagner, Erwin F/0000-0001-7872-0196; bakiri, latifa/0000-0002-6300-2420	National Science Foundation of China [31071238]; Ministry of Science and Technology of China [2012CB945001, 2011ZX09307-302-01]; Chinese Academy of Sciences (the Hundred Talents Program); F-BBVA; ERC-Advanced grant [ERC-FCK/2008/37]; Austrian genome program GEN-AU	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences (the Hundred Talents Program); F-BBVA(BBVA Foundation); ERC-Advanced grant(European Research Council (ERC)); Austrian genome program GEN-AU	This work was initiated at the Research Institute of Molecular Pathology, which is funded by Boehringer Ingelheim. We thank S. Ji for technical support and R. Eferl, P. Hasselblatt, M. Sibilia, P. Angel and J. Hess for critical reading of the manuscript. We are also grateful to D. Altieri (University of Massachusetts, USA) for survivin and SurT34A adenoviruses, K. Chua (Stanford University, USA) for SIRT6 and SIRT6HY plasmids, M. F. Rajewsky (University of Essen, Germany) for antibodies against DNA adducts, and the Biobank of the Medical University of Graz, Austria for providing further human liver samples. Work in the L.H. laboratory is funded by the National Science Foundation of China (31071238), the Ministry of Science and Technology of China (2012CB945001, 2011ZX09307-302-01) and the Chinese Academy of Sciences (the Hundred Talents Program). Work in the E.F.W. laboratory is supported by a grant from F-BBVA and an ERC-Advanced grant ERC-FCK/2008/37. K.Z. is supported by the Austrian genome program GEN-AU.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fausto N, 2010, SEMIN LIVER DIS, V30, P87, DOI 10.1055/s-0030-1247135; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; Gotay CC, 2010, EXPERT REV PHARM OUT, V10, P143, DOI [10.1586/erp.10.9, 10.1586/ERP.10.9]; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasselblatt P, 2007, P NATL ACAD SCI USA, V104, P17105, DOI 10.1073/pnas.0706272104; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Meixner A., 2010, CELL DEATH DIFFER; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI12983; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mikula M, 2003, ONCOGENE, V22, P6725, DOI 10.1038/sj.onc.1206781; Montorsi M, 2007, HEPATO-GASTROENTEROL, V54, P2040; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Poon RTP, 2011, HEPATOLOGY, V54, P757, DOI 10.1002/hep.24569; Ramachandran R, 2009, J CLIN PATHOL, V62, P481, DOI 10.1136/jcp.2008.058248; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011	40	185	196	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1203	+		10.1038/ncb2590	http://dx.doi.org/10.1038/ncb2590			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23041974				2022-12-25	WOS:000310778100013
J	Ousset, M; Van Keymeulen, A; Bouvencourt, G; Sharma, N; Achouri, Y; Simons, BD; Blanpain, C				Ousset, Marielle; Van Keymeulen, Alexandra; Bouvencourt, Gaelle; Sharma, Neha; Achouri, Younes; Simons, Benjamin D.; Blanpain, Cedric			Multipotent and unipotent progenitors contribute to prostate postnatal development	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; EPITHELIAL-CELLS; BASAL-CELLS; MURINE; P63; CANCER; IDENTIFICATION; PROLIFERATION; MORPHOGENESIS; LINEAGES	The prostate is a glandular epithelium composed of basal, luminal and neuroendocrine cells that originate from the urogenital sinus during embryonic development. After birth, the prostate keeps developing until the end of puberty. Here, we used inducible genetic lineage tracing experiments in mice to investigate the cellular hierarchy that governs prostate postnatal development. We found that prostate postnatal development is mediated by basal multipotent stem cells that differentiate into basal, luminal and neuroendocrine cells, as well as by unipotent basal and luminal progenitors. Clonal analysis of basal cells revealed the existence of bipotent and unipotent basal progenitors as well as basal cells already committed to the luminal lineage with intermediate cells co-expressing basal and luminal markers associated with this commitment step. The existence of multipotent basal progenitors during prostate postnatal development contrasts with the distinct pools of unipotent basal and luminal stem cells that mediate adult prostate regeneration. Our results uncover the cellular hierarchy acting during prostate development and will be instrumental in defining the cellular origin and the mechanisms underlying prostate cancer initiation.	[Ousset, Marielle; Van Keymeulen, Alexandra; Bouvencourt, Gaelle; Sharma, Neha] ULB, IRIBHM, B-1070 Brussels, Belgium; [Achouri, Younes] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Blanpain, Cedric] WELBIO, B-1070 Brussels, Belgium; [Ousset, Marielle; Van Keymeulen, Alexandra; Blanpain, Cedric] FRS FNRS, Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; University of Cambridge; University of Cambridge; WELBIO; Fonds de la Recherche Scientifique - FNRS	Blanpain, C (corresponding author), ULB, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Simons, Benjamin/AAY-8920-2020; Blanpain, Cedric/ABD-8392-2021	Simons, Benjamin/0000-0002-3875-7071; ACHOURI, Younes/0000-0001-7409-1441; Sharma, Neha/0000-0002-8062-1661; OUSSET, Marielle/0000-0002-2092-2729	FNRS, TELEVIE; program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer; ULB fondation; fond Gaston Ithier, a starting grant of the European Research Council (ERC); EMBO Young Investigator Program	FNRS, TELEVIE(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer; ULB fondation; fond Gaston Ithier, a starting grant of the European Research Council (ERC); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	We thank our colleagues who provided us with reagents, which are cited in the text. We thank our colleagues from the Blanpain laboratory and C. Govaerts for their comments on the manuscript and J-M. Vanderwinden and F. Bollet-Quivogne for their help with confocal imaging. C.B. and A.V.K. are chercheur qualifie, M.O. is a collaborateur scientifique of the FRS/FNRS. C.B. is an investigator of WELBIO. This work was supported by the FNRS, TELEVIE, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB fondation, the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Cunha GR, 2008, DIFFERENTIATION, V76, P578, DOI 10.1111/j.1432-0436.2008.00290.x; CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Kasper S, 2008, STEM CELL REV, V4, P193, DOI 10.1007/s12015-008-9033-1; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; Liu J, 2011, MOL ENDOCRINOL, V25, P1849, DOI 10.1210/me.2011-1081; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Peehl DM, 1996, CELL TISSUE RES, V285, P171, DOI 10.1007/s004410050633; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Taylor RA, 2010, ENDOCR-RELAT CANCER, V17, pR273, DOI 10.1677/ERC-10-0145; Timms BG, 2008, DIFFERENTIATION, V76, P565, DOI 10.1111/j.1432-0436.2008.00278.x; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Wu CS, 2007, SCI TECHNOL WELD JOI, V12, P1, DOI 10.1179/174329307X160548; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Xue Y, 1998, PROSTATE, V34, P292, DOI 10.1002/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	42	153	156	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1130	+		10.1038/ncb2600	http://dx.doi.org/10.1038/ncb2600			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23064263				2022-12-25	WOS:000310778100006
J	Bhave, G; Cummings, CF; Vanacore, RM; Kumagai-Cresse, C; Ero-Tolliver, IA; Rafi, M; Kang, JS; Pedchenko, V; Fessler, LI; Fessler, JH; Hudson, BG				Bhave, Gautam; Cummings, Christopher F.; Vanacore, Roberto M.; Kumagai-Cresse, Chino; Ero-Tolliver, Isi A.; Rafi, Mohamed; Kang, Jeong-Suk; Pedchenko, Vadim; Fessler, Liselotte I.; Fessler, John H.; Hudson, Billy G.			Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis	NATURE CHEMICAL BIOLOGY			English	Article							HUMAN MYELOPEROXIDASE; EXTRACELLULAR-MATRIX; HYDROGEN-PEROXIDE; AMINO-ACIDS; IDENTIFICATION; MUTATIONS; BIOLOGY; PROTEIN; IV; SUPERFAMILY	Collagen IV comprises the predominant protein network of basement membranes, a specialized extracellular matrix, which underlie epithelia and endothelia. These networks assemble through oligomerization and covalent crosslinking to endow mechanical strength and shape cell behavior through interactions with cell-surface receptors. A recently discovered sulfilimine (S=N) bond between a methionine sulfur and hydroxylysine nitrogen reinforces the collagen IV network. We demonstrate that peroxidasin, an enzyme found in basement membranes, catalyzes formation of the sulfilimine bond. Drosophila peroxidasin mutants have disorganized collagen IV networks and torn visceral muscle basement membranes, pointing to a critical role for the enzyme in tissue biogenesis. Peroxidasin generates hypohalous acids as reaction intermediates, suggesting a paradoxically anabolic role for these usually destructive oxidants. This work highlights sulfilimine bond formation as what is to our knowledge the first known physiologic function for peroxidasin, a role for hypohalous oxidants in tissue biogenesis, and a possible role for peroxidasin in inflammatory diseases.	[Bhave, Gautam; Vanacore, Roberto M.; Ero-Tolliver, Isi A.; Rafi, Mohamed; Pedchenko, Vadim; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Internal Med, Nashville, TN 37235 USA; [Bhave, Gautam; Vanacore, Roberto M.; Ero-Tolliver, Isi A.; Rafi, Mohamed; Pedchenko, Vadim; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN USA; [Cummings, Christopher F.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN USA; [Kumagai-Cresse, Chino; Fessler, Liselotte I.; Fessler, John H.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Kumagai-Cresse, Chino; Fessler, Liselotte I.; Fessler, John H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Hudson, Billy G.] Kathryn W Davis Ctr Regenerat Biol & Med, Mt Desert Isl Biol Lab, Salsbury Cove, ME USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vanderbilt University; Vanderbilt University; Vanderbilt University; Mount Desert Island Biological Laboratory	Bhave, G (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Internal Med, Nashville, TN 37235 USA.	billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020; Ero-Tolliver, Isi/AAD-6038-2019	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	US National Institutes of Health [RO1 DK18381, DK18381-38S1, 2PO1 DK065123]; Mount Desert Island Biological Laboratory Salisbury Cove Research Fund; F.H. Epstein Fellowship; Vanderbilt Division of Nephrology Faculty Development Fund; Vanderbilt Physician Scientist Development Award; Vanderbilt Academic Venture Capital Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, P01DK065123, T32DK007569, R01DK099467, R01DK018381] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Desert Island Biological Laboratory Salisbury Cove Research Fund; F.H. Epstein Fellowship; Vanderbilt Division of Nephrology Faculty Development Fund; Vanderbilt Physician Scientist Development Award; Vanderbilt Academic Venture Capital Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health (RO1 DK18381, DK18381-38S1 and 2PO1 DK065123 to B.G.H.), the Mount Desert Island Biological Laboratory Salisbury Cove Research Fund and F.H. Epstein Fellowship (to B. G. H.), the Vanderbilt Division of Nephrology Faculty Development Fund (to R.M.V.) and a Vanderbilt Physician Scientist Development Award (to G.B.). We are grateful to K.L. Rose and W.H. McDonald of the Mass Spectrometry Resource Center at Vanderbilt University for assistance with mass spectrometry, which was supported in part by the Vanderbilt Academic Venture Capital Fund. We acknowledge A. Chisholm and A. Page-McCaw for fruitful discussions during the writing of this manuscript. We thank M. Geizst (Semmelweis University) for the human peroxidasin coding sequence and L.Cooley (Yale University) for the viking<SUP>G454</SUP> protein trap Drosophila line. P. Todd, N.Danylevych and C. Venkov provided technical assistance.	ADENIYIJONES SK, 1981, J CLIN INVEST, V68, P365, DOI 10.1172/JCI110264; ALEXANDER NM, 1959, J BIOL CHEM, V234, P1530; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; Armesto XL, 2000, TETRAHEDRON, V56, P1103, DOI 10.1016/S0040-4020(99)01066-2; Bai YP, 2011, FREE RADICAL BIO MED, V51, P1492, DOI 10.1016/j.freeradbiomed.2011.07.004; Beal JL, 2009, BIOCHEMISTRY-US, V48, P11142, DOI 10.1021/bi901343d; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Brandes RP, 2011, CARDIOVASC RES, V91, P1, DOI 10.1093/cvr/cvr120; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Coupry I, 2010, ARCH OPHTHALMOL-CHIC, V128, P483, DOI 10.1001/archophthalmol.2010.42; DEMONTELLANO PRO, 1988, BIOCHEMISTRY-US, V27, P5470, DOI 10.1021/bi00415a013; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; FESSLER LI, 1982, J BIOL CHEM, V257, P9804; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; HUWILER M, 1985, EUR J BIOCHEM, V147, P469; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; KRAMER RH, 1984, J CELL BIOL, V99, P692, DOI 10.1083/jcb.99.2.692; Labelle-Dumais C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002062; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Li H, 2012, INFECT IMMUN, V80, P2528, DOI 10.1128/IAI.06337-11; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; NAGASAKA A, 1976, J CLIN ENDOCR METAB, V43, P152, DOI 10.1210/jcem-43-1-152; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Obinger C, 2006, ARCH BIOCHEM BIOPHYS, V445, P197, DOI 10.1016/j.abb.2005.10.015; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Peskin AV, 2009, BIOCHEMISTRY-US, V48, P10175, DOI 10.1021/bi901266w; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; TANG SS, 1983, J BIOL CHEM, V258, P4331; TAUROG A, 1992, ARCH BIOCHEM BIOPHYS, V296, P239, DOI 10.1016/0003-9861(92)90568-H; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Yokoyama M, 2004, CURR OPIN PHARMACOL, V4, P110, DOI 10.1016/j.coph.2003.12.004; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950	47	164	166	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					784	790		10.1038/NCHEMBIO.1038	http://dx.doi.org/10.1038/NCHEMBIO.1038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22842973	Green Accepted			2022-12-25	WOS:000308077600010
J	McIntyre, JC; Davis, EE; Joiner, A; Williams, CL; Tsai, IC; Jenkins, PM; McEwen, DP; Zhang, L; Escobado, J; Thomas, S; Szymanska, K; Johnson, CA; Beales, PL; Green, ED; Mullikin, JC; Sabo, A; Muzny, DM; Gibbs, RA; Attie-Bitach, T; Yoder, BK; Reed, RR; Katsanis, N; Martens, JR				McIntyre, Jeremy C.; Davis, Erica E.; Joiner, Ariell; Williams, Corey L.; Tsai, I-Chun; Jenkins, Paul M.; McEwen, Dyke P.; Zhang, Lian; Escobado, John; Thomas, Sophie; Szymanska, Katarzyna; Johnson, Colin A.; Beales, Philip L.; Green, Eric D.; Mullikin, James C.; Sabo, Aniko; Muzny, Donna M.; Gibbs, Richard A.; Attie-Bitach, Tania; Yoder, Bradley K.; Reed, Randall R.; Katsanis, Nicholas; Martens, Jeffrey R.		NISC Comparative Sequencing Prog	Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model	NATURE MEDICINE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN; MOUSE; MUTATIONS; ANOSMIA; ABNORMALITIES; DEGENERATION; EXPRESSION; SURVIVAL; MOTILITY; ALLELES	Cilia are evolutionarily conserved microtubule-based organelles that are crucial for diverse biological functions, including motility, cell signaling and sensory perception(1). In humans, alterations in the formation and function of cilia manifest clinically as ciliopathies, a growing class of pleiotropic genetic disorders(2-4). Despite the substantial progress that has been made in identifying genes that cause ciliopathies, therapies for these disorders are not yet available to patients. Although mice with a hypomorphic mutation in the intraflagellar transport protein IFT88 (Ift88(Tg737Rpw) mice, also known as ORPK mice)(5) have been well studied, the relevance of IFT88 mutations to human pathology is unknown. We show that a mutation in IFT88 causes a hitherto unknown human ciliopathy. In vivo complementation assays in zebrafish and mIMCD3 cells show the pathogenicity of this newly discovered allele. We further show that ORPK mice are functionally anosmic as a result of the loss of cilia on their olfactory sensory neurons (OSNs). Notably, adenoviral-mediated expression of IFT88 in mature, fully differentiated OSNs of ORPK mice is sufficient to restore ciliary structures and rescue olfactory function. These studies are the first to use in vivo therapeutic treatment to reestablish cilia in a mammalian ciliopathy. More broadly, our studies indicate that gene therapy is a viable option for cellular and functional rescue of the complex ciliary organelle in established differentiated cells.	[McIntyre, Jeremy C.; Joiner, Ariell; Williams, Corey L.; Jenkins, Paul M.; McEwen, Dyke P.; Zhang, Lian; Escobado, John; Martens, Jeffrey R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Davis, Erica E.; Tsai, I-Chun; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Davis, Erica E.; Tsai, I-Chun; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Thomas, Sophie; Attie-Bitach, Tania] Univ Paris 05, Dept Genet, Paris, France; [Thomas, Sophie; Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Szymanska, Katarzyna; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Beales, Philip L.] UCL, Mol Med Unit, Inst Child Hlth, London, England; [Green, Eric D.; Mullikin, James C.; NISC Comparative Sequencing Prog] NHGRI, US Natl Inst Hlth Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL USA; [Sabo, Aniko; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Reed, Randall R.] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD USA	University of Michigan System; University of Michigan; Duke University; Duke University; Duke University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint James's University Hospital; University of Leeds; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Johns Hopkins University	Martens, JR (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	martensj@umich.edu	thomas, sophie/GVS-1279-2022; Jenkins, Paul/C-9098-2015; ATTIE-BITACH, Tania/K-1453-2017; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012; THOMAS, Sophie/F-4492-2017	Jenkins, Paul/0000-0002-4207-5823; ATTIE-BITACH, Tania/0000-0002-1155-3626; THOMAS, Sophie/0000-0002-8569-3277; Katsanis, Nicholas/0000-0002-2480-0171; Johnson, Colin/0000-0002-2979-8234; Davis, Erica/0000-0002-2412-8397	US National Institutes of Health [R01DC009606, F32DC011990, R01DC004553, R01DC008295, R01DK75996, R01EY021872, R01HD04260, R01DK072301, R01DK075972]; l'Agence National pour la Recherche (ANR) [2010 FOETOCILPATH 1122 01]; University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center [DK074083]; European Community's Seventh Framework Programme [241955]; MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, U54HG003273, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094578, R01DK075996, R01DK075972, R01DK072301, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC011990, R01DC004553, R01DC008295, T32DC000011, R01DC009606] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); l'Agence National pour la Recherche (ANR)(French National Research Agency (ANR)); University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center; European Community's Seventh Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was support by US National Institutes of Health grants R01DC009606 (J.R.M.), F32DC011990 (J.C.M.), R01DC004553, R01DC008295 (R.R.R.), R01DK75996 (B.K.Y.), R01EY021872 (E.E.D.), R01HD04260, R01DK072301 and R01DK075972 (N.K.), by l'Agence National pour la Recherche (ANR) 2010 FOETOCILPATH 1122 01 (T.A.-B.) and by the University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center (DK074083). E.E.D., C.A.J., P.L.B. and N.K. are supported by the European Community's Seventh Framework Programme FP7/2009 under grant agreement 241955, SYSCILIA. N.K. is a Distinguished Jean and George W. Brumley Professor. We thank P. Loget for referring the family for this study, S. Dugan-Rocha, U. Nagaswamy and A. Hawes for assistance with mutational screening and R. Margolskee (Mount Sinai School of Medicine of New York University) for providing antibodies.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; BAKER H, 1983, J NEUROSCI, V3, P69; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bennett MK, 2010, MOL CELL NEUROSCI, V43, P353, DOI 10.1016/j.mcn.2010.01.002; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Coon BG, 2012, HUM MOL GENET, V21, P1835, DOI 10.1093/hmg/ddr615; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lehman JM, 2008, DEV DYNAM, V237, P1960, DOI 10.1002/dvdy.21515; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; MALICK LE, 1975, STAIN TECHNOL, V50, P265, DOI 10.3109/10520297509117069; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; RISSER JM, 1987, PHYSIOL BEHAV, V40, P545, DOI 10.1016/0031-9384(87)90042-4; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons DL, 2011, P NATL ACAD SCI USA, V108, P6276, DOI 10.1073/pnas.1019222108; Sommardahl CS, 1997, PEDIATR NEPHROL, V11, P728, DOI 10.1007/s004670050376; Tadenev ALD, 2011, P NATL ACAD SCI USA, V108, P10320, DOI 10.1073/pnas.1016531108; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	40	74	78	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1423	+		10.1038/nm.2860	http://dx.doi.org/10.1038/nm.2860			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22941275	Green Accepted			2022-12-25	WOS:000308472300040
J	Bernard, JJ; Cowing-Zitron, C; Nakatsuji, T; Muehleisen, B; Muto, J; Borkowski, AW; Martinez, L; Greidinger, EL; Yu, BD; Gallo, RL				Bernard, Jamie J.; Cowing-Zitron, Christopher; Nakatsuji, Teruaki; Muehleisen, Beda; Muto, Jun; Borkowski, Andrew W.; Martinez, Laisel; Greidinger, Eric L.; Yu, Benjamin D.; Gallo, Richard L.			Ultraviolet radiation damages self noncoding RNA and is detected by TLR3	NATURE MEDICINE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; DNA-DAMAGE; SKIN; ACTIVATION; LIGHT; IRRADIATION; CELLS; GENE; PART	Exposure to ultraviolet B (UVB) radiation from the sun can result in sunburn, premature aging and carcinogenesis, but the mechanism responsible for acute inflammation of the skin is not well understood. Here we show that RNA is released from keratinocytes after UVB exposure and that this stimulates production of the inflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) from nonirradiated keratinocytes and peripheral blood mononuclear cells (PBMCs). Whole-transcriptome sequencing revealed that UVB irradiation of keratinocytes induced alterations in the double-stranded domains of some noncoding RNAs. We found that this UVB-damaged RNA was sufficient to induce cytokine production from nonirradiated cells, as UVB irradiation of a purified noncoding RNA (U1 RNA) reproduced the same response as the one we observed to UVB-damaged keratinocytes. The responses to both UVB-damaged self-RNAs and UVB-damaged keratinocytes were dependent on Toll-like receptor 3 (TLR3) and Toll-like receptor adaptor molecule 1 (TRIF). In response to UVB exposure, Tlr3(-/-) mice did not upregulate TNF-alpha in the skin. Moreover, TLR3 was also necessary for UVB-radiation-induced immune suppression. These findings establish that UVB damage is detected by TLR3 and that self-RNA is a damage-associated molecular pattern that serves as an endogenous signal of solar injury.	[Bernard, Jamie J.; Cowing-Zitron, Christopher; Nakatsuji, Teruaki; Muehleisen, Beda; Muto, Jun; Borkowski, Andrew W.; Yu, Benjamin D.; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Bernard, Jamie J.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ USA; [Martinez, Laisel; Greidinger, Eric L.] Miami Vet Affairs Med Ctr, Miami, FL USA; [Greidinger, Eric L.] Univ Miami, Miller Sch Med, Div Rheumatol, Miami, FL 33136 USA; [Gallo, Richard L.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; Rutgers State University New Brunswick; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Gallo, RL (corresponding author), Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009; Nakatsuji, Teruaki/O-6794-2014	Gallo, Richard L/0000-0002-1401-7861; Nakatsuji, Teruaki/0000-0002-6187-2991; Yu, Benjamin/0000-0001-6663-6616; Martinez, Laisel/0000-0002-3009-8761; Bernard, Jamie/0000-0002-3800-2576; Greidinger, Eric/0000-0003-3473-3846	US National Institutes of Health (NIH) [R01-AR052728, NIH R01-AI052453, R01 AI0833358]; Veterans Affairs Merit Award [NIH R01-AR056667]; US National Institute of Environmental Health Sciences (NIEHS) [ES007148]; NIEHS Center [ES005022]; Department of Veterans Affairs [NIH AR48805]; Lupus Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R37AI052453, R01AI083358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056667, R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, T32ES007148] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); US National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Veterans Affairs(US Department of Veterans Affairs); Lupus Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Head from The Scripps Research Institute DNA Core Facility for performing RNA-Seq. We thank B. Gilchrest (Boston University, Boston, MA) for telomere oligonucleotides and advice, J. Laskin for advice and helpful discussion and M. Karin (University of California, San Diego, San Diego, CA) for providing Il1r<SUP>-/-</SUP> mice and for helpful discussion. This work was supported by US National Institutes of Health (NIH) grants R01-AR052728, NIH R01-AI052453 and R01 AI0833358 and a Veterans Affairs Merit Award to R. L. G., NIH R01-AR056667 to B.D.Y., the US National Institute of Environmental Health Sciences (NIEHS) Training Grant ES007148 and the NIEHS Center Grant ES005022 supporting J. J. B., and the Department of Veterans Affairs, NIH AR48805 and the Lupus Research Institute to E. L. G.	AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; DEFABO EC, 1983, J EXP MED, V158, P84, DOI 10.1084/jem.158.1.84; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilchrest BA, 2009, J INVEST DERM SYMP P, V14, P25, DOI 10.1038/jidsymp.2009.9; GRISWOLD DE, 1991, J INVEST DERMATOL, V97, P1019, DOI 10.1111/1523-1747.ep12492422; Hoffman RW, 2004, ARTHRITIS RHEUM-US, V50, P2891, DOI 10.1002/art.20428; Kosmadaki MG, 2004, MICRON, V35, P155, DOI 10.1016/j.micron.2003.11.002; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; MURPHY GM, 1989, PHOTODERMATOLOGY, V6, P268; NORVAL M, 1989, PHOTODERMATOLOGY, V6, P142; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363; SONTAG Y, 1995, J INVEST DERMATOL, V104, P734, DOI 10.1111/1523-1747.ep12606971; VERMEER M, 1990, PHOTODERMATOL PHOTO, V7, P258; VINCEK V, 1993, CANCER RES, V53, P728; WALSH LJ, 1995, IMMUNOL CELL BIOL, V73, P226, DOI 10.1038/icb.1995.37; Wei YD, 1999, CHEM-BIOL INTERACT, V118, P127, DOI 10.1016/S0009-2797(98)00118-5; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]	27	272	275	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1286	+		10.1038/nm.2861	http://dx.doi.org/10.1038/nm.2861			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22772463	Green Accepted			2022-12-25	WOS:000307469300036
J	Dulauroy, S; Di Carlo, SE; Langa, F; Eberl, G; Peduto, L				Dulauroy, Sophie; Di Carlo, Selene E.; Langa, Francina; Eberl, Gerard; Peduto, Lucie			Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury	NATURE MEDICINE			English	Article							CREST STEM-CELLS; NEURAL CREST; MUSCLE REGENERATION; SKELETAL-MUSCLE; MELTRIN ALPHA; IN-VIVO; EXPRESSION; BETA; MOUSE; DIFFERENTIATION	Profibrotic cells that develop upon injury generate permanent scar tissue and impair organ recovery, though their origin and fate are unclear. Here we show that transient expression of ADAM12 (a disintegrin and metalloprotease 12) identifies a distinct proinflammatory subset of platelet-derived growth factor receptor-alpha-positive stromal cells that are activated upon acute injury in the muscle and dermis. By inducible genetic fate mapping, we demonstrate in vivo that injury-induced ADAM12(+) cells are specific progenitors of a major fraction of collagen-overproducing cells generated during scarring, which are progressively eliminated during healing. Genetic ablation of ADAM12(+) cells, or knockdown of ADAM12, is sufficient to limit generation of profibrotic cells and interstitial collagen accumulation. ADAM12(+) cells induced upon injury are developmentally distinct from muscle and skin lineage cells and are derived from fetal ADAM12(+) cells programmed during vascular wall development. Thus, our data identify injury-activated profibrotic progenitors residing in the perivascular space that can be targeted through ADAM12 to limit tissue scarring.	[Dulauroy, Sophie; Di Carlo, Selene E.; Eberl, Gerard; Peduto, Lucie] Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France; [Dulauroy, Sophie; Di Carlo, Selene E.; Eberl, Gerard; Peduto, Lucie] CNRS, Unite Rech Associee URA 1961, Paris, France; [Langa, Francina] Inst Pasteur, Ctr Ingn Genet Murine, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Peduto, L (corresponding author), Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France.	lucie.peduto@pasteur.fr	Eberl, Gerard/A-1160-2013	Peduto, Lucie/0000-0003-2414-4407; Eberl, Gerard/0000-0002-1119-5638; di carlo, selene/0000-0001-5315-102X	Institut Pasteur; Mairie de Paris; Agence Nationale de la Recherche; European Commission; La Ligue contre le Cancer	Institut Pasteur(European Commission); Mairie de Paris(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was funded by the Institut Pasteur, grants from the Mairie de Paris, the Agence Nationale de la Recherche and an Excellence grant from the European Commission. S.E.D.C. is funded by La Ligue contre le Cancer. We thank H.-J. Fehling (University Clinics Ulm, Ulm, Germany) for providing the Rosa26<SUP>floxSTOP-RFP</SUP> mice, H. Bujard (ZMBH, Heidelberg, Germany) for providing the LC-1 mice and A. Farr (University of Washington, Seattle) for gp38-specific antibody. We thank L. Polomack and the team of the Centre d'Ingenierie Genetique Murine for technical assistance and members of the Development of Lymphoid Tissue Unit for discussions.	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Buchstaller J, 2004, J NEUROSCI, V24, P2357, DOI 10.1523/JNEUROSCI.4083-03.2004; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jorgensen LH, 2007, AM J PATHOL, V171, P1599, DOI 10.2353/ajpath.2007.070435; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; PAPPENHEIMER AM, 1982, J INFECT DIS, V145, P94, DOI 10.1093/infdis/145.1.94; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Real C, 2005, INT J DEV BIOL, V49, P151, DOI 10.1387/ijdb.041940cr; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Skubitz KM, 2004, J LAB CLIN MED, V143, P89, DOI 10.1016/j.lab.2003.10.002; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Sparwasser T, 2004, GENESIS, V38, P39, DOI 10.1002/gene.10249; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003	57	279	284	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1262	+		10.1038/nm.2848	http://dx.doi.org/10.1038/nm.2848			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22842476	Green Published			2022-12-25	WOS:000307469300033
J	Birsoy, K; Sabatini, DM; Possemato, R				Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard			Targeting cancer metabolism: a bedside lesson	NATURE MEDICINE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; PANCREATIC-CANCER; DIABETIC-PATIENTS; BREAST-CANCER; CELL-GROWTH; METFORMIN; PROLIFERATION; RESTRICTION; MUTATIONS; MECHANISM		[Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] MIT, Dept Biol, Cambridge, MA USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] Broad Inst, Cambridge, MA USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Birsoy, K (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	posse@wi.mit.edu		Possemato, Richard/0000-0002-2401-0030; /0000-0002-1446-7256	NCI NIH HHS [K99 CA168940] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K99CA168940] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; BROOME JD, 1981, CANCER TREAT REP, V65, P111; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Clark RAF, 2009, J INVEST DERMATOL, V129, P529, DOI 10.1038/jid.2008.441; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Sanli Y, 2012, ANN NUCL MED, V26, P345, DOI 10.1007/s12149-012-0579-2; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Seyfried BTN, 2009, J CANCER RES THER, V5, P7, DOI 10.4103/0973-1482.55134; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	21	51	53	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1022	1023		10.1038/nm.2870	http://dx.doi.org/10.1038/nm.2870			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772555				2022-12-25	WOS:000306121600030
J	Nakayama, M; Nakayama, A; van Lessen, M; Yamamoto, H; Hoffmann, S; Drexler, HCA; Itoh, N; Hirose, T; Breier, G; Vestweber, D; Cooper, JA; Ohno, S; Kaibuchi, K; Adams, RH				Nakayama, Masanori; Nakayama, Akiko; van Lessen, Max; Yamamoto, Hiroyuki; Hoffmann, Sarah; Drexler, Hannes C. A.; Itoh, Norimichi; Hirose, Tomonori; Breier, Georg; Vestweber, Dietmar; Cooper, Jonathan A.; Ohno, Shigeo; Kaibuchi, Kozo; Adams, Ralf H.			Spatial regulation of VEGF receptor endocytosis in angiogenesis	NATURE CELL BIOLOGY			English	Article							CELL-MIGRATION; ENDOTHELIAL-CELLS; POLARITY PROTEINS; PAR COMPLEX; TIP CELLS; MORPHOGENESIS; NOTCH; POLARIZATION; TRAFFICKING; VASCULATURE	Activities as diverse as migration, proliferation and patterning occur simultaneously and in a coordinated fashion during tissue morphogenesis. In the growing vasculature, the formation of motile, invasive and filopodia-carrying endothelial sprouts is balanced with the stabilization of blood-transporting vessels. Here, we show that sprouting endothelial cells in the retina have high rates of VEGF uptake, VEGF receptor endocytosis and turnover. These internalization processes are opposed by atypical protein kinase C activity in more stable and mature vessels. aPKC phosphorylates Dab2, a clathrin-associated sorting protein that, together with the transmembrane protein ephrin-B2 and the cell polarity regulator PAR-3, enables VEGF receptor endocytosis and downstream signal transduction. Accordingly, VEGF receptor internalization and the angiogenic growth of vascular beds are defective in loss-of-function mice lacking key components of this regulatory pathway. Our work uncovers how vessel growth is dynamically controlled by local VEGF receptor endocytosis and the activity of cell polarity proteins.	[Nakayama, Masanori; Nakayama, Akiko; van Lessen, Max; Yamamoto, Hiroyuki; Hoffmann, Sarah; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Nakayama, Masanori; Nakayama, Akiko; van Lessen, Max; Yamamoto, Hiroyuki; Hoffmann, Sarah; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Drexler, Hannes C. A.] Max Planck Inst Mol Biomed, Bioanalyt Mass Spectrometry Facil, D-48149 Munster, Germany; [Itoh, Norimichi; Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Hirose, Tomonori; Ohno, Shigeo] Yokohama City Univ, Dept Mol Biol, Sch Med, Yokohama, Kanagawa 2360004, Japan; [Breier, Georg] Tech Univ Dresden, Inst Pathol, Med Fac Carl Gustav Carus, D-01307 Dresden, Germany; [Vestweber, Dietmar] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, D-48149 Munster, Germany; [Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Max Planck Society; University of Munster; Max Planck Society; Nagoya University; Yokohama City University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Fred Hutchinson Cancer Center	Nakayama, M (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	mnakaya@gwdg.de; ralf.adams@mpi-muenster.mpg.de	Drexler, Hannes/AAI-3449-2020; Itoh, Norimichi/M-4874-2014; Breier, Georg/E-3580-2016; Hirose, Tomonori/M-8872-2019; Yamamoto, Hiroyuki/O-7668-2019; Ohno, Shigeo/B-1768-2010; Hirose, Tomonori/F-6015-2010; Kaibuchi, Kozo/M-4887-2014; Adams, Ralf H/AAE-9274-2019	Breier, Georg/0000-0002-9467-780X; Hirose, Tomonori/0000-0003-2428-0919; Yamamoto, Hiroyuki/0000-0003-4742-7653; Ohno, Shigeo/0000-0002-1294-5269; Hirose, Tomonori/0000-0003-2428-0919; Kaibuchi, Kozo/0000-0003-0714-1992; Vestweber, Dietmar/0000-0002-3517-732X	The Max Planck Society; German Research Foundation [SFB 629]; EMBO LTF programme; Japan Society for the Promotion of Science; US National Institutes of Health; Grants-in-Aid for Scientific Research [23790342] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093242] Funding Source: NIH RePORTER	The Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); EMBO LTF programme; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Ebnet and T. Nishioka for reagents and discussions. The Max Planck Society, the German Research Foundation program SFB 629 (R.H.A.), the EMBO LTF programme, the Japan Society for the Promotion of Science (M.N.), and the US National Institutes of Health (J.A.C) provided funding.	Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bush JO, 2010, GENE DEV, V24, P2068, DOI 10.1101/gad.1963210; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kim JD, 2012, DEV CELL, V23, P441, DOI 10.1016/j.devcel.2012.07.007; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Titchenell PM, 2012, BIOCHEM J, V446, P455, DOI 10.1042/BJ20111961; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	43	176	182	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					249	260		10.1038/ncb2679	http://dx.doi.org/10.1038/ncb2679			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23354168	Green Accepted			2022-12-25	WOS:000315844900006
J	Helenius, A				Helenius, Ari			Virus entry: What has pH got to do with it?	NATURE CELL BIOLOGY			English	Editorial Material									Swiss Fed Inst Technol, Inst Biochem, HPM E6 3, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), Swiss Fed Inst Technol, Inst Biochem, HPM E6 3, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch							0	27	27	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2013	15	2					125	125		10.1038/ncb2678	http://dx.doi.org/10.1038/ncb2678			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	088SF	23377025	Bronze			2022-12-25	WOS:000314856700001
J	Akhtar, N; Streuli, CH				Akhtar, Nasreen; Streuli, Charles H.			An integrin-ILK-microtubule network orients cell polarity and lumen formation in glandular epithelium	NATURE CELL BIOLOGY			English	Article							LINKED KINASE; SPINDLE ORIENTATION; APICAL SURFACE; BETA-1-INTEGRIN; MEMBRANE; RAC1; DIFFERENTIATION; MORPHOGENESIS; ORGANIZATION; TRAFFICKING	The extracellular matrix has a crucial role in determining the spatial orientation of epithelial polarity and the formation of lumens in glandular tissues; however, the underlying mechanisms remain elusive. By using Cre-Lox deletion we show that beta(1) integrins are required for normal mammary gland morphogenesis and lumen formation, both in vivo and in a three-dimensional primary culture model in which epithelial cells directly contact a basement membrane. Downstream of basement membrane beta(1) integrins, Rac1 is not involved; however, ILK is needed to polarize microtubule plus ends at the basolateral membrane and disrupting each of these components prevents lumen formation. The integrin microtubule axis is necessary for the endocytic removal of apical proteins from the basement-membrane cell interface and for internal Golgi positioning. We propose that this integrin signalling network controls the delivery of apical components to the correct surface and thereby governs the orientation of polarity and development of lumens.	[Akhtar, Nasreen; Streuli, Charles H.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Akhtar, Nasreen; Streuli, Charles H.] Univ Manchester, Manchester Breast Ctr, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Akhtar, N (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	nasreen.akhtar@manchester.ac.uk; cstreuli@manchester.ac.uk		Akhtar, Nasreen/0000-0002-5099-8767	BBSRC; Wellcome; University of Manchester; Wellcome Trust [081203/Z/06/Z, 088785/Z/09/Z]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome; University of Manchester; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C. Jones for doing the electron microscopy, S. Schmid (Scripps Research Institute, La Jolla, USA) and B. Ceresa (University of Louisville, USA) for dynamin and Rah5a adenoviruses, C. Wu (University of Pittsburgh, USA) for anti-ILK monoclonal, M. Lowe (University of Manchester, UK) for GM130 polyclonal and P. March for confocal microscope training. The FLS Bioimaging Facility microscopes were purchased with grants from the BBSRC, Wellcome and the University of Manchester Strategic Fund. Thanks to P. Caswell, T. Hardingham, M. Humphries, M. Lowe, N. Papalopulu and P. Lu and for critical appraisal of the manuscript. This work was supported by the Wellcome Trust (no. 081203/Z/06/Z). The Wellcome Trust Centre for Cell-Matrix Research is supported by core funding from the Wellcome Trust (no. 088785/Z/09/Z).	Akhtar N, 2009, DEVELOPMENT, V136, P1019, DOI 10.1242/dev.028423; Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; BRE MH, 1990, J CELL BIOL, V111, P3013, DOI 10.1083/jcb.111.6.3013; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Carmosino M, 2010, BIOL CELL, V102, P75, DOI 10.1042/BC20090134; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Cohen D, 2011, J CELL BIOL, V192, P525, DOI 10.1083/jcb.201007002; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jeanes AI, 2012, J BIOL CHEM, V287, P24103, DOI 10.1074/jbc.M112.360834; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Klinowska TCM, 2001, DEV BIOL, V233, P449, DOI 10.1006/dbio.2001.0204; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Nishimura Noriyuki, 2008, V440, P89, DOI 10.1007/978-1-59745-178-9_7; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; OJAKIAN GK, 1994, J CELL SCI, V107, P561; PAYNE CM, 1980, J CLIN PATHOL, V33, P505, DOI 10.1136/jcp.33.5.505; Pearson JF, 2009, CELL DEATH DIFFER, V16, P475, DOI 10.1038/cdd.2008.181; Pullan S, 1996, J CELL SCI, V109, P631; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Valentijn AJ, 2003, J CELL BIOL, V162, P599, DOI 10.1083/jcb.200302154; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; WANG AZ, 1990, J CELL SCI, V95, P137; WANG AZ, 1990, J CELL SCI, V95, P153; Wang P, J CELL BIOL, V195, P499; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	51	156	161	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					17	U48		10.1038/ncb2646	http://dx.doi.org/10.1038/ncb2646			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23263281	Green Accepted			2022-12-25	WOS:000312841300006
J	Bianco, P; Cao, X; Frenette, PS; Mao, JJ; Robey, PG; Simmons, PJ; Wang, CY				Bianco, Paolo; Cao, Xu; Frenette, Paul S.; Mao, Jeremy J.; Robey, Pamela G.; Simmons, Paul J.; Wang, Cun-Yu			The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine	NATURE MEDICINE			English	Article							BONE-MARROW; HEMATOPOIETIC STEM; STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; STEM/PROGENITOR CELLS; FIBROUS DYSPLASIA; IN-VITRO; ADULT; TRANSPLANTATION; THERAPY	Mesenchymal stem cells (MSCs) are the focus of intensive efforts worldwide directed not only at elucidating their nature and unique properties but also developing cell-based therapies for a diverse range of diseases. More than three decades have passed since the original formulation of the concept, revolutionary at the time, that multiple connective tissues could emanate from a common progenitor or stem cell retained in the postnatal bone marrow. Despite the many important advances made since that time, substantial ambiguities still plague the field regarding the nature, identity, function, mode of isolation and experimental handling of MSCs. These uncertainties have a major impact on their envisioned therapeutic use.	[Bianco, Paolo] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Cao, Xu] Johns Hopkins Univ, Dept Orthoped Surg, Baltimore, MD USA; [Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Dept Cell Biol, Dept Med, New York, NY USA; [Mao, Jeremy J.] Columbia Univ, Coll Dent Med, Ctr Craniofacial Regenerat, New York, NY USA; [Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Simmons, Paul J.] Mesoblast Ltd, Melbourne, Vic, Australia; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol, Lab Mol Signaling, Los Angeles, CA 90024 USA	Sapienza University Rome; Johns Hopkins University; Yeshiva University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of California System; University of California Los Angeles	Bianco, P (corresponding author), Univ Roma La Sapienza, Dept Mol Med, Rome, Italy.	paolo.bianco@uniroma1.it	Frenette, Paul S/J-8272-2012; Robey, Pamela Gehron/H-1429-2011	Frenette, Paul S/0000-0003-0862-9922; Robey, Pamela Gehron/0000-0002-5316-5576	Telethon [GGP09227]; Fondazione Roma; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Ministero della Salute; EU (Angioscaff); Fondazione Institut Pasteur-Cenci Bolognetti; US National Institutes of Health (NIH) [R01 DK056638, HL69438, HL097819, HL097700, HL116340]; NIH [DK57501, R01 DE018248, R01 EB009663]; National Institute of Dental and Craniofacial Research (NIDCR), NIH [DE019412, DE016513]; Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097819, R01HL116340, R01HL097700, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016513, ZIADE000380, R01DE019412, R01DE018248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); Fondazione Roma(Fondazione RomaEuropean Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy); EU (Angioscaff); Fondazione Institut Pasteur-Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research (NIDCR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Note that the authors are listed in alphabetical order in the author list. This work was supported in part by grants from Telethon (GGP09227), Fondazione Roma, Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Ministero della Salute, EU (Angioscaff) and Fondazione Institut Pasteur-Cenci Bolognetti (to P.B.), the US National Institutes of Health (NIH) (R01 DK056638, HL69438, HL097819, HL097700, HL116340 to P.S.F.), NIH DK57501 (to X.C.), the National Institute of Dental and Craniofacial Research (NIDCR), NIH (DE019412 and DE016513 to C.-Y.W.), NIH R01 DE018248 and R01 EB009663 to J.J.M. and the Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, Department of Health and Human Services (to P.G.R.).	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Arai F, 2002, J EXP MED, V195, P1549, DOI 10.1084/jem.20011700; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Bianco P, 1999, CRIT REV EUKAR GENE, V9, P159, DOI 10.1615/CritRevEukarGeneExpr.v9.i2.30; BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P183, DOI 10.1177/41.2.8419458; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco Paolo, 2015, Development, V142, P1023, DOI 10.1242/dev.102210; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Bush V., 1945, ATLANTIC MONTHLY, V176, P101, DOI DOI 10.1145/227181.227186; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DELUCA M, 1992, BURNS, V18, pS16, DOI 10.1016/0305-4179(92)90105-4; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; GREEN H, 1989, LAB INVEST, V60, P583; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kuznetsov S., 2006, CELL BIOL LAB MANUAL, P79; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Park D, 2012, FRONT BIOSCI-LANDMRK, V17, P30, DOI 10.2741/3913; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Piersanti S, 2010, J BONE MINER RES, V25, P1103, DOI 10.1359/jbmr.091036; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; STREETER GL, 1949, CONTRIB EMBRYOL, V33, P151; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; WILLINGHAM MC, 1975, J CELL BIOL, V67, P146, DOI 10.1083/jcb.67.1.146; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	64	839	898	6	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					35	42		10.1038/nm.3028	http://dx.doi.org/10.1038/nm.3028			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296015	Green Accepted			2022-12-25	WOS:000313230300023
J	Deeks, S; Drosten, C; Picker, L; Subbarao, K; Suzich, J				Deeks, Steven; Drosten, Christian; Picker, Louis; Subbarao, Kanta; Suzich, Joann			Roadblocks to translational challenges on viral pathogenesis	NATURE MEDICINE			English	Article							SYNCYTIAL VIRUS-INFECTION; INFLUENZA-VIRUSES; ENHANCED DISEASE; TRANSMISSION; VACCINE; PREVENTION; ORIGIN; LIVE; RSV; IDENTIFICATION		[Deeks, Steven] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Suzich, Joann] Medimmune Inc, Gaithersburg, MD 20878 USA; [Picker, Louis] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Drosten, Christian] Univ Bonn, Inst Virol, Bonn, Germany; [Subbarao, Kanta] NIAID, National Institutes Health, Bethesda, MD USA	University of California System; University of California San Francisco; AstraZeneca; Medimmune; Oregon Health & Science University; University of Bonn; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Deeks, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.	sdeeks@php.ucsf.edu; drosten@virologybonn.de; pickerl@ohsu.edu; ksubbarao@niaid.nih.gov; suzichj@medimmune.com		Subbarao, Kanta/0000-0003-1713-3056				Allander T, 2008, NEW ENGL J MED, V358, P2638, DOI 10.1056/NEJMc080743; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brahic M, 2010, ANN NEUROL, V68, P6, DOI 10.1002/ana.22057; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen GL, 2011, P NATL ACAD SCI USA, V108, P1140, DOI 10.1073/pnas.1009908108; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Connor E, 1997, PEDIATRICS, V99, P93; Corey L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001863; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Denton PW, 2012, TRENDS MICROBIOL, V20, P268, DOI 10.1016/j.tim.2012.03.007; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fauci AS, 2012, JAMA-J AM MED ASSOC, V308, P343, DOI 10.1001/jama.2012.8142; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Lakdawala SS, 2012, NAT MED, V18, P1468, DOI 10.1038/nm.2953; Lauber C, 2012, J VIROL, V86, P3905, DOI 10.1128/JVI.07174-11; Lifson JD, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007310; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Mejias A, 2008, BIOL-TARGETS THER, V2, P433; Morens DM, 2012, NATURE, V486, P335, DOI 10.1038/nature11170; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Murata Y, 2007, ANTIVIR THER, V12, P659; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pike BL, 2010, CLIN INFECT DIS, V50, P1636, DOI 10.1086/652860; Power K.A., 2012, SCI TRANSL MED, V4; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sikkel MB, 2008, PEDIATR INFECT DIS J, V27, pS63, DOI 10.1097/INF.0b013e3181684d67; Tang RS, 2008, VACCINE, V26, P6373, DOI 10.1016/j.vaccine.2008.09.018; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Van Rompay KKA, 2012, AIDS RES HUM RETROV, V28, P16, DOI [10.1089/AID.2011.0234, 10.1089/aid.2011.0234]; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walsh EE, 2004, J MED VIROL, V73, P295, DOI 10.1002/jmv.20090; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	54	6	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					30	34		10.1038/nm.3050	http://dx.doi.org/10.1038/nm.3050			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296014	Bronze, Green Published			2022-12-25	WOS:000313230300022
J	Michalek, M; Sonnichsen, FD; Wechselberger, R; Dingley, AJ; Hung, CW; Kopp, A; Wienk, H; Simanski, M; Herbst, R; Lorenzen, I; Marciano-Cabral, F; Gelhaus, C; Gutsmann, T; Tholey, A; Grotzinger, J; Leippe, M				Michalek, Matthias; Soennichsen, Frank D.; Wechselberger, Rainer; Dingley, Andrew J.; Hung, Chien-Wen; Kopp, Annika; Wienk, Hans; Simanski, Maren; Herbst, Rosa; Lorenzen, Inken; Marciano-Cabral, Francine; Gelhaus, Christoph; Gutsmann, Thomas; Tholey, Andreas; Groetzinger, Joachim; Leippe, Matthias			Structure and function of a unique pore-forming protein from a pathogenic acanthamoeba	NATURE CHEMICAL BIOLOGY			English	Article							FREE-LIVING AMEBAS; ENTAMOEBA-HISTOLYTICA; NK-LYSIN; NAEGLERIA-FOWLERI; PEPTIDES; MEMBRANES; AMOEBAPORES; SYSTEM; POLYPEPTIDES; MOLECULES	Human pathogens often produce soluble protein toxins that generate pores inside membranes, resulting in the death of target cells and tissue damage. In pathogenic amoebae, this has been exemplified with amoebapores of the enteric protozoan parasite Entamoeba histolytica. Here we characterize acanthaporin, to our knowledge the first pore-forming toxin to be described from acanthamoebae, which are free-living, bacteria-feeding, unicellular organisms that are opportunistic pathogens of increasing importance and cause severe and often fatal diseases. We isolated acanthaporin from extracts of virulent Acanthamoeba culbertsoni by tracking its pore-forming activity, molecularly cloned the gene of its precursor and recombinantly expressed the mature protein in bacteria. Acanthaporin was cytotoxic for human neuronal cells and exerted antimicrobial activity against a variety of bacterial strains by permeabilizing their membranes. The tertiary structures of acanthaporin's active monomeric form and inactive dimeric form, both solved by NMR spectroscopy, revealed a currently unknown protein fold and a pH-dependent trigger mechanism of activation.	[Michalek, Matthias; Simanski, Maren; Herbst, Rosa; Gelhaus, Christoph; Leippe, Matthias] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Michalek, Matthias; Lorenzen, Inken; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Soennichsen, Frank D.] Univ Kiel, Otto Diels Inst Organ Chem, D-24098 Kiel, Germany; [Wechselberger, Rainer; Wienk, Hans] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect Res Grp, Utrecht, Netherlands; [Dingley, Andrew J.] Univ Auckland, Sch Chem Sci, Auckland 1, New Zealand; [Dingley, Andrew J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Hung, Chien-Wen; Tholey, Andreas] Univ Kiel, Inst Expt Med, Div Systemat Proteome Res, D-24098 Kiel, Germany; [Kopp, Annika; Gutsmann, Thomas] Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, Borstel, Germany; [Marciano-Cabral, Francine] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA	University of Kiel; University of Kiel; University of Kiel; Utrecht University; University of Auckland; University of Auckland; University of Kiel; Forschungszentrum Borstel; Virginia Commonwealth University	Michalek, M (corresponding author), Univ Kiel, Inst Zool, D-24098 Kiel, Germany.	mleippe@zoologie.uni-kiel.de	Gelhaus, Christoph/D-8050-2011; Tholey, Andreas/B-3407-2010; Sönnichsen, Frank D/D-8408-2011; Wienk, Hans/P-8929-2015; Dingley, Andrew/G-6427-2013; Gutsmann, Thomas/E-6100-2011; Leippe, Matthias/AAP-1677-2020	Tholey, Andreas/0000-0002-8687-6817; Sönnichsen, Frank D/0000-0002-4539-3755; Wienk, Hans/0000-0001-9577-0064; Dingley, Andrew/0000-0002-6838-5803; Herbst, Rosa/0000-0002-2379-7433	European Union [RII3-026145]; German Research Council (DFG) [LE 1075/2-4]; excellence cluster 306 'Inflammation at Interfaces'	European Union(European Commission); German Research Council (DFG)(German Research Foundation (DFG)); excellence cluster 306 'Inflammation at Interfaces'	The authors acknowledge support in measuring the 750-MHz NMR spectra at The Netherlands Foundation for Chemical Research (SON) NMR Large Scale Facility in Utrecht, The Netherlands, funded by the European Union (contract number RII3-026145). We thank F. Buck, Institute for Cell Biochemistry and Clinical Neurobiology, University of Hamburg, for protein sequencing, C. Ott for expert technical assistance during purification of the natural acanthaporin and H. Liessegang for technical help during antibacterial activity testing. This work was supported by German Research Council (DFG) grant LE 1075/2-4 to M.L. and J.G. and the excellence cluster 306 'Inflammation at Interfaces'.	Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; Andra J, 2003, DEV COMP IMMUNOL, V27, P291, DOI 10.1016/S0145-305X(02)00106-4; ANDRA J, 1994, FEBS LETT, V354, P97, DOI 10.1016/0014-5793(94)01103-6; BAUMANN G, 1974, Journal of Supramolecular Structure, V2, P538, DOI 10.1002/jss.400020504; BOMAN HG, 1974, INFECT IMMUN, V10, P136, DOI 10.1128/IAI.10.1.136-145.1974; Bruhn H, 2003, BIOCHEM J, V375, P737, DOI 10.1042/BJ20030250; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingley Andrew J., 2008, V451, P441, DOI 10.1007/978-1-59745-102-4_30; DOUGHERTY RM, 1987, AM J CLIN NUTR, V45, P443, DOI 10.1093/ajcn/45.2.443; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gutsmann T, 2003, BIOCHEMISTRY-US, V42, P9804, DOI 10.1021/bi034686u; Hecht O, 2004, J BIOL CHEM, V279, P17834, DOI 10.1074/jbc.M312978200; Herbst R, 2004, J BIOL CHEM, V279, P25955, DOI 10.1074/jbc.M401965200; Herbst R, 2002, J BIOL CHEM, V277, P22353, DOI 10.1074/jbc.M201475200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kneller, 2003, SPARKY 3; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Leippe M, 2005, TRENDS PARASITOL, V21, P5, DOI 10.1016/j.pt.2004.10.009; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; LEIPPE M, 1994, MOL MICROBIOL, V14, P895, DOI 10.1111/j.1365-2958.1994.tb01325.x; Leippe M, 1999, DEV COMP IMMUNOL, V23, P267, DOI 10.1016/S0145-305X(99)00010-5; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; MARTINEZ AJ, 1993, MT SINAI J MED, V60, P271; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Visvesvara GS, 2010, CURR OPIN INFECT DIS, V23, P590, DOI 10.1097/QCO.0b013e32833ed78b; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	47	29	30	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					37	+		10.1038/NCHEMBIO.1116	http://dx.doi.org/10.1038/NCHEMBIO.1116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143413				2022-12-25	WOS:000312484200010
J	Justice, CM; Yagnik, G; Kim, Y; Peter, I; Jabs, EW; Erazo, M; Ye, XQ; Ainehsazan, E; Shi, LS; Cunningham, ML; Kimonis, V; Roscioli, T; Wall, SA; Wilkie, AOM; Stoler, J; Richtsmeier, JT; Heuze, Y; Sanchez-Lara, PA; Buckley, MF; Druschel, CM; Mills, JL; Caggana, M; Romitti, PA; Kay, DM; Senders, C; Taub, PJ; Klein, OD; Boggan, J; Zwienenberg-Lee, M; Naydenov, C; Kim, J; Wilson, AF; Boyadjiev, SA				Justice, Cristina M.; Yagnik, Garima; Kim, Yoonhee; Peter, Inga; Jabs, Ethylin Wang; Erazo, Monica; Ye, Xiaoqian; Ainehsazan, Edmond; Shi, Lisong; Cunningham, Michael L.; Kimonis, Virginia; Roscioli, Tony; Wall, Steven A.; Wilkie, Andrew O. M.; Stoler, Joan; Richtsmeier, Joan T.; Heuze, Yann; Sanchez-Lara, Pedro A.; Buckley, Michael F.; Druschel, Charlotte M.; Mills, James L.; Caggana, Michele; Romitti, Paul A.; Kay, Denise M.; Senders, Craig; Taub, Peter J.; Klein, Ophir D.; Boggan, James; Zwienenberg-Lee, Marike; Naydenov, Cyrill; Kim, Jinoh; Wilson, Alexander F.; Boyadjiev, Simeon A.			A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; GENETIC-BASIS; NEURAL CREST; MSX2 GENE; MUTATIONS; CILIA; TWIST; RISK; FAMILY	Sagittal craniosynostosis is the most common form of craniosynostosis, affecting approximately one in 5,000 newborns. We conducted, to our knowledge, the first genome-wide association study for nonsyndromic sagittal craniosynostosis (sNSC) using 130 non-Hispanic case-parent trios of European ancestry (NHW). We found robust associations in a 120-kb region downstream of BMP2 flanked by rs1884302 (P = 1.13 x 10(-14), odds ratio (OR) = 4.58) and rs6140226 (P = 3.40 x 10(-11), OR = 0.24) and within a 167-kb region of BBS9 between rs10262453 (P = 1.61 x 10(-10), OR = 0.19) and rs17724206 (P = 1.50 x 10(-8), OR = 0.22). We replicated the associations to both loci (rs1884302, P = 4.39 x 10(-31) and rs10262453, P= 3.50 x 10(-14)) in an independent NHW population of 172 unrelated probands with sNSC and 548 controls. Both BMP2 and BBS9 are genes with roles in skeletal development that warrant functional studies to further understand the etiology of sNSC.	[Yagnik, Garima; Kim, Jinoh; Boyadjiev, Simeon A.] Univ Calif Davis, Dept Pediat, Genet Sect, Sacramento, CA 95817 USA; [Justice, Cristina M.; Kim, Yoonhee; Wilson, Alexander F.] NHGRI, Genometr Sect, Inherited Dis Res Branch, Div Intramural Res,US Natl Inst Hlth NIH, Baltimore, MD USA; [Peter, Inga; Jabs, Ethylin Wang; Erazo, Monica; Ye, Xiaoqian; Ainehsazan, Edmond; Shi, Lisong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Cunningham, Michael L.] Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Cunningham, Michael L.] Seattle Childrens Res Inst, Seattle, WA USA; [Kimonis, Virginia] Univ Calif Irvine, Dept Pediat, Div Genet, Irvine, CA 92717 USA; [Roscioli, Tony] Univ New S Wales, Sydney Childrens Hosp, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Wall, Steven A.; Wilkie, Andrew O. M.] John Radcliffe Hosp, Craniofacial Unit, Oxford Univ Hosp Natl Hlth Serv Trust, Oxford OX3 9DU, England; [Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Stoler, Joan] Harvard Univ, Div Genet, Childrens Hosp Boston, Boston, MA 02115 USA; [Richtsmeier, Joan T.; Heuze, Yann] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Sanchez-Lara, Pedro A.] Univ So Calif, Childrens Hosp Los Angeles, Dept Pathol & Pediat, Los Angeles, CA USA; [Buckley, Michael F.] SE Area Lab Serv, Dept Haematol & Genet, Sydney, NSW, Australia; [Druschel, Charlotte M.] New York State Dept Hlth, Congenital Malformat Registry, Albany, NY USA; [Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Caggana, Michele; Kay, Denise M.] New York State Dept Hlth, Div Genet, Wadsworth Ctr, Albany, NY USA; [Romitti, Paul A.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA; [Senders, Craig] Univ Calif Davis, Dept Otolaryngol, Sacramento, CA 95817 USA; [Taub, Peter J.] Mt Sinai Med Ctr, Kravis Childrens Hosp, Div Plast & Reconstruct Surg, New York, NY 10029 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Boggan, James; Zwienenberg-Lee, Marike] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; [Naydenov, Cyrill] Med Univ Sofia, Dept Chem & Biochem, Sofia, Bulgaria	University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California Irvine; University of New South Wales Sydney; University of Sydney; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Harvard University; Boston Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Children's Hospital Los Angeles; University of Southern California; State University of New York (SUNY) System; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; Wadsworth Center; University of Iowa; University of California System; University of California Davis; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Medical University Sofia	Boyadjiev, SA (corresponding author), Univ Calif Davis, Dept Pediat, Genet Sect, Sacramento, CA 95817 USA.	simeon.boyd@ucdmc.ucdavis.edu	HEUZE, Yann/A-9371-2011; Wilkie, Andrew/AAC-3820-2020; Kim, Jinoh/AAF-9178-2020; Sanchez, Pedro/HHM-5713-2022; Wilson, Alexander F./Q-6910-2019; Sanchez, Pedro/P-1377-2018; Sanchez-Lara, Pedro A./AAP-5644-2021	Wilkie, Andrew/0000-0002-2972-5481; Kim, Jinoh/0000-0003-2841-147X; Sanchez, Pedro/0000-0003-1181-7828; Sanchez-Lara, Pedro A./0000-0003-1181-7828; Jabs, Ethylin/0000-0001-8983-5466; Klein, Ophir/0000-0002-6254-7082; buckley, michael/0000-0002-8298-8758; Mills, James/0000-0003-4496-332X; Justice, Cristina/0000-0002-6190-6821; Kay, Denise/0000-0002-9928-2698; Heuze, Yann/0000-0002-0660-9613	Children's Miracle Network Endowed Chair; National Institute of Dental and Craniofacial Research (NIDCR)/NIH [K23 DE00462, R03 DE016342, R01 DE016886]; National Center for Research Resources/NIH [M01-RR00052]; Zlatka; Anton; Alec Boyadjiev; US Centers for Disease Control and Prevention (CDC) [5 R01 DD000350]; Wellcome Trust [093329]; CDC [5U01DD000492]; NIDCR/NIH [R21DE022419]; Intramural Research Program (IRP) of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Robert Wood Johnson Foundation [3R37DE012711-13S1]; Children's Hospital Los Angeles-University of Southern California Child Health Research Career Development Program [NIH K12-HD05954]; NIDCR/NIH; American Recovery and Reinvestment Act [R01 DE018500, 3R01 DE018500-02S1]; National Center for Advancing Translational Sciences [NIH UL1TR000067]; Division of Intramural Research Program of the National Human Genome Research Institute, NIH; NIH [HHSN268200782096C];  [R01 DE018227];  [HHSN267200703431C];  [NICHD N01-DK-7-3431]; CENTERS FOR DISEASE CONTROL AND PREVENTION [R01DD000350] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U01DD000492] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016886, R21DE022419, R01DE022988, R01DE018227, R37DE012711, R01DE018500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE000462, R03DE016342] Funding Source: NIH RePORTER	Children's Miracle Network Endowed Chair; National Institute of Dental and Craniofacial Research (NIDCR)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Zlatka; Anton; Alec Boyadjiev; US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural Research Program (IRP) of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Children's Hospital Los Angeles-University of Southern California Child Health Research Career Development Program; NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Recovery and Reinvestment Act; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Division of Intramural Research Program of the National Human Genome Research Institute, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank all families who contributed to this study. S.A.B. is partially funded through a Children's Miracle Network Endowed Chair and through grants K23 DE00462, R03 DE016342 and R01 DE016886 from the National Institute of Dental and Craniofacial Research (NIDCR)/NIH and M01-RR00052 from the National Center for Research Resources/NIH and was fully supported by Zlatka, Anton and Alec Boyadjiev. Partial funding was also obtained from grants to E.W.J. (US Centers for Disease Control and Prevention (CDC) 5 R01 DD000350), M.L.C. (R01 DE018227), A.O.M.W. (Wellcome Trust 093329), P.A.R. (CDC 5U01DD000492), J.K. (NIDCR/NIH R21DE022419), J.L.M. (Intramural Research Program (IRP) of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); IRP HHSN267200703431C; NICHD N01-DK-7-3431), P.A.S.-L. (Robert Wood Johnson Foundation 3R37DE012711-13S1 and Children's Hospital Los Angeles-University of Southern California Child Health Research Career Development Program; NIH K12-HD05954), J.T.R. (NIDCR/NIH and the American Recovery and Reinvestment Act R01 DE018500 and 3R01 DE018500-02S1) and I.P. (National Center for Advancing Translational Sciences, NIH UL1TR000067). This project was also supported in part by the Division of Intramural Research Program of the National Human Genome Research Institute, NIH (C.M.J., Y.K. and A.F.W). Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to Johns Hopkins University, contract number HHSN268200782096C. We thank B. Wilson, N. Issac, C. Nauta, E. Goude, E. Cherkez, L. Peters and J. Harrison for patient recruitment, C. Boehm and A. Scott for coordination of discovery-phase genotyping, C. Stevens, A. Stoner, J.L. Liu, A. Gearhart, A. Atkins and E. McGrath for bench work, D. Mortlock for bioinformatic analysis and informative discussion and J. Graham (Cedars-Sinai Hospital, Los Angeles, California, USA), J. Bernstein (Stanford University, Palo Alto, California, USA), J. Marsh (Washington University, St. Louis, Missouri, USA), J. Panchal (University of Oklahoma Health Science Center, Oklahoma, USA), T. Tollefson (University of California Davis, Sacramento, California, USA) and M. Passos-Bueno (University of Sao Paolo, Brazil) for contributing clinical information and biospecimens for this project.	Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Choi DS, 1997, DEVELOPMENT, V124, P1745; Cohen MM, 2000, CRANIOSYNOSTOSIS DIA, V2nd; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Gardner JS, 1998, INT J EPIDEMIOL, V27, P64, DOI 10.1093/ije/27.1.64; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Johnson D, 2000, EUR J HUM GENET, V8, P571, DOI 10.1038/sj.ejhg.5200499; Kallen K, 1999, TERATOLOGY, V60, P146; Keen TJ, 2002, EUR J HUM GENET, V10, P245, DOI 10.1038/sj.ejhg.5200797; Kim SD, 2012, FEBS LETT, V586, P1516, DOI 10.1016/j.febslet.2012.04.010; Kimonis Virginia, 2007, Semin Pediatr Neurol, V14, P150, DOI 10.1016/j.spen.2007.08.008; Kolar JC, 2011, J CRANIOFAC SURG, V22, P47, DOI 10.1097/SCS.0b013e3181f6c2fb; Lajeunie E, 1998, AM J MED GENET, V75, P211, DOI 10.1002/(SICI)1096-8628(19980113)75:2<211::AID-AJMG19>3.0.CO;2-S; Lajeunie E, 2005, J NEUROSURG, V103, P353, DOI 10.3171/ped.2005.103.4.0353; Lajeunie E, 1996, AM J MED GENET, V62, P282, DOI 10.1002/(SICI)1096-8628(19960329)62:3<282::AID-AJMG15>3.0.CO;2-G; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Marinaki AM, 2001, BLOOD, V97, P3327, DOI 10.1182/blood.V97.11.3327; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Melville H, 2010, AM J MED GENET A, V152A, P3007, DOI 10.1002/ajmg.a.33703; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Sanchez-Lara PA, 2010, AM J MED GENET A, V152A, P394, DOI 10.1002/ajmg.a.33246; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Seto ML, 2007, AM J MED GENET A, V143A, P678, DOI 10.1002/ajmg.a.31630; Spruijt L, 2005, AM J MED GENET A, V139A, P45, DOI 10.1002/ajmg.a.30923; Stankiewicz P, 2001, AM J MED GENET, V103, P56, DOI 10.1002/ajmg.1512; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Vissers LELM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002278; Weber I., 2001, European Journal of Human Genetics, V9, pP0409; Wilkie AOM, 2007, AM J MED GENET A, V143A, P1941, DOI 10.1002/ajmg.a.31905; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yagnik G, 2012, HUM MUTAT, V33, P1626, DOI 10.1002/humu.22166; Zeiger JS, 2002, J CRANIOFAC SURG, V13, P602, DOI 10.1097/00001665-200209000-00002; Zhang X, 2010, J DENT RES, V89, P865, DOI 10.1177/0022034510376401	52	83	85	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1360	1364		10.1038/ng.2463	http://dx.doi.org/10.1038/ng.2463			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23160099	Green Submitted, Green Accepted			2022-12-25	WOS:000311713200016
J	Watson, PY; Fedor, MJ				Watson, Peter Y.; Fedor, Martha J.			The ydaO motif is an ATP-sensing riboswitch in Bacillus subtilis	NATURE CHEMICAL BIOLOGY			English	Article							BINDS ATP; RNA; HOMEOSTASIS; CANDIDATE; BACTERIA; REVEALS; SENSOR	We report what is to our knowledge the first natural RNA that regulates gene expression in response to intracellular ATP. Using a biochemical screen, we found that several putative riboswitches bind ATP in vitro. The ydaO motif specifically bound ATP and regulated expression of endogenous and reporter genes in response to ATP concentrations in Bacillus subtilis. This discovery demonstrates a role for RNAs in regulating gene expression in response to energy balance in bacteria.	[Watson, Peter Y.; Fedor, Martha J.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Watson, Peter Y.; Fedor, Martha J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Watson, Peter Y.; Fedor, Martha J.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Fedor, MJ (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	mfedor@scripps.edu			Skaggs Institute for Chemical Biology	Skaggs Institute for Chemical Biology	We acknowledge J. Viladoms for thoughtful conversations and critical reading of this manuscript. We thank the groups of E. Winzeler and P. Sun for access to qPCR instruments and the Skaggs Institute for Chemical Biology for graduate fellowship support of P.Y. Watson.	Allenby NEE, 2005, J BACTERIOL, V187, P8063, DOI 10.1128/JB.187.23.8063-8080.2005; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Bastet L, 2011, MOL MICROBIOL, V80, P1148, DOI 10.1111/j.1365-2958.2011.07654.x; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dieckmann T, 1996, RNA, V2, P628; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GUFFANTI AA, 1987, J BACTERIOL, V169, P4469, DOI 10.1128/jb.169.10.4469-4478.1987; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Kato-Yamada Y, 2005, FEBS LETT, V579, P6875, DOI 10.1016/j.febslet.2005.11.036; Lee EJ, 2012, NATURE, V486, P271, DOI 10.1038/nature11090; McCabe BC, 2004, J BACTERIOL, V186, P5157, DOI 10.1128/jb.186.15.5157-5159.2004; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; Sluse FE, 2012, ADV EXP MED BIOL, V942, P137, DOI 10.1007/978-94-007-2869-1_6; Smith AM, 2010, RNA BIOL, V7, P104, DOI 10.4161/rna.7.1.10757; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Watson PY, 2011, NAT STRUCT MOL BIOL, V18, P359, DOI 10.1038/nsmb.1989; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31	25	45	47	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					963	965		10.1038/NCHEMBIO.1095	http://dx.doi.org/10.1038/NCHEMBIO.1095			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23086297				2022-12-25	WOS:000311491200009
J	Yang, WW; Zheng, YH; Xia, Y; Ji, HT; Chen, XM; Guo, F; Lyssiotis, CA; Aldape, K; Cantley, LC; Liu, ZM				Yang, Weiwei; Zheng, Yanhua; Xia, Yan; Ji, Haitao; Chen, Xiaomin; Guo, Fang; Lyssiotis, Costas A.; Aldape, Kenneth; Cantley, Lewis C.; Liu, Zhimin			ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect	NATURE CELL BIOLOGY			English	Article							PYRUVATE-KINASE M2; BETA-CATENIN; TRANSCRIPTIONAL ACTIVITY; GENE-TRANSCRIPTION; DOWN-REGULATION; PROTEIN-KINASE; CANCER; METABOLISM; ACTIVATION; APOPTOSIS	Pyruvate kinase M2 (PKM2) is upregulated in multiple cancer types and contributes to the Warburg effect by unclear mechanisms. Here we demonstrate that EGFR-activated ERK2 binds directly to PKM2 Ile 4291Leu 431 through the ERK2 docking groove and phosphorylates PKM2 at Ser 37, but does not phosphorylate PKM1. Phosphorylated PKM2 Ser 37 recruits PIN1 for cis-trans isomerization of PKM2, which promotes PKM2 binding to importin a5 and translocating to the nucleus. Nuclear PKM2 acts as a coactivator of beta-catenin to induce c-Myc expression, resulting in the upregulation of GLUT1, LDHA and, in a positive feedback loop, PTB-dependent PKM2 expression. Replacement of wild-type PKM2 with a nuclear translocation-deficient mutant (S37A) blocks the EGFR-promoted Warburg effect and brain tumour development in mice. In addition, levels of PKM2 Ser 37 phosphorylation correlate with EGFR and ERK1/2 activity in human glioblastoma specimens. Our findings highlight the importance of nuclear functions of PKM2 in the Warburg effect and tumorigenesis.	[Yang, Weiwei; Zheng, Yanhua; Xia, Yan; Ji, Haitao; Liu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Yang, Weiwei; Zheng, Yanhua; Xia, Yan; Ji, Haitao; Liu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Chen, Xiaomin] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Guo, Fang] Chinese Acad Sci, Nanomed Ctr, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Liu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Liu, Zhimin] Univ Texas Houston, Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Liu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org	Ji, Haitao/L-1615-2013; Cantley, Lewis C/D-1800-2014; Lyssiotis, Costas A/AAI-1923-2019; yang, zheng/HGC-7753-2022	Cantley, Lewis C/0000-0002-1298-7653; Lyssiotis, Costas A/0000-0001-9309-6141; Yang, Weiwei/0000-0002-1661-9137	National Institute of Health [2R01CA109035, R01GM068566, R01GM56302, CA16672]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP 110252]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA109035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068566, R01GM056203] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health grants 2R01CA109035 (Z.L.), R01GM068566 (X.C.), R01GM56302 (L.C.C.) and CA16672 (Cancer Center Support Grant) and a research grant (RP 110252; Z.L.) from the Cancer Prevention and Research Institute of Texas (CPRIT).	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Cairns R.A., NAT REV CANC, V11, P85; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Koppenol W. H., NAT REV CANC, V11, P325; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Lu ZM, 2012, CHIN J CANCER, V31, P5, DOI 10.5732/cjc.011.10446; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; VANDERHEIDEN MG, SCIENCE, V329, P1492; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	28	534	554	8	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1295	+		10.1038/ncb2629	http://dx.doi.org/10.1038/ncb2629			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23178880	Green Accepted			2022-12-25	WOS:000311890300011
J	MacArthur, BD; Sevilla, A; Lenz, M; Muller, FJ; Schuldt, BM; Schuppert, AA; Ridden, SJ; Stumpf, PS; Fidalgo, M; Ma'ayan, A; Wang, JL; Lemischka, IR				MacArthur, Ben D.; Sevilla, Ana; Lenz, Michel; Mueller, Franz-Josef; Schuldt, Berhard M.; Schuppert, Andreas A.; Ridden, Sonya J.; Stumpf, Patrick S.; Fidalgo, Miguel; Ma'ayan, Avi; Wang, Jianlong; Lemischka, Ihor R.			Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity	NATURE CELL BIOLOGY			English	Article							SIGNALING PATHWAYS; POSITIVE-FEEDBACK; GENE-EXPRESSION; TRANSCRIPTIONAL NETWORK; SYSTEMS BIOLOGY; SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; FATE; IDENTIFICATION	A number of key regulators of mouse embryonic stem (ES) cell identity, including the transcription factor Nanog, show strong expression fluctuations at the single-cell level. The molecular basis for these fluctuations is unknown. Here we used a genetic complementation strategy to investigate expression changes during transient periods of Nanog downregulation. Employing an integrated approach that includes high-throughput single-cell transcriptional profiling and mathematical modelling, we found that early molecular changes subsequent to Nanog loss are stochastic and reversible. However, analysis also revealed that Nanog loss severely compromises the self-sustaining feedback structure of the ES cell regulatory network. Consequently, these nascent changes soon become consolidated to committed fate decisions in the prolonged absence of Nanog. Consistent with this, we found that exogenous regulation of Nanog-dependent feedback control mechanisms produced a more homogeneous ES cell population. Taken together our results indicate that Nanog-dependent feedback loops have a role in controlling both ES cell fate decisions and population variability.	[Sevilla, Ana; Fidalgo, Miguel; Wang, Jianlong; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [MacArthur, Ben D.; Stumpf, Patrick S.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Southampton SO17 1BJ, Hants, England; [MacArthur, Ben D.; Ridden, Sonya J.] Univ Southampton, Sch Math, Southampton SO17 1BJ, Hants, England; [MacArthur, Ben D.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Sevilla, Ana; Fidalgo, Miguel; Wang, Jianlong; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Lenz, Michel; Schuldt, Berhard M.; Schuppert, Andreas A.] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, D-52062 Aachen, Germany; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, D-24105 Kiel, Germany; [Ridden, Sonya J.] Univ Southampton, Inst Complex Syst Simulat, Southampton SO17 1BJ, Hants, England; [Ma'ayan, Avi; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of Southampton; University of Southampton; University of Southampton; Icahn School of Medicine at Mount Sinai; RWTH Aachen University; University of Southampton; Icahn School of Medicine at Mount Sinai	Lemischka, IR (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	ihor.lemischka@mssm.edu	Müller, Franz-Josef/E-3336-2010; Stumpf, Patrick/AAK-1895-2020; Ma'ayan, Avi/AAG-3131-2019; Sevilla, Ana/N-8579-2017; Wang, Jianlong/AAG-9425-2020; Lenz, Michael/J-4401-2016; Fidalgo, Miguel/I-7006-2019; Wang, Jianlong/GQR-1191-2022	Müller, Franz-Josef/0000-0001-9478-8430; Stumpf, Patrick/0000-0003-0862-0290; Ma'ayan, Avi/0000-0002-6904-1017; Sevilla, Ana/0000-0002-9251-4759; Lenz, Michael/0000-0002-6319-6480; Fidalgo, Miguel/0000-0003-1134-2674; Wang, Jianlong/0000-0002-1317-6457; Schuppert, Andreas/0000-0003-3783-6605; MacArthur, Ben/0000-0002-5396-9750	NIH [GM078465, GM095942]; NYSTEM [C024410, C026420]; EPSRC Doctoral Training Centre grant [EP/G03690X/1]; EPSRC Institutional Sponsorship Award [EP/J501530/1]; Engineering and Physical Sciences Research Council [893454] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM095942, R01GM098316, R01GM078465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; EPSRC Doctoral Training Centre grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Institutional Sponsorship Award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hochedlinger for the Nanog-GFP mouse ES cells<SUP>53</SUP>.We gratefully acknowledge funding support by the NIH (GM078465) and NYSTEM (C024410) to I.R.L. and by the NIH (GM095942) and NYSTEM (C026420) to J.W. This work was also supported by an EPSRC Doctoral Training Centre grant (EP/G03690X/1) and an EPSRC 2011/12 Institutional Sponsorship Award (EP/J501530/1).	Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cristianini N, 2000, INTRO SUPPORT VECTOR; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2009, LINEAR ALGEBRA APPL, V430, P1886, DOI 10.1016/j.laa.2008.09.033; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Gower J.C., 1974, APPL STATIST, V23, P466; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Harary F., 1971, MAT CAS SLOVEN AKAD, V21, P55; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Lee DF, 2012, NAT PROTOC, V7, P729, DOI 10.1038/nprot.2012.018; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; MacArthur BD, 2008, COLD SH Q B, V73, P211, DOI 10.1101/sqb.2008.73.061; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Manly B. F. J., 2005, MULTIVARIATE STAT ME; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; OBRIEN PC, 1992, BIOMETRICS, V48, P819, DOI 10.2307/2532347; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; Ramirez JM, 2011, STEM CELLS, V29, P1469, DOI 10.1002/stem.681; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Stewart MH, 2010, NAT METHODS, V7, P917, DOI 10.1038/nmeth.1519; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trott J, 2012, MOL BIOSYST, V8, P744, DOI 10.1039/c1mb05398a; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Williams R, 2011, BIOESSAYS, V33, P880, DOI 10.1002/bies.201100073; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	59	115	116	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1139	+		10.1038/ncb2603	http://dx.doi.org/10.1038/ncb2603			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23103910	Green Accepted			2022-12-25	WOS:000310778100007
J	Harris, AF; McKemey, AR; Nimmo, D; Curtis, Z; Black, I; Morgan, SA; Oviedo, MN; Lacroix, R; Naish, N; Morrison, NI; Collado, A; Stevenson, J; Scaife, S; Dafa'alla, T; Fu, GL; Phillips, C; Miles, A; Raduan, N; Kelly, N; Beech, C; Donnelly, CA; Petrie, WD; Alphey, L				Harris, Angela F.; McKemey, Andrew R.; Nimmo, Derric; Curtis, Zoe; Black, Isaac; Morgan, Sian A.; Oviedo, Marco Neira; Lacroix, Renaud; Naish, Neil; Morrison, Neil I.; Collado, Amandine; Stevenson, Jessica; Scaife, Sarah; Dafa'alla, Tarig; Fu, Guoliang; Phillips, Caroline; Miles, Andrea; Raduan, Norzahira; Kelly, Nick; Beech, Camilla; Donnelly, Christl A.; Petrie, William D.; Alphey, Luke			Successful suppression of a field mosquito population by sustained release of engineered male mosquitoes	NATURE BIOTECHNOLOGY			English	Letter							DOMINANT		[Harris, Angela F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [McKemey, Andrew R.; Nimmo, Derric; Curtis, Zoe; Black, Isaac; Morgan, Sian A.; Oviedo, Marco Neira; Lacroix, Renaud; Naish, Neil; Morrison, Neil I.; Collado, Amandine; Stevenson, Jessica; Scaife, Sarah; Dafa'alla, Tarig; Fu, Guoliang; Phillips, Caroline; Miles, Andrea; Raduan, Norzahira; Beech, Camilla; Alphey, Luke] Oxitec Ltd, Oxford, England; [Black, Isaac; Collado, Amandine; Fu, Guoliang; Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Raduan, Norzahira] Inst Med Res, Infect Dis Res Ctr, Med Entomol Unit, Kuala Lumpur 50588, Malaysia; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, MRC,Ctr Outbreak Anal & Modelling, London, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; Kementerian Kesihatan Malaysia; Imperial College London		luke.alphey@oxitec.com		Donnelly, Christl/0000-0002-0195-2463; Neira, Marco/0000-0001-8068-5772; Alphey, Luke/0000-0002-2916-3802	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline; Medical Research Council [G0600719B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Dyck V.A., 2006, STERILE INSECT TECHN; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474	10	253	265	2	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					828	830		10.1038/nbt.2350	http://dx.doi.org/10.1038/nbt.2350			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965050				2022-12-25	WOS:000308705700013
J	Kang, HJ; Voleti, B; Hajszan, T; Rajkowska, G; Stockmeier, CA; Licznerski, P; Lepack, A; Majik, MS; Jeong, LS; Banasr, M; Son, H; Duman, RS				Kang, Hyo Jung; Voleti, Bhavya; Hajszan, Tibor; Rajkowska, Grazyna; Stockmeier, Craig A.; Licznerski, Pawel; Lepack, Ashley; Majik, Mahesh S.; Jeong, Lak Shin; Banasr, Mounira; Son, Hyeon; Duman, Ronald S.			Decreased expression of synapse-related genes and loss of synapses in major depressive disorder	NATURE MEDICINE			English	Article							PREFRONTAL CORTEX; TRANSCRIPTION FACTORS; PROTEIN; STRESS; ABNORMALITIES; ANTIDEPRESSANT; PROLIFERATION; ENVIRONMENT; CALMODULIN; VESICLES	Previous imaging and postmortem studies have reported a lower brain volume and a smaller size and density of neurons in the dorsolateral prefrontal cortex (dlPFC) of subjects with major depressive disorder (MDD)(1,2). These findings suggest that synapse number and function are decreased in the dlPFC of patients with MDD. However, there has been no direct evidence reported for synapse loss in MDD, and the gene expression alterations underlying these effects have not been identified. Here we use microarray gene profiling and electron microscopic stereology to reveal lower expression of synaptic-function-related genes (CALM2, SYN1, RAB3A, RAB4B and TUBB4) in the dlPFC of subjects with MDD and a corresponding lower number of synapses. We also identify a transcriptional repressor, GATA1, expression of which is higher in MDD and that, when expressed in PFC neurons, is sufficient to decrease the expression of synapse-related genes, cause loss of dendritic spines and dendrites, and produce depressive behavior in rat models of depression.	[Kang, Hyo Jung; Voleti, Bhavya; Licznerski, Pawel; Lepack, Ashley; Banasr, Mounira; Duman, Ronald S.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Hajszan, Tibor] Yale Univ, Dept Obstet & Gynecol, New Haven, CT 06520 USA; [Hajszan, Tibor] Hungarian Acad Sci, Biol Res Ctr, Dept Biophys, H-6701 Szeged, Hungary; [Rajkowska, Grazyna; Stockmeier, Craig A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Majik, Mahesh S.; Jeong, Lak Shin] Ewha Womans Univ, Coll Pharm, Dept Bioinspired Sci, Seoul, South Korea; [Son, Hyeon] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Duman, Ronald S.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; Yale University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Mississippi; University of Mississippi Medical Center; Ewha Womans University; Hanyang University; Yale University	Duman, RS (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06520 USA.	ronald.duman@yale.edu	Majik, Mahesh/AAS-1659-2021	Licznerski, Pawel/0000-0003-2761-8428; Majik, Mahesh/0000-0002-8255-0895	US Public Health Service [MH45481, 2 P01 MH25642, MH67996, P20 RR17701]; Connecticut Mental Health Center; National Research Foundation of Korea (NRF) [2011-0028317]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045481, R01MH067996, R29MH045481, R37MH045481, P01MH025642] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Mental Health Center; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by US Public Health Service grants MH45481 (R.S.D.), 2 P01 MH25642 (R.S.D.), MH67996 (C.A.S.) and P20 RR17701 (C.A.S.), the Connecticut Mental Health Center (R.S.D.) and a National Research Foundation of Korea grant (NRF, 2011-0028317; H.S.). We acknowledge the invaluable contributions made by the families consenting to donate brain tissue and be interviewed. We also thank the Cuyahoga County Coroner and staff, Cleveland, Ohio, for their willing assistance. We thank J. Overholser, G. Jurjus, H. Meltzer, L. Konick, L. Dieter, N. Herbst, G. Mahajan, H. Kooiman and J. Cobb for their contributions to the psychiatric assessment and human tissue dissection and preparation. We thank T.H. Kim (Yale University) for his advice and suggestions regarding the binding motif analysis and chromatin immunoprecipitation. The pXM-GATA1 plasmid was provided by A.B. Cantor (Harvard University), and the pAAV-eGFP-pA vector was provided by R.J. Dileone (Yale University). The GATA1-specific antibody was provided by E.H. Bresnick (University of Wisconsin).	Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Barabassy A, 2010, PSYCHIAT RES, V176, P26, DOI 10.1016/j.psychres.2008.06.045; Belizaire R, 2004, J COMP NEUROL, V470, P266, DOI 10.1002/cne.20008; Bianchi M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P597; Boyle LL, 2010, J CLIN PSYCHIAT, V71, P74, DOI 10.4088/JCP.08m04724gry; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; DECAMILLI P, 1986, BIOCHEM PHARMACOL, V35, P4349, DOI 10.1016/0006-2952(86)90747-1; DELORENZO RJ, 1978, BIOCHEM BIOPH RES CO, V80, P183, DOI 10.1016/0006-291X(78)91121-X; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drevets WC, 2000, PROG BRAIN RES, V126, P413; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Elferink LA, 1995, PROG BRAIN RES, V105, P79; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gorwood P, 2009, ENCEPHALE, V35, pS306, DOI 10.1016/S0013-7006(09)73492-X; Hajszan T, 2010, BIOL PSYCHIAT, V67, P168, DOI 10.1016/j.biopsych.2009.08.017; Hajszan T, 2009, BIOL PSYCHIAT, V65, P392, DOI 10.1016/j.biopsych.2008.09.031; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; HOFFMAN PN, 1988, CIBA F SYMP, V138, P192; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Kala K, 2009, DEVELOPMENT, V136, P253, DOI 10.1242/dev.029900; Kang HJ, 2007, J NEUROSCI, V27, P13329, DOI 10.1523/JNEUROSCI.4083-07.2007; Kim S, 2011, MOL PSYCHIATR, V16, P452, DOI 10.1038/mp.2010.23; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Lecrubier Y, 2001, J CLIN PSYCHIAT, V62, P4; Levens SM, 2009, DEPRESS ANXIETY, V26, P403, DOI 10.1002/da.20565; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Matthews G, 2001, NEURON, V32, P962, DOI 10.1016/S0896-6273(01)00546-3; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Noh JS, 1997, EXP NEUROL, V146, P604, DOI 10.1006/exnr.1997.6569; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; SHOLL DA, 1953, J ANAT, V87, P387; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valentine G, 2008, PSYCHOPHARMACOLOGY, V200, P585, DOI 10.1007/s00213-008-1239-z; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236	47	457	474	4	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1413	+		10.1038/nm.2886	http://dx.doi.org/10.1038/nm.2886			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22885997	Green Accepted			2022-12-25	WOS:000308472300038
J	Pines, M; Das, R; Ellis, SJ; Morin, A; Czerniecki, S; Yuan, L; Klose, M; Coombs, D; Tanentzapf, G				Pines, Mary; Das, Raibatak; Ellis, Stephanie J.; Morin, Alexander; Czerniecki, Stefan; Yuan, Lin; Klose, Markus; Coombs, Daniel; Tanentzapf, Guy			Mechanical force regulates integrin turnover in Drosophila in vivo	NATURE CELL BIOLOGY			English	Article							BETA(3) INTEGRIN; BINDING DOMAIN; ACTIVATION; INTEGRATION; MUTATIONS; DYNAMICS; SUBUNIT; NU	Regulated assembly and disassembly, or turnover, of integrin-mediated cell-extracellular matrix (ECM) adhesions is essential for dynamic cell movements and long-term tissue maintenance. For example, in Drosophila, misregulation of integrin turnover disrupts muscle-tendon attachment at myotendinous junctions (MTJs). We demonstrate that mechanical force, which modulates integrin activity, also regulates integrin and intracellular adhesion complex (IAC) turnover in vivo. Using conditional mutants to alter the tensile force on MTJs, we found that the proportion of IAC components undergoing turnover inversely correlated with the force applied on MTJs. This effect was disrupted by point mutations in beta-integrin that interfere with ECM-induced conformational changes and activation of beta-integrin or integrin-mediated cytoplasmic signalling. These mutants also disrupted integrin dynamics at MTJs during larval development. Together, these data suggest that specific beta-integrin-mediated signals regulate adhesion turnover in response to tension during tissue formation. We propose that integrin-ECM adhesive stability is continuously controlled by force in vivo through integrin-dependent auto-regulatory feedback mechanisms so that tissues can quickly adapt to and withstand mechanical stresses.	[Pines, Mary; Ellis, Stephanie J.; Morin, Alexander; Czerniecki, Stefan; Yuan, Lin; Klose, Markus; Tanentzapf, Guy] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Das, Raibatak; Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; [Das, Raibatak; Coombs, Daniel] Univ British Columbia, Inst Appl Math, Vancouver, BC V6T 1Z2, Canada; [Yuan, Lin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of British Columbia; University of British Columbia; University of British Columbia; University of California System; University of California Berkeley	Tanentzapf, G (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	tanentz@mail.ubc.ca	Tanentzapf, Guy/C-8864-2012; Ellis, Stephanie/AGH-2164-2022	Tanentzapf, Guy/0000-0002-2443-233X; Ellis, Stephanie/0000-0003-3341-3453; Coombs, Daniel/0000-0002-8038-6278; Yuan, Lin/0000-0003-3820-8651; Klose, Markus/0000-0001-5861-2366	NSERC discovery grant [356502]; Canadian Institutes of Health Research operating grant [89835]	NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR))	We thank T. Littleton (MIT, USA) and F. Schock (McGill University, Canada) for flies, and D. Moerman and members of the laboratory for helpful discussions and comments on the manuscript. S.J.E. holds an NSERC Alexander Graham Bell Canada Graduate Scholarship. D.C. is financially supported through an NSERC discovery grant. G.T. is financially supported through NSERC discovery grant 356502 and Canadian Institutes of Health Research operating grant 89835. G.T. is a CIHR New Investigator and Michael Smith Foundation for Health Research Scholar.	Anthis N. J., 2009, J BIOL CHEM, P1; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen J, 1996, CELL ADHES COMMUN, V4, P237, DOI 10.3109/15419069609010769; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Efron B., 1994, INTRO BOOTSTRAP; Ellis SJ, 2011, J CELL SCI, V124, P1844, DOI 10.1242/jcs.083337; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Franco-Cea A, 2010, DEV BIOL, V345, P64, DOI 10.1016/j.ydbio.2010.06.027; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hudson AM, 2008, DEV BIOL, V314, P329, DOI 10.1016/j.ydbio.2007.11.029; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jannuzi AL, 2004, MOL BIOL CELL, V15, P3829, DOI 10.1091/mbc.E04-02-0085; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Montana ES, 2004, J CELL BIOL, V164, P1045, DOI 10.1083/jcb.200308158; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pines M, 2011, DEV DYNAM, V240, P36, DOI 10.1002/dvdy.22488; Sanyal S, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-24-j0005.1999; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, J CELL SCI, V119, P1632, DOI 10.1242/jcs.02859; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Wasserman L., 2004, ALL STAT CONCISE COU; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; YEE GH, 1993, DEVELOPMENT, V118, P845; Yuan L, 2010, J CELL SCI, V123, P939, DOI 10.1242/jcs.063040	37	57	58	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2012	14	9					935	+		10.1038/ncb2555	http://dx.doi.org/10.1038/ncb2555			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	004GJ	22885771				2022-12-25	WOS:000308668600009
J	Rangachari, M; Zhu, C; Sakuishi, K; Xiao, S; Karman, J; Chen, A; Angin, M; Wakeham, A; Greenfield, EA; Sobel, RA; Okada, H; McKinnon, PJ; Mak, TW; Addo, MM; Anderson, AC; Kuchroo, VK				Rangachari, Manu; Zhu, Chen; Sakuishi, Kaori; Xiao, Sheng; Karman, Jozsef; Chen, Andrew; Angin, Mathieu; Wakeham, Andrew; Greenfield, Edward A.; Sobel, Raymond A.; Okada, Hitoshi; McKinnon, Peter J.; Mak, Tak W.; Addo, Marylyn M.; Anderson, Ana C.; Kuchroo, Vijay K.			Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion	NATURE MEDICINE			English	Article							CHRONIC VIRAL-INFECTION; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE INHIBITORY RECEPTORS; TH1/TH2 CELLS; UP-REGULATION; TIM-3; ACTIVATION; EXPRESSION; PROTEIN; VIRUS	T cell immunoglobulin and mucin domain-containing 3 (Tim-3) is an inhibitory receptor that is expressed on exhausted T cells during infection with HIV-1 and hepatitis C virus. By contrast, Tim-3 expression and function are defective in multiple human autoimmune diseases. However, the molecular mechanisms modulating Tim-3 function are not well understood. Here we show that human leukocyte antigen B (HLA-B)-associated transcript 3 (Bat3) binds to, and represses the function of, Tim-3. Bat3 protects T helper type 1 (T(H)1) cells from galectin-9-mediated cell death and promotes both proliferation and proinflammatory cytokine production. Bat3-deficient T cells have elevated expression of exhaustion-associated molecules such as Tim-3, Lag3, Prdm1 and Pbx3, and Bat3 knockdown in myelin-antigen-specific CD4(+) T cells markedly inhibits the development of experimental autoimmune encephalomyelitis while promoting the expansion of a dysfunctional Tim-3(hi), interferon-gamma (IFN-gamma)(lo)CD4(+) cell population. Furthermore, expression of Bat3 is reduced in exhausted Tim-3(+) T cells from mouse tumors and HIV-1-infected individuals. These data indicate that Bat3 acts as an inhibitor of Tim-3-dependent exhaustion and cell death. Bat3 may thus represent a viable therapeutic target in autoimmune disorders, chronic infections and cancers.	[Rangachari, Manu; Zhu, Chen; Sakuishi, Kaori; Xiao, Sheng; Karman, Jozsef; Chen, Andrew; Anderson, Ana C.; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Angin, Mathieu; Addo, Marylyn M.] Ragon Inst MGH MIT & Harvard, Charlestown, MA USA; [Wakeham, Andrew; Okada, Hitoshi; Mak, Tak W.] Princess Margaret Hosp, Campbell Family Breast Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Greenfield, Edward A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sobel, Raymond A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Okada, Hitoshi] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M4X 1K9, Canada; [Okada, Hitoshi] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [McKinnon, Peter J.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Dana-Farber Cancer Institute; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Jude Children's Research Hospital	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Addo, Marylyn M./GNP-2548-2022; Anderson, Ana C/ABD-6829-2021	Anderson, Ana C/0000-0002-0877-2932; Angin, Mathieu/0000-0002-6867-4680; Addo, Marylyn/0000-0003-2836-9224; Sobel, Raymond/0000-0002-0477-9002	Multiple Sclerosis Society of Canada (MSSOC); Canadian Institutes of Health Research (CIHR); EMD Serono, Canada; Multiple Sclerosis Scientific Research Foundation; Sankyo Foundation of Life Science; US National Institutes of Health [NS045937, AI073748, NS038037, K01DK090105]; Ragon Institute of MGH; MIT; Harvard; American Cancer Society; Harvard University Center for AIDS Research [P30 AI060354]; MSSOC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI074405, P30AI060354, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037, R01NS037956, R01NS030843, R01NS045937] Funding Source: NIH RePORTER	Multiple Sclerosis Society of Canada (MSSOC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EMD Serono, Canada; Multiple Sclerosis Scientific Research Foundation; Sankyo Foundation of Life Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH; MIT; Harvard; American Cancer Society(American Cancer Society); Harvard University Center for AIDS Research; MSSOC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz, D. Lee, J. Sullivan and M. King for technical assistance; J. Zhang (Brigham and Women's Hospital, Boston) for reagents; B.H. Waksman for valuable guidance and discussion; and B. Walker for critical reading of the manuscript. M. R. was previously supported by Fellowships from the Multiple Sclerosis Society of Canada (MSSOC) and the Canadian Institutes of Health Research (CIHR) and is currently supported by the EMD Serono, Canada and an MS Research and Training Network Transitional Career Development Award from the MSSOC and the Multiple Sclerosis Scientific Research Foundation. K.S. holds a Fellowship from the Sankyo Foundation of Life Science. These studies were funded by grants from the US National Institutes of Health to V.K.K. (NS045937, AI073748 and NS038037) and S.X. (K01DK090105), the Ragon Institute of MGH, MIT and Harvard (V.K.K., C.Z. and M.M.A.), the American Cancer Society (A.C.A.) and the Harvard University Center for AIDS Research (M.M.A.; P30 AI060354).	Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Dunn GP, 2005, IMMUNOL RES, V32, P231, DOI 10.1385/IR:32:1-3:231; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hara H, 2002, J IMMUNOL, V168, P2288, DOI 10.4049/jimmunol.168.5.2288; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; KUCHROO VK, 1992, J IMMUNOL, V148, P3776; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Morimoto K, 2011, SCAND J GASTROENTERO, V46, P701, DOI 10.3109/00365521.2011.568518; Moss RB, 2004, EXPERT OPIN BIOL TH, V4, P1887, DOI 10.1517/14712598.4.12.1887; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Myrmel H, 2009, APMIS, V117, P427, DOI 10.1111/j.1600-0463.2009.02454.x; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Priatel JJ, 2007, J IMMUNOL, V179, P2143, DOI 10.4049/jimmunol.179.4.2143; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	46	221	241	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1394	+		10.1038/nm.2871	http://dx.doi.org/10.1038/nm.2871			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22863785	Green Accepted			2022-12-25	WOS:000308472300035
J	Califano, A; Butte, AJ; Friend, S; Ideker, T; Schadt, E				Califano, Andrea; Butte, Atul J.; Friend, Stephen; Ideker, Trey; Schadt, Eric			Leveraging models of cell regulation and GWAS data in integrative network-based association studies	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; PROTEIN-INTERACTION; MOLECULAR NETWORKS; PREDICTION; PATHWAYS; MAP; PROLIFERATION; PERTURBATION; MECHANISMS		[Califano, Andrea] Columbia Univ, Columbia Initiat Syst Biol, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Butte, Atul J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Butte, Atul J.] Stanford Univ, Ctr Pediat Bioinformat, Lucile Packard Childrens Hosp, Stanford, CA 94305 USA; [Friend, Stephen] Sage Bionetworks, Seattle, WA USA; [Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Schadt, Eric] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY USA	Columbia University; Columbia University; Columbia University; Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Califano, A (corresponding author), Columbia Univ, Columbia Initiat Syst Biol, New York, NY 10027 USA.	califano@c2b2.columbia.edu; eric.schadt@mssm.edu		Ideker, Trey/0000-0002-1708-8454; Califano, Andrea/0000-0003-4742-3679	US National Institutes of Health (NIH) under the grant award Common Fund and National Cancer Institute, Roadmap grant for the Center for the Multiscale Analysis of Genetic Networks (MAGNet) [U54CA121852]; US National Institutes of Health (NIH) under the grant award National Cancer Institute, In Silico Research Centre of Excellence [NCI-caBIG 29XS192]; US National Institutes of Health (NIH) under the grant award National Cancer Institute CCSB Program [U54CA149237]; US National Institutes of Health (NIH) under the grant award [P41 GM103504]; US National Institutes of Health (NIH) under the grant award National Institute of General Medical Sciences [R01 GM079719]; NATIONAL CANCER INSTITUTE [U54CA121852, U54CA149237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719, P41GM103504] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) under the grant award Common Fund and National Cancer Institute, Roadmap grant for the Center for the Multiscale Analysis of Genetic Networks (MAGNet)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH) under the grant award National Cancer Institute, In Silico Research Centre of Excellence; US National Institutes of Health (NIH) under the grant award National Cancer Institute CCSB Program; US National Institutes of Health (NIH) under the grant award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH) under the grant award National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge the generous funding provided by the US National Institutes of Health (NIH) under the following grant awards: (i) Common Fund and National Cancer Institute, Roadmap grant for the Center for the Multiscale Analysis of Genetic Networks (MAGNet) (U54CA121852), (ii) National Cancer Institute, In Silico Research Centre of Excellence (NCI-caBIG 29XS192), (iii) National Cancer Institute CCSB Program (U54CA149237), (iv) (P41 GM103504) and (v) National Institute of General Medical Sciences (R01 GM079719). We would also like to acknowledge the State of Washington Life Sciences Discovery Fund and the Lucile Packard Foundation for Children's Health.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chen GK, 2010, GENET EPIDEMIOL, V34, P863, DOI 10.1002/gepi.20542; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Huang Y, 2010, PROTEIN CELL, V1, P979, DOI 10.1007/s13238-010-0129-4; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Leonardson AS, 2010, HUM MOL GENET, V19, P159, DOI 10.1093/hmg/ddp476; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Marko NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020826; Narayanan M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000742; Nelander S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.53; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orozco G, 2005, HUM IMMUNOL, V66, P1235, DOI 10.1016/j.humimm.2006.02.003; Pan W, 2008, HUM GENET, V124, P225, DOI 10.1007/s00439-008-0545-1; Pandey G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000928; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Quayle AP, 2007, CANCER INFORM, V5, P45; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; ULITSKY I, 2010, PLOS ONE, V0005; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P264; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yang X, 2010, J CLIN INVEST, V120, P2414, DOI 10.1172/JCI42742; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000671; Zien A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P407	87	183	189	0	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					841	847		10.1038/ng.2355	http://dx.doi.org/10.1038/ng.2355			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22836096	Green Accepted, hybrid			2022-12-25	WOS:000306854700006
J	Galvez-Santisteban, M; Rodriguez-Fraticelli, AE; Bryant, DM; Vergarajauregui, S; Yasuda, T; Banon-Rodriguez, I; Bernascone, I; Datta, A; Spivak, N; Young, K; Slim, CL; Brakeman, PR; Fukuda, M; Mostov, KE; Martin-Belmonte, F				Galvez-Santisteban, Manuel; Rodriguez-Fraticelli, Alejo E.; Bryant, David M.; Vergarajauregui, Silvia; Yasuda, Takao; Banon-Rodriguez, Inmaculada; Bernascone, Ilenia; Datta, Anirban; Spivak, Natalie; Young, Kitty; Slim, Christiaan L.; Brakeman, Paul R.; Fukuda, Mitsunori; Mostov, Keith E.; Martin-Belmonte, Fernando			Synaptotagmin-like proteins control the formation of a single apical membrane domain in epithelial cells	NATURE CELL BIOLOGY			English	Article							PLASMA-MEMBRANE; TRAFFICKING; LUMEN; SLP4-A/GRANUPHILIN-A; RAB27; PHOSPHOINOSITIDES; MORPHOGENESIS; EXOCYTOSIS; GENERATION; JUNCTIONS	The formation of epithelial tissues requires both the generation of apical-basal polarity and the coordination of this polarity between neighbouring cells to form a central lumen. During de novo lumen formation, vectorial membrane transport contributes to the formation of a singular apical membrane, resulting in the contribution of each cell to only a single lumen. Here, from a functional screen for genes required for three-dimensional epithelial architecture, we identify key roles for synaptotagmin-like proteins 2-a and 4-a (Slp2-a/4-a) in the generation of a single apical surface percell. Slp2-a localizes to the luminal membrane in a PtdIns(4,5)P-2-dependent manner, where it targets Rab27-loaded vesicles to initiate a single lumen. Vesicle tethering and fusion is controlled by Slp4-a, in conjunction with Rab27/Rab3/Rab8 and the SNARE syntaxin-3. Together, Slp2-a/4-a coordinate the spatiotemporal organization of vectorial apical transport to ensure that only a single apical surface, and thus the formation of a single lumen, occurs per cell.	[Galvez-Santisteban, Manuel; Rodriguez-Fraticelli, Alejo E.; Vergarajauregui, Silvia; Banon-Rodriguez, Inmaculada; Bernascone, Ilenia; Martin-Belmonte, Fernando] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Bryant, David M.; Datta, Anirban; Spivak, Natalie; Young, Kitty; Slim, Christiaan L.; Brakeman, Paul R.; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Yasuda, Takao; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Spivak, Natalie; Brakeman, Paul R.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Mostov, Keith E.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of California System; University of California San Francisco; Tohoku University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin-Belmonte, F (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1, Madrid 28049, Spain.	fmartin@cbm.uam.es	Fukuda, MItsunori/I-1511-2015; Vergarajauregui, Silvia/ABG-8402-2020; Martin-Belmonte, Fernando/J-8029-2014; Bryant, David/AAH-5620-2019; Rodriguez-Fraticelli, Alejo/AAG-7462-2020	Fukuda, MItsunori/0000-0002-8620-5853; Vergarajauregui, Silvia/0000-0002-9247-6123; Bryant, David/0000-0003-2721-5012; Rodriguez-Fraticelli, Alejo/0000-0002-4017-8714; mostov, keith/0000-0002-8123-6247; Martin-Belmonte, Fernando/0000-0002-2564-4430	Human Frontiers Science Program (HFSP-CDA) [00011/2009]; Marie Curie [IRG-209382]; MICINN [BFU2008-01916, BFU2011-22622]; CONSOLIDER [CSD2009-00016]; NIH [R01DK074398, R01AI25144, R01DK91530]; March of Dimes Basil O'Connor Starter Research Award; JAE fellowship, from CSIC; FPI fellowship, from MICINN; AECC fellowship; Fundacion Ramon Areces; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, R01DK091530] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Human Frontiers Science Program (HFSP-CDA)(Human Frontier Science Program); Marie Curie(European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor Starter Research Award; JAE fellowship, from CSIC; FPI fellowship, from MICINN; AECC fellowship; Fundacion Ramon Areces; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. M. Ruiz-Jarabo for comments on the manuscript, and members of the Martin-Belmonte laboratory for discussion. We thank M. ter Beest, J. Peranen, and K. Simons, Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany, for generous gifts of reagents, and the Mostov laboratory for kind assistance. This work was supported by grants from the Human Frontiers Science Program (HFSP-CDA 00011/2009), Marie Curie (IRG-209382), MICINN (BFU2008-01916), (BFU2011-22622) and CONSOLIDER (CSD2009-00016) to F.M-B.; by NIH R01DK074398, R01AI25144 and R01DK91530 to K.M., and The March of Dimes Basil O'Connor Starter Research Award to P.R.B. A.E.R-F. is the recipient of a JAE fellowship, from CSIC; M.G-S. is the recipient of a FPI fellowship, from MICINN; and I.B-R. is the recipient of an AECC fellowship. An institutional Grant from the Fundacion Ramon Areces to CBMSO is also acknowledged.	Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Bolasco G, 2011, AM J PHYSIOL-CELL PH, V300, pC466, DOI 10.1152/ajpcell.00446.2010; Brady DC, 2009, MOL CELL BIOL, V29, P1035, DOI 10.1128/MCB.00336-08; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Chavas LMG, 2008, STRUCTURE, V16, P1468, DOI 10.1016/j.str.2008.07.015; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 2005, J BIOL CHEM, V280, P39175, DOI 10.1074/jbc.M505759200; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Ishii Naoki, 2008, Gan To Kagaku Ryoho, V35, P1403; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Rodriguez-Boulan E, 2004, CURR OPIN CELL BIOL, V16, P436, DOI 10.1016/j.ceb.2004.06.013; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Tsuboi T, 2006, MOL BIOL CELL, V17, P2101, DOI 10.1091/mbc.E05-11-1047; van IJzendoorn SCD, 2002, DEV CELL, V2, P219, DOI 10.1016/S1534-5807(02)00115-6; Yu M, 2007, MOL BIOL CELL, V18, P688, DOI 10.1091/mbc.E06-10-0914; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	36	90	91	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					838	U148		10.1038/ncb2541	http://dx.doi.org/10.1038/ncb2541			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22820376	Green Accepted, Green Submitted			2022-12-25	WOS:000307115900013
J	Howitt, MR; Garrett, WS				Howitt, Michael R.; Garrett, Wendy S.			A complex microworld in the gut Gut microbiota and cardiovascular disease connectivity	NATURE MEDICINE			English	Editorial Material							OBESITY; MICE	Millions of healthy bacteria colonize our guts from the moment we are born. Changes in the composition and abundance of these commensals affect the entire immune system and can predispose us to a variety of diseases, including intestinal infections, inflammatory and metabolic diseases, and cancer. The gut microbiome interacts not only with the host mucosa but also with potential pathogens; understanding what interactions and pathways are crucial for maintaining homeostasis and protecting the host from harmful bacteria and diseases can open new avenues to developing gut microbiota-based therapeutic approaches. In 'Bench to Bedside', Michael R. Howitt and Wendy S. Garrett examine the importance of metabolic crosstalk between the microbiota and the host in human metabolism and the development of cardiovascular disease. This adds one more layer of complexity to understanding what contributes to this pathology and how to harness the microbiota and their metabolic pathways to prevent it. In 'Bedside to Bench', Nobuhiko Kamada, Grace Chen and Gabriel Nunez discuss how targeting interactions between commensals and bacteria causing intestinal disease can lead to effective therapies to control these infections, which currently seem to lack an adequate treatment. Unraveling how commensals help the host prevent or block colonization of these pathogens can suggest new ways to increase our armamentarium to deal with these sometimes deadly intestinal infections.	[Howitt, Michael R.; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Sch Med, Boston, MA 02115 USA; [Howitt, Michael R.; Garrett, Wendy S.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Howitt, MR (corresponding author), Harvard Univ, Sch Publ Hlth, Sch Med, 665 Huntington Ave, Boston, MA 02115 USA.	wgarrett@hsph.harvard.edu		Garrett, Wendy/0000-0002-5092-0150	NIAID NIH HHS [K08 AI078942] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078942] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	16	61	73	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1188	1189		10.1038/nm.2895	http://dx.doi.org/10.1038/nm.2895			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869188				2022-12-25	WOS:000307469300022
J	Nishida, M; Sawa, T; Kitajima, N; Ono, K; Inoue, H; Ihara, H; Motohashi, H; Yamamoto, M; Suematsu, M; Kurose, H; van der Vliet, A; Freeman, BA; Shibata, T; Uchida, K; Kumagai, Y; Akaike, T				Nishida, Motohiro; Sawa, Tomohiro; Kitajima, Naoyuki; Ono, Katsuhiko; Inoue, Hirofumi; Ihara, Hideshi; Motohashi, Hozumi; Yamamoto, Masayuki; Suematsu, Makoto; Kurose, Hitoshi; van der Vliet, Albert; Freeman, Bruce A.; Shibata, Takahiro; Uchida, Koji; Kumagai, Yoshito; Akaike, Takaaki			Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN S-GUANYLATION; H-RAS; EXPRESSION; HYPERTROPHY; DYSFUNCTION; MECHANISMS; SENESCENCE; OXYGEN; HEART	An emerging aspect of redox signaling is the pathway mediated by electrophilic byproducts, such as nitrated cyclic nucleotide (for example, 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP)) and nitro or keto derivatives of unsaturated fatty acids, generated via reactions of inflammation-related enzymes, reactive oxygen species, nitric oxide and secondary products. Here we report that enzymatically generated hydrogen sulfide anion (HS-) regulates the metabolism and signaling actions of various electrophiles. HS- reacts with electrophiles, best represented by 8-nitro-cGMP, via direct sulfhydration and modulates cellular redox signaling. The relevance of this reaction is reinforced by the significant 8-nitro-cGMP formation in mouse cardiac tissue after myocardial infarction that is modulated by alterations in HS- biosynthesis. Cardiac HS-, in turn, suppresses electrophile-mediated H-Ras activation and cardiac cell senescence, contributing to the beneficial effects of HS- on myocardial infarction-associated heart failure. Thus, this study reveals HS--induced electrophile sulfhydration as a unique mechanism for regulating electrophile-mediated redox signaling.	[Sawa, Tomohiro; Ono, Katsuhiko; Inoue, Hirofumi; Akaike, Takaaki] Kumamoto Univ, Dept Microbiol, Grad Sch Med Sci, Kumamoto, Japan; [Nishida, Motohiro; Kitajima, Naoyuki; Kurose, Hitoshi] Kyushu Univ, Dept Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Nishida, Motohiro; Kitajima, Naoyuki] Kyushu Univ, Dept Drug Discovery & Evolut, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Sawa, Tomohiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Ihara, Hideshi] Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Osaka, Japan; [Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi 980, Japan; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [van der Vliet, Albert] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Freeman, Bruce A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kumagai, Yoshito] Univ Tsukuba, Doctoral Program Biomed Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Kumamoto University; Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tohoku University; Keio University; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagoya University; University of Tsukuba	Akaike, T (corresponding author), Kumamoto Univ, Dept Microbiol, Grad Sch Med Sci, Kumamoto, Japan.	takakaik@gpo.kumamoto-u.ac.jp	Suematsu, Makoto/I-8135-2013; Yamamoto, Masayuki/A-4873-2010; Motohashi, Hozumi/AAZ-2628-2020; Freeman, Bruce A/H-9342-2012; Suematsu, Makoto/O-5762-2018; Shibata, Takahiro/I-6872-2014	Suematsu, Makoto/0000-0002-7165-6336; Yamamoto, Masayuki/0000-0002-9073-9436; Suematsu, Makoto/0000-0002-7165-6336; Uchida, Koji/0000-0003-3894-5299; Nishida, Motohiro/0000-0002-2587-5458; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Sciences, Sports and Technology, Japan; Japan Science and Technology Agency PRESTO program; Ministry of Health, Labor and Welfare of Japan; US National Institutes of Health; Grants-in-Aid for Scientific Research [23651239, 22500337] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646, R01HL064937, R01HL058115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021476] Funding Source: NIH RePORTER	Ministry of Education, Sciences, Sports and Technology, Japan; Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J.B. Gandy for her editing of the manuscript. Thanks are also due to T. Okamoto, S. Fujii, Md. M. Rahaman, S. Khan, K. A. Ahmed, J. Yoshitake, T. Matsunaga, M. H. A. Rahman, J. Sakamoto, J. Minkyung, K. Hara, M. Goto, F. Sohma, K. Taguchi, T. Miura, T. Toyama, Y. Shinkai, I. Ishii and M. Toyataka for technical assistance; S. Kasamatsu, T. Ida and K. Kunieda for 8-nitro-cGMP preparation; Y. Kawai for technical assistance with LC/MS/MS experiments; H. Arimoto for helpful discussion; and J. Wu for reading our paper to evaluate its concepts and interdisciplinary accessibility. This work was supported in part by Grants-in-Aid for Scientific Research and Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Area) from the Ministry of Education, Sciences, Sports and Technology, Japan; a grant from the Japan Science and Technology Agency PRESTO program; grants from the Ministry of Health, Labor and Welfare of Japan; and grants from the US National Institutes of Health.	Akaike T, 2010, NITRIC OXIDE-BIOL CH, V23, P166, DOI 10.1016/j.niox.2010.06.006; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Carballal S, 2011, FREE RADICAL BIO MED, V50, P196, DOI 10.1016/j.freeradbiomed.2010.10.705; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Gelb BD, 2011, J CLIN INVEST, V121, P844, DOI 10.1172/JCI46399; Glushchenko AV, 2007, ANTIOXID REDOX SIGN, V9, P1883, DOI 10.1089/ars.2007.1809; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liu YH, 2005, AM J PHYSIOL-HEART C, V289, pH2616, DOI 10.1152/ajpheart.00546.2005; LoPachin RM, 2007, TOXICOL SCI, V98, P561, DOI 10.1093/toxsci/kfm127; Nishida M, 2011, P NATL ACAD SCI USA, V108, P6662, DOI 10.1073/pnas.1017640108; Ohshima H, 2006, ANTIOXID REDOX SIGN, V8, P1033, DOI 10.1089/ars.2006.8.1033; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Pechkovsky DV, 2002, AM J PHYSIOL-LUNG C, V282, pL684, DOI 10.1152/ajplung.00320.2000; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Wintner EA, 2010, BRIT J PHARMACOL, V160, P941, DOI 10.1111/j.1476-5381.2010.00704.x; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004; Zaki MH, 2009, J IMMUNOL, V182, P3746, DOI 10.4049/jimmunol.0803363; Zhang P, 2007, CIRC RES, V100, P1089, DOI 10.1161/01.RES.0000264081.78659.45; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	41	223	232	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					714	724		10.1038/NCHEMBIO.1018	http://dx.doi.org/10.1038/NCHEMBIO.1018			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22772154	Green Accepted			2022-12-25	WOS:000306527600011
J	Sherlock, JP; Joyce-Shaikh, B; Turner, SP; Chao, CC; Sathe, M; Grein, J; Gorman, DM; Bowman, EP; McClanahan, TK; Yearley, JH; Eberl, G; Buckley, CD; Kastelein, RA; Pierce, RH; LaFace, DM; Cua, DJ				Sherlock, Jonathan P.; Joyce-Shaikh, Barbara; Turner, Scott P.; Chao, Cheng-Chi; Sathe, Manjiri; Grein, Jeff; Gorman, Daniel M.; Bowman, Edward P.; McClanahan, Terrill K.; Yearley, Jennifer H.; Eberl, Gerard; Buckley, Christopher D.; Kastelein, Robert A.; Pierce, Robert H.; LaFace, Drake M.; Cua, Daniel J.			IL-23 induces spondyloarthropathy by acting on ROR-gamma t(+) CD3(+)CD4(-)CD8(-) entheseal resident T cells	NATURE MEDICINE			English	Article							LIGAMENT-BONE INTERFACE; EXPRESSION IN-VIVO; ANKYLOSING-SPONDYLITIS; ACHILLES-TENDON; PROINFLAMMATORY IL-17(+); DISTINCT FIBROCARTILAGES; IL-17-PRODUCING CELLS; RHEUMATOID-ARTHRITIS; DISEASE; COLLAGENS	The spondyloarthropathies are a group of rheumatic diseases that are associated with inflammation at anatomically distal sites, particularly the tendon-bone attachments (entheses) and the aortic root. Serum concentrations of interleukin-23 (IL-23) are elevated and polymorphisms in the IL-23 receptor are associated with ankyosing spondylitis, however, it remains unclear whether IL-23 acts locally at the enthesis or distally on circulating cell populations. We show here that IL-23 is essential in enthesitis and acts on previously unidentified IL-23 receptor (IL-23R)(+), RAR-related orphan receptor gamma t (ROR-gamma t)(+)CD3(+)CD4(-)CD8(-), stem cell antigen 1 (Sca1)(+) entheseal resident T cells. These cells allow entheses to respond to IL-23 in vitro-in the absence of further cellular recruitment-and to elaborate inflammatory mediators including IL-6, IL-17, IL-22 and chemokine (C-X-C motif) ligand 1 (CXCL1). Notably, the in vivo expression of IL-23 is sufficient to phenocopy the human disease, with the specific and characteristic development of enthesitis and entheseal new bone formation in the initial complete absence of synovitis. As in the human condition, inflammation also develops in vivo at the aortic root and valve, which are structurally similar to entheses. The presence of these entheseal resident cells and their production of IL-22, which activates signal transducer and activator of transcription 3 (STAT3)-dependent osteoblastmediated bone remodeling, explains why dysregulation of IL-23 results in inflammation at this precise anatomical site.	[Sherlock, Jonathan P.; Joyce-Shaikh, Barbara; Turner, Scott P.; Chao, Cheng-Chi; Sathe, Manjiri; Grein, Jeff; Gorman, Daniel M.; Bowman, Edward P.; McClanahan, Terrill K.; Yearley, Jennifer H.; Kastelein, Robert A.; Pierce, Robert H.; LaFace, Drake M.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA USA; [Sherlock, Jonathan P.] Univ Oxford, Trinity Coll, Oxford, England; [Sherlock, Jonathan P.; Buckley, Christopher D.] Univ Birmingham, Birmingham, W Midlands, England; [Eberl, Gerard] Inst Pasteur, Paris, France	Merck & Company; University of Oxford; University of Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cua, DJ (corresponding author), Merck Res Labs, Palo Alto, CA USA.	daniel.cua@merck.com	Buckley, Christopher/AAN-6378-2021; Eberl, Gerard/A-1160-2013	Buckley, Christopher/0000-0001-6924-6402; Pierce, MD, Robert Hamilton/0000-0002-2677-144X; Eberl, Gerard/0000-0002-1119-5638	Merck Research Laboratories; Medical Research Council [G9818340B] Funding Source: researchfish; National Institute for Health Research [CL-2011-09-004(1)] Funding Source: researchfish; Versus Arthritis [19791] Funding Source: researchfish	Merck Research Laboratories(Merck & Company); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	We are grateful for the assistance of S. Jungers for flow cytometric sorting. We also thank P. Bowness, H. Gaston, A. van der Merwe and A. Cooke for helpful comments on this study. This research was funded by and conducted within Merck Research Laboratories. We thank Z.-Y. Chen (Departments of Pediatrics and Genetics, Stanford University School of Medicine) for the minicircle vector plasmid.	Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Appel H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2035; Appel H, 2006, ARTHRITIS RHEUM-US, V54, P2845, DOI 10.1002/art.22060; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bellow M, 2000, ANN RHEUM DIS, V59, P135, DOI 10.1136/ard.59.2.135; Benjamin M, 2007, ARTHRITIS RHEUM, V56, P224, DOI 10.1002/art.22290; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fukuta S, 1998, MATRIX BIOL, V17, P65, DOI 10.1016/S0945-053X(98)90074-9; Gao J, 1996, ANAT EMBRYOL, V194, P399; GILLET P, 1989, J RHEUMATOL, V16, P721; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Grateau G, 2010, BEST PRACT RES CL RH, V24, P401, DOI 10.1016/j.berh.2009.12.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kruithof E, 2005, ARTHRITIS RES THER, V7, pR569, DOI 10.1186/ar1698; KUMAGAI J, 1994, J ANAT, V185, P279; Lambert RGW, 2007, ARTHRITIS RHEUM, V56, P4005, DOI 10.1002/art.23044; Ling E, 2007, AUTOIMMUN REV, V6, P237, DOI 10.1016/j.autrev.2006.08.008; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lories RJU, 2010, BEST PRACT RES CL RH, V24, P625, DOI 10.1016/j.berh.2010.05.005; Maksymowych WP, 2010, NAT REV RHEUMATOL, V6, P75, DOI 10.1038/nrrheum.2009.258; May E, 2003, J IMMUNOL, V170, P1099, DOI 10.4049/jimmunol.170.2.1099; McGonagle D, 1998, LANCET, V352, P1137, DOI 10.1016/S0140-6736(97)12004-9; McGonagle D, 1998, ARTHRITIS RHEUM, V41, P694, DOI 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#; McGonagle D, 2002, ANN RHEUM DIS, V61, P534, DOI 10.1136/ard.61.6.534; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Melis L, 2010, ANN RHEUM DIS, V69, P618, DOI 10.1136/ard.2009.107649; MIELANTS H, 1995, J RHEUMATOL, V22, P2279; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Niyibizi C, 1996, BIOCHEM BIOPH RES CO, V222, P584, DOI 10.1006/bbrc.1996.0787; Palazzi C, 2011, JOINT BONE SPINE, V78, P451, DOI 10.1016/j.jbspin.2010.11.003; Rahman P, 2008, ARTHRITIS RHEUM-US, V58, P1020, DOI 10.1002/art.23389; Rahman P, 2009, J RHEUMATOL, V36, P137, DOI 10.3899/jrheum.080458; RALPHS JR, 1994, J ANAT, V184, P503; RALPHS JR, 1992, ANAT EMBRYOL, V185, P181; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; RUFAI A, 1992, ANAT EMBRYOL, V186, P611; SAKAMOTO A, 1992, ARTHRITIS RHEUM, V35, P944, DOI 10.1002/art.1780350815; Taurog JD, 2009, ARTHRITIS RHEUM, V60, P1977, DOI 10.1002/art.24599; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; Venzor J, 1997, AM J MED SCI, V313, P236, DOI 10.1097/00000441-199704000-00007; Visconti CS, 1996, ARCH BIOCHEM BIOPHYS, V328, P135, DOI 10.1006/abbi.1996.0153; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Wang XW, 2009, RHEUMATOL INT, V29, P1343, DOI 10.1007/s00296-009-0883-x; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; WOFSY D, 1984, J IMMUNOL, V132, P2686	54	722	757	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1069	+		10.1038/nm.2817	http://dx.doi.org/10.1038/nm.2817			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772566				2022-12-25	WOS:000306121600036
J	Chuong, EB; Rumi, MAK; Soares, MJ; Baker, JC				Chuong, Edward B.; Rumi, M. A. Karim; Soares, Michael J.; Baker, Julie C.			Endogenous retroviruses function as species-specific enhancer elements in the placenta	NATURE GENETICS			English	Article							HISTONE MODIFICATIONS; EVOLUTION; METHYLATION; IMPACT	The mammalian placenta is remarkably distinct between species, suggesting a history of rapid evolutionary diversification(1). To gain insight into the molecular drivers of placental evolution, we compared biochemically predicted enhancers in mouse and rat trophoblast stem cells (TSCs) and found that species-specific enhancers are highly enriched for endogenous retroviruses (ERVs) on a genome-wide level. One of these ERV families, RLTR13D5, contributes hundreds of mouse-specific histone H3 lysine 4 monomethylation (H3K4me1)- and histone H3 lysine 27 acetylation (H3K27ac)-defined enhancers that functionally bind Cdx2, Eomes and Elf5-core factors that define the TSC regulatory network. Furthermore, we show that RLTR13D5 is capable of driving gene expression in rat placental cells. Analysis in other tissues shows that species-specific ERV enhancer activity is generally restricted to hypomethylated tissues, suggesting that tissues permissive for ERV activity gain access to an otherwise silenced source of regulatory variation. Overall, our results implicate ERV enhancer co-option as a mechanism underlying the extensive evolutionary diversification of placental development.	[Chuong, Edward B.; Baker, Julie C.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Rumi, M. A. Karim; Soares, Michael J.] Univ Kansas, Med Ctr, Dept Pathol, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66103 USA; [Rumi, M. A. Karim; Soares, Michael J.] Univ Kansas, Med Ctr, Dept Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66103 USA	Stanford University; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Chuong, EB (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	echuong@stanford.edu; jbaker@stanford.edu		Chuong, Edward/0000-0002-5392-937X	Stanford Genome Training Grant [T32 HG000044]; National Science Foundation Graduate Research Fellowship [2008052909]; Stanford Bio-X program; Burroughs Welcome Prematurity Initiative [1008847]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD020676] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	Stanford Genome Training Grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Bio-X program; Burroughs Welcome Prematurity Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors wish to thank G. Barsh for helpful comments, the laboratory of A. Sidow for assistance with sequencing and J. Rossant (Hospital for Sick Children) for contribution of mouse TSCs. This work was supported by the Stanford Genome Training Grant (E.B.C.; T32 HG000044), a National Science Foundation Graduate Research Fellowship (E.B.C.; 2008052909), the Stanford Bio-X program (J.C.B.) and the Burroughs Welcome Prematurity Initiative (J.C.B.; 1008847).	Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chuong EB, 2010, MOL BIOL EVOL, V27, P1221, DOI 10.1093/molbev/msq034; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Enders AC, 2009, PLACENTA, V30, pS15, DOI 10.1016/j.placenta.2008.09.018; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig D, 2012, CURR BIOL, V22, pR609, DOI 10.1016/j.cub.2012.06.002; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Hou Z, 2009, GENOMICS, V93, P33, DOI 10.1016/j.ygeno.2008.09.005; Hughes AL, 2000, P NATL ACAD SCI USA, V97, P3319, DOI 10.1073/pnas.050002797; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Mossman HW, 1987, VERTEBRATE FETAL MEM; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Prudhomme S, 2005, CYTOGENET GENOME RES, V110, P353, DOI 10.1159/000084967; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Yoon SJ, 2011, GENE DEV, V25, P1654, DOI 10.1101/gad.16800511; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	31	243	246	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					325	329		10.1038/ng.2553	http://dx.doi.org/10.1038/ng.2553			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23396136	Green Accepted			2022-12-25	WOS:000315664800020
J	Fu, Y; Tsui, HCT; Bruce, KE; Sham, LT; Higgins, KA; Lisher, JP; Kazmierczak, KM; Maroney, MJ; Dann, CE; Winkler, ME; Giedroc, DP				Fu, Yue; Tsui, Ho-Ching Tiffany; Bruce, Kevin E.; Sham, Lok-To; Higgins, Khadine A.; Lisher, John P.; Kazmierczak, Krystyna M.; Maroney, Michael J.; Dann, Charles E., III; Winkler, Malcolm E.; Giedroc, David P.			A new structural paradigm in copper resistance in Streptococcus pneumoniae	NATURE CHEMICAL BIOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; METAL; VIRULENCE; HOMEOSTASIS; MECHANISM; INTERPLAY; DELIVERY; TARGETS; CSOR	Copper resistance has emerged as an important virulence determinant of microbial pathogens. In Streptococcus pneumoniae, copper resistance is mediated by the copper-responsive repressor CopY, CupA and the copper-effluxing P-18-type ATPase CopA. We show here that CupA is a previously uncharacterized cell membrane-anchored Cu-(I) chaperone and that a Cu-(I) binding-competent, membrane-localized CupA is obligatory for copper resistance. The crystal structures of the soluble domain of CupA and the N-terminal metal-binding domain (MBD) of CopA (CopA(MBD)) reveal isostructural cupredoxin-like folds that each harbor a binuclear Cu-(I) cluster unprecedented in bacterial copper trafficking. NMR studies reveal unidirectional Cu-(I) transfer from the low-affinity site on the soluble domain of CupA to the high-affinity site of CopA(MBD). However, copper binding by CopA(MBD) is not essential for cellular copper resistance, consistent with a primary role of CupA in cytoplasmic Cu-(I) sequestration and/or direct delivery to the transmembrane site of CopA for cellular efflux.	[Fu, Yue; Higgins, Khadine A.; Lisher, John P.; Dann, Charles E., III; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Fu, Yue; Lisher, John P.; Dann, Charles E., III; Winkler, Malcolm E.; Giedroc, David P.] Indiana Univ, Interdisciplinary Grad Program Biochem, Bloomington, IN USA; [Tsui, Ho-Ching Tiffany; Bruce, Kevin E.; Sham, Lok-To; Kazmierczak, Krystyna M.; Winkler, Malcolm E.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Maroney, Michael J.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Massachusetts System; University of Massachusetts Amherst	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	giedroc@indiana.edu	Johnson, Michael D. L./B-4352-2012; Dann, Charles E/C-2747-2018; Giedroc, David/A-8608-2018; Sham, Lok To/L-8149-2016	Giedroc, David/0000-0002-2342-1620; Sham, Lok To/0000-0001-9047-0310; Maroney, Michael/0000-0002-5598-3038	US National Institutes of Health (NIH) [GM042569, GM094472, AI095814, GM069696]; Lilly Endowment; Indiana University Quantitative and Chemical Biology Training Fellowship; US Department of Energy, Office of Biological and Environmental Research; NIH National Center for Research Resources, Biomedical Technology Program; Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering [P30-EB-009998]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094472, R01GM069696, T32GM109825, R01GM042569, R29GM042569] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment; Indiana University Quantitative and Chemical Biology Training Fellowship; US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Synchrotron Biosciences from the National Institute of Biomedical Imaging and Bioengineering; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support from the US National Institutes of Health (NIH; GM042569 to D.P.G., GM094472 to C.E.D. III, AI095814 to M.E.W and GM069696 to M.J.M.), the Lilly Endowment (to M.E.W.) and an Indiana University Quantitative and Chemical Biology Training Fellowship (to J.P.L.). We thank L. Christiansen for assistance in strain construction, members of the Giedroc laboratory for help in acquiring the NMR data and H. Hu and N. Giri from of the Maroney laboratory for XAS data collection. Crystallographic data collection at the Advanced Light Source at the Lawrence Berkeley National Laboratory is supported by the US Department of Energy and Indiana University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the US Department of Energy, Office of Biological and Environmental Research and by the NIH National Center for Research Resources, Biomedical Technology Program. XAS data collected at the National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory was supported by the US Department of Energy, Division of Materials Sciences and Division of Chemical Sciences. Beamline X3B at NSLS is supported by the Center for Synchrotron Biosciences (grant P30-EB-009998) from the National Institute of Biomedical Imaging and Bioengineering.	Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Badarau A, 2011, P NATL ACAD SCI USA, V108, P13007, DOI 10.1073/pnas.1101448108; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Bersch B, 2011, BIOCHEMISTRY-US, V50, P2194, DOI 10.1021/bi200005k; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Kazmierczak KM, 2009, MOL MICROBIOL, V72, P590, DOI 10.1111/j.1365-2958.2009.06669.x; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Percival SS, 1998, AM J CLIN NUTR, V67, p1064S, DOI 10.1093/ajcn/67.5.1064S; Portmann R, 2006, BIOMETALS, V19, P61, DOI 10.1007/s10534-005-5381-3; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Rowland JL, 2012, TUBERCULOSIS, V92, P202, DOI 10.1016/j.tube.2011.12.006; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zaballa ME, 2012, P NATL ACAD SCI USA, V109, P9254, DOI 10.1073/pnas.1119460109	47	69	69	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					177	183		10.1038/NCHEMBIO.1168	http://dx.doi.org/10.1038/NCHEMBIO.1168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23354287	Green Accepted			2022-12-25	WOS:000315132900013
J	Wang, ZA; Mitrofanova, A; Bergren, SK; Abate-Shen, C; Cardiff, RD; Califano, A; Shen, MM				Wang, Zhu A.; Mitrofanova, Antonina; Bergren, Sarah K.; Abate-Shen, Cory; Cardiff, Robert D.; Califano, Andrea; Shen, Michael M.			Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; MURINE; SUBTYPES; IDENTIFICATION; SUBPOPULATION; ARCHITECTURE; TRACKING; TARGETS; MARKER; DUCTS	A key issue in cancer biology is whether oncogenic transformation of different cell types of origin within an adult tissue gives rise to distinct tumour subtypes that differ in their prognosis and/or treatment response. We now show that initiation of prostate tumours in basal or luminal epithelial cells in mouse models results in tumours with distinct molecular signatures that are predictive of human patient outcomes. Furthermore, our analysis of untransformed basal cells reveals an unexpected assay dependence of their stem cell properties in sphere formation and transplantation assays versus genetic lineage tracing during prostate regeneration and adult tissue homeostasis. Although oncogenic transformation of basal cells gives rise to tumours with luminal phenotypes, cross-species bioinformatic analyses indicate that tumours of luminal origin are more aggressive than tumours of basal origin, and identify a molecular signature associated with patient outcome. Our results reveal the inherent plasticity of basal cells, and support a model in which different cells of origin generate distinct molecular subtypes of prostate cancer.	[Wang, Zhu A.; Bergren, Sarah K.; Shen, Michael M.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Wang, Zhu A.; Bergren, Sarah K.; Shen, Michael M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Wang, Zhu A.; Mitrofanova, Antonina; Bergren, Sarah K.; Abate-Shen, Cory; Califano, Andrea; Shen, Michael M.] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Mitrofanova, Antonina; Califano, Andrea] Columbia Univ Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; [Mitrofanova, Antonina; Califano, Andrea] Columbia Univ Coll Phys & Surg, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Cardiff, Robert D.] Univ Calif Davis, Sch Med, Ctr Comparat Med, Davis, CA 95616 USA; [Cardiff, Robert D.] Univ Calif Davis, Sch Med, Dept Pathol, Davis, CA 95616 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California Davis; University of California System; University of California Davis	Shen, MM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	mshen@columbia.edu	Abate-Shen, Cory/O-2520-2014; Shen, Michael M/C-7546-2009	Abate-Shen, Cory/0000-0002-5021-0570; Shen, Michael M/0000-0002-4042-1657; Wang, Zhu/0000-0002-8855-8951; Califano, Andrea/0000-0003-4742-3679	DOD Prostate Cancer Research Program; NSF; CRA; CCC; National Institutes of Health; NATIONAL CANCER INSTITUTE [U01CA168426, U01CA084294, P01CA154293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076602] Funding Source: NIH RePORTER	DOD Prostate Cancer Research Program; NSF(National Science Foundation (NSF)); CRA; CCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Rock and B. Hogan (Duke University Medical School, USA) for their generous gift of CK5-CreER<SUP>T2</SUP> transgenic mice, O. Couronne and the Columbia University Genome Sequencing Facility for RNA-seq analysis, and R. DePinho (MD Anderson Cancer Center) for assistance in obtaining the Glinsky data set. This work was supported by a postdoctoral fellowship from the DOD Prostate Cancer Research Program (Z.A.W.), a postdoctoral Computing Innovation Fellowship (CIFellow) from NSF, CRA and CCC (A.M.), and by grants from the National Institutes of Health (C.A-S., A.C. and M.M.S.).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; De Marzo AM, 2010, NAT REV UROL, V7, P650, DOI 10.1038/nrurol.2010.188; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Goldstein AS, 2010, MOL ONCOL, V4, P385, DOI 10.1016/j.molonc.2010.06.009; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Liu J, 2011, MOL ENDOCRINOL, V25, P1849, DOI 10.1210/me.2011-1081; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Martin NE, 2011, CANCER J, V17, P429, DOI 10.1097/PPO.0b013e31823b042c; Moscatelli D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001445; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shibata M., 2012, BIOESSAYS; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor RA, 2010, ENDOCR-RELAT CANCER, V17, pR273, DOI 10.1677/ERC-10-0145; Taylor RA, 2009, STEM CELLS, V27, P3032, DOI 10.1002/stem.244; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	48	214	216	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					274	283		10.1038/ncb2697	http://dx.doi.org/10.1038/ncb2697			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23434823	Green Accepted, Green Submitted			2022-12-25	WOS:000315844900008
J	Grallert, A; Patel, A; Tallada, VA; Chan, KY; Bagley, S; Krapp, A; Simanis, V; Hagan, IM				Grallert, Agnes; Patel, Avinash; Tallada, Victor A.; Chan, Kuan Yoow; Bagley, Steven; Krapp, Andrea; Simanis, Viesturs; Hagan, Iain M.			Centrosomal MPF triggers the mitotic and morphogenetic switches of fission yeast	NATURE CELL BIOLOGY			English	Article							SPINDLE POLE BODY; CHEMICAL GENETIC-ANALYSIS; CELL-CYCLE CONTROL; SCHIZOSACCHAROMYCES-POMBE; PROTEIN-KINASE; S-POMBE; MONOCLONAL-ANTIBODIES; BIPOLAR SPINDLE; NUTRIENT STRESS; PLO1 KINASE	Activation of mitosis-promoting factor (MPF) drives mitotic commitment(1). In human cells active MPF appears first on centrosomes(2). We show that local activation of MPF on the equivalent organelle of fission yeast, the spindle pole body (SPB), promotes Polo kinase activity at the SPBs long before global MPF activation drives mitotic commitment. Artificially promoting MPF or Polo activity at various locations revealed that this local control of Plo1 activity on G2 phase SPBs dictates the timing of mitotic commitment. Cytokinesis of the rod-shaped fission yeast cell generates a naive, new, cell end. Growth is restricted to the experienced old end until a point in G2 phase called new end take off (NETO) when bipolar growth is triggered(3). NETO coincided with MPF activation of Plo1 on G2 phase SPBs (ref. 4). Both MPF and Polo activities were required for NETO and both induced NETO when ectopically activated at interphase SPBs. NETO promotion by MPF required polo. Thus, local MPF activation on G2 SPBs directs polo kinase to control at least two distinct and temporally separated, cell-cycle transitions at remote locations.	[Grallert, Agnes; Patel, Avinash; Tallada, Victor A.; Chan, Kuan Yoow; Hagan, Iain M.] Paterson Inst Canc Res, CRUK Cell Div Grp, Manchester M20 4BX, Lancs, England; [Krapp, Andrea; Simanis, Viesturs] EPFL SV ISREC UPSIM, CH-1015 Lausanne, Switzerland	Paterson Institute for Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Hagan, IM (corresponding author), Paterson Inst Canc Res, CRUK Cell Div Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	ihagan@picr.man.ac.uk	Chan, Kuan Yoow/AAU-4603-2021; Tallada, Victor/F-5454-2016	Chan, Kuan Yoow/0000-0002-5974-1650; Tallada, Victor/0000-0001-9526-5957; Hagan, Iain/0000-0002-5858-9415; Grallert, Agnes/0000-0002-0127-3495; Bagley, Steve/0000-0002-9007-7292	Cancer Research UK (CRUK) [C147/A6058]; Swiss National Science Foundation; EPFL; Cancer Research UK [16406] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; Cancer Research UK(Cancer Research UK)	We thank B. Hodgson for technical assistance; V. Doye (Insitut Jacques Monod, Paris, France), D. Mulvihill (University of Kent, UK), U. Fleig (Dusseldorf, Germany) and D. Feret (Paterson Institute, UK) for strains; K. Gull (Oxford University, UK) and H. Ohkura (Edinburgh University, UK) for antibodies; D. Feret (Paterson Institute, UK), G. Pereira (DKFZ, Germany) and A. Carr (GDSC, Sussex, UK) for plasmids; and D. Bitton (Paterson Institute, UK) for discussions during the design of plo1.as8. This work was supported by Cancer Research UK (CRUK) grant number C147/A6058. V.S. and A.K. were supported by the Swiss National Science Foundation and EPFL.	ALFA CE, 1990, NATURE, V347, P680, DOI 10.1038/347680a0; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Bertazzi DT, 2011, J CELL BIOL, V193, P1033, DOI 10.1083/jcb.201101056; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Cipak L, 2011, CELL CYCLE, V10, P3527, DOI 10.4161/cc.10.20.17792; CREANOR J, 1979, J GEN MICROBIOL, V112, P385, DOI 10.1099/00221287-112-2-385; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Decottignies A, 2001, J CELL SCI, V114, P2627; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Halova L, 2011, J CELL SCI, V124, P3441, DOI 10.1242/jcs.083683; Hartmuth S, 2009, J CELL SCI, V122, P1737, DOI 10.1242/jcs.049387; HUDSON JD, 1990, GENETICS, V126, P309; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; MacIver FH, 2003, YEAST, V20, P587, DOI 10.1002/yea.983; MacIver FH, 2003, GENE DEV, V17, P1507, DOI 10.1101/gad.256003; MARKS J, 1985, EUR J CELL BIOL, V39, P27; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MAY JW, 1986, NATURE, V322, P752, DOI 10.1038/322752a0; May KM, 2002, J CELL BIOL, V156, P23, DOI 10.1083/jcb.200106150; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Mulvihill DP, 1999, MOL BIOL CELL, V10, P2771, DOI 10.1091/mbc.10.8.2771; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Petersen J, 2001, J CELL SCI, V114, P4371; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Petersen J, 2009, BIOCHEM SOC T, V37, P273, DOI 10.1042/BST0370273; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; Simanis V, 2003, J CELL SCI, V116, P4263, DOI 10.1242/jcs.00807; Tallada VA, 2007, GENETICS, V176, P73, DOI 10.1534/genetics.107.072090; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; WOODS A, 1989, J CELL SCI, V93, P491; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	44	54	54	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					88	U192		10.1038/ncb2633	http://dx.doi.org/10.1038/ncb2633			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23222840	Green Submitted, Green Accepted			2022-12-25	WOS:000312841300013
J	Becher, B; Pantelyushin, S				Becher, Burkhard; Pantelyushin, Stanislav			Hiding under the skin Interleukin-17-producing gamma delta T cells go under the skin?	NATURE MEDICINE			English	Editorial Material							MONOCLONAL-ANTIBODY; PSORIASIS; ETANERCEPT; IMIQUIMOD; MODERATE; PLACEBO	Despite the irrefutable role of inflammation in psoriasis, a complete knowledge of what immune cells and cytokines are involved during initiation and progression of this skin disease is lacking. Moreover, the complexities of the immune cell network and potential differences between mice and humans have led to translational failures. It is therefore important that we acquire indepth understanding of what inflammatory players, of the many involved, are crucial, if we wish to develop effective therapies. In 'Bedside to Bench', James Krueger discusses how a subset of T cells, T(H)17 cells, which release interleukin-17 in humans, seem to be essential for pathogenesis of psoriasis. The interplay between interleukin-17 and other cytokines that may potentially be involved in psoriasis also needs further investigation. Additionally, there are open questions as to what subset of T cells, other than T(H)17, also produce interleukin-17 and when. In 'Bench to Bedside', Burkhard Becher and Stanislav Pantelyushin examine this issue by looking at a mouse model of skin inflammation that resembles psoriasis in humans. A class of skin-invading innate immune cells called gamma delta T cells was shown to drive skin inflammation in this model, particularly during the early stages of the disease, suggesting that innate immunity plays an important part in the initiation of psoriasis.	[Becher, Burkhard; Pantelyushin, Stanislav] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	becher@immunology.uzh.ch	Pantelyushin, Stanislav/AAH-8637-2021; Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Pantelyushin, Stanislav/0000-0002-3490-3860				Antoniu SA, 2012, EXPERT OPIN INV DRUG, V21, P1607, DOI 10.1517/13543784.2012.712112; Bissonnette R, 2010, J AM ACAD DERMATOL, V62, P427, DOI 10.1016/j.jaad.2009.05.042; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Gottlieb AB, 2011, BRIT J DERMATOL, V165, P652, DOI 10.1111/j.1365-2133.2011.10418.x; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999	18	60	65	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1748	1750		10.1038/nm.3016	http://dx.doi.org/10.1038/nm.3016			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223063				2022-12-25	WOS:000311999800021
J	Fang, G; Munera, D; Friedman, DI; Mandlik, A; Chao, MC; Banerjee, O; Feng, ZX; Losic, B; Mahajan, MC; Jabado, OJ; Deikus, G; Clark, TA; Luong, K; Murray, IA; Davis, BM; Keren-Paz, A; Chess, A; Roberts, RJ; Korlach, J; Turner, SW; Kumar, V; Waldor, MK; Schadt, EE				Fang, Gang; Munera, Diana; Friedman, David I.; Mandlik, Anjali; Chao, Michael C.; Banerjee, Onureena; Feng, Zhixing; Losic, Bojan; Mahajan, Milind C.; Jabado, Omar J.; Deikus, Gintaras; Clark, Tyson A.; Luong, Khai; Murray, Iain A.; Davis, Brigid M.; Keren-Paz, Alona; Chess, Andrew; Roberts, Richard J.; Korlach, Jonas; Turner, Steve W.; Kumar, Vipin; Waldor, Matthew K.; Schadt, Eric E.			Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing	NATURE BIOTECHNOLOGY			English	Article							DNA METHYLTRANSFERASE; BASE-RESOLUTION; DAM METHYLATION; CELL-CYCLE; 5-HYDROXYMETHYLCYTOSINE; VIRULENCE; EXPRESSION; REVEALS; 5-METHYLCYTOSINE; TRANSCRIPTION	Single-molecule real-time (SMRT) DNA sequencing allows the systematic detection of chemical modifications such as methylation but has not previously been applied on a genome-wide scale. We used this approach to detect 49,311 putative 6-methyladenine (m6A) residues and 1,407 putative 5-methylcytosine (m5C) residues in the genome of a pathogenic Escherichia coli strain. We obtained strand-specific information for methylation sites and a quantitative assessment of the frequency of methylation at each modified position. We deduced the sequence motifs recognized by the methyltransferase enzymes present in this strain without prior knowledge of their specificity. Furthermore, we found that deletion of a phage-encoded methyltransferase-endonuclease (restriction-modification; RM) system induced global transcriptional changes and led to gene amplification, suggesting that the role of RM systems extends beyond protecting host genomes from foreign DNA.	[Fang, Gang; Kumar, Vipin] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Munera, Diana; Mandlik, Anjali; Chao, Michael C.; Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Div Infect Dis, Sch Med, Boston, MA 02115 USA; [Munera, Diana; Mandlik, Anjali; Chao, Michael C.; Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Friedman, David I.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Banerjee, Onureena; Clark, Tyson A.; Luong, Khai; Korlach, Jonas; Turner, Steve W.] Pacific Biosci, Menlo Pk, CA USA; [Feng, Zhixing] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Feng, Zhixing] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Beijing 100084, Peoples R China; [Feng, Zhixing] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Losic, Bojan; Mahajan, Milind C.; Jabado, Omar J.; Deikus, Gintaras; Keren-Paz, Alona; Chess, Andrew; Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Murray, Iain A.; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Stanford University; Tsinghua University; Tsinghua University; Icahn School of Medicine at Mount Sinai; New England Biolabs	Schadt, EE (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA.	mwaldor@rics.bwh.harvard.edu; eschadt@pacificbiosciences.com	Friedman, David/G-3198-2015	Friedman, David/0000-0002-2741-4671; Waldor, Matthew/0000-0003-1843-7000; Roberts, Richard/0000-0002-4348-0169; Chao, Michael/0000-0003-3158-7337; Clark, Tyson/0000-0002-7779-3227; Fang, Gang/0000-0002-2462-9124; Chao, Michael/0000-0002-6046-585X	US National Science Foundation [IIS0916439]; NIH [R37 AI-42347]; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM105125, R44GM100560] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [0916439] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was supported in part by a US National Science Foundation grant IIS0916439 (G. F. and V. K.) and NIH R37 AI-42347 and HHMI (M.K.W.).	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Broadbent SE, 2007, J BACTERIOL, V189, P4325, DOI 10.1128/JB.01854-06; Camacho EM, 2005, MOL MICROBIOL, V57, P1700, DOI 10.1111/j.1365-2958.2005.04788.x; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DHILLON TS, 1976, JPN J MICROBIOL, V20, P385, DOI 10.1111/j.1348-0421.1976.tb01004.x; Drozdz M, 2012, NUCLEIC ACIDS RES, V40, P2119, DOI 10.1093/nar/gkr1039; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kahramanoglou C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1878; KAISER AD, 1957, VIROLOGY, V4, P509, DOI 10.1016/0042-6822(57)90083-1; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karam J. D., 1994, MOL BIOL BACTERIOPHA; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; Roberts R.J., 1993, TYPE 2 RESTRICTION E; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schadt EE, 2013, GENOME RES, V23, P129, DOI 10.1101/gr.136739.111; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; SWINTON D, 1983, P NATL ACAD SCI-BIOL, V80, P7400, DOI 10.1073/pnas.80.24.7400; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; WYATT GR, 1952, NATURE, V170, P1072, DOI 10.1038/1701072a0; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	51	225	248	5	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1232	+		10.1038/nbt.2432	http://dx.doi.org/10.1038/nbt.2432			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23138224	Green Accepted, Bronze			2022-12-25	WOS:000312092400027
J	Getts, DR; Martin, AJ; McCarthy, DP; Terry, RL; Hunter, ZN; Yap, WT; Getts, MT; Pleiss, M; Luo, XR; King, NJC; Shea, LD; Miller, SD				Getts, Daniel R.; Martin, Aaron J.; McCarthy, Derrick P.; Terry, Rachael L.; Hunter, Zoe N.; Yap, Woon Teck; Getts, Meghann Teague; Pleiss, Michael; Luo, Xunrong; King, Nicholas J. C.; Shea, Lonnie D.; Miller, Stephen D.			Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis	NATURE BIOTECHNOLOGY			English	Article							MARGINAL ZONE MACROPHAGES; SCAVENGER RECEPTOR MARCO; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; GLATIRAMER ACETATE; REGULATORY-CELLS; CLONAL ANERGY; SINGLE COURSE; SR-AI/II; ANTIGEN	Aberrant T-cell activation underlies many autoimmune disorders, yet most attempts to induce T-cell tolerance have failed. Building on previous strategies for tolerance induction that exploited natural mechanisms for clearing apoptotic debris, we show that antigen-decorated microparticles (500-nm diameter) induce long-term T-cell tolerance in mice with relapsing experimental autoimmune encephalomyelitis. Specifically, intravenous infusion of either polystyrene or biodegradable poly(lactide-co-glycolide) microparticles bearing encephalitogenic peptides prevents the onset and modifies the course of the disease. These beneficial effects require microparticle uptake by marginal zone macrophages expressing the scavenger receptor MARCO and are mediated in part by the activity of regulatory T cells, abortive T-cell activation and T-cell anergy. Together these data highlight the potential for using microparticles to target natural apoptotic clearance pathways to inactivate pathogenic T cells and halt the disease process in autoimmunity.	[Getts, Daniel R.; Martin, Aaron J.; McCarthy, Derrick P.; Hunter, Zoe N.; Getts, Meghann Teague; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Getts, Daniel R.; Martin, Aaron J.; McCarthy, Derrick P.; Hunter, Zoe N.; Getts, Meghann Teague; Luo, Xunrong; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA; [Terry, Rachael L.; King, Nicholas J. C.] Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Pathol, Sydney, NSW 2006, Australia; [Yap, Woon Teck; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Pleiss, Michael] Myelin Repair Fdn, Saratoga, CA USA; [Luo, Xunrong] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Sydney; Northwestern University; Northwestern University; Feinberg School of Medicine	Miller, SD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	nickk@pathology.usyd.edu.au; l-shea@northwestern.edu; s-d-miller@northwestern.edu	Shea, Lonnie D/B-7615-2009; Yap, Woon Teck/G-6874-2013	King, Nicholas Jonathan Cole/0000-0002-3877-9772; Terry, Rachael/0000-0002-6260-7372	Myelin Repair Foundation; US National Institutes of Health [NS026543, EB013198]; Juvenile Diabetes Research Foundation [17-2011-343]; Australian National Health and Medical Research Council [512413, 1030897]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026543] Funding Source: NIH RePORTER	Myelin Repair Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the Myelin Repair Foundation, US National Institutes of Health grants NS026543 and EB013198, Juvenile Diabetes Research Foundation grant 17-2011-343 and the Australian National Health and Medical Research Council grants 512413 and 1030897. We also thank V. Kuchroo and L. Kobchik of Harvard University for providing transgenic mice.	Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Chen XW, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3230; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; DESILVA DR, 1991, J IMMUNOL, V147, P3261; Eagar TN, 2004, J IMMUNOL, V172, P7442, DOI 10.4049/jimmunol.172.12.7442; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fontoura P, 2010, RESULTS PROBL CELL D, V51, P259, DOI 10.1007/400_2010_36; Freedman MS, 2011, NEUROLOGY, V77, P1551, DOI 10.1212/WNL.0b013e318233b240; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2009, CLIN IMMUNOL, V132, P166, DOI 10.1016/j.clim.2009.04.007; Ilan Y, 2010, J CLIN IMMUNOL, V30, P167, DOI 10.1007/s10875-009-9323-7; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Kohm AP, 2005, INT REV IMMUNOL, V24, P361, DOI 10.1080/08830180500371207; KRAAL G, 1989, EUR J IMMUNOL, V19, P675, DOI 10.1002/eji.1830190416; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Lalive PH, 2011, CNS DRUGS, V25, P401, DOI 10.2165/11588120-000000000-00000; LIBLAU RS, 1994, IMMUNOL REV, V142, P193, DOI 10.1111/j.1600-065X.1994.tb00890.x; Ludvigsson J, 2012, NEW ENGL J MED, V366, P433, DOI 10.1056/NEJMoa1107096; Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Lyszkiewicz M, 2011, J LEUKOCYTE BIOL, V89, P607, DOI 10.1189/jlb.0610368; Martin AJ, 2010, J IMMUNOL, V185, P3326, DOI 10.4049/jimmunol.1000802; Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Papadopoulou A, 2012, J NEUROL, V259, P1375, DOI 10.1007/s00415-011-6361-x; Racke MK, 2011, J IMMUNOL, V186, P1887, DOI 10.4049/jimmunol.1090138; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; Sherr J, 2008, NAT CLIN PRACT ENDOC, V4, P334, DOI 10.1038/ncpendmet0832; Smarr CB, 2011, J IMMUNOL, V187, P5090, DOI 10.4049/jimmunol.1100608; Smith CE, 2005, P NATL ACAD SCI USA, V102, P9595, DOI 10.1073/pnas.0504131102; Thakur SA, 2009, TOXICOL SCI, V107, P238, DOI 10.1093/toxsci/kfn210; Thelen T, 2010, J IMMUNOL, V185, P4328, DOI 10.4049/jimmunol.1000989; Turley DM, 2007, J IMMUNOL, V178, P2212, DOI 10.4049/jimmunol.178.4.2212; Tyner K, 2011, METHODS MOL BIOL, V697, P17, DOI 10.1007/978-1-60327-198-1_3; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	49	280	296	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1217	+		10.1038/nbt.2434	http://dx.doi.org/10.1038/nbt.2434			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159881	Green Accepted			2022-12-25	WOS:000312092400025
J	Schattling, B; Steinbach, K; Thies, E; Kruse, M; Menigoz, A; Ufer, F; Flockerzi, V; Bruck, W; Pongs, O; Vennekens, R; Kneussel, M; Freichel, M; Merkler, D; Friese, MA				Schattling, Benjamin; Steinbach, Karin; Thies, Edda; Kruse, Martin; Menigoz, Aurelie; Ufer, Friederike; Flockerzi, Veit; Brueck, Wolfgang; Pongs, Olaf; Vennekens, Rudi; Kneussel, Matthias; Freichel, Marc; Merkler, Doron; Friese, Manuel A.			TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis	NATURE MEDICINE			English	Article							GRAY-MATTER ATROPHY; MITOCHONDRIAL DYSFUNCTION; CELL-ACTIVATION; GLUTAMATE; INJURY; DISABILITY; LESIONS; BRAINS; MODEL; MICE	In multiple sclerosis, an inflammatory disease of the central nervous system (CNS), axonal and neuronal loss are major causes for irreversible neurological disability. However, which molecules contribute to axonal and neuronal injury under inflammatory conditions remains largely unknown. Here we show that the transient receptor potential melastatin 4 (TRPM4) cation channel is crucial in this process. TRPM4 is expressed in mouse and human neuronal somata, but it is also expressed in axons in inflammatory CNS lesions in experimental autoimmune encephalomyelitis (EAE) in mice and in human multiple sclerosis tissue. Deficiency or pharmacological inhibition of TRPM4 using the antidiabetic drug glibenclamide resulted in reduced axonal and neuronal degeneration and attenuated clinical disease scores in EAE, but this occurred without altering EAE-relevant immune function. Furthermore, Trpm4(-/-) mouse neurons were protected against inflammatory effector mechanisms such as excitotoxic stress and energy deficiency in vitro. Electrophysiological recordings revealed TRPM4-dependent neuronal ion influx and oncotic cell swelling upon excitotoxic stimulation. Therefore, interference with TRPM4 could translate into a new neuroprotective treatment strategy.	[Schattling, Benjamin; Steinbach, Karin; Thies, Edda; Ufer, Friederike; Friese, Manuel A.] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Forschergrp Neuroimmunol, Hamburg, Germany; [Steinbach, Karin; Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Steinbach, Karin; Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Thies, Edda; Kneussel, Matthias] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Inst Mol Neurogenet, Hamburg, Germany; [Kruse, Martin; Pongs, Olaf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Inst Neurale Signalverarbeitung, Hamburg, Germany; [Menigoz, Aurelie; Vennekens, Rudi] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Mol & Cellular Biol, Louvain, Belgium; [Flockerzi, Veit] Univ Saarland, Homburg, Germany; [Brueck, Wolfgang; Merkler, Doron] Univ Gottingen, Univ Med Gottingen, Inst Neuropathol, Gottingen, Germany; [Freichel, Marc] Heidelberg Univ, Inst Pharmakol, D-6900 Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Geneva; University of Geneva; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; KU Leuven; Saarland University; University of Gottingen; Ruprecht Karls University Heidelberg	Friese, MA (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Forschergrp Neuroimmunol, Hamburg, Germany.	manuel.friese@zmnh.uni-hamburg.de	Vennekens, Rudi/AAQ-1664-2020; Merkler, Doron/N-9157-2016	Vennekens, Rudi/0000-0002-2564-5150; Merkler, Doron/0000-0002-0247-2007; Kneussel, Matthias/0000-0003-4900-366X; Friese, Manuel A./0000-0001-6380-2420	Deutsche Forschungsgemeinschaft Emmy Noether-Programme [FR1720/3-1]; Gemeinnutzige Hertie-Stiftung [1.01.1/11/003]; Swiss National Science Foundation [PP00P3_128372]	Deutsche Forschungsgemeinschaft Emmy Noether-Programme(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	M.A.F. is supported by the Deutsche Forschungsgemeinschaft Emmy Noether-Programme (FR1720/3-1) and the Gemeinnutzige Hertie-Stiftung (1.01.1/11/003). D.M. is supported by the Swiss National Science Foundation (PP00P3_128372). O.P. is supported by the Gemeinnutzige Hertie-Stiftung. We would like to thank N. Lin Marq and N. Kursawe for excellent technical assistance.	Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; Armstrong WE, 2010, J NEUROENDOCRINOL, V22, P330, DOI 10.1111/j.1365-2826.2010.01989.x; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Baranzini SE, 2010, BRAIN, V133, P2603, DOI 10.1093/brain/awq192; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Chen MK, 2003, J NEUROSCI, V23, P8568; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fisher E, 2007, ANN NEUROL, V62, P219, DOI 10.1002/ana.21113; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Groom AJ, 2003, ANN NY ACAD SCI, V993, P229, DOI 10.1111/j.1749-6632.2003.tb07533.x; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Mironov SL, 2008, J PHYSIOL-LONDON, V586, P2277, DOI 10.1113/jphysiol.2007.149021; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shpak G, 2012, J NEUROSCI, V32, P6251, DOI 10.1523/JNEUROSCI.4397-11.2012; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Sun L, 2007, J PHYSIOL-LONDON, V583, P537, DOI 10.1113/jphysiol.2007.136788; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Weber KS, 2010, J IMMUNOL, V185, P2836, DOI 10.4049/jimmunol.1000880; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Yoo JC, 2010, BIOCHEM BIOPH RES CO, V391, P806, DOI 10.1016/j.bbrc.2009.11.142; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	58	137	142	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2012	18	12					1805	+		10.1038/nm.3015	http://dx.doi.org/10.1038/nm.3015			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160238				2022-12-25	WOS:000311999800028
J	Landan, G; Cohen, NM; Mukamel, Z; Bar, A; Molchadsky, A; Brosh, R; Horn-Saban, S; Zalcenstein, DA; Goldfinger, N; Zundelevich, A; Gal-Yam, EN; Rotter, V; Tanay, A				Landan, Gilad; Cohen, Netta Mendelson; Mukamel, Zohar; Bar, Amir; Molchadsky, Alina; Brosh, Ran; Horn-Saban, Shirley; Zalcenstein, Daniela Amann; Goldfinger, Naomi; Zundelevich, Adi; Gal-Yam, Einav Nil; Rotter, Varda; Tanay, Amos			Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues	NATURE GENETICS			English	Article							WHOLE-GENOME DATA; DNA METHYLATION; HISTONE; IDENTIFICATION; CHROMATIN; PATTERNS; COMPLEX; HYPERMETHYLATION; PROMOTERS; PROTEINS	DNA methylation has been comprehensively profiled in normal and cancer cells, but the dynamics that form, maintain and reprogram differentially methylated regions remain enigmatic. Here, we show that methylation patterns within populations of cells from individual somatic tissues are heterogeneous and polymorphic. Using in vitro evolution of immortalized fibroblasts for over 300 generations, we track the dynamics of polymorphic methylation at regions developing significant differential methylation on average. The data indicate that changes in population-averaged methylation occur through a stochastic process that generates a stream of local and uncorrelated methylation aberrations. Despite the stochastic nature of the process, nearly deterministic epigenetic remodeling emerges on average at loci that lose or gain resistance to methylation accumulation. Changes in the susceptibility to methylation accumulation are correlated with changes in histone modification and CTCF occupancy. Characterizing epigenomic polymorphism within cell populations is therefore critical to understanding methylation dynamics in normal and cancer cells.	[Landan, Gilad; Cohen, Netta Mendelson; Mukamel, Zohar; Bar, Amir; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Landan, Gilad; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Landan, Gilad; Molchadsky, Alina; Brosh, Ran; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Horn-Saban, Shirley; Zalcenstein, Daniela Amann] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Zundelevich, Adi; Gal-Yam, Einav Nil] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il	Landan, Giddy/C-1086-2019; Brosh, Ran/H-7309-2019; Brosh, Ran/HDL-9562-2022	Landan, Giddy/0000-0002-2502-8750; Brosh, Ran/0000-0001-9714-8623; 	Israel Science Foundation [1372/08]; European Commission Framework Programme 7 Network of Excellence EPIGENESYS; BLUEPRINT European Union consortium; Center of Excellence grant from the Flight Attendant Medical Research Institute (FAMRI)	Israel Science Foundation(Israel Science Foundation); European Commission Framework Programme 7 Network of Excellence EPIGENESYS; BLUEPRINT European Union consortium; Center of Excellence grant from the Flight Attendant Medical Research Institute (FAMRI)	We thank the members of the Tanay group for discussions. Research in the Tanay laboratory was supported by grants from the Israel Science Foundation (grant 1372/08), the European Commission Framework Programme 7 Network of Excellence EPIGENESYS and the BLUEPRINT European Union consortium. Research in the Rotter laboratory was supported by a Center of Excellence grant from the Flight Attendant Medical Research Institute (FAMRI). E.N.G.-Y. is a fellow of the Talpiot Medical Leadership Program at the Sheba Medical Center.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Cohen NM, 2009, GENOME RES, V19, P2193, DOI 10.1101/gr.096685.109; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Milosavljevic A, 2011, TRENDS GENET, V27, P242, DOI 10.1016/j.tig.2011.03.001; Milyavsky M, 2003, CANCER RES, V63, P7147; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siegmund KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021657; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Sottoriva A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001132; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	51	186	192	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1207	1214		10.1038/ng.2442	http://dx.doi.org/10.1038/ng.2442			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23064413				2022-12-25	WOS:000310495800011
J	Meserve, JH; Duronio, RJ				Meserve, Joy H.; Duronio, Robert J.			Atypical E2Fs drive atypical cell cycles	NATURE CELL BIOLOGY			English	Editorial Material							LIVER PROLIFERATION; POLYPLOIDY; ENDOREPLICATION	It is well documented that polyploid cells exist in mammalian tissues such as the placenta and liver, but their function and the mechanisms for their formation have remained elusive. Two studies now identify a role for atypical E2F transcription factors in promoting polyploidy in mammals and challenge present theories about the function of polyploidy.	[Meserve, Joy H.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Duronio, Robert J.] Univ N Carolina, Dept Biol, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; [Duronio, Robert J.] Univ N Carolina, Dept Genet, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; [Duronio, Robert J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Meserve, JH (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	duronio@med.unc.edu		Duronio, Robert/0000-0001-6469-6965	NIGMS NIH HHS [T32 GM007092, R01 GM057859] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057859, T32GM007092] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bramsiepe J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000996; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2010, CELL CYCLE, V9, P460, DOI 10.4161/cc.9.3.10542; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; Gentric G, 2012, CLIN RES HEPATOL GAS, V36, P29, DOI 10.1016/j.clinre.2011.05.011; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585; Ullah Z, 2008, GENE DEV, V22, P3024, DOI 10.1101/gad.1718108; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	13	9	9	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1124	1125		10.1038/ncb2609	http://dx.doi.org/10.1038/ncb2609			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23064265				2022-12-25	WOS:000310778100004
J	Pandit, SK; Westendorp, B; Nantasanti, S; van Liere, E; Tooten, PCJ; Cornelissen, PWA; Toussaint, MJM; Lamers, WH; de Bruin, A				Pandit, Shusil K.; Westendorp, Bart; Nantasanti, Sathidpak; van Liere, Elsbeth; Tooten, Peter C. J.; Cornelissen, Peter W. A.; Toussaint, Mathilda J. M.; Lamers, Wouter H.; de Bruin, Alain			E2F8 is essential for polyploidization in mammalian cells	NATURE CELL BIOLOGY			English	Article							FAMILY-MEMBER; TRANSCRIPTION FACTORS; PARTIAL-HEPATECTOMY; REGENERATING MOUSE; LIVER; ENDOREPLICATION; REPLICATION; EXPRESSION; DIVISION; ORGANIZATION	Polyploidization is observed in all mammalian species and is a characteristic feature of hepatocytes, but its molecular mechanism and biological significance are unknown. Hepatocyte polyploidization in rodents occurs through incomplete cytokinesis, starts after weaning and increases with age. Here, we show in mice that atypical E2F8 is induced after weaning and required for hepatocyte binucleation and polyploidization. A deficiency in E2f8 led to an increase in the expression level of E2F target genes promoting cytokinesis and thereby preventing polyploidization. In contrast, loss of E2f1 enhanced polyploidization and suppressed the polyploidization defect of hepatocytes deficient for atypical E2Fs. In addition, E2F8 and E2F1 were found on the same subset of target promoters. Contrary to the long-standing hypothesis that polyploidization indicates terminal differentiation and senescence, we show that prevention of polyploidization through inactivation of atypical E2Fs has, surprisingly, no impact on liver differentiation, zonation, metabolism and regeneration. Together, these results identify E2F8 as a repressor and E2F1 as an activator of a transcriptional network controlling polyploidization in mammalian cells.	[Pandit, Shusil K.; Westendorp, Bart; Nantasanti, Sathidpak; van Liere, Elsbeth; Tooten, Peter C. J.; Cornelissen, Peter W. A.; Toussaint, Mathilda J. M.; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, NL-3584 CL Utrecht, Netherlands; [Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands	Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	de Bruin, A (corresponding author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, NL-3584 CL Utrecht, Netherlands.	a.debruin@uu.nl	de Bruin, Alain/AAL-9195-2020; Lamers, Wouter H./D-2965-2012	de Bruin, Alain/0000-0001-8579-2649; Pandit, Shusil/0000-0002-8375-6684; Westendorp, Bart/0000-0003-1043-3638				Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Christensen J., NUCL ACIDS RES, V33, P5458; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Gorla GR, 2001, J CELL SCI, V114, P2943; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JANZEN JWG, 1984, J HISTOCHEM CYTOCHEM, V32, P557, DOI 10.1177/32.6.6373912; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kester MHA, 2009, ENDOCRINOLOGY, V150, P540, DOI 10.1210/en.2008-0344; KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139; Lammens T, 2008, P NATL ACAD SCI USA, V105, P14721, DOI 10.1073/pnas.0806510105; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Maqbool SB, 2010, J CELL SCI, V123, P4095, DOI 10.1242/jcs.064519; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Sakata H, 2000, HEPATOLOGY, V32, P193, DOI 10.1053/jhep.2000.8271; SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205; Seguin L, 2009, MOL CELL BIOL, V29, P570, DOI 10.1128/MCB.01275-08; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torres S, 1999, AM J PHYSIOL-GASTR L, V276, pG155, DOI 10.1152/ajpgi.1999.276.1.G155; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Weng L, 2003, EMBO J, V22, P3865, DOI 10.1093/emboj/cdg373; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	52	104	110	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1181	+		10.1038/ncb2585	http://dx.doi.org/10.1038/ncb2585			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23064264				2022-12-25	WOS:000310778100011
J	Wang, XX; Lord, DM; Cheng, HY; Osbourne, DO; Hong, SH; Sanchez-Torres, V; Quiroga, C; Zheng, K; Herrmann, T; Peti, W; Benedik, MJ; Page, R; Wood, TK				Wang, Xiaoxue; Lord, Dana M.; Cheng, Hsin-Yao; Osbourne, Devon O.; Hong, Seok Hoon; Sanchez-Torres, Viviana; Quiroga, Cecilia; Zheng, Kevin; Herrmann, Torsten; Peti, Wolfgang; Benedik, Michael J.; Page, Rebecca; Wood, Thomas K.			A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS	NATURE CHEMICAL BIOLOGY			English	Article							GENERAL STRESS-RESPONSE; NMR STRUCTURE DETERMINATION; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; MULTIDRUG TOLERANCE; BIOFILM FORMATION; PROTEIN; EXPRESSION; CELLS; REGULATOR	Among bacterial toxin-antitoxin systems, to date no antitoxin has been identified that functions by cleaving toxin mRNA. Here we show that YjdO (renamed GhoT) is a membrane lytic peptide that causes ghost cell formation (lysed cells with damaged membranes) and increases persistence (persister cells are tolerant to antibiotics without undergoing genetic change). GhoT is part of a new toxin-antitoxin system with YjdK (renamed GhoS) because in vitro RNA degradation studies, quantitative real-time reverse-transcription PCR and whole-transcriptome studies revealed that GhoS masks GhoT toxicity by cleaving specifically yjdO (ghoT) mRNA. Alanine substitutions showed that Arg28 is important for GhoS activity, and RNA sequencing indicated that the GhoS cleavage site is rich in U and A. The NMR structure of GhoS indicates it is related to the CRISPR-associated-2 RNase, and GhoS is a monomer. Hence, GhoT-GhoS is to our knowledge the first type V toxin-antitoxin system where a protein antitoxin inhibits the toxin by cleaving specifically its mRNA.	[Zheng, Kevin; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Wang, Xiaoxue] Chinese Acad Sci, S China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaoxue; Hong, Seok Hoon; Sanchez-Torres, Viviana; Wood, Thomas K.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Lord, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Cheng, Hsin-Yao; Osbourne, Devon O.; Quiroga, Cecilia; Wood, Thomas K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Herrmann, Torsten] Univ Lyon, Ctr Europeen Resonance Magnet Nucl Tres Champ, CNRS, Ecole Normale Super Lyon, Lyon, France; [Benedik, Michael J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Wood, Thomas K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Brown University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Texas A&M University System; Texas A&M University College Station; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Rebecca_Page@brown.edu; TWood@engr.psu.edu	Peti, Wolfgang/L-3492-2014; Hong, Seok Hoon/AAF-7163-2021; Quiroga, Cecilia/AAK-2933-2020; Hong, Seok Hoon/E-1289-2014; Benedik, Michael J/H-2478-2011; Wood, Thomas/GWZ-2481-2022; Herrmann, Torsten/B-9978-2008	Hong, Seok Hoon/0000-0003-2401-6368; Hong, Seok Hoon/0000-0003-2401-6368; Benedik, Michael J/0000-0002-7435-0092; Wood, Thomas/0000-0001-8962-8571; Quiroga, Cecilia/0000-0002-5552-3349; Herrmann, Torsten/0000-0003-2115-4781; Wang, Xiaoxue/0000-0002-7257-1916; Zheng, Kevin/0000-0003-4654-1809; Wood, Thomas/0000-0002-6258-529X; Sanchez-Torres, Viviana/0000-0002-0047-9459	US National Institutes of Health [R01 GM089999]; US National Science Foundation (CAREER award) [MCB 0952550]; 1000-Youth Elite Program from China.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (CAREER award)(National Science Foundation (NSF)); 1000-Youth Elite Program from China.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (R01 GM089999 to T.K.W.) and the US National Science Foundation (CAREER award MCB 0952550 to R.P.). X.W. is partially supported by the 1000-Youth Elite Program from China. We are grateful for the Keio and ASKA strains provided by the Genome Analysis Project in Japan and for the initial growth studies conducted by X. Yan and T. Benefield. We also thank S. Vitha for assistance with microscope imaging and Y. Hu for assistance with western blotting. T.K.W. is the Biotechnology Endowed Professor at the Pennsylvania State University.	Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; DONEGAN K, 1991, APPL ENVIRON MICROB, V57, P51, DOI 10.1128/AEM.57.1.51-56.1991; Donegan NP, 2009, J BACTERIOL, V191, P2795, DOI 10.1128/JB.01713-08; Faridani OR, 2006, NUCLEIC ACIDS RES, V34, P5915, DOI 10.1093/nar/gkl750; FLETCHER M, 1977, CAN J MICROBIOL, V23, P1, DOI 10.1139/m77-001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 1988, NAT BIOTECHNOL, V6, P1402; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Jayaraman R, 2008, J BIOSCIENCES, V33, P795, DOI 10.1007/s12038-008-0099-3; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Pecota DC, 1996, J BACTERIOL, V178, P2044, DOI 10.1128/jb.178.7.2044-2050.1996; Pedersen K, 1999, MOL MICROBIOL, V32, P1090, DOI 10.1046/j.1365-2958.1999.01431.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904	48	204	223	4	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					855	861		10.1038/NCHEMBIO.1062	http://dx.doi.org/10.1038/NCHEMBIO.1062			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22941047	Green Accepted			2022-12-25	WOS:000309056200011
J	De Rybel, B; Audenaert, D; Xuan, W; Overvoorde, P; Strader, LC; Kepinski, S; Hoye, R; Brisbois, R; Parizot, B; Vanneste, S; Liu, X; Gilday, A; Graham, IA; Nguyen, L; Jansen, L; Njo, MF; Inze, D; Bartel, B; Beeckman, T				De Rybel, Bert; Audenaert, Dominique; Xuan, Wei; Overvoorde, Paul; Strader, Lucia C.; Kepinski, Stefan; Hoye, Rebecca; Brisbois, Ronald; Parizot, Boris; Vanneste, Steffen; Liu, Xing; Gilday, Alison; Graham, Ian A.; Nguyen, Long; Jansen, Leentje; Njo, Maria Fransiska; Inze, Dirk; Bartel, Bonnie; Beeckman, Tom			A role for the root cap in root branching revealed by the non-auxin probe naxillin	NATURE CHEMICAL BIOLOGY			English	Article							PEROXISOMAL BETA-OXIDATION; BOX PROTEIN TIR1; INDOLE-3-BUTYRIC ACID; ARABIDOPSIS-THALIANA; MULTIFUNCTIONAL PROTEIN; GENE; IDENTIFICATION; DEGRADATION; TRANSPORTER; ACTIVATION	The acquisition of water and nutrients by plant roots is a fundamental aspect of agriculture and strongly depends on root architecture. Root branching and expansion of the root system is achieved through the development of lateral roots and is to a large extent controlled by the plant hormone auxin. However, the pleiotropic effects of auxin or auxin-like molecules on root systems complicate the study of lateral root development. Here we describe a small-molecule screen in Arabidopsis thaliana that identified naxillin as what is to our knowledge the first non-auxin-like molecule that promotes root branching. By using naxillin as a chemical tool, we identified a new function for root cap-specific conversion of the auxin precursor indole-3-butyric acid into the active auxin indole-3-acetic acid and uncovered the involvement of the root cap in root branching. Delivery of an auxin precursor in peripheral tissues such as the root cap might represent an important mechanism shaping root architecture.	[De Rybel, Bert; Audenaert, Dominique; Xuan, Wei; Parizot, Boris; Vanneste, Steffen; Jansen, Leentje; Njo, Maria Fransiska; Inze, Dirk; Beeckman, Tom] VIB, Dept Plant Syst Biol, Ghent, Belgium; [De Rybel, Bert; Audenaert, Dominique; Xuan, Wei; Parizot, Boris; Vanneste, Steffen; Jansen, Leentje; Njo, Maria Fransiska; Inze, Dirk; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Overvoorde, Paul] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Strader, Lucia C.; Bartel, Bonnie] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Kepinski, Stefan] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Hoye, Rebecca; Brisbois, Ronald] Macalester Coll, Dept Chem, St Paul, MN 55105 USA; [Liu, Xing] Univ Minnesota, Dept Hort Sci, Plant Biol Sci Grad Program, St Paul, MN USA; [Liu, Xing] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Gilday, Alison; Graham, Ian A.] Univ York, Ctr Novel Agr Prod, Dept Biol, York YO10 5DD, N Yorkshire, England; [Nguyen, Long] VIB, Compound Screening Facil, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Macalester College; Rice University; University of Leeds; Macalester College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of York - UK; Flanders Institute for Biotechnology (VIB)	Beeckman, T (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	Tom.Beeckman@psb.vib-ugent.be	Beeckman, Tom/ABI-1703-2020; Bartel, Bonnie/D-3550-2011; Inzé, Dirk/AAW-6381-2021; Beeckman, Tom/ABA-1164-2020; Bartel, Bonnie/O-8119-2019; Vanneste, Steffen/K-8353-2013	Beeckman, Tom/0000-0001-8656-2060; Bartel, Bonnie/0000-0002-6367-346X; Inzé, Dirk/0000-0002-3217-8407; Bartel, Bonnie/0000-0002-6367-346X; Vanneste, Steffen/0000-0002-9948-9672; De Rybel, Bert/0000-0002-9551-042X; Strader, Lucia/0000-0002-7600-7204; Liu, Xing/0000-0001-9677-4470; PARIZOT, Boris/0000-0003-1445-6925	Interuniversity Attraction Poles Programme [IUAP VI/33]; Belgian State Science Policy Office; Special Research Fund of Ghent University; long-term Federation of European Biochemical Societies fellowship; Robert A. Welch Foundation [C-1309]; US National Institutes of Health [R00-GM089987-03]; US National Science Foundation [DBI-1039655, DBI-0923960]; Research Foundation Flanders (FWO) [3G002911]; BBSRC [BB/F013981/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013981/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM089987] Funding Source: NIH RePORTER	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State Science Policy Office(Belgian Federal Science Policy Office); Special Research Fund of Ghent University(Ghent University); long-term Federation of European Biochemical Societies fellowship; Robert A. Welch Foundation(The Welch Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Research Foundation Flanders (FWO)(FWO); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Cohen and J. Normanly for helpful discussions, and E. Feraru and M. Feraru for help with mapping the nar1 mutant. This work was supported by the Interuniversity Attraction Poles Programme (IUAP VI/33) initiated by the Belgian State Science Policy Office, the Special Research Fund of Ghent University, a long-term Federation of European Biochemical Societies fellowship (pre- and post-doctoral fellowships to B.D.R.), the Robert A. Welch Foundation (C-1309 to B.B.), the US National Institutes of Health (R00-GM089987-03 to L.C.S.), the US National Science Foundation (DBI-1039655 to P.J.O., R.H. and R.B.; DBI-0923960 to P.J.O. and R.H.) and the Research Foundation Flanders (FWO, research project 3G002911). S.V. is a postdoctoral fellow of the Research Foundation-Flanders. D.A. is a postdoctoral fellow of the FWO. D.A. and L.N. are part of the VIB Compound Screening Facility.	Arent S, 2010, J BIOL CHEM, V285, P24066, DOI 10.1074/jbc.M110.106005; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Choi YM, 2006, CHEM BIOL, V13, P241, DOI 10.1016/j.chembiol.2005.12.011; De Rybel B, 2011, PLANT PHYSIOL, V156, P1292, DOI 10.1104/pp.111.177337; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Du XH, 2002, J MED CHEM, V45, P2695, DOI 10.1021/jm010459j; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lingard MJ, 2009, P NATL ACAD SCI USA, V106, P4561, DOI 10.1073/pnas.0811329106; Liu X, 2011, PLANT PHYSIOL, V157, P891, DOI 10.1104/pp.111.181388; Malamy JE, 1997, DEVELOPMENT, V124, P33; Moreno-Risueno MA, 2010, SCIENCE, V329, P1306, DOI 10.1126/science.1191937; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Rylott EL, 2006, PLANT J, V45, P930, DOI 10.1111/j.1365-313X.2005.02650.x; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Strader LC, 2011, PLANT CELL, V23, P984, DOI 10.1105/tpc.111.083071; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550; Zolman BK, 2000, GENETICS, V156, P1323	49	88	90	3	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					798	805		10.1038/NCHEMBIO.1044	http://dx.doi.org/10.1038/NCHEMBIO.1044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22885787	Green Accepted, Green Published			2022-12-25	WOS:000308077600012
J	Lindsay, ME; Schepers, D; Bolar, NA; Doyle, JJ; Gallo, E; Fert-Bober, J; Kempers, MJE; Fishman, EK; Chen, YC; Myers, L; Bjeda, D; Oswald, G; Elias, AF; Levy, HP; Anderlid, BM; Yang, MH; Bongers, EMHF; Timmermans, J; Braverman, AC; Canham, N; Mortier, GR; Brunner, HG; Byers, PH; Van Eyk, J; Van Laer, L; Dietz, HC; Loeys, BL				Lindsay, Mark E.; Schepers, Dorien; Bolar, Nikhita Ajit; Doyle, Jefferson J.; Gallo, Elena; Fert-Bober, Justyna; Kempers, Marlies J. E.; Fishman, Elliot K.; Chen, Yichun; Myers, Loretha; Bjeda, Djahita; Oswald, Gretchen; Elias, Abdallah F.; Levy, Howard P.; Anderlid, Britt-Marie; Yang, Margaret H.; Bongers, Ernie M. H. F.; Timmermans, Janneke; Braverman, Alan C.; Canham, Natalie; Mortier, Geert R.; Brunner, Han G.; Byers, Peter H.; Van Eyk, Jennifer; Van Laer, Lut; Dietz, Harry C.; Loeys, Bart L.			Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; MARFAN-SYNDROME; MOUSE MODEL; PATHOGENESIS; RECEPTOR; MICE; CONTRIBUTES; ACTIVATION; FIBRILLIN	Loeys-Dietz syndrome (LDS) associates with a tissue signature for high transforming growth factor (TGF)-beta signaling but is often caused by heterozygous mutations in genes encoding positive effectors of TGF-beta signaling, including either subunit of the TGF-beta receptor or SMAD3, thereby engendering controversy regarding the mechanism of disease. Here, we report heterozygous mutations or deletions in the gene encoding the TGF-beta 2 ligand for a phenotype within the LDS spectrum and show upregulation of TGF-beta signaling in aortic tissue from affected individuals. Furthermore, haploinsufficient Tgfb2(+/-) mice have aortic root aneurysm and biochemical evidence of increased canonical and noncanonical TGF-beta signaling. Mice that harbor both a mutant Marfan syndrome (MFS) allele (Fbn1(C1039G/+)) and Tgfb2 haploinsufficiency show increased TGF-beta signaling and phenotypic worsening in association with normalization of TGF-beta 2 expression and high expression of TGF-beta 1. Taken together, these data support the hypothesis that compensatory autocrine and/or paracrine events contribute to the pathogenesis of TGF-beta-mediated vasculopathies.	[Schepers, Dorien; Bolar, Nikhita Ajit; Mortier, Geert R.; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2020 Antwerp, Belgium; [Lindsay, Mark E.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Helen B Taussig Childrens Heart Ctr, Baltimore, MD 21205 USA; [Lindsay, Mark E.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Lindsay, Mark E.; Doyle, Jefferson J.; Gallo, Elena; Chen, Yichun; Myers, Loretha; Bjeda, Djahita; Oswald, Gretchen; Elias, Abdallah F.; Levy, Howard P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Schepers, Dorien; Bolar, Nikhita Ajit; Mortier, Geert R.; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp Hosp, Antwerp, Belgium; [Fert-Bober, Justyna; Van Eyk, Jennifer] Johns Hopkins Univ, Dept Med, Div Cardiol, Bayview Prote Ctr, Baltimore, MD USA; [Kempers, Marlies J. E.; Bongers, Ernie M. H. F.; Brunner, Han G.; Loeys, Bart L.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kempers, Marlies J. E.; Bongers, Ernie M. H. F.; Brunner, Han G.; Loeys, Bart L.] Radboud Univ Nijmegen, Inst Genet & Metab Disorders, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Fishman, Elliot K.] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Anderlid, Britt-Marie] Karolinska Inst, Dept Clin Genet, Karolinska Univ Hosp, Stockholm, Sweden; [Yang, Margaret H.; Byers, Peter H.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Yang, Margaret H.; Byers, Peter H.] Univ Washington, Sch Med, Dept Genet, Seattle, WA USA; [Timmermans, Janneke] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Braverman, Alan C.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Canham, Natalie] Northwick Pk Hosp & Clin Res Ctr, Dept Clin Genet, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Loeys, Bart L.] Univ Ghent, Dept Pediat & Genet, B-9000 Ghent, Belgium	University of Antwerp; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of Antwerp; Johns Hopkins University; Radboud University Nijmegen; Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Medicine; Karolinska Institutet; Karolinska University Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Radboud University Nijmegen; Washington University (WUSTL); Imperial College London; Ghent University	Loeys, BL (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2020 Antwerp, Belgium.	Bart.Loeys@ua.ac.be	Elias, Abdallah Frederic/ABH-8521-2020; Loeys, Bart/B-3236-2017; Brunner, Han/C-9928-2013; Timmermans, J./L-4693-2015; Elias, Abdallah F./R-7187-2019; Bongers, M.H.F./L-4214-2015; Chen, Yi-Chun/H-4468-2013; Doyle, Jefferson/C-3156-2013; Mortier, Geert/D-2542-2012; Loeys, B.L./L-4493-2015	Loeys, Bart/0000-0003-3703-9518; Mortier, Geert/0000-0001-9871-4578; Byers, Peter H./0000-0001-7786-7030; Schepers, Dorien/0000-0003-4225-6621; fishman, elliot/0000-0002-2567-1658	Fund for Scientific Research, Flanders (FWO; Belgium) [G.0458.09, G.0221.12]; European Grant Fighting Aneurysmal Disease [EC-FP7]; Special Research Fund of Ghent University [BOF10/GOA/005]; US National Institutes of Health [RO1-AR41135, PO1-AR049698, 5RC1HL100021-02]; Institutional Clinical and Translational Science Award [1U54RR023561-01A1]; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute; Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; Baylor-Hopkins Center for Mendelian Genetics [1U54HG006542]; Scientific Research, Flanders (Belgium); Aneurysmal Pathology Foundation; Agency for Innovation by Science and Technology (IWT); Helen Hay Whitney Foundation; McKusick Fellowship of the National Marfan Foundation; NHLBI K08 Award [HL107738-01]; Fellow-to-Faculty Award from the National Marfan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100021, K08HL107738] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER	Fund for Scientific Research, Flanders (FWO; Belgium)(FWO); European Grant Fighting Aneurysmal Disease; Special Research Fund of Ghent University(Ghent University); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science Award; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; Baylor-Hopkins Center for Mendelian Genetics; Scientific Research, Flanders (Belgium)(FWO); Aneurysmal Pathology Foundation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Helen Hay Whitney Foundation; McKusick Fellowship of the National Marfan Foundation; NHLBI K08 Award; Fellow-to-Faculty Award from the National Marfan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported in part by funding from the Fund for Scientific Research, Flanders (FWO; Belgium) (G.0458.09 and G.0221.12); a European Grant Fighting Aneurysmal Disease (EC-FP7); the Special Research Fund of Ghent University (BOF10/GOA/005); the US National Institutes of Health (RO1-AR41135 and PO1-AR049698 to H.C.D., 5RC1HL100021-02 to J.V.E. and H.C.D. and an Institutional Clinical and Translational Science Award 1U54RR023561-01A1 to J.V.E.); the National Marfan Foundation; the Smilow Center for Marfan Syndrome Research; the Howard Hughes Medical Institute; the Freudmann Fund for Research in Ehlers Danlos Syndrome and Related Disorders; and the Baylor-Hopkins Center for Mendelian Genetics (1U54HG006542). B.L.L. is senior clinical investigator of the Fund for Scientific Research, Flanders (Belgium); N.A.B. is supported by the Aneurysmal Pathology Foundation; D.S. is supported by a PhD grant from the Agency for Innovation by Science and Technology (IWT); E.G. is supported by a fellowship from the Helen Hay Whitney Foundation; J.J.D. is supported by the McKusick Fellowship of the National Marfan Foundation; and M.E.L. is supported by an NHLBI K08 Award (HL107738-01) and by a Fellow-to-Faculty Award from the National Marfan Foundation.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Bartram U, 2001, CIRCULATION, V103, P2745; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Choudhary B, 2009, GENESIS, V47, P115, DOI 10.1002/dvg.20466; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Langlois D, 2010, TRANSGENIC RES, V19, P1069, DOI 10.1007/s11248-010-9379-4; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Maleszewski JJ, 2009, AM J SURG PATHOL, V33, P194, DOI 10.1097/PAS.0b013e31817f3661; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744	31	291	307	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					922	+		10.1038/ng.2349	http://dx.doi.org/10.1038/ng.2349			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22772368	Green Accepted			2022-12-25	WOS:000306854700019
J	Bhatia, S; Frangioni, JV; Hoffman, RM; Iafrate, AJ; Polyak, K				Bhatia, Sangeeta; Frangioni, John V.; Hoffman, Robert M.; Iafrate, A. John; Polyak, Kornelia			The challenges posed by cancer heterogeneity	NATURE BIOTECHNOLOGY			English	Article								A panel of five experts discuss the implications of cancer heterogeneity for diagnostics and therapy.	[Bhatia, Sangeeta] MIT, Cambridge, MA 02139 USA; [Bhatia, Sangeeta] Brigham & Womens Hosp, Boston, MA 02115 USA; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Boston, MA USA; [Iafrate, A. John] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Diego; Anti Cancer Inc	Bhatia, S (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		li, jie/A-3133-2011; damiani, chiara/R-4256-2016		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		2011, CANC CELL, V20, P810	1	76	82	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					604	610		10.1038/nbt.2294	http://dx.doi.org/10.1038/nbt.2294			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781679				2022-12-25	WOS:000306293400015
J	Chou, J; Lin, JH; Brenot, A; Kim, JW; Provot, S; Werb, Z				Chou, Jonathan; Lin, Jeffrey H.; Brenot, Audrey; Kim, Jung-whan; Provot, Sylvain; Werb, Zena			GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER METASTASIS; EXTRACELLULAR-MATRIX; MESSENGER-RNA; CELLS; TARGETS; DIFFERENTIATION; PROGRESSION; MAINTAINS	Despite advances in our understanding of breast cancer, patients with metastatic disease have poor prognoses. GATA3 is a transcription factor that specifies and maintains mammary luminal epithelial cell fate, and its expression is lost in breast cancer, correlating with a worse prognosis in human patients. Here, we show that GATA3 promotes differentiation, suppresses metastasis and alters the tumour microenvironment in breast cancer by inducing microRNA-29b (miR-29b) expression. Accordingly, miR-29b is enriched in luminal breast cancers and loss of miR-29b, even in GATA3-expressing cells, increases metastasis and promotes a mesenchymal phenotype. Mechanistically, miR-29b inhibits metastasis by targeting a network of pro-metastatic regulators involved in angiogenesis, collagen remodelling and proteolysis, including VEGFA, ANGPTL4, PDGF, LOX and MMP9, and targeting ITGA6, ITGB1 and TGFB, thereby indirectly affecting differentiation and epithelial plasticity. The discovery that a GATA3-miR-29b axis regulates the tumour microenvironment and inhibits metastasis opens up possibilities for therapeutic intervention in breast cancer.	[Chou, Jonathan; Lin, Jeffrey H.; Brenot, Audrey; Kim, Jung-whan; Provot, Sylvain; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Chou, Jonathan; Werb, Zena] Univ Calif San Francisco, Biomed Sci Program, San Francisco, CA 94143 USA; [Provot, Sylvain] Univ Paris 07, U606, INSERM, F-75010 Paris, France	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu		PROVOT, SYLVAIN/0000-0003-4087-4450; Kim, Jung-whan/0000-0002-7829-1480	National Cancer Institute [R01 CA129523]; Developmental Research grant from the Bay Area Breast Cancer SPORE [P50 CA058207]; Department of Defense [W81XWH-10-1-0168]; UCSF; NATIONAL CANCER INSTITUTE [R01CA129523, P50CA058207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Developmental Research grant from the Bay Area Breast Cancer SPORE; Department of Defense(United States Department of Defense); UCSF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Werb laboratory for discussions, P. Shahi, I. Dai and J. Tai for experimental assistance and E. Atamaniuc, Y. Yu, and H, Capili for technical assistance. We thank T. Rambaldo and M. Kissner for flow cytometer assistance, the UCSF Biological Imaging Development Center for microscopy assistance, J. Debnath, G. Bergers, and D. Sheppard for discussions, and A. Goga, V. Weaver, J. Mott, P. Gonzalez, K. Xie and E. Raines for reagents. We also thank C. Choi for discussion and support. This research was supported by funds from the National Cancer Institute (R01 CA129523 to Z.W.), a Developmental Research grant from the Bay Area Breast Cancer SPORE (P50 CA058207 to Z.W.), a Department of Defense Predoctoral Fellowship (W81XWH-10-1-0168 to J.C.) and the UCSF Medical Scientist Training Program (J.C.). We dedicate this work to the memory of L. Verber.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Chu IM, 2012, ONCOGENE, V31, P2017, DOI 10.1038/onc.2011.382; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dumont N, 2000, BREAST CANCER RES, V2, P125, DOI 10.1186/bcr44; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Jacquemier J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2249; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen T, 2011, EPIGENETICS-US, V6, P388, DOI 10.4161/epi.6.3.14056; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	62	276	286	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2013	15	2					201	213		10.1038/ncb2672	http://dx.doi.org/10.1038/ncb2672			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	088SF	23354167	Green Accepted			2022-12-25	WOS:000314856700011
J	Scott, C				Scott, Christopher			CASE STUDY Liquid refreshment	NATURE BIOTECHNOLOGY			English	Editorial Material																		[Anonymous], 2010, MONOCLONAL ANTIBODIE; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295	2	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					115	115		10.1038/nbt.2481	http://dx.doi.org/10.1038/nbt.2481			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23392506	Bronze			2022-12-25	WOS:000315322100016
J	Kalinina, I; Nandi, A; Delivani, P; Chacon, MR; Klemm, AH; Ramunno-Johnson, D; Krull, A; Lindner, B; Pavin, N; Tolic-Norrelykke, IM				Kalinina, Iana; Nandi, Amitabha; Delivani, Petrina; Chacon, Mariola R.; Klemm, Anna H.; Ramunno-Johnson, Damien; Krull, Alexander; Lindner, Benjamin; Pavin, Nenad; Tolic-Norrelykke, Iva M.			Pivoting of microtubules around the spindle pole accelerates kinetochore capture	NATURE CELL BIOLOGY			English	Article							FISSION YEAST; MITOTIC-SPINDLE; SCHIZOSACCHAROMYCES-POMBE; INTERPHASE MICROTUBULES; CELLS; MECHANISMS; EFFICIENT; DYNAMICS; SEARCH; INVITRO	During cell division, spindle microtubules attach to chromosomes through kinetochores, protein complexes on the chromosome(1). The central question is how microtubules find kinetochores. According to the pioneering idea termed search-and-capture, numerous microtubules grow from a centrosome in all directions and by chance capture kinetochores(2-4). The efficiency of search-and-capture can be improved by a bias in microtubule growth towards the kinetochores(5,6), by nucleation of microtubules at the kinetochores(7-9) and at spindle microtubules(10,11), by kinetochore movement(9), or by a combination of these processes(12-14). Here we show in fission yeast that kinetochores are captured by microtubules pivoting around the spindle pole, instead of growing towards the kinetochores. This pivoting motion of microtubules is random and independent of ATP-driven motor activity. By introducing a theoretical model, we show that the measured random movement of microtubules and kinetochores is sufficient to explain the process of kinetochore capture. Our theory predicts that the speed of capture depends mainly on how fast microtubules pivot, which was confirmed experimentally by speeding up and slowing down microtubule pivoting. Thus, pivoting motion allows microtubules to explore space laterally, as they search for targets such as kinetochores.	[Kalinina, Iana; Delivani, Petrina; Chacon, Mariola R.; Klemm, Anna H.; Ramunno-Johnson, Damien; Krull, Alexander; Pavin, Nenad; Tolic-Norrelykke, Iva M.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Nandi, Amitabha; Lindner, Benjamin; Pavin, Nenad] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Pavin, Nenad] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 10002, Croatia	Max Planck Society; Max Planck Society; University of Zagreb	Pavin, N (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	npavin@phy.hr; tolic@mpi-cbg.de	Tolić, Iva/F-1704-2014; Lindner, Benjamin/D-5438-2009; Pavin, Nenad/N-6376-2013	Tolić, Iva/0000-0003-1305-7922; Lindner, Benjamin/0000-0001-5617-127X; Pavin, Nenad/0000-0002-4313-1081; Chacon Rodriguez, Mariola/0000-0003-2866-870X; Kalinina, Iana/0000-0002-4701-6355; Krull, Alexander/0000-0002-7778-7169	German Research Foundation (DFG); Human Frontier Science Program (HFSP); Marie Curie Intra-European Fellowship; Humboldt Research Fellowship for Postdoctoral Researchers	German Research Foundation (DFG)(German Research Foundation (DFG)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Marie Curie Intra-European Fellowship(European Commission); Humboldt Research Fellowship for Postdoctoral Researchers	We thank K. Sawin, A. Haese, Y. Caldarelli, E. Guarino, S. Kearsey and the Yeast Genetic Resource Center for strains and plasmids; B. Schroth-Diez from the Light Microscopy Facility of MPI-CBG for help with microscopy; I. Saric for the drawings; W. Zachariae, S. Grill, J. Howard, D. Cimini, J. Gregan, M. Zanic, E. Paluch, N. Maghelli, M. Coelho and V. Ananthanarayanan for discussions and advice; the German Research Foundation (DFG) and the Human Frontier Science Program (HFSP) for financial support. M.R.C. was supported by a Marie Curie Intra-European Fellowship and D.R-J. by a Humboldt Research Fellowship for Postdoctoral Researchers.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Berg, 2018, RANDOM WALKS BIOL; BROERSMA S, 1960, J CHEM PHYS, V32, P1626, DOI 10.1063/1.1730994; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Duncan T, 2011, CHROMOSOME RES, V19, P321, DOI 10.1007/s10577-011-9205-8; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Gachet Y, 2008, MOL BIOL CELL, V19, P1646, DOI 10.1091/mbc.E07-09-0910; Gehlen LR, 2011, CURR BIOL, V21, P25, DOI 10.1016/j.cub.2010.12.016; Gopalakrishnan M, 2011, B MATH BIOL, V73, P2483, DOI 10.1007/s11538-011-9633-9; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Kitamura E, 2010, DEV CELL, V18, P248, DOI 10.1016/j.devcel.2009.12.018; LEE GM, 1989, J CELL SCI, V94, P425; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; MASUDA H, 1990, J CELL BIOL, V110, P417, DOI 10.1083/jcb.110.2.417; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; Mogilner A, 2010, J CELL SCI, V123, P3435, DOI 10.1242/jcs.062208; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Paul R, 2009, P NATL ACAD SCI USA, V106, P15708, DOI 10.1073/pnas.0908261106; Penkett CJ, 2006, YEAST, V23, P921, DOI 10.1002/yea.1422; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613; Vogel SK, 2007, CURR BIOL, V17, P438, DOI 10.1016/j.cub.2007.01.047; WITT PL, 1980, CHROMOSOMA, V81, P483, DOI 10.1007/BF00368158; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Zimmerman S, 2004, NAT CELL BIOL, V6, P1245, DOI 10.1038/ncb1200	39	45	45	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					82	U178		10.1038/ncb2640	http://dx.doi.org/10.1038/ncb2640			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23222841				2022-12-25	WOS:000312841300012
J	Thathiah, A; Horre, K; Snellinx, A; Vandewyer, E; Huang, YH; Ciesielska, M; De Kloe, G; Munck, S; De Strooper, B				Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; De Kloe, Gerdien; Munck, Sebastian; De Strooper, Bart			beta-arrestin 2 regulates A beta generation and gamma-secretase activity in Alzheimer's disease	NATURE MEDICINE			English	Article							PROTEIN-COUPLED RECEPTORS; LIPID RAFTS; ACTIVATION; BETA-ARRESTIN-2; PRESENILIN-1; REVEALS; DESENSITIZATION; THERAPEUTICS; CONTRIBUTES; DEFICIENCY	beta-arrestins are associated with numerous aspects of G protein-coupled receptor (GPCR) signaling and regulation and accordingly influence diverse physiological and pathophysiological processes. Here we report that beta-arrestin 2 expression is elevated in two independent cohorts of individuals with Alzheimer's disease. Overexpression of beta-arrestin 2 leads to an increase in amyloid-beta (A beta) peptide generation, whereas genetic silencing of Arrb2 (encoding beta-arrestin 2) reduces generation of A beta in cell cultures and in Arrb2(-/-) mice. Moreover, in a transgenic mouse model of Alzheimer's disease, genetic deletion of Arrb2 leads to a reduction in the production of A beta(40) and A beta(42). Two GPCRs implicated previously in Alzheimer's disease (GPR3 and the beta(2)-adrenergic receptor) mediate their effects on A beta generation through interaction with beta-arrestin 2. beta-arrestin 2 physically associates with the Aph-1a subunit of the gamma-secretase complex and redistributes the complex toward detergent-resistant membranes, increasing the catalytic activity of the complex. Collectively, these studies identify beta-arrestin 2 as a new therapeutic target for reducing amyloid pathology and GPCR dysfunction in Alzheimer's disease.	[Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; De Kloe, Gerdien; Munck, Sebastian; De Strooper, Bart] VIB, Ctr Biol Dis, Louvain, Belgium; [Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; Munck, Sebastian; De Strooper, Bart] Univ Leuven KU Leuven, Ctr Human Genet, Louvain, Belgium; [Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; Munck, Sebastian; De Strooper, Bart] Univ Leuven KU Leuven, LIND, Louvain, Belgium; [De Kloe, Gerdien] Janssen Pharmaceut, Dept Neurosci, Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Johnson & Johnson; Janssen Pharmaceuticals	Thathiah, A (corresponding author), VIB, Ctr Biol Dis, Louvain, Belgium.	amantha.thathiah@cme.vib.kuleuven.be; bart.destrooper@cme.vib-kuleuven.be	Huang, Yunhong/V-9329-2018; de+Strooper, Bart/Z-1638-2019	Horre, Katrien/0000-0002-6801-3137; Vandewyer, Elke/0000-0003-1774-1764; Munck, Sebastian/0000-0002-5182-5358	Alzheimer's Association; Fund for Scientific Research Flanders, KU Leuven; Methusalem grant from the KU Leuven; Flemish government; Foundation for Alzheimer Research (SAO/FRMA)	Alzheimer's Association(Alzheimer's Association); Fund for Scientific Research Flanders, KU Leuven; Methusalem grant from the KU Leuven; Flemish government(European Commission); Foundation for Alzheimer Research (SAO/FRMA)	We are grateful to R.J. Lefkowitz and S. Ahn (Duke University Medical Center, Durham, North Carolina, USA) for the generous gift of the beta-arrestin 2 wild-type and knockout mouse embryonic fibroblasts, the Arrb1<SUP>-/-</SUP> and Arrb2<SUP>-/-</SUP> mice, the beta-arrestin 2-GFP-Flag cDNA and helpful discussion. We thank M. Jucker (University of Tubingen, Germany) for the gift of APP/PS1 transgenic mice. We greatly appreciate the kind gift of human control and Alzheimer's disease brain samples from K. Bossers and D.F. Swaab (Netherlands Institute for Neuroscience, Amsterdam, The Netherlands) and C. Troakes (the London Neurodegenerative Diseases Brain Bank, London, UK). We thank M. Mercken (Johnson & Johnson Pharmaceuticals Research and Development, Beerse, Belgium) for the antibodies to A beta. We are grateful to Y. Li (Memorial Sloan Kettering Cancer Center, New York, USA) for the kind initial gift of JC-8. This work was supported by a Mentored New Investigator Research grant from the Alzheimer's Association to A.T., the Fund for Scientific Research Flanders, KU Leuven, a Methusalem grant from the KU Leuven and the Flemish government, and the Foundation for Alzheimer Research (SAO/FRMA) to B.D.S. B.D.S. is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Chun J, 2004, J ORG CHEM, V69, P7344, DOI 10.1021/jo0486948; Conner DA, 1997, CIRC RES, V81, P1021; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gotz J, 2012, BRIT J PHARMACOL, V165, P1246, DOI 10.1111/j.1476-5381.2011.01713.x; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Olson KR, 2007, ASSAY DRUG DEV TECHN, V5, P137, DOI 10.1089/adt.2006.052; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Watson S.A.S., 1994, G PROTEIN COUPLED RE; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200	52	118	121	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					43	49		10.1038/nm.3023	http://dx.doi.org/10.1038/nm.3023			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202293				2022-12-25	WOS:000313230300024
J	Gibbings, D; Mostowy, S; Jay, F; Schwab, Y; Cossart, P; Voinnet, O				Gibbings, Derrick; Mostowy, Serge; Jay, Florence; Schwab, Yannick; Cossart, Pascale; Voinnet, Olivier			Selective autophagy degrades DICER and AGO2 and regulates miRNA activity	NATURE CELL BIOLOGY			English	Article							MICRORNA BIOGENESIS; MESSENGER-RNAS; ARGONAUTE; TRANSLATION; COMPLEXES; BODIES; CELLS; LOCALIZATION; DEGRADATION; EXPRESSION	MicroRNAs (miRNAs) form a class of short RNAs (similar to 21 nucleotides) that post-transcriptionally regulate partially complementary messenger RNAs. Each miRNA may target tens to hundreds of transcripts to control key biological processes. Although the biochemical reactions underpinning miRNA biogenesis and activity are relatively well defined(1,2) and the importance of their homeostasis is increasingly evident, the processes underlying regulation of the miRNA pathway in vivo are still largely elusive(3). Autophagy, a degradative process in which cytoplasmic material is targeted into double-membrane vacuoles, is recognized to critically contribute to cellular homeostasis. Here, we show that the miRNA-processing enzyme, DICER (also known as DICER 1), and the main miRNA effector, AGO2 (also known as eukaryotic translation initiation factor 2C, 2 (EIF2C2)), are targeted for degradation as miRNA-free entities by the selective autophagy receptor NDP52 (also known as calcium binding and coiled-coil domain 2 (CALCOCO2)). Autophagy establishes a checkpoint required for continued loading of miRNA into AGO2; accordingly, NDP52 and autophagy are required for homeostasis and activity of the tested miRNAs. Autophagy also engages post-transcriptional regulation of the DICER mRNA, underscoring the importance of fine-tuned regulation of the miRNA pathway. These findings have implications for human diseases linked to misregulated autophagy, DICER- and miRNA-levels, including cancer.	[Gibbings, Derrick; Jay, Florence; Voinnet, Olivier] Swiss Fed Inst Technol ETH Z, Dept Biol, CH-8092 Zurich, Switzerland; [Gibbings, Derrick] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Mostowy, Serge; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Dept Biol Cellulaire & Infect, F-75015 Paris, France; [Mostowy, Serge; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Mostowy, Serge; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Mostowy, Serge] Univ London Imperial Coll Sci Technol & Med, Sect Microbiol, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Schwab, Yannick] CNRS, Inst Genet & Biol Mol & Cellulaire, Unite Mixte Rech 7104, INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Voinnet, Olivier] IBMP, F-67084 Strasbourg, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Ottawa; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), Swiss Fed Inst Technol ETH Z, Dept Biol, CH-8092 Zurich, Switzerland.	voinneto@ethz.ch		Mostowy, Serge/0000-0002-7286-6503; JAY, Florence/0000-0001-7353-8299; Gibbings, Derrick/0000-0002-9305-8898; Schwab, Yannick/0000-0001-8027-1836; Voinnet, Olivier/0000-0001-6982-9544	ETH-Z; Pasteur Institute	ETH-Z(ETH Zurich); Pasteur Institute	The authors would like to thank M. Johnston (ETH-Zurich, Switzerland) for providing HEK293T cells stably transfected with Tet-inducible Flag-AGO2 as well as the protocol for detection of ubiquitylated Flag-AGO2. Financial support was provided by a core grant from ETH-Z to O.V., and the Pasteur Institute to P.C. S.M. is a Wellcome Trust Research Career Development Fellow. The authors thank K. McGourty and D. Li for helpful discussions.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Csorba T, 2010, PLANT J, V62, P463, DOI 10.1111/j.1365-313X.2010.04163.x; Derrien B, 2012, P NATL ACAD SCI USA, V109, P15942, DOI 10.1073/pnas.1209487109; Di YJ, 2003, J BIOCHEM, V133, P713, DOI 10.1093/jb/mvg091; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gibbings D, 2010, TRENDS CELL BIOL, V20, P491, DOI 10.1016/j.tcb.2010.06.001; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Noland CL, 2011, MOL CELL, V43, P110, DOI 10.1016/j.molcel.2011.05.028; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sakurai K, 2011, NUCLEIC ACIDS RES, V39, P1510, DOI 10.1093/nar/gkq846; Shaid S., 2012, CELL DEATH DIFF; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Slack F, 2009, CELL CYCLE, V8, P1823, DOI 10.4161/cc.8.12.8639; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232	50	187	191	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1314	+		10.1038/ncb2611	http://dx.doi.org/10.1038/ncb2611			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23143396	Green Accepted, Green Submitted			2022-12-25	WOS:000311890300013
J	Hsu, KL; Tsuboi, K; Adibekian, A; Pugh, H; Masuda, K; Cravatt, BF				Hsu, Ku-Lung; Tsuboi, Katsunori; Adibekian, Alexander; Pugh, Holly; Masuda, Kim; Cravatt, Benjamin F.			DAGL beta inhibition perturbs a lipid network involved in macrophage inflammatory responses	NATURE CHEMICAL BIOLOGY			English	Article							DIACYLGLYCEROL-LIPASE-ALPHA; CYTOSOLIC PHOSPHOLIPASE A(2); RECEPTOR KNOCKOUT MICE; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; CANNABINOID RECEPTORS; MOLECULAR CHARACTERIZATION; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; ARACHIDONIC-ACID; C-BETA	The endocannabinoid 2-arachidonoylglycerol (2-AG) is biosynthesized by diacylglycerol lipases DAGL alpha and DAGL beta. Chemical probes to perturb DAGLs are needed to characterize endocannabinoid function in biological processes. Here we report a series of 1,2,3-triazole urea inhibitors, along with paired negative-control and activity-based probes, for the functional analysis of DAGL beta in living systems. Optimized inhibitors showed high selectivity for DAGL beta over other serine hydrolases, including DAGL alpha (similar to 60-fold selectivity), and the limited off-targets, such as ABHD6, were also inhibited by the negative-control probe. Using these agents and Daglb(-/-) mice, we show that DAGL beta inactivation lowers 2-AG, as well as arachidonic acid and eicosanoids, in mouse peritoneal macrophages in a manner that is distinct and complementary to disruption of cytosolic phospholipase-A2. We observed a corresponding reduction in lipopolysaccharide-induced tumor necrosis factor-alpha release. These findings indicate that DAGL beta is a key metabolic hub within a lipid network that regulates proinflammatory responses in macrophages.	[Hsu, Ku-Lung; Tsuboi, Katsunori; Adibekian, Alexander; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hsu, Ku-Lung; Tsuboi, Katsunori; Adibekian, Alexander; Pugh, Holly; Masuda, Kim; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	Hsu, Ku-Lung/J-2885-2014; Hsu, Ku-Lung/L-6256-2019	Hsu, Ku-Lung/0000-0001-5620-3972; Hsu, Ku-Lung/0000-0001-5620-3972	US National Institutes of Health [DA009789, DA033760, MH084512]; Hewitt Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA033760] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hewitt Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Niphakis, H.-C. Lee and G. Simon for helpful discussions and C. Joslyn for technical assistance. We thank M. Watanabe (Hokkaido University School of Medicine) for providing the antibody to DAGL alpha. This work was supported by the US National Institutes of Health (DA009789, DA033760, MH084512) and a Hewitt Foundation Postdoctoral Fellowship (K.-L.H.).	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Bondeson J, 1997, GEN PHARMACOL-VASC S, V29, P127, DOI 10.1016/S0306-3623(96)00419-3; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Burstein SH, 2009, AAPS J, V11, P109, DOI 10.1208/s12248-009-9084-5; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gregg LC, 2012, J NEUROSCI, V32, P9457, DOI 10.1523/JNEUROSCI.0013-12.2012; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Hashimotodani Y, 2007, J PHYSIOL-LONDON, V584, P373, DOI 10.1113/jphysiol.2007.137497; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jung KM, 2007, MOL PHARMACOL, V72, P612, DOI 10.1124/mol.107.037796; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kunos G, 2001, NEUROCHEM RES, V26, P1015, DOI 10.1023/A:1012301021419; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lin Hen-I, 2004, Journal of Microbiology Immunology and Infection, V37, P8; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Oudin MJ, 2011, EUR J NEUROSCI, V34, P1634, DOI 10.1111/j.1460-9568.2011.07831.x; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pedicord DL, 2011, BIOCHEM BIOPH RES CO, V411, P809, DOI 10.1016/j.bbrc.2011.07.037; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Rouzer CA, 2005, J LIPID RES, V46, P1027, DOI 10.1194/jlr.M500006-JLR200; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Turunen PM, 2012, MOL PHARMACOL, V82, P156, DOI 10.1124/mol.112.078063; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WATANABE S, 1994, J LIPID MEDIAT CELL, V10, P283; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	50	157	158	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					999	1007		10.1038/NCHEMBIO.1105	http://dx.doi.org/10.1038/NCHEMBIO.1105			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103940	Green Accepted			2022-12-25	WOS:000311491200015
J	Petsch, B; Schnee, M; Vogel, AB; Lange, E; Hoffmann, B; Voss, D; Schlake, T; Thess, A; Kallen, KJ; Stitz, L; Kramps, T				Petsch, Benjamin; Schnee, Margit; Vogel, Annette B.; Lange, Elke; Hoffmann, Bernd; Voss, Daniel; Schlake, Thomas; Thess, Andreas; Kallen, Karl-Josef; Stitz, Lothar; Kramps, Thomas			Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection	NATURE BIOTECHNOLOGY			English	Article							CYTOTOXIC T-LYMPHOCYTES; LETHAL INFLUENZA; IMMUNITY; VACCINATION; CHALLENGE; IMMUNIZATION; ANTIBODIES; INDUCTION; CORRELATE; A/H1N1	Despite substantial improvements, influenza vaccine production-and availability-remain suboptimal. Influenza vaccines based on mRNA may offer a solution as sequence-matched, clinical-grade material could be produced reliably and rapidly in a scalable process, allowing quick response to the emergence of pandemic strains. Here we show that mRNA vaccines induce balanced, long-lived and protective immunity to influenza A virus infections in even very young and very old mice and that the vaccine remains protective upon thermal stress. This vaccine format elicits B and T cell-dependent protection and targets multiple antigens, including the highly conserved viral nucleoprotein, indicating its usefulness as a cross-protective vaccine. In ferrets and pigs, mRNA vaccines induce immunological correlates of protection and protective effects similar to those of a licensed influenza vaccine in pigs. Thus, mRNA vaccines could address substantial medical need in the area of influenza prophylaxis and the broader realm of anti-infective vaccinology.	[Petsch, Benjamin; Vogel, Annette B.; Stitz, Lothar] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Schnee, Margit; Voss, Daniel; Schlake, Thomas; Thess, Andreas; Kallen, Karl-Josef; Kramps, Thomas] CureVac GmbH, Tubingen, Germany; [Lange, Elke] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Hoffmann, Bernd] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute; CureVac N.V.; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Stitz, L (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany.	lothar.stitz@fli.bund.de; karl-josef.kallen@curevac.com	Petsch, Benni/AAL-7767-2020	Petsch, Benni/0000-0001-7431-0683; Vogel, Annette/0000-0002-9940-5379	Federal Ministry for Education and Research (BMBF), Germany (KMU-innovativ) [0315802]; Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI) [2-43]	Federal Ministry for Education and Research (BMBF), Germany (KMU-innovativ)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI)	We thank A. Carnitz, A. Mobes, K. Neumann, M. Queiser, N. Schneck, H. Schneider and E. Zirdum for excellent technical assistance and T. Ketterer, T. Mutzke, A. Schmid and their team for production of mRNA vaccines. We thank the following colleagues for graciously providing virus strains: M. Buttner (A/mallard/Bavaria/1/2006 (H5N1)), J. McCauley (A/Vietnam/1194/2004 (H5N1)), S. Becker (A/Regensburg/D6/2009 (H1N1v); received from M. Beer and T. Mettenleiter), O. Haller and G. Kochs (A/HongKong/1/1968 (H3N2)). We thank R. Zinkernagel and B. Schonfisch for critically reading the manuscript. This work was supported by grants from the Federal Ministry for Education and Research (BMBF), Germany (KMU-innovativ, grant no. 0315802 to T. K.) and by the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI, project no. 2-43 to L.S.).	Belshe RB, 2007, CLIN PHARMACOL THER, V82, P745, DOI 10.1038/sj.clpt.6100419; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Chaloupka I, 1996, EUR J CLIN MICROBIOL, V15, P121, DOI 10.1007/BF01591484; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Deng YP, 1997, J IMMUNOL, V158, P1507; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Forde GM, 2005, NAT BIOTECHNOL, V23, P1059, DOI 10.1038/nbt0905-1059; Fotin-Mleczek M, 2012, J GENE MED, V14, P428, DOI 10.1002/jgm.2605; Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hoerr I, 2000, EUR J IMMUNOL, V30, P1; Hoffmann B, 2010, BERL MUNCH TIERARZTL, V123, P286, DOI 10.2376/0005-9366-123-286; Johansson DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029732; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Knipe DM., 2006, FIELDS VIROLOGY, V5th ed; Kubler H, 2011, J CLIN ONCOL, V29; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Laurent PE, 2007, VACCINE, V25, P8833, DOI 10.1016/j.vaccine.2007.10.020; Lefevre EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032400; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Pascolo Steve, 2008, V183, P221; Pascolo Steve, 2006, V127, P23; Plotkin S.A, 2008, VACCINES EXPERT CONS; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Pyo HM, 2012, VACCINE, V30, P1297, DOI 10.1016/j.vaccine.2011.12.083; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Schlake T, 2012, RNA BIOL IN PRESS; Sebastian M, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.2584; Thalhamer J, 2012, GENE VACCINES, P1, DOI 10.1007/978-3-7091-0439-2; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Van Reeth K, 2001, VACCINE, V19, P4479, DOI 10.1016/S0264-410X(01)00206-7; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	47	271	336	4	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1210	+		10.1038/nbt.2436	http://dx.doi.org/10.1038/nbt.2436			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159882				2022-12-25	WOS:000312092400024
J	Sun, SY; Cleveland, DW				Sun, Shuying; Cleveland, Don W.			TDP-43 toxicity and the usefulness of junk	NATURE GENETICS			English	Editorial Material							FRONTOTEMPORAL LOBAR DEGENERATION; RNA TARGETS	A new study shows that loss of the lariat debranching enzyme Dbr1 suppresses TDP-43 toxicity. The accumulated intronic lariat RNAs, which are normally degraded after splicing, likely act as decoys to sequester TDP-43 away from binding to and disrupting functions of other RNAs.	[Sun, Shuying] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Sun, SY (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682; Sun, Shuying/0000-0002-8449-7370	NINDS NIH HHS [R37 NS027036, R01 NS027036] Funding Source: Medline; Wellcome Trust [089701] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; ARENAS J, 1987, J BIOL CHEM, V262, P4274; Armakola M, 2012, NAT GENET, V44, P1302, DOI 10.1038/ng.2434; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013	13	3	3	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1289	1291		10.1038/ng.2473	http://dx.doi.org/10.1038/ng.2473			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23192178	Green Accepted			2022-12-25	WOS:000311713200003
J	Baldauf, HM; Pan, XY; Erikson, E; Schmidt, S; Daddacha, W; Burggraf, M; Schenkova, K; Ambiel, I; Wabnitz, G; Gramberg, T; Panitz, S; Flory, E; Landau, NR; Sertel, S; Rutsch, F; Lasitschka, F; Kim, B; Konig, R; Fackler, OT; Keppler, OT				Baldauf, Hanna-Mari; Pan, Xiaoyu; Erikson, Elina; Schmidt, Sarah; Daddacha, Waaqo; Burggraf, Manja; Schenkova, Kristina; Ambiel, Ina; Wabnitz, Guido; Gramberg, Thomas; Panitz, Sylvia; Flory, Egbert; Landau, Nathaniel R.; Sertel, Serkan; Rutsch, Frank; Lasitschka, Felix; Kim, Baek; Koenig, Renate; Fackler, Oliver T.; Keppler, Oliver T.			SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; RODENT CELLS; TYPE-1; VPX; REPLICATION; ACTIVATION; PROTEIN; GENE; TRANSDUCTION	Unlike activated CD4(+) T cells, resting CD4(+) T cells are highly resistant to productive HIV-1 infection(1-8). Early after HIV-1 entry, a major block limits reverse transcription of incoming viral genomes. Here we show that the deoxynucleoside triphosphate triphosphohydrolase SAMHD1 prevents reverse transcription of HIV-1 RNA in resting CD4(+) T cells. SAMHD1 is abundantly expressed in resting CD4(+) T cells circulating in peripheral blood and residing in lymphoid organs. The early restriction to infection in unstimulated CD4(+) T cells is overcome by HIV-1 or HIV-2 virions into which viral Vpx is artificially or naturally packaged, respectively, or by addition of exogenous deoxynucleosides. Vpx-mediated proteasomal degradation of SAMHD1 and elevation of intracellular deoxynucleotide pools precede successful infection by Vpx-carrying HIV. Resting CD4(+) T cells from healthy donors following SAMHD1 silencing or from a patient with Aicardi-Goutieres syndrome homozygous for a nonsense mutation in SAMHD1 were permissive for HIV-1 infection. Thus, SAMHD1 imposes an effective restriction to HIV-1 infection in the large pool of noncycling CD4(+) T cells in vivo. Bypassing SAMHD1 was insufficient for the release of viral progeny, implicating other barriers at later stages of HIV replication. Together, these findings may unveil new ways to interfere with the immune evasion and T cell immunopathology of pandemic HIV-1.	[Baldauf, Hanna-Mari; Pan, Xiaoyu; Erikson, Elina; Schmidt, Sarah; Schenkova, Kristina; Ambiel, Ina; Fackler, Oliver T.; Keppler, Oliver T.] Heidelberg Univ, Dept Infect Dis Virol, Heidelberg, Germany; [Baldauf, Hanna-Mari; Erikson, Elina; Ambiel, Ina; Keppler, Oliver T.] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany; [Daddacha, Waaqo; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Burggraf, Manja; Koenig, Renate] Paul Ehrlich Inst, Res Grp Host Pathogen Interact, D-6070 Langen, Germany; [Wabnitz, Guido] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany; [Gramberg, Thomas] Univ Erlangen Nurnberg, Inst Virol, D-91054 Erlangen, Germany; [Panitz, Sylvia; Flory, Egbert] Paul Ehrlich Inst, Div Med Biotechnol, D-6070 Langen, Germany; [Landau, Nathaniel R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Sertel, Serkan] Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Rutsch, Frank] Univ Munster, Childrens Hosp, Dept Gen Pediat, Munster, Germany; [Lasitschka, Felix] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Kim, Baek] Kyung Hee Univ, Dept Pharm, Coll Pharm, Seoul, South Korea; [Koenig, Renate] Sanford Burnham Med Res Inst, Infectious & Inflammatory Dis Ctr, La Jolla, CA USA	Ruprecht Karls University Heidelberg; Goethe University Frankfurt; University of Rochester; Paul Ehrlich Institute; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Paul Ehrlich Institute; New York University; Ruprecht Karls University Heidelberg; University of Munster; Ruprecht Karls University Heidelberg; Kyung Hee University; Sanford Burnham Prebys Medical Discovery Institute	Fackler, OT (corresponding author), Heidelberg Univ, Dept Infect Dis Virol, Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de; oliver.keppler@kgu.de	König, Renate/AAB-8918-2019; Gramberg, Thomas/AAW-8706-2020	König, Renate/0000-0003-4882-9179; Wabnitz, Guido/0000-0001-5101-9885; Fackler, Oliver Till/0000-0003-2982-4209	Deutsche Forschungsgemeinschaft [KE742/4-1]; SFB [938/Z2]; US National Institutes of Health [GM1041981, AI049781, F31 GM095190]; Medical Faculty of the University of Heidelberg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190, R01GM104198] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Faculty of the University of Heidelberg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Emerman (Fred Hutchinson Cancer Research Center, Seattle, USA; for pROD9, pROD9-Delta Env-GFP, pROD9-Delta Env-delVpx-GFP), M. Fujita (Research Institute for Drug Discovery, Kumamoto University, Japan; for pEF-FVpxHIV-2<INF>GH1</INF>), H.-G. Krausslich (Department of Infectious Diseases, Virology, University of Heidelberg, Germany; for AMD3100), B. Muller (Department of Infectious Diseases, Virology, University of Heidelberg, Germany; for pDisplay GFP and sheep anti-HIV-1 p24 antibody) and J. Munch (Institute of Molecular Virology, University Hospital Ulm, Germany; for HIV-1 GFP) for reagents. We thank T. Adam, A. Imle, P. Klein, S. Kutscheidt, A. Ruggieri and the Nikon Imaging Center at University of Heidelberg for technical assistance, and G. Howard for editorial assistance. This work was in part funded by the Deutsche Forschungsgemeinschaft (O.T.K., grant KE742/4-1), SFB 938/Z2 (F. L.) and the US National Institutes of Health (GM1041981 and AI049781 to B. K.; and F31 GM095190 to W. D.). O.T.F. and O.T.K. are members of the CellNetworks Cluster of Excellence EXC81 and the German Centre for Infection Research, University of Heidelberg. H.-M. B. is recipient of a fellowship of the Medical Faculty of the University of Heidelberg.	Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2009, GENE THER, V16, P159, DOI 10.1038/gt.2008.128; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Geuenich S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-27; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; Goffinet C, 2010, J VIROL, V84, P11374, DOI 10.1128/JVI.01067-10; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Keppler OT, 2006, J LEUKOCYTE BIOL, V79, P616, DOI 10.1189/jlb.0805461; Keppler OT, 2005, J VIROL, V79, P1655, DOI 10.1128/JVI.79.3.1655-1665.2005; Keppler OT, 2001, J VIROL, V75, P8063, DOI 10.1128/JVI.75.17.8063-8073.2001; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Plesa G, 2007, J VIROL, V81, P13938, DOI 10.1128/JVI.01745-07; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ruggieri A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-17; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tervo HM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-58; Thiele H, 2010, HUM MUTAT, V31, pE1836, DOI 10.1002/humu.21357; Verhoeyen E, 2003, BLOOD, V101, P2167, DOI 10.1182/blood-2002-07-2224; Wabnitz GH, 2010, EUR J IMMUNOL, V40, P2437, DOI 10.1002/eji.201040345; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	47	432	446	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1682	+		10.1038/nm.2964	http://dx.doi.org/10.1038/nm.2964			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	22972397	Green Accepted			2022-12-25	WOS:000310837000029
J	van Es, JH; Sato, T; van de Wetering, M; Lyubimova, A; Nee, ANY; Gregorieff, A; Sasaki, N; Zeinstra, L; van den Born, M; Korving, J; Martens, ACM; Barker, N; van Oudenaarden, A; Clevers, H				van Es, Johan H.; Sato, Toshiro; van de Wetering, Marc; Lyubimova, Anna; Nee, Annie Ng Yee; Gregorieff, Alex; Sasaki, Nobuo; Zeinstra, Laura; van den Born, Maaike; Korving, Jeroen; Martens, Anton C. M.; Barker, Nick; van Oudenaarden, Alexander; Clevers, Hans			Dll1(+) secretory progenitor cells revert to stem cells upon crypt damage	NATURE CELL BIOLOGY			English	Article							MOUSE SMALL INTESTINE; ORIGIN; GENE; EXPRESSION; DIFFERENTIATION; POPULATION; COMMITMENT; RENEWAL; MARKER; MATH1	Lgr5(+) intestinal stem cells generate enterocytes and secretory cells. Secretory lineage commitment requires Notch silencing. The Notch ligand Dill is expressed by a subset of immediate stem cell daughters. Lineage tracing in Dll1(GFP-ires-CreERT2) mice reveals that single Dll1(high) cells generate small, short-lived clones containing all four secretory cell types. Lineage specification thus occurs in immediate stem cell daughters through Notch lateral inhibition. Cultured Dll(1)high cells form long-lived organoids (mini-guts) on brief Wnt3A exposure. When Dll1(high) cells are genetically marked before tissue damage, stem cell tracing events occur. Thus, secretory progenitors exhibit plasticity by regaining stemness on damage.	[van Es, Johan H.; Sato, Toshiro; van de Wetering, Marc; Sasaki, Nobuo; Zeinstra, Laura; van den Born, Maaike; Korving, Jeroen; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [van Es, Johan H.; Sato, Toshiro; van de Wetering, Marc; Sasaki, Nobuo; Zeinstra, Laura; van den Born, Maaike; Korving, Jeroen; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lyubimova, Anna; van Oudenaarden, Alexander] MIT, Dept Phys & Biol, Cambridge, MA 02139 USA; [Nee, Annie Ng Yee; Barker, Nick] Inst Med Biol, Singapore, Singapore; [Gregorieff, Alex] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Martens, Anton C. M.] UMC Utrecht, Dept Immunol, NL-3508 AB Utrecht, Netherlands; [Martens, Anton C. M.] UMC Utrecht, Dept Cell Biol, NL-3508 AB Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Massachusetts Institute of Technology (MIT); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/AAS-2774-2020; Sasaki, Nobuo/HDO-8251-2022; Barker, Nick/AAE-9833-2021; Sato, Toshiro/J-3522-2014; Barker, Nick/A-5535-2011; van+Es, Johan/ABD-5411-2021; van Oudenaarden, Alexander/AAA-1705-2019	Sasaki, Nobuo/0000-0002-8798-7244; Barker, Nick/0000-0003-3566-4475; Sato, Toshiro/0000-0001-8353-8137; 	NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; TI Pharma [T3-106]; NIRM;  [KWF/HUBR2005-3237];  [KWF/HUBR2005-3956];  [EU/Health-F4-2007-200720]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER	NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TI Pharma; NIRM; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by KWF/HUBR2005-3237 (T.S.), KWF/HUBR2005-3956 (L.Z.), EU/Health-F4-2007-200720 (M.v.d.W.), NIH/NCI Physical Sciences Oncology Center at MIT: U54CA143874 (AI. and A.v.O.), TI Pharma T3-106 (J.H.v.E. and M.v.d.B.) and NIRM (N.S.). We thank D. Stange for critically reading the manuscript.	Anderson Eric C, 2011, Cancers (Basel), V3, P319, DOI 10.3390/cancers3010319; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beckers J, 1999, MECH DEVELOP, V84, P165, DOI 10.1016/S0925-4773(99)00065-9; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Davies EJ, 2011, MOL CARCINOGEN, V50, P254, DOI 10.1002/mc.20631; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	41	512	519	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1099	+		10.1038/ncb2581	http://dx.doi.org/10.1038/ncb2581			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	23000963	Green Accepted			2022-12-25	WOS:000309543800018
J	Karsten, CM; Pandey, MK; Figge, J; Kilchenstein, R; Taylor, PR; Rosas, M; McDonald, JU; Orr, SJ; Berger, M; Petzold, D; Blanchard, V; Winkler, A; Hess, C; Reid, DM; Majoul, IV; Strait, RT; Harris, NL; Kohl, G; Wex, E; Ludwig, R; Zillikens, D; Nimmerjahn, F; Finkelman, FD; Brown, GD; Ehlers, M; Kohl, J				Karsten, Christian M.; Pandey, Manoj K.; Figge, Julia; Kilchenstein, Regina; Taylor, Philip R.; Rosas, Marcela; McDonald, Jacqueline U.; Orr, Selinda J.; Berger, Markus; Petzold, Dominique; Blanchard, Veronique; Winkler, Andre; Hess, Constanze; Reid, Delyth M.; Majoul, Irina V.; Strait, Richard T.; Harris, Nathaniel L.; Koehl, Gabriele; Wex, Eva; Ludwig, Ralf; Zillikens, Detlef; Nimmerjahn, Falk; Finkelman, Fred D.; Brown, Gordon D.; Ehlers, Marc; Koehl, Joerg			Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc gamma RIIB and dectin-1	NATURE MEDICINE			English	Article							IN-VIVO; AUTOIMMUNE ARTHRITIS; RECEPTOR DECTIN-1; C5A ANAPHYLATOXIN; IMMUNE-RESPONSES; COMPLEMENT; INDUCTION; MICE; NEUTROPHILS; DISEASE	Complement is an ancient danger-sensing system that contributes to host defense, immune surveillance and homeostasis(1). C5a and its G protein-coupled receptor mediate many of the proinflammatory properties of complement(2). Despite the key role of C5a in allergic asthma(3), autoimmune arthritis(4), sepsis(5) and cancer(6), knowledge about its regulation is limited. Here we demonstrate that IgG1 immune complexes (ICs), the inhibitory IgG receptor Fc gamma RIIB and the C-type lectin-like receptor dectin-1 suppress C5a receptor (C5aR) functions. IgG1 ICs promote the association of Fc gamma RIIB with dectin-1, resulting in phosphorylation of Src homology 2 domain-containing inositol phosphatase (SHIP) downstream of Fc gamma RIIB and spleen tyrosine kinase downstream of dectin-1. This pathway blocks C5aR-mediated ERK1/2 phosphorylation, C5a effector functions in vitro and C5a-dependent inflammatory responses in vivo, including peritonitis and skin blisters in experimental epidermolysis bullosa acquisita. Notably, high galactosylation of IgG N-glycans is crucial for this inhibitory property of IgG1 ICs, as it promotes the association between Fc gamma RIIB and dectin-1. Thus, galactosylated IgG1 and Fc gamma RIIB exert anti-inflammatory properties beyond their impact on activating Fc gamma Rs.	[Karsten, Christian M.; Figge, Julia; Kilchenstein, Regina; Koehl, Gabriele; Ehlers, Marc; Koehl, Joerg] Med Univ Lubeck, Inst System Inflammat Res, D-23538 Lubeck, Germany; [Pandey, Manoj K.; Harris, Nathaniel L.; Finkelman, Fred D.; Koehl, Joerg] Univ Cincinnati, Coll Med, Div Cellular & Mol Immunol, Cincinnati, OH USA; [Taylor, Philip R.; Rosas, Marcela; McDonald, Jacqueline U.; Orr, Selinda J.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales; [Berger, Markus; Petzold, Dominique; Blanchard, Veronique] Charite, Cent Inst Lab Med & Pathobiochem, D-13353 Berlin, Germany; [Winkler, Andre; Hess, Constanze; Ehlers, Marc] German Rheumatism Res Ctr, Lab Tolerance & Autoimmun, Berlin, Germany; [Reid, Delyth M.; Brown, Gordon D.] Univ Aberdeen, Sect Infect & Immun, Aberdeen, Scotland; [Majoul, Irina V.] Med Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biol, D-23538 Lubeck, Germany; [Strait, Richard T.] Univ Cincinnati, Coll Med, Div Emergency Med, Cincinnati, OH USA; [Wex, Eva] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Resp Dis Res, Biberach, Germany; [Ludwig, Ralf; Zillikens, Detlef] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Chair Genet, D-91054 Erlangen, Germany; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Div Immunol, Cincinnati, OH USA; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr Cincinnati, Dept Med, Cincinnati, OH USA	University of Lubeck; University System of Ohio; University of Cincinnati; Cardiff University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Aberdeen; University of Lubeck; University System of Ohio; University of Cincinnati; Boehringer Ingelheim; University of Lubeck; University of Erlangen Nuremberg; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Kohl, J (corresponding author), Med Univ Lubeck, Inst System Inflammat Res, D-23538 Lubeck, Germany.	joerg.koehl@uksh.de	Rosas Nexticapa, Marcela/HGU-1088-2022; Majoul, Irina V/K-5339-2013; Ludwig, Ralf/F-3996-2018; Nimmerjahn, Falk/J-4986-2013; Koehl, Joerg/C-8531-2011; Karsten, Christian/J-4372-2013; Zillikens, Detlef/C-8572-2011; Ludwig, Ralf J/A-2629-2008; Pandey, Manoj Kumar/V-4557-2019; Ehlers, Marc/C-9441-2011	Ludwig, Ralf/0000-0002-1394-1737; Koehl, Joerg/0000-0003-1121-3178; Ludwig, Ralf J/0000-0002-1394-1737; Pandey, Manoj Kumar/0000-0002-0495-830X; Ehlers, Marc/0000-0002-5383-8603; Taylor, Philip/0000-0003-0163-1421; Braumann, Dominique/0000-0001-9987-0257; Wex, Eva/0000-0002-4643-1899; Orr, Selinda/0000-0001-8539-7825; brown, gordon/0000-0002-0287-5383; Blanchard, Veronique/0000-0002-5980-6450; Nimmerjahn, Falk/0000-0002-5418-316X	German Research Foundation (Deutsche Forschungsgemeinschaft) [GRK1727, SFB/TR22, A21, EXC306/1, EH221-5]; Wellcome Trust; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, GRK1727; project 8 and SFB/TR22; project A21) to J.K., EXC306/1 to D.Z., R.L. and J.K., and by Deutsche Forschungsgemeinschaft EH221-5 to M.E. P.R.T. is a Medical Research Council (UK) Senior Fellow (G0601617). G.D.B. was supported by the Wellcome Trust. We thank T. Kohli for technical assistance with the surface plasmon resonance analysis, T. Gutsmann for help with the fluorescence spectroscopy measurements, T. Peters and L. Wollin for helpful discussions and B. Heyman (Uppsala University, Sweden) for providing the H5 and the 7B4 hybridoma clones.	Agarwal S, 2009, CURR ALLERGY ASTHM R, V9, P347, DOI 10.1007/s11882-009-0051-0; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Godau J, 2004, J IMMUNOL, V173, P3437, DOI 10.4049/jimmunol.173.5.3437; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; GRAHAM IL, 1994, J CELL BIOL, V127, P1139, DOI 10.1083/jcb.127.4.1139; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn Falk, 2008, V415, P151, DOI 10.1007/978-1-59745-570-1_9; Otto M, 2004, J BIOL CHEM, V279, P142, DOI 10.1074/jbc.M310078200; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wedepohl S, 2010, J PROTEOME RES, V9, P3403, DOI 10.1021/pr100170c; Wenderfer SE, 2005, J AM SOC NEPHROL, V16, P3572, DOI 10.1681/ASN.2005040373; Wernersson S, 1999, J IMMUNOL, V163, P618; Wex E, 2011, EUR J IMMUNOL, V41, P3208, DOI 10.1002/eji.201141502; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	39	304	309	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1401	+		10.1038/nm.2862	http://dx.doi.org/10.1038/nm.2862			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922409	Green Accepted			2022-12-25	WOS:000308472300036
J	Lee, VMY; Citron, M; Kosik, KS				Lee, Virginia M-Y; Citron, Martin; Kosik, Kenneth S.			Tracking the insidious course of Alzheimer's disease	NATURE MEDICINE			English	Editorial Material							THERAPEUTICS	Determining the sequence of events that occurs in Alzheimer's disease and the extent of the pathological changes involved will be essential for devising appropriate therapeutic strategies for this disease, but these parameters are not well defined. In a recent prospective, longitudinal study to compare individuals who were either carriers or noncarriers of dominantly inherited Alzheimer's disease, Bateman et al.(1) analyzed a number of clinical, cognitive and biological biomarkers allowing them to trace the series of pathological changes that occur over time in Alzheimer's disease. Notably, the authors found that some changes could be observed 25 years before the expected onset of symptoms. These findings may have important implications for the design of clinical trials to test Alzheimer's disease therapies. We asked three experts to comment on the results of this study.										Acosta-Baena N, 2011, LANCET NEUROL, V10, P213, DOI 10.1016/S1474-4422(10)70323-9; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; US Food and Drug Administration (FDA), 2007, GUID IND CLIN TRIAL	7	1	1	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1342	1343		10.1038/nm.2922	http://dx.doi.org/10.1038/nm.2922			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22961163				2022-12-25	WOS:000308472300026
J	Zhang, HJ; Peng, C; Hu, YG; Li, HW; Sheng, Z; Chen, YY; Sullivan, C; Cerny, J; Hutchinson, L; Higgins, A; Miron, P; Zhang, XQ; Brehm, MA; Li, DG; Green, MR; Li, SG				Zhang, Haojian; Peng, Cong; Hu, Yiguo; Li, Huawei; Sheng, Zhi; Chen, Yaoyu; Sullivan, Con; Cerny, Jan; Hutchinson, Lloyd; Higgins, Anne; Miron, Patricia; Zhang, Xueqing; Brehm, Michael A.; Li, Dongguang; Green, Michael R.; Li, Shaoguang			The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells	NATURE GENETICS			English	Article							BCR-ABL; TYROSINE KINASE; BETA-CATENIN; IMATINIB MESYLATE; CANCER; INHIBITION; MICE; DIFFERENTIATION; EXPRESSION; APOPTOSIS	A therapeutic strategy for treating cancer is to target and eradicate cancer stem cells (CSCs) without harming their normal stem cell counterparts. The success of this approach relies on the identification of molecular pathways that selectively regulate CSC function. Using BCR-ABL-induced chronic myeloid leukemia (CML) as a disease model for CSCs, we show that BCR-ABL downregulates the Blk gene (encoding B-lymphoid kinase) through c-Myc in leukemic stem cells (LSCs) in CML mice and that Blk functions as a tumor suppressor in LSCs but does not affect normal hematopoietic stem cells (HSCs) or hematopoiesis. Blk suppresses LSC function through a pathway involving an upstream regulator, Pax5, and a downstream effector, p27. Inhibition of this Blk pathway accelerates CML development, whereas increased activity of the Blk pathway delays CML development. Blk also suppresses the proliferation of human CML stem cells. Our results show the feasibility of selectively targeting LSCs, an approach that should be applicable to other cancers.	[Zhang, Haojian; Peng, Cong; Li, Huawei; Chen, Yaoyu; Cerny, Jan; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01605 USA; [Hu, Yiguo] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Sheng, Zhi; Green, Michael R.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA; [Sheng, Zhi; Brehm, Michael A.; Green, Michael R.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Sullivan, Con] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA; [Hutchinson, Lloyd; Higgins, Anne; Miron, Patricia] Univ Massachusetts, Dept Pathol, Div Anat Pathol, Mem Med Ctr, Worcester, MA 01605 USA; [Zhang, Xueqing] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Li, Dongguang] Edith Cowan Univ, Sch Comp & Informat Sci, Mt Lawley, WA, Australia; [Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Maine System; University of Maine Orono; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Edith Cowan University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Li, SG (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA 01605 USA.	shaoguang.li@umassmed.edu	Zhang, Haojian/H-7897-2013	Brehm, Michael/0000-0001-6813-3262; Hu, Yiguo/0000-0002-3973-2140	Leukemia & Lymphoma Society; US National Institutes of Health (NIH) [R01-CA122142, R01-CA114199]; NIH [AI46629]; NATIONAL CANCER INSTITUTE [R01CA114199, R01CA122142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Tarakhovsky (Rockefeller University) for providing Blk<SUP>-/-</SUP> mice and K. Calame (Columbia University) for pGL3-Pax5 plasmid. We thank S. Deibler for editorial assistance. This work was supported by grants from the Leukemia & Lymphoma Society and the US National Institutes of Health (NIH) (R01-CA122142 and R01-CA114199) to S.L. M.A.B. was supported by the NIH (AI46629). S.L. is a Scholar of the Leukemia & Lymphoma Society.	Affer M, 2011, J ONCOL, V2011, DOI 10.1155/2011/798592; Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Copland M, 2008, BLOOD, V111, P2843, DOI 10.1182/blood-2007-09-112573; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Heaney NB, 2010, BLOOD, V115, P2241, DOI 10.1182/blood-2008-06-164582; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nordon RE, 1997, BRIT J HAEMATOL, V98, P528, DOI 10.1046/j.1365-2141.1997.2823097.x; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ramaraj P, 2004, CANCER RES, V64, P5322, DOI 10.1158/0008-5472.CAN-03-3656; Rangatia J, 2006, LEUKEMIA, V20, P68, DOI 10.1038/sj.leu.2403999; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Xiao WB, 2008, J CLIN INVEST, V118, P924, DOI 10.1172/JCI34013; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; ZWOLLO P, 1994, J BIOL CHEM, V269, P15310	59	57	63	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					861	+		10.1038/ng.2350	http://dx.doi.org/10.1038/ng.2350			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22797726	Green Accepted, Green Submitted			2022-12-25	WOS:000306854700009
J	Choi, HS; Gibbs, SL; Lee, JH; Kim, SH; Ashitate, Y; Liu, FB; Hyun, H; Park, G; Xie, Y; Bae, S; Henary, M; Frangioni, JV				Choi, Hak Soo; Gibbs, Summer L.; Lee, Jeong Heon; Kim, Soon Hee; Ashitate, Yoshitomo; Liu, Fangbing; Hyun, Hoon; Park, GwangLi; Xie, Yang; Bae, Soochan; Henary, Maged; Frangioni, John V.			Targeted zwitterionic near-infrared fluorophores for improved optical imaging	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; CLINICAL TRANSLATION; RENAL CLEARANCE; DERIVATIVES; NANOPARTICLES; FUNDAMENTALS; ANTIBODIES; PROBES; LIGHT; BODY	The signal-to-background ratio (SBR) is the key determinant of sensitivity, detectability and linearity in optical imaging. As signal strength is often constrained by fundamental limits, background reduction becomes an important approach for improving the SBR. We recently reported that a zwitterionic near-infrared (NIR) fluorophore, ZW800-1, exhibits low background. Here we show that this fluorophore provides a much-improved SBR when targeted to cancer cells or proteins by conjugation with a cyclic RGD peptide, fibrinogen or antibodies. ZW800-1 outperforms the commercially available NIR fluorophores IRDye800-CW and Cy5.5 in vitro for immunocytometry, histopathology and immunoblotting and in vivo for image-guided surgery. In tumor model systems, a tumor-to-background ratio of 17.2 is achieved at 4 h after injection of ZW800-1 conjugated to cRGD compared to ratios of 5.1 with IRDye800-CW and 2.7 with Cy5.5. Our results suggest that introducing zwitterionic properties into targeted fluorophores may be a general strategy for improving the SBR in diagnostic and therapeutic applications.	[Choi, Hak Soo; Gibbs, Summer L.; Lee, Jeong Heon; Kim, Soon Hee; Ashitate, Yoshitomo; Liu, Fangbing; Hyun, Hoon; Park, GwangLi; Xie, Yang; Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Kim, Soon Hee] Chonbuk Natl Univ, Dept BIN Fus Technol, WCU Program, Jeonju, South Korea; [Bae, Soochan] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA; [Henary, Maged] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Jeonbuk National University; Harvard University; Beth Israel Deaconess Medical Center; University System of Georgia; Georgia State University; Harvard University; Beth Israel Deaconess Medical Center	Frangioni, JV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA.	jfrangio@bidmc.harvard.edu	Kim, Soon Hee/GXF-6736-2022; Choi, Hak Soo/C-9954-2011		US National Institutes of Health: National Cancer Institute Bioengineering Research Partnership [R01-CA-115296]; National Institute of Biomedical Imaging and Bioengineering grant [R01-EB-010022, R01-EB-011523]; Dana Foundation Program in Brain and Immuno-Imaging; WCU Program from the Korea Ministry of Education, Science and Technology (KMEST) [R31-20029]; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010022, R01EB011523] Funding Source: NIH RePORTER	US National Institutes of Health: National Cancer Institute Bioengineering Research Partnership; National Institute of Biomedical Imaging and Bioengineering grant; Dana Foundation Program in Brain and Immuno-Imaging; WCU Program from the Korea Ministry of Education, Science and Technology (KMEST); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank S. Gioux; R. Oketokoun and A. Stockdale for assistance with development of the FLARE (Fluorescence-Assisted Resection and Exploration) imaging system and software. We also thank D. Burrington Jr. for manuscript editing and E. Trabucchi for administrative assistance. This study was supported by the following grants from the US National Institutes of Health: National Cancer Institute Bioengineering Research Partnership grant #R01-CA-115296 (J.V.E) and National Institute of Biomedical Imaging and Bioengineering grants #R01-EB-010022 and #R01-EB-011523 (both to H.S.C. and J.V.F.); this study was also supported by the Dana Foundation Program in Brain and Immuno-Imaging (H.S.C.). S.H.K. was,supported by a WCU Program (R31-20029) from the Korea Ministry of Education, Science and Technology (KMEST).	Achilefu S, 2003, J MED CHEM, V46, P3403, DOI 10.1021/jm030081k; ADAMS JC, 1991, J CELL BIOL, V115, P829, DOI 10.1083/jcb.115.3.829; BALLOU B, 1995, CANCER IMMUNOL IMMUN, V41, P257, DOI 10.1007/s002620050226; Ballou B, 1998, CANCER DETECT PREV, V22, P251, DOI 10.1046/j.1525-1500.1998.0OA25.x; Bourre L, 2009, BRIT J CANCER, V100, P723, DOI 10.1038/sj.bjc.6604928; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Choi HS, 2011, ANGEW CHEM INT EDIT, V50, P6258, DOI 10.1002/anie.201102459; Choi HS, 2010, NAT BIOTECHNOL, V28, P1300, DOI 10.1038/nbt.1696; Choi HS, 2010, MOL IMAGING, V9, P291, DOI 10.2310/7290.2010.00031; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Colton IJ, 1998, ELECTROPHORESIS, V19, P367, DOI 10.1002/elps.1150190303; Frangioni JV, 2008, J CLIN ONCOL, V26, P4012, DOI 10.1200/JCO.2007.14.3065; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Gitlin I, 2006, CHEMBIOCHEM, V7, P1241, DOI 10.1002/cbic.200600191; Humblet V, 2006, CONTRAST MEDIA MOL I, V1, P196, DOI 10.1002/cmmi.106; Hyun H, 2012, CONTRAST MEDIA MOL I, V7, P516, DOI 10.1002/cmmi.1484; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Kobayashi T, 2007, J AM CHEM SOC, V129, P6696, DOI 10.1021/ja070376d; Lee S, 2008, CHEM COMMUN, P4250, DOI 10.1039/b806854m; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Ohnishi S, 2006, SURGERY, V140, P785, DOI 10.1016/j.surg.2006.03.027; RASMUSSEN F, 1983, VET RES COMMUN, V7, P301, DOI 10.1007/BF02228637; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Tanaka E, 2008, SURGERY, V144, P39, DOI 10.1016/j.surg.2008.03.017; te Velde EA, 2010, EJSO-EUR J SURG ONC, V36, P6, DOI 10.1016/j.ejso.2009.10.014; Tung CH, 1999, BIOCONJUGATE CHEM, V10, P892, DOI 10.1021/bc990052h; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; Ye YP, 2011, THERANOSTICS, V1, P102, DOI 10.7150/thno/v01p0102; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0	31	380	387	19	338	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					148	153		10.1038/nbt.2468	http://dx.doi.org/10.1038/nbt.2468			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23292608	Green Accepted			2022-12-25	WOS:000315322100026
J	Hope, BT; Skinner, MK; Kenny, PJ; Akbarian, S				Hope, Bruce T.; Skinner, Michael K.; Kenny, Paul J.; Akbarian, Schahram			Exploring the epigenetics of cocaine resistance	NATURE MEDICINE			English	Editorial Material							TRANSGENERATIONAL ACTIONS; BDNF; RELAPSE	Drug addiction is known to have a heritable component and to run in families. However, a recent study in rats by Vassoler et al.(1) shows an unexpected result-that the sons of males who had self-administered cocaine had a reduced propensity to take this drug and a delay in their acquisition of drug-seeking behavior. The authors linked these behavioral changes to epigenetic changes in the sperm from cocaine-exposed males and in the brains of their male offspring. We asked four experts to comment on the results of this study and their implications for understanding how addictive phenotypes are inherited.	[Hope, Bruce T.] NIDA, Intramural Res Program, NIH, Baltimore, MD USA; [Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Kenny, Paul J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Kenny, Paul J.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Akbarian, Schahram] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Washington State University; Scripps Research Institute; Scripps Research Institute; Icahn School of Medicine at Mount Sinai	Hope, BT (corresponding author), NIDA, Intramural Res Program, NIH, Baltimore, MD USA.		Hope, Bruce T/A-9223-2010	Hope, Bruce T/0000-0001-5804-7061	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000467] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Bonduriansky R, 2012, TRENDS ECOL EVOL, V27, P330, DOI 10.1016/j.tree.2012.02.003; D'Sa C, 2011, BIOL PSYCHIAT, V70, P706, DOI 10.1016/j.biopsych.2011.05.013; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Gogineni A, 2006, ALCOHOL CLIN EXP RES, V30, P377, DOI 10.1111/j.1530-0277.2006.00042.x; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Pawlow IP, 1923, SCIENCE, V58, P359, DOI 10.1126/science.58.1506.359; Shulha HP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001427; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280	14	3	3	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					136	137						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389607				2022-12-25	WOS:000314675900019
J	Baker, DJ; Dawlaty, MM; Wijshake, T; Jeganathan, KB; Malureanu, L; van Ree, JH; Crespo-Diaz, R; Reyes, S; Seaburg, L; Shapiro, V; Behfar, A; Terzic, A; van de Sluis, B; van Deursen, JM				Baker, Darren J.; Dawlaty, Meelad M.; Wijshake, Tobias; Jeganathan, Karthik B.; Malureanu, Liviu; van Ree, Janine H.; Crespo-Diaz, Ruben; Reyes, Santiago; Seaburg, Lauren; Shapiro, Virginia; Behfar, Atta; Terzic, Andre; van de Sluis, Bart; van Deursen, Jan M.			Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan	NATURE CELL BIOLOGY			English	Article							AGING-ASSOCIATED PHENOTYPES; MITOTIC-SPINDLE CHECKPOINT; CAUSES EARLY-ONSET; CHROMOSOME MISSEGREGATION; TUMOR-FORMATION; MUTANT MICE; DNA-DAMAGE; STEM-CELLS; INSTABILITY; PATHWAY	The BubR1 gene encodes for a mitotic regulator that ensures accurate segregation of chromosomes through its role in the mitotic checkpoint and the establishment of proper microtubule-kinetochore attachments. Germline mutations that reduce BubR1 abundance cause aneuploidy, shorten lifespan and induce premature ageing phenotypes and cancer in both humans and mice. A reduced BubR1 expression level is also a feature of chronological ageing, but whether this age-related decline has biological consequences is unknown. Using a transgenic approach in mice, we show that sustained high-level expression of BubR1 preserves genomic integrity and reduces tumorigenesis, even in the presence of genetic alterations that strongly promote aneuplodization and cancer, such as oncogenic Ras. We find that BubR1 overabundance exerts its protective effect by correcting mitotic checkpoint impairment and microtubule-kinetochore attachment defects. Furthermore, sustained high-level expression of BubR1 extends lifespan and delays age-related deterioration and aneuploidy in several tissues. Collectively, these data uncover a generalized function for BubR1 in counteracting defects that cause whole-chromosome instability and suggest that modulating BubR1 provides a unique opportunity to extend healthy lifespan.	[Baker, Darren J.; Wijshake, Tobias; Jeganathan, Karthik B.; Malureanu, Liviu; van Ree, Janine H.; van Deursen, Jan M.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Baker, Darren J.; Dawlaty, Meelad M.; Malureanu, Liviu; van Deursen, Jan M.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wijshake, Tobias; van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 RB Groningen, Netherlands; [Crespo-Diaz, Ruben; Reyes, Santiago; Behfar, Atta; Terzic, Andre] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Seaburg, Lauren; Shapiro, Virginia] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Groningen; Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, 200 1st St SW, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Jeganathan, KARTHIK/0000-0001-5587-1266; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; Wijshake, Tobias/0000-0003-1784-2100; Behfar, Atta/0000-0003-3775-5784; Baker, Darren/0000-0001-9006-1939	NIH [CA96985, AG41122]; Ellison Medical Foundation; Noaber Foundation; Kogod Center on Aging; NATIONAL CANCER INSTITUTE [R01CA096985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG041122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Noaber Foundation; Kogod Center on Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Galardy, R. Ricke, Kirkland, N. LeBrasseur and R. Miller for feedback on the manuscript, and K. Nath and J. Grande for help with the analysis of kidney phenotypes. This study was supported by NIH grants CA96985 and AG41122, the Ellison Medical Foundation, the Noaber Foundation and The Kogod Center on Aging.	Ameri A, 2003, BLOOD, V101, P1871, DOI 10.1182/blood-2002-05-1581; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Bayani J., 2004, CURR PROTOCOLS CELL, P1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x; Fang Y, 2006, ONCOGENE, V25, P3598, DOI 10.1038/sj.onc.1209392; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Li H, 2008, MECH AGEING DEV, V129, P416, DOI 10.1016/j.mad.2008.02.002; Liu XK, 2004, DIABETES, V53, pS165, DOI 10.2337/diabetes.53.suppl_3.S165; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lushnikova T, 2011, ONCOGENE, V30, P4622, DOI 10.1038/onc.2011.172; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matsumoto T, 2007, STROKE, V38, P1050, DOI 10.1161/01.STR.0000257967.86132.01; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; Miyamoto T, 2011, HUM MOL GENET, V20, P2058, DOI 10.1093/hmg/ddr090; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nath KA, 2011, AM J PHYSIOL-RENAL, V301, pF436, DOI 10.1152/ajprenal.00162.2011; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pajerowski AG, 2010, BLOOD, V116, P2684, DOI 10.1182/blood-2010-02-268391; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Saavedra HI, 2000, ONCOGENE, V19, P3948, DOI 10.1038/sj.onc.1203723; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; van Ree J, 2011, METHODS MOL BIOL, V693, P143, DOI 10.1007/978-1-60761-974-1_9; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Yang Y, 2009, SCIENCE, V326, P575, DOI 10.1126/science.1177087	52	176	179	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					96	U208		10.1038/ncb2643	http://dx.doi.org/10.1038/ncb2643			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23242215	Green Accepted			2022-12-25	WOS:000312841300014
J	Bruchard, M; Mignot, G; Derangere, V; Chalmin, F; Chevriaux, A; Vegran, F; Boireau, W; Simon, B; Ryffel, B; Connat, JL; Kanellopoulos, J; Martin, F; Rebe, C; Apetoh, L; Ghiringhelli, F				Bruchard, Melanie; Mignot, Gregoire; Derangere, Valentin; Chalmin, Fanny; Chevriaux, Angelique; Vegran, Frederique; Boireau, Wilfrid; Simon, Benoit; Ryffel, Bernhard; Connat, Jean Louis; Kanellopoulos, Jean; Martin, Francois; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois			Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth	NATURE MEDICINE			English	Article							ANTITUMOR IMMUNITY; T-CELLS; CANCER-CHEMOTHERAPY; BEARING MICE; GEMCITABINE; INHIBITION; BETA; MICROENVIRONMENT; 5-FLUOROURACIL; ANGIOGENESIS	Chemotherapeutic agents are widely used for cancer treatment. In addition to their direct cytotoxic effects, these agents harness the host's immune system, which contributes to their antitumor activity. Here we show that two clinically used chemotherapeutic agents, gemcitabine (Gem) and 5-fluorouracil (5FU), activate the NOD-like receptor family, pyrin domain containing-3 protein (Nlrp3)-dependent caspase-1 activation complex (termed the inflammasome) in myeloid-derived suppressor cells (MDSCs), leading to production of interleukin-1 beta (IL-beta), which curtails anticancer immunity. Chemotherapy-triggered IL-1 beta secretion relied on lysosomal permeabilization and the release of cathepsin B, which bound to Nlrp3 and drove caspase-1 activation. MDSC-derived IL-1 beta induced secretion of IL-17 by CD4(+) T cells, which blunted the anticancer efficacy of the chemotherapy. Accordingly, Gem and 5FU exerted higher antitumor effects when tumors were established in Nlrp3(-/-) or Casp1(-/-) mice or wild-type mice treated with interleukin-1 receptor antagonist (IL-1Ra). Altogether, these results identify how activation of the Nlrp3 inflammasome in MDSCs by 5FU and Gem limits the antitumor efficacy of these chemotherapeutic agents.	[Connat, Jean Louis; Ghiringhelli, Francois] Univ Bourgogne, Inst Federat Rech IFR Sante Sci & Tech Informat &, Lab Physiopathol & Pharmacol Cardiovasc Expt, Fac Med,INSERM U866, Dijon, France; [Bruchard, Melanie; Mignot, Gregoire; Derangere, Valentin; Chalmin, Fanny; Chevriaux, Angelique; Vegran, Frederique; Martin, Francois; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois] Univ Bourgogne, Fac Med & Pharm, Dijon, France; [Chevriaux, Angelique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France; [Boireau, Wilfrid; Simon, Benoit] Univ Franche Comte, Franche Comte Elect Mecan Therm & Opt Sci & Techn, F-25030 Besancon, France; [Ryffel, Bernhard] CNRS, Lab Mol Immunol & Embryol, UMR 6218, F-45071 Orleans, France; [Kanellopoulos, Jean] Univ Paris 11, UMR 8619, Orsay, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ghiringhelli, F (corresponding author), Univ Bourgogne, Inst Federat Rech IFR Sante Sci & Tech Informat &, Lab Physiopathol & Pharmacol Cardiovasc Expt, Fac Med,INSERM U866, Dijon, France.	fghiringhelli@cgfl.fr	Bruchard, Melanie/E-6508-2017; VEGRAN, Frédérique/H-4792-2017; Apetoh, Lionel/G-3310-2014; Mignot, Grégoire/R-4976-2017; Apetoh, Lionel/AIC-2384-2022; Connat, Jean-Louis/GWR-0438-2022; REBE, Cédric/AAD-4316-2019; VEGRAN, Frederique/O-9986-2018	Bruchard, Melanie/0000-0003-0004-2887; Apetoh, Lionel/0000-0002-2774-438X; Mignot, Grégoire/0000-0002-0682-0152; Apetoh, Lionel/0000-0002-2774-438X; REBE, Cédric/0000-0001-8831-145X; VEGRAN, Frederique/0000-0002-4377-1441; ghiringhelli, francois/0000-0002-5465-8305; Chalmin, Fanny/0000-0002-0855-9453; Connat, Jean-Louis/0000-0002-2885-2323	Fondation pour la Recherche Medicale (FRM); Association pour le Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa); Ligue Regionale Contre le Cancer Comite Grand-Est; Fondation de France; Agence Nationale de la Recherche (ANR) [ANR-10-PDOC-014-01]; European Commission (Marie Curie Fellowship) [PCIG10-GA-2011-303719]; Ministere de l'Enseignement Superieur et de la Recherche; INSERM; Region Bourgogne; LabEx [ANR-11-LABX-0021]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour le Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Regionale Contre le Cancer Comite Grand-Est; Fondation de France(Fondation de France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Commission (Marie Curie Fellowship)(European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bourgogne(Region Bourgogne-Franche-Comte); LabEx	The authors of this work are supported by the Fondation pour la Recherche Medicale (FRM) (F.G.), the Association pour le Recherche Contre le Cancer (ARC) (F.G., G.M. and M.B.), the Ligue Nationale Contre le Cancer (F.V.), the Institut National du Cancer (INCa) (F.G.), the Ligue Regionale Contre le Cancer Comite Grand-Est (F.G., C.R. and L.A.), the Fondation de France (F.G.), the Agence Nationale de la Recherche (ANR, ANR-10-PDOC-014-01) (L.A.), the European Commission (Marie Curie Fellowship PCIG10-GA-2011-303719) (L.A.), the Ministere de l'Enseignement Superieur et de la Recherche (M.B.), INSERM and Region Bourgogne (F.C.) and LabEx ANR-11-LABX-0021. We thank P. Schneider (Biochemistry Department, Universite de Lausanne), V. Bronte (Istituto Oncologico, Padova, Italy) and T. Reinheckel (Institute of Molecular Medicine and Cell Research Freiburg, Germany) for providing essential material.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Apetoh L, 2011, CURR MOL MED, V11, P365, DOI 10.2174/156652411795976574; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Hagemann T, 2007, CANCER CELL, V12, P300, DOI 10.1016/j.ccr.2007.10.005; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Le HK, 2009, INT IMMUNOPHARMACOL, V9, P900, DOI 10.1016/j.intimp.2009.03.015; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Menard C, 2008, CANCER IMMUNOL IMMUN, V57, P1579, DOI 10.1007/s00262-008-0505-6; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Mundy-Bosse BL, 2011, CANCER RES, V71, P5101, DOI 10.1158/0008-5472.CAN-10-2670; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	44	507	534	8	178	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2013	19	1					57	64		10.1038/nm.2999	http://dx.doi.org/10.1038/nm.2999			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202296				2022-12-25	WOS:000313230300026
J	Horikoshi, M; Yaghootkar, H; Mook-Kanamori, DO; Sovio, U; Taal, HR; Hennig, BJ; Bradfield, JP; St Pourcain, B; Evans, DM; Charoen, P; Kaakinen, M; Cousminer, DL; Lehtimaki, T; Kreiner-Moller, E; Warrington, NM; Bustamante, M; Feenstra, B; Berry, DJ; Thiering, E; Pfab, T; Barton, SJ; Shields, BM; Kerkhof, M; van Leeuwen, EM; Fulford, AJ; Kutalik, Z; Zhao, JH; den Hoed, M; Mahajan, A; Lindi, V; Goh, LK; Hottenga, JJ; Wu, Y; Raitakari, OT; Harder, MN; Meirhaeghe, A; Ntalla, I; Salem, RM; Jameson, KA; Zhou, KX; Monies, DM; Lagou, V; Kirin, M; Heikkinen, J; Adair, LS; Alkuraya, FS; Al-Odaib, A; Amouyel, P; Andersson, EA; Bennett, AJ; Blakemore, AIF; Buxton, JL; Dallongeville, J; Das, S; de Geus, EJC; Estivill, X; Flexeder, C; Froguel, P; Geller, F; Godfrey, KM; Gottrand, F; Groves, CJ; Hansen, T; Hirschhorn, JN; Hofman, A; Hollegaard, MV; Hougaard, DM; Hypponen, E; Inskip, HM; Isaacs, A; Jorgensen, T; Kanaka-Gantenbein, C; Kemp, JP; Kiess, W; Kilpelainen, TO; Klopp, N; Knight, BA; Kuzawa, CW; McMahon, G; Newnham, JP; Niinikoski, H; Oostra, BA; Pedersen, L; Postma, DS; Ring, SM; Rivadeneira, F; Robertson, NR; Sebert, S; Simell, O; Slowinski, T; Tiesler, CMT; Tonjes, A; Vaag, A; Viikari, JS; Vink, JM; Vissing, NH; Wareham, NJ; Willemsen, G; Witte, DR; Zhang, HT; Zhao, JH; Wilson, JF; Stumvoll, M; Prentice, AM; Meyer, BF; Pearson, ER; Boreham, CAG; Cooper, C; Gillman, MW; Dedoussis, GV; Moreno, LA; Pedersen, O; Saarinen, M; Mohlke, KL; Boomsma, DI; Saw, SM; Lakka, TA; Korner, A; Loos, RJF; Ong, KK; Vollenweider, P; van Duijn, CM; Koppelman, GH; Hattersley, AT; Holloway, JW; Hocher, B; Heinrich, J; Power, C; Melbye, M; Guxens, M; Pennell, CE; Bonnelykke, K; Bisgaard, H; Eriksson, JG; Widen, E; Hakonarson, H; Uitterlinden, AG; Pouta, A; Lawlor, DA; Smith, GD; Frayling, TM; McCarthy, MI; Grant, SFA; Jaddoe, VWV; Jarvelin, MR; Timpson, NJ; Prokopenko, I; Freathy, RM				Horikoshi, Momoko; Yaghootkar, Hanieh; Mook-Kanamori, Dennis O.; Sovio, Ulla; Taal, H. Rob; Hennig, Branwen J.; Bradfield, Jonathan P.; St Pourcain, Beate; Evans, David M.; Charoen, Pimphen; Kaakinen, Marika; Cousminer, Diana L.; Lehtimaki, Terho; Kreiner-Moller, Eskil; Warrington, Nicole M.; Bustamante, Mariona; Feenstra, Bjarke; Berry, Diane J.; Thiering, Elisabeth; Pfab, Thiemo; Barton, Sheila J.; Shields, Beverley M.; Kerkhof, Marjan; van Leeuwen, Elisabeth M.; Fulford, Anthony J.; Kutalik, Zoltan; Zhao, Jing Hua; den Hoed, Marcel; Mahajan, Anubha; Lindi, Virpi; Goh, Liang-Kee; Hottenga, Jouke-Jan; Wu, Ying; Raitakari, Olli T.; Harder, Marie N.; Meirhaeghe, Aline; Ntalla, Ioanna; Salem, Rany M.; Jameson, Karen A.; Zhou, Kaixin; Monies, Dorota M.; Lagou, Vasiliki; Kirin, Mirna; Heikkinen, Jani; Adair, Linda S.; Alkuraya, Fowzan S.; Al-Odaib, Ali; Amouyel, Philippe; Andersson, Ehm Astrid; Bennett, Amanda J.; Blakemore, Alexandra I. F.; Buxton, Jessica L.; Dallongeville, Jean; Das, Shikta; de Geus, Eco J. C.; Estivill, Xavier; Flexeder, Claudia; Froguel, Philippe; Geller, Frank; Godfrey, Keith M.; Gottrand, Frederic; Groves, Christopher J.; Hansen, Torben; Hirschhorn, Joel N.; Hofman, Albert; Hollegaard, Mads V.; Hougaard, David M.; Hyppoenen, Elina; Inskip, Hazel M.; Isaacs, Aaron; Jorgensen, Torben; Kanaka-Gantenbein, Christina; Kemp, John P.; Kiess, Wieland; Kilpelainen, Tuomas O.; Klopp, Norman; Knight, Bridget A.; Kuzawa, Christopher W.; McMahon, George; Newnham, John P.; Niinikoski, Harri; Oostra, Ben A.; Pedersen, Louise; Postma, Dirkje S.; Ring, Susan M.; Rivadeneira, Fernando; Robertson, Neil R.; Sebert, Sylvain; Simell, Olli; Slowinski, Torsten; Tiesler, Carla M. T.; Toenjes, Anke; Vaag, Allan; Viikari, Jorma S.; Vink, Jacqueline M.; Vissing, Nadja Hawwa; Wareham, Nicholas J.; Willemsen, Gonneke; Witte, Daniel R.; Zhang, Haitao; Zhao, Jianhua; Wilson, James F.; Stumvoll, Michael; Prentice, Andrew M.; Meyer, Brian F.; Pearson, Ewan R.; Boreham, Colin A. G.; Cooper, Cyrus; Gillman, Matthew W.; Dedoussis, George V.; Moreno, Luis A.; Pedersen, Oluf; Saarinen, Maiju; Mohlke, Karen L.; Boomsma, Dorret I.; Saw, Seang-Mei; Lakka, Timo A.; Koerner, Antje; Loos, Ruth J. F.; Ong, Ken K.; Vollenweider, Peter; van Duijn, Cornelia M.; Koppelman, Gerard H.; Hattersley, Andrew T.; Holloway, John W.; Hocher, Berthold; Heinrich, Joachim; Power, Chris; Melbye, Mads; Guxens, Monica; Pennell, Craig E.; Bonnelykke, Klaus; Bisgaard, Hans; Eriksson, Johan G.; Widen, Elisabeth; Hakonarson, Hakon; Uitterlinden, Andre G.; Pouta, Anneli; Lawlor, Debbie A.; Smith, George Davey; Frayling, Timothy M.; McCarthy, Mark I.; Grant, Struan F. A.; Jaddoe, Vincent W. V.; Jarvelin, Marjo-Riitta; Timpson, Nicholas J.; Prokopenko, Inga; Freathy, Rachel M.		MAGIC; Early Growth Genetics EGG	New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DIABETES RISK ALLELES; COMMON VARIANTS; SUSCEPTIBILITY LOCI; FASTING GLUCOSE; BLOOD-PRESSURE; TCF7L2; HYPERGLYCEMIA; POLYMORPHISM; METAANALYSIS	Birth weight within the normal range is associated with a variety of adult-onset diseases, but the mechanisms behind these associations are poorly understood(1). Previous genome-wide association studies of birth weight identified a variant in the ADCY5 gene associated both with birth weight and type 2 diabetes and a second variant, near CCNL1, with no obvious link to adult traits(2). In an expanded genome-wide association metaanalysis and follow-up study of birth weight (of up to 69,308 individuals of European descent from 43 studies), we have now extended the number of loci associated at genome-wide significance to 7, accounting for a similar proportion of variance as maternal smoking. Five of the loci are known to be associated with other phenotypes: ADCY5 and CDKAL1 with type 2 diabetes, ADRB1 with adult blood pressure and HMGA2 and LCORL with adult height. Our findings highlight genetic links between fetal growth and postnatal growth and metabolism.	[Horikoshi, Momoko; Lagou, Vasiliki; Bennett, Amanda J.; Groves, Christopher J.; McCarthy, Mark I.; Prokopenko, Inga] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Horikoshi, Momoko; Mahajan, Anubha; Lagou, Vasiliki; Robertson, Neil R.; McCarthy, Mark I.; Prokopenko, Inga] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Yaghootkar, Hanieh; Frayling, Timothy M.; Freathy, Rachel M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Mook-Kanamori, Dennis O.; Taal, H. Rob; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Taal, H. Rob; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Taal, H. Rob; Jaddoe, Vincent W. V.] Erasmus MC, Dept Paediat, Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Sovio, Ulla; Charoen, Pimphen; Das, Shikta; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Sovio, Ulla] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Med Stat, London WC1, England; [Hennig, Branwen J.; Fulford, Anthony J.; Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England; [Hennig, Branwen J.; Fulford, Anthony J.; Prentice, Andrew M.] MRC Keneba, Med Res Council Labs, Banjul, Gambia; [Bradfield, Jonathan P.; Zhang, Haitao; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [St Pourcain, Beate; Evans, David M.; Kemp, John P.; McMahon, George; Lawlor, Debbie A.; Smith, George Davey; Timpson, Nicholas J.; Freathy, Rachel M.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol, Avon, England; [Charoen, Pimphen] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Kaakinen, Marika; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Cousminer, Diana L.; Heikkinen, Jani; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Fimlab Labs, FIN-33521 Tampere, Finland; [Kreiner-Moller, Eskil; Pedersen, Louise; Vissing, Nadja Hawwa; Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Fac Hlth Sci, Copenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark; [Kreiner-Moller, Eskil; Pedersen, Louise; Vissing, Nadja Hawwa; Bonnelykke, Klaus; Bisgaard, Hans] Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Copenhagen, Denmark; [Warrington, Nicole M.; Newnham, John P.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Bustamante, Mariona; Guxens, Monica] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona; Guxens, Monica] Hosp del Mar Res Inst IMIM, Barcelona, Spain; [Bustamante, Mariona; Estivill, Xavier; Guxens, Monica] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Bustamante, Mariona; Estivill, Xavier] Pompeu Fabra Univ, Barcelona, Spain; [Bustamante, Mariona; Estivill, Xavier] CRG, Genes & Dis Program, Barcelona, Spain; [Feenstra, Bjarke; Geller, Frank; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Berry, Diane J.; Hyppoenen, Elina; Power, Chris] UCL, Ctr Paediat Epidemiol & Biostat, MRC Ctr Epidemiol Child Hlth, Inst Child Hlth, London, England; [Thiering, Elisabeth; Flexeder, Claudia; Tiesler, Carla M. T.; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol 1, Munich, Germany; [Pfab, Thiemo] Charite, Med Klin Nephrol, D-13353 Berlin, Germany; [Pfab, Thiemo; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Barton, Sheila J.; Jameson, Karen A.; Godfrey, Keith M.; Inskip, Hazel M.; Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Shields, Beverley M.; Knight, Bridget A.; Hattersley, Andrew T.] Royal Devon & Exeter Natl Hlth Serv NHS Fdn Trust, Exeter, Devon, England; [Shields, Beverley M.; Knight, Bridget A.; Hattersley, Andrew T.] Univ Exeter, Peninsula Natl Inst Hlth Res NIHR Clin Res Facil, Peninsula Coll Med & Dent, Exeter, Devon, England; [Kerkhof, Marjan] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Leeuwen, Elisabeth M.; Isaacs, Aaron; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Genet Epidemiol Unit, Dept Epidemiol, Rotterdam, Netherlands; [Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Geneva, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Basel, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Bern, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Zurich, Switzerland; [Zhao, Jing Hua; den Hoed, Marcel; Kilpelainen, Tuomas O.; Wareham, Nicholas J.; Loos, Ruth J. F.; Ong, Ken K.] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Lindi, Virpi; Kilpelainen, Tuomas O.; Lakka, Timo A.] Univ Eastern Finland, Dept Physiol, Inst Biomed, Kuopio, Finland; [Goh, Liang-Kee; Saw, Seang-Mei] Duke Natl Univ Singapore NUS, Grad Sch Med, Singapore, Singapore; [Goh, Liang-Kee; Saw, Seang-Mei] NUS, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Hottenga, Jouke-Jan; de Geus, Eco J. C.; Vink, Jacqueline M.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ VU Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Raitakari, Olli T.; Simell, Olli; Saarinen, Maiju] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.; Niinikoski, Harri; Simell, Olli; Viikari, Jorma S.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol & Nucl Med, Turku, Finland; [Harder, Marie N.; Andersson, Ehm Astrid; Hansen, Torben; Kilpelainen, Tuomas O.; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [Meirhaeghe, Aline; Amouyel, Philippe; Dallongeville, Jean] INSERM, U744, F-59045 Lille, France; [Meirhaeghe, Aline; Amouyel, Philippe; Dallongeville, Jean; Froguel, Philippe] Inst Pasteur, F-59019 Lille, France; [Meirhaeghe, Aline; Amouyel, Philippe; Dallongeville, Jean; Froguel, Philippe] Univ Lille Nord France, Lille, France; [Meirhaeghe, Aline; Amouyel, Philippe; Dallongeville, Jean] Univ Lille 2, Lille, France; [Ntalla, Ioanna; Dedoussis, George V.] Harokopio Univ Athens, Dept Dietet Nutr, Athens, Greece; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Broad Inst, Metab Program, Cambridge, MA USA; [Salem, Rany M.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Salem, Rany M.; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Salem, Rany M.; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Zhou, Kaixin; Pearson, Ewan R.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Monies, Dorota M.; Alkuraya, Fowzan S.; Al-Odaib, Ali; Meyer, Brian F.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Kirin, Mirna; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Alkuraya, Fowzan S.] King Khalid Eye Specialist Hosp, Dept Pediat, Riyadh, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia; [Blakemore, Alexandra I. F.; Buxton, Jessica L.] Univ London Imperial Coll Sci Technol & Med, Sect Invest Med, Div Diabet Endocrinol & Metab, London, England; [Estivill, Xavier] UPF, Dept Expt & Hlth Sci, Barcelona, Spain; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Hammersmith Hosp, London, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Gottrand, Frederic] Univ Lille 2, Fac Med, INSERM U995, Lille, France; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Isaacs, Aaron] Ctr Med Syst Biol, Leiden, Netherlands; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Dept Publ Hlth, Copenhagen, Denmark; [Kanaka-Gantenbein, Christina] Univ Athens, Sch Med, Div Endocrinol Diabetol & Metab, Aghia Sophia Childrens Hosp,Dept Pediat 1, GR-11527 Athens, Greece; [Kiess, Wieland; Koerner, Antje] Univ Leipzig, Dept Womens & Child Hlth, Pediat Res Ctr, Leipzig, Germany; [Klopp, Norman] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Munich, Germany; [Klopp, Norman] Hannover Med Sch, Hannover Unified Biobank, D-3000 Hannover, Germany; [Kuzawa, Christopher W.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Kuzawa, Christopher W.] Northwestern Univ, Cells Soc Ctr Social Dispar & Hlth 2, Inst Policy Res, Evanston, IL USA; [Niinikoski, Harri; Simell, Olli] Univ Turku, Dept Pediat, Turku, Finland; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, GRIAC,Res Inst, Groningen, Netherlands; [Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Slowinski, Torsten] Charite, Med Klin Schwerpunkt Nephrol, D-13353 Berlin, Germany; [Tiesler, Carla M. T.] Univ Munich, Div Metab Dis & Nutr Med, Dr von Hauner Childrens Hosp, Munich, Germany; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Toenjes, Anke; Stumvoll, Michael; Koerner, Antje] Univ Leipzig, Integrierte Forsch & Behandlungszentren IFB Adipo, Leipzig, Germany; [Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Vaag, Allan; Witte, Daniel R.] Steno Diabet Ctr, Gentofte, Denmark; [Viikari, Jorma S.] Univ Turku, Dept Med, Turku, Finland; [Zhao, Jianhua; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Dept Human Genet, Philadelphia, PA 19104 USA; [Wilson, James F.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Boreham, Colin A. G.] Univ Coll Dublin, Inst Sport & Hlth, Dublin 2, Ireland; [Gillman, Matthew W.] Harvard Univ, Sch Med, Obes Prevent Program, Dept Populat Med,Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Moreno, Luis A.] Univ Zaragoza, Escuela Univ Ciencias Salud, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza, Spain; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Fac Hlth Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Saw, Seang-Mei] Singapore Eye Res Inst, Singapore, Singapore; [Lakka, Timo A.] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Vollenweider, Peter] Fac Biol & Med, Lausanne, Switzerland; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [Holloway, John W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Hocher, Berthold] Charite, Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Hakonarson, Hakon; Grant, Struan F. A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynaecol, Oulu, Finland; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Hlth Protect Agcy HPA MRC Ctr, Sch Publ Hlth, London, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Plymouth; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Bristol; Mahidol University; University of Oulu; University of Oulu; University of Helsinki; Tampere University; Tampere University; Tampere University Hospital; University of Copenhagen; University of Copenhagen; University of Western Australia; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Statens Serum Institut; University of London; University College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam; University of Southampton; University of Exeter; University of Plymouth; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Lausanne; Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Eastern Finland; National University of Singapore; Vrije Universiteit Amsterdam; University of North Carolina; University of North Carolina Chapel Hill; University of Turku; University of Turku; University of Turku; Novo Nordisk Foundation; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Harokopio University Athens; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Dundee; King Faisal Specialist Hospital & Research Center; University of Edinburgh; University of North Carolina; University of North Carolina Chapel Hill; King Khaled Eye Specialist Hospital; Alfaisal University; Imperial College London; Pompeu Fabra University; Imperial College London; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of Southern Denmark; Statens Serum Institut; University of Copenhagen; University of Copenhagen; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Northwestern University; Northwestern University; University of Turku; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Bristol; Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Leipzig University; Leipzig University; Rigshospitalet; University of Copenhagen; Steno Diabetes Center; University of Turku; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Edinburgh; University College Dublin; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; University of Zaragoza; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; National University of Singapore; Singapore National Eye Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Groningen; University of Southampton; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; Finland National Institute for Health & Welfare; University of Pennsylvania; Finland National Institute for Health & Welfare; University of Oulu; University of Oxford; Imperial College London	McCarthy, MI (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	mark.mccarthy@drl.ox.ac.uk; grants@chop.edu; v.jaddoe@erasmusmc.nl; m.jarvelin@imperial.ac.uk; n.j.timpson@bristol.ac.uk; ingap@well.ox.ac.uk; rachel.freathy@pms.ac.uk	Koppelman, Gerard/AAG-9187-2020; den Hoed, Marcel/I-7138-2017; Wilson, James F/A-5704-2009; Kemp, John P./R-3091-2018; Loos, Ruth J F/Q-2862-2016; Heinrich, Joachim/N-1720-2013; Kirin, Mirna/AAZ-6587-2020; Bisgaard, Hans/N-4761-2016; Horikoshi, Momoko/AAF-9034-2019; Kutalik, Zoltan/HHZ-5697-2022; Guxens, Monica/T-2285-2018; FROGUEL, Philippe/O-6799-2017; Kanaka-Gantenbein, Christina/AAP-3697-2020; Buxton, Jessica/L-9849-2019; Timpson, Nicholas John/O-7548-2015; Colaus, PsyColaus/K-6607-2013; Blakemore, Alexandra I F/D-2253-2009; Bustamante, Mariona/M-7277-2015; Fox, Laura J/C-6249-2016; Moreno, Luis/S-1780-2019; Lagou, Vasiliki/N-8451-2013; Evans, David M/H-6325-2013; Stumvoll, Michael/ABE-1121-2021; Kronow, Joern/B-1054-2011; van Leeuwen, Elisabeth/G-3382-2017; Witte, Daniel R/C-1722-2008; Sovio, Ulla/H-8532-2019; Taal, Hendrik R/B-4847-2018; Pennell, Craig/ABD-6902-2020; Bustamante, Mariona/ABB-9142-2021; Hennig, Branwen/M-6444-2014; Lindi, Virpi/K-9008-2018; Körner, Antje/B-3988-2015; Dedoussis, George/AAN-7252-2021; gottrand, frederic F/G-7370-2015; Jørgensen, Torben/Z-1335-2018; Study, Raine/K-4517-2013; Hocher, Berthold/AAC-3510-2020; Davey Smith, George/A-7407-2013; Pedersen, Oluf/Z-1731-2019; Estivill, Xavier/A-3125-2013; Prentice, Andrew/AAG-1961-2019; Witte, Daniel/AAF-9535-2019; Pedersen, Oluf/AAG-8015-2020; Warrington, Nicole/P-4868-2014; Boomsma, Dorret I/AAX-4470-2020; Loos, Ruth/GON-5877-2022; Thiering, Elisabeth/B-3342-2013; Meirhaeghe, Aline/E-4663-2015; Lehtimäki, Terho/AAD-1094-2022; Kilpeläinen, Tuomas/F-8569-2012; Hypponen, Elina/B-2596-2014; Wu, Ying/B-7283-2009; Buxton, Jessica L/I-4033-2014; Prokopenko, Inga/AAU-9895-2020; Rivadeneira, Fernando/O-5385-2015; Attrill, Lauren/V-1688-2018; Holloway, John W/B-5424-2009; de Geus, Eco J.C./M-9318-2015; Prokopenko, Inga/H-3241-2014; Raitakari, Olli/AAQ-7389-2021; Hougaard, David/AAD-6368-2019; Inskip, Hazel/L-5467-2018; McCarthy, Mark/M-3763-2015	den Hoed, Marcel/0000-0001-8081-428X; Wilson, James F/0000-0001-5751-9178; Kemp, John P./0000-0002-9105-2249; Loos, Ruth J F/0000-0002-8532-5087; Heinrich, Joachim/0000-0002-9620-1629; Bisgaard, Hans/0000-0003-4131-7592; Kutalik, Zoltan/0000-0001-8285-7523; Guxens, Monica/0000-0002-8624-0333; FROGUEL, Philippe/0000-0003-2972-0784; Timpson, Nicholas John/0000-0002-7141-9189; Blakemore, Alexandra I F/0000-0003-0661-564X; Bustamante, Mariona/0000-0003-0127-2860; Moreno, Luis/0000-0003-0454-653X; Evans, David M/0000-0003-0663-4621; Stumvoll, Michael/0000-0001-6225-8240; Witte, Daniel R/0000-0002-0769-2922; Sovio, Ulla/0000-0002-0799-1105; Pennell, Craig/0000-0002-0937-6165; Bustamante, Mariona/0000-0003-0127-2860; Lindi, Virpi/0000-0001-6257-7209; Körner, Antje/0000-0001-6001-0356; Dedoussis, George/0000-0002-7798-6221; gottrand, frederic F/0000-0002-5290-0436; Davey Smith, George/0000-0002-1407-8314; Pedersen, Oluf/0000-0002-3321-3972; Estivill, Xavier/0000-0002-0723-2256; Witte, Daniel/0000-0002-0769-2922; Warrington, Nicole/0000-0003-4195-775X; Meirhaeghe, Aline/0000-0001-6983-2364; Lehtimäki, Terho/0000-0002-2555-4427; Kilpeläinen, Tuomas/0000-0002-8349-3028; Hypponen, Elina/0000-0003-3670-9399; Buxton, Jessica L/0000-0002-0918-9335; Rivadeneira, Fernando/0000-0001-9435-9441; Holloway, John W/0000-0001-9998-0464; de Geus, Eco J.C./0000-0001-6022-2666; Prokopenko, Inga/0000-0003-1624-7457; Feenstra, Bjarke/0000-0003-1478-649X; Eriksson, Johan/0000-0002-2516-2060; Hansen, Torben/0000-0001-8748-3831; bennett, amanda/0000-0003-2140-8710; s, hema/0000-0002-3440-9475; Van Duijn, Cornelia/0000-0002-2374-9204; Koppelman, Gerard/0000-0001-8567-3252; Amouyel, Philippe/0000-0001-9088-234X; Hennig, Branwen J./0000-0003-4127-8386; Salem, Rany/0000-0001-8816-6862; Lakka, Timo/0000-0002-9199-2871; Barton, Sheila/0000-0003-4963-4242; Hocher, Berthold/0000-0001-8143-0579; , Hanieh/0000-0001-9672-9477; Kreiner, Eskil/0000-0003-1204-2438; Lawlor, Debbie A/0000-0002-6793-2262; Geller, Frank/0000-0002-9238-3269; Godfrey, Keith/0000-0002-4643-0618; St Pourcain, Beate/0000-0002-4680-3517; Freathy, Rachel/0000-0003-4152-2238; Willemsen, Gonneke/0000-0003-3755-0236; Grant, Struan/0000-0003-2025-5302; Vaag, Allan Arthur/0000-0002-3690-2191; Sebert, Sylvain/0000-0001-6681-6983; Meyer, Brian/0000-0002-0388-9568; Kaakinen, Marika/0000-0002-9228-0462; melbye, mads/0000-0001-8264-6785; Inskip, Hazel/0000-0001-8897-1749; McCarthy, Mark/0000-0002-4393-0510; Cooper, Cyrus/0000-0003-3510-0709; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hattersley, Andrew/0000-0001-5620-473X; Saarinen, Maiju/0000-0003-3346-3688; Thiering, Elisabeth/0000-0002-5429-9584; Newnham, John/0000-0001-9983-7457; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Mahajan, Anubha/0000-0001-5585-3420; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Bonnelykke, Klaus/0000-0003-2003-1018; charoen, Pimphen/0000-0001-8851-0520; Lagou, Vasiliki/0000-0003-3165-8940; Niinikoski, Harri/0000-0002-7071-918X; Jorgensen, Torben/0000-0001-9453-2830; Frayling, Timothy/0000-0001-8362-2603	Academy of Finland [126925, 121584, 124282, 129378, 117787, 41071, 209072, 129255, 104781, 120315, 129269, 1114194, 206374, 251360, 139900/24300796]; Biocentrum Helsinki; Arthritis Research UK; Augustinus Foundation; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); Biomedical Research Council, Singapore [BMRC 06/1/21/19/466]; BIF: Boehringer Ingelheim Fonds; British Heart Foundation; C.G. Sundell Foundation; Canadian Institutes of Health Research [MOP-82893]; Cancer Research UK; Chief Scientist Office of the Scottish Government; Children's Hospital of Philadelphia (Institute Development Award); Conselleria de Sanitat Generalitat Valenciana; Copenhagen Graduate School of Health Sciences; Cotswold Foundation (Research Development Award); Curtin University and Women and Infants Research Foundation; Danish Health Insurance Societies (Health Fund); Danish Medical Research Council; Danish National Research Foundation; Danish Pediatric Asthma Centre; Danish Pharmacists' Fund; Danish Strategic Research Council; Darlington Trust; Department of Health and Social Services in Northern Ireland; Deutsche Forschungsgemeinschaft (DFG); Diabetes Hilfs-und Forschungsfonds Deutschland (DHFD); Diabetes UK [RD08/0003704, RD08/0003692]; Dunhill Medical Trust; Dutch Asthma Foundation [3.4.01.26, 3.2.06.022, 3.4.09.081, 3.2.10.085CO]; Dutch Ministry of the Environment (EFRE); Europaische Fonds fur Regionale Entwicklung (LIFE Child Obesity); Egmont Foundation; Else Kroner-Fresenius Foundation; Emil Aaltonen Foundation; ENGAGE project [HEALTH-F4-2007-201413]; Erasmus Medical Center; Erasmus University, Rotterdam; European Commission [QLG1-CT-2000-01643, 018996, LSHG-CT-2006-018947, FOOD-CT-2005-007034]; European Research Council (ERC Advanced) [230374]; European Science Foundation (ESF) [EU/QLRT-2001-01254]; Exeter NHS Research and Development; Faculty of Biology and Medicine of Lausanne; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Finnish Innovation Fund Sitra; Finnish Ministry of Education and Culture; Finnish Ministry of Social Affairs and Health; Finnish Social Insurance Institution; Foundation for Paediatric Research; Fundacio La Marato de TV3; Fundacion Roger Torne; Generalitat de Catalunya-Interminesterial Council for Research and Technological Innovation (CIRIT) [(1999SGR) 00241]; German Diabetes Association; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; German Research Foundation for the Clinical Research Group Atherobesity [KO3512/1]; GlaxoSmithKline; Hagedorn Research Institute; Instituto de Salud Carlos III [CB06/02/0041, FIS PI041436, PI081151, PI041705, PS09/00432, FISFEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647]; Interdisciplinary Centre for Clinical Research at the University of Leipzig [B27]; Integrated Research and Treatment Centre (IFB) Adiposity Diseases; Jackstadt-Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF); Kuopio, Tampere and Turku University Hospital Medical Funds [5031343, 9M048]; Lundbeck Foundation; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); March of Dimes Birth Defects Foundation [6-FY09-507]; MRC, UK [74882, G0000934, G0601653, G0500539, G0600705, G0601261, G0600331, PrevMetSyn/SALVE PS0476, MC-A760-5QX00]; Munich Center of Health Sciences (MC Health); National Health and Medical Research Council of Australia [403981, 003209]; US National Human Genome Research Institute; US National Institute of Allergy and Infectious Diseases; US National Institute of Child Health and Human Development; US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); US National Institutes of Health [U01DK062418, U01HG004423, U01HG004446, U01HG004438, R01DK075787, 1R01HD056465-01A, R01D0042157-01A, DK078150, TW05596, HL085144, HD054501, RR20649, ES10126, DK56350]; Netherlands Bioinformatics Centre (NBIC) BioAssist [RK/2008.024]; National Heart, Lung, and Blood Institute (NHLBI) [5R01HL087679-02]; National Heart, Lung, and Blood Institute (NHLBI) through the STAMPEED program [1RL1MH083268-01]; NIH Genetic Association Information Network (GAIN); NIH/National Institute of Mental Health (NIMH) [5R01MH63706: 02, MH081802]; Rutgers University Cell and DNA Repository cooperative agreement [NIMH U24 MH068457-06]; Novo Nordisk Foundation Center for Basic Metabolic Research; Center for Medical Systems Biology (CMSB; NWO Genomics); Netherlands Organization for Scientific Research (NWO: Social Sciences (MaGW); Netherlands Organization for Health Research and Development (ZonMw) [Middelgroot-911-09-032, Spinozapremie 56-464-14192, 904-61-090, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008, 985-10-002, 40-005698- 9032, 912-03-031]; Paavo Nurmi Foundation; Peninsula NIHR Clinical Research Facility; Pharmacy Foundation of 1991; PhD School of Molecular Metabolism University of Southern Denmark; Raine Medical Research Foundation; Royal Society; Sigrid Juselius Foundation; South West NHS Research and Development; Spanish Ministry of Science and Innovation [SAF2008-00357]; Turku University Hospital; Swiss National Science Foundation [33CSCO-122661]; Tampere Tuberculosis Foundation; Telethon Institute for Child Health Research; Turku University Foundation; US Centers for Disease Control and Prevention; University Hospital Oulu, Biocenter, the University of Oulu [75617]; University of Bristol; University of Potsdam; University of Southampton; University of Western Australia (UWA); VU Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); Wellcome Trust [GR069224, WT088806, 068545/Z/02, 076467, 085301, 090532, 083270, 083948, 085541/Z/08/Z, WT089549, WT083431MA]; Yrjo Jahnsson Foundation; Academy of Finland (Center of Excellence in Complex Disease Genetics); Academy of Finland (SALVE); MRC [MC_U106179472, G0600331, G0601261, MC_PC_U127561128, MC_UU_12011/4, G0600705, MC_U106188470, MC_U123292701, MC_UP_A620_1017, MC_UU_12015/1, MC_U147585819, G0601653, MC_U123292700, MC_UU_12015/2, G0400491, MC_U147585827] Funding Source: UKRI; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Diabetes UK [08/0003692] Funding Source: researchfish; Medical Research Council [G0400491, MC_U123292701, MC_UP_A620_1014, G0801056B, MC_UP_A620_1017, MC_U147585819, MC_UU_12015/2, G0601653, MC_PC_U127561128, MC_U106188470, G0600331, G9815508, MC_U147585827, MC_UU_12011/1, MC_UU_12015/1, G0601261, U1475000001, G0600705, MC_UU_12011/4, MC_U106179472, MC_U147585824, MC_U123292700, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0611-10219, NF-SI-0611-10099] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054501, R24HD050924, R01HD056465] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005596] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U22PS000476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020649] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679, R01HL085144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004423, U01HG004438, U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787, P30DK056350, R01DK078150, U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH081802, U24MH068457, R01MH063706] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Arthritis Research UK(Versus Arthritis); Augustinus Foundation; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); BIF: Boehringer Ingelheim Fonds(Boehringer Ingelheim); British Heart Foundation(British Heart Foundation); C.G. Sundell Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); Chief Scientist Office of the Scottish Government; Children's Hospital of Philadelphia (Institute Development Award); Conselleria de Sanitat Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Copenhagen Graduate School of Health Sciences; Cotswold Foundation (Research Development Award); Curtin University and Women and Infants Research Foundation; Danish Health Insurance Societies (Health Fund); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Pediatric Asthma Centre; Danish Pharmacists' Fund; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Darlington Trust; Department of Health and Social Services in Northern Ireland; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Diabetes Hilfs-und Forschungsfonds Deutschland (DHFD); Diabetes UK(Diabetes UK); Dunhill Medical Trust(Dunhill Medical Trust); Dutch Asthma Foundation; Dutch Ministry of the Environment (EFRE); Europaische Fonds fur Regionale Entwicklung (LIFE Child Obesity); Egmont Foundation; Else Kroner-Fresenius Foundation; Emil Aaltonen Foundation; ENGAGE project(General Electric); Erasmus Medical Center; Erasmus University, Rotterdam; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC Advanced)(European Research Council (ERC)); European Science Foundation (ESF)(European Science Foundation (ESF)); Exeter NHS Research and Development; Faculty of Biology and Medicine of Lausanne; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Innovation Fund Sitra; Finnish Ministry of Education and Culture; Finnish Ministry of Social Affairs and Health; Finnish Social Insurance Institution; Foundation for Paediatric Research; Fundacio La Marato de TV3; Fundacion Roger Torne; Generalitat de Catalunya-Interminesterial Council for Research and Technological Innovation (CIRIT); German Diabetes Association; German Bundesministerium fuer Forschung und Technology; German Research Foundation for the Clinical Research Group Atherobesity(German Research Foundation (DFG)); GlaxoSmithKline(GlaxoSmithKline); Hagedorn Research Institute(Novo Nordisk); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Interdisciplinary Centre for Clinical Research at the University of Leipzig; Integrated Research and Treatment Centre (IFB) Adiposity Diseases; Jackstadt-Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Kuopio, Tampere and Turku University Hospital Medical Funds; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); March of Dimes Birth Defects Foundation(March of Dimes); MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Munich Center of Health Sciences (MC Health); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Bioinformatics Centre (NBIC) BioAssist; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute (NHLBI) through the STAMPEED program; NIH Genetic Association Information Network (GAIN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Rutgers University Cell and DNA Repository cooperative agreement; Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Center for Medical Systems Biology (CMSB; NWO Genomics); Netherlands Organization for Scientific Research (NWO: Social Sciences (MaGW); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Paavo Nurmi Foundation; Peninsula NIHR Clinical Research Facility; Pharmacy Foundation of 1991; PhD School of Molecular Metabolism University of Southern Denmark; Raine Medical Research Foundation; Royal Society(Royal Society of London); Sigrid Juselius Foundation(Sigrid Juselius Foundation); South West NHS Research and Development; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Turku University Hospital; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Tampere Tuberculosis Foundation; Telethon Institute for Child Health Research; Turku University Foundation; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University Hospital Oulu, Biocenter, the University of Oulu; University of Bristol; University of Potsdam; University of Southampton; University of Western Australia (UWA); VU Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); Wellcome Trust(Wellcome Trust); Yrjo Jahnsson Foundation; Academy of Finland (Center of Excellence in Complex Disease Genetics)(Academy of Finland); Academy of Finland (SALVE)(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	A complete list of acknowledgments is given in the Supplementary Note. Major funding for the research in this paper is provided by the Academy of Finland (project grants 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), 41071 (Skidi), 209072, 129255, 104781, 120315, 129269, 1114194, 206374, 251360, 139900/24300796, Center of Excellence in Complex Disease Genetics and SALVE) and Biocentrum Helsinki; Arthritis Research UK; the Augustinus Foundation; the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); the Biomedical Research Council, Singapore (BMRC 06/1/21/19/466); BIF: Boehringer Ingelheim Fonds (travel grant to A. T.); the British Heart Foundation; the C.G. Sundell Foundation; the Canadian Institutes of Health Research (grant MOP-82893); Cancer Research UK; the Chief Scientist Office of the Scottish Government; the Children's Hospital of Philadelphia (Institute Development Award); Conselleria de Sanitat Generalitat Valenciana; the Copenhagen Graduate School of Health Sciences; the Cotswold Foundation (Research Development Award); the Curtin University and Women and Infants Research Foundation; the Danish Health Insurance Societies (Health Fund); the Danish Medical Research Council; the Danish National Research Foundation; the Danish Pediatric Asthma Centre; the Danish Pharmacists' Fund; the Danish Strategic Research Council; the Darlington Trust; the Department of Health and Social Services in Northern Ireland; Deutsche Forschungsgemeinschaft (DFG); Diabetes Hilfs-und Forschungsfonds Deutschland (DHFD; travel grant to M. Stumvoll); Diabetes UK (grants RD08/0003704 and RD08/0003692); the Dunhill Medical Trust; the Dutch Asthma Foundation (grants 3.4.01.26, 3.2.06.022, 3.4.09.081 and 3.2.10.085CO); the Dutch Ministry of the Environment (EFRE): Europaische Fonds fur Regionale Entwicklung (LIFE Child Obesity); the Egmont Foundation; the Else Kroner-Fresenius Foundation; the Emil Aaltonen Foundation (T. L.); the ENGAGE project and grant agreement HEALTH-F4-2007-201413; the Erasmus Medical Center; Erasmus University, Rotterdam; the European Commission (EURO-BLCS, Beta-JUDO, Framework 5 award QLG1-CT-2000-01643, GABRIEL (Integrated Program LSH-2004-1.2.5-1 contract 018996), framework programme 6 EUROSPAN project (contract LSHG-CT-2006-018947), Sixth Research, Technological Development (RTD) Framework Programme (Contract FOOD-CT-2005-007034) and Seventh Framework Programme (FP7/2007-2013)); the European Research Council (ERC Advanced; 230374); the European Science Foundation (ESF; EU/QLRT-2001-01254); the Exeter NHS Research and Development; Faculty of Biology and Medicine of Lausanne; the Finnish Foundation of Cardiovascular Research; the Finnish Cultural Foundation; the Finnish Innovation Fund Sitra; the Finnish Ministry of Education and Culture; the Finnish Ministry of Social Affairs and Health; the Finnish Social Insurance Institution; the Foundation for Paediatric Research; Fundacio La Marato de TV3; Fundacion Roger Torne; Generalitat de Catalunya-Interminesterial Council for Research and Technological Innovation (CIRIT; 1999SGR) 00241; the German Diabetes Association (A. T.); the German Bundesministerium fuer Forschung und Technology (grants 01 AK 803 A-H and 01 IG 07015 G); the German Research Foundation for the Clinical Research Group Atherobesity KFO 152 (KO3512/1 to A. K.; ); GlaxoSmithKline; the Hagedorn Research Institute; Instituto de Salud Carlos III (CB06/02/0041, FIS PI041436, PI081151, PI041705 and PS09/00432 and FISFEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314 and 09/02647); the Interdisciplinary Centre for Clinical Research at the University of Leipzig (B27 to A. T. and M. Stumvoll); the Integrated Research and Treatment Centre (IFB) Adiposity Diseases; the Jackstadt-Foundation; the Juho Vainio Foundation; the Juvenile Diabetes Research Foundation International (JDRF); Kuopio, Tampere and Turku University Hospital Medical Funds (grant 5031343 to T. A. Lakka and grant 9M048 to T. L.); The Lundbeck Foundation; the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP); the March of Dimes Birth Defects Foundation (6-FY09-507); the MRC, UK (grants 74882, G0000934, G0601653, G0500539, G0600705, G0601261, G0600331, PrevMetSyn/SALVE PS0476 and MC-A760-5QX00); the Munich Center of Health Sciences (MC Health); the National Health and Medical Research Council of Australia (grants 403981 and 003209); the US National Human Genome Research Institute; the US National Institute of Allergy and Infectious Diseases; the US National Institute of Child Health and Human Development; the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the US National Institutes of Health (grants U01DK062418, U01HG004423, U01HG004446, U01HG004438, R01DK075787, 1R01HD056465-01A, R01D0042157-01A, DK078150, TW05596, HL085144, HD054501, RR20649, ES10126, DK56350 and Biomedical Research Centers funding); the Netherlands Bioinformatics Centre (NBIC) BioAssist (RK/2008.; 024); a National Heart, Lung, and Blood Institute (NHLBI) grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); the NIH Genetic Association Information Network (GAIN); the NIH/National Institute of Mental Health (NIMH) (5R01MH63706: 02 and MH081802); the Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06); the Novo Nordisk Foundation Center for Basic Metabolic Research; the Center for Medical Systems Biology (CMSB; NWO Genomics); the Netherlands Organization for Scientific Research (NWO: Social Sciences (MaGW) and the Netherlands Organization for Health Research and Development (ZonMw) (Middelgroot-911-09-032, Spinozapremie 56-464-14192, 904-61-090, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008, 985-10-002, 40-005698- 9032 and 912-03-031); the Paavo Nurmi Foundation; the Peninsula NIHR Clinical Research Facility; the Pharmacy Foundation of 1991; the PhD School of Molecular Metabolism University of Southern Denmark; the Raine Medical Research Foundation; the Royal Society; the Sigrid Juselius Foundation; South West NHS Research and Development; the Spanish Ministry of Science and Innovation (SAF2008-00357), Turku University Hospital; the Swiss National Science Foundation (33CSCO-122661); the Tampere Tuberculosis Foundation; the Telethon Institute for Child Health Research; the Turku University Foundation; the US Centers for Disease Control and Prevention; University Hospital Oulu, Biocenter, the University of Oulu (75617); the University of Bristol; the University of Potsdam; the University of Southampton; the University of Western Australia (UWA); the VU Institute for Health and Care Research (EMGO+) and the Neuroscience Campus Amsterdam (NCA); the Wellcome Trust (grants GR069224, WT088806, 068545/Z/02, 076467, 085301, 090532, 083270, 083948, 085541/Z/08/Z, WT089549 and WT083431MA); and the Yrjo Jahnsson Foundation.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Freathy RM, 2010, DIABETES, V59, P2682, DOI 10.2337/db10-0177; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Freathy RM, 2009, DIABETES, V58, P1428, DOI 10.2337/db08-1739; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Krestyaninova M, 2009, BIOINFORMATICS, V25, P2768, DOI 10.1093/bioinformatics/btp420; Lenfant C, 2008, METABOLISM, V57, pS32, DOI 10.1016/j.metabol.2008.07.013; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2005, DIABETES, V54, P576, DOI 10.2337/diabetes.54.2.576; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao JH, 2009, DIABETES, V58, P2414, DOI 10.2337/db09-0506	53	224	227	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					76	U115		10.1038/ng.2477	http://dx.doi.org/10.1038/ng.2477			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202124	Green Accepted, Green Submitted			2022-12-25	WOS:000312838800016
J	Kloss, CC; Condomines, M; Cartellieri, M; Bachmann, M; Sadelain, M				Kloss, Christopher C.; Condomines, Maud; Cartellieri, Marc; Bachmann, Michael; Sadelain, Michel			Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells	NATURE BIOTECHNOLOGY			English	Article							ADOPTIVE IMMUNOTHERAPY; PROSTATE-CANCER; CD28; PROLIFERATION; EXPRESSION; CD80	Current T-cell engineering approaches redirect patient T cells to tumors by transducing them with antigen-specific T-cell receptors (TCRs) or chimeric antigen receptors (CARs) that target a single antigen(1-3). However, few truly tumor-specific antigens have been identified, and healthy tissues that express the targeted antigen may undergo T cell-mediated damage(4-7). Here we present a strategy to render T cells specific for a tumor in the absence of a truly tumor-restricted antigen. T cells are transduced with both a CAR that provides suboptimal activation upon binding of one antigen and a chimeric costimulatory receptor (CCR) that recognizes a second antigen. Using the prostate tumor antigens PSMA and PSCA, we show that co-transduced T cells destroy tumors that express both antigens but do not affect tumors expressing either antigen alone. This 'tumor-sensing' strategy may help broaden the applicability and avoid some of the side effects of targeted T-cell therapies.	[Kloss, Christopher C.; Condomines, Maud; Sadelain, Michel] MSKCC, Ctr Cell Engn, New York, NY USA; [Kloss, Christopher C.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Biochem Cell & Mol Biol Program, New York, NY 10021 USA; [Cartellieri, Marc; Bachmann, Michael] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany; [Bachmann, Michael] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Sadelain, Michel] MSKCC, Mol Pharmacol & Chem Program, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), MSKCC, Ctr Cell Engn, New York, NY USA.	m-sadelain@ski.mskcc.org	Cartellieri, Marc/M-3281-2013; Bachmann, Michael P/E-8850-2010; Cartellieri, Marc/AAL-8197-2020; Bachmann, Michael/AAA-5153-2020	Cartellieri, Marc/0000-0002-4672-3963; Bachmann, Michael P/0000-0002-8029-5755; Bachmann, Michael/0000-0002-8029-5755	Department of Defense Prostate Cancer Training Award [PC101964]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Major Family Fund for Cancer Research at Memorial Sloan-Kettering; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Training Award(United States Department of Defense); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Major Family Fund for Cancer Research at Memorial Sloan-Kettering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Riviere for reviewing the manuscript and J. Plotkin and G. Gunset for outstanding technical assistance. Our work is supported by Department of Defense Prostate Cancer Training Award PC101964 (C. C. K.), the Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center, the Major Family Fund for Cancer Research at Memorial Sloan-Kettering, the support of Mr. and Mrs. Joel S. Mallah, and Mr. Lewis Sanders.	Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Duong CPM, 2011, IMMUNOTHERAPY-UK, V3, P33, DOI 10.2217/IMT.10.81; Feldmann A, 2012, J IMMUNOL, V189, P3249, DOI 10.4049/jimmunol.1200341; Feldmann A, 2011, PROSTATE, V71, P998, DOI 10.1002/pros.21315; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Krause A, 1998, J EXP MED, V188, P619, DOI 10.1084/jem.188.4.619; Lam JS, 2005, CLIN CANCER RES, V11, P2591, DOI 10.1158/1078-0432.CCR-04-1842; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liu JC, 2012, P NATL ACAD SCI USA, V109, P5832, DOI 10.1073/pnas.1201105109; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shih IM, 2009, FUTURE ONCOL, V5, P1641, DOI [10.2217/fon.09.126, 10.2217/FON.09.126]; Shin SM, 2007, J LEUKOCYTE BIOL, V81, P1455, DOI 10.1189/jlb.1006619; Silver DA, 1997, CLIN CANCER RES, V3, P81; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Tammana S, 2010, HUM GENE THER, V21, P75, DOI 10.1089/hum.2009.122; Wang J, 2007, HUM GENE THER, V18, P712, DOI 10.1089/hum.2007.028; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilkie S, 2012, J CLIN IMMUNOL, V32, P1059, DOI 10.1007/s10875-012-9689-9; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	34	578	666	4	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					71	+		10.1038/nbt.2459	http://dx.doi.org/10.1038/nbt.2459			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242161	Green Accepted			2022-12-25	WOS:000313563600024
J	Knapp, S; Arruda, P; Blagg, J; Burley, S; Drewry, DH; Edwards, A; Fabbro, D; Gillespie, P; Gray, NS; Kuster, B; Lackey, KE; Mazzafera, P; Tomkinson, NCO; Willson, TM; Workman, P; Zuercher, WJ				Knapp, Stefan; Arruda, Paulo; Blagg, Julian; Burley, Stephen; Drewry, David H.; Edwards, Aled; Fabbro, Doriano; Gillespie, Paul; Gray, Nathanael S.; Kuster, Bernhard; Lackey, Karen E.; Mazzafera, Paulo; Tomkinson, Nicholas C. O.; Willson, Timothy M.; Workman, Paul; Zuercher, William J.			A public-private partnership to unlock the untargeted kinome	NATURE CHEMICAL BIOLOGY			English	Article							KINASE INHIBITOR; SELECTIVE INHIBITOR; CELL; DISCOVERY; CANCER; POTENT; ABL		[Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Arruda, Paulo; Mazzafera, Paulo] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Blagg, Julian; Workman, Paul] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England; [Burley, Stephen] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Edwards, Aled] Struct Genom Consortium, Toronto, ON, Canada; [Fabbro, Doriano] Novartis, Expertise Platform Kinases, Basel, Switzerland; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kuster, Bernhard] Tech Univ Munich, Munich, Germany; [Gillespie, Paul; Lackey, Karen E.] Hoffmann La Roche Inc, Pharmaceut Res & Early Dev, Nutley, NJ 07110 USA; [Tomkinson, Nicholas C. O.] Univ Strathclyde, Glasgow, Lanark, Scotland; [Drewry, David H.; Willson, Timothy M.; Zuercher, William J.] GlaxoSmithKline, Dept Biol Chem, Res Triangle Pk, NC USA	University of Oxford; University of Oxford; Universidade de Sao Paulo; Universidade Estadual de Campinas; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of California System; University of California San Diego; University of Toronto; Structural Genomics Consortium; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Technical University of Munich; Roche Holding; University of Strathclyde; GlaxoSmithKline	Knapp, S (corresponding author), Univ Oxford, Dept Clin Pharmacol, Oxford, England.	william.j.zuercher@gsk.com	Kuster, Bernhard/Q-6031-2016; Arruda, Paulo/H-1440-2011; Knapp, Stefan/AAG-2347-2019; Mazzafera, Paulo/D-4766-2012; feinstein, doug/M-9414-2019	Kuster, Bernhard/0000-0002-9094-1677; Knapp, Stefan/0000-0001-5995-6494; Mazzafera, Paulo/0000-0001-9073-4056; Drewry, David Harold/0000-0001-5973-5798; Tomkinson, Nicholas/0000-0002-5509-0133; Burley, Stephen K./0000-0002-2487-9713; Edwards, Aled/0000-0002-4782-6016	Cancer Research UK [11566] Funding Source: Medline; Wellcome Trust [092809] Funding Source: Medline; EPSRC [EP/H031111/2, EP/H031111/1, EP/I037229/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I037229/1, EP/H031111/2, EP/H031111/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Cohen P, 2010, BIOCHEM J, V425, P53, DOI 10.1042/BJ20091428; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Dowling JE, 2012, ACS MED CHEM LETT, V3, P278, DOI 10.1021/ml200257n; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Lin XY, 2012, J MED CHEM, V55, P5749, DOI 10.1021/jm300338m; Medina JR, 2011, J MED CHEM, V54, P1871, DOI 10.1021/jm101527u; Mott BT, 2009, BIOORG MED CHEM LETT, V19, P6700, DOI 10.1016/j.bmcl.2009.09.121; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Shimomura T, 2010, MOL CANCER THER, V9, P157, DOI 10.1158/1535-7163.MCT-09-0609; Weigelt J, 2009, EMBO REP, V10, P941, DOI 10.1038/embor.2009.193; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	24	110	111	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					3	7		10.1038/nchembio.1113	http://dx.doi.org/10.1038/nchembio.1113			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23238671				2022-12-25	WOS:000312484200002
J	Trapnell, C; Hendrickson, DG; Sauvageau, M; Goff, L; Rinn, JL; Pachter, L				Trapnell, Cole; Hendrickson, David G.; Sauvageau, Martin; Goff, Loyal; Rinn, John L.; Pachter, Lior			Differential analysis of gene regulation at transcript resolution with RNA-seq	NATURE BIOTECHNOLOGY			English	Article							EXPRESSION ANALYSIS; REVEALS; IDENTIFICATION; PLURIPOTENT; PACKAGE	Differential analysis of gene and transcript expression using high-throughput RNA sequencing (RNA-seq) is complicated by several sources of measurement variability and poses numerous statistical challenges. We present Cuffdiff 2, an algorithm that estimates expression at transcript-level resolution and controls for variability evident across replicate libraries. Cuffdiff 2 robustly identifies differentially expressed transcripts and genes and reveals differential splicing and promoter-preference changes. We demonstrate the accuracy of our approach through differential analysis of lung fibroblasts in response to loss of the developmental transcription factor HOXA1, which we show is required for lung fibroblast and HeLa cell cycle progression. Loss of HOXA1 results in significant expression level changes in thousands of individual transcripts, along with isoform switching events in key regulators of the cell cycle. Cuffdiff 2 performs robust differential analysis in RNA-seq experiments at transcript resolution, revealing a layer of regulation not readily observable with other high-throughput technologies.	[Trapnell, Cole; Hendrickson, David G.; Sauvageau, Martin; Goff, Loyal; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Trapnell, Cole; Hendrickson, David G.; Sauvageau, Martin; Goff, Loyal; Rinn, John L.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Goff, Loyal] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pachter, L (corresponding author), Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA.	john_rinn@harvard.edu; lpachter@math.berkeley.edu	Sauvageau, Martin/A-8967-2013	Sauvageau, Martin/0000-0001-9487-5016; Goff, Loyal/0000-0003-2875-451X; Rinn, John/0000-0002-7231-7539; Pachter, Lior/0000-0002-9164-6231	US National Institutes of Health [DP2OD006670, P01GM099117, P50HG006193, RO1ES020260, R01 HG006129, R01 DK094699]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006129, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to D. Kelley for a careful reading of the manuscript, and B. Wold for sharing the hESC RNA-seq data. We are also thankful for the ongoing development efforts of A. Roberts, B. Langmead, D. Kim, G. Pertea, H. Pimentel and S. Salzberg. C. T. and D. G. H. are Damon Runyon Postdoctoral Fellows. J.L.R. is a Damon Runyon-Rachleff Inovator fellow. This work was supported by US National Institutes of Health grants DP2OD006670, P01GM099117, P50HG006193 and RO1ES020260 (to J.L.R.) and R01 HG006129 and R01 DK094699 (to L.P.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; Cabili MN, 2011, GENES DEV; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Guillamot M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00189; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hiller D, 2009, BIOINFORMATICS, V25, P3056, DOI 10.1093/bioinformatics/btp544; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang X, 2010, J BIOINF COMPUT BIOL, V8, P177, DOI 10.1142/S0219720010005178; Washkowitz AJ, 2012, WIRES SYST BIOL MED, V4, P273, DOI 10.1002/wsbm.1162; Wilson V, 2002, GENOME BIOL, V3, P30081, DOI [10.1186/gb-2002-3-6-reviews3008, DOI 10.1186/GB-2002-3-6-REVIEWS3008]; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	50	2336	2388	5	491	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					46	+		10.1038/nbt.2450	http://dx.doi.org/10.1038/nbt.2450			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23222703	Green Accepted			2022-12-25	WOS:000313563600021
J	Xu, Q; Chen, LL; Ruan, XA; Chen, DJ; Zhu, AD; Chen, CL; Bertrand, D; Jiao, WB; Hao, BH; Lyon, MP; Chen, JJ; Gao, S; Xing, F; Lan, H; Chang, JW; Ge, XH; Lei, Y; Hu, Q; Miao, Y; Wang, L; Xiao, SX; Biswas, MK; Zeng, WF; Guo, F; Cao, HB; Yang, XM; Xu, XW; Cheng, YJ; Xu, J; Liu, JH; Luo, OJ; Tang, ZH; Guo, WW; Kuang, HH; Zhang, HY; Roose, ML; Nagarajan, N; Deng, XX; Ruan, YJ				Xu, Qiang; Chen, Ling-Ling; Ruan, Xiaoan; Chen, Dijun; Zhu, Andan; Chen, Chunli; Bertrand, Denis; Jiao, Wen-Biao; Hao, Bao-Hai; Lyon, Matthew P.; Chen, Jiongjiong; Gao, Song; Xing, Feng; Lan, Hong; Chang, Ji-Wei; Ge, Xianhong; Lei, Yang; Hu, Qun; Miao, Yin; Wang, Lun; Xiao, Shixin; Biswas, Manosh Kumar; Zeng, Wenfang; Guo, Fei; Cao, Hongbo; Yang, Xiaoming; Xu, Xi-Wen; Cheng, Yun-Jiang; Xu, Juan; Liu, Ji-Hong; Luo, Oscar Junhong; Tang, Zhonghui; Guo, Wen-Wu; Kuang, Hanhui; Zhang, Hong-Yu; Roose, Mikeal L.; Nagarajan, Niranjan; Deng, Xiu-Xin; Ruan, Yijun			The draft genome of sweet orange (Citrus sinensis)	NATURE GENETICS			English	Article							LTR-RETROTRANSPOSONS; MOLECULAR MARKERS; RNA-SEQ; SEQUENCE; FRUIT; GENE; PLANTS; ORIGIN; IDENTIFICATION; ALIGNMENT	Oranges are an important nutritional source for human health and have immense economic value. Here we present a comprehensive analysis of the draft genome of sweet orange (Citrus sinensis). The assembled sequence covers 87.3% of the estimated orange genome, which is relatively compact, as 20% is composed of repetitive elements. We predicted 29,445 protein-coding genes, half of which are in the heterozygous state. With additional sequencing of two more citrus species and comparative analyses of seven citrus genomes, we present evidence to suggest that sweet orange originated from a backcross hybrid between pummelo and mandarin. Focused analysis on genes involved in vitamin C metabolism showed that GalUR, encoding the rate-limiting enzyme of the galacturonate pathway, is significantly upregulated in orange fruit, and the recent expansion of this gene family may provide a genomic basis. This draft genome represents a valuable resource for understanding and improving many important citrus traits in the future.	[Xu, Qiang; Zhu, Andan; Chen, Chunli; Chen, Jiongjiong; Lan, Hong; Hu, Qun; Wang, Lun; Xiao, Shixin; Biswas, Manosh Kumar; Zeng, Wenfang; Guo, Fei; Cao, Hongbo; Yang, Xiaoming; Cheng, Yun-Jiang; Xu, Juan; Liu, Ji-Hong; Guo, Wen-Wu; Kuang, Hanhui; Deng, Xiu-Xin] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China; [Chen, Ling-Ling; Chen, Dijun; Chen, Chunli; Jiao, Wen-Biao; Hao, Bao-Hai; Xing, Feng; Chang, Ji-Wei; Lei, Yang; Miao, Yin; Xu, Xi-Wen; Tang, Zhonghui; Zhang, Hong-Yu; Ruan, Yijun] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Ruan, Xiaoan; Bertrand, Denis; Gao, Song; Luo, Oscar Junhong; Nagarajan, Niranjan; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Lyon, Matthew P.; Roose, Mikeal L.] Univ Calif Riverside, Riverside, CA 92521 USA; [Ge, Xianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California Riverside; Huazhong Agricultural University	Deng, XX (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China.	xxdeng@mail.hzau.edu.cn; yijun.ruan@gmail.com	Luo, Oscar Junhong/G-3293-2018; Luo, Junhong/N-8583-2019; Chen, Ling-Ling/AAY-3547-2021; Chen, Dijun/P-3877-2014; cheng, yj/G-4049-2011; cheng, yunjiang/B-1199-2015	Chen, Dijun/0000-0002-7456-2511; cheng, yj/0000-0002-9159-9455; cheng, yunjiang/0000-0002-9159-9455; Chen, Chunli/0000-0002-6464-4580; Jiao, Wen-Biao/0000-0001-8355-2959; Luo, Oscar Junhong/0000-0002-1266-3069; Xiuxin, Deng/0000-0003-4490-4514; Nagarajan, Niranjan/0000-0003-0850-5604	Ministry of Science and Technology of China [2011CB100600]; National Natural Science Foundation of China [30921002, 30830078, 31071779]; Ministry of Agriculture [2011-g21, CARS-27]; Citrus Research Board [5200-125]; University of California [itl-bio-10155]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Citrus Research Board; University of California(University of California System)	The sweet orange genome project was supported by the Ministry of Science and Technology of China (2011CB100600), the National Natural Science Foundation of China (30921002, 30830078 and 31071779) and the Ministry of Agriculture (2011-g21 and CARS-27). Sweet orange mapping was funded by the Citrus Research Board (5200-125) and University of California Discovery grant program (itl-bio-10155). We thank W. Xie and Z. Li for their assistance in bioinformatic analysis and cytological experiments.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Baig MNR, 2009, GENOME, V52, P484, DOI [10.1139/G09-017, 10.1139/g09-017]; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Cao HB, 2011, PLANT CELL TISS ORG, V104, P415, DOI 10.1007/s11240-010-9860-z; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen CX, 2008, TREE GENET GENOMES, V4, P1, DOI 10.1007/s11295-007-0083-3; Chinese Society of Citriculture, 2008, CITR IND CHIN; Cruz-Rus E, 2010, J PLANT PHYSIOL, V167, P739, DOI 10.1016/j.jplph.2009.12.017; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Du JC, 2010, PLANT J, V63, P584, DOI 10.1111/j.1365-313X.2010.04263.x; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Gao S, 2011, J COMPUT BIOL, V18, P1681, DOI 10.1089/cmb.2011.0170; GMITTER FG, 1990, ECON BOT, V44, P267, DOI 10.1007/BF02860491; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; GUERRA M, 1993, HEREDITY, V71, P234, DOI 10.1038/hdy.1993.131; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; IWAMASA M., 1963, Chromosome Information Service, P9; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Legge J., 1865, CHINESE CLASSICS 3, V3, P111; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lyon M.P, 2008, THESIS U CALIFORNIA; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendel K., 1981, P INT SOC CITRICULTU, V1, P86; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Roose M. L., 2008, Genomics of tropical crop plants, P187; Ruan XA, 2012, METHODS MOL BIOL, V809, P535, DOI 10.1007/978-1-61779-376-9_35; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Webber H.J., 1967, CITRUS IND, V1, P1; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246	57	605	712	30	332	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					59	U92		10.1038/ng.2472	http://dx.doi.org/10.1038/ng.2472			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23179022	hybrid			2022-12-25	WOS:000312838800013
J	Marks, DS; Hopf, TA; Sander, C				Marks, Debora S.; Hopf, Thomas A.; Sander, Chris			Protein structure prediction from sequence variation	NATURE BIOTECHNOLOGY			English	Review							RESIDUE CONTACTS; SOFTWARE SUITE; CRYSTALLOGRAPHY; COEVOLUTION; INFORMATION; COVARIANCE; PRINCIPLES; FAMILIES; GENOMICS; DESIGN	Genomic sequences contain rich evolutionary information about functional constraints on macromolecules such as proteins. This information can be efficiently mined to detect evolutionary couplings between residues in proteins and address the long-standing challenge to compute protein three-dimensional structures from amino acid sequences. Substantial progress has recently been made on this problem owing to the explosive growth in available sequences and the application of global statistical methods. In addition to three-dimensional structure, the improved understanding of covariation may help identify functional residues involved in ligand binding, protein-complex formation and conformational changes. We expect computation of covariation patterns to complement experimental structural biology in elucidating the full spectrum of protein structures, their functional interactions and evolutionary dynamics.	[Marks, Debora S.; Hopf, Thomas A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Marks, DS (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ecreview@hms.harvard.edu; ecreview@hms.harvard.edu			NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ANFINSEN CB, 1962, COMP BIOCHEM PHYSIOL, V4, P229, DOI 10.1016/0010-406X(62)90007-5; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Ezkurdia I, 2009, PROTEINS, V77, P196, DOI 10.1002/prot.22554; Fariselli P, 2001, PROTEINS, P157, DOI 10.1002/prot.1173; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; GEORGES A, 1991, J PHYS A-MATH GEN, V24, P2173, DOI 10.1088/0305-4470/24/9/024; Giraud BG, 1999, PHYS REV E, V59, P4983, DOI 10.1103/PhysRevE.59.4983; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Godzik A, 2011, CURR OPIN STRUC BIOL, V21, P398, DOI 10.1016/j.sbi.2011.03.010; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HAVEL TF, 1983, J THEOR BIOL, V104, P359, DOI 10.1016/0022-5193(83)90112-1; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; Kryshtafovych A, 2011, PROTEINS, V79, P196, DOI 10.1002/prot.23182; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Lapedes A.B.G., 2012, 29 ARXIV, P29; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lees J, 2012, NUCLEIC ACIDS RES, V40, pD465, DOI 10.1093/nar/gkr1181; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Liu LC, 1999, MONOGRAPH SERIES I M, P236; Livesay DR, 2012, METHODS MOL BIOL, V796, P385, DOI 10.1007/978-1-61779-334-9_21; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Monastyrskyy B, 2011, PROTEINS, V79, P119, DOI 10.1002/prot.23160; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Newman M. E. J., 1992, THEORY CRITICAL PHEN; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; PLEFKA T, 1982, J PHYS A-MATH GEN, V15, P1971, DOI 10.1088/0305-4470/15/6/035; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Taylor WR, 2012, PROTEIN SCI, V21, P299, DOI 10.1002/pro.2002; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; TIKOCHINSKY Y, 1984, PHYS REV A, V30, P2638, DOI 10.1103/PhysRevA.30.2638; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wright S., 1921, J AGR RES, P29; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	61	399	403	7	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1072	1080		10.1038/nbt.2419	http://dx.doi.org/10.1038/nbt.2419			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138306	Bronze, Green Accepted			2022-12-25	WOS:000311087500026
J	Muramatsu, R; Takahashi, C; Miyake, S; Fujimura, H; Mochizuki, H; Yamashita, T				Muramatsu, Rieko; Takahashi, Chisato; Miyake, Shuzo; Fujimura, Harutoshi; Mochizuki, Hideki; Yamashita, Toshihide			Angiogenesis induced by CNS inflammation promotes neuronal remodeling through vessel-derived prostacyclin	NATURE MEDICINE			English	Article							SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; CORTICOSPINAL NEURONS; ANIMAL-MODEL; CONNECTIONS; RECOVERY; GUIDANCE; RATS; REGENERATION	Angiogenesis is a prominent feature of central nervous system (CNS) disease and has roles in both the continued promotion of inflammation and the subsequent repair processes. Here we report that prostacyclin (or prostaglandin I-2 (PGI(2))) derived from new vessels promotes axonal remodeling of injured neuronal networks after CNS inflammation. In a localized model of experimental autoimmune encephalomyelitis (EAE), new vessels formed around the inflammatory lesion, followed by sprouting of adjacent corticospinal tract (CST) fibers. These sprouting fibers formed a compensatory motor circuit, leading to recovery of motor function. Capillary endothelial cell-derived prostacyclin bound to its receptor, the type I prostaglandin receptor (IP receptor), on CST neurons, promoting sprouting of CST fibers and contributing to the repair process. Inhibition of prostacyclin receptor signaling impaired motor recovery, whereas the IP receptor agonist iloprost promoted axonal remodeling and motor recovery after the induction of EAE. These findings reveal an important function of angiogenesis in neuronal rewiring and suggest that prostacyclin is a promising molecule for enhancing functional recovery from CNS disease.	[Muramatsu, Rieko; Takahashi, Chisato; Miyake, Shuzo; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Muramatsu, Rieko; Takahashi, Chisato; Miyake, Shuzo; Mochizuki, Hideki; Yamashita, Toshihide] Japan Sci & Technol Agcy, Tokyo, Japan; [Fujimura, Harutoshi] Toneyama Natl Hosp, Toyonaka, Osaka, Japan; [Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Muramatsu, Rieko/F-4109-2014	Muramatsu, Rieko/0000-0001-5342-7823; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Sciences [23122512]; Core Research for Evolutional Science and Technology from Japan Science and Technology Agency	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology from Japan Science and Technology Agency	The authors are grateful to N. Takakura, H. Kidoya and M. Ueno for helpful comments and M. Niwa and S. Nakagawa for technical advice on culturing of endothelial cells. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (23122512) from the Japan Society for the Promotion of Sciences to R. M. and the Core Research for Evolutional Science and Technology from Japan Science and Technology Agency to T.Y.	Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Black JA, 2006, BRAIN, V129, P3196, DOI 10.1093/brain/awl216; Buddeberg BS, 2004, J NEUROIMMUNOL, V153, P158, DOI 10.1016/j.jneuroim.2004.05.006; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Fokman J., 1992, INFLAMMATION BASIC P, P821; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hino T, 2006, BIOCHEM BIOPH RES CO, V340, P263, DOI 10.1016/j.bbrc.2005.11.173; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jung S, 1997, J AUTOIMMUN, V10, P519, DOI 10.1006/jaut.1997.0159; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kirk S, 2004, J NEUROL SCI, V217, P125, DOI 10.1016/j.jns.2003.10.016; Kirk SL, 2003, J AUTOIMMUN, V21, P353, DOI 10.1016/S0896-8411(03)00139-2; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; MENETREY D, 1985, NEUROSCI LETT, V58, P257, DOI 10.1016/0304-3940(85)90174-0; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Uesugi N, 2009, BIOCHEM BIOPH RES CO, V383, P509, DOI 10.1016/j.bbrc.2009.04.085; VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087	32	74	76	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1658	+		10.1038/nm.2943	http://dx.doi.org/10.1038/nm.2943			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23042236				2022-12-25	WOS:000310837000026
J	Smith, C; Strauss, S; DeFrancesco, L				Smith, Caitlin; Strauss, Stephen; DeFrancesco, Laura			DNA goes to court	NATURE BIOTECHNOLOGY			English	Article															Canadian Institutes of Health Research, Ottowa, Canada	Canadian Institutes of Health Research, Ottowa, Canada(Canadian Institutes of Health Research (CIHR))	SS received funding from the Canadian Institutes of Health Research, Ottowa, Canada.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Ackerman MJ, 1999, NEW ENGL J MED, V341, P1121, DOI 10.1056/NEJM199910073411504; Illumina Enters Collaborative Research Agreement with UNTHSC for Next-Generation Sequencing in Forensic DNA Analysis, 2011, ILL ENT COLL RES AGR; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Kayser M, 2011, NAT REV GENET, V12, P179, DOI 10.1038/nrg2952; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Thompson W., GENETIC EXPLORATIONS, P227	8	4	4	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1047	1053		10.1038/nbt.2408	http://dx.doi.org/10.1038/nbt.2408			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138297				2022-12-25	WOS:000311087500019
J	Bacchus, W; Lang, M; El-Baba, MD; Weber, W; Stelling, J; Fussenegger, M				Bacchus, William; Lang, Moritz; El-Baba, Marie Daoud; Weber, Wilfried; Stelling, Joerg; Fussenegger, Martin			Synthetic two-way communication between mammalian cells	NATURE BIOTECHNOLOGY			English	Article							GLUCOSE-HOMEOSTASIS; MICE; ANGIOPOIETIN-1; EXPRESSION; CIRCUIT; NETWORKS; LEAKAGE; GROWTH; SWITCH	The design of synthetic biology-inspired control devices enabling entire mammalian cells to receive, process and transfer metabolic information and so communicate with each other via synthetic multichannel networks may provide new insight into the organization of multicellular organisms and future clinical interventions(1). Here we describe communication networks that orchestrate behavior in individual mammalian cells in response to cell-to-cell metabolic signals. We engineered sender, processor and receiver cells that interact with each other in ways that resemble natural intercellular communication networks such as multistep information processing cascades, feed-forward-based signaling loops, and two-way communication. The engineered two-way communication devices mimicking natural control systems in the development of vertebrate extremities(2) and vasculature(3-5) was used to program temporal permeability in vascular endothelial cell layers. These synthetic multicellular communication systems may inspire future therapies or tissue engineering strategies.	[Bacchus, William; Lang, Moritz; Weber, Wilfried; Stelling, Joerg; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [El-Baba, Marie Daoud] IUTA, Dept Genie Biol, Inst Univ Technol, Villeurbanne, France; [Weber, Wilfried] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Weber, Wilfried] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany; [Stelling, Joerg] ETH, Swiss Inst Bioinformat, Zurich, Switzerland; [Fussenegger, Martin] Univ Basel, Fac Sci, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Basel	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Weber, Wilfried/B-4732-2012; Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X; Lang, Moritz/0000-0002-9380-8679; Weber, Wilfried/0000-0003-4340-4446	Swiss National Science Foundation [31003A0-126022]; EC Framework 7 (Persist); Excellence Initiative of the German Federal and State Governments [EXC 294]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC Framework 7 (Persist)(European Commission); Excellence Initiative of the German Federal and State Governments	We thank M. Tan (pMT1182), M. Ehrbar (pVEGF165pcDNA3), G.Y. Koh (pAng-1) and K. Frei (EA.hy926 cells) for providing reagents and D. Grasso for critical comments on the manuscript. This work was supported by the Swiss National Science Foundation (grant no. 31003A0-126022) and in part by the EC Framework 7 (Persist). Work of W.W. is supported by the Excellence Initiative of the German Federal and State Governments (EXC 294).	Akers JC, 2006, J BACTERIOL, V188, P4236, DOI 10.1128/JB.01660-05; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; HARTMAN SC, 1988, P NATL ACAD SCI USA, V85, P8047, DOI 10.1073/pnas.85.21.8047; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Schlatter S, 2002, GENE, V282, P19, DOI 10.1016/S0378-1119(01)00824-1; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Thurston G, 2002, J ANAT, V200, P575, DOI 10.1046/j.1469-7580.2002.00061.x; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Weber W, 2004, NAT BIOTECHNOL, V22, P1440, DOI 10.1038/nbt1021; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535	30	71	77	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					991	+		10.1038/nbt.2351	http://dx.doi.org/10.1038/nbt.2351			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	22983089				2022-12-25	WOS:000309965500026
J	Bidwell, BN; Slaney, CY; Withana, NP; Forster, S; Cao, Y; Loi, S; Andrews, D; Mikeska, T; Mangan, NE; Samarajiwa, SA; de Weerd, NA; Gould, J; Argani, P; Moller, A; Smyth, MJ; Anderson, RL; Hertzog, PJ; Parker, BS				Bidwell, Bradley N.; Slaney, Clare Y.; Withana, Nimali P.; Forster, Sam; Cao, Yuan; Loi, Sherene; Andrews, Daniel; Mikeska, Thomas; Mangan, Niamh E.; Samarajiwa, Shamith A.; de Weerd, Nicole A.; Gould, Jodee; Argani, Pedram; Moeller, Andreas; Smyth, Mark J.; Anderson, Robin L.; Hertzog, Paul J.; Parker, Belinda S.			Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape	NATURE MEDICINE			English	Article							SUPPRESSOR-CELLS; MAMMARY CARCINOMAS; GENE-EXPRESSION; I INTERFERONS; MOLECULAR PORTRAITS; ADAPTIVE IMMUNITY; GENOMIC ANALYSIS; TUMORS; BETA; METHYLATION	Breast cancer metastasis is a key determinant of long-term patient survival. By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7. Restoration of Irf7 in tumor cells or administration of interferon led to reduced bone metastases and prolonged survival time. In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells. We confirmed the clinical relevance of these findings in over 800 patients in which high expression of Irf7-regulated genes in primary tumors was associated with prolonged bone metastasis-free survival. This gene signature may identify patients that could benefit from IFN-based therapies. Thus, we have identified an innate immune pathway intrinsic to breast cancer cells, the suppression of which restricts immunosurveillance to enable metastasis.	[Bidwell, Bradley N.; Slaney, Clare Y.; Withana, Nimali P.; Cao, Yuan; Andrews, Daniel; Mikeska, Thomas; Moeller, Andreas; Smyth, Mark J.; Anderson, Robin L.; Parker, Belinda S.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bidwell, Bradley N.; Cao, Yuan; Andrews, Daniel; Moeller, Andreas; Parker, Belinda S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Slaney, Clare Y.; Andrews, Daniel; Smyth, Mark J.; Anderson, Robin L.; Parker, Belinda S.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Withana, Nimali P.; Mikeska, Thomas; Moeller, Andreas; Anderson, Robin L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Forster, Sam; Mangan, Niamh E.; Samarajiwa, Shamith A.; de Weerd, Nicole A.; Gould, Jodee; Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Loi, Sherene] Inst Jules Bordet, Breast Canc Translat Res Lab, B-1000 Brussels, Belgium; [Samarajiwa, Shamith A.] Canc Res UK, Cambridge Res Inst, Dept Oncol, Cambridge, England; [Argani, Pedram] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Monash University; Institut Jules Bordet; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Johns Hopkins University; Johns Hopkins Medicine	Parker, BS (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	paul.hertzog@monash.edu	Hertzog, Paul J/G-6734-2013; de Weerd, Nicole/X-5886-2019; Mikeska, Thomas/B-4876-2008; Anderson, Robin/I-2306-2013; Hertzog, Paul J/I-7053-2013; Möller, Andreas/O-1063-2015; Slaney, Clare/AHC-2382-2022; Smyth, Mark J/H-8709-2014; Forster, Samuel C/F-4206-2014; Loi, Sherene/H-1979-2016; Samarajiwa, Shamith/B-1601-2013; Anderson, Robin/K-6966-2019; Anderson, Robin/S-1005-2017	Hertzog, Paul J/0000-0002-1373-8472; de Weerd, Nicole/0000-0002-7985-189X; Mikeska, Thomas/0000-0003-1318-0859; Hertzog, Paul J/0000-0002-1373-8472; Möller, Andreas/0000-0002-8618-6998; Smyth, Mark J/0000-0001-7098-7240; Forster, Samuel C/0000-0003-4144-2537; Loi, Sherene/0000-0001-6137-9171; Samarajiwa, Shamith/0000-0003-1046-0601; Slaney, Clare/0000-0002-6986-6115; Mangan, Niamh/0000-0003-3844-0709; Anderson, Robin/0000-0002-6841-7422; Parker, Belinda/0000-0002-8333-1926; Andrews, Dan/0000-0002-5896-7885	Cancer Council Victoria; Australian National Health and Medical Research Council (NHMRC); Association of International Cancer Research (AICR); Operational Infrastructure Scheme of the Victorian State government Department of Business and Innovation; Australian Research Council (ARC) Centre for Structural and Functional Microbial Genomics; Australian National Breast Cancer Foundation, NBCF; NBCF; NBCF, Cure Cancer Australia; Cancer Research UK [19556] Funding Source: researchfish; National Breast Cancer Foundation [PF-12-14] Funding Source: researchfish	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Association of International Cancer Research (AICR); Operational Infrastructure Scheme of the Victorian State government Department of Business and Innovation; Australian Research Council (ARC) Centre for Structural and Functional Microbial Genomics(Australian Research Council); Australian National Breast Cancer Foundation, NBCF; NBCF; NBCF, Cure Cancer Australia; Cancer Research UK(Cancer Research UK); National Breast Cancer Foundation	This work was supported by the Cancer Council Victoria (B.S.P.), the Australian National Health and Medical Research Council (NHMRC) (P.J.H.), the Association of International Cancer Research (AICR) (A.M.), the Operational Infrastructure Scheme of the Victorian State government Department of Business and Innovation, the Australian Research Council (ARC) Centre for Structural and Functional Microbial Genomics and fellowship support for B.S.P. (NHMRC), R.L.A. (Australian National Breast Cancer Foundation, NBCF), A.M. (NBCF), C.Y.S. (NBCF, Cure Cancer Australia). We thank P. Hill (St Vincent's Pathology, St Vincent's Hospital, Fitzroy, Australia) for providing archived human breast cancer tissues assistance in the pathological assessment of immunohistochemistry staining and B. Haibe-Kains for assistance with codes in R. We also thank F. Miller (Karmanos Cancer Institute, Detroit, MI) for providing 66cl4 and 4T1 cell lines.	Adeegbe D, 2011, CELL TRANSPLANT, V20, P941, DOI 10.3727/096368910X540621; American Cancer Society, 2012, BREAST CANC FACTS FI; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chin AI, 2010, CANCER RES, V70, P2595, DOI 10.1158/0008-5472.CAN-09-1162; Cimino A, 2010, BREAST CANCER RES TR, V123, P701, DOI 10.1007/s10549-009-0671-z; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Coppin C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006017.pub2; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Fehm T, 2008, APMIS, V116, P742, DOI 10.1111/j.1600-0463.2008.01047.x; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Garbe C, 2008, MELANOMA RES, V18, P61, DOI 10.1097/CMR.0b013e3282f0c893; Gnant M, 2011, LANCET ONCOL, V12, P631, DOI 10.1016/S1470-2045(11)70122-X; Hadden JW, 1999, INT J IMMUNOPHARMACO, V21, P79, DOI 10.1016/S0192-0561(98)00077-0; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mikeska T, 2011, METHODS MOL BIOL, V791, P33, DOI 10.1007/978-1-61779-316-5_4; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Oruc MT, 2004, LIVER TRANSPLANT, V10, P1, DOI 10.1002/lt.20025; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Repetto L, 1996, BREAST CANCER RES TR, V39, P235, DOI 10.1007/BF01806190; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; St Croix B, 2000, SCIENCE, V289, P1197; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	66	297	315	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1224	1231		10.1038/nm.2830	http://dx.doi.org/10.1038/nm.2830			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820642				2022-12-25	WOS:000307469300028
J	Dong, J; Hu, ZB; Wu, C; Guo, H; Zhou, BS; Lv, JC; Lu, DR; Chen, KX; Shi, YY; Chu, MJ; Wang, C; Zhang, RY; Dai, JC; Jiang, Y; Cao, SY; Qin, ZZ; Yu, DAK; Ma, HX; Jin, GF; Gong, JH; Sun, CQ; Zhao, XY; Yin, ZH; Yang, L; Li, ZQ; Deng, QF; Wang, JC; Wu, W; Zheng, H; Zhou, GQ; Chen, HY; Guan, P; Peng, ZH; Chen, YJ; Shu, YQ; Xu, L; Liu, XY; Liu, L; Xu, P; Han, BH; Bai, CX; Zhao, YX; Zhang, HB; Yan, Y; Amos, CI; Chen, F; Tan, W; Jin, L; Wu, TC; Lin, DX; Shen, HB				Dong, Jing; Hu, Zhibin; Wu, Chen; Guo, Huan; Zhou, Baosen; Lv, Jiachun; Lu, Daru; Chen, Kexin; Shi, Yongyong; Chu, Minjie; Wang, Cheng; Zhang, Ruyang; Dai, Juncheng; Jiang, Yue; Cao, Songyu; Qin, Zhenzhen; Yu, Dianke; Ma, Hongxia; Jin, Guangfu; Gong, Jianhang; Sun, Chongqi; Zhao, Xueying; Yin, Zhihua; Yang, Lei; Li, Zhiqiang; Deng, Qifei; Wang, Jiucun; Wu, Wei; Zheng, Hong; Zhou, Guoquan; Chen, Hongyan; Guan, Peng; Peng, Zhihang; Chen, Yijiang; Shu, Yongqian; Xu, Lin; Liu, Xiangyang; Liu, Li; Xu, Pin; Han, Baohui; Bai, Chunxue; Zhao, Yuxia; Zhang, Haibo; Yan, Ying; Amos, Christopher I.; Chen, Feng; Tan, Wen; Jin, Li; Wu, Tangchun; Lin, Dongxin; Shen, Hongbing			Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; CIGARETTE-SMOKE; CELLS; VARIANTS; PROTEIN; 5P15.33; ALPHA; GATA3; GAMMA	To find additional susceptibility loci for lung cancer, we tested promising associations from our previous genome-wide association study (GWAS)(1) of lung cancer in the Chinese population in an extended validation sample size of 7,436 individuals with lung cancer (cases) and 7,483 controls. We found genome-wide significant (P < 5.0 x 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 x 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 x 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 x 10(-8)). We also found consistent associations for rs247008 at 5q31.1 (IL3-CSF2-P4HA2, P = 7.68 x 10(-8)) and rs9439519 at 1p36.32 (AJAP1-NPHP4, P = 3.65 x 10(-6)). Four of these loci showed evidence for interactions with smoking dose (P = 1.72 x 10(-10), P = 5.07 x 10(-3), P = 6.77 x 10(-3) and P = 4.49 x 10(-2) for rs2895680, rs4809957, rs247008 and rs9439519, respectively). These results advance our understanding of lung cancer susceptibility and highlight potential pathways that integrate genetic variants and smoking in the development of lung cancer.	[Dong, Jing; Hu, Zhibin; Chu, Minjie; Wang, Cheng; Zhang, Ruyang; Dai, Juncheng; Jiang, Yue; Cao, Songyu; Qin, Zhenzhen; Ma, Hongxia; Jin, Guangfu; Gong, Jianhang; Sun, Chongqi; Peng, Zhihang; Chen, Feng; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Dong, Jing; Hu, Zhibin; Chu, Minjie; Wang, Cheng; Zhang, Ruyang; Dai, Juncheng; Jiang, Yue; Cao, Songyu; Qin, Zhenzhen; Ma, Hongxia; Jin, Guangfu; Gong, Jianhang; Sun, Chongqi; Peng, Zhihang; Chen, Feng; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, MOE, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Jin, Guangfu; Shen, Hongbing] Nanjing Med Univ, Sect Clin Epidemiol, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wu, Chen; Yu, Dianke; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wu, Chen; Yu, Dianke; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wu, Chen; Yu, Dianke; Liu, Xiangyang; Tan, Wen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Guo, Huan; Deng, Qifei; Wu, Tangchun] Huazhong Univ Sci & Technol, Inst Occupat Med, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Guo, Huan; Deng, Qifei; Wu, Tangchun] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Peoples R China; [Zhou, Baosen; Yin, Zhihua; Wu, Wei; Guan, Peng] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China; [Lv, Jiachun; Yang, Lei] Guangzhou Med Coll, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Lu, Daru; Zhao, Xueying; Wang, Jiucun; Chen, Hongyan; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Ctr Fudan VARI Genet Epidemiol, Shanghai 200433, Peoples R China; [Lu, Daru; Zhao, Xueying; Wang, Jiucun; Chen, Hongyan; Jin, Li] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Chen, Kexin; Zheng, Hong] Tianjin Med Univ, Dept Epidemiol & Biostat, Canc Hosp & Inst, Tianjin, Peoples R China; [Li, Zhiqiang; Zhou, Guoquan] Shanghai Jiao Tong Univ, Bio X Ctr, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Chen, Yijiang; Shu, Yongqian] Nanjing Med Univ, Dept Thorac Surg & Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Xu, Lin] Nanjing Med Univ, Dept Thorac Surg, Affiliated Canc Hosp, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Liu, Xiangyang] Chinese Acad Med Sci, Dept Thorac Surg, Canc Hosp, Beijing 100730, Peoples R China; [Li, Zhiqiang; Zhou, Guoquan] Shanghai Jiao Tong Univ, Affiliated Changning Mental Hlth Ctr, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Liu, Li] Huazhong Univ Sci & Technol, Ctr Canc, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Pin] Corp Staff Worker Hosp, Dept Oncol, Wuhan Iron & Steel Grp, Wuhan, Peoples R China; [Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Resp Dis, Shanghai 200030, Peoples R China; [Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Resp Dis, Shanghai 200433, Peoples R China; [Zhao, Yuxia] China Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Shenyang, Peoples R China; [Zhang, Haibo; Yan, Ying] Shenyang No Hosp, Dept Radiotherapy, Shenyang, Peoples R China; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology; Huazhong University of Science & Technology; China Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Fudan University; Fudan University; Tianjin Medical University; Shanghai Jiao Tong University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Shanghai Jiao Tong University; Huazhong University of Science & Technology; China Baowu Steel Group; Shanghai Jiao Tong University; Fudan University; China Medical University; University of Texas System; UTMD Anderson Cancer Center	Shen, HB (corresponding author), Nanjing Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.	hbshen@njmu.edu.cn	Li, Zhiqiang/AAI-4003-2021; Wang, Jiucun/J-8744-2012; Shu, Yongqian/ABD-5698-2021; Guan, Peng/GWM-9170-2022; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Shi, Yongyong/GSO-1627-2022	Li, Zhiqiang/0000-0002-0174-9254; Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; Shi, Yongyong/0000-0003-1710-1505; Wu, Chen/0000-0003-4954-1011; Lin, Dongxin/0000-0002-8723-8868; Shen, Hongbing/0000-0002-2581-5906; Chen, Kexin/0000-0003-4248-7681; Bai, Chunxue/0000-0001-5798-3130; Dong, Jing/0000-0001-9856-5963; Ma, Hongxia/0000-0002-9821-6955; Jin, Guangfu/0000-0003-0249-5337	China National High-Tech Research and Development Program Grant [2009AA022705]; National Key Basic Research Program Grant [2011CB503805]; National Natural Science Foundation of China [30730080, 30972541, 30901233]; Jiangsu Natural Science Foundation [BK2011028]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJA330001]; US National Institutes of Health Grant [U19 CA148127]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE [R01CA121197, R01CA141716, U19CA148127, P30CA022453] Funding Source: NIH RePORTER	China National High-Tech Research and Development Program Grant; National Key Basic Research Program Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is funded by the China National High-Tech Research and Development Program Grant (2009AA022705) and partly funded by the National Key Basic Research Program Grant (2011CB503805) and the National Natural Science Foundation of China (30730080, 30972541 and 30901233), Jiangsu Natural Science Foundation (BK2011028), Natural Science Foundation of the Jiangsu Higher Education Institutions of China (11KJA330001), the US National Institutes of Health Grant (U19 CA148127) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors thank all the study subjects, research staff and students who participated in this work.	Ahn MJ, 2012, HUM GENET, V131, P365, DOI 10.1007/s00439-011-1080-z; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Chen GA, 2011, CLIN CANCER RES, V17, P817, DOI 10.1158/1078-0432.CCR-10-1789; Chen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028790; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dougan M, 2011, J CLIN INVEST, V121, P2436, DOI 10.1172/JCI44796; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; HUANG M, 1995, CANCER RES, V55, P3847; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kim B, 2007, CANCER RES, V67, P7431, DOI 10.1158/0008-5472.CAN-07-0003; Li MY, 2010, AM J RESP CELL MOL, V43, P674, DOI 10.1165/rcmb.2009-0349OC; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Matsunawa M, 2009, TOXICOL SCI, V109, P50, DOI 10.1093/toxsci/kfp044; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; McDonald JM, 2006, CANCER BIOL THER, V5, P300, DOI 10.4161/cbt.5.3.2391; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Okita K, 2010, CANCER SCI, V101, P2333, DOI 10.1111/j.1349-7006.2010.01696.x; PEEHL DM, 1994, CANCER RES, V54, P805; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sorrentino R, 2010, AM J RESP CELL MOL, V43, P422, DOI 10.1165/rcmb.2009-0224OC; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tan J, 2010, CANCER CELL, V18, P459, DOI 10.1016/j.ccr.2010.10.021; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wen GP, 2010, BIOCHEM PHARMACOL, V79, P768, DOI 10.1016/j.bcp.2009.10.002; YAMAMURA M, 1993, J CLIN INVEST, V91, P1005, DOI 10.1172/JCI116256; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	45	108	111	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					895	+		10.1038/ng.2351	http://dx.doi.org/10.1038/ng.2351			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22797725	Green Accepted			2022-12-25	WOS:000306854700014
J	Gembarska, A; Luciani, F; Fedele, C; Russell, EA; Dewaele, M; Villar, S; Zwolinska, A; Haupt, S; de Lange, J; Yip, D; Goydos, J; Haigh, JJ; Haupt, Y; Larue, L; Jochemsen, A; Shi, HB; Moriceau, G; Lo, RS; Ghanem, G; Shackleton, M; Bernal, F; Marine, JC				Gembarska, Agnieszka; Luciani, Flavie; Fedele, Clare; Russell, Elisabeth A.; Dewaele, Michael; Villar, Stephanie; Zwolinska, Aleksandra; Haupt, Sue; de Lange, Job; Yip, Dana; Goydos, James; Haigh, Jody J.; Haupt, Ygal; Larue, Lionel; Jochemsen, Aart; Shi, Hubing; Moriceau, Gatien; Lo, Roger S.; Ghanem, Ghanem; Shackleton, Mark; Bernal, Federico; Marine, Jean-Christophe			MDM4 is a key therapeutic target in cutaneous melanoma	NATURE MEDICINE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; IN-VIVO; MALIGNANT-MELANOMA; P53 PATHWAY; N-RAS; METASTATIC MELANOMA; BREAST-CANCER; STAPLED P53; CELL-DEATH; BRAF	The inactivation of the p53 tumor suppressor pathway, which often occurs through mutations in TP53 (encoding tumor protein 53) is a common step in human cancer. However, in melanoma-a highly chemotherapy-resistant disease-TP53 mutations are rare, raising the possibility that this cancer uses alternative ways to overcome p53-mediated tumor suppression. Here we show that Mdm4 p53 binding protein homolog (MDM4), a negative regulator of p53, is upregulated in a substantial proportion (similar to 65%) of stage I-IV human melanomas and that melanocyte-specific Mdm4 overexpression enhanced tumorigenesis in a mouse model of melanoma induced by the oncogene Nras. MDM4 promotes the survival of human metastatic melanoma by antagonizing p53 proapoptotic function. Notably, inhibition of the MDM4-p53 interaction restored p53 function in melanoma cells, resulting in increased sensitivity to cytotoxic chemotherapy and to inhibitors of the BRAF (V600E) oncogene. Our results identify MDM4 as a key determinant of impaired p53 function in human melanoma and designate MDM4 as a promising target for antimelanoma combination therapy.	[Gembarska, Agnieszka; Luciani, Flavie; Dewaele, Michael; Zwolinska, Aleksandra; Marine, Jean-Christophe] VIB, Lab Mol Canc Biol, Ctr Biol Dis, Louvain, Belgium; [Gembarska, Agnieszka; Luciani, Flavie; Dewaele, Michael; Zwolinska, Aleksandra; Marine, Jean-Christophe] Katholieke Univ KU Leuven, Ctr Human Genet, Louvain, Belgium; [Fedele, Clare; Shackleton, Mark] Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Australia; [Fedele, Clare; Shackleton, Mark] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Russell, Elisabeth A.; Bernal, Federico] NCI, Metab Branch, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Villar, Stephanie] Int Agcy Res Canc IARC CIRC, Lyon, France; [Haupt, Sue; Haupt, Ygal; Shackleton, Mark] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Haupt, Sue; Haupt, Ygal] Peter MacCallum Canc Ctr, Div Res, Melbourne, Australia; [Jochemsen, Aart] Univ Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Yip, Dana; Goydos, James] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Haigh, Jody J.] VIB, Dept Mol Biomed Res, Vasc Cell Biol Unit, Ghent, Belgium; [Haigh, Jody J.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Haupt, Ygal] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Larue, Lionel] CNRS, INSERM, U1021, Inst Curie,UMR3347, F-91405 Orsay, France; [Shi, Hubing; Moriceau, Gatien; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Med,Div Dermatol, Los Angeles, CA 90095 USA; [Shi, Hubing; Moriceau, Gatien; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Ghanem, Ghanem] Inst Jules Bordet, B-1000 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Peter Maccallum Cancer Center; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Flanders Institute for Biotechnology (VIB); Ghent University; Monash University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Institut Jules Bordet	Marine, JC (corresponding author), VIB, Lab Mol Canc Biol, Ctr Biol Dis, Louvain, Belgium.	jeanchristophe.marine@cme.vib-kuleuven.be	Marine, Jean Christophe/J-2237-2015; Larue, Lionel/F-7355-2013; Marine, Jean-Christophe/K-3292-2016; Shi, Hubing/B-8445-2014; Larue, Lionel/I-6532-2016; Goydos, James/AAR-8990-2020	Marine, Jean-Christophe/0000-0003-2433-9837; Goydos, James/0000-0001-9811-939X; Haupt, Ygal/0000-0001-5925-0096; Shi, Hubing/0000-0002-2926-3440; de Lange, Job/0000-0002-9002-8829; haigh, jody/0000-0002-7319-8922; Luciani, Flavie/0000-0002-6130-0889	'Het Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)' scholarship; Clare Oliver Memorial Fellowship from the Victorian Cancer Agency; Pfizer Australia; Victorian Endowment for Science, Knowledge and Innovation (VESKI); Australian National Health and Medical Research Council [509197, 1026990, 628426]; Stand Up to Cancer; Joint Center for Translational Medicine; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Seaver Institute; US National Institutes of Health; National Cancer Institute; Association for International Cancer Research (AICR); Melbourne Melanoma Project; Victorian Cancer Agency; Belgian Foundation against Cancer; NATIONAL CANCER INSTITUTE [ZIABC011261] Funding Source: NIH RePORTER	'Het Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)' scholarship(FWO); Clare Oliver Memorial Fellowship from the Victorian Cancer Agency; Pfizer Australia(PfizerPfizer Australia); Victorian Endowment for Science, Knowledge and Innovation (VESKI); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Stand Up to Cancer; Joint Center for Translational Medicine; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Seaver Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Association for International Cancer Research (AICR); Melbourne Melanoma Project; Victorian Cancer Agency; Belgian Foundation against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank O.Van Goethem for excellent technical assistance. We thank P. Agostinis, P. Wolter and M. Skipper for helpful discussions and comments on the manuscript. We thank M. Cario-Andre and A. Taied for materials from human nevi. A. Zwolinska is a recipient of a 'Het Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)' scholarship. C. Fedele was supported by a Clare Oliver Memorial Fellowship from the Victorian Cancer Agency. M. Shackleton was supported by fellowships from Pfizer Australia and the Victorian Endowment for Science, Knowledge and Innovation (VESKI). Y. and S. Haupt were supported by the Australian National Health and Medical Research Council (nos. 509197, 1026990 and 628426) and VESKI. R.S. Lo was supported by Stand Up to Cancer, the Joint Center for Translational Medicine, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, and the Seaver Institute. This work was supported by the Intramural Research Program of the US National Institutes of Health and the National Cancer Institute, the Association for International Cancer Research (AICR), the Melbourne Melanoma Project, the Victorian Cancer Agency and the 'Belgian Foundation against Cancer'.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Canner JA, 2009, BRIT J CANCER, V101, P774, DOI 10.1038/sj.bjc.6605199; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Clercq S, 2010, MOL CELL BIOL, V30, P5394, DOI 10.1128/MCB.00330-10; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Fedorenko IV, 2011, BIOCHEM PHARMACOL, V82, P201, DOI 10.1016/j.bcp.2011.05.015; Ferguson B, 2010, PIGM CELL MELANOMA R, V23, P771, DOI 10.1111/j.1755-148X.2010.00752.x; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Hedstrom E, 2009, EXP CELL RES, V315, P451, DOI 10.1016/j.yexcr.2008.11.009; Houben R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022096; Ibrahim N, 2009, ANNU REV PATHOL-MECH, V4, P551, DOI 10.1146/annurev.pathol.3.121806.151541; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Marine JC, 2011, CURR TOP DEV BIOL, V94, P45, DOI 10.1016/B978-0-12-380916-2.00003-6; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Muthusamy V, 2006, GENE CHROMOSOME CANC, V45, P447, DOI 10.1002/gcc.20310; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Papp T, 1999, J MED GENET, V36, P610; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	53	220	223	5	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1239	+		10.1038/nm.2863	http://dx.doi.org/10.1038/nm.2863			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820643	Green Accepted			2022-12-25	WOS:000307469300030
J	Gloerich, M; ten Klooster, JP; Vliem, MJ; Koorman, T; Zwartkruis, FJ; Clevers, H; Bos, JL				Gloerich, Martijn; ten Klooster, Jean Paul; Vliem, Marjolein J.; Koorman, Thijs; Zwartkruis, Fried J.; Clevers, Hans; Bos, Johannes L.			Rap2A links intestinal cell polarity to brush border formation	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDIC-ACID; PUTATIVE EFFECTOR; ACTIVATION; PROTEIN; KINASE; LKB1; RAS; LOCALIZATION; POLARIZATION; BINDING	The microvillus brush border at the apex of the highly polarized enterocyte allows the regulated uptake of nutrients from the intestinal lumen. Here, we identify the small G protein Rap2A as a molecular link that couples the formation of microvilli directly to the preceding cell polarization. Establishment of apicobasal polarity, which can be triggered by the kinase LKB1 in single, isolated colon cells, results in enrichment of PtdIns(4,5)P-2 at the apical membrane. The subsequent recruitment of phospholipase D1 allows polarized accumulation of phosphatidic acid, which provides a local cue for successive signalling by the guanine nucleotide exchange factor PDZGEF, the small G protein Rap2A, its effector TNIK, the kinase MST4 and, ultimately, the actin-binding protein Ezrin. Thus, epithelial cell polarization is translated directly into the acquisition of brush borders through a small G protein signalling module whose action is positioned by a cortical lipid cue.	[Gloerich, Martijn; Vliem, Marjolein J.; Zwartkruis, Fried J.; Bos, Johannes L.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Gloerich, Martijn; Vliem, Marjolein J.; Zwartkruis, Fried J.; Bos, Johannes L.] Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [ten Klooster, Jean Paul; Clevers, Hans] Hubrecht Inst, KNAW, NL-3584 CT Utrecht, Netherlands; [ten Klooster, Jean Paul; Clevers, Hans] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; [ten Klooster, Jean Paul; Clevers, Hans] Canc Genom Ctr, NL-3584 CT Utrecht, Netherlands; [Koorman, Thijs] Univ Utrecht, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Gloerich, M (corresponding author), Stanford Univ, Bio X Program, James H Clark Ctr, Dept Biol, 318 Campus Dr,E200-B, Stanford, CA 94305 USA.	Gloerich@stanford.edu; J.L.Bos@umcutrecht.nl		ten Klooster, Jean Paul/0000-0002-4979-7482; Koorman, Thijs/0000-0002-6064-3353	Dutch Cancer Society; Chemical Sciences; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO)	Dutch Cancer Society(KWF Kankerbestrijding); Chemical Sciences; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We are grateful to R. Wedlich-Soldner (Max Planck Institute of Biochemistry, Martinsried, Germany), N. Vitale (Institut des Neurosciences Cellulaires et Integratives, Strasbourg, France), T. Balla (National Institutes of Health, Bethesda, USA), J. Chen (University of Illinois, Urbana, USA) and S. van den Heuvel (Universiteit Utrecht, Utrecht, The Netherlands) for providing reagents. We thank W. Vonk, L. Kleij and K. Lee for technical assistance, C. Garner for assistance with lentiviral infections, K. Jalink for discussions, G. Kops, T. Pawson and J. Nelson for critical reading of the manuscript, and the members of our laboratories for continuous support and stimulating discussions. This study is supported by the Dutch Cancer Society (KWF; J.P.t.K. and M.J.V.), Chemical Sciences (M.G.) and the Netherlands Genomics Initiative (J.L.B. and H.C.) of the Netherlands Organization for Scientific Research (NWO).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Dube N, 2008, CELL SIGNAL, V20, P1608, DOI 10.1016/j.cellsig.2008.05.006; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hodgkin MN, 2000, CURR BIOL, V10, P43, DOI 10.1016/S0960-9822(99)00264-X; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Lee KJ, 2011, NEURON, V69, P957, DOI 10.1016/j.neuron.2011.02.004; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nonaka H, 2008, BIOCHEM BIOPH RES CO, V377, P573, DOI 10.1016/j.bbrc.2008.10.038; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Shewan A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004796; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Van Galen J, 2010, MOL MEMBR BIOL, V27, P81, DOI 10.3109/09687680903507080; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	41	79	80	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					793	+		10.1038/ncb2537	http://dx.doi.org/10.1038/ncb2537			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22797597				2022-12-25	WOS:000307115900008
J	Koyama, R; Tao, K; Sasaki, T; Ichikawa, J; Miyamoto, D; Muramatsu, R; Matsuki, N; Ikegaya, Y				Koyama, Ryuta; Tao, Kentaro; Sasaki, Takuya; Ichikawa, Junya; Miyamoto, Daisuke; Muramatsu, Rieko; Matsuki, Norio; Ikegaya, Yuji			GABAergic excitation after febrile seizures induces ectopic granule cells and adult epilepsy	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; HIGH-FREQUENCY OSCILLATIONS; POSTNATAL SUBVENTRICULAR ZONE; GABA(A) RECEPTOR ACTIVATION; INDUCED STATUS EPILEPTICUS; RAT DENTATE GYRUS; NEURONAL MIGRATION; PYRAMIDAL CELLS; ANIMAL-MODEL; CORTICAL MALFORMATIONS	Temporal lobe epilepsy (TLE) is accompanied by an abnormal location of granule cells in the dentate gyrus. Using a rat model of complex febrile seizures, which are thought to be a precipitating insult of TLE later in life, we report that aberrant migration of neonatal-generated granule cells results in granule cell ectopia that persists into adulthood. Febrile seizures induced an upregulation of GABA(A) receptors (GABA(A)-Rs) in neonatally generated granule cells, and hyperactivation of excitatory GABA(A)-Rs caused a reversal in the direction of granule cell migration. This abnormal migration was prevented by RNAi-mediated knockdown of the Na(+)K(+)2Cl(-) co-transporter (NKCC1), which regulates the excitatory action of GABA. NKCC1 inhibition with bumetanide after febrile seizures rescued the granule cell ectopia, susceptibility to limbic seizures and development of epilepsy. Thus, this work identifies a previously unknown pathogenic role of excitatory GABA(A)-R signaling and highlights NKCC1 as a potential therapeutic target for preventing granule cell ectopia and the development of epilepsy after febrile seizures.	[Koyama, Ryuta; Tao, Kentaro; Sasaki, Takuya; Ichikawa, Junya; Miyamoto, Daisuke; Muramatsu, Rieko; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan	University of Tokyo	Koyama, R (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.	rkoyama@mol.f.u-tokyo.ac.jp	Tao, Kentaro/Q-5647-2017; Miyamoto, Daisuke/I-2195-2016; Miyamoto, Daisuke/AAG-4537-2020; Sasaki, Takuya/J-3283-2015	Tao, Kentaro/0000-0002-8845-6891; Miyamoto, Daisuke/0000-0003-4735-9240; Ikegaya, Yuji/0000-0003-2260-8191	Ministry of Education, Culture, Sports, Science and Technology of Japan [19790048, 22115003]; Research Foundation for Pharmaceutical Sciences; Funding Program for Next Generation World-Leading Researchers [LS023]; Grants-in-Aid for Scientific Research [10J10641] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Pharmaceutical Sciences; Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Science Research on Young Scientists (B) (19790048) and on Innovative Areas 'Mesoscopic Neurocircuitry' (22115003) from The Ministry of Education, Culture, Sports, Science and Technology of Japan; the Research Foundation for Pharmaceutical Sciences; and the Funding Program for Next Generation World-Leading Researchers (LS023).	Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bender RA, 2004, ADV EXP MED BIOL, V548, P213; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chevassus-au-Louis N, 1999, EPILEPSIA, V40, P811, DOI 10.1111/j.1528-1157.1999.tb00786.x; Chevassus-Au-Louis N, 1998, J COMP NEUROL, V394, P520, DOI 10.1002/(SICI)1096-9861(19980518)394:4<520::AID-CNE9>3.0.CO;2-3; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Dyhrfjeld-Johnsen J, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.002.2008; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Engel J, 2009, EPILEPSIA, V50, P598, DOI 10.1111/j.1528-1167.2008.01917.x; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Fukuda A, 1998, J NEUROPHYSIOL, V79, P439, DOI 10.1152/jn.1998.79.1.439; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Koyama R, 2010, J PHARMACOL SCI, V113, P14, DOI 10.1254/jphs.09R19FM; Lee KS, 1997, J NEUROSCI, V17, P6236; Lurton D, 1998, J NEUROL SCI, V154, P133, DOI 10.1016/S0022-510X(97)00220-7; Manent JB, 2005, J NEUROSCI, V25, P4755, DOI 10.1523/JNEUROSCI.0553-05.2005; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; McCloskey DP, 2006, EUR J NEUROSCI, V24, P2203, DOI 10.1111/j.1460-9568.2006.05101.x; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Muramatsu R, 2008, EXP NEUROL, V211, P503, DOI 10.1016/j.expneurol.2008.02.026; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; PATEL S, 1988, BEHAV BRAIN RES, V31, P165, DOI 10.1016/0166-4328(88)90019-8; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Romo-Parra H, 2003, J NEUROPHYSIOL, V89, P3155, DOI 10.1152/jn.00985.2002; ROPER SN, 1995, EPILEPSY RES, V21, P205, DOI 10.1016/0920-1211(95)00027-8; Safiulina VF, 2006, J NEUROSCI, V26, P597, DOI 10.1523/JNEUROSCI.4493-05.2006; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman HE, 2002, NEUROSCIENCE, V111, P71, DOI 10.1016/S0306-4522(01)00599-1; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Sullivan JE, 1996, CLIN PHARMACOL THER, V60, P405, DOI 10.1016/S0009-9236(96)90197-6; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006; Yamada RX, 2008, J NEUROSCI, V28, P4613, DOI 10.1523/JNEUROSCI.0019-08.2008	58	121	125	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1271	+		10.1038/nm.2850	http://dx.doi.org/10.1038/nm.2850			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22797810				2022-12-25	WOS:000307469300034
J	Doan, PL; Himburg, HA; Helms, K; Russell, JL; Fixsen, E; Quarmyne, M; Harris, JR; Deoliviera, D; Sullivan, JM; Chao, NJ; Kirsch, DG; Chute, JP				Doan, Phuong L.; Himburg, Heather A.; Helms, Katherine; Russell, J. Lauren; Fixsen, Emma; Quarmyne, Mamle; Harris, Jeffrey R.; Deoliviera, Divino; Sullivan, Julie M.; Chao, Nelson J.; Kirsch, David G.; Chute, John P.			Epidermal growth factor regulates hematopoietic regeneration after radiation injury	NATURE MEDICINE			English	Article							EX-VIVO CULTURE; FACTOR RECEPTOR; ENDOTHELIAL-CELLS; STEM-CELLS; PROGENITOR CELLS; EGF RECEPTOR; REPOPULATING CAPACITY; SOLUBLE FACTORS; DNA-DAMAGE; ACTIVATION	The mechanisms that regulate hematopoietic stem cell (HSC) regeneration after myelosuppressive injury are not well understood. We identified epidermal growth factor (EGF) to be highly enriched in the bone marrow serum of mice bearing deletion of Bak and Bax in TIE2-expressing cells in Tie2Cre; Bak1(-/-); Bax(flox/-) mice. These mice showed radioprotection of the HSC pool and 100% survival after a lethal dose of total-body irradiation (TBI). Bone marrow HSCs from wild-type mice expressed functional EGF receptor (EGFR), and systemic administration of EGF promoted the recovery of the HSC pool in vivo and improved the survival of mice after TBI. Conversely, administration of erlotinib, an EGFR antagonist, decreased both HSC regeneration and the survival of mice after TBI. Mice with EGFR deficiency in VAV-expressing hematopoietic cells also had delayed recovery of bone marrow stem and progenitor cells after TBI. Mechanistically, EGF reduced radiation-induced apoptosis of HSCs and mediated this effect through repression of the proapoptotic protein PUMA. Our findings show that EGFR signaling regulates HSC regeneration after myelosuppressive injury.	[Doan, Phuong L.; Himburg, Heather A.; Helms, Katherine; Russell, J. Lauren; Fixsen, Emma; Harris, Jeffrey R.; Deoliviera, Divino; Chao, Nelson J.; Chute, John P.] Duke Univ, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA; [Quarmyne, Mamle; Kirsch, David G.; Chute, John P.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Sullivan, Julie M.; Kirsch, David G.] Duke Univ, Dept Radiat Oncol, Durham, NC USA; [Chao, Nelson J.] Duke Univ, Dept Immunol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Chute, JP (corresponding author), Duke Univ, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA.	john.chute@duke.edu	Doan, Phuong L./Q-2093-2019	Doan, Phuong L./0000-0003-1361-2068	National Heart, Lung and Blood Institute [HL-086998-01]; National Institute of Allergy and Infectious Diseases (NIAID) [AI-067798-06]; NIAID Centers for Medical Countermeasures [AI-067798-01]; US National Institutes of Health [T32 HL0070757-33]; Barton Haynes Award; Duke Cancer Center Seed Grant (Duke University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, K02AI093866] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Centers for Medical Countermeasures; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barton Haynes Award; Duke Cancer Center Seed Grant (Duke University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Heart, Lung and Blood Institute grant HL-086998-01 (J.P.C.), National Institute of Allergy and Infectious Diseases (NIAID) grant AI-067798-06 (J.P.C.) and a pilot project from the NIAID Centers for Medical Countermeasures grant AI-067798-01 (D.G.K.). P.L.D. was supported by US National Institutes of Health training grant T32 HL0070757-33, the Barton Haynes Award and a Duke Cancer Center Seed Grant (Duke University).	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Boehrer S, 2011, CELL CYCLE, V10, P3168, DOI 10.4161/cc.10.18.16599; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Cardo-Vila M, 2010, P NATL ACAD SCI USA, V107, P5118, DOI 10.1073/pnas.0915146107; Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Chute JP, 2005, BLOOD, V105, P576, DOI 10.1182/blood-2004-04-1467; Chute JP, 2004, EXP HEMATOL, V32, P308, DOI 10.1016/j.exphem.2003.12.002; Chute JP, 2002, BLOOD, V100, P4433, DOI 10.1182/blood-2002-04-1238; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; DOOLEY DC, 1995, J CELL PHYSIOL, V165, P386, DOI 10.1002/jcp.1041650220; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Herodin F, 2003, BLOOD, V101, P2609, DOI 10.1182/blood-2002-06-1634; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kriegs M, 2010, DNA REPAIR, V9, P889, DOI 10.1016/j.dnarep.2010.05.005; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Minder P, 2012, J BIOL CHEM, V287, P35201, DOI 10.1074/jbc.M112.368910; Montfort MJ, 2002, EXP HEMATOL, V30, P950, DOI 10.1016/S0301-472X(02)00813-5; Muramoto GG, 2006, BIOL BLOOD MARROW TR, V12, P530, DOI 10.1016/j.bbmt.2005.12.039; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; PAIN B, 1991, CELL, V65, P37, DOI 10.1016/0092-8674(91)90405-N; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Quelle FW, 1998, GENE DEV, V12, P1099, DOI 10.1101/gad.12.8.1099; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Shao LJ, 2010, BLOOD, V115, P4707, DOI 10.1182/blood-2009-10-248872; Shen HM, 2012, BLOOD, V119, P3629, DOI 10.1182/blood-2011-08-373621; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; SINCLAIR WK, 1968, RADIAT RES, V33, P620, DOI 10.2307/3572419; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Takahashi T, 1998, BLOOD, V91, P4509, DOI 10.1182/blood.V91.12.4509.412a01_4509_4515; VONRUDEN T, 1988, EMBO J, V7, P2749, DOI 10.1002/j.1460-2075.1988.tb03129.x; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	60	128	132	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					295	304		10.1038/nm.3070	http://dx.doi.org/10.1038/nm.3070			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23377280	Green Accepted, Green Submitted			2022-12-25	WOS:000316040700022
J	Dutkowski, J; Kramer, M; Surma, MA; Balakrishnan, R; Cherry, JM; Krogan, NJ; Ideker, T				Dutkowski, Janusz; Kramer, Michael; Surma, Michal A.; Balakrishnan, Rama; Cherry, J. Michael; Krogan, Nevan J.; Ideker, Trey			A gene ontology inferred from molecular networks	NATURE BIOTECHNOLOGY			English	Article							YEAST; ORGANIZATION; MODULARITY; MAP; DNA; INTERACTOME; PREDICTION; REVEALS; PATHWAY; COMPLEX	Ontologies have proven very useful for capturing knowledge as a hierarchy of terms and their interrelationships. In biology a major challenge has been to construct ontologies of gene function given incomplete biological knowledge and inconsistencies in how this knowledge is manually curated. Here we show that large networks of gene and protein interactions in Saccharomyces cerevisiae can be used to infer an ontology whose coverage and power are equivalent to those of the manually curated Gene Ontology (GO). The network-extracted ontology (NeXO) contains 4,123 biological terms and 5,766 term-term relations, capturing 58% of known cellular components. We also explore robust NeXO terms and term relations that were initially not cataloged in GO, a number of which have now been added based on our analysis. Using quantitative genetic interaction profiling and chemogenomics, we find further support for many of the uncharacterized terms identified by NeXO, including multisubunit structures related to protein trafficking or mitochondrial function. This work enables a shift from using ontologies to evaluate data to using data to construct and evaluate ontologies.	[Dutkowski, Janusz; Kramer, Michael; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dutkowski, Janusz; Kramer, Michael; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Surma, Michal A.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Surma, Michal A.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Balakrishnan, Rama; Cherry, J. Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA USA; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	janusz@ucsd.edu; tideker@ucsd.edu	Surma, Michal/B-1955-2016	Surma, Michal/0000-0001-7833-2214; Ideker, Trey/0000-0002-1708-8454; Kramer, Michael/0000-0003-2544-7266; Cherry, J. Michael/0000-0001-9163-5180	US National Institutes of Health [P41-GM103504, P50-GM085764, R01-GM084448, P50-GM081879]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG002273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, P41GM103504, P50GM081879, T32GM007198, R01GM084448] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Bader and Y. Park for assistance with the HAC-ML software and to I. Lee and E. Marcotte for advice on YeastNet. We would also like to thank D. Botstein, C. Boone, R. Sharan and R. Shamir for constructive advice on the manuscript. This work was generously supported by US National Institutes of Health grants P41-GM103504 and P50-GM085764 (TI) and R01-GM084448 and P50-GM081879 (N.J.K.). N.J.K. is a Searle Scholar and Keck Young Investigator.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Addinall SG, 2008, GENETICS, V180, P2251, DOI 10.1534/genetics.108.092577; Araragi S, 2003, TOXICOLOGY, V184, P1, DOI 10.1016/S0300-483X(02)00443-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Buitelaar P, 2008, FRONT ARTIF INTEL AP, V167, pV; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dotan-Cohen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005313; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hayes MJ, 2011, TRAFFIC, V12, P260, DOI 10.1111/j.1600-0854.2010.01151.x; Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jean-Mary YR, 2009, J WEB SEMANT, V7, P235, DOI 10.1016/j.websem.2009.04.001; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krallinger M, 2010, METHODS MOL BIOL, V593, P341, DOI 10.1007/978-1-60327-194-3_16; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Leonelli S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-325; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Musen MA, 2012, J AM MED INFORM ASSN, V19, P190, DOI 10.1136/amiajnl-2011-000523; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Park Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S44; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raychaudhuri S, 2002, GENOME RES, V12, P203, DOI 10.1101/gr.199701; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	57	133	135	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					38	+		10.1038/nbt.2463	http://dx.doi.org/10.1038/nbt.2463			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242164	Green Accepted, Bronze			2022-12-25	WOS:000313563600020
J	Slavoff, SA; Mitchell, AJ; Schwaid, AG; Cabili, MN; Ma, J; Levin, JZ; Karger, AD; Budnik, BA; Rinn, JL; Saghatelian, A				Slavoff, Sarah A.; Mitchell, Andrew J.; Schwaid, Adam G.; Cabili, Moran N.; Ma, Jiao; Levin, Joshua Z.; Karger, Amir D.; Budnik, Bogdan A.; Rinn, John L.; Saghatelian, Alan			Peptidomic discovery of short open reading frame-encoded peptides in human cells	NATURE CHEMICAL BIOLOGY			English	Article							HYDROPHILIC INTERACTION CHROMATOGRAPHY; LOW ABUNDANCE PROTEINS; AMINO-ACID-SEQUENCES; NONCODING RNAS; MESSENGER-RNA; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; BINDING PROTEIN; GENE-EXPRESSION	The complete extent to which the human genome is translated into polypeptides is of fundamental importance. We report a peptidomic strategy to detect short open reading frame (sORF)-encoded polypeptides (SEPs) in human cells. We identify 90 SEPs, 86 of which are previously uncharacterized, which is the largest number of human SEPs ever reported. SEP abundances range from 10-1,000 molecules per cell, identical to abundances of known proteins. SEPs arise from sORFs in noncoding RNAs as well as multicistronic mRNAs, and many SEPs initiate with non-AUG start codons, indicating that noncanonical translation may be more widespread in mammals than previously thought. In addition, coding sORFs are present in a small fraction (8 out of 1,866) of long intergenic noncoding RNAs. Together, these results provide strong evidence that the human proteome is more complex than previously appreciated.	[Slavoff, Sarah A.; Schwaid, Adam G.; Ma, Jiao; Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Mitchell, Andrew J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Levin, Joshua Z.] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA USA; [Cabili, Moran N.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Cabili, Moran N.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Karger, Amir D.] Harvard Univ, Fac Arts & Sci, Div Sci, Cambridge, MA 02138 USA; [Budnik, Bogdan A.] Harvard Univ, Fac Arts & Sci, Mass Spectrometry & Prote Lab, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University	Slavoff, SA (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	saghatelian@chemistry.harvard.edu	slavoff, sarah/HIK-2036-2022; Budnik, Bogdan/AAH-9987-2019; Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003; Rinn, John/0000-0002-7231-7539; Levin, Joshua/0000-0002-0170-3598; Karger, Amir/0000-0002-4561-3850; Slavoff, Sarah/0000-0002-4443-2070	Howard Hughes Medical Institute International Student Research Fellowship; National Research Service Award postdoctoral fellowship [1F32GM099408-01]; Damon Runyon-Rachleff Innovator Award; Searle Scholars Award; Richard and Susan Smith Family Foundation Fellowship; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Alfred P. Sloan Fellowship; US National Institutes of Health [T32GM007598]; US National Human Genome Research Institute [3U54HG003067]; Director's New Innovator Awards [DP2OD00667, DP2OD002374]; National Institute of General Medical Sciences [R01GM102491]; Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102491, F32GM099408, T32GM007598] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670, DP2OD002374] Funding Source: NIH RePORTER	Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon-Rachleff Innovator Award; Searle Scholars Award; Richard and Susan Smith Family Foundation Fellowship; Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Director's New Innovator Awards; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Adiconis and L. Fan for constructing the cDNA libraries used in this study. M.N.C. is supported by a Howard Hughes Medical Institute International Student Research Fellowship, and S.A.S. is supported by an National Research Service Award postdoctoral fellowship (1F32GM099408-01). J.L.R. is supported by a Damon Runyon-Rachleff Innovator Award, a Searle Scholars Award and a Richard and Susan Smith Family Foundation Fellowship. A.S. is supported by a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Searle Scholars Award and an Alfred P. Sloan Fellowship. This work was also supported by the US National Institutes of Health training grant T32GM007598 (A.J.M.), the US National Human Genome Research Institute grant 3U54HG003067 (J.Z.L.), Director's New Innovator Awards DP2OD00667 (J.L.R.) and DP2OD002374 (A.S.), National Institute of General Medical Sciences grant R01GM102491 (A.S.) and support from Harvard University (A.S.).	ABASTADO JP, 1991, NEW BIOL, V3, P511; Alpert AJ, 2008, ANAL CHEM, V80, P62, DOI 10.1021/ac070997P; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Casson SA, 2002, PLANT CELL, V14, P1705, DOI 10.1105/tpc.002618; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fonslow BR, 2011, J PROTEOME RES, V10, P3690, DOI 10.1021/pr200304u; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hao PL, 2010, J PROTEOME RES, V9, P3520, DOI 10.1021/pr100037h; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; JAY G, 1981, NATURE, V291, P346, DOI 10.1038/291346a0; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Oyama M, 2007, MOL CELL PROTEOMICS, V6, P1000, DOI 10.1074/mcp.M600297-MCP200; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Svensson M, 2003, J PROTEOME RES, V2, P213, DOI 10.1021/pr020010u; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Tinoco AD, 2010, J AM CHEM SOC, V132, P3819, DOI 10.1021/ja909524e; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang F, 2011, NUCLEIC ACIDS RES, V39, P3128, DOI 10.1093/nar/gkq1251	50	384	395	6	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					59	+		10.1038/NCHEMBIO.1120	http://dx.doi.org/10.1038/NCHEMBIO.1120			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23160002	Green Submitted, Green Accepted			2022-12-25	WOS:000312484200013
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Masson, G; Agnarsson, BA; Benediktsdottir, KR; Sigurdsson, A; Magnusson, OT; Gudjonsson, SA; Magnusdottir, DN; Johannsdottir, H; Helgadottir, HT; Stacey, SN; Jonasdottir, A; Olafsdottir, SB; Thorleifsson, G; Jonasson, JG; Tryggvadottir, L; Navarrete, S; Fuertes, F; Helfand, BT; Hu, QY; Csiki, IE; Mates, IN; Jinga, V; Aben, KKH; van Oort, IM; Vermeulen, SH; Donovan, JL; Hamdy, FC; Ng, CF; Chiu, PKF; Lau, KM; Ng, MCY; Gulcher, JR; Kong, A; Catalona, WJ; Mayordomo, JI; Einarsson, GV; Barkardottir, RB; Jonsson, E; Mates, D; Neal, DE; Kiemeney, LA; Thorsteinsdottir, U; Rafnar, T; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Masson, Gisli; Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Sigurdsson, Asgeir; Magnusson, Olafur Th; Gudjonsson, Sigurjon A.; Magnusdottir, Droplaug N.; Johannsdottir, Hrefna; Helgadottir, Hafdis Th; Stacey, Simon N.; Jonasdottir, Adalbjorg; Olafsdottir, Stefania B.; Thorleifsson, Gudmar; Jonasson, Jon G.; Tryggvadottir, Laufey; Navarrete, Sebastian; Fuertes, Fernando; Helfand, Brian T.; Hu, Qiaoyan; Csiki, Irma E.; Mates, Ioan N.; Jinga, Viorel; Aben, Katja K. H.; van Oort, Inge M.; Vermeulen, Sita H.; Donovan, Jenny L.; Hamdy, Freddy C.; Ng, Chi-Fai; Chiu, Peter K. F.; Lau, Kin-Mang; Ng, Maggie C. Y.; Gulcher, Jeffrey R.; Kong, Augustine; Catalona, William J.; Mayordomo, Jose I.; Einarsson, Gudmundur V.; Barkardottir, Rosa B.; Jonsson, Eirikur; Mates, Dana; Neal, David E.; Kiemeney, Lambertus A.; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari			A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer	NATURE GENETICS			English	Article							WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; COLORECTAL-CANCER; COMMON VARIANTS; RISK; SCAN	In Western countries, prostate cancer is the most prevalent cancer of men and one of the leading causes of cancer-related death in men. Several genome-wide association studies have yielded numerous common variants conferring risk of prostate cancer. Here, we analyzed 32.5 million variants discovered by whole-genome sequencing 1,795 Icelanders. We identified a new low-frequency variant at 8q24 associated with prostate cancer in European populations, rs188140481[A] (odds ratio (OR) 2.90; P-combined = 6.2 x 10(-34)), with an average risk allele frequency in controls of 0.54%. This variant is only very weakly correlated (r(2) <= 0.06) with previously reported risk variants at 8q24, and its association remains significant after adjustment for all known risk-associated variants. Carriers of rs188140481[A] were diagnosed with prostate cancer 1.26 years younger than non-carriers (P = 0.0059). We also report results for a previously described HOXB13 variant (rs138213197[T]), confirming it as a prostate cancer risk variant in populations from across Europe.	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Masson, Gisli; Sigurdsson, Asgeir; Magnusson, Olafur Th; Gudjonsson, Sigurjon A.; Magnusdottir, Droplaug N.; Johannsdottir, Hrefna; Helgadottir, Hafdis Th; Stacey, Simon N.; Jonasdottir, Adalbjorg; Olafsdottir, Stefania B.; Thorleifsson, Gudmar; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Jonasson, Jon G.; Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Jonasson, Jon G.; Tryggvadottir, Laufey; Barkardottir, Rosa B.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [Navarrete, Sebastian; Fuertes, Fernando] Univ Hosp, Div Radiat Oncol, Zaragoza, Spain; [Helfand, Brian T.] N Shore Univ Hlth Syst, Dept Urol, Glenview, IL USA; [Hu, Qiaoyan; Catalona, William J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Csiki, Irma E.; Mates, Dana] Natl Inst Publ Hlth, Bucharest, Romania; [Mates, Ioan N.; Jinga, Viorel] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Aben, Katja K. H.; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [van Oort, Inge M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 ED Nijmegen, Netherlands; [Donovan, Jenny L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hamdy, Freddy C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England; [Ng, Chi-Fai; Chiu, Peter K. F.] Chinese Univ Hong Kong, Dept Surg, Div Urol, Shatin, Hong Kong, Peoples R China; [Lau, Kin-Mang] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Ng, Maggie C. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Zaragoza, Spain; [Einarsson, Gudmundur V.; Jonsson, Eirikur] Landspitali Univ Hosp, Dept Urol, Reykjavik, Iceland; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England	Landspitali National University Hospital; University of Iceland; Miguel Servet University Hospital; Northwestern University; Feinberg School of Medicine; Carol Davila University of Medicine & Pharmacy; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Bristol; University of Oxford; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Zaragoza; Landspitali National University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Stefansson, K (corresponding author), deCODE Genet, Reykjavik, Iceland.	julius@decode.is; kstefans@decodes.is	van Oort, Inge/AAD-1197-2020; Ng, Chi-Fai/E-5134-2011; Stefansson, Kari/AAE-7187-2019; van Oort, Inge/L-4554-2015; Kiemeney, Lambertus A./D-3357-2009; Mates, Ioan Nicolae/E-9255-2017; Aben, Katja KH/G-9686-2016; Vermeulen, Sita H./L-4716-2015; Mayordomo, Jose/K-3453-2013; Chi-fai, NG/AAV-8270-2021	van Oort, Inge/0000-0002-8002-1869; Ng, Chi-Fai/0000-0002-1723-9646; van Oort, Inge/0000-0002-8002-1869; Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Vermeulen, Sita H./0000-0003-4913-8601; Jonasson, Jon G./0000-0002-2635-5032; Helgadottir, Hafdis/0000-0003-4352-152X; mates, dana/0000-0002-6219-9807; Neal, David/0000-0002-6033-5086; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Tryggvadottir, Laufey/0000-0001-8067-9030; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Hamdy, Freddie/0000-0003-2627-2154; Lau, Kin-Mang/0000-0001-5888-1937; Ioan Nicoale, Mates/0000-0001-7210-0615	European Union [202059]; Urological Research Foundation [U01 CA089600, P50 CA90386, P30 CA60553]; Health Technology Assessment Programme [96/20/06, 96/20/99]; Department of Health, England; Cancer Research UK [C522/A8649]; Medical Research Council of England [G0500966_ID-75466]; National Cancer Research Institute (NCRI), UK; Southwest National Health Service Research and Development; NCRI (ProMPT) study; Cambridge and Oxford British Medical Research Council grants from the National Institute for Health Research; NATIONAL CANCER INSTITUTE [U01CA089600, P50CA090386] Funding Source: NIH RePORTER	European Union(European Commission); Urological Research Foundation; Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Department of Health, England; Cancer Research UK(Cancer Research UK); Medical Research Council of England(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Research Institute (NCRI), UK; Southwest National Health Service Research and Development; NCRI (ProMPT) study; Cambridge and Oxford British Medical Research Council grants from the National Institute for Health Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the individuals who participated in the study and whose contribution made this work possible. This project was funded in part by contract number 202059 (PROMARK) from the Seventh Framework Programme of the European Union and, in part, by the Urological Research Foundation (U01 CA089600, P50 CA90386 and P30 CA60553). The UK ProtecT study is ongoing and is funded by the Health Technology Assessment Programme (projects 96/20/06 and 96/20/99). The ProtecT trial is supported by the Department of Health, England; Cancer Research UK grant C522/A8649; Medical Research Council of England grant G0500966_ID-75466; the National Cancer Research Institute (NCRI), UK; and the Southwest National Health Service Research and Development. The biorepository from ProtecT is supported by the NCRI (ProMPT) study and Cambridge and Oxford British Medical Research Council grants from the National Institute for Health Research.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	21	134	140	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1326	1329		10.1038/ng.2437	http://dx.doi.org/10.1038/ng.2437			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23104005	Green Accepted			2022-12-25	WOS:000311713200010
J	Frei, AP; Jeon, OY; Kilcher, S; Moest, H; Henning, LM; Jost, C; Pluckthun, A; Mercer, J; Aebersold, R; Carreira, EM; Wollscheid, B				Frei, Andreas P.; Jeon, Ock-Youm; Kilcher, Samuel; Moest, Hansjoerg; Henning, Lisa M.; Jost, Christian; Plueckthun, Andreas; Mercer, Jason; Aebersold, Ruedi; Carreira, Erick M.; Wollscheid, Bernd			Direct identification of ligand-receptor interactions on living cells and tissues	NATURE BIOTECHNOLOGY			English	Article							PROTEIN INTERACTIONS; VIRUS; PROTEOMICS; ENTRY; MACROPINOCYTOSIS; GLYCOPROTEINS; SULFATE; BINDS	Many cellular responses are triggered by proteins, drugs or pathogens binding to cell-surface receptors, but it can be challenging to identify which receptors are bound by a given ligand. Here we describe TRICEPS, a chemoproteomic reagent with three moieties-one that binds ligands containing an amino group, a second that binds glycosylated receptors on living cells and a biotin tag for purifying the receptor peptides for identification by quantitative mass spectrometry. We validated this ligand-based, receptor-capture (LRC) technology using insulin, transferrin, apelin, epidermal growth factor, the therapeutic antibody trastuzumab and two DARPins targeting ErbB2. In some cases, we could also determine the approximate ligand-binding sites on the receptors. Using TRICEPS to label intact mature vaccinia viruses, we identified the cell surface proteins AXL, M6PR, DAG1, CSPG4 and CDH13 as binding factors on human cells. This technology enables the identification of receptors for many types of ligands under near-physiological conditions and without the need for genetic manipulations.	[Frei, Andreas P.; Moest, Hansjoerg; Henning, Lisa M.; Aebersold, Ruedi; Wollscheid, Bernd] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland; [Frei, Andreas P.; Moest, Hansjoerg; Henning, Lisa M.; Wollscheid, Bernd] Univ Zurich, NCCR Neuro Ctr Prote, CH-8006 Zurich, Switzerland; [Frei, Andreas P.; Kilcher, Samuel; Jost, Christian] Univ Zurich, PhD Program Mol Life Sci MLS, ETH Zurich, CH-8006 Zurich, Switzerland; [Jeon, Ock-Youm; Carreira, Erick M.] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Organ Chem Lab, Zurich, Switzerland; [Kilcher, Samuel; Mercer, Jason] Swiss Fed Inst Technol, Dept Biol, Inst Biochem, Zurich, Switzerland; [Moest, Hansjoerg] Swiss Fed Inst Technol, Dept Hlth & Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Jost, Christian; Plueckthun, Andreas] Univ Zurich, Dept Biochem, CH-8006 Zurich, Switzerland; [Plueckthun, Andreas; Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland; [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Wollscheid, B (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland.	bernd.wollscheid@imsb.biol.ethz.ch	Plückthun, Andreas/C-2746-2009; Wollscheid, Bernd/E-8909-2010	Plückthun, Andreas/0000-0003-4191-5306; Wollscheid, Bernd/0000-0002-3923-1610; Carreira, Erick/0000-0003-1472-490X; Jost, Christian/0000-0002-4169-5879; Mercer, Jason/0000-0003-1466-9541	National Center of Competence in Research (NCCR) Neural Plasticity and Repair; Swiss National Science Foundation (SNSF); SystemsX.ch/InfectX; SNSF Ambizione; SystemsX.ch; European Research Council (ERC); ERC	National Center of Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SystemsX.ch/InfectX; SNSF Ambizione; SystemsX.ch; European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission)	We greatly acknowledge T. Clough and O. Vitek at Purdue University for help with statistical data analysis. We are grateful to A. Hofmann, T. Bock, D. Bausch-Fluck, F. Cerciello, A. Jacobs and A. Leitner for suggestions and support at all stages of the project. We acknowledge S. Dettwiler, P. Schraml, M. Tinguely, H. Moch and the Laboratory for In situ Technologies, University Hospital Zurich, for preparation and staining of breast cancer tissues. This work was supported by funding from National Center of Competence in Research (NCCR) Neural Plasticity and Repair (to B.W.), Swiss National Science Foundation (SNSF) (to B.W.), SystemsX.ch/InfectX (to B.W.), SNSF Ambizione (to J.M.), SystemsX.ch and European Research Council (ERC) (to R.A.) and SystemsX.ch/InfectX and ERC (to S.K. on behalf of A. Helenius). Immortalized murine pre-adipocytes were kindly provided by M. Rosenwald and C. Wolfrum (ETH Zurich). ErbB2-negative breast carcinoma tissue cut into 50 mu m slices was kindly provided by the tissue biobank of the Institute of Surgical Pathology, University Hospital Zurich.	Bantscheff M, 2012, BIOORGAN MED CHEM, V20, P1973, DOI 10.1016/j.bmc.2011.11.003; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Clough T, 2009, J PROTEOME RES, V8, P5275, DOI 10.1021/pr900610q; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Frei A., 2012, European Patent Application, Patent No. 11000731; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Helbig AO, 2010, J PROTEOMICS, V73, P868, DOI 10.1016/j.jprot.2010.01.005; Hofmann A, 2010, BLOOD, V116, pE26, DOI 10.1182/blood-2010-02-271270; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lenz T, 2011, J PROTEOMICS, V75, P100, DOI 10.1016/j.jprot.2011.07.017; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107; Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Schroeder N, 2012, J VIROL, V86, P4868, DOI 10.1128/JVI.06610-11; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Steu S, 2008, VIRCHOWS ARCH, V452, P305, DOI 10.1007/s00428-008-0584-y; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]	28	114	121	1	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					997	+		10.1038/nbt.2354	http://dx.doi.org/10.1038/nbt.2354			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	22983091				2022-12-25	WOS:000309965500027
J	Price, JV; Tangsombatvisit, S; Xu, GY; Yu, JT; Levy, D; Baechler, EC; Gozani, O; Varma, M; Utz, PJ; Liu, CL				Price, Jordan V.; Tangsombatvisit, Stephanie; Xu, Guangyu; Yu, Jiangtao; Levy, Dan; Baechler, Emily C.; Gozani, Or; Varma, Madoo; Utz, Paul J.; Liu, Chih Long			On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions	NATURE MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATIC-DISEASES; HISTONE H2B; DIAGNOSIS; ARRAYS; METHYLTRANSFERASE; METHYLATION; SIGNATURE; RESPONSES; CHROMATIN	We developed a new, silicon-based peptide array for a broad range of biological applications, including potential development as a real-time point-of-care platform. We used photolithography on silicon wafers to synthesize microarrays (Intel arrays) that contained every possible overlapping peptide within a linear protein sequence covering the N-terminal tail of human histone H2B. These arrays also included peptides with acetylated and methylated lysine residues, reflecting post-translational modifications of H2B. We defined minimum binding epitopes for commercial antibodies recognizing the modified and unmodified H2B peptides. We further found that this platform is suitable for the highly sensitive characterization of methyltransferases and kinase substrates. The Intel arrays also revealed specific H2B epitopes that are recognized by autoantibodies in individuals with systemic lupus erythematosus who have elevated disease severity. By combining emerging nonfluorescence-based detection methods with an underlying integrated circuit, we are now poised to create a truly transformative proteomics platform with applications in bioscience, drug development and clinical diagnostics.	[Price, Jordan V.; Tangsombatvisit, Stephanie; Utz, Paul J.; Liu, Chih Long] Stanford Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA USA; [Xu, Guangyu; Yu, Jiangtao; Varma, Madoo] Intel Corp, Santa Clara, CA USA; [Levy, Dan; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Baechler, Emily C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	Stanford University; Intel Corporation; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Price, JV (corresponding author), Stanford Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA USA.	jvprice@stanford.edu; pjutz@stanford.edu	Gillespie, Emily/N-1265-2013; Levy, Dan/A-3226-2013; Gozani, Or P/I-6157-2013	Gillespie, Emily/0000-0001-5261-3931; Levy, Dan/0000-0003-0719-0305; Gozani, Or/0000-0002-1365-4463	US National Science Foundation Graduate Research Fellowship (NSF GRFP); Stanford Genome Training Program (SGTP; US National Institutes of Health (NIH), US National Human Genome Research Institute); European Molecular Biology Organization; Human Frontier Science Program; Machiah Foundation; Ellison Senior Scholar Award; Donald E. and Delia B. Baxter Foundation; National Heart, Lung, and Blood Institute (NHLBI) [HHSN288201000034C]; Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension; NIH [5 U19-AI082719, 5 U19-AI050864, 5 U19-AI056363, 1 U19 AI090019, 4 U19 AI090019, R01 GM079641]; Canadian Institutes of Health Research [2 OR-92141]; Alliance for Lupus Research [21858]; European Union [261382]; NIH National Research Service Award Fellowship [5 F32 AI-080086-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, T32AI007290, U19AI056363, U19AI082719, F32AI080086, U19AI090019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	US National Science Foundation Graduate Research Fellowship (NSF GRFP); Stanford Genome Training Program (SGTP; US National Institutes of Health (NIH), US National Human Genome Research Institute); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Machiah Foundation; Ellison Senior Scholar Award(Lawrence Ellison Foundation); Donald E. and Delia B. Baxter Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alliance for Lupus Research; European Union(European Commission); NIH National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Lee, J. Zhu and the other members of the peptide array team at Biomedical Life Science at Digital Health Intel for development of the early peptide array process and G. Credo for help with the Online Methods section of the manuscript. We thank D. Hall, K.C. Garcia, S. Sidhu, J. Haddon, J. Jarrell and other members of our laboratories for helpful discussion. J.V.P. was funded by a US National Science Foundation Graduate Research Fellowship (NSF GRFP) and is supported by the Stanford Genome Training Program (SGTP; US National Institutes of Health (NIH), US National Human Genome Research Institute). D.L. is supported by the European Molecular Biology Organization, the Human Frontier Science Program and the Machiah Foundation. O.G. is a recipient of an Ellison Senior Scholar Award and is funded by a grant from the NIH (R01 GM079641). P.J.U. is the recipient of a Donald E. and Delia B. Baxter Foundation Career Development Award and is supported by National Heart, Lung, and Blood Institute (NHLBI) Proteomics contract HHSN288201000034C, Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension; grants from the NIH (5 U19-AI082719, 5 U19-AI050864, 5 U19-AI056363, 1 U19 AI090019 and 4 U19 AI090019); Canadian Institutes of Health Research (2 OR-92141); Alliance for Lupus Research (grant number 21858); a gift from the Ben May Trust and a gift from the Floren Family Trust. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 261382. C.L.L. is a recipient of an NIH National Research Service Award Fellowship (5 F32 AI-080086-02).	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bailey RC, 2010, NAT CHEM BIOL, V6, P857, DOI 10.1038/nchembio.488; Baker M, 2005, NAT BIOTECHNOL, V23, P1065, DOI 10.1038/nbt0905-1065; Barone AD, 2001, NUCLEOS NUCLEOT NUCL, V20, P525, DOI 10.1081/NCN-100002328; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cortese DA, 2007, CLIN PHARMACOL THER, V82, P491, DOI 10.1038/sj.clpt.6100390; de Vegvar HEN, 2003, J VIROL, V77, P11125, DOI 10.1128/JVI.77.20.11125-11138.2003; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Dieker JW, 2007, ARTHRITIS RHEUM-US, V56, P1921, DOI 10.1002/art.22646; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gao XL, 2003, PROTEOMICS, V3, P2135, DOI 10.1002/pmic.200300597; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Gaster RS, 2011, LAB CHIP, V11, P950, DOI [10.1039/c0lc00534g, 10.1039/c01c00534g]; Haab BB, 2005, MOL CELL PROTEOMICS, V4, P377, DOI 10.1074/mcp.M500010-MCP200; Hoffman IEA, 2005, CLIN CHEM, V51, P261; Kattah MG, 2008, NAT MED, V14, P1284, DOI 10.1038/nm.1755; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee DM, 2003, ANN RHEUM DIS, V62, P870, DOI 10.1136/ard.62.9.870; Lee MS, 1999, MASS SPECTROM REV, V18, P187, DOI 10.1002/(SICI)1098-2787(1999)18:3/4<187::AID-MAS2>3.0.CO;2-K; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Liskamp RMJ, 2011, CHEMBIOCHEM, V12, P1626, DOI 10.1002/cbic.201000717; Monestier M, 2000, J BIOL CHEM, V275, P13558, DOI 10.1074/jbc.275.18.13558; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Petri M, 2000, RHEUM DIS CLIN N AM, V26, P199, DOI 10.1016/S0889-857X(05)70135-6; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Shin DS, 2010, J COMB CHEM, V12, P463, DOI 10.1021/cc100009g; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Bavel CC, 2011, ANN RHEUM DIS, V70, P201, DOI 10.1136/ard.2010.129320; van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009; Vigh-Conrad KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010174; Volta U, 2010, J CLIN GASTROENTEROL, V44, P186, DOI 10.1097/MCG.0b013e3181c378f6; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	39	78	87	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1434	+		10.1038/nm.2913	http://dx.doi.org/10.1038/nm.2913			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22902875	Green Accepted			2022-12-25	WOS:000308472300042
J	Fromy, B; Lingueglia, E; Sigaudo-Roussel, D; Saumet, JL; Lazdunski, M				Fromy, Berengere; Lingueglia, Eric; Sigaudo-Roussel, Dominique; Saumet, Jean Louis; Lazdunski, Michel			Asic3 is a neuronal mechanosensor for pressure-induced vasodilation that protects against pressure ulcers	NATURE MEDICINE			English	Article							SENSING ION CHANNELS; SENSORY NEURONS; NA+ CHANNEL; ACID; PAIN; MICE; EXPRESSION; NEUROPATHY; HYPOXIA; PATHWAY	Pressure-induced vasodilation (PIV) delays the decrease in cutaneous blood flow produced by local application of low pressure to the skin, a physiologically appropriate adjustment of local vasomotor function. Individuals without a normal PIV response have a high risk of ulceration. Here we demonstrate that acid-sensing ion channel 3 (Asic3) is an essential neuronal sensor for the vasodilation response to direct pressure in both humans and rodents and for protecting against pressure ulcers in mice.	[Lingueglia, Eric; Lazdunski, Michel] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Lingueglia, Eric; Lazdunski, Michel] Univ Nice Sophia Antipolis, UMR 7275, Valbonne, France; [Lingueglia, Eric] LabEx ICST Valbonne, Valbonne, France; [Fromy, Berengere; Sigaudo-Roussel, Dominique; Saumet, Jean Louis] CNRS, Inst Biol & Chim Prot, FRE 3310, Lyon, France; [Fromy, Berengere; Sigaudo-Roussel, Dominique; Saumet, Jean Louis] Univ Lyon 1, FRE 3310, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lazdunski, M (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	jean-louis.saumet@univ-lyon1.fr; lazdunski@ipmc.cnrs.fr	LINGUEGLIA, Eric/F-5509-2013	LINGUEGLIA, Eric/0000-0003-3902-3405; Fromy, Berengere/0000-0003-2457-0334	Fondation pour la Recherche Medicale and Prevention Education Recherche Soins Escarres	Fondation pour la Recherche Medicale and Prevention Education Recherche Soins Escarres	We would like to thank the subjects who participated in this study. We thank C. Viart-Ferber, A. Josset-Lamaugarny, G. James and N. Pleche (AnexPeau facility, Lyon) for helpful assistance in human and rodent studies. We are very grateful to S. Diochot and E. Deval (CNRS UMR 7275) for providing APETx2 and knockout mice, to P. Inquimbert, V. Friend (CNRS UMR 7275) and N. Gadot (Anipath facility, Lyon) for histological studies, and to R. Buttin and D. Katz for technical support for Perimed equipment. We also thank Fondation pour la Recherche Medicale and Prevention Education Recherche Soins Escarres for financial support.	Allman R M, 1999, Adv Wound Care, V12, P22; ALLMAN RM, 1989, NEW ENGL J MED, V320, P850; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Costa R, 2008, BRIT J PHARMACOL, V154, P1094, DOI 10.1038/bjp.2008.172; Demiot C, 2006, DIABETES, V55, P1478, DOI 10.2337/db05-1433; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2011, J NEUROSCI, V31, P6059, DOI 10.1523/JNEUROSCI.5266-10.2011; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Fromy B, 2000, BRAIN RES PROTOC, V5, P198, DOI 10.1016/S1385-299X(00)00013-1; Fromy B, 1998, BRAIN RES, V811, P166, DOI 10.1016/S0006-8993(98)00973-1; Fromy B, 2000, BRIT J PHARMACOL, V131, P1161, DOI 10.1038/sj.bjp.0703685; Fromy B, 2010, J INVEST DERMATOL, V130, P849, DOI 10.1038/jid.2009.279; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Koitka A, 2004, DIABETES, V53, P721, DOI 10.2337/diabetes.53.3.721; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Potter C, 2004, CELL CYCLE, V3, P164; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reddy M, 2008, JAMA-J AM MED ASSOC, V300, P2647, DOI 10.1001/jama.2008.778; Sigaudo-Roussel D, 2004, DIABETES, V53, P1564, DOI 10.2337/diabetes.53.6.1564; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wultsch T, 2008, PAIN, V134, P245, DOI 10.1016/j.pain.2007.04.025; Wykoff CC, 2000, CANCER RES, V60, P7075	32	70	71	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1205	+		10.1038/nm.2844	http://dx.doi.org/10.1038/nm.2844			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22842475				2022-12-25	WOS:000307469300025
J	Nivala, J; Marks, DB; Akeson, M				Nivala, Jeff; Marks, Douglas B.; Akeson, Mark			Unfoldase-mediated protein translocation through an alpha-hemolysin nanopore	NATURE BIOTECHNOLOGY			English	Article							DNA; CLPXP	Using nanopores to sequence biopolymers was proposed more than a decade ago(1). Recent advances in enzyme-based control of DNA translocation(2) and in DNA nucleotide resolution using modified biological pores(3) have satisfied two technical requirements of a functional nanopore DNA sequencing device. Nanopore sequencing of proteins was also envisioned(1). Although proteins have been shown to move through nanopores(4-6), a technique to unfold proteins for processive translocation has yet to be demonstrated. Here we describe controlled unfolding and translocation of proteins through the alpha-hemolysin (alpha-HL) pore using the AAA+ unfoldase CIpX. Sequence-dependent features of individual engineered proteins were detected during translocation. These results demonstrate that molecular motors can reproducibly drive proteins through a model nanopore-a feature required for protein sequence analysis using this single-molecule technology.	[Nivala, Jeff; Marks, Douglas B.; Akeson, Mark] Univ Calif Santa Cruz, Dept Biomol Engn, Nanopore Grp, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Akeson, M (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Nanopore Grp, Santa Cruz, CA 95064 USA.	makeson@soe.ucsc.edu	Akeson, Mark/HCH-3046-2022	Nivala, Jeff/0000-0002-8210-5417	UC startup grant; National Human Genome Research Institute [R01HG006321]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006321] Funding Source: NIH RePORTER	UC startup grant; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Oxford Nanopore Technologies (Oxford, UK) for supplying alpha-HL heptamers, and A. Martin (UC Berkeley) for supplying ClpX-related expression plasmids and for helpful discussions on their use. R. Abu-Shumays, D. Bernick, K. Lieberman and H. Olsen commented on drafts of the manuscript. This work was supported by a UC startup grant to MA., and by equipment purchased previously using National Human Genome Research Institute grant R01HG006321. The C1pX-Delta N<INF>3</INF> BLR expression strain was obtained from A. Martin (UC Berkeley), as was a his-tagged ClpP expression strain.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Christensen C, 2011, J PEPT SCI, V17, P726, DOI 10.1002/psc.1393; Church G, 1998, US Patent, Patent No. [5,795,782, 5795782]; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Merstorf C, 2012, ACS CHEM BIOL, V7, P652, DOI 10.1021/cb2004737; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; Movileanu L, 2009, TRENDS BIOTECHNOL, V27, P333, DOI 10.1016/j.tibtech.2009.02.008; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Oukhaled G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158101; Sheng WY, 2002, PROTEIN SCI, V11, P1482, DOI 10.1110/ps.0201602; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Talaga DS, 2009, J AM CHEM SOC, V131, P9287, DOI 10.1021/ja901088b	18	227	248	5	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					247	250		10.1038/nbt.2503	http://dx.doi.org/10.1038/nbt.2503			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23376966	Green Accepted			2022-12-25	WOS:000316439500020
J	Pugh, TJ; Morozova, O; Attiyeh, EF; Asgharzadeh, S; Wei, JS; Auclair, D; Carter, SL; Cibulskis, K; Hanna, M; Kiezun, A; Kim, J; Lawrence, MS; Lichenstein, L; McKenna, A; Pedamallu, CS; Ramos, AH; Shefler, E; Sivachenko, A; Sougnez, C; Stewart, C; Ally, A; Birol, I; Chiu, R; Corbett, RD; Hirst, M; Jackman, SD; Kamoh, B; Khodabakshi, AH; Krzywinski, M; Lo, A; Moore, RA; Mungall, KL; Qian, J; Tam, A; Thiessen, N; Zhao, YJ; Cole, KA; Diamond, M; Diskin, SJ; Mosse, YP; Wood, AC; Ji, LY; Sposto, R; Badgett, T; London, WB; Moyer, Y; Gastier-Foster, JM; Smith, MA; Auvil, JMG; Gerhard, DS; Hogarty, MD; Jones, SJM; Lander, ES; Gabriel, SB; Getz, G; Seeger, RC; Khan, J; Marra, MA; Meyerson, M; Maris, JM				Pugh, Trevor J.; Morozova, Olena; Attiyeh, Edward F.; Asgharzadeh, Shahab; Wei, Jun S.; Auclair, Daniel; Carter, Scott L.; Cibulskis, Kristian; Hanna, Megan; Kiezun, Adam; Kim, Jaegil; Lawrence, Michael S.; Lichenstein, Lee; McKenna, Aaron; Pedamallu, Chandra Sekhar; Ramos, Alex H.; Shefler, Erica; Sivachenko, Andrey; Sougnez, Carrie; Stewart, Chip; Ally, Adrian; Birol, Inanc; Chiu, Readman; Corbett, Richard D.; Hirst, Martin; Jackman, Shaun D.; Kamoh, Baljit; Khodabakshi, Alireza Hadj; Krzywinski, Martin; Lo, Allan; Moore, Richard A.; Mungall, Karen L.; Qian, Jenny; Tam, Angela; Thiessen, Nina; Zhao, Yongjun; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Ji, Lingyun; Sposto, Richard; Badgett, Thomas; London, Wendy B.; Moyer, Yvonne; Gastier-Foster, Julie M.; Smith, Malcolm A.; Auvil, Jaime M. Guidry; Gerhard, Daniela S.; Hogarty, Michael D.; Jones, Steven J. M.; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Seeger, Robert C.; Khan, Javed; Marra, Marco A.; Meyerson, Matthew; Maris, John M.			The genetic landscape of high-risk neuroblastoma	NATURE GENETICS			English	Article							ACTIVATING MUTATIONS; SOMATIC MUTATIONS; NOONAN-SYNDROME; SOLID TUMORS; ALK KINASE; CANCER; PTPN11; SUSCEPTIBILITY; AMPLIFICATION; PROTEINS	Neuroblastoma is a malignancy of the developing sympathetic nervous system that often presents with widespread metastatic disease, resulting in survival rates of less than 50%. To determine the spectrum of somatic mutation in high-risk neuroblastoma, we studied 240 affected individuals (cases) using a combination of whole-exome, genome and transcriptome sequencing as part of the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative. Here we report a low median exonic mutation frequency of 0.60 per Mb (0.48 nonsilent) and notably few recurrently mutated genes in these tumors. Genes with significant somatic mutation frequencies included ALK (9.2% of cases), PTPN11 (2.9%), ATRX (2.5%, and an additional 7.1% had focal deletions), MYCN (1.7%, causing a recurrent p.Pro44Leu alteration) and NRAS (0.83%). Rare, potentially pathogenic germline variants were significantly enriched in ALK, CHEK2, PINK1 and BARD1. The relative paucity of recurrent somatic mutations in neuroblastoma challenges current therapeutic strategies that rely on frequently altered oncogenic drivers.	[Pugh, Trevor J.; Auclair, Daniel; Carter, Scott L.; Cibulskis, Kristian; Hanna, Megan; Kiezun, Adam; Kim, Jaegil; Lawrence, Michael S.; Lichenstein, Lee; McKenna, Aaron; Pedamallu, Chandra Sekhar; Ramos, Alex H.; Shefler, Erica; Sivachenko, Andrey; Sougnez, Carrie; Stewart, Chip; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA USA; [Pugh, Trevor J.; Ramos, Alex H.; London, Wendy B.; Meyerson, Matthew] Harvard Univ, Sch Med, Boston, MA USA; [Pugh, Trevor J.; Hanna, Megan; Pedamallu, Chandra Sekhar; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Morozova, Olena; Ally, Adrian; Birol, Inanc; Chiu, Readman; Corbett, Richard D.; Hirst, Martin; Jackman, Shaun D.; Kamoh, Baljit; Khodabakshi, Alireza Hadj; Krzywinski, Martin; Lo, Allan; Moore, Richard A.; Mungall, Karen L.; Qian, Jenny; Tam, Angela; Thiessen, Nina; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.] Univ British Columbia, British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada; [Morozova, Olena; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Attiyeh, Edward F.; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Attiyeh, Edward F.; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Attiyeh, Edward F.; Cole, Kristina A.; Diamond, Maura; Diskin, Sharon J.; Mosse, Yael P.; Wood, Andrew C.; Hogarty, Michael D.; Maris, John M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asgharzadeh, Shahab; Ji, Lingyun; Sposto, Richard; Seeger, Robert C.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Ji, Lingyun; Sposto, Richard; Seeger, Robert C.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Ji, Lingyun; Sposto, Richard; Seeger, Robert C.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Wei, Jun S.; Badgett, Thomas; Khan, Javed] NIH, Pediat Oncol Branch, Oncogen Sect, Ctr Canc Res, Gaithersburg, MD USA; [London, Wendy B.] Childrens Hosp Boston, Dana Farber Canc Inst, Boston, MA USA; [London, Wendy B.] Childrens Oncol Grp, Boston, MA USA; [Moyer, Yvonne; Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Biopathol Ctr, Columbus, OH USA; [Moyer, Yvonne; Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Malcolm A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Auvil, Jaime M. Guidry; Gerhard, Daniela S.] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Maris, John M.] Abramson Family Canc Res Inst, Philadelphia, PA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Children's Oncology Group (COG); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); University of Pennsylvania; Pennsylvania Medicine	Marra, MA (corresponding author), Univ British Columbia, British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada.	mmarra@bcgsc.ca; matthew_meyerson@dfci.harvard.edu; maris@chop.edu	Birol, Inanc/G-5440-2011; Jones, Steven J/C-3621-2009; London, Wendy Beth/ABA-8948-2021; Marra, Marco A/B-5987-2008; Pedamallu, Chandra Sekhar/AAV-6723-2020; Lawrence, Michael/AAC-8202-2020; Hirst, Martin/B-7684-2016; Khan, Javed/P-9157-2014; Pugh, Trevor/Y-2535-2019; Cole, Kristina/M-3922-2015; Pedamallu, Chandra Sekhar/AAV-6745-2020; London, Wendy/ABD-4624-2021; Cibulskis, Kristian/AAC-7380-2019; Jackman, Shaun/G-9622-2013	Birol, Inanc/0000-0003-0950-7839; Jones, Steven J/0000-0003-3394-2208; London, Wendy Beth/0000-0003-3571-6538; Marra, Marco A/0000-0001-7146-7175; Pugh, Trevor/0000-0002-8073-5888; Vaske, Olena/0000-0002-1677-417X; Meyerson, Matthew/0000-0002-9133-8108; Jackman, Shaun/0000-0002-9275-5966; Cibulskis, Kristian/0000-0003-1343-1582; Smith, Malcolm/0000-0001-9880-9876	US National Institutes of Health [CA98543, CA98413, RC1MD004418, CA124709, CA060104]; National Human Genome Research Institute grant [U54HG003067]; National Cancer Institute, US National Institutes of Health [HHSN261200800001E]; Canadian Institutes of Health Research Fellowship; Roman M. Babicki Fellowship in Medical Research at the University of British Columbia; Canada Research Chair in Genome Science; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Arms Wide Open Foundation; Cookies for Kids Foundation; NATIONAL CANCER INSTITUTE [ZIABC010998, ZIASC010366] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute grant; National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); Roman M. Babicki Fellowship in Medical Research at the University of British Columbia; Canada Research Chair in Genome Science; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Arms Wide Open Foundation; Cookies for Kids Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Children's Oncology Group for the collection and annotation of samples for this study, and all TARGET co-investigators for scientific support of this project. Funding was provided by US National Institutes of Health grants CA98543 and CA98413 to the Children's Oncology Group, RC1MD004418 to the TARGET consortium, CA124709 (J.M.M.) and CA060104 (R.C.S.) and National Human Genome Research Institute grant U54HG003067 (E.S.L., D.A., S.B.G., G.G. and M.M.), as well as a contract from the National Cancer Institute, US National Institutes of Health (HHSN261200800001E). Additional support included a Canadian Institutes of Health Research Fellowship (T.J.P.), a Roman M. Babicki Fellowship in Medical Research at the University of British Columbia (O.M.), the Canada Research Chair in Genome Science (M.A.M.), the Giulio D'Angio Endowed Chair (J.M.M.), the Alex's Lemonade Stand Foundation (J.M.M.), the Arms Wide Open Foundation (J.M.M.) and the Cookies for Kids Foundation (J.M.M.). We thank E. Nickerson, S. Charmer, K. Novik, C. Suragh and R. Roscoe for project management support. We also thank the staff of the Genome Sciences Centre Biospecimen Core, Library Construction, Sequencing and Bioinformatics teams, and the staff of the Broad Institute Biological Samples, Genome Sequencing and Genetic Analysis Platforms for their expertise in genomic processing of samples, and generating the sequencing data used in this analysis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Choi JM, 2008, NEUROGENETICS, V9, P263, DOI 10.1007/s10048-008-0138-0; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Deyell RJ, 2011, CANCER GENET-NY, V204, P113, DOI 10.1016/j.cancergen.2011.03.001; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Klein C, 2005, EUR J HUM GENET, V13, P1086, DOI 10.1038/sj.ejhg.5201455; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lee SB, 2001, CANCER RES, V61, P8062; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Marongiu R, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20719; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Sarkozy A, 2004, EUR J HUM GENET, V12, P1069, DOI 10.1038/sj.ejhg.5201290; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Sijmons RH, 2008, HERED CANCER CLIN PR, V6, P22, DOI 10.1186/1897-4287-6-1-22; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	69	715	729	1	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					279	284		10.1038/ng.2529	http://dx.doi.org/10.1038/ng.2529			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23334666	Green Submitted, Green Accepted			2022-12-25	WOS:000315664800011
J	Luxan, G; Casanova, JC; Martinez-Poveda, B; Prados, B; D'Amato, G; MacGrogan, D; Gonzalez-Rajal, A; Dobarro, D; Torroja, C; Martinez, F; Izquierdo-Garcia, JL; Fernandez-Friera, L; Sabater-Molina, M; Kong, YY; Pizarro, G; Ibanez, B; Medrano, C; Garcia-Pavia, P; Gimeno, JR; Monserrat, L; Jimenez-Borreguero, LJ; de la Pompa, JL				Luxan, Guillermo; Casanova, Jesus C.; Martinez-Poveda, Beatriz; Prados, Belen; D'Amato, Gaetano; MacGrogan, Donal; Gonzalez-Rajal, Alvaro; Dobarro, David; Torroja, Carlos; Martinez, Fernando; Luis Izquierdo-Garcia, Jose; Fernandez-Friera, Leticia; Sabater-Molina, Maria; Kong, Young-Y; Pizarro, Gonzalo; Ibanez, Borja; Medrano, Constancio; Garcia-Pavia, Pablo; Gimeno, Juan R.; Monserrat, Lorenzo; Jimenez-Borreguero, Luis J.; Luis de la Pompa, Jose			Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy	NATURE MEDICINE			English	Article							CARDIAC DEVELOPMENT; DISTINCT CARDIOMYOPATHY; UBIQUITIN LIGASE; GENE-MUTATIONS; BARTH-SYNDROME; HEART; HYPERTRABECULATION/NONCOMPACTION; ACTIVATION; DISEASE; DELTA	Left ventricular noncompaction (LVNC) causes prominent ventricular trabeculations and reduces cardiac systolic function. The clinical presentation of LVNC ranges from asymptomatic to heart failure. We show that germline mutations in human MIB1 (mindbomb homolog 1), which encodes an E3 ubiquitin ligase that promotes endocytosis of the NOTCH ligands DELTA and JAGGED, cause LVNC in autosomal-dominant pedigrees, with affected individuals showing reduced NOTCH I activity and reduced expression of target genes. Functional studies in cells and zebrafish embryos and in silico modeling indicate that MIB1 functions as a dimer, which is disrupted by the human mutations. Targeted inactivation of Mib1 in mouse myocardium causes LVNC, a phenotype mimicked by inactivation of myocardial Jagged1 or endocardial Notch 1. Myocardial Mib1 mutants show reduced ventricular Notch1 activity, expansion of compact myocardium to proliferative, immature trabeculae and abnormal expression of cardiac development and disease genes. These results implicate NOTCH signaling in LVNC and indicate that MIB1 mutations arrest chamber myocardium development, preventing trabecular maturation and compaction.	[Luxan, Guillermo; Casanova, Jesus C.; Martinez-Poveda, Beatriz; Prados, Belen; D'Amato, Gaetano; MacGrogan, Donal; Gonzalez-Rajal, Alvaro; Dobarro, David; Luis de la Pompa, Jose] CNIC, Dept Cardiovasc Dev & Repair, Program Cardiovasc Dev Biol, Madrid, Spain; [Torroja, Carlos; Martinez, Fernando] CNIC, Bioinformat Unit, Madrid, Spain; [Luis Izquierdo-Garcia, Jose; Fernandez-Friera, Leticia; Pizarro, Gonzalo; Ibanez, Borja; Jimenez-Borreguero, Luis J.] CNIC, Department Epidemiol Atherothrombosis & Image, Madrid, Spain; [Sabater-Molina, Maria; Gimeno, Juan R.] Hosp Univ Virgen Arrixaca, Murcia, Spain; [Kong, Young-Y] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Pizarro, Gonzalo] Univ Europea Madrid, Hosp Univ Quiron Madrid, Madrid, Spain; [Ibanez, Borja] Hosp Clin San Carlos, Inst Cardiovasc, Madrid, Spain; [Medrano, Constancio] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain; [Garcia-Pavia, Pablo] Hosp Univ Puerta Hierro, Dept Cardiol, Cardiomyopathy Unit, Majadahonda, Spain; [Monserrat, Lorenzo] Complejo Hosp Univ A Coruna, Inst Invest Biomed A Coruna, La Coruna, Spain; [Jimenez-Borreguero, Luis J.] Hosp Univ La Princesa, Inst Invest Sanitaria, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Clinico Universitario Virgen de la Arrixaca; Seoul National University (SNU); European University of Madrid; Hospital Clinico San Carlos; General University Gregorio Maranon Hospital; Hospital Puerta de Hierro-Majadahonda; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Hospital de La Princesa	de la Pompa, JL (corresponding author), CNIC, Dept Cardiovasc Dev & Repair, Program Cardiovasc Dev Biol, Madrid, Spain.	jlpompa@cnic.es	Blanes, Juan R Gimeno/I-4269-2015; Izquierdo-Garcia, Jose/L-3293-2013; Sabater-Molina, Maria/I-2722-2015; De La Pompa, José Luis/F-9719-2014; D'Amato, Gaetano/S-1847-2019; Ibáñez, Borja/J-6993-2014; Pizarro, Gonzalo/AAQ-8123-2020; Jiménez-Borreguero, Luis Jesús/L-8107-2014; Fernández Friera, Leticia/E-9931-2015; MacGrogan, Donal/E-8604-2016; Izquierdo Garcia, Jose/L-2654-2015; Garcia-Pavia, Pablo/T-9100-2019; MacGrogan, Donal/AAR-7392-2021; Martinez, Fernando/E-8026-2016; Gonzalez-Rajal, Alvaro/ABA-6874-2020; Martinez-Poveda, Beatriz/T-6973-2017; D'Amato, Gaetano/Q-3141-2019; Torroja, Carlos/N-6022-2014; Pizarro, Gonzalo/K-2438-2015	Blanes, Juan R Gimeno/0000-0001-5818-1754; Izquierdo-Garcia, Jose/0000-0002-7907-3776; Sabater-Molina, Maria/0000-0003-1352-1748; De La Pompa, José Luis/0000-0001-6761-7265; Ibáñez, Borja/0000-0002-5036-254X; Pizarro, Gonzalo/0000-0002-5082-3596; Jiménez-Borreguero, Luis Jesús/0000-0001-5870-237X; Fernández Friera, Leticia/0000-0002-4237-2166; MacGrogan, Donal/0000-0003-2808-8422; MacGrogan, Donal/0000-0003-2808-8422; Martinez, Fernando/0000-0003-1904-5164; Gonzalez-Rajal, Alvaro/0000-0002-9230-0339; Martinez-Poveda, Beatriz/0000-0003-3927-3877; D'Amato, Gaetano/0000-0003-2640-5826; Torroja, Carlos/0000-0001-8914-3400; Martinez Estrada, Fernando O/0000-0003-0908-9366; Monserrat, Lorenzo/0000-0001-5776-0623; Luxan, Guillermo/0000-0001-8350-8659; Prados, Belen/0000-0001-6240-5626; MEDRANO-LOPEZ, CONSTANCIO/0000-0003-4097-2448	Spanish Ministry of Economy and Competition (MINECO) [SAF2010-17555, RD06/0014/0038, RD06/0010/1013]; MINECO (FPI Program) [BES-2008-002904]; MINECO; Pro-CNIC Foundation	Spanish Ministry of Economy and Competition (MINECO)(Spanish Government); MINECO (FPI Program)(Spanish Government); MINECO(Spanish Government); Pro-CNIC Foundation	We thank P.J. Gallagher (Indiana University) for the Mib1-specific antibody, U. Lendahl (Karolinska Institute) for the Jag1- and Notch1-HEK293 cells, A. Martin-Pendas (Cancer Center, CSIC, Salamanca) for the pCELF plamid, D. Saura and J. Gonzalez for carrying out the CMRI of the patients, M. Manzanares, A. Martin-Pendas, J.M. Perez-Pomares, J.M. Redondo, J.J. Schott and M. Torres for critical reading of the manuscript and S. Bartlett (CNIC) for English editing. This study was funded by grants SAF2010-17555, RD06/0014/0038 (RECAVA) and RD06/0010/1013 (TERCEL) from the Spanish Ministry of Economy and Competition (MINECO) to J.L.d.l.P. G.L. has a PhD fellowship from the MINECO (FPI Program, BES-2008-002904). The CNIC is supported by the MINECO and the Pro-CNIC Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barsi JC, 2005, MECH DEVELOP, V122, P1106, DOI 10.1016/j.mod.2005.06.005; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Captur G, 2010, INT J CARDIOL, V140, P145, DOI 10.1016/j.ijcard.2009.07.003; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Hermida-Prieto M, 2004, AM J CARDIOL, V94, P50, DOI 10.1016/j.amjcard.2004.03.029; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Ichida F, 2001, CIRCULATION, V103, P1256; Ichida F, 2009, CIRC J, V73, P19, DOI 10.1253/circj.CJ-08-0995; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; Macias-Vidal J, 2009, MOL GENET METAB, V97, P60, DOI 10.1016/j.ymgme.2009.01.007; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; MOENS CB, 1993, DEVELOPMENT, V119, P485; Oechslin EN, 2000, J AM COLL CARDIOL, V36, P493, DOI 10.1016/S0735-1097(00)00755-5; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Ritter M, 1997, MAYO CLIN PROC, V72, P26, DOI 10.4065/72.1.26; Rodighiero S, 2008, CELL PHYSIOL BIOCHEM, V21, P489, DOI 10.1159/000129642; Sarma RJ, 2010, PROG CARDIOVASC DIS, V52, P264, DOI 10.1016/j.pcad.2009.11.001; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stollberger C, 2004, J AM SOC ECHOCARDIOG, V17, P91, DOI 10.1016/S0894-7317(03)00514-5; Stollberger C, 2004, J AM SOC ECHOCARDIOG, V17, P1120, DOI 10.1016/j.echo.2004.06.018; Towbin Jeffrey A, 2010, Heart Fail Clin, V6, P453, DOI 10.1016/j.hfc.2010.06.005; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; VanKempen MJA, 1996, CARDIOVASC RES, V32, P886; ZELLER R, 1987, GENE DEV, V1, P693, DOI 10.1101/gad.1.7.693; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	51	222	230	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					193	201		10.1038/nm.3046	http://dx.doi.org/10.1038/nm.3046			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23314057				2022-12-25	WOS:000314675900027
J	Miyauchi, K; Kimura, S; Suzuki, T				Miyauchi, Kenjyo; Kimura, Satoshi; Suzuki, Tsutomu			A cyclic form of N-6-threonylcarbamoyladenosine as a widely distributed tRNA hypermodification	NATURE CHEMICAL BIOLOGY			English	Article							POSTTRANSCRIPTIONAL MODIFICATIONS; ANTICODON; NUCLEOSIDES; TRNA(LYS); N-(PURIN-6-YLCARBAMOYL)THREONINE; BIOSYNTHESIS; SYNTHETASE; ADJACENT; FAMILY; COLI	N-6-threonylcarbamoyladenosine (t(6)A) is a universally conserved, essential modified nucleoside found in transfer RNAs (tRNAs) responsible for ANN codons in all three domains of life. t(6)A has a crucial role in maintaining decoding accuracy during protein synthesis. The presence of t(6)A in cellular tRNAs has been well documented for more than four decades. However, under conditions optimized for nucleoside preparation, we detected little t(6)A in tRNAs from Escherichia coli. Instead, we identified a new modified base named 'cyclic t(6)A' (ct(6)A), which is a cyclized active ester with an oxazolone ring. An El-like enzyme, CsdL (renamed as TcdA), which catalyzes ATP-dependent dehydration of t(6)A to form ct(6)A, was also identified. Two yeast homologs of tcdA, YHR003C (TCD1) and YKL027W (TCD2), were required for ct(6)A formation and respiratory cell growth. ct(6)A was involved in promoting decoding efficiency. Structural modeling suggests that ct(6)A recognizes the first adenine base of ANN codon at the ribosomal A site.	[Miyauchi, Kenjyo; Kimura, Satoshi; Suzuki, Tsutomu] Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan	University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Tokyo, Japan.	ts@chembio.t.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731; Kimura, Satoshi/0000-0003-3555-5877	Ministry of Education, Science, Sports and Culture of Japan; New Energy and Industrial Technology Development Organization	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	We are grateful to the members of the Suzuki laboratory, especially T. Suzuki, A. Nagao, Y. Sakaguchi, T. Ohira, M. Ohara, T. Chujo, H. Takeda, Y. Ikeuchi, T. Taniguchi and T. Sakashita for technical assistance and fruitful discussions. Special thanks are due to R.W. Adamiak (Polish Academy of Sciences) for providing t<SUP>6</SUP>A. This work was supported by the Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan (to T.S.) and by a grant from the New Energy and Industrial Technology Development Organization (to T.S.).	ADAMIAK RW, 1975, B ACAD POL SCI-CHIM, V23, P241; Bolstad HM, 2010, J PROTEOME RES, V9, P5358, DOI 10.1021/pr1006087; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; ELKINS BN, 1974, BIOCHEMISTRY-US, V13, P4622, DOI 10.1021/bi00719a024; Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; KASAI H, 1976, EUR J BIOCHEM, V69, P435, DOI 10.1111/j.1432-1033.1976.tb10928.x; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Krog JS, 2011, FEBS J, V278, P4782, DOI 10.1111/j.1742-4658.2011.08379.x; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MARTIN D, 1994, Z NATURFORSCH C, V49, P834; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; NIIMI T, 1994, NUCLEOS NUCLEOT NUCL, V13, P1231, DOI 10.1080/15257779408012147; Nishimura S, 1972, Prog Nucleic Acid Res Mol Biol, V12, P49; PARTHASARATHY R, 1974, BIOCHEM BIOPH RES CO, V60, P211, DOI 10.1016/0006-291X(74)90193-4; Phelps SS, 2004, J MOL BIOL, V338, P439, DOI 10.1016/j.jmb.2004.02.070; Salazar JC, 2004, P NATL ACAD SCI USA, V101, P7536, DOI 10.1073/pnas.0401982101; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Stuart JW, 2000, BIOCHEMISTRY-US, V39, P13396, DOI 10.1021/bi0013039; Sundaram M, 2000, BIOCHEMISTRY-US, V39, P15652, DOI 10.1021/bi005120y; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	29	119	127	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					105	111		10.1038/NCHEMBIO.1137	http://dx.doi.org/10.1038/NCHEMBIO.1137			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23242255				2022-12-25	WOS:000314083200009
J	Zhong, SL; Fei, ZJ; Chen, YR; Zheng, Y; Huang, MY; Vrebalov, J; McQuinn, R; Gapper, N; Liu, B; Xiang, J; Shao, Y; Giovannoni, JJ				Zhong, Silin; Fei, Zhangjun; Chen, Yun-Ru; Zheng, Yi; Huang, Mingyun; Vrebalov, Julia; McQuinn, Ryan; Gapper, Nigel; Liu, Bao; Xiang, Jenny; Shao, Ying; Giovannoni, James J.			Single-base resolution methylomes of tomato fruit development reveal epigenome modifications associated with ripening	NATURE BIOTECHNOLOGY			English	Article							EPIGENETIC MUTATION; REGULATORY REGIONS; GENE-EXPRESSION; DNA; ETHYLENE; METHYLATION; TRANSCRIPTION; ARABIDOPSIS; GENOME; PLANTS	Ripening of tomato fruits is triggered by the plant hormone ethylene, but its effect is restricted by an unknown developmental cue to mature fruits containing viable seeds. To determine whether this cue involves epigenetic remodeling, we expose tomatoes to the methyltransferase inhibitor 5-azacytidine and find that they ripen prematurely. We performed whole-genome bisulfite sequencing on fruit in four stages of development, from immature to ripe. We identified 52,095 differentially methylated regions (representing 1% of the genome) in the 90% of the genome covered by our analysis. Furthermore, binding sites for RIN, one of the main ripening transcription factors, are frequently localized in the demethylated regions of the promoters of numerous ripening genes, and binding occurs in concert with demethylation. Our data show that the epigenome is not static during development and may have been selected to ensure the fidelity of developmental processes such as ripening. Crop-improvement strategies could benefit by taking into account not only DNA sequence variation among plant lines, but also the information encoded in the epigenome.	[Zhong, Silin; Fei, Zhangjun; Chen, Yun-Ru; Zheng, Yi; Huang, Mingyun; Vrebalov, Julia; McQuinn, Ryan; Gapper, Nigel; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Zhong, Silin; Liu, Bao] NE Normal Univ, Minist Educ, Key Labs Mol Epigenet, Changchun, Peoples R China; [Fei, Zhangjun; Giovannoni, James J.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Xiang, Jenny; Shao, Ying] Cornell Univ, Weill Med Coll, Genom Resource Core Facil, New York, NY 10021 USA	Cornell University; Boyce Thompson Institute for Plant Research; Northeast Normal University - China; United States Department of Agriculture (USDA); Cornell University	Giovannoni, JJ (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	sz284@cornell.edu; zf25@cornell.edu; jjg33@cornell.edu	Fei, Zhangjun/H-5152-2012; Zheng, Yi/F-6150-2016; zhong, silin/O-7029-2015	Zheng, Yi/0000-0002-8042-7770; zhong, silin/0000-0002-0198-7383; Liu, Bao/0000-0001-5481-1675; McQuinn, Ryan/0000-0002-5549-5181; Fei, Zhangjun/0000-0001-9684-1450; zakaria, seyed moein/0000-0002-0086-1279	United States Department of Agriculture - Agricultural Research Service, National Science Foundation [IOS-0606595, IOS-0923312, DBI-0820612]; National Natural Science Foundation of China [30900783, 3090243]; Human Frontier Science Program [LTF000076/2009]	United States Department of Agriculture - Agricultural Research Service, National Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Human Frontier Science Program(Human Frontier Science Program)	We thank E. Richards, R. Schmitz and J. Ecker for discussion and thoughtful advice in preparing this manuscript, and R. White, Y. Xu and Z. Li for technical assistance. This project was supported by the United States Department of Agriculture - Agricultural Research Service, National Science Foundation IOS-0606595 and IOS-0923312 to J.J.G. and Z.F., DBI-0820612 to J.J.G., National Natural Science Foundation of China 30900783 and 3090243 to S.Z. and B.L. and the Human Frontier Science Program LTF000076/2009 to S.Z.	Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; BURG SP, 1965, SCIENCE, V148, P1190, DOI 10.1126/science.148.3674.1190; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DEIKMAN J, 1992, PLANT PHYSIOL, V100, P2013, DOI 10.1104/pp.100.4.2013; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fujisawa M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-26; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; KING GN, 1947, PLANT PHYSIOL, V22, P572, DOI 10.1104/pp.22.4.572; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; MCMURCHIE EJ, 1972, NATURE, V237, P235, DOI 10.1038/237235a0; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; NICHOLASS FJ, 1995, PLANT MOL BIOL, V28, P423, DOI 10.1007/BF00020391; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; PATTERSON GI, 1993, GENETICS, V135, P881; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Seymour G, 2008, CURR OPIN PLANT BIOL, V11, P58, DOI 10.1016/j.pbi.2007.09.003; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	30	483	513	22	351	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					154	159		10.1038/nbt.2462	http://dx.doi.org/10.1038/nbt.2462			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23354102				2022-12-25	WOS:000315322100027
J	Lazarus, MB; Jiang, JY; Gloster, TM; Zandberg, WF; Whitworth, GE; Vocadlo, DJ; Walker, S				Lazarus, Michael B.; Jiang, Jiaoyang; Gloster, Tracey M.; Zandberg, Wesley F.; Whitworth, Garrett E.; Vocadlo, David J.; Walker, Suzanne			Structural snapshots of the reaction coordinate for O-GlcNAc transferase	NATURE CHEMICAL BIOLOGY			English	Article							SUBSTRATE; INHIBITORS; ANALOGS; GLYCOSYLTRANSFERASES; GLYCOSYLATION; INSIGHTS; ACCEPTOR; PATHWAY; COMPLEX; STRESS	Visualization of the reaction coordinate undertaken by glycosyltransferases has remained elusive but is critical for understanding this important class of enzyme. Using substrates and substrate mimics, we describe structural snapshots of all species along the kinetic pathway for human O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase), an intracellular enzyme that catalyzes installation of a dynamic post-translational modification. The structures reveal key features of the mechanism and show that substrate participation is important during catalysis.	[Lazarus, Michael B.; Jiang, Jiaoyang; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gloster, Tracey M.; Zandberg, Wesley F.; Whitworth, Garrett E.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Harvard University; Harvard Medical School; Harvard University; Simon Fraser University; Simon Fraser University	Walker, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.	suzanne_walker@hms.harvard.edu	Zandberg, Wesley/AAX-5568-2021; Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Lazarus, Michael/0000-0002-6738-2563	US National Institutes of Health (NIH) [R01GM094263]; Natural Sciences and Engineering Research Council of Canada; Simon Fraser University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Simon Fraser University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (NIH) grant R01GM094263 to S. W. and the Natural Sciences and Engineering Research Council of Canada and Simon Fraser University. T. M. G. is a Sir Henry Wellcome postdoctoral fellow and a Michael Smith for Health Research (MSFHR) trainee award holder. D.J.V. is an E. W. R. Steacie Memorial Fellow and holds a Canada Research Chair in Chemical Glycobiology. We thank L. Deng for assistance with the chemical synthesis. We thank L. Cai (University of South Carolina, Salkehatchie) for the kind gift of UDP-2-ketoGlc.	Burkart MD, 2000, BIOORGAN MED CHEM, V8, P1937, DOI 10.1016/S0968-0896(00)00139-5; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dorfmueller HC, 2011, AMINO ACIDS, V40, P781, DOI 10.1007/s00726-010-0688-y; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602	25	106	106	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					966	968		10.1038/NCHEMBIO.1109	http://dx.doi.org/10.1038/NCHEMBIO.1109			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103939	Green Accepted, Green Submitted			2022-12-25	WOS:000311491200010
J	MacAlister, CA; Park, SJ; Jiang, K; Marcel, F; Bendahmane, A; Izkovich, Y; Eshed, Y; Lippman, ZB				MacAlister, Cora A.; Park, Soon Ju; Jiang, Ke; Marcel, Fabien; Bendahmane, Abdelhafid; Izkovich, Yinon; Eshed, Yuval; Lippman, Zachary B.			Synchronization of the flowering transition by the tomato TERMINATING FLOWER gene	NATURE GENETICS			English	Article							FLORAL MERISTEM; REGULATE GROWTH; ORTHOLOG; IDENTITY; SIGNALS; PROTEIN; FAMILY; EXPRESSION; FLORIGEN; GENOME	The transition to flowering is a major determinant of plant architecture, and variation in the timing of flowering can have profound effects on inflorescence architecture, flower production and yield. Here, we show that the tomato mutant terminating flower (tmf) flowers early and converts the multiflowered inflorescence into a solitary flower as a result of precocious activation of a conserved floral specification complex encoded by ANANTHA (AN) and FALSIFLORA (FA). Without TMF, the coordinated flowering process is disrupted, causing floral identity genes, such as AN and members of the SEPALLATA (SEP) family, to activate precociously, while the expression of flowering transition genes, such as FRUITFULL (FUL), is delayed. Indeed, driving AN expression precociously is sufficient to cause early flowering, and this expression transforms multiflowered inflorescences into normal solitary flowers resembling those of the Solanaceae species petunia and tobacco. Thus, by timing AN activation, TMF synchronizes flower formation with the gradual reproductive transition, which, in turn, has a key role in determining simple versus complex inflorescences.	[MacAlister, Cora A.; Park, Soon Ju; Jiang, Ke; Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Marcel, Fabien; Bendahmane, Abdelhafid] Univ Evry Val dEssonne, Unit Innovat & Dev Agr 1165, Unite Rech Genome Vegetale, Inst Natl Rech Agron,Ctr Natl Rech Sci,ERL 8196, Evry, France; [Izkovich, Yinon; Eshed, Yuval] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Weizmann Institute of Science	Lippman, ZB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lippman@cshl.edu		MacAlister, Cora/0000-0003-1470-0596; Eshed, Yuval/0000-0001-8290-0018; Lippman, Zachary/0000-0001-7668-9025	Tomato Genetics Resource Center (TGRC) at the University of California, Davis; European Research Council (ERC); European Union [FOOD-CT-2006-016214]; Israel Science Foundation [1294-10]; Binational Agricultural Research & Development Fund [IS-4249-09]; International Human Frontier Science Program Organization	Tomato Genetics Resource Center (TGRC) at the University of California, Davis(University of California System); European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission); Israel Science Foundation(Israel Science Foundation); Binational Agricultural Research & Development Fund; International Human Frontier Science Program Organization(Human Frontier Science Program)	We thank A. Aharoni for allowing screening of the population from which tmf2-D was derived. We also thank the Tomato Genetics Resource Center (TGRC) at the University of California, Davis, for germplasm, J. Van Eck for generating transgenic plants and DuPont Pioneer for funding. The work in the laboratory of A. Aharoni was supported by European Research Council (ERC) project SAMIT (Framework Programme 7). The tomato TILLING project is supported by funding from the European Union SOL Integrated Project FOOD-CT-2006-016214 to A.B. C.A.M. is a Gordon and Betty Moore Foundation Fellow of the Life Sciences Research Foundation. This research was supported by research grant 1294-10 from the Israel Science Foundation and Binational Agricultural Research & Development Fund IS-4249-09 to Y.E. and a Career Development Award from The International Human Frontier Science Program Organization to Z.B.L.	Allen KD, 1996, PLANTA, V200, P254, DOI 10.1007/BF00208316; BELL AD, 1993, PLANT FORM ILLUSTRAT; Chae E, 2008, DEVELOPMENT, V135, P1235, DOI 10.1242/dev.015842; Cheng XD, 2009, GENETICS, V181, P1183, DOI 10.1534/genetics.108.099150; Child A., 1979, BIOL TAXONOMY SOLANA, P345; Cho EN, 2011, P NATL ACAD SCI USA, V108, P2154, DOI 10.1073/pnas.1018542108; Danert S, 1958, ABHANDLUNGEN DTSCH A, V6, P1; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Egeyan M., 1973, TGC REPORT, V23, P24; FRIJTERS D, 1978, ANN BOT-LONDON, V42, P549, DOI 10.1093/oxfordjournals.aob.a085490; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Ikeda-Kawakatsu K, 2012, PLANT J, V69, P168, DOI 10.1111/j.1365-313X.2011.04781.x; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Rickett H. W., 1944, BOT REV, V10, P187, DOI 10.1007/BF02861094; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Souer E, 2008, PLANT CELL, V20, P2033, DOI 10.1105/tpc.108.060871; Takeda S, 2011, PLANT J, V66, P1066, DOI 10.1111/j.1365-313X.2011.04571.x; Torti S, 2012, PLANT CELL, V24, P444, DOI 10.1105/tpc.111.092791; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Uimari A, 2004, P NATL ACAD SCI USA, V101, P15817, DOI 10.1073/pnas.0406844101; Weberling F, 1989, MORPHOLOGY FLOWERS I; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; William DA, 2004, P NATL ACAD SCI USA, V101, P1775, DOI 10.1073/pnas.0307842100; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yoshida A, 2009, P NATL ACAD SCI USA, V106, P20103, DOI 10.1073/pnas.0907896106; Zhao L, 2004, PLANT J, V37, P694, DOI 10.1111/j.1365-313X.2003.01993.x	39	84	90	9	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1393	1398		10.1038/ng.2465	http://dx.doi.org/10.1038/ng.2465			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143603				2022-12-25	WOS:000311713200022
J	Chen, DH; Sun, YT; Wei, YK; Zhang, PJ; Rezaeian, AH; Teruya-Feldstein, J; Gupta, S; Liang, H; Lin, HK; Hung, MC; Ma, L				Chen, Dahu; Sun, Yutong; Wei, Yongkun; Zhang, Peijing; Rezaeian, Abdol Hossein; Teruya-Feldstein, Julie; Gupta, Sumeet; Liang, Han; Lin, Hui-Kuan; Hung, Mien-Chie; Ma, Li			LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker	NATURE MEDICINE			English	Article							GENE-EXPRESSION PATTERNS; E-CADHERIN; TUMOR INVASION; GROWTH-CONTROL; SIZE-CONTROL; MICRORNAS; CARCINOMAS; CELLS; ONCOPROTEIN; MECHANISM	There is a pressing need to identify prognostic markers of metastatic disease and targets for treatment. Combining high-throughput RNA sequencing, functional characterization, mechanistic studies and clinical validation, we identify leukemia inhibitory factor receptor (LIFR) as a breast cancer metastasis suppressor downstream of the microRNA miR-9 and upstream of Hippo signaling. Restoring LIFR expression in highly malignant tumor cells suppresses metastasis by triggering a Hippo kinase cascade that leads to phosphorylation, cytoplasmic retention and functional inactivation of the transcriptional coactivator YES-associated protein (YAP). Conversely, loss of LIFR in nonmetastatic breast cancer cells induces migration, invasion and metastatic colonization through activation of YAP. LIFR is downregulated in human breast carcinomas and inversely correlates with metastasis. Notably, in approximately 1,000 nonmetastatic breast tumors, LIFR expression status correlated with metastasis-free, recurrence-free and overall survival outcomes in the patients. These findings identify LIFR as a metastasis suppressor that functions through the Hippo-YAP pathway and has significant prognostic power.	[Chen, Dahu; Zhang, Peijing; Ma, Li] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Sun, Yutong; Wei, Yongkun; Rezaeian, Abdol Hossein; Lin, Hui-Kuan; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Gupta, Sumeet] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lin, Hui-Kuan; Hung, Mien-Chie; Ma, Li] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan	Ma, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	lma4@mdanderson.org	Rezaeian, Abdol-Hossein/AAV-6900-2021; Ma, Li/GQR-1313-2022; Chen, Dahu/AAX-6349-2021; Hung, Mien-Chie/ABD-5911-2021	Ma, Li/0000-0001-9965-989X; Hung, Mien-Chie/0000-0003-4317-4740; Sun, Yutong/0000-0002-9368-2957; Liang, Han/0000-0001-7633-286X; Zhang, Peijing/0000-0003-1586-8710	US National Institutes of Health [R00CA138572, R01CA166051, R01CA109311, P01CA099031]; Cancer Prevention and Research Institute of Texas Scholar Award [R1004]; University of Texas STARS Award; Faculty Development Award; MD Anderson Cancer Center from the US National Institutes of Health, Center for Biological Pathways [CA016672]; Susan G. Komen for the Cure grant [SAC110016]; National Breast Cancer Foundation, Inc.; China Medical University and Hospital; MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R00CA138572, R01CA109311, R01CA166051, P01CA099031, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Scholar Award; University of Texas STARS Award; Faculty Development Award; MD Anderson Cancer Center from the US National Institutes of Health, Center for Biological Pathways; Susan G. Komen for the Cure grant(Susan G. Komen Breast Cancer Foundation); National Breast Cancer Foundation, Inc.; China Medical University and Hospital(China Medical University); MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to R. A. Weinberg for his advice and reagents. We thank S. Ethier for providing cell lines; F. Reinhardt for advice on mouse surgery; the Genome Technology Core at the Whitehead Institute, the ShRNA and ORFeome Core at MD Anderson Cancer Center and the Histology Core Laboratories at MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center for technical assistance; and members of the Ma Lab for discussion. We thank J. Chen, K. Muller, W. Pagel, K. Keyomarsi, L. Li and R. Cleveland for critical reading of the manuscript. This work is supported by the US National Institutes of Health grants R00CA138572 (to L. M.), R01CA166051 (to L. M.), R01CA109311 (to M.-C. H.) and P01CA099031 (to M.-C. H.), a Cancer Prevention and Research Institute of Texas Scholar Award R1004 (to L. M.), a University of Texas STARS Award (to L. M.), a Faculty Development Award (to L. M.) from the MD Anderson Cancer Center Support grant CA016672 from the US National Institutes of Health, Center for Biological Pathways (to Y. S. and M.-C. H.), a Susan G. Komen for the Cure grant SAC110016 (to M.-C. H.), the National Breast Cancer Foundation, Inc. and the Sister Institution Fund of China Medical University and Hospital and MD Anderson Cancer Center (to M.-C. H.).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JKC, 2001, ADV ANAT PATHOL, V8, P165, DOI 10.1097/00125480-200105000-00005; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; GEARING DP, 1993, ADV IMMUNOL, V53, P31, DOI 10.1016/S0065-2776(08)60497-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vaidya KS, 2007, J MAMMARY GLAND BIOL, V12, P175, DOI 10.1007/s10911-007-9049-1; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	42	306	311	0	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1511	U105		10.1038/nm.2940	http://dx.doi.org/10.1038/nm.2940			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23001183	Green Accepted			2022-12-25	WOS:000309587500029
J	Gross, JC; Chaudhary, V; Bartscherer, K; Boutros, M				Gross, Julia Christina; Chaudhary, Varun; Bartscherer, Kerstin; Boutros, Michael			Active Wnt proteins are secreted on exosomes	NATURE CELL BIOLOGY			English	Article							LONG-RANGE ACTION; GRADIENT FORMATION; MEMBRANE-PROTEINS; P24 PROTEINS; ENDOSOME; VESICLES; PROMOTES; LIPOPROTEINS; TRAFFICKING; RETRIEVAL	Wnt signalling has important roles during development and in many diseases. As morphogens, hydrophobic Wnt proteins exert their function over a distance to induce patterning and cell differentiation decisions. Recent studies have identified several factors that are required for the secretion of Wnt proteins; however, how Wnts travel in the extracellular space remains a largely unresolved question. Here we show that Wnts are secreted on exosomes both during Drosophila development and in human cells. We demonstrate that exosomes carry Wnts on their surface to induce Wnt signalling activity in target cells. Together with the cargo receptor Evi/WIs, Wnts are transported through endosomal compartments onto exosomes, a process that requires the R-SNARE Ykt6. Our study demonstrates an evolutionarily conserved functional role of extracellular vesicular transport of Wnt proteins.	[Gross, Julia Christina; Chaudhary, Varun; Bartscherer, Kerstin; Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany; [Gross, Julia Christina; Chaudhary, Varun; Bartscherer, Kerstin; Boutros, Michael] Heidelberg Univ, Dept Cell & Mol Biol, Med Fac Mannheim, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Boutros, M (corresponding author), German Canc Res Ctr, Div Signaling & Funct Genom, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	m.boutros@dkfz.de	Boutros, Michael/C-3566-2008; Gross, Julia Christina/AAN-5730-2020	Boutros, Michael/0000-0002-9458-817X; Gross, Julia Christina/0000-0002-8939-5664	CellNetworks postdoctoral fellowship programme; DFG Wnt Research Group [FOR1036]	CellNetworks postdoctoral fellowship programme; DFG Wnt Research Group	We thank T. Soellner, T. Buechling and D. Kranz for helpful comments on the manuscript. We would like to thank T. Vaccari, S. Eaton, S. Cohen, C. Niehrs, H. Bellen and the Bloomington stock centre for fly strains and reagents. We thank VDRC for the RNAi lines. We are grateful for help from the CellNetworks Electron Microscopy Core Facility (EMCF), the Light Microscopy Core Facility at the DKFZ and the Mass Spectrometry Core Facility at the DKFZ. J.C.G was supported by the CellNetworks postdoctoral fellowship programme. The DFG Wnt Research Group FOR1036 supported research in the laboratory of M.B.	Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Carayon K, 2011, J BIOL CHEM, V286, P34426, DOI 10.1074/jbc.M111.257444; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FOREMAN JR, 1977, J LIPID RES, V18, P759; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jullien J, 2005, GENE DEV, V19, P2682, DOI 10.1101/gad.341605; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Koppen T, 2011, PROTEOMICS, V11, P4397, DOI 10.1002/pmic.201000774; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.E03-12-0876; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; VIDAL MJ, 1993, EUR J CELL BIOL, V60, P261; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang P, 2011, CELL RES, V21, P1677, DOI 10.1038/cr.2011.167	72	636	665	7	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1036	+		10.1038/ncb2574	http://dx.doi.org/10.1038/ncb2574			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	22983114				2022-12-25	WOS:000309543800012
J	Cheung, CL; Lau, KS; Ho, AYY; Lee, KK; Tiu, SC; Lau, EYF; Leung, J; Tsang, MW; Chan, KW; Yeung, CY; Woo, YC; Cheung, EYN; Hung, VHF; Pang, HK; Hung, CS; Sham, PC; Kung, AWC				Cheung, Ching-Lung; Lau, Kam-Shing; Ho, Andrew Y. Y.; Lee, Ka-Kui; Tiu, Sau-Cheung; Lau, Emmy Y. F.; Leung, Jenny; Tsang, Man-Wo; Chan, Kin-Wah; Yeung, Chun-Yip; Woo, Yu-Cho; Cheung, Elaine Y. N.; Hung, Victor H. F.; Pang, Ho-Kwong; Hung, Chi-Sang; Sham, Pak-Chung; Kung, Annie W. C.			Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3	NATURE GENETICS			English	Article							RECTIFYING POTASSIUM CHANNELS; VISUALIZATION; KIR5.1; MAPS	Thyrotoxic periodic paralysis (TPP) is a potentially life-threatening complication of thyrotoxicosis. We conducted a genome-wide association study (GWAS) and a replication study with a total of 123 southern Chinese with TPP (cases) and 1,170 healthy controls and identified a susceptibility locus on chromosome 17q24.3 near KCNJ2 (rs312691: odds ratio (OR) = 3.3; Pmeta-analysis = 1.8 x 10(-14)). All subjects with TPP also had Graves' disease, and subsequent TPP versus Graves' disease comparison confirmed that the association at 17q24.3 was specific to TPP. The area under the curve (AUC) of rs312691 genotype for risk prediction of TPP in subjects with Graves' disease was 0.73. Expression quantitative trait locus (eQTL) analysis identified SNPs in the region flanking rs312691 (+/- 10 kb) that could potentially affect KCNJ2 expression (P = 0.0001). Our study has identified a susceptibility locus associated with TPP and provides insight into the causes of TPP.	[Cheung, Ching-Lung; Lau, Kam-Shing; Lee, Ka-Kui; Kung, Annie W. C.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Cheung, Ching-Lung; Sham, Pak-Chung] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Ho, Andrew Y. Y.] Tuen Mun Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Tiu, Sau-Cheung] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lau, Emmy Y. F.; Yeung, Chun-Yip; Pang, Ho-Kwong] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Leung, Jenny; Woo, Yu-Cho] Ruttonjee Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Leung, Jenny; Woo, Yu-Cho] Tang Shiu Kin Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Tsang, Man-Wo; Cheung, Elaine Y. N.; Hung, Chi-Sang] United Christian Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Chan, Kin-Wah; Hung, Victor H. F.] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung] Univ Hong Kong, Li Ka Shing LKS Fac Med, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung] Univ Hong Kong, LKS Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Tuen Mun Hospital; Pamela Youde Nethersole Eastern Hospital; United Christian Hospital; University of Hong Kong; University of Hong Kong	Kung, AWC (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam, Hong Kong, Peoples R China.	lung@hku.hk; pcsham@hku.hk; awckung@hkucc.hku.hk	Cheung, Ching-Lung/C-2529-2012	Cheung, Ching-Lung/0000-0002-6233-9144	University of Hong Kong Strategic Research Theme of Genomics	University of Hong Kong Strategic Research Theme of Genomics	We are grateful to all study participants and investigators at the individual centers for taking part. We are extremely grateful to all investigators who contributed to the generation of this data set. P.-C.S. was supported by The University of Hong Kong Strategic Research Theme of Genomics.	Andelfinger G, 2002, AM J HUM GENET, V71, P663, DOI 10.1086/342360; ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; D'Adamo MC, 2011, J BIOL CHEM, V286, P192, DOI 10.1074/jbc.M110.189290; Dassau L, 2011, J BIOL CHEM, V286, P9526, DOI 10.1074/jbc.M110.170597; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jongjaroenprasert W, 2012, J HUM GENET, V57, P301, DOI 10.1038/jhg.2012.20; Kung AWC, 2006, J CLIN ENDOCR METAB, V91, P2490, DOI 10.1210/jc.2006-0356; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu Y, 2000, CYTOGENET CELL GENET, V90, P60, DOI 10.1159/000015662; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	20	28	32	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2012	44	9					1026	+		10.1038/ng.2367	http://dx.doi.org/10.1038/ng.2367			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22863731				2022-12-25	WOS:000308491200014
J	Weiss, SJ				Weiss, Stephen J.			PEROXIDASIN Tying the collagen-sulfilimine knot	NATURE CHEMICAL BIOLOGY			English	News Item							BASEMENT-MEMBRANE; IDENTIFICATION; PROTEIN; IV		[Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Weiss, Stephen J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu						Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Gu SQ, 2012, RNA, V18, P1186, DOI 10.1261/rna.031369.111; HUDSON BG, 1972, J BIOL CHEM, V247, P4229; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Li H, 2012, INFECT IMMUN, V80, P2528, DOI 10.1128/IAI.06337-11; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WEISS SJ, 1989, NEW ENGL J MED, V320, P365	12	14	15	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					740	741		10.1038/nchembio.1050	http://dx.doi.org/10.1038/nchembio.1050			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22907088				2022-12-25	WOS:000308077600001
J	Emond, MJ; Louie, T; Emerson, J; Zhao, W; Mathias, RA; Knowles, MR; Wright, FA; Rieder, MJ; Tabor, HK; Nickerson, DA; Barnes, KC; Go, L; Gibson, RL; Bamshad, MJ				Emond, Mary J.; Louie, Tin; Emerson, Julia; Zhao, Wei; Mathias, Rasika A.; Knowles, Michael R.; Wright, Fred A.; Rieder, Mark J.; Tabor, Holly K.; Nickerson, Deborah A.; Barnes, Kathleen C.; Go, Lung; Gibson, Ronald L.; Bamshad, Michael J.		Natl Heart Lung Blood Inst NHLBI G	Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CF PATIENTS; DISEASE; ACQUISITION; DISCOVERY; AUTOPHAGY; CHILDREN	Exome sequencing has become a powerful and effective strategy for the discovery of genes underlying Mendelian disorders(1). However, use of exome sequencing to identify variants associated with complex traits has been more challenging, partly because the sample sizes needed for adequate power may be very large(2). One strategy to increase efficiency is to sequence individuals who are at both ends of a phenotype distribution (those with extreme phenotypes). Because the frequency of alleles that contribute to the trait are enriched in one or both phenotype extremes, a modest sample size can potentially be used to identify novel candidate genes and/or alleles(3). As part of the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP), we used an extreme phenotype study design to discover that variants in DCTN4, encoding a dynactin protein, are associated with time to first P. aeruginosa airway infection, chronic P. aeruginosa infection and mucoid P. aeruginosa in individuals with cystic fibrosis.	[Emond, Mary J.; Louie, Tin; Zhao, Wei] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Emerson, Julia; Tabor, Holly K.; Gibson, Ronald L.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Emerson, Julia] Seattle Childrens Res Inst, Ctr Clin & Translat Med, Seattle, WA USA; [Mathias, Rasika A.; Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Rieder, Mark J.; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Tabor, Holly K.] Seattle Childrens Res Inst, Trueman Katz Ctr Pediat Bioeth, Seattle, WA USA; [Gibson, Ronald L.] Seattle Childrens Hosp, Div Pulm Med, Seattle, WA USA; [Bamshad, Michael J.] Seattle Childrens Hosp, Div Med Genet, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; Seattle Children's Hospital	Emond, MJ (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	emond@u.washington.edu; mbamshad@u.washington.edu	Altshuler, David M/A-4476-2009; Singleton, Andrew B/C-3010-2009; de Bakker, Paul IW/B-8730-2009	Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; O'Connor, Timothy/0000-0002-0276-1896; Seshadri, Sudha/0000-0001-6135-2622; Ballantyne, Christie/0000-0002-6432-1730; Shendure, Jay/0000-0002-1516-1865; Akey, Joshua/0000-0002-4411-1330; Turner, Emily/0000-0001-9040-9229; Caan, Bette/0000-0002-5803-310X; Quinlan, Aaron/0000-0003-1756-0859	NHLBI and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research; NHLBI grants [RC2 HL-103010, RC2 HL-102923, RC2 HL-102925, RC2 HL-102926]; Women's Health Initiative Sequencing Project (WHISP) [RC2 HL-102924]; Cystic Fibrosis Foundation [GIBSON07K0, CFF EPIC09K0]; US National Institutes of Health/National Human Genome Research Institute [5RO1 HG004316]; Life Sciences Discovery Fund [2065508, 0905001]; Mary Beryl Patch Turnbull Scholar Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102924, RC2HL103010, RC2HL102925, RC2HL102923, R01HL068890, RC2HL102926] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004316, K99HG004316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	NHLBI and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research; NHLBI grants; Women's Health Initiative Sequencing Project (WHISP); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); US National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Life Sciences Discovery Fund; Mary Beryl Patch Turnbull Scholar Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the families for their participation and the EPIC study site investigators and research coordinators (Supplementary Note) for their assistance. We thank A. Bigham, S. Leal, M. Rosenfeld, B. Ramsey, N. Hamblett, K. Buckingham, M. McMillin, S. McNamara and S. Ruuska for technical assistance and helpful discussion. The authors wish to acknowledge the support of the NHLBI and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research. Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (Lung GO) and RC2 HL-102924 (Women's Health Initiative Sequencing Project (WHISP)). Exome sequencing was performed with support from NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). Our work was supported in part by grants from the Cystic Fibrosis Foundation (to R.L.G. (GIBSON07K0) and to M. Rosenfeld and R.L.G. (CFF EPIC09K0)), the US National Institutes of Health/National Human Genome Research Institute (5RO1 HG004316 to H.K.T.), and the Life Sciences Discovery Fund (2065508 and 0905001). K.C.B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Green DM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-140; Haspel JA, 2011, AM J RESP CRIT CARE, V184, P1237, DOI 10.1164/rccm.201106-0966CI; Johansen HK, 2004, PEDIATR PULM, V37, P427, DOI 10.1002/ppul.10457; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P215, DOI 10.1161/CIRCGENETICS.109.934505; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Proesmans M, 2006, EUR RESPIR J, V27, P937, DOI 10.1183/09031936.06.00100805; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Treggiari MM, 2009, CONTEMP CLIN TRIALS, V30, P256, DOI 10.1016/j.cct.2009.01.003; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Yu LZ, 2004, BIOTECHNIQUES, V37, P662, DOI 10.2144/04374DD01; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573	19	166	168	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					886	+		10.1038/ng.2344	http://dx.doi.org/10.1038/ng.2344			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22772370	Green Accepted			2022-12-25	WOS:000306854700012
J	Giusti, K				Giusti, Kathy			The Multiple Myeloma Research Foundation's evolving focus on drug R&D	NATURE BIOTECHNOLOGY			English	Letter								The Multiple Myeloma Research Foundation (MMRF) has developed innovative, collaborative business models to reshape the R&D enterprise with the single-minded focus of accelerating the development of new treatments for patients to extend their lives and lead to a cure.	Multiple Myeloma Res Fdn, Norwalk, CT USA		Giusti, K (corresponding author), Multiple Myeloma Res Fdn, Norwalk, CT USA.	giustik@themmrf.org						Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Wear S., 2011, P AM SOC HEM SAN DIE	3	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					600	603		10.1038/nbt.2297	http://dx.doi.org/10.1038/nbt.2297			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781678				2022-12-25	WOS:000306293400014
J	Kim, Y; Kweon, J; Kim, A; Chon, JK; Yoo, JY; Kim, HJ; Kim, S; Lee, C; Jeong, E; Chung, E; Kim, D; Lee, MS; Go, EM; Song, HJ; Kim, H; Cho, N; Bang, D; Kim, S; Kim, JS				Kim, Yongsub; Kweon, Jiyeon; Kim, Annie; Chon, Jae Kyung; Yoo, Ji Yeon; Kim, Hye Joo; Kim, Sojung; Lee, Choongil; Jeong, Euihwan; Chung, Eugene; Kim, Doyoung; Lee, Mi Seon; Go, Eun Mi; Song, Hye Jung; Kim, Hwangbeom; Cho, Namjin; Bang, Duhee; Kim, Seokjoong; Kim, Jin-Soo			A library of TAL effector nucleases spanning the human genome	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; NF-KAPPA-B; DNA-BINDING SPECIFICITY; TARGETED GENE KNOCKOUT; HOMOLOGOUS RECOMBINATION; CELLS; ACTIVATION; TRANSCRIPTION; CONSTRUCTION; RECOGNITION	Transcription activator-like (TAL) effector nucleases (TALENs) can be readily engineered to bind specific genomic loci, enabling the introduction of precise genetic modifications such as gene knockouts and additions. Here we present a genome-scale collection of TALENs for efficient and scalable gene targeting in human cells. We chose target sites that did not have highly similar sequences elsewhere in the genome to avoid off-target mutations and assembled TALEN plasmids for 18,740 protein-coding genes using a high-throughput Golden-Gate cloning system. A pilot test involving 124 genes showed that all TALENs were active and disrupted their target genes at high frequencies, although two of these TALENs became active only after their target sites were partially demethylated using an inhibitor of DNA methyltransferase. We used our TALEN library to generate single- and double-gene-knockout cells in which NF-kappa B signaling pathways were disrupted. Compared with cells treated with short interfering RNAs, these cells showed unambiguous suppression of signal transduction.	[Kim, Yongsub; Kweon, Jiyeon; Kim, Annie; Kim, Hye Joo; Kim, Sojung; Lee, Choongil; Jeong, Euihwan; Chung, Eugene; Kim, Doyoung; Kim, Jin-Soo] Seoul Natl Univ, Natl Creat Initiat Res Ctr Genome Engn, Seoul, South Korea; [Kim, Yongsub; Kweon, Jiyeon; Kim, Annie; Kim, Hye Joo; Kim, Sojung; Lee, Choongil; Jeong, Euihwan; Chung, Eugene; Kim, Doyoung; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Chon, Jae Kyung] Seoul Natl Univ, Dept Interdisciplinary Program Bioinformat, Seoul, South Korea; [Yoo, Ji Yeon; Lee, Mi Seon; Go, Eun Mi; Song, Hye Jung; Kim, Seokjoong] ToolGen Inc, Seoul, South Korea; [Kim, Hwangbeom; Cho, Namjin; Bang, Duhee] Yonsei Univ, Dept Chem, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University	Kim, JS (corresponding author), Seoul Natl Univ, Natl Creat Initiat Res Ctr Genome Engn, Seoul, South Korea.	sj.kim@toolgen.com; jskim01@snu.ac.kr	KIM, Jin-Soo/M-6918-2013	KIM, Jin-Soo/0000-0003-4847-1306; Kim, Yongsub/0000-0002-9334-4333	National Research Foundation of Korea [2012-0001225]; Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science and Technology, Korea [2011-0031956]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [311062-04-2-sb1010]; Plant Molecular Breeding Center of Next-Generation BioGreen 21 Program [PJ009081]	National Research Foundation of Korea(National Research Foundation of Korea); Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); Plant Molecular Breeding Center of Next-Generation BioGreen 21 Program	This work was supported by the National Research Foundation of Korea (J.-S.K., 2012-0001225), the Intelligent Synthetic Biology Center of the Global Frontier Project funded by the Ministry of Education, Science and Technology, Korea (D.B., 2011-0031956), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (S.K., 311062-04-2-sb1010), and Plant Molecular Breeding Center of Next-Generation BioGreen 21 Program (S.K., PJ009081).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim JS, 2010, NAT METHODS, V7, P91, DOI 10.1038/nmeth0210-91a; Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Macville M, 1999, CANCER RES, V59, P141; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	57	261	305	4	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					251	258		10.1038/nbt.2517	http://dx.doi.org/10.1038/nbt.2517			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23417094				2022-12-25	WOS:000316439500021
J	Nie, H; Zheng, YX; Li, RS; Guo, TB; He, DY; Fang, L; Liu, XB; Xiao, LB; Chen, X; Wan, B; Chin, YE; Zhang, JWZ				Nie, Hong; Zheng, Yingxia; Li, Runsheng; Guo, Taylor B.; He, Dongyi; Fang, Lei; Liu, Xuebin; Xiao, Lianbo; Chen, Xi; Wan, Bing; Chin, Y. Eugene; Zhang, Jingwu Z.			Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis	NATURE MEDICINE			English	Article							NF-KAPPA-B; THERAPY; BINDING; GENES	Regulatory T (T-reg) cells suppress autoimmune disease, and impaired T-reg cell function is associated with rheumatoid arthritis. Here we demonstrate that forkhead box P3 (FOXP3) transcriptional activity and, consequently, T-reg cell suppressive function are regulated by phosphorylation at Ser418 in the C-terminal DNA-binding domain. In rheumatoid arthritis-derived T-reg cells, the Ser418 site was specifically dephosphorylated by protein phosphatase 1 (PP1), whose expression and enzymatic activity were induced in the inflamed synovium by tumor necrosis factor alpha (TNF-alpha), leading to impaired T-reg cell function. Moreover, TNF-alpha-induced T-reg cell dysfunction correlated with increased numbers of interleukin-17 (IL-17)(+) and interferon-gamma (IFN-gamma)(+)CD4(+) T cells within the inflamed synovium in rheumatoid arthritis. Treatment with a INF-alpha-specific antibody restored T-reg cell function in subjects with rheumatoid arthritis, which was associated with decreased PP1 expression and increased FOXP3 phosphorylation in T-reg cells. Thus, TNF-alpha controls the balance between T-reg cells and pathogenic T(H)17 and T(H)1 cells in the synovium of individuals with rheumatoid arthritis through FOXP3 dephosphorylation.	[Nie, Hong; Zheng, Yingxia; Zhang, Jingwu Z.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Li, Runsheng; Guo, Taylor B.; Fang, Lei; Chen, Xi; Wan, Bing; Chin, Y. Eugene; Zhang, Jingwu Z.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [He, Dongyi] Guanghua Rheumatol Hosp, Dept Med, Shanghai, Peoples R China; [Liu, Xuebin; Zhang, Jingwu Z.] GlaxoSmithKline Res & Dev Ctr, Shanghai, Peoples R China; [Xiao, Lianbo] Guanghua Rheumatol Hosp, Dept Surg, Shanghai, Peoples R China; [Chin, Y. Eugene] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; GlaxoSmithKline; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Zhang, JWZ (corresponding author), GlaxoSmithKline Res & Dev Ctr, Zhangjiang Hitech Pk, Shanghai, Peoples R China.	jingwu.z.zang@gsk.com			National Natural Science Foundation of China [81072470]; Shanghai Municipal Education Commission [J50207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was partly supported by grants from National Natural Science Foundation of China (81072470) and the Shanghai Municipal Education Commission (J50207).	Ali M, 2001, J CLIN INVEST, V107, P519, DOI 10.1172/JCI8027; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Burstein E, 2008, J CLIN INVEST, V118, P464, DOI [10.1172/JC134831, 10.1172/JCI34831]; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Costantino CM, 2008, J CLIN IMMUNOL, V28, P697, DOI 10.1007/s10875-008-9236-x; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Kim JY, 2007, BIOCHEM BIOPH RES CO, V362, P44, DOI 10.1016/j.bbrc.2007.07.187; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mihindukulasuriya KA, 2004, J BIOL CHEM, V279, P46588, DOI 10.1074/jbc.M408067200; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ranganathan A, 2005, PHARMACOGENOMICS, V6, P481, DOI 10.2217/14622416.6.5.481; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Schett G, 2003, CELL DEATH DIFFER, V10, P1126, DOI 10.1038/sj.cdd.4401276; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Suryaprasad AG, 2003, AUTOIMMUN REV, V2, P346, DOI 10.1016/S1568-9972(03)00048-X; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Wang LQ, 2009, IMMUNOL CELL BIOL, V87, P195, DOI 10.1038/icb.2008.106; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	36	363	393	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					322	328		10.1038/nm.3085	http://dx.doi.org/10.1038/nm.3085			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396208				2022-12-25	WOS:000316040700025
J	Gora, MJ; Sauk, JS; Carruth, RW; Gallagher, KA; Suter, MJ; Nishioka, NS; Kava, LE; Rosenberg, M; Bouma, BE; Tearney, GJ				Gora, Michalina J.; Sauk, Jenny S.; Carruth, Robert W.; Gallagher, Kevin A.; Suter, Melissa J.; Nishioka, Norman S.; Kava, Lauren E.; Rosenberg, Mireille; Bouma, Brett E.; Tearney, Guillermo J.			Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure	NATURE MEDICINE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; BARRETTS-ESOPHAGUS; INTESTINAL METAPLASIA; FEASIBILITY; ENDOSCOPY; DIAGNOSIS	Here we introduce tethered capsule endomicroscopy, which involves swallowing an optomechanically engineered pill that captures cross-sectional microscopic images of the gut wall at 30 mu m (lateral) x 7 mu m (axial) resolution as it travels through the digestive tract. Results in human subjects show that this technique rapidly provides three-dimensional, microstructural images of the upper gastrointestinal tract in a simple and painless procedure, opening up new opportunities for screening for internal diseases.	[Gora, Michalina J.; Carruth, Robert W.; Gallagher, Kevin A.; Nishioka, Norman S.; Kava, Lauren E.; Rosenberg, Mireille; Bouma, Brett E.; Tearney, Guillermo J.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Gora, Michalina J.; Sauk, Jenny S.; Carruth, Robert W.; Gallagher, Kevin A.; Nishioka, Norman S.; Kava, Lauren E.; Rosenberg, Mireille; Bouma, Brett E.; Tearney, Guillermo J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Sauk, Jenny S.; Nishioka, Norman S.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; [Suter, Melissa J.] Massachusetts Gen Hosp, Dept Pulmonol, Boston, MA 02114 USA; [Tearney, Guillermo J.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA; [Tearney, Guillermo J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital	Tearney, GJ (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	gtearney@partners.org	Jovani, Manol/AAF-5333-2020		US National Institutes of Health [NIH R01DK091923, NIH R01CA103769]; NATIONAL CANCER INSTITUTE [R01CA103769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091923, P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Puricelli for his valuable assistance in the conduct of the clinical studies and M. Shishkov for useful discussions pertaining to device design. This work was supported in part by US National Institutes of Health grants NIH R01DK091923 (G.J.T.) and NIH R01CA103769 (G.J.T.).	Cullen Karen A, 2009, Natl Health Stat Report, P1; Evans JA, 2006, CLIN GASTROENTEROL H, V4, P38, DOI 10.1016/S1542-3565(05)00746-9; Evans JA, 2007, GASTROINTEST ENDOSC, V65, P50, DOI 10.1016/j.gie.2006.04.027; Kiesslich Ralf, 2005, Gastrointest Endosc Clin N Am, V15, P715, DOI 10.1016/j.giec.2005.08.010; Kim B, 2006, SENSOR ACTUAT A-PHYS, V125, P429, DOI 10.1016/j.sna.2005.05.004; Maffei M, 2008, SWISS MED WKLY, V138, P658, DOI 2008/45/smw-12220; Poneros JM, 2001, GASTROENTEROLOGY, V120, P7, DOI 10.1053/gast.2001.20911; Quirini M, 2008, GASTROINTEST ENDOSC, V67, P1153, DOI 10.1016/j.gie.2007.11.052; Ramirez FC, 2005, GASTROINTEST ENDOSC, V61, P741, DOI 10.1016/S0016-5107(05)00322-6; Seibel EJ, 2008, IEEE T BIO-MED ENG, V55, P1032, DOI 10.1109/TBME.2008.915680; Vakoc BJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714027; Wallace MB, 2009, GASTROENTEROLOGY, V136, P1509, DOI 10.1053/j.gastro.2009.03.034; Wasielica-Berger J, 2011, DIGEST DIS SCI, V56, P1987, DOI 10.1007/s10620-010-1551-4; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	14	194	200	5	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					238	240		10.1038/nm.3052	http://dx.doi.org/10.1038/nm.3052			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23314056	Green Accepted, Green Submitted			2022-12-25	WOS:000314675900033
J	Huyghe, JR; Jackson, AU; Fogarty, MP; Buchkovich, ML; Stancakova, A; Stringham, HM; Sim, XL; Yang, LY; Fuchsberger, C; Cederberg, H; Chines, PS; Teslovich, TM; Romm, JM; Ling, H; McMullen, I; Ingersoll, R; Pugh, EW; Doheny, KF; Neale, BM; Daly, MJ; Kuusisto, J; Scott, LJ; Kang, HM; Collins, FS; Abecasis, GR; Watanabe, RM; Boehnke, M; Laakso, M; Mohlke, KL				Huyghe, Jeroen R.; Jackson, Anne U.; Fogarty, Marie P.; Buchkovich, Martin L.; Stancakova, Alena; Stringham, Heather M.; Sim, Xueling; Yang, Lingyao; Fuchsberger, Christian; Cederberg, Henna; Chines, Peter S.; Teslovich, Tanya M.; Romm, Jane M.; Ling, Hua; McMullen, Ivy; Ingersoll, Roxann; Pugh, Elizabeth W.; Doheny, Kimberly F.; Neale, Benjamin M.; Daly, Mark J.; Kuusisto, Johanna; Scott, Laura J.; Kang, Hyun Min; Collins, Francis S.; Abecasis, Goncalo R.; Watanabe, Richard M.; Boehnke, Michael; Laakso, Markku; Mohlke, Karen L.			Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; COMMON VARIANTS; GLYCEMIC TRAITS; GLUCOSE; PROTEIN; EXPRESSION; RELEASE; GTPASES; FAMILY	Insulin secretion has a crucial role in glucose homeostasis, and failure to secrete sufficient insulin is a hallmark of type 2 diabetes. Genome-wide association studies (GWAS) have identified loci contributing to insulin processing and secretion(1,2); however, a substantial fraction of the genetic contribution remains undefined. To examine low-frequency (minor allele frequency (MAF) 0.5-5%) and rare (MAF < 0.5%) nonsynonymous variants, we analyzed exome array data in 8,229 nondiabetic Finnish males using the Illumina HumanExome Beadchip. We identified low-frequency coding variants associated with fasting proinsulin concentrations at the SGSM2 and MADD GWAS loci and three new genes with low-frequency variants associated with fasting proinsulin or insulinogenic index: TBC1D30, KANK1 and PAM. We also show that the interpretation of single-variant and gene-based tests needs to consider the effects of noncoding SNPs both nearby and megabases away. This study demonstrates that exome array genotyping is a valuable approach to identify low-frequency variants that contribute to complex traits.	[Huyghe, Jeroen R.; Jackson, Anne U.; Stringham, Heather M.; Sim, Xueling; Yang, Lingyao; Fuchsberger, Christian; Teslovich, Tanya M.; Scott, Laura J.; Kang, Hyun Min; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Fogarty, Marie P.; Buchkovich, Martin L.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Stancakova, Alena; Cederberg, Henna; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Stancakova, Alena; Cederberg, Henna; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Chines, Peter S.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Romm, Jane M.; Ling, Hua; McMullen, Ivy; Ingersoll, Roxann; Pugh, Elizabeth W.; Doheny, Kimberly F.] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA; [Neale, Benjamin M.; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Southern California; University of Southern California	Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	mohlke@med.unc.edu	Stancakova, Alena/AAN-6723-2020; Sim, Xueling/AAZ-6652-2020; Daly, Mark J/B-2453-2017; Abecasis, Goncalo R/B-7840-2010; Fuchsberger, Christian/ABD-7127-2021	Stancakova, Alena/0000-0002-1375-0252; Sim, Xueling/0000-0002-1233-7642; Daly, Mark J/0000-0002-0949-8752; Fuchsberger, Christian/0000-0002-5918-8947; Abecasis, Goncalo/0000-0003-1509-1825; , Roxann/0000-0002-4266-613X; Cederberg, Henna/0000-0003-2901-9373	Academy of Finland [124243]; Finnish Heart Foundation; Finnish Diabetes Foundation; Tekes [1510/31/06]; Commission of the European Community [HEALTH-F2-2007-201681]; US National Institutes of Health [DK093757, DK072193, DK062370, 1Z01 HG000024]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Finnish Heart Foundation; Finnish Diabetes Foundation; Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Commission of the European Community(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Academy of Finland (contract 124243) (to M.L.), the Finnish Heart Foundation (to M.L.), the Finnish Diabetes Foundation (to M.L.), Tekes (contract 1510/31/06) (to M.L.), the Commission of the European Community (HEALTH-F2-2007-201681) (to M.L.) and US National Institutes of Health grants DK093757 (to K.L.M.), DK072193 (to K.L.M.), DK062370 (to M.B.) and 1Z01 HG000024 (to F.S.C.). Genotyping was conducted at the Genetic Resources Core Facility (GRCF) at the Johns Hopkins Institute of Genetic Medicine.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Hammar E, 2009, ENDOCRINOLOGY, V150, P2072, DOI 10.1210/en.2008-1135; Hanley KP, 2010, J ENDOCRINOL, V207, P151, DOI 10.1677/JOE-10-0120; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kowluru A, 2011, BIOCHEM PHARMACOL, V81, P965, DOI 10.1016/j.bcp.2011.01.013; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Nottingham RM, 2011, J BIOL CHEM, V286, P33213, DOI 10.1074/jbc.M111.261115; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Rajagopal C, 2012, CRIT REV BIOCHEM MOL, V47, P391, DOI 10.3109/10409238.2012.694845; Regazzi R, 1996, J CELL SCI, V109, P2265; Rutter GA, 2006, PHYSIOLOGY, V21, P189, DOI 10.1152/physiol.00002.2006; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047	31	198	201	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					197	201		10.1038/ng.2507	http://dx.doi.org/10.1038/ng.2507			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23263489	Green Accepted, Green Submitted			2022-12-25	WOS:000314333000016
J	Prokunina-Olsson, L; Muchmore, B; Tang, W; Pfeiffer, RM; Park, H; Dickensheets, H; Hergott, D; Porter-Gill, P; Mumy, A; Kohaar, I; Chen, S; Brand, N; Tarway, M; Liu, LY; Sheikh, F; Astemborski, J; Bonkovsky, HL; Edlin, BR; Howell, CD; Morgan, TR; Thomas, DL; Rehermann, B; Donnelly, RP; O'Brien, TR				Prokunina-Olsson, Ludmila; Muchmore, Brian; Tang, Wei; Pfeiffer, Ruth M.; Park, Heiyoung; Dickensheets, Harold; Hergott, Dianna; Porter-Gill, Patricia; Mumy, Adam; Kohaar, Indu; Chen, Sabrina; Brand, Nathan; Tarway, McAnthony; Liu, Luyang; Sheikh, Faruk; Astemborski, Jacquie; Bonkovsky, Herbert L.; Edlin, Brian R.; Howell, Charles D.; Morgan, Timothy R.; Thomas, David L.; Rehermann, Barbara; Donnelly, Raymond P.; O'Brien, Thomas R.			A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus	NATURE GENETICS			English	Article							EARLY VIRAL KINETICS; INTERLEUKIN 28B; MULTIETHNIC COHORT; STIMULATED GENES; LAMBDA; EXPRESSION; GENOTYPE; RIBAVIRIN; THERAPY; FOS	Chronic infection with hepatitis C virus (HCV) is a common cause of liver cirrhosis and cancer. We performed RNA sequencing in primary human hepatocytes activated with synthetic double-stranded RNA to mimic HCV infection. Upstream of IFNL3 (IL28B) on chromosome 19q13.13, we discovered a new transiently induced region that harbors a dinucleotide variant ss469415590 (TT or Delta G), which is in high linkage disequilibrium with rs12979860, a genetic marker strongly associated with HCV clearance. ss469415590[Delta G] is a frameshift variant that creates a novel gene, designated IFNL4, encoding the interferon-lambda 4 protein (IFNL4), which is moderately similar to IFNL3. Compared to rs12979860, ss469415590 is more strongly associated with HCV clearance in individuals of African ancestry, although it provides comparable information in Europeans and Asians. Transient overexpression of IFNL4 in a hepatoma cell line induced STAT1 and STAT2 phosphorylation and the expression of interferon-stimulated genes. Our findings provide new insights into the genetic regulation of HCV clearance and its clinical management.	[Prokunina-Olsson, Ludmila; Muchmore, Brian; Tang, Wei; Hergott, Dianna; Porter-Gill, Patricia; Mumy, Adam; Kohaar, Indu; Brand, Nathan; Tarway, McAnthony; Liu, Luyang] NCI, Lab Translat Gen, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Park, Heiyoung; Rehermann, Barbara] NIDDK, Immunol Sect, Liver Dis Branch, US NIH, Bethesda, MD 20892 USA; [Dickensheets, Harold; Sheikh, Faruk; Donnelly, Raymond P.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [Hergott, Dianna; O'Brien, Thomas R.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Chen, Sabrina] Informat Management Serv Inc, Silver Spring, MD USA; [Astemborski, Jacquie; Thomas, David L.] Johns Hopkins Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Bonkovsky, Herbert L.] Carolinas Med Ctr, Dept Med, Charlotte, NC 28203 USA; [Edlin, Brian R.] Natl Dev & Res Inst Inc, New York, NY USA; [Edlin, Brian R.] Cornell Univ, Ctr Study Hepatitis C, Weill Med Coll, New York, NY 10021 USA; [Howell, Charles D.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Morgan, Timothy R.] Vet Affairs VA Long Beach Healthcare Syst, Gastroenterol Serv, Long Beach, CA USA; [Morgan, Timothy R.] Univ Calif Irvine, Div Gastroenterol, Irvine, CA USA; [Thomas, David L.] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Johns Hopkins University; Carolinas Medical Center; National Development & Research Institutes, Inc; Cornell University; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; Johns Hopkins University	Prokunina-Olsson, L (corresponding author), NCI, Lab Translat Gen, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA.	prokuninal@mail.nih.gov; obrient@mail.nih.gov	Kohaar, Indu/AAA-2405-2020; Kohaar, Indu/W-2530-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Tang, Wei/H-7103-2013; Donnelly, Raymond P./AFT-8600-2022; Bonkovsky, Herbert L./AAH-1892-2021; Prokunina-Olsson, Ludmila/A-8240-2019; Edlin, Brian R/F-2966-2018	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Tang, Wei/0000-0002-7089-4391; Donnelly, Raymond P./0000-0002-0695-5276; Bonkovsky, Herbert L./0000-0001-7387-3230; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Edlin, Brian R/0000-0001-8172-8797; Rehermann, Barbara/0000-0001-6832-9951	Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics); Intramural Research Program of the US National Institutes of Health (National Institute for Diabetes, Digestive and Kidney Diseases); ALIVE cohort [R01-DA-04334, R01-DA-12568]; US National Institutes of Health [R01-DA09532, R01-DA12109, R01-DA13245, R01-DA16159]; National Cancer Institute [N02-CP-91027, N01-CO-12400]; Substance Abuse and Mental Health Services Administration [H79-TI12103]; National Cancer Institute Director's Innovation Award; National Institute of Diabetes and Digestive and Kidney Diseases;  [DA R01 013324]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA016159, R01DA012568, R01DA013324, R01DA012109, R01DA013245, U01DA036297, R01DA009532] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Intramural Research Program of the US National Institutes of Health (National Institute for Diabetes, Digestive and Kidney Diseases); ALIVE cohort; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); National Cancer Institute Director's Innovation Award; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the National Cancer Institute Sequencing Core Facility for help with RNA-seq. This research was supported by the Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics; National Institute for Diabetes, Digestive and Kidney Diseases), as well as the following grants: DA R01 013324 (J.A. and D.L.T.); ALIVE cohort, R01-DA-04334 and R01-DA-12568, and US National Institutes of Health grants R01-DA09532, R01-DA12109, R01-DA13245 and R01-DA16159 (B.R.E.); National Cancer Institute contracts N02-CP-91027 and N01-CO-12400 (B.R.E.); Substance Abuse and Mental Health Services Administration grant H79-TI12103 (B.R.E.); and the National Cancer Institute Director's Innovation Award (L.P.-O.). The Virahep-C and HALT-C studies were conducted, respectively, by the Virahep-C and HALT-C Investigators and supported by the National Institute of Diabetes and Digestive and Kidney Diseases. The data and samples from the Virahep-C and HALT-C studies reported here were supplied by the National Institute of Diabetes and Digestive and Kidney Diseases Central Repositories. This manuscript was not prepared in collaboration with the Virahep-C study group or the HALT-C study group and does not necessarily reflect the opinions or views of the Virahep-C Trial and HALT-C Trial, the National Institute of Diabetes and Digestive and Kidney Diseases Central Repositories or the National Institute of Diabetes and Digestive and Kidney Diseases. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; [Anonymous], 2002, Gastroenterology, V123, P2082, DOI 10.1053/gast.2002.1232082; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Trivella DBB, 2010, CELL MOL LIFE SCI, V67, P2909, DOI 10.1007/s00018-010-0380-0; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Ciesek S, 2011, NAT REV GASTRO HEPAT, V8, P69, DOI 10.1038/nrgastro.2010.219; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Davar D, 2012, CANCER J, V18, P192, DOI 10.1097/PPO.0b013e31824f118b; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Howell CD, 2012, J HEPATOL, V56, P557, DOI 10.1016/j.jhep.2011.10.004; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Kang SM, 2011, FEBS LETT, V585, P3236, DOI 10.1016/j.febslet.2011.08.041; Katsounas A, 2011, INT REV IMMUNOL, V30, P366, DOI 10.3109/08830185.2011.593105; Kempuraj D, 2004, INT J IMMUNOPATH PH, V17, P103, DOI 10.1177/039463200401700201; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lampertico P, 2013, HEPATOLOGY, V57, P890, DOI 10.1002/hep.25749; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Okamura K, 2006, GENOMICS, V88, P690, DOI 10.1016/j.ygeno.2006.06.009; Onomoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019799; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Shebl FM, 2011, J INFECT DIS, V204, P1843, DOI 10.1093/infdis/jir647; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Smith KR, 2011, GENOME MED, V3, DOI 10.1186/gm273; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tappero G, 1997, ITAL J GASTROENTEROL, V29, P148; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Uccellini L, 2012, HEPATOLOGY, V56, P86, DOI 10.1002/hep.25652; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vlahov D, 1991, NIDA Res Monogr, V109, P75; WHITE SH, 1994, J MOL EVOL, V38, P383, DOI 10.1007/BF00163155; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	54	692	727	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					164	171		10.1038/ng.2521	http://dx.doi.org/10.1038/ng.2521			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23291588	Green Accepted			2022-12-25	WOS:000314333000011
J	Devi, S; Li, AQ; Westhorpe, CLV; Lo, CY; Abeynaike, LD; Snelgrove, SL; Hall, P; Ooi, JD; Sobey, CG; Kitching, AR; Hickey, MJ				Devi, Sapna; Li, Anqi; Westhorpe, Clare L. V.; Lo, Camden Y.; Abeynaike, Latasha D.; Snelgrove, Sarah L.; Hall, Pam; Ooi, Joshua D.; Sobey, Christopher G.; Kitching, A. Richard; Hickey, Michael J.			Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus	NATURE MEDICINE			English	Article							NEUTROPHIL RESPIRATORY BURST; CRESCENTIC GLOMERULONEPHRITIS; P-SELECTIN; IN-VIVO; PULMONARY INFLAMMATION; INFLAMED GLOMERULUS; ADHESION MOLECULE-1; NOX2-DEFICIENT MICE; NADPH OXIDASE; RENAL INJURY	In contrast with many capillary beds, the glomerulus readily supports leukocyte recruitment. However, little is known regarding the actions of leukocytes following their recruitment to glomeruli. We used multiphoton confocal microscopy to examine leukocyte behavior in the glomerular microvasculature. In normal glomeruli, neutrophils and monocytes were retained in capillaries for several minutes, remaining static or migrating intravascularly. Induction of glomerular inflammation resulted in an increase in the duration of retention of static and migratory leukocytes. In response to immune complex deposition, both static and migratory neutrophils generated oxidants in inflamed glomeruli via a Mac-1-dependent mechanism. Our results describe a new paradigm for glomerular inflammation, suggesting that the major effect of acute inflammation is to increase the duration of leukocyte retention in the glomerulus. Moreover, these findings describe a previously unknown form of multicellular intravascular patrolling that involves both monocytes and neutrophils, which may underlie the susceptibility of the glomerulus to inflammation.	[Devi, Sapna; Li, Anqi; Westhorpe, Clare L. V.; Abeynaike, Latasha D.; Snelgrove, Sarah L.; Hall, Pam; Ooi, Joshua D.; Kitching, A. Richard; Hickey, Michael J.] Monash Univ, Monash Med Ctr, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia; [Lo, Camden Y.] Monash Univ, Monash Micro Imaging, Clayton, Vic, Australia; [Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Kitching, A. Richard] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia; [Kitching, A. Richard] Monash Med Ctr, Dept Pediat Nephrol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University; Monash University; Monash University	Hickey, MJ (corresponding author), Monash Univ, Monash Med Ctr, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia.	michael.hickey@monash.edu	Sobey, Christopher G/A-2786-2008; Kitching, A Richard/B-6947-2013; Hickey, Michael/A-5429-2012	Sobey, Christopher G/0000-0001-6525-9097; Kitching, A Richard/0000-0002-2713-2391; Lo, Camden/0000-0002-6215-2363; Hickey, Michael/0000-0003-2354-357X; Devi, Sapna/0000-0003-4714-6018; Ooi, Joshua/0000-0003-3328-2561; Westhorpe, Clare/0000-0002-5789-0425	National Health and Medical Research Council (Australia) Program grant [334067]; National Health and Medical Research Council (Australia) Project grant [606564]; Genzyme Renal Innovations Program Project grant	National Health and Medical Research Council (Australia) Program grant; National Health and Medical Research Council (Australia) Project grant; Genzyme Renal Innovations Program Project grant	The authors gratefully acknowledge the assistance of J. Peti-Peterdi for advice on intravital imaging of the kidney, T. Graf (Center for Genomic Regulation) for LysM-eGFP mice, M. Tymms and E. Williams for assistance with fluorochrome labeling, D.-B. Borza (Vanderbilt University School of Medicine) for providing 8D1 monoclonal antibody, and C. Lo for technical assistance. This work was supported by a National Health and Medical Research Council (Australia) Program grant (#334067), a National Health and Medical Research Council (Australia) Project grant (#606564) and a Genzyme Renal Innovations Program Project grant. M.J.H. is a National Health and Medical Research Council (Australia) Senior Research Fellow.	Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BOYCE NW, 1986, KIDNEY INT, V30, P813, DOI 10.1038/ki.1986.260; Chen ZP, 2004, P NATL ACAD SCI USA, V101, P13014, DOI 10.1073/pnas.0405389101; COCHRANE CG, 1965, J EXP MED, V122, P99, DOI 10.1084/jem.122.1.99; DAPINO P, 1993, CLIN EXP IMMUNOL, V94, P533; Devi S, 2010, AM J PATHOL, V177, P1131, DOI 10.2353/ajpath.2010.091143; DOWNEY GP, 1993, AM REV RESPIR DIS, V147, P168, DOI 10.1164/ajrccm/147.1.168; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Huang XR, 1997, KIDNEY INT, V51, P94, DOI 10.1038/ki.1997.12; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jung U, 1997, MICROCIRCULATION-LON, V4, P311, DOI 10.3109/10739689709146794; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Kitching AR, 2000, HISTOL HISTOPATHOL, V15, P993, DOI 10.14670/HH-15.993; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Kuligowski MP, 2006, J IMMUNOL, V176, P6991, DOI 10.4049/jimmunol.176.11.6991; Kuligowski MP, 2009, BLOOD, V113, P6485, DOI 10.1182/blood-2008-12-192617; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Massberg S, 1998, BLOOD, V92, P507, DOI 10.1182/blood.V92.2.507; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Norman MU, 2003, AM J PATHOL, V163, P1491, DOI 10.1016/S0002-9440(10)63506-7; Odobasic D, 2007, J AM SOC NEPHROL, V18, P760, DOI 10.1681/ASN.2006040375; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Sipos A, 2007, KIDNEY INT, V72, P1188, DOI 10.1038/sj.ki.5002461; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; TIPPING PG, 1994, KIDNEY INT, V46, P79, DOI 10.1038/ki.1994.246; Tipping PG, 1998, AM J PATHOL, V152, P1541; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	36	134	137	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2013	19	1					107	112		10.1038/nm.3024	http://dx.doi.org/10.1038/nm.3024			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23242472				2022-12-25	WOS:000313230300032
J	Vanharanta, S; Shu, WP; Brenet, F; Hakimi, AA; Heguy, A; Viale, A; Reuter, VE; Hsieh, JJD; Scandura, JM; Massague, J				Vanharanta, Sakari; Shu, Weiping; Brenet, Fabienne; Hakimi, A. Ari; Heguy, Adriana; Viale, Agnes; Reuter, Victor E.; Hsieh, James J-D; Scandura, Joseph M.; Massague, Joan			Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer	NATURE MEDICINE			English	Article							TUMOR-SUPPRESSOR GENE; HIPPEL-LINDAU-DISEASE; CELL-CARCINOMA; T-CELL; CYTOHESIN BINDER; EXPRESSION; PROTEIN; ACTIVATION; CHROMATIN; RECEPTOR	Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical outcome. Here we show that during ccRCC progression, cancer cells exploit diverse epigenetic alterations to empower a branch of the VHL-HIF pathway for metastasis, and the strength of this activation is associated with poor clinical outcome. By analyzing metastatic subpopulations of VHL-deficient ccRCC cells, we discovered an epigenetically altered VHL-HIF response that is specific to metastatic ccRCC. Focusing on the two most prominent pro-metastatic VHL-HIF target genes, we show that loss of Polycomb repressive complex 2 (PRC2)-dependent histone H3 Lys27 trimethylation (H3K27me3) activates H IF-driven chemokine (C-X-C motif) receptor 4 (CXCR4) expression in support of chemotactic cell invasion, whereas loss of DNA methylation enables HIF-driven cytohesin 1 interacting protein (CYTIP) expression to protect cancer cells from death cytokine signals. Thus, metastasis in ccRCC is based on an epigenetically expanded output of the tumor-initiating pathway.	[Vanharanta, Sakari; Shu, Weiping; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Brenet, Fabienne; Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Hakimi, A. Ari; Hsieh, James J-D] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Heguy, Adriana] Mem Sloan Kettering Canc Ctr, Geoffrey Beene Translat Oncol Core Facil, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Facil, New York, NY 10021 USA; [Reuter, Victor E.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	massaguj@mskcc.org	Heguy, Adriana/GPP-3907-2022; Brenet, Fabienne/R-1881-2016	Brenet, Fabienne/0000-0003-4098-1096; Scandura, Joseph/0000-0002-9525-143X; Massague, Joan/0000-0001-9324-8408	Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; Paulo Foundation; Orion-Farmos Research Foundation; Instrumentarium Science Foundation; Finnish Medical Foundation; Academy of Finland; NATIONAL CANCER INSTITUTE [T32CA082088, P30CA008748, P01CA129243] Funding Source: NIH RePORTER	Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; Paulo Foundation; Orion-Farmos Research Foundation; Instrumentarium Science Foundation; Finnish Medical Foundation; Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Massague lab for discussion, J. Brooks (Stanford University, California) for clinical annotations, W. Krek (ETH, Swiss Federal Institute of Technology, Zurich, Switzerland) for CXCR4 promoter constructs and C. David and S. Malladi for critical review of the manuscript. Gene expression profiling and high-throughput sequencing were done at the Memorial Sloan-Kettering Cancer Center (MSKCC) Genomics Core Facility, immunohistochemical staining was done at the MSKCC Molecular Cytology Core Facility, and DNA methylation analysis, RNA analysis of clinical samples and Sanger sequencing were done at the MSKCC Geoffrey Beene Translational Oncology Core Facility. The GSE2109 dataset was provided by the International Genomics Consortium and Expression Project for Oncology. S.V. received postdoctoral support from the Maud Kuistila Memorial Foundation, the Emil Aaltonen Foundation, the Paulo Foundation, the Orion-Farmos Research Foundation, the Instrumentarium Science Foundation, The Finnish Medical Foundation and the Academy of Finland. J.M. is an investigator of the Howard Hughes Medical Institute.	Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chauveau D, 1996, KIDNEY INT, V50, P944, DOI 10.1038/ki.1996.395; Chen Q, 2006, J BIOL CHEM, V281, P19985, DOI 10.1074/jbc.M601629200; D'Alterio C, 2010, CELL CYCLE, V9, P4492, DOI 10.4161/cc.9.22.13680; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hofer S, 2006, BLOOD, V107, P1003, DOI 10.1182/blood-2005-01-0425; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Montani M, 2010, AM J SURG PATHOL, V34, P806, DOI 10.1097/PAS.0b013e3181ddf54d; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Schlesinger-Raab A, 2008, EUR J CANCER, V44, P2485, DOI 10.1016/j.ejca.2008.07.039; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; SHI J, 2012, ONCOGENE; Song L., 2010, COLD SPRING HARB PRO; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang LH, 2009, CLIN EXP METASTAS, V26, P1049, DOI 10.1007/s10585-009-9294-3; Watford WT, 2006, MOL CELL BIOL, V26, P6623, DOI 10.1128/MCB.02460-05; WILLIAMS RD, 1978, IN VITRO CELL DEV B, V14, P779, DOI 10.1007/BF02617972; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Young AC, 2009, CLIN CANCER RES, V15, P7582, DOI 10.1158/1078-0432.CCR-09-2131; Zagzag D, 2005, CANCER RES, V65, P6178, DOI 10.1158/0008-5472.CAN-04-4406; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	56	151	175	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					50	56		10.1038/nm.3029	http://dx.doi.org/10.1038/nm.3029			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23223005	Green Accepted, Green Submitted			2022-12-25	WOS:000313230300025
J	Wang, XG; Guo, BS; Li, Q; Peng, J; Yang, ZJ; Wang, AY; Li, D; Hou, ZB; Lv, K; Kan, GH; Cao, HQ; Wu, H; Song, JP; Pan, XH; Sun, Q; Ling, SK; Li, YH; Zhu, M; Zhang, PF; Peng, SL; Xie, XQ; Tang, T; Hong, A; Bian, ZX; Bai, YQ; Lu, AP; Li, YH; He, FC; Zhang, G; Li, YX				Wang, Xiaogang; Guo, Baosheng; Li, Qi; Peng, Jiang; Yang, Zhijun; Wang, Aiyuan; Li, Dong; Hou, Zhibo; Lv, Ke; Kan, Guanghan; Cao, Hongqing; Wu, Heng; Song, Jinping; Pan, Xiaohua; Sun, Qiao; Ling, Shukuan; Li, Yuheng; Zhu, Mu; Zhang, Pengfei; Peng, Songlin; Xie, Xiaoqing; Tang, Tao; Hong, An; Bian, Zhaoxiang; Bai, Yanqiang; Lu, Aiping; Li, Yinghui; He, Fuchu; Zhang, Ge; Li, Yingxian			miR-214 targets ATF4 to inhibit bone formation	NATURE MEDICINE			English	Article							OSTEOBLAST DIFFERENTIATION; PARATHYROID-HORMONE; OSTEOGENIC DIFFERENTIATION; OVARIAN-CANCER; CELL-SURVIVAL; ALENDRONATE; OSTEOPOROSIS; PROLIFERATION; CONTRIBUTES; EXPRESSION	Emerging evidence indicates that microRNAs (miRNAs) have important roles in regulating osteogenic differentiation and bone formation. Thus far, no study has established the pathophysiological role for miRNAs identified in human osteoporotic bone specimens. Here we found that elevated miR-214 levels correlated with a lower degree of bone formation in bone specimens from aged patients with fractures. We also found that osteoblast-specific manipulation of miR-214 levels by miR-214 antagomir treatment in miR-214 transgenic, ovariectomized, or hindlimb-unloaded mice revealed an inhibitory role of miR-214 in regulating bone formation. Further, in vitro osteoblast activity and matrix mineralization were promoted by antagomir-214 and decreased by agomir-214, and miR-214 directly targeted ATF4 to inhibit osteoblast activity. These data suggest that miR-214 has a crucial role in suppressing bone formation and that miR-214 inhibition in osteoblasts may be a potential anabolic strategy for ameliorating osteoporosis.	[Wang, Xiaogang; Li, Qi; Lv, Ke; Kan, Guanghan; Cao, Hongqing; Song, Jinping; Sun, Qiao; Ling, Shukuan; Li, Yuheng; Zhu, Mu; Zhang, Pengfei; Bai, Yanqiang; Li, Yinghui; Li, Yingxian] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Guo, Baosheng; Yang, Zhijun; Wu, Heng; Tang, Tao; Bian, Zhaoxiang; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Inst Adv Translat Med Bone & Joint Dis, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Guo, Baosheng; Hou, Zhibo; Wu, Heng; Pan, Xiaohua; Peng, Songlin; Xie, Xiaoqing; Hong, An; Zhang, Ge] Jinan Univ, Dept Orthoped Hosp Med Coll Shenzhen 2, Natl Engn Res Ctr Genet Med Guangzhou, Jinan, Peoples R China; [Peng, Jiang; Wang, Aiyuan] Gen Hosp Chinese Peoples Liberat Army, Inst Orthoped, Beijing, Peoples R China; [Li, Dong; He, Fuchu] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	Hong Kong Baptist University; University of Jinan; Academy of Military Medical Sciences - China	Li, YX (corresponding author), China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China.	zhangge@hkbu.edu.hk; yingxianli@yahoo.cn	Zhang, Ge/K-9118-2019; Guo, Baosheng/ABD-4800-2021; Zhang, Ge/N-4150-2013; wang, Xiaogang/J-5003-2017; Song, Jin/HHS-8731-2022; GUO, Baosheng/M-6023-2013	Zhang, Ge/0000-0002-7807-7695; Guo, Baosheng/0000-0002-4510-5418; Zhang, Ge/0000-0002-7807-7695; Yang, Zhijun/0000-0002-6094-0438; Wang, Xiaogang/0000-0001-9798-834X; Peng, Songlin/0000-0002-4042-7071; Ling, Shukuan/0000-0002-4622-4160	National Basic Research Program of China 973 program [2011CB711003, 2011CB707704]; State Key Lab of Space Medicine Fundamentals and Application [SMFA10A02, SMFA12B01]; National Natural Science Foundation [31170811, 31000386, 81272045]; Hong Kong General Research Fund [HKBU 479111, HKBU478312]; Research Grants Council/Natural Science Foundation Council Joint Research Scheme [N_HKBU435/12]	National Basic Research Program of China 973 program(National Basic Research Program of China); State Key Lab of Space Medicine Fundamentals and Application; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hong Kong General Research Fund; Research Grants Council/Natural Science Foundation Council Joint Research Scheme	We thank the academic staff (L. Qin and L. Hung) from the Chinese University of Hong Kong and the research staff from G.Z.'s lab (http://www.gezhanglab.com/index.php) at Hong Kong Baptist University for providing critical comments and technical support. We thank X. Yang (Institute of Biotechnology) for providing the Bglap2 promoter vector. We also thank L. Zhang, K. Guan and H. Ouyang for constructive suggestions and careful revisions to this manuscript. This work was supported by the National Basic Research Program of China 973 program (2011CB711003 and 2011CB707704), State Key Lab of Space Medicine Fundamentals and Application Grants (SMFA10A02 and SMFA12B01), National Natural Science Foundation Projects (31170811, 31000386 and 81272045), the Hong Kong General Research Fund (HKBU 479111 and HKBU478312) and the Research Grants Council/Natural Science Foundation Council Joint Research Scheme (N_HKBU435/12).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Fuller KE, 2004, NEW ENGL J MED, V350, P190; Furnari F, 2010, NATURE, V465, P1016, DOI 10.1038/4651016a; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh T, 2010, J BIOL CHEM, V285, P27745, DOI 10.1074/jbc.M110.105080; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Marx J, 2004, SCIENCE, V305, P1420, DOI 10.1126/science.305.5689.1420; Miller P.O., 2004, NEW ENGL J MED, V350, P189; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Tromans A, 2003, NATURE, V425, P909, DOI 10.1038/425909a; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377	37	422	458	4	177	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					93	100		10.1038/nm.3026	http://dx.doi.org/10.1038/nm.3026			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23223004				2022-12-25	WOS:000313230300030
J	Armakola, M; Higgins, MJ; Figley, MD; Barmada, SJ; Scarborough, EA; Diaz, Z; Fang, XD; Shorter, J; Krogan, NJ; Finkbeiner, S; Farese, RV; Gitler, AD				Armakola, Maria; Higgins, Matthew J.; Figley, Matthew D.; Barmada, Sami J.; Scarborough, Emily A.; Diaz, Zamia; Fang, Xiaodong; Shorter, James; Krogan, Nevan J.; Finkbeiner, Steven; Farese, Robert V., Jr.; Gitler, Aaron D.			Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models	NATURE GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOGENOUS MESSENGER-RNAS; GENOMIC INTEGRATION METHOD; MUTANT HUNTINGTIN; DROSOPHILA MODEL; WILD-TYPE; M-TAG; MUTATIONS; GENE; AGGREGATION	Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease primarily affecting motor neurons. Mutations in the gene encoding TDP-43 cause some forms of the disease, and cytoplasmic TDP-43 aggregates accumulate in degenerating neurons of most individuals with ALS. Thus, strategies aimed at targeting the toxicity of cytoplasmic TDP-43 aggregates may be effective. Here, we report results from two genome-wide loss-of-function TDP-43 toxicity suppressor screens in yeast. The strongest suppressor of TDP-43 toxicity was deletion of DBR1, which encodes an RNA lariat debranching enzyme. We show that, in the absence of Dbr1 enzymatic activity, intronic lariats accumulate in the cytoplasm and likely act as decoys to sequester TDP-43, preventing it from interfering with essential cellular RNAs and RNA-binding proteins. Knockdown of Dbr1 in a human neuronal cell line or in primary rat neurons is also sufficient to rescue TDP-43 toxicity. Our findings provide insight into TDP-43 mediated cytotoxicity and suggest that decreasing Dbr1 activity could be a potential therapeutic approach for ALS.	[Armakola, Maria; Figley, Matthew D.; Fang, Xiaodong; Gitler, Aaron D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Armakola, Maria] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Higgins, Matthew J.; Krogan, Nevan J.; Farese, Robert V., Jr.] J David Gladstone Inst, Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Barmada, Sami J.; Finkbeiner, Steven] J David Gladstone Inst, Hellman Family Fdn Program, Taube Koret Ctr, Gladstone Inst Neurol Dis, San Francisco, CA USA; [Barmada, Sami J.; Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Scarborough, Emily A.; Diaz, Zamia; Shorter, James] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Krogan, Nevan J.] California Inst Quantitat Biosci, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Stanford University; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gitler, AD (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	bfarese@gladstone.ucsf.edu; agitler@stanford.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Gitler, Aaron/0000-0001-8603-1526; Barmada, Sami/0000-0002-9604-968X; Figley, Matthew/0000-0003-2125-829X	US National Institutes of Health (NIH) [1DP2OD004417, 1DP2OD002177]; NIH [NS065317, NS067354, GM084448, GM084279, GM081879, GM098101, NS39074, NS045491, NS072233, 2P01AG02074]; Ellison Medical Foundation; Packard Center for ALS Research at Johns Hopkins; Consortium for Frontotemporal Research; ALS Association; Taube-Koret Center; Hellman Family Foundation; Pew Charitable Trusts; Rita Allen Foundation Scholar; National Center for Research Resources [RR18928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448, R01GM084279, R01GM098101, P50GM081879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS072233, R21NS067354, R01NS065317, R24NS045491, R01NS039074] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177, DP2OD004417] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Packard Center for ALS Research at Johns Hopkins; Consortium for Frontotemporal Research; ALS Association; Taube-Koret Center; Hellman Family Foundation; Pew Charitable Trusts; Rita Allen Foundation Scholar; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Lynch and S. Smith for helpful suggestions and discussions about RNA and splicing; T. Nakaya for advice and assistance with lentivirus transduction experiments and analysis; C. Kurischko for advice and assistance with visualizing P bodies and stress granules; Q. Mitrovich and A. Plocik for advice with running the two-dimensional nucleic acid gels; S. Collins and D. Cameron for useful advice and assistance in performing the data analysis for screen 2; B. Hodges, D. Hosangadi, P. Patel, P. Nathanson and C. Mrejen for assistance with yeast experiments; J. Epstein and A. Raphael for critical comments on the manuscript and helpful suggestions; and G. Howard for editorial assistance. A. Elden helped with initial stages of this project. We are grateful to J. Gerst (Weizmann Institute) for providing the yeast m-TAG plasmids, R. Parker (University of Arizona) for sharing the P-body and stress granule marker plasmids and J. Weibezahn (University of California, San Francisco) for providing temperature-sensitive CDC48 (cdc48-3, SM 4783) and wild-type CDC48 isogenic (SM 5124) yeast strains. We thank B. Schwer (Weill Cornell Medical College) for providing the yeast mutant Dbr1 expression plasmids. We thank C. Boone (University of Toronto) for the MAT alpha strain Y7092. This work was supported by US National Institutes of Health (NIH) Director's New Innovator Awards 1DP2OD004417 (to A.D.G.) and 1DP2OD002177 (to J.S.), NIH grants NS065317 and NS065317 (to A.D.G.), NS067354 (to IS.), GM084448, GM084279, GM081879 and GM098101 (to N.J.K.), NS39074 and NS045491 (to SE) and NS072233 (to S.J.B.), a New Scholar in Aging Award from the Ellison Medical Foundation (to J.S.), a grant from the Packard Center for ALS Research at Johns Hopkins (A.D.G. and J.S.), a grant from the Consortium for Frontotemporal Research (to R.V.F.), NIH grant 2P01AG02074 (to S.F.), a grant from the ALS Association (to S.F.) and the Taube-Koret Center and Hellman Family Foundation (to S.F.). A.D.G. is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts, and a Rita Allen Foundation Scholar. N.J.K. is a Searle Scholar and a Keck Young Investigator. R.V.F. is an Investigator of the Gladstone Institutes. The J. David Gladstone Institutes received support from National Center for Research Resources Grant RR18928.	ARENAS J, 1987, J BIOL CHEM, V262, P4274; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Belzil VV, 2009, NEUROLOGY, V73, P1176, DOI 10.1212/WNL.0b013e3181bbfeef; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DOMDEY H, 1984, CELL, V39, P611, DOI 10.1016/0092-8674(84)90468-9; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Haim L, 2007, NAT METHODS, V4, P409, DOI 10.1038/NMETH1040; Haim-Vilmovsky L, 2011, METHODS MOL BIOL, V714, P237, DOI 10.1007/978-1-61779-005-8_15; Haim-Vilmovsky L, 2009, NAT PROTOC, V4, P1274, DOI 10.1038/nprot.2009.115; Hewitt C, 2010, ARCH NEUROL-CHICAGO, V67, P455, DOI 10.1001/archneurol.2010.52; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, NATURE, V466, P1052, DOI 10.1038/4661052a; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Ye Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-63; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	61	174	185	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1302	1309		10.1038/ng.2434	http://dx.doi.org/10.1038/ng.2434			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23104007	Green Accepted, Green Submitted			2022-12-25	WOS:000311713200006
J	Lee, G; Ramirez, CN; Kim, H; Zeltner, N; Liu, B; Radu, C; Bhinder, B; Kim, YJ; Choi, IY; Mukherjee-Clavin, B; Djaballah, H; Studer, L				Lee, Gabsang; Ramirez, Christina N.; Kim, Hyesoo; Zeltner, Nadja; Liu, Becky; Radu, Constantin; Bhinder, Bhavneet; Kim, Yong Jun; Choi, In Young; Mukherjee-Clavin, Bipasha; Djaballah, Hakim; Studer, Lorenz			Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression	NATURE BIOTECHNOLOGY			English	Article							INHIBITORS; MODELS; ASSAY	Patient-specific induced pluripotent stem cells (iPSCs) represent a novel system for modeling human genetic disease and could provide a source of cells for large-scale drug-discovery screens. Here we demonstrate the feasibility of performing a primary screen in neural crest precursors derived from iPSCs that were generated from individuals with familial dysautonomia (FD), a rare, fatal genetic disorder affecting neural crest lineages. We tested 6,912 small-molecule compounds and characterized eight that rescued expression of IKBKAP, the gene responsible for FD. One of the hits, SKF-86466, was found to induce IKBKAP transcription through modulation of intracellular cAMP levels and PKA-dependent CREB phosphorylation. SKF-86466 also rescued IKAP protein expression and the disease-specific loss of autonomic neuronal marker expression. Our data implicate alpha-2 adrenergic receptor activity in regulating IKBKAP expression and demonstrate that small-molecule discovery using an iPSC-based disease model can identify candidate drugs for potential therapeutic intervention.	[Lee, Gabsang; Kim, Hyesoo; Zeltner, Nadja; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY USA; [Lee, Gabsang; Kim, Hyesoo; Zeltner, Nadja; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY USA; [Kim, Hyesoo] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurol & Neurosci,Stem Cell Core Facil, Baltimore, MD USA; [Ramirez, Christina N.; Radu, Constantin; Bhinder, Bhavneet; Djaballah, Hakim] Sloan Kettering Inst Canc Res, HTS Core Facil, New York, NY USA; [Djaballah, Hakim] Sloan Kettering Inst Canc Res, Mol Pharmacol & Chem Program, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY USA.	glee48@jhmi.edu; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Lee, Gabsang/0000-0002-5052-5927; Djaballah, Hakim/0000-0002-6039-0181; Kim, Yong Jun/0000-0002-5374-712X	NYSTEM; New York Stem Cell Foundation; Maryland Stem Cell Research Funding; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center at MSKCC; W.R. Hearst Fund in Experimental Therapeutics; L.S. Wells Foundation; National Institutes of Health National Cancer Institute [5 P30 CA008748-44]; W.H. Goodwin; A. Goodwin; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053655] Funding Source: NIH RePORTER	NYSTEM; New York Stem Cell Foundation; Maryland Stem Cell Research Funding; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center at MSKCC; W.R. Hearst Fund in Experimental Therapeutics; L.S. Wells Foundation; National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); W.H. Goodwin; A. Goodwin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Studer lab for valuable discussions on the manuscript and the members of the HTS Core Facility for their help during the course of this study. We also thank J. Hendrikx and P. Anderson for technical help in flow cytometry assays. Work in the Studer lab was supported by grants from NYSTEM (L. S.) and Druckenmiller Fellowship from New York Stem Cell Foundation (G. L.). Robertson Investigator Award from New York Stem Cell Foundation (G. L.) and Maryland Stem Cell Research Funding (G. L.) supported experiments in the Lee lab. Work of the HTS Core Facility was supported by W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center at MSKCC, the W.R. Hearst Fund in Experimental Therapeutics, the L.S. Wells Foundation, and by grant 5 P30 CA008748-44 from National Institutes of Health National Cancer Institute.	Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ooi YH, 2009, INVEST OPHTH VIS SCI, V50, P4237, DOI 10.1167/iovs.08-2312; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pauwels PJ, 2000, J PHARMACOL EXP THER, V292, P654; Pfenning AR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-20; Rodriguez Luis G., 2004, V294, P23; Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Trendelenburg AU, 1996, N-S ARCH PHARMACOL, V353, P245, DOI 10.1007/BF00168625; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	23	166	173	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1244	+		10.1038/nbt.2435	http://dx.doi.org/10.1038/nbt.2435			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159879	Green Accepted			2022-12-25	WOS:000312092400029
J	Pierre, S; Guillot, A; Benjdia, A; Sandstrom, C; Langella, P; Berteau, O				Pierre, Stephane; Guillot, Alain; Benjdia, Alhosna; Sandstrom, Corine; Langella, Philippe; Berteau, Olivier			Thiostrepton tryptophan methyltransferase expands the chemistry of radical SAM enzymes	NATURE CHEMICAL BIOLOGY			English	Article							SULFATASE-MATURATING ENZYME; S-ADENOSYLMETHIONINE; DEPENDENT METHYLTRANSFERASES; BIOSYNTHESIS; METHYLATION; CONFIGURATION; METHIONINE; RETENTION; FOXM1	Methylation is among the most widespread chemical modifications encountered in biomolecules and has a pivotal role in many major biological processes. In the biosynthetic pathway of the antibiotic thiostrepton A, we identified what is to our knowledge the first tryptophan methyltransferase. We show that it uses unprecedented chemistry to methylate inactivated sp(2)-hybridized carbon atoms, despite being predicted to be a radical SAM enzyme.	[Pierre, Stephane; Guillot, Alain; Langella, Philippe; Berteau, Olivier] INRA, UMR Micalis 1319, Jouy En Josas, France; [Pierre, Stephane; Guillot, Alain; Langella, Philippe; Berteau, Olivier] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Benjdia, Alhosna] Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany; [Sandstrom, Corine] Swedish Univ Agr Sci, Dept Chem, S-75007 Uppsala, Sweden	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Swedish University of Agricultural Sciences	Berteau, O (corresponding author), INRA, UMR Micalis 1319, Jouy En Josas, France.	olivier.berteau@jouy.inra.fr	Berteau, Olivier/AAF-9080-2019; Benjdia, Alhosna/AAM-7415-2021; Langella, Philippe/N-8368-2017	Berteau, Olivier/0000-0002-3434-5168; Benjdia, Alhosna/0000-0002-3544-2541; Langella, Philippe/0000-0001-5960-4341	French National Research Agency	French National Research Agency(French National Research Agency (ANR))	We are grateful to J. Ulmer for critical reading of this manuscript. MS experiments were performed at Plateforme d'Analyse Proteomique de Paris Sud Ouest. This work was supported by grants from the French National Research Agency to S.P.	Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; FRENZEL T, 1990, ARCH BIOCHEM BIOPHYS, V278, P35, DOI 10.1016/0003-9861(90)90227-P; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; HOUCK DR, 1986, J AM CHEM SOC, V108, P5365, DOI 10.1021/ja00277a063; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; Moore BN, 2012, PHYS CHEM CHEM PHYS, V14, P3148, DOI 10.1039/c2cp23443b; Mosimann H, 2000, ANGEW CHEM INT EDIT, V39, P393, DOI 10.1002/(SICI)1521-3773(20000117)39:2<393::AID-ANIE393>3.0.CO;2-M; Nicolaou KC, 2005, J AM CHEM SOC, V127, P15042, DOI 10.1021/ja0552803; Tarr SJ, 2011, MOL BIOCHEM PARASIT, V179, P37, DOI 10.1016/j.molbiopara.2011.05.004; Walsh CT, 2010, J BIOL CHEM, V285, P27525, DOI 10.1074/jbc.R110.135970; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c; ZHOU P, 1989, J AM CHEM SOC, V111, P7274, DOI 10.1021/ja00200a065	22	88	91	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					957	959		10.1038/NCHEMBIO.1091	http://dx.doi.org/10.1038/NCHEMBIO.1091			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23064318				2022-12-25	WOS:000311491200007
J	Mathsyaraja, H; Ostrowski, MC				Mathsyaraja, Haritha; Ostrowski, Michael C.			Setting Snail2's pace during EMT	NATURE CELL BIOLOGY			English	Editorial Material							EPITHELIAL-MESENCHYMAL TRANSITION	Epithelial to mesenchymal transition (EMT) is a fundamental process in both development and cancer progression. The transcription factor Elf5 is now reported as an upstream regulator of the key EMT inducer Snail2, and is shown to regulate the earliest known rewiring events required for tumour cell invasiveness and metastasis.	[Mathsyaraja, Haritha] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Mathsyaraja, Haritha; Ostrowski, Michael C.] OSU Comprehens Canc Ctr, Columbus, OH USA; [Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Ohio State University; James Cancer Hospital & Solove Research Institute; Ohio State University; Ohio State University	Mathsyaraja, H (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA.	Michael.Ostrowski@osumc.edu	Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297	NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Lee HJ, 2011, STEM CELLS, V29, P1611, DOI 10.1002/stem.706; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas RS, 2000, ADV EXP MED BIOL, V480, P123; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	15	7	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1122	1123		10.1038/ncb2616	http://dx.doi.org/10.1038/ncb2616			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23131919				2022-12-25	WOS:000310778100003
J	Jenkins, RB; Xiao, YY; Sicotte, H; Decker, PA; Kollmeyer, TM; Hansen, HM; Kosel, ML; Zheng, SC; Walsh, KM; Rice, T; Bracci, P; McCoy, LS; Smirnov, I; Patoka, JS; Hsuang, G; Wiemels, JL; Tihan, T; Pico, AR; Prados, MD; Chang, SM; Berger, MS; Caron, AA; Fink, SR; Halder, C; Rynearson, AL; Fridley, BL; Buckner, JC; O'Neill, BP; Giannini, C; Lachance, DH; Wiencke, JK; Eckel-Passow, JE; Wrensch, MR				Jenkins, Robert B.; Xiao, Yuanyuan; Sicotte, Hugues; Decker, Paul A.; Kollmeyer, Thomas M.; Hansen, Helen M.; Kosel, Matthew L.; Zheng, Shichun; Walsh, Kyle M.; Rice, Terri; Bracci, Paige; McCoy, Lucie S.; Smirnov, Ivan; Patoka, Joseph S.; Hsuang, George; Wiemels, Joe L.; Tihan, Tarik; Pico, Alexander R.; Prados, Michael D.; Chang, Susan M.; Berger, Mitchel S.; Caron, Alissa A.; Fink, Stephanie R.; Halder, Chandralekha; Rynearson, Amanda L.; Fridley, Brooke L.; Buckner, Jan C.; O'Neill, Brian P.; Giannini, Caterina; Lachance, Daniel H.; Wiencke, John K.; Eckel-Passow, Jeanette E.; Wrensch, Margaret R.			A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MULTIPLE LOCI; SURVIVAL; REPLICATION; AGE	Variants at 8q24.21 have been shown to be associated with glioma development. By means of tag SNP genotyping and imputation, pooled next-generation sequencing using long-range PCR and subsequent validation SNP genotyping, we identified seven low-frequency SNPs at 8q24.21 that were strongly associated with glioma risk (P = 1 x 10(-25) to 1 x 10(-14)). The most strongly associated SNP, rs55705857, remained highly significant after individual adjustment for the other top six SNPs and two previously published SNPs. After stratifying by histological and tumor genetic subtype, the most significant associations of rs55705857 were with oligodendroglial tumors and gliomas with mutant IDH1 or IDH2 (odds ratio (OR) = 5.1, P = 1.1 x 10(-31) and OR = 4.8, P = 6.6 x 10(-22), respectively). Strong associations were observed for astrocytomas with mutated IDH1 or IDH2 (grades 2-4) (OR = 5.16-6.66, P = 4.7 x 10(-12) to 2.2 x 10(-8)) but not for astrocytomas with wild-type IDH1 and IDH2 (smallest P = 0.26). The conserved sequence block that includes rs55705857 is consistently modeled as a microRNA.	[Jenkins, Robert B.; Kollmeyer, Thomas M.; Caron, Alissa A.; Fink, Stephanie R.; Halder, Chandralekha; Rynearson, Amanda L.; Giannini, Caterina; Lachance, Daniel H.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Xiao, Yuanyuan; Bracci, Paige; Wiemels, Joe L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Sicotte, Hugues; Decker, Paul A.; Kosel, Matthew L.; Fridley, Brooke L.; Eckel-Passow, Jeanette E.] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN USA; [Hansen, Helen M.; Zheng, Shichun; Walsh, Kyle M.; Rice, Terri; McCoy, Lucie S.; Smirnov, Ivan; Patoka, Joseph S.; Hsuang, George; Prados, Michael D.; Chang, Susan M.; Berger, Mitchel S.; Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Walsh, Kyle M.] Univ Calif San Francisco, Program Canc Genet, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Wiemels, Joe L.; Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Tihan, Tarik] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Pico, Alexander R.] Gladstone Inst, San Francisco, CA USA; [Buckner, Jan C.] Mayo Clin, Coll Med, Dept Oncol, Rochester, MN USA; [O'Neill, Brian P.; Lachance, Daniel H.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA	Mayo Clinic; University of California System; University of California San Francisco; Mayo Clinic; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Mayo Clinic; Mayo Clinic	Jenkins, RB (corresponding author), Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	rjenkins@mayo.edu	Tihan, Tarik/AAU-6371-2021; Fridley, Brooke L/D-8315-2015; Prados, Michael/N-5220-2019; Rice, Terri/J-6071-2014; Giannini, Caterina/AAB-7551-2022; Buckner, Jan/AAE-6388-2019; Pico, Alexander/HCH-4305-2022	Fridley, Brooke L/0000-0001-7739-7956; Walsh, Kyle/0000-0002-5879-9981; Tihan, Tarik/0000-0003-4551-2555; Pico, Alexander/0000-0001-5706-2163	US National Institutes of Health (NIH) [P50CA108961, P30CA15083]; National Institute of Neurological Disorders and Stroke [RC1NS068222Z]; Bernie and Edith Waterman Foundation; Ting Tsung and Wei Fong Chao Family Foundation; NIH [R01CA52689, P50CA097257, R01CA126831, R25CA112355]; National Brain Tumor Foundation; UCSF Lewis Chair in Brain Tumor Research; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA052689, R01CA126831, R25CA112355, P30CA015083, P50CA097257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068222] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bernie and Edith Waterman Foundation; Ting Tsung and Wei Fong Chao Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Foundation; UCSF Lewis Chair in Brain Tumor Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to acknowledge study participants, the clinicians and research staff at the participating medical centers, deCODE Genetics, the late Bernd Scheithauer, the Mayo Clinic Comprehensive Cancer Center Biospecimens Accessioning and Processing Shared Resource and Genotyping Shared Resource and the UCSF Diller Cancer Center Genomics Core. Work at the Mayo Clinic was supported by the US National Institutes of Health (NIH; grants P50CA108961 and P30CA15083), the National Institute of Neurological Disorders and Stroke (grant RC1NS068222Z), the Bernie and Edith Waterman Foundation and the Ting Tsung and Wei Fong Chao Family Foundation. Work at the University of California, San Francisco, was supported by the NIH (grants R01CA52689, P50CA097257, R01CA126831 and R25CA112355), as well as the National Brain Tumor Foundation and the UCSF Lewis Chair in Brain Tumor Research, and by donations from families and friends of John Berardi, Helen Glaser, Elvera Olsen, Raymond E. Cooper and William Martinusen.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Felini MJ, 2009, CANCER CAUSE CONTROL, V20, P87, DOI 10.1007/s10552-008-9220-z; Gayther SA, 2010, CURR OPIN GENET DEV, V20, P231, DOI 10.1016/j.gde.2010.03.001; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Idbaih A, 2011, J NEURO-ONCOL, V103, P221, DOI 10.1007/s11060-010-0380-9; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mu Wenbo, 2012, Frontiers in Genetics, V3, P31, DOI 10.3389/fgene.2012.00031; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rice T, 2011, NEURO-ONCOLOGY, V13, P27; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Sato Y, 2011, J THORAC ONCOL, V6, P132, DOI 10.1097/JTO.0b013e318200f415; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Teerlink C, 2012, HUM GENET, V131, P77, DOI 10.1007/s00439-011-1048-z; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wrensch M, 2007, CLIN CANCER RES, V13, P197, DOI 10.1158/1078-0432.CCR-06-1199; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	35	107	108	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1122	+		10.1038/ng.2388	http://dx.doi.org/10.1038/ng.2388			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922872	Green Accepted			2022-12-25	WOS:000309550200012
J	Kwong, LN; Costello, JC; Liu, HY; Jiang, S; Helms, TL; Langsdorf, AE; Jakubosky, D; Genovese, G; Muller, FL; Jeong, JH; Bender, RP; Chu, GC; Flaherty, KT; Wargo, JA; Collins, JJ; Chin, LD				Kwong, Lawrence N.; Costello, James C.; Liu, Huiyun; Jiang, Shan; Helms, Timothy L.; Langsdorf, Aliete E.; Jakubosky, David; Genovese, Giannicola; Muller, Florian L.; Jeong, Joseph H.; Bender, Ryan P.; Chu, Gerald C.; Flaherty, Keith T.; Wargo, Jennifer A.; Collins, James J.; Chin, Lynda			Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma	NATURE MEDICINE			English	Article							TUMOR PROGRESSION; PHASE-I; K-RAS; BRAF; INHIBITOR; MEK; PATHWAY; ARRY-142886; SELUMETINIB; AZD6244	The discovery of potent inhibitors of the BRAF proto-oncogene has revolutionized therapy for melanoma harboring mutations in BRAF, yet NRAS-mutant melanoma remains without an effective therapy. Because direct pharmacological inhibition of the RAS proto-oncogene has thus far been unsuccessful, we explored systems biology approaches to identify synergistic drug combination(s) that can mimic RAS inhibition. Here, leveraging an inducible mouse model of NRAS-mutant melanoma, we show that pharmacological inhibition of mitogen-activated protein kinase kinase (MEK) activates apoptosis but not cell-cycle arrest, which is in contrast to complete genetic neuroblastoma RAS homolog (NRAS) extinction, which triggers both of these effects. Network modeling pinpointed cyclin-dependent kinase 4 (CDK4) as a key driver of this differential phenotype. Accordingly, combined pharmacological inhibition of MEK and CDK4 in vivo led to substantial synergy in therapeutic efficacy. We suggest a gradient model of oncogenic NRAS signaling in which the output is gated, resulting in the decoupling of discrete downstream biological phenotypes as a result of incomplete inhibition. Such a gated signaling model offers a new framework to identify nonobvious coextinction target(s) for combined pharmacological inhibition in NRAS-mutant melanomas.	[Kwong, Lawrence N.; Liu, Huiyun; Jiang, Shan; Langsdorf, Aliete E.; Jakubosky, David; Genovese, Giannicola; Muller, Florian L.; Jeong, Joseph H.; Bender, Ryan P.; Chu, Gerald C.; Chin, Lynda] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kwong, Lawrence N.; Jiang, Shan; Helms, Timothy L.; Genovese, Giannicola; Muller, Florian L.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Costello, James C.; Collins, James J.] Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02115 USA; [Costello, James C.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Chu, Gerald C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Div Med Oncol, Boston, MA 02114 USA; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Texas System; UTMD Anderson Cancer Center	Chin, LD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	lchin@mdanderson.org		Costello, James/0000-0003-3158-9682; Genovese, Giannicola/0000-0003-1392-9954; Muller, Florian/0000-0001-7568-2948	American Cancer Society [117842-PF-09-261-01-TBG]; US National Institutes of Health Director's Pioneer Award Program; Howard Hughes Medical Institute; US National Institutes of Health [U01 CA141508]; Abby S. and Howard P. Milstein Innovation Award for Melanoma and Skin Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672, U01CA141508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); US National Institutes of Health Director's Pioneer Award Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abby S. and Howard P. Milstein Innovation Award for Melanoma and Skin Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Mills, Y. Lu and N. Shih at the MD Anderson Reverse Phase Protein Array core facility; E. Fox at the Dana-Farber Cancer Institute Microarray core facility; S. Zhou for mouse husbandry; R. DePinho and G. Draetta and members of the laboratory, including S. Quayle, M. Chen, A. Blanchette and J. Kamara, for insightful discussions; R. Kwong for manuscript proofreading; D. Camacho for helping develop the TRAP algorithm; and M. Bar-Eli (University of Texas MD Anderson Cancer Center, Houston, Texas) for the SB-2 cell line. L. N. K. is supported by the Postdoctoral Fellowship (117842-PF-09-261-01-TBG) from the American Cancer Society. J. J. C. is supported by the US National Institutes of Health Director's Pioneer Award Program and the Howard Hughes Medical Institute. This work was supported by funding from the US National Institutes of Health to L. C. (U01 CA141508). L. C. is a recipient of the Abby S. and Howard P. Milstein 2009 Innovation Award for Melanoma and Skin Cancer Research and a CPRIT (Cancer Prevention Research Institute of Texas) Scholar in Cancer Research.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chiarion-Sileni V, 2013, J CLIN ONCOL, V31; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jakob J.A, 2011, CANCER, V118, P4013; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Sachs Karen, 2002, Sci STKE, V2002, ppe38, DOI 10.1126/stke.2002.148.pe38; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; VanBrocklin MW, 2009, CANCER RES, V69, P1985, DOI 10.1158/0008-5472.CAN-08-3934; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	45	254	264	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1503	U96		10.1038/nm.2941	http://dx.doi.org/10.1038/nm.2941			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22983396	Green Accepted			2022-12-25	WOS:000309587500028
J	Povlsen, LK; Beli, P; Wagner, SA; Poulsen, SL; Sylvestersen, KB; Poulsen, JW; Nielsen, ML; Bekker-Jensen, S; Mailand, N; Choudhary, C				Povlsen, Lou K.; Beli, Petra; Wagner, Sebastian A.; Poulsen, Sara L.; Sylvestersen, Kathrine B.; Poulsen, Jon W.; Nielsen, Michael L.; Bekker-Jensen, Simon; Mailand, Niels; Choudhary, Chunaram			Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass	NATURE CELL BIOLOGY			English	Article							UBIQUITIN; PROTEINS; REPLICATION; PCNA; IDENTIFICATION; POLYMERASES; ACTIVATION; CRL4(CDT2)	Protein ubiquitylation has emerged as a key regulatory mechanism in DNA-damage signalling and repair pathways. We report a proteome-wide, site-specific survey of ubiquitylation changes after ultraviolet irradiation, identifying numerous upregulated and downregulated ubiquitylation sites on known components of DNA-damage signalling, as well as on proteins not previously implicated in this process. Our results uncover a critical role for PCNA-associated factor PAF15 (p15(PAF)/KIAA0101) ubiquitylation during DNA replication. During unperturbed S phase, chromatin-associated PAF15 is modified by double mono-ubiquitylation of Lys 15 and 24 templated through PCNA binding. Replication blocks trigger rapid, proteasome-dependent removal of Lys 15/24-ubiquitylated PAF15 from PCNA, facilitating bypass of replication-fork-blocking lesions by allowing recruitment of translesion DNA synthesis polymerase pol eta to mono-ubiquitylated PCNA at stalled replisomes. Our findings demonstrate widespread involvement of ubiquitin signalling in genotoxic-stress responses and identify a critical function for dynamic PAF15 ubiquitylation in safeguarding genome integrity when DNA replication is challenged.	[Povlsen, Lou K.; Poulsen, Sara L.; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Ubiquitin Signaling Grp,Dept Dis Biol, DK-2200 Copenhagen, Denmark; [Beli, Petra; Wagner, Sebastian A.; Sylvestersen, Kathrine B.; Poulsen, Jon W.; Nielsen, Michael L.; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Dept Prote, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Mailand, N (corresponding author), Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Ubiquitin Signaling Grp,Dept Dis Biol, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	niels.mailand@cpr.ku.dk; chuna.choudhary@cpr.ku.dk	choudhary, chunaram/ABE-6634-2020	choudhary, chunaram/0000-0002-9863-433X; Bekker-Jensen, Simon/0000-0002-7308-4597; Beck Sylvestersen, Kathrine/0000-0002-8201-4769; Beli, Petra/0000-0001-9507-9820; Nielsen, Michael/0000-0002-0067-9039	Danish Medical Research Council [FSS10-081753, FSS10-083519]; Danish Cancer Society; Lundbeck Foundation; European Commission seventh Framework Programme (PRIME-XS); Danish Research Council [F5512-12610, FSS10-085134]; Novo Nordisk Foundation; Lundbeck Foundation [R34-2009-3790] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand, PI Chunaram Choudhary] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); European Commission seventh Framework Programme (PRIME-XS); Danish Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation Center for Protein Research	We are grateful to R. Schwab and W. Niedzwiedz for help with setting up the DNA fibre assay, and we thank A. Lehmann and M. Seidman for providing reagents. This work was supported by a generous donation from the Novo Nordisk Foundation, and grants from the Danish Medical Research Council (FSS10-081753 and FSS10-083519), the Danish Cancer Society, the Lundbeck Foundation and the European Commission seventh Framework Programme (PRIME-XS). P.B. and S.A.W. are supported by postdoctoral grants from the Danish Research Council (F5512-12610, FSS10-085134). The Center for Protein Research is supported by a generous grant from the Novo Nordisk Foundation.	Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Choi JH, 2005, DNA REPAIR, V4, P211, DOI 10.1016/j.dnarep.2004.09.006; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cox J, 2009, COMMENTARY, V127, P4; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; MacCoss MJ, 2005, ANAL CHEM, V77, P7646, DOI 10.1021/ac0508393; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; PARRIS CN, 1992, GENE, V117, P1, DOI 10.1016/0378-1119(92)90482-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654	52	190	195	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1089	+		10.1038/ncb2579	http://dx.doi.org/10.1038/ncb2579			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	23000965				2022-12-25	WOS:000309543800017
J	Schlame, M; Acehan, D; Berno, B; Xu, Y; Valvo, S; Ren, MD; Stokes, DL; Epand, RM				Schlame, Michael; Acehan, Devrim; Berno, Bob; Xu, Yang; Valvo, Salvatore; Ren, Mindong; Stokes, David L.; Epand, Richard M.			The physical state of lipid substrates provides transacylation specificity for tafazzin	NATURE CHEMICAL BIOLOGY			English	Article							BARTH-SYNDROME; CARDIOLIPIN METABOLISM; DEUTERIUM-NMR; ATP SYNTHASE; MITOCHONDRIA; MEMBRANES; MODEL; ORGANIZATION; POLYMORPHISM; MUTANT	Cardiolipin is a mitochondrial phospholipid with a characteristic acyl chain composition that depends on the function of tafazzin, a phospholipid-lysophospholipid transacylase, although the enzyme itself lacks acyl specificity. We incubated isolated tafazzin with various mixtures of phospholipids and lysophospholipids, characterized the lipid phase by P-31-NMR and measured newly formed molecular species by MS. Substantial transacylation was observed only in nonbilayer lipid aggregates, and the substrate specificity was highly sensitive to the lipid phase. In particular, tetralinoleoyl-cardiolipin, a prototype molecular species, formed only under conditions that favor the inverted hexagonal phase. In isolated mitochondria, <1% of lipids participated in transacylations, suggesting that the action of tafazzin was limited to privileged lipid domains. We propose that tafazzin reacts with non-bilayer-type lipid domains that occur in curved or hemifused membrane zones and that acyl specificity is driven by the packing properties of these domains.	[Schlame, Michael; Xu, Yang] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Schlame, Michael; Ren, Mindong] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Acehan, Devrim; Valvo, Salvatore; Stokes, David L.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Berno, Bob; Epand, Richard M.] McMaster Univ, Dept Chem, Hamilton, ON, Canada; [Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	New York University; New York University; New York University; McMaster University; McMaster University	Schlame, M (corresponding author), NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA.	michael.schlame@med.nyu.edu	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Barth Syndrome Foundation; National Institutes of Health [HL078788, HL091154, 1U54GM094598]; Canadian Natural Sciences and Engineering Research Council [9848]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091154, R01HL078788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598] Funding Source: NIH RePORTER	Barth Syndrome Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to B. De Kruijff for stimulating discussions. This work was supported by the Barth Syndrome Foundation, by the National Institutes of Health (HL078788 to M.S., HL091154 to M. R., 1U54GM094598 to D.L.S.) and by the Canadian Natural Sciences and Engineering Research Council (9848 to R.M.E.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Cook A M, 1981, Methods Enzymol, V72, P292, DOI 10.1016/S0076-6879(81)72017-2; CULLIS PR, 1980, BIOCHIM BIOPHYS ACTA, V600, P625, DOI 10.1016/0005-2736(80)90466-6; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V684, P47, DOI 10.1016/0005-2736(82)90047-5; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V693, P1, DOI 10.1016/0005-2736(82)90464-3; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; MCLAUGHLIN AC, 1975, J MAGN RESON, V20, P146, DOI 10.1016/0022-2364(75)90162-6; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; NICOLAY K, 1985, BIOCHIM BIOPHYS ACTA, V819, P55, DOI 10.1016/0005-2736(85)90195-6; Nishizawa Manami, 2010, Journal of Biophysical Chemistry, V1, P86, DOI 10.4236/jbpc.2010.12011; OTTEN D, 1995, BIOPHYS J, V68, P584, DOI 10.1016/S0006-3495(95)80220-1; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; SANKARAM MB, 1989, BIOCHIM BIOPHYS ACTA, V980, P389, DOI 10.1016/0005-2736(89)90331-3; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2012, CHEM PHYS LIPIDS, V165, P512, DOI 10.1016/j.chemphyslip.2012.03.001; Schlame M, 2009, BBA-MOL CELL BIOL L, V1791, P321, DOI 10.1016/j.bbalip.2009.01.018; Shulga YV, 2011, J MOL BIOL, V409, P101, DOI 10.1016/j.jmb.2011.03.071; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; THURMOND RL, 1993, BIOCHEMISTRY-US, V32, P5394, DOI 10.1021/bi00071a015; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	39	94	95	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					862	869		10.1038/NCHEMBIO.1064	http://dx.doi.org/10.1038/NCHEMBIO.1064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22941046	Green Accepted			2022-12-25	WOS:000309056200012
J	Tumbarello, DA; Waxse, BJ; Arden, SD; Bright, NA; Kendrick-Jones, J; Buss, F				Tumbarello, David A.; Waxse, Bennett J.; Arden, Susan D.; Bright, Nicholas A.; Kendrick-Jones, John; Buss, Folma			Autophagy receptors link myosin VI to autophagosomes to mediate Tom 1-dependent autophagosome maturation and fusion with the lysosome	NATURE CELL BIOLOGY			English	Article							GOLGI-COMPLEX; UBIQUITIN; BINDING; OPTINEURIN; PROTEINS; PHOSPHORYLATION; LOCALIZATION; BIOGENESIS; HUNTINGTIN; MUTATIONS	Autophagy targets pathogens, damaged organelles and protein aggregates for lysosomal degradation. These ubiquitylated cargoes are recognized by specific autophagy receptors, which recruit LC3-positive membranes to form autophagosomes. Subsequently, autophagosomes fuse with endosomes and lysosomes, thus facilitating degradation of their content; however, the machinery that targets and mediates fusion of these organelles with autophagosomes remains to be established. Here we demonstrate that myosin VI, in concert with its adaptor proteins NDP52, optineurin, T6BP and Tom 1, plays a crucial role in autophagy. We identify Tom1 as a myosin VI binding partner on endosomes, and demonstrate that loss of myosin VI and Tom1 reduces autophagosomal delivery of endocytic cargo and causes a block in autophagosome-lysosome fusion. We propose that myosin VI delivers endosomal membranes containing Tom1 to autophagosomes by docking to NDP52, T6BP and optineurin, thereby promoting autophagosome maturation and thus driving fusion with lysosomes.	[Tumbarello, David A.; Waxse, Bennett J.; Arden, Susan D.; Bright, Nicholas A.; Buss, Folma] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Kendrick-Jones, John] MRC Lab Mol Biol, Cambridge CB2 0QH, England	University of Cambridge; MRC Laboratory Molecular Biology	Tumbarello, DA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England.	dat39@cam.ac.uk; fb1@mole.bio.cam.ac.uk		Buss, Folma/0000-0003-4457-3479; Waxse, Bennett/0000-0001-5086-3419; Tumbarello, David/0000-0002-5169-0561	Wellcome Trust; Medical Research Council; NIH-Oxford-Cambridge Ph.D. studentship; Wellcome Trust [079895]; Medical Research Council [MC_U105184323] Funding Source: researchfish; MRC [MC_U105184323] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH-Oxford-Cambridge Ph.D. studentship; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was financially supported by the Wellcome Trust (F.B., D.A.T. and S.D.A.), the Medical Research Council (J.K-J. and N.A.B.) and a NIH-Oxford-Cambridge Ph.D. studentship (B.J.W.). The CIMR is in receipt of a strategic award from the Wellcome Trust (079895). We thank M. Seaman, F. Randow, L. Wartosch, D. Rubinsztein and D. Owen for critical reading of the manuscript and helpful discussions.	Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Chibalina MV, 2008, METHOD ENZYMOL, V438, P11, DOI 10.1016/S0076-6879(07)38002-6; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Feuillette S, 2010, BRAIN RES, V1345, P182, DOI 10.1016/j.brainres.2010.05.007; Finan D, 2011, P NATL ACAD SCI USA, V108, P5566, DOI 10.1073/pnas.1101415108; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herman EK, 2011, J CELL SCI, V124, P613, DOI 10.1242/jcs.078436; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lawrence SP, 2010, MOL BIOL CELL, V21, P3540, DOI 10.1091/mbc.E09-12-1053; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Wang TL, 2010, TRAFFIC, V11, P1119, DOI 10.1111/j.1600-0854.2010.01098.x; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405	41	198	199	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1024	+		10.1038/ncb2589	http://dx.doi.org/10.1038/ncb2589			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	23023224	Green Accepted			2022-12-25	WOS:000309543800011
J	van der Vos, KE; Eliasson, P; Proikas-Cezanne, T; Vervoort, SJ; van Boxtel, R; Putker, M; van Zutphen, IJ; Mauthe, M; Zellmer, S; Pals, C; Verhagen, LP; Koerkamp, MJAG; Braat, AK; Dansen, TB; Holstege, FC; Gebhardt, R; Burgering, BM; Coffer, PJ				van der Vos, Kristan E.; Eliasson, Pernilla; Proikas-Cezanne, Tassula; Vervoort, Stephin J.; van Boxtel, Ruben; Putker, Marrit; van Zutphen, Iris J.; Mauthe, Mario; Zellmer, Sebastian; Pals, Cornelieke; Verhagen, Liesbeth P.; Koerkamp, Marian J. A. Groot; Braat, A. Koen; Dansen, Tobias B.; Holstege, Frank C.; Gebhardt, Rolf; Burgering, Boudewijn M.; Coffer, Paul J.			Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-B; TRANSCRIPTION FACTOR; RAT-LIVER; SYNTHETASE GENE; FAMILY-MEMBER; AMINO-ACIDS; LIFE-SPAN; CELLS; ACTIVATION; INDUCTION	The PI(3)K-PKB-FOXO signalling network provides a major intracellular hub for the regulation of cell proliferation, survival and stress resistance. Here we report an unexpected role for FOXO transcription factors inregulating autophagy by modulating intracellular glutamine levels. To identify transcriptional targets of this network, we performed global transcriptional analyses after conditional activation of the key components PI(3)K, PKB/Akt, FOXO3 and FOXO4. Using this pathway approach, we identified glutamine synthetase as being transcriptionally regulated by PI(3)K-PKB-FOXO signalling. Conditional activation of FOXO also led to an increased level of glutamine production. FOXO activation resulted in mTOR inhibition by preventing the translocation of mTOR to lysosomal membranes in a glutamine-synthetase-dependent manner. This resulted in an increased level of autophagy as measured by LC3 lipidation, p62 degradation and fluorescent imaging of multiple autophagosomal markers. Inhibition of FOXO3-mediated autophagy increased the level of apoptosis, suggesting that the induction of autophagy by FOXO3-mediated glutamine synthetase expression is important for cellular survival. These findings reveal a growth-factor-responsive network that can directly modulate autophagy through the regulation of glutamine metabolism.	[van der Vos, Kristan E.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Immunol, NL-3584 CX Utrecht, Netherlands; [Eliasson, Pernilla; Vervoort, Stephin J.; van Boxtel, Ruben; Pals, Cornelieke; Verhagen, Liesbeth P.; Braat, A. Koen; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Proikas-Cezanne, Tassula; Mauthe, Mario] Univ Tubingen, Interfac Inst Cell Biol, Autophagy Lab, D-72076 Tubingen, Germany; [Putker, Marrit; van Zutphen, Iris J.; Koerkamp, Marian J. A. Groot; Dansen, Tobias B.; Holstege, Frank C.; Burgering, Boudewijn M.] Univ Med Ctr, Dept Mol Canc Res, NL-3584 CX Utrecht, Netherlands; [Zellmer, Sebastian; Gebhardt, Rolf] Univ Leipzig, Fak Med, Inst Biochim, D-04103 Leipzig, Germany; [Vervoort, Stephin J.; Braat, A. Koen; Coffer, Paul J.] Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, NL-3584 EA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Eberhard Karls University of Tubingen; Utrecht University; Utrecht University Medical Center; Leipzig University; Wilhelmina Kinderziekenhuis	Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, NL-3584 CX Utrecht, Netherlands.	P.J.Coffer@umcutrecht.nl	Holstege, Frank/AAM-9944-2021; Vervoort, Stephin/AAP-7854-2020; Coffer, Paul/AAF-7970-2020	Mauthe, Mario/0000-0003-0049-7961; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X; Groot Koerkamp, Marian JA/0000-0002-0867-0821; van Boxtel, Ruben/0000-0003-1285-2836; Dansen, Tobias/0000-0001-5259-8815; Vervoort, Stephin/0000-0001-7459-126X	Dutch Scientific Organisation (NWO-VIDI); German Federal Ministry of Education and Research (BMBF) [0313081F, 0315735]; German Research Foundation (DFG) [SFB773, A03]; CTMM; NIRM	Dutch Scientific Organisation (NWO-VIDI); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); CTMM; NIRM	We thank R. Korswagen for helpful discussions. K.E.v.d.V. was supported by a grant from the Dutch Scientific Organisation (NWO-VIDI), R.G. was supported by grants (0313081F and 0315735, Virtual Liver) from the German Federal Ministry of Education and Research (BMBF), T.P-C. was supported by the German Research Foundation (DFG; SFB773, A03), R.v.B. was supported by a grant from CTMM and L.P.V. was supported by a grant from NIRM.	Berlicki L, 2008, MINI-REV MED CHEM, V8, P869, DOI 10.2174/138955708785132800; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BRENNER S, 1974, GENETICS, V77, P71; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CALDENHOVEN E, 1995, J BIOL CHEM, V270, P25778, DOI 10.1074/jbc.270.43.25778; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; DEUEL TF, 1978, J BIOL CHEM, V253, P6111; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DORMAN JB, 1995, GENETICS, V141, P1399; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; FAHRNER J, 1993, EUR J BIOCHEM, V213, P1067, DOI 10.1111/j.1432-1033.1993.tb17854.x; Gaunitz F, 2001, BIOCHEM BIOPH RES CO, V284, P377, DOI 10.1006/bbrc.2001.4967; GEBHARDT R, 1983, EMBO J, V2, P567, DOI 10.1002/j.1460-2075.1983.tb01464.x; Guthke R, 2006, BIOPROC BIOSYST ENG, V28, P331, DOI 10.1007/s00449-005-0040-1; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krause U, 2002, EUR J BIOCHEM, V269, P3742, DOI 10.1046/j.1432-1033.2002.03069.x; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pfisterer SG, 2011, MOL PHARMACOL, V80, P1066, DOI 10.1124/mol.111.071761; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Raaben M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-221; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; SEGLEN PO, 1984, J CELL BIOL, V99, P435, DOI 10.1083/jcb.99.2.435; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tardito S, 2012, AMINO ACIDS, V42, P2507, DOI 10.1007/s00726-011-0981-4; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	55	174	177	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					829	U121		10.1038/ncb2536	http://dx.doi.org/10.1038/ncb2536			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22820375				2022-12-25	WOS:000307115900012
J	Berndsen, CE; Wiener, R; Yu, IW; Ringel, AE; Wolberger, C				Berndsen, Christopher E.; Wiener, Reuven; Yu, Ian W.; Ringel, Alison E.; Wolberger, Cynthia			A conserved asparagine has a structural role in ubiquitin-conjugating enzymes	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; E3 LIGASE; INSIGHTS; REVEALS; HEXOKINASE; ACTIVATION; MECHANISM; COMPLEX	It is widely accepted that ubiquitin-conjugating enzymes contain an active site asparagine that serves as an oxyanion hole, thereby stabilizing a negatively charged transition state intermediate and promoting ubiquitin transfer. Using structural and biochemical approaches to study the role of the conserved asparagine to ubiquitin conjugation by Ubc13-Mms2, we conclude that the importance of this residue stems primarily from its structural role in stabilizing an active site loop.	[Berndsen, Christopher E.; Wiener, Reuven; Yu, Ian W.; Ringel, Alison E.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Berndsen, Christopher E.; Wiener, Reuven; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969; Ringel, Alison/0000-0002-6451-9376; Berndsen, Christopher/0000-0002-4285-4341	US National Science Foundation [MCB-0920082]; Ruth Kirchstein Fellowship from the National Institute of General Medical Science [F32GM089037]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089037] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Ruth Kirchstein Fellowship from the National Institute of General Medical Science; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hurley (National Institute of Diabetes and Digestive and Kidney Diseases) for the UbcI3-Mms2 coexpression plasmid and X. Zhang (Johns Hopkins University) for human El protein. We also thank J. Stivers, A. Hengge and L. Spyracopoulos for helpful discussions. This work was supported in part by a grant from the US National Science Foundation (MCB-0920082). C.E.B. was supported in part by a Ruth Kirchstein Fellowship from the National Institute of General Medical Science (F32GM089037). General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BRUICE TC, 1960, P NATL ACAD SCI USA, V46, P402, DOI 10.1073/pnas.46.4.402; Carlile CM, 2009, J BIOL CHEM, V284, P29326, DOI 10.1074/jbc.M109.043885; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; WILKINSON KD, 1981, J BIOL CHEM, V256, P9890; WILKINSON KD, 1979, J BIOL CHEM, V254, P2567; Wu PY, 2007, EMBO J, V26, P4051, DOI 10.1038/sj.emboj.7601829; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	22	49	49	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2013	9	3					154	156		10.1038/NCHEMBIO.1159	http://dx.doi.org/10.1038/NCHEMBIO.1159			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	092OW	23292652	Green Accepted			2022-12-25	WOS:000315132900008
J	Tsai, JJ; Dudakov, JA; Takahashi, K; Shieh, JH; Velardi, E; Holland, AM; Singer, NV; West, ML; Smith, OM; Young, LF; Shono, Y; Ghosh, A; Hanash, AM; Tran, HT; Moore, MAS; van den Brink, MRM				Tsai, Jennifer J.; Dudakov, Jarrod A.; Takahashi, Koichi; Shieh, Jae-Hung; Velardi, Enrico; Holland, Amanda M.; Singer, Natalie V.; West, Mallory L.; Smith, Odette M.; Young, Lauren F.; Shono, Yusuke; Ghosh, Arnab; Hanash, Alan M.; Tran, Hien T.; Moore, Malcolm A. S.; van den Brink, Marcel R. M.			Nrf2 regulates haematopoietic stem cell function	NATURE CELL BIOLOGY			English	Article							SIGNALING PATHWAY; OXIDATIVE STRESS; GENE; INHIBITION	Coordinating the balance between haematopoietic stem cell (HSC) quiescence and self-renewal is crucial for maintaining haematopoiesis lifelong. Equally important for haematopoietic function is modulating HSC localization within the bone marrow niches, as maintenance of HSC function is tightly controlled by a complex network of intrinsic molecular mechanisms and extrinsic signalling interactions with their surrounding microenvironment(1). In this study we demonstrate that nuclear factor erythroid 2-related factor 2 (Nfe212, or Nrf2), well established as a global regulator of the oxidative stress response, plays a regulatory role in several aspects of HSC homeostasis. Nrf2 deficiency results in an expansion of the haematopoietic stem and progenitor cell compartment due to cell-intrinsic hyperproliferation, which was accomplished at the expense of HSC quiescence and self-renewal. We further show that Nrf2 modulates both migration and retention of HSCs in their niche. Moreover, we identify a previously unrecognized link between Nrf2 and CXCR4, contributing, at least partially, to the maintenance of HSC function.	[Tsai, Jennifer J.; Dudakov, Jarrod A.; Takahashi, Koichi; Velardi, Enrico; Holland, Amanda M.; Singer, Natalie V.; West, Mallory L.; Smith, Odette M.; Young, Lauren F.; Shono, Yusuke; Ghosh, Arnab; Hanash, Alan M.; Tran, Hien T.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA; [Tsai, Jennifer J.; Dudakov, Jarrod A.; Takahashi, Koichi; Velardi, Enrico; Holland, Amanda M.; Singer, Natalie V.; West, Mallory L.; Smith, Odette M.; Young, Lauren F.; Shono, Yusuke; Ghosh, Arnab; Hanash, Alan M.; Tran, Hien T.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Tsai, Jennifer J.; Holland, Amanda M.] Weill Cornell Grad Sch Med Sci, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Dudakov, Jarrod A.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia; [Shieh, Jae-Hung; Moore, Malcolm A. S.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Velardi, Enrico] Univ Perugia, Dept Clin & Expt Med, I-06122 Perugia, Italy	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Monash University; Memorial Sloan Kettering Cancer Center; University of Perugia	van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA.	m-van-den-brink@ski.mskcc.org	Velardi, Enrico/AAB-7443-2019; van den Brink, Marcel R. M./HGB-9434-2022; velardi, Enrico/AAC-5440-2022	Velardi, Enrico/0000-0001-8383-0453; Dudakov, Jarrod/0000-0001-6220-5632; Ghosh, Arnab/0000-0003-3355-5427	National Institutes of Health [RO1-HL069929, R01-AI100288, R01-AI080455, R01-AI101406, P01-CA023766]; Radiation Effects Research Foundation (RERF-NIAID); W. H. Goodwin and A. Goodwin; The Lymphoma Foundation; Alex's Lemonade Stand; The Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; The Peter Solomon Fund; Australian National Health and Medical Research Council Biomedical Training Fellowship; Leukemia and Lymphoma Society; Italian Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100288, R01AI101406, R01AI080455] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radiation Effects Research Foundation (RERF-NIAID); W. H. Goodwin and A. Goodwin; The Lymphoma Foundation; Alex's Lemonade Stand; The Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; The Peter Solomon Fund; Australian National Health and Medical Research Council Biomedical Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank). Chan (University of California, Irvine, USA) for providing the Nrf2<SUP>-/-</SUP> mice; the staff of the Memorial Sloan-Kettering Cancer Center Research Animal Resources Center for excellent animal care; and the staff of the Flow Cytometry Core Facility and M. S. Jiao of the Comparative Pathology Laboratories for assistance with sample preparation. This research was supported by National Institutes of Health award numbers RO1-HL069929 (M.R.M.v.d.B.), R01-AI100288 (M.R.M.v.d.B.), R01-AI080455 (M.R.M.v.d.B.), R01-AI101406 (M.R.M.v.d.B.) and P01-CA023766 (ROR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Support was also received from the Radiation Effects Research Foundation (RERF-NIAID; M.R.M.v.d.B.), The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by W. H. Goodwin and A. Goodwin, The Lymphoma Foundation, Alex's Lemonade Stand, The Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center, and The Peter Solomon Fund. J.A.D. was supported by an Australian National Health and Medical Research Council Biomedical Training Fellowship and a Research Fellowship from the Leukemia and Lymphoma Society. E.V. was supported by a fellowship from the Italian Foundation for Cancer Research.	Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kuroha T, 1998, J BIOCHEM-TOKYO, V123, P376; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2010, BLOOD, V115, P677, DOI 10.1182/blood-2009-05-223107; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Papaconstantinou J, 2009, MOL CELL ENDOCRINOL, V299, P89, DOI 10.1016/j.mce.2008.11.025; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	30	145	150	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					309	316		10.1038/ncb2699	http://dx.doi.org/10.1038/ncb2699			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23434824	Green Accepted			2022-12-25	WOS:000315844900012
J	Dong, Y; Xie, M; Jiang, Y; Xiao, NQ; Du, XY; Zhang, WG; Tosser-Klopp, G; Wang, JH; Yang, S; Liang, J; Chen, WB; Chen, J; Zeng, P; Hou, Y; Bian, C; Pan, SK; Li, YX; Liu, X; Wang, WL; Servin, B; Sayre, B; Zhu, B; Sweeney, D; Moore, R; Nie, WH; Shen, YY; Zhao, RP; Zhang, GJ; Li, JQ; Faraut, T; Womack, J; Zhang, YP; Kijas, J; Cockett, N; Xu, X; Zhao, SH; Wang, J; Wang, W				Dong, Yang; Xie, Min; Jiang, Yu; Xiao, Nianqing; Du, Xiaoyong; Zhang, Wenguang; Tosser-Klopp, Gwenola; Wang, Jinhuan; Yang, Shuang; Liang, Jie; Chen, Wenbin; Chen, Jing; Zeng, Peng; Hou, Yong; Bian, Chao; Pan, Shengkai; Li, Yuxiang; Liu, Xin; Wang, Wenliang; Servin, Bertrand; Sayre, Brian; Zhu, Bin; Sweeney, Deacon; Moore, Rich; Nie, Wenhui; Shen, Yongyi; Zhao, Ruoping; Zhang, Guojie; Li, Jinquan; Faraut, Thomas; Womack, James; Zhang, Yaping; Kijas, James; Cockett, Noelle; Xu, Xun; Zhao, Shuhong; Wang, Jun; Wang, Wen			Sequencing and automated whole-genome optical mapping of the genome of a domestic goat (Capra hircus)	NATURE BIOTECHNOLOGY			English	Article							RETINOIC ACID; HAIR; CHROMOSOME; EVOLUTION; VALIDATION; ORIGINS; GROWTH; MILK; MAPS	We report the similar to 2.66-Gb genome sequence of a female Yunnan black goat. The sequence was obtained by combining short-read sequencing data and optical mapping data from a high-throughput whole-genome mapping instrument. The whole-genome mapping data facilitated the assembly of super-scaffolds >5x longer by the N50 metric than scaffolds augmented by fosmid end sequencing (scaffold N50 = 3.06 Mb, super-scaffold N50 = 16.3 Mb). Super-scaffolds are anchored on chromosomes based on conserved synteny with cattle, and the assembly is well supported by two radiation hybrid maps of chromosome 1. We annotate 22,175 protein-coding genes, most of which were recovered in the RNA-seq data of ten tissues. Comparative transcriptomic analysis of the primary and secondary follicles of a cashmere goat reveal 51 genes that are differentially expressed between the two types of hair follicles. This study, whose results will facilitate goat genomics, shows that whole-genome mapping technology can be used for the de novo assembly of large genomes.	[Dong, Yang; Jiang, Yu; Zhang, Wenguang; Wang, Jinhuan; Nie, Wenhui; Shen, Yongyi; Zhao, Ruoping; Zhang, Yaping; Xu, Xun; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Dong, Yang; Shen, Yongyi; Xu, Xun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xie, Min; Yang, Shuang; Liang, Jie; Chen, Wenbin; Chen, Jing; Zeng, Peng; Hou, Yong; Bian, Chao; Pan, Shengkai; Li, Yuxiang; Liu, Xin; Wang, Wenliang; Zhang, Guojie; Xu, Xun; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Du, Xiaoyong; Zhao, Shuhong] Huazhong Agr Univ, Wuhan, Peoples R China; [Jiang, Yu; Kijas, James] CSIRO Livestock Ind, St Lucia, Qld, Australia; [Zhang, Wenguang; Li, Jinquan] Inner Mongolia Agr Univ, Hohhot, Peoples R China; [Tosser-Klopp, Gwenola; Servin, Bertrand; Faraut, Thomas] INRA, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; [Cockett, Noelle] Utah State Univ, Logan, UT 84322 USA; [Womack, James] Texas A&M Univ, College Stn, TX USA; [Xiao, Nianqing; Zhu, Bin; Sweeney, Deacon; Moore, Rich] OpGen Inc, Gaithersburg, MD USA; [Sayre, Brian] Virginia State Univ, Petersburg, VA 23806 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Huazhong Agricultural University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Inner Mongolia Agricultural University; INRAE; Utah System of Higher Education; Utah State University; Texas A&M University System; Texas A&M University College Station; Virginia State University	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	xuxun@genomics.cn; shzhao@mail.hzau.edu.cn; wangj@genomics.cn; wwang@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022; Zhang, Guojie/J-7273-2019; Zhang, Guojie/B-6188-2014; Sayre, Brian/V-7889-2019; Servin, Bertrand/B-2206-2008; Jiang, Yu/O-5114-2015; XIE, MIN/P-8062-2019; Wang, Wen/AAP-9873-2020; Li, yu/HHZ-5236-2022; Kijas, James W/A-4656-2011; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Servin, Bertrand/0000-0001-5141-0913; Jiang, Yu/0000-0003-4821-3585; XIE, MIN/0000-0002-5652-5039; Kijas, James W/0000-0002-1417-8278; Xu, Xun/0000-0002-5338-5173; hou, yong/0000-0002-0420-0726; Wang, Jun/0000-0002-8540-8931; Shen, Yongyi/0000-0001-7660-5522; Bian, Chao/0000-0001-9904-721X; Liu, Xin/0000-0003-3256-2940; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673; Wang, Wen/0000-0002-7801-2066; Wang, Jun/0000-0002-2113-5874	CAS [KSZD-EW-Z-005]; Chinese 973 programs [2007CB815700]; National Natural Science Foundation of China [30960246, 31260538]; Shenzhen Municipal Government; Yantian District local government of Shenzhen; CAS-Max Planck Society Fellowship; CAS	CAS(Chinese Academy of Sciences); Chinese 973 programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government; Yantian District local government of Shenzhen; CAS-Max Planck Society Fellowship(Max Planck Society); CAS(Chinese Academy of Sciences)	This work was supported by the key project of CAS (KSZD-EW-Z-005), Chinese 973 programs (2007CB815700), the National Natural Science Foundation of China (30960246 and 31260538), the Shenzhen Municipal Government and the Yantian District local government of Shenzhen, and a CAS-Max Planck Society Fellowship and the 100 talent program of CAS to W.W. and Jun W.	Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Anantharaman T, 1999, Proc Int Conf Intell Syst Mol Biol, P18; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; EBERT KM, 1991, BIO-TECHNOL, V9, P835, DOI 10.1038/nbt0991-835; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gao JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-466; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Hanakawa Y, 2004, J INVEST DERMATOL, V123, P817, DOI 10.1111/j.0022-202X.2004.23479.x; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Iannuzzi L, 2009, CYTOGENET GENOME RES, V126, P49, DOI 10.1159/000245906; IBRAHEEM M, 1994, J ANAT, V185, P135; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Ko JH, 2000, TRANSGENIC RES, V9, P215, DOI 10.1023/A:1008972010351; LEFEBVRE PP, 1993, SCIENCE, V260, P692, DOI 10.1126/science.8480180; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lim A, 2001, GENOME RES, V11, P1584, DOI 10.1101/gr.172101; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Rogers MA, 2005, J INVEST DERMATOL, V124, pVII, DOI 10.1111/j.0022-202X.2005.23728.x; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schlake T, 2005, DEVELOPMENT, V132, P2981, DOI 10.1242/dev.01873; SUN TT, 1983, J INVEST DERMATOL, V81, pS109, DOI 10.1111/1523-1747.ep12540831; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; VIALLET JP, 1994, DEV BIOL, V166, P277, DOI 10.1006/dbio.1994.1314; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; WEI FS, 2009, PLOS GENET, V5; White C., 1840, CASHMERE SHAWL E FIC, V1; Wu CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-25; WURSTER DH, 1968, CHROMOSOMA, V25, P152, DOI 10.1007/BF00327175; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zhang Dongliang, 2011, Indian J Dermatol, V56, P14, DOI 10.4103/0019-5154.77544; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhou S., 2009, PLOS GENET, V5; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278	42	329	365	8	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					135	141		10.1038/nbt.2478	http://dx.doi.org/10.1038/nbt.2478			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23263233	hybrid			2022-12-25	WOS:000315322100024
J	LeBleu, VS; Teng, YQ; O'Connell, JT; Charytan, D; Muller, GA; Muller, CA; Sugimoto, H; Kalluri, R				LeBleu, Valerie S.; Teng, Yingqi; O'Connell, Joyce T.; Charytan, David; Mueller, Gerhard A.; Mueller, Claudia A.; Sugimoto, Hikaru; Kalluri, Raghu			Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis	NATURE MEDICINE			English	Article							RENAL INTERSTITIAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; HE-4; INHIBITORS; MECHANISMS; EXPRESSION; HOMOLOGY; TISSUES; ORIGIN; LOCUS	The functional contribution of myofibroblasts in fibrosis is not well understood(1-3). Using a new genetic mouse model to track and isolate myofibroblasts, we performed gene expression profiling followed by biological validation to identify HE4 (encoding human epididymis protein 4, also known as WAP 4-disulfide core domain-2 or Wfdc2) as the most upregulated gene in fibrosis-associated myofibroblasts. The HE4 gene encodes for a putative serine protease inhibitor that is upregulated in human and mouse fibrotic kidneys and is elevated in the serum of patients with kidney fibrosis. HE4 suppresses the activity of multiple proteases, including serine proteases and matrix metalloproteinases, and specifically inhibits their capacity to degrade type I collagen. In particular, we identified two serine proteases, Prss35 and Prss23, as HE4 targets with functional relevance in kidney fibrosis. Administration of HE4-neutralizing antibodies accelerated collagen I degradation and inhibited fibrosis in three different mouse models of renal disease. Collectively these studies suggest that HE4 is a potential biomarker of renal fibrosis and a new therapeutic target.	[LeBleu, Valerie S.; Teng, Yingqi; O'Connell, Joyce T.; Sugimoto, Hikaru; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Charytan, David] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Mueller, Gerhard A.; Mueller, Claudia A.] Univ Gottingen, Med Ctr, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kalluri, Raghu] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; University of Gottingen; Harvard University; Harvard Medical School; Harvard University; University of Texas System; UTMD Anderson Cancer Center	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	rkalluri@mdanderson.org	LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; charytan, david/0000-0002-7695-3583	US National Institutes of Health (NIH) [DK55001, DK081976, CA125550, CA155370, CA151925, CA163191, 2T32DK007760-11, 5T32HL007374-30, GM07226]; Harvard Stem Cell Institute; Metastasis Research Center at the MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Department of Defense [BC083229]; NATIONAL CANCER INSTITUTE [R01CA155370, U01CA151925, R01CA125550, U54CA163191] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055001, T32DK007760, R01DK081576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Metastasis Research Center at the MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US National Institutes of Health (NIH) grants DK55001, DK081976, CA125550, CA155370, CA151925 and CA163191, funding from the Harvard Stem Cell Institute, the Metastasis Research Center at the MD Anderson Cancer Center and the Cancer Prevention and Research Institute of Texas (all to R.K.). V.S.L. was funded from the NIH Research Training grant in Gastroenterology (2T32DK007760-11), H.S. was funded by the NIH Research Training grant in Cardiovascular Biology (5T32HL007374-30), and J.T.O. was funded by the NIH Cell and Development Biology Training grant GM07226 and the Department of Defense Breast Cancer Predoctoral Traineeship Award BC083229.	Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bignotti E, 2011, BRIT J CANCER, V104, P1418, DOI 10.1038/bjc.2011.109; Bingle L, 2002, ONCOGENE, V21, P2768, DOI 10.1038/sj.onc.1205363; Bingle L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-61; Bunnag S, 2009, J AM SOC NEPHROL, V20, P1149, DOI 10.1681/ASN.2008080863; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Clauss A, 2005, BIOCHEM BIOPH RES CO, V333, P383, DOI 10.1016/j.bbrc.2005.05.125; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Galgano MT, 2006, MODERN PATHOL, V19, P847, DOI 10.1038/modpathol.3800612; Greer KA, 2006, MAMM GENOME, V17, P976, DOI 10.1007/s00335-005-0179-8; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Kirchhoff C, 1998, REV REPROD, V3, P86; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Okada H, 1996, CONTRIB NEPHROL, V118, P147; Sivashanmugam P, 2003, GENE, V312, P125, DOI 10.1016/S0378-1119(03)00608-5; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Zeisberg M, 2000, J NEPHROL, V13, pS111; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB	26	131	142	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					227	231		10.1038/nm.2989	http://dx.doi.org/10.1038/nm.2989			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23353556	Green Accepted			2022-12-25	WOS:000314675900031
J	Palles, C; Cazier, JB; Howarth, KM; Domingo, E; Jones, AM; Broderick, P; Kemp, Z; Spain, SL; Almeida, EG; Salguero, I; Sherborne, A; Chubb, D; Carvajal-Carmona, LG; Ma, Y; Kaur, K; Dobbins, S; Barclay, E; Gorman, M; Martin, L; Kovac, MB; Humphray, S; Lucassen, A; Holmes, CC; Bentley, D; Donnelly, P; Taylor, J; Petridis, C; Roylance, R; Sawyer, EJ; Kerr, DJ; Clark, S; Grimes, J; Kearsey, SE; Thomas, HJW; McVean, G; Houlston, RS; Tomlinson, I				Palles, Claire; Cazier, Jean-Baptiste; Howarth, Kimberley M.; Domingo, Enric; Jones, Angela M.; Broderick, Peter; Kemp, Zoe; Spain, Sarah L.; Almeida, Estrella Guarino; Salguero, Israel; Sherborne, Amy; Chubb, Daniel; Carvajal-Carmona, Luis G.; Ma, Yusanne; Kaur, Kulvinder; Dobbins, Sara; Barclay, Ella; Gorman, Maggie; Martin, Lynn; Kovac, Michal B.; Humphray, Sean; Lucassen, Anneke; Holmes, Christopher C.; Bentley, David; Donnelly, Peter; Taylor, Jenny; Petridis, Christos; Roylance, Rebecca; Sawyer, Elinor J.; Kerr, David J.; Clark, Susan; Grimes, Jonathan; Kearsey, Stephen E.; Thomas, Huw J. W.; McVean, Gilean; Houlston, Richard S.; Tomlinson, Ian		CORGI Consortium; WGS500 Consortium	Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas	NATURE GENETICS			English	Article							DNA-POLYMERASE-DELTA; CANCER SUSCEPTIBILITY; EXCISION-REPAIR; MUTATOR; YEAST; PHENOTYPES; EPSILON; GENE	Many individuals with multiple or large colorectal adenomas or early-onset colorectal cancer (CRC) have no detectable germline mutations in the known cancer predisposition genes. Using whole-genome sequencing, supplemented by linkage and association analysis, we identified specific heterozygous POLE or POLD1 germline variants in several multiple-adenoma and/or CRC cases but in no controls. The variants associated with susceptibility, POLE p.Leu424Val and POLD1 p.Ser478Asn, have high penetrance, and POLD1 mutation was also associated with endometrial cancer predisposition. The mutations map to equivalent sites in the proofreading (exonuclease) domain of DNA polymerases E and 8 and are predicted to cause a defect in the correction of mispaired bases inserted during DNA replication. In agreement with this prediction, the tumors from mutation carriers were microsatellite stable but tended to acquire base substitution mutations, as confirmed by yeast functional assays. Further analysis of published data showed that the recently described group of hypermutant, microsatellite-stable CRCs is likely to be caused by somatic POLE mutations affecting the exonuclease domain.	[Palles, Claire; Howarth, Kimberley M.; Domingo, Enric; Jones, Angela M.; Kemp, Zoe; Spain, Sarah L.; Carvajal-Carmona, Luis G.; Barclay, Ella; Gorman, Maggie; Martin, Lynn; Kovac, Michal B.; Tomlinson, Ian] Univ Oxford, Mol & Populat Genet Lab, Wellcome Trust Ctr Human Genet, Oxford, England; [Cazier, Jean-Baptiste; Donnelly, Peter; McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Broderick, Peter; Sherborne, Amy; Chubb, Daniel; Ma, Yusanne; Dobbins, Sara; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Almeida, Estrella Guarino; Salguero, Israel; Kearsey, Stephen E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Kaur, Kulvinder; Taylor, Jenny; Tomlinson, Ian] Univ Oxford, Oxford Natl Inst Hlth Res NIHR Comprehens Biomed, Wellcome Trust Ctr Human Genet, Oxford, England; [Kovac, Michal B.] Univ Basel, Res Grp Human Genet, Dept Biomed, Basel, Switzerland; [Humphray, Sean; Bentley, David] Illumina Cambridge Ltd, Saffron Walden, England; [Lucassen, Anneke] Princess Anne Hosp, Wessex Reg Genet Lab, Southampton, Hants, England; [Holmes, Christopher C.; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Petridis, Christos; Sawyer, Elinor J.] Kings Coll London, Div Canc Studies, NIHR Comprehens Biomed Res Ctr, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust Par, London WC2R 2LS, England; [Roylance, Rebecca] Univ London, Inst Canc, Barts & London Med Sch, Queen Mary Coll, London, England; [Kerr, David J.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Clark, Susan] Univ London Imperial Coll Sci Technol & Med, Polyposis Registry, Sch Med, St Marks Hosp, Harrow, Middx, England; [Grimes, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England; [Grimes, Jonathan] Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England; [Thomas, Huw J. W.] Univ London Imperial Coll Sci Technol & Med, Family Canc Clin, Sch Med, St Marks Hosp, Harrow, Middx, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of London; Institute of Cancer Research - UK; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Basel; Illumina; University of Oxford; University of London; King's College London; University of London; Queen Mary University London; University of Oxford; Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source; Imperial College London	Tomlinson, I (corresponding author), Univ Oxford, Mol & Populat Genet Lab, Wellcome Trust Ctr Human Genet, Oxford, England.	iant@well.ox.ac.uk	Pinheiro, Maísa/E-7424-2012; Cazier, Jean-Baptiste/GLR-2949-2022; Kanapin, Alexander A/Q-7590-2016; Kovac, Michal/A-4027-2011; Domingo, Enric/A-9099-2018; Kovac, Michal/AAF-9605-2020; Evans, D Gareth/AAB-4308-2022; Humburg, Peter/A-4191-2009; wei, wei/HHR-8613-2022; Wilkie, Andrew/AAC-3820-2020; Knight, Julian Charles/W-2399-2019; Cazier, Jean-Baptiste/F-2369-2010; Carvajal-Carmona, Luis G/B-3882-2010; Spain, Sarah/G-1968-2010; Lucassen, Anneke/D-7764-2017	Cazier, Jean-Baptiste/0000-0001-7581-9051; Kanapin, Alexander A/0000-0001-9802-5297; Domingo, Enric/0000-0003-4390-8767; Kovac, Michal/0000-0003-4526-1071; Evans, D Gareth/0000-0002-8482-5784; Humburg, Peter/0000-0002-3331-6496; Wilkie, Andrew/0000-0002-2972-5481; Knight, Julian Charles/0000-0002-0377-5536; Cazier, Jean-Baptiste/0000-0001-7581-9051; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Spain, Sarah/0000-0002-7591-8364; Green, Andrew/0000-0002-0488-5913; McVean, Gil/0000-0002-5012-4162; Taylor, Jenny/0000-0003-3602-5704; Palles, Claire/0000-0002-9670-2263; Houlston, Richard/0000-0002-5268-0242; Lunter, Gerton/0000-0002-3798-2058; Kerr, David/0000-0001-7811-6722; Bishop, Tim/0000-0002-8752-8785; Broderick, Peter/0000-0002-8348-5829; Grimes, Jonathan Mark/0000-0001-9698-0389; Lucassen, Anneke/0000-0003-3324-4338	Cancer Research UK [C6199/A10417, C1298/A8362]; Oxford NIHR Comprehensive Biomedical Research Centre; Wellcome Trust [090532/Z/09/Z]; John Fell Oxford University Press (OUP) Research Fund; Junta de Extremadura, Spain (Consejeria de Economia, Comercio e Innovacion); European Union Seventh Framework Programme under FP7 collaborative project SYSCOL [FP7/207-2013, 258236]; Bobby Moore Fund; BBSRC [BB/I02593X/1] Funding Source: UKRI; MRC [MC_UP_A390_1107] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02593X/1] Funding Source: researchfish; Cancer Research UK [10589, 16459] Funding Source: researchfish; Medical Research Council [MC_UP_A390_1107] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Oxford NIHR Comprehensive Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); John Fell Oxford University Press (OUP) Research Fund; Junta de Extremadura, Spain (Consejeria de Economia, Comercio e Innovacion); European Union Seventh Framework Programme under FP7 collaborative project SYSCOL; Bobby Moore Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We are grateful to all the affected individuals and their relatives in the families studied and to those who have provided their medical care. We acknowledge the help of many colleagues who are part of the teams who work on the CORGI study. We acknowledge the use of DNA from the British 1958 Birth Cohort collection. This work was principally funded by Cancer Research UK (C6199/A10417) and the Oxford NIHR Comprehensive Biomedical Research Centre (to We also acknowledge core funding to the Wellcome Trust Centre for Human Genetics from the Wellcome Trust (090532/Z/09/Z). Work in the laboratory of R.S.H. is supported by funding from Cancer Research UK (C1298/A8362, supported by the Bobby Moore Fund). Work in the laboratory of S.E.K. was supported by project grants from Cancer Research UK and the John Fell Oxford University Press (OUP) Research Fund. We thank O. Fleck (University of Copenhagen) for fission yeast strains. I.S. is supported by a fellowship from the Junta de Extremadura, Spain (Consejeria de Economia, Comercio e Innovacion). R.S.H. and I.T. acknowledge funding from the European Union Seventh Framework Programme (FP7/207-2013) under grant 258236, FP7 collaborative project SYSCOL.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Bellacosa A, 2001, CELL DEATH DIFFER, V8, P1076, DOI 10.1038/sj.cdd.4400948; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; DACOSTA LT, 1995, NAT GENET, V9, P10, DOI 10.1038/ng0195-10; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Fleck O, 1999, NAT GENET, V21, P314, DOI 10.1038/6838; Flohr T, 1999, INT J CANCER, V80, P919, DOI 10.1002/(SICI)1097-0215(19990315)80:6<919::AID-IJC19>3.0.CO;2-U; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Hindges R, 1997, BIOL CHEM, V378, P345; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jones AM, 2007, J PATHOL, V213, P249, DOI 10.1002/path.2234; Kemp Z, 2006, HUM MOL GENET, V15, P2903, DOI 10.1093/hmg/ddl231; LANSPA SJ, 1990, GASTROENTEROLOGY, V98, P1117, DOI 10.1016/0016-5085(90)90323-S; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Murphy K, 2006, GENOME, V49, P403, DOI 10.1139/G05-106; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Papaemmanuil E, 2008, EUR J HUM GENET, V16, P1477, DOI 10.1038/ejhg.2008.129; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Yoshida R, 2011, EUR J HUM GENET, V19, P320, DOI 10.1038/ejhg.2010.216	29	650	670	0	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					136	144		10.1038/ng.2503	http://dx.doi.org/10.1038/ng.2503			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23263490	Green Accepted, Green Submitted			2022-12-25	WOS:000314333000008
J	Robinson, DR; Wu, YM; Kalyana-Sundaram, S; Cao, XH; Lonigro, RJ; Sung, YS; Chen, CL; Zhang, L; Wang, R; Su, FY; Iyer, MK; Roychowdhury, S; Siddiqui, J; Pienta, KJ; Kunju, LP; Talpaz, M; Mosquera, JM; Singer, S; Schuetze, SM; Antonescu, CR; Chinnaiyan, AM				Robinson, Dan R.; Wu, Yi-Mi; Kalyana-Sundaram, Shanker; Cao, Xuhong; Lonigro, Robert J.; Sung, Yun-Shao; Chen, Chun-Liang; Zhang, Lei; Wang, Rui; Su, Fengyun; Iyer, Matthew K.; Roychowdhury, Sameek; Siddiqui, Javed; Pienta, Kenneth J.; Kunju, Lakshmi P.; Talpaz, Moshe; Mosquera, Juan Miguel; Singer, Samuel; Schuetze, Scott M.; Antonescu, Cristina R.; Chinnaiyan, Arul M.			Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing	NATURE GENETICS			English	Article							EXPRESSION; NAB2; TRANSCRIPTION; COREPRESSOR; SPECTRUM; CELLS; EGR-1	A 44-year old woman with recurrent solitary fibrous tumor (SFT)/hemangiopericytoma was enrolled in a clinical sequencing program including whole-exome and transcriptome sequencing. A gene fusion of the transcriptional repressor NAB2 with the transcriptional activator STAT6 was detected. Transcriptome sequencing of 27 additional SFTs identified the presence of a NAB2-STAT6 gene fusion in all tumors. Using RT-PCR and sequencing, we detected this fusion in all 51 SFTs, indicating high levels of recurrence. Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6. Overexpression of the NAB2-STAT6 gene fusion induced proliferation in cultured cells and activated the expression of EGR-responsive genes. These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.	[Robinson, Dan R.; Wu, Yi-Mi; Kalyana-Sundaram, Shanker; Cao, Xuhong; Lonigro, Robert J.; Wang, Rui; Su, Fengyun; Iyer, Matthew K.; Roychowdhury, Sameek; Siddiqui, Javed; Pienta, Kenneth J.; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan R.; Wu, Yi-Mi; Kalyana-Sundaram, Shanker; Wang, Rui; Su, Fengyun; Siddiqui, Javed; Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Kalyana-Sundaram, Shanker] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Lonigro, Robert J.; Pienta, Kenneth J.; Talpaz, Moshe; Schuetze, Scott M.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI USA; [Sung, Yun-Shao; Chen, Chun-Liang; Zhang, Lei; Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Iyer, Matthew K.; Chinnaiyan, Arul M.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Roychowdhury, Sameek; Pienta, Kenneth J.; Talpaz, Moshe; Schuetze, Scott M.] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA; [Pienta, Kenneth J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Mosquera, Juan Miguel] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Bharathidasan University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; Memorial Sloan Kettering Cancer Center	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	antonesc@mskcc.org; arul@umich.edu	; Pienta, Kenneth/E-7679-2015	Talpaz, Moshe/0000-0003-3361-3981; Singer, Samuel/0000-0001-9713-8230; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Pienta, Kenneth/0000-0002-4138-2186	National Cancer Institute (NCI) Early Detection Research Network [U01 CA111275]; National Functional Genomics Center [W81XWH-11-1-0520]; US Department of Defense; US National Institutes of Health through the University of Michigan's Cancer Center Support Grant [5 P30 CA46592, PO1 CA047179-15A2, P50 CA 140146-01]; Linn Fund; Cycle for Survival; Alan Rosenthal Research Fund for research in sarcoma; Weinstein Solitary Fibrous Tumor Research Fund; Doris Duke Charitable Foundation Clinical Scientist Award; Burroughs Wellcome Foundation Award in Clinical Translational Research; NATIONAL CANCER INSTITUTE [U01CA111275, P30CA008748, P30CA046592, P50CA069568, P50CA140146, P01CA047179] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Functional Genomics Center; US Department of Defense(United States Department of Defense); US National Institutes of Health through the University of Michigan's Cancer Center Support Grant; Linn Fund; Cycle for Survival; Alan Rosenthal Research Fund for research in sarcoma; Weinstein Solitary Fibrous Tumor Research Fund; Doris Duke Charitable Foundation Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Foundation Award in Clinical Translational Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank T. Barrette for hardware and database management, S. Birkeland, M. Pierce-Burlingame and K. Giles for assistance with sample and manuscript preparation and X. Jing for carrying out microarray experiments. We also thank the larger MI-ONCOSEQ team, including cancer geneticists S. Gruber and J. Innis; bioethicists J.S. Roberts and S.Y. Kim; genetic counselors J. Everett, J. Long and V. Raymond; and radiologists E. Higgins, E. Caoili and R. Dunnick. M. Quist performed initial SNV analysis. L. Sam, A. Balbin and P. Vats assisted with bioinformatics analysis. This project was supported in part by the National Cancer Institute (NCI) Early Detection Research Network (U01 CA111275), the National Functional Genomics Center (W81XWH-11-1-0520) and the US Department of Defense (A.M.C.). Additional infrastructure support was generously provided by the Prostate Cancer Foundation. The work was also supported in part by the US National Institutes of Health through the University of Michigan's Cancer Center Support Grant (5 P30 CA46592) and grants PO1 CA047179-15A2 (C.R.A. and S.S.) and P50 CA 140146-01 (C.R.A. and S.S.); the Linn Fund and Cycle for Survival (C.R.A.); the Alan Rosenthal Research Fund for research in sarcoma (C.R.A.); and the Weinstein Solitary Fibrous Tumor Research Fund (C.R.A.). A.M.C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award and a Burroughs Wellcome Foundation Award in Clinical Translational Research. A.M.C. is an American Cancer Society Research Professor and an A. Alfred Taubman Scholar.	Aparicio SAJR, 2010, J PATHOL, V220, P307, DOI 10.1002/path.2636; Gold JS, 2002, CANCER, V94, P1057, DOI 10.1002/cncr.10328; Hajdu M, 2010, J PATHOL, V221, P300, DOI 10.1002/path.2715; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mosquera JM, 2009, AM J SURG PATHOL, V33, P1314, DOI 10.1097/PAS.0b013e3181a6cd33; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Park MS, 2009, CURR OPIN ONCOL, V21, P327, DOI 10.1097/CCO.0b013e32832c9532; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Stacchiotti S, 2010, MOL CANCER THER, V9, P1286, DOI 10.1158/1535-7163.MCT-09-1205; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	18	465	501	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					180	185		10.1038/ng.2509	http://dx.doi.org/10.1038/ng.2509			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313952	Green Accepted			2022-12-25	WOS:000314333000013
J	Kim, KH; Jeong, YT; Oh, H; Kim, SH; Cho, JM; Kim, YN; Kim, SS; Kim, DH; Hur, KY; Kim, HK; Ko, T; Han, J; Kim, HL; Kim, J; Back, SH; Komatsu, M; Chen, HC; Chan, DC; Konishi, M; Itoh, N; Choi, CS; Lee, MS				Kim, Kook Hwan; Jeong, Yeon Taek; Oh, Hyunhee; Kim, Seong Hun; Cho, Jae Min; Kim, Yo-Na; Kim, Su Sung; Kim, Do Hoon; Hur, Kyu Yeon; Kim, Hyoung Kyu; Ko, TaeHee; Han, Jin; Kim, Hong Lim; Kim, Jin; Back, Sung Hoon; Komatsu, Masaaki; Chen, Hsiuchen; Chan, David C.; Konishi, Morichika; Itoh, Nobuyuki; Choi, Cheol Soo; Lee, Myung-Shik			Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine	NATURE MEDICINE			English	Article							GROWTH-FACTOR 21; INTEGRATED STRESS-RESPONSE; INDUCED HEPATIC STEATOSIS; BETA-CELL MASS; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; ACID-METABOLISM; KNOCKOUT MICE; FATTY-ACIDS	Despite growing interest and a recent surge in papers, the role of autophagy in glucose and lipid metabolism is unclear. We produced mice with skeletal muscle specific deletion of Atg7 (encoding autophagy-related 7). Unexpectedly, these mice showed decreased fat mass and were protected from diet-induced obesity and insulin resistance; this phenotype was accompanied by increased fatty acid oxidation and browning of white adipose tissue (WAT) owing to induction of fibroblast growth factor 21 (Fgf21). Mitochondrial dysfunction induced by autophagy deficiency increased Fgf21 expression through induction of Atf4, a master regulator of the integrated stress response. Mitochondrial respiratory chain inhibitors also induced Fgf21 in an Atf4-dependent manner. We also observed induction of Fgf21, resistance to diet-induced obesity and amelioration of insulin resistance in mice with autophagy deficiency in the liver, another insulin target tissue. These findings suggest that autophagy deficiency and subsequent mitochondrial dysfunction promote Fgf21 expression, a hormone we consequently term a 'mitokine', and together these processes promote protection from diet-induced obesity and insulin resistance.	[Kim, Kook Hwan; Jeong, Yeon Taek; Cho, Jae Min; Kim, Do Hoon; Hur, Kyu Yeon; Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kim, Kook Hwan; Kim, Seong Hun; Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Oh, Hyunhee; Kim, Yo-Na; Kim, Su Sung; Choi, Cheol Soo] Gachon Univ, Grad Sch Med, Korea Mouse Metab Phenotyping Ctr, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Hyoung Kyu; Ko, TaeHee; Han, Jin] Inje Univ, FIRST Mitochondrial Res Grp, Natl Res Lab Mitochondrial Signaling, Dept Physiol,Coll Med,Cardiovasc & Metab Dis Ctr, Pusan, South Korea; [Kim, Hong Lim] Catholic Univ Korea, Coll Med, Integrat Res Support Ctr, Seoul, South Korea; [Kim, Jin] Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Jin] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Seoul, South Korea; [Back, Sung Hoon] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Tokyo 113, Japan; [Chen, Hsiuchen; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo 658, Japan; [Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genet Biochem, Kyoto, Japan; [Choi, Cheol Soo] Gachon Univ, Grad Sch Med, Gil Med Ctr, Dept Internal Med, Inchon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Gachon University; Inje University; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of Ulsan; Tokyo Metropolitan Institute of Medical Science; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Kobe Pharmaceutical University; Kyoto University; Gachon University	Choi, CS (corresponding author), Gachon Univ, Grad Sch Med, Korea Mouse Metab Phenotyping Ctr, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	cschoi@gachon.ac.kr; mslee0923@skku.edu	Lee, Myung Shik/C-9606-2011; Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Kim, Hyoung Kyu/0000-0002-1791-7865; Kim, Kook Hwan/0000-0003-2702-9156	Global Research Laboratory Grant of the National Research Foundation of Korea [K21004000003-10A0500-00310]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea [A080967, A102060]; Bio RD Program [2008-04090]; Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea [20110019335]	Global Research Laboratory Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea; Bio RD Program; Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea	We thank S.R. Farmer (Boston University) for pGL3B-Fgf21 (-1370/+129), D. Ron (University of Cambridge) for Atf4-null MEFs, R.J. Kaufman (University of Michigan Medical Center) for Eif2a<SUP>S/S</SUP> and Eif2a<SUP>A/A</SUP> MEFs, S.J. Burden (New York University) for Mlc1f-Cre mice, N. Mizushima (Tokyo Medical and Dental University) for Tet-off Atg5-null MEFs, and H.W. Virgin for insightful comments on the manuscript. This study was supported by the Global Research Laboratory Grant of the National Research Foundation of Korea (K21004000003-10A0500-00310 to M.-S.L. and M. Komatsu) and the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea (A080967 to M.-S.L. and A102060 to C.S.C). M.-S.L. received the Bio R&D Program (2008-04090) and the Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea (20110019335).	BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; DANFORTH E, 1984, CLIN ENDOCRINOL META, V13, P581, DOI 10.1016/S0300-595X(84)80039-0; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shibata M, 2009, BIOCHEM BIOPH RES CO, V382, P419, DOI 10.1016/j.bbrc.2009.03.039; Silva JM, 2009, NEUROBIOL DIS, V34, P357, DOI 10.1016/j.nbd.2009.02.005; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Tschop M., 2001, NAT METHODS, V9, P57; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	57	559	580	6	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					83	92		10.1038/nm.3014	http://dx.doi.org/10.1038/nm.3014			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202295				2022-12-25	WOS:000313230300029
J	[Anonymous]				[Anonymous]			Unlocking the mysterious mechanisms of Myc	NATURE MEDICINE			English	Editorial Material							C-MYC; CELLS; P15(INK4B); EXPRESSION; TARGET; MIZ-1; GENE							Dang, Chi/0000-0002-4031-2522				Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Haggerty TJ, 2003, P NATL ACAD SCI USA, V100, P5313, DOI 10.1073/pnas.0931346100; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Sloan Elizabeth J, 2010, Genes Cancer, V1, P587, DOI 10.1177/1947601910377489; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710	15	10	10	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					26	26						1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296005				2022-12-25	WOS:000313230300016
J	Ge, W; Wolf, A; Feng, TS; Ho, CH; Sekirnik, R; Zayer, A; Granatino, N; Cockman, ME; Loenarz, C; Loik, ND; Hardy, AP; Claridge, TDW; Hamed, RB; Chowdhury, R; Gong, LZ; Robinson, CV; Trudgian, DC; Jiang, M; Mackeen, MM; Mccullagh, JS; Gordiyenko, Y; Thalhammer, A; Yamamoto, A; Yang, M; Liu-Yi, P; Zhang, ZH; Schmidt-Zachmann, M; Kessler, BM; Ratcliffe, PJ; Preston, GM; Coleman, ML; Schofield, CJ				Ge, Wei; Wolf, Alexander; Feng, Tianshu; Ho, Chia-hua; Sekirnik, Rok; Zayer, Adam; Granatino, Nicolas; Cockman, Matthew E.; Loenarz, Christoph; Loik, Nikita D.; Hardy, Adam P.; Claridge, Timothy D. W.; Hamed, Refaat B.; Chowdhury, Rasheduzzaman; Gong, Lingzhi; Robinson, Carol V.; Trudgian, David C.; Jiang, Miao; Mackeen, Mukram M.; Mccullagh, James S.; Gordiyenko, Yuliya; Thalhammer, Armin; Yamamoto, Atsushi; Yang, Ming; Liu-Yi, Phebee; Zhang, Zhihong; Schmidt-Zachmann, Marion; Kessler, Benedikt M.; Ratcliffe, Peter J.; Preston, Gail M.; Coleman, Mathew L.; Schofield, Christopher J.			Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans	NATURE CHEMICAL BIOLOGY			English	Article							MYC TARGET GENE; LUNG-CANCER; JMJC-DOMAIN; CELL CARCINOMA; MINA53; PROTEIN; RNA; IDENTIFICATION; EXPRESSION; MDIG	The finding that oxygenase-catalyzed protein hydroxylation regulates animal transcription raises questions as to whether the translation machinery and prokaryotic proteins are analogously modified. Escherichia coli ycfD is a growth-regulating 2-oxoglutarate oxygenase catalyzing arginyl hydroxylation of the ribosomal protein Rpl16. Human ycfD homologs, Myc-induced nuclear antigen (MINA53) and NO66, are also linked to growth and catalyze histidyl hydroxylation of Rpl27a and Rpl8, respectively. This work reveals new therapeutic possibilities via oxygenase inhibition and by targeting modified over unmodified ribosomes.	[Ge, Wei; Wolf, Alexander; Ho, Chia-hua; Sekirnik, Rok; Granatino, Nicolas; Loenarz, Christoph; Loik, Nikita D.; Hardy, Adam P.; Claridge, Timothy D. W.; Hamed, Refaat B.; Chowdhury, Rasheduzzaman; Gong, Lingzhi; Robinson, Carol V.; Jiang, Miao; Mackeen, Mukram M.; Mccullagh, James S.; Gordiyenko, Yuliya; Thalhammer, Armin; Zhang, Zhihong; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England; [Ge, Wei; Wolf, Alexander; Ho, Chia-hua; Sekirnik, Rok; Granatino, Nicolas; Loenarz, Christoph; Loik, Nikita D.; Hardy, Adam P.; Claridge, Timothy D. W.; Hamed, Refaat B.; Chowdhury, Rasheduzzaman; Gong, Lingzhi; Robinson, Carol V.; Jiang, Miao; Mackeen, Mukram M.; Mccullagh, James S.; Gordiyenko, Yuliya; Thalhammer, Armin; Zhang, Zhihong; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Trudgian, David C.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Trudgian, David C.] Univ Texas SW Med Ctr Dallas, Prote Core, Dallas, TX 75390 USA; [Schmidt-Zachmann, Marion] German Canc Res Ctr, Clin Cooperat Unit Mol Hematol Oncol, D-6900 Heidelberg, Germany; [Preston, Gail M.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford; University of Oxford; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, Oxford, England.	mcoleman@well.ox.ac.uk; christopher.schofield@chem.ox.ac.uk	Chowdhury, Rashed/I-7697-2014; Cockman, Matthew/V-9619-2019; Hamed, Refaat/K-5669-2019; Trudgian, David/D-4785-2012; Wolf, Alexander/K-2178-2013; Mackeen, Mukram Mohamed/AAN-6344-2020; McCullagh, James/AAD-2669-2022; zhang, zh/GWV-4677-2022; Kessler, Benedikt/AAY-8614-2021; Claridge, Tim/A-8324-2018; Coleman, Mathew L/C-1676-2014	Chowdhury, Rashed/0000-0002-8058-6149; Cockman, Matthew/0000-0002-3310-4821; Hamed, Refaat/0000-0002-9160-9414; Trudgian, David/0000-0002-7084-6787; Mackeen, Mukram Mohamed/0000-0001-7344-2932; McCullagh, James/0000-0003-4733-1205; Kessler, Benedikt/0000-0002-8160-2446; Claridge, Tim/0000-0001-5583-6460; Coleman, Mathew L/0000-0001-6020-9023; Wolf, Alexander/0000-0003-0649-3363; Loenarz, Christoph/0000-0002-8843-2531; robinson, carol/0000-0001-7829-5505; Sekirnik, Rok/0000-0001-6008-9500; Preston, Gail/0000-0003-3882-4438; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X	Biotechnology and Biological Sciences Research Council [BB/G014124/1]; Wellcome Trust [091857/Z/10/Z]; Cancer Research UK; Slovenian Academy of Sciences and Arts; Oxford Cancer Research Centre; Oak Foundation; BBSRC [BB/D011523/1, BB/J003018/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1, BB/J003018/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Slovenian Academy of Sciences and Arts; Oxford Cancer Research Centre; Oak Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Biotechnology and Biological Sciences Research Council (BB/G014124/1 to P.J.R. and C.J.S.), Wellcome Trust (091857/Z/10/Z to P.J.R. and C.J.S.), Cancer Research UK for studentships (to R. S. and A.Z.), the Slovenian Academy of Sciences and Arts (R. S.), the Oxford Cancer Research Centre (M. L. C.) and the Oak Foundation (M. L. C.) for funding. We thank C. Ducho (Georg-August University, Gottingen, Germany) for the kind gift of standards of hydroxyarginine stereoisomers, R. Fischer for generating MS data and U. Ackermann and C. Tessmer for technical assistance in antibody preparation. R. B. H. is on leave from the Department of Pharmacognosy, Assiut University, Egypt.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Coleman ML, 2009, CURR PHARM DESIGN, V15, P3904, DOI 10.2174/138161209789649448; Eilbracht J, 2005, EUR J CELL BIOL, V84, P279, DOI 10.1016/j.ejcb.2004.12.022; Eilbracht J, 2004, MOL BIOL CELL, V15, P1816, DOI 10.1091/mbc.e03-08-0623; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Ishizaki H, 2007, PATHOL INT, V57, P672, DOI 10.1111/j.1440-1827.2007.02156.x; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; Mullen AR, 2012, TRENDS ENDOCRIN MET, V23, P552, DOI 10.1016/j.tem.2012.06.009; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; Ogasawara S, 2010, HEPATOL RES, V40, P330, DOI 10.1111/j.1872-034X.2009.00604.x; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Suzuki C, 2007, MOL CANCER THER, V6, P542, DOI 10.1158/1535-7163.MCT-06-0659; Teye K, 2004, AM J PATHOL, V164, P205, DOI 10.1016/S0002-9440(10)63111-2; Tsuneoka M, 2004, CLIN CANCER RES, V10, P7347, DOI 10.1158/1078-0432.CCR-03-0543; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Yin XH, 2004, CHEMBIOCHEM, V5, P1274, DOI 10.1002/cbic.200400082; Zhang YD, 2005, ONCOGENE, V24, P4873, DOI 10.1038/sj.onc.1208668	25	114	125	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					960	962		10.1038/NCHEMBIO.1093	http://dx.doi.org/10.1038/NCHEMBIO.1093			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23103944	Green Accepted			2022-12-25	WOS:000311491200008
J	Lienkamp, SS; Liu, K; Karner, CM; Carroll, TJ; Ronneberger, O; Wallingford, JB; Walz, G				Lienkamp, Soeren S.; Liu, Kun; Karner, Courtney M.; Carroll, Thomas J.; Ronneberger, Olaf; Wallingford, John B.; Walz, Gerd			Vertebrate kidney tubules elongate using a planar cell polarity-dependent, rosette-based mechanism of convergent extension	NATURE GENETICS			English	Article							DISEASE; MORPHOGENESIS; GASTRULATION; CYTOKINESIS; DROSOPHILA; DIVISION; XENOPUS	Cystic kidney diseases are a global public health burden, affecting over 12 million people(1). Although much is known about the genetics of kidney development and disease, the cellular mechanisms driving normal kidney tubule elongation remain unclear(2,3). Here, we used in vivo imaging to show for the first time that mediolaterally oriented cell intercalation is fundamental to vertebrate kidney morphogenesis. Unexpectedly, we found that kidney tubule elongation is driven in large part by a myosin-dependent, multicellular rosette based mechanism, previously only described in Drosophila melanogaster. In contrast to findings in Drosophila, however, non-canonical Wnt and planar cell polarity (PCP) signaling is required to control rosette topology and orientation during vertebrate kidney tubule elongation. These data resolve long-standing questions concerning the role of PCP signaling in the developing kidney and, moreover, establish rosette-based intercalation as a deeply conserved cellular engine for epithelial morphogenesis.	[Wallingford, John B.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Wallingford, John B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Wallingford, John B.] Howard Hughes Med Inst, Austin, TX USA; [Lienkamp, Soeren S.; Walz, Gerd] Univ Freiburg, Med Ctr, Dept Med, Div Renal, Freiburg, Germany; [Liu, Kun; Ronneberger, Olaf] Univ Freiburg, Dept Comp Sci, Image Anal Lab, D-79106 Freiburg, Germany; [Liu, Kun; Ronneberger, Olaf; Walz, Gerd] Ctr Biol Signalling Studies BIOSS, Freiburg, Germany; [Karner, Courtney M.; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nephrol, Dallas, TX 75390 USA; [Karner, Courtney M.; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Howard Hughes Medical Institute; University of Freiburg; University of Freiburg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wallingford, JB (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu; gerd.walz@uniklinik-freiburg.de	Lienkamp, Soeren/AAH-6296-2020; Liu, Kun/G-3203-2018	Lienkamp, Soeren/0000-0003-2963-6865; Liu, Kun/0000-0001-6048-0622; Karner, Courtney/0000-0003-0387-4486	Deutsche Forschungsgemeinschaft (DFG) [Klinische Forschergruppe (KFO) 201]; March of Dimes; US National Institutes of Health (NIH) [1R01DK080004]; UT Southwestern O'Brien Kidney Research Foundation [NIH P30DK079328]; Excellence Initiative of the German Federal and State Governments [EXC 294-BIOSS]; NIH/National Institute of General Medical Sciences (NIGMS); March of Dimes, the Burroughs Wellcome Fund; UT Southwestern O'Brien Kidney Research Center [NIH P30DK079328]; DFG [KFO 201]; European Community [241955]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080004, R01DK090127, R01DK095057, P30DK079328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); March of Dimes(March of Dimes); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Southwestern O'Brien Kidney Research Foundation; Excellence Initiative of the German Federal and State Governments; NIH/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); March of Dimes, the Burroughs Wellcome Fund; UT Southwestern O'Brien Kidney Research Center; DFG(German Research Foundation (DFG)); European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Ewald for critical comments on the manuscript; A. Ley for excellent technical assistance, the Life Imaging Center (LIC) at the Centre of Systems Biology at Freiburg University for technical support with confocal microscopy and, in particular, S. Jin form the LIC for programming the tracking macro used in the acquisition of some time-lapse analysis; M. Keuper for digital image analysis; and E.J. Bellefroid (Bruxelles, Belgium) for providing the pCS2+MT-GR plasmid. S.S.L. is supported by the Deutsche Forschungsgemeinschaft (DFG) as part of the Klinische Forschergruppe (KFO) 201. T.J.C. is supported by grants from the March of Dimes, the US National Institutes of Health (NIH; 1R01DK080004) and the UT Southwestern O'Brien Kidney Research Foundation (NIH P30DK079328). O.R., K.L. and G.W. are supported by the Excellence Initiative of the German Federal and State Governments (EXC 294-BIOSS). J.B.W. is supported by the NIH/National Institute of General Medical Sciences (NIGMS), the March of Dimes, the Burroughs Wellcome Fund and the UT Southwestern O'Brien Kidney Research Center (NIH P30DK079328). J.B.W. is an Early Career Scientist of the Howard Hughes Medical Institute. G.W. is supported by the DFG KFO 201 and by the European Community's Seventh Framework Programme (grant agreement 241955, SYSCILIA).	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Jones EA, 2005, J AM SOC NEPHROL, V16, P313, DOI 10.1681/ASN.2004070617; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kieserman EK, 2008, CURR BIOL, V18, P116, DOI 10.1016/j.cub.2007.12.028; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; McNeill H, 2009, J AM SOC NEPHROL, V20, P2104, DOI 10.1681/ASN.2008111173; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishio S, 2010, J AM SOC NEPHROL, V21, P295, DOI 10.1681/ASN.2009060603; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Wagstaff LJ, 2008, DEV DYNAM, V237, P91, DOI 10.1002/dvdy.21390; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	25	148	148	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2012	44	12					1382	1387		10.1038/ng.2452	http://dx.doi.org/10.1038/ng.2452			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143599	Green Accepted			2022-12-25	WOS:000311713200020
J	Varshney, RK; Ribaut, JM; Buckler, ES; Tuberosa, R; Rafalski, JA; Langridge, P				Varshney, Rajeev K.; Ribaut, Jean-Marcel; Buckler, Edward S.; Tuberosa, Roberto; Rafalski, J. Antoni; Langridge, Peter			Can genomics boost productivity of orphan crops?	NATURE BIOTECHNOLOGY			English	Letter							MIXED-MODEL APPROACH; WIDE ASSOCIATION; GENETIC ARCHITECTURE; COMPLEX TRAITS; SELECTION; OPPORTUNITIES; TECHNOLOGIES		[Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, CEG, Hyderabad, Andhra Pradesh, India; [Varshney, Rajeev K.; Ribaut, Jean-Marcel] Int Maize & Wheat Improvement Ctr CIMMYT, CGIAR Generat Challenge Programme GCP, Mexico City, DF, Mexico; [Varshney, Rajeev K.] UWA, Sch Plant Biol M084, Fac Nat & Agr Sci, Crawley, WA, Australia; [Buckler, Edward S.] ARS, USDA, Ithaca, NY USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Tuberosa, Roberto] Univ Bologna, Dept Agroenvironm Sci & Technol, Bologna, Italy; [Rafalski, J. Antoni] DuPont Pioneer, Wilmington, DE USA; [Langridge, Peter] Univ Adelaide, ACPFG, Adelaide, SA, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Western Australia; United States Department of Agriculture (USDA); Cornell University; University of Bologna; DuPont; University of Adelaide	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, CEG, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Langridge, Peter/G-5864-2010; Tuberosa, Roberto/A-2781-2016; Varshney, Rajeev K/C-5295-2014	Buckler, Edward/0000-0002-3100-371X; Langridge, Peter/0000-0001-9494-400X; Tuberosa, Roberto/0000-0001-9143-9569; Varshney, Rajeev K/0000-0002-4562-9131				Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Eathington SR, 2007, CROP SCI, V47, pS154, DOI 10.2135/cropsci2007.04.0015IPBS; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Ribaut JM, 2010, CURR OPIN PLANT BIOL, V13, P213, DOI 10.1016/j.pbi.2009.12.011; Ribaut JM, 1998, TRENDS PLANT SCI, V3, P236, DOI 10.1016/S1360-1385(98)01240-0; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Septiningsih EM, 2009, ANN BOT-LONDON, V103, P151, DOI 10.1093/aob/mcn206; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Varshney RK, 2006, TRENDS BIOTECHNOL, V24, P490, DOI 10.1016/j.tibtech.2006.08.006; Varshney RK, 2012, BRIEF FUNCT GENOMICS, V11, P1, DOI 10.1093/bfgp/els001; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Varshney RK, 2009, CURR OPIN PLANT BIOL, V12, P202, DOI 10.1016/j.pbi.2008.12.004; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Walter A, 2012, ANN BOT-LONDON, V110, P1271, DOI 10.1093/aob/mcs026; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	40	158	163	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1172	1176		10.1038/nbt.2440	http://dx.doi.org/10.1038/nbt.2440			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222781	Green Accepted			2022-12-25	WOS:000312092400014
J	Galban, CJ; Han, MLK; Boes, JL; Chughtai, KA; Meyer, CR; Johnson, TD; Galban, S; Rehemtulla, A; Kazerooni, EA; Martinez, FJ; Ross, BD				Galban, Craig J.; Han, Meilan K.; Boes, Jennifer L.; Chughtai, Komal A.; Meyer, Charles R.; Johnson, Timothy D.; Galban, Stefanie; Rehemtulla, Alnawaz; Kazerooni, Ella A.; Martinez, Fernando J.; Ross, Brian D.			Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression	NATURE MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FUNCTIONAL DIFFUSION MAP; PARAMETRIC RESPONSE MAP; QUANTITATIVE ASSESSMENT; IMAGE REGISTRATION; AIRWAY-OBSTRUCTION; CANCER-TREATMENT; FUNCTION TESTS; LUNG-FUNCTION; EMPHYSEMA	Chronic obstructive pulmonary disease (COPD) is increasingly being recognized as a highly heterogeneous disorder, composed of varying pathobiology. Accurate detection of COPD subtypes by image biomarkers is urgently needed to enable individualized treatment, thus improving patient outcome. We adapted the parametric response map (PRM), a voxel-wise image analysis technique, for assessing COPD phenotype. We analyzed whole-lung computed tomography (CT) scans acquired at inspiration and expiration of 194 individuals with COPD from the COPDGene study. PRM identified the extent of functional small airways disease (fSAD) and emphysema as well as provided CT-based evidence that supports the concept that fSAD precedes emphysema with increasing COPD severity. PRM is a versatile imaging biomarker capable of diagnosing disease extent and phenotype while providing detailed spatial information of disease distribution and location. PRM's ability to differentiate between specific COPD phenotypes will allow for more accurate diagnosis of individual patients, complementing standard clinical techniques.	[Galban, Craig J.; Boes, Jennifer L.; Chughtai, Komal A.; Meyer, Charles R.; Kazerooni, Ella A.; Ross, Brian D.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Galban, Craig J.; Boes, Jennifer L.; Chughtai, Komal A.; Meyer, Charles R.; Galban, Stefanie; Rehemtulla, Alnawaz; Ross, Brian D.] Univ Michigan, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Han, Meilan K.; Martinez, Fernando J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Galban, Stefanie; Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ross, BD (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	bdross@umich.edu			US National Institutes of Health [P50CA93990, T32EB005172]; COPDGene [U01HL089897, U01HL089856]; NATIONAL CANCER INSTITUTE [P50CA093990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, U01HL089897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005172] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPDGene; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We would like to acknowledge S. Sarkar, M. Bule and S. A. Blanks for their indispensable contribution in processing the CT data sets. We would also like to acknowledge D. A. Lynch and the COPDGene investigators for providing the CT scans from National Jewish Health and recruiting the subjects included in this analysis. This work was supported by the US National Institutes of Health research grant P50CA93990 and COPDGene grants U01HL089897 and U01HL089856. J.L.B. is a recipient of support from the US National Institutes of Health training grant T32EB005172.	Agusti A, 2011, AM J RESP CRIT CARE, V184, P507, DOI 10.1164/rccm.201103-0405PP; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Eda S, 1997, AM J RESP CRIT CARE, V155, P1290, DOI 10.1164/ajrccm.155.4.9105069; Galban CJ, 2009, TRANSL ONCOL, V2, P184, DOI 10.1593/tlo.09175; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gorbunova V, 2010, LECT NOTES COMPUT SC, V6362, P193; Gorbunova V, 2008, LECT NOTES COMPUT SC, V5242, P863, DOI 10.1007/978-3-540-85990-1_104; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Kohansal R, 2009, CHEST, V135, P1330, DOI 10.1378/chest.08-1750; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; Li BJ, 2008, MED PHYS, V35, P5575, DOI 10.1118/1.3005633; Ma B, 2009, LECT NOTES COMPUT SC, V5636, P276; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Matsuoka S, 2007, J COMPUT ASSIST TOMO, V31, P384, DOI 10.1097/01.rct.0000243457.00437.10; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Meyer C R, 1997, Med Image Anal, V1, P195, DOI 10.1016/S1361-8415(97)85010-4; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Oga Toru, 2010, Allergol Int, V59, P257, DOI 10.2332/allergolint.10-RA-0184; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Reischauer C, 2010, RADIOLOGY, V257, P523, DOI 10.1148/radiol.10092469; Yamamoto T, 2011, PHYS MED BIOL, V56, P2279, DOI 10.1088/0031-9155/56/7/023	29	461	482	7	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1711	+		10.1038/nm.2971	http://dx.doi.org/10.1038/nm.2971			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23042237	Green Accepted			2022-12-25	WOS:000310837000034
J	Zhan, YY; Chen, Y; Zhang, Q; Zhuang, JJ; Tian, M; Chen, HZ; Zhang, LR; Zhang, HK; He, JP; Wang, WJ; Wu, R; Wang, Y; Shi, CF; Yang, K; Li, AZ; Xin, YZ; Li, TY; Yang, JY; Zheng, ZH; Yu, CD; Lin, SC; Chang, CS; Huang, PQ; Lin, TW; Wu, Q				Zhan, Yan-yan; Chen, Yan; Zhang, Qian; Zhuang, Jia-jia; Tian, Min; Chen, Hang-zi; Zhang, Lian-ru; Zhang, Hong-kui; He, Jian-ping; Wang, Wei-jia; Wu, Rong; Wang, Yuan; Shi, Chunfang; Yang, Kai; Li, An-zhong; Xin, Yong-zhen; Li, Terytty Yang; Yang, James Y.; Zheng, Zhong-hui; Yu, Chun-dong; Lin, Sheng-Cai; Chang, Chawnshang; Huang, Pei-qiang; Lin, Tianwei; Wu, Qiao			The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK	NATURE CHEMICAL BIOLOGY			English	Article							ACETYL-COA CARBOXYLASE; LIGAND-BINDING DOMAIN; FATTY-ACID OXIDATION; PROTEIN-KINASE AMPK; GLUCOSE-METABOLISM; TUMOR-SUPPRESSOR; SKELETAL-MUSCLE; RETINOIC ACID; PHOSPHORYLATION; LIVER	Liver kinase B1 (LKB1) has important roles in governing energy homeostasis by regulating the activity of the energy sensor kinase AMP-activated protein kinase (AMPK). The regulation of LKB1 function, however, is still poorly understood. Here we demonstrate that the orphan nuclear receptor Nur77 binds and sequesters LKB1 in the nucleus, thereby attenuating AMPK activation. This Nur77 function is antagonized by the chemical compound ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (TMPA), which interacts with Nur77 with high affinity and at specific sites. TMPA binding of Nur77 results in the release and shuttling of LKB1 to the cytoplasm to phosphorylate AMPK alpha. Moreover, TMPA effectively reduces blood glucose and alleviates insulin resistance in type II db/db and high-fat diet-and streptozotocin-induced diabetic mice but not in diabetic littermates with the Nur77 gene knocked out. This study attains a mechanistic understanding of the regulation of LKB1-AMPK axis and implicates Nur77 as a new and amenable target for the design and development of therapeutics to treat metabolic diseases.	[Zhan, Yan-yan; Chen, Yan; Zhang, Qian; Tian, Min; Chen, Hang-zi; Zhang, Lian-ru; He, Jian-ping; Wang, Wei-jia; Wu, Rong; Wang, Yuan; Shi, Chunfang; Yang, Kai; Li, An-zhong; Xin, Yong-zhen; Li, Terytty Yang; Yang, James Y.; Zheng, Zhong-hui; Yu, Chun-dong; Lin, Sheng-Cai; Lin, Tianwei; Wu, Qiao] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Zhuang, Jia-jia; Zhang, Hong-kui; Huang, Pei-qiang] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Jiangsu, Peoples R China; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA	Xiamen University; Xiamen University; University of Rochester; University of Rochester; University of Rochester	Zhan, YY (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	twlin@xmu.edu.cn; qiaow@xmu.edu.cn	Zheng, ZH/G-4657-2010; Huang, Peiqiang/G-4094-2010; Yu, C/G-4626-2010; Zhang, HK/G-3428-2010; Li, Terytty Yang/HCI-2446-2022; Lin, SC/G-4666-2010; Yang, Kai S./AAC-9906-2021; Wu, Q/G-4646-2010	Huang, Peiqiang/0000-0003-3230-0457; Li, Terytty Yang/0000-0003-3684-7935; Yang, Kai S./0000-0002-1890-4169; 	Ministry of Science and Technology [2011CB910802]; National Natural Science Fund of China [30810103905, 30630070, 30921005, 30870479]; Program of Introducing Talents of Discipline to Universities [B12001, B06016]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2012KF002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	We are grateful to P. Li (Tsinghua University) for the plasmids encoding AMPK beta, AMPK gamma and AMPK alpha(1-312) and to J. Wu (Tsinghua University) for the tricistronic expression plasmids for all three subunits of AMPK. This work was supported by the grants from '973' Project of the Ministry of Science and Technology (2011CB910802), the National Natural Science Fund of China (30810103905, 30630070, 30921005 and 30870479), the Program of Introducing Talents of Discipline to Universities (B12001 and B06016) and the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2012KF002). We also gratefully acknowledge the use of Beamline BL17U1 at Shanghai Synchrotron Radiation Facility for crystallographic data collection.	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gilbert ER, 2011, EXP DIABETES RES, DOI 10.1155/2011/416254; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Huypens P, 2005, EUR J PHARMACOL, V518, P90, DOI 10.1016/j.ejphar.2005.06.016; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kim EJ, 2012, HEPATOLOGY, V55, P1379, DOI 10.1002/hep.25529; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kishi K, 2000, BIOCHEM BIOPH RES CO, V276, P16, DOI 10.1006/bbrc.2000.3417; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Linher-Melville K, 2012, BIOCHEM BIOPH RES CO, V417, P1063, DOI 10.1016/j.bbrc.2011.12.096; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Nath-Sain S, 2009, MOL BIOL CELL, V20, P2785, DOI 10.1091/mbc.E08-11-1138; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106	44	110	121	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					897	904		10.1038/NCHEMBIO.1069	http://dx.doi.org/10.1038/NCHEMBIO.1069			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	22983157				2022-12-25	WOS:000310052100008
J	Bal, NC; Maurya, SK; Sopariwala, DH; Sahoo, SK; Gupta, SC; Shaikh, SA; Pant, M; Rowland, LA; Goonasekera, SA; Molkentin, JD; Periasamy, M				Bal, Naresh C.; Maurya, Santosh K.; Sopariwala, Danesh H.; Sahoo, Sanjaya K.; Gupta, Subash C.; Shaikh, Sana A.; Pant, Meghna; Rowland, Leslie A.; Goonasekera, Sanjeewa A.; Molkentin, Jeffery D.; Periasamy, Muthu			Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; RETICULUM CALCIUM-TRANSPORT; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; HEAT-PRODUCTION; CA2+-ATPASE ISOFORMS; UNCOUPLING PROTEIN; MICE; CA2+; OVEREXPRESSION	The role of skeletal muscle in nonshivering thermogenesis (NST) is not well understood. Here we show that sarcolipin (Sln), a newly identified regulator of the sarco/endoplasmic reticulum Ca2+-ATPase (Serca) pump(1-5), is necessary for muscle-based thermogenesis. When challenged to acute cold (4 degrees C), Sln(-/-) mice were not able to maintain their core body temperature (37 degrees C) and developed hypothermia. Surgical ablation of brown adipose tissue and functional knockdown of Ucp1 allowed us to highlight the role of muscle in NST. Overexpression of Sln in the Sln-null background fully restored muscle-based thermogenesis, suggesting that Sln is the basis for Serca-mediated heat production. We show that ryanodine receptor 1 (Ryr1)-mediated Ca2+ leak is an important mechanism for Serca-activated heat generation. Here we present data to suggest that Sln can continue to interact with Serca in the presence of Ca2+, which can promote uncoupling of the Serca pump and cause futile cycling. We further show that loss of Sln predisposes mice to diet-induced obesity, which suggests that Sln-mediated NST is recruited during metabolic overload. These data collectively suggest that SLN is an important mediator of muscle thermogenesis and whole-body energy metabolism.	[Bal, Naresh C.; Maurya, Santosh K.; Sopariwala, Danesh H.; Sahoo, Sanjaya K.; Gupta, Subash C.; Shaikh, Sana A.; Pant, Meghna; Rowland, Leslie A.; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Goonasekera, Sanjeewa A.; Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH USA; [Periasamy, Muthu] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; Ohio State University	Periasamy, M (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Bal, Naresh/E-9377-2011; Maurya, Santosh/O-9066-2017; Gupta, Subash/AAF-2563-2019	Maurya, Santosh/0000-0002-7610-2463; Gupta, Subash/0000-0002-0418-1940; Periasamy, Muthu/0000-0001-8834-5975; Molkentin, Jeffery/0000-0002-3558-6529; Tupling, A. Russell/0000-0002-3895-6767	US National Institutes of Health [R01 (HL080551)]; American Physiological Society; American Heart Association [10POST3360007]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Physiological Society; American Heart Association(American Heart Association)	This work was supported in part by US National Institutes of Health grant R01 (HL080551) to M. Periasamy. N.C.B. was supported by a postdoctoral fellowship from the American Physiological Society and the American Heart Association (10POST3360007). We thank P. Mohler, J.A. Rafael-Fortney and J.E. Ostler, for comments on the manuscript. We thank N. Manivannan and K. Powell (Ohio State University Medical Center, Davis Heart and Lung Research Institute, Small Animal Imaging Facility, Columbus, Ohio, USA) for MRI of mice.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Arruda AP, 2008, ENDOCRINOLOGY, V149, P6262, DOI 10.1210/en.2008-0564; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Bicudo JEPW, 2001, BIOSCIENCE REP, V21, P181, DOI 10.1023/A:1013648208428; BLOCK BA, 1994, J CELL BIOL, V127, P1275, DOI 10.1083/jcb.127.5.1275; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; BLOCK BA, 1988, J CELL BIOL, V107, P1099, DOI 10.1083/jcb.107.3.1099; Bowman WC, 2006, BRIT J PHARMACOL, V147, pS277, DOI 10.1038/sj.bjp.0706404; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; de Meis L, 2005, BIOSCIENCE REP, V25, P181, DOI 10.1007/s10540-005-2884-7; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; da Costa DCF, 2009, AM J PHYSIOL-REG I, V297, pR1460, DOI 10.1152/ajpregu.90993.2008; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; KASHIMURA O, 1992, AVIAT SPACE ENVIR MD, V63, P1082; Kjelstrup S, 2008, EUR BIOPHYS J BIOPHY, V38, P59, DOI 10.1007/s00249-008-0358-0; Kjelstrup S, 2009, BIOPHYS J, V96, P4376, DOI 10.1016/j.bpj.2009.02.070; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morrissette JM, 2003, J EXP BIOL, V206, P805, DOI 10.1242/jeb.00158; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; Silva J Enrique, 2011, Front Biosci (Schol Ed), V3, P352, DOI 10.2741/s156; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316	38	353	362	3	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1575	U183		10.1038/nm.2897	http://dx.doi.org/10.1038/nm.2897			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22961106	Green Accepted			2022-12-25	WOS:000309587500037
J	Li, JX; Tang, YZ; Cai, DS				Li, Juxue; Tang, Yizhe; Cai, Dongsheng			IKK beta/NF-kappa B disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes	NATURE CELL BIOLOGY			English	Article							SUBVENTRICULAR ZONE; ENERGY-BALANCE; NEUROGENESIS; NOTCH; DIFFERENTIATION; ASTROCYTES; STRESS; BRAIN; DEATH; PROLIFERATION	Adult neural stem cells (NSCs) are known to exist in a few regions of the brain; however, the entity and physiological/disease relevance of adult hypothalamic NSCs (htNSCs) remain unclear. This work shows that adult htNSCs are multipotent and predominantly present in the mediobasal hypothalamus of adult mice. Chronic high-fat-diet feeding led to not only depletion but also neurogenic impairment of htNSCs associated with IKK beta/NF-kappa B activation. In vitro htNSC models demonstrated that their survival and neurogenesis markedly decreased on IKK beta/NF-kappa B activation but increased on IKK beta/NF-kappa B inhibition, mechanistically mediated by IKK beta/NF-kappa B-controlled apoptosis and Notch signalling. Mouse studies revealed that htNSC-specific IKK beta/NF-kappa B activation led to depletion and impaired neuronal differentiation of htNSCs, and ultimately the development of obesity and pre-diabetes. In conclusion, adult htNSCs are important for the central regulation of metabolic physiology, and IKK beta/NF-kappa B-mediated impairment of adult htNSCs is a critical neurodegenerative mechanism for obesity and related diabetes.	[Li, Juxue; Tang, Yizhe; Cai, Dongsheng] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Li, Juxue; Tang, Yizhe; Cai, Dongsheng] Ctr Diabet Res & Training, Bronx, NY 10461 USA; [Li, Juxue; Tang, Yizhe; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu	Tang, Yizhe/A-8682-2014	Tang, Yizhe/0000-0001-5354-478X; Li, Juxue/0000-0003-0681-5713	Albert Einstein College of Medicine internal start-up funds; NIH [R01 DK078750, R01 AG031774]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	Albert Einstein College of Medicine internal start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	0The authors sincerely thank F. H. Gage (The Salk Institute for Biological Studies, USA) for the Sox2-promoter-containing lentiviral vector, D. Hickstein (National Cancer Institute, National Institutes of Health, USA) for the CD11b-promoter cDNA, and the members of the Cai laboratory for general technical assistance. This study was supported by Albert Einstein College of Medicine internal start-up funds and NIH R01 DK078750 and R01 AG031774 (all to D. Cai).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Flier JS, 2006, SCIENCE, V312, P861, DOI 10.1126/science.1127971; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hayden Matthew S, 2006, Cell, V127, P1286; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Is-Donini S., 2008, J NEUROSCI, V28, P3911; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lutolf S, 2002, DEVELOPMENT, V129, P373; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Morrison SJ, 2001, CURR OPIN CELL BIOL, V13, P666, DOI 10.1016/S0955-0674(00)00269-6; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Vacca A, 2006, EMBO J, V25, P1000, DOI 10.1038/sj.emboj.7600996; Villeda S, 2008, NEURON, V59, P527, DOI 10.1016/j.neuron.2008.08.005; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vousden KH, 2009, AGING-US, V1, P275, DOI 10.18632/aging.100033; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	57	254	261	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					999	+		10.1038/ncb2562	http://dx.doi.org/10.1038/ncb2562			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	22940906	Green Accepted			2022-12-25	WOS:000309543800009
J	Peret, B; Li, GW; Zhao, J; Band, LR; Voss, U; Postaire, O; Luu, DT; Da Ines, O; Casimiro, I; Lucas, M; Wells, DM; Lazzerini, L; Nacry, P; King, JR; Jensen, OE; Schaffner, AR; Maurel, C; Bennett, MJ				Peret, Benjamin; Li, Guowei; Zhao, Jin; Band, Leah R.; Voss, Ute; Postaire, Olivier; Doan-Trung Luu; Da Ines, Olivier; Casimiro, Ilda; Lucas, Mikael; Wells, Darren M.; Lazzerini, Laure; Nacry, Philippe; King, John R.; Jensen, Oliver E.; Schaeffner, Anton R.; Maurel, Christophe; Bennett, Malcolm J.			Auxin regulates aquaporin function to facilitate lateral root emergence	NATURE CELL BIOLOGY			English	Article							ARABIDOPSIS-THALIANA; WATER TRANSPORT; PLASMA-MEMBRANE; HYDRAULIC CONDUCTIVITY; CELL ELONGATION; EXPRESSION; ARF19; ORGANOGENESIS; MUTAGENESIS; INITIATION	Aquaporins are membrane channels that facilitate water movement across cell membranes. In plants, aquaporins contribute to water relations. Here, we establish a new link between aquaporin-dependent tissue hydraulics and auxin-regulated root development in Arabidopsis thaliana. We report that most aquaporin genes are repressed during lateral root formation and by exogenous auxin treatment. Auxin reduces root hydraulic conductivity both at the cell and whole-organ levels. The highly expressed aquaporin PIP2;1 is progressively excluded from the site of the auxin response maximum in lateral root primordia (LRP) whilst being maintained at their base and underlying vascular tissues. Modelling predicts that the positive and negative perturbations of PIP2;1 expression alter water flow into LRP, thereby slowing lateral root emergence (LRE). Consistent with this mechanism, pip2;1 mutants and PIP2;1-overexpressing lines exhibit delayed LRE. We conclude that auxin promotes LRE by regulating the spatial and temporal distribution of aquaporin-dependent root tissue water transport.	[Zhao, Jin; Da Ines, Olivier; Schaeffner, Anton R.] Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, D-85764 Neuherberg, Germany; [Peret, Benjamin; Band, Leah R.; Voss, Ute; Lucas, Mikael; Wells, Darren M.; Lazzerini, Laure; King, John R.; Jensen, Oliver E.; Bennett, Malcolm J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Li, Guowei; Postaire, Olivier; Doan-Trung Luu; Nacry, Philippe; Maurel, Christophe] Univ Montpellier 2, Inst Biol Integrat Plantes, Ctr Natl Rech Sci,Unite Mixte Rech 5004, Inst Natl Rech Agron,MontpellierSupAgro,Unite Mix, F-34060 Montpellier 2, France; [Casimiro, Ilda] Univ Extremadura, Fac Ciencias, Badajoz 06006, Spain; [Jensen, Oliver E.] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Nottingham; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universidad de Extremadura; University of Manchester	Schaffner, AR (corresponding author), Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, D-85764 Neuherberg, Germany.	schaeffner@helmholtz-muenchen.de; maurel@supagro.inra.fr; malcolm.bennett@nottingham.ac.uk	Jensen, Oliver/B-5880-2008; DA INES, Olivier/J-6901-2015; LUCAS, Mikaël/A-5925-2015; Wells, Darren/GOJ-9739-2022; Casimiro, Ilda/R-3506-2019; Voss, Ute/X-3755-2019; Nacry, Philippe/AAK-4361-2020; Bennett, Malcolm/G-4004-2010	Jensen, Oliver/0000-0003-0172-6578; DA INES, Olivier/0000-0002-1868-3781; Wells, Darren/0000-0002-4246-4909; Voss, Ute/0000-0003-2124-9334; Nacry, Philippe/0000-0001-7766-4989; Bennett, Malcolm/0000-0003-0475-390X; LUCAS, Mikael/0000-0001-6286-7759; PERET, Benjamin/0000-0003-1336-0796; Luu, Doan Trung/0000-0001-9765-2125; Band, Leah/0000-0002-6979-1117	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme [PIEF-GA-2008-220506]; Grand Federative Project (Rhizopolis) of the Agropolis Fondation (Montpellier, France); Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); BBSRC responsive mode grant; BBSRC Professorial Research Fellowship; Deutsche Forschungsgemeinschaft priority programme [SPP1108 (SCHA 454/8)]; Biotechnology and Biological Sciences Research Council [BB/D019613/1, BB/H020314/1] Funding Source: researchfish; BBSRC [BB/H020314/1, BB/D019613/1] Funding Source: UKRI	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme(European Commission); Grand Federative Project (Rhizopolis) of the Agropolis Fondation (Montpellier, France); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC responsive mode grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Professorial Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft priority programme(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme PIEF-GA-2008-220506 (B.P.) and by a Grand Federative Project (Rhizopolis) of the Agropolis Fondation (Montpellier, France) to C.M. We are indebted to H. Scherb (Helmholtz Zentrum Munchen) for his help with statistical analyses. L.R.B., U.V., M.L., D.M.W., J.R.K., O.E.J. and M.J.B. acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC) and Engineering and Physical Sciences Research Council (EPSRC) funding to the Centre for Plant Integrative Biology (CPIB), BBSRC responsive mode grant support to U.V., L.R.B. and M.J.B. and the BBSRC Professorial Research Fellowship funding to D.M.W. and M.J.B. A.R.S. and O.D.I. acknowledge the support of the Deutsche Forschungsgemeinschaft priority programme SPP1108 (SCHA 454/8).	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Boyer JS, 2004, FUNCT PLANT BIOL, V31, P761, DOI 10.1071/FP04062; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COSGROVE DJ, 1993, INT J PLANT SCI, V154, P10, DOI 10.1086/297087; Da Ines O, 2010, PLANT BIOLOGY, V12, P129, DOI 10.1111/j.1438-8677.2010.00385.x; Danielson JAH, 2010, ADV EXP MED BIOL, V679, P19; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Ehlert C, 2009, PLANT PHYSIOL, V150, P1093, DOI 10.1104/pp.108.131458; Fricke W, 2002, ANN BOT-LONDON, V90, P157, DOI 10.1093/aob/mcf180; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Hukin D, 2002, PLANTA, V215, P1047, DOI 10.1007/s00425-002-0841-2; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; KAZAMA H, 1978, PLANT CELL PHYSIOL, V19, P1145; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Laskowski M, 2006, PLANT CELL PHYSIOL, V47, P788, DOI 10.1093/pcp/pcj043; Lucas M, 2008, J EXP BOT, V59, P55, DOI 10.1093/jxb/erm171; Malamy JE, 1997, DEVELOPMENT, V124, P33; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Monneuse JM, 2011, PROTEOMICS, V11, P1789, DOI 10.1002/pmic.201000660; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; OPARKA KJ, 1995, J EXP BOT, V46, P187, DOI 10.1093/jxb/46.2.187; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Peret B, 2007, PLANT PHYSIOL, V144, P1852, DOI 10.1104/pp.107.101337; Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Postaire O, 2010, PLANT PHYSIOL, V152, P1418, DOI 10.1104/pp.109.145326; Richter GL, 2009, PLANT PHYSIOL, V151, P1855, DOI 10.1104/pp.109.142448; Santoni V, 2003, BIOCHEM J, V373, P289, DOI 10.1042/BJ20030159; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151	43	245	253	2	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					991	+		10.1038/ncb2573	http://dx.doi.org/10.1038/ncb2573			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	22983115				2022-12-25	WOS:000309543800008
J	Lopez-Arredondo, DL; Herrera-Estrella, L				Lizbeth Lopez-Arredondo, Damar; Herrera-Estrella, Luis			Engineering phosphorus metabolism in plants to produce a dual fertilization and weed control system	NATURE BIOTECHNOLOGY			English	Article							PHOSPHATE STARVATION RESPONSES; REDUCED PHOSPHORUS; ENVIRONMENT; EXPRESSION; GENES; ROOT	High crop yields depend on the continuous input of orthophosphate (PO4-3)-based fertilizers and herbicides(1,2). Two major challenges for agriculture are that phosphorus is a nonrenewable resource and that weeds have developed broad herbicide resistance(3-5). One strategy to overcome both problems is to engineer plants to outcompete weeds and microorganisms for limiting resources, thereby reducing the requirement for both fertilizers and herbicides. Plants and most microorganisms are unable to metabolize phosphite (PO3-3), so we developed a dual fertilization and weed control system by generating transgenic plants that can use phosphite as a sole phosphorus source. Under greenhouse conditions, these transgenic plants require 30-50% less phosphorus input when fertilized with phosphite to achieve similar productivity to that obtained by the same plants using orthophosphate fertilizer and, when in competition with weeds, accumulate 2-10 times greater biomass than when fertilized with orthophosphate.	[Lizbeth Lopez-Arredondo, Damar; Herrera-Estrella, Luis] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Herrera-Estrella, L (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	lherrera@langebio.cinvestav.mx	Herrera-Estrella, Luis/AAL-2472-2020; Estrella, Luis R Herrera/G-7351-2011; Herrera-Estrella, Luis/ABC-7431-2020	Herrera-Estrella, Luis/0000-0001-7936-3856; Estrella, Luis R Herrera/0000-0001-7936-3856; LOPEZ ARREDONDO, DAMAR/0000-0001-7389-3143	Howard Hughes Medical Institute [55005946]; CONACyT, Mexico [207308]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank O. Martinez for advice in statistical analysis; M. A. Leyva, A. Vera and J.L. Cabrera for technical support; K. Wrobel and K. Wrobel for the phosphite detection method; V. Limones for assistance in Tobacco transformation and C. Castro and E. Alva in Arabidopsis greenhouse experiments. We are grateful to A. Estrada, J.D. Frier and Universidad Autonoma Chapingo for providing Brachypodium distachyon, Amaranthus hybridus and Ipomoea purpurea and Brachiaria plantaginea seeds, respectively; and C. Morales for assistance in photosynthesis measurements. We thank S. Gillmore and V. Albert for critical reading this manuscript. This work was supported in part by grant from the Howard Hughes Medical Institute (grant 55005946) to L.H.-E. D.L.L.-A. is indebted to CONACyT, Mexico, for a PhD fellowship (no. 207308). pWM302 was a gift from W. W. Metcalf.	Abelson PH, 1999, SCIENCE, V283, P2015, DOI 10.1126/science.283.5410.2015; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; Carswell C, 1996, PLANT PHYSIOL, V110, P105, DOI 10.1104/pp.110.1.105; Carswell MC, 1997, PLANTA, V203, P67, DOI 10.1007/s004250050166; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Costas AMG, 2001, J BIOL CHEM, V276, P17429, DOI 10.1074/jbc.M011764200; Dawson CJ, 2011, FOOD POLICY, V36, pS14, DOI 10.1016/j.foodpol.2010.11.012; Downing JA, 2001, CAN J FISH AQUAT SCI, V58, P1905, DOI 10.1139/cjfas-58-10-1905; Forster H, 1998, PLANT DIS, V82, P1165, DOI 10.1094/PDIS.1998.82.10.1165; Gianessi LP, 2007, WEED TECHNOL, V21, P559, DOI 10.1614/WT-06-130.1; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Hesse P.R., 1971, AUST J SOIL RES, V35, P227; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Lee TM, 2005, J PHYCOL, V41, P975, DOI 10.1111/j.1529-8817.2005.00119.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; McDonald AE, 2001, J PLANT NUTR, V24, P1505, DOI 10.1081/PLN-100106017; Metcalf WW, 1998, J BACTERIOL, V180, P5547, DOI 10.1128/JB.180.21.5547-5558.1998; Morton SC, 2005, ENVIRON SCI TECHNOL, V39, P4369, DOI 10.1021/es0401038; OUIMETTE DG, 1989, PLANT DIS, V73, P212, DOI 10.1094/PD-73-0212; Pasek MA, 2008, P NATL ACAD SCI USA, V105, P853, DOI 10.1073/pnas.0708205105; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; RAO IM, 1989, PLANT PHYSIOL, V90, P820, DOI 10.1104/pp.90.3.820; Ruthbaum HP, 1964, NZ J SCI, V7, P446; SAINDRENAN P, 1988, PLANT SCI, V58, P245, DOI 10.1016/0168-9452(88)90015-5; Sambrook J, 2001, MOL CLONING LAB MANU; Schroetter S, 2006, LANDBAUFORSCH VOLK, V56, P87; Syers J.K., 2008, FAO FERTILIZER PLANT, V18; Ticconi CA, 2001, PLANT PHYSIOL, V127, P963, DOI 10.1104/pp.010396; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Varadarajan DK, 2002, PLANT PHYSIOL, V129, P1232, DOI 10.1104/pp.010835; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Wrobel K, 2010, J CHROMATOGR B, V878, P609, DOI 10.1016/j.jchromb.2010.01.008	36	77	84	2	106	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					889	U123		10.1038/nbt.2346	http://dx.doi.org/10.1038/nbt.2346			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22922674				2022-12-25	WOS:000308705700024
J	Breakefield, XO				Breakefield, Xandra O.			Refocus the Recombinant DNA Advisory Committee	NATURE MEDICINE			English	Editorial Material								The Recombinant DnA Advisory committee, formed in 1974, was originally charged with advising on potential risks of recombinant technology and took on review of clinical gene therapy protocols in the late 1980s. But as gene therapy has made headway with safety, it's time to shift the committee's mission toward broader ethical and technical issues linked to the field.	[Breakefield, Xandra O.] Amer Soc Gene & Cell Therapy, Boston, MA USA; [Breakefield, Xandra O.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Breakefield, XO (corresponding author), Amer Soc Gene & Cell Therapy, Boston, MA USA.								0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1007	1007		10.1038/nm0712-1007	http://dx.doi.org/10.1038/nm0712-1007			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772546	Bronze			2022-12-25	WOS:000306121600019
J	Johnston, CW; Wyatt, MA; Li, X; Ibrahim, A; Shuster, J; Southam, G; Magarvey, NA				Johnston, Chad W.; Wyatt, Morgan A.; Li, Xiang; Ibrahim, Ashraf; Shuster, Jeremiah; Southam, Gordon; Magarvey, Nathan A.			Gold biomineralization by a metallophore from a gold-associated microbe	NATURE CHEMICAL BIOLOGY			English	Article							SIDEROPHORE; NANOPARTICLES; BACTERIA; BIOFILMS; COPPER	Microorganisms produce and secrete secondary metabolites to assist in their survival. We report that the gold resident bacterium Delftia acidovorans produces a secondary metabolite that protects from soluble gold through the generation of solid gold forms. This finding is the first demonstration that a secreted metabolite can protect against toxic gold and cause gold biomineralization.	[Johnston, Chad W.; Wyatt, Morgan A.; Li, Xiang; Ibrahim, Ashraf; Magarvey, Nathan A.] McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Johnston, Chad W.; Wyatt, Morgan A.; Li, Xiang; Ibrahim, Ashraf; Magarvey, Nathan A.] McMaster Univ, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Shuster, Jeremiah; Southam, Gordon] Univ Western Ontario, Dept Earth Sci, London, ON, Canada; [Southam, Gordon] Univ Western Ontario, Dept Biol, London, ON, Canada	McMaster University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Magarvey, NA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	magarv@mcmaster.ca	Southam, Gordon/D-1983-2013	Southam, Gordon/0000-0002-8941-1249; Johnston, Chad/0000-0002-1988-709X; Shuster, Jeremiah/0000-0002-9839-6618; Ibrahim, Ashraf/0000-0001-5775-7037	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 371576-2009, 101997-2006]; NSERC [STPGP385235-09]; Canadian Foundation for Innovation [2010M00022]; Canadian Institutes of Health (CIHR); CIHR	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded through Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grants (RGPIN 371576-2009; 101997-2006), an NSERC Strategic grant (STPGP385235-09) and a Canadian Foundation for Innovation grant (2010M00022). M.A.W. is funded through a Canadian Institutes of Health (CIHR) Doctoral Research Award. N.A.M. is funded by a CIHR New Investigator Award.	Amin SA, 2007, J AM CHEM SOC, V129, P478, DOI 10.1021/ja067369u; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; DIELS L, 1995, J IND MICROBIOL, V14, P142, DOI 10.1007/BF01569896; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hough RM, 2008, GEOLOGY, V36, P571, DOI 10.1130/G24749A.1; Kashefi K, 2001, APPL ENVIRON MICROB, V67, P3275, DOI 10.1128/AEM.67.7.3275-3279.2001; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Miller MC, 2010, MICROBIOL-SGM, V156, P2226, DOI 10.1099/mic.0.037945-0; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Ojea-Jimenez I, 2010, J PHYS CHEM C, V114, P1800, DOI 10.1021/jp9091305; Reith F, 2007, ISME J, V1, P567, DOI 10.1038/ismej.2007.75; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Reith F, 2010, GEOLOGY, V38, P843, DOI 10.1130/G31052.1; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Salem I.B., 2012, ANN MICROBIOL, DOI [10.1007/s13213-012-0462-3, DOI 10.1007/S13213-012-0462-3]; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Usher A, 2009, GEOCHIM COSMOCHIM AC, V73, P3359, DOI 10.1016/j.gca.2009.01.036; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143	18	148	153	10	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					241	243		10.1038/NCHEMBIO.1179	http://dx.doi.org/10.1038/NCHEMBIO.1179			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23377039				2022-12-25	WOS:000317025800012
J	Fernandez-Saiz, V; Targosz, BS; Lemeer, S; Eichner, R; Langer, C; Bullinger, L; Reiter, C; Slotta-Huspenina, J; Schroeder, S; Knorn, AM; Kurutz, J; Peschel, C; Pagano, M; Kuster, B; Bassermann, F				Fernandez-Saiz, Vanesa; Targosz, Bianca-Sabrina; Lemeer, Simone; Eichner, Ruth; Langer, Christian; Bullinger, Lars; Reiter, Clemens; Slotta-Huspenina, Julia; Schroeder, Sonja; Knorn, Anna-Maria; Kurutz, Julia; Peschel, Christian; Pagano, Michele; Kuster, Bernhard; Bassermann, Florian			SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE CK2; FORMALIN-FIXED TISSUES; MTOR; INHIBITION; STABILITY; COMPLEX; CANCER; TEL2; ATR; MECHANISM	The Tel2 (also known as Telo2) and Tti1 proteins control the cellular abundance of mammalian PIKKs and are integral components of mTORC1 and mTORC2. Here we report that Tel2 and Tti1 are targeted for degradation within mTORC1 by the SCFFbxo9 ubiquitin ligase to adjust mTOR signalling to growth factor availability. This process is primed by CK2, which translocates to the cytoplasm to mediate mTORC1-specific phosphorylation of Tel2/Tti1, subsequent to growth factor deprivation. As a consequence, mTORC1 is inactivated to restrain cell growth and protein translation whereas relief of feedback inhibition activates the PI(3)K/TORC2/Akt pathway to sustain survival. Significantly, primary human multiple myelomas exhibit high levels of Fbxo9. In this setting, PI(3)K/TORC2/Akt signalling and survival of multiple myeloma cells is dependent on Fbxo9 expression. Thus, mTORC1-specific degradation of the Tel2 and Tti1 proteins represents a central mTOR regulatory mechanism with implications in multiple myeloma, both in promoting survival and in providing targets for the specific treatment of multiple myeloma with high levels of Fbxo9 expression.	[Fernandez-Saiz, Vanesa; Targosz, Bianca-Sabrina; Eichner, Ruth; Reiter, Clemens; Schroeder, Sonja; Knorn, Anna-Maria; Kurutz, Julia; Peschel, Christian; Bassermann, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-81675 Munich, Germany; [Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Dept Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany; [Langer, Christian; Bullinger, Lars] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Slotta-Huspenina, Julia] Tech Univ Munich, Klinikum Rechts Isar, Dept Pathol, D-81675 Munich, Germany; [Pagano, Michele] NYU, Sch Med, NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Kuster, Bernhard] CIPSM, D-85354 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Ulm University; Technical University of Munich; New York University	Bassermann, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, Ismaninger Str 22, D-81675 Munich, Germany.	florian.bassermann@lrz.tum.de	Bullinger, Lars/AAL-7965-2020; Kuster, Bernhard/Q-6031-2016; Fernandez, Vanesa/ABD-6688-2021; Lemeer, Simone/I-4363-2016	Kuster, Bernhard/0000-0002-9094-1677; Bullinger, Lars/0000-0002-5890-5510; pagano, michele/0000-0003-3210-2442; Fernandez-Saiz, Vanesa/0000-0002-7139-8680; Eichner, Ruth/0000-0002-8433-9452	German Research Foundation (Emmy Noether Program) [BA 2851/3-1]; German Cancer Aid [109543]	German Research Foundation (Emmy Noether Program)(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe)	We thank T. deLange, T. Dechow, J. Duyster, D. Guardavaccaro, R. Humar, N. Mizushima and M. Rudelius for reagents; K. Engel and C. Proud for suggestions; R. Faessler and D. Moik for help with the antibody production; A. L. Illert for help with the preparation of liver extracts; and K-F. Becker for help with the reverse-phase protein arrays. M.P. is an investigator with the Howard Hughes Medical Institute. This work was supported by grants from the German Research Foundation (Emmy Noether Program, BA 2851/3-1) and the German Cancer Aid (#109543) to F.B.	Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bassermann F, 2010, CELL DEATH DIFFER, V17, P78, DOI 10.1038/cdd.2009.104; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bassermann F, 2007, J BIOL CHEM, V282, P15965, DOI 10.1074/jbc.M610819200; Battistutta R, 2009, CELL MOL LIFE SCI, V66, P1868, DOI 10.1007/s00018-009-9155-x; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Mattioli M, 2005, ONCOGENE, V24, P2461, DOI 10.1038/sj.onc.1208447; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; MEREDITH MJ, 1988, CELL BIOL TOXICOL, V4, P405, DOI 10.1007/BF00117769; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Olsen BB, 2010, METHOD ENZYMOL, V484, P515, DOI [10.1016/B978-0-12-381298-8.00025-3, 10.1016/S0076-6879(10)84025-X]; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Varshavsky A, 2012, METHODS MOL BIOL, V832, P1, DOI 10.1007/978-1-61779-474-2_1; Wolff C, 2011, METHODS MOL BIOL, V785, P123, DOI 10.1007/978-1-61779-286-1_9; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	62	68	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					72	U164		10.1038/ncb2651	http://dx.doi.org/10.1038/ncb2651			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23263282				2022-12-25	WOS:000312841300011
J	Eichelbaum, K; Winter, M; Diaz, MB; Herzig, S; Krijgsveld, J				Eichelbaum, Katrin; Winter, Markus; Diaz, Mauricio Berriel; Herzig, Stephan; Krijgsveld, Jeroen			Selective enrichment of newly synthesized proteins for quantitative secretome analysis	NATURE BIOTECHNOLOGY			English	Article							SERUM STARVATION; CELL-LINES; IDENTIFICATION; PHOSPHORYLATION; EXPRESSION; BIOMARKERS; DISCOVERY; PEPTIDES; PROTEOME; BIOLOGY	Secreted proteins constitute a large and biologically important subset of proteins that are involved in cellular communication, adhesion and migration. Yet secretomes are understudied because of technical limitations in the detection of low-abundance proteins against a background of serum-containing media. Here we introduce a method that combines click chemistry and pulsed stable isotope labeling with amino acids in cell culture to selectively enrich and quantify secreted proteins. The combination of these two labeling approaches allows cells to be studied irrespective of the complexity of the background proteins. We provide an in-depth and differential secretome analysis of various cell lines and primary cells, quantifying secreted factors, including cytokines, chemokines and growth factors. In addition, we reveal that serum starvation has a marked effect on secretome composition. We also analyze the kinetics of protein secretion by macrophages in response to lipopolysaccharides.	[Eichelbaum, Katrin; Winter, Markus; Krijgsveld, Jeroen] EMBL, Genome Biol Unit, Heidelberg, Germany; [Diaz, Mauricio Berriel; Herzig, Stephan] Univ Heidelberg Hosp, Joint Div Mol Metab Control, DKFZ ZMBH Alliance, Ctr Mol Biol ZMBH, Heidelberg, Germany; [Diaz, Mauricio Berriel; Herzig, Stephan] German Canc Res Ctr, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Krijgsveld, J (corresponding author), EMBL, Genome Biol Unit, Heidelberg, Germany.	jeroen.krijgsveld@embl.de	Diaz, Mauricio Berriel/AAF-8285-2021; Krijgsveld, Jeroen/F-5974-2011	Krijgsveld, Jeroen/0000-0001-7549-9326; Berriel Diaz, Mauricio/0000-0003-4670-919X; Herzig, Stephan/0000-0003-3950-3652	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We gratefully acknowledge the EMBL Proteomics Core Facility for expert technical assistance. This study was supported by the Netherlands Organisation for Scientific Research (NWO).	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Bailey MJ, 2011, IMMUNOL CELL BIOL, V89, P283, DOI 10.1038/icb.2010.92; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Burghoff S, 2011, J PROTEOME RES, V10, P1160, DOI 10.1021/pr100937a; Caccia D, 2011, J PROTEOME RES, V10, P4196, DOI 10.1021/pr200344n; Colzani M, 2009, J PROTEOME RES, V8, P4779, DOI 10.1021/pr900476b; Cooper S, 2003, FASEB J, V17, P333, DOI 10.1096/fj.02-0352rev; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Finoulst I, 2011, J PROTEOMICS, V75, P23, DOI 10.1016/j.jprot.2011.03.034; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hasan NM, 1999, INT J CANCER, V80, P400, DOI 10.1002/(SICI)1097-0215(19990129)80:3<400::AID-IJC11>3.0.CO;2-U; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Levin VA, 2010, J PROTEOME RES, V9, P179, DOI 10.1021/pr900392b; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; YAN XQ, 1993, J IMMUNOL, V150, P2440; Zhu XC, 2006, J IMMUNOL, V177, P4299, DOI 10.4049/jimmunol.177.7.4299	44	173	176	2	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					984	+		10.1038/nbt.2356	http://dx.doi.org/10.1038/nbt.2356			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23000932				2022-12-25	WOS:000309965500025
J	Holland, JP; Evans, MJ; Rice, SL; Wongvipat, J; Sawyers, CL; Lewis, JS				Holland, Jason P.; Evans, Michael J.; Rice, Samuel L.; Wongvipat, John; Sawyers, Charles L.; Lewis, Jason S.			Annotating MYC status with Zr-89-transferrin imaging	NATURE MEDICINE			English	Article							TRANSFERRIN RECEPTOR; INFLAMMATION; CANCER; PET; EXPRESSION; ANTIBODIES; LOCALIZATION; INHIBITION; ACTIVATION; KINETICS	A noninvasive technology that quantitatively measures the activity of oncogenic signaling pathways could have a broad impact on cancer diagnosis and treatment with targeted therapies. Here we describe the development of Zr-89-desferrioxamine-labeled transferrin (Zr-89-transferrin), a new positron emission tomography (PET) radiotracer that binds the transferrin receptor 1 (TFRC, CD71) with high avidity. The use of Zr-89-transferrin produces high-contrast PET images that quantitatively reflect treatment-induced changes in MYC-regulated TFRC expression in a MYC-driven prostate cancer xenograft model. Moreover, Zr-89-transferrin imaging can detect the in situ development of prostate cancer in a transgenic MYC prostate cancer model, as well as in prostatic intraepithelial neoplasia (PIN) before histological or anatomic evidence of invasive cancer. These preclinical data establish Zr-89-transferrin as a sensitive tool for noninvasive measurement of oncogene-driven TFRC expression in prostate and potentially other cancers, with prospective near-term clinical application.	[Holland, Jason P.; Rice, Samuel L.; Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, New York, NY 10021 USA; [Evans, Michael J.; Wongvipat, John; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lewis, JS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, 1275 York Ave, New York, NY 10021 USA.	sawyersc@mskcc.org; lewisj2@mskcc.org	Holland, Jason P./AAO-5718-2020; Sawyers, Charles/G-5327-2016	Holland, Jason P./0000-0002-0066-219X; Lewis, Jason/0000-0001-7065-4534; Rice, Samuel/0000-0002-0158-8921	Geoffrey Beene Cancer Research Center of MSKCC; Office of Science (BER)-US Department of Energy [DE-SC0002456]; US National Cancer Institute [2R25-CA096945]; US National Institutes of Health (NIH) [R24-CA83084]; NIH Center [P30-CA08748]; NIH Prostate SPORE [P50-CA92629]; NATIONAL CANCER INSTITUTE [P50CA092629, R25CA096945, P30CA008748, R24CA083084] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center of MSKCC; Office of Science (BER)-US Department of Energy(United States Department of Energy (DOE)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Prostate SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Pillarsetty, B. Carver, D. Ulmert and P. Zanzonico for informative discussions, V. Longo for assistance with the in vivo studies, and M. Balbas for help with in vitro experiments. We thank C. Le and D. Winkleman for recording the MRI data and B. Beattie for assistance with co-registering PET/CT data. We thank M. McDevitt for assistance with HPLC stability studies. We also thank the staff of the Radiochemistry and Cyclotron Core at MSKCC. Funded in part by the Geoffrey Beene Cancer Research Center of MSKCC (J.S.L.), the Office of Science (BER)-US Department of Energy (Award DE-SC0002456, J.S.L.) and the R25T Molecular Imaging for Training in Oncology Program (2R25-CA096945; principal investigator H. Hricak; fellows: M.J.E. and S. L. R.) from the US National Cancer Institute. Technical services provided by the MSKCC Small-Animal Imaging Core Facility were supported in part by the US National Institutes of Health (NIH) grant R24-CA83084; NIH Center grant P30-CA08748; and NIH Prostate SPORE, P50-CA92629.	Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Aloj L, 1997, HEPATOLOGY, V25, P986, DOI 10.1002/hep.510250432; Aloj L, 1996, J NUCL MED, V37, P1408; Aloj L, 1999, J NUCL MED, V40, P1547; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beattie BJ, 2007, MOL IMAGING, V6, P108, DOI 10.2310/7290.2007.00008; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gayed I, 2004, J NUCL MED, V45, P17; Gotthardt M, 2010, J NUCL MED, V51, P1937, DOI 10.2967/jnumed.110.076232; HAYNES BF, 1981, J IMMUNOL, V126, P1409; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Holland J.P., 2010, TECHNETIUM OTHER RAD, P187; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Holland JP, 2010, MOL IMAGING, V9, P1, DOI 10.2310/7290.2010.00008; Holland JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008859; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; LARSON SM, 1978, SEMIN NUCL MED, V8, P193, DOI 10.1016/S0001-2998(78)80028-2; Lee SI, 2008, RHEUMATOL INT, V29, P153, DOI 10.1007/s00296-008-0655-z; MEIJS WE, 1992, APPL RADIAT ISOTOPES, V43, P1443, DOI 10.1016/0883-2889(92)90170-J; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; OHKUBO Y, 1985, Radioisotopes, V34, P7; Pellegrino D, 2005, J NUCL MED, V46, P1522; Prost A C, 1990, Int J Rad Appl Instrum B, V17, P209, DOI 10.1016/0883-2897(90)90149-U; Richardson DR, 2002, ADV EXP MED BIOL, V509, P231; SOM P, 1983, EUR J NUCL MED, V8, P491, DOI 10.1007/BF00598908; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; TAETLE R, 1983, INT J CANCER, V32, P343, DOI 10.1002/ijc.2910320314; Vavere AL, 2005, J NUCL MED, V46, P683; Verel I, 2003, J NUCL MED, V44, P1271; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Weiner RE, 1996, NUCL MED BIOL, V23, P745, DOI 10.1016/0969-8051(96)00119-9; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	40	70	71	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1586	U197		10.1038/nm.2935	http://dx.doi.org/10.1038/nm.2935			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23001181	Green Submitted, Green Accepted			2022-12-25	WOS:000309587500039
J	Qi, L; Haurwitz, RE; Shao, WJ; Doudna, JA; Arkin, AP				Qi, Lei; Haurwitz, Rachel E.; Shao, Wenjun; Doudna, Jennifer A.; Arkin, Adam P.			RNA processing enables predictable programming of gene expression	NATURE BIOTECHNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; ANTIVIRAL DEFENSE; CRISPR RNA; NETWORKS; BACTERIA; PATHWAY; PROKARYOTES; MATURATION; REGULATORS	Complex interactions among genetic components often result in variable systemic performance in designed multigene systems(1,2). Using the bacterial clustered regularly interspaced short palindromic repeat (CRISPR) pathway(3,4) we develop a synthetic RNA-processing platform, and show that efficient and specific cleavage of precursor mRNA enables reliable and predictable regulation of multigene operons. Physical separation of linked genetic elements by CRISPR-mediated cleavage is an effective strategy to achieve assembly of promoters, ribosome binding sites, cis-regulatory elements, and riboregulators into single- and multigene operons with predictable functions in bacteria. We also demonstrate that CRISPR-based RNA cleavage is effective for regulation in bacteria, archaea and eukaryotes. Programmable RNA processing using CRISPR offers a general approach for creating context-free genetic elements and can be readily used in the bottom-up construction of increasingly complex biological systems in a plug-and-play manner.	[Qi, Lei; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Haurwitz, Rachel E.; Shao, Wenjun; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Arkin, Adam P.] Calif Inst Quantitat Biosci QB3, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Arkin, AP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008; Qi, Lei S/AAC-5088-2019	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Qi, Lei S/0000-0002-3965-3223	US National Science Foundation (SynBERC); Department of Energy through Laboratory Directed Research and Development [DE-AC02-05CH11231d]; Howard Hughes Medical Institute	US National Science Foundation (SynBERC); Department of Energy through Laboratory Directed Research and Development; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank members of BIOFAB, International Open Facility Advancing Biotechnology, for distributing genetic parts, and J. Dueber, M. Lee and H. Lee (University of California, Berkeley) for providing the yeast vector. This work was supported by the US National Science Foundation (SynBERC, NSFEEC-0540879, L.Q. and A.P.A.), Department of Energy through Laboratory Directed Research and Development (DE-AC02-05CH11231d, L.Q., W.S. and A.P.A.) and Howard Hughes Medical Institute (R.E.H. and J.A.D.).	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DUNN JJ, 1973, P NATL ACAD SCI USA, V70, P3296, DOI 10.1073/pnas.70.12.3296; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Espeli O, 2001, J MOL BIOL, V314, P375, DOI 10.1006/jmbi.2001.5150; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WEK RC, 1987, J BIOL CHEM, V262, P15256; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zaslaver A, 2011, CELL, V145, P981, DOI 10.1016/j.cell.2011.05.013	34	142	170	4	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					1002	+		10.1038/nbt.2355	http://dx.doi.org/10.1038/nbt.2355			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	22983090				2022-12-25	WOS:000309965500028
J	Ramachandran, R; Zhao, XF; Goldman, D				Ramachandran, Rajesh; Zhao, Xiao-Feng; Goldman, Daniel			Insm1a-mediated gene repression is essential for the formation and differentiation of Muller glia-derived progenitors in the injured retina	NATURE CELL BIOLOGY			English	Article							ZEBRAFISH RETINA; CELL PROLIFERATION; LUNG-CANCER; NEUROENDOCRINE DIFFERENTIATION; SIGNALING PATHWAYS; ADULT ZEBRAFISH; MOUSE RETINA; INSM1 IA-1; REGENERATION; EXPRESSION	In zebrafish, retinal injury stimulates Muller glia (MG) reprograming, allowing them to generate multipotent progenitors that replace damaged cells and restore vision. Recent studies suggest that transcriptional repression may underlie these events. To identify transcriptional repressors, we compared the transcriptomes of MG and MG-derived progenitors and identified insm1a, a repressor exhibiting a biphasic pattern of expression that is essential for retina regeneration. Insm1a was found to suppress ascl1a and its own expression, and link injury-dependent ascl1a induction with the suppression of the Wnt inhibitor dickkopf (dkk), which is necessary for MG dedifferentiation. We also found that Insm1a was responsible for sculpting the zone of injury-responsive MG by suppressing hb-egf(a) expression. Finally, we provide evidence that Insm1a stimulates progenitor cell-cycle exit by suppressing a genetic program driving progenitor proliferation. Our studies identify Insm1a as a key regulator of retina regeneration and provide a mechanistic understanding of how it contributes to multiple phases of this process.	[Ramachandran, Rajesh; Zhao, Xiao-Feng; Goldman, Daniel] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Ramachandran, Rajesh; Zhao, Xiao-Feng; Goldman, Daniel] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Goldman, D (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	neuroman@umich.edu		Ramachandran, Rajesh/0000-0002-9888-4750	NEI from the NIH [RO1 EY 018132]; NATIONAL EYE INSTITUTE [R01EY018132] Funding Source: NIH RePORTER	NEI from the NIH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NEI grant RO1 EY 018132 from the NIH. We thank D. Hyde (University of Notre Dame, USA) for gfap:gfp transgenic fish; R. Moon (University of Washington, USA) for hsp70:dkk1b-gfp transgenic fish; the University of Michigan Flow Cytometry Core for cell sorting; A. Dombrowski (Wayne State, USA) for microarray screen; R. Thompson (University of Michigan, USA) for assistance with microarray data organization; M. Uhler and D. Turner (University of Michigan, USA) for providing the pEL and pCS2 vectors, respectively; J. Beals (University of Michigan, USA) for help with confocal microscopy; the Goldman laboratory for helpful comments and suggestions during the course of this research; and R. Karr for fish care.	Barthel LK, 2000, METHOD ENZYMOL, V316, P579; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Hochmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030365; Jacob J, 2009, DEVELOPMENT, V136, P2477, DOI 10.1242/dev.034546; Johansson TA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-321; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kassen SC, 2009, EXP EYE RES, V88, P1051, DOI 10.1016/j.exer.2009.01.007; LAN MS, 1993, CANCER RES, V53, P4169; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Lukowski CM, 2006, GENE EXPR PATTERNS, V6, P711, DOI 10.1016/j.modgep.2005.12.008; Momiji H, 2008, ADV EXP MED BIOL, V641, P72; Morris AC, 2011, INVEST OPHTH VIS SCI, V52, P2255, DOI 10.1167/iovs.10-6022; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Pedersen N, 2003, CANCER RES, V63, P1943; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; Rosenbaum JN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-6; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Shkumatava A, 2005, EMBO REP, V6, P563, DOI 10.1038/sj.embor.7400416; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Thummel R, 2010, EXP EYE RES, V90, P572, DOI 10.1016/j.exer.2010.02.001; Tiana G, 2007, PHYS BIOL, V4, pR1, DOI 10.1088/1478-3975/4/2/R01; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Wan J, 2008, VISION RES, V48, P223, DOI 10.1016/j.visres.2007.11.002; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783; Zhang T, 2009, J BIOL CHEM, V284, P5574, DOI 10.1074/jbc.M808843200	44	76	78	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1013	+		10.1038/ncb2586	http://dx.doi.org/10.1038/ncb2586			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	23000964	Green Accepted			2022-12-25	WOS:000309543800010
J	Maruyama, C; Toyoda, J; Kato, Y; Izumikawa, M; Takagi, M; Shin-ya, K; Katano, H; Utagawa, T; Hamano, Y				Maruyama, Chitose; Toyoda, Junya; Kato, Yasuo; Izumikawa, Miho; Takagi, Motoki; Shin-ya, Kazuo; Katano, Hajime; Utagawa, Takashi; Hamano, Yoshimitsu			A stand-alone adenylation domain forms amide bonds in streptothricin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; LABORATORY-ANIMALS; SELECTABLE MARKER; GENE DISRUPTION; STREPTOMYCES; NOURSEOTHRICIN; ANTIBIOTICS; CASSETTES; TOXICITY; PRODUCTS	The streptothricin (ST) antibiotics, produced by Streptomyces bacteria, contain L-beta-lysine ((3S)-3,6-diaminohexanoic acid) oligopeptides as pendant chains. Here we describe three unusual nonribosomal peptide synthetases (NRPSs) involved in ST biosynthesis: ORF 5 (a stand-alone adenylation (A) domain), ORF 18 (containing thiolation (T) and condensation (C) domains) and ORF 19 (a stand-alone A domain). We demonstrate that ST biosynthesis begins with adenylation of L-beta-lysine by ORF 5, followed by transfer to the T domain of ORF 18. In contrast, L-beta-lysine molecules adenylated by ORF 19 are used to elongate an L-beta-lysine peptide chain on ORF 18, a reaction unexpectedly catalyzed by ORF 19 itself. Finally, the C domain of ORF 18 catalyzes the condensation of L-beta-lysine oligopeptides covalently bound to ORF 18 with a freely diffusible intermediate to release the ST products. These results highlight an unusual activity for an A domain and unique mechanisms of crosstalk within NRPS machinery.	[Maruyama, Chitose; Toyoda, Junya; Katano, Hajime; Utagawa, Takashi; Hamano, Yoshimitsu] Fukui Prefectural Univ, Dept Biosci, Fukui, Japan; [Kato, Yasuo] Toyama Prefectural Univ, Dept Biotechnol, Toyama, Japan; [Izumikawa, Miho; Takagi, Motoki] Japan Biol Informat Consortium, Tokyo, Japan; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan	Fukui Prefectural University; Toyama Prefectural University; National Institute of Advanced Industrial Science & Technology (AIST)	Hamano, Y (corresponding author), Fukui Prefectural Univ, Dept Biosci, Fukui, Japan.	hamano@fpu.ac.jp	Takagi, Motoki/Q-7390-2019; Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661; Maruyama, Chitose/0000-0001-7354-9342; Katano, Hajime/0000-0001-6937-3858; Hamano, Yoshimitsu/0000-0001-5117-5116	Japan Society for the Promotion of Science (JSPS) [22688007]; Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan; JSPS [23108520]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank N. Iwasaki and J. Seta (Bruker Daltonics K.K.) for assistance with HPLC/Q-TOF MS data collection. Plasmids pKD46 and pCP 20 and E. coli BW25113 were supplied by H. Mori (Nara Institute of Science and Technology). This work was supported, in part, by Grant-in-Aid for Young Scientists (A) (22688007) from the Japan Society for the Promotion of Science (JSPS; to Y.H.), the Industrial Technology Research Grant Program in 2008 from the New Energy and Industrial Technology Development Organization of Japan (to Y.H.) and by Grant-in-Aid for Scientific Research on Innovative Area (23108520) from the JSPS (to Y.H.).	BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; CHAMBERLAIN DA, 1994, AUST J PLANT PHYSIOL, V21, P95, DOI 10.1071/PP9940095; FernandezMoreno MA, 1997, J BACTERIOL, V179, P6929, DOI 10.1128/jb.179.22.6929-6936.1997; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grammel N, 2002, EUR J BIOCHEM, V269, P347, DOI 10.1046/j.0014-2956.2001.02657.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hamano Y, 2006, J BIOL CHEM, V281, P16842, DOI 10.1074/jbc.M602294200; HARTL A, 1986, ARCH EXP VET MED, V40, P727; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hisamoto M, 1998, J ANTIBIOT, V51, P607, DOI 10.7164/antibiotics.51.607; HOFFMANN H, 1986, ARCH EXP VET MED, V40, P710; HOFFMANN H, 1986, ARCH EXP VET MED, V40, P699; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Ji ZQ, 2007, J ANTIBIOT, V60, P739, DOI 10.1038/ja.2007.96; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KUSUMOTO S, 1982, J ANTIBIOT, V35, P925, DOI 10.7164/antibiotics.35.925; KUSUMOTO S, 1982, TETRAHEDRON LETT, V23, P2961, DOI 10.1016/S0040-4039(00)87506-1; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Schmutz E, 2003, EUR J BIOCHEM, V270, P4413, DOI 10.1046/j.1432-1033.2003.03830.x; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; TAKEMOTO T, 1980, CHEM PHARM BULL, V28, P2884; Waksman SA, 1943, J BACTERIOL, V46, P299, DOI 10.1128/JB.46.3.299-310.1943; Walsh C., 2003, ANTIBIOTICS ACTION O; Zhang WJ, 2011, J AM CHEM SOC, V133, P5240, DOI 10.1021/ja2011109	29	79	81	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					791	797		10.1038/NCHEMBIO.1040	http://dx.doi.org/10.1038/NCHEMBIO.1040			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22820420				2022-12-25	WOS:000308077600011
J	Harper, AL; Trick, M; Higgins, J; Fraser, F; Clissold, L; Wells, R; Hattori, C; Werner, P; Bancroft, I				Harper, Andrea L.; Trick, Martin; Higgins, Janet; Fraser, Fiona; Clissold, Leah; Wells, Rachel; Hattori, Chie; Werner, Peter; Bancroft, Ian			Associative transcriptomics of traits in the polyploid crop species Brassica napus	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; OILSEED RAPE; RNA-SEQ; GENE; ARCHITECTURE; PATTERNS; SEGMENTS; OLERACEA; REVEALS	Association genetics can quickly and efficiently delineate regions of the genome that control traits and provide markers to accelerate breeding by marker-assisted selection. But most crops are polyploid, making it difficult to identify the required markers and to assemble a genome sequence to order those markers. To circumvent this difficulty, we developed associative transcriptomics, which uses transcriptome sequencing to identify and score molecular markers representing variation in both gene sequences and gene expression, and correlate this with trait variation. Applying the method in the recently formed tetraploid crop Brassica napus, we identified genomic deletions that underlie two quantitative trait loci for glucosinolate content of seeds. The deleted regions contained orthologs of the transcription factor HAG1 (At5g61420), which controls aliphatic glucosinolate biosynthesis in Arabidopsis thaliana. This approach facilitates the application of association genetics in a broad range of crops, even those with complex genomes.	[Harper, Andrea L.; Trick, Martin; Higgins, Janet; Fraser, Fiona; Clissold, Leah; Wells, Rachel; Hattori, Chie; Bancroft, Ian] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Werner, Peter] KWS UK Ltd, Thriplow, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bancroft, I (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	ian.bancroft@jic.ac.uk	Bancroft, Ian/AAH-3831-2020	Harper, Andrea/0000-0003-3859-1152; Bancroft, Ian/0000-0001-7707-1171	UK Biotechnology and Biological Sciences Research Council [BBSRC BB/H004351/1, BB/E017363/1, ERAPG08.008]; UK Department for Environment, Food and Rural Affairs [Defra IF0144]; BBSRC [BBS/E/T/000PR6193, BB/E017363/1, BB/H004351/1, BB/G024952/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017363/1, BB/H004351/1, BBS/E/T/000PR6193, BB/G024952/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank The Genome Analysis Centre for generating Illumina sequence data. This work was supported by UK Biotechnology and Biological Sciences Research Council (BBSRC BB/H004351/1 (IBTI Club), BB/E017363/1, ERAPG08.008) and UK Department for Environment, Food and Rural Affairs (Defra IF0144). We would like to thank R. Snowdon, J. Barker and G. Teakle for providing germplasm. We would like to thank D. Manning and M. Turner of KWS-UK and P. Tillmann of Verband Deutscher Landwirtschaftlicher Untersuchungs und Forschungsanstalten (VDLUFA) Qualitatssicherung NIRS/NIT, Kassel, Germany, for their assistance with NIRS measurements.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hasan M, 2006, GENET RESOUR CROP EV, V53, P793, DOI 10.1007/s10722-004-5541-2; Higgins J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-247; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Howell PM, 2003, GENOME, V46, P454, DOI 10.1139/G03-028; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Parkin IAP, 2003, GENOME, V46, P291, DOI [10.1139/g03-006, 10.1139/G03-006]; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Schmidt R, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0; Stokes D, 2010, MOL BREEDING, V26, P91, DOI 10.1007/s11032-009-9379-3; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	29	207	231	1	157	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					798	802		10.1038/nbt.2302	http://dx.doi.org/10.1038/nbt.2302			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22820317				2022-12-25	WOS:000307416900024
J	Loh, PR; Baym, M; Berger, B				Loh, Po-Ru; Baym, Michael; Berger, Bonnie			Compressive genomics	NATURE BIOTECHNOLOGY			English	Article							SEQUENCE; ALIGNMENT; RETRIEVAL; STORAGE; TOOL	Algorithms that compute directly on compressed genomic data allow analyses to keep pace with data generation.	[Loh, Po-Ru; Baym, Michael; Berger, Bonnie] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; [Loh, Po-Ru; Baym, Michael; Berger, Bonnie] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Baym, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Loh, PR (corresponding author), MIT, Dept Math & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bab@mit.edu; baym@mit.edu		Berger, Bonnie/0000-0002-2724-7228; Baym, Michael/0000-0003-1303-5598	Direct For Mathematical & Physical Scien [0903013] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brandon MC, 2009, BIOINFORMATICS, V25, P1731, DOI 10.1093/bioinformatics/btp319; CARTER DM, 2005, SACCHAROMYCES GENOME; Chen X, 2002, BIOINFORMATICS, V18, P1696, DOI 10.1093/bioinformatics/18.12.1696; Christley S, 2009, BIOINFORMATICS, V25, P274, DOI 10.1093/bioinformatics/btn582; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Gross M, 2011, CURR BIOL, V21, pR204, DOI 10.1016/j.cub.2011.03.009; Grumbach S., 1994, J INFORM PROCESSING, V30, P875; Huttenhower C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000779; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kozanitis C, 2010, LECT N BIOINFORMAT, V6044, P310, DOI 10.1007/978-3-642-12683-3_20; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makinen V, 2009, LECT NOTES COMPUT SC, V5541, P121, DOI 10.1007/978-3-642-02008-7_9; Schatz MC, 2010, NAT BIOTECHNOL, V28, P691, DOI 10.1038/nbt0710-691; Stratton M, 2008, NAT BIOTECHNOL, V26, P65, DOI 10.1038/nbt0108-65; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	24	78	78	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					627	630		10.1038/nbt.2241	http://dx.doi.org/10.1038/nbt.2241			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781691	Bronze			2022-12-25	WOS:000306293400021
J	Wang, W; Barnabei, MS; Asp, ML; Heinis, FI; Arden, E; Davis, J; Braunlin, E; Li, Q; Davis, JP; Potter, JD; Metzger, JM				Wang, Wang; Barnabei, Matthew S.; Asp, Michelle L.; Heinis, Frazer I.; Arden, Erik; Davis, Jennifer; Braunlin, Elizabeth; Li, Qi; Davis, Jonathan P.; Potter, James D.; Metzger, Joseph M.			Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance	NATURE MEDICINE			English	Article							CALCIUM-BINDING PROTEIN; DIASTOLIC DYSFUNCTION; TROPONIN-I; GENE-TRANSFER; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY; PARVALBUMIN ISOFORMS; HEART-FAILURE; ANIMAL-MODEL; ION-BINDING	EF-hand proteins are ubiquitous in cell signaling. Parvalbumin (Parv), the archetypal EF-hand protein, is a high-affinity Ca2+ buffer in many biological systems. Given the centrality of Ca2+ signaling in health and disease, EF-hand motifs designed to have new biological activities may have widespread utility. Here, an EF-hand motif substitution that had been presumed to destroy EF-hand function, that of glutamine for glutamate at position 12 of the second cation binding loop domain of Parv (ParvE101Q), markedly inverted relative cation affinities: Mg2+ affinity increased, whereas Ca2+ affinity decreased, forming a new ultra-delayed Ca2+ buffer with favorable properties for promoting cardiac relaxation. In therapeutic testing, expression of ParvE101Q fully reversed the severe myocyte intrinsic contractile defect inherent to expression of native Parv and corrected abnormal myocardial relaxation in diastolic dysfunction disease models in vitro and in vivo. Strategic design of new EF-hand motif domains to modulate intracellular Ca2+ signaling could benefit many biological systems with abnormal Ca2+ handling, including the diseased heart.	[Wang, Wang; Barnabei, Matthew S.; Asp, Michelle L.; Heinis, Frazer I.; Arden, Erik; Davis, Jennifer; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Braunlin, Elizabeth] Univ Minnesota, Sch Med, Dept Pediat Cardiol, Minneapolis, MN 55455 USA; [Li, Qi; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Miami; University System of Ohio; Ohio State University	Metzger, JM (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98195 USA.	metzgerj@umn.edu	wang, wang/GWQ-7272-2022	DAVIS, JENNIFER/0000-0003-2380-1321; Wang, Wang/0000-0001-9093-412X	Lillehei Heart Institute; US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL115876, R01HL059301, R01HL091986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034107, T32AG029796] Funding Source: NIH RePORTER	Lillehei Heart Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Herron, E. Devaney, I. Turner, M. Maerz, F. Sjaastad, B. Liu, S. Little and T. Edwards for their assistance. We thank the Lillehei Heart Institute for support. We thank H Sabbah (Henry Ford Hospital Heart and Vascular Institute) for providing the canine failing myocytes. We thank K B. Andersson and G. Christensen (Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway) for providing the mice with inducible cardiac myocyte-specific excision of the SERCA2a. This work was supported by the US National Institutes of Health (J.M.M. and J.D.P.).	Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; BABU A, 1992, J BIOL CHEM, V267, P15469; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; Coutu P, 2002, BIOPHYS J, V82, P2565, DOI 10.1016/S0006-3495(02)75599-9; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Davis J, 2012, J MOL CELL CARDIOL, V53, P446, DOI 10.1016/j.yjmcc.2012.05.018; Day SM, 2008, PHYSIOL GENOMICS, V33, P312, DOI 10.1152/physiolgenomics.00302.2007; DECLERCQ JP, 1991, J MOL BIOL, V220, P1017, DOI 10.1016/0022-2836(91)90369-H; Dzimiri N, 1999, PHARMACOL REV, V51, P465; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HARRISON SM, 1990, AM J PHYSIOL, V258, pC282, DOI 10.1152/ajpcell.1990.258.2.C282; HEIZMANN CW, 1984, EXPERIENTIA, V40, P910, DOI 10.1007/BF01946439; Hirsch JC, 2004, AM J PHYSIOL-HEART C, V286, pH2314, DOI 10.1152/ajpheart.01137.2003; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HUTNIK CML, 1990, J BIOL CHEM, V265, P11456; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Johnson JD, 1999, BIOPHYS J, V76, P1514, DOI 10.1016/S0006-3495(99)77310-8; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P305; Kaye DM, 2008, ANNU REV MED, V59, P13, DOI 10.1146/annurev.med.59.052407.103237; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kitzman DW, 2007, HEART FAIL CLIN, V3, P437, DOI DOI 10.1016/J.HFC.2007.07.008; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LORELL BH, 1991, ANNU REV MED, V42, P411, DOI 10.1146/annurev.med.42.1.411; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mann D.L., 2004, HEART FAILURE COMPAN; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; NEGELE JC, 1992, J BIOL CHEM, V267, P825; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Rodenbaugh DW, 2007, AM J PHYSIOL-HEART C, V293, pH1705, DOI 10.1152/ajpheart.00232.2007; Rome LC, 2006, ANNU REV PHYSIOL, V68, P193, DOI 10.1146/annurev.physiol.68.040104.105418; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Schwartz A, 1984, METHOD PHARMACOL, V5, P63; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tang WHW, 2008, J AM COLL CARDIOL, V52, P1671, DOI 10.1016/j.jacc.2008.08.026; Townsend D, 2007, MOL THER, V15, P1086, DOI 10.1038/sj.mt.6300144; Wahr PA, 1999, P NATL ACAD SCI USA, V96, P11982, DOI 10.1073/pnas.96.21.11982; Wang W, 2008, CELL BIOCHEM BIOPHYS, V51, P1, DOI 10.1007/s12013-008-9011-x; Yang JJ, 2003, PROTEIN PEPTIDE LETT, V10, P331, DOI 10.2174/0929866033478852; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	55	32	33	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					305	312		10.1038/nm.3079	http://dx.doi.org/10.1038/nm.3079			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396207	Green Accepted			2022-12-25	WOS:000316040700023
J	Wirschell, M; Olbrich, H; Werner, C; Tritschler, D; Bower, R; Sale, WS; Loges, NT; Pennekamp, P; Lindberg, S; Stenram, U; Carlen, B; Horak, E; Kohler, G; Nurnberg, P; Nurnberg, G; Porter, ME; Omran, H				Wirschell, Maureen; Olbrich, Heike; Werner, Claudius; Tritschler, Douglas; Bower, Raqual; Sale, Winfield S.; Loges, Niki T.; Pennekamp, Petra; Lindberg, Sven; Stenram, Unne; Carlen, Birgitta; Horak, Elisabeth; Koehler, Gabriele; Nuernberg, Peter; Nuernberg, Gudrun; Porter, Mary E.; Omran, Heymut			The nexin-dynein regulatory complex subunit DRC1 is essential for motile cilia function in algae and humans	NATURE GENETICS			English	Article							CHLAMYDOMONAS-FLAGELLA; RADIAL SPOKES; DYSKINESIA; INNER; ARMS; MUTATIONS; IDENTIFICATION; ASYMMETRY; DEFECTS; MUTANTS	Primary ciliary dyskinesia (PCD) is characterized by dysfunction of respiratory cilia and sperm flagella and random determination of visceral asymmetry. Here, we identify the DRC1 subunit of the nexin-dynein regulatory complex (N-DRC), an axonemal structure critical for the regulation of dynein motors, and show that mutations in the gene encoding DRC1, CCDC164, are involved in PCD pathogenesis. Loss-of-function mutations disrupting DRC1 result in severe defects in assembly of the N-DRC structure and defective ciliary movement in Chlamydomonas reinhardtii and humans. Our results highlight a role for N-DRC integrity in regulating ciliary beating and provide the first direct evidence that mutations in DRC genes cause human disease.	[Wirschell, Maureen; Sale, Winfield S.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Olbrich, Heike; Werner, Claudius; Loges, Niki T.; Pennekamp, Petra; Omran, Heymut] Univ Hosp Muenster, Dept Pediat, Munster, Germany; [Tritschler, Douglas; Bower, Raqual; Porter, Mary E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Lindberg, Sven] Lund Univ, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden; [Lindberg, Sven] Skane Univ Hosp SUS, Lund, Sweden; [Stenram, Unne; Carlen, Birgitta] Lund Univ, Dept Pathol, Lund, Sweden; [Stenram, Unne; Carlen, Birgitta] SUS, Lund, Sweden; [Horak, Elisabeth] Med Univ Innsbruck, Div Cardiol & Pulmonol, Dept Pediat & Adolescents, A-6020 Innsbruck, Austria; [Koehler, Gabriele] Univ Hosp Muenster, Inst Pathol, Munster, Germany; [Nuernberg, Peter; Nuernberg, Gudrun] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter; Nuernberg, Gudrun] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Nuernberg, Peter; Nuernberg, Gudrun] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Emory University; University of Munster; University of Minnesota System; University of Minnesota Twin Cities; Lund University; Lund University; Skane University Hospital; Lund University; Medical University of Innsbruck; University of Munster; University of Cologne; University of Cologne; University of Cologne	Omran, H (corresponding author), Univ Hosp Muenster, Dept Pediat, Munster, Germany.	porte001@umn.edu; heymut.omran@ukmuenster.de		Omran, Heymut/0000-0003-0282-6765	US National Institutes of Health (NIH) [GM-55667, GM-051173]; National Research Service Award (NRSA) postdoctoral fellowship [GM-075446]; Children's Healthcare of Atlanta; Emory University School of Medicine Pediatric Research Center; Deutsche Forschungsgemeinschaft DFG [Om 6/4, Om 6/5, GRK1104, SFB592]; IZKF Muenster; Cell Dynamics and Disease (CEDAD) graduate school; SYSCILIA from the European Community; National Science Foundation (NSF) Major Research Instrumentation grants [9871237, NSF-DBI-0215759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055667, R37GM051173, R37GM055667, F32GM075446, R01GM051173] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA) postdoctoral fellowship; Children's Healthcare of Atlanta; Emory University School of Medicine Pediatric Research Center; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); IZKF Muenster; Cell Dynamics and Disease (CEDAD) graduate school; SYSCILIA from the European Community; National Science Foundation (NSF) Major Research Instrumentation grants(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Piperno for providing the peptide sequences used to identify the Chlamydomonas DRC1 gene. M.E.P. also thanks C. Perrone, T. vy Le, A. Bostrom, J. Mueller and J.A. Knott for assistance with mapping the DRC1 locus, P. Kathir, C. Silflow and S. Dutcher for advice on RFLP mapping and T. Markowski and B. Witthun for assistance with mass spectrometry and spectral counting. We thank the German patient support group Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V. We also thank A. Heer and C. Westermann for excellent technical assistance. We thank M. Laudon and the Chlamydomonas Genetics Center for strains. For antibodies, we thank R. Linck (University of Minnesota) for antibody to Rib72, M. Sanders (University of Minnesota) for MC1 antibody to centrin, R. Kamiya (University of Tokyo) for antibodies to tektin, p44 and p38, T. Yagi (Kyoto University) for antibodies to DHC5, DHC9 and DHC11, P. Yang (Marquette University) for antibody to RSP16, E. Smith (Dartmouth College) for antibody to CaM-IP3 and G. Piperno (Mount Sinai School of Medicine) for antibody to p28). This work was supported by US National Institutes of Health (NIH) grants to M.E.P. (GM-55667) and W.S.S. (GM-051173), a National Research Service Award (NRSA) postdoctoral fellowship to M.W. (GM-075446), funding to W.S.S. from the Children's Healthcare of Atlanta and Emory University School of Medicine Pediatric Research Center and funding to H. Omran (Deutsche Forschungsgemeinschaft DFG Om 6/4 and Om 6/5, GRK1104, SFB592, IZKF Muenster and the Cell Dynamics and Disease (CEDAD) graduate school as well as SYSCILIA from the European Community). The Center for Mass Spectrometry and Proteomics at the University of Minnesota is supported by multiple grants, including National Science Foundation (NSF) Major Research Instrumentation grants 9871237 and NSF-DBI-0215759. Technical and software support was also provided by the Minnesota Supercomputing Institute.	Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Carlen B, 2003, ULTRASTRUCT PATHOL, V27, P123, DOI 10.1080/01913120309930; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Dymek EE, 2011, MOL BIOL CELL, V22, P2520, DOI 10.1091/mbc.E11-03-0271; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Kabututu ZP, 2010, J CELL SCI, V123, P3587, DOI 10.1242/jcs.073817; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; O'Toole ET, 2012, CYTOSKELETON, V69, P577, DOI 10.1002/cm.21035; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; SILFLOW CD, 1981, COLD SPRING HARB SYM, V46, P157, DOI 10.1101/SQB.1982.046.01.019; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Yagi T, 2009, J CELL SCI, V122, P1306, DOI 10.1242/jcs.045096; Yanagisawa H, 2004, MOL BIOL CELL, V15, P2105, DOI 10.1091/mbc.E03-11-0854; Zadro C, 2010, INT J PEDIATR OTORHI, V74, P494, DOI 10.1016/j.ijporl.2010.02.004; Zariwala Maimoona A, 2011, Proc Am Thorac Soc, V8, P430, DOI 10.1513/pats.201103-023SD	31	133	142	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					262	268		10.1038/ng.2533	http://dx.doi.org/10.1038/ng.2533			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23354437	Green Accepted			2022-12-25	WOS:000315664800009
J	Piazza, R; Valletta, S; Winkelmann, N; Redaelli, S; Spinelli, R; Pirola, A; Antolini, L; Mologni, L; Donadoni, C; Papaemmanuil, E; Schnittger, S; Kim, DW; Boultwood, J; Rossi, F; Gaipa, G; De Martini, GP; Di Celle, PF; Jang, HG; Fantin, V; Bignell, GR; Magistroni, V; Haferlach, T; Pogliani, EM; Campbell, PJ; Chase, AJ; Tapper, WJ; Cross, NCP; Gambacorti-Passerini, C				Piazza, Rocco; Valletta, Simona; Winkelmann, Nils; Redaelli, Sara; Spinelli, Roberta; Pirola, Alessandra; Antolini, Laura; Mologni, Luca; Donadoni, Carla; Papaemmanuil, Elli; Schnittger, Susanne; Kim, Dong-Wook; Boultwood, Jacqueline; Rossi, Fabio; Gaipa, Giuseppe; De Martini, Greta P.; Di Celle, Paola Francia; Jang, Hyun Gyung; Fantin, Valeria; Bignell, Graham R.; Magistroni, Vera; Haferlach, Torsten; Pogliani, Enrico Maria; Campbell, Peter J.; Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.; Gambacorti-Passerini, Carlo			Recurrent SETBP1 mutations in atypical chronic myeloid leukemia	NATURE GENETICS			English	Article							SCHINZEL-GIEDION SYNDROME; MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS; DIFFERENTIAL EXPRESSION; RNA-SEQ; TUMOR-SUPPRESSOR; SELF-RENEWAL; GENOME; PROTEIN; FUSION; DISORDERS	Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML, but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and identified somatic alterations of SETBP1 (encoding a p.Gly870Ser alteration) in two cases. Targeted resequencing of 70 aCMLs, 574 diverse hematological malignancies and 344 cancer cell lines identified SETBP1 mutations in 24 cases, including 17 of 70 aCMLs (24.3%; 95% confidence interval (CI) = 16-35%). Most mutations (92%) were located between codons 858 and 871 and were identical to changes seen in individuals with Schinzel-Giedion syndrome. Individuals with mutations had higher white blood cell counts (P = 0.008) and worse prognosis (P = 0.01). The p.Gly870Ser alteration abrogated a site for ubiquitination, and cells exogenously expressing this mutant exhibited higher amounts of SETBP1 and SET protein, lower PP2A activity and higher proliferation rates relative to those expressing the wild-type protein. In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases.	[Piazza, Rocco; Valletta, Simona; Redaelli, Sara; Spinelli, Roberta; Pirola, Alessandra; Antolini, Laura; Mologni, Luca; Donadoni, Carla; De Martini, Greta P.; Magistroni, Vera; Pogliani, Enrico Maria; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Winkelmann, Nils; Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Winkelmann, Nils] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany; [Papaemmanuil, Elli; Bignell, Graham R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Schnittger, Susanne; Haferlach, Torsten] MLL, Munich, Germany; [Kim, Dong-Wook] Catholic Univ, Dept Hematol, Seoul, South Korea; [Boultwood, Jacqueline] John Radcliffe Hosp, Leukaemia & Lymphoma Res Mol Hematol Unit, Oxford OX3 9DU, England; [Rossi, Fabio] San Gerardo Hosp, Immunotransfus Unit, Monza, Italy; [Gaipa, Giuseppe] Univ Milano Bicocca, Pediat Clin, M Tettamanti Res Ctr, Monza, Italy; [Di Celle, Paola Francia] Azienda Ospeda San Giovanni Battista Torino, Lab Oncol Mol, Ctr Ric Med Sperimentale CeRMS, Turin, Italy; [Jang, Hyun Gyung; Fantin, Valeria] Agios Pharmaceut, Cambridge, MA USA; [Pogliani, Enrico Maria] San Gerardo Hosp, Hematol Unit, Monza, Italy; [Chase, Andrew J.; Tapper, William J.; Cross, Nicholas C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Gambacorti-Passerini, Carlo] San Gerardo Hosp, Hematol & Clin Res Unit, Monza, Italy	University of Milano-Bicocca; Salisbury District Hospital; Friedrich Schiller University of Jena; University of Cambridge; Wellcome Trust Sanger Institute; MLL Munich Leukemia Laboratory; Catholic University of Korea; University of Oxford; San Gerardo Hospital; University of Milano-Bicocca; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Agios Pharmaceuticals; San Gerardo Hospital; University of Southampton; San Gerardo Hospital	Gambacorti-Passerini, C (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	carlo.gambacorti@unimib.it	高, 雨莉/HGU-8187-2022; Antolini, Laura/C-6115-2018; Cross, Nicholas/B-4817-2009; Mologni, Luca/AAC-1065-2022; redaelli, sara/I-5146-2012; Magistroni, Vera/AAA-5582-2020	Cross, Nicholas/0000-0001-5481-2555; Mologni, Luca/0000-0002-6365-5149; redaelli, sara/0000-0003-0166-1188; Magistroni, Vera/0000-0002-7334-9401; Chase, Andrew/0000-0001-6617-9953; Rocco, Piazza/0000-0003-4198-9620; Tapper, William/0000-0002-5896-1889; Gaipa, Giuseppe/0000-0002-1006-5946; Valletta, Simona/0000-0002-3524-4991; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Boultwood, Jacqueline/0000-0002-4330-2928	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-10092]; Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) program [20084XBENM_004]; Fondazione Cariplo [2009-2667]; Lombardy Region [ID-16871, ID14546A]; Lombardy Region (FSE Dote Ricercatori) [16-AR]; Leukaemia and Lymphoma Research (UK); Korea Research Foundation [R21-2007-000-10041-0]; Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany) [109590]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) program(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); Lombardy Region(Regione Lombardia); Lombardy Region (FSE Dote Ricercatori); Leukaemia and Lymphoma Research (UK); Korea Research Foundation(National Research Foundation of Korea); Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany)	We kindly acknowledge the contributions of S. Mori in the preparation of this manuscript, M. Viltadi for technical help, G. Cazzaniga (Tettamanti Foundation, San Gerardo Hospital) for the MIGR1-EGFP plasmid and C. Cecchetti, Z. Sortino and C. Rizzo for clinical sample management. We thank M. Vogel for her critical reading of the manuscript. This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) 2010 (IG-10092 to C. G.-P.); Programmi di ricerca di Rilevante Interesse Nazionale (PRIN) program (20084XBENM_004 to R. P.); Fondazione Cariplo (2009-2667 to C. G.-P.); the Lombardy Region (ID-16871 and ID14546A to C. G.-P. and FSE Dote Ricercatori 16-AR to S. R.); Leukaemia and Lymphoma Research (UK) grants (to N.C.P.C. and J.B.); the Basic Research Program of the Korea Research Foundation (R21-2007-000-10041-0 to D.-W.K.) (2007); and Mildred Scheel Stiftung fuer Krebsforschung (Deutsche Krebshilfe, Germany, grant 109590 to N.W.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cristobal I, 2010, BLOOD, V115, P615, DOI 10.1182/blood-2009-06-227363; Cross NCP, 2012, ONCOTARGET, V3, P3; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ernst T, 2010, HAEMATOL-HEMATOL J, V95, P1473, DOI 10.3324/haematol.2010.021808; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Godley LA, 2012, NEW ENGL J MED, V366, P1152, DOI 10.1056/NEJMe1200409; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldman JM, 2010, SEMIN HEMATOL, V47, P302, DOI 10.1053/j.seminhematol.2010.07.001; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurzrock R, 2001, J CLIN ONCOL, V19, P2915, DOI 10.1200/JCO.2001.19.11.2915; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Manfredini R, 2005, STEM CELLS, V23, P496, DOI 10.1634/stemcells.2004-0265; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marubini E, 1995, ANAL SURVIVAL DATA C; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUNDY GR, 1991, CIBA F SYMP, V157, P137; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; NOWELL PC, 1960, SCIENCE, V132, P1497; Oakley K, 2012, BLOOD, V119, P6099, DOI 10.1182/blood-2011-10-388710; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Piazza R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks394; Randles R, 1979, INTRO THEORY NONPARA; Rebora P, 2010, AM J EPIDEMIOL, V172, P1028, DOI 10.1093/aje/kwq262; Reiter A, 2009, HAEMATOL-HEMATOL J, V94, P1634, DOI 10.3324/haematol.2009.014001; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Score J, 2012, BLOOD, V119, P1208, DOI 10.1182/blood-2011-07-367243; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2	52	268	273	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					18	U41		10.1038/ng.2495	http://dx.doi.org/10.1038/ng.2495			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23222956	Green Accepted			2022-12-25	WOS:000312838800008
J	Zhao, SC; Zheng, PP; Dong, SS; Zhan, XJ; Wu, Q; Guo, XS; Hu, YB; He, WM; Zhang, SN; Fan, W; Zhu, LF; Li, D; Zhang, XM; Chen, Q; Zhang, HM; Zhang, ZH; Jin, XL; Zhang, JG; Yang, HM; Wang, J; Wang, J; Wei, FW				Zhao, Shancen; Zheng, Pingping; Dong, Shanshan; Zhan, Xiangjiang; Wu, Qi; Guo, Xiaosen; Hu, Yibo; He, Weiming; Zhang, Shanning; Fan, Wei; Zhu, Lifeng; Li, Dong; Zhang, Xuemei; Chen, Quan; Zhang, Hemin; Zhang, Zhihe; Jin, Xuelin; Zhang, Jinguo; Yang, Huanming; Wang, Jian; Wang, Jun; Wei, Fuwen			Whole-genome sequencing of giant pandas provides insights into demographic history and local adaptation	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; TIBETAN PLATEAU; CLIMATE-CHANGE; F-STATISTICS; CHINA; RATES	The panda lineage dates back to the late Miocene(1) and ultimately leads to only one extant species, the giant panda (Ailuropoda melanoleuca). Although global climate change and anthropogenic disturbances are recognized to shape animal population demography(2,3) their contribution to panda population dynamics remains largely unknown. We sequenced the whole genomes of 34 pandas at an average 4.7-fold coverage and used this data set together with the previously deep-sequenced panda genome(4) to reconstruct a continuous demographic history of pandas from their origin to the present. We identify two population expansions, two bottlenecks and two divergences. Evidence indicated that, whereas global changes in climate were the primary drivers of population fluctuation for millions of years, human activities likely underlie recent population divergence and serious decline. We identified three distinct panda populations that show genetic adaptation to their environments. However, in all three populations, anthropogenic activities have negatively affected pandas for 3,000 years.	[Zhao, Shancen; Zheng, Pingping; Zhan, Xiangjiang; Wu, Qi; Hu, Yibo; Zhu, Lifeng; Wei, Fuwen] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhao, Shancen; Dong, Shanshan; Guo, Xiaosen; He, Weiming; Fan, Wei; Li, Dong; Zhang, Xuemei; Chen, Quan; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen, Peoples R China; [Zheng, Pingping] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Zhang, Shanning] China Wildlife Conservat Soc, Beijing, Peoples R China; [Zhang, Hemin] China Conservat & Res Ctr Giant Panda, Wolong, Peoples R China; [Zhang, Zhihe] Chengdu Res Base Giant Panda Breeding, Chengdu, Peoples R China; [Jin, Xuelin] Shaanxi Wild Anim Rescue & Res Ctr, Xian, Peoples R China; [Zhang, Jinguo] Beijing Zoo, Beijing, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen	Wei, FW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	wangj@genomics.org.cn; weifw@ioz.ac.cn	Zhu, Lifeng/AAK-8892-2020; Wang, Jun/A-7261-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Wang, Jun/0000-0002-8540-8931; Zheng, Pingping/0000-0002-6059-8919; Hu, Yibo/0000-0003-3409-3164; Wang, Jun/0000-0002-2113-5874	National Natural Science Foundation of China [31230011]; Chinese Academy of Sciences [KSCX2-EW-Z-4]; State Forestry Administration of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); State Forestry Administration of China	This study was supported by grants from the National Natural Science Foundation of China (31230011), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4) and the State Forestry Administration of China. We thank the Chongqing Zoo, the Fuzhou Research Center of the Giant Panda, the Shanghai Zoo, the Shanghai Wildlife Park and the Zhengzhou Zoo for assistance during sample collection. We acknowledge T. Meng for generation of the panda distribution map, R.N. Gutenkunst for suggestions on analysis with partial derivative a partial derivative i, H. Li for suggestions on PSMC simulations and L. Goodman, J. Elser, M. Holyoak, S. Kumar and R. R. Swaisgood for comments and revisions of this manuscript. We also thank G. Tian, M. Jian, H. Jiang, M. Zhao, Q. Zhang, B. Wang, Y. Huang, G. Wang, C. Lin and F. Xi for laboratory assistance and B. Li for assistance on polar bear data analysis.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Buckley J, 2012, MOL ECOL, V21, P267, DOI 10.1111/j.1365-294X.2011.05388.x; COCKERHAM CC, 1993, EVOLUTION, V47, P855, DOI 10.1111/j.1558-5646.1993.tb01239.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hagey L, 2003, J CHEM ECOL, V29, P1479, DOI 10.1023/A:1024225806263; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hu Jinchu, 2004, P137; Huang K, 2012, HEREDITY, V108, P96, DOI 10.1038/hdy.2011.52; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jin CZ, 2007, P NATL ACAD SCI USA, V104, P10932, DOI 10.1073/pnas.0704198104; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Pan W., 2001, CHANCE LASTING SURVI; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PEI W-C, 1974, Acta Zoologica Sinica, V20, P188; Qiu Zhanxiang, 1989, Vertebrata Palasiatica, V27, P153; Ren GY, 2000, J QUATERNARY SCI, V15, P273, DOI 10.1002/(SICI)1099-1417(200003)15:3<273::AID-JQS504>3.3.CO;2-U; Ren GY, 2002, QUATERNARY SCI REV, V21, P1395, DOI 10.1016/S0277-3791(01)00119-6; Ren N., 1987, ILLUSTRATIONS ANNOTA; ROOT TL, 1995, SCIENCE, V269, P334, DOI 10.1126/science.269.5222.334; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaller GB, 1985, GIANT PANDA WOLONG; State Forestry Administration, 2006, 3 NAT SURV REP GAINT; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun YB, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006064; Swaisgood Ronald R., 2004, P106; TAJIMA F, 1983, GENETICS, V105, P437; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Wang JK, 1974, ACTA ZOOL SINICA, V20, P191; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEI F, 1989, Acta Theriologica Sinica, V9, P81; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; Zhao HB, 2010, MOL BIOL EVOL, V27, P2669, DOI 10.1093/molbev/msq153; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhu LF, 2010, CONSERV BIOL, V24, P1299, DOI 10.1111/j.1523-1739.2010.01499.x	46	198	222	11	352	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					67	U99		10.1038/ng.2494	http://dx.doi.org/10.1038/ng.2494			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23242367				2022-12-25	WOS:000312838800014
J	Lan, Q; Hsiung, CA; Matsuo, K; Hong, YC; Seow, A; Wang, ZM; Hosgood, HD; Chen, KX; Wang, JC; Chatterjee, N; Hu, W; Wong, MP; Zheng, W; Caporaso, N; Park, JY; Chen, CJ; Kim, YH; Kim, YT; Landi, MT; Shen, HB; Lawrence, C; Burdett, L; Yeager, M; Yuenger, J; Jacobs, KB; Chang, IS; Mitsudomi, T; Kim, HN; Chang, GC; Bassig, BA; Tucker, M; Wei, FS; Yin, ZH; Wu, C; An, SJ; Qian, BY; Lee, VHF; Lu, DR; Liu, JJ; Jeon, HS; Hsiao, CF; Sung, JS; Kim, JH; Gao, YT; Tsai, YH; Jung, YJ; Guo, H; Hu, ZB; Hutchinson, A; Wang, WC; Klein, R; Chung, CC; Oh, IJ; Chen, KY; Berndt, SI; He, XZ; Wu, W; Chang, J; Zhang, XC; Huang, MS; Zheng, H; Wang, JW; Zhao, XY; Li, YQ; Choi, JE; Su, WC; Park, KH; Sung, SW; Shu, XO; Chen, YM; Liu, L; Kang, CH; Hu, LM; Chen, CH; Pao, W; Kim, YC; Yang, TY; Xu, J; Guan, P; Tan, W; Su, J; Wang, CL; Li, HX; Sihoe, ADL; Zhao, ZH; Chen, Y; Choi, YY; Hung, JY; Kim, JS; Yoon, HI; Cai, QY; Lin, CC; Park, IK; Xu, P; Dong, J; Kim, C; He, QC; Perng, RP; Kohno, T; Kweon, SS; Chen, CY; Vermeulen, R; Wu, JJ; Lim, WY; Chen, KC; Chow, WH; Ji, BT; Chan, JKC; Chu, MJ; Li, YJ; Yokota, J; Li, JH; Chen, HY; Xiang, YB; Yu, CJ; Kunitoh, H; Wu, GP; Jin, L; Lo, YL; Shiraishi, K; Chen, YH; Lin, HC; Wu, TC; Wu, YL; Yang, PC; Zhou, BS; Shin, MH; Fraumeni, JF; Lin, DX; Chanock, SJ; Rothman, N				Lan, Qing; Hsiung, Chao A.; Matsuo, Keitaro; Hong, Yun-Chul; Seow, Adeline; Wang, Zhaoming; Hosgood, H. Dean, III; Chen, Kexin; Wang, Jiu-Cun; Chatterjee, Nilanjan; Hu, Wei; Wong, Maria Pik; Zheng, Wei; Caporaso, Neil; Park, Jae Yong; Chen, Chien-Jen; Kim, Yeul Hong; Kim, Young Tae; Landi, Maria Teresa; Shen, Hongbing; Lawrence, Charles; Burdett, Laurie; Yeager, Meredith; Yuenger, Jeffrey; Jacobs, Kevin B.; Chang, I-Shou; Mitsudomi, Tetsuya; Kim, Hee Nam; Chang, Gee-Chen; Bassig, Bryan A.; Tucker, Margaret; Wei, Fusheng; Yin, Zhihua; Wu, Chen; An, She-Juan; Qian, Biyun; Lee, Victor Ho Fun; Lu, Daru; Liu, Jianjun; Jeon, Hyo-Sung; Hsiao, Chin-Fu; Sung, Jae Sook; Kim, Jin Hee; Gao, Yu-Tang; Tsai, Ying-Huang; Jung, Yoo Jin; Guo, Huan; Hu, Zhibin; Hutchinson, Amy; Wang, Wen-Chang; Klein, Robert; Chung, Charles C.; Oh, In-Jae; Chen, Kuan-Yu; Berndt, Sonja I.; He, Xingzhou; Wu, Wei; Chang, Jiang; Zhang, Xu-Chao; Huang, Ming-Shyan; Zheng, Hong; Wang, Junwen; Zhao, Xueying; Li, Yuqing; Choi, Jin Eun; Su, Wu-Chou; Park, Kyong Hwa; Sung, Sook Whan; Shu, Xiao-Ou; Chen, Yuh-Min; Liu, Li; Kang, Chang Hyun; Hu, Lingmin; Chen, Chung-Hsing; Pao, William; Kim, Young-Chul; Yang, Tsung-Ying; Xu, Jun; Guan, Peng; Tan, Wen; Su, Jian; Wang, Chih-Liang; Li, Haixin; Sihoe, Alan Dart Loon; Zhao, Zhenhong; Chen, Ying; Choi, Yi Young; Hung, Jen-Yu; Kim, Jun Suk; Yoon, Ho-Il; Cai, Qiuyin; Lin, Chien-Chung; Park, In Kyu; Xu, Ping; Dong, Jing; Kim, Christopher; He, Qincheng; Perng, Reury-Perng; Kohno, Takashi; Kweon, Sun-Seog; Chen, Chih-Yi; Vermeulen, Roel; Wu, Junjie; Lim, Wei-Yen; Chen, Kun-Chieh; Chow, Wong-Ho; Ji, Bu-Tian; Chan, John K. C.; Chu, Minjie; Li, Yao-Jen; Yokota, Jun; Li, Jihua; Chen, Hongyan; Xiang, Yong-Bing; Yu, Chong-Jen; Kunitoh, Hideo; Wu, Guoping; Jin, Li; Lo, Yen-Li; Shiraishi, Kouya; Chen, Ying-Hsiang; Lin, Hsien-Chih; Wu, Tangchun; Wu, Yi-Long; Yang, Pan-Chyr; Zhou, Baosen; Shin, Min-Ho; Fraumeni, Joseph F., Jr.; Lin, Dongxin; Chanock, Stephen J.; Rothman, Nathaniel			Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia	NATURE GENETICS			English	Article							SMOKERS; RISK; ADENOCARCINOMA; VARIANTS; VTI1A; IMPUTATION; JAPANESE; DISEASE; COMMON; 15Q25	To identify common genetic variants that contribute to lung cancer susceptibility, we conducted a multistage genome-wide association study of lung cancer in Asian women who never smoked. We scanned 5,510 never-smoking female lung cancer' cases and 4,544 controls drawn from 14 studies from mainland China, South Korea, Japan, Singapore, Taiwan and Hong Kong. We genotyped the most promising variants (associated at P < 5 x 10(-6)) in an additional 1,099 cases and 2,913 controls. We identified three new susceptibility loci at 10q25.2 (rs7086803, P = 3.54 x 10(-18)), 6q22.2 (rs9387478, P = 4.14 x 10(-10)) and 6p21.32 (rs2395185, P = 9.51 x 10(-9)). We also confirmed associations reported for loci at 5p15.33 and 3q28 and a recently reported finding at 17q24.3. We observed no evidence of association for lung cancer at 15q25 in never-smoking women in Asia, providing strong evidence that this locus is not associated with lung cancer independent of smoking.	[Lan, Qing; Wang, Zhaoming; Burdett, Laurie; Yeager, Meredith; Yuenger, Jeffrey; Jacobs, Kevin B.; Hutchinson, Amy] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Hsiung, Chao A.; Hsiao, Chin-Fu; Wang, Wen-Chang; Lo, Yen-Li; Chen, Ying-Hsiang; Lin, Hsien-Chih] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Matsuo, Keitaro] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Seow, Adeline; Chen, Ying; Lim, Wei-Yen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hosgood, H. Dean, III] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Chen, Kexin; Qian, Biyun; Zheng, Hong; Li, Haixin] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Wang, Jiu-Cun; Lu, Daru; Zhao, Xueying; Zhao, Zhenhong; Wu, Junjie; Chen, Hongyan; Jin, Li] Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Lu, Daru; Zhao, Xueying; Zhao, Zhenhong; Wu, Junjie; Chen, Hongyan; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wong, Maria Pik] Univ Hong Kong, Li Ka Shing LKS Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Zheng, Wei; Shu, Xiao-Ou; Cai, Qiuyin] Vanderbilt Univ, Dept Med, Vanderbilt Epidemiol Ctr, Vanderbilt Ingram Canc Ctr,Inst Med & Publ Hlth, Nashville, TN USA; [Park, Jae Yong] Kyungpook Natl Univ, Med Ctr, Lung Canc Ctr, Taegu, South Korea; [Chen, Chien-Jen; Li, Yao-Jen] Genom Res Ctr, Taipei, Taiwan; [Kim, Yeul Hong; Sung, Jae Sook; Park, Kyong Hwa] Korea Univ, Coll Med, Anam Hosp, Dept Internal Med,Div Oncol Hematol, Seoul 136705, South Korea; [Kim, Young Tae; Jung, Yoo Jin; Kang, Chang Hyun; Park, In Kyu] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Shen, Hongbing; Hu, Zhibin; Hu, Lingmin; Dong, Jing; Chu, Minjie] Nanjing Med Univ, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Shen, Hongbing; Hu, Zhibin; Hu, Lingmin; Dong, Jing; Chu, Minjie] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Lawrence, Charles] Westat Corp, Rockville, MD USA; [Chang, I-Shou; Chen, Chung-Hsing] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Taiwan; [Mitsudomi, Tetsuya] Kinki Univ, Sch Med, Div Thorac Surg, Sayama, Osaka 589, Japan; [Kim, Hee Nam] Chonnam Natl Univ, Hwasun Hosp, Genome Res Ctr Hematopoiet Dis, Hwasun Eup, South Korea; [Chang, Gee-Chen; Chen, Yuh-Min] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan; [Chang, Gee-Chen; Yang, Tsung-Ying; Chen, Kun-Chieh] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Bassig, Bryan A.] Yale Univ, Sch Publ Hlth, Div Environm Hlth Sci, New Haven, CT USA; [Wei, Fusheng; Wu, Guoping] China Natl Environm Monitoring Ctr, Beijing, Peoples R China; [Yin, Zhihua; Wu, Wei; Guan, Peng; He, Qincheng; Zhou, Baosen] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Peoples R China; [Wu, Chen; Chang, Jiang; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Wu, Chen; Chang, Jiang; Tan, Wen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Chen; Chang, Jiang; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [An, She-Juan; Zhang, Xu-Chao; Su, Jian; Wu, Yi-Long] Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [An, She-Juan; Zhang, Xu-Chao; Su, Jian; Wu, Yi-Long] Guangdong Acad Med Sci, Guangdong Gen Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Lee, Victor Ho Fun] Univ Hong Kong, LKS Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Liu, Jianjun; Li, Yuqing] Genome Inst Singapore, Dept Human Genet, Singapore, Singapore; [Liu, Jianjun] Anhui Med Univ, Sch Life Sci, Hefei, Peoples R China; [Jeon, Hyo-Sung; Choi, Jin Eun; Choi, Yi Young] Kyungpook Natl Univ, Med Ctr, Canc Res Ctr, Taegu, South Korea; [Kim, Jin Hee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Tsai, Ying-Huang] Chang Gung Mem Hosp, Dept Resp Therapy, Chiayi, Taiwan; [Guo, Huan; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Inst Occupat Med, Wuhan 430074, Peoples R China; [Guo, Huan; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Klein, Robert; Wu, Tangchun] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Oh, In-Jae; Kim, Young-Chul] Chonnam Natl Univ, Hwasun Hosp, Lung & Esophageal Canc Clin, Hwasun Eup, South Korea; [Oh, In-Jae; Kim, Young-Chul] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Chen, Kuan-Yu; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [He, Xingzhou] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Huang, Ming-Shyan; Hung, Jen-Yu] Kaohsiung Med Univ, Sch Med, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Junwen] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Wang, Junwen] Univ Hong Kong, LKS Fac Med, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Su, Wu-Chou; Lin, Chien-Chung] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Sung, Sook Whan] Seoul Natl Univ, Bundang Hosp, Dept Thorac & Cardiovasc Surg, Songnam, South Korea; [Chen, Yuh-Min; Perng, Reury-Perng] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Liu, Li] Huazhong Univ Sci & Technol, Union Hosp, Ctr Canc, Wuhan 430074, Peoples R China; [Pao, William] Vanderbilt Univ, Med Ctr, Div Hematol & Oncol, Nashville, TN USA; [Xu, Jun] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wang, Chih-Liang] Chang Gung Mem Hosp, Dept Pulm & Crit Care, Tao Yuan, Taiwan; [Sihoe, Alan Dart Loon] Queen Mary Hosp, Div Cardiothorac Surg, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kim, Jun Suk] Korea Univ, Coll Med, Guro Hosp, Dept Internal Med,Div Med Oncol, Seoul 136705, South Korea; [Yoon, Ho-Il] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Xu, Ping] Wuhan Iron & Steel Corp Staff Worker Hosp, Dept Oncol, Wuhan, Peoples R China; [Kohno, Takashi; Shiraishi, Kouya] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Kweon, Sun-Seog] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, Hwasun Eup, South Korea; [Kweon, Sun-Seog; Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea; [Chen, Chih-Yi] China Med Univ & Hosp, Ctr Canc, Taichung, Taiwan; [Vermeulen, Roel] Univ Utrecht, IRAS, Div Environm Epidemiol, Utrecht, Netherlands; [Chan, John K. C.] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Yokota, Jun] Natl Canc Ctr, Res Inst, Div Multistep Carcinogenesis, Tokyo 104, Japan; [Li, Jihua] Qujing Ctr Dis Control & Prevent, Sanjiangdadao, Qujing, Peoples R China; [Kunitoh, Hideo] Mitsui Mem Hosp, Dept Resp Med, Tokyo 101, Japan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Health Research Institutes - Taiwan; Aichi Cancer Center; Seoul National University (SNU); National University of Singapore; Yeshiva University; Albert Einstein College of Medicine; Tianjin Medical University; Fudan University; Fudan University; University of Hong Kong; Vanderbilt University; Kyungpook National University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Nanjing Medical University; Nanjing Medical University; Westat; National Health Research Institutes - Taiwan; Kindai University (Kinki University); Chonnam National University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Yale University; China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Hong Kong; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Anhui Medical University; Kyungpook National University; Seoul National University (SNU); Shanghai Jiao Tong University; Chang Gung Memorial Hospital; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Memorial Sloan Kettering Cancer Center; Chonnam National University; Chonnam National University; National Taiwan University; National Taiwan University Hospital; Chinese Center for Disease Control & Prevention; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Hong Kong; University of Hong Kong; National Cheng Kung University; National Cheng Kung University Hospital; Seoul National University (SNU); Taipei Veterans General Hospital; Huazhong University of Science & Technology; Vanderbilt University; University of Hong Kong; Chang Gung Memorial Hospital; University of Hong Kong; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); China Baowu Steel Group; National Cancer Center - Japan; Chonnam National University; Chonnam National University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Utrecht University; National Cancer Center - Japan; Mitsui Memorial Hospital; National Taiwan University	Lan, Q (corresponding author), NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	qingl@mail.nih.gov	Guan, Peng/GWM-9170-2022; Wu, Yi-Long/AAB-9137-2022; Oh, In-Jae/AAG-5919-2020; Wang, Junwen/C-4432-2009; Hsiao, Chin-Fu/E-3993-2010; gao, yi/HCI-8298-2022; wang, chih-liang/GSD-6038-2022; Jin, Li/C-1468-2009; Matsuo, Keitaro/H-6758-2019; Vermeulen, Roel/F-8037-2011; Wang, Jiucun/J-8744-2012; Gao, Yu/HGE-1937-2022; Chang, I-Shou/D-2084-2010; Berndt, Sonja I/J-8423-2016; Chen, Chien-Jen/N-4723-2019; Yoon, Ho Il/J-5567-2012; Kang, Chang-Hyun/J-5364-2012; Wu, Yi-Long/GRJ-9238-2022; Yeager, Meredith/AAA-5322-2020; Tucker, Margaret A/B-4297-2015; Wu, Yi-Long/C-3396-2008; Gao, Y./GWZ-3665-2022; Wang, Junwen/D-3700-2011; Wu, Yi-Long/AAW-9832-2020; Liu, Jianjun/AAK-4989-2020; Jin, Li/M-5063-2019; zhang, weihua/GXV-1334-2022; zhang, xu/GYE-3558-2022; Klein, Robert/K-1888-2013; zhang, xu/GRX-9733-2022; Lin, Chien-Chung/T-1496-2019; Hsiung, Chao Agnes/E-3994-2010; wei, hu/GXW-2391-2022; Kweon, Sun-Seog/AAZ-4732-2021; zhang, xian/GYA-0290-2022; Wang, Zhaoming/R-5527-2018; Zheng, Wei/O-3351-2013; Zhang, xiaoyu/GXA-3206-2022; Hong, Yun-Chul/J-5725-2012; Chen, Chien-Jen/C-6976-2008	Oh, In-Jae/0000-0003-4837-1321; Jin, Li/0000-0002-4546-2415; Matsuo, Keitaro/0000-0003-1761-6314; Vermeulen, Roel/0000-0003-4082-8163; Wang, Jiucun/0000-0003-2765-0620; Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; Wang, Junwen/0000-0002-4432-4707; Liu, Jianjun/0000-0002-3255-3019; Klein, Robert/0000-0003-3539-5391; Lin, Chien-Chung/0000-0002-4739-5631; Kweon, Sun-Seog/0000-0003-2378-8550; Wang, Zhaoming/0000-0001-7556-3869; Zheng, Wei/0000-0003-1226-070X; Shen, Hongbing/0000-0002-2581-5906; Wang, Wen-Chang/0000-0003-3124-2136; Chen, Kexin/0000-0003-4248-7681; Kim, Young Tae/0000-0001-9006-4881; Dong, Jing/0000-0001-9856-5963; Hsiao, Chin-Fu/0000-0003-1284-7260; Wu, Chen/0000-0003-4954-1011; Chen, Chung-Hsing/0000-0002-1205-7368; PARK, KYONG HWA/0000-0002-2464-7920; Su, Wu-Chou/0000-0003-2953-4105; Kim, Yeul Hong/0000-0002-2555-2333; Lin, Dongxin/0000-0002-8723-8868; Yu, Chong-Jen/0000-0001-5664-9392; Shin, Min-Ho/0000-0002-2217-5624; Kang, Chang Hyun/0000-0002-1612-1937; Lee, Victor/0000-0002-6283-978X; Jacobs, Kevin/0000-0002-4657-6473; KIM, JIN HEE/0000-0003-1204-7079; Kim, Hee Nam/0000-0002-6153-2612; YANG, PAN-CHYR/0000-0001-6330-6048; Mitsudomi, Tetsuya/0000-0001-9860-8505	US National Institutes of Health/National Cancer Institute; NATIONAL CANCER INSTITUTE [R37CA070867, R01CA121210] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J.-J. Yang, X.-N. Yang, Q. Zhou, W.-B. Guo, S.-L. Chen, Y. Huang, Z. Xie, J.-G. Chen, H.-H. Yan, K. Tajima, Y. Yatabe, T. Hida, K.-L. Chuah, A. Ng, P. Cog, S.-S. Leong, M.-K. Ang, E. Lim, T.-K. Lim, M.Teh, W-T. Poh and A. Tee. The overall GWAS project was supported by the intramural program of the US National Institutes of Health/National Cancer Institute. A list of support provided to individual studies is provided in the Supplementary Note.	Acquaviva J, 2009, BBA-REV CANCER, V1795, P37, DOI 10.1016/j.bbcan.2008.07.006; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Chanock SJ, 2008, NATURE, V452, P537, DOI 10.1038/452537a; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Hosgood HD, 2012, HUM GENET, V131, P1197, DOI 10.1007/s00439-012-1144-8; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kim M, 2008, MOL CANCER RES, V6, P222, DOI 10.1158/1541-7786.MCR-07-0142; Koshikawa K, 2002, ONCOGENE, V21, P2822, DOI 10.1038/sj.onc.1205405; Kunwar AJ, 2011, P NATL ACAD SCI USA, V108, P2575, DOI 10.1073/pnas.1013891108; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Lo YL, 2013, CANCER CAUSE CONTROL, V24, P567, DOI 10.1007/s10552-012-9994-x; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Nagai H, 2007, ONCOGENE, V26, P4025, DOI 10.1038/sj.onc.1210183; Nakanishi K, 2010, DIABETES CARE, V33, P162, DOI 10.2337/dc09-1210; Petridou ET, 2007, ONCOLOGY-BASEL, V73, P261, DOI 10.1159/000127424; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Shi JX, 2012, CANCER DISCOV, V2, P131, DOI 10.1158/2159-8290.CD-11-0246; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Wang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019085; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wang ZM, 2012, NAT GENET, V44, P6, DOI 10.1038/ng.1044; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081	48	231	234	1	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1330	1335		10.1038/ng.2456	http://dx.doi.org/10.1038/ng.2456			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143601	Green Accepted, Green Submitted			2022-12-25	WOS:000311713200011
J	Lupski, JR				Lupski, James R.			Digenic inheritance and Mendelian disease	NATURE GENETICS			English	Editorial Material							MUTATION	Powerful genomic technologies, such as exome sequencing, are providing new insights into the genetics underlying Mendelian traits. A new study identifies a role for digenic inheritance and an epigenetic modifier in facioscapulohumeral muscular dystrophy type 2.	[Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu						Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; El-Hattab AW, 2010, GENET MED, V12, P573, DOI 10.1097/GIM.0b013e3181eb9b4a; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; van der Maarel SM, 2011, TRENDS MOL MED, V17, P252, DOI 10.1016/j.molmed.2011.01.001	15	40	40	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1291	+		10.1038/ng.2479	http://dx.doi.org/10.1038/ng.2479			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23192179				2022-12-25	WOS:000311713200004
J	Wollman, R; Meyer, T				Wollman, R.; Meyer, T.			Coordinated oscillations in cortical actin and Ca2+ correlate with cycles of vesicle secretion	NATURE CELL BIOLOGY			English	Article							FILAMENTS; GRANULES; MICROFILAMENTS; EXOCYTOSIS; SENSOR; TOXIN; WASP	The actin cortex both facilitates and hinders the exocytosis of secretory granules. How cells consolidate these two opposing roles was not well understood. Here we show that antigen activation of mast cells induces oscillations in Ca2+ and PtdIns(4,5)P-2 lipid levels that in turn drive cyclic recruitment of N-WASP and cortical actin level oscillations. Experimental and computational analysis argues that vesicle fusion correlates with the observed actin and Ca2+ level oscillations. A vesicle secretion cycle starts with the capture of vesicles by actin when cortical F-actin levels are high, followed by vesicle passage through the cortex when F-actin levels are low, and vesicle fusion with the plasma membrane when Ca2+ levels subsequently increase. Thus, cells employ oscillating levels of Ca2+, PtdIns(4,5)P-2 and cortical F-actin to increase secretion efficiency, explaining how the actin cortex can function as a carrier as well as barrier for vesicle secretion.	[Wollman, R.; Meyer, T.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Meyer, T (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	tobiasmeyer@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	NIH [MH064801, GM030179]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R37GM030179, R01GM048113, R01GM063702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants MH064801 and GM030179 to T.M.	Becker KA, 1999, J CELL SCI, V112, P97; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHEEK TR, 1986, FEBS LETT, V207, P110, DOI 10.1016/0014-5793(86)80022-9; Chowdhury HH, 1999, J PHYSIOL-LONDON, V521, P389, DOI 10.1111/j.1469-7793.1999.00389.x; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Eichler TW, 2006, BIOCHEM SOC T, V34, P671, DOI 10.1042/BST0340671; Frigeri L, 1999, J IMMUNOL, V162, P2243; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Kim TD, 1997, J BIOL CHEM, V272, P31225, DOI 10.1074/jbc.272.50.31225; KOFFER A, 1990, J CELL BIOL, V111, P919, DOI 10.1083/jcb.111.3.919; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P2268, DOI 10.1073/pnas.71.6.2268; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Masedunskas A, 2011, P NATL ACAD SCI USA, V108, P13552, DOI 10.1073/pnas.1016778108; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; NARASIMHAN V, 1990, BIOCHEM BIOPH RES CO, V171, P222, DOI 10.1016/0006-291X(90)91380-B; Nightingale TD, 2011, J CELL BIOL, V194, P613, DOI 10.1083/jcb.201011119; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163	30	85	86	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1261	+		10.1038/ncb2614	http://dx.doi.org/10.1038/ncb2614			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23143397	Green Accepted, Green Submitted			2022-12-25	WOS:000311890300008
J	Moore, PL; Gray, ES; Wibmer, CK; Bhiman, JN; Nonyane, M; Sheward, DJ; Hermanus, T; Bajimaya, S; Tumba, NL; Abrahams, MR; Lambson, BE; Ranchobe, N; Ping, LH; Ngandu, N; Karim, QA; Karim, SSA; Swanstrom, RI; Seaman, MS; Williamson, C; Morris, L				Moore, Penny L.; Gray, Elin S.; Wibmer, C. Kurt; Bhiman, Jinal N.; Nonyane, Molati; Sheward, Daniel J.; Hermanus, Tandile; Bajimaya, Shringkhala; Tumba, Nancy L.; Abrahams, Melissa-Rose; Lambson, Bronwen E.; Ranchobe, Nthabeleng; Ping, Lihua; Ngandu, Nobubelo; Karim, Quarraisha Abdool; Karim, Salim S. Abdool; Swanstrom, Ronald I.; Seaman, Michael S.; Williamson, Carolyn; Morris, Lynn			Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUBTYPE-C INFECTION; MONOCLONAL-ANTIBODIES; SOUTH-AFRICA; ENVELOPE; POTENT; RESPONSES; GP120; INDIVIDUALS; GLYCOPROTEINS	Neutralizing antibodies are likely to play a crucial part in a preventative HIV-1 vaccine. Although efforts to elicit broadly cross-neutralizing (BCN) antibodies by vaccination have been unsuccessful(1-3), a minority of individuals naturally develop these antibodies after many years of infection(4-7). How such antibodies arise, and the role of viral evolution in shaping these responses, is unknown. Here we show, in two HIV-1-infected individuals who developed BCN antibodies targeting the glycan at Asn332 on the gp120 envelope, that this glycan was absent on the initial infecting virus. However, this BCN epitope evolved within 6 months, through immune escape from earlier strain-specific antibodies that resulted in a shift of a glycan to position 332. Both viruses that lacked the glycan at amino acid 332 were resistant to the Asn332-dependent BCN monoclonal antibody PGT128 (ref. 8), whereas escaped variants that acquired this glycan were sensitive. Analysis of large sequence and neutralization data sets showed the 332 glycan to be significantly under-represented in transmitted subtype C viruses compared to chronic viruses, with the absence of this glycan corresponding with resistance to PGT128. These findings highlight the dynamic interplay between early antibodies and viral escape in driving the evolution of conserved BCN antibody epitopes.	[Moore, Penny L.; Gray, Elin S.; Wibmer, C. Kurt; Bhiman, Jinal N.; Nonyane, Molati; Hermanus, Tandile; Tumba, Nancy L.; Lambson, Bronwen E.; Ranchobe, Nthabeleng; Morris, Lynn] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [Moore, Penny L.; Wibmer, C. Kurt; Bhiman, Jinal N.; Morris, Lynn] Univ Witwatersrand, Johannesburg, South Africa; [Sheward, Daniel J.; Abrahams, Melissa-Rose; Ngandu, Nobubelo; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Bajimaya, Shringkhala; Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis,Dept Med, Boston, MA USA; [Ping, Lihua; Swanstrom, Ronald I.] Univ N Carolina, Chapel Hill, NC USA; [Karim, Quarraisha Abdool; Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa CAPRISA, Durban, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Cape Town; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Kwazulu Natal	Morris, L (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa.	lynnm@nicd.ac.za	Karim, Salim Safurdeen Abdool/N-5947-2013; Morris, Lynn/V-3941-2018; Gray, Elin/V-6707-2019; Wibmer, Constantinos Kurt/AAO-3035-2021; Sheward, Daniel/GSJ-0708-2022; Karim, Salim Abdool/P-3117-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Bhiman, Jinal/ABA-6029-2021; Ngandu, Nobubelo/AAP-8543-2021; Wibmer, Constantinos Kurt/AAH-8669-2019; Karim, Salim Abdool/AAE-7118-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Morris, Lynn/0000-0003-3961-7828; Gray, Elin/0000-0002-8613-3570; Wibmer, Constantinos Kurt/0000-0003-2329-2280; Sheward, Daniel/0000-0002-0227-5636; Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Bhiman, Jinal/0000-0001-6354-4003; Ngandu, Nobubelo/0000-0001-8883-3821; , Carolyn/0000-0003-0125-1226; Moore, Penny/0000-0001-8719-4028	CAPRISA; Centre for HIV/AIDS Vaccine Immunology; South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology; US National Institutes of Health [AI088610]; US Department of Health and Human Services; US National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services [U19 AI51794]; Bill & Melinda Gates Foundation; Vaccine Immune Monitoring Consortium of the Collaboration for AIDS Vaccine Discovery [1032144]; Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, National Institutes of Health [5 D43 TW000231]; Wellcome Trust [089933/Z/09/Z]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794, P01AI088610, P30AI050410] Funding Source: NIH RePORTER	CAPRISA; Centre for HIV/AIDS Vaccine Immunology; South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; US National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Vaccine Immune Monitoring Consortium of the Collaboration for AIDS Vaccine Discovery; Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, National Institutes of Health; Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the participants in the CAPRISA 002 and 004 cohorts and the clinical and laboratory staff at CAPRISA for managing the cohort and providing specimens. 293T cells were obtained from G. Shaw (University of Alabama, Birmingham). We are grateful to D. Burton and W. Koff of the International AIDS Vaccine Initiative for providing the PGT monoclonal antibodies and to S. Gnanakaran (Los Alamos National Laboratories, Los Alamos, New Mexico) for providing transmitted/founder and chronic subtype B sequences. We thank Z. Valley-Omar and N. Ndabambi for generating some envelope sequences. We are grateful to B. Hahn and J. Kim, who contributed transmitted/founder subtype C clones to the Vaccine Immune Monitoring Core Standard Virus Panel Consortium. This work was funded by CAPRISA, the Centre for HIV/AIDS Vaccine Immunology, the South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology and by a US National Institutes of Health grant (number AI088610). CAPRISA was initially supported by the US National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services grant U19 AI51794. M. S. S. is funded by the Bill & Melinda Gates Foundation, Vaccine Immune Monitoring Consortium of the Collaboration for AIDS Vaccine Discovery (grant 1032144). P. L. M. and E. S. G. were supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, National Institutes of Health (grant 5 D43 TW000231). P. L. M. is a Wellcome Trust Intermediate Fellow in Public Health and Tropical Medicine (grant 089933/Z/09/Z).	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Gorny MK, 2006, PLOS MED, V3, P966, DOI 10.1371/journal.pmed.0030259; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Gray ES, 2006, PLOS MED, V3, P1023, DOI 10.1371/journal.pmed.0030255; Haynes BF, 2006, EXPERT REV VACCINES, V5, P347, DOI 10.1586/14760584.5.3.347; Hu SL, 2007, CURR HIV RES, V5, P507, DOI 10.2174/157016207782418542; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	36	228	235	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1688	+		10.1038/nm.2985	http://dx.doi.org/10.1038/nm.2985			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086475	Green Accepted, Green Submitted			2022-12-25	WOS:000310837000030
J	Barry, SM; Kers, JA; Johnson, EG; Song, LJ; Aston, PR; Patel, B; Krasnoff, SB; Crane, BR; Gibson, DM; Loria, R; Challis, GL				Barry, Sarah M.; Kers, Johan A.; Johnson, Evan G.; Song, Lijiang; Aston, Philip R.; Patel, Bhumit; Krasnoff, Stuart B.; Crane, Brian R.; Gibson, Donna M.; Loria, Rosemary; Challis, Gregory L.			Cytochrome P450-catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; REGIOSELECTIVE NITRATION; STREPTOMYCES; SYNTHETASE; SUBSTRATE; PROTEINS; BINDING	Thaxtomin phytotoxins produced by plant-pathogenic Streptomyces species contain a nitro group that is essential for phytotoxicity. The N,N'-dimethyldiketopiperazine core of thaxtomins is assembled from L-phenylalanine and L-4-nitrotryptophan by a nonribosomal peptide synthetase, and nitric oxide synthase-generated NO is incorporated into the nitro group, but the biosynthesis of the nonproteinogenic amino acid L-4-nitrotryptophan is unclear. Here we report that TxtE, a unique cytochrome P450, catalyzes L-tryptophan nitration using NO and O-2.	[Barry, Sarah M.; Song, Lijiang; Aston, Philip R.; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Kers, Johan A.; Johnson, Evan G.; Loria, Rosemary] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Patel, Bhumit; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Krasnoff, Stuart B.; Gibson, Donna M.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	University of Warwick; Cornell University; Cornell University; United States Department of Agriculture (USDA)	Challis, GL (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	rloria@ufl.edu; g.l.challis@warwick.ac.uk	Johnson, Evan G/B-9864-2008	Johnson, Evan G/0000-0001-7672-2120; Barry, Sarah/0000-0001-8188-2153; Challis, Gregory/0000-0001-5976-3545	UK Biotechnology and Biological Sciences Research Council [BB/H006281/1]; National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2008-35319-19202]; Advantage West Midlands; European Regional Development Fund; BBSRC [BB/H006265/1, BB/H006281/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H006265/1, BB/H006281/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Advantage West Midlands(General Electric); European Regional Development Fund(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank P. Patel for assistance with fitting the L-tryptophan binding data to the one-site binding model. We also thank The UK Biotechnology and Biological Sciences Research Council (grant ref. BB/H006281/1 to G.L.C.) and the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (grant no. 2008-35319-19202 to R.L.) for funding this research. The Bruker maXis mass spectrometer used in this research was obtained through Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World with support from Advantage West Midlands and was partially funded by the European Regional Development Fund.	BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; Buddha MR, 2004, J BIOL CHEM, V279, P49567, DOI 10.1074/jbc.C400418200; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Franke A, 2004, J AM CHEM SOC, V126, P4181, DOI 10.1021/ja038774d; Ishii Y, 2007, J PHARMACEUT BIOMED, V44, P150, DOI 10.1016/j.jpba.2007.01.012; Johnson EG, 2009, MOL MICROBIOL, V73, P409, DOI 10.1111/j.1365-2958.2009.06780.x; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; OMURA T, 1964, J BIOL CHEM, V239, P2379; Osborne AS, 2008, BIOORG MED CHEM LETT, V18, P5750, DOI 10.1016/j.bmcl.2008.09.086; Ottoni O, 1999, TETRAHEDRON LETT, V40, P1117, DOI 10.1016/S0040-4039(98)02636-7; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; Roncone R, 2006, COORDIN CHEM REV, V250, P1286, DOI 10.1016/j.ccr.2005.11.015; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Wach MJ, 2005, NITRIC OXIDE-BIOL CH, V12, P46, DOI 10.1016/j.niox.2004.11.004; Winkler R, 2007, CHEMBIOCHEM, V8, P973, DOI 10.1002/cbic.200700042	19	136	142	10	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					814	816		10.1038/nchembio.1048	http://dx.doi.org/10.1038/nchembio.1048			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22941045	Green Accepted			2022-12-25	WOS:000309056200005
J	Zimon, M; Baets, J; Almeida-Souza, L; De Vriendt, E; Nikodinovic, J; Parman, Y; Battaloglu, E; Matur, Z; Guergueltcheva, V; Tournev, I; Auer-Grumbach, M; De Rijk, P; Petersen, BS; Muller, T; Fransen, E; Van Damme, P; Loscher, WN; Barisic, N; Mitrovic, Z; Previtali, SC; Topaloglu, H; Bernert, G; Beleza-Meireles, A; Todorovic, S; Savic-Pavicevic, D; Ishpekova, B; Lechner, S; Peeters, K; Ooms, T; Hahn, AF; Zuchner, S; Timmerman, V; Van Dijck, P; Rasic, VM; Janecke, AR; De Jonghe, P; Jordanova, A				Zimon, Magdalena; Baets, Jonathan; Almeida-Souza, Leonardo; De Vriendt, Els; Nikodinovic, Jelena; Parman, Yesim; Battaloglu, Esra; Matur, Zeliha; Guergueltcheva, Velina; Tournev, Ivailo; Auer-Grumbach, Michaela; De Rijk, Peter; Petersen, Britt-Sabina; Mueller, Thomas; Fransen, Erik; Van Damme, Philip; Loescher, Wolfgang N.; Barisic, Nina; Mitrovic, Zoran; Previtali, Stefano C.; Topaloglu, Haluk; Bernert, Guenther; Beleza-Meireles, Ana; Todorovic, Slobodanka; Savic-Pavicevic, Dusanka; Ishpekova, Boryana; Lechner, Silvia; Peeters, Kristien; Ooms, Tinne; Hahn, Angelika F.; Zuechner, Stephan; Timmerman, Vincent; Van Dijck, Patrick; Rasic, Vedrana Milic; Janecke, Andreas R.; De Jonghe, Peter; Jordanova, Albena			Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia	NATURE GENETICS			English	Article							GENERATED LYSYL-ADENYLATE; HISTIDINE; SUPPORTS; MICE	Inherited peripheral neuropathies are frequent neuromuscular disorders known for their clinical and genetic heterogeneity. In 33 families, we identified 8 mutations in HINT1 (encoding histidine triad nucleotide-binding protein 1) by combining linkage analyses with next-generation sequencing and subsequent cohort screening of affected individuals. Our study provides evidence that loss of functional HINT1 protein results in a distinct phenotype of autosomal recessive axonal neuropathy with neuromyotonia.	[Zimon, Magdalena; De Vriendt, Els; Peeters, Kristien; Ooms, Tinne; Jordanova, Albena] Univ Antwerp VIB, Dept Mol Genet, Mol Neurogen Grp, B-2610 Antwerp, Belgium; [Zimon, Magdalena; Baets, Jonathan; Almeida-Souza, Leonardo; De Vriendt, Els; Peeters, Kristien; Ooms, Tinne; Timmerman, Vincent; De Jonghe, Peter; Jordanova, Albena] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Almeida-Souza, Leonardo; Timmerman, Vincent] Univ Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, B-2610 Antwerp, Belgium; [Nikodinovic, Jelena; Todorovic, Slobodanka; Rasic, Vedrana Milic] Univ Belgrade, Clin Neurol & Psychiat Children & Youth, Belgrade, Serbia; [Parman, Yesim; Matur, Zeliha] Istanbul Univ, Dept Neurol, Istanbul Fac Med, Istanbul, Turkey; [Battaloglu, Esra] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Guergueltcheva, Velina; Tournev, Ivailo; Ishpekova, Boryana] Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; [Tournev, Ivailo; Ishpekova, Boryana] New Bulgarian Univ, Dept Cognit Sci & Psychol, Sofia, Bulgaria; [Auer-Grumbach, Michaela] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [De Rijk, Peter] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Unit, B-2610 Antwerp, Belgium; [Petersen, Britt-Sabina] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Mueller, Thomas; Janecke, Andreas R.] Innsbruck Med Univ, Dept Pediat 2, Innsbruck, Austria; [Fransen, Erik] Univ Antwerp, Dept Mol Genet, B-2020 Antwerp, Belgium; [Fransen, Erik] Univ Antwerp, StatUA Ctr Stat, B-2020 Antwerp, Belgium; [Van Damme, Philip] Univ Louvain, LIND, Louvain, Belgium; [Van Damme, Philip] VIB, Vesalius Res Ctr, Louvain, Belgium; [Van Damme, Philip] Univ Louvain, Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Loescher, Wolfgang N.] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Barisic, Nina] Univ Zagreb, Dept Paediat, Sch Med, Univ Hosp Ctr Zagreb, Zagreb 41000, Croatia; [Mitrovic, Zoran] Univ Hosp Ctr Zagreb, Dept Neurol, Natl Ctr Neuromuscular Dis, Zagreb, Croatia; [Previtali, Stefano C.] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy; [Previtali, Stefano C.] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Topaloglu, Haluk] Hacettepe Univ, Fac Med, Dept Paediat Neurol, TR-06100 Ankara, Turkey; [Bernert, Guenther] Gottfried von Preyersches Kinderspital, Dept Paediat, Vienna, Austria; [Beleza-Meireles, Ana] Univ Aveiro, Autonomous Sect Hlth Sci, P-3800 Aveiro, Portugal; [Beleza-Meireles, Ana] Coimbra Paediat Hosp, Dept Genet, Ctr Hosp, Coimbra, Portugal; [Beleza-Meireles, Ana] Univ Coimbra CHUC EPE, Coimbra, Portugal; [Savic-Pavicevic, Dusanka] Univ Belgrade, Fac Biol, PCR Ctr, Belgrade, Serbia; [Lechner, Silvia; Janecke, Andreas R.] Innsbruck Med Univ, Div Human Genet, Innsbruck, Austria; [Hahn, Angelika F.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada; [Zuechner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genet, Miami, FL 33136 USA; [Van Dijck, Patrick] Univ Louvain, VIB, Dept Mol Microbiol, Mol Cell Biol Lab, Louvain, Belgium; [Rasic, Vedrana Milic] Univ Belgrade, Fac Med, Belgrade, Serbia; [Jordanova, Albena] Med Univ Sofia, Dept Med Chem & Biochem, Mol Med Ctr, Sofia, Bulgaria	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Belgrade; Istanbul University; Bogazici University; Medical University Sofia; New Bulgarian University; Medical University of Graz; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Kiel; Medical University of Innsbruck; University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Medical University of Innsbruck; University of Zagreb; University of Zagreb; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hacettepe University; Universidade de Aveiro; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Belgrade; Medical University of Innsbruck; London Health Sciences Centre; Western University (University of Western Ontario); University of Miami; Flanders Institute for Biotechnology (VIB); University of Belgrade; Medical University Sofia	Jordanova, A (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Mol Neurogen Grp, B-2610 Antwerp, Belgium.	peter.dejonghe@molgen.vib-ua.be; albena.jordanova@molgen.vib-ua.be	Matur, Zeliha/AAE-9246-2020; Löscher, Britt-Sabina/I-1671-2012; Janecke, Andreas/AAA-5227-2019; Jordanova, Albena/H-8323-2015; Previtali, Stefano/Z-1962-2019; Savic-Pavicevic, Dusanka L/R-1255-2016; Van Damme, Philip/A-6464-2009; Almeida-Souza, Leonardo/C-3437-2011; Timmerman, Vincent/O-7283-2019; TOPALOGLU, HALUK AYDIN/I-9318-2013; De Rijk, Peter/GXH-9837-2022; Savic-Pavicevic, Dusanka/O-5543-2019; Battaloğlu, Esra/AAF-1559-2020; Fransen, Erik/C-4102-2015	Matur, Zeliha/0000-0002-3895-0410; Löscher, Britt-Sabina/0000-0001-9022-9017; Jordanova, Albena/0000-0002-3833-3754; Previtali, Stefano/0000-0003-2546-4357; Savic-Pavicevic, Dusanka L/0000-0002-2079-4077; Van Damme, Philip/0000-0002-4010-2357; Almeida-Souza, Leonardo/0000-0002-7169-1238; Timmerman, Vincent/0000-0002-2162-0933; De Rijk, Peter/0000-0001-8558-9288; Savic-Pavicevic, Dusanka/0000-0002-2079-4077; Fransen, Erik/0000-0001-7785-4790; Beleza-Meireles, Ana/0000-0002-5583-9175; Janecke, Andreas/0000-0001-7155-0315; Zimon, Magdalena/0000-0001-7255-6639; Loscher, Wolfgang/0000-0002-7593-3222	University of Antwerp (in part by IWS BOF) [23064]; Fund for Scientific Research-Flanders; Medical Foundation Queen Elisabeth (GSKE); Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office (BELSPO) [P6/43]; Methusalem Excellence Grant of the Flemish Government; Association Belge Contre les Maladies Neuromusculaires (ABMM); VIB TechWatch Fund; Medizinische Forschungsfonds Tirol (MFF Tirol); US National Institue of Neurological Disorders and Stroke (NINDS) [R01NS075764, U54NS065712-03, R01NS052767]; Austrian Science Fond (FWF) [P23223-B19]; Ministry of Science and Technology of the Republic of Serbia [17 3016, 17 508]; PhD fellowship; clinical investigatorship of the Fund for Scientific Research Flanders (FWO-Vlaanderen); Austrian Science Fund (FWF) [P 23223] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052767, U54NS065712, R01NS075764] Funding Source: NIH RePORTER	University of Antwerp (in part by IWS BOF); Fund for Scientific Research-Flanders(FWO); Medical Foundation Queen Elisabeth (GSKE); Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); Methusalem Excellence Grant of the Flemish Government; Association Belge Contre les Maladies Neuromusculaires (ABMM); VIB TechWatch Fund; Medizinische Forschungsfonds Tirol (MFF Tirol); US National Institue of Neurological Disorders and Stroke (NINDS); Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); Ministry of Science and Technology of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); PhD fellowship; clinical investigatorship of the Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the study participants and their families for their cooperation. We thank A. Suls, N. Avonce, G. Milternberger-Milteny, B. Ramirez Escorcia, W. Glassee, E. Ydens and C. Claes for their expert help with some of the experiments; the VIB Genetic Service Facility for sequencing and cell maintenance support; and C. Brenner (University of Iowa) for providing the BY8-5c yeast strain. This work was supported by the University of Antwerp (in part by IWS BOF 2008 23064 to A.J. and P.D.J.); the Fund for Scientific Research-Flanders (to A.J., P.D.J. and V.T.); the Medical Foundation Queen Elisabeth (GSKE; to P.D.J. and V.T.); the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office (BELSPO; to A.J., P.D.J. and V.T.); the Methusalem Excellence Grant of the Flemish Government; the Association Belge Contre les Maladies Neuromusculaires (ABMM; to A.J., J.B., P.D.J. and V.T.); the VIB TechWatch Fund (to A.J. and P.D.J.), the Medizinische Forschungsfonds Tirol (MFF Tirol) (to S.L. and A.R.J.), the US National Institue of Neurological Disorders and Stroke (NINDS; R01NS075764, U54NS065712-03 and R01NS052767 to S.Z.), the Austrian Science Fond (FWF; P23223-B19 to M.A.-G.) and the Ministry of Science and Technology of the Republic of Serbia (17 3016 and 17 508 to V.M.R. and D.S.-P.). J.B., M.Z. and K.P. are supported by a PhD fellowship, and P. Van Damme is supported by a clinical investigatorship of the Fund for Scientific Research Flanders (FWO-Vlaanderen). All patients or their legal representatives signed an informed consent form prior to enrollment. This study was approved by local institutional review boards.	Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chou TF, 2007, J BIOL CHEM, V282, P15137, DOI 10.1074/jbc.M606972200; Chou TF, 2007, J BIOL CHEM, V282, P4719, DOI 10.1074/jbc.M610530200; de Planell-Saguer M, 2009, HUM MOL GENET, V18, P2115, DOI 10.1093/hmg/ddp134; Dolot R, 2011, ACTA CRYSTALLOGR D, V67, P601, DOI 10.1107/S0907444911015605; HAHN AF, 1991, J NEUROL NEUROSUR PS, V54, P230, DOI 10.1136/jnnp.54.3.230; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Ozga M, 2010, J BIOL CHEM, V285, P40809, DOI 10.1074/jbc.M110.162065; Parks KP, 2004, PHYSIOL GENOMICS, V20, P12, DOI 10.1152/physiolgenomics.00204.2004; SKRE H, 1974, CLIN GENET, V6, P98; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200	15	84	94	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2012	44	10					1080	1083		10.1038/ng.2406	http://dx.doi.org/10.1038/ng.2406			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22961002				2022-12-25	WOS:000309550200005
J	Heinecke, JW				Heinecke, Jay W.			A new era for quantifying HDL and cardiovascular risk?	NATURE MEDICINE			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; EFFLUX; ATHEROSCLEROSIS; CAPACITY		Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Heinecke, JW (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	heinecke@u.washington.edu						Berard AM, 1997, NAT MED, V3, P744, DOI 10.1038/nm0797-744; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Green PS, 2008, CIRCULATION, V118, P1259, DOI 10.1161/CIRCULATIONAHA.108.770669; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206	10	49	51	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1346	1347		10.1038/nm.2930	http://dx.doi.org/10.1038/nm.2930			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22961165				2022-12-25	WOS:000308472300029
J	Shi, YY; Zhao, H; Shi, YH; Cao, YX; Yang, DZ; Li, ZQ; Zhang, B; Liang, XY; Li, T; Chen, JH; Shen, JW; Zhao, JZ; You, L; Gao, X; Zhu, DY; Zhao, XM; Yan, Y; Qin, YY; Li, WJ; Junhao, YH; Wang, QZ; Zhao, JL; Geng, L; Ma, JL; Zhao, YR; He, G; Zhang, AP; Zou, SH; Yang, AJ; Liu, JY; Li, WD; Li, BJ; Wan, CL; Qin, Y; Shi, JZ; Yang, J; Jiang, H; Xu, JE; Qi, XJ; Sun, Y; Zhang, YJ; Hao, CF; Ju, XQ; Zhao, DN; Ren, CE; Li, XQ; Zhang, W; Zhang, YW; Zhang, JT; Wu, D; Zhang, CM; He, L; Chen, ZJ				Shi, Yongyong; Zhao, Han; Shi, Yuhua; Cao, Yunxia; Yang, Dongzi; Li, Zhiqiang; Zhang, Bo; Liang, Xiaoyan; Li, Tao; Chen, Jianhua; Shen, Jiawei; Zhao, Junzhao; You, Li; Gao, Xuan; Zhu, Dongyi; Zhao, Xiaoming; Yan, Ying; Qin, Yingying; Li, Wenjin; Yan, Junhao; Wang, Qingzhong; Zhao, Junli; Geng, Ling; Ma, Jinlong; Zhao, Yueran; He, Guang; Zhang, Aiping; Zou, Shuhua; Yang, Aijun; Liu, Jiayin; Li, Weidong; Li, Baojie; Wan, Chunling; Qin, Ying; Shi, Juanzi; Yang, Jing; Jiang, Hong; Xu, Jin-e; Qi, Xiujuan; Sun, Yun; Zhang, Yajie; Hao, Cuifang; Ju, Xiuqing; Zhao, Dongni; Ren, Chun-e; Li, Xiuqing; Zhang, Wei; Zhang, Yiwen; Zhang, Jiangtao; Wu, Di; Zhang, Changming; He, Lin; Chen, Zi-Jiang			Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome	NATURE GENETICS			English	Article							INSULIN-RECEPTOR GENE; SUSCEPTIBILITY LOCI; POLYMORPHISMS; METAANALYSIS; KNOWLEDGEBASE; SUBFAMILY; REACTOME; PANTHER; DEATH; PART	Following a previous genome-wide association study (GWAS 1) including 744 cases and 895 controls, we analyzed genome-wide association data from a new cohort of Han Chinese (GWAS 2) with 1,510 polycystic ovary syndrome (PCOS) cases and 2,016 controls. We followed up significantly associated signals identified in the combined results of GWAS 1 and 2 in a total of 8,226 cases and 7,578 controls. In addition to confirming the three loci we previously reported, we identify eight new PCOS association signals at P < 5 x 10(-8): 9q22.32, 11q22.1, 12q13.2, 12q14.3, 16q12.1, 19p13.3, 20q13.2 and a second independent signal at 2p16.3 (the FSHR gene). These PCOS association signals show evidence of enrichment for candidate genes related to insulin signaling, sexual hormone function and type 2 diabetes (T2D). Other candidate genes were related to calcium signaling and endocytosis. Our findings provide new insight and direction for discovering the biological mechanisms of PCOS.	[Shi, Yongyong; Li, Zhiqiang; Chen, Jianhua; Shen, Jiawei; Li, Wenjin; Wang, Qingzhong; He, Guang; Zhang, Aiping; Li, Weidong; Li, Baojie; Wan, Chunling; He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Shi, Yongyong; Li, Zhiqiang; He, Lin] Shanghai GenomePilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [Shi, Yongyong; Li, Zhiqiang] Changning Mental Hlth Ctr, Shanghai, Peoples R China; [Shi, Yongyong] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Zhao, Han; Shi, Yuhua; You, Li; Gao, Xuan; Qin, Yingying; Yan, Junhao; Geng, Ling; Ma, Jinlong; Zhao, Yueran; Zhang, Jiangtao; Wu, Di; Zhang, Changming; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Zhao, Han; Shi, Yuhua; You, Li; Gao, Xuan; Qin, Yingying; Yan, Junhao; Geng, Ling; Ma, Jinlong; Zhao, Yueran; Chen, Zi-Jiang] Minist Educ Peoples Republ China, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Zhao, Han; Shi, Yuhua; You, Li; Gao, Xuan; Qin, Yingying; Yan, Junhao; Geng, Ling; Ma, Jinlong; Zhao, Yueran; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China; [Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Hefei, Peoples R China; [Yang, Dongzi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Bo] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Reprod Med Ctr, Nanning, Peoples R China; [Liang, Xiaoyan] Sun Yat Sen Univ, Affiliated Hosp 6, Reprod Med Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jianhua] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [Zhao, Junzhao] Wenzhou Med Coll, Affiliated Hosp 1, Reprod Med Unit, Wenzhou, Peoples R China; [Zhu, Dongyi] Linyi Peoples Hosp, Reprod Med Ctr, Linyi, Peoples R China; [Zhao, Xiaoming; Sun, Yun; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Ctr Reprod Med, Shanghai 200030, Peoples R China; [Yan, Ying] Minist Hlth Peoples Republ China, Natl Inst Hosp Adm, Beijing, Peoples R China; [Zhao, Junli] Ningxia Med Univ, Affiliated Hosp, Reprod Med Ctr, Yinchuan, Peoples R China; [Zou, Shuhua] Qingdao Women & Children Med Healthcare Ctr, Ctr Reprod Med, Qingdao, Peoples R China; [Yang, Aijun] Jining Med Coll, Affiliated Hosp, Reprod Med Ctr, Jining, Peoples R China; [Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Peoples R China; [Qin, Ying] GlaxoSmithKline R&D China, Oncol Translat Med, Shanghai, Peoples R China; [Shi, Juanzi] Maternal & Child Hlth Care Hosp Shaanxi Prov, Assisted Reprod Ctr, Xian, Peoples R China; [Yang, Jing] Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China; [Jiang, Hong] Peoples Liberat Army, Hosp 105, Dept Obstet & Gynecol, Hefei, Peoples R China; [Xu, Jin-e; Qi, Xiujuan] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Obstet & Gynecol, Qingdao 266071, Peoples R China; [Zhang, Yajie] Jinan Hlth Inst Matern & Infant, Dept Obstet & Gynecol, Jinan, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Reprod Med Ctr, Yantai, Peoples R China; [Ju, Xiuqing] Tengzhou Peoples Hosp, Dept Obstet & Gynecol, Tengzhou, Peoples R China; [Zhao, Dongni] China Med Univ, Shengjing Hosp, Reprod Med Ctr, Shenyang, Peoples R China; [Ren, Chun-e] Weifang Med Coll, Affiliated Hosp, Dept Obstet & Gynecol, Weifang, Peoples R China; [Li, Xiuqing] Anqiu Peoples Hosp, Dept Obstet & Gynecol, Anqiu, Peoples R China; [Zhang, Wei] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200433, Peoples R China; [Zhang, Yiwen] Weihai Women & Children Hosp, Reprod Med Unit, Weihai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Ministry of Education, China; Anhui Medical University; Sun Yat Sen University; Sun Yat Sen University; Wenzhou Medical University; Shanghai Jiao Tong University; Ningxia Medical University; Jining Medical University; Nanjing Medical University; GlaxoSmithKline; Wuhan University; Qingdao University; China Medical University; Weifang Medical University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China.	helinhelin@gmail.com; chenzijiang@hotmail.com	Li, Zhiqiang/AAI-4003-2021; Shi, Yongyong/GSO-1627-2022; liang, xiaoyan/GYJ-5006-2022; Yan, Junhao/AAH-8310-2019; Chen, Jianhua/AAS-8417-2020; He, Guang/ABF-7381-2021; Chen, Zi-Jiang/GOE-6119-2022	Li, Zhiqiang/0000-0002-0174-9254; Shi, Yongyong/0000-0003-1710-1505; He, Guang/0000-0002-4911-088X; Chen, Zi-Jiang/0000-0001-6637-6631; Li, Weidong/0000-0001-5384-4838	National Basic Research Program of China (973 Program) [2012CB944700, 2010CB529600, 2011CB944502, 2010CB945002]; 863 Program [2012AA02A515]; National Natural Science Foundation of China [81130022, 30973170, 81121001, 31000553, 81000238, 81070461, 81000236]; National Key Technology Research and Development Program [2011BAI17B00]; Science Research Foundation Item of No-earnings Health Vocation [201002013]; Program for Changjiang Scholars and the Innovative Research Team in University [IRT1025]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201026]; Program for New Century Excellent Talents in University [NCET-09-0550]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program(National Key Technology R&D Program); Science Research Foundation Item of No-earnings Health Vocation; Program for Changjiang Scholars and the Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	We thank all participants involved in this study. This study was supported by grants from the National Basic Research Program of China (973 Program: 2012CB944700, 2010CB529600, 2011CB944502 and 2010CB945002), the 863 Program (2012AA02A515), the National Natural Science Foundation of China (81130022, 30973170, 81121001, 31000553, 81000238, 81070461 and 81000236), the National Key Technology Research and Development Program (2011BAI17B00), the Science Research Foundation Item of No-earnings Health Vocation (201002013), the Program for Changjiang Scholars and the Innovative Research Team in University (IRT1025), the Foundation for the Author of National Excellent Doctoral Dissertation of China (201026) and the Program for New Century Excellent Talents in University (NCET-09-0550).	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; ASHAR HR, 1995, CELL, V82, P57; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Chen Zi-jiang, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P582; Cooper JD, 2009, GENES IMMUN, V10, pS95, DOI 10.1038/gene.2009.98; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Kazmierczak B, 1998, AM J PATHOL, V152, P431; Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036; Li T, 2012, J MED GENET, V49, P254, DOI 10.1136/jmedgenet-2011-100727; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; MOLLER DE, 1988, NEW ENGL J MED, V319, P1526, DOI 10.1056/NEJM198812083192306; MOLLER DE, 1990, J BIOL CHEM, V265, P14979; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Siegel S, 2002, FERTIL STERIL, V78, P1240, DOI 10.1016/S0015-0282(02)04241-3; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011789; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wild Sarah, 2000, Hum Fertil (Camb), V3, P101, DOI 10.1080/1464727002000198781; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	50	382	407	5	113	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1020	+		10.1038/ng.2384	http://dx.doi.org/10.1038/ng.2384			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22885925				2022-12-25	WOS:000308491200013
J	Tkach, JM; Yimit, A; Lee, AY; Riffle, M; Costanzo, M; Jaschob, D; Hendry, JA; Ou, JW; Moffat, J; Boone, C; Davis, TN; Nislow, C; Brown, GW				Tkach, Johnny M.; Yimit, Askar; Lee, Anna Y.; Riffle, Michael; Costanzo, Michael; Jaschob, Daniel; Hendry, Jason A.; Ou, Jiongwen; Moffat, Jason; Boone, Charles; Davis, Trisha N.; Nislow, Corey; Brown, Grant W.			Dissecting DNA damage response pathways by analysing protein localization and abundance changes during DNA replication stress	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; RIBONUCLEOTIDE REDUCTASE; METHYL METHANESULFONATE; CHECKPOINT PATHWAYS; OXIDATIVE STRESS; GLOBAL ANALYSIS; MESSENGER-RNA; DNTP POOLS; YEAST; EXPRESSION	Relocalization of proteins is a hallmark of the DNA damage response. We use high-throughput microscopic screening of the yeast GFP fusion collection to develop a systems-level view of protein reorganization following drug-induced DNA replication stress. Changes in protein localization and abundance reveal drug-specific patterns of functional enrichments. Classification of proteins by subcellular destination enables the identification of pathways that respond to replication stress. We analysed pairwise combinations of GFP fusions and gene deletion mutants to define and order two previously unknown DNA damage responses. In the first, Cmr1 forms subnuclear foci that are regulated by the histone deacetylase Hos2 and are distinct from the typical Rad52 repair foci. In a second example, we find that the check point kinases Mec1/Tel1 and the translation regulator Asc1 regulate P-body formation. This method identifies response pathways that were not detected in genetic and protein interaction screens, and can be readily applied to any form of chemical or genetic stress to reveal cellular response pathways.	[Tkach, Johnny M.; Yimit, Askar; Hendry, Jason A.; Ou, Jiongwen; Brown, Grant W.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Tkach, Johnny M.; Yimit, Askar; Lee, Anna Y.; Costanzo, Michael; Hendry, Jason A.; Ou, Jiongwen; Moffat, Jason; Boone, Charles; Nislow, Corey; Brown, Grant W.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3F1, Canada; [Lee, Anna Y.; Costanzo, Michael; Moffat, Jason; Boone, Charles; Nislow, Corey] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Lee, Anna Y.; Costanzo, Michael; Moffat, Jason; Boone, Charles; Nislow, Corey] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L6, Canada; [Riffle, Michael; Jaschob, Daniel; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle	Brown, GW (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	grant.brown@utoronto.ca	Moffat, Jason/AAC-1110-2020; Davis, Trisha/F-8584-2010	Moffat, Jason/0000-0002-5663-8586; Nislow, Corey/0000-0002-4016-8874; Davis, Trisha/0000-0003-4797-3152; Brown, Grant/0000-0002-9002-5003; Riffle, Michael/0000-0003-1633-8607	Canadian Cancer Society Research Institute [020254]; National Institutes of Health [1R01HG005853, P41RR11823, GM103533]; Canadian Institutes of Health [MOP-102629, MOP-97939]; Ontario Research Fund [GL2-01-22]; Canadian Foundation for Innovation [16304]; Ontario Institute of Cancer Research Equipment Competition; National Human Genome Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Institute of Cancer Research Equipment Competition; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Cox and B. Andrews for assistance with high-throughput microscopy, A. Baryshnikova, and Q. Morris for advice on the data analysis and R. Tsien for providing them Cherry fusion plasmid. This work was supported by grant 020254 from the Canadian Cancer Society Research Institute to G.W.B., by grant 1R01HG005853 from the National Institutes of Health, grants MOP-102629 and MOP-97939 from the Canadian Institutes of Health Research and grant GL2-01-22 from the Ontario Research Fund to C.B., by grants P41RR11823 (NCRR) and P41 GM103533 (NIGMS) from the National Institutes of Health to T.N.D., by grants from the Canadian Foundation for Innovation (16304) and the Ontario Institute of Cancer Research Equipment Competition (2007) to J.M., and by a grant from the National Human Genome Research Institute to C.N.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Brachmann CB, 1998, YEAST, V14, P115; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chantrel Y, 1998, GENETICS, V148, P559; CHITAMBAR CR, 1995, CANCER RES, V55, P4361; Choi DH, 2012, J MICROBIOL, V50, P112, DOI 10.1007/s12275-012-1597-4; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Groth P, 2010, J MOL BIOL, V402, P70, DOI 10.1016/j.jmb.2010.07.010; Herrero AB, 2011, EMBO J, V30, P2008, DOI 10.1038/emboj.2011.117; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kitanovic A, 2006, MUTAT RES-FUND MOL M, V594, P135, DOI 10.1016/j.mrfmmm.2005.08.005; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Melo JA, 2001, GENE DEV, V15, P2809; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; MIZUMOTO K, 1993, BIOCHEM PHARMACOL, V46, P1811, DOI 10.1016/0006-2952(93)90587-M; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Singh J, 2009, GENE DEV, V23, P1944, DOI 10.1101/gad.1804409; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Stirling PC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002057; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Van Dongen S., 2000, R0010 INS NAT RES I; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Winzeler E. A., 1999, LOGIC CIRCUITS CARBO, V285, P901; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100	68	317	321	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2012	14	9					966	+		10.1038/ncb2549	http://dx.doi.org/10.1038/ncb2549			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	004GJ	22842922	Green Accepted			2022-12-25	WOS:000308668600013
J	Zhou, WB; Otto, EA; Cluckey, A; Airik, R; Hurd, TW; Chaki, M; Diaz, K; Lach, FP; Bennett, GR; Gee, HY; Ghosh, AK; Natarajan, S; Thongthip, S; Veturi, U; Allen, SJ; Janssen, S; Ramaswami, G; Dixon, J; Burkhalter, F; Spoendlin, M; Moch, H; Mihatsch, MJ; Verine, J; Reade, R; Soliman, H; Godin, M; Kiss, D; Monga, G; Mazzucco, G; Amann, K; Artunc, F; Newland, RC; Wiech, T; Zschiedrich, S; Huber, TB; Friedl, A; Slaats, GG; Joles, JA; Goldschmeding, R; Washburn, J; Giles, RH; Levy, S; Smogorzewska, A; Hildebrandt, F				Zhou, Weibin; Otto, Edgar A.; Cluckey, Andrew; Airik, Rannar; Hurd, Toby W.; Chaki, Moumita; Diaz, Katrina; Lach, Francis P.; Bennett, Geoffrey R.; Gee, Heon Yung; Ghosh, Amiya K.; Natarajan, Sivakumar; Thongthip, Supawat; Veturi, Uma; Allen, Susan J.; Janssen, Sabine; Ramaswami, Gokul; Dixon, Joanne; Burkhalter, Felix; Spoendlin, Martin; Moch, Holger; Mihatsch, Michael J.; Verine, Jerome; Reade, Richard; Soliman, Hany; Godin, Michel; Kiss, Denes; Monga, Guido; Mazzucco, Gianna; Amann, Kerstin; Artunc, Ferruh; Newland, Ronald C.; Wiech, Thorsten; Zschiedrich, Stefan; Huber, Tobias B.; Friedl, Andreas; Slaats, Gisela G.; Joles, Jaap A.; Goldschmeding, Roel; Washburn, Joseph; Giles, Rachel H.; Levy, Shawn; Smogorzewska, Agata; Hildebrandt, Friedhelm			FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair	NATURE GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; HOODED HYPERTENSIVE-RATS; FANCONI-ANEMIA; CYSTIC-DISEASE; NUCLEASE; KIAA1018/FAN1; ZEBRAFISH; PATHWAY; INVERSIN; ENTITY	Chronic kidney disease (CKD) represents a major health burden(1). Its central feature of renal fibrosis is not well understood. By exome sequencing, we identified mutations in FAN1 as a cause of karyomegalic interstitial nephritis (KIN), a disorder that serves as a model for renal fibrosis. Renal histology in KIN is indistinguishable from that of nephronophthisis, except for the presence of karyomegaly(2). The FAN1 protein has nuclease activity and acts in DNA interstrand cross-link (ICL) repair within the Fanconi anemia DNA damage response (DDR) pathway(3-6). We show that cells from individuals with FAN1 mutations have sensitivity to the ICL-inducing agent mitomycin C but do not exhibit chromosome breakage or cell cycle arrest after diepoxybutane treatment, unlike cells from individuals with Fanconi anemia. We complemented ICL sensitivity with wild-type FAN1 but not with cDNA having mutations found in individuals with KIN. Depletion of fan1 in zebrafish caused increased DDR, apoptosis and kidney cysts. Our findings implicate susceptibility to environmental genotoxins and inadequate DNA repair as novel mechanisms contributing to renal fibrosis and CKD.	[Zhou, Weibin; Otto, Edgar A.; Cluckey, Andrew; Airik, Rannar; Hurd, Toby W.; Chaki, Moumita; Diaz, Katrina; Gee, Heon Yung; Ghosh, Amiya K.; Natarajan, Sivakumar; Allen, Susan J.; Janssen, Sabine; Ramaswami, Gokul; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Lach, Francis P.; Bennett, Geoffrey R.; Thongthip, Supawat; Veturi, Uma; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10021 USA; [Dixon, Joanne] Wellington Hosp, Cent & So Reg Genet Serv, Wellington, New Zealand; [Mihatsch, Michael J.] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Spoendlin, Martin] Merian Iselin Klin, Basel, Switzerland; [Moch, Holger] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Verine, Jerome] Univ Paris Diderot, Pathol Lab, Unite Mixte Rech Sante UMR S 728, Paris, France; [Reade, Richard] Clin Nephrol Pont Allant, Maubeuge, France; [Soliman, Hany] Hop St Louis, Assistance Publ Hop Paris, Serv Biochim, Paris, France; [Godin, Michel] Rouen Univ Hosp, Dept Nephrol & Hemodialysis, Rouen, France; [Kiss, Denes] Kantonsspital Liestal, Div Renal, CH-4410 Liestal, Switzerland; [Monga, Guido] Univ Amedeo Avogadro Eastern Piedmont, Fac Med, Dept Med Sci, Novara, Italy; [Monga, Guido] Maggiore Carita Hosp, Dept Pathol, Novara, Italy; [Mazzucco, Gianna] Univ Turin, Dept Biomed Sci & Human Oncol, Fac Med, I-10124 Turin, Italy; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; [Artunc, Ferruh] Univ Tubingen Hosp, Dept Internal Med, Div Nephrol, Tubingen, Germany; [Newland, Ronald C.] Concord Hosp, Dept Anat Pathol, Sydney, NSW, Australia; [Wiech, Thorsten] Univ Hosp Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Zschiedrich, Stefan; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Huber, Tobias B.] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany; [Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Slaats, Gisela G.; Joles, Jaap A.; Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Washburn, Joseph] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Michigan System; University of Michigan; Rockefeller University; University of Basel; University of Zurich; University Zurich Hospital; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Rouen; Kantonsspital Baselland; University of Eastern Piedmont Amedeo Avogadro; University of Turin; University of Erlangen Nuremberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Concord Repatriation General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Freiburg; University of Wisconsin System; University of Wisconsin Madison; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	asmogorzewska@mail.rockefeller.edu; fhilde@umich.edu	Gee, Heon Yung/K-7781-2019; Joles, Jaap/AAX-3249-2020; Slaats, Gisela/HDO-1608-2022; Janssen, S./F-2917-2016; Airik, Rannar/AAS-7810-2021; Zschiedrich, Stefan/ABE-9871-2020; Goldschmeding, Roel/I-1723-2014; Wiech, Thorsten/ABA-3632-2020	Gee, Heon Yung/0000-0002-8741-6177; Slaats, Gisela/0000-0002-4567-0134; Janssen, S./0000-0001-8470-3050; Airik, Rannar/0000-0002-7055-6325; Wiech, Thorsten/0000-0003-4053-1474; Muraglia, Katrina/0000-0002-4162-4667; Giles, Rachel/0000-0001-9133-2008; Otto, Edgar/0000-0002-2387-9973; Huber, Tobias B./0000-0001-7175-5062; Lach, Francis/0000-0003-3708-7122; Levy, Shawn/0000-0002-1369-5740; Smogorzewska, Agata/0000-0001-6285-1562	US National Institutes of Health [DK068306, DK090917, DK091405]; Burroughs Wellcome Fund Career Award for Medical Scientists; Doris Duke Charitable Foundation Clinical Scientist Development Awards; European Union Seventh Framework Programme FP7 [241955]; SYSCILIA; Netherlands Organization for Scientific Research; NWO [Vidi-917.66.354]; US National Institute of Diabetes and Digestive and Kidney Diseases [DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090917, R00DK091405, P60DK020572, P30DK020572, K99DK091405, R01DK068306] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Doris Duke Charitable Foundation Clinical Scientist Development Awards; European Union Seventh Framework Programme FP7; SYSCILIA; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to the families and study individuals for their contribution. We thank A. Francois (Rouen) for contribution of pathology data and J. Amatruda (UT Southwestern) for antibodies. This research was supported by grants from the US National Institutes of Health to F.H. (DK068306), E.A.O. (DK090917) and W.Z. (DK091405), by the Burroughs Wellcome Fund Career Award for Medical Scientists and by Doris Duke Charitable Foundation Clinical Scientist Development Awards to A.S. W.Z. is a Carl W. Gottschalk Scholar of the American Society of Nephrology (ASN). A.S. is a Rita Allen Foundation Scholar and an Irma T. Hirschl Scholar. F.H. is an Investigator of the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist and a Frederick G.L. Huetwell Professor. This research was supported by grants from the European Union Seventh Framework Programme FP7/2009 under grant agreement 241955, SYSCILIA and the Netherlands Organization for Scientific Research to R.H.G. (NWO Vidi-917.66.354). This work used two Core facilities at the Michigan Diabetes Research and Training Center funded by DK020572 from the US National Institute of Diabetes and Digestive and Kidney Diseases.	AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Baba F, 2006, PATHOL RES PRACT, V202, P555, DOI 10.1016/j.prp.2006.02.004; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BURRY AF, 1974, J PATHOL, V113, P147, DOI 10.1002/path.1711130303; Chaki M, CELL IN PRESS; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Godin M, 1996, AM J KIDNEY DIS, V27, P166, DOI 10.1016/S0272-6386(96)90047-5; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Koeners MP, 2008, AM J PHYSIOL-REG I, V294, pR1847, DOI 10.1152/ajpregu.00073.2008; Koeners MP, 2010, AM J HYPERTENS, V23, P802, DOI 10.1038/ajh.2010.48; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; MIHATSCH MJ, 1979, CLIN NEPHROL, V12, P54; MOCH H, 1994, PATHOLOGE, V15, P44, DOI 10.1007/s002920050024; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Palmer D, 2007, DIAGN CYTOPATHOL, V35, P179, DOI 10.1002/dc.20603; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; SPOENDLIN M, 1995, AM J KIDNEY DIS, V25, P242, DOI 10.1016/0272-6386(95)90005-5; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Verine J, 2010, ANN PATHOL, V30, P240, DOI 10.1016/j.annpat.2010.03.001; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zeng ZQ, 2009, ZEBRAFISH, V6, P405, DOI 10.1089/zeb.2009.0611; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010; ZOLLINGER HU, 1980, HELV PAEDIATR ACTA, V35, P509	38	149	154	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					910	+		10.1038/ng.2347	http://dx.doi.org/10.1038/ng.2347			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22772369	Green Accepted			2022-12-25	WOS:000306854700017
J	Sandercock, CG; Storz, U				Sandercock, Colin G.; Storz, Ulrich			Antibody specification beyond the target: claiming a later-generation therapeutic antibody by its target epitope	NATURE BIOTECHNOLOGY			English	Editorial Material								It may be possible to patent both antibodies to new targets and later-developed antibodies to known targets.	[Sandercock, Colin G.] Perkins Coie LLP, Washington, DC USA; [Storz, Ulrich] Michalski Huttermann Patent Attorneys, Dusseldorf, Germany		Sandercock, CG (corresponding author), Perkins Coie LLP, Washington, DC USA.	csandercock@perkinscoie.com; st@mhpatent.de						[Anonymous], 1999, T054295 EUR PAT OFF; [Anonymous], 2004, 355F3D1343 US; [Anonymous], 2011, 10CV00608 BEN US DIS; Storz U, 2012, SPRINGERBRIEFS BIOTE	4	11	11	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					615	619		10.1038/nbt.2291	http://dx.doi.org/10.1038/nbt.2291			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781681				2022-12-25	WOS:000306293400017
J	Barbuto, S; Idoyaga, J; Vila-Perello, M; Longhi, MP; Breton, G; Steinman, RM; Muir, TW				Barbuto, Scott; Idoyaga, Juliana; Vila-Perello, Miquel; Longhi, Maria P.; Breton, Gaelle; Steinman, Ralph M.; Muir, Tom W.			Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells	NATURE CHEMICAL BIOLOGY			English	Article							SENSITIVE ANTIGEN-DETECTION; EXPRESSED PROTEIN LIGATION; HIV-GAG; CYTOSOLIC DNA; DEC-205 RECEPTOR; MHC-I; ANTIBODY; RNA; PCR; SEMISYNTHESIS	Targeted delivery of antigens to dendritic cells (DCs) is a promising vaccination strategy. However, to ensure immunity, the approach depends on coadministration of an adjuvant. Here we ask whether targeting of both adjuvant and antigen to DCs is sufficient to induce immunity. Using a protein ligation method, we develop a general approach for linking the immune stimulant, poly dA:dT (pdA:dT), to a monoclonal antibody (mAb) specific for DEC205 (DEC). We show that DEC-specific mAbs deliver pdA:dT to DCs for the efficient production of type I interferon in human monocyte-derived DCs and in mice. Notably, adaptive T-cell immunity is elicited when mAbs specific for DEC-pdA:dT are used as the activation stimuli and are administered together with a DC-targeted antigen. Collectively, our studies indicate that DCs can integrate innate and adaptive immunity in vivo and suggest that dual delivery of antigen and adjuvant to DCs might be an efficient approach to vaccine development.	[Barbuto, Scott; Vila-Perello, Miquel; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; [Barbuto, Scott; Idoyaga, Juliana; Longhi, Maria P.; Breton, Gaelle; Steinman, Ralph M.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Barbuto, Scott; Idoyaga, Juliana; Longhi, Maria P.; Breton, Gaelle] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University	Muir, TW (corresponding author), Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA.	muir@princeton.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344; Longhi, Paula/0000-0003-1854-4594	National Institutes of Health [GM086868, AI013013]; Foundation for the National Institutes of Health Gates Foundation [334]; NIH MSTP [GM07739]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013013, R37AI013013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM086868, R01GM086868, T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health Gates Foundation; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of the Steinman and Muir laboratories for many valuable discussions. Funding was provided by National Institutes of Health Grants GM086868 (to T.W.M.), AI013013 (to R.M.S.), a Foundation for the National Institutes of Health Gates Foundation grant no. 334 (to R.M.S.) and a graduate fellowship to S. Barbuto by NIH MSTP grant GM07739.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Bar-On L, 2010, METHODS MOL BIOL, V595, P429, DOI 10.1007/978-1-60761-421-0_28; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Burbulis I, 2007, NAT METHODS, V4, P1011, DOI 10.1038/nmeth1127; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Ebensen T, 2008, HUM VACCINES, V4, P13, DOI 10.4161/hv.4.1.5560; Flinsenberg TWH, 2011, CLIN EXP IMMUNOL, V165, P8, DOI 10.1111/j.1365-2249.2011.04411.x; HENDRICKSON ER, 1995, NUCLEIC ACIDS RES, V23, P522, DOI 10.1093/nar/23.3.522; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Katashiba Y, 2011, IMMUNOLOGY, V132, P165, DOI 10.1111/j.1365-2567.2010.03350.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Kotlyar AB, 2005, NUCLEIC ACIDS RES, V33, P525, DOI 10.1093/nar/gki178; Kreutz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040208; LAMPKIN BC, 1985, CANCER RES, V45, P5904; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lovrinovic M, 2005, BIOCHEM BIOPH RES CO, V335, P943, DOI 10.1016/j.bbrc.2005.08.001; Mata M, 1998, J IMMUNOL, V161, P2985; McKie A, 2002, J IMMUNOL METHODS, V261, P167, DOI 10.1016/S0022-1759(02)00003-0; Mohlmann S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-76; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Niemeyer CM, 2010, ANGEW CHEM INT EDIT, V49, P1200, DOI 10.1002/anie.200904930; Niemeyer CM, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng090; Nolte MA, 2007, J EXP MED, V204, P1487, DOI 10.1084/jem.20070325; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Singla N, 2008, PROTEIN SCI, V17, P1740, DOI 10.1110/ps.035659.108; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Tacken PJ, 2011, BLOOD, V118, P6836, DOI 10.1182/blood-2011-07-367615; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Trumpfheller C, 2012, J INTERN MED, V271, P183, DOI 10.1111/j.1365-2796.2011.02496.x; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Vila-Perello M, 2013, J AM CHEM SOC, V135, P286, DOI 10.1021/ja309126m; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	50	29	35	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					250	256		10.1038/NCHEMBIO.1186	http://dx.doi.org/10.1038/NCHEMBIO.1186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23416331	Green Accepted, Bronze			2022-12-25	WOS:000317025800015
J	Vallot, C; Huret, C; Lesecque, Y; Resch, A; Oudrhiri, N; Bennaceur-Griscelli, A; Duret, L; Rougeulle, C				Vallot, Celine; Huret, Christophe; Lesecque, Yann; Resch, Alissa; Oudrhiri, Noufissa; Bennaceur-Griscelli, Annelise; Duret, Laurent; Rougeulle, Claire			XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells	NATURE GENETICS			English	Article							STEM-CELLS; INACTIVATION; PROMOTERS; MAMMALS; PATTERN; RNAS	X-chromosome inactivation (XCI) in mammals relies on XIST, a long noncoding transcript that coats and silences the X chromosome in cis. Here we report the discovery of a long noncoding RNA, XACT, that is expressed from and coats the active X chromosome specifically in human pluripotent cells. In the absence of XIST, XACT is expressed from both X chromosomes in humans but not in mice, suggesting a unique role for XACT in the control of human XCI initiation.	[Vallot, Celine; Huret, Christophe; Rougeulle, Claire] Univ Paris Diderot, Paris, France; [Vallot, Celine; Huret, Christophe; Rougeulle, Claire] CNRS, Unite Mixte Rech UMR Epigenet & Cell Fate 7216, Paris, France; [Lesecque, Yann; Duret, Laurent] Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Resch, Alissa] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Farmington, CT USA; [Oudrhiri, Noufissa; Bennaceur-Griscelli, Annelise] Univ Paris 11, AP HP, ESTeam Paris Sud, Inst Natl Sante & Rech Med INSERM U935, Villejuif, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Connecticut; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Rougeulle, C (corresponding author), Univ Paris Diderot, Paris, France.	claire.rougeulle@univ-paris-diderot.fr		Duret, Laurent/0000-0003-2836-3463; bennaceur griscelli, annelise/0000-0002-3557-4499; Rougeulle, Claire/0000-0003-3861-4940	European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7)/ERC [206875]; INSERM (Avenir Program) [R0721HS]	European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); INSERM (Avenir Program)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank members of our laboratory and M. Lalande for stimulating discussion and critical reading of the manuscript. The research leading to these results has received funding from the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 206875 and the INSERM (Avenir Program R0721HS).	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Dvash T, 2009, EPIGENETICS-US, V4, P19, DOI 10.4161/epi.4.1.7438; Giuliani M, 2011, BLOOD, V118, P3254, DOI 10.1182/blood-2010-12-325324; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mitjavila-Garcia MT, 2010, J MOL CELL BIOL, V2, P291, DOI 10.1093/jmcb/mjq026; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; Rougeulle C, 2003, SEMIN CELL DEV BIOL, V14, P331, DOI 10.1016/j.semcdb.2003.09.014; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105	15	96	98	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					239	241		10.1038/ng.2530	http://dx.doi.org/10.1038/ng.2530			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23334669				2022-12-25	WOS:000315664800006
J	Collison, A; Hatchwell, L; Verrills, N; Wark, PAB; de Siqueira, AP; Tooze, M; Carpenter, H; Don, AS; Morris, JC; Zimmermann, N; Bartlett, NW; Rothenberg, ME; Johnston, SL; Foster, PS; Mattes, J				Collison, Adam; Hatchwell, Luke; Verrills, Nicole; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Carpenter, Helen; Don, Anthony S.; Morris, Jonathan C.; Zimmermann, Nives; Bartlett, Nathan W.; Rothenberg, Marc E.; Johnston, Sebastian L.; Foster, Paul S.; Mattes, Joerg			The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity	NATURE MEDICINE			English	Article							NF-KAPPA-B; SERINE/THREONINE PHOSPHATASE; AIRWAY HYPERRESPONSIVENESS; EPITHELIAL-CELLS; DENDRITIC CELLS; T(H)2 CELLS; KINASE; PP2A; MID1; ACTIVATION	Allergic airway inflammation is associated with activation of innate immune pathways by allergens. Acute exacerbations of asthma are commonly associated with rhinovirus infection. Here we show that, after exposure to house dust mite (HDM) or rhinovirus infection, the E3 ubiquitin ligase midline 1 (MID1) is upregulated in mouse bronchial epithelium. HDM regulates MIDI expression in a Toll-like receptor 4 (TLR4)- and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent manner. MIDI decreases protein phosphatase 2A (PP2A) activity through association with its catalytic subunit PP2Ac. siRNA-mediated knockdown of MID1 or pharmacological activation of PP2A using a nonphosphorylatable FTY720 analog in mice exposed to HDM reduces airway hyperreactivity and inflammation, including the expression of interleukin-25 (IL-25), IL-33 and CCL20, IL-5 and IL-13 release, nuclear factor (NF)kappa B activity, p38 mitogen-activated protein kinase (MAPK) phosphorylation, accumulation of eosinophils, T lymphocytes and myeloid dendritic cells, and the number of mucus-producing cells. MID1 inhibition also limited rhinovirus-induced exacerbation of allergic airway disease. We found that MID1 was upregulated in primary human bronchial epithelial cells upon HDM or rhinovirus exposure, and this correlated with TRAIL and CCL20 expression. Together, these findings identify a key role of MID1 in allergic airway inflammation and links innate immune pathway activation to the development and exacerbation of asthma.	[Collison, Adam; Hatchwell, Luke; de Siqueira, Ana Pereira; Mattes, Joerg] Univ Newcastle, Expt & Translat Resp Grp, Newcastle, NSW 2300, Australia; [Collison, Adam; Hatchwell, Luke; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Mattes, Joerg] Hunter Med Res Inst, Newcastle, NSW, Australia; [Collison, Adam; Hatchwell, Luke; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Foster, Paul S.; Mattes, Joerg] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Verrills, Nicole; Carpenter, Helen] Univ Newcastle, Discipline Med Biochem, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Wark, Peter A. B.; Tooze, Melinda] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Don, Anthony S.] Univ New S Wales, Prince Wales Clin Sch, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Morris, Jonathan C.] Univ New S Wales, Sch Chem, Sydney, NSW, Australia; [Zimmermann, Nives; Rothenberg, Marc E.] Univ Cincinnati, Dept Pediat, Div Allergy & Immunol, Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Bartlett, Nathan W.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Sect Airway Dis Infect, Natl Heart & Lung Inst, Med Res Council, London, England; [Bartlett, Nathan W.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London, England; [Mattes, Joerg] Newcastle Childrens Hosp, Paediat Resp & Sleep Med Unit, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle; John Hunter Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Imperial College London; University of London; King's College London	Mattes, J (corresponding author), Univ Newcastle, Expt & Translat Resp Grp, Newcastle, NSW 2300, Australia.	joerg.mattes@newcastle.edu.au	Don, Anthony Simon/AAE-9687-2021; Johnston, Sebastian Lennox/I-2423-2012; Wark, Peter/G-7037-2013; Morris, Jonathan C/A-9923-2008; Foster, Paul/G-5057-2013; MATTES, JOERG/M-5179-2019; Collison, Adam/G-7718-2013	Don, Anthony Simon/0000-0003-1655-1184; Johnston, Sebastian Lennox/0000-0003-3009-9200; Wark, Peter/0000-0001-5676-6126; Morris, Jonathan C/0000-0002-5109-9069; Bartlett, Nathan/0000-0002-2715-5163; , Paul/0000-0002-0827-8299; Collison, Adam/0000-0002-3074-3046; Verrills, Nicole/0000-0002-7894-0137	National Health and Medical Research Council [NHMRC 631075, 1011153]; Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Practitioner Research Fellowship [455623]; Asthma UK [06-050]; MRC Centre grant [G1000758]; ERC FP7 Advanced grant [233015]; Chair from Asthma UK [CH1155]; Medical Research Council [G1100168, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; MRC [G1100168] Funding Source: UKRI	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Practitioner Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Asthma UK; MRC Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC FP7 Advanced grant; Chair from Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the National Health and Medical Research Council (NH&MRC 631075 and 1011153) (J.M., P.S.F., N.V.), the Hunter Medical Research Institute (J.M., P.A.B.W., P.S.F.), the Hunter Children's Research Foundation (J.M., P.S.F., A.P.d.S.) and an NH&MRC Health Practitioner Research Fellowship to J.M. (455623). N.W.B. was supported by a project grant from Asthma UK (06-050) and S.L.J. by a Chair from Asthma UK (CH1155). This work was supported in part by MRC Centre grant G1000758 and ERC FP7 Advanced grant 233015 (to S.L.J.). We would like to thank M. Smyth, Peter MacCallum Cancer Centre, and J. Peschon, Amgen, for providing Tnfsf10<SUP>-/-</SUP> mice and S. Akira, Osaka University, for providing Tlr4<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice. We appreciate technical assistance from C. Cesar de Souza Alves, F. Eyers, J. Girkin, J. Grehan, H. MacDonald, M. Morten, K. Parsons, S. Reeves, L. Sokulsky and the staff from the animal care facilities of the contributing institutes.	Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Cornell TT, 2009, AM J PHYSIOL-LUNG C, V296, pL849, DOI 10.1152/ajplung.90516.2008; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Don AS, 2007, J BIOL CHEM, V282, P15833, DOI 10.1074/jbc.M609124200; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Fontanella B, 2008, HUM MUTAT, V29, P584, DOI 10.1002/humu.20706; Francis JN, 2008, CLIN EXP IMMUNOL, V152, P440, DOI 10.1111/j.1365-2249.2008.03657.x; Griego SD, 2000, J IMMUNOL, V165, P5211, DOI 10.4049/jimmunol.165.9.5211; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holgate ST, 2010, DISCOV MED, V9, P439; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Latta EJ, 2012, MECH DEVELOP, V128, P560, DOI 10.1016/j.mod.2012.01.002; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Miskolci V, 2003, ARCH BIOCHEM BIOPHYS, V417, P44, DOI 10.1016/S0003-9861(03)00336-9; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; Sim ATR, 2006, PHARMACOL THERAPEUT, V112, P425, DOI 10.1016/j.pharmthera.2006.04.011; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wong WSF, 2005, CURR OPIN PHARMACOL, V5, P264, DOI 10.1016/j.coph.2005.01.009; Xatzipsalti Maria, 2007, V14, P33, DOI 10.1159/000107053	40	110	112	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					232	237		10.1038/nm.3049	http://dx.doi.org/10.1038/nm.3049			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23334847				2022-12-25	WOS:000314675900032
J	Steinman, L				Steinman, Lawrence			'Hub-and-spoke' T cell traffic in autoimmunity	NATURE MEDICINE			English	Editorial Material							MULTIPLE-SCLEROSIS; NATALIZUMAB; LYMPHOCYTES; DISCOVERY; RECEPTORS; ANTIGEN		Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu		Steinman, Lawrence/0000-0002-2437-2250				Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725	13	9	9	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					139	141		10.1038/nm.3088	http://dx.doi.org/10.1038/nm.3088			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389609				2022-12-25	WOS:000314675900021
J	He, M; Miyajima, F; Roberts, P; Ellison, L; Pickard, DJ; Martin, MJ; Connor, TR; Harris, SR; Fairley, D; Bamford, KB; D'Arc, S; Brazier, J; Brown, D; Coia, JE; Douce, G; Gerding, D; Kim, HJ; Koh, TH; Kato, H; Senoh, M; Louie, T; Michell, S; Butt, E; Peacock, SJ; Brown, NM; Riley, T; Songer, G; Wilcox, M; Pirmohamed, M; Kuijper, E; Hawkey, P; Wren, BW; Dougan, G; Parkhill, J; Lawley, TD				He, Miao; Miyajima, Fabio; Roberts, Paul; Ellison, Louise; Pickard, Derek J.; Martin, Melissa J.; Connor, Thomas R.; Harris, Simon R.; Fairley, Derek; Bamford, Kathleen B.; D'Arc, Stephanie; Brazier, Jon; Brown, Derek; Coia, John E.; Douce, Gill; Gerding, Dale; Kim, Hee Jung; Koh, Tse Hsien; Kato, Haru; Senoh, Mitsutoshi; Louie, Tom; Michell, Stephen; Butt, Emma; Peacock, Sharon J.; Brown, Nick M.; Riley, Tom; Songer, Glen; Wilcox, Mark; Pirmohamed, Munir; Kuijper, Ed; Hawkey, Peter; Wren, Brendan W.; Dougan, Gordon; Parkhill, Julian; Lawley, Trevor D.			Emergence and global spread of epidemic healthcare-associated Clostridium difficile	NATURE GENETICS			English	Article							RIBOTYPE 027; NORTH-AMERICA; GENOME; DISEASE; STRAIN; EVOLUTIONARY; OUTBREAK; TRANSMISSION; MORTALITY; INFECTION	Epidemic C. difficile (027/BI/NAP1) has rapidly emerged in the past decade as the leading cause of antibiotic-associated diarrhea worldwide. However, the key events in evolutionary history leading to its emergence and the subsequent patterns of global spread remain unknown. Here, we define the global population structure of C. difficile 027/BI/NAP1 using whole-genome sequencing and phylogenetic analysis. We show that two distinct epidemic lineages, FQR1 and FQR2, not one as previously thought, emerged in North America within a relatively short period after acquiring the same fluoroquinolone resistance-conferring mutation and a highly related conjugative transposon. The two epidemic lineages showed distinct patterns of global spread, and the FQR2 lineage spread more widely, leading to healthcare-associated outbreaks in the UK, continental Europe and Australia. Our analysis identifies key genetic changes linked to the rapid transcontinental dissemination of epidemic C. difficile 027/BI/NAP1 and highlights the routes by which it spreads through the global healthcare system.	[He, Miao; Ellison, Louise; Pickard, Derek J.; Connor, Thomas R.; Harris, Simon R.; Dougan, Gordon; Parkhill, Julian; Lawley, Trevor D.] Wellcome Trust Sanger Inst, Cambridge, England; [Miyajima, Fabio; Roberts, Paul] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Miyajima, Fabio; Roberts, Paul; Pirmohamed, Munir] Royal Liverpool & Broadgreen Univ Hosp Natl Hlth, Liverpool, Merseyside, England; [Miyajima, Fabio; Roberts, Paul; Pirmohamed, Munir] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Martin, Melissa J.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Fairley, Derek] Belfast Hlth & Social Trust, Belfast, Antrim, North Ireland; [Bamford, Kathleen B.; D'Arc, Stephanie] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Bamford, Kathleen B.; D'Arc, Stephanie] Imperial Coll Healthcare NHS Trust, Dept Bacteriol, London, England; [Brazier, Jon] Anaerob Reference Lab, Cardiff, S Glam, Wales; [Brown, Derek; Coia, John E.; Douce, Gill] Scottish Salmonella Shigella & Clostridium Diffic, Glasgow, Lanark, Scotland; [Gerding, Dale] Hines VA Hosp, Hines, IL USA; [Kim, Hee Jung] Yonsei Univ, Coll Med, Seoul, South Korea; [Koh, Tse Hsien] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Kato, Haru; Senoh, Mitsutoshi] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Louie, Tom] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Michell, Stephen; Butt, Emma] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Peacock, Sharon J.; Brown, Nick M.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Peacock, Sharon J.; Brown, Nick M.] Hlth Protect Agcy, London, England; [Riley, Tom] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Songer, Glen] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Wilcox, Mark] Univ Leeds, Healthcare Associate Infect Res Grp, Leeds, W Yorkshire, England; [Kuijper, Ed] Leiden Univ, Med Ctr, Dept Expt Microbiol, Leiden, Netherlands; [Hawkey, Peter] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England	Wellcome Trust Sanger Institute; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Yonsei University; Yonsei University Health System; Singapore General Hospital; National Institute of Infectious Diseases (NIID); University of Calgary; University of Exeter; University of Cambridge; University of Cambridge; Health Protection Agency; University of Western Australia; Iowa State University; University of Leeds; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham	Lawley, TD (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	parkhill@sanger.ac.uk; tl2@sanger.ac.uk	Connor, Thomas/ABE-5989-2020; Connor, Thomas/ABD-6533-2021; Kuijper, ed/AAB-7853-2022; Pirmohamed, Munir/H-6004-2011; Parkhill, Julian/G-4703-2011; Miyajima, Fabio/K-6587-2012; Roberts, Peter/J-8535-2016; Coia, John/AAP-5379-2020; Peacock, Sharon J/ABE-6331-2020; Brown, Derek/AAE-5597-2020; Harris, Simon R/K-1318-2013; Martin, Melissa/GYV-4162-2022	Connor, Thomas/0000-0003-2394-6504; Kuijper, ed/0000-0001-5726-2405; Pirmohamed, Munir/0000-0002-7534-7266; Parkhill, Julian/0000-0002-7069-5958; Miyajima, Fabio/0000-0002-1347-4825; Coia, John/0000-0002-4966-8453; Brown, Derek/0000-0003-3742-8257; Harris, Simon R/0000-0003-1512-6194; Butt, Emma/0000-0003-3972-1246; Brown, Nicholas/0000-0002-6657-300X; Peacock, Sharon/0000-0002-1718-2782; Kim, Heejung/0000-0002-0190-703X; Brazier, John/0000-0001-8645-4780; Martin, Melissa Janet/0000-0002-8772-9392; Douce, Gillian/0000-0002-6654-7346	Wellcome Trust [098051, 086418]; Medical Research Council [93614]; Scottish Infection Research Network; National Institute for Health Research (NIHR) Biomedical Research Centre in Liverpool; Liverpool BRC (Biomedical Research Centre); Medical Research Council [G1000214, G0901743, MR/K000551/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10064] Funding Source: researchfish; MRC [MR/K000551/1, G1000214, G0901743] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Infection Research Network; National Institute for Health Research (NIHR) Biomedical Research Centre in Liverpool(National Institute for Health Research (NIHR)); Liverpool BRC (Biomedical Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to members of the European Study Group of Clostridium difficile (ESGCD), a working group of ESCMID (European Society of Clinical Microbiology and Infectious Diseases), including F. Barbut, T. Eckmanns, M. L. Lambert, F. Fitzpatrick, C. Wiuff, H. Pituch, P. Reichert, A. F. Widmer, F. Allerberger, D. W. Notermans, M. Delmee, R. Frei, O. Lyytikainen, A. Ingebretsen and I. R. Poxton. We thank the Wellcome Trust Sanger Institute sequencing and informatics teams. This project was funded by the Wellcome Trust (grants 098051 and 086418), a Medical Research Council New Investigator Research Grant (T. D. L.; grant 93614) and the Scottish Infection Research Network. We acknowledge funding from the National Institute for Health Research (NIHR) Biomedical Research Centre in Liverpool. Both F. M. and P. R. were supported by the Liverpool BRC (Biomedical Research Centre). M. P. is an NIHR Senior Investigator.	[Anonymous], [No title captured]; Bartlett JG, 2010, ANN NY ACAD SCI, V1213, P62, DOI 10.1111/j.1749-6632.2010.05863.x; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Brazier JS, 2012, ANAEROBE, V18, P197, DOI 10.1016/j.anaerobe.2011.12.021; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Carter GP, 2011, FUTURE MICROBIOL, V6, P121, DOI 10.2217/fmb.10.169; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kim H, 2011, KOREAN J LAB MED, V31, P191, DOI 10.3343/kjlm.2011.31.3.191; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper E.J., 2008, EURO SURVEILL, V13; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Nyc O, 2011, LANCET, V377, P1407, DOI 10.1016/S0140-6736(11)60575-8; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Richards M, 2011, MED J AUSTRALIA, V194, P369, DOI 10.5694/j.1326-5377.2011.tb03012.x; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Spigaglia P, 2010, MOL CELL PROBE, V24, P61, DOI 10.1016/j.mcp.2009.10.002; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	506	523	1	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2013	45	1					109	U155		10.1038/ng.2478	http://dx.doi.org/10.1038/ng.2478			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23222960	Green Accepted			2022-12-25	WOS:000312838800022
J	Cymes, GD; Grosman, C				Cymes, Gisela D.; Grosman, Claudio			The unanticipated complexity of the selectivity-filter glutamates of nicotinic receptors	NATURE CHEMICAL BIOLOGY			English	Article							GATED ION-CHANNEL; ACIDIC SIDE-CHAINS; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; DEUTERIUM OXIDE; PROTON-TRANSFER; PK(A) VALUES; IONIZATION; EQUILIBRIA; PROTEINS	In ion channels, 'rings' of ionized side chains that decorate the walls of the permeation pathway often lower the energetic barrier to ion conduction. Using single-channel electrophysiological recordings, we studied the poorly understood ring of four glutamates (and one glutamine) that dominates this catalytic effect in the muscle nicotinic acetylcholine receptor ('the intermediate ring of charge'). We show that all four wild-type glutamate side chains are deprotonated in the range of 6.0-9.0 pH, that only two of them contribute to the size of the single-channel current, that these side chains must be able to adopt alternate conformations that either allow or prevent their negative charges from increasing the rate of cation conduction and that the location of these glutamate side chains squarely at one of the ends of the transmembrane pore is critical for their largely unshifted pK(a) values and for the unanticipated impact of their conformational flexibility on cation permeation.	[Cymes, Gisela D.; Grosman, Claudio] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61802 USA; [Grosman, Claudio] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Grosman, Claudio] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Grosman, C (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61802 USA.	grosman@illinois.edu		Grosman, Claudio/0000-0001-8093-8362; Cymes, Gisela/0000-0002-4155-585X	US National Institutes of Health [R01-NS042169]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042169] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Sine (Mayo Clinic College of Medicine, Rochester, MN, USA) for wild-type muscle AChR cDNA, M. Slaughter (University at Buffalo School of Medicine, Buffalo, NY, USA) for wild-type alpha 1 GlyR cDNA, and A. Holmstrom, M. Pasquini, J. Pizarek and M. Rigby for technical assistance. This work was supported by a grant from the US National Institutes of Health (R01-NS042169 to C.G.).	BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; Bell R. P, 1973, PROTON CHEM, P250; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bombarda E, 2010, J PHYS CHEM B, V114, P1994, DOI 10.1021/jp908926w; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2011, PROTEINS, V79, P3485, DOI 10.1002/prot.23087; DAHLGREN G, 1960, J AM CHEM SOC, V82, P1303, DOI 10.1021/ja01491a007; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Elenes S, 2009, J GEN PHYSIOL, V133, P151, DOI 10.1085/jgp.200810089; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fayer MD, 2010, ANNU REV ANAL CHEM, V3, P89, DOI 10.1146/annurev-anchem-070109-103410; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GLASOE PK, 1964, J PHYS CHEM-US, V68, P1560, DOI 10.1021/j100788a501; GLASOE PK, 1964, J PHYS CHEM-US, V68, P1562, DOI 10.1021/j100788a502; GUTMAN M, 1992, BIOCHIM BIOPHYS ACTA, V1109, P141, DOI 10.1016/0005-2736(92)90077-Y; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Lancaster CRD, 1996, BIOPHYS J, V70, P2469, DOI 10.1016/S0006-3495(96)79820-X; Lindman S, 2006, BIOCHEMISTRY-US, V45, P13993, DOI 10.1021/bi061555v; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MCDANIEL DH, 1953, SCIENCE, V118, P370, DOI 10.1126/science.118.3066.370; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin J, 1996, BIOCHEMISTRY-US, V35, P7, DOI 10.1021/bi952299h; RAJASEKARAN E, 1994, J AM CHEM SOC, V116, P8238, DOI 10.1021/ja00097a033; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; SALOMAA P, 1964, J AM CHEM SOC, V86, P1, DOI 10.1021/ja01055a001; Sondergaard CR, 2008, J MOL BIOL, V376, P269, DOI 10.1016/j.jmb.2007.09.070; Wohlfahrt G, 2005, PROTEINS, V58, P396, DOI 10.1002/prot.20328	39	28	29	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2012	8	12					975	981		10.1038/NCHEMBIO.1092	http://dx.doi.org/10.1038/NCHEMBIO.1092			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042SL	23064317	Green Accepted			2022-12-25	WOS:000311491200012
J	Ghosh, A; Saginc, G; Leow, SC; Khattar, E; Shin, EM; Yan, TD; Wong, M; Zhang, ZZ; Li, GL; Sung, WK; Zhou, JB; Chng, WJ; Li, S; Liu, E; Tergaonkar, V				Ghosh, Arkasubhra; Saginc, Gaye; Leow, Shi Chi; Khattar, Ekta; Shin, Eun Myong; Yan, Ting Dong; Wong, Marc; Zhang, Zhizhuo; Li, Guoliang; Sung, Wing-Kin; Zhou, Jianbiao; Chng, Wee Joo; Li, Shang; Liu, Edison; Tergaonkar, Vinay			Telomerase directly regulates NF-kappa B-dependent transcription	NATURE CELL BIOLOGY			English	Article							HUMAN CANCER-CELLS; GROWTH-INHIBITION; INDUCED APOPTOSIS; GENOME BROWSER; EXPRESSION; GENE; RNA; INDUCTION; ROLES; ACTIVATION	Although elongation of telomeres is thought to be the prime function of reactivated telomerase in cancers, this activity alone does not account for all of the properties that telomerase reactivation attributes to human cancer cells. Here, we uncover a link between telomerase and NF-kappa B, a master regulator of inflammation. We observe that while blocking NF-kappa B signalling can inhibit effects of telomerase overexpression on processes relevant to transformation, increasing NF-kappa B activity can functionally substitute for reduced telomerase activity. Telomerase directly regulates NF-kappa B-dependent gene expression by binding to the NF-kappa B p65 subunit and recruitment to a subset of NF-kappa B promoters such as those of IL-6 and TNF-alpha, cytokines that are critical for inflammation and cancer progression. As NF-kappa B can transcriptionally upregulate telomerase levels, our findings suggest that a feed-forward regulation between them could be the key mechanistic basis for the coexistence of chronic inflammation and sustained telomerase activity in human cancers.	[Ghosh, Arkasubhra; Leow, Shi Chi; Khattar, Ekta; Shin, Eun Myong; Wong, Marc; Tergaonkar, Vinay] IMCB, Lab NFkB Signaling, Proteos 138673, Singapore; [Saginc, Gaye; Li, Guoliang; Sung, Wing-Kin; Liu, Edison] Genome Inst Singapore, Singapore 138672, Singapore; [Yan, Ting Dong; Li, Shang] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Zhang, Zhizhuo; Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Singapore 119077, Singapore; [Zhou, Jianbiao; Chng, Wee Joo] Canc Sci Inst Singapore, Singapore 119074, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Tergaonkar, V (corresponding author), IMCB, Lab NFkB Signaling, Proteos 138673, Singapore.	vinayt@imcb.a.star.edu.sg	Khattar, Ekta/AAE-7597-2020; Li, Guoliang/D-8014-2012; LI, SHANG/HII-4989-2022	Li, Guoliang/0000-0003-1601-6640; LI, SHANG/0000-0002-6226-3362; Sung, Wing-Kin/0000-0001-7806-7086; Ghosh, Arkasubhra/0000-0002-6570-5891	Agency for Science Technology and Research, Singapore (A*Star)	Agency for Science Technology and Research, Singapore (A*Star)(Agency for Science Technology & Research (A*STAR))	We thank the Agency for Science Technology and Research, Singapore (A*Star) for funding and support to the V.T. laboratory.	Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Chang S, 2002, P NATL ACAD SCI USA, V99, P12520, DOI 10.1073/pnas.212514699; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Dejager L, 2008, CYTOKINE, V42, P55, DOI 10.1016/j.cyto.2008.01.014; DeNardo DG, 2008, CANCER CELL, V14, P7, DOI 10.1016/j.ccr.2008.06.010; Eaton KA, 2011, VET PATHOL, V48, P713, DOI 10.1177/0300985810383876; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gizard F, 2011, ARTERIOSCL THROM VAS, V31, P245, DOI 10.1161/ATVBAHA.110.219808; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Gordon DM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/390791; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Jones RL, 2011, J CLIN PATHOL, V64, P130, DOI 10.1136/jcp.2010.082966; Joseph I, 2010, CANCER RES, V70, P9494, DOI 10.1158/0008-5472.CAN-10-0233; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li S, 2005, J BIOL CHEM, V280, P23709, DOI 10.1074/jbc.M502782200; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, pE1363, DOI 10.1073/pnas.1112414108; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ogoshi M, 1997, J IMMUNOL, V158, P622; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ping L, 2003, J LEUKOCYTE BIOL, V74, P270, DOI 10.1189/jlb.0103014; Ren JG, 2001, FEBS LETT, V488, P133, DOI 10.1016/S0014-5793(00)02397-8; Rentoukas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035739; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Seimiya H, 2002, MOL CANCER THER, V1, P657; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Teo HL, 2010, NAT CELL BIOL, V12, P758, DOI 10.1038/ncb2080; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Yin L, 2000, J BIOL CHEM, V275, P36671, DOI 10.1074/jbc.M007378200; Zhang ZH, 2011, NUCLEIC ACIDS RES, V39, pW391, DOI 10.1093/nar/gkr387	70	237	240	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1270	+		10.1038/ncb2621	http://dx.doi.org/10.1038/ncb2621			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23159929				2022-12-25	WOS:000311890300009
J	Shao, HL; Chung, J; Balaj, L; Charest, A; Bigner, DD; Carter, BS; Hochberg, FH; Breakefield, XO; Weissleder, R; Lee, H				Shao, Huilin; Chung, Jaehoon; Balaj, Leonora; Charest, Alain; Bigner, Darell D.; Carter, Bob S.; Hochberg, Fred H.; Breakefield, Xandra O.; Weissleder, Ralph; Lee, Hakho			Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; INTEGRATED GENOMIC ANALYSIS; PARAMETRIC RESPONSE MAP; MOLECULAR MARKER; EGFR; TARGET; EXPRESSION; BIOMARKERS; EXOSOMES	Glioblastomas shed large quantities of small, membrane-bound microvesicles into the circulation. Although these hold promise as potential biomarkers of therapeutic response, their identification and quantification remain challenging. Here, we describe a highly sensitive and rapid analytical technique for profiling circulating microvesicles directly from blood samples of patients with glioblastoma. Microvesicles, introduced onto a dedicated microfluidic chip, are labeled with target-specific magnetic nanoparticles and detected by a miniaturized nuclear magnetic resonance system. Compared with current methods, this integrated system has a much higher detection sensitivity and can differentiate glioblastoma multiforme (GBM) microvesicles from nontumor host cell-derived microvesicles. We also show that circulating GBM microvesicles can be used to analyze primary tumor mutations and as a predictive metric of treatment-induced changes. This platform could provide both an early indicator of drug efficacy and a potential molecular stratifier for human clinical trials.	[Shao, Huilin; Chung, Jaehoon; Weissleder, Ralph; Lee, Hakho] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Shao, Huilin] Harvard Univ, Sch Med, Harvard Biophys Program, Boston, MA USA; [Balaj, Leonora; Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurosci, Boston, MA 02114 USA; [Charest, Alain] Tufts Univ, Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA; [Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Brain Tumor Ctr, Durham, NC 27710 USA; [Carter, Bob S.] Univ Calif San Diego, Sch Med, Div Neurol Surg, San Diego, CA 92103 USA; [Hochberg, Fred H.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Breakefield, Xandra O.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Tufts University; Duke University; University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lee, H (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; hlee@mgh.harvard.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324; Balaj, Leonora/0000-0003-0931-9715; /0000-0003-0828-4143; Chung, Jaehoon/0000-0003-1499-7449	NIH [U54CA151884, R01EB010011, R01EB004626, P01CA069246, P50CA86355, U01CA141556, U24CA092782, R21CA14122]; Singapore Agency for Science, Technology and Research; American Cancer Society Research Scholar Award [117409]; NATIONAL CANCER INSTITUTE [P50CA086355, U01CA141556, P01CA069246, U54CA151884, U24CA092782] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011, R01EB004626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank T. Reiner (Massachusetts General Hospital (MGH)) for preparing TCO, N. Sergeyev (MGH) for synthesizing MNPs, S. Hilderbrand (MGH) for synthesizing reactive TZ, M. Pittet (MGH) for LNZ308 cells and T. Chan (Memorial Sloan-Kettering Cancer Center) for SkMG3 cells, as well as M. Liong and A. Ghazani for assay assistance, B. Marinelli for mu NMR measurements, C. Min for software implementation, M. McKee for transmission electron microscopy, J. Skog for advice on NTA measurements, L. Zhu and S. Sivaraman for technical assistance and Y. Fisher-Jeffes for critical reading of the manuscript. Special thanks to C. Castro, J. Carlson and clinical colleagues for many helpful discussions. This work was supported in part by NIH grants U54CA151884, R01EB010011, R01EB004626, P01CA069246, P50CA86355, U01CA141556, U24CA092782 and R21CA14122; H.S. received a BS-PhD National Science Scholarship awarded by the Singapore Agency for Science, Technology and Research; A.C. received an American Cancer Society Research Scholar Award 117409.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Elkhaled A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002796; FLEMING TP, 1992, CANCER RES, V52, P4550; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Haun JB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002048; Haun JB, 2010, NAT NANOTECHNOL, V5, P660, DOI [10.1038/NNANO.2010.148, 10.1038/nnano.2010.148]; Issadore D, 2011, LAB CHIP, V11, P2282, DOI 10.1039/c1lc20177h; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Pedersen NM, 2009, MOL CANCER RES, V7, P275, DOI 10.1158/1541-7786.MCR-07-2183; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Yoon TJ, 2011, ANGEW CHEM INT EDIT, V50, P4663, DOI 10.1002/anie.201100101; Zhu HH, 2010, MOL CANCER THER, V9, P2618, DOI 10.1158/1535-7163.MCT-10-0248; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	38	515	533	7	320	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1835	+		10.1038/nm.2994	http://dx.doi.org/10.1038/nm.2994			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142818	Green Accepted			2022-12-25	WOS:000311999800032
J	Bhargava, P; Li, CL; Stanya, KJ; Jacobi, D; Dai, LL; Liu, SH; Gangl, MR; Harn, DA; Lee, CH				Bhargava, Prerna; Li, Changlin; Stanya, Kristopher J.; Jacobi, David; Dai, Lingling; Liu, Sihao; Gangl, Matthew R.; Harn, Donald A.; Lee, Chih-Hao			Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways	NATURE MEDICINE			English	Article							SCHISTOSOMA-MANSONI; ADIPOSE-TISSUE; PROTEIN-KINASE; ALTERNATIVE ACTIVATION; IMMUNE-RESPONSES; DENDRITIC CELLS; TH2 RESPONSES; BILE-ACIDS; IKK-BETA; T-CELLS	Parasitic worms express host-like glycans to attenuate the immune response of human hosts. The therapeutic potential of this immunomodulatory mechanism in controlling the metabolic dysfunction that is associated with chronic inflammation remains unexplored. We demonstrate here that administration of lacto-N-fucopentaose III (LNFPIII), a Lewis(X)-containing immunomodulatory glycan found in human milk and on parasitic helminths, improves glucose tolerance and insulin sensitivity in diet-induced obese mice. This effect is mediated partly through increased interleukin-10 (Il-10) production by LNFPIII-activated macrophages and dendritic cells, which reduces white adipose tissue inflammation and sensitizes the insulin response of adipocytes. Concurrently, LNFPIII treatment upregulates nuclear receptor subfamily 1, group H, member 4 (Fxr-alpha, also known as Nr1h4) to suppress lipogenesis in the liver, conferring protection against hepatosteatosis. At the signaling level, the extracellular signal-regulated kinase (Erk)-activator protein 1 (Ap1) pathway seems to mediate the effects of LNFPIII on both inflammatory and metabolic pathways. Our results suggest that LNFPIII may provide new therapeutic approaches to treat metabolic diseases.	[Bhargava, Prerna; Stanya, Kristopher J.; Jacobi, David; Dai, Lingling; Liu, Sihao; Gangl, Matthew R.; Lee, Chih-Hao] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Div Biol Sci, Boston, MA 02115 USA; [Li, Changlin; Harn, Donald A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Jacobi, David] Univ Tours, INSERM U1069, Ctr Hospr Reg, Serv Med Interne Nutr, Tours, France; [Dai, Lingling] Cent S Univ, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China	Harvard University; Harvard Medical School; University System of Georgia; University of Georgia; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Central South University	Lee, CH (corresponding author), Harvard Univ, Sch Med, Dept Genet & Complex Dis, Div Biol Sci, Boston, MA 02115 USA.	dharn@uga.edu; clee@hsph.harvard.edu	jacobi, david/J-1322-2014; jacobi, david/N-8553-2017; liu, sihao/A-8823-2015	jacobi, david/0000-0001-8674-223X; liu, sihao/0000-0002-4188-3693; Stanya, Kristopher/0000-0002-5369-729X	US National Institutes of Health [T32ES016645, R01AI056484, R01DK075046]; American Diabetes Association; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank E. Hu and S.M. Reilly for technical support and T. Horng (Harvard School of Public Health) for providing reagents. P. Bhargava and K. Stanya were supported by a US National Institutes of Health training grant (T32ES016645). This work was supported by the American Diabetes Association, the American Heart Association and a US National Institutes of Health grant (R01AI056484, D.A.H. and R01DK075046, C.-H.L.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Atochina O, 2001, J IMMUNOL, V167, P4293, DOI 10.4049/jimmunol.167.8.4293; Atochina O, 2008, IMMUNOLOGY, V125, P111, DOI 10.1111/j.1365-2567.2008.02826.x; Badr SGE, 1999, PARASITOL RES, V85, P421, DOI 10.1007/s004360050570; Bassols J, 2010, OBESITY, V18, P611, DOI 10.1038/oby.2009.313; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chang YH, 2005, HUM IMMUNOL, V66, P1258, DOI 10.1016/j.humimm.2005.05.001; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Dutta P, 2010, TRANSPLANTATION, V90, P1071, DOI 10.1097/TP.0b013e3181f8f296; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Foss-Freitas MC, 2004, BRAZ J MED BIOL RES, V37, P663, DOI 10.1590/S0100-879X2004000500006; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; HARN DA, 1984, J EXP MED, V159, P1371, DOI 10.1084/jem.159.5.1371; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; KO AI, 1990, P NATL ACAD SCI USA, V87, P4159, DOI 10.1073/pnas.87.11.4159; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Liu SH, 2011, J BIOL CHEM, V286, P1237, DOI 10.1074/jbc.M110.138115; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okano M, 1999, J IMMUNOL, V163, P6712; Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; STAHL B, 1994, ANAL BIOCHEM, V223, P218, DOI 10.1006/abio.1994.1577; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Van der Kleij D, 2002, J INFECT DIS, V185, P531, DOI 10.1086/338574; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200	60	89	94	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1665	+		10.1038/nm.2962	http://dx.doi.org/10.1038/nm.2962			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23104131	Green Submitted, Green Accepted			2022-12-25	WOS:000310837000027
J	Deery, E; Schroeder, S; Lawrence, AD; Taylor, SL; Seyedarabi, A; Waterman, J; Wilson, KS; Brown, D; Geeves, MA; Howard, MJ; Pickersgill, RW; Warren, MJ				Deery, Evelyne; Schroeder, Susanne; Lawrence, Andrew D.; Taylor, Samantha L.; Seyedarabi, Arefeh; Waterman, Jitka; Wilson, Keith S.; Brown, David; Geeves, Michael A.; Howard, Mark J.; Pickersgill, Richard W.; Warren, Martin J.			An enzyme-trap approach allows isolation of intermediates in cobalamin biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PSEUDOMONAS-DENITRIFICANS; HYDROGENOBYRINIC ACID; MAXIMUM-LIKELIHOOD; VITAMIN-B12; PRECORRIN-8X; PURIFICATION; SUBSTRATE; CRYSTALLOGRAPHY; IDENTIFICATION; REFINEMENT	The biosynthesis of many vitamins and coenzymes has often proven difficult to elucidate owing to a combination of low abundance and kinetic lability of the pathway intermediates. Through a serial reconstruction of the cobalamin (vitamin B-12) pathway in Escherichia coli and by His tagging the terminal enzyme in the reaction sequence, we have observed that many unstable intermediates can be isolated as tightly bound enzyme-product complexes. Together, these approaches have been used to extract intermediates between precorrin-4 and hydrogenobyrinic acid in their free acid form and permitted the delineation of the overall reaction catalyzed by CobL, including the formal elucidation of precorrin-7 as a metabolite. Furthermore, a substrate-carrier protein, CobE, that can also be used to stabilize some of the transient metabolic intermediates and enhance their onward transformation, has been identified. The tight association of pathway intermediates with enzymes provides evidence for a form of metabolite channeling.	[Deery, Evelyne; Schroeder, Susanne; Lawrence, Andrew D.; Taylor, Samantha L.; Brown, David; Geeves, Michael A.; Howard, Mark J.; Warren, Martin J.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Seyedarabi, Arefeh; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Waterman, Jitka; Wilson, Keith S.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England	University of Kent; University of London; Queen Mary University London; University of York - UK	Deery, E (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.	r.w.pickersgill@qmul.ac.uk; m.j.warren@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Lodge, Samantha/0000-0001-9193-0462; Howard, Mark/0000-0002-0762-2887; Wilson, Keith/0000-0002-3581-2194; Warren, Martin/0000-0002-6028-6456; Schroeder, Susanne/0000-0003-1703-9158	Biotechnology and Biological Sciences Research Council [BB/E024203, BB/I013334]; Wellcome Trust [091163/Z/10/Z]; BBSRC [BB/E024203/1, BB/I012079/1, BB/I013334/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I012079/1, BB/I013334/1, BB/E024203/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/E024203 and BB/I013334) and the Wellcome Trust (091163/Z/10/Z). We thank M. Rowe for additional NMR technical support. Diffraction data were collected at the European Synchrotron Radiation Facility, Grenoble, France (for CobE) and the Diamond Light Source, Oxfordshire, UK (for CobL and CobH). We thank C. Roessner (Texas A&M University) for a clone of the P. denitrificans cobG.	BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; BLANCHE F, 1995, ANGEW CHEM INT EDIT, V34, P383, DOI 10.1002/anie.199503831; BLANCHE F, 1990, ANGEW CHEM INT EDIT, V29, P884, DOI 10.1002/anie.199008841; BLANCHE F, 1992, J BACTERIOL, V174, P1036, DOI 10.1128/jb.174.3.1036-1042.1992; BLANCHE F, 1992, J BACTERIOL, V174, P1050, DOI 10.1128/jb.174.3.1050-1052.1992; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DEBUSSCHE L, 1993, J CHEM SOC CHEM COMM, P1100, DOI 10.1039/c39930001100; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dogutan DK, 2011, J AM CHEM SOC, V133, P131, DOI 10.1021/ja108904s; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Lee CH, 2011, J AM CHEM SOC, V133, P8775, DOI 10.1021/ja202136y; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; MIN CH, 1993, J AM CHEM SOC, V115, P10380, DOI 10.1021/ja00075a072; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PETTERSSON G, 1991, J THEOR BIOL, V152, P65, DOI 10.1016/S0022-5193(05)80512-0; ROBINSON JB, 1987, J BIOL CHEM, V262, P1786; Sambrook J., 2001, MOL CLONING LAB MANU; Santander PJ, 2006, BIOORGAN MED CHEM, V14, P724, DOI 10.1016/j.bmc.2005.08.062; SCOTT AI, 1993, FEBS LETT, V331, P105, DOI 10.1016/0014-5793(93)80306-F; SCOTT AI, 1990, J CHEM SOC CHEM COMM, P593, DOI 10.1039/c39900000593; Seyedarabi A, 2010, ACTA CRYSTALLOGR F, V66, P1652, DOI 10.1107/S1744309110042910; Shipman LW, 2001, STRUCTURE, V9, P587, DOI 10.1016/S0969-2126(01)00618-9; THIBAUT D, 1990, P NATL ACAD SCI USA, V87, P8800, DOI 10.1073/pnas.87.22.8800; THIBAUT D, 1992, J BACTERIOL, V174, P1043, DOI 10.1128/jb.174.3.1043-1049.1992; THIBAUT D, 1993, J CHEM SOC CHEM COMM, P513, DOI 10.1039/c39930000513; UZAR HC, 1987, J CHEM SOC PERK T 1, P1689, DOI 10.1039/p19870001689; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vevodova J, 2005, ACTA CRYSTALLOGR F, V61, P442, DOI 10.1107/S1744309105006731; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WARREN MJ, 1992, BIOCHEMISTRY-US, V31, P603, DOI 10.1021/bi00117a043; Webb ME, 2007, NAT PROD REP, V24, P988, DOI 10.1039/b703105j; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497	45	40	42	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					933	940		10.1038/NCHEMBIO.1086	http://dx.doi.org/10.1038/NCHEMBIO.1086			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23042036	Green Accepted			2022-12-25	WOS:000310052100013
J	Holland, AJ; Cleveland, DW				Holland, Andrew J.; Cleveland, Don W.			Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements	NATURE MEDICINE			English	Article							ONCOGENE-INDUCED SENESCENCE; BREAKPOINT CLUSTER REGION; MAMMALIAN-CELL FUSION; DNA-DAMAGE RESPONSE; GENOMIC REARRANGEMENTS; COLORECTAL CANCERS; CHROMOTHRIPSIS; INSTABILITY; REPLICATION; ANEUPLOIDY	Next-generation sequencing of DNA from human tumors or individuals with developmental abnormalities has led to the discovery of a process we term chromoanagenesis, in which large numbers of complex rearrangements occur at one or a few chromosomal loci in a single catastrophic event. Two mechanisms underlie these rearrangements, both of which can be facilitated by a mitotic chromosome segregation error to produce a micronucleus containing the chromosome to undergo rearrangement. In the first, chromosome shattering (chromothripsis) is produced by mitotic entry before completion of DNA replication within the micronucleus, with a failure to disassemble the micronuclear envelope encapsulating the chromosomal fragments for random reassembly in the subsequent interphase. Alternatively, locally defective DNA replication initiates serial, microhomology-mediated template switching (chromoanasynthesis) that produces local rearrangements with altered gene copy numbers. Complex rearrangements are present in a broad spectrum of tumors and in individuals with congenital or developmental defects, highlighting the impact of chromoanagenesis on human disease.	[Holland, Andrew J.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Holland, AJ (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	a1holland@ucsd.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	US National Institutes of Health [GM29513]; Ludwig Institute for Cancer Research; Leukemia AMP; Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029513, R37GM029513] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Leukemia AMP; Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all whose work was not cited because of space restrictions. This work was supported by a grant (GM29513) from the US National Institutes of Health to D. W. C., who receives salary support from the Ludwig Institute for Cancer Research. A.J.H. is supported by a Leukemia & Lymphoma Society special fellowship.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen JM, 2012, MUTAT RES-REV MUTAT, V750, P52, DOI 10.1016/j.mrrev.2011.10.002; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Eldredge N., 1972, P82; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Meyerson M, 2011, CELL, V144, P9, DOI 10.1016/j.cell.2010.12.025; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; SPERLING K, 1974, HUMANGENETIK, V23, P235, DOI 10.1007/BF00272508; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Stanulla M, 2001, HUM MOL GENET, V10, P2481, DOI 10.1093/hmg/10.22.2481; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Terradas M, 2012, MUTAT RES-FUND MOL M, V729, P35, DOI 10.1016/j.mrfmmm.2011.09.003; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tubio JMC, 2011, NATURE, V470, P476, DOI 10.1038/470476a; WAHL GM, 1989, CANCER RES, V49, P1333; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690	53	180	183	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1630	1638		10.1038/nm.2988	http://dx.doi.org/10.1038/nm.2988			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135524	Green Accepted			2022-12-25	WOS:000310837000022
J	Tan, X; Hu, L; Luquette, LJ; Gao, G; Liu, YF; Qu, HJ; Xi, RB; Lu, ZJ; Park, PJ; Elledge, SJ				Tan, Xu; Hu, Long; Luquette, Lovelace J., III; Gao, Geng; Liu, Yifang; Qu, Hongjing; Xi, Ruibin; Lu, Zhi John; Park, Peter J.; Elledge, Stephen J.			Systematic identification of synergistic drug pairs targeting HIV	NATURE BIOTECHNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL-ACTIVATION; ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; IMMUNE ACTIVATION; VIRAL LOAD; IN-VIVO; INFECTION; REPLICATION; DISCOVERY	The systematic identification of effective drug combinations has been hindered by the unavailability of methods that can explore the large combinatorial search space of drug interactions. Here we present multiplex screening for interacting compounds (MuSIC), which expedites the comprehensive assessment of pairwise compound interactions. We examined similar to 500,000 drug pairs from 1,000 US Food and Drug Administration (FDA)-approved or clinically tested drugs and identified drugs that synergize to inhibit HIV replication. Our analysis reveals an enrichment of anti-inflammatory drugs in drug combinations that synergize against HIV. As inflammation accompanies HIV infection, these findings indicate that inhibiting inflammation could curb HIV propagation. Multiple drug pairs identified in this study, including various glucocorticoids and nitazoxanide (NTZ), synergize by targeting different steps in the HIV life cycle. MuSIC can be applied to a wide variety of disease-relevant screens to facilitate efficient identification of compound combinations.	[Tan, Xu; Gao, Geng; Qu, Hongjing; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Sch Med,Div Genet, Boston, MA 02115 USA; [Hu, Long; Liu, Yifang; Lu, Zhi John] Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China; [Luquette, Lovelace J., III; Xi, Ruibin; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Tsinghua University; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Sch Med,Div Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	hu, long/GQI-0544-2022; Tan, Xu/E-7170-2011; liu, yifang/AAC-1520-2020	Tan, Xu/0000-0003-4861-4573; Park, Peter/0000-0001-9378-960X; Xi, Ruibin/0000-0001-7545-7361; Hu, Long/0000-0003-2120-3416	Damon Runyon Cancer Research Foundation [DRG 2008-09]; Charles A. King Trust, N.A.; Bank of America; National Natural Science Foundation of China [31100601]; National Key Basic Research Program [2012CB316503]	Damon Runyon Cancer Research Foundation; Charles A. King Trust, N.A.; Bank of America; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China)	We thank the Institute of Chemistry and Cell Biology (ICCB)-Longwood: C. Shamu, S. Chiang, S. Rudnicki, A. Daab, D. Flood, S. Johnston, Z. Cooper, T. Ren; We also thank A. Brass for help with the HIV infection assay, N. Yan, Y. Koh, K. Matreyek and A. Engelman for help with virology, M. Mankowski for help with ELISA, M. Mefford for the BlaM assay protocol, NIH AIDS Research & Reference Reagent Program for reagents, J. Zhu, Q. Xu and other Elledge laboratory members for discussion and D. Fusco for reading the manuscript. X.T. is supported by the Damon Runyon Cancer Research Foundation (DRG 2008-09) and the Charles A. King Trust, N.A., Bank of America, co-trustee. Z.J.L. is supported by grants from the National Natural Science Foundation of China (31100601) and the National Key Basic Research Program (2012CB316503); S.J.E. is an investigator with the Howard Hughes Medical Institute.	Andrieu JM, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-17; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Hanley TM, 2011, J VIROL, V85, P10834, DOI 10.1128/JVI.00789-11; Hawkins T, 2010, ANTIVIR RES, V85, P201, DOI 10.1016/j.antiviral.2009.10.016; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Kutsch O, 2004, ANTIMICROB AGENTS CH, V48, P1652, DOI 10.1128/AAC.48.5.1652-1663.2004; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Petraitis V, 2009, ANTIMICROB AGENTS CH, V53, P2382, DOI 10.1128/AAC.00329-09; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossignol JF, 2009, J BIOL CHEM, V284, P29798, DOI 10.1074/jbc.M109.029470; Russo FO, 1999, VIRUS RES, V64, P87, DOI 10.1016/S0168-1702(99)00082-9; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Ulmer A, 2005, EUR J MED RES, V10, P105; WilsonLingardo L, 1996, J MED CHEM, V39, P2720, DOI 10.1021/jm960169g; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755	37	85	87	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1125	+		10.1038/nbt.2391	http://dx.doi.org/10.1038/nbt.2391			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23064238	Green Accepted, Green Submitted			2022-12-25	WOS:000311087500032
J	Winkler, IG; Barbier, V; Nowlan, B; Jacobsen, RN; Forristal, CE; Patton, JT; Magnani, JL; Levesque, JP				Winkler, Ingrid G.; Barbier, Valerie; Nowlan, Bianca; Jacobsen, Rebecca N.; Forristal, Catherine E.; Patton, John T.; Magnani, John L.; Levesque, Jean-Pierre			Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance	NATURE MEDICINE			English	Article							BONE-MARROW; P-SELECTIN; PROGENITOR CELLS; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; DEFICIENT MICE; CANCER-CELLS; LIGANDS; EXPRESSION; RECEPTORS	The microenvironment, or niche, surrounding a stem cell largely governs its cellular fate. Two anatomical niches for hematopoietic stem cells (HSCs) have been reported in the bone marrow, but a distinct function for each of these niches remains unclear. Here we report a new role for the adhesion molecule E-selectin expressed exclusively by bone marrow endothelial cells in the vascular HSC niche. HSC quiescence was enhanced and self-renewal potential was increased in E-selectin knockout (Sele(-/-)) mice or after administration of an E-selectin antagonist, demonstrating that E-selectin promotes HSC proliferation and is a crucial component of the vascular niche. These effects are not mediated by canonical E-selectin ligands. Deletion or blockade of E-selectin enhances HSC survival threefold to sixfold after treatment of mice with chemotherapeutic agents or irradiation and accelerates blood neutrophil recovery. As bone marrow suppression is a severe side effect of high-dose chemotherapy, transient blockade of E-selectin is potentially a promising treatment for the protection of HSCs during chemotherapy or irradiation.	[Winkler, Ingrid G.; Barbier, Valerie] Mater Med Res Inst, Stem Cells & Canc Grp, Brisbane, Qld, Australia; [Nowlan, Bianca; Jacobsen, Rebecca N.; Forristal, Catherine E.; Levesque, Jean-Pierre] Mater Med Res Inst, Stem Cell Biol Grp, Brisbane, Qld, Australia; [Jacobsen, Rebecca N.; Levesque, Jean-Pierre] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Patton, John T.; Magnani, John L.] GlycoMimetics Inc, Gaithersburg, MD USA	Mater Research; Mater Research; University of Queensland	Winkler, IG (corresponding author), Mater Med Res Inst, Stem Cells & Canc Grp, Brisbane, Qld, Australia.	iwinkler@mmri.mater.org.au; jplevesque@mmri.mater.org.au	Levesque, Jean-Pierre/C-5426-2011; Jacobsen, Rebecca/D-5092-2012; Winkler, Ingrid G/F-3263-2011; Forristal, Catherine/B-6602-2013; , Catherine/D-9925-2019	Levesque, Jean-Pierre/0000-0002-7299-6025; Winkler, Ingrid G/0000-0001-6026-3572; Forristal, Catherine/0000-0002-6299-0885; Nowlan, Bianca/0000-0002-1049-5284; , Catherine/0000-0002-6304-1286	National Health and Medical Research Council of Australia [350406, 543706, 488817, APP1033736]; Cancer Council of Queensland; GlycoMimetics Inc	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); GlycoMimetics Inc	The authors wish to thank R. Wadley for assistance with cell sorting, P. Frenette (Albert Einstein College of Medicine, New York) for providing selectin knockout mice, B. Furie (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston) for Selplg<SUP>-/-</SUP> mice, T. Mak (Ontario Cancer Institute, Toronto) for Cd44<SUP>-/-</SUP> mice, D. Vestweber (Max Planck Institute of Molecular Biomedicine, Munster, Germany) for antibody to ESL-1, K. Snapp (Northwestern University, Chicago) for selectin-IgM constructs and L. Purton, C. Walkley and C. Bonder for helpful discussions. This work was supported by project grants 350406 and 543706 (I. G. W. and J.-P.L.) and Career Development Fellowships 488817 and APP1033736 (I. G. W.) from the National Health and Medical Research Council of Australia, a Senior Research Fellowship from the Cancer Council of Queensland (J.-P.L.) and a research contract with GlycoMimetics Inc to generate the data in Figure 5.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barbier Valerie, 2012, Methods Mol Biol, V904, P117, DOI 10.1007/978-1-61779-943-3_11; Barbier V, 2012, METHODS MOL BIOL, V844, P31, DOI 10.1007/978-1-61779-527-5_3; Barbier V, 2012, METHODS MOL BIOL, V844, P45, DOI 10.1007/978-1-61779-527-5_4; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Dimitroff CJ, 2005, CANCER RES, V65, P5750, DOI 10.1158/0008-5472.CAN-04-4653; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Eto T, 2005, EXP HEMATOL, V33, P232, DOI 10.1016/j.exphem.2004.10.018; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Gout S, 2006, CANCER RES, V66, P9117, DOI 10.1158/0008-5472.CAN-05-4605; Hakomori S, 1996, CANCER RES, V56, P5309; Hidalgo A, 2002, J CLIN INVEST, V110, P559, DOI 10.1172/JCI200214047; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Huttmann A, 2001, EXP HEMATOL, V29, P1109, DOI 10.1016/S0301-472X(01)00684-1; Jacobsen K, 1996, BLOOD, V87, P73; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Levesque JP, 2007, STEM CELLS, V25, P1954, DOI 10.1634/stemcells.2006-0688; Levesque JP, 1999, IMMUNITY, V11, P369, DOI 10.1016/S1074-7613(00)80112-0; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; LORD BI, 1992, BLOOD, V79, P2605; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyaoka Y, 2011, BIOCHEM J, V440, P33, DOI 10.1042/BJ20110318; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Sandvig K, 1996, MOL BIOL CELL, V7, P1391, DOI 10.1091/mbc.7.9.1391; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Steegmaier M, 1997, J CELL SCI, V110, P687; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Wild MK, 2001, J BIOL CHEM, V276, P31602, DOI 10.1074/jbc.M104844200; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Winkler IG, 2004, BLOOD, V103, P1685, DOI 10.1182/blood-2003-06-1921; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	56	289	297	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1651	+		10.1038/nm.2969	http://dx.doi.org/10.1038/nm.2969			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086476				2022-12-25	WOS:000310837000025
J	Winter, GE; Rix, U; Carlson, SM; Gleixner, KV; Grebien, F; Gridling, M; Muller, AC; Breitwieser, FP; Bilban, M; Colinge, J; Valent, P; Bennett, KL; White, FM; Superti-Furga, G				Winter, Georg E.; Rix, Uwe; Carlson, Scott M.; Gleixner, Karoline V.; Grebien, Florian; Gridling, Manuela; Mueller, Andre C.; Breitwieser, Florian P.; Bilban, Martin; Colinge, Jacques; Valent, Peter; Bennett, Keiryn L.; White, Forest M.; Superti-Furga, Giulio			Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML	NATURE CHEMICAL BIOLOGY			English	Article							CHRONIC MYELOID-LEUKEMIA; C-MYC; GENE-EXPRESSION; SMALL MOLECULES; CANCER; INHIBITOR; MUTATION; PHOSPHORYLATION; TRANSFORMATION; NETWORK	Occurrence of the BCR-ABL(T315I) gatekeeper mutation is among the most pressing challenges in the therapy of chronic myeloid leukemia (CML). Several BCR-ABL inhibitors have multiple targets and pleiotropic effects that could be exploited for their synergistic potential. Testing combinations of such kinase inhibitors identified a strong synergy between danusertib and bosutinib that exclusively affected CML cells harboring BCR-ABL(T315I). To elucidate the underlying mechanisms, we applied a systems-level approach comprising phosphoproteomics, transcriptomics and chemical proteomics. Data integration revealed that both compounds targeted Mapk pathways downstream of BCR-ABL, resulting in impaired activity of c-Myc. Using pharmacological validation, we assessed that the relative contributions of danusertib and bosutinib could be mimicked individually by Mapk inhibitors and collectively by downregulation of c-Myc through Brd4 inhibition. Thus, integration of genome-and proteome-wide technologies enabled the elucidation of the mechanism by which a new drug synergy targets the dependency of BCR-ABL(T315I) CML cells on c-Myc through nonobvious off targets.	[Winter, Georg E.; Rix, Uwe; Grebien, Florian; Gridling, Manuela; Mueller, Andre C.; Breitwieser, Florian P.; Colinge, Jacques; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Carlson, Scott M.; White, Forest M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Carlson, Scott M.; White, Forest M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Gleixner, Karoline V.; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; [Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute	Winter, GE (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Test, Test/Y-7921-2019; Grebien, Florian/H-9234-2019; Valent, Peter/B-8533-2016; Colinge, Jacques/D-1578-2017; Gamperl, Susi/V-2715-2019; Superti-Furga, Giulio/AAE-5681-2019; Colinge, Jacques/Z-2613-2019; Carlson, Scott/E-4606-2010; Superti-Furga, Giulio/F-4755-2015; Test, PV/U-9451-2019	Grebien, Florian/0000-0003-4289-2281; Valent, Peter/0000-0003-0456-5095; Colinge, Jacques/0000-0003-2466-4824; Gamperl, Susi/0000-0003-0456-5095; Colinge, Jacques/0000-0003-2466-4824; Carlson, Scott/0000-0003-1996-0012; Superti-Furga, Giulio/0000-0002-0570-1768; Mueller, Andre/0000-0002-0608-8176; White, Forest/0000-0002-1545-1651; Bennett, Keiryn L./0000-0001-9356-7708; Winter, Georg/0000-0001-6606-1437; Bilban, Martin/0000-0001-7043-7142; Gleixner, Karoline/0000-0001-5753-0203; Breitwieser, Florian P/0000-0001-6192-0853	'GEN-AU' initiative of the Austrian Federal Ministry for Science and Research [PLACEBO GZ BMWF-70.081/0018-II/1a/2008]; Austrian Science Fund [P 24321-B21]; Austrian Science Fund (FWF) [P 24321] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083273] Funding Source: NIH RePORTER	'GEN-AU' initiative of the Austrian Federal Ministry for Science and Research; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Bradner (Dana Faber Cancer Institute-Harvard Medical School) for providing JQ1S and JQ1R and R. Giambruno, C. Tan, J. Bigenzahn and O. Hantschel for skillful advice and help. We also thank J. Lehar for inspiring discussions and S. Nijman and O. Hantschel for carefully reading this manuscript. We thank Cell Signaling Technology for allowing reproduction of the kinome map. We acknowledge L. Brecker for measuring NMR spectra. The present work was, in part, financed by the 'GEN-AU' initiative of the Austrian Federal Ministry for Science and Research (PLACEBO GZ BMWF-70.081/0018-II/1a/2008) as well as the Austrian Science Fund (P 24321-B21).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cortes JE, 2011, BLOOD, V118, P4567, DOI 10.1182/blood-2011-05-355594; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donato NJ, 2004, CANCER RES, V64, P2306; Dopazo J, 1997, J MOL EVOL, V44, P226, DOI 10.1007/PL00006139; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Eide CA, 2011, CANCER RES, V71, P3189, DOI 10.1158/0008-5472.CAN-10-3224; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P2796, DOI 10.1074/mcp.M900285-MCP200; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Rix U, 2010, LEUKEMIA, V24, P44, DOI 10.1038/leu.2009.228; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; SETH A, 1991, J BIOL CHEM, V266, P23521; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	45	79	83	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					905	912		10.1038/NCHEMBIO.1085	http://dx.doi.org/10.1038/NCHEMBIO.1085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23023260	Green Accepted, Green Published			2022-12-25	WOS:000310052100009
J	Lakdawala, SS; Subbarao, K				Lakdawala, Seema S.; Subbarao, Kanta			The ongoing battle against influenza The challenge of flu transmission	NATURE MEDICINE			English	Editorial Material							VIRUS; FERRETS; MODEL	Influenza viruses can cause a broad spectrum of disease severity, including devastating cases in some people. Several factors influence the epidemiological success of the virus; the mechanisms of transmission and the strategies for prevention and treatment have an impact on the disease outcome and the incidence of flu infection in the population. Understanding how and why the viruses spread so efficiently among people and determining possible ways to harness this transmission have been arduous tasks, given the limitations of flu animal models. In 'Bedside to Bench', Kanta Subbarao and Seema S. Lakdawala peruse a study that used a human challenge model to assess influenza transmission; this experimental approach shows how transmission can be studied in humans and emphasizes factors that are different compared to animals, such as distinct disease severity and incidence. Lessons can be taken to optimize animal studies. Another issue that dictates the severity of flu episodes is the potential emergence of drug-resistant strains in treated individuals. In 'Bench to Bedside', Anne Kelso and Aeron C. Hurt discuss another concern-the presence of drug-resistant viruses with additional permissive mutations that make them fit to infect and compete with wild-type strains. The fact that these strains can be found in untreated people and can spread poses a public health concern and a challenge for scientists to find new drugs and assess antiviral combinations.	[Lakdawala, Seema S.; Subbarao, Kanta] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lakdawala, SS (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.	ksubbarao@niaid.nih.gov	Lakdawala, Seema/AAO-2217-2020	Lakdawala, Seema/0000-0002-7679-2150; Subbarao, Kanta/0000-0003-1713-3056				Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; LITTLE JW, 1979, J MED VIROL, V3, P177, DOI 10.1002/jmv.1890030303; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Powell TJ, 2012, J INFECT DIS, V205, P20, DOI 10.1093/infdis/jir689; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	19	19	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1468	1470		10.1038/nm.2953	http://dx.doi.org/10.1038/nm.2953			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042349	Bronze			2022-12-25	WOS:000309587500018
J	Li, GJ; Yu, MC; Lee, WW; Tsang, M; Krishnan, E; Weyand, CM; Goronzy, JJ				Li, Guangjin; Yu, Mingcan; Lee, Won-Woo; Tsang, Michael; Krishnan, Eswar; Weyand, Cornelia M.; Goronzy, Joerg J.			Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity	NATURE MEDICINE			English	Article							INFLUENZA VACCINE; CLONAL EXPANSIONS; REPERTOIRE; LYMPHOCYTES; NAIVE; IMMUNOSENESCENCE; PROLIFERATION; PHOSPHATASE; ACTIVATION; DIVERSITY	The ability of the human immune system to respond to vaccination declines with age. We identified an age-associated defect in T cell receptor (TCR)-induced extracellular signal-regulated kinase (ERK) phosphorylation in naive CD4(+) T cells, whereas other signals, such as z chain-associated protein kinase 70 (ZAP70) and phospholipase C-gamma 1 phosphorylation, were not impaired. The defective ERK signaling was caused by the dual specific phosphatase 6 (DUSP6), whose protein expression increased with age due to a decline in repression by miR-181a. Reconstitution of miR-181a lowered DUSP6 expression in naive CD4(+) T cells in elderly individuals. DUSP6 repression using miR-181a or specific siRNA and DUSP6 inhibition by the allosteric inhibitor (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one improved CD4(+) T cell responses, as seen by increased expression of activation markers, improved proliferation and supported preferential T helper type 1 cell differentiation. DUSP6 is a potential intervention target for restoring T cell responses in the elderly, which may augment the effectiveness of vaccination.	[Li, Guangjin; Yu, Mingcan; Krishnan, Eswar; Weyand, Cornelia M.; Goronzy, Joerg J.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Li, Guangjin; Yu, Mingcan; Krishnan, Eswar; Weyand, Cornelia M.; Goronzy, Joerg J.] Palo Alto Dept Vet Affairs Hlth Care Syst, Palo Alto, CA USA; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Immunol & Microbiol, Seoul, South Korea; [Tsang, Michael] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Stanford University; Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goronzy, JJ (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	jgoronzy@stanford.edu	Weyand, Cornelia/AAH-3343-2021; krishnan, Eswar/AAY-1269-2020; TSANG, Michael/E-2758-2013; Tsang, Michael W/I-9305-2014; Tsang, Michael/ABV-0504-2022; Tsang, Michael/AAG-9338-2020; Lee, Won-Woo/J-5588-2012	TSANG, Michael/0000-0001-6384-2422; Tsang, Michael W/0000-0001-7123-0063; Tsang, Michael/0000-0001-7123-0063; Goronzy, Jorg/0000-0001-7670-1856; Lee, Won-Woo/0000-0002-5347-9591	US National Institutes of Health [U19 AI090019, R01 AG015043, U19 AI057266, R01 AR042527, R01 EY011916, R01 AI044142, PO1 HL058000]; NATIONAL EYE INSTITUTE [R01EY011916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R01AI044142, U19AI090019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015043] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.J.G. was supported by US National Institutes of Health grants U19 AI090019, R01 AG015043 and U19 AI057266, and C. M. W. was supported by US National Institutes of Health grants R01 AR042527, R01 EY011916, R01 AI044142 and PO1 HL058000. Antibody to PTPN22 was a gift from A. C. Chan (Genentech).	Akha AAS, 2005, CURR OPIN IMMUNOL, V17, P486, DOI 10.1016/j.coi.2005.07.004; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Aspinall Richard, 2007, Immun Ageing, V4, P9, DOI 10.1186/1742-4933-4-9; Berg LJ, 2009, IMMUNITY, V31, P529, DOI 10.1016/j.immuni.2009.09.008; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Clambey ET, 2005, IMMUNOL REV, V205, P170, DOI 10.1111/j.0105-2896.2005.00265.x; Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Del Giudice G, 2006, VACCINE, V24, P3063, DOI 10.1016/j.vaccine.2006.01.015; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gorgas G, 1997, MECH AGEING DEV, V94, P71, DOI 10.1016/S0047-6374(96)01857-X; Goronzy J. J., 2012, SEMIN IMMUN IN PRESS; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; GROSSMANN A, 1989, EXP CELL RES, V180, P367, DOI 10.1016/0014-4827(89)90064-5; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; LEDBETTER JA, 1988, EUR J IMMUNOL, V18, P525, DOI 10.1002/eji.1830180406; Lee WW, 2008, REJUV RES, V11, P1001, DOI 10.1089/rej.2008.0747; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	43	244	248	1	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1518	U113		10.1038/nm.2963	http://dx.doi.org/10.1038/nm.2963			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23023500	Green Accepted			2022-12-25	WOS:000309587500030
J	Van Dyke, M				Van Dyke, Mark			How much risk are you prepared to take?	NATURE BIOTECHNOLOGY			English	Editorial Material								Any faculty member wishing to commercialize a discovery or technology should contemplate the pros and cons of pursuing the entrepreneurial route or licensing to an outside entity.	[Van Dyke, Mark] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center	Van Dyke, M (corresponding author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.	mvandyk5@vt.edu							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					821	824		10.1038/nbt.2330	http://dx.doi.org/10.1038/nbt.2330			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965046				2022-12-25	WOS:000308705700009
J	Howie, B; Fuchsberger, C; Stephens, M; Marchini, J; Abecasis, GR				Howie, Bryan; Fuchsberger, Christian; Stephens, Matthew; Marchini, Jonathan; Abecasis, Goncalo R.			Fast and accurate genotype imputation in genome-wide association studies through pre-phasing	NATURE GENETICS			English	Article							UNRELATED INDIVIDUALS; COMMON; TRIOS	The 1000 Genomes Project and disease-specific sequencing efforts are producing large collections of haplotypes that can be used as reference panels for genotype imputation in genome-wide association studies (GWAS). However, imputing from large reference panels with existing methods imposes a high computational burden. We introduce a strategy called 'pre-phasing' that maintains the accuracy of leading methods while reducing computational costs. We first statistically estimate the haplotypes for each individual within the GWAS sample (pre-phasing) and then impute missing genotypes into these estimated haplotypes. This reduces the computational cost because (i) the GWAS samples must be phased only once, whereas standard methods would implicitly repeat phasing with each reference panel update, and (ii) it is much faster to match a phased GWAS haplotype to one reference haplotype than to match two unphased GWAS genotypes to a pair of reference haplotypes. We implemented our approach in the MaCH and IMPUTE2 frameworks, and we tested it on data sets from the Wellcome Trust Case Control Consortium 2 (WTCCC2), the Genetic Association Information Network (GAIN), the Women's Health Initiative (WHI) and the 1000 Genomes Project. This strategy will be particularly valuable for repeated imputation as reference panels evolve.	[Fuchsberger, Christian; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Howie, Bryan; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Marchini, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Michigan System; University of Michigan; University of Chicago; University of Chicago; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	mstephens@uchicago.edu; marchini@stats.ox.ac.uk; goncalo@umich.edu	Fuchsberger, Christian/ABD-7127-2021; Abecasis, Goncalo R/B-7840-2010; Marchini, Jonathan/ABE-9024-2020	Fuchsberger, Christian/0000-0002-5918-8947; Marchini, Jonathan/0000-0003-0610-8322; Abecasis, Goncalo/0000-0003-1509-1825	National Human Genome Research Institute (NHGRI) [HGO2585]; UK Medical Research Council [G0801823]; US National Institutes of Health (NIH) [DK0855840, HG005552, HG005581]; Wellcome Trust [076113, 085475]; MRC [G1001799, G0801823] Funding Source: UKRI; Medical Research Council [G0801823, G1001799] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005552, RC2HG005581, R01HG002651, U01HG006513, R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084698] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Boehnke for critical reading, advice and suggestion, Y. Li for aid with cleaning the WHI data and the two anonymous reviewers for their helpful comments. B. H. and M. S. were supported by a grant from the National Human Genome Research Institute (NHGRI; HGO2585) to M.S.J.M. was supported by a grant from the UK Medical Research Council (G0801823). C.F. and G.R.A. were supported by grants from the US National Institutes of Health (NIH; DK0855840, HG005552 and HG005581). This study makes use of data generated by the WTCCC, GAIN and WHI. A full list of the investigators who contributed to the generation of the WTCCC data is available from the WTCCC web site (see URLs). The WTCCC was partially funded by the Wellcome Trust under awards 076113 and 085475. For details of contributors to the GAIN and WHI studies, please see the corresponding dbGaP accessions.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008	25	1154	1204	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					955	+		10.1038/ng.2354	http://dx.doi.org/10.1038/ng.2354			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22820512	Green Accepted, Green Published			2022-12-25	WOS:000306854700025
J	Beuschlein, F; Boulkroun, S; Osswald, A; Wieland, T; Nielsen, HN; Lichtenauer, UD; Penton, D; Schack, VR; Amar, L; Fischer, E; Walther, A; Tauber, P; Schwarzmayr, T; Diener, S; Graf, E; Allolio, B; Samson-Couterie, B; Benecke, A; Quinkler, M; Fallo, F; Plouin, PF; Mantero, F; Meitinger, T; Mulatero, P; Jeunemaitre, X; Warth, R; Vilsen, B; Zennaro, MC; Strom, TM; Reincke, M				Beuschlein, Felix; Boulkroun, Sheerazed; Osswald, Andrea; Wieland, Thomas; Nielsen, Hang N.; Lichtenauer, Urs D.; Penton, David; Schack, Vivien R.; Amar, Laurence; Fischer, Evelyn; Walther, Anett; Tauber, Philipp; Schwarzmayr, Thomas; Diener, Susanne; Graf, Elisabeth; Allolio, Bruno; Samson-Couterie, Benoit; Benecke, Arndt; Quinkler, Marcus; Fallo, Francesco; Plouin, Pierre-Francois; Mantero, Franco; Meitinger, Thomas; Mulatero, Paolo; Jeunemaitre, Xavier; Warth, Richard; Vilsen, Bente; Zennaro, Maria-Christina; Strom, Tim M.; Reincke, Martin			Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension	NATURE GENETICS			English	Article							ZONA GLOMERULOSA; KCNJ5 MUTATIONS; ATPASE; PREVALENCE; PATHWAYS; CELLS; PUMP	Primary aldosteronism is the most prevalent form of secondary hypertension. To explore molecular mechanisms of autonomous aldosterone secretion, we performed exome sequencing of aldosterone-producing adenomas (APAs). We identified somatic hotspot mutations in the ATP1A1 (encoding an Na+/K+ ATPase (1 subunit) and ATP2B3 (encoding a Ca2+ ATPase) genes in three and two of the nine APAs, respectively. These ATPases are expressed in adrenal cells and control sodium, potassium and calcium ion homeostasis. Functional in vitro studies of ATP1A1 mutants showed loss of pump activity and strongly reduced affinity for potassium. Electrophysiological ex vivo studies on primary adrenal adenoma cells provided further evidence for inappropriate depolarization of cells with ATPase alterations. In a collection of 308 APAs, we found 16(5.2%) somatic mutations in ATP1A1 and 5 (1.6%) in ATP2B3. Mutation-positive cases showed male dominance, increased plasma aldosterone concentrations and lower potassium concentrations compared with mutationnegative cases. In summary, dominant somatic alterations in two members of the ATPase gene family result in autonomous aldosterone secretion.	[Beuschlein, Felix; Osswald, Andrea; Lichtenauer, Urs D.; Fischer, Evelyn; Reincke, Martin] Univ Munich, Med Klin & Poliklin 4, Munich, Germany; [Boulkroun, Sheerazed; Amar, Laurence; Samson-Couterie, Benoit; Plouin, Pierre-Francois; Jeunemaitre, Xavier; Zennaro, Maria-Christina] Paris Cardiovasc Res Ctr, INSERM, UMRS 970, Paris, France; [Boulkroun, Sheerazed; Amar, Laurence; Samson-Couterie, Benoit; Plouin, Pierre-Francois; Jeunemaitre, Xavier; Zennaro, Maria-Christina] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Wieland, Thomas; Walther, Anett; Schwarzmayr, Thomas; Diener, Susanne; Graf, Elisabeth; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Nielsen, Hang N.; Schack, Vivien R.; Vilsen, Bente] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Penton, David; Tauber, Philipp; Warth, Richard] Univ Regensburg, D-93053 Regensburg, Germany; [Amar, Laurence; Plouin, Pierre-Francois; Jeunemaitre, Xavier; Zennaro, Maria-Christina] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Allolio, Bruno] Univ Hosp Wurzburg, Dept Med 1, Endocrine & Diabet Unit, Wurzburg, Germany; [Benecke, Arndt] Inst Hautes Etud Sci, CNRS, F-91440 Bures Sur Yvette, France; [Quinkler, Marcus] Univ Hosp Charite, Berlin, Germany; [Fallo, Francesco] Univ Padua, Dept Med, Padua, Italy; [Mantero, Franco] Univ Padua, Dept Med, Endocrine Unit, Padua, Italy; [Meitinger, Thomas; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Mulatero, Paolo] Univ Turin, Dept Med Sci, Div Internal Med & Hypertens, Turin, Italy	University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Aarhus University; University of Regensburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Padua; University of Padua; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Turin	Reincke, M (corresponding author), Univ Munich, Med Klin & Poliklin 4, Munich, Germany.	felix.beuschlein@med.uni-muenchen.de; martin.reincke@med.uni-muenchen.de	Amar, Laurence/P-5278-2017; Lichtenauer, Urs/AFU-2746-2022; Boulkroun, Sheerazed/AAX-8348-2021; Warth, Richard/N-7119-2014; Boulkroun, Sheerazed/M-4459-2017; Meitinger, Thomas/O-1318-2015; JEUNEMAITRE, Xavier/AAQ-4853-2021; Zennaro, Maria-Christina/G-2841-2013; Penton, David/L-2597-2016; Benecke, Arndt G./T-1079-2019	Amar, Laurence/0000-0003-3942-4276; Boulkroun, Sheerazed/0000-0002-8796-7534; Warth, Richard/0000-0001-6084-0659; Boulkroun, Sheerazed/0000-0002-8796-7534; JEUNEMAITRE, Xavier/0000-0001-5925-381X; Zennaro, Maria-Christina/0000-0001-5449-9191; Schack, Vivien/0000-0002-1365-3938; Quinkler, Marcus/0000-0003-4028-1671; Beuschlein, Felix/0000-0001-7826-3984; Meitinger, Thomas/0000-0002-8838-8403; Vilsen, Bente/0000-0002-4727-9382; FALLO, FRANCESCO/0000-0002-7511-0226	Else Kroner-Fresenius-Stiftung; German Conn's Registry-Else-Kroner Hyperaldosteronism Registry; Deutsche Forschungsgemeinschaft [Re 752/17-1, FOR1086]; German Ministry of Education and Research [01GR0802, 01GM0867]; European Commission's Seventh Framework Programme [261123]; GEUVADIS; DZHK Paris; INSERM [U982]; University Hospital of Rouen; INSERM; Agence Nationale pour la Recherche; ANR Physio [013-01]; Genopat [08-GEN0-021]; Fondation pour la Recherche sur l'Hypertension Arterielle [AO 2007]; Fondation pour la Recherche Medicate [ING20101221177]; Programme Hospitalier de Recherche Clinique; PHRC [AOM 06179]; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; Fondi Ricerca Ex-60% MIUR (Ministry of University, Scientific and Technological Research); Lundbeck Foundation [R118-2012-11726] Funding Source: researchfish	Else Kroner-Fresenius-Stiftung; German Conn's Registry-Else-Kroner Hyperaldosteronism Registry; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission's Seventh Framework Programme(European Commission); GEUVADIS; DZHK Paris; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Hospital of Rouen; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); ANR Physio(French National Research Agency (ANR)); Genopat; Fondation pour la Recherche sur l'Hypertension Arterielle; Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Programme Hospitalier de Recherche Clinique; PHRC; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Fondi Ricerca Ex-60% MIUR (Ministry of University, Scientific and Technological Research); Lundbeck Foundation(Lundbeckfonden)	Munich and Regensburg. This work has been made possible by a grant of the Else Kroner-Fresenius-Stiftung in support of the German Conn's Registry-Else-Kroner Hyperaldosteronism Registry (to M.R.). Additional funding was received from the Deutsche Forschungsgemeinschaft to F.B. and M.R. (Re 752/17-1) and R.W. (FOR1086). The work was also supported by the German Ministry of Education and Research (01GR0802 and 01GM0867), the European Commission's Seventh Framework Programme (261123, GEUVADIS) and the DZHK. Paris. We thank H. Lefebvre and E. Louiset (INSERM U982 and University Hospital of Rouen) and M. Sibony (Assistance Publique-Hopitaux de Paris, Hopital Cochin) for providing control adrenal samples. We thank the COMETE (COrtico et MEdullo-surrenale: les Tumeurs Endocrines) network for providing tissue samples from individuals with APA. This work was funded through institutional support from INSERM and by the Agence Nationale pour la Recherche (ANR Physio 2007, 013-01; Genopat 2008, 08-GEN0-021), the Fondation pour la Recherche sur l'Hypertension Arterielle (AO 2007), the Fondation pour la Recherche Medicate (ING20101221177), the Programme Hospitalier de Recherche Clinique (PHRC grant AOM 06179) and by grants from INSERM and the Ministere Delegue a. la Recherche et des Nouvelles Technologies. Aarhus. This work was supported in part by grants to B.V. from the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat) and the Lundbeck Foundation. Turin. This study was supported by grants from the Fondi Ricerca Ex-60% MIUR (Ministry of University, Scientific and Technological Research) 2012 and the Compagnia di San Paolo.	Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; BEUSCHLEIN F, 1994, CANCER RES, V54, P4927; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eide IK, 2004, J HYPERTENS, V22, P2217, DOI 10.1097/00004872-200411000-00026; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; GICQUEL C, 1994, CLIN ENDOCRINOL, V40, P465, DOI 10.1111/j.1365-2265.1994.tb02485.x; HAJNOCZKY G, 1992, ENDOCRINOLOGY, V130, P1637, DOI 10.1210/en.130.3.1637; Hannemann A, 2012, EUR J ENDOCRINOL, V167, P7, DOI 10.1530/EJE-11-1013; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moseley AE, 2005, CELL PHYSIOL BIOCHEM, V15, P145, DOI 10.1159/000083647; Mulatero P, 2012, HYPERTENSION, V59, P235, DOI 10.1161/HYPERTENSIONAHA.111.183996; Neri G, 2006, INT J MOL MED, V18, P315; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Yingst DR, 1999, METABOLISM, V48, P1167, DOI 10.1016/S0026-0495(99)90133-6	22	379	391	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					440	444		10.1038/ng.2550	http://dx.doi.org/10.1038/ng.2550			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23416519	Green Published			2022-12-25	WOS:000316840600016
J	Kokel, D; Cheung, CYJ; Mills, R; Coutinho-Budd, J; Huang, LY; Setola, V; Sprague, J; Jin, S; Jin, YN; Huang, XP; Bruni, G; Woolf, CJ; Roth, BL; Hamblin, MR; Zylka, MJ; Milan, DJ; Peterson, RT				Kokel, David; Cheung, Chung Yan J.; Mills, Robert; Coutinho-Budd, Jaeda; Huang, Liyi; Setola, Vincent; Sprague, Jared; Jin, Shan; Jin, Youngnam N.; Huang, Xi-Ping; Bruni, Giancarlo; Woolf, Clifford J.; Roth, Bryan L.; Hamblin, Michael R.; Zylka, Mark J.; Milan, David J.; Peterson, Randall T.			Photochemical activation of TRPA1 channels in neurons and animals	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; ION CHANNELS; GLUTAMATE-RECEPTOR; REMOTE-CONTROL; COVALENT MODIFICATION; CAGED GLUTAMATE; OPTICAL CONTROL; ZEBRAFISH; LIGHT; PHOTOSTIMULATION	Optogenetics is a powerful research tool because it enables high-resolution optical control of neuronal activity. However, current optogenetic approaches are limited to transgenic systems expressing microbial opsins and other exogenous photoreceptors. Here, we identify optovin, a small molecule that enables repeated photoactivation of motor behaviors in wild-type zebrafish and mice. To our surprise, optovin's behavioral effects are not visually mediated. Rather, photodetection is performed by sensory neurons expressing the cation channel TRPA1. TRPA1 is both necessary and sufficient for the optovin response. Optovin activates human TRPA1 via structure-dependent photochemical reactions with redox-sensitive cysteine residues. In animals with severed spinal cords, optovin treatment enables control of motor activity in the paralyzed extremities by localized illumination. These studies identify a light-based strategy for controlling endogenous TRPA1 receptors in vivo, with potential clinical and research applications in nontransgenic animals, including humans.	[Kokel, David; Cheung, Chung Yan J.; Mills, Robert; Jin, Shan; Jin, Youngnam N.; Bruni, Giancarlo; Milan, David J.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiovasc Res Ctr, Charlestown, MA USA; [Kokel, David; Cheung, Chung Yan J.; Mills, Robert; Jin, Shan; Jin, Youngnam N.; Bruni, Giancarlo; Milan, David J.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA USA; [Kokel, David; Cheung, Chung Yan J.; Jin, Shan; Jin, Youngnam N.; Bruni, Giancarlo; Peterson, Randall T.] Broad Inst, Cambridge, MA USA; [Coutinho-Budd, Jaeda; Zylka, Mark J.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA; [Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Huang, Liyi; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Huang, Liyi; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Huang, Liyi] Guangxi Med Univ, Affiliated Coll & Hosp 1, Dept Infect Dis, Nanning, Peoples R China; [Setola, Vincent; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Setola, Vincent; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, NIMH, Psychoact Drug Screening Program, Chapel Hill, NC USA; [Sprague, Jared; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp Boston, Boston, MA 02115 USA; [Sprague, Jared] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard Massachusetts Inst Technol Div Hlth Sci &, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Guangxi Medical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kokel, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiovasc Res Ctr, Charlestown, MA USA.	dkokel@cvrc.mgh.harvard.edu; peterson@cvrc.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Roth, Bryan L/F-3928-2010; Woolf, Clifford/A-9784-2010; Roth, Bryan/ABE-7032-2020; Hamblin, Mike/AAB-2511-2022	Hamblin, Michael R/0000-0001-6431-4605; Roth, Bryan/0000-0002-0561-6520; kokel, david/0000-0002-1981-1511; Mills, Robert/0000-0003-4201-7137; Bruni, Giancarlo/0000-0003-2850-4633; Huang, Xi-Ping/0000-0002-2585-653X; Setola, Vincent/0000-0002-9791-2270; Peterson, Randall/0000-0003-0727-3469	US National Institutes of Health (NIH) [K01MH091449, MH086867, MH085205, P01 NS072040, R01 AI050875]; Charles and Ann Sanders Massachusetts General Hospital; Michael Hooker Chair; NIMH PDSP; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS060725, R01NS067688]; NINDS [F31NS068038]; NIH [HL109004, DA026982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH091449, R01MH086867, R21MH085205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067688, F31NS068038, P01NS072040, R01NS060725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026982] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Ann Sanders Massachusetts General Hospital; Michael Hooker Chair; NIMH PDSP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Kwan and D. Corey (Harvard Medical School), T. Miyamoto and A. Patapoutian (Scripps Research Institute), and T. Numata and Y. Mori (Kyoto University) for human TrpA1 constructs. A. Schier, D. Prober and D. Robson (Harvard University) generously provided TrpA1 mutant zebrafish. We thank R. Gaudet, A. Vakkasglu, B. Shoichet, T. Dunn, M. Ahrens, F. Engert, R. Mazitschek and members of our research groups for helpful advice. This work was supported by US National Institutes of Health (NIH) grants K01MH091449 (D.K.), MH086867 and MH085205 (R.T.P.), P01 NS072040 (C.J.W.), R01 AI050875 (L.H. and M.R.H.); the Charles and Ann Sanders Massachusetts General Hospital Research Scholar award (R.T.P.); and the Michael Hooker Chair and the NIMH PDSP (B.L.R.). M.J.Z. was supported by grants from National Institute of Neurological Disorders and Stroke (NINDS; R01NS060725, R01NS067688), J.C.-B. was supported by a National Research Service Award training grant from NINDS (F31NS068038) and D.J.M. was supported by NIH grants HL109004 and DA026982.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BARTON HJ, 1990, J PHOTOCH PHOTOBIO A, V54, P187, DOI 10.1016/1010-6030(90)85031-Q; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brain SD, 2011, ANN NY ACAD SCI, V1245, P36, DOI 10.1111/j.1749-6632.2011.06326.x; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Escalera J, 2008, J BIOL CHEM, V283, P24136, DOI 10.1074/jbc.M710280200; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Fortin DL, 2011, J NEUROPHYSIOL, V106, P488, DOI 10.1152/jn.00251.2011; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Jordt S. E., 2007, V45, P253; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAUSTRIAT G, 1986, BIOCHIMIE, V68, P771, DOI 10.1016/S0300-9084(86)80092-X; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; Marinado T, 2009, PHYS CHEM CHEM PHYS, V11, P133, DOI 10.1039/b812154k; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; OUANNES C, 1968, J AM CHEM SOC, V90, P6527, DOI 10.1021/ja01025a059; Patch RJ, 2011, J MED CHEM, V54, P788, DOI 10.1021/jm101063h; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Schwartz ES, 2011, GASTROENTEROLOGY, V140, P1283, DOI 10.1053/j.gastro.2010.12.033; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t; WIEBOLDT R, 1994, P NATL ACAD SCI USA, V91, P8752, DOI 10.1073/pnas.91.19.8752; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	45	69	98	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					257	263		10.1038/NCHEMBIO.1183	http://dx.doi.org/10.1038/NCHEMBIO.1183			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23396078	Green Accepted, Green Submitted			2022-12-25	WOS:000317025800016
J	Smith, JJ; Kuraku, S; Holt, C; Sauka-Spengler, T; Jiang, N; Campbell, MS; Yandell, MD; Manousaki, T; Meyer, A; Bloom, OE; Morgan, JR; Buxbaum, JD; Sachidanandam, R; Sims, C; Garruss, AS; Cook, M; Krumlauf, R; Wiedemann, LM; Sower, SA; Decatur, WA; Hall, JA; Amemiya, CT; Saha, NR; Buckley, KM; Rast, JP; Das, S; Hirano, M; McCurley, N; Guo, P; Rohner, N; Tabin, CJ; Piccinelli, P; Elgar, G; Ruffier, M; Aken, BL; Searle, SMJ; Muffato, M; Pignatelli, M; Herrero, J; Jones, M; Brown, CT; Chung-Davidson, YW; Nanlohy, KG; Libants, SV; Yeh, CY; McCauley, DW; Langeland, JA; Pancer, Z; Fritzsch, B; de Jong, PJ; Zhu, BL; Fulton, LL; Theising, B; Flicek, P; Bronner, ME; Warren, WC; Clifton, SW; Wilson, RK; Li, WM				Smith, Jeramiah J.; Kuraku, Shigehiro; Holt, Carson; Sauka-Spengler, Tatjana; Jiang, Ning; Campbell, Michael S.; Yandell, Mark D.; Manousaki, Tereza; Meyer, Axel; Bloom, Ona E.; Morgan, Jennifer R.; Buxbaum, Joseph D.; Sachidanandam, Ravi; Sims, Carrie; Garruss, Alexander S.; Cook, Malcolm; Krumlauf, Robb; Wiedemann, Leanne M.; Sower, Stacia A.; Decatur, Wayne A.; Hall, Jeffrey A.; Amemiya, Chris T.; Saha, Nil R.; Buckley, Katherine M.; Rast, Jonathan P.; Das, Sabyasachi; Hirano, Masayuki; McCurley, Nathanael; Guo, Peng; Rohner, Nicolas; Tabin, Clifford J.; Piccinelli, Paul; Elgar, Greg; Ruffier, Magali; Aken, Bronwen L.; Searle, Stephen M. J.; Muffato, Matthieu; Pignatelli, Miguel; Herrero, Javier; Jones, Matthew; Brown, C. Titus; Chung-Davidson, Yu-Wen; Nanlohy, Kaben G.; Libants, Scot V.; Yeh, Chu-Yin; McCauley, David W.; Langeland, James A.; Pancer, Zeev; Fritzsch, Bernd; de Jong, Pieter J.; Zhu, Baoli; Fulton, Lucinda L.; Theising, Brenda; Flicek, Paul; Bronner, Marianne E.; Warren, Wesley C.; Clifton, Sandra W.; Wilson, Richard K.; Li, Weiming			Sequencing of the sea lamprey (Petromyzon marinus) genome provides insights into vertebrate evolution	NATURE GENETICS			English	Article							LIMB; SHH; PERSPECTIVES; EXPRESSION; HAGFISH; FAMILY; MYELIN; FIN	Lampreys are representatives of an ancient vertebrate lineage that diverged from our own similar to 500 million years ago. By virtue of this deeply shared ancestry, the sea lamprey (P. marinus) genome is uniquely poised to provide insight into the ancestry of vertebrate genomes and the underlying principles of vertebrate biology. Here, we present the first lamprey whole-genome sequence and assembly. We note challenges faced owing to its high content of repetitive elements and GC bases, as well as the absence of broad-scale sequence information from closely related species. Analyses of the assembly indicate that two whole-genome duplications likely occurred before the divergence of ancestral lamprey and gnathostome lineages. Moreover, the results help define key evolutionary events within vertebrate lineages, including the origin of myelin-associated proteins and the development of appendages. The lamprey genome provides an important resource for reconstructing vertebrate origins and the evolutionary events that have shaped the genomes of extant organisms.	[Smith, Jeramiah J.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Smith, Jeramiah J.; Amemiya, Chris T.; Saha, Nil R.] Virginia Mason, Benaroya Res Inst, Seattle, WA USA; [Kuraku, Shigehiro] RIKEN, Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo, Japan; [Kuraku, Shigehiro; Manousaki, Tereza; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany; [Holt, Carson; Campbell, Michael S.; Yandell, Mark D.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Sauka-Spengler, Tatjana; Jones, Matthew; Bronner, Marianne E.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Bloom, Ona E.] Feinstein Inst Med Res, Manhasset, NY USA; [Bloom, Ona E.] Hofstra North Shore Long Isl Jewish LIJ, Sch Med, Hempstead, NY USA; [Morgan, Jennifer R.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Buxbaum, Joseph D.; Sachidanandam, Ravi] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Sims, Carrie; Garruss, Alexander S.; Cook, Malcolm; Krumlauf, Robb; Wiedemann, Leanne M.] Stowers Inst Med Res, Kansas City, MO USA; [Krumlauf, Robb] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA; [Wiedemann, Leanne M.] Univ Kansas, Sch Med, Dept Pathol & Lab Med, Kansas City, KS USA; [Sower, Stacia A.; Decatur, Wayne A.; Hall, Jeffrey A.] Univ New Hampshire, Ctr Mol & Comparat Endocrinol, Durham, NH 03824 USA; [Amemiya, Chris T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Buckley, Katherine M.; Rast, Jonathan P.] Univ Toronto, Dept Immunol, Sunnybrook Res Inst, Toronto, ON, Canada; [Buckley, Katherine M.; Rast, Jonathan P.] Univ Toronto, Dept Med Biophys, Sunnybrook Res Inst, Toronto, ON, Canada; [Das, Sabyasachi; Hirano, Masayuki; McCurley, Nathanael; Guo, Peng] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Das, Sabyasachi; Hirano, Masayuki; McCurley, Nathanael; Guo, Peng] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Rohner, Nicolas; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Piccinelli, Paul; Elgar, Greg] Natl Inst Med Res, MRC, London NW7 1AA, England; [Ruffier, Magali; Aken, Bronwen L.; Searle, Stephen M. J.] Wellcome Trust Sanger Inst, Cambridge, England; [Muffato, Matthieu; Pignatelli, Miguel; Herrero, Javier; Flicek, Paul] European Bioinformat Inst, Cambridge, England; [Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Brown, C. Titus] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Chung-Davidson, Yu-Wen; Nanlohy, Kaben G.; Libants, Scot V.; Yeh, Chu-Yin; Li, Weiming] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [McCauley, David W.] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; [Langeland, James A.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49007 USA; [Pancer, Zeev] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [de Jong, Pieter J.; Zhu, Baoli] Childrens Hosp Oakland, Oakland, CA USA; [Fulton, Lucinda L.; Theising, Brenda; Warren, Wesley C.; Clifton, Sandra W.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	University of Kentucky; Benaroya Research Institute; Virginia Mason Medical Center; RIKEN; University of Konstanz; Utah System of Higher Education; University of Utah; California Institute of Technology; Michigan State University; Northwell Health; Hofstra University; Marine Biological Laboratory - Woods Hole; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University System Of New Hampshire; University of New Hampshire; University of Washington; University of Washington Seattle; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Emory University; Emory University; Harvard University; Harvard Medical School; MRC National Institute for Medical Research; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Michigan State University; Michigan State University; Michigan State University; University of Oklahoma System; University of Oklahoma - Norman; Kalamazoo College; University System of Maryland; University of Maryland Baltimore; University of Iowa; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Washington University (WUSTL)	Li, WM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	jjsmit3@uky.edu; liweim@msu.edu	Jiang, Ning/G-6546-2012; Herrero, Javier/H-6971-2019; Buxbaum, Joseph D/G-6001-2010; Buckley, Katherine Michele/AAY-8151-2021; Wilson, Richard K./AAF-4139-2019; Chung-Davidson, Yu-Wen/L-6161-2019; Krumlauf, Robb/AAH-5012-2019; Meyer, Axel/C-9826-2009; Li, Weiming/D-9615-2013; Kuraku, Shigehiro/B-2801-2009; sachidanandam, ravi/Q-6916-2019	Herrero, Javier/0000-0001-7313-717X; Buckley, Katherine Michele/0000-0002-6585-8943; Wilson, Richard K./0000-0002-1992-1358; Chung-Davidson, Yu-Wen/0000-0001-5784-2653; Krumlauf, Robb/0000-0001-9102-7927; Meyer, Axel/0000-0002-0888-8193; Li, Weiming/0000-0001-5437-1518; Kuraku, Shigehiro/0000-0003-1464-8388; sachidanandam, ravi/0000-0001-9844-4459; Cook, Malcolm/0000-0002-2825-9183; Ruffier, Magali/0000-0002-8386-1580; Fritzsch, Bernd/0000-0002-4882-8398; Buxbaum, Joseph/0000-0001-8898-8313; Rohner, Nicolas/0000-0003-3248-2772; Aken, Bronwen/0000-0002-3032-4095; Bronner, Marianne/0000-0003-4274-1862; Elgar, Greg/0000-0001-7323-1596; Brown, C. Titus/0000-0001-6001-2677; Decatur, Wayne/0000-0002-6961-7514; Flicek, Paul/0000-0002-3897-7955; Smith, Jeramiah/0000-0001-5333-5531; BLOOM, ONA/0000-0002-8340-2392; Das, Sabyasachi/0000-0002-9116-9623; Nanlohy, Kaben/0000-0003-3752-7968; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Wiedemann, Leanne/0000-0002-0964-4676; Muffato, Matthieu/0000-0002-7860-3560	National Human Genome Research Institute [U54HG003079]; US National Institutes of Health [F32GM087919, T32HG00035, DE017911, R03NS078519, R01HG004694, GM079492, GM090049, RR014085, R37HD032443]; National Science Foundation [MCB-0719558, IOS-0849569]; New Hampshire Agricultural Experiment Station [2471]; Charles Evans Research Award; Wellcome Trust [WT095908, WT098051]; Canadian Institutes of Health Research [MOP74667]; Natural Sciences and Engineering Research Council of Canada [312221];  [R24GM83982]; MRC [MC_U117597141] Funding Source: UKRI; Medical Research Council [MC_U117597141] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR014085] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, U54HG003079, R01HG004694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM095471, T32GM007464, R21GM079492, R01GM090049, F32GM087919, R24GM083982, R01GM100151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086907, R03NS078519, R01NS078165] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); New Hampshire Agricultural Experiment Station; Charles Evans Research Award; Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Genome Institute, Washington University School of Medicine, Production Sequencing group for all sample procurement and genome sequencing work, the Michigan State University Genomic Core for transcriptome sequencing and the US Geological Survey, Lake Huron Biological Station for providing lamprey samples for sequencing. We thank F. Antonacci and E.E. Eichler (University of Washington) for performing FISH and providing access to computational facilities, respectively. We thank M. Robinson for bioinformatic analysis of immune system related genes and conversion of GFF files for BAC end mapping. A portion of this research was conducted at the Marine Biological Laboratory (Woods Hole, Massachusetts). We acknowledge the support of the Stowers Institute for Medical Research (SIMR) and technical support from the SIMR Molecular Biology Core, particularly K. Staehling, A. Perera and K. Delventhal for BAC screening and sequencing. We acknowledge the Center for High-Performance Computing at the University of Utah for the allocation of computational resources toward gene annotation. We recognize all the important work that could not be cited owing to space limitations. The lamprey genome project was funded by the National Human Genome Research Institute (U54HG003079 (R.K.W.)). Additional support was provided by grants from the US National Institutes of Health (R24GM83982 (W.L.)) and the Great Lakes Fisheries commission (W.L.). Partial funding was provided by several additional sources, including grants from the US National Institutes of Health (F32GM087919 and T32HG00035 (J.J.S.); DE017911 (M.E.B.); R03NS078519 (O.E.B.); R01HG004694 (M.D.Y.); GM079492, GM090049 and RR014085 (C.T.A.); and R37HD032443 (C.J.T.)), the National Science Foundation (MCB-0719558 (C.T.A.); IOS-0849569 (S.A.S.); IBN-0208138 (L. Holland); and IOS-1126998 (M.D.Y.)), the New Hampshire Agricultural Experiment Station (Scientific Contribution Number 2471 (S.A.S.)), the Charles Evans Research Award (O.E.B., J.D.B. and J.R.M.), the Wellcome Trust (WT095908 (P.F.) and WT098051), the Canadian Institutes of Health Research (MOP74667 (J.P.R.)) and the Natural Sciences and Engineering Research Council of Canada (312221 (J.P.R.)).	BULLOCK TH, 1984, NEUROSCI LETT, V48, P145, DOI 10.1016/0304-3940(84)90010-7; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Gould RM, 2005, BIOL BULL-US, V209, P49, DOI 10.2307/3593141; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Nikitina N., 2009, EMERGING MODEL ORGAN, V1, P405; Nikitina N, 2008, P NATL ACAD SCI USA, V105, P20083, DOI 10.1073/pnas.0806009105; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Saha NR, 2010, SEMIN IMMUNOL, V22, P25, DOI 10.1016/j.smim.2009.12.002; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Smith JJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-219; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Woolfe A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-100	27	444	460	0	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					415	421		10.1038/ng.2568	http://dx.doi.org/10.1038/ng.2568			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435085	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000316840600012
J	Sharma, VP; Fenwick, AL; Brockop, MS; McGowan, SJ; Goos, JAC; Hoogeboom, AJM; Brady, AF; Jeelani, NO; Lynch, SA; Mulliken, JB; Murray, DJ; Phipps, JM; Sweeney, E; Tomkins, SE; Wilson, LC; Bennett, S; Cornall, RJ; Broxholme, J; Kanapin, A; Johnson, D; Wall, SA; van der Spek, PJ; Mathijssen, IMJ; Maxson, RE; Twigg, SRF; Wilkie, AOM				Sharma, Vikram P.; Fenwick, Aimee L.; Brockop, Mia S.; McGowan, Simon J.; Goos, Jacqueline A. C.; Hoogeboom, A. Jeannette M.; Brady, Angela F.; Jeelani, Nu Owase; Lynch, Sally Ann; Mulliken, John B.; Murray, Dylan J.; Phipps, Julie M.; Sweeney, Elizabeth; Tomkins, Susan E.; Wilson, Louise C.; Bennett, Sophia; Cornall, Richard J.; Broxholme, John; Kanapin, Alexander; Johnson, David; Wall, Steven A.; van der Spek, Peter J.; Mathijssen, Irene M. J.; Maxson, Robert E.; Twigg, Stephen R. F.; Wilkie, Andrew O. M.		500 Whole-Genome Sequences WGS500	Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; GENE; E2A; ACTIVATION; BINDING; HEB	Craniosynostosis, the premature fusion of the cranial sutures, is a heterogeneous disorder with a prevalence of similar to 1 in 2,200 (refs. 1,2). A specific genetic etiology can be identified in similar to 21% of cases(3), including mutations of TWIST1, which encodes a class II basic helix-loop-helix (bHLH) transcription factor, and causes Saethre-Chotzen syndrome, typically associated with coronal synostosis(4-6). Using exome sequencing, we identified 38 heterozygous TCF12 mutations in 347 samples from unrelated individuals with craniosynostosis. The mutations predominantly occurred in individuals with coronal synostosis and accounted for 32% and 10% of subjects with bilateral and unilateral pathology, respectively. TCF12 encodes one of three class I E proteins that heterodimerize with class II bHLH proteins such as TWIST1. We show that TCF12 and TWIST1 act synergistically in a transactivation assay and that mice doubly heterozygous for loss-of-function mutations in Tcf12 and Twist1 have severe coronal synostosis. Hence, the dosage of TCF12-TWIST1 heterodimers is critical for normal coronal suture development.	[Sharma, Vikram P.; Fenwick, Aimee L.; Phipps, Julie M.; Twigg, Stephen R. F.; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford, England; [Sharma, Vikram P.; Johnson, David; Wall, Steven A.; Wilkie, Andrew O. M.] Oxford Univ Hosp Natl Hlth Serv NHS Trust, Craniofacial Unit, Oxford, England; [Brockop, Mia S.; Maxson, Robert E.] Univ So Calif, Norris Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Brockop, Mia S.] Univ Paris 11, Orsay, France; [McGowan, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England; [Goos, Jacqueline A. C.; Mathijssen, Irene M. J.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands; [Goos, Jacqueline A. C.; van der Spek, Peter J.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Hoogeboom, A. Jeannette M.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Brady, Angela F.] North West London Hosp NHS Trust, Kennedy Galton Ctr, London, England; [Jeelani, Nu Owase] Great Ormond St Hosp Sick Children, Dept Neurosurg, London WC1N 3JH, England; [Lynch, Sally Ann] Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin, Ireland; [Mulliken, John B.] Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Murray, Dylan J.] Childrens Univ Hosp, Natl Paediat Craniofacial Ctr, Dublin, Ireland; [Sweeney, Elizabeth] Liverpool Womens NHS Fdn Trust, Dept Clin Genet, Liverpool, Merseyside, England; [Tomkins, Susan E.] Musgrove Pk Hosp, Dept Clin Genet, Taunton, Somerset, England; [Wilson, Louise C.] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Bennett, Sophia; Cornall, Richard J.] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford, England; [Broxholme, John; Kanapin, Alexander] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Southern California; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Our Ladys Children Hospital Crumlin; Harvard University; Boston Children's Hospital; Childrens University Hospital - Temple Street; Musgrove Park Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Maxson, RE (corresponding author), Univ So Calif, Norris Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	robert.maxson@med.usc.edu; andrew.wilkie@imm.ox.ac.uk	Humburg, Peter/A-4191-2009; Kanapin, Alexander/E-7632-2013; Wilkie, Andrew/AAC-3820-2020; McCarthy, Davis James/B-5332-2018; Twigg, Stephen/AAU-1135-2021; Cazier, Jean-Baptiste/GLR-2949-2022; Kanapin, Alexander A/Q-7590-2016	Humburg, Peter/0000-0002-3331-6496; Wilkie, Andrew/0000-0002-2972-5481; McCarthy, Davis James/0000-0002-2218-6833; Twigg, Stephen/0000-0001-5024-049X; Cazier, Jean-Baptiste/0000-0001-7581-9051; Kanapin, Alexander A/0000-0001-9802-5297; Jeelani, Noor ul Owase/0000-0002-3240-681X; Green, Andrew/0000-0002-1077-7417; Lynch, Sally Ann/0000-0003-3540-1333; McGowan, Simon/0000-0001-9720-1914; Lise, Stefano/0000-0003-4472-6893; Jones, Aimee/0000-0003-0279-1814	National Institute for Health Research (NIHR) Biomedical Research Centre Oxford; Oxford University Clinical Academic Graduate School; Oxfordshire Health Services Research Committee; Oxford Craniofacial Unit Charitable Fund; Thames Valley Comprehensive Local Research Network; Dutch Center for Translational Molecular Medicine; Carolien Bijl Foundation; US National Institutes of Health (NIH) [R01DE016320, R01DE019650]; Wellcome Trust [093329]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019650, R01DE016320] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12010/6] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre Oxford(National Institute for Health Research (NIHR)); Oxford University Clinical Academic Graduate School; Oxfordshire Health Services Research Committee; Oxford Craniofacial Unit Charitable Fund; Thames Valley Comprehensive Local Research Network; Dutch Center for Translational Molecular Medicine; Carolien Bijl Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the families for their participation, S. Butler for cell culture, J. Frankland and T. Rostron for DNA sequencing, S. Knight for coordinating array-comparative genomic hybridization (aCGH), L. Gregory and the High-Throughput Genomics core at the Wellcome Trust Centre for Human Genetics for exome sequencing, R. Evans for review of anesthetic records, W. Baggley for clinical photography, A. van den Ouweland for genetic testing, E.-M. Fuchtbauer (Aarhus University) for constructs and Y. Zhuang (Duke University) for the gift of the Tcf12<SUP>flox</SUP> mutant. This work was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre Oxford (V.P.S. and R.J.C.), the Oxford University Clinical Academic Graduate School and the Oxfordshire Health Services Research Committee (V.P.S.), the Oxford Craniofacial Unit Charitable Fund (V.P.S.), the Thames Valley Comprehensive Local Research Network (J.M.P.), The Dutch Center for Translational Molecular Medicine (P.J.v.d.S.), the Carolien Bijl Foundation (J.A.C.G.), the US National Institutes of Health (NIH; R01DE016320 and R01DE019650 to R.E.M.) and the Wellcome Trust (093329 to S.R.F.T. and A.O.M.W.).	ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; ElGhouzzi V, 1997, NAT GENET, V15, P42; Gan TI, 2002, CYTOGENET GENOME RES, V98, P245, DOI 10.1159/000071042; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Hiraki Y, 2008, AM J MED GENET A, V146A, P1462, DOI 10.1002/ajmg.a.32339; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; Jabs E. W., 2008, INBORN ERRORS DEV MO, P474; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laursen KB, 2007, J BIOL CHEM, V282, P34623, DOI 10.1074/jbc.M707085200; Markus M, 2002, J BIOL CHEM, V277, P6469, DOI 10.1074/jbc.M110659200; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NIELSEN AL, 1992, MOL CELL BIOL, V12, P3449, DOI 10.1128/MCB.12.8.3449; Wang DC, 2006, J IMMUNOL, V177, P109, DOI 10.4049/jimmunol.177.1.109; Whalen S, 2012, HUM MUTAT, V33, P64, DOI 10.1002/humu.21639; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717	25	148	152	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					304	307		10.1038/ng.2531	http://dx.doi.org/10.1038/ng.2531			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23354436	Green Accepted			2022-12-25	WOS:000315664800016
J	Tzoneva, G; Perez-Garcia, A; Carpenter, Z; Khiabanian, H; Tosello, V; Allegretta, M; Paietta, E; Racevskis, J; Rowe, JM; Tallman, MS; Paganin, M; Basso, G; Hof, J; Kirschner-Schwabe, R; Palomero, T; Rabadan, R; Ferrando, A				Tzoneva, Gannie; Perez-Garcia, Arianne; Carpenter, Zachary; Khiabanian, Hossein; Tosello, Valeria; Allegretta, Maddalena; Paietta, Elisabeth; Racevskis, Janis; Rowe, Jacob M.; Tallman, Martin S.; Paganin, Maddalena; Basso, Giuseppe; Hof, Jana; Kirschner-Schwabe, Renate; Palomero, Teresa; Rabadan, Raul; Ferrando, Adolfo			Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR; 1ST RELAPSE; 5'-NUCLEOTIDASE; NELARABINE; CANCER; MERCAPTOPURINE; CHILDREN; ADULTS	Acute lymphoblastic leukemia (ALL) is an aggressive hematological tumor resulting from the malignant transformation of lymphoid progenitors. Despite intensive chemotherapy, 20% of pediatric patients and over 50% of adult patients with ALL do not achieve a complete remission or relapse after intensified chemotherapy, making disease relapse and resistance to therapy the most substantial challenge in the treatment of this disease(1,2). Using whole-exome sequencing, we identify mutations in the cytosolic 5'-nucleotidase II gene (NT5C2), which encodes a 5'-nucleotidase enzyme that is responsible for the inactivation of nucleoside-analog chemotherapy drugs, in 20/103 (19%) relapse T cell ALLs and 1/35 (3%) relapse B-precursor ALLs. NT5C2 mutant proteins show increased nucleotidase activity in vitro and conferred resistance to chemotherapy with 6-mercaptopurine and 6-thioguanine when expressed in ALL lymphoblasts. These results support a prominent role for activating mutations in NT5C2 and increased nucleoside-analog metabolism in disease progression and chemotherapy resistance in ALL.	[Tzoneva, Gannie; Perez-Garcia, Arianne; Allegretta, Maddalena; Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Carpenter, Zachary; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Tosello, Valeria] IRCCS, Ist Oncol Veneto, Padua, Italy; [Paietta, Elisabeth; Racevskis, Janis] Albert Einstein Coll Med, New York, NY USA; [Rowe, Jacob M.] Technion Israel Inst Technol, Haifa, Israel; [Rowe, Jacob M.] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Paganin, Maddalena; Basso, Giuseppe] Univ Padua, Dept Pediat, Hematooncol Lab, Padua, Italy; [Hof, Jana; Kirschner-Schwabe, Renate] Charite, Dept Pediat Oncol Hematol, D-13353 Berlin, Germany; [Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Ferrando, Adolfo] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; IRCCS Istituto Oncologico Veneto (IOV); Yeshiva University; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Memorial Sloan Kettering Cancer Center; University of Padua; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Columbia University; Columbia University	Ferrando, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	tp2151@columbia.edu; rabadan@dbmi.columbia.edu; af2196@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Khiabanian, Hossein/N-7207-2019; Tosello, Valeria/N-1010-2016	Khiabanian, Hossein/0000-0003-1446-4394; Tosello, Valeria/0000-0001-9560-340X; Tzoneva, Gannie/0000-0001-5784-7796; Rabadan, Raul/0000-0001-7946-9255; BASSO, GIUSEPPE/0000-0002-2634-9302; Kirschner-Schwabe, Renate/0000-0001-6335-3274	St. Baldrick's Foundation; Partnership for Cure Foundation; Innovative Research Award by the Stand Up to Cancer Foundation; Chemotherapy Foundation; Leukemia and Lymphoma Society Scholar Award; German Federal Ministry for Education and Research in the National Genome Research Network [01GS0870]; German Foundation for Childhood Cancer [DKS 2003.08, 2007.02]; US National Institutes of Health [U24 CA114737]; ECOG Leukemia Tissue Bank; Rally Foundation; NATIONAL CANCER INSTITUTE [U24CA114737, U10CA037403] Funding Source: NIH RePORTER	St. Baldrick's Foundation; Partnership for Cure Foundation; Innovative Research Award by the Stand Up to Cancer Foundation; Chemotherapy Foundation; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); German Federal Ministry for Education and Research in the National Genome Research Network; German Foundation for Childhood Cancer; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECOG Leukemia Tissue Bank; Rally Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A.A. Da Silva for technical support in the production of recombinant NT5C2 proteins and R. Parsons for insightful comments and advice. We also thank P.H. Wiernik as the Eastern Cooperative Oncology Group (ECOG) leukemia committee chair at the time the E2993 study was initiated. This work was supported by the St. Baldrick's Foundation (A.F.), the Partnership for Cure Foundation (R.R.), the Innovative Research Award by the Stand Up to Cancer Foundation (A.F.), the Chemotherapy Foundation (A.F.), the Leukemia and Lymphoma Society Scholar Award (A.F.), the German Federal Ministry for Education and Research in the National Genome Research Network (grant 01GS0870 to R.K.-S.), the German Foundation for Childhood Cancer (grants DKS 2003.08 and 2007.02 to R.K.-S.), the US National Institutes of Health (U24 CA114737 to E.P.) and the ECOG Leukemia Tissue Bank. A.P.-G. is a postdoctoral researcher funded by the Rally Foundation.	Allegrini S, 2004, EUR J BIOCHEM, V271, P4881, DOI 10.1111/j.1432-1033.2004.04457.x; Berg SL, 2005, J CLIN ONCOL, V23, P3376, DOI 10.1200/JCO.2005.03.426; Bhatia S, 2012, J CLIN ONCOL, V30, P2094, DOI 10.1200/JCO.2011.38.9924; Brouwer C, 2005, CLIN CHIM ACTA, V361, P95, DOI 10.1016/j.cccn.2005.05.006; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; DeAngelo DJ, 2007, BLOOD, V109, P5136, DOI 10.1182/blood-2006-11-056754; Galmarini CM, 2003, LEUKEMIA LYMPHOMA, V44, P1105, DOI 10.1080/1042819031000077142; Gaynon PS, 1998, CANCER, V82, P1387, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1; Gokbuget N, 2011, BLOOD, V118, P3504, DOI 10.1182/blood-2011-01-329441; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; LUBBERT M, 1990, BLOOD, V75, P1163; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; OKA J, 1994, BIOCHEM BIOPH RES CO, V205, P917, DOI 10.1006/bbrc.1994.2752; PIETERS R, 1992, LEUKEMIA RES, V16, P873, DOI 10.1016/0145-2126(92)90033-4; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Relling MV, 1999, BLOOD, V93, P2817; Salzer WL, 2010, LEUKEMIA, V24, P355, DOI 10.1038/leu.2009.261; Sanford M, 2008, DRUGS, V68, P439, DOI 10.2165/00003495-200868040-00004; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	31	237	251	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					368	371		10.1038/nm.3078	http://dx.doi.org/10.1038/nm.3078			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23377281	Green Accepted			2022-12-25	WOS:000316040700032
J	Trynka, G; Sandor, C; Han, B; Xu, H; Stranger, BE; Liu, XS; Raychaudhuri, S				Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Xu, Han; Stranger, Barbara E.; Liu, X. Shirley; Raychaudhuri, Soumya			Chromatin marks identify critical cell types for fine mapping complex trait variants	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; T-CELLS; EXPRESSION; METHYLATIONS; METAANALYSIS; ENHANCERS; ARTHRITIS; DYNAMICS; PROVIDES	If trait-associated variants alter regulatory regions, then they should fall within chromatin marks in relevant cell types. However, it is unclear which of the many marks are most useful in defining cell types associated with disease and fine mapping variants. We hypothesized that informative marks are phenotypically cell type specific; that is, SNPs associated with the same trait likely overlap marks in the same cell type. We examined 15 chromatin marks and found that those highlighting active gene regulation were phenotypically cell type specific. Trimethylation of histone H3 at lysine 4 (H3K4me3) was the most phenotypically cell type specific (P < 1 x 10(-6)), driven by colocalization of variants and marks rather than gene proximity (P < 0.001). H3K4me3 peaks overlapped with 37 SNPs for plasma low-density lipoprotein concentration in the liver (P < 7 x 10(-5)), 31 SNPs for rheumatoid arthritis within CD4(+) regulatory T cells (P = 1 x 10(-4)), 67 SNPs for type 2 diabetes in pancreatic islet cells (P = 0.003) and the liver (P = 0.003), and 14 SNPs for neuropsychiatric disease in neuronal tissues (P = 0.007). We show how cell type-specific H3K4me3 peaks can inform the fine mapping of associated SNPs to identify causal variation.	[Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Stranger, Barbara E.; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol, Sch Med, Boston, MA 02115 USA; [Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Trynka, Gosia; Sandor, Cynthia; Han, Buhm; Stranger, Barbara E.; Raychaudhuri, Soumya] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Xu, Han; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Xu, Han; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Manchester	Raychaudhuri, S (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.	soumya@broadinstitute.org	Han, Buhm/AAQ-9672-2020	Stranger, Barbara/0000-0001-9021-7331; Raychaudhuri, Soumya/0000-0002-1901-8265; Trynka, Gosia/0000-0002-6955-9529	Rubicon grant from The Netherlands Organization for Scientific Research (NWO); Harvard University Milton Fund; Brigham and Women's Hospital; US NIH [K08AR055688, U01HG0070033, R01 HG004069]; Arthritis Foundation; NHGRI; NIH Roadmap Epigenomics Mapping Consortium; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007033, R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, K08AR055688] Funding Source: NIH RePORTER	Rubicon grant from The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Harvard University Milton Fund; Brigham and Women's Hospital; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Roadmap Epigenomics Mapping Consortium; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Daly, M. Kellis, D. Diogo, X. Hu, Y. Okada, R. Plenge, S. Ripke, G. Srivastava, E. Stahl and S. Sunyaev for critical feedback and discussion. G.T. is supported by the Rubicon grant from The Netherlands Organization for Scientific Research (NWO). B.E.S. and S.R. are supported by the Harvard University Milton Fund, and Brigham and Women's Hospital. S.R. is also supported by funds from the US NIH (K08AR055688 and U01HG0070033) and the Arthritis Foundation. X.S.L. is also supported by funds from the US NIH (R01 HG004069). We thank the ENCODE Project, supported by the NHGRI, and the NIH Roadmap Epigenomics Mapping Consortium for making data available.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ATCHISON ML, 1988, ANNU REV CELL BIOL, V4, P127, DOI 10.1146/annurev.cellbio.4.1.127; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; SMITH LC, 1978, ANNU REV BIOCHEM, V47, P751, DOI 10.1146/annurev.bi.47.070178.003535; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660	55	373	374	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					124	130		10.1038/ng.2504	http://dx.doi.org/10.1038/ng.2504			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23263488	Green Accepted			2022-12-25	WOS:000314333000005
J	You, MS; Yue, Z; He, WY; Yang, XH; Yang, G; Xie, M; Zhan, DL; Baxter, SW; Vasseur, L; Gurr, GM; Douglas, CJ; Bai, JL; Wang, P; Cui, K; Huang, SG; Li, XC; Zhou, Q; Wu, ZY; Chen, QL; Liu, CH; Wang, B; Li, XJ; Xu, XF; Lu, CX; Hu, M; Davey, JW; Smith, SM; Chen, MS; Xia, XF; Tang, WQ; Ke, FS; Zheng, DD; Hu, YL; Song, FQ; You, YC; Ma, XL; Peng, L; Zheng, YK; Liang, Y; Chen, YQ; Yu, LY; Zhang, YN; Liu, YY; Li, GQ; Fang, L; Li, JX; Zhou, X; Luo, YD; Gou, CY; Wang, JY; Wang, J; Yang, HM; Wang, J				You, Minsheng; Yue, Zhen; He, Weiyi; Yang, Xinhua; Yang, Guang; Xie, Miao; Zhan, Dongliang; Baxter, Simon W.; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Wang, Ping; Cui, Kai; Huang, Shiguo; Li, Xianchun; Zhou, Qing; Wu, Zhangyan; Chen, Qilin; Liu, Chunhui; Wang, Bo; Li, Xiaojing; Xu, Xiufeng; Lu, Changxin; Hu, Min; Davey, John W.; Smith, Sandy M.; Chen, Mingshun; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan; Liu, Yuanyuan; Li, Guoqing; Fang, Lin; Li, Jingxiang; Zhou, Xin; Luo, Yadan; Gou, Caiyun; Wang, Junyi; Wang, Jian; Yang, Huanming; Wang, Jun			A heterozygous moth genome provides insights into herbivory and detoxification	NATURE GENETICS			English	Article							DIAMONDBACK MOTH; PLUTELLA-XYLOSTELLA; GENE; SEQUENCE; RESISTANCE; LEPIDOPTERA; MECHANISMS; PREDICTION; EVOLUTION; ALIGNMENT	How an insect evolves to become a successful herbivore is of profound biological and practical importance. Herbivores are often adapted to feed on a specific group of evolutionarily and biochemically related host plants(1), but the genetic and molecular bases for adaptation to plant defense compounds remain poorly understood(2). We report the first whole-genome sequence of a basal lepidopteran species, Plutella xylostella, which contains 18,071 protein-coding and 1,412 unique genes with an expansion of gene families associated with perception and the detoxification of plant defense compounds. A recent expansion of retrotransposons near detoxification-related genes and a wider system used in the metabolism of plant defense compounds are shown to also be involved in the development of insecticide resistance. This work shows the genetic and molecular bases for the evolutionary success of this worldwide herbivore and offers wider insights into insect adaptation to plant feeding, as well as opening avenues for more sustainable pest management.	[You, Minsheng; He, Weiyi; Yang, Guang; Xie, Miao; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Cui, Kai; Huang, Shiguo; Liu, Chunhui; Li, Xiaojing; Xu, Xiufeng; Smith, Sandy M.; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China; [You, Minsheng; He, Weiyi; Yang, Guang; Xie, Miao; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Cui, Kai; Huang, Shiguo; Liu, Chunhui; Li, Xiaojing; Xu, Xiufeng; Smith, Sandy M.; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Peoples R China; [Yue, Zhen; Yang, Xinhua; Zhan, Dongliang; Zhou, Qing; Wu, Zhangyan; Chen, Qilin; Wang, Bo; Lu, Changxin; Hu, Min; Li, Guoqing; Fang, Lin; Li, Jingxiang; Zhou, Xin; Luo, Yadan; Gou, Caiyun; Wang, Junyi; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Baxter, Simon W.] Univ Cambridge, Dept Zool, Cambridge, England; [Baxter, Simon W.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Vasseur, Liette] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Gurr, Geoff M.] Charles Sturt Univ, EH Graham Ctr, Orange, NSW, Australia; [Douglas, Carl J.; Liu, Yuanyuan] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Davey, John W.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Smith, Sandy M.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Chen, Mingshun] Kansas State Univ, USDA ARS, Manhattan, KS 66506 USA; [Chen, Mingshun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); University of Cambridge; University of Adelaide; Brock University; Charles Sturt University; University of British Columbia; Cornell University; University of Arizona; University of Edinburgh; University of Toronto; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; University of Copenhagen	You, MS (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China.	msyou@iae.fjau.edu.cn; yxg@iae.fjau.edu.cn; wangj@genomics.cn	wang, junyi/GYA-3213-2022; Zhou, Xin/AAI-9326-2021; Davey, John/B-5075-2013; GURR, GEOFFREY M/F-3519-2011; liu, yuanyuan/GWZ-5838-2022; Zhou, Xin/D-4025-2009; He, Weiyi/N-6148-2017; Wang, Jun/A-7261-2013; Huang, Shiguo/GLU-2694-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhou, Xin/0000-0002-1407-7952; Zhou, Xin/0000-0002-1407-7952; He, Weiyi/0000-0001-8659-3123; Huang, Shiguo/0000-0002-6402-0858; Davey, John/0000-0002-1017-9775; Wang, Jun/0000-0002-8540-8931; Baxter, Simon/0000-0001-5773-6578; Wang, Jun/0000-0002-2113-5874; Gurr, Geoff/0000-0001-5008-7966	Educational Department of Fujian Province [JB09315]; National Natural Science Foundation of China [31230061]; BBSRC [BBS/E/D/20310000] Funding Source: UKRI	Educational Department of Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported through a special project of Research on Diamondback Moth Genomics (grant JB09315) to M.Y. and a Minjiang Scholar Program to L.V., G.M.G., C.J.D. and S.M.S. by the Educational Department of Fujian Province and through a key project (grant 31230061) to M.Y. from the National Natural Science Foundation of China. Insect rearing and sampling, as well as some of the DNA extractions, were conducted at the Fujian Provincial Key Laboratory of Biodiversity and Eco-safety and the Key Laboratory of Integrated Pest Management for Fujian-Taiwan Crops, the Ministry of Agriculture, China. We are grateful to AD. Briscoe (University of California Irvine) for her help in organizing and for providing ORs, OBPs and CSPs from Danaus plexippus and Heliconius melpomene and to G.L. Lovei (Aarhus University) for his comments and suggestions on the manuscript. We appreciate J. Liao and M. Zou (Fujian Agriculture and Forestry University) for providing the Bt-treated P. xylostella larvae used for quantitative gene expression analysis. We thank H. Wang, J. Luo, Y. Hong, S. Pan, L. Yang, Y. Weng, Y. Hong and Y. Liu for their technical assistance in rearing insects and preparing samples.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; ANKERSMIT GW, 1953, B ENTOMOL RES, V44, P421, DOI 10.1017/S0007485300025530; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Buono M, 2010, CELL MOL LIFE SCI, V67, P769, DOI 10.1007/s00018-009-0203-3; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Henniges-Janssen K, 2011, HEREDITY, V107, P421, DOI 10.1038/hdy.2011.27; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kvist J., 2012, MOL ECOL, DOI [10.1111/j.1365-294X.2012.05521.x, DOI 10.1111/1.1365-294X.2012.05521.X]; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Li AG, 2006, J ECON ENTOMOL, V99, P914, DOI 10.1603/0022-0493-99.3.914; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Pillai S, 2005, NUCLEIC ACIDS RES, V33, pW25, DOI 10.1093/nar/gki491; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whiteman NK, 2010, PLANT PHYSIOL, V154, P475, DOI 10.1104/pp.110.161117; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6	85	356	415	17	279	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					220	225		10.1038/ng.2524	http://dx.doi.org/10.1038/ng.2524			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313953	Green Published, hybrid			2022-12-25	WOS:000314333000020
J	Chen, JK; Liu, H; Liu, J; Qi, J; Wei, B; Yang, JQ; Liang, HQ; Chen, Y; Chen, J; Wu, YR; Guo, L; Zhu, JY; Zhao, XJ; Peng, TR; Zhang, YX; Chen, S; Li, XJ; Li, DW; Wang, T; Pei, DQ				Chen, Jiekai; Liu, He; Liu, Jing; Qi, Jing; Wei, Bei; Yang, Jiaqi; Liang, Hanquan; Chen, You; Chen, Jing; Wu, Yaran; Guo, Lin; Zhu, Jieying; Zhao, Xiangjie; Peng, Tianran; Zhang, Yixin; Chen, Shen; Li, Xuejia; Li, Dongwei; Wang, Tao; Pei, Duanqing			H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; FIBROBLASTS; INDUCTION; GENERATION; KLF4	The induction of pluripotent stem cells (iPSCs) by defined factors is poorly understood stepwise. Here, we show that histone H3 lysine 9 (H3K9) methylation is the primary epigenetic determinant for the intermediate pre-iPSC state, and its removal leads to fully reprogrammed iPSCs. We generated a panel of stable pre-iPSCs that exhibit pluripotent properties but do not activate the core pluripotency network, although they remain sensitive to vitamin C for conversion into iPSCs. Bone morphogenetic proteins (BMPs) were subsequently identified in serum as critical signaling molecules in arresting reprogramming at the pre-iPSC state. Mechanistically, we identified H3K9 methyltransferases as downstream targets of BMPs and showed that they function with their corresponding demethylases as the on/off switch for the pre-iPSC fate by regulating H3K9 methylation status at the core pluripotency loci. Our results not only establish pre-iPSCs as an epigenetically stable signpost along the reprogramming road map, but they also provide mechanistic insights into the epigenetic reprogramming of cell fate.	[Chen, Jiekai; Liu, He; Liu, Jing; Qi, Jing; Wei, Bei; Yang, Jiaqi; Liang, Hanquan; Chen, You; Chen, Jing; Wu, Yaran; Guo, Lin; Zhu, Jieying; Zhao, Xiangjie; Peng, Tianran; Zhang, Yixin; Chen, Shen; Li, Xuejia; Li, Dongwei; Wang, Tao; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Chen, Jiekai; Liu, He; Liu, Jing; Qi, Jing; Wei, Bei; Yang, Jiaqi; Liang, Hanquan; Chen, You; Chen, Jing; Wu, Yaran; Guo, Lin; Zhu, Jieying; Zhao, Xiangjie; Peng, Tianran; Zhang, Yixin; Chen, Shen; Li, Xuejia; Li, Dongwei; Wang, Tao; Pei, Duanqing] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Pei, DQ (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Peng, Tianran/AAG-9825-2022; Peng, Tianran/AES-0353-2022	Wei, Bei/0000-0003-1516-8802; Chen, Jiekai/0000-0001-5168-7074; Peng, Tianran/0000-0001-8309-4652	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020401, XDA01020202, XDA01020302]; National Basic Research Program of China [2009CB941102, 2011CBA01106, 2011CB965204, 2012CB966802]; National Natural Science Foundation of China [31271357, 91213304]; Ministry of Science and Technology International Technology Cooperation Program [2010DFB30430, 2012DFH30050]; National Science and Technology Major Special Project on Major New Drug Innovation [2011ZX09102-010]; Bureau of Science and Technology of Guangzhou Municipality, China [2010U1-E00521]; Guangdong Science and Technology Project [2010A090603001, 2011A08030002]; Science and Technology Planning Project of Guangdong Province, China [2011A060901019]; One Hundred Person Project of The Chinese Academy of Sciences; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Pearl River Nova program [2012J2200070]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Technology Cooperation Program; National Science and Technology Major Special Project on Major New Drug Innovation; Bureau of Science and Technology of Guangzhou Municipality, China; Guangdong Science and Technology Project; Science and Technology Planning Project of Guangdong Province, China; One Hundred Person Project of The Chinese Academy of Sciences; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Pearl River Nova program	We are grateful to X. Shu for careful reading and critical comments of the manuscript. We appreciate the contributions of J. Nie to microarray data analysis. We thank H. Zheng, X. Liu, J. Zhao, H. Wu, F. Li, D. Qin, R. Li, M. Esteban, G. Xu and B. Qin for constructive criticism. We also thank L. Zeng, G. Zhu, S. Sun, Y. Wu, K. Lai, H. Pang, H. Zhang, W. He, A. Jiang, T. Zhou, J. Li, S. Huang, J. Xu and D. Yang for technical assistance. We deeply appreciate the assistance of H. Song, K. Mo and S. Chu in blastocyst injection. This work is supported in part by the Strategic Priority Research Program of the Chinese Academy of Sciences (grants XDA01020401, XDA01020202 and XDA01020302), the National Basic Research Program of China (grants 2009CB941102, 2011CBA01106, 2011CB965204 and 2012CB966802), the National Natural Science Foundation of China (grants 31271357 and 91213304), the Ministry of Science and Technology International Technology Cooperation Program (grants 2010DFB30430 and 2012DFH30050), the National Science and Technology Major Special Project on Major New Drug Innovation (grant 2011ZX09102-010), the Bureau of Science and Technology of Guangzhou Municipality, China (grant 2010U1-E00521), the Guangdong Science and Technology Project (grants 2010A090603001 and 2011A08030002), Science and Technology Planning Project of Guangdong Province, China (grant 2011A060901019), the One Hundred Person Project of The Chinese Academy of Sciences to D. P., the Youth Innovation Promotion Association of the Chinese Academy of Sciences and the Pearl River Nova program (grant 2012J2200070). We wish to thank all members of our laboratories for their support.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Frontelo P, 2004, ONCOGENE, V23, P5242, DOI 10.1038/sj.onc.1207660; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	39	360	393	2	158	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					34	U62		10.1038/ng.2491	http://dx.doi.org/10.1038/ng.2491			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202127				2022-12-25	WOS:000312838800010
J	Fievet, BT; Rodriguez, J; Naganathan, S; Lee, C; Zeiser, E; Ishidate, T; Shirayama, M; Grill, S; Ahringer, J				Fievet, Bruno Thomas; Rodriguez, Josana; Naganathan, Sundar; Lee, Christine; Zeiser, Eva; Ishidate, Takao; Shirayama, Masaki; Grill, Stephan; Ahringer, Julie			Systematic genetic interaction screens uncover cell polarity regulators and functional redundancy	NATURE CELL BIOLOGY			English	Article							ANTERIOR-POSTERIOR POLARITY; ANAPHASE-PROMOTING COMPLEX; ELEGANS CHROMOSOME-I; CAENORHABDITIS-ELEGANS; C-ELEGANS; PAR PROTEINS; EMBRYONIC POLARITY; G-ALPHA; CYTOPLASMIC LOCALIZATION; ASYMMETRIC DIVISION	Although single-gene loss-of-function analyses can identify components of particular processes, important molecules are missed owing to the robustness of biological systems. Here we show that large-scale RNAi screening for suppression interactions with functionally related mutants greatly expands the repertoire of genes known to act in a shared process and reveals a new layer of functional relationships. We performed RNAi screens for 17 Caenorhabditis elegans cell polarity mutants, generating the most comprehensive polarity network in a metazoan, connecting 184 genes. Of these, 72% were not previously linked to cell polarity and 80% have human homologues. We experimentally confirmed functional roles predicted by the network and characterized through biophysical analyses eight myosin regulators. In addition, we discovered functional redundancy between two unknown polarity genes. Similar systematic genetic interaction screens for other biological processes will help uncover the inventory of relevant genes and their patterns of interactions.	[Fievet, Bruno Thomas; Rodriguez, Josana; Lee, Christine; Zeiser, Eva; Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Fievet, Bruno Thomas; Rodriguez, Josana; Lee, Christine; Zeiser, Eva; Ahringer, Julie] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Naganathan, Sundar; Grill, Stephan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Ishidate, Takao; Shirayama, Masaki] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Grill, Stephan] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	University of Cambridge; University of Cambridge; Max Planck Society; University of Massachusetts System; University of Massachusetts Worcester; Max Planck Society	Ahringer, J (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.	j.ahringer@gurdon.cam.ac.uk	Grill, Stephan/D-9427-2012	Ahringer, Julie/0000-0002-7074-4051	Wellcome Trust [054523]; Human Frontier Science Program; Herchel Smith Post-doctoral fellowship; EMBO fellowship; NIH National Center for Research Resources (NCRR); NICHD	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); Herchel Smith Post-doctoral fellowship; EMBO fellowship(European Molecular Biology Organization (EMBO)); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Wellcome Trust Senior Research Fellowship (054523, to LA.), postdoctoral fellowships from the Human Frontier Science Program (to B.T.F. and J.R.), a Herchel Smith Post-doctoral fellowship (to J.R.) and an EMBO fellowship (to B.T.F.). We thank P. Mains (Department of Biochemistry and Molecular Biology, University of Calgary, Canada) for providing let-502(ts) and mel-11(ts) mutants, and K. Kemphues (Department of Molecular Biology and Genetics, Cornell University, USA) for NMY-2-expressing bacteria. We thank F. Antigny, D. Lefer, V. Karabacak, S. Kroschwald, A. Maffioletti and A. Sayadian for their contribution in visual scoring and S. Furthauer for help with hydrodynamic length measurements. We thank the media team of the Gurdon Institute for preparing screen reagents. We also thank C. Dix and R. Durbin for comments on the manuscript. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). The P4A1 monoclonal antibody developed by J. Priess was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; Boyd L, 1996, DEVELOPMENT, V122, P3075; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Coradini D, 2011, ACTA PHARMACOL SIN, V32, P552, DOI 10.1038/aps.2011.20; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; DeBella LR, 2006, MOL BIOL CELL, V17, P4911, DOI 10.1091/mbc.E06-02-0107; Dong Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-19; Dorfman M, 2009, GENETICS, V182, P1035, DOI 10.1534/genetics.109.104885; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Galli M, 2011, NAT CELL BIOL, V13, P1132, DOI 10.1038/ncb2315; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Hung TJ, 1999, DEVELOPMENT, V126, P127; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kim JSM, 2010, DEVELOPMENT, V137, P93, DOI 10.1242/dev.041459; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; Krueger LE, 2010, J CELL BIOL, V189, P481, DOI 10.1083/jcb.201001115; Kumfer KT, 2010, MOL BIOL CELL, V21, P266, DOI 10.1091/mbc.E09-01-0060; Labbe JC, 2006, GENETICS, V174, P285, DOI 10.1534/genetics.106.060517; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Liu J, 2010, DEV BIOL, V339, P366, DOI 10.1016/j.ydbio.2009.12.041; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matsubara Y, 2007, GENES CELLS, V12, P407, DOI 10.1111/j.1365-2443.2007.01061.x; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; MENEELY PM, 1979, GENETICS, V92, P99; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MIWA J, 1980, DEV BIOL, V76, P160, DOI 10.1016/0012-1606(80)90369-3; MORTON DG, 1992, GENETICS, V130, P771; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Panbianco C, 2008, DEV CELL, V15, P198, DOI 10.1016/j.devcel.2008.06.002; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Piekny AJ, 2002, J CELL SCI, V115, P2271; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Rappleye CA, 2002, DEV CELL, V2, P195, DOI 10.1016/S1534-5807(02)00114-4; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; ROSE LS, 1995, DEV BIOL, V168, P479, DOI 10.1006/dbio.1995.1096; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sandmann T, 2012, CURR OPIN GENET DEV, V22, P36, DOI 10.1016/j.gde.2012.02.001; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spilker AC, 2009, GENETICS, V183, P965, DOI 10.1534/genetics.109.106716; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Watts JL, 1996, DEVELOPMENT, V122, P3133; Willis JH, 2006, MOL BIOL CELL, V17, P1051, DOI 10.1091/mbc.E05-09-0886; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017; Wu JC, 2007, MOL BIOL CELL, V18, P4470, DOI 10.1091/mbc.E07-02-0105; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	91	47	58	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					103	U229		10.1038/ncb2639	http://dx.doi.org/10.1038/ncb2639			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23242217	Green Accepted			2022-12-25	WOS:000312841300015
J	Fuchs, T; Saunders-Pullman, R; Masuho, I; Luciano, MS; Raymond, D; Factor, S; Lang, AE; Liang, TW; Trosch, RM; White, S; Ainehsazan, E; Herve, D; Sharma, N; Ehrlich, ME; Martemyanov, KA; Bressman, SB; Ozelius, LJ				Fuchs, Tania; Saunders-Pullman, Rachel; Masuho, Ikuo; Luciano, Marta San; Raymond, Deborah; Factor, Stewart; Lang, Anthony E.; Liang, Tsao-Wei; Trosch, Richard M.; White, Sierra; Ainehsazan, Edmond; Herve, Denis; Sharma, Nutan; Ehrlich, Michelle E.; Martemyanov, Kirill A.; Bressman, Susan B.; Ozelius, Laurie J.			Mutations in GNAL cause primary torsion dystonia	NATURE GENETICS			English	Article							PROTEIN ALPHA-SUBUNIT; ADULT-ONSET; ADENYLYL-CYCLASE; GENETIC-ANALYSIS; ASHKENAZI JEWS; BASAL GANGLIA; MOUSE MODEL; RECEPTOR; DOPAMINE; G-ALPHA(OLF)	Dystonia is a movement disorder characterized by repetitive twisting muscle contractions and postures(1,2). Its molecular pathophysiology is poorly understood, in part owing to limited knowledge of the genetic basis of the disorder. Only three genes for primary torsion dystonia (PTD), TOR1A (DYT1)(3), THAP1 (DYT6)(4) and CIZ1 (ref. 5), have been identified. Using exome sequencing in two families with PTD, we identified a new causative gene, GNAL, with a nonsense mutation encoding p.Ser293* resulting in a premature stop codon in one family and a missense mutation encoding p.Val137Met in the other. Screening of GNAL in 39 families with PTD identified 6 additional new mutations in this gene. Impaired function of several of the mutants was shown by bioluminescence resonance energy transfer (BRET) assays.	[Fuchs, Tania; White, Sierra; Ainehsazan, Edmond; Ozelius, Laurie J.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Saunders-Pullman, Rachel; Raymond, Deborah; Bressman, Susan B.] Beth Israel Deaconess Med Ctr, Dept Neurol, New York, NY 10003 USA; [Saunders-Pullman, Rachel; Bressman, Susan B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Luciano, Marta San] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Factor, Stewart] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Lang, Anthony E.] Toronto Western Hosp, Dept Neurol, Toronto, ON M5T 2S8, Canada; [Liang, Tsao-Wei] Jefferson Hosp Neurosci, Dept Neurol, Philadelphia, PA USA; [Trosch, Richard M.] Parkinsons & Movement Disorders Ctr, Southfield, MI USA; [Herve, Denis] INSERM, Unite Mixte Rech UMR S839, Paris, France; [Herve, Denis] Inst Fer Moulin, Paris, France; [Herve, Denis] Univ Paris 06, Paris, France; [Sharma, Nutan] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Ehrlich, Michelle E.; Ozelius, Laurie J.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Ehrlich, Michelle E.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA	Icahn School of Medicine at Mount Sinai; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University; Albert Einstein College of Medicine; Scripps Research Institute; University of California System; University of California San Francisco; Emory University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Jefferson University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ozelius, LJ (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	laurie.ozelius@mssm.edu	Lang, Anthony/ABF-8114-2021; Masuho, Ikuo/J-6115-2014; HERVE, Denis/E-2929-2017	HERVE, Denis/0000-0003-1376-1522; Lang, Anthony/0000-0003-1229-3667; San Luciano, Marta/0000-0002-9885-704X	Dystonia Medical Research Foundation; Bachmann-Strauss Dystonia and Parkinson Foundation; Lockwood Family Foundation; National Institute of Neurological Disorders and Stroke [NS26656, NS037409, K02-NS073836]; National Institute on Drug Abuse [DA021743, DA026405]; Agence Nationale de la Recherche [ANR09-MNPS-014]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (WHI) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS073836, P01NS037409, P50NS037409, R01NS026656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA021743] Funding Source: NIH RePORTER	Dystonia Medical Research Foundation; Bachmann-Strauss Dystonia and Parkinson Foundation; Lockwood Family Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Lung GO Sequencing Project; Women's Health Initiative (WHI) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We wish to thank all individuals with dystonia and their family members who participated in this study. We are indebted to the following physicians for referring families with dystonia included in this manuscript: S. Reich, J. Hammerstadt, D. Hobson, D. Truong, F. Danisi, M. Hutchinson, S. O'Riordan, T. Lynch and J. Rogers. We would also like to thank the following physicians who examined study subjects during their movement disorder fellowships: R. Tabamo, E. Chai, K. Blatt, P. Kavanagh, P. Kapoor and G. Petzinger. We thank R. Sachidanandam for the bioinformatics analysis related to the splice-site mutation; H. Lederman for technical help; N.A. Lambert (Georgia Health Sciences University) for sharing Venus155-239-G beta<INF>1</INF> and Venus1-155-G gamma<INF>2</INF>; and B. Malnic (Universidade de Sao Paulo) for the gift of the Ric-8B construct. This work was supported by research grants from the Dystonia Medical Research Foundation (T. F.), the Bachmann-Strauss Dystonia and Parkinson Foundation (L. J. O.), the Lockwood Family Foundation (N. S. and L. J. O.), the National Institute of Neurological Disorders and Stroke (NS26656, S. B. B., R. S.-P. and L. J. O.; NS037409, N. S. and L. J. O.; K02-NS073836, R. S.-P.) the National Institute on Drug Abuse (DA021743 and DA026405, K. A. M.) and Agence Nationale de la Recherche (ANR09-MNPS-014, D. H.). The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison, including the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	AHMAD F, 1993, GENOMICS, V15, P9, DOI 10.1006/geno.1993.1003; Albanese A, 2011, EUR J NEUROL, V18, P5, DOI 10.1111/j.1468-1331.2010.03042.x; Alcacer C, 2012, J NEUROSCI, V32, P5900, DOI 10.1523/JNEUROSCI.0837-12.2012; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; Blanchard A, 2011, HUM MUTAT, V32, P1213, DOI 10.1002/humu.21564; Bonsi P, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00006; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BRESSMAN SB, 1994, NEUROLOGY, V44, P283, DOI 10.1212/WNL.44.2.283; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; Bressman SB, 2009, LANCET NEUROL, V8, P441, DOI 10.1016/S1474-4422(09)70081-X; Corradi JP, 2005, MOL PSYCHIATR, V10, P1017, DOI 10.1038/sj.mp.4001713; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Corvol JC, 2004, J NEUROSCI, V24, P7007, DOI 10.1523/JNEUROSCI.0676-04.2004; Corvol JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1109, DOI 10.1038/sj.npp.1301230; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; DasBanerjee T, 2008, AM J MED GENET B, V147B, P1554, DOI 10.1002/ajmg.b.30877; DEFAZIO G, 1993, EUR NEUROL, V33, P345, DOI 10.1159/000116969; Del Sorbo F, 2008, J NEUROL, V255, P32, DOI 10.1007/s00415-008-4006-5; DRINNAN S L, 1991, Molecular and Cellular Neuroscience, V2, P66, DOI 10.1016/1044-7431(91)90040-U; Factor SA, 2002, MOVEMENT DISORD, V17, P846, DOI 10.1002/mds.10215; Fahn S, 1998, Adv Neurol, V78, P1; Fahn S, 1988, Adv Neurol, V50, P1; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Gopalakrishna KN, 2011, J BIOL CHEM, V286, P28954, DOI 10.1074/jbc.M111.268821; Graziadio C, 2009, ARQ NEURO-PSIQUIAT, V67, P689, DOI 10.1590/S0004-282X2009000400021; Grimes DA, 2002, NEUROLOGY, V59, P1183, DOI 10.1212/WNL.59.8.1183; Han FB, 2007, MOVEMENT DISORD, V22, P888, DOI 10.1002/mds.21400; Herve D, 2001, J NEUROSCI, V21, P4390, DOI 10.1523/JNEUROSCI.21-12-04390.2001; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Herve D, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00048; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Jarman PR, 1999, J NEUROL NEUROSUR PS, V67, P395, DOI 10.1136/jnnp.67.3.395; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kamnasaran D, 2003, CLIN INVEST MED, V26, P285; Klein C, 1999, NEUROLOGY, V52, P649, DOI 10.1212/WNL.52.3.649; Kowarik MC, 2011, MOVEMENT DISORD, V26, P560, DOI 10.1002/mds.23446; Kull B, 2000, MOL PHARMACOL, V58, P771, DOI 10.1124/mol.58.4.771; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laurin N, 2008, J PSYCHIATR RES, V42, P117, DOI 10.1016/j.jpsychires.2006.10.010; Leube B, 1996, HUM MOL GENET, V5, P1673, DOI 10.1093/hmg/5.10.1673; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nasir J, 2006, MOVEMENT DISORD, V21, P859, DOI 10.1002/mds.20846; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; NIZNIK HB, 1986, J BIOL CHEM, V261, P8397; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ozelius LJ, 2011, MOVEMENT DISORD, V26, P1106, DOI 10.1002/mds.23775; Ozelius LJ, 2011, NEUROBIOL DIS, V42, P127, DOI 10.1016/j.nbd.2010.12.012; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; Postma AG, 2009, CLIN NEUROL NEUROSUR, V111, P880, DOI 10.1016/j.clineuro.2009.07.013; RISCH NJ, 1990, AM J HUM GENET, V46, P533; Rozen S, 2000, Methods Mol Biol, V132, P365; Sako W, 2010, NEUROSCIENCE, V170, P497, DOI 10.1016/j.neuroscience.2010.06.072; Saunders-Pullman R, 2012, NEUROLOGY, V78, P649, DOI 10.1212/WNL.0b013e3182494d51; Sciamanna G, 2009, NEUROBIOL DIS, V34, P133, DOI 10.1016/j.nbd.2009.01.001; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tezzon F, 1998, ITAL J NEUROL SCI, V19, P90, DOI 10.1007/BF02427563; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; WADDY HM, 1991, ANN NEUROL, V29, P320, DOI 10.1002/ana.410290315; Xiao JF, 2012, ANN NEUROL, V71, P458, DOI 10.1002/ana.23547; Zhuang XX, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0001.2000	66	210	214	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					88	U128		10.1038/ng.2496	http://dx.doi.org/10.1038/ng.2496			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23222958	Green Accepted, Green Submitted			2022-12-25	WOS:000312838800018
J	Krishnamurty, R; Brigham, JL; Leonard, SE; Ranjitkar, P; Larson, ET; Dale, EJ; Merritt, EA; Maly, DJ				Krishnamurty, Ratika; Brigham, Jennifer L.; Leonard, Stephen E.; Ranjitkar, Pratistha; Larson, Eric T.; Dale, Edward J.; Merritt, Ethan A.; Maly, Dustin J.			Active site profiling reveals coupling between domains in SRC-family kinases	NATURE CHEMICAL BIOLOGY			English	Article							TYROSINE KINASE; C-SRC; CRYSTAL-STRUCTURE; PROTEIN-KINASES; ACTIVATION; INHIBITORS; HCK; MECHANISM; ABL; PROTEOMICS	Protein kinases, key regulators of intracellular signal transduction, have emerged as an important class of drug targets. Chemical proteomic tools that facilitate the functional interrogation of protein kinase active sites are powerful reagents for studying the regulation of this large enzyme family and performing inhibitor selectivity screens. Here we describe a new crosslinking strategy that enables rapid and quantitative profiling of protein kinase active sites in lysates and live cells. Applying this methodology to the SRC-family kinases (SFKs) SRC and HCK led to the identification of a series of conformation-specific, ATP-competitive inhibitors that have a distinct preference for the autoinhibited forms of these kinases. Furthermore, we show that ligands that have this selectivity are able to modulate the ability of the regulatory domains of SRC and HCK to engage in intermolecular binding interactions. These studies provide insight into the regulation of this important family of tyrosine kinases.	[Krishnamurty, Ratika; Brigham, Jennifer L.; Leonard, Stephen E.; Ranjitkar, Pratistha; Dale, Edward J.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Larson, Eric T.; Merritt, Ethan A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Krishnamurty, R (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	maly@chem.washington.edu		Maly, Dustin/0000-0003-0094-0177; Larson, Eric T./0000-0002-2862-4291	US National Institutes of Health [R01GM086858, R01AI089441]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Several ATP-competitive inhibitors were provided by R. Murphy (University of Washington, Seattle) and G. Perera (University of Washington, Seattle). This research was supported by US National Institutes of Health grants R01GM086858 (D.J.M.) and R01AI089441 (E.A.M.) and the Alfred P. Sloan Foundation (D.J.M.).	Alvarado JJ, 2010, J BIOL CHEM, V285, P35455, DOI 10.1074/jbc.M110.145102; Ayrapetov MK, 2006, J BIOL CHEM, V281, P23776, DOI 10.1074/jbc.M604219200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Cheng HC, 2010, CLIN EXP PHARMACOL P, V37, P93, DOI 10.1111/j.1440-1681.2009.05237.x; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Georghiou G, 2012, NAT CHEM BIOL, V8, P366, DOI [10.1038/nchembio.792, 10.1038/NCHEMBIO.792]; Getlik M, 2009, J MED CHEM, V52, P3915, DOI 10.1021/jm9002928; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Katsuta H, 1998, J IMMUNOL, V160, P1547; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Shi HB, 2012, J AM CHEM SOC, V134, P3001, DOI 10.1021/ja208518u; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Simard JR, 2009, NAT CHEM BIOL, V5, P394, DOI 10.1038/nchembio.162; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	50	48	48	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					43	+		10.1038/NCHEMBIO.1118	http://dx.doi.org/10.1038/NCHEMBIO.1118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143416	Green Accepted			2022-12-25	WOS:000312484200011
J	Maller, JB; McVean, G; Byrnes, J; Vukcevic, D; Palin, K; Su, Z; Howson, JMM; Auton, A; Myers, S; Morris, A; Pirinen, M; Brown, MA; Burton, PR; Caulfield, MJ; Compston, A; Farrall, M; Hall, AS; Hattersley, AT; Hill, AVS; Mathew, CG; Pembrey, M; Satsangi, J; Stratton, MR; Worthington, J; Craddock, N; Hurles, M; Ouwehand, W; Parkes, M; Rahman, N; Duncanson, A; Todd, JA; Kwiatkowski, DP; Samani, NJ; Gough, SCL; McCarthy, MI; Deloukas, P; Donnelly, P				Maller, Julian B.; McVean, Gilean; Byrnes, Jake; Vukcevic, Damjan; Palin, Kimmo; Su, Zhan; Howson, Joanna M. M.; Auton, Adam; Myers, Simon; Morris, Andrew; Pirinen, Matti; Brown, Matthew A.; Burton, Paul R.; Caulfield, Mark J.; Compston, Alastair; Farrall, Martin; Hall, Alistair S.; Hattersley, Andrew T.; Hill, Adrian V. S.; Mathew, Christopher G.; Pembrey, Marcus; Satsangi, Jack; Stratton, Michael R.; Worthington, Jane; Craddock, Nick; Hurles, Matthew; Ouwehand, Willem; Parkes, Miles; Rahman, Nazneen; Duncanson, Audrey; Todd, John A.; Kwiatkowski, Dominic P.; Samani, Nilesh J.; Gough, Stephen C. L.; McCarthy, Mark I.; Deloukas, Panagiotis; Donnelly, Peter		Wellcome Trust Case Control Consor	Bayesian refinement of association signals for 14 loci in 3 common diseases	NATURE GENETICS			English	Article								To further investigate susceptibility loci identified by genome-wide association studies, we genotyped 5,500 SNPs across 14 associated regions in 8,000 samples from a control group and 3 diseases: type 2 diabetes (T2D), coronary artery disease (CAD) and Graves' disease. We defined, using Bayes theorem, credible sets of SNPs that were 95% likely, based on posterior probability, to contain the causal disease-associated SNPs. In 3 of the 14 regions, TCF7L2 (T2D), CTLA4 (Graves' disease) and CDKN2A-CDKN2B (T2D), much of the posterior probability rested on a single SNP, and, in 4 other regions (CDKN2A-CDKN2B (CAD) and CDKAL1, FTO and HHEX (T2D)), the 95% sets were small, thereby excluding most SNPs as potentially causal. Very few SNPs in our credible sets had annotated functions, illustrating the limitations in understanding the mechanisms underlying susceptibility to common diseases. Our results also show the value of more detailed mapping to target sequences for functional studies.	[Maller, Julian B.; McVean, Gilean; Byrnes, Jake; Vukcevic, Damjan; Su, Zhan; Auton, Adam; Myers, Simon; Morris, Andrew; Pirinen, Matti; Farrall, Martin; Hill, Adrian V. S.; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Maller, Julian B.; McVean, Gilean; Myers, Simon; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Palin, Kimmo; Stratton, Michael R.; Hurles, Matthew; Ouwehand, Willem; Kwiatkowski, Dominic P.; Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge, England; [Howson, Joanna M. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Howson, Joanna M. M.; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge, England; [Brown, Matthew A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Burton, Paul R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London, England; [Compston, Alastair] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Hall, Alistair S.] Univ Leeds, LIGHT, MCRC, Leeds, W Yorkshire, England; [Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Mathew, Christopher G.] Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Pembrey, Marcus] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Worthington, Jane] Univ Manchester, Arthritis Res UK Epidemiol Unit, Manchester, Lancs, England; [Craddock, Nick] Cardiff Univ, Sch Med, Ctr Neuropsychiat Genet & Genom, MRC, Cardiff, S Glam, Wales; [Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge, England; [Parkes, Miles] Addenbrookes Hosp, Inflammatory Bowel Dis Genet Res Grp, Cambridge, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Samani, Nilesh J.] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Gen Hosp, Leicester Natl Inst Hlth Res NIHR, Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Gough, Stephen C. L.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford, England; [Gough, Stephen C. L.; McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Nuffield Orthopaedic Centre; University of Oxford; University of Queensland; University of Leicester; University of Leicester; University of London; Queen Mary University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Leeds; University of Exeter; University of Plymouth; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of Edinburgh; University of London; Institute of Cancer Research - UK; University of Manchester; Cardiff University; University of Cambridge; NHS Blood & Transplant (NHSBT); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Oxford; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	donnelly@well.ox.ac.uk	Brown, Matthew A/E-5749-2010; Palin, Kimmo/ABG-5710-2020; Mathew, Christopher G/G-3434-2015; Todd, John A/A-3542-2010; Burton, Paul R/H-7527-2016; Hall, Alistair/K-1953-2019; Dominiczak, Anna F/P-9390-2017; eyre, stephen/K-3776-2017; Deloukas, Panos/B-2922-2013; Myers, Simon R/A-6792-2015; Worthington, Jane/M-9770-2014; Rahman, Nazneen/D-2802-2013; McCarthy, Mark/M-3763-2015	Brown, Matthew A/0000-0003-0538-8211; Palin, Kimmo/0000-0002-4621-6128; Mathew, Christopher G/0000-0003-4178-1838; Todd, John A/0000-0003-2740-8148; Dominiczak, Anna F/0000-0003-4913-3608; eyre, stephen/0000-0002-1251-6974; Deloukas, Panos/0000-0001-9251-070X; Myers, Simon R/0000-0002-2585-9626; Worthington, Jane/0000-0003-0544-042X; Howson, Joanna/0000-0001-7618-0050; Weedon, Michael/0000-0002-6174-6135; Hocking, Lynne J/0000-0002-2414-2826; Walker, Neil/0000-0001-9796-7688; Lindgren, Cecilia/0000-0002-4903-9374; Munroe, Patricia/0000-0002-4176-2947; Rahman, Nazneen/0000-0003-4376-0440; McCarthy, Mark/0000-0002-4393-0510; Caulfield, Mark/0000-0001-9295-3594; Vukcevic, Damjan/0000-0001-7780-9586; Mentzer, Alexander/0000-0002-4502-2209; bennett, amanda/0000-0003-2140-8710; Hall, Alistair/0000-0003-0306-7887; Massey, Dunecan/0000-0002-7144-4579; Harrison, Pille/0000-0003-4117-6910; Donnelly, Peter/0000-0001-9495-3408; Wain, Louise/0000-0003-4951-1867; McVean, Gil/0000-0002-5012-4162; Burren, Oliver/0000-0002-3388-5760; Kwiatkowski, Dominic/0000-0002-5023-0176; Lango Allen, Hana/0000-0002-7803-8688; Ouwehand, Willem/0000-0002-7744-1790; Pirinen, Matti/0000-0002-1664-1350; Maller, Julian/0000-0002-1565-9559; Parkes, Miles/0000-0002-6467-0631; Newman, William/0000-0002-6382-4678; Wallace, Chris/0000-0001-9755-1703; Hattersley, Andrew/0000-0001-5620-473X; Zeggini, Eleftheria/0000-0003-4238-659X	Wellcome Trust; UK Medical Research Council; Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory; NIHR Biomedical Research Centers; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0600329, G9521010, G19/9, G0600718B, G0800759, G0800675, G1100226, G0801418B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10219, NF-SI-0508-10335, NF-SI-0508-10275] Funding Source: researchfish; Chief Scientist Office [ETM/75, ETM/137, CZB/4/540] Funding Source: researchfish; MRC [G9521010, G1100226, G19/9, G0800759, G0800675, G0600329] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory; NIHR Biomedical Research Centers; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. Altshuler and colleagues at the Broad Institute for provision of SNP discovery information in some of our fine-mapping regions. We acknowledge the many physicians, research fellows and research nurses who contributed to the various case collections and the collection teams and senior management of the UK Blood Services responsible for the UK Blood Services Collection. The principal funder of the project was the Wellcome Trust. For the 1958 Birth Cohort, venous blood collection was funded by the UK Medical Research Council, and cell line production and DNA extraction and processing were funded by the Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory. Many of the authors of this paper received funding from the NIHR Biomedical Research Centers.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639	7	282	285	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1294	1301		10.1038/ng.2435	http://dx.doi.org/10.1038/ng.2435			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23104008	Green Accepted, Green Published			2022-12-25	WOS:000311713200005
J	Freyer, C; Cree, LM; Mourier, A; Stewart, JB; Koolmeister, C; Milenkovic, D; Wai, T; Floros, VI; Hagstrom, E; Chatzidaki, EE; Wiesner, RJ; Samuels, DC; Larsson, NG; Chinnery, PF				Freyer, Christoph; Cree, Lynsey M.; Mourier, Arnaud; Stewart, James B.; Koolmeister, Camilla; Milenkovic, Dusanka; Wai, Timothy; Floros, Vasileios I.; Hagstrom, Erik; Chatzidaki, Emmanouella E.; Wiesner, Rudolf J.; Samuels, David C.; Larsson, Nils-Goeran; Chinnery, Patrick F.			Variation in germline mtDNA heteroplasmy is determined prenatally but modified during subsequent transmission	NATURE GENETICS			English	Article							MITOCHONDRIAL-DNA HETEROPLASMY; PURIFYING SELECTION; MUTATION; SEGREGATION; REDUCTION; EVOLUTION; DRIFT; MICE	A genetic bottleneck explains the marked changes in mitochondria! DNA (mtDNA) heteroplasmy that are observed during the transmission of pathogenic mutations, but the precise timing of these changes remains controversial, and it is not clear whether selection has a role. These issues are important for the genetic counseling of prospective mothers and for the development of treatments aimed at disease prevention. By studying mice transmitting a heteroplasmic single-base-pair deletion in the mitochondrial tRNA(Met) gene, we show that the extent of mammalian mtDNA heteroplasmy is principally determined prenatally within the developing female germline. Although we saw no evidence of mtDNA selection prenatally, skewed heteroplasmy levels were observed in the offspring of the next generation, consistent with purifying selection. High percentages of mtDNA genomes with the tRNAMet mutation were linked to a compensatory increase in overall mitochondrial RNA levels, ameliorating the biochemical phenotype and explaining why fecundity is not compromised.	[Freyer, Christoph; Mourier, Arnaud; Stewart, James B.; Milenkovic, Dusanka; Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Cologne, Germany; [Freyer, Christoph; Koolmeister, Camilla; Hagstrom, Erik; Chatzidaki, Emmanouella E.; Larsson, Nils-Goeran] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Cree, Lynsey M.; Floros, Vasileios I.; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wai, Timothy] Univ Cologne, Dept Genet, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, Ctr Physiol, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Samuels, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA	Max Planck Society; Karolinska Institutet; Newcastle University - UK; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Vanderbilt University	Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.	larsson@age.mpg.de; patrick.chinnery@ncl.ac.uk	Stewart, James B/C-9633-2011; Samuels, David/C-1365-2012; Samuels, David/AHC-8381-2022; Samuels, David C/A-5393-2008; Wai, Timothy/AAA-7226-2019; MOURIER, Arnaud/F-9657-2019; koolmeister, camilla/AHB-4630-2022; MOURIER, Arnaud/I-8117-2012	Stewart, James B/0000-0002-2902-4968; Samuels, David/0000-0003-3529-7791; Samuels, David C/0000-0003-3529-7791; MOURIER, Arnaud/0000-0002-5413-611X; MOURIER, Arnaud/0000-0002-5413-611X; Larsson, Nils-Goran/0000-0001-5100-996X; Freyer, Christoph/0000-0003-0418-1673; Wai, Timothy/0000-0002-6770-6222; Cree, Lynsey/0000-0003-2090-1589; Chinnery, Patrick/0000-0002-7065-6617	long-term Human Frontier Science Program (HFSP) fellowship; Wellcome Centre for Mitochondrial Research; Medical Research Council (UK) Translational Muscle Centre; UK NIHR Biomedical Research Centre for Ageing and Age-Related Disease; NIHR Dementia Biomedical Research Unit; Swedish Research Council; Leducq foundation; European Research Council; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish	long-term Human Frontier Science Program (HFSP) fellowship; Wellcome Centre for Mitochondrial Research; Medical Research Council (UK) Translational Muscle Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR Biomedical Research Centre for Ageing and Age-Related Disease(National Institute for Health Research (NIHR)); NIHR Dementia Biomedical Research Unit; Swedish Research Council(Swedish Research CouncilEuropean Commission); Leducq foundation(Leducq Foundation); European Research Council(European Research Council (ERC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank C. Gottlinger and G. Rappl for help with the fluorescence-activated cell sorting (FACS) analysis. T.W. is supported by a long-term Human Frontier Science Program (HFSP) fellowship. P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science and a National Institute for Health Research (NIHR) Senior Investigator, who also receives funding from the Wellcome Centre for Mitochondrial Research, the Medical Research Council (UK) Translational Muscle Centre, the UK NIHR Biomedical Research Centre for Ageing and Age-Related Disease and NIHR Dementia Biomedical Research Unit awards to the Newcastle upon Tyne Foundation Hospitals National Health Service (NHS) Trust. N.-G.L. is supported by the Swedish Research Council, the Leducq foundation and a European Research Council Advanced Investigator grant.	BOULET L, 1992, AM J HUM GENET, V51, P1187; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Manfredi G, 1996, HUM MUTAT, V7, P158; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Samuels DC, 2010, NAT GENET, V42, P471, DOI 10.1038/ng0610-471; Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007; Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023	21	98	100	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1282	1285		10.1038/ng.2427	http://dx.doi.org/10.1038/ng.2427			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23042113	Green Accepted			2022-12-25	WOS:000310495800024
J	Riazuddin, S; Belyantseva, IA; Giese, APJ; Lee, K; Indzhykulian, AA; Nandamuri, P; Yousaf, R; Sinha, GP; Lee, S; Terrell, D; Hegde, RS; Ali, RA; Anwar, S; Andrade-Elizondo, PB; Sirmaci, A; Parise, LV; Basit, S; Wali, A; Ayub, M; Ansar, M; Ahmad, W; Khan, SN; Akram, J; Tekin, M; Riazuddin, S; Cook, T; Buschbeck, EK; Frolenkov, GI; Leal, SM; Friedman, TB; Ahmed, ZM				Riazuddin, Saima; Belyantseva, Inna A.; Giese, Arnaud P. J.; Lee, Kwanghyuk; Indzhykulian, Artur A.; Nandamuri, Pratima; Yousaf, Rizwan; Sinha, Ghanshyam P.; Lee, Sue; Terrell, David; Hegde, Rashmi S.; Ali, Rana A.; Anwar, Saima; Andrade-Elizondo, Paula B.; Sirmaci, Asli; Parise, Leslie V.; Basit, Sulman; Wali, Abdul; Ayub, Muhammad; Ansar, Muhammad; Ahmad, Wasim; Khan, Shaheen N.; Akram, Javed; Tekin, Mustafa; Riazuddin, Sheikh; Cook, Tiffany; Buschbeck, Elke K.; Frolenkov, Gregory I.; Leal, Suzanne M.; Friedman, Thomas B.; Ahmed, Zubair M.			Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48	NATURE GENETICS			English	Article							OUTER HAIR-CELLS; CA2+ RELEASE; BIOCHEMICAL-CHARACTERIZATION; BUFFERING PROTEINS; LOCALIZATION; ADAPTATION; TRANSDUCTION; CALMODULIN; EXPRESSION; CHANNELS	Sensorineural hearing loss is genetically heterogeneous. Here, we report that mutations in CIB2, which encodes a calcium- and integrin-binding protein, are associated with nonsyndromic deafness (DFNB48) and Usher syndrome type 11 (USH1J). One mutation in CIB2 is a prevalent cause of deafness DFNB48 in Pakistan; other CIB2 mutations contribute to deafness elsewhere in the world. In mice, CIB2 is localized to the mechanosensory stereocilia of inner ear hair cells and to retinal photoreceptor and pigmented epithelium cells. Consistent with molecular modeling predictions of calcium binding, CIB2 significantly decreased the ATP-induced calcium responses in heterologous cells, whereas mutations in deafness DFNB48 altered CIB2 effects on calcium responses. Furthermore, in zebrafish and Drosophila melanogaster, CIB2 is essential for the function and proper development of hair cells and retinal photoreceptor cells. We also show that CIB2 is a new member of the vertebrate Usher interactome.	[Riazuddin, Saima; Giese, Arnaud P. J.; Yousaf, Rizwan; Ahmed, Zubair M.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati, OH USA; [Riazuddin, Saima; Giese, Arnaud P. J.; Terrell, David; Cook, Tiffany; Ahmed, Zubair M.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Cincinnati, OH USA; [Riazuddin, Saima; Ahmed, Zubair M.] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH USA; [Riazuddin, Saima; Cook, Tiffany; Ahmed, Zubair M.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH USA; [Belyantseva, Inna A.; Lee, Sue; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, Rockville, MD USA; [Lee, Kwanghyuk; Andrade-Elizondo, Paula B.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Indzhykulian, Artur A.; Sinha, Ghanshyam P.; Frolenkov, Gregory I.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Nandamuri, Pratima; Buschbeck, Elke K.] Univ Cincinnati, Dept Biol Sci, McMicken Coll Arts & Sci, Cincinnati, OH 45221 USA; [Yousaf, Rizwan; Ali, Rana A.; Anwar, Saima; Khan, Shaheen N.] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; [Hegde, Rashmi S.; Cook, Tiffany] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Sirmaci, Asli; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Parise, Leslie V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Basit, Sulman; Ansar, Muhammad; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan; [Wali, Abdul] Baluchistan Univ Informat Technol, Inst Biotechnol, Quetta, Pakistan; [Ayub, Muhammad] Univ Baluchistan, Inst Biochem, Quetta, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Allama Iqbal Med Coll, Lahore, Pakistan; [Riazuddin, Sheikh] Univ Lahore, Lahore, Pakistan; [Ahmed, Zubair M.] Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Baylor College of Medicine; University of Kentucky; University System of Ohio; University of Cincinnati; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Cincinnati Children's Hospital Medical Center; University of Miami; University of North Carolina; University of North Carolina Chapel Hill; Quaid I Azam University; University of Balochistan; University of Lahore; Bahauddin Zakariya University	Ahmed, ZM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati, OH USA.	zubair.ahmed@cchmc.org	Basit, Sulman/Q-7939-2018; Ansar, Muhammad/H-5967-2011; Ahmad, Wasim/GSD-8904-2022; Basit, Sulman/F-6395-2015; Giese, Arnaud P.J./P-1683-2019; Yousaf, Rizwan/AAJ-8437-2020; Indzhykulian, Artur/L-9222-2018; Ansar, Muhammad/F-4808-2015; Ahmad, Wasim/E-9713-2015; Wali, Abdul/AEP-0680-2022; Wali, Abdul/GVS-1840-2022; Tekin, Mustafa/ABG-7627-2020; Nasim Khan, Shaheen/F-2135-2015; Anwar, Saima/C-7477-2016; Basit, Sulman/AAY-9763-2021; Basit, Sulman/B-2947-2013	Basit, Sulman/0000-0003-4294-6825; Ansar, Muhammad/0000-0001-5891-7063; Indzhykulian, Artur/0000-0002-2076-6818; Wali, Abdul/0000-0001-8818-5369; Basit, Sulman/0000-0003-4294-6825; Sinha, Ghanshyam/0000-0003-3190-2878; Frolenkov, Gregory/0000-0002-9810-5024; Tekin, Mustafa/0000-0002-3525-7960; Cook, Tiffany/0000-0002-3100-5248; Lee, Kwanghyuk/0000-0003-1389-1220; Lee, Kwanghyuk/0000-0001-7781-9696; Yousaf, Rizwan/0000-0003-2323-0004; Giese, Arnaud/0000-0001-7228-9542	US National Institutes of Health (NIH) [N01-HG-65403]; Research to Prevent Blindness; Higher Education Commission (Islamabad, Pakistan); Ministry of Science and Technology (Islamabad, Pakistan); International Center for Genetic Engineering and Biotechnology (Trieste, Italy) [08/009]; Cincinnati Children's Hospital Research Foundation (CCHMC); National Science Foundation [IOS-1050754]; US National Institute on Deafness and Other Communication Disorders (NIDCD/NIH) [R01 DC03594, DC011651, R01 HL092544, R01 DC009645, R01 DC008861, R01 DC012564, R00 DC009287, R01 DC011803, R01 DC011748]; NIDCD [DC000039-15]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Higher Education Commission (Islamabad, Pakistan)(Higher Education Commission of Pakistan); Ministry of Science and Technology (Islamabad, Pakistan); International Center for Genetic Engineering and Biotechnology (Trieste, Italy); Cincinnati Children's Hospital Research Foundation (CCHMC); National Science Foundation(National Science Foundation (NSF)); US National Institute on Deafness and Other Communication Disorders (NIDCD/NIH); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the families for their participation and cooperation. We also thank G.N. Sarangdhar, R. Rachel, T. Jaworek, V. Ponferrada and K. Gul for technical assistance and R.J. Morell, J. Schultz, D. Drayna, A. Swaroop and A.J. Griffith for critique of the manuscript. We thank T.M. Leisner (University of North Carolina at Chapel Hill) for the generous gift of antibodies to CIB. Genotyping services were provided to S.M.L. by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract (N01-HG-65403) from the US National Institutes of Health (NIH) to Johns Hopkins University. Z.M.A. is a recipient of a Research to Prevent Blindness Career Development Award. This work was also supported by funding from the Higher Education Commission and the Ministry of Science and Technology (Islamabad, Pakistan) to Sheikh Riazuddin and W.A., the International Center for Genetic Engineering and Biotechnology (Trieste, Italy) under project CRP/PAK08-01 contract 08/009 to Sheikh Riazuddin, the Cincinnati Children's Hospital Research Foundation (CCHMC) Intramural Research Funds to Saima Riazuddin and Z.M.A., a National Science Foundation grant (IOS-1050754) to E.K.B., US National Institute on Deafness and Other Communication Disorders (NIDCD/NIH) research grants R01 DC03594 and DC011651 to S.M.L., R01 HL092544 to L.V.P., R01 DC009645 to M.T., R01 DC008861 to G.I.F., R01 DC012564 and R00 DC009287 to Z.M.A., and R01 DC011803 and R01 DC011748 to Saima Riazuddin, and intramural funds from the NIDCD (DC000039-15) to T.B.F.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmad J, 2005, HUM GENET, V116, P407, DOI 10.1007/s00439-004-1247-y; Ahmed ZM, 2009, CLIN GENET, V75, P86, DOI 10.1111/j.1399-0004.2008.01038.x; Baird RA, 1997, HEARING RES, V103, P85, DOI 10.1016/S0378-5955(96)00167-0; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Benser ME, 1996, J NEUROSCI, V16, P5629; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; Blazejczyk M, 2009, ARCH BIOCHEM BIOPHYS, V487, P66, DOI 10.1016/j.abb.2009.05.002; Brandt A, 2003, J NEUROSCI, V23, P10832; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Dallos P, 1997, J NEUROSCI, V17, P2212; DECHESNE CJ, 1991, BRAIN RES, V560, P139, DOI 10.1016/0006-8993(91)91224-O; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DULON D, 1990, J NEUROSCI, V10, P1388; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Frolenkov GI, 2000, J NEUROSCI, V20, P5940, DOI 10.1523/JNEUROSCI.20-16-05940.2000; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hackney CM, 2003, J NEUROSCI, V23, P4577; Hager M, 2008, J BIOL CHEM, V283, P24760, DOI 10.1074/jbc.M801166200; Hennings JK, 2008, J NEUROCHEM, V106, P2249, DOI 10.1111/j.1471-4159.2008.05563.x; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Huang H, 2011, J BIOL CHEM, V286, P17181, DOI 10.1074/jbc.M110.179028; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; Jones SM, 2002, J NEUROSCI METH, V118, P23, DOI 10.1016/S0165-0270(02)00125-5; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Mammano F, 1999, J NEUROSCI, V19, P6918, DOI 10.1523/JNEUROSCI.19-16-06918.1999; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; O'Tousa JE, 2002, ADV EXP MED BIOL, V514, P493; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Sakaguchi N, 1998, J HISTOCHEM CYTOCHEM, V46, P29, DOI 10.1177/002215549804600105; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Silverstein RS, 2006, NEUROSCIENCE, V141, P245, DOI 10.1016/j.neuroscience.2006.03.036; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Wood JD, 2004, JARO-J ASSOC RES OTO, V5, P99, DOI 10.1007/s10162-003-4022-1; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yang D, 2004, J NEUROBIOL, V58, P479, DOI 10.1002/neu.10289	52	169	178	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1265	1271		10.1038/ng.2426	http://dx.doi.org/10.1038/ng.2426			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23023331	Green Accepted			2022-12-25	WOS:000310495800021
J	Diskin, SJ; Capasso, M; Schnepp, RW; Cole, KA; Attiyeh, EF; Hou, CP; Diamond, M; Carpenter, EL; Winter, C; Lee, H; Jagannathan, J; Latorre, V; Iolascon, A; Hakonarson, H; Devoto, M; Maris, JM				Diskin, Sharon J.; Capasso, Mario; Schnepp, Robert W.; Cole, Kristina A.; Attiyeh, Edward F.; Hou, Cuiping; Diamond, Maura; Carpenter, Erica L.; Winter, Cynthia; Lee, Hanna; Jagannathan, Jayanti; Latorre, Valeria; Iolascon, Achille; Hakonarson, Hakon; Devoto, Marcella; Maris, John M.			Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE AMPLIFICATION; TUMOR; EXPRESSION; METHYLATION; IMPUTATION; MUTATIONS; VARIANTS; LIGASE; LOCUS	Neuroblastoma is a cancer of the sympathetic nervous system that accounts for approximately 10% of all pediatric oncology deaths(1). Here, we report a genome-wide association study of 2,817 neuroblastoma cases and 7,473 controls. We identified two new associations at 6q16, the first within HACE1 (rs4336470; combined P = 2.7 x 10(-11); odds ratio 1.26, 95% confidence interval (CI) 1.18-1.35) and the second within LIN28B (rs17065417; combined P = 1.2 x 10(-8); odds ratio 1.38, 95% CI 1.23-1.54). Expression of LIN28B and let-7 miRNA correlated with rs17065417 genotype in neuroblastoma cell lines, and we observed significant growth inhibition upon depletion of LIN28B, specifically in neuroblastoma cells that were homozygous for the risk allele. Low HACE1 and high LIN28B expression in diagnostic primary neuroblastomas were associated with worse overall survival (P = 0.008 and 0.014, respectively). Taken together, these data show that common variants in HACE1 and LIN28B influence neuroblastoma susceptibility and indicate that both genes likely have a role in disease progression.	[Diskin, Sharon J.; Schnepp, Robert W.; Cole, Kristina A.; Attiyeh, Edward F.; Diamond, Maura; Carpenter, Erica L.; Winter, Cynthia; Lee, Hanna; Jagannathan, Jayanti; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Schnepp, Robert W.; Cole, Kristina A.; Attiyeh, Edward F.; Diamond, Maura; Carpenter, Erica L.; Winter, Cynthia; Lee, Hanna; Jagannathan, Jayanti; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Cole, Kristina A.; Attiyeh, Edward F.; Hakonarson, Hakon; Devoto, Marcella; Maris, John M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Capasso, Mario; Iolascon, Achille] Univ Naples Federico II, Dipartimento Biochimicae Biotecnol Med, Naples, Italy; [Capasso, Mario; Iolascon, Achille] Ceinge Biotecnol Avanzate, Naples, Italy; [Hou, Cuiping; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Latorre, Valeria; Hakonarson, Hakon; Devoto, Marcella] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Latorre, Valeria] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; [Devoto, Marcella] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Devoto, Marcella] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Maris, John M.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Calabria; Sapienza University Rome; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Maris, JM (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA.	maris@chop.edu	Iolascon, Achille/A-4461-2014; Capasso, Mario/D-1617-2014; Cole, Kristina/M-3922-2015; Devoto, Marcella/AAP-7595-2021	Capasso, Mario/0000-0003-3306-1259; DEVOTO, MARCELLA/0000-0002-4431-5114; iolascon, achille/0000-0002-9558-0356	US National Institutes of Health (NIH) [R01-CA124709, K99-CA151869, P30-HD026979, K08-CA136979]; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Andrew's Army Foundation; PressOn Foundation; Abramson Family Cancer Research Institute; Fondazione Italiana per la Lotta al Neuroblastoma and Associazione Italiana per la Ricerca sul Cancro; Center for Applied Genomics at the Children's Hospital of Philadelphia Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA124709, R00CA151869, K99CA151869, K08CA136979] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Andrew's Army Foundation; PressOn Foundation; Abramson Family Cancer Research Institute; Fondazione Italiana per la Lotta al Neuroblastoma and Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Center for Applied Genomics at the Children's Hospital of Philadelphia Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Sleiman for useful discussions regarding meta-analysis using METAL. This work was supported in part by US National Institutes of Health (NIH) grants R01-CA124709 (J.M.M.), K99-CA151869 (S.J.D.), P30-HD026979 (M. Devoto) and K08-CA136979 (K.A.C.); the Giulio D'Angio Endowed Chair (J.M.M.); the Alex's Lemonade Stand Foundation (J.M.M.); Andrew's Army Foundation (J.M.M.); the PressOn Foundation (J.M.M.); the Abramson Family Cancer Research Institute (J.M.M.); Fondazione Italiana per la Lotta al Neuroblastoma and Associazione Italiana per la Ricerca sul Cancro (M.C.); and the Center for Applied Genomics at the Children's Hospital of Philadelphia Research Institute (H.H.).	Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Henderson TO, 2011, J CLIN ONCOL, V29, P76, DOI 10.1200/JCO.2010.29.6103; Hibi K, 2008, ANTICANCER RES, V28, P1581; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Latorre V, 2012, CANCER EPIDEM BIOMAR, V21, P658, DOI 10.1158/1055-9965.EPI-11-0830; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Sakata M, 2009, ANTICANCER RES, V29, P2231; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Slade I, 2010, J MED GENET, V47, P342, DOI 10.1136/jmg.2009.072983; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621; Zhao JH, 2009, J CELL BIOCHEM, V107, P482, DOI 10.1002/jcb.22146; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	48	187	191	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1126	+		10.1038/ng.2387	http://dx.doi.org/10.1038/ng.2387			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22941191	Green Accepted			2022-12-25	WOS:000309550200013
J	Jaremko, M; Jaremko, L; Kim, HY; Cho, MK; Schwieters, CD; Giller, K; Becker, S; Zweckstetter, M				Jaremko, Mariusz; Jaremko, Lukasz; Kim, Hai-Young; Cho, Min-Kyu; Schwieters, Charles D.; Giller, Karin; Becker, Stefan; Zweckstetter, Markus			Cold denaturation of a protein dimer monitored at atomic resolution	NATURE CHEMICAL BIOLOGY			English	Article							FOLDING INTERMEDIATE; RELAXATION; PATHWAY; STATE; MECHANISM; RESIDUES; DYNAMICS; MONOMER; MODEL; FORM	Protein folding and unfolding are crucial for a range of biological phenomena and human diseases. Defining the structural properties of the involved transient species is therefore of prime interest. Using a combination of cold denaturation with NMR spectroscopy, we reveal detailed insight into the unfolding of the homodimeric repressor protein CylR2. Seven three-dimensional structures of CylR2 at temperatures from 25 degrees C to 16 degrees C reveal a progressive dissociation of the dimeric protein into a native-like monomeric intermediate followed by transition into a highly dynamic, partially folded state. The core of the partially folded state seems critical for biological function and misfolding.	[Jaremko, Mariusz; Jaremko, Lukasz; Kim, Hai-Young; Cho, Min-Kyu; Giller, Karin; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Jaremko, Mariusz] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Jaremko, Lukasz] Warsaw Univ, Fac Chem, Warsaw, Poland; [Schwieters, Charles D.] US Natl Inst Hlth, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD USA; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Gottingen, Germany	Max Planck Society; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Zweckstetter, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany.	Markus.Zweckstetter@dzne.de	Cho, Min-Kyu/H-1303-2011; Jaremko, Lukasz/GQB-5017-2022; Jaremko, Lukasz/A-3101-2009	Cho, Min-Kyu/0000-0003-0537-2340; Jaremko, Lukasz/0000-0001-7684-9359; Jaremko, Mariusz/0000-0002-0787-702X; Zweckstetter, Markus/0000-0002-2536-6581	START; Ventures Programmes of Foundation for Polish Science (Fundacja narzecz Nauki Polskiej); Polish Ministry of Sciences and Higher Education; Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center; Center for Information Technology at the US National Institutes of Health; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER	START(Austrian Science Fund (FWF)); Ventures Programmes of Foundation for Polish Science (Fundacja narzecz Nauki Polskiej); Polish Ministry of Sciences and Higher Education(Ministry of Science and Higher Education, Poland); Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center; Center for Information Technology at the US National Institutes of Health; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))	We thank N. Rezaei-Ghaleh for useful discussions. This work was supported by the START and Ventures Programmes of Foundation for Polish Science (Fundacja narzecz Nauki Polskiej; http://www.frip.org.pl/)operated within the Innovative Economy Operational Programme (IE OP) 2007-2013 within European Regional Development Fund (L.J. and M.J.), the Iuventus Plus project no. IP2011 019471 from Polish Ministry of Sciences and Higher Education (M.J.) and the Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain" (to M.Z.). C.D.S. was supported by the Intramural Research Program of the Center for Information Technology at the US National Institutes of Health.	Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739; Balbach J, 1996, SCIENCE, V274, P1161, DOI 10.1126/science.274.5290.1161; Bernstein R, 2011, P NATL ACAD SCI USA, V108, P10532, DOI 10.1073/pnas.1103629108; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Campbell JC, 2012, PROTEINS, V80, P184, DOI 10.1002/prot.23178; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; Davidovic M, 2009, J AM CHEM SOC, V131, P1025, DOI 10.1021/ja8056419; Ecroyd H, 2010, BIOCHEM J, V429, P251, DOI 10.1042/BJ20091949; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Feng HQ, 2003, BIOCHEMISTRY-US, V42, P12461, DOI 10.1021/bi035561s; Feng HQ, 2005, P NATL ACAD SCI USA, V102, P5026, DOI 10.1073/pnas.0501372102; FERSHT A, 1992, TRENDS BIOCHEM SCI, V17, P292, DOI 10.1016/0968-0004(92)90438-F; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Kato H, 2007, J MOL BIOL, V365, P870, DOI 10.1016/j.jmb.2006.10.047; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kiefhaber T, 1995, Methods Mol Biol, V40, P313; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Lassalle MW, 2003, PROTEIN SCI, V12, P66, DOI 10.1110/ps.0221303; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Ramboarina S, 2008, J AM CHEM SOC, V130, P15318, DOI 10.1021/ja802967k; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Skalicky JJ, 2000, J AM CHEM SOC, V122, P3230, DOI 10.1021/ja9938884; Szyperski Thomas, 2011, Journal of Structural and Functional Genomics, V12, P1, DOI 10.1007/s10969-011-9111-5; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Whittaker SBM, 2007, J MOL BIOL, V366, P1001, DOI 10.1016/j.jmb.2006.11.012; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Zhou Z, 2008, J MOL BIOL, V384, P531, DOI 10.1016/j.jmb.2008.09.044	47	27	27	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					264	270		10.1038/NCHEMBIO.1181	http://dx.doi.org/10.1038/NCHEMBIO.1181			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23396077	Green Published, Green Accepted			2022-12-25	WOS:000317025800017
J	Zheng, ZY; Guo, YX; Novak, O; Dai, XH; Zhao, YD; Ljung, K; Noel, JP; Chory, J				Zheng, Zuyu; Guo, Yongxia; Novak, Ondrej; Dai, Xinhua; Zhao, Yunde; Ljung, Karin; Noel, Joseph P.; Chory, Joanne			Coordination of auxin and ethylene biosynthesis by the aminotransferase VAS1	NATURE CHEMICAL BIOLOGY			English	Article							ARABIDOPSIS; PATHWAY; TRYPTOPHAN; METHIONINE; EXPRESSION; RESPONSES; PROTEINS; GENE	We identify an Arabidopsis pyridoxal-phosphate-dependent aminotransferase, VAS1, whose loss-of-function simultaneously increases amounts of the phytohormone auxin and the ethylene precursor 1-aminocyclopropane-1-carboxylate. VAS1 uses the ethylene biosynthetic intermediate methionine as an amino donor and the auxin biosynthetic intermediate indole-3-pyruvic acid as an amino acceptor to produce L-tryptophan and 2-oxo-4-methylthiobutyric acid. Our data indicate that VAS1 serves key roles in coordinating the amounts of these two vital hormones.	[Zheng, Zuyu; Noel, Joseph P.; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Zheng, Zuyu; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Guo, Yongxia; Noel, Joseph P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Novak, Ondrej; Ljung, Karin] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Novak, Ondrej] Palacky Univ, Fac Sci, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Novak, Ondrej] Acad Sci Czech Republ, Inst Expt Bot, Olomouc, Czech Republic; [Dai, Xinhua; Zhao, Yunde] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; Swedish University of Agricultural Sciences; Umea University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of California System; University of California San Diego	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	noel@salk.edu; chory@salk.edu	Noel, Joseph P/A-9459-2009; Zhao, Yunde/AAC-5360-2019; Ljung, Karin/AAE-8691-2019; NOVAK, Ondrej/F-7031-2014; Zheng, Zuyu/I-1134-2013	Ljung, Karin/0000-0003-2901-189X; NOVAK, Ondrej/0000-0003-3452-0154; 	US National Institutes of Health (NIH) [5R01GM52413]; Internal Grant Agency of Palacky University [PrF_2012_016]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN200380801]; NIH [R01GM6863I]; National Science Foundation [EEC-0813570, MCB-0645794]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068631, R01GM052413] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Internal Grant Agency of Palacky University; Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Chen for technical assistance and the Arabidopsis Biological Resource Center for mutant seeds. These studies were supported by US National Institutes of Health (NIH) grant 5R01GM52413 to J.C., the Internal Grant Agency of Palacky University (PrF_2012_016) and the Grant Agency of the Academy of Sciences of the Czech Republic (KAN200380801) to (IN., the Swedish Governmental Agency for Innovation Systems and the Swedish Research Council (K.L.), NIH grant R01GM6863I to Y.Z., the National Science Foundation under award nos. EEC-0813570 and MCB-0645794 to J.P.N. and the Howard Hughes Medical Institute (Z.Z., J.P.N., J.C.).	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; BAUR AH, 1972, PHYTOCHEMISTRY, V11, P3207, DOI 10.1016/S0031-9422(00)86375-X; Burstenbinder K, 2007, PLANT J, V49, P238, DOI 10.1111/j.1365-313X.2006.02942.x; Chowdhury G, 2009, CHEM RES TOXICOL, V22, P1905, DOI 10.1021/tx9000418; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Liepman AH, 2004, CRIT REV PLANT SCI, V23, P73, DOI 10.1080/07352680490273419; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Pierik R, 2009, PLANT PHYSIOL, V149, P1701, DOI 10.1104/pp.108.133496; Poeggeler B, 1999, BRAIN RES, V815, P382, DOI 10.1016/S0006-8993(98)01027-0; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Yamada M, 2009, PLANT PHYSIOL, V151, P168, DOI 10.1104/pp.109.138859; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104	21	75	78	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					244	246		10.1038/NCHEMBIO.1178	http://dx.doi.org/10.1038/NCHEMBIO.1178			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23377040	Green Accepted			2022-12-25	WOS:000317025800013
J	Berry, R; Rodeheffer, MS				Berry, Ryan; Rodeheffer, Matthew S.			Characterization of the adipocyte cellular lineage in vivo	NATURE CELL BIOLOGY			English	Article							ADIPOSE-TISSUE; PROGENITOR CELLS; STEM-CELLS; WHITE; PREADIPOCYTES; MACROPHAGE; EXPRESSION; CRE; DIFFERENTIATION; IDENTIFICATION	Mature adipocytes are generated through the proliferation and differentiation of precursor cells. Our previous studies identified adipocyte progenitors in white adipose tissue (WAT) as Lin(-) :CD29(+) :CD34(+) :Sca-1(+) :CD24(+) (CD24(+)) cells that are capable of generating functional WAT (ref. 1). Here, we employ several Cre recombinase mouse models to identify the adipocyte cellular lineage in vivo. Although it has been proposed that white adipocytes are derived from endothelial(2) and haematopoietic(3,4) lineages, we find that neither of these lineages label white adipocytes. However, platelet-derived growth factor receptor alpha (PdgfR alpha)-Cre trace labels all white adipocytes. Analysis of WAT from PdgfR alpha-Cre reporter mice identifies CD24(+) and Lin(-) :CD29(+) :CD34(+) CD24(-)(CD24(-)) cells as adipocyte precursors. We show that CD24(+) cells generate the CD24(-) population in vivo and the CD24(-) cells express late markers of adipogenesis. From these data we propose a model where the CD24(+) adipocyte progenitors become further committed to the adipocyte lineage as CD24 expression is lost, generating CD24(-) preadipocytes. This characterization of the adipocyte cellular lineage will facilitate the study of the mechanisms that regulate WAT formation in vivo and WAT mass expansion in obesity.	[Berry, Ryan; Rodeheffer, Matthew S.] Yale Univ, Sch Med, Dept Mol Cell & Dev Biol, New Haven, CT 06520 USA; [Rodeheffer, Matthew S.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Rodeheffer, Matthew S.] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Rodeheffer, MS (corresponding author), Yale Univ, Sch Med, Dept Mol Cell & Dev Biol, 375 Congress Ave, New Haven, CT 06520 USA.	matthew.rodeheffer@yale.edu			American Diabetes Association [7-12-JF-46]; DERC [DK045735]; NIDDK [DK090489, DK041096]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090489, P30DK045735, R56DK090489, R01DK041096] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); DERC; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Jeffery, C. Church, D. Krause and V. Horsley for critical reading of the manuscript and valuable discussions. This work was supported by American Diabetes Association Award 7-12-JF-46, DERC pilot project grant DK045735 and NIDDK grant DK090489 to M.S.R. and NIDDK grant DK041096 to J. M. Friedman.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; BACHMEIER M, 1995, EUR J CELL BIOL, V68, P323; Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fitter S, 2012, J MOL ENDOCRINOL, V48, P229, DOI 10.1530/JME-12-0003; Godina G., 1939, NOTA I ARCH ITAL ANA, V42, P455; HARRIS RBS, 1990, FASEB J, V4, P3310, DOI 10.1096/fasebj.4.15.2253845; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Latta S. S. a. D. I. R., 1935, AM J ANAT, V56, P481; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; McCollough A. W, 1944, J MORPHOL, V75, P193; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; PILLAI PS, 1986, J IMMUNOL, V137, P791; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Sera Y, 2009, EXP HEMATOL, V37, P1108, DOI 10.1016/j.exphem.2009.06.008; Simon G., 1965, ADIPOSE TISSUE HDB P, V5, P101; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; WASSERMANN F, 1926, Z ZELLFORSCH MIKROSK, V3, P325; White P. a. M. A., 2008, INFLAMMATION INDUCED; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	33	355	361	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2013	15	3					302	308		10.1038/ncb2696	http://dx.doi.org/10.1038/ncb2696			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	102LA	23434825	Green Accepted			2022-12-25	WOS:000315844900011
J	Bommert, P; Nagasawa, NS; Jackson, D				Bommert, Peter; Nagasawa, Namiko Satoh; Jackson, David			Quantitative variation in maize kernel row number is controlled by the FASCIATED EAR2 locus	NATURE GENETICS			English	Article							SHOOT APICAL MERISTEM; RECEPTOR-LIKE KINASE; STEM-CELL SPECIFICATION; ARABIDOPSIS SHOOT; NATURAL VARIATION; GENE ENCODES; RICE; POPULATION; CLV3; PROTEIN	Domestication of cereal crops, such as maize, wheat and rice, had a profound influence on agriculture and the establishment of human civilizations. One major improvement was an increase in seed number per inflorescence, which enhanced yield and simplified harvesting and storage(1,2). The ancestor of maize, teosinte, makes 2 rows of kernels, and modern varieties make similar to 8-20 rows(3). Kernel rows are initiated by the inflorescence shoot meristem, and shoot meristem size is controlled by a feedback loop involving the CLAVATA signaling proteins and the WUSCHEL transcription factor(4,5). We present a hypothesis that variation in inflorescence meristem size affects kernel row number (KRN), with the potential to increase yield. We also show that variation in the CLAVATA receptor-like protein FASCIATED EAR2 leads to increased inflorescence meristem size and KRN. These findings indicate that modulation of fundamental stem cell proliferation control pathways has the potential to enhance crop yields.	[Bommert, Peter; Nagasawa, Namiko Satoh; Jackson, David] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jackson, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu			US Department of Agriculture (USDA) [NRICGP 2003-35304-13277]; National Science Foundation (NSF) Plant Genome Program [DBI-0604923]; German Science Society (DFG) [Bo 3012/1-1]; Direct For Biological Sciences [1238202] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [24780004] Funding Source: KAKEN	US Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); National Science Foundation (NSF) Plant Genome Program(National Science Foundation (NSF)); German Science Society (DFG); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We wish to thank C. Weil and the Maize TILLING facility for the isolation of the fea2 TILLING alleles, F. Taguchi Shiobara for SEM images, U. Au, L.A. Haller and K. Lau for KRN counting, P. Yin and K. Chen for assistance with genotyping, M. Bohn and S. Goldshmidt for assistance with statistical analysis, members of the Jackson laboratory for comments on the manuscript, T. Rocheford for growing IBM recombinant inbred lines, M. Komatsu, L. Heetland, K. Simcox and H. Sakai (DuPont- Pioneer) for grow-outs of TILLING populations and yield trait measurements, P. Brown and E. Buckler for discussions and A. Eveland for informatics. Funding from the US Department of Agriculture (USDA; grant NRICGP 2003-35304-13277), the National Science Foundation (NSF) Plant Genome Program (grant DBI-0604923) and the German Science Society (DFG) for a postdoctoral fellowship (grant Bo 3012/1-1) to P.B. is gratefully acknowledged.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Betsuyaku S, 2011, PLANT CELL PHYSIOL, V52, P14, DOI 10.1093/pcp/pcq157; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bommert P, 2005, PLANT CELL PHYSIOL, V46, P69, DOI 10.1093/pcp/pci504; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Evans LT., 1993, CROP EVOLUTION ADAPT; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gregory PJ, 2011, J EXP BOT, V62, P5233, DOI 10.1093/jxb/err232; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Ha CM, 2010, CURR TOP DEV BIOL, V91, P103, DOI 10.1016/S0070-2153(10)91004-1; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lu M, 2011, MOL BREEDING, V28, P143, DOI 10.1007/s11032-010-9468-3; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Muller R, 2006, PLANT CELL, V18, P1188, DOI 10.1105/tpc.105.040444; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nimchuk ZL, 2011, PLANT CELL, V23, P851, DOI 10.1105/tpc.110.075622; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Shepard KA, 2003, GENETICS, V163, P1083; Suzaki T, 2004, DEVELOPMENT, V131, P5649, DOI 10.1242/dev.01441; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; VELDBOOM LR, 1994, THEOR APPL GENET, V88, P7, DOI 10.1007/BF00222387; Wang S., 2011, WINDOWS QTL CARTOGRA; Weil CF, 2009, PLANT PHYSIOL, V149, P158, DOI 10.1104/pp.108.128785	47	152	168	5	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					334	337		10.1038/ng.2534	http://dx.doi.org/10.1038/ng.2534			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23377180				2022-12-25	WOS:000315664800022
J	Jiang, WY; Bikard, D; Cox, D; Zhang, F; Marraffini, LA				Jiang, Wenyan; Bikard, David; Cox, David; Zhang, Feng; Marraffini, Luciano A.			RNA-guided editing of bacterial genomes using CRISPR-Cas systems	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; IMMUNE-SYSTEM; STREPTOCOCCUS-THERMOPHILUS; SEED SEQUENCE; DNA CLEAVAGE; IN-VIVO; ENDONUCLEASE; PROTEIN; RECOMBINATION; INTERFERENCE	Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and circumvents the need for selectable markers or counter-selection systems. We reprogram dual-RNA:Cas9 specificity by changing the sequence of short CRISPR RNA (crRNA) to make single- and multinucleotide changes carried on editing templates. Simultaneous use of two crRNAs enables multiplex mutagenesis. In S. pneumoniae, nearly 100% of cells that were recovered using our approach contained the desired mutation, and in E. coli, 65% that were recovered contained the mutation, when the approach was used in combination with recombineering. We exhaustively analyze dual-RNA:Cas9 target requirements to define the range of targetable sequences and show strategies for editing sites that do not meet these requirements, suggesting the versatility of this technique for bacterial genome engineering.	[Jiang, Wenyan; Bikard, David; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10021 USA; [Cox, David; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA USA; [Cox, David; Zhang, Feng] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cox, David; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Rockefeller University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bikard, D (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10021 USA.	dbikard@rockefeller.edu; marraffini@rockefeller.edu	Macrae, Rhiannon/AAX-1536-2020; Bikard, David/AAZ-3752-2021; Bikard, David/L-2971-2015	Bikard, David/0000-0002-5729-1211; Bikard, David/0000-0002-5729-1211	Harvey L. Karp Discovery Award; Bettencourt Schuller Foundation; Medical Scientist Training Program; US National Institutes of Health (NIH) [DP1MH100706]; Keck Foundation; McKnight Foundation; Gates Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; Transformative R01; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; NIH [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	Harvey L. Karp Discovery Award; Bettencourt Schuller Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Gates Foundation(Bill & Melinda Gates Foundation); Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; Transformative R01; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Fischetti and C. Euler for plasmid pLZ12spec, D. Court for the HME63 strain, J. Kern for plasmid pKD46, the Rockefeller University Genomic Resource Center for technical support and J. Roberts for the MG1655 strain. D.B. is supported by a Harvey L. Karp Discovery Award and the Bettencourt Schuller Foundation. D.C. is supported by the Medical Scientist Training Program. F.Z. is supported by a US National Institutes of Health (NIH) Director's Pioneer Award (DP1MH100706), Transformative R01, the Keck, McKnight, Gates, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations, Bob Metcalfe, Mike Boylan and Jane Pauley. L.A.M. is supported by the Searle Scholars Program, the Rita Allen Scholars Program, a Irma T. Hirschl Award and a NIH Director's New Innovator Award (1DP2AI104556-01).	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barrangou R, 2012, NAT BIOTECHNOL, V30, P836, DOI 10.1038/nbt.2357; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brouns SJJ, 2012, SCIENCE, V337, P808, DOI 10.1126/science.1227253; Carroll D, 2012, MOL THER, V20, P1658, DOI 10.1038/mt.2012.171; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hosaka T, 2004, MOL GENET GENOMICS, V271, P317, DOI 10.1007/s00438-004-0982-z; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	40	1498	2044	36	1053	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					233	239		10.1038/nbt.2508	http://dx.doi.org/10.1038/nbt.2508			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23360965	Green Submitted, Green Accepted			2022-12-25	WOS:000316439500018
J	Kiechl, S; Wittmann, J; Giaccari, A; Knoflach, M; Willeit, P; Bozec, A; Moschen, AR; Muscogiuri, G; Sorice, GP; Kireva, T; Summerer, M; Wirtz, S; Luther, J; Mielenz, D; Billmeier, U; Egger, G; Mayr, A; Oberhollenzer, F; Kronenberg, F; Orthofer, M; Penninger, JM; Meigs, JB; Bonora, E; Tilg, H; Willeit, J; Schett, G				Kiechl, Stefan; Wittmann, Juergen; Giaccari, Andrea; Knoflach, Michael; Willeit, Peter; Bozec, Aline; Moschen, Alexander R.; Muscogiuri, Giovanna; Sorice, Gian Pio; Kireva, Trayana; Summerer, Monika; Wirtz, Stefan; Luther, Julia; Mielenz, Dirk; Billmeier, Ulrike; Egger, Georg; Mayr, Agnes; Oberhollenzer, Friedrich; Kronenberg, Florian; Orthofer, Michael; Penninger, Josef M.; Meigs, James B.; Bonora, Enzo; Tilg, Herbert; Willeit, Johann; Schett, Georg			Blockade of receptor activator of nuclear factor-kappa B (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus	NATURE MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; IKK-BETA; OSTEOPROTEGERIN; RISK; LIGAND; OBESITY; LIVER; INFLAMMATION; OSTEOBLASTS; METABOLISM	Hepatic insulin resistance is a driving force in the pathogenesis of type 2 diabetes mellitus (T2DM) and is tightly coupled with excessive storage of fat and the ensuing inflammation within the liver(1-3). There is compelling evidence that activation of the transcription factor nuclear factor-kappa B (NF-kappa B) and downstream inflammatory signaling pathways systemically and in the liver are key events in the etiology of hepatic insulin resistance and p-cell dysfunction, although the molecular mechanisms involved are incompletely understood(3-6). We here test the hypothesis that receptor activator of NE-kappa B ligand (RANKL), a prototypic activator of NF-kappa B, contributes to this process using both an epidemiological and experimental approach. In the prospective population-based Bruneck Study, a high serum concentration of soluble RANKL emerged as a significant (P < 0.001) and independent risk predictor of T2DM manifestation. In close agreement, systemic or hepatic blockage of RANKL signaling in genetic and nutritional mouse models of T2DM resulted in a marked improvement of hepatic insulin sensitivity and amelioration or even normalization of plasma glucose concentrations and glucose tolerance. Overall, this study provides evidence for a role of RANKL signaling in the pathogenesis of T2DM. If so, translation to the clinic may be feasible given current pharmacological strategies to lower RANKL activity to treat osteoporosis.	[Kiechl, Stefan; Knoflach, Michael; Willeit, Peter; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Wittmann, Juergen; Mielenz, Dirk] Univ Erlangen Nurnberg, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany; [Giaccari, Andrea; Muscogiuri, Giovanna; Sorice, Gian Pio] Univ Cattolica Sacro Cuore, Div Endocrinol & Metab Dis, Policlin A Gemelli, Rome, Italy; [Giaccari, Andrea] Fdn Don C Gnocchi, Milan, Italy; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Bozec, Aline; Kireva, Trayana; Luther, Julia; Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Moschen, Alexander R.; Tilg, Herbert] Med Univ Innsbruck, Div Endocrinol Gastroenterol & Metab, Dept Med 1, A-6020 Innsbruck, Austria; [Summerer, Monika; Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol Mol & Clin Pharmacol, Dept Med Genet, A-6020 Innsbruck, Austria; [Wirtz, Stefan; Billmeier, Ulrike] Univ Erlangen Nurnberg, Dept Internal Med 1, D-91054 Erlangen, Germany; [Egger, Georg; Oberhollenzer, Friedrich] Bruneck Hosp, Dept Internal Med, Brunico, Italy; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Orthofer, Michael; Penninger, Josef M.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Meigs, James B.] Harvard Univ, Dept Internal Med, Boston, MA 02115 USA; [Meigs, James B.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Bonora, Enzo] Univ & Hosp Trust Verona, Div Endocrinol Diabet & Metab Dis, Verona, Italy	Medical University of Innsbruck; University of Erlangen Nuremberg; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Cambridge; University of Erlangen Nuremberg; Medical University of Innsbruck; Medical University of Innsbruck; University of Erlangen Nuremberg; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Harvard University; Harvard University; Massachusetts General Hospital; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Kiechl, S (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	stefan.kiechl@i-med.ac.at; georg.schett@uk-erlangen.de	Moschen, Alexander/ABF-2267-2021; Muscogiuri, Giovanna/K-5817-2016; Willeit, Peter/HCI-7091-2022; Penninger, Josef M/I-6860-2013; Kronenberg, Florian/B-1736-2008; Bonora, Enzo/AAA-5300-2022; Meigs, James/P-3927-2019; Giaccari, Andrea/AAA-7824-2022	Willeit, Peter/0000-0002-1866-7159; Penninger, Josef M/0000-0002-8194-3777; Kronenberg, Florian/0000-0003-2229-1120; Meigs, James/0000-0002-2439-2657; Giaccari, Andrea/0000-0002-7462-7792; Knoflach, Michael/0000-0001-5576-6562; BONORA, Enzo/0000-0003-1074-5164; Wirtz, Stefan/0000-0001-6936-7431; , Agnes Mayr/0000-0001-9363-873X; Moschen, Alexander R/0000-0003-3598-7848; Muscogiuri, Giovanna/0000-0002-8809-4931	Deutsche Forschungsgemeinschaft [SPP1468-IMMUNOBONE]; Bundesministerium fur Bildung und Forschung (Bundesministerium fur Bildung und Forschung project ANCYLOSS); European Union; Innovative Medicines Initiative funded project BTCure; National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK080140]; Genomics of Lipid-associated Disorders of the Austrian Genome Research Programme GEN-AU; 'Pustertaler Verein zur Pravention von Herz- und Hirngefasserkrankungen; Gesundheitsbetrieb Bruneck; Assessorat fur Gesundheitswesen, Familie und Soziales, Bolzand; Umberto Di Mario Prize by the Societa Italiana di Diabetologia; Fondazione Don Gnocchi; Universita Cattolica del Sacro Cuore (Fondi Ateneo Linea D.3.2 Sindrome Metabolica); Italian Ministry of Education, University and Research [PRIN 2010JS3PMZ_011]; Christian Doppler Research Society; Italian Ministry of Education, University and Research; University of Verona; European Research Council; Austrian Academy of Sciences; National Bank Foundation; Era of Hope/US Department of Defense; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Bundesministerium fur Bildung und Forschung project ANCYLOSS); European Union(European Commission); Innovative Medicines Initiative funded project BTCure; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Genomics of Lipid-associated Disorders of the Austrian Genome Research Programme GEN-AU; 'Pustertaler Verein zur Pravention von Herz- und Hirngefasserkrankungen; Gesundheitsbetrieb Bruneck; Assessorat fur Gesundheitswesen, Familie und Soziales, Bolzand; Umberto Di Mario Prize by the Societa Italiana di Diabetologia; Fondazione Don Gnocchi; Universita Cattolica del Sacro Cuore (Fondi Ateneo Linea D.3.2 Sindrome Metabolica); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Christian Doppler Research Society; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); University of Verona; European Research Council(European Research Council (ERC)European Commission); Austrian Academy of Sciences; National Bank Foundation; Era of Hope/US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Deutsche Forschungsgemeinschaft (SPP1468-IMMUNOBONE to G.S.), the Bundesministerium fur Bildung und Forschung (Bundesministerium fur Bildung und Forschung project ANCYLOSS to G.S.), the European Union (Masterswitch to G.S.), the Innovative Medicines Initiative funded project BTCure (to G.S.), the National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK080140 to J.B.M.), the Genomics of Lipid-associated Disorders of the Austrian Genome Research Programme GEN-AU (to EK.), the 'Pustertaler Verein zur Pravention von Herz- und Hirngefasserkrankungen; the 'Gesundheitsbetrieb Bruneck' and the Assessorat fur Gesundheitswesen, Familie und Soziales, Bolzand. G.M. is recipient of the Umberto Di Mario Prize by the Societa Italiana di Diabetologia 2011. A.G. was supported by grants from Fondazione Don Gnocchi, Universita Cattolica del Sacro Cuore (Fondi Ateneo Linea D.3.2 Sindrome Metabolica) and the Italian Ministry of Education, University and Research (PRIN 2010JS3PMZ_011). A.M. and H.T. were supported by the Christian Doppler Research Society. E.B. is recipient of grants from the Italian Ministry of Education, University and Research and the University of Verona. J.M.P. holds an advanced European Research Council grant and is supported by the Austrian Academy of Sciences, a Grant by the National Bank Foundation and Era of Hope/US Department of Defense. We thank B. Enrich for technical support.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Goto H, 2011, CYTOKINE, V56, P662, DOI 10.1016/j.cyto.2011.09.005; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; Kanazawa I, 2011, BONE, V48, P720, DOI 10.1016/j.bone.2010.12.020; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kiechl Stefan, 2006, Expert Rev Cardiovasc Ther, V4, P801, DOI 10.1586/14779072.4.6.801; Kiechl S, 2007, CIRCULATION, V116, P385, DOI 10.1161/CIRCULATIONAHA.106.686774; Kindle L, 2006, J BONE MINER RES, V21, P193, DOI 10.1359/JBMR.051027; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lieb W, 2010, ARTERIOSCL THROM VAS, V30, P1849, DOI 10.1161/ATVBAHA.109.199661; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu LS, 2012, J ENDODONT, V38, P943, DOI 10.1016/j.joen.2012.03.010; Mai QG, 2011, J CELL BIOCHEM, V112, P2902, DOI 10.1002/jcb.23206; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Moschen AR, 2005, GUT, V54, P479, DOI 10.1136/gut.2004.044370; Nathan DM, 2010, NEW ENGL J MED, V362, P1533, DOI 10.1056/NEJMe1002322; Nishikawa M, 2008, HUM GENE THER, V19, P1009, DOI 10.1089/hum.2008.020; Schett G, 2004, JAMA-J AM MED ASSOC, V291, P1108, DOI 10.1001/jama.291.9.1108; Secchiero P, 2006, AM J PATHOL, V169, P2236, DOI 10.2353/ajpath.2006.060398; Semb AG, 2009, ARTERIOSCL THROM VAS, V29, P975, DOI 10.1161/ATVBAHA.109.184101; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Ziolkowska M, 2002, ARTHRITIS RHEUM-US, V46, P1744, DOI 10.1002/art.10388	40	168	191	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					358	363		10.1038/nm.3084	http://dx.doi.org/10.1038/nm.3084			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396210				2022-12-25	WOS:000316040700030
J	Varshney, RK; Song, C; Saxena, RK; Azam, S; Yu, S; Sharpe, AG; Cannon, S; Baek, J; Rosen, BD; Tar'an, B; Millan, T; Zhang, XD; Ramsay, LD; Iwata, A; Wang, Y; Nelson, W; Farmer, AD; Gaur, PM; Soderlund, C; Penmetsa, RV; Xu, CY; Bharti, AK; He, WM; Winter, P; Zhao, SC; Hane, JK; Carrasquilla-Garcia, N; Condie, JA; Upadhyaya, HD; Luo, MC; Thudi, M; Gowda, CLL; Singh, NP; Lichtenzveig, J; Gali, KK; Rubio, J; Nadarajan, N; Dolezel, J; Bansal, KC; Xu, X; Edwards, D; Zhang, GY; Kahl, G; Gil, J; Singh, KB; Datta, SK; Jackson, SA; Wang, J; Cook, DR				Varshney, Rajeev K.; Song, Chi; Saxena, Rachit K.; Azam, Sarwar; Yu, Sheng; Sharpe, Andrew G.; Cannon, Steven; Baek, Jongmin; Rosen, Benjamin D.; Tar'an, Bunyamin; Millan, Teresa; Zhang, Xudong; Ramsay, Larissa D.; Iwata, Aiko; Wang, Ying; Nelson, William; Farmer, Andrew D.; Gaur, Pooran M.; Soderlund, Carol; Penmetsa, R. Varma; Xu, Chunyan; Bharti, Arvind K.; He, Weiming; Winter, Peter; Zhao, Shancen; Hane, James K.; Carrasquilla-Garcia, Noelia; Condie, Janet A.; Upadhyaya, Hari D.; Luo, Ming-Cheng; Thudi, Mahendar; Gowda, C. L. L.; Singh, Narendra P.; Lichtenzveig, Judith; Gali, Krishna K.; Rubio, Josefa; Nadarajan, N.; Dolezel, Jaroslav; Bansal, Kailash C.; Xu, Xun; Edwards, David; Zhang, Gengyun; Kahl, Guenter; Gil, Juan; Singh, Karam B.; Datta, Swapan K.; Jackson, Scott A.; Wang, Jun; Cook, Douglas R.			Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement	NATURE BIOTECHNOLOGY			English	Article							L.; INTEGRATION; EVOLUTION; QUALITY; LEGUME	Chickpea (Cicer arietinum) is the second most widely grown legume crop after soybean, accounting for a substantial proportion of human dietary nitrogen intake and playing a crucial role in food security in developing countries. We report the similar to 738-Mb draft whole genome shotgun sequence of CDC Frontier, a kabuli chickpea variety, which contains an estimated 28,269 genes. Resequencing and analysis of 90 cultivated and wild genotypes from ten countries identifies targets of both breeding-associated genetic sweeps and breeding-associated balancing selection. Candidate genes for disease resistance and agronomic traits are highlighted, including traits that distinguish the two main market classes of cultivated chickpea-desi and kabuli. These data comprise a resource for chickpea improvement through molecular breeding and provide insights into both genome diversity and domestication.	[Varshney, Rajeev K.; Saxena, Rachit K.; Azam, Sarwar; Gaur, Pooran M.; Upadhyaya, Hari D.; Thudi, Mahendar; Gowda, C. L. L.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Varshney, Rajeev K.] CGIAR Generat Challenge Programme, Texcoco, Mexico; [Song, Chi; Yu, Sheng; Zhang, Xudong; Wang, Ying; Xu, Chunyan; He, Weiming; Zhao, Shancen; Zhang, Gengyun; Wang, Jun] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Sharpe, Andrew G.; Ramsay, Larissa D.; Condie, Janet A.; Gali, Krishna K.] Natl Res Council Canada NRC CNRC, Ottawa, ON, Canada; [Cannon, Steven] Iowa State Univ, USDA ARS, Ames, IA USA; [Baek, Jongmin; Rosen, Benjamin D.; Penmetsa, R. Varma; Carrasquilla-Garcia, Noelia; Luo, Ming-Cheng; Cook, Douglas R.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Tar'an, Bunyamin] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 0W0, Canada; [Millan, Teresa; Rubio, Josefa; Gil, Juan] Univ Cordoba, Dept Genet, Cordoba, Spain; [Iwata, Aiko; Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Nelson, William; Soderlund, Carol] Univ Arizona, Tucson, AZ USA; [Farmer, Andrew D.; Bharti, Arvind K.] NCGR, Santa Fe, NM USA; [Winter, Peter] GenXPro GmbH, Frankfurt, Germany; [Hane, James K.; Singh, Karam B.] CSIRO, Canberra, ACT, Australia; [Singh, Narendra P.] ICAR Res Complex, All India Coordinated Res Project Chickpea AICRP, New Delhi, India; [Lichtenzveig, Judith] Curtin Univ, Bentley, WA, Australia; [Nadarajan, N.] ICAR Res Complex, IIPR, Kanpur, Uttar Pradesh, India; [Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Bansal, Kailash C.] ICAR Res Complex, NBPGR, New Delhi, India; [Edwards, David] ACPFG, St Lucia, Qld, Australia; [Edwards, David] Univ Queensland, St Lucia, Qld, Australia; [Kahl, Guenter] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Singh, Karam B.] Univ Western Australia, Univ Western Australia Inst Agr, Crawley, Australia; [Datta, Swapan K.] ICAR Res Complex, Div Crop Sci, New Delhi, India; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; Beijing Genomics Institute (BGI); National Research Council Canada; Iowa State University; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of Saskatchewan; Universidad de Cordoba; University System of Georgia; University of Georgia; University of Arizona; National Center for Genome Resources (NCGR); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Curtin University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Pulses Research; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; University of Queensland; Goethe University Frankfurt; University of Western Australia; University of Copenhagen	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org; wangj@genomics.org.cn; drcook@ucdavis.edu	Dolezel, Jaroslav/B-7716-2008; Millan, Teresa/L-1362-2014; Gaur, Pooran/AAR-5729-2021; Zhang, xiaoyu/GXA-3206-2022; Singh, Karam B/C-3235-2012; Edwards, David/H-3710-2015; Rubio, Josefa/ABC-5786-2020; Gil, Juan/L-7167-2014; zhang, xu/GRX-9733-2022; Rubio, Josefa J Rubio/L-1868-2014; THUDI, MAHENDAR/GXA-1578-2022; Xu, Xun/AAI-6763-2020; Updhayaya, Hari/C-4858-2014; Hane, James/A-7062-2011; Wang, Jun/A-7261-2013; Varshney, Rajeev K/C-5295-2014; Gaur, Pooran Mal/ABE-6102-2020; zhang, xu/GYE-3558-2022; zhang, xian/GYA-0290-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Dolezel, Jaroslav/0000-0002-6263-0492; Millan, Teresa/0000-0003-1302-1794; Singh, Karam B/0000-0002-2777-7448; Edwards, David/0000-0001-7599-6760; Rubio, Josefa/0000-0002-5185-2719; Gil, Juan/0000-0001-7938-442X; Rubio, Josefa J Rubio/0000-0002-5185-2719; THUDI, MAHENDAR/0000-0003-2851-6837; Xu, Xun/0000-0002-5338-5173; Updhayaya, Hari/0000-0002-5166-6844; Hane, James/0000-0002-7651-0977; Varshney, Rajeev K/0000-0002-4562-9131; Gaur, Pooran Mal/0000-0002-7086-5873; Iwata-Otsubo, Aiko/0000-0001-9378-3961; jackson, scott/0000-0002-3172-1607; Ramsay, Larissa/0000-0002-8768-5959; Tar'an, Bunyamin/0000-0003-3583-3910; Wang, Jun/0000-0002-8540-8931; Yu, Sheng/0000-0001-7356-9343; Wang, Jun/0000-0002-2113-5874; Datta, Swapan/0000-0003-2961-8915; Luo, Ming-Cheng/0000-0002-9744-5887	CGIAR Generation Challenge Programme [G7009.06]; US National Science Foundation [DBI 0605251, IOS-0965531, DBI 0822258]; Rural Development Administration of the Republic of Korea [PJ906910]; Indo-German Science Technology Centre; BGI, Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Grains Research Development Corporation [UWA00149]; Australian Research Council [DP0985953, LP110100200]; Saskatchewan Pulse Growers; Saskatchewan Agriculture Development Fund; University of Cordoba; National Institute for Agricultural and Food Research and Technology (INIA) [RTA2010-00059]; National Research Initiative of US Department of Agriculture's National Institute of Food and Agriculture [0214643]; Ministry of Education, Youth and Sports of the Czech Republic; European Regional Development Fund [ED0007/01/01]; Indian Council of Agricultural Research (ICAR); ICRISAT	CGIAR Generation Challenge Programme(CGIAR); US National Science Foundation(National Science Foundation (NSF)); Rural Development Administration of the Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Indo-German Science Technology Centre; BGI, Shenzhen Key Laboratory of Transomics Biotechnologies; Grains Research Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); Saskatchewan Pulse Growers; Saskatchewan Agriculture Development Fund; University of Cordoba; National Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); National Research Initiative of US Department of Agriculture's National Institute of Food and Agriculture; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission); Indian Council of Agricultural Research (ICAR)(Indian Council of Agricultural Research (ICAR)); ICRISAT(CGIAR)	We would like to thank CGIAR Generation Challenge Programme (Theme Leader Discretionary grant to R.K.V., G7009.06 to D.R.C. and R.K.V.); US National Science Foundation (DBI 0605251 to D.R.C., IOS-0965531 to D.R.C. and R.K.V., and DBI 0822258 to S.A.J.); Rural Development Administration of the Republic of Korea (Woo Jang Choon Project No. PJ906910 to D.R.C.); Indo-German Science Technology Centre (R.K.V., G.K. and P.W.); BGI, Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A); Grains Research Development Corporation (UWA00149 to K.S.B.), Australian Research Council (DP0985953, LP110100200 to D.E.); Saskatchewan Pulse Growers (B.T. and A.G.S.); Saskatchewan Agriculture Development Fund (to A.G.S.); University of Cordoba and National Institute for Agricultural and Food Research and Technology (INIA) (RTA2010-00059 to T.M.); National Research Initiative of US Department of Agriculture's National Institute of Food and Agriculture (#0214643 to M.-C.L.); Ministry of Education, Youth and Sports of the Czech Republic and the European Regional Development Fund (ED0007/01/01 to J.D. and J.A.C.); Indian Council of Agricultural Research (ICAR) and ICRISAT for financial support to undertake parts of research presented in this study. Thanks are due to K. Hobson of Pulse Breeding Australia (PBA) for providing seeds of some genotypes used in this study. We would also like to thank W.D. Dar (director general, ICRISAT), D.A. Hoisington (deputy director general-research, ICRISAT) and J.-M. Ribaut (director, CGIAR GCP) for their helpful advice and assistance, wherever required, during the course of the study.	Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Millan T, 2010, EUPHYTICA, V175, P175, DOI 10.1007/s10681-010-0157-4; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pritchard JK, 2000, GENETICS, V155, P945; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Singh K.B., 1987, CHICKPEA, P11, DOI DOI 10.1016/J.YMPEV.2021.107235; Staginnus C, 1999, PLANT MOL BIOL, V39, P1037, DOI 10.1023/A:1006125430386; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2010, PLANT BREEDING REV, V33, P257; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Warkentin T, 2005, CAN J PLANT SCI, V85, P909, DOI 10.4141/P04-185; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zatloukalova P, 2011, CHROMOSOME RES, V19, P729, DOI 10.1007/s10577-011-9235-2; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819; ZOHARY D, 1973, SCIENCE, V182, P887, DOI 10.1126/science.182.4115.887	28	740	771	12	206	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					240	246		10.1038/nbt.2491	http://dx.doi.org/10.1038/nbt.2491			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23354103	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000316439500019
J	De Keersmaecker, K; Atak, ZK; Li, N; Vicente, C; Patchett, S; Girardi, T; Gianfelici, V; Geerdens, E; Clappier, E; Porcu, M; Lahortiga, I; Luca, R; Yan, JK; Hulselmans, G; Vranckx, H; Vandepoel, R; Sweron, B; Jacobs, K; Mentens, N; Wlodarska, I; Cauwelier, B; Cloos, J; Soulier, J; Uyttebroeck, A; Bagni, C; Hassan, BA; Vandenberghe, P; Johnson, AW; Aerts, S; Cools, J				De Keersmaecker, Kim; Atak, Zeynep Kalender; Li, Ning; Vicente, Carmen; Patchett, Stephanie; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Clappier, Emmanuelle; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Hulselmans, Gert; Vranckx, Hilde; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Wlodarska, Iwona; Cauwelier, Barbara; Cloos, Jacqueline; Soulier, Jean; Uyttebroeck, Anne; Bagni, Claudia; Hassan, Bassem A.; Vandenberghe, Peter; Johnson, Arlen W.; Aerts, Stein; Cools, Jan			Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; SOMATIC MUTATIONS; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CODING GENOME; PROTEIN; NOTCH; PATHWAY; MLL; INACTIVATION	T-cell acute lymphoblastic leukemia (T-ALL) is caused by the cooperation of multiple oncogenic lesions(1,2). We used exome sequencing on 67 T-ALLs to gain insight into the mutational spectrum in these leukemias. We detected protein-altering mutations in 508 genes, with an average of 8.2 mutations in pediatric and 21.0 mutations in adult T-ALL. Using stringent filtering, we predict seven new oncogenic driver genes in T-ALL. We identify CNOT3 as a tumor suppressor mutated in 7 of 89 (7.9%) adult T-ALLs, and its knockdown causes tumors in a sensitized Drosophila melanogaster model(3). In addition, we identify mutations affecting the ribosomal proteins RPL5 and RPL10 in 12 of 122 (9.8%) pediatric T-ALLs, with recurrent alterations of Arg98 in RPL10. Yeast and lymphoid cells expressing the RPL10 Arg98Ser mutant showed a ribosome biogenesis defect. Our data provide insights into the mutational landscape of pediatric versus adult T-ALL and identify the ribosome as a potential oncogenic factor.	[De Keersmaecker, Kim; Atak, Zeynep Kalender; Vicente, Carmen; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Hulselmans, Gert; Vranckx, Hilde; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Wlodarska, Iwona; Bagni, Claudia; Hassan, Bassem A.; Vandenberghe, Peter; Aerts, Stein; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Keersmaecker, Kim; Vicente, Carmen; Girardi, Tiziana; Gianfelici, Valentina; Geerdens, Ellen; Porcu, Michael; Lahortiga, Idoya; Luca, Rossella; Yan, Jiekun; Vandepoel, Roel; Sweron, Bram; Jacobs, Kris; Mentens, Nicole; Bagni, Claudia; Hassan, Bassem A.; Cools, Jan] VIB, Ctr Biol Dis, Louvain, Belgium; [Li, Ning] BGI Europe, Copenhagen, Denmark; [Patchett, Stephanie; Johnson, Arlen W.] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Clappier, Emmanuelle; Soulier, Jean] Hop St Louis, Paris, France; [Cauwelier, Barbara] Acad Hosp St Jan, Brugge, Belgium; [Cloos, Jacqueline] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Uyttebroeck, Anne] Katholieke Univ Leuven Hosp, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); University of Texas System; University of Texas Austin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Aerts, S (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	stein.aerts@med.kuleuven.be; jan.cools@cme.vib-kuleuven.be	Lucà, Rossella/J-5921-2018; De Keersmaecker, Kim/W-9702-2018; Aerts, Stein/A-1100-2009; Gianfelici, Valentina/AAA-8632-2020; Vicente, Carmen/AAA-7098-2021; Hassan, Bassem A/D-5221-2012; Atak, Zeynep Kalender/AAW-1560-2020; Clappier, Emmanuelle/V-2921-2017	Lucà, Rossella/0000-0003-2495-7803; De Keersmaecker, Kim/0000-0002-7420-9531; Aerts, Stein/0000-0002-8006-0315; Vicente, Carmen/0000-0002-3363-3459; Hassan, Bassem A/0000-0001-9533-4908; Atak, Zeynep Kalender/0000-0003-4761-8169; Bagni, Claudia/0000-0002-4419-210X; Cloos, Jacqueline/0000-0001-9150-8026; Porcu, Michael/0000-0002-9369-5547; Vandenberghe, Peter/0000-0003-4719-1935; Girardi, Tiziana/0000-0002-1344-8459; Hulselmans, Gert/0000-0003-2205-1899; Gianfelici, Valentina/0000-0003-3326-091X; Cools, Jan/0000-0001-6626-5843; Johnson, Arlen/0000-0002-4742-085X	KU Leuven [PF/10/016 SymBioSys]; FWO-Vlaanderen [G.0546.11, G.0704.11N]; Foundation against Cancer [SCIE2006-34, 2010-154]; European Research Council (ERC); Federal Office for Scientific, Technical and Cultural Affairs, Belgium; Ministry of Health, Cancer Plan; French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer); Canceropole d'Ile de France; US National Institutes of Health (NIH) [GM53655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053655] Funding Source: NIH RePORTER	KU Leuven(KU Leuven); FWO-Vlaanderen(FWO); Foundation against Cancer; European Research Council (ERC)(European Research Council (ERC)European Commission); Federal Office for Scientific, Technical and Cultural Affairs, Belgium; Ministry of Health, Cancer Plan; French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer); Canceropole d'Ile de France(Region Ile-de-France); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from KU Leuven (concerted action grant to J. Cools and P.V. and PF/10/016 SymBioSys to J. Cools and S.A.), FWO-Vlaanderen (G.0546.11 to J. Cools, P.V., S.A. and A.U. and G.0704.11N to S.A.), the Foundation against Cancer (SCIE2006-34 to J. Cools and 2010-154 to S.A.), a European Research Council (ERC) starting grant (J. Cools), the Interuniversity Attraction Poles (IAP) granted by the Federal Office for Scientific, Technical and Cultural Affairs, Belgium (J. Cools and P.V.), a grant from the Ministry of Health, Cancer Plan (J. Cools, P.V. and S.A.), a grant from the French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer) and from Canceropole d'Ile de France (J.S.), and a grant from the US National Institutes of Health (NIH; GM53655 to A.W.J. and SE). K.D.K. is a postdoctoral researcher, and P.V. is a senior clinical investigator of FWO-Vlaanderen.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Bossuyt W, 2009, PLOS BIOL, V7, P301, DOI 10.1371/journal.pbio.1000040; Burmeister T, 2009, BLOOD, V113, P4011, DOI 10.1182/blood-2008-10-183483; Chiocchetti A, 2011, AM J MED GENET A, V155A, P1472, DOI 10.1002/ajmg.a.33977; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hofer A, 2007, J BIOL CHEM, V282, P32630, DOI 10.1074/jbc.M705057200; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; King-Underwood L, 1998, BLOOD, V91, P2961, DOI 10.1182/blood.V91.8.2961.2961_2961_2968; Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Lower KM, 2004, EUR J HUM GENET, V12, P787, DOI 10.1038/sj.ejhg.5201228; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Ono R, 2002, CANCER RES, V62, P4075; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rao SY, 2012, BLOOD, V120, P3764, DOI 10.1182/blood-2012-03-415349; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	51	284	289	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					186	190		10.1038/ng.2508	http://dx.doi.org/10.1038/ng.2508			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23263491	Green Accepted			2022-12-25	WOS:000314333000014
J	Kapoor, N; Liang, WB; Marban, E; Cho, HC				Kapoor, Nidhi; Liang, Wenbin; Marban, Eduardo; Cho, Hee Cheol			Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18	NATURE BIOTECHNOLOGY			English	Article							CARDIAC GENE-EXPRESSION; BIOLOGICAL PACEMAKER; SINOATRIAL NODE; HUMAN FIBROBLASTS; STEM-CELLS; HEART; DIFFERENTIATION; INTEGRATION; INDUCTION; CHANNEL	The heartbeat originates within the sinoatrial node (SAN), a small structure containing <10,000 genuine pacemaker cells. If the SAN fails, the similar to 5 billion working cardiomyocytes downstream of it become quiescent, leading to circulatory collapse in the absence of electronic pacemaker therapy. Here we demonstrate conversion of rodent cardiomyocytes to SAN cells in vitro and in vivo by expression of Tbx18, a gene critical for early SAN specification. Within days of in vivo Tbx18 transduction, 9.2% of transduced, ventricular cardiomyocytes develop spontaneous electrical firing physiologically indistinguishable from that of SAN cells, along with morphological and epigenetic features characteristic of SAN cells. In vivo, focal Tbx18 gene transfer in the guinea-pig ventricle yields ectopic pacemaker activity, correcting a bradycardic disease phenotype. Myocytes transduced in vivo acquire the cardinal tapering morphology and physiological automaticity of native SAN pacemaker cells. The creation of induced SAN pacemaker (iSAN) cells opens new prospects for bioengineered pacemakers.	[Kapoor, Nidhi; Liang, Wenbin; Marban, Eduardo; Cho, Hee Cheol] Cedars Sinai Heart Inst, Los Angeles, CA USA	Cedars Sinai Medical Center	Marban, E (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA USA.	MarbanE@cshs.org; ChoHC@cshs.org	Marban, Eduardo/GWC-8514-2022		Cedars-Sinai Board of Governors Heart Stem Cell Center; Heart Rhythm Society fellowship; Heart and Stroke Foundation of Canada fellowship; American Heart Association [12SDG9020030]; NHLBI [1R01HL111646-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111646] Funding Source: NIH RePORTER	Cedars-Sinai Board of Governors Heart Stem Cell Center; Heart Rhythm Society fellowship; Heart and Stroke Foundation of Canada fellowship(Heart & Stroke Foundation of Canada); American Heart Association(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Galang, R. Rafi, B. Sun and W. Liu for technical assistance; S. Groenke of J.I. Goldhaber's laboratory for help with SAN tissue dissection; and D. Sareen of Clive Svendsen's laboratory for RNA samples of human iPSCs and the parental fibroblasts. The study was supported by the Cedars-Sinai Board of Governors Heart Stem Cell Center. E. M. holds the Mark S. Siegel Family Professorship. N.K. is supported by the Heart Rhythm Society fellowship. W. L. is supported by the Heart and Stroke Foundation of Canada fellowship. H. C. C. is supported by grants from the American Heart Association (12SDG9020030) and NHLBI (1R01HL111646-01A1).	Bakker M.L., 2012, CARDIOVASC RES; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; BLEEKER WK, 1980, CIRC RES, V46, P11, DOI 10.1161/01.RES.46.1.11; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Cho HC, 2007, CIRC RES, V100, P1112, DOI 10.1161/01.RES.0000265845.04439.78; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Espinoza-Lewis RA, 2011, DEV BIOL, V356, P359, DOI 10.1016/j.ydbio.2011.05.663; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Goldberger E, 1968, INTERPRET ELECTROCAR; Honjo H, 1996, J PHYSIOL-LONDON, V496, P795, DOI 10.1113/jphysiol.1996.sp021728; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kapoor N, 2011, J BIOL CHEM, V286, P14073, DOI 10.1074/jbc.M110.185298; Kashiwakura Y, 2006, CIRCULATION, V114, P1682, DOI 10.1161/CIRCULATIONAHA.106.634865; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; KOJIMA M, 1990, BRIT J PHARMACOL, V99, P327, DOI 10.1111/j.1476-5381.1990.tb14703.x; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lyashkov AE, 2007, CIRC RES, V100, P1723, DOI 10.1161/CIRCRESAHA.107.153676; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Nagashima M, 2001, J MOL CELL CARDIOL, V33, P533, DOI 10.1006/jmcc.2000.1327; NAKAYAMA T, 1984, PFLUG ARCH EUR J PHY, V402, P248, DOI 10.1007/BF00585507; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Qu JH, 2003, CIRCULATION, V107, P1106, DOI 10.1161/01.CIR.0000059939.97249.2C; Ripplinger CM, 2012, CIRCULATION, V125, P856, DOI 10.1161/CIRCULATIONAHA.111.086827; Rosemann M, 2003, CARCINOGENESIS, V24, P371, DOI 10.1093/carcin/24.3.371; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SOLA C, 1990, J HISTOCHEM CYTOCHEM, V38, P1123, DOI 10.1177/38.8.2142177; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TRAUTWEIN W, 1963, Z ZELLFORSCH MIK ANA, V61, P96, DOI 10.1007/BF00341523; VANGINNEKEN ACG, 1991, J PHYSIOL-LONDON, V434, P57, DOI 10.1113/jphysiol.1991.sp018459; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	56	210	225	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					54	+		10.1038/nbt.2465	http://dx.doi.org/10.1038/nbt.2465			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242162	Green Accepted			2022-12-25	WOS:000313563600022
J	Finan, B; Yang, B; Ottaway, N; Stemmer, K; Muller, TD; Yi, CX; Habegger, K; Schriever, SC; Garcia-Caceres, C; Kabra, DG; Hembree, J; Holland, J; Raver, C; Seeley, RJ; Hans, W; Irmler, M; Beckers, J; de Angelis, MH; Tiano, JP; Mauvais-Jarvis, F; Perez-Tilve, D; Pfluger, P; Zhang, LS; Gelfanov, V; DiMarchi, RD; Tschop, MH				Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; de Angelis, Martin Hrabe; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.			Targeted estrogen delivery reverses the metabolic syndrome	NATURE MEDICINE			English	Article							LEPTIN RESPONSIVENESS; DIABETES-MELLITUS; RECEPTOR-ALPHA; GLUCAGON; BINDING; OBESITY; CELLS; BETA; EXTRANUCLEAR; MECHANISMS	We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacology while eliminating adverse effects in other tissues. Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice. The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metabolism, as shown by loss-of-function models and genetic action profiling. Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity. Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism. This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small molecules. Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small molecules may offer equal promise for other diseases.	[Finan, Brian; Yang, Bin; Gelfanov, Vasily; DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Finan, Brian; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Pfluger, Paul; Tschoep, Matthias H.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Diabet & Obes, Neuherberg, Germany; [Finan, Brian; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Pfluger, Paul; Tschoep, Matthias H.] Tech Univ Munich, Div Metabol Dis, Dept Med, Munich, Germany; [Ottaway, Nickki; Habegger, Kirk; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Perez-Tilve, Diego; Pfluger, Paul; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Internal Med, Metabol Dis Inst,Div Endocrinol, Cincinnati, OH USA; [Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen GmbH, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany; [Tiano, Joseph P.; Mauvais-Jarvis, Franck] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Comprehens Ctr Obes,Dept Med, Chicago, IL 60611 USA; [Zhang, Lianshan] Jiangsu Hengrui Med Co Ltd, Nanjing, Jiangsu Provinc, Peoples R China	Indiana University System; Indiana University Bloomington; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University System of Ohio; University of Cincinnati; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Northwestern University; Feinberg School of Medicine	DiMarchi, RD (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	rdimarch@indiana.edu; tschoep@helmholtz-muenchen.de	Tschoep, Matthias H/I-5443-2014; Yang, Bin/J-4044-2015; Pfluger, Paul T/A-3770-2019; Irmler, Martin/B-3317-2013; García-Cáceres, Cristina/O-6601-2016; de Angelis, Martin Hrabe/F-5531-2012; Müller, Timo D./AAZ-4445-2020; Yang, Bin/W-7014-2019; Yi, Chun-Xia/J-4068-2016; Beckers, Johannes/K-7237-2012	Yang, Bin/0000-0003-4110-1513; Pfluger, Paul T/0000-0002-8118-7588; Irmler, Martin/0000-0003-3169-479X; García-Cáceres, Cristina/0000-0001-6376-9448; de Angelis, Martin Hrabe/0000-0002-7898-2353; Yang, Bin/0000-0003-1180-6184; Yi, Chun-Xia/0000-0003-1184-4615; Beckers, Johannes/0000-0001-7874-3822; Muller, Timo/0000-0002-0624-9339; Tschoep, Matthias/0000-0002-4744-371X; Habegger, Kirk/0000-0002-0342-5480; Stemmer, Kerstin/0000-0002-7526-2326; Perez-Tilve, Diego/0000-0002-0351-4133; Gelfanov, Vasily/0000-0001-5216-5227; Seeley, Randy/0000-0002-3721-5625; Schriever, Sonja C./0000-0001-5461-3214	Marcadia Biotech; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093848] Funding Source: NIH RePORTER	Marcadia Biotech; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Smiley and J. Levy for assistance in peptide synthesis, purification and characterization; J. Patterson and J. Day for their contribution to optimizing the peptide sequences; J. Ford for cell culture maintenance; J. Gidda and S. Vignati for their expert advice on pharmacology studies; and Y.-X. Li (Medpace Bioanalytical Labs) for assistance with in vivo pharmacokinetic studies. Partial research funding was provided by Marcadia Biotech, which has been acquired by Roche Pharma.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Cho MA, 2007, J ENDOCRINOL, V195, P255, DOI 10.1677/JOE-06-0193; Cvetkovic RS, 2007, DRUGS, V67, P935, DOI 10.2165/00003495-200767060-00008; Davies MJ, 2011, DIABETES OBES METAB, V13, P207, DOI 10.1111/j.1463-1326.2010.01330.x; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Grundy SM, 2006, NAT REV DRUG DISCOV, V5, P294, DOI 10.1038/nrd2005; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Jankowski M, 2001, P NATL ACAD SCI USA, V98, P11765, DOI 10.1073/pnas.201394198; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Krop IE, 2010, J CLIN ONCOL, V28, P2698, DOI 10.1200/JCO.2009.26.2071; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee KW, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-158; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Papageorgiou A, 2007, ENDOCRINOLOGY, V148, P1384, DOI 10.1210/en.2006-1198; Park CJ, 2011, J CLIN INVEST, V121, P604, DOI 10.1172/JCI41702; Patterson JT, 2011, ACS CHEM BIOL, V6, P135, DOI 10.1021/cb1002015; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Shughrue PJ, 2002, ENDOCRINOLOGY, V143, P1643, DOI 10.1210/en.143.5.1643; Son S, 2009, J MED CHEM, V52, P6889, DOI 10.1021/jm901153x; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; Williams DL, 2006, DIABETES, V55, P3387, DOI 10.2337/db06-0558; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	40	205	213	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1847	+		10.1038/nm.3009	http://dx.doi.org/10.1038/nm.3009			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142820	Green Accepted			2022-12-25	WOS:000311999800034
J	Weil, TT; Parton, RM; Herpers, B; Soetaert, J; Veenendaal, T; Xanthakis, D; Dobbie, IM; Halstead, JM; Hayashi, R; Rabouille, C; Davis, I				Weil, Timothy T.; Parton, Richard M.; Herpers, Bram; Soetaert, Jan; Veenendaal, Tineke; Xanthakis, Despina; Dobbie, Ian M.; Halstead, James M.; Hayashi, Rippei; Rabouille, Catherine; Davis, Ilan			Drosophila patterning is established by differential association of mRNAs with P bodies	NATURE CELL BIOLOGY			English	Article							LOCALIZATION; GURKEN; GENE; TRANSPORT; PROTEIN; OOCYTE; BODY; CELL; ORGANIZATION; TRANSLATION	The primary embryonic axes in flies, frogs and fish are formed through translational regulation of localized transcripts before fertilization(1). In Drosophila melanogaster, the axes are established through the transport and translational regulation of gurken (grk) and bicoid (bcd) messenger RNA in the oocyte and embryo(1). Both transcripts are translationally silent while being localized within the oocyte along microtubules by cytoplasmic dynein(1-4). Once localized, grk is translated at the dorsoanterior of the oocyte to send a TGF-alpha signal to the overlying somatic cells(5). In contrast, bcd is translationally repressed in the oocyte until its activation in early embryos when it forms an anteroposterior morphogenetic gradient(6). How this differential translational regulation is achieved is not fully understood. Here, we address this question using ultrastructural analysis, super-resolution microscopy and live-cell imaging. We show that grk and bcd ribonucleoprotein (RNP) complexes associate with electron-dense bodies that lack ribosomes and contain translational repressors. These properties are characteristic of processing bodies (P bodies), which are considered to be regions of cytoplasm where decisions are made on the translation and degradation of mRNA. Endogenous grk mRNA forms dynamic RNP particles that become docked and translated at the periphery of P bodies, where we show that the translational activator Oo18 RNA-binding protein (Orb, a homologue of CEPB) and the anchoring factor Squid (Sqd) are also enriched. In contrast, an excess of grk mRNA becomes localized inside the P bodies, where endogenous bcd mRNA is localized and translationally repressed. Interestingly, bcd mRNA dissociates from P bodies in embryos following egg activation, when it is known to become translationally active. We propose a general principle of translational regulation during axis specification involving remodelling of transport RNPs and dynamic partitioning of different transcripts between the translationally active edge of P bodies and their silent core.	[Herpers, Bram; Xanthakis, Despina; Rabouille, Catherine] UMC Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Weil, Timothy T.; Parton, Richard M.; Soetaert, Jan; Dobbie, Ian M.; Halstead, James M.; Davis, Ilan] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Veenendaal, Tineke; Xanthakis, Despina; Rabouille, Catherine] Hubrecht Inst Stem Cell Res & Dev Biol, NL-3584 CT Utrecht, Netherlands; [Hayashi, Rippei] Canc Res UK, London Res Inst, London WC2A 3LY, England	Utrecht University; Utrecht University Medical Center; University of Oxford; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Cancer Research UK	Rabouille, C (corresponding author), UMC Utrecht, Dept Cell Biol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	c.rabouille@hubrecht.eu; ilan.davis@bioch.ox.ac.uk	Herpers, Bram/P-1272-2014	Davis, Ilan/0000-0002-5385-3053; Hayashi, Rippei/0000-0002-5848-9019; Dobbie, Ian/0000-0002-5531-5865; Halstead, James/0000-0002-8321-2927	Marie Curie International Incoming Fellowship [ROXA0]; Wellcome Trust [081858]; Cancer Research UK; Wellcome Trust	Marie Curie International Incoming Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to: E. R. Gavis (Princeton University, USA), D. Ish Horowicz (CRUK, UK), T. Schupbach (Princeton University, USA), A. Jaramillo (Princeton University, USA), J. van Minnen (University of Calgary, Canada), L. Cooley (Yale University, USA), R. Singer (Albert Einstein College of Medicine, USA) and A. Nakamura (AIKEN, Japan) for fly stocks, antibodies and reagents; all members of the Cell Microscopy Center in Utrecht, Netherlands for assistance with electron microscopy; J. W. Sedat (UCSF, USA) and D. Agard (UCSF, USA) for advise on super-resolution imaging; E. R. Gavis for experimental advice; A. Ephrussi (EMBL, Germany) for discussions of the data. This work was supported by: Marie Curie International Incoming Fellowship (ROXA0) to T.T.W.; Wellcome Trust Senior Research Fellowship (081858) to I.D. and supporting A.M.P. and T.T.W.; Cancer Research UK funding to R.H.; studentship from Wellcome Trust to J.M.H.; Darwin Trust to J.S.	Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chang JS, 2001, DEVELOPMENT, V128, P3169; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; Court FA, 2008, J NEUROSCI, V28, P11024, DOI 10.1523/JNEUROSCI.2429-08.2008; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Dobbie I., 2010, LIVE CELL IMAGING LA, P203; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Filardo P, 2003, MECH DEVELOP, V120, P289, DOI 10.1016/S0925-4773(02)00454-9; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Gross D. J., 1988, SPECTROSCOPIC MEMBRA, VII, P19; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398; Herpers B, 2010, NAT PROTOC, V5, P678, DOI 10.1038/nprot.2010.12; Horner VL, 2006, CURR BIOL, V16, P1441, DOI 10.1016/j.cub.2006.06.024; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; King ML, 2005, BIOL CELL, V97, P19; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Nakamura A, 2001, DEVELOPMENT, V128, P3233; NEUMANSILBERBERG FS, 1994, DEVELOPMENT, V120, P2457; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Norvell A, 2005, DEV GENES EVOL, V215, P340, DOI 10.1007/s00427-005-0480-2; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parton R. M., 2010, COLD SPRING HARB PRO, V2010, P387; Rabouille C, 1999, METH MOL B, V117, P125; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Tadakuma H, 2006, BIOCHEM BIOPH RES CO, V344, P772, DOI 10.1016/j.bbrc.2006.03.202; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Updike D, 2010, J ANDROL, V31, P53, DOI 10.2164/jandrol.109.008292; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Weil TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3679; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817	50	82	83	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1305	+		10.1038/ncb2627	http://dx.doi.org/10.1038/ncb2627			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23178881	Green Accepted			2022-12-25	WOS:000311890300012
J	Chen, HZ; Ouseph, MM; Li, J; Pecot, T; Chokshi, V; Kent, L; Bae, S; Byrne, M; Duran, C; Comstock, G; Trikha, P; Mair, M; Senapati, S; Martin, CK; Gandhi, S; Wilson, N; Liu, B; Huang, YW; Thompson, JC; Raman, S; Singh, S; Leone, M; Machiraju, R; Huang, K; Mo, XK; Fernandez, S; Kalaszczynska, I; Wolgemuth, DJ; Sicinski, P; Huang, T; Jin, V; Leone, G				Chen, Hui-Zi; Ouseph, Madhu M.; Li, Jing; Pecot, Thierry; Chokshi, Veda; Kent, Lindsey; Bae, Sooin; Byrne, Morgan; Duran, Camille; Comstock, Grant; Trikha, Prashant; Mair, Markus; Senapati, Shantibhusan; Martin, Chelsea K.; Gandhi, Sagar; Wilson, Nicholas; Liu, Bin; Huang, Yi-Wen; Thompson, John C.; Raman, Sundaresan; Singh, Shantanu; Leone, Marcelo; Machiraju, Raghu; Huang, Kun; Mo, Xiaokui; Fernandez, Soledad; Kalaszczynska, Ilona; Wolgemuth, Debra J.; Sicinski, Piotr; Huang, Tim; Jin, Victor; Leone, Gustavo			Canonical and atypical E2Fs regulate the mammalian endocycle	NATURE CELL BIOLOGY			English	Article							S-PHASE; LIVER; MICE; ENDOREPLICATION; CELLS; POLYPLOIDY; REPRESSION; ACTIVATORS; PATTERNS; GROWTH	The endocycle is a variant cell cycle consisting of successive DNA synthesis and gap phases that yield highly polyploid cells. Although essential formetazoan development, relatively little is known about its control or physiologic role in mammals. Using lineage-specific cre mice we identified two opposing arms of the E2F program, one driven by canonical transcription activation (E2F1, E2F2 and E2F3) and the other by atypical repression (E2F7 and E2F8), that converge on the regulation of endocycles in vivo. Ablation of canonical activators in the two endocycling tissues of mammals, trophoblast giant cells in the placenta and hepatocytes in the liver, augmented genome ploidy, whereas ablation of atypical repressors diminished ploidy. These two antagonistic arms coordinate the expression of a unique G2/M transcriptional program that is critical for mitosis, karyokinesis and cytokinesis. These results provide in vivo evidence for a direct role of E2F family members in regulating non-traditional cell cycles in mammals.	[Chen, Hui-Zi; Ouseph, Madhu M.; Li, Jing; Pecot, Thierry; Chokshi, Veda; Kent, Lindsey; Bae, Sooin; Byrne, Morgan; Duran, Camille; Comstock, Grant; Trikha, Prashant; Mair, Markus; Senapati, Shantibhusan; Martin, Chelsea K.; Gandhi, Sagar; Wilson, Nicholas; Liu, Bin; Thompson, John C.; Huang, Tim; Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Dept Mol Virol Immunol & Med Genet, Solid Tumor Biol Program,Comprehens Canc Ctr, Columbus, OH 43210 USA; [Chen, Hui-Zi; Leone, Gustavo] Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA; [Chen, Hui-Zi; Leone, Gustavo] Ohio State Univ, Coll Med, Integrated Biomed Grad Program, Columbus, OH 43210 USA; [Ouseph, Madhu M.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Huang, Yi-Wen] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Mo, Xiaokui; Fernandez, Soledad] Ohio State Univ, Ctr Biostat, Off Hlth Sci, Columbus, OH 43210 USA; [Kalaszczynska, Ilona; Sicinski, Piotr] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Kalaszczynska, Ilona; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Dept Genet & Dev, Dept Obstet & Gynecol,Inst Human Nutr, New York, NY 10032 USA; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Medical College of Wisconsin; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Columbia University	Leone, G (corresponding author), Ohio State Univ, Dept Mol Genet, Dept Mol Virol Immunol & Med Genet, Solid Tumor Biol Program,Comprehens Canc Ctr, 484 W 12Th Ave, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	Kalaszczynska, Ilona/AAG-4832-2021; Huang, Kun/E-3272-2011; Machiraju, Raghu/D-5963-2012; Singh, Shantanu/GZB-9333-2022; Liu, Bin/E-9480-2013; Ouseph, Madhu/B-8940-2009	Singh, Shantanu/0000-0001-5008-8950; Ouseph, Madhu/0000-0002-3422-1675; Senapati, Shantibhusan/0000-0001-7108-8255; Kent, Lindsey N./0000-0003-4990-8477; Kalaszczynska, Ilona/0000-0001-6698-1372; Pecot, Thierry/0000-0003-0772-9753; Duran, Camille/0000-0002-7614-3265; Liu, Bin/0000-0002-8520-8374	NIH [R01CA85619, R01CA82259, R01HD047470, P01CA097189, R01CA132740]; Pew Charitable Trust Scholar Award; Leukemia & Lymphoma Society Scholar Award; Pelotonia Fellowship Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA082259, R01CA085619, P01CA097189, R01CA132740] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trust Scholar Award; Leukemia & Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Pelotonia Fellowship Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank L. Rawahneh, J. Moffitt and N. Lovett for excellent technical assistance with histology, and P. Wenzel for generating and collecting 123tko placentae. We also thank these individuals from OSUCCC Shared Resources: T. Wise, J. Palatini, H. Alders, P. Yan, P. Fada and B. Rodriguez (Microarray and Nucleic Acid Shared Resources); B. McElwain (Analytic Cytometry); R. Burry, K. Wolken, and B. Kemmenoe (Microscopy and Imaging); and K. La Perle (Comparative Pathology and Mouse Phenotyping). We are grateful for PL-1 antibodies provided by F. Talamantes (University of California, Santa Cruz, CA), Rcho-1 trophoblast stem cells from M. J. Soares (University of Kansas Medical Center, Kansas City, KS) and HepG2 cells from S. Jacobs. This work was funded by NIH grants to G.L. (R01CA85619, R01CA82259, R01HD047470, P01CA097189) and P.S. (R01CA132740). G.L. is a recipient of The Pew Charitable Trust Scholar Award and the Leukemia & Lymphoma Society Scholar Award. H-Z.C., M.M., S.S., S.R. and T. P. are recipients of the Pelotonia Fellowship Award.	BARBASON H, 1974, CELL TISSUE KINET, V7, P319, DOI 10.1111/j.1365-2184.1974.tb00414.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; DALLMAN PR, 1974, J NUTR, V104, P1234, DOI 10.1093/jn/104.10.1234; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hardie DC, 2002, J HISTOCHEM CYTOCHEM, V50, P735, DOI 10.1177/002215540205000601; Humbert PO, 2000, GENE DEV, V14, P690; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lammens T, 2008, P NATL ACAD SCI USA, V105, P14721, DOI 10.1073/pnas.0806510105; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Nagahama H, 2001, ANAT EMBRYOL, V203, P77, DOI 10.1007/s004290000146; Normand G, 2010, ADV EXP MED BIOL, V676, P27; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Sahgal N, 2006, METH MOLEC MED, V121, P159; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Schultze B., 1975, LIVER REGENERATION E; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Ullah Z., 2008, GEN DEV, V22, P3204; Ullah Z, 2009, CELL CYCLE, V8, P1501, DOI 10.4161/cc.8.10.8325; VARMUZA S, 1988, DEVELOPMENT, V102, P127; Weng L, 2003, EMBO J, V22, P3865, DOI 10.1093/emboj/cdg373; Wenzel PL, 2011, DEV BIOL, V351, P35, DOI 10.1016/j.ydbio.2010.12.025; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	59	97	103	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1192	+		10.1038/ncb2595	http://dx.doi.org/10.1038/ncb2595			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23064266	Green Accepted, Green Submitted			2022-12-25	WOS:000310778100012
J	Kulis, M; Heath, S; Bibikova, M; Queiros, AC; Navarro, A; Clot, G; Martinez-Trillos, A; Castellano, G; Brun-Heath, I; Pinyol, M; Barberan-Soler, S; Papasaikas, P; Jares, P; Bea, S; Rico, D; Ecker, S; Rubio, M; Royo, R; Ho, V; Klotzle, B; Hernandez, L; Conde, L; Lopez-Guerra, M; Colomer, D; Villamor, N; Aymerich, M; Rozman, M; Bayes, M; Gut, M; Gelpi, JL; Orozco, M; Fan, JB; Quesada, V; Puente, XS; Pisano, DG; Valencia, A; Lopez-Guillermo, A; Gut, I; Lopez-Otin, C; Campo, E; Martin-Subero, JI				Kulis, Marta; Heath, Simon; Bibikova, Marina; Queiros, Ana C.; Navarro, Alba; Clot, Guillem; Martinez-Trillos, Alejandra; Castellano, Giancarlo; Brun-Heath, Isabelle; Pinyol, Magda; Barberan-Soler, Sergio; Papasaikas, Panagiotis; Jares, Pedro; Bea, Silvia; Rico, Daniel; Ecker, Simone; Rubio, Miriam; Royo, Romina; Ho, Vincent; Klotzle, Brandy; Hernandez, Lluis; Conde, Laura; Lopez-Guerra, Monica; Colomer, Dolors; Villamor, Neus; Aymerich, Marta; Rozman, Maria; Bayes, Monica; Gut, Marta; Gelpi, Josep L.; Orozco, Modesto; Fan, Jian-Bing; Quesada, Victor; Puente, Xose S.; Pisano, David G.; Valencia, Alfonso; Lopez-Guillermo, Armando; Gut, Ivo; Lopez-Otin, Carlos; Campo, Elias; Martin-Subero, Jose I.			Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia	NATURE GENETICS			English	Article							METHYLATION; MUTATIONS; PHENOTYPE; SIGNATURE; SF3B1; ARRAY	We have extensively characterized the DNA methylomes of 139 patients with chronic lymphocytic leukemia (CLL) with mutated or unmutated IGHV and of several mature B-cell subpopulations through the use of whole-genome bisulfite sequencing and high-density microarrays. The two molecular subtypes of CLL have differing DNA methylomes that seem to represent epigenetic imprints from distinct normal B-cell subpopulations. DNA hypomethylation in the gene body, targeting mostly enhancer sites, was the most frequent difference between naive and memory B cells and between the two molecular subtypes of CLL and normal B cells. Although DNA methylation and gene expression were poorly correlated, we identified gene-body CpG dinucleotides whose methylation was positively or negatively associated with expression. We have also recognized a DNA methylation signature that distinguishes new clinicobiological subtypes of CLL. We propose an epigenomic scenario in which differential methylation in the gene body may have functional and clinical implications in leukemogenesis.	[Queiros, Ana C.; Martin-Subero, Jose I.] Univ Barcelona, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain; [Kulis, Marta; Navarro, Alba; Clot, Guillem; Castellano, Giancarlo; Jares, Pedro; Bea, Silvia; Hernandez, Lluis; Conde, Laura; Lopez-Guerra, Monica; Colomer, Dolors; Villamor, Neus; Aymerich, Marta; Rozman, Maria; Campo, Elias] Univ Barcelona, Hosp Clin, Serv Anat Patol, Unidad Hematopatol,IDIBAPS, Barcelona, Spain; [Heath, Simon; Brun-Heath, Isabelle; Bayes, Monica; Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona, Spain; [Bibikova, Marina; Ho, Vincent; Klotzle, Brandy; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA; [Martinez-Trillos, Alejandra; Lopez-Guillermo, Armando] Univ Barcelona, Hosp Clin, Serv Hematol, Barcelona, Spain; [Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona, Spain; [Barberan-Soler, Sergio; Papasaikas, Panagiotis] Univ Pompeu Fabra, Ctr Regulacio Genom, Barcelona, Spain; [Rico, Daniel; Ecker, Simone; Rubio, Miriam; Pisano, David G.; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Program, Madrid, Spain; [Royo, Romina; Gelpi, Josep L.; Orozco, Modesto] BSC, Joint Program Computat Biol, Barcelona, Spain; [Royo, Romina; Gelpi, Josep L.; Orozco, Modesto] IRB, Barcelona, Spain; [Quesada, Victor; Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Illumina; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Martin-Subero, JI (corresponding author), Univ Barcelona, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain.	imartins@clinic.ub.es	Ecker, Simone/W-8200-2019; COLOMER, DOLORS/ABG-6894-2020; Gut, Ivo/ABF-3188-2020; Hernandez, Luis/D-4684-2018; Navarro, Alba/H-2611-2015; Campo, Elias/AAC-5593-2019; Gelpí, Josep Ll./M-6401-2013; Heath, Simon C/J-4138-2012; Puente, Xosé S./ADB-0672-2022; Quesada, Víctor/B-6557-2014; bea, silvia/K-7699-2014; Brun-Heath, Isabelle/G-9844-2013; Valencia, Alfonso/I-3127-2015; Clot, Guillem/AAD-9087-2020; Papasaikas, Panagiotis/J-8581-2015; López-Otín, Carlos/AAB-2106-2020; Pisano, David/N-5817-2014; Lopez-Guillermo, Armando/Z-5684-2019; Jares, Pedro/T-3778-2019; Rico, Daniel/I-2049-2013	Ecker, Simone/0000-0001-5648-1710; Gut, Ivo/0000-0001-7219-632X; Hernandez, Luis/0000-0002-4854-3069; Navarro, Alba/0000-0002-4041-0974; Campo, Elias/0000-0001-9850-9793; Gelpí, Josep Ll./0000-0002-0566-7723; Heath, Simon C/0000-0002-9550-0897; Puente, Xosé S./0000-0001-9525-1483; Quesada, Víctor/0000-0002-8398-3457; bea, silvia/0000-0001-7192-2385; Brun-Heath, Isabelle/0000-0002-5828-0020; Valencia, Alfonso/0000-0002-8937-6789; Clot, Guillem/0000-0003-2588-7413; Papasaikas, Panagiotis/0000-0002-1640-7636; López-Otín, Carlos/0000-0001-6964-1904; Pisano, David/0000-0002-4895-4124; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Barberan-Soler, Sergio/0000-0002-5243-6813; Orozco Lopez, Modesto/0000-0002-8608-3278; Castellano, Giancarlo/0000-0002-5715-7733; Royo, Romina/0000-0003-3493-0874; Queiros, Ana/0000-0001-8585-4803; Rico, Daniel/0000-0002-6561-2310; COLOMER, DOLORS/0000-0001-7486-8484; Kulis, Marta/0000-0001-8104-9620; JARES, PEDRO/0000-0002-8401-579X; Rozman, Maria/0000-0002-2641-1110	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII; European Union's Seventh Framework Programme through the Blueprint Consortium [282510]; Botin Foundation; MINECO; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya); Portuguese Fundacao para a Ciencia e a Tecnologia; EMBO Long-Term Fellowship; La Caixa;  [SAF2009-08663];  [MCyT-BIO2007-666855]	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII; European Union's Seventh Framework Programme through the Blueprint Consortium; Botin Foundation; MINECO(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); La Caixa(La Caixa Foundation); ; 	We thank M. Seifert for advice about isolating normal mature B-cell subpopulations and C. Rozman, J. Valcarcel, R. Kuppers and R. Siebert for their comments on the manuscript. We are grateful to S. Guijarro, S. Martin, C. Capdevila, M. Sanchez and L. Pla for excellent technical assistance; to M. Lozano for helping us obtain normal peripheral blood samples; and to N. Villahoz and C. Muro for excellent work in the coordination of the CLL Spanish Consortium. We are indebted to the Hospital Clinic de Barcelona-IDIBAPS Biobank-Tumor Bank and Hematopathology Collection for the sample procurement. We are also very grateful to the patients with CLL who have participated in this study. This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII) (to E.C. and C.L.-O.) and the Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII (to E.C.), project SAF2009-08663 (to J.I.M.-S.) and project MCyT-BIO2007-666855 (to A.V.), as well as the European Union's Seventh Framework Programme through the Blueprint Consortium (grant agreement 282510) (to E.C. and I.G.) and the Botin Foundation (to C.L.-O.). J.I.M.-S. is supported by a Ramon y Cajal contract of the MINECO, M.K. by the Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya), A.C.Q. by the Portuguese Fundacao para a Ciencia e a Tecnologia, S.B.-S. by an EMBO Long-Term Fellowship and S.E. by La Caixa.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rahmatpanah FB, 2009, EPIGENOMICS-UK, V1, P39, DOI 10.2217/EPI.09.10; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	34	409	419	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1236	1242		10.1038/ng.2443	http://dx.doi.org/10.1038/ng.2443			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23064414				2022-12-25	WOS:000310495800016
J	Saalau-Bethell, SM; Woodhead, AJ; Chessari, G; Carr, MG; Coyle, J; Graham, B; Hiscock, SD; Murray, CW; Pathuri, P; Rich, SJ; Richardson, CJ; Williams, PA; Jhoti, H				Saalau-Bethell, Susanne M.; Woodhead, Andrew J.; Chessari, Gianni; Carr, Maria G.; Coyle, Joseph; Graham, Brent; Hiscock, Steven D.; Murray, Christopher W.; Pathuri, Puja; Rich, Sharna J.; Richardson, Caroline J.; Williams, Pamela A.; Jhoti, Harren			Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function	NATURE CHEMICAL BIOLOGY			English	Article							RNA HELICASE; BINDING; DOMAIN; HIV; INHIBITORS; INTEGRASE; DESIGN	Here we report a highly conserved new binding site located at the interface between the protease and helicase domains of the hepatitis C virus (HCV) NS3 protein. Using a chemical lead, identified by fragment screening and structure-guided design, we demonstrate that this site has a regulatory function on the protease activity via an allosteric mechanism. We propose that compounds binding at this allosteric site inhibit the function of the NS3 protein by stabilizing an inactive conformation and thus represent a new class of direct-acting antiviral agents.	[Saalau-Bethell, Susanne M.; Woodhead, Andrew J.; Chessari, Gianni; Carr, Maria G.; Coyle, Joseph; Graham, Brent; Hiscock, Steven D.; Murray, Christopher W.; Pathuri, Puja; Rich, Sharna J.; Richardson, Caroline J.; Williams, Pamela A.; Jhoti, Harren] Astex Pharmaceut, Cambridge, England	Astex Pharmaceuticals	Saalau-Bethell, SM (corresponding author), Astex Pharmaceut, Cambridge Sci Pk, Cambridge, England.	jhoti@astx.com		Murray, Chris/0000-0003-3733-0700; Williams, Pamela/0000-0002-1257-2351; Chessari, Gianni/0000-0002-8151-7778	Wellcome Trust [087738]	Wellcome Trust(Wellcome TrustEuropean Commission)	We acknowledge the contributions of M. Vinkovic, H. Angove, G. E. Besong, F. Holding, E. Chiarparin and M. L. Verdonk. We thank C. Cartwright for producing figures. X-ray data were collected at the European Synchrotron Radiation Facility and at the Diamond Lightsource. Sedimentation velocity experiments were performed by C. May and T. Laue at the Center to Advance Molecular Interaction Science at the University of New Hampshire. This research was supported by grant 087738 from the Wellcome Trust.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bartenschlager R, 2002, NAT REV DRUG DISCOV, V1, P911, DOI 10.1038/nrd942; Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Bricogne G., 2011, BUSTER VERSION 1 11; Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804; Chen KX, 2009, CURR OPIN INVEST DR, V10, P821; Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Ding SC, 2011, J VIROL, V85, P4343, DOI 10.1128/JVI.02130-10; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Hopkins AL, 1996, J MED CHEM, V39, P1589, DOI 10.1021/jm960056x; Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Krimm I, 2012, J MED CHEM, V55, P1287, DOI 10.1021/jm201439b; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mooij WTM, 2006, CHEMMEDCHEM, V1, P827, DOI 10.1002/cmdc.200600074; Morgenstern KA, 1997, J VIROL, V71, P3767, DOI 10.1128/JVI.71.5.3767-3775.1997; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perryman AL, 2010, CHEM BIOL DRUG DES, V75, P257, DOI 10.1111/j.1747-0285.2009.00943.x; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rhodes David I., 2011, Antiviral Chemistry & Chemotherapy, V21, P155, DOI 10.3851/IMP1716; Richman DD, 2000, HEPATOLOGY, V32, P866, DOI 10.1053/jhep.2000.18194; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Walker MA, 2009, CURR OPIN INVEST DR, V10, P129; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8	44	83	86	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					920	925		10.1038/NCHEMBIO.1081	http://dx.doi.org/10.1038/NCHEMBIO.1081			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23023261	Green Accepted			2022-12-25	WOS:000310052100011
J	Scott, RC; Holmes, GL				Scott, Rod C.; Holmes, Gregory L.			Opening up the potassium door in neonatal seizures	NATURE MEDICINE			English	Editorial Material							RETIGABINE EZOGABINE; DEVELOPING BRAIN; KCNQ2; CONVULSIONS; SPECTRUM; EPILEPSY; MODELS; DRUGS		[Scott, Rod C.] UCL, Inst Child Hlth, London, England; [Scott, Rod C.; Holmes, Gregory L.] Geisel Sch Med Dartmouth, Hanover, NH USA	University of London; University College London; Dartmouth College	Scott, RC (corresponding author), UCL, Inst Child Hlth, London, England.	gregory.l.holmes@dartmouth.edu		Scott, Rod/0000-0002-8944-928X				Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Lanska MJ, 1996, NEUROEPIDEMIOLOGY, V15, P117, DOI 10.1159/000109898; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Mazarati A, 2008, EPILEPSIA, V49, P1777, DOI 10.1111/j.1528-1167.2008.01674.x; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c; Sankar R, 2010, EPILEPSIA, V51, P39, DOI 10.1111/j.1528-1167.2010.02607.x; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644	18	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1624	1625		10.1038/nm.2987	http://dx.doi.org/10.1038/nm.2987			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135515				2022-12-25	WOS:000310837000020
J	Rossier, O; Octeau, V; Sibarita, JB; Leduc, C; Tessier, B; Nair, D; Gatterdam, V; Destaing, O; Albiges-Rizo, C; Tampe, R; Cognet, L; Choquet, D; Lounis, B; Giannone, G				Rossier, Olivier; Octeau, Vivien; Sibarita, Jean-Baptiste; Leduc, Cecile; Tessier, Beatrice; Nair, Deepak; Gatterdam, Volker; Destaing, Olivier; Albiges-Rizo, Corinne; Tampe, Robert; Cognet, Laurent; Choquet, Daniel; Lounis, Brahim; Giannone, Gregory			Integrins beta(1) and beta(3) exhibit distinct dynamic nanoscale organizations inside focal adhesions	NATURE CELL BIOLOGY			English	Article							CELL-MATRIX ADHESIONS; STRUCTURAL BASIS; C-TERMINUS; TALIN; BINDING; LOCALIZATION; ACTIVATION; FIBRONECTIN; PROTEINS; AFFINITY	Integrins in focal adhesions (FAs) mediate adhesion and force transmission to extracellular matrices essential for cell motility, proliferation and differentiation. Different fibronectin-binding integrins, simultaneously present in FAs, perform distinct functions. Yet, how integrin dynamics control biochemical and biomechanical processes in FAs is still elusive. Using single-protein tracking and super-resolution imaging we revealed the dynamic nano-organizations of integrins and talin inside FAs. Integrins reside in FAs through free-diffusion and immobilization cycles. Integrin activation promotes immobilization, stabilized in FAs by simultaneous connection to fibronectin and actin-binding proteins. Talin is recruited in FAs directly from the cytosol without membrane free-diffusion, restricting integrin immobilization to FAs. Immobilized beta(3)-integrins are enriched and stationary within FAs, whereas immobilized beta(1)-integrins are less enriched and exhibit rearward movements. Talin is enriched and mainly stationary, but also exhibited rearward movements in FAs, consistent with stable connections with both beta-integrins. Thus, differential transmission of actin motion to fibronectin occurs through specific integrins within FAs.	[Rossier, Olivier; Sibarita, Jean-Baptiste; Tessier, Beatrice; Nair, Deepak; Choquet, Daniel; Giannone, Gregory] Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Rossier, Olivier; Sibarita, Jean-Baptiste; Tessier, Beatrice; Nair, Deepak; Choquet, Daniel; Giannone, Gregory] CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Octeau, Vivien; Leduc, Cecile; Cognet, Laurent; Lounis, Brahim] Univ Bordeaux, LP2N, F-33405 Talence, France; [Octeau, Vivien; Leduc, Cecile; Cognet, Laurent; Lounis, Brahim] CNRS, F-33405 Talence, France; [Octeau, Vivien; Leduc, Cecile; Cognet, Laurent; Lounis, Brahim] Inst Opt, LP2N, F-33405 Talence, France; [Gatterdam, Volker; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Destaing, Olivier; Albiges-Rizo, Corinne] Univ Grenoble 1, Inst Albert Bonniot, INSERM, CNRS,ERL 3148,U823, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Goethe University Frankfurt; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Giannone, G (corresponding author), Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France.	gregory.giannone@u-bordeaux2.fr	Albiges-Rizo, Corinne/M-2568-2013; Cognet, Laurent/F-4163-2011; Leduc, Cécile/AGB-1431-2022; Choquet, Daniel/E-4203-2013; destaing, olivier/M-3802-2013; Choquet, Daniel/GOJ-8825-2022; Cognet, Laurent/M-4505-2019; Choquet, Daniel/K-7893-2018; Lounis, Brahim/I-7862-2016; Tampé, Robert/H-2953-2015; Rossier, Olivier M/I-6569-2013; Leduc, Cecile/AAC-1998-2019	Cognet, Laurent/0000-0002-3573-5387; Leduc, Cécile/0000-0002-1806-4120; Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Lounis, Brahim/0000-0001-7501-0236; Tampé, Robert/0000-0002-0403-2160; Rossier, Olivier M/0000-0002-6932-931X; ALBIGES-RIZO, Corinne/0000-0002-6333-4150; Giannone, Gregory/0000-0002-0932-1690; destaing, olivier/0000-0001-7622-3700; Sibarita, Jean-Baptiste/0000-0002-9920-7700; Gatterdam, Volker/0000-0001-7078-9885; Nair, Deepak/0000-0002-2103-1653	French Ministry of Research; CNRS; ANR grant Nanomotility; Fondation ARC pour la Recherche sur le Cancer; Conseil Regional Aquitaine; Fondation pour la Recherche Medicate; ERC [232942 Nano-Dyn-Syn, 235552 Glutraf]; Human Frontiers Science Programme; Ligue National contre le Cancer-equipe labellisee	French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR grant Nanomotility(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Conseil Regional Aquitaine(Region Nouvelle-Aquitaine); Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); ERC(European Research Council (ERC)European Commission); Human Frontiers Science Programme(Human Frontier Science Program); Ligue National contre le Cancer-equipe labellisee	We thank C. Breillat, A. Frouin, D. Bouchet and P. Gonzales for technical assistance; M. P. Sheetz, O. Thoumine, J. Petersen, B. Fourcade, M. Block, L. Duchesne and D.G. Fernig for helpful discussions; M. Humphries, N. Kieffer, J. Wehland, A. Gautreau and P. Kanchanawong for the gift of reagents; P. Legros and C. Poujol (Bordeaux Imaging Center) for STED imaging. We acknowledge financial support from the French Ministry of Research and CNRS, ANR grant Nanomotility (G.G., B.L., OR.), Fondation ARC pour la Recherche sur le Cancer (O.R.), Conseil Regional Aquitaine, Fondation pour la Recherche Medicate, the ERC Program numbers 232942 Nano-Dyn-Syn (D.C., B.L.) and 235552 Glutraf (D.N.), the Human Frontiers Science Programme (B.L.) and The Ligue National contre le Cancer-equipe labellisee 2010 (C.A-R., O.D.). The research was conducted in the scope of the International Associated Laboratory LIA CAFS.	Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Banno A, 2012, J BIOL CHEM, V287, P13799, DOI 10.1074/jbc.M112.341214; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Grunwald C, 2011, J AM CHEM SOC, V133, P8090, DOI 10.1021/ja200967z; Himmel M, 2009, J BIOL CHEM, V284, P13832, DOI 10.1074/jbc.M900266200; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Izeddin I, 2012, OPT EXPRESS, V20, P2081, DOI 10.1364/OE.20.002081; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lata S, 2006, J AM CHEM SOC, V128, P2365, DOI 10.1021/ja0563105; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; McCleverty CJ, 2007, PROTEIN SCI, V16, P1223, DOI 10.1110/ps.072798707; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Plancon S, 2001, BIOCHEM J, V357, P529, DOI 10.1042/0264-6021:3570529; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Racine V, 2006, I S BIOMED IMAGING, P1020; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	70	256	259	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1057	+		10.1038/ncb2588	http://dx.doi.org/10.1038/ncb2588			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	23023225	Green Submitted			2022-12-25	WOS:000309543800014
J	Bai, MY; Shang, JX; Oh, E; Fan, M; Bai, Y; Zentella, R; Sun, TP; Wang, ZY				Bai, Ming-Yi; Shang, Jian-Xiu; Oh, Eunkyoo; Fan, Min; Bai, Yang; Zentella, Rodolfo; Sun, Tai-ping; Wang, Zhi-Yong			Brassinosteroid, gibberellin and phytochrome impinge on a common transcription module in Arabidopsis	NATURE CELL BIOLOGY			English	Article							PLANT-GROWTH REGULATION; SIGNAL-TRANSDUCTION; EXPRESSION ANALYSIS; CELL ELONGATION; COORDINATED REGULATION; INTERACTING FACTOR-3; RECEPTOR KINASES; GENE-EXPRESSION; LIGHT; DEGRADATION	Brassinosteroid and gibberellin promote many similar developmental responses in plants; however, their relationship remains unclear. Here we show that BR and GA act interdependently through a direct interaction between the BR-activated BZR1 and GA-inactivated DELLA transcription regulators. GA promotion of cell elongation required BR signalling, where as BR or active BZR1 suppressed the GA-defcient dwarf phenotype. DELLAs directly interacted with BZR1 and inhibited BZR1-DNA binding both in vitro and in vivo. Genome-wide analysis defined a BZR1-dependent GA-regulated transcriptome, which is enriched with light-regulated genes and genes involved in cell wall synthesis and photosynthesis/chloroplast function. GA promotion of hypocotyl elongation requires both BZR1 and the phytochrome-interacting factors (PIFs), as well as their common downstream targets encoding the PRE-family helix-loop-helix factors. The results demonstrate that GA releases DELLA-mediated inhibition of BZR1, and that the DELLA-BZR1-PIF4 interaction defines a core transcription module that mediates coordinated growth regulation by GA, BR and light signals.	[Bai, Ming-Yi; Shang, Jian-Xiu; Oh, Eunkyoo; Fan, Min; Bai, Yang; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Shang, Jian-Xiu] Hebei Normal Univ, Coll Life Sci, Inst Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China; [Zentella, Rodolfo; Sun, Tai-ping] Duke Univ, Dept Biol, Durham, NC 27708 USA	Carnegie Institution for Science; Hebei Normal University; Duke University	Wang, ZY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Zentella, Rodolfo/0000-0003-3986-6250; Bai, Ming-yi/0000-0001-5992-7511	NIH [R01GM066258]; NSF [MCB-0923723]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100051, R01GM066258] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. W. Deng (Department of Molecular, Cellular, and Developmental Biology, Yale University) for providing seeds of the della pentuple mutant. This study was supported by grants from the NIH (R01GM066258 to Z.Y.W.) and from the NSF (MCB-0923723 to T.P.S.). J-X.S. was supported by the China Scholarship Council.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; An F, 2012, CELL RES, V22, P915, DOI 10.1038/cr.2012.29; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnaud N, 2010, GENE DEV, V24, P2127, DOI 10.1101/gad.593410; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Chapman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036210; Cheminant S, 2011, PLANT CELL, V23, P1849, DOI 10.1105/tpc.111.085233; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hirano K., 2012, PLANT J; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Kim TW, 2011, MOL CELL, V43, P561, DOI 10.1016/j.molcel.2011.05.037; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Oh E., 2012, NATURE CELL BIOL; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Sekimata K, 2002, J AGR FOOD CHEM, V50, P3486, DOI 10.1021/jf011716w; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tanaka K, 2003, J PLANT GROWTH REGUL, V22, P259, DOI 10.1007/s00344-003-0119-3; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Wang F, 2009, PLANT CELL, V21, P2378, DOI 10.1105/tpc.108.065433; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108	54	413	450	13	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					810	U78		10.1038/ncb2546	http://dx.doi.org/10.1038/ncb2546			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22820377	Green Accepted			2022-12-25	WOS:000307115900010
J	Guo, SG; Zhang, JG; Sun, HH; Salse, J; Lucas, WJ; Zhang, HY; Zheng, Y; Mao, LY; Ren, Y; Wang, ZW; Min, JM; Guo, XS; Murat, F; Ham, BK; Zhang, ZL; Gao, S; Huang, MY; Xu, YM; Zhong, SL; Bombarely, A; Mueller, LA; Zhao, H; He, HJ; Zhang, Y; Zhang, ZH; Huang, SW; Tan, T; Pang, EL; Lin, K; Hu, Q; Kuang, HH; Ni, PX; Wang, B; Liu, JA; Kou, QH; Hou, WJ; Zou, XH; Jiang, J; Gong, GY; Klee, K; Schoof, H; Huang, Y; Hu, XS; Dong, SS; Liang, DQ; Wang, J; Wu, K; Xia, Y; Zhao, X; Zheng, ZQ; Xing, M; Liang, XM; Huang, BQ; Lv, T; Wang, JY; Yin, Y; Yi, HP; Li, RQ; Wu, MZ; Levi, A; Zhang, XP; Giovannoni, JJ; Wang, J; Li, YF; Fei, ZJ; Xu, Y				Guo, Shaogui; Zhang, Jianguo; Sun, Honghe; Salse, Jerome; Lucas, William J.; Zhang, Haiying; Zheng, Yi; Mao, Linyong; Ren, Yi; Wang, Zhiwen; Min, Jiumeng; Guo, Xiaosen; Murat, Florent; Ham, Byung-Kook; Zhang, Zhaoliang; Gao, Shan; Huang, Mingyun; Xu, Yimin; Zhong, Silin; Bombarely, Aureliano; Mueller, Lukas A.; Zhao, Hong; He, Hongju; Zhang, Yan; Zhang, Zhonghua; Huang, Sanwen; Tan, Tao; Pang, Erli; Lin, Kui; Hu, Qun; Kuang, Hanhui; Ni, Peixiang; Wang, Bo; Liu, Jingan; Kou, Qinghe; Hou, Wenju; Zou, Xiaohua; Jiang, Jiao; Gong, Guoyi; Klee, Kathrin; Schoof, Heiko; Huang, Ying; Hu, Xuesong; Dong, Shanshan; Liang, Dequan; Wang, Juan; Wu, Kui; Xia, Yang; Zhao, Xiang; Zheng, Zequn; Xing, Miao; Liang, Xinming; Huang, Bangqing; Lv, Tian; Wang, Junyi; Yin, Ye; Yi, Hongping; Li, Ruiqiang; Wu, Mingzhu; Levi, Amnon; Zhang, Xingping; Giovannoni, James J.; Wang, Jun; Li, Yunfu; Fei, Zhangjun; Xu, Yong			The draft genome of watermelon (Citrullus lanatus) and resequencing of 20 diverse accessions	NATURE GENETICS			English	Article							MADS-BOX GENE; DNA-SEQUENCES; FRUIT; RNA; PLANT; IDENTIFICATION; EXPRESSION; RICE; CLASSIFICATION; RECONSTRUCTION	Watermelon, Citrullus lanatus, is an important cucurbit crop grown throughout the world. Here we report a high-quality draft genome sequence of the east Asia watermelon cultivar 97103 (2n = 2x = 22) containing 23,440 predicted protein-coding genes. Comparative genomics analysis provided an evolutionary scenario for the origin of the 11 watermelon chromosomes derived from a 7-chromosome paleohexaploid eudicot ancestor. Resequencing of 20 watermelon accessions representing three different C. lanatus subspecies produced numerous haplotypes and identified the extent of genetic diversity and population structure of watermelon germplasm. Genomic regions that were preferentially selected during domestication were identified. Many disease-resistance genes were also found to be lost during domestication. In addition, integrative genomic and transcriptomic analyses yielded important insights into aspects of phloem-based vascular signaling in common between watermelon and cucumber and identified genes crucial to valuable fruit-quality traits, including sugar accumulation and citrulline metabolism.	[Guo, Shaogui; Sun, Honghe; Zhang, Haiying; Ren, Yi; Zhao, Hong; He, Hongju; Zhang, Yan; Liu, Jingan; Kou, Qinghe; Hou, Wenju; Zou, Xiaohua; Jiang, Jiao; Gong, Guoyi; Xia, Yang; Zhang, Xingping; Li, Yunfu; Xu, Yong] Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops N Chi, Beijing, Peoples R China; [Guo, Shaogui; Sun, Honghe; Zheng, Yi; Mao, Linyong; Gao, Shan; Huang, Mingyun; Xu, Yimin; Zhong, Silin; Bombarely, Aureliano; Mueller, Lukas A.; Giovannoni, James J.; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Zhang, Jianguo; Wang, Zhiwen; Min, Jiumeng; Guo, Xiaosen; Ni, Peixiang; Wang, Bo; Huang, Ying; Hu, Xuesong; Dong, Shanshan; Liang, Dequan; Wang, Juan; Wu, Kui; Zhao, Xiang; Zheng, Zequn; Xing, Miao; Liang, Xinming; Huang, Bangqing; Lv, Tian; Wang, Junyi; Yin, Ye; Wang, Jun] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Zhang, Jianguo; Ni, Peixiang] Fudan Univ, T Life Res, Shanghai 200433, Peoples R China; [Sun, Honghe] Beijing Agr Univ, Coll Plant Sci & Technol, Beijing 100094, Peoples R China; [Salse, Jerome; Murat, Florent] INRA, Unites Mixtes Rech 1095, Genet Divers & Ecophysiol Cereals, Clermont Ferrand, France; [Lucas, William J.; Ham, Byung-Kook; Zhang, Zhaoliang] Univ Calif Davis, Dept Plant Biol, Coll Biol Sci, Davis, CA 95616 USA; [Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Tan, Tao; Pang, Erli; Lin, Kui] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Hu, Qun; Kuang, Hanhui] Huazhong Agr Univ, Coll Hort & Forestry, Wuhan, Peoples R China; [Klee, Kathrin; Schoof, Heiko] Univ Bonn, Inst Nutzpflanzenwissensch & Ressource, Bonn, Germany; [Yi, Hongping; Wu, Mingzhu] Xinjiang Acad Agr Sci, Urumqi, Peoples R China; [Li, Ruiqiang] Beijing Novogene Bioinformat Technol Co Ltd, Beijing, Peoples R China; [Levi, Amnon] ARS, USDA, US Vegetable Lab, Charleston, SC USA; [Giovannoni, James J.; Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Academy of Agriculture & Forestry; Cornell University; Boyce Thompson Institute for Plant Research; Beijing Genomics Institute (BGI); Fudan University; Beijing University of Agriculture; INRAE; University of California System; University of California Davis; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Beijing Normal University; Huazhong Agricultural University; University of Bonn; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Copenhagen	Xu, Y (corresponding author), Beijing Acad Agr & Forestry Sci, Natl Engn Res Ctr Vegetables, Key Lab Biol & Genet Improvement Hort Crops N Chi, Beijing, Peoples R China.	wangj@genomics.org.cn; liyunfu@baafs.net.cn; zf25@cornell.edu; xuyong@nercv.org	Ham, Byung-Kook/AAU-7771-2020; zhong, silin/O-7029-2015; Huang, Sanwen/ABE-9053-2020; Bombarely, Aureliano/C-6580-2009; wang, junyi/GYA-3213-2022; Zheng, Yi/F-6150-2016; Galaxy, Yuuki/S-4013-2017; Lin, Kui/P-4492-2015; Schoof, Heiko/Y-7073-2018; Wang, Jun/A-7261-2013; Fei, Zhangjun/H-5152-2012; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	zhong, silin/0000-0002-0198-7383; Huang, Sanwen/0000-0002-8547-5309; Bombarely, Aureliano/0000-0001-6257-8914; Zheng, Yi/0000-0002-8042-7770; Galaxy, Yuuki/0000-0002-7135-520X; Lin, Kui/0000-0002-5993-1972; Schoof, Heiko/0000-0002-1527-3752; Klee, Kathrin/0000-0003-2408-1282; Wang, Jun/0000-0002-8540-8931; zhang, zhonghua/0000-0002-1034-227X; Wang, Jun/0000-0002-2113-5874; Zhang, Jianguo/0000-0003-0723-1701; Ren, Yi/0000-0003-3770-6093; Fei, Zhangjun/0000-0001-9684-1450; Murat, Florent/0000-0003-2116-2511	Ministry of Science and Technology of the People's Republic of China [2010DFB33740, 2012AA020103, 2012AA100101, 2012AA100103, 2012AA100105]; Ministry of Agriculture of the People's Republic of China [CARS-26]; Major Program of Beijing Natural Science Foundation of China [5100001]; Beijing Municipal Science and Technology Commission of China [D111100001311002]; National Natural Science Foundation of China [30972015, 31171980, 31272184]; Agence Nationale de la Recherche [ANR-09-JCJC-0058-01]; USDA National Institute of Food and Agriculture [NIFA 201015479]; US National Science Foundation [IOS-0923312, IOS-1025642]; US-Israel Binational Agricultural Research and Development Fund [IS-4223-09C]; USDA Agricultural Research Service	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Major Program of Beijing Natural Science Foundation of China; Beijing Municipal Science and Technology Commission of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); US National Science Foundation(National Science Foundation (NSF)); US-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We are grateful to E. Legg of Syngenta and J. de Wit and Z. Sun of Rijk Zwaan for management support of this project. This research was supported by grants from the Ministry of Science and Technology of the People's Republic of China (2010DFB33740, 2012AA020103, 2012AA100101, 2012AA100103 and 2012AA100105), the Ministry of Agriculture of the People's Republic of China (CARS-26), the Major Program of Beijing Natural Science Foundation of China (5100001), the Beijing Municipal Science and Technology Commission of China (D111100001311002) to Yong Xu, the National Natural Science Foundation of China (30972015 and 31171980) to H. Zhang, the National Natural Science Foundation of China (31272184) to S. Guo, the Agence Nationale de la Recherche (Program ANRjc-PaleoCereal, ANR-09-JCJC-0058-01) to J. S., the USDA National Institute of Food and Agriculture (NIFA 201015479) to W. J. L., the US National Science Foundation (IOS-0923312 and IOS-1025642) and US-Israel Binational Agricultural Research and Development Fund (IS-4223-09C) to Z.F. and the USDA Agricultural Research Service.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BROWN AC, 1985, J AM SOC HORTIC SCI, V110, P683; Collins JK, 2007, NUTRITION, V23, P261, DOI 10.1016/j.nut.2007.01.005; Dai N, 2011, PLANT MOL BIOL, V76, P1, DOI 10.1007/s11103-011-9757-1; Dane F, 2007, GENET RESOUR CROP EV, V54, P327, DOI 10.1007/s10722-005-4897-2; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Erickson DL, 2005, P NATL ACAD SCI USA, V102, P18315, DOI 10.1073/pnas.0509279102; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fritz-Laylin LK, 2005, PLANT PHYSIOL, V138, P611, DOI 10.1104/pp.104.054452; FURSA T B, 1972, Botanicheskii Zhurnal (St. Petersburg), V57, P31; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Ham B.K., 2009, COLD SPRING HARB PRO, V21, P197; Harris KR, 2009, J AM SOC HORTIC SCI, V134, P649, DOI 10.21273/JASHS.134.6.649; Harushima Y, 2002, GENETICS, V160, P313; Hayashi T, 2005, P NATL ACAD SCI USA, V102, P13681, DOI 10.1073/pnas.0506595102; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeffrey C., 2001, MANSFELDS ENCY AGR H, V3, P1510; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levi A, 2001, HORTSCIENCE, V36, P1096, DOI 10.21273/HORTSCI.36.6.1096; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; NASRALLAH JB, 1993, PLANT CELL, V5, P1325, DOI 10.2307/3869785; Perkins-Veazie P, 2006, J AGR FOOD CHEM, V54, P2593, DOI 10.1021/jf052066p; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ren Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029453; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Salse J, 2009, BRIEF BIOINFORM, V10, P619, DOI 10.1093/bib/bbp037; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaefer H, 2011, TAXON, V60, P122, DOI 10.1002/tax.601011; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Slewinski TL, 2011, MOL PLANT, V4, P641, DOI 10.1093/mp/ssr051; Slewinski TL, 2010, PLANT SCI, V178, P341, DOI 10.1016/j.plantsci.2010.01.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thalor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033111; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Wada M, 1930, BIOCHEM Z, V224, P420; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	76	493	557	17	376	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					51	+		10.1038/ng.2470	http://dx.doi.org/10.1038/ng.2470			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23179023	hybrid			2022-12-25	WOS:000312838800012
J	Kwong, GA; von Maltzahn, G; Murugappan, G; Abudayyeh, O; Mo, S; Papayannopoulos, IA; Sverdlov, DY; Liu, SB; Warren, AD; Popov, Y; Schuppan, D; Bhatia, SN				Kwong, Gabriel A.; von Maltzahn, Geoffrey; Murugappan, Gayathree; Abudayyeh, Omar; Mo, Steven; Papayannopoulos, Ioannis A.; Sverdlov, Deanna Y.; Liu, Susan B.; Warren, Andrew D.; Popov, Yury; Schuppan, Detlef; Bhatia, Sangeeta N.			Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease	NATURE BIOTECHNOLOGY			English	Article							MATRIX-METALLOPROTEINASE; BILIARY FIBROSIS; CANCER-PATIENTS; LIVER FIBROSIS; DISCOVERY; PROTEASES; STRATEGY; TUMORS; DRUGS	Biomarkers are becoming increasingly important in the clinical management of complex diseases, yet our ability to discover new biomarkers remains limited by our dependence on endogenous molecules. Here we describe the development of exogenously administered 'synthetic biomarkers' composed of mass-encoded peptides conjugated to nanoparticles that leverage intrinsic features of human disease and physiology for noninvasive urinary monitoring. These protease-sensitive agents perform three functions in vivo: they target sites of disease, sample dysregulated protease activities and emit mass-encoded reporters into host urine for multiplexed detection by mass spectrometry. Using mouse models of liver fibrosis and cancer, we show that these agents can noninvasively monitor liver fibrosis and resolution without the need for invasive core biopsies and substantially improve early detection of cancer compared with current clinically used blood biomarkers. This approach of engineering synthetic biomarkers for multiplexed urinary monitoring should be broadly amenable to additional pathophysiological processes and point-of-care diagnostics.	[Kwong, Gabriel A.; von Maltzahn, Geoffrey; Murugappan, Gayathree; Abudayyeh, Omar; Mo, Steven; Warren, Andrew D.; Bhatia, Sangeeta N.] MIT, Harvard MIT Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Kwong, Gabriel A.; von Maltzahn, Geoffrey; Papayannopoulos, Ioannis A.; Warren, Andrew D.; Bhatia, Sangeeta N.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Murugappan, Gayathree; Sverdlov, Deanna Y.; Liu, Susan B.; Popov, Yury; Schuppan, Detlef; Bhatia, Sangeeta N.] Harvard Univ, Sch Med, Boston, MA USA; [Papayannopoulos, Ioannis A.] MIT, Swanson Biotechnol Ctr, Cambridge, MA 02139 USA; [Sverdlov, Deanna Y.; Liu, Susan B.; Popov, Yury; Schuppan, Detlef] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA; [Schuppan, Detlef] Johannes Gutenberg Univ Mainz, Dept Med 1, Div Mol & Translat Med, Sch Med, Mainz, Germany; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bhatia, Sangeeta N.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Johannes Gutenberg University of Mainz; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Bhatia, SN (corresponding author), MIT, Harvard MIT Hlth Sci & Technol, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sbhatia@mit.edu	Popov, Yury V./A-7781-2008; Kwong, Gabriel A/M-5376-2013; Abudayyeh, Omar/ABF-1746-2020; Kwong, Gabriel/AAO-8266-2021	Popov, Yury V./0000-0001-7973-942X; Kwong, Gabriel A/0000-0002-6255-6755; Abudayyeh, Omar/0000-0002-7979-3220; Kwong, Gabriel/0000-0002-6255-6755; /0000-0003-1948-0289	US National Institutes of Health (Bioengineering Research Partnership) [R01 CA124427]; Kathy and Curt Marble Cancer Research Fund; US National Institutes of Health [U19 AI066313, 1R21 DK075857]; Ruth L. Kirschstein National Research Service Award [F32CA159496-01]; NATIONAL CANCER INSTITUTE [F32CA159496, R01CA124427, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075857, R21DK076873] Funding Source: NIH RePORTER	US National Institutes of Health (Bioengineering Research Partnership)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kathy and Curt Marble Cancer Research Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Cook, N. Schiller and M. Brown (Swanson Biotechnology Center (SBC), Massachusetts Institute of Technology (MIT)) for peptide synthesis and tissue sectioning, C. Whittaker (SBC, MIT) for bioinformatic insight, R. Tomaino (Harvard Taplin mass spectrometry facility) for mass spectrometry analysis, F. Giammo and D. Kim (MIT) for initial probe work and urine purification, S. Carr (Broad Institute of MIT/Harvard) for mass spectrometry expertise and M. Sailor (University of California San Diego (UCSD)), J. Park (UCSD) and S. Friedman (Mount Sinai School of Medicine) for insightful discussions. This work was funded by the US National Institutes of Health (Bioengineering Research Partnership: R01 CA124427 to S. N. B.), the Kathy and Curt Marble Cancer Research Fund to S. N. B. and US National Institutes of Health grants U19 AI066313 and 1R21 DK075857 to D. S. G. A. K. is supported by the Ruth L. Kirschstein National Research Service Award (F32CA159496-01). S. N. B. is a Howard Hughes Institute Investigator.	Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Brown BB, 1995, MOL DIVERS, V1, P4, DOI 10.1007/BF01715804; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; D'Souza AL, 2009, P NATL ACAD SCI USA, V106, P17152, DOI 10.1073/pnas.0903437106; Dekker LJM, 2010, PROTEOMICS, V10, P2348, DOI 10.1002/pmic.200900682; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Findeisen P, 2012, PROTEOM CLIN APPL, V6, P60, DOI 10.1002/prca.201100058; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Haun JB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002048; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Hori SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003110; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Lutz AM, 2008, PLOS MED, V5, P1287, DOI 10.1371/journal.pmed.0050170; Mahmood U, 2003, MOL CANCER THER, V2, P489; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Moon PG, 2011, MASS SPECTROM REV, V30, P1185, DOI 10.1002/mas.20319; Morris TA, 2003, THROMB RES, V110, P159, DOI 10.1016/S0049-3848(03)00334-7; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Park JH, 2008, ADV MATER, V20, P1630, DOI 10.1002/adma.200800004; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; Thompson A, 2006, ANAL CHEM, V78, P4235, DOI 10.1021/ac060310l; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2008, MOL CELL PROTEOMICS, V7, P509, DOI 10.1074/mcp.M700397-MCP200	44	129	146	8	160	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					63	+		10.1038/nbt.2464	http://dx.doi.org/10.1038/nbt.2464			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242163	Green Accepted, Green Submitted			2022-12-25	WOS:000313563600023
J	Sun, Y; Bak, B; Schoenmakers, N; van Trotsenburg, ASP; Oostdijk, W; Voshol, P; Cambridge, E; White, JK; le Tissier, P; Gharavy, SNM; Martinez-Barbera, JP; Stokvis-Brantsma, WH; Vulsma, T; Kempers, MJ; Persani, L; Campi, I; Bonomi, M; Beck-Peccoz, P; Zhu, HD; Davis, TME; Hokken-Koelega, ACS; Del Blanco, DG; Rangasami, JJ; Ruivenkamp, CAL; Laros, JFJ; Kriek, M; Kant, SG; Bosch, CAJ; Biermasz, NR; Appelman-Dijkstra, NM; Corssmit, EP; Hovens, GCJ; Pereira, AM; den Dunnen, JT; Wade, MG; Breuning, MH; Hennekam, RC; Chatterjee, K; Dattani, MT; Wit, JM; Bernard, DJ				Sun, Yu; Bak, Beata; Schoenmakers, Nadia; van Trotsenburg, A. S. Paul; Oostdijk, Wilma; Voshol, Peter; Cambridge, Emma; White, Jacqueline K.; le Tissier, Paul; Gharavy, S. Neda Mousavy; Martinez-Barbera, Juan P.; Stokvis-Brantsma, Wilhelmina H.; Vulsma, Thomas; Kempers, Marlies J.; Persani, Luca; Campi, Irene; Bonomi, Marco; Beck-Peccoz, Paolo; Zhu, Hongdong; Davis, Timothy M. E.; Hokken-Koelega, Anita C. S.; Del Blanco, Dania Gorbenko; Rangasami, Jayanti J.; Ruivenkamp, Claudia A. L.; Laros, Jeroen F. J.; Kriek, Marjolein; Kant, Sarina G.; Bosch, Cathy A. J.; Biermasz, Nienke R.; Appelman-Dijkstra, Natasha M.; Corssmit, Eleonora P.; Hovens, Guido C. J.; Pereira, Alberto M.; den Dunnen, Johan T.; Wade, Michael G.; Breuning, Martijn H.; Hennekam, Raoul C.; Chatterjee, Krishna; Dattani, Mehul T.; Wit, Jan M.; Bernard, Daniel J.			Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement	NATURE GENETICS			English	Article							THYROTROPIN-RELEASING-HORMONE; INHIBIN-BINDING-PROTEIN; STIMULATION TEST; DIAGNOSIS; PITUITARY; BIOACTIVITY; EXPRESSION; THYROXINE; DISEASE	Congenital central hypothyroidism occurs either in isolation or in conjunction with other pituitary hormone deficits. Using exome and candidate gene sequencing, we identified 8 distinct mutations and 2 deletions in IGSF1 in males from 11 unrelated families with central hypothyroidism, testicular enlargement and variably low prolactin concentrations. IGSF1 is a membrane glycoprotein that is highly expressed in the anterior pituitary gland, and the identified mutations impair its trafficking to the cell surface in heterologous cells. Igsf1-deficient male mice show diminished pituitary and serum thyroid-stimulating hormone (TSH) concentrations, reduced pituitary thyrotropin-releasing hormone (TRH) receptor expression, decreased triiodothyronine concentrations and increased body mass. Collectively, our observations delineate a new X-linked disorder in which loss-of-function mutations in IGSF1 cause central hypothyroidism, likely secondary to an associated impairment in pituitary TRH signaling.	[Oostdijk, Wilma; Stokvis-Brantsma, Wilhelmina H.; Wit, Jan M.] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Sun, Yu; Ruivenkamp, Claudia A. L.; Laros, Jeroen F. J.; Kriek, Marjolein; Kant, Sarina G.; Bosch, Cathy A. J.; den Dunnen, Johan T.; Breuning, Martijn H.] Leiden Univ, Ctr Human & Clin Genet, Med Ctr, Leiden, Netherlands; [Bak, Beata; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Schoenmakers, Nadia; Voshol, Peter; Chatterjee, Krishna] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [van Trotsenburg, A. S. Paul; Vulsma, Thomas; Kempers, Marlies J.; Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [Cambridge, Emma; White, Jacqueline K.] Wellcome Trust Sanger Inst, Sanger Inst Mouse Genet Project, Cambridge, England; [le Tissier, Paul; Gharavy, S. Neda Mousavy; Martinez-Barbera, Juan P.] UCL, Inst Child Hlth, Neural Dev Unit, London, England; [le Tissier, Paul] Natl Inst Med Res, Div Mol Neuroendocrinol, London NW7 1AA, England; [Kempers, Marlies J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Persani, Luca; Campi, Irene; Beck-Peccoz, Paolo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Persani, Luca; Bonomi, Marco] Ist Auxol Italiano, IRCCS, Div Endocrine & Metab Disorders, Milan, Italy; [Campi, Irene; Beck-Peccoz, Paolo] Fdn IRCCS Ca Granda, Endocrine Unit, Milan, Italy; [Zhu, Hongdong; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp Unit, Perth, WA 6009, Australia; [Hokken-Koelega, Anita C. S.; Del Blanco, Dania Gorbenko] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands; [Rangasami, Jayanti J.] W Middlesex Univ Hosp, Dept Paediat, Isleworth, England; [Biermasz, Nienke R.; Appelman-Dijkstra, Natasha M.; Corssmit, Eleonora P.; Hovens, Guido C. J.; Pereira, Alberto M.] Leiden Univ, Dept Endocrinol & Metab Disorders, Med Ctr, Leiden, Netherlands; [den Dunnen, Johan T.] Leiden Univ, Leiden Genome Technol Ctr, Med Ctr, Leiden, Netherlands; [Wade, Michael G.] Hlth Canada, Hazard Identificat Div, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Dattani, Mehul T.] UCL Inst Child Hlth, Dev Endocrinol Res Grp, Clin & Mol Genet Unit, London, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; McGill University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Wellcome Trust Sanger Institute; University of London; University College London; MRC National Institute for Medical Research; Radboud University Nijmegen; University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Western Australia; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Health Canada; University of London; University College London	Wit, JM (corresponding author), Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands.	kkc1@medschl.cam.ac.uk; m.dattani@ucl.ac.uk; j.m.wit@lumc.nl; daniel.bernard@mcgill.ca	Biermasz, Nienke/ABE-9436-2021; Campi, Irene/AAB-1335-2019; dunnen, johan den/ABH-4228-2020; Pereira, Alberto M./Q-7175-2017; Appelman-Dijkstra, Natasha/V-7322-2018; Kant, Sarina/F-8596-2010; Martinez-Barbera, Juan Pedro/AAE-9284-2020; del Blanco, Darya Gorbenko/N-6069-2018; Davis, Timothy ME/M-5144-2014; Persani, Luca/B-6543-2008; Appelman-Dijkstra, Natasha/CAE-9054-2022; van Trotsenburg, Paul/ABC-2379-2020; Bonomi, Marco/T-6487-2019	Biermasz, Nienke/0000-0001-5817-3594; dunnen, johan den/0000-0002-6304-1710; Pereira, Alberto M./0000-0002-1194-9866; Appelman-Dijkstra, Natasha/0000-0001-5035-127X; Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; del Blanco, Darya Gorbenko/0000-0002-9674-2388; Persani, Luca/0000-0003-2068-9581; Appelman-Dijkstra, Natasha/0000-0001-5035-127X; van Trotsenburg, Paul/0000-0002-9677-7441; Le Tissier, Paul/0000-0002-7220-5705; Laros, Jeroen F.J./0000-0002-8715-7371; Bernard, Daniel/0000-0001-5365-5586; Davis, Timothy/0000-0003-0749-7411; Sun, Yu/0000-0002-2938-0233; Schoenmakers, Nadia/0000-0002-0847-2884; Wade, Michael/0000-0002-7331-3839; Bonomi, Marco/0000-0001-5454-6074; CAMPI, IRENE/0000-0002-0340-9923; Chatterjee, Vengalil Krishna/0000-0002-2654-8854	US National Institutes of Health (NIH) [DK15700]; China Scholarship Council; National Sciences and Engineering Research Council (NSERC); NSERC [341801-07]; Fonds de la Recherche en Sante du Quebec (FRSQ) Chercheur Boursier Senior Award; Wellcome Trust [095564, WT077157/Z/05/Z, 084361, 078432, 086545]; National Institutes of Health Research Cambridge Biomedical Research Centre; UK Medical Research Council (MRE) [U117570590]; National Health and Medical Research Council of Australia; Dutch Growth Research Foundation; Istituto Auxologico Italian IRCCS [GR-2008-1137632]; Great Ormond Street Children's Hospital Charity; Italian Ministry of Health; MRC [MC_U117570590] Funding Source: UKRI; Medical Research Council [MC_U117570590] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10198] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1255] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015700] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ) Chercheur Boursier Senior Award; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Research Cambridge Biomedical Research Centre; UK Medical Research Council (MRE)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dutch Growth Research Foundation; Istituto Auxologico Italian IRCCS; Great Ormond Street Children's Hospital Charity; Italian Ministry of Health(Ministry of Health, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank X.-H. Liao from the Refetoff laboratory (The University of Chicago, supported by US National Institutes of Health (NIH) grant DK15700) for measuring T4, T3, FT4I and TSH in mice, P. Scheiffele for the antibody to IGSF1 CTD and S. Kimmins (McGill University) and P. Bisschop (Academic Medical Center, University of Amsterdam) for human testis and pituitary RNA, respectively. We also thank H. Bikker, J.C. Moreno, A. Escudero, E. Aten, M. Losekoot, E. Endert, J.W.A. Smit, R.van Rijn and E.L. van Persijn-van Meerten for technical support and advice. We thank F.J. de Jong and Y. de Rijke for measuring serum inhibin B and AMH and for providing age references. We thank S. Iran and X. Zhou for assistance with collection of mouse serum samples. We acknowledge the help of N. Zwaveling, J. Gosen, E.J. Schroor, L.C.G. de Graaff and G. Radetti in providing clinical data. We acknowledge The Eastern Region Sequencing and Informatics Hub (see URLs), who undertook sequencing and preliminary bioinformatics analyses of data from the UK families. We thank the subjects and their families for participating. Our work was supported in part by a grant from the China Scholarship Council (to Y.S.); a National Sciences and Engineering Research Council (NSERC) Doctoral Research Award (to B.B.), NSERC Discovery Grant 341801-07 and a Fonds de la Recherche en Sante du Quebec (FRSQ) Chercheur Boursier Senior Award (to D.J.B.); grants from the Wellcome Trust (095564 to N.S. and K.C.; WT077157/Z/05/Z to E.C. and J.K.W.; 084361, 078432 and 086545 to J.P.M.-B.), the National Institutes of Health Research Cambridge Biomedical Research Centre (to N.S. and K.C.) and the UK Medical Research Council (MRE; U117570590 to P.I.T.); a National Health and Medical Research Council of Australia Practitioner Fellowship (to T.M.E.D.); the Dutch Growth Research Foundation (D.G.D.B.); the Young Investigator grant of the Italian Ministry of Health and Istituto Auxologico Italian IRCCS (GR-2008-1137632 to M.B.); and the Great Ormond Street Children's Hospital Charity (to M.T.D.).	Bernard DJ, 2003, MOL CELL BIOL, V23, P4882, DOI 10.1128/MCB.23.14.4882-4891.2003; Bernard DJ, 2001, MOL ENDOCRINOL, V15, P654, DOI 10.1210/me.15.4.654; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Chapman SC, 2002, MOL CELL ENDOCRINOL, V196, P79, DOI 10.1016/S0303-7207(02)00227-7; Chapman SC, 2001, MOL ENDOCRINOL, V15, P668, DOI 10.1210/me.15.4.668; Chong HR, 2000, ENDOCRINOLOGY, V141, P2600, DOI 10.1210/en.141.7.2600; Cole TJ, 1999, ANN HUM BIOL, V26, P303, DOI 10.1080/030144699282633; Crofton PM, 2008, HORM RES, V69, P53, DOI 10.1159/000111796; Doin FC, 2012, EUR J ENDOCRINOL, V166, P631, DOI 10.1530/EJE-11-0907; Elmlinger MW, 2001, CLIN CHEM LAB MED, V39, P973, DOI 10.1515/CCLM.2001.158; FAGLIA G, 1973, J CLIN ENDOCR METAB, V37, P595, DOI 10.1210/jcem-37-4-595; Frattini A, 1998, GENE, V214, P1, DOI 10.1016/S0378-1119(98)00253-4; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Goede J, 2011, HORM RES PAEDIAT, V76, P56, DOI 10.1159/000326057; Hindmarsh P.C., 2009, BROOKS CLIN PEDIAT E, P213; Mazzarella R, 1998, GENOMICS, V48, P157, DOI 10.1006/geno.1997.5156; Mehta A, 2003, J CLIN ENDOCR METAB, V88, P5696, DOI 10.1210/jc.2003-030943; Mul D, 2001, PEDIATR RES, V50, P479, DOI 10.1203/00006450-200110000-00010; PERSANI L, 1994, J CLIN ENDOCR METAB, V78, P1034, DOI 10.1210/jc.78.5.1034; Persani L, 2000, J CLIN ENDOCR METAB, V85, P3631, DOI 10.1210/jc.85.10.3631; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Robakis T, 2008, J BIOL CHEM, V283, P36369, DOI 10.1074/jbc.M807527200; SCHNAKENBURG KV, 1980, EUR J PEDIATR, V133, P259, DOI 10.1007/BF00496086; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Van Tijn DA, 2008, J CLIN ENDOCR METAB, V93, P410, DOI 10.1210/jc.2006-2656	27	124	128	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1375	1381		10.1038/ng.2453	http://dx.doi.org/10.1038/ng.2453			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143598	Green Accepted, Green Published			2022-12-25	WOS:000311713200019
J	Trajkovski, M; Ahmed, K; Esau, CC; Stoffel, M				Trajkovski, Mirko; Ahmed, Kashan; Esau, Christine C.; Stoffel, Markus			MyomiR-133 regulates brown fat differentiation through Prdm16	NATURE CELL BIOLOGY			English	Article							ADIPOSE-TISSUE; CARDIAC-HYPERTROPHY; ADULT HUMANS; ADIPOCYTES; MICRORNAS; EXPRESSION; MOUSE; PROLIFERATION; METABOLISM; CELLS	Brown adipose tissue (BAT) uses the chemical energy of lipids and glucose to produce heat, a function that can be induced by cold exposure or diet(1). A key regulator of BAT is the gene encoding PR domain containing 16 (Prdm16), whose expression can drive differentiation of myogenic and white fat precursors to brown adipocytes(2,3). Here we show that after cold exposure, the muscle-enriched miRNA-133 is markedly downregulated in BAT and subcutaneous white adipose tissue (SAT) as a result of decreased expression of its transcriptional regulator Mef2. miR-133 directly targets and negatively regulates PRDM16, and inhibition of miR-133 or Mef2 promotes differentiation of precursors from BAT and SAT to mature brown adipocytes, thereby leading to increased mitochondria! activity. Forced expression of miR-133 in brown adipogenic conditions prevents the differentiation to brown adipocytes in both BAT and SAT precursors. Our results point to Mef2 and miR-133 as central upstream regulators of Prdm16 and hence of brown adipogenesis in response to cold exposure in BAT and SAT.	[Trajkovski, Mirko; Ahmed, Kashan; Stoffel, Markus] ETH, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Trajkovski, Mirko; Ahmed, Kashan; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Esau, Christine C.] Regulus Therapeut Inc, San Diego, CA 92121 USA; [Stoffel, Markus] Univ Zurich, Fac Med, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Isis Pharmaceuticals Inc; University of Geneva; University of Zurich	Stoffel, M (corresponding author), ETH, Inst Mol Hlth Sci, Schafmattstr 22,HPL H36, CH-8093 Zurich, Switzerland.	stoffel@biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817; Trajkovski, Mirko/0000-0002-3152-9551	ERG grant Metabolomirs; Leducq Foundation; Swiss National Science Foundation (SNSF)	ERG grant Metabolomirs; Leducq Foundation(Leducq Foundation); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	We thank F. von Meyenn, M. Gustafsson Trajkovska, J. Kruetzfeldt and C. Wolfrum for technical help and discussions. This work was in part supported by the ERG grant Metabolomirs (MS), the Leducq Foundation and a Prodoc grant from the Swiss National Science Foundation (SNSF).	Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen LH, 1998, MOL ENDOCRINOL, V12, P1140, DOI 10.1210/me.12.8.1140; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	27	196	212	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1330	+		10.1038/ncb2612	http://dx.doi.org/10.1038/ncb2612			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23143398				2022-12-25	WOS:000311890300015
J	Fukazawa, Y; Park, H; Cameron, MJ; Lefebvre, F; Lum, R; Coombes, N; Mahyari, E; Hagen, SI; Bae, JY; Delos Reyes, M; Swanson, T; Legasse, AW; Sylwester, A; Hansen, SG; Smith, AT; Stafova, P; Shoemaker, R; Li, Y; Oswald, K; Axthelm, MK; McDermott, A; Ferrari, G; Montefiori, DC; Edlefsen, PT; Piatak, M; Lifson, JD; Sekaly, RP; Picker, LJ				Fukazawa, Yoshinori; Park, Haesun; Cameron, Mark J.; Lefebvre, Francois; Lum, Richard; Coombes, Noel; Mahyari, Eisa; Hagen, Shoko I.; Bae, Jin Young; Delos Reyes, Marcelo, III; Swanson, Tonya; Legasse, Alfred W.; Sylwester, Andrew; Hansen, Scott G.; Smith, Andrew T.; Stafova, Petra; Shoemaker, Rebecca; Li, Yuan; Oswald, Kelli; Axthelm, Michael K.; McDermott, Adrian; Ferrari, Guido; Montefiori, David C.; Edlefsen, Paul T.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Sekaly, Rafick P.; Picker, Louis J.			Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines	NATURE MEDICINE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; FOLLICULAR HELPER; CONTROL REPLICATION; MEMORY; PROTECTION; EFFECTOR; CHALLENGE; DEPLETION; HIV-1; MACROPHAGES	Live attenuated simian immunodeficiency virus (SIV) vaccines (LAVs) remain the most efficacious of all vaccines in nonhuman primate models of HIV and AIDS, yet the basis of their robust protection remains poorly understood. Here we show that the degree of LAV-mediated protection against intravenous wild-type SIVmac239 challenge strongly correlates with the magnitude and function of SIV-specific, effector-differentiated T cells in the lymph node but not with the responses of such T cells in the blood or with other cellular, humoral and innate immune parameters. We found that maintenance of protective T cell responses is associated with persistent LAV replication in the lymph node, which occurs almost exclusively in follicular helper T cells. Thus, effective LAVs maintain lymphoid tissue-based, effector-differentiated, SIV-specific T cells that intercept and suppress early wild-type SIV amplification and, if present in sufficient frequencies, can completely control and perhaps clear infection, an observation that provides a rationale for the development of safe, persistent vectors that can elicit and maintain such responses.	[Fukazawa, Yoshinori; Park, Haesun; Lum, Richard; Coombes, Noel; Mahyari, Eisa; Hagen, Shoko I.; Bae, Jin Young; Delos Reyes, Marcelo, III; Swanson, Tonya; Legasse, Alfred W.; Sylwester, Andrew; Hansen, Scott G.; Axthelm, Michael K.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Fukazawa, Yoshinori; Park, Haesun; Lum, Richard; Coombes, Noel; Mahyari, Eisa; Hagen, Shoko I.; Bae, Jin Young; Delos Reyes, Marcelo, III; Swanson, Tonya; Legasse, Alfred W.; Sylwester, Andrew; Hansen, Scott G.; Axthelm, Michael K.; Edlefsen, Paul T.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Cameron, Mark J.; Lefebvre, Francois; Smith, Andrew T.; Stafova, Petra; Sekaly, Rafick P.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Shoemaker, Rebecca; Li, Yuan; Oswald, Kelli; Piatak, Michael, Jr.; Lifson, Jeffrey D.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [McDermott, Adrian] US NIAID, Vaccine Res Inst, Bethesda, MD USA; [Ferrari, Guido; Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Vaccine & Gene Therapy Institute of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; Fred Hutchinson Cancer Center	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.	pickerl@ohsu.edu	Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019; Cameron, Mark/O-6775-2019; mahyari, eisa/L-2002-2016; Wilkinson, Peter/AAK-6426-2020	Ferrari, Guido/0000-0001-7747-3349; Cameron, Mark/0000-0003-4768-4094; mahyari, eisa/0000-0002-5613-3131; Wilkinson, Peter/0000-0002-1365-0470; McDermott, Adrian/0000-0003-0616-9117	Bill and Melinda Gates Foundation [41185]; International AIDS Vaccine Initiative (IAVI); National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028871] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U24OD010850, P51OD011092] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative (IAVI); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Bill and Melinda Gates Foundation (grant #41185), the International AIDS Vaccine Initiative (IAVI), the National Institute of Allergy and Infectious Diseases (including the US National Institutes of Health (NIH) kits (Ambion). The microarray analysis was conducted using 750 ng of biotinylated complementary RNA hybridized to HumanHT-12_V4 BeadChips (Illumina) at 58 degrees C for 20 h. The arrays were scanned using Illumina's iSCAN and quantified using Genome Studio (Illumina). The analysis of the GenomeStudio output data was conducted using the R<SUP>54</SUP> and Bioconductor<SUP>55</SUP> software packages. Quantile normalization was applied, followed by a log<INF>2</INF> transformation. The LIMMA package<SUP>56</SUP> was used to fit a linear model to each probe and perform (moderated) t tests or F tests on the groups being compared. To control the expected proportions of false positives, the FDR for each unadjusted P value was calculated using the Benjamini and Hochberg method implemented in LIMMA. Multidimensional scaling was used as a dimensionality reduction method in R to generate plots for the evaluation of similarities or dissimilarities between datasets. Ingenuity Pathway Analysis software (IPA, Ingenuity Systems) was used to annotate genes and rank canonical pathways. An immune response gene filter, constructed from innate and adaptive immune response gene queries of Gene Ontology (http://www.geneontology.org/),T cell activation and complement pathway genes from IPA and our own IFN- and inflammasomeresponse gene lists<SUP>57</SUP>, was used where noted to reduce datasets for visualization before FDR estimation. The microarray data are available through the National Center for Biotechnology Information Gene Expression Omnibus (GEO superseries GSE40006).	Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; CHACKERIAN B, 1995, VIROLOGY, V213, P386, DOI 10.1006/viro.1995.0011; Cline AN, 2005, J MED PRIMATOL, V34, P303; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grossman Z, 2008, CURR OPIN HIV AIDS, V3, P380, DOI 10.1097/COH.0b013e3282fbaae6; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000272; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; PICKER LJ, 1993, J IMMUNOL, V150, P1105; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; R Core Team, 2011, R LANG ENV STAT COMP; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 2000, J IMMUNOL, V164, P6015, DOI 10.4049/jimmunol.164.11.6015; Shen AD, 2007, J VIROL, V81, P1660, DOI 10.1128/JVI.01396-06; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Stebbings R, 2004, VIROLOGY, V330, P249, DOI 10.1016/j.virol.2004.09.026; Sugimoto C, 2003, J VIROL, V77, P4169, DOI 10.1128/JVI.77.7.4169-4180.2003; Sugimoto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011678; Taylor JJ, 2011, CURR OPIN IMMUNOL, V23, P319, DOI 10.1016/j.coi.2011.03.010; Todd CA, 2012, J IMMUNOL METHODS, V375, P57, DOI 10.1016/j.jim.2011.09.007; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Walker JM, 2004, METHOD CELL BIOL, V75, P535; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; Wolfe D. A., 1973, NONPARAMETRIC STAT M	57	110	111	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1673	+		10.1038/nm.2934	http://dx.doi.org/10.1038/nm.2934			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	22961108	Green Accepted			2022-12-25	WOS:000310837000028
J	Rice, GI; Kasher, PR; Forte, GMA; Mannion, NM; Greenwood, SM; Szynkiewicz, M; Dickerson, JE; Bhaskar, SS; Zampini, M; Briggs, TA; Jenkinson, EM; Bacino, CA; Battini, R; Bertini, E; Brogan, PA; Brueton, LA; Carpanelli, M; De Laet, C; de Lonlay, P; del Toro, M; Desguerre, I; Fazzi, E; Garcia-Cazorla, A; Heiberg, A; Kawaguchi, M; Kumar, R; Lin, JPSM; Lourenco, CM; Male, AM; Marques, W; Mignot, C; Olivieri, I; Orcesi, S; Prabhakar, P; Rasmussen, M; Robinson, RA; Rozenberg, F; Schmidt, JL; Steindl, K; Tan, TY; van der Merwe, WG; Vanderver, A; Vassallo, G; Wakeling, EL; Wassmer, E; Whittaker, E; Livingston, JH; Lebon, P; Suzuki, T; McLaughlin, PJ; Keegan, LP; O'Connell, MA; Lovell, SC; Crow, YJ				Rice, Gillian I.; Kasher, Paul R.; Forte, Gabriella M. A.; Mannion, Niamh M.; Greenwood, Sam M.; Szynkiewicz, Marcin; Dickerson, Jonathan E.; Bhaskar, Sanjeev S.; Zampini, Massimiliano; Briggs, Tracy A.; Jenkinson, Emma M.; Bacino, Carlos A.; Battini, Roberta; Bertini, Enrico; Brogan, Paul A.; Brueton, Louise A.; Carpanelli, Marialuisa; De Laet, Corinne; de Lonlay, Pascale; del Toro, Mireia; Desguerre, Isabelle; Fazzi, Elisa; Garcia-Cazorla, Angels; Heiberg, Arvid; Kawaguchi, Masakazu; Kumar, Ram; Lin, Jean-Pierre S-M; Lourenco, Charles M.; Male, Alison M.; Marques, Wilson, Jr.; Mignot, Cyril; Olivieri, Ivana; Orcesi, Simona; Prabhakar, Prab; Rasmussen, Magnhild; Robinson, Robert A.; Rozenberg, Flore; Schmidt, Johanna L.; Steindl, Katharina; Tan, Tiong Y.; van der Merwe, William G.; Vanderver, Adeline; Vassallo, Grace; Wakeling, Emma L.; Wassmer, Evangeline; Whittaker, Elizabeth; Livingston, John H.; Lebon, Pierre; Suzuki, Tamio; McLaughlin, Paul J.; Keegan, Liam P.; O'Connell, Mary A.; Lovell, Simon C.; Crow, Yanick J.			Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature	NATURE GENETICS			English	Article							DYSCHROMATOSIS SYMMETRICA HEREDITARIA; RNA; SAMHD1; TREX1; GENE; LUPUS	Adenosine deaminases acting on RNA (ADARs) catalyze the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) and thereby potentially alter the information content and structure of cellular RNAs. Notably, although the overwhelming majority of such editing events occur in transcripts derived from Alu repeat elements, the biological function of non-coding RNA editing remains uncertain. Here, we show that mutations in ADAR1 (also known as ADAR) cause the autoimmune disorder Aicardi-Goutieres syndrome (AGS). As in Adar1-null mice, the human disease state is associated with upregulation of interferon-stimulated genes, indicating a possible role for ADAR1 as a suppressor of type I interferon signaling. Considering recent insights derived from the study of other AGS-related proteins, we speculate that ADAR1 may limit the cytoplasmic accumulation of the dsRNA generated from genomic repetitive elements.	[Rice, Gillian I.; Kasher, Paul R.; Forte, Gabriella M. A.; Szynkiewicz, Marcin; Dickerson, Jonathan E.; Bhaskar, Sanjeev S.; Zampini, Massimiliano; Briggs, Tracy A.; Jenkinson, Emma M.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Mannion, Niamh M.; Greenwood, Sam M.; Keegan, Liam P.; O'Connell, Mary A.] Univ Edinburgh, Human Genet Unit, MRC, IGMM, Edinburgh EH8 9YL, Midlothian, Scotland; [Bacino, Carlos A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Battini, Roberta] Ist Ricovero & Cura Carattere Sci IRCCS Stella Ma, Dept Dev Neurosci, Pisa, Italy; [Bertini, Enrico] Bambino Gesu Childrens Res Hosp, Dept Neurosci, Mol Med Lab, Rome, Italy; [Brogan, Paul A.] UCL, Inst Child Hlth, London, England; [Brueton, Louise A.] Birmingham Womens Natl Hlth Serv NHS Fdn Trust, Birmingham, W Midlands, England; [Carpanelli, Marialuisa] A Manzoni Hosp, Dept Child Neurol & Psychiat, Lecce, Italy; [De Laet, Corinne] Hop Univ Enfants Reine Fabiola ULB, Nutr & Metab Unit, Brussels, Belgium; [de Lonlay, Pascale] Paris Descartes Univ, Hop Necker Enfants Malad, Reference Ctr Metab Dis, Paris, France; [del Toro, Mireia] Hosp Valle De Hebron, Pediat Neurol Unit, Barcelona, Spain; [Desguerre, Isabelle] Univ Paris 05, Necker Hosp, AP HP, Neuropediat Unit, Paris, France; [Fazzi, Elisa] Univ Brescia, Unit Child Neurol & Psychiat, Civil Hosp, Mother & Child Dept, Brescia, Italy; [Garcia-Cazorla, Angels] HSJD, Dept Neurol, Barcelona, Spain; [Garcia-Cazorla, Angels] Inst Salud Carlos III, CIBER ER, Madrid, Spain; [Heiberg, Arvid] Univ Oslo, Natl Hosp, Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Kawaguchi, Masakazu; Suzuki, Tamio] Yamagata Univ, Fac Med, Dept Dermatol, Yamagata 990, Japan; [Kumar, Ram] Alder Hey Childrens NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Lin, Jean-Pierre S-M] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Gen Neurol & Complex Motor Disorders Serv, London, England; [Lourenco, Charles M.; Marques, Wilson, Jr.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurosci & Behav Sci, Sao Paulo, Brazil; [Male, Alison M.] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 3JH, England; [Mignot, Cyril] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75634 Paris, France; [Mignot, Cyril] Hop Armand Trousseau, AP HP, Serv Neuropediat, Paris, France; [Mignot, Cyril] Ctr Deficience Deficiences Intellectuelles Causes, Paris, France; [Olivieri, Ivana; Orcesi, Simona] IRCCS C Mondino Natl Inst Neurol Fdn, Child Neurol & Psychiat Unit, Pavia, Italy; [Prabhakar, Prab; Robinson, Robert A.] Great Ormond St Hosp Sick Children, Dept Neurol, London, England; [Rasmussen, Magnhild] Oslo Univ Hosp, Sect Child Neurol, Women & Childrens Div, Oslo, Norway; [Rozenberg, Flore; Lebon, Pierre] Paris Descartes Univ, Hop Cochin St Vincent de Paul, AP HP, Serv Virol, Paris, France; [Schmidt, Johanna L.; Vanderver, Adeline] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Steindl, Katharina] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Tan, Tiong Y.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [Vassallo, Grace] Royal Manchester Childrens Hosp, Dept Neurol, Manchester M27 1HA, Lancs, England; [Wakeling, Emma L.] NW London Hosp NHS Trust, NW Thames Reg Genet Serv, Harrow, Middx, England; [Wassmer, Evangeline] Birmingham Childrens Hosp, Dept Neurol, Birmingham, W Midlands, England; [Whittaker, Elizabeth] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London, England; [Livingston, John H.] Leeds Gen Infirm, Dept Paediat Neurol, Leeds, W Yorkshire, England; [McLaughlin, Paul J.] Univ Edinburgh, Sch Biol Sci, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland; [Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Edinburgh; Baylor College of Medicine; IRCCS Fondazione Stella Maris; IRCCS Bambino Gesu; University of London; University College London; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Universitari Vall d'Hebron; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Brescia; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Oslo; National Hospital Norway; Yamagata University; Alder Hey Children's NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Universidade de Sao Paulo; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; IRCCS Fondazione Casimiro Mondino; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oslo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Children's National Health System; University of Zurich; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Manchester Children's Hospital; University of Birmingham; Imperial College London; Leeds General Infirmary; University of Leeds; University of Edinburgh; University of Manchester	Crow, YJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	yanickcrow@mac.com	battini, roberta/P-9095-2017; OConnell, Mary Anne/G-4740-2015; Bertini, Enrico/A-2284-2014; Vanderver, Adeline/CAG-5072-2022; Fazzi, Elisa/J-6076-2016; Tan, Tiong Yang/AAV-6563-2020; O'Connell, Mary Anne/U-7693-2019; Keegan, Liam P/F-1106-2017; Bertini, Enrico/ABG-1278-2020; Rice, Gillian I/G-3128-2015; Crow, Yanick J/N-6120-2014; Lin, Jean-Pierre/R-3779-2019; Wassmer, Evangeline/K-5467-2019; Rozenberg, Flore/O-8854-2017; Marques Junior, Wilson/G-4240-2012; orcesi, simona/J-6030-2016; Lourenço, Charles M/O-2731-2013; Keegan, Liam P./AAL-3753-2021	battini, roberta/0000-0002-7889-1355; OConnell, Mary Anne/0000-0003-3844-6174; Bertini, Enrico/0000-0001-9276-4590; Fazzi, Elisa/0000-0003-4805-7906; Tan, Tiong Yang/0000-0001-8455-7778; O'Connell, Mary Anne/0000-0003-3844-6174; Keegan, Liam P/0000-0001-7915-5790; Rice, Gillian I/0000-0002-4223-0571; Crow, Yanick J/0000-0001-7211-7564; Lin, Jean-Pierre/0000-0001-9314-2259; Marques Junior, Wilson/0000-0002-4589-2749; orcesi, simona/0000-0001-8947-9342; Keegan, Liam P./0000-0001-7915-5790; Kasher, Paul/0000-0002-9213-502X; Olivieri, Ivana/0000-0003-0502-205X; Brogan, Paul/0000-0001-6178-6893; Prabhakar, Prab/0000-0002-1641-8714; Whittaker, Elizabeth/0000-0002-7944-8793; Vanderver, Adeline/0000-0002-6290-6751; Briggs, Tracy/0000-0001-5208-2691; Lovell, Simon/0000-0002-4092-8458; Wakeling, Emma/0000-0001-5712-0044	European Union [241779]; Great Ormond Street Hospital Children's Charity; MRC [MC_PC_U127584490] Funding Source: UKRI; Medical Research Council [MC_PC_U127584490] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1212] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	European Union(European Commission); Great Ormond Street Hospital Children's Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We sincerely thank the participating families for the use of genetic samples and clinical information. We thank B. Hamel, H. Brunner and other clinical collaborators for contributing samples not included in the current manuscript, A.P. Jackson for highlighting the presence of intracranial calcification in individuals with DSH with a p.Gly1007Arg alteration in ADAR1 and D.B. Stetson and D.T. Bonthron for critical reading of the manuscript. D.B. Stetson (University of Washington) provided the ADAR1 constructs used in the editing assays. We thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (WHI) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). Y.J.C. acknowledges the Manchester National Institute for Health Research (NIHR) Biomedical Research Centre. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 241779 and from the Great Ormond Street Hospital Children's Charity.	Abdel-Salam GMH, 2010, NEUROPEDIATRICS, V41, P18, DOI 10.1055/s-0030-1255059; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Beck-Engeser GB, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-91; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Crow YJ, 2008, DEV MED CHILD NEUROL, V50, P410, DOI 10.1111/j.1469-8749.2008.02062.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Genovesio A, 2011, J BIOMOL SCREEN, V16, P945, DOI 10.1177/1087057111415521; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Haaxma CA, 2010, AM J MED GENET A, V152A, P2612, DOI 10.1002/ajmg.a.33620; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kondo T, 2008, J DERMATOL, V35, P662, DOI 10.1111/j.1346-8138.2008.00540.x; Kondo T, 2008, J DERMATOL, V35, P395, DOI 10.1111/j.1346-8138.2008.00493.x; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li M, 2010, ARCH DERMATOL RES, V302, P469, DOI 10.1007/s00403-010-1039-2; Miyamura Y, 2003, AM J HUM GENET, V73, P693, DOI 10.1086/378209; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Tojo K, 2006, MOVEMENT DISORD, V21, P1510, DOI 10.1002/mds.21011; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200	40	524	536	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1243	1248		10.1038/ng.2414	http://dx.doi.org/10.1038/ng.2414			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23001123	Green Accepted			2022-12-25	WOS:000310495800017
J	Anastasiou, D; Yu, YM; Israelsen, WJ; Jiang, JK; Boxer, MB; Hong, BS; Tempel, W; Dimov, S; Shen, M; Jha, A; Yang, H; Mattaini, KR; Metallo, CM; Fiske, BP; Courtney, KD; Malstrom, S; Khan, TM; Kung, C; Skoumbourdis, AP; Veith, H; Southall, N; Walsh, MJ; Brimacombe, KR; Leister, W; Lunt, SY; Johnson, ZR; Yen, KE; Kunii, K; Davidson, SM; Christofk, HR; Austin, CP; Inglese, J; Harris, MH; Asara, JM; Stephanopoulos, G; Salituro, FG; Jin, SF; Dang, L; Auld, DS; Park, HW; Cantley, LC; Thomas, CJ; Heiden, MGV				Anastasiou, Dimitrios; Yu, Yimin; Israelsen, William J.; Jiang, Jian-Kang; Boxer, Matthew B.; Hong, Bum Soo; Tempel, Wolfram; Dimov, Svetoslav; Shen, Min; Jha, Abhishek; Yang, Hua; Mattaini, Katherine R.; Metallo, Christian M.; Fiske, Brian P.; Courtney, Kevin D.; Malstrom, Scott; Khan, Tahsin M.; Kung, Charles; Skoumbourdis, Amanda P.; Veith, Henrike; Southall, Noel; Walsh, Martin J.; Brimacombe, Kyle R.; Leister, William; Lunt, Sophia Y.; Johnson, Zachary R.; Yen, Katharine E.; Kunii, Kaiko; Davidson, Shawn M.; Christofk, Heather R.; Austin, Christopher P.; Inglese, James; Harris, Marian H.; Asara, John M.; Stephanopoulos, Gregory; Salituro, Francesco G.; Jin, Shengfang; Dang, Lenny; Auld, Douglas S.; Park, Hee-Won; Cantley, Lewis C.; Thomas, Craig J.; Heiden, Matthew G. Vander			Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis	NATURE CHEMICAL BIOLOGY			English	Article							CANCER-CELL METABOLISM; TUMOR-GROWTH; NUCLEAR TRANSLOCATION; THYROID-HORMONE; BINDING PROTEIN; ISOFORM; FRUCTOSE-1,6-BISPHOSPHATE; ISOZYME; INHIBITION; CONVERSION	Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. The interaction of PKM2 with phosphotyrosine-containing proteins inhibits enzyme activity and increases the availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small-molecule PKM2 activators inhibits the growth of xenograft tumors. Structural studies reveal that small-molecule activators bind PKM2 at the subunit interaction interface, a site that is distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small-molecule activation of PKM2 can interfere with anabolic metabolism.	[Anastasiou, Dimitrios; Courtney, Kevin D.; Christofk, Heather R.; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA; [Anastasiou, Dimitrios; Courtney, Kevin D.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Yu, Yimin; Israelsen, William J.; Mattaini, Katherine R.; Fiske, Brian P.; Malstrom, Scott; Khan, Tahsin M.; Lunt, Sophia Y.; Johnson, Zachary R.; Davidson, Shawn M.; Heiden, Matthew G. Vander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jiang, Jian-Kang; Boxer, Matthew B.; Shen, Min; Skoumbourdis, Amanda P.; Veith, Henrike; Southall, Noel; Walsh, Martin J.; Brimacombe, Kyle R.; Leister, William; Austin, Christopher P.; Inglese, James; Auld, Douglas S.; Thomas, Craig J.] Natl Ctr Adv Translat Sci, NIH, Chem Genom Ctr, Bethesda, MD USA; [Hong, Bum Soo; Tempel, Wolfram; Dimov, Svetoslav; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Jha, Abhishek; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Yang, Hua; Kung, Charles; Yen, Katharine E.; Kunii, Kaiko; Salituro, Francesco G.; Jin, Shengfang; Dang, Lenny] Agios Pharmaceut, Cambridge, MA USA; [Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Courtney, Kevin D.; Heiden, Matthew G. Vander] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Harris, Marian H.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Toronto; Structural Genomics Consortium; Massachusetts Institute of Technology (MIT); Agios Pharmaceuticals; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto	Anastasiou, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA.	mvh@mit.edu	Cantley, Lewis C/D-1800-2014; Metallo, Christian/HCH-3476-2022; Southall, Noel T/H-8991-2012; Harris, Marian/R-7049-2019	Cantley, Lewis C/0000-0002-1298-7653; Metallo, Christian/0000-0003-2404-3040; Southall, Noel T/0000-0003-4500-880X; Thomas, Craig/0000-0001-9386-9001; Israelsen, William/0000-0002-3653-9353; Fiske, Brian/0000-0001-5891-4268; Christofk, Heather/0000-0002-8662-4425; Dang, Lenny/0000-0002-2073-6109; Anastasiou, Dimitrios/0000-0002-1269-843X; Lunt, Sophia/0000-0003-4522-6065; Jha, Abhishek/0000-0001-9161-0450	NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516, R01CA160458, P30CA014051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085679] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [5P01CA120964, 5P30CA1405141, P30 CA006516, 5P30CA006516, P01 CA120964, R01 CA160458] Funding Source: Medline; NIGMS NIH HHS [R01 GM56203, R01 GM056203] Funding Source: Medline; NIMH NIH HHS [R03MH085679, R03 MH085679] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, BIOCHEMISTRY-US, V30, P7105, DOI 10.1021/bi00243a010; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; Ikeda Y, 2000, J BIOL CHEM, V275, P9150, DOI 10.1074/jbc.275.13.9150; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; KATO H, 1989, P NATL ACAD SCI USA, V86, P7861, DOI 10.1073/pnas.86.20.7861; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Locasale JW, 2010, CELL CYCLE, V9, P4253, DOI 10.4161/cc.9.21.13925; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHUMACKER PT, 1993, AM J PHYSIOL, V265, pL395, DOI 10.1152/ajplung.1993.265.4.L395; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	43	485	502	13	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					839	847		10.1038/NCHEMBIO.1060	http://dx.doi.org/10.1038/NCHEMBIO.1060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22922757	Green Submitted, Green Accepted			2022-12-25	WOS:000309056200009
J	Huang, J; Deng, Q; Wang, Q; Li, KY; Dai, JH; Li, N; Zhu, ZD; Zhou, B; Liu, XY; Liu, RF; Fei, QL; Chen, H; Cai, B; Zhou, BP; Xiao, HS; Qin, LX; Han, ZG				Huang, Jian; Deng, Qing; Wang, Qun; Li, Kun-Yu; Dai, Ji-Hong; Li, Niu; Zhu, Zhi-Dong; Zhou, Bo; Liu, Xiao-Yan; Liu, Rui-Fang; Fei, Qian-Lan; Chen, Hui; Cai, Bing; Zhou, Boping; Xiao, Hua-Sheng; Qin, Lun-Xiu; Han, Ze-Guang			Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma	NATURE GENETICS			English	Article							ARISTOLOCHIC ACID; FREQUENT MUTATIONS; LIVER-CANCER; HUMAN BREAST; TP53; GENE; ARID1A; PFTK1	Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and shows a propensity to metastasize and infiltrate adjacent and more distant tissues(1). HCC is associated with multiple risk factors, including hepatitis B virus (HBV) infection, which is especially prevalent in China. Here, we used exome sequencing to identify somatic mutations in ten HBV-positive individuals with HCC with portal vein tumor thromboses (PVTTs), intrahepatic metastases. Both C:G>A: T and T:A>A:T transversions were frequently found among the 331 non-silent mutations. Notably, ARID1A, which encodes a component of the SWI/SNF chromatin remodeling complex, was mutated in 14 of 110 (13%) HBV-associated HCC specimens. We used RNA interference to assess the roles of 91 of the confirmed mutated genes in cellular survival. The results suggest that seven of these genes, including VCAM1 and CDK14, may confer growth and infiltration capacity to HCC cells. This study provides a view of the landscape of somatic mutations that may be implicated in advanced HCC.	[Huang, Jian; Deng, Qing; Wang, Qun; Li, Niu; Zhou, Bo; Liu, Xiao-Yan; Liu, Rui-Fang; Han, Ze-Guang] Shanghai Jiao Tong Univ, Sch Med, Human Genome Ctr, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Huang, Jian; Deng, Qing; Wang, Qun; Li, Kun-Yu; Dai, Ji-Hong; Li, Niu; Zhou, Bo; Liu, Xiao-Yan; Liu, Rui-Fang; Fei, Qian-Lan; Chen, Hui; Han, Ze-Guang] Chinese Natl Human Genome Ctr, Shanghai Minist Sci & Technol MOST, Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Huang, Jian; Zhu, Zhi-Dong; Xiao, Hua-Sheng] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China; [Huang, Jian; Zhou, Boping] Guangdong Med Coll, Shenzhen Key Lab Diag & Treatment Infect Dis, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China; [Cai, Bing] Nanjing Med Univ, Dept Hepatobiliary Surg, Wuxi Peoples Hosp, Wuxi, Peoples R China; [Qin, Lun-Xiu] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Guangdong Medical University; Jiangnan University; Nanjing Medical University; Fudan University	Han, ZG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Human Genome Ctr, Rui Jin Hosp, Shanghai 200030, Peoples R China.	hanzg@chgc.sh.cn	Deng, Qing/H-6506-2019	Deng, Qing/0000-0001-5116-461X; Han, Ze-Guang/0000-0002-1018-1752	Chinese National Key Program on Basic Research [2010CB529204, 2010CB529206]; China National Key Projects for Infectious Disease [2012ZX10002012-008]; National Natural Science Foundation of China [81071722, 81101875]; Shanghai Commission for Science and Technology [11ZR1425300]; International Scientific Collaborative Project [2011ZR0001]; National High Technology Research and Development Program of China (863 Program) [2012AA02A205, SS2012AA020103]	Chinese National Key Program on Basic Research; China National Key Projects for Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission for Science and Technology; International Scientific Collaborative Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	We gratefully acknowledge support from the Chinese National Key Program on Basic Research (2010CB529204 and 2010CB529206), the China National Key Projects for Infectious Disease (2012ZX10002012-008), the National Natural Science Foundation of China (81071722 and 81101875), the Shanghai Commission for Science and Technology (11ZR1425300), the International Scientific Collaborative Project (2011ZR0001) and the National High Technology Research and Development Program of China (863 Program, 2012AA02A205 and SS2012AA020103).	AGUILAR F, 1993, P NATL ACAD SCI USA, V90, P8586, DOI 10.1073/pnas.90.18.8586; Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Barbin A, 2000, MUTAT RES-REV MUTAT, V462, P55, DOI 10.1016/S1383-5742(00)00014-4; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Liver Cancer Study Group of Japan, 1990, Ann Surg, V211, P277; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriya M, 2011, INT J CANCER, V129, P1532, DOI 10.1002/ijc.26077; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shu F, 2007, P NATL ACAD SCI USA, V104, P9248, DOI 10.1073/pnas.0703327104; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Topaz O, 2006, AM J HUM GENET, V79, P759, DOI 10.1086/508069; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang YY, 2011, MUTAGENESIS, V26, P619, DOI 10.1093/mutage/ger023; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	37	303	324	4	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1117	+		10.1038/ng.2391	http://dx.doi.org/10.1038/ng.2391			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922871				2022-12-25	WOS:000309550200011
J	Kusminski, CM; Holland, WL; Sun, K; Park, J; Spurgin, SB; Lin, Y; Askew, GR; Simcox, JA; McClain, DA; Li, C; Scherer, PE				Kusminski, Christine M.; Holland, William L.; Sun, Kai; Park, Jiyoung; Spurgin, Stephen B.; Lin, Ying; Askew, G. Roger; Simcox, Judith A.; McClain, Don A.; Li, Cai; Scherer, Philipp E.			MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity	NATURE MEDICINE			English	Article							HUMAN SKELETAL-MUSCLE; OXIDATIVE STRESS; ADIPOSE-TISSUE; MEMBRANE PROTEIN; METABOLIC SYNDROME; GENE-EXPRESSION; RESISTANCE; ADIPONECTIN; DYSFUNCTION; MECHANISMS	We examined mouse models with altered adipocyte expression of mitoNEET, a protein residing in the mitochondrial outer membrane, to probe its impact on mitochondrial function and subsequent cellular responses. We found that overexpression of mitoNEET enhances lipid uptake and storage, leading to an expansion of the mass of adipose tissue. Despite the resulting massive obesity, benign aspects of adipose tissue expansion prevail, and insulin sensitivity is preserved. Mechanistically, we also found that mitoNEET inhibits mitochondrial iron transport into the matrix and, because iron is a rate-limiting component for electron transport, lowers the rate of beta-oxidation. This effect is associated with a lower mitochondrial membrane potential and lower levels of reactive oxygen species-induced damage, along with increased production of adiponectin. Conversely, a reduction in mitoNEET expression enhances mitochondrial respiratory capacity through enhanced iron content in the matrix, ultimately corresponding to less weight gain on a high-fat diet. However, this reduction in mitoNEET expression also causes heightened oxidative stress and glucose intolerance. Thus, manipulation of mitochondrial function by varying mitoNEET expression markedly affects the dynamics of cellular and whole-body lipid homeostasis.	[Kusminski, Christine M.; Holland, William L.; Sun, Kai; Park, Jiyoung; Spurgin, Stephen B.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Lin, Ying] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Askew, G. Roger; Li, Cai] Merck Res Labs, Dept Metab Disorders, Rahway, NJ USA; [Simcox, Judith A.; McClain, Don A.] Univ Utah, Sch Med, Dept Med & Biochem, Salt Lake City, UT USA; [McClain, Don A.] Virginia Med Ctr, Res Serv, Salt Lake City, UT USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Albert Einstein College of Medicine; Merck & Company; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	park, Jiyoung/G-4592-2013; Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392; Sun, Kai/0000-0002-4778-4549; Simcox, Judith/0000-0001-7350-6342; Spurgin, Stephen/0000-0003-0615-7626; McClain, Don/0000-0002-3310-2359	US National Institutes of Health [R01-DK55758, RC1-DK086629, P01-DK088761, K99-DK094973]; American Heart Association [12BGIA8910006, R01-DK081842, T32-DK091317]; Department of Defense [USAMRMC-BC085909]; Juvenile Diabetes Foundation [JDRF 3-2008-130]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088761, R01DK055758, R01DK081842, T32DK091317, RC1DK086629, K99DK094973] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. D. Neufer, G. Schatz and C. B. Newgard for helpful comments and suggestions. We also thank J. Song and J. Xia for technical assistance, in addition to the rest of the Scherer laboratory, R. Unger and D. Clegg for helpful discussions. We also thank P. Blanchard and Y. Deshaies for kindly providing LPL activity measurements, R. Hammer and the University of Texas Southwestern (UTSW) Transgenic Core Facility for the generation of mouse models, as well as the UTSW Metabolic Core Facility for help in the phenotypic characterization of the mice and G. Milne from Vanderbilt University Medical Center for the F2-isoprostane analysis. The authors were supported by US National Institutes of Health grants R01-DK55758, RC1-DK086629 and P01-DK088761 (P. E. S.), K99-DK094973 and an American Heart Association Beginning Grant in Aid 12BGIA8910006 (W. L. H.), R01-DK081842 (D. A. M.), T32-DK091317 (J. A. S.) and Department of Defense Fellowship USAMRMC-BC085909 (J. P.). C. M. K. was supported by a fellowship from the Juvenile Diabetes Foundation (JDRF 3-2008-130).	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; HULTIN M, 1995, J LIPID RES, V36, P2174; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Laplante M, 2009, AM J PHYSIOL-REG I, V296, pR57, DOI 10.1152/ajpregu.90552.2008; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MACDONALD VW, 1985, J LAB CLIN MED, V105, P11; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mehta JL, 2006, INT J BIOCHEM CELL B, V38, P794, DOI 10.1016/j.biocel.2005.12.008; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SHERRATT HSA, 1991, REV NEUROL, V147, P417; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	57	306	314	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1539	U144		10.1038/nm.2899	http://dx.doi.org/10.1038/nm.2899			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22961109	Green Accepted			2022-12-25	WOS:000309587500033
J	You, CJ; Dai, XX; Yuan, BF; Wang, J; Wang, JS; Brooks, PJ; Niedernhofer, LJ; Wang, YS				You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Jin; Wang, Jianshuang; Brooks, Philip J.; Niedernhofer, Laura J.; Wang, Yinsheng			A quantitative assay for assessing the effects of DNA lesions on transcription	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; MAMMALIAN-CELLS; RNA-POLYMERASE; IN-VIVO; TRANSLESION SYNTHESIS; MUTAGENESIS CAUSES; BYPASS; DAMAGE; 8,5'-CYCLOPURINE-2'-DEOXYNUCLEOSIDES	Most mammalian cells in nature are quiescent but actively transcribing mRNA for normal physiological processes; thus, it is important to investigate how endogenous and exogenous DNA damage compromises transcription in cells. Here we describe a new competitive transcription and adduct bypass (CTAB) assay to determine the effects of DNA lesions on the fidelity and efficiency of transcription. Using this strategy, we demonstrate that the oxidatively induced lesions 8,5'-cyclo-2'-deoxyadenosine (cdA) and 8,5'-cyclo-2'-deoxyguanosine (cdG) and the methylglyoxal-induced lesion N-2-(1-carboxyethyl)-2'-deoxyguanosine (N-2-CEdG) strongly inhibited transcription in vitro and in mammalian cells. In addition, cdA and cdG, but not N-2-CEdG, induced transcriptional mutagenesis in vitro and in vivo. Furthermore, when located on the template DNA strand, all examined lesions were primarily repaired by transcription-coupled nucleotide excision repair in mammalian cells. This newly developed CTAB assay should be generally applicable for quantitatively assessing how other DNA lesions affect DNA transcription in vitro and in cells.	[You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Jin; Wang, Jianshuang; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Brooks, Philip J.] NIAAA, Lab Neurogenet, Rockville, MD 20852 USA; [Niedernhofer, Laura J.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	You, CJ (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013; Wang, Jin/AAE-3809-2022	Yuan, Bi-Feng/0000-0001-5223-4659; Wang, Jin/0000-0001-5511-3983; You, Changjun/0000-0003-4301-2098; Dai, Xiaoxia/0000-0002-3514-5061	NATIONAL CANCER INSTITUTE [R01CA101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019873, R01ES016114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA101864] Funding Source: Medline; NIDDK NIH HHS [R01 DK082779] Funding Source: Medline; NIEHS NIH HHS [R01 ES016114, R01 ES019873] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Belmadoui N, 2010, ORG BIOMOL CHEM, V8, P3211, DOI 10.1039/c004531d; Bregeon D, 2003, MOL CELL, V12, P959, DOI 10.1016/S1097-2765(03)00360-5; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Chatgilialoglu C, 2011, CHEM SOC REV, V40, P1368, DOI 10.1039/c0cs00061b; Cheng TF, 2008, J BIOL CHEM, V283, P27820, DOI 10.1074/jbc.M804086200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Clauson CL, 2010, DNA REPAIR, V9, P842, DOI 10.1016/j.dnarep.2010.04.004; Clauson CL, 2010, P NATL ACAD SCI USA, V107, P3657, DOI 10.1073/pnas.0913191107; Cohen SE, 2010, P NATL ACAD SCI USA, V107, P15517, DOI 10.1073/pnas.1005203107; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Frischmann M, 2005, CHEM RES TOXICOL, V18, P1586, DOI 10.1021/tx0501278; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jasti VP, 2011, BIOCHEMISTRY-US, V50, P3862, DOI 10.1021/bi2004944; Kornberg R, 2007, ANGEW CHEM INT EDIT, V46, P6957, DOI 10.1002/anie.200701832; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Kuraoka I, 2001, J BIOL CHEM, V276, P49283, DOI 10.1074/jbc.M107779200; Kuraoka I, 2006, METHOD ENZYMOL, V408, P214, DOI 10.1016/S0076-6879(06)08013-X; Li H, 2006, KIDNEY INT, V69, P388, DOI 10.1038/sj.ki.5000064; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Murata-Kamiya N, 1999, MUTAT RES-GEN TOX EN, V442, P19, DOI 10.1016/S1383-5718(99)00054-6; Rodriguez H, 2007, BIOCHEMISTRY-US, V46, P2488, DOI 10.1021/bi062022p; Rolig RL, 1997, MUTAGENESIS, V12, P277, DOI 10.1093/mutage/12.4.277; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Schneider M, 2004, CHEM RES TOXICOL, V17, P1385, DOI 10.1021/tx049929d; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Synold T, 2008, CHEM RES TOXICOL, V21, P2148, DOI 10.1021/tx800224y; Tamae D, 2011, BIOCHEMISTRY-US, V50, P2321, DOI 10.1021/bi101933p; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Viswanathan A, 1999, SCIENCE, V284, P159, DOI 10.1126/science.284.5411.159; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835	47	64	63	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					817	822		10.1038/NCHEMBIO.1046	http://dx.doi.org/10.1038/NCHEMBIO.1046			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22902614	Green Accepted			2022-12-25	WOS:000309056200006
J	Koenekoop, RK; Wang, H; Majewski, J; Wang, X; Lopez, I; Ren, HN; Chen, YY; Li, YM; Fishman, GA; Genead, M; Schwartzentruber, J; Solanki, N; Traboulsi, EI; Cheng, JL; Logan, CV; McKibbin, M; Hayward, BE; Parry, DA; Johnson, CA; Nageeb, M; Poulter, JA; Mohamed, MD; Jafri, H; Rashid, Y; Taylor, GR; Keser, V; Mardon, G; Xu, HD; Inglehearn, CF; Fu, Q; Toomes, C; Chen, R				Koenekoop, Robert K.; Wang, Hui; Majewski, Jacek; Wang, Xia; Lopez, Irma; Ren, Huanan; Chen, Yiyun; Li, Yumei; Fishman, Gerald A.; Genead, Mohammed; Schwartzentruber, Jeremy; Solanki, Naimesh; Traboulsi, Elias I.; Cheng, Jingliang; Logan, Clare V.; McKibbin, Martin; Hayward, Bruce E.; Parry, David A.; Johnson, Colin A.; Nageeb, Mohammed; Poulter, James A.; Mohamed, Moin D.; Jafri, Hussain; Rashid, Yasmin; Taylor, Graham R.; Keser, Vafa; Mardon, Graeme; Xu, Huidan; Inglehearn, Chris F.; Fu, Qing; Toomes, Carmel; Chen, Rui		Finding Rare Dis Genes FORGE	Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration	NATURE GENETICS			English	Article							WALLERIAN DEGENERATION; MONONUCLEOTIDE ADENYLYLTRANSFERASE; WLD(S); ACTIVATION; IQCB1; MICE	Leber congenital amaurosis (LCA) is a blinding retinal disease that presents within the first year after birth. Using exome sequencing, we identified mutations in the nicotinamide adenine dinucleotide (NAD) synthase gene NMNAT1 encoding nicotinamide mononucleotide adenylyltransferase 1 in eight families with LCA, including the family in which LCA was originally linked to the LCA9 locus. Notably, all individuals with NMNAT1 mutations also have macular colobomas, which are severe degenerative entities of the central retina (fovea) devoid of tissue and photoreceptors. Functional assays of the proteins encoded by the mutant alleles identified in our study showed that the mutations reduce the enzymatic activity of NMNAT1 in NAD biosynthesis and affect protein folding. Of note, recent characterization of the slow Wallerian degeneration (Wld(s)) mouse model, in which prolonged axonal survival after injury is observed, identified NMNAT1 as a neuroprotective protein when ectopically expressed. Our findings identify a new disease mechanism underlying LCA and provide the first link between endogenous NMNAT1 dysfunction and a human nervous system disorder.	[Wang, Hui; Li, Yumei; Solanki, Naimesh; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Koenekoop, Robert K.; Lopez, Irma; Ren, Huanan; Nageeb, Mohammed; Keser, Vafa; Fu, Qing] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ, Canada; [Wang, Hui; Wang, Xia; Chen, Yiyun; Li, Yumei; Cheng, Jingliang; Mardon, Graeme; Xu, Huidan; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Majewski, Jacek; Schwartzentruber, Jeremy] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Majewski, Jacek; Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Fishman, Gerald A.; Genead, Mohammed] Chicago Lighthouse People Who Are Blind Visually, Chicago, IL USA; [Traboulsi, Elias I.] Cole Eye Inst, Ctr Genet Eye Dis, Cleveland, OH USA; [Logan, Clare V.; Hayward, Bruce E.; Parry, David A.; Johnson, Colin A.; Poulter, James A.; Taylor, Graham R.; Inglehearn, Chris F.; Toomes, Carmel] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [McKibbin, Martin] St James Univ Hosp, Dept Ophthalmol, Leeds, W Yorkshire, England; [Mohamed, Moin D.] St Thomas Hosp, Dept Ophthalmol, London, England; [Jafri, Hussain] Gene Tech Labs, Lahore, Pakistan; [Rashid, Yasmin] King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; [Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Fu, Qing] Second Mil Med Univ, Affiliated Hosp 1, Shanghai, Peoples R China; [Chen, Rui] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA	Baylor College of Medicine; McGill University; Baylor College of Medicine; McGill University; University of Leeds; Saint James's University Hospital; Guy's & St Thomas' NHS Foundation Trust; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Naval Medical University; Baylor College of Medicine	Chen, R (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	ruichen@bcm.edu	Wang, Xia/O-4036-2014; Inglehearn, Chris/GYD-9783-2022; Scherer, Stephen W./B-3785-2013; Poulter, James A/A-8190-2013; Traboulsi, Elias/AAY-7443-2020; Koenekoop, Robert/AAT-6676-2021	Wang, Xia/0000-0002-7750-1167; Scherer, Stephen W./0000-0002-8326-1999; Poulter, James A/0000-0003-2048-5693; Schwartzentruber, Jeremy/0000-0002-6183-2092; Logan, Clare/0000-0003-4323-1602; Toomes, Carmel/0000-0001-8373-9545; Parry, David/0000-0003-0376-7736; Johnson, Colin/0000-0002-2979-8234	Foundation Fighting Blindness Canada; Canadian Institutes for Health Research; US National Institutes of Health (NIH); Reseau Vision; Fonds de la Recherche en Sante du Quebec (FRSQ); FORGE Canada; Pangere Corporation; Grousbeck Foundation; Wynn-Gund Foundation; Sir Jules Thorn Charitable Trust [09/JTA]; NIH [1S10RR026550]; Graduate Innovation Foundation of Hunan Province [CX2011B388]; Retinal Research Foundation; National Eye Institute [R01EY018571]; Government of Canada through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia;  [F32EY19430]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018571, F32EY019430] Funding Source: NIH RePORTER; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Foundation Fighting Blindness Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reseau Vision; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FORGE Canada; Pangere Corporation; Grousbeck Foundation; Wynn-Gund Foundation; Sir Jules Thorn Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Innovation Foundation of Hunan Province; Retinal Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); The Sir Jules Thorn Charitable Trust	We thank all of the individuals with LCA and their parents who were involved in this study. We thank R. Sifers for scientific discussion and J.E. Zaneveld for critical reading of the manuscript. R.K.K. is supported by the Foundation Fighting Blindness Canada, the Canadian Institutes for Health Research, the US National Institutes of Health (NIH), Reseau Vision, the Fonds de la Recherche en Sante du Quebec (FRSQ) and FORGE Canada. We acknowledge the FORGE Canada Consortium. We thank R. Pigeon for coordinating all the individuals with LCA. G.A.F. acknowledges the Pangere Corporation, Grousbeck Foundation and the Wynn-Gund Foundation for financial support. We sincerely acknowledge The Royal Society (C.T. is a university research fellow), Yorkshire Eye Research and The Sir Jules Thorn Charitable Trust (grant 09/JTA). Exome sequencing was performed at the BCM-Functional Genome Initiative (BCM-FGI) core facility, which is supported by NIH shared instrument grant 1S10RR026550 to R.C.H.W. was supported by postdoctoral fellowship F32EY19430. J.C. was supported by the Graduate Innovation Foundation of Hunan Province (CX2011B388). This work is supported by grants from the Retinal Research Foundation and the National Eye Institute (R01EY018571) to G.M. and R.C.; The FORGE Steering Committee comprises K. Boycott (leader; University of Ottawa, Ottawa, Ontario, Canada), J. Friedman (co-lead; University of British Columbia, Vancouver, British Columbia, Canada), J. Michaud (co-lead; Universite de Montreal, Montreal, Quebec, Canada), F. Bernier (University of Calgary, Calgary, Alberta, Canada), M. Brudno (University of Toronto, Toronto, Ontario, Canada), B. Fernandez (Memorial University, St. John's, Newfoundland, Canada), B. Knoppers (McGill University, Montreal, Quebec, Canada), M. Samuels (Universite de Montreal, Montreal, Quebec, Canada) and S. Scherer (University of Toronto, Toronto, Ontario, Canada). This work was funded in part by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia. We thank J. Marcadier (Clinical Coordinator) and C. Beaulieu (Project Manager) for their contribution to the infrastructure of the FORGE Canada Consortium.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LUDWIN SK, 1992, J NEUROL SCI, V109, P140, DOI 10.1016/0022-510X(92)90160-M; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Sasaki Y, 2010, J BIOL CHEM, V285, P41211, DOI 10.1074/jbc.C110.193904; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Wang H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/j.ajhg.2009.02.005; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Wishart TM, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-21; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	29	141	148	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1035	+		10.1038/ng.2356	http://dx.doi.org/10.1038/ng.2356			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22842230	Green Accepted			2022-12-25	WOS:000308491200016
J	Nurse, P				Nurse, Paul			Finding CDK: Linking yeast with humans	NATURE CELL BIOLOGY			English	Editorial Material									Royal Soc, London SW1Y 5AG, England		Nurse, P (corresponding author), Royal Soc, 6-9 Carlton House, London SW1Y 5AG, England.	paul.nurse@royalsociety.org		Nurse, Paul/0000-0002-9244-7787	Cancer Research UK [15699] Funding Source: researchfish; Wellcome Trust [093917] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)			0	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2012	14	8					776	776		10.1038/ncb2547	http://dx.doi.org/10.1038/ncb2547			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	983JP	22854809	Bronze			2022-12-25	WOS:000307115900002
J	Ramskold, D; Luo, SJ; Wang, YC; Li, R; Deng, QL; Faridani, OR; Daniels, GA; Khrebtukova, I; Loring, JF; Laurent, LC; Schroth, GP; Sandberg, R				Ramskold, Daniel; Luo, Shujun; Wang, Yu-Chieh; Li, Robin; Deng, Qiaolin; Faridani, Omid R.; Daniels, Gregory A.; Khrebtukova, Irina; Loring, Jeanne F.; Laurent, Louise C.; Schroth, Gary P.; Sandberg, Rickard			Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIATION; TRANSCRIPTOMES; MELANOMA; REVEALS; MARKERS	Genome-wide transcriptome analyses are routinely used to monitor tissue-, disease- and cell type specific gene expression, but it has been technically challenging to generate expression profiles from single cells. Here we describe a robust mRNA-Seq protocol (Smart-Seq) that is applicable down to single cell levels. Compared with existing methods, Smart-Seq has improved read coverage across transcripts, which enhances detailed analyses of alternative transcript isoforms and identification of single-nucleotide polymorphisms. We determined the sensitivity and quantitative accuracy of Smart-Seq for single-cell transcriptomics by evaluating it on total RNA dilution series. We found that although gene expression estimates from single cells have increased noise, hundreds of differentially expressed genes could be identified using few cells per cell type. Applying Smart-Seq to circulating tumor cells from melanomas, we identified distinct gene expression patterns, including candidate biomarkers for melanoma circulating tumor cells. Our protocol will be useful for addressing fundamental biological problems requiring genome-wide transcriptome profiling in rare cells.	[Ramskold, Daniel; Deng, Qiaolin; Faridani, Omid R.; Sandberg, Rickard] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Ramskold, Daniel; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Luo, Shujun; Li, Robin; Khrebtukova, Irina; Schroth, Gary P.] Illumina Inc, Hayward, CA USA; [Wang, Yu-Chieh; Loring, Jeanne F.] Scripps Res Inst, Ctr Regenerat Med, Dept Physiol Chem, La Jolla, CA 92037 USA; [Daniels, Gregory A.] Rebecca & John Moores Canc Ctr, La Jolla, CA USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; Karolinska Institutet; Illumina; Scripps Research Institute; University of California System; University of California San Diego	Sandberg, R (corresponding author), Ludwig Inst Canc Res, Stockholm Branch, S-10401 Stockholm, Sweden.	rickard.sandberg@ki.se	Loring, Jeanne F/A-1620-2011; Deng, Qiaolin/AAD-6905-2020; Gotoh, Osamu/B-4704-2012	Loring, Jeanne F/0000-0001-6226-9767; Deng, Qiaolin/0000-0001-5934-7816; Ramskold, Daniel/0000-0003-2892-673X; Sandberg, Rickard/0000-0001-6473-1740; Faridani, Omid/0000-0001-9330-887X; Laurent, Louise/0000-0002-2095-7534	Marie Mayer Foundation; US National Institutes of Health (NIH) [K12HD001259]; NIH [R33MH87925]; California Institute for Regenerative Medicine [CL1-00502, RT1-01108, TR1-01250, RN2-00931]; European Research Council [243066]; Swedish Research Council [2008-4562]; Foundation for Strategic Research [FFL4]; Ake Wiberg Foundation [756194131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087925] Funding Source: NIH RePORTER	Marie Mayer Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Strategic Research; Ake Wiberg Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Burge and G. Winberg for critical reading of the manuscript, T. Juarez and J. Cotton at the University of California San Diego for their help in Internal Review Board protocol preparation and aquisition of clinical samples, A.A. Talasaz and G. Cann for assistance with the Magsweeper, members of the Science for Life laboratory (Stockholm) for assistance with MiSeq sequencer. Y.-C.W. was supported by a fellowship from the Marie Mayer Foundation. L.C.L. was supported by US National Institutes of Health (NIH) K12HD001259. J.F.L. was supported by NIH R33MH87925 and California Institute for Regenerative Medicine (CL1-00502, RT1-01108, TR1-01250, and RN2-00931). R.S. was supported by European Research Council (starting grant 243066), Swedish Research Council (2008-4562), Foundation for Strategic Research (FFL4) and Ake Wiberg Foundation (756194131).	Chomez P, 2001, CANCER RES, V61, P5544; Duncan LM, 1998, CANCER RES, V58, P1515; Fang D, 1999, BIOCHEM BIOPH RES CO, V256, P657, DOI 10.1006/bbrc.1999.0400; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jungbluth AA, 1999, VIRCHOWS ARCH, V434, P429, DOI 10.1007/s004280050362; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; TANG A, 1994, J CELL SCI, V107, P983; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; TOMITA Y, 1985, J INVEST DERMATOL, V85, P426, DOI 10.1111/1523-1747.ep12277121; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	20	967	1081	18	352	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					777	782		10.1038/nbt.2282	http://dx.doi.org/10.1038/nbt.2282			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22820318	Green Accepted			2022-12-25	WOS:000307416900021
J	Harbour, JW; Roberson, EDO; Anbunathan, H; Onken, MD; Worley, LA; Bowcock, AM				Harbour, J. William; Roberson, Elisha D. O.; Anbunathan, Hima; Onken, Michael D.; Worley, Lori A.; Bowcock, Anne M.			Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma	NATURE GENETICS			English	Article							GENES; GNAQ	Uveal melanoma is the most common primary cancer of the eye and often results in fatal metastasis. Here, we describe mutations occurring exclusively at codon 625 of the SF3B1 gene, encoding splicing factor 3B subunit 1, in low-grade uveal melanomas with good prognosis. Thus, uveal melanoma is among a small group of cancers associated with SF3B1 mutations, and these mutations denote a distinct molecular subset of uveal melanomas.	[Harbour, J. William; Onken, Michael D.; Worley, Lori A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Roberson, Elisha D. O.; Anbunathan, Hima; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Harbour, JW (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jwharbour@med.miami.edu; bowcock@genetics.wustl.edu	Roberson, Elisha/ABC-1810-2020; Roberson, Elisha D.O./J-1747-2012; Harbour, J. William/B-1448-2015; Onken, Michael D/H-5620-2013; Anbunathan, Hima/AAU-9360-2021	Roberson, Elisha/0000-0001-5921-2399; Roberson, Elisha D.O./0000-0001-5921-2399; Harbour, J. William/0000-0002-1104-9809; Onken, Michael D/0000-0003-4082-1105; Anbunathan, Hima/0000-0002-8458-4845; Bowcock, Anne/0000-0001-8691-9090	US National Institutes of Health (NIH) [R01 CA16187001, CA12597007]; Melanoma Research Alliance; Melanoma Research Foundation; Tumori Foundation; Research to Prevent Blindness, Inc.; US NIH Vision Core grant [P30 EY02687c]; US NIH training grant [5 T32 AR007279-32]; NATIONAL CANCER INSTITUTE [R01CA125970, R01CA161870] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Melanoma Research Foundation; Tumori Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); US NIH Vision Core grant; US NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by US National Institutes of Health (NIH) grants R01 CA16187001 (A.M.B. and J.W.H.) and CA12597007 (J.W.H.), the Melanoma Research Alliance (J.W.H.), the Melanoma Research Foundation (J.W.H.), the Tumori Foundation (J.W.H.), Research to Prevent Blindness, Inc. (J.W.H.) and awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness, Inc., Unrestricted grant and the US NIH Vision Core grant P30 EY02687c. E.D.O.R. was supported under US NIH training grant 5 T32 AR007279-32. We thank L. Cao for technical assistance and C. Jordan for exome capture. We thank the patients who volunteered to participate in the study in order to make this work possible. This study was approved by the Human Studies Committee at Washington University in St. Louis, and informed consent was obtained from all subjects.	An M, 2012, INT J DEV BIOL, V56, P223, DOI 10.1387/ijdb.113383ma; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Harbour JW, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00979.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Visconte V, 2012, LEUKEMIA, V26, P2447, DOI 10.1038/leu.2012.130; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	13	331	337	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					133	135		10.1038/ng.2523	http://dx.doi.org/10.1038/ng.2523			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313955	Green Accepted			2022-12-25	WOS:000314333000007
J	McIntosh, JR				McIntosh, J. Richard			Motors or dynamics: What really moves chromosomes?	NATURE CELL BIOLOGY			English	Editorial Material									Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	McIntosh, JR (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	Richard.Mcintosh@colorado.edu	McIntosh, Richard/GLN-3533-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033787] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM033787] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1234	1234		10.1038/ncb2649	http://dx.doi.org/10.1038/ncb2649			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23196840	Green Accepted, Bronze			2022-12-25	WOS:000311890300002
J	Paschos, GK; Ibrahim, S; Song, WL; Kunieda, T; Grant, G; Reyes, TM; Bradfield, CA; Vaughan, CH; Eiden, M; Masoodi, M; Griffin, JL; Wang, FF; Lawson, JA; FitzGerald, GA				Paschos, Georgios K.; Ibrahim, Salam; Song, Wen-Liang; Kunieda, Takeshige; Grant, Gregory; Reyes, Teresa M.; Bradfield, Christopher A.; Vaughan, Cheryl H.; Eiden, Michael; Masoodi, Mojgan; Griffin, Julian L.; Wang, Fenfen; Lawson, John A.; FitzGerald, Garret A.			Obesity in mice with adipocyte-specific deletion of clock component Arntl	NATURE MEDICINE			English	Review							CIRCADIAN CLOCK; FOOD-INTAKE; METABOLIC SYNDROME; SHIFT WORK; LEPTIN; RECEPTOR; FAT; TRANSCRIPTION; RESISTANCE; ENERGY	Adipocytes store excess energy in the form of triglycerides and signal the levels of stored energy to the brain. Here we show that adipocyte-specific deletion of Arntl (also known as Bmal1), a gene encoding a core molecular clock component, results in obesity in mice with a shift in the diurnal rhythm of food intake, a result that is not seen when the gene is disrupted in hepatocytes or pancreatic islets. Changes in the expression of hypothalamic neuropeptides that regulate appetite are consistent with feedback from the adipocyte to the central nervous system to time feeding behavior. Ablation of the adipocyte clock is associated with a reduced number of polyunsaturated fatty acids in adipocyte triglycerides. This difference between mutant and wild-type mice is reflected in the circulating concentrations of polyunsaturated fatty acids and nonesterified polyunsaturated fatty acids in hypothalamic neurons that regulate food intake. Thus, this study reveals a role for the adipocyte clock in the temporal organization of energy regulation, highlights timing as a modulator of the adipocyte-hypothalamic axis and shows the impact of timing of food intake on body weight.	[Paschos, Georgios K.; Ibrahim, Salam; Song, Wen-Liang; Kunieda, Takeshige; Grant, Gregory; Reyes, Teresa M.; Lawson, John A.; FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab, Madison, WI USA; [Vaughan, Cheryl H.] Georgia State Univ, Ctr Obes Reversal, Dept Biol, Atlanta, GA 30303 USA; [Eiden, Michael; Masoodi, Mojgan; Griffin, Julian L.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Wang, Fenfen] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Georgia State University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	garret@upenn.edu	MASOODI, MOJGAN/P-1499-2019; Grant, Gregory Robert/I-3599-2019; Reyes, Teresa/GYI-8942-2022; Paschos, Georgios K/F-2802-2011	MASOODI, MOJGAN/0000-0001-9840-1731; Grant, Gregory Robert/0000-0002-0139-7658; Reyes, Teresa/0000-0003-3009-3749; Song, Wenliang/0000-0002-1866-0635	US National Institutes of Health (NIH) [RO1 HL097800]; Medical Research Council [UD99999906]; NIH [R01 DK45586]; Biotechnology and Biological Sciences Research Council [BB/H013539/1, BB/H013539/2] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006, MC_EX_G0800783] Funding Source: researchfish; BBSRC [BB/H013539/2, BB/H013539/1] Funding Source: UKRI; MRC [MC_UP_A090_1006, MC_EX_G0800783] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK045586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by US National Institutes of Health (NIH) grant RO1 HL097800 and Medical Research Council grant UD99999906. We thank M. Lazar for help with the ChIP experiments (funded by NIH R01 DK45586). We thank R. Ahima and the Mouse Phenotyping, Physiology and Metabolism Core of the Penn Diabetes Research Center (P30 DK19525) for performing body composition and behavioral analysis; D. Baldwin's Microarray Core Facility for performing the microarray analysis; and R. Freer and M. Adam for technical assistance. G.A.F. is the McNeil Professor of Translational Medicine and Therapeutics.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Ellingsen T, 2007, J R SOC PROMO HEALTH, V127, P265, DOI 10.1177/1466424007083702; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reyes TM, 2003, J NEUROSCI, V23, P5607; Roberts LD, 2009, GENOME MED, V1, DOI 10.1186/gm115; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Stunkard A, 1996, INT J OBESITY, V20, P1; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227	50	286	295	4	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1768	+		10.1038/nm.2979	http://dx.doi.org/10.1038/nm.2979			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142819	Green Accepted			2022-12-25	WOS:000311999800024
J	vom Berg, J; Prokop, S; Miller, KR; Obst, J; Kalin, RE; Lopategui-Cabezas, I; Wegner, A; Mair, F; Schipke, CG; Peters, O; Winter, Y; Becher, B; Heppner, FL				vom Berg, Johannes; Prokop, Stefan; Miller, Kelly R.; Obst, Juliane; Kaelin, Roland E.; Lopategui-Cabezas, Ileana; Wegner, Anja; Mair, Florian; Schipke, Carola G.; Peters, Oliver; Winter, York; Becher, Burkhard; Heppner, Frank L.			Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; PLAQUE PSORIASIS; CROHNS-DISEASE; IL-12 RECEPTOR; DOUBLE-BLIND; MOUSE MODEL; IFN-GAMMA	The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-beta (A beta). Using the APPPS1 Alzheimer's disease mouse model, we found increased production of the common interleukin-12 (IL-12) and IL-23 subunit p40 by microglia. Genetic ablation of the IL-12/IL-23 signaling molecules p40, p35 or p19, in which deficiency of p40 or its receptor complex had the strongest effect, resulted in decreased cerebral amyloid load. Although deletion of IL-12/IL-23 signaling from the radiation-resistant glial compartment of the brain was most efficient in mitigating cerebral amyloidosis, peripheral administration of a neutralizing p40-specific antibody likewise resulted in a reduction of cerebral amyloid load in APPPS1 mice. Furthermore, intracerebroventricular delivery of antibodies to p40 significantly reduced the concentration of soluble Ab species and reversed cognitive deficits in aged APPPS1 mice. The concentration of p40 was also increased in the cerebrospinal fluid of subjects with Alzheimer's disease, which suggests that inhibition of the IL-12/IL-23 pathway may attenuate Alzheimer's disease pathology and cognitive deficits.	[Prokop, Stefan; Miller, Kelly R.; Obst, Juliane; Kaelin, Roland E.; Lopategui-Cabezas, Ileana; Wegner, Anja; Schipke, Carola G.; Heppner, Frank L.] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [vom Berg, Johannes; Mair, Florian; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Schipke, Carola G.; Peters, Oliver] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Winter, York] Humboldt Univ, Cognit Neurobiol & Berlin Mouse Clin Neurol & Psy, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Heppner, FL (corresponding author), Charite, Dept Neuropathol, D-13353 Berlin, Germany.	becher@immunology.uzh.ch; frank.heppner@charite.de	Becher, Burkhard/ABE-4225-2020; Wegner, Anja/AAD-2685-2019; Kälin, Roland/AAG-9161-2020; Wegner, Anja/AAL-8877-2021; Berg, Johannes vom/B-8983-2018; Prokop, Stefan/Y-1257-2019; Heppner, Frank/ABH-8393-2020	Becher, Burkhard/0000-0002-1541-7867; Wegner, Anja/0000-0003-0086-2498; Berg, Johannes vom/0000-0002-4086-1564; Prokop, Stefan/0000-0002-5633-2149; Heppner, Frank/0000-0001-9816-8917; Winter, York/0000-0002-7828-1872; Obst, Juliane/0000-0001-9534-8488; Mair, Florian/0000-0001-6732-5449; Peters, Oliver/0000-0003-0568-2998	Deutsche Forschungsgemeinschaft [SFB TRR 43]; Swiss national science foundation; Koetzer foundation; NeuroCure Exc 257 visiting fellowship; US National Institutes of Health [NINDS R01 NS046006]; European Union; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046006] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); Koetzer foundation; NeuroCure Exc 257 visiting fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TRR 43 to F.L.H. and NeuroCure Exc 257 to F.L.H. and Y.W.), the Swiss national science foundation (B.B.), the Koetzer foundation (B.B.), a NeuroCure Exc 257 visiting fellowship (B.B.), the US National Institutes of Health (NINDS R01 NS046006 to F.L.H.) and the European Union (FP7 HEALTH, Project LUPAS to F.L.H.). J.v.B. is a member of the Neuroscience Center Zurich, and F.M. is a member of the Molecular Life Sciences Zurich. We thank P. Matylewski, C. Hempt, C. Klatt and C. Gehlhaar for excellent technical help, F. Hiemeyer for performing the ANOVA statistics, K. Saeger for scanning and processing of histological mouse slides and M. Jucker, University of Tubingen, for generously providing APPPS1 mice.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Guerreiro RJ, 2007, NEURODEGENER DIS, V4, P406, DOI 10.1159/000107700; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Ireland DDC, 2004, VIRAL IMMUNOL, V17, P411, DOI 10.1089/vim.2004.17.411; Jucker M, 2008, NEURON, V59, P8, DOI 10.1016/j.neuron.2008.06.014; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kornhuber J, 2009, DEMENT GERIATR COGN, V27, P404, DOI 10.1159/000210388; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Magram J, 1996, ANN NY ACAD SCI, V795, P60, DOI 10.1111/j.1749-6632.1996.tb52655.x; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Matthys P, 1998, EUR J IMMUNOL, V28, P2143, DOI 10.1002/(SICI)1521-4141(199807)28:07<2143::AID-IMMU2143>3.0.CO;2-C; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rentzos M, 2006, J NEUROL SCI, V249, P110, DOI 10.1016/j.jns.2006.05.063; Romagnani P, 1997, CURR OPIN IMMUNOL, V9, P793, DOI 10.1016/S0952-7915(97)80180-X; Rota E, 2006, NEUROL SCI, V27, P33, DOI 10.1007/s10072-006-0562-6; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schipke CG, 2011, DEMENT GERIATR COGN, V31, P139, DOI 10.1159/000322588; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Town T, 2002, J NEUROIMMUNOL, V132, P49, DOI 10.1016/S0165-5728(02)00307-7; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wu CY, 1997, J IMMUNOL, V159, P1658; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	51	271	278	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2012	18	12					1812	+		10.1038/nm.2965	http://dx.doi.org/10.1038/nm.2965			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23178247				2022-12-25	WOS:000311999800029
J	Campbell, CD; Chong, JX; Malig, M; Ko, A; Dumont, BL; Han, LD; Vives, L; O'Roak, BJ; Sudmant, PH; Shendure, J; Abney, M; Ober, C; Eichler, EE				Campbell, Catarina D.; Chong, Jessica X.; Malig, Maika; Ko, Arthur; Dumont, Beth L.; Han, Lide; Vives, Laura; O'Roak, Brian J.; Sudmant, Peter H.; Shendure, Jay; Abney, Mark; Ober, Carole; Eichler, Evan E.			Estimating the human mutation rate using autozygosity in a founder population	NATURE GENETICS			English	Article							GENOME; ASSOCIATION; NUCLEOTIDE; REVEALS; DNA	Knowledge of the rate and pattern of new mutation is critical to the understanding of human disease and evolution. We used extensive autozygosity in a genealogically well-defined population of Hutterites to estimate the human sequence mutation rate over multiple generations. We sequenced whole genomes from 5 parent-offspring trios and identified 44 segments of autozygosity. Using the number of meioses separating each pair of autozygous alleles and the 72 validated heterozygous single-nucleotide variants (SNVs) from 512 Mb of autozygous DNA, we obtained an SNV mutation rate of 1.20 x 10(-8) (95% confidence interval 0.89-1.43 x 10(-8)) mutations per base pair per generation. The mutation rate for bases within CpG dinucleotides (9.72 x 10(-8)) was 9.5-fold that of non-CpG bases, and there was strong evidence (P = 2.67 x 10(-4)) for a paternal bias in the origin of new mutations (85% paternal). We observed a non-uniform distribution of heterozygous SNVs (both newly identified and known) in the autozygous segments (P = 0.001), which is suggestive of mutational hotspots or sites of long-range gene conversion.	[Campbell, Catarina D.; Malig, Maika; Ko, Arthur; Dumont, Beth L.; Vives, Laura; O'Roak, Brian J.; Sudmant, Peter H.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chong, Jessica X.; Han, Lide; Abney, Mark; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ober, Carole] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Chicago; University of Chicago; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Chong, Jessica/GZH-1625-2022; Shendure, Jay/AAU-3684-2021	O'Roak, Brian/0000-0002-4141-0095; Chong, Jessica/0000-0002-1616-2448; Ober, Carole/0000-0003-4626-9809; Shendure, Jay/0000-0002-1516-1865; Sudmant, Peter/0000-0002-9573-8248	US National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA) [F32HG006070]; Howard Hughes Medical Institute; American Asthma Foundation; US NIH [R01 HD21244, R01 HL085197, R01 HG002899]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006070, R01HG002899] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Asthma Foundation; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to M. Przeworski for thoughtful comments on the manuscript. We thank C. Lee, B. Paeper, J. Smith and M. Rieder for assistance with sequence data generation and J. Huddleston for technical advice. We are grateful to T. Brown for assistance with manuscript preparation. C.D.C. was supported by a US National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA; F32HG006070). P.H.S. is supported by a Howard Hughes Medical Institute International Student Research Fellowship. This work was supported by an American Asthma Foundation Senior Investigator Award to E.E.E., by US NIH grants R01 HD21244 and R01 HL085197 to C.O. and by US NIH grant R01 HG002899 to M.A. E.E.E. is an Investigator of the Howard Hughes Medical Institute.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chong JX, 2011, EUR J HUM GENET, V19, P1045, DOI 10.1038/ejhg.2011.85; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cusanovich DA, 2012, HUM MOL GENET, V21, P2111, DOI 10.1093/hmg/dds021; Drake JW, 1998, GENETICS, V148, P1667; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Han L, 2011, GENET EPIDEMIOL, V35, P557, DOI 10.1002/gepi.20606; Khalak HG, 2012, GENET MED, V14, P515, DOI 10.1038/gim.2011.28; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nachman MW, 2000, GENETICS, V156, P297; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257	24	151	152	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1277	1281		10.1038/ng.2418	http://dx.doi.org/10.1038/ng.2418			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23001126	Green Accepted, Green Submitted			2022-12-25	WOS:000310495800023
J	Chakrabarti, R; Hwang, J; Blanco, MA; Wei, Y; Lukacisin, M; Romano, RA; Smalley, K; Liu, S; Yang, QF; Ibrahim, T; Mercatali, L; Amadori, D; Haffty, BG; Sinha, S; Kang, Y				Chakrabarti, Rumela; Hwang, Julie; Blanco, Mario Andres; Wei, Yong; Lukacisin, Martin; Romano, Rose-Anne; Smalley, Kirsten; Liu, Song; Yang, Qifeng; Ibrahim, Toni; Mercatali, Laura; Amadori, Dino; Haffty, Bruce G.; Sinha, Satrajit; Kang, Yibin			Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION SIGNATURE; MIR-200 FAMILY; TUMOR-METASTASIS; CELL FATE; RECIPROCAL REPRESSION; EWING TUMORS; STEM-CELLS; ETS FAMILY; DISEASE; ZEB1	The epithelial-mesenchymal transition (EMT) is a complex process that occurs during organogenesis and in cancer metastasis. Despite recent progress, the molecular pathways connecting the physiological and pathological functions of EMT need to be better defined. Here we show that the transcription factor Elf5, a key regulator of mammary gland alveologenesis, controls EMT in both mammary gland development and metastasis. We uncovered this role for Elf5 through analyses of Elf5 conditional knockout animals, various in vitro and in vivo models of EMT and metastasis, an MMTV-neu transgenic model of mammary tumour progression and clinical breast cancer samples. Furthermore, we demonstrate that Elf5 suppresses EMT by directly repressing the transcription of Snail2, a master regulator of mammary stem cells and a known inducer of EMT. These findings establish Elf5 not only as a key cell lineage regulator during normal mammary gland development, but also as a suppressor of EMT and metastasis in breast cancer.	[Chakrabarti, Rumela; Romano, Rose-Anne; Smalley, Kirsten; Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA; [Chakrabarti, Rumela; Hwang, Julie; Blanco, Mario Andres; Wei, Yong; Lukacisin, Martin; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA; [Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Yang, Qifeng; Haffty, Bruce G.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ 08901 USA; [Yang, Qifeng; Haffty, Bruce G.; Kang, Yibin] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Ibrahim, Toni; Mercatali, Laura; Amadori, Dino] Ist Sci Romagnolo Studio & Cura Tumori IRST, Osteoncol Ctr, Meldola, Italy	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Princeton University; Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; IRCCS Meldola (IRST)	Sinha, S (corresponding author), SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA.	ssinha2@buffalo.edu; ykang@princeton.edu	yang, qiang/GYJ-0971-2022; Mercatali, Laura/J-9154-2016	Mercatali, Laura/0000-0003-2162-8238; Kang, Yibin/0000-0002-1626-6730; Blanco, M. Andres/0000-0003-4404-2301; Yang, Qifeng/0000-0003-0576-8513; Ibrahim, Toni/0000-0003-0259-4167; Lukacisin, Martin/0000-0001-6549-4177	Breast Cancer Research Foundation; Brewster Foundation; Champalimaud Foundation; Komen for the Cure; National Institutes of Health [R01CA134519, R01CA141062]; DOD postdoctoral fellowship [W81XWH-11-1-0681]; NRSA pre-doctoral fellowship from the National Institutes of Health;  [R01GM069417]; NATIONAL CANCER INSTITUTE [R01CA141062, R01CA134519, P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069417] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Brewster Foundation; Champalimaud Foundation; Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD postdoctoral fellowship; NRSA pre-doctoral fellowship from the National Institutes of Health; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Korpal, B. I. Koh, H. Zheng and B. Ell for helpful discussions, M. Yuan and X. Hang for technical assistance, C. DeCoste for assistance with flow cytometry, J. Goodhouse for assistance with confocal microscopy and L. Cong and J. Friedman at the Tissue Analytic Service Core of Cancer Institute of New Jersey for assistance with clinical breast tumour sample immunohistochemistry analysis. This research was supported by grants from R01GM069417 to S.S., from the Breast Cancer Research Foundation to B.G.H. and Y.K. and from the Brewster Foundation, the Champalimaud Foundation, Komen for the Cure and the National Institutes of Health (R01CA134519 and R01CA141062) to Y.K. R.C. is a recipient of a DOD postdoctoral fellowship (W81XWH-11-1-0681) and M.A.B. is a recipient of an NRSA pre-doctoral fellowship from the National Institutes of Health.	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Desmaze C, 1997, CANCER GENET CYTOGEN, V97, P12, DOI 10.1016/S0165-4608(96)00326-3; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; Escamilla-Hernandez R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-68; Feldman RJ, 2003, CANCER RES, V63, P4626; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee S, 2007, AM J PATHOL, V171, P252, DOI 10.2353/ajpath.2007.061010; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Liu YN, 2012, ONCOGENE; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Miller F. R., 1983, INV METASTASIS, V3, P22; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Sapi E, 1998, CANCER RES, V58, P1027; Sementchenko VI, 1998, ONCOGENE, V17, P2883, DOI 10.1038/sj.onc.1202220; Sethi N, 2011, BONE, V48, P16, DOI 10.1016/j.bone.2010.07.005; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198	65	199	207	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1212	+		10.1038/ncb2607	http://dx.doi.org/10.1038/ncb2607			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23086238	Green Accepted			2022-12-25	WOS:000310778100014
J	Erb, TJ; Evans, BS; Cho, K; Warlick, BP; Sriram, J; Wood, BM; Imker, HJ; Sweedler, JV; Tabita, FR; Gerlt, JA				Erb, Tobias J.; Evans, Bradley S.; Cho, Kyuil; Warlick, Benjamin P.; Sriram, Jaya; Wood, B. McKay; Imker, Heidi J.; Sweedler, Jonathan V.; Tabita, F. Robert; Gerlt, John A.			A RubisCO-like protein links SAM metabolism with isoprenoid biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							METHIONINE SALVAGE PATHWAY; PHOTOSYNTHETIC RUBISCO; EVOLUTIONARY RELATIONSHIPS; MECHANISTIC DIVERSITY; SULFUR METABOLISM; METHANETHIOL; SUPERFAMILY; INHIBITION; POLYAMINES; BACTERIA	Functional assignment of uncharacterized proteins is a challenge in the era of large-scale genome sequencing. Here, we combine in extracto NMR, proteomics and transcriptomics with a newly developed (knock-out) metabolomics platform to determine a potential physiological role for a ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO)-like protein from Rhodospirillum rubrum. Our studies unraveled an unexpected link in bacterial central carbon metabolism between S-adenosylmethionine-dependent polyamine metabolism and isoprenoid biosynthesis and also provide an alternative approach to assign enzyme function at the organismic level.	[Erb, Tobias J.; Evans, Bradley S.; Cho, Kyuil; Warlick, Benjamin P.; Wood, B. McKay; Imker, Heidi J.; Sweedler, Jonathan V.; Gerlt, John A.] Univ Illinois, Inst Genom Biol, Champaign, IL USA; [Erb, Tobias J.; Warlick, Benjamin P.; Gerlt, John A.] Univ Illinois, Dept Biochem, Champaign, IL USA; [Evans, Bradley S.; Cho, Kyuil; Sweedler, Jonathan V.; Gerlt, John A.] Univ Illinois, Dept Chem, Champaign, IL USA; [Sriram, Jaya; Tabita, F. Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio State University	Erb, TJ (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	j-gerlt@uiuc.edu	Evans, Bradley S/M-2842-2013; Erb, Tobias/J-5214-2013; Sweedler, Jonathan V/A-9405-2009	Evans, Bradley S/0000-0002-1207-9006; Erb, Tobias/0000-0003-3685-0894; Sweedler, Jonathan V/0000-0003-3107-9922; Imker, Heidi/0000-0003-4748-7453	Deutsche Forschungsgemeinschaft [ER 646/1-1]; US National Institutes of Health [R01GM065155, R01GM095742, P01GM071790, U54GM093342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095742, U54GM093342, P01GM071790, R01GM065155] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a fellowship to T.J.E. from the Deutsche Forschungsgemeinschaft (ER 646/1-1) and research grants from the US National Institutes of Health (R01GM065155, R01GM095742, P01GM071790 and U54GM093342). We would like to thank J.E. Cronan for critical comments and C. Deane and T. Miyairi for excellent technical assistance. We also acknowledge S. C. Almo and B. S. Hillerich (New York Structural Genomics Research Consortium) for providing expression plasmids and purified cupin for in vitro assays.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Ashida H, 2005, RES MICROBIOL, V156, P611, DOI 10.1016/j.resmic.2005.01.014; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Ashida H, 2008, J EXP BOT, V59, P1543, DOI 10.1093/jxb/ern104; Bolten CJ, 2010, J MICROBIOL BIOTECHN, V20, P1196, DOI 10.4014/jmb.1002.02018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carre-Mlouka A, MICROCYSTIS J BIOL C, V281, P24462; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Gopishetty B, 2009, J AM CHEM SOC, V131, P1243, DOI 10.1021/ja808206w; HAMANA K, 1985, J BIOCHEM-TOKYO, V97, P1653, DOI 10.1093/oxfordjournals.jbchem.a135223; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; PAECH C, 1978, BIOCHEM BIOPH RES CO, V83, P1084, DOI 10.1016/0006-291X(78)91506-1; PAULIN LG, 1985, ANTIMICROB AGENTS CH, V28, P157, DOI 10.1128/AAC.28.1.157; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Phillips R, 2009, P NATL ACAD SCI USA, V106, P21465, DOI 10.1073/pnas.0907732106; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Salim HMW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000701; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2001, BMC Microbiol, V1, P15, DOI 10.1186/1471-2180-1-15; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Sekowska A, 2001, GENOME BIOL, V2; Singh J, 2010, J BACTERIOL, V192, P1324, DOI 10.1128/JB.01442-09; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810	36	61	65	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					926	932		10.1038/NCHEMBIO.1087	http://dx.doi.org/10.1038/NCHEMBIO.1087			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23042035	Green Accepted			2022-12-25	WOS:000310052100012
J	Vezzani, A				Vezzani, Annamaria			Finding the epileptogenesis switch	NATURE MEDICINE			English	Editorial Material							MAMMALIAN TARGET; TUBEROUS SCLEROSIS; SEIZURE FREQUENCY; RAPAMYCIN MTOR; MOUSE MODEL; INHIBITION; PATHWAY; EPILEPSY		Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Vezzani, A (corresponding author), Mario Negri Inst Pharmacol Res, Dept Neurosci, Via Eritrea 62, Milan, Italy.	annamaria.vezzani@marionegri.it	Vezzani, Annamaria/AAB-1882-2020	Vezzani, Annamaria/0000-0003-0573-6175				Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Krueger D.A., 2012, NEW ENGL J MED, V363, P1801; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lalis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037068; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Muncy J, 2009, J CHILD NEUROL, V24, P477, DOI 10.1177/0883073808324535; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Ryther RCC, 2012, CURR NEUROL NEUROSCI, V12, P410, DOI 10.1007/s11910-012-0276-5; Sha LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039152; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Zeng LH, 2010, CELL CYCLE, V9, P2281, DOI 10.4161/cc.9.12.11866; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	17	24	24	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1626	1627		10.1038/nm.2982	http://dx.doi.org/10.1038/nm.2982			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135516				2022-12-25	WOS:000310837000021
J	Sun, JX; Helgason, A; Masson, G; Ebenesersdottir, SS; Li, H; Mallick, S; Gnerre, S; Patterson, N; Kong, A; Reich, D; Stefansson, K				Sun, James X.; Helgason, Agnar; Masson, Gisli; Ebenesersdottir, Sigriour Sunna; Li, Heng; Mallick, Swapan; Gnerre, Sante; Patterson, Nick; Kong, Augustine; Reich, David; Stefansson, Kari			A direct characterization of human mutation based on microsatellites	NATURE GENETICS			English	Article							GENETIC DISTANCES; RATES; RECOMBINATION; CONSTRAINTS; NUCLEOTIDE; SEQUENCES; PATTERNS; MODELS; LOCI; AGE	Mutations are the raw material of evolution but have been difficult to study directly. We report the largest study of new mutations to date, comprising 2,058 germline changes discovered by analyzing 85,289 Icelanders at 2,477 microsatellites. The paternal-to-maternal mutation rate ratio is 3.3, and the rate in fathers doubles from age 20 to 58, whereas there is no association with age in mothers. Longer microsatellite alleles are more mutagenic and tend to decrease in length, whereas the opposite is seen for shorter alleles. We use these empirical observations to build a model that we apply to individuals for whom we have both genome sequence and microsatellite data, allowing us to estimate key parameters of evolution without calibration to the fossil record. We infer that the sequence mutation rate is 1.4-2.3 x 10(-8) mutations per base pair per generation (90% credible interval) and that human-chimpanzee speciation occurred 3.7-6.6 million years ago.	[Sun, James X.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Sun, James X.; Li, Heng; Mallick, Swapan; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Helgason, Agnar; Masson, Gisli; Ebenesersdottir, Sigriour Sunna; Kong, Augustine; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Li, Heng; Gnerre, Sante; Patterson, Nick; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA USA; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University of Iceland; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iceland	Sun, JX (corresponding author), MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	toxinsun@gmail.com; reich@genetics.med.harvard.edu; kari.stefansson@decode.is	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015; Li, Heng/D-9344-2011	Li, Heng/0000-0003-4874-2874; Helgason, Agnar/0000-0002-8545-3767; Kong, Augustine/0000-0001-8193-5438	Harvard University; Bioinformatics and Integrative Genomics PhD training grant; Burroughs Wellcome Travel Grant; Burroughs Wellcome Career Development Award in the Biomedical Sciences; Broad Institute of Harvard and MIT; National Science Foundation HOMINID [1032255]; US National Institutes of Health [R01HG006399]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Harvard University; Bioinformatics and Integrative Genomics PhD training grant; Burroughs Wellcome Travel Grant; Burroughs Wellcome Career Development Award in the Biomedical Sciences(Burroughs Wellcome Fund); Broad Institute of Harvard and MIT; National Science Foundation HOMINID; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D.F. Gudbjartsson for advice on running Allegro 2.0; J. Fenner, J. Hawks, K. Langergraber, D. Pilbeam and L. Vigilant for discussions that informed the Bayesian prior distributions on evolutionary parameters; and Y. Erlich, M. Gymrek, D. Lieberman, B. Payseur, D. Pilbeam, A. Siepel, S. Sunyaev and the anonymous reviewers for critiques. This work was supported by a Bioinformatics and Integrative Genomics PhD training grant (J.X.S.), a Burroughs Wellcome Travel Grant (J.X.S.), a Burroughs Wellcome Career Development Award in the Biomedical Sciences (D.R.), a HUSEC seed grant from Harvard University (D.R.), a SPARC award from the Broad Institute of Harvard and MIT (D.R.), a National Science Foundation HOMINID grant 1032255 (D.R.) and US National Institutes of Health grant R01HG006399 (D.R.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnheim N, 2009, NAT REV GENET, V10, P478, DOI 10.1038/nrg2529; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Burgess R, 2008, MOL BIOL EVOL, V25, P1979, DOI 10.1093/molbev/msn148; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Feldman MW, 1997, GENETICS, V145, P207; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Johansson AM, 2008, EUR J HUM GENET, V16, P1225, DOI 10.1038/ejhg.2008.75; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Nachman MW, 2000, GENETICS, V156, P297; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sainudiin R, 2004, GENETICS, V168, P383, DOI 10.1534/genetics.103.022665; SLATKIN M, 1995, GENETICS, V139, P457; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Whittaker JC, 2003, GENETICS, V164, P781; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Zhivotovsky LA, 1997, MOL BIOL EVOL, V14, P926, DOI 10.1093/oxfordjournals.molbev.a025835	45	206	208	0	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1161	+		10.1038/ng.2398	http://dx.doi.org/10.1038/ng.2398			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922873	Green Submitted, Green Accepted			2022-12-25	WOS:000309550200020
J	Nittner, D; Lambertz, I; Clermont, F; Mestdagh, P; Kohler, C; Nielsen, SJ; Jochemsen, A; Speleman, F; Vandesompele, J; Dyer, MA; Schramm, A; Schulte, JH; Marine, JC				Nittner, David; Lambertz, Irina; Clermont, Frederic; Mestdagh, Pieter; Kohler, Corinna; Nielsen, Soren Jensby; Jochemsen, Aart; Speleman, Frank; Vandesompele, Jo; Dyer, Michael A.; Schramm, Alexander; Schulte, Johannes H.; Marine, Jean-Christophe			Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation	NATURE CELL BIOLOGY			English	Article							PATHWAY; INACTIVATION; EXPRESSION; MUTATIONS; CLUSTER; TUMOR	Synthetic lethality is a promising strategy for specific targeting of cancer cells that carry mutations that are absent in normal cells(1). This approach may help over come the challenge associated with targeting dysfunctional tumour suppressors, such as p53 and Rb (refs 1,2). Here we show that Dicer1 targeting prevents retinoblastoma formation in mice by synthetic lethality with combined inactivation of p53 and Rb. Although Dicer1 functions as a haploinsufficient tumour suppressor, its complete loss of function is selected against during tumorigenesis(3-5). We show that Dicer1 deficiency is tolerated in Rb-deficient retinal progenitor cells harbouring an intact p53 pathway, but not in the absence of p53. This synthetic lethality is mediated by the oncogenic miR-17-92 cluster because its deletion phenocopies Dicer1 loss in this context. miR-17-92 inactivation suppresses retinoblastoma formation in mice and co-silencing of miR-17/20a and p53 cooperatively decreases the viability of human retinoblastoma cells. These data provide an explanation for the selective pressure against loss of Dicer1 during tumorigenesis and a proof-of-concept that targeting miRNAs may potentially represent a general approach for synthetic lethal targeting of cancer cells that harbour specific cancer-inducing genotypes.	[Nittner, David; Lambertz, Irina; Clermont, Frederic; Kohler, Corinna; Marine, Jean-Christophe] VIB, Lab Mol Canc Biol, Ctr Biol Dis, B-3000 Louvain, Belgium; [Nittner, David; Lambertz, Irina] Univ Ghent, Dept Mol Biomed Res, B-9000 Ghent, Belgium; [Nittner, David; Clermont, Frederic; Kohler, Corinna; Marine, Jean-Christophe] Katholieke Univ Leuven, Lab Mol Canc Biol, Ctr Human Genet, Louvain, Belgium; [Mestdagh, Pieter; Speleman, Frank; Vandesompele, Jo] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Nielsen, Soren Jensby] Exiqon AS, DK-2950 Vedbaek, Denmark; [Jochemsen, Aart] Univ Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Schramm, Alexander; Schulte, Johannes H.] Univ Childrens Hosp Essen, Dept Pediat Hematol & Oncol, D-45122 Essen, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; Ghent University; Ghent University Hospital; Exiqon; St Jude Children's Research Hospital; Howard Hughes Medical Institute; University of Duisburg Essen	Marine, JC (corresponding author), VIB, Lab Mol Canc Biol, Ctr Biol Dis, B-3000 Louvain, Belgium.	JeanChristophe.Marine@cme.vib-kuleuven.be	Marine, Jean-Christophe/K-3292-2016; Schramm, Alexander/G-5688-2010; speleman, frank/AAR-5184-2020; Schulte, Johannes H./V-2474-2018; Vandesompele, Jo/W-3411-2018; Dyer, Michael/N-8134-2018; Schulte, Johannes H/G-3981-2010; Marine, Jean Christophe/J-2237-2015	Marine, Jean-Christophe/0000-0003-2433-9837; Schramm, Alexander/0000-0001-7670-7529; speleman, frank/0000-0002-6628-8559; Vandesompele, Jo/0000-0001-6274-0184; Schulte, Johannes Hubertus/0000-0003-0671-1201; Nittner, David/0000-0002-2939-2453; Mestdagh, Pieter/0000-0001-7821-9684	FWO; Belgian Foundation against Cancer (BFK); Geconcerteerde Onderzoek Aangelegenheden (GOA, KULeuven, Belgium); German Federal Ministry of Education and Research, BMBF (NGFNplus, ENGINE); EU [201102]	FWO(FWO); Belgian Foundation against Cancer (BFK); Geconcerteerde Onderzoek Aangelegenheden (GOA, KULeuven, Belgium); German Federal Ministry of Education and Research, BMBF (NGFNplus, ENGINE)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	We thank O. Van Goethem, H. Stephan and M. Baumann for excellent technical advice and/or assistance. We thank M. Skipper for helpful comments on the manuscript and G. Hannon (Watson School of Biological Sciences, Cold Spring Harbor Laboratory, USA) for providing the Dicer 1 floxed mice. This work was supported in part by FWO, the Belgian Foundation against Cancer (BFK), Geconcerteerde Onderzoek Aangelegenheden (GOA, KULeuven, Belgium) and the German Federal Ministry of Education and Research, BMBF (NGFNplus, ENGINE) as well as the EU (FP7, ONCOMIRS, Contract 201102). This publication reflects only the authors' views. The commission is not liable for any use that may be made of the information herein.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Arrate MP, 2010, CANCER RES, V70, P6083, DOI 10.1158/0008-5472.CAN-09-4736; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Conkrite K, 2012, J CLIN INVEST, V122, P1726, DOI 10.1172/JCI61403; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Donovan SL, 2004, VISION RES, V44, P3323, DOI 10.1016/j.visres.2004.08.007; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pampalakis G, 2010, CLIN BIOCHEM, V43, P324, DOI 10.1016/j.clinbiochem.2009.09.014; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sangwan M, 2012, ONCOGENE; Singh MK, 2011, J BIOL CHEM, V286, P41036, DOI 10.1074/jbc.M111.268573; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; van Haaften G, 2010, GENE DEV, V24, P1, DOI 10.1101/gad.1887110; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang JK, 2004, CELL CYCLE, V3, P952	37	65	73	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2012	14	9					958	+		10.1038/ncb2556	http://dx.doi.org/10.1038/ncb2556			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	004GJ	22864477				2022-12-25	WOS:000308668600012
J	Rong, YG; Liu, M; Ma, L; Du, WQ; Zhang, HS; Tian, Y; Cao, Z; Li, Y; Ren, H; Zhang, CM; Li, L; Chen, S; Xi, JZ; Yu, L				Rong, Yueguang; Liu, Mei; Ma, Liang; Du, Wanqing; Zhang, Hanshuo; Tian, Yuan; Cao, Zhen; Li, Ying; Ren, He; Zhang, Chuanmao; Li, Lin; Chen, She; Xi, Jianzhong; Yu, Li			Clathrin and phosphatidylinositol-4,5-bisphosphate regulate autophagic lysosome reformation	NATURE CELL BIOLOGY			English	Article							MEDIATED ENDOCYTOSIS; TRANSPORT; PROTEINS; FAMILY; SITE	Autophagy is a lysosome-based degradation pathway. During autophagy, lysosomes fuse with autophagosomes to form autolysosomes. Following starvation-induced autophagy, nascent lysosomes are formed from autolysosomal membranes through an evolutionarily conserved cellular process, autophagic lysosome reformation (ALR), which is critical for maintaining lysosome homeostasis. Here we report that clathrin and phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2) regulate ALR. Combining a screen of candidates identified through proteomic analysis of purified ALR tubules, and large-scale RNAi knockdown, we unveiled a tightly regulated molecular pathway that controls lysosome homeostasis, in which clathrin and PtdIns(4,5)P-2 are the central components. Our functional study demonstrates the central role of clathrin and its associated proteins in cargo sorting, phospholipid conversion, initiation of autolysosome tubulation, and proto-lysosome budding during ALR. Our data not only uncover a molecular pathway by which lysosome homeostasis is maintained through the ALR process, but also reveal unexpected functions of clathrin and PtdIns(4,5)P-2 in lysosome homeostasis.	[Rong, Yueguang; Liu, Mei; Ma, Liang; Du, Wanqing; Cao, Zhen; Yu, Li] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Peking Univ, Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Hanshuo; Xi, Jianzhong] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Tian, Yuan] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China; [Li, Ying] Tsinghua Univ, Cell Biol Core Facil, Beijing 100084, Peoples R China; [Ren, He; Zhang, Chuanmao] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Li, Lin; Chen, She] Natl Inst Biol Sci, Prote Facil, Beijing 102206, Peoples R China	Peking University; Tsinghua University; Peking University; China Agricultural University; Tsinghua University; Peking University; National Institute of Biological Sciences, Beijing	Xi, JZ (corresponding author), Peking Univ, Coll Engn, Beijing 100871, Peoples R China.	jzxi@pku.edu.cn; liyulab@mail.tsinghua.edu.cn	Ma, Liang/ABB-7268-2022; Xi, Jianzhong/J-1420-2014	Ma, Liang/0000-0003-3227-5917; RONG, YUEGUANG/0000-0001-6661-9664; Ren, He/0000-0003-0660-3657	973 Program [2010CB833704, 2011CB910100]; National Science Foundation [31030043, 30971484]; Tsinghua University [2010THZ0, 2009THZ03071]; NSFC [81030040]; MOST [2008ZX09401-002, 2011CB809106]	973 Program(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Tsinghua University; NSFC(National Natural Science Foundation of China (NSFC)); MOST	We are grateful to Olympus China, Nikon Instruments (Shanghai) and the Tsinghua Cell Biology Core Facility for providing technical support, and to Q. Dong, Y. Li and L. Huang for assistance with microscopy, TEM and image processing. We thank J-J. Liu for helpful discussions and J. Lippincott-Schwartz and J. Bonifacino (Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, Bethesda, USA) for constructs and antibodies. This research was supported by 973 Program grants 2010CB833704 and 2011CB910100, National Science Foundation grants 31030043 and 30971484, and Tsinghua University grants 2010THZ0 and 2009THZ03071 to L.Y., and NSFC grant 81030040, MOST grant 2008ZX09401-002, 2011CB809106 to J.X.	BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Funakoshi Y, 2010, ADV ENZYME REGUL, V50, P72, DOI 10.1016/j.advenzreg.2009.11.001; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kraft C., 2012, CURR OPIN CELL BIOL; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pawlowski N, 2010, BIOESSAYS, V32, P1033, DOI 10.1002/bies.201000086; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Popoff V, 2009, TRAFFIC, V10, P1868, DOI 10.1111/j.1600-0854.2009.00993.x; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rong YG, 2011, P NATL ACAD SCI USA, V108, P7826, DOI 10.1073/pnas.1013800108; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; SMYTHE E, 1992, J CELL BIOL, V119, P1163, DOI 10.1083/jcb.119.5.1163; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	29	187	195	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2012	14	9					924	+		10.1038/ncb2557	http://dx.doi.org/10.1038/ncb2557			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	004GJ	22885770				2022-12-25	WOS:000308668600008
J	Wong, AP; Bear, CE; Chin, S; Pasceri, P; Thompson, TO; Huan, LJ; Ratjen, F; Ellis, J; Rossant, J				Wong, Amy P.; Bear, Christine E.; Chin, Stephanie; Pasceri, Peter; Thompson, Tadeo O.; Huan, Ling-Jun; Ratjen, Felix; Ellis, James; Rossant, Janet			Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein	NATURE BIOTECHNOLOGY			English	Article							CYSTIC-FIBROSIS; LUNG MORPHOGENESIS; DEFINITIVE ENDODERM; GROWTH-FACTOR; BASAL-CELLS; MOUSE LUNG; F508DEL-CFTR; MULTIPOTENT; MECHANISMS; GENERATION	Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which regulates chloride and water transport across all epithelia and affects multiple organs, including the lungs. Here we report an in vitro directed differentiation protocol for generating functional CFTR-expressing airway epithelia from human embryonic stem cells. Carefully timed treatment by exogenous growth factors that mimic endoderm developmental pathways in vivo followed by air-liquid interface culture results in maturation of patches of tight junction-coupled differentiated airway epithelial cells that demonstrate active CFTR transport function. As a proof of concept, treatment of CF patient induced pluripotent stem cell-derived epithelial cells with a small-molecule compound to correct for the common CF processing mutation resulted in enhanced plasma membrane localization of mature CFTR protein. Our study provides a method for generating patient-specific airway epithelial cells for disease modeling and in vitro drug testing.	[Wong, Amy P.; Pasceri, Peter; Ellis, James; Rossant, Janet] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Wong, Amy P.; Thompson, Tadeo O.; Ellis, James] Ontario Human Induced Pluripotent Stem Cell Facil, Toronto, ON, Canada; [Bear, Christine E.; Chin, Stephanie; Huan, Ling-Jun] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Ratjen, Felix] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Ratjen, Felix] Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Ellis, James; Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rossant, Janet] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Rossant, J (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jellis@sickkids.ca; janet.rossant@sickkids.ca	Ellis, James/F-4789-2011	Ellis, James/0000-0002-4400-0091; Ratjen, Felix/0000-0003-4057-6592; Wong, Amy/0000-0002-9580-1980	Canadian Institutes of Health Research [GPG-102171]; Ontario Ministry of Economic Development and Innovation (MEDI); MEDI Post-doctoral Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Economic Development and Innovation (MEDI); MEDI Post-doctoral Award	We would like to thank S. Yamanaka (CiRA, Kyoto, Japan) and A. Nagy (Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada) for providing human iPSC lines (201B7, 253G1 and PB-4Fout, respectively). We would also like to thank R. Bridges (Rosalind Franklin University, Chicago) who provided the C18 analog. This work was funded by an Emerging Team grant from the Canadian Institutes of Health Research (GPG-102171) to C. E. B., F. R., J.E. and J.R. This work was supported (in part) by an Ontario Ministry of Economic Development and Innovation (MEDI) grant. A. P. W. was a recipient of the MEDI Post-doctoral Award. Monoclonal CFTR antibodies #450 and #660 were courtesy of J.R. Riordan (University of North Carolina, Chapel Hill, North Carolina, USA). CA1, CA2 hESC were obtained from A. Nagy (Mount Sinai Hospital, Toronto, Canada). H9 hESC were obtained from The WiCell Research Institute (Wisconsin, USA).	Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; Desai TJ, 2006, DEV BIOL, V291, P12, DOI 10.1016/j.ydbio.2005.10.045; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; HUANG TH, 1994, AM J RESP CELL MOL, V10, P192, DOI 10.1165/ajrcmb.10.2.7509163; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kimura J, 2007, PEDIATR DEVEL PATHOL, V10, P335, DOI 10.2350/07-06-0290.1; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; METZLER MD, 1993, ENDOCRINOLOGY, V133, P1990, DOI 10.1210/en.133.5.1990; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Pan QP, 2004, GENE, V331, P73, DOI 10.1016/j.gene.2004.01.026; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Samadikuchaksaraei A, 2006, TISSUE ENG, V12, P867, DOI 10.1089/ten.2006.12.867; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Shiratori M, 1996, AM J RESP CELL MOL, V15, P328, DOI 10.1165/ajrcmb.15.3.8810636; SOOD R, 1992, EMBO J, V11, P2487, DOI 10.1002/j.1460-2075.1992.tb05313.x; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Haute L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-105; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Weaver M, 1999, DEVELOPMENT, V126, P4005; Whitsett JA, 2002, J BIOL CHEM, V277, P22743, DOI 10.1074/jbc.M202253200; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	32	271	302	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					876	U108		10.1038/nbt.2328	http://dx.doi.org/10.1038/nbt.2328			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22922672	Green Accepted			2022-12-25	WOS:000308705700022
J	Duffield, JS				Duffield, Jeremy S.			The elusive source of myofibroblasts: problem solved?	NATURE MEDICINE			English	Editorial Material							FIBROSIS; ORIGIN; LIVER	Fibrosis is omnipresent and contributes to a substantial proportion of all natural deaths. A recent study (pages 1262-1270) provides evidence that the mysterious perivascular cell, also known as the pericyte, is the cell type responsible for fibrotic disease in skin and skeletal muscle.	[Duffield, Jeremy S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Duffield, Jeremy S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Duffield, JS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jeremysd@uw.edu						Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BRUNS RR, 1968, J CELL BIOL, V37, P244, DOI 10.1083/jcb.37.2.244; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; GRILLO HC, 1963, ANN SURG, V157, P453; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hung C., 2012, AM J RESP CRIT CARE, V185; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; ROSS R, 1970, Journal of Cell Biology, V44, P645, DOI 10.1083/jcb.44.3.645; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zimmermann K. W., 1923, Zeitschrift Ges Anat Munchen Abt 1, V68, P29, DOI 10.1007/BF02593544	12	21	22	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1178	1180		10.1038/nm.2867	http://dx.doi.org/10.1038/nm.2867			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869183				2022-12-25	WOS:000307469300016
J	Ouchi, T; Tomita, T; Horie, A; Yoshida, A; Takahashi, K; Nishida, H; Lassak, K; Taka, H; Mineki, R; Fujimura, T; Kosono, S; Nishiyama, C; Masui, R; Kuramitsu, S; Albers, SV; Kuzuyama, T; Nishiyama, M				Ouchi, Takuya; Tomita, Takeo; Horie, Akira; Yoshida, Ayako; Takahashi, Kento; Nishida, Hiromi; Lassak, Kerstin; Taka, Hikari; Mineki, Reiko; Fujimura, Tsutomu; Kosono, Saori; Nishiyama, Chiharu; Masui, Ryoji; Kuramitsu, Seiki; Albers, Sonja-Verena; Kuzuyama, Tomohisa; Nishiyama, Makoto			Lysine and arginine biosyntheses mediated by a common carrier protein in Sulfolobus	NATURE CHEMICAL BIOLOGY			English	Article							THERMUS-THERMOPHILUS; EVOLUTION; BACTERIUM; PATHWAYS; ENZYME; ACID	LysW has been identified as a carrier protein in the lysine biosynthetic pathway that is active through the conversion of alpha-aminoadipate (AAA) to lysine. In this study, we found that the hyperthermophilic archaeon, Sulfolobus acidocaldarius, not only biosynthesizes lysine through LysW-mediated protection of AAA but also uses LysW to protect the amino group of glutamate in arginine biosynthesis. In this archaeon, after LysW modification, AAA and glutamate are converted to lysine and ornithine, respectively, by a single set of enzymes with dual functions. The crystal structure of ArgX, the enzyme responsible for modification and protection of the amino moiety of glutamate with LysW, was determined in complex with LysW. Structural comparison and enzymatic characterization using Sulfolobus LysX, Sulfolobus ArgX and Thermus LysX identify the amino acid motif responsible for substrate discrimination between AAA and glutamate. Phylogenetic analysis reveals that gene duplication events at different stages of evolution led to ArgX and LysX.	[Ouchi, Takuya; Tomita, Takeo; Horie, Akira; Yoshida, Ayako; Takahashi, Kento; Kosono, Saori; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan; [Nishida, Hiromi] Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan; [Lassak, Kerstin; Albers, Sonja-Verena] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Taka, Hikari; Mineki, Reiko; Fujimura, Tsutomu] Juntendo Univ, Sch Med, Div Biochem Anal, Cent Lab Med Sci, Tokyo 113, Japan; [Nishiyama, Chiharu] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Tokyo 113, Japan; [Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan; [Masui, Ryoji; Kuramitsu, Seiki; Nishiyama, Makoto] RIKEN SPring 8 Ctr, Kobe, Hyogo, Japan	University of Tokyo; University of Tokyo; Max Planck Society; Juntendo University; Juntendo University; Osaka University; RIKEN	Nishiyama, M (corresponding author), Nihon Unisys Ltd, Tokyo, Japan.	umanis@mail.ecc.u-tokyo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022; Albers, Sonja-Verena/H-8689-2019; Nishida, Hiromi/B-1635-2008	Albers, Sonja-Verena/0000-0003-2459-2226; Nishiyama, Makoto/0000-0001-8143-8052; Fujimura, Tsutomu/0000-0003-1744-7725; Yoshida, Ayako/0000-0002-3668-9001; Kuzuyama, Tomohisa/0000-0002-7221-5858	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21380057, 24228001]; Nagase Science and Technology Foundation; Asahi Glass Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagase Science and Technology Foundation; Asahi Glass Foundation	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant nos. 21380057 and 24228001 to M.N.), Nagase Science and Technology Foundation to M.N., and from the Asahi Glass Foundation to M.N.	Baetens M, 1998, MICROBIOL-SGM, V144, P479, DOI 10.1099/00221287-144-2-479; Brinkman AB, 2002, J BIOL CHEM, V277, P29537, DOI 10.1074/jbc.M203528200; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; LEISINGER T, 1975, J BIOL CHEM, V250, P1690; MARTIN PR, 1992, J BACTERIOL, V174, P2694, DOI 10.1128/jb.174.8.2694-2701.1992; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Sakai H, 2003, J MOL BIOL, V332, P729, DOI 10.1016/S0022-2836(03)00946-X; STRASSMAN M, 1953, J AM CHEM SOC, V75, P1680, DOI 10.1021/ja01103a049; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06	20	34	48	2	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					277	283		10.1038/NCHEMBIO.1200	http://dx.doi.org/10.1038/NCHEMBIO.1200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23434852				2022-12-25	WOS:000317025800019
J	Castanon, I; Abrami, L; Holtzer, L; Heisenberg, CP; van der Goot, FG; Gonzalez-Gaitan, M				Castanon, I.; Abrami, L.; Holtzer, L.; Heisenberg, C. P.; van der Goot, F. G.; Gonzalez-Gaitan, M.			Anthrax toxin receptor 2a controls mitotic spindle positioning	NATURE CELL BIOLOGY			English	Article							CELL-DIVISION ORIENTATION; ZEBRAFISH GASTRULATION; RHO GTPASES; F-ACTIN; EXTENSION MOVEMENTS; IN-VIVO; POLARITY; PROTEIN; EXPRESSION; MECHANISM	Oriented mitosis is essential during tissue morphogenesis. The Wnt/planar cell polarity (Wnt/PCP) pathway orients mitosis in a number of developmental systems, including dorsal epiblast cell divisions along the animal-vegetal (A-V) axis during zebrafish gastrulation. How Wnt signalling orients the mitotic plane is, however, unknown. Here we show that, in dorsal epiblast cells, anthrax toxin receptor 2a (Antxr2a) accumulates in a polarized cortical cap, which is aligned with the embryonic A-V axis and forecasts the division plane. Filamentous actin (F-actin) also forms an A-V polarized cap, which depends on Wnt/PCP and its effectors RhoA and Rock2. Antxr2a is recruited to the cap by interacting with actin. Antxr2a also interacts with RhoA and together they activate the diaphanous-related formin zDia2. Mechanistically, Antxr2a functions as a Wnt-dependent polarized determinant, which, through the action of RhoA and zDia2, exerts torque on the spindle to align it with the A-V axis.	[Abrami, L.; van der Goot, F. G.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Castanon, I.; Holtzer, L.; Gonzalez-Gaitan, M.] Dept Biochem, CH-1211 Geneva 4, Switzerland; [Castanon, I.; Holtzer, L.; Gonzalez-Gaitan, M.] Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Heisenberg, C. P.] IST Austria, A-3400 Klosterneuburg, Austria	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; Institute of Science & Technology - Austria	van der Goot, FG (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Stn 15, CH-1015 Lausanne, Switzerland.	gisou.vandergoot@epfl.ch; Marcos.Gonzalez@unige.ch	Holtzer, Laurent/B-9016-2008; van der Goot, Gisou/B-2279-2012	Holtzer, Laurent/0000-0002-4421-6597; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; van der Goot, Gisou/0000-0002-8522-274X; Heisenberg, Carl-Philipp/0000-0002-0912-4566; ABRAMI, laurence/0000-0002-1774-0481	SNSF; Swiss SystemsX.ch initiative; Fondation SANTE-Vaduz/Aide au Soutien des Nouvelles Therapies; ERG; NCCR Frontiers in Genetics and Chemical Biology programmes; Polish-Swiss research program;  [LipidX-2008/011]	SNSF(Swiss National Science Foundation (SNSF)); Swiss SystemsX.ch initiative; Fondation SANTE-Vaduz/Aide au Soutien des Nouvelles Therapies; ERG; NCCR Frontiers in Genetics and Chemical Biology programmes; Polish-Swiss research program; 	We are grateful to B. Kunz and N. Zangger for generating the zAntxr2a construct for the pulldown, the phylogenetic tree and multiple sequence alignments, S. Abke, E. Paluch, C. Low, G. Weidinger, R. W. Koster, E. Kardash, L. Solnica-Krezel, A. J. Ridley, G. Davidson, S. Loubery and O. Schaad, and the bioimaging and fish platforms for reagents and technical help and T. Hannich for critical reading. This work was supported by the SNSF, the Swiss SystemsX.ch initiative and LipidX-2008/011 (M.G-G. and F.G.v.d.G.), by the Fondation SANTE-Vaduz/Aide au Soutien des Nouvelles Therapies (F.G.v.d.G.) and by the ERG, the NCCR Frontiers in Genetics and Chemical Biology programmes and the Polish-Swiss research program (M.G-G.).	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Bouzigues C, 2007, BIOPHYS J, V92, P654, DOI 10.1529/biophysj.106.094524; CAO LG, 1990, J CELL BIOL, V111, P1905, DOI 10.1083/jcb.111.5.1905; Castanon I, 2011, CURR OPIN CELL BIOL, V23, P697, DOI 10.1016/j.ceb.2011.09.009; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Deuquet J, 2012, EMBO J, V31, P3, DOI 10.1038/emboj.2011.442; Distel M, 2010, J CELL BIOL, V191, P875, DOI 10.1083/jcb.201004154; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Fukui Y, 1999, J CELL SCI, V112, P877; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Lai SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003439; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Macqueen DJ, 2008, DEV GENES EVOL, V218, P1, DOI 10.1007/s00427-007-0194-8; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Miller RK, 1999, J CELL BIOL, V144, P963, DOI 10.1083/jcb.144.5.963; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; O'Connor MN, 2009, BLOOD, V113, P4754, DOI 10.1182/blood-2008-06-162693; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Quesada-Hernandez E, 2010, CURR BIOL, V20, P1966, DOI 10.1016/j.cub.2010.10.009; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	58	39	40	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					28	U71		10.1038/ncb2632	http://dx.doi.org/10.1038/ncb2632			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23201782				2022-12-25	WOS:000312841300007
J	Comadran, J; Kilian, B; Russell, J; Ramsay, L; Stein, N; Ganal, M; Shaw, P; Bayer, M; Thomas, W; Marshall, D; Hedley, P; Tondelli, A; Pecchioni, N; Francia, E; Korzun, V; Walther, A; Waugh, R				Comadran, Jordi; Kilian, Benjamin; Russell, Joanne; Ramsay, Luke; Stein, Nils; Ganal, Martin; Shaw, Paul; Bayer, Micha; Thomas, William; Marshall, David; Hedley, Pete; Tondelli, Alessandro; Pecchioni, Nicola; Francia, Enrico; Korzun, Viktor; Walther, Alexander; Waugh, Robbie			Natural variation in a homolog of Antirrhinum CENTRORADIALIS contributed to spring growth habit and environmental adaptation in cultivated barley	NATURE GENETICS			English	Article							FLOWERING-LOCUS-T; GENOME-WIDE ASSOCIATION; GENE; TIME; DOMESTICATION; WHEAT; PHOTOPERIOD; ORTHOLOG; QTL; FT	As early farming spread from the Fertile Crescent in the Near East around 10,000 years before the present(1), domesticated crops encountered considerable ecological and environmental change. Spring-sown crops that flowered without the need for an extended period of cold to promote flowering and day length insensitive crops able to exploit the longer, cooler days of higher latitudes emerged and became established. To investigate the genetic consequences of adaptation to these new environments, we identified signatures of divergent selection in the highly differentiated modern-day spring and winter barleys. In one genetically divergent region, we identify a natural variant of the barley homolog of Antirrhinum CENTRORADIALIS(2) (HvCEN) as a contributor to successful environmental adaptation. The distribution of HvCEN alleles in a large collection of wild and landrace accessions indicates that this involved selection and enrichment of preexisting genetic variants rather than the acquisition of mutations after domestication.	[Comadran, Jordi; Russell, Joanne; Ramsay, Luke; Shaw, Paul; Bayer, Micha; Thomas, William; Marshall, David; Hedley, Pete; Waugh, Robbie] James Hutton Inst, Cell & Mol Sci Grp, Dundee, Scotland; [Kilian, Benjamin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Dept Genome Divers Grp, Gatersleben, Germany; [Ganal, Martin] TraitGenetics, Gatersleben, Germany; [Tondelli, Alessandro] Genom Res Ctr, Consiglio Ric Sperimentaz Agr CRA, Fiorenzuola Darda, Italy; [Pecchioni, Nicola; Francia, Enrico] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Korzun, Viktor] KWS LOCHOW, KWS Cereals Biotechnol, Bergen, Germany; [Walther, Alexander] Univ Gothenburg, Reg Climate Grp, Dept Earth Sci, Gothenburg, Sweden	James Hutton Institute; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Universita di Modena e Reggio Emilia; KWS Saat AG; University of Gothenburg	Waugh, R (corresponding author), James Hutton Inst, Cell & Mol Sci Grp, Dundee, Scotland.	robbie.waugh@hutton.ac.uk	Francia, Enrico/N-7931-2019; Francia, Enrico/C-8444-2015; Pecchioni, Nicola/E-5389-2015; Tondelli, Alessandro/AAJ-1720-2020; Hedley, Peter/F-1149-2011; Shaw, Paul D/E-9718-2011; Stein, Nils/F-7507-2017; Tondelli, Alessandro/I-7433-2015; Korzun, Viktor/U-6352-2019; Bayer, Micha/F-2255-2013	Francia, Enrico/0000-0001-8709-1002; Francia, Enrico/0000-0001-8709-1002; Pecchioni, Nicola/0000-0003-1704-2541; Tondelli, Alessandro/0000-0001-9299-7773; Hedley, Peter/0000-0003-0866-324X; Shaw, Paul D/0000-0002-0202-1150; Stein, Nils/0000-0003-3011-8731; Tondelli, Alessandro/0000-0001-9299-7773; Korzun, Viktor/0000-0003-0760-8249; Bayer, Micha/0000-0003-0041-3115; Kilian, Benjamin/0000-0002-9145-6980; Marshall, David/0000-0001-9309-2570	Scottish Government Rural and Environment Science and Analytical Services Division Research Programme [WP 5.2]; European Union International Research Cooperation with Mediterranean Partner Countries program [ICA3-CT2002-10026, FP7-212019]; German Science Foundation [SPP1530]; BBSRC [BB/D522003/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D522003/1] Funding Source: researchfish	Scottish Government Rural and Environment Science and Analytical Services Division Research Programme; European Union International Research Cooperation with Mediterranean Partner Countries program; German Science Foundation(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Graner, S. Friedel, F. Blattner, R. Sharma, R.K. Pasam, R. Neef and G. Willcox for discussions, K. Mayer and M. Pfeifer for searches for conservation of synteny in sequenced model grass genomes, J. Plieske and G. Durstewitz for their assistance in mapping and development of the cluster file and C. Trautewig, M. Ziems, K. Wolf, N. Uzrek and J. Morris for excellent technical assistance. We thank H. Ozkan, E. Fridman and the IPK Genebank for providing seeds and/or DNA for barley accessions. The authors would like to acknowledge the support given by the Scottish Government Rural and Environment Science and Analytical Services Division Research Programme (WP 5.2), the European Union International Research Cooperation with Mediterranean Partner Countries program ICA3-CT2002-10026 (Mapping Adaptation of Barley to Drought Environments) and Framework Programme 7 (FP7) TriticeaeGenome grant (FP7-212019), and the German Science Foundation Priority Programme SPP1530 to B.K.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Bradley D, 1996, NATURE, V379, P791, DOI 10.1038/379791a0; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2011, THEOR APPL GENET, V122, P523, DOI 10.1007/s00122-010-1466-7; Coventry SJ, 2003, AUST J AGR RES, V54, P1103, DOI 10.1071/AR02194; Diamond J., 2010, RUZHYA MIKROBY STALI; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kilian B, 2009, PLANT GENET GENOMICS, V7, P81, DOI 10.1007/978-0-387-77489-3_3; Koti K, 2006, EUPHYTICA, V152, P17, DOI 10.1007/s10681-006-9170-z; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Nilan RA, 1971, P388; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Reinheimer JL, 2004, THEOR APPL GENET, V109, P1267, DOI 10.1007/s00122-004-1736-3; Sameri M, 2011, BREEDING SCI, V61, P183, DOI 10.1270/jsbbs.61.183; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; von Bothmer R, 2003, DEV PL GEN, V7, P9; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	40	335	341	0	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1388	1392		10.1038/ng.2447	http://dx.doi.org/10.1038/ng.2447			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23160098				2022-12-25	WOS:000311713200021
J	Lemmers, RJLF; Tawil, R; Petek, LM; Balog, J; Block, GJ; Santen, GWE; Amell, AM; van der Vliet, PJ; Almomani, R; Straasheijm, KR; Krom, YD; Klooster, R; Sun, Y; den Dunnen, JT; Helmer, Q; Donlin-Smith, CM; Padberg, GW; van Engelen, BGM; de Greef, JC; Aartsma-Rus, AM; Frants, RR; de Visser, M; Desnuelle, C; Sacconi, S; Filippova, GN; Bakker, B; Bamshad, MJ; Tapscott, SJ; Miller, DG; van der Maarel, SM				Lemmers, Richard J. L. F.; Tawil, Rabi; Petek, Lisa M.; Balog, Judit; Block, Gregory J.; Santen, Gijs W. E.; Amell, Amanda M.; van der Vliet, Patrick J.; Almomani, Rowida; Straasheijm, Kirsten R.; Krom, Yvonne D.; Klooster, Rinse; Sun, Yu; den Dunnen, Johan T.; Helmer, Quinta; Donlin-Smith, Colleen M.; Padberg, George W.; van Engelen, Baziel G. M.; de Greef, Jessica C.; Aartsma-Rus, Annemieke M.; Frants, Rune R.; de Visser, Marianne; Desnuelle, Claude; Sacconi, Sabrina; Filippova, Galina N.; Bakker, Bert; Bamshad, Michael J.; Tapscott, Stephen J.; Miller, Daniel G.; van der Maarel, Silvere M.			Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2	NATURE GENETICS			English	Article							CHROMOSOMES HINGE DOMAIN; GENE-EXPRESSION; DOSAGE COMPENSATION; DNA REARRANGEMENTS; CONDENSIN SUBUNIT; CANDIDATE GENE; LOCUS; DUX4; VARIEGATION; SEQUENCE	Facioscapulohumeral dystrophy (FSHD) is characterized by chromatin relaxation of the D4Z4 macrosatellite array on chromosome 4 and expression of the D4Z4-encoded DUX4 gene in skeletal muscle. The more common form, autosomal dominant FSHD1, is caused by contraction of the D4Z4 array, whereas the genetic determinants and inheritance of D4Z4 array contraction-independent FSHD2 are unclear. Here, we show that mutations in SMCHD1 (encoding structural maintenance of chromosomes flexible hinge domain containing 1) on chromosome 18 reduce SMCHD1 protein levels and segregate with genome-wide D4Z4 CpG hypomethylation in human kindreds. FSHD2 occurs in individuals who inherited both the SMCHD1 mutation and a normal-sized D4Z4 array on a chromosome 4 haplotype permissive for DUX4 expression. Reducing SMCHD1 levels in skeletal muscle results in D4Z4 contraction-independent DUX4 expression. Our study identifies SMCHD1 as an epigenetic modifier of the D4Z4 metastable epiallele and as a causal genetic determinant of FSHD2 and possibly other human diseases subject to epigenetic regulation.	[Lemmers, Richard J. L. F.; Balog, Judit; van der Vliet, Patrick J.; Straasheijm, Kirsten R.; Krom, Yvonne D.; Klooster, Rinse; Sun, Yu; den Dunnen, Johan T.; de Greef, Jessica C.; Aartsma-Rus, Annemieke M.; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Tawil, Rabi; Donlin-Smith, Colleen M.] Univ Rochester, Med Ctr, Dept Neurol, Neuromuscular Dis Unit, Rochester, NY 14642 USA; [Petek, Lisa M.; Block, Gregory J.; Amell, Amanda M.; Bamshad, Michael J.; Miller, Daniel G.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Santen, Gijs W. E.; Almomani, Rowida; den Dunnen, Johan T.; Bakker, Bert] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands; [Helmer, Quinta] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Padberg, George W.; van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Med Ctr, Neuromuscular Ctr Nijmegen, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Desnuelle, Claude; Sacconi, Sabrina] Nice Univ Hosp, Ctr Reference Malad Neuromusculaires, Nice, France; [Desnuelle, Claude; Sacconi, Sabrina] Nice Univ Hosp, CNRS, Unite Mixte Rech UMR 7277, Nice, France; [Filippova, Galina N.; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Rochester; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	van der Maarel, SM (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	stapscot@fhcrc.org; maarel@lumc.nl	Bakker, Egbert/D-3525-2009; van Engelen, Baziel/H-8027-2014; van der Maarel, Silvere/X-3631-2018; dunnen, johan den/ABH-4228-2020; Padberg, G.W.A.M./H-8079-2014; SACCONI, Sabrina/AFT-1096-2022; de Greef, Jessica/AAN-2716-2020	Bakker, Egbert/0000-0002-2843-7357; van Engelen, Baziel/0000-0001-9867-9047; van der Maarel, Silvere/0000-0001-8103-711X; dunnen, johan den/0000-0002-6304-1710; SACCONI, Sabrina/0000-0002-0246-1455; de Greef, Jessica/0000-0002-2819-6098; Sun, Yu/0000-0002-2938-0233; Aartsma-Rus, Annemieke/0000-0003-1565-654X; Tapscott, Stephen/0000-0002-0319-0968; Miller, Daniel/0000-0002-5700-3048	US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke (NINDS)) [P01NS069539]; US National Institutes of Health (NIH) (Clinical & Translational Science Award (CTSA)) [UL1RR024160]; US National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) [R01AR045203]; US National Institutes of Health (NIH) (National Human Genome Research Institute (NHGRI)) [HG005608, HG006493]; Netherlands Genomics Initiative (NGI) [93515504]; University of Washington Center for Mendelian Genomics; Muscular Dystrophy Association (MDA) [217596]; Fields Center for FSHD Research; Geraldi Norton and Eklund family foundation; FSH Society; Friends of FSH Research; European Union [223026, 223143, 2012-305121]; Stichting FSHD; China Scholarship Council; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493, RC2HG005608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045203, R01AR066248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke (NINDS))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health (NIH) (Clinical & Translational Science Award (CTSA)); US National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institutes of Health (NIH) (National Human Genome Research Institute (NHGRI)); Netherlands Genomics Initiative (NGI); University of Washington Center for Mendelian Genomics; Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Fields Center for FSHD Research; Geraldi Norton and Eklund family foundation; FSH Society; Friends of FSH Research; European Union(European Commission); Stichting FSHD; China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank all subjects and family members for their participation. We thank D. Nickerson and). Shendure for excellent assistance and B. Trask for helpful discussions and critical reading of the manuscript. This work was supported by grants from the US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke (NINDS) P01NS069539, Clinical & Translational Science Award (CTSA) UL1RR024160, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR045203 and National Human Genome Research Institute (NHGRI) HG005608 and HG006493), a Netherlands Genomics Initiative (NGI) Horizon Valorization Project Grant (93515504), The University of Washington Center for Mendelian Genomics, the Muscular Dystrophy Association (MDA; 217596), the Fields Center for FSHD Research, the Geraldi Norton and Eklund family foundation, the FSH Society, The Friends of FSH Research, European Union Framework Programme 7 agreements 223026 (NMD-chip), 223143 (TechGene) and 2012-305121 (NEUROMICS) and the Stichting FSHD. Y.S. is supported by the China Scholarship Council.	Balog J, 2012, EPIGENETICS-US, V7, P579, DOI 10.4161/epi.20001; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gendrel AV, 2012, DEV CELL, V23, P265, DOI 10.1016/j.devcel.2012.06.011; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Scionti I, 2012, J MED GENET, V49, P171, DOI 10.1136/jmedgenet-2011-100454; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Spurlock G, 2010, MUSCLE NERVE, V42, P820, DOI 10.1002/mus.21766; Statland JM, 2011, CURR OPIN NEUROL, V24, P423, DOI 10.1097/WCO.0b013e32834959af; Thomas NST, 2007, J MED GENET, V44, P215, DOI 10.1136/jmg.2006.042804; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van der Maarel SM, 2011, TRENDS MOL MED, V17, P252, DOI 10.1016/j.molmed.2011.01.001; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	42	368	386	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1370	1374		10.1038/ng.2454	http://dx.doi.org/10.1038/ng.2454			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143600	Green Accepted			2022-12-25	WOS:000311713200018
J	Xu, B; Ionita-Laza, J; Roos, JL; Boone, B; Woodrick, S; Sun, Y; Levy, S; Gogos, JA; Karayiorgou, M				Xu, Bin; Ionita-Laza, Juliana; Roos, J. Louw; Boone, Braden; Woodrick, Scarlet; Sun, Yan; Levy, Shawn; Gogos, Joseph A.; Karayiorgou, Maria			De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia	NATURE GENETICS			English	Article							ARCHITECTURE; PHENOTYPE; VARIANT	To evaluate evidence for de novo etiologies in schizophrenia, we sequenced at high coverage the exomes of families recruited from two populations with distinct demographic structures and history. We sequenced a total of 795 exomes from 231 parent-proband trios enriched for sporadic schizophrenia cases, as well as 34 unaffected trios. We observed in cases an excess of de novo nonsynonymous single-nucleotide variants as well as a higher prevalence of gene-disruptive de novo mutations relative to controls. We found four genes (LAMA2, DPYD, TRRAP and VPS39) affected by recurrent de novo events within or across the two populations, which is unlikely to have occurred by chance. We show that de novo mutations affect genes with diverse functions and developmental profiles, but we also find a substantial contribution of mutations in genes with higher expression in early fetal life. Our results help define the genomic and neural architecture of schizophrenia.	[Xu, Bin; Woodrick, Scarlet; Sun, Yan; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Ionita-Laza, Juliana] Columbia Univ, Dept Biostat, New York, NY USA; [Roos, J. Louw] Weskoppies Hosp, Pretoria, South Africa; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Boone, Braden; Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Woodrick, Scarlet; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University; University of Pretoria; HudsonAlpha Institute for Biotechnology; Columbia University; Columbia University	Karayiorgou, M (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	jag90@columbia.edu; mk2758@columbia.edu		Levy, Shawn/0000-0002-1369-5740; Roos, Johannes/0000-0002-0572-1072	National Institute of Mental Health (NIMH) [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077235, R01MH095797, R01MH061399] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are enormously grateful to all the families who participated in this research. We thank H. Pretorius and nursing sisters R. van Wyk, C. Botha and H. van den Berg for their assistance with subject recruitment, family history assessments and diagnostic evaluations. We thank S.L. Lundy for valuable assistance with clinical database maintenance and L. Rodriguez-Murillo for help with Supplementary Figure 9. We also thank B. Plummer and NI. Robinson and the HudsonAlpha Genomics Services Laboratory for experimental support. Finally, we thank L.J. Mienie for the thymine loading test. This work was partially supported by National Institute of Mental Health (NIMH) grants MH061399 (to MAC) and MH077235 (to J.A.G.) and the Lieber Center for Schizophrenia Research at Columbia University. B.X. was partially supported by a National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award.	Arguello PA, 2012, TRENDS NEUROSCI, V35, P3, DOI 10.1016/j.tins.2011.11.007; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Carter MT, 2011, CLIN GENET, V80, P435, DOI 10.1111/j.1399-0004.2010.01578.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gilman S.R., NAT NEUROSC IN PRESS; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karayiorgou M, 2012, NAT NEUROSCI, V15, P811, DOI 10.1038/nn.3115; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; McGrath JJ, 2009, MED J AUSTRALIA, V190, pS7, DOI 10.5694/j.1326-5377.2009.tb02366.x; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sobin C, 2003, PSYCHIAT RES, V117, P113, DOI 10.1016/S0165-1781(02)00321-9; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Van Kuilenburg ABP, 1999, HUM GENET, V104, P1, DOI 10.1007/PL00008711; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	31	307	312	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1365	1369		10.1038/ng.2446	http://dx.doi.org/10.1038/ng.2446			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23042115	Green Accepted			2022-12-25	WOS:000311713200017
J	Youssef, KK; Lapouge, G; Bouvree, K; Rorive, S; Brohee, S; Appelstein, O; Larsimont, JC; Sukumaran, V; Van de Sande, B; Pucci, D; Dekoninck, S; Berthe, JV; Aerts, S; Salmon, I; del Marmol, V; Blanpain, C				Youssef, Khalil Kass; Lapouge, Gaelle; Bouvree, Karine; Rorive, Sandrine; Brohee, Sylvain; Appelstein, Ornella; Larsimont, Jean-Christophe; Sukumaran, Vijayakumar; Van de Sande, Bram; Pucci, Doriana; Dekoninck, Sophie; Berthe, Jean-Valery; Aerts, Stein; Salmon, Isabelle; del Marmol, Veronique; Blanpain, Cedric			Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiation	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN ACTIVITY; STEM-CELLS; KERATIN EXPRESSION; DERMAL PAPILLA; SKIN; HEDGEHOG; DIFFERENTIATION; CANCER; MORPHOGENESIS; ACTIVATION	Basal cell carcinoma, the most frequent human skin cancer, arises from activating hedgehog (HH) pathway mutations; however, little is known about the temporal changes that occur in tumour-initiating cells from the first oncogenic hit to the development of invasive cancer. Using an inducible mouse model enabling the expression of a constitutively active Smoothened mutant (SmoM2) in the adult epidermis, we carried out transcriptional profiling of SmoM2-expressing cells at different times during cancer initiation. We found that tumour-initiating cells are massively reprogrammed into a fate resembling that of embryonic hair follicle progenitors (EHFPs). Wnt/beta-catenin signalling was very rapidly activated following SmoM2 expression in adult epidermis and coincided with the expression of EHFP markers. Deletion of beta-catenin in adult SmoM2-expressing cells prevents EHFP reprogramming and tumour initiation. Finally, human basal cell carcinomas also express genes of the Wnt signalling and EHFP signatures.	[Youssef, Khalil Kass; Lapouge, Gaelle; Bouvree, Karine; Brohee, Sylvain; Appelstein, Ornella; Larsimont, Jean-Christophe; Sukumaran, Vijayakumar; Pucci, Doriana; Dekoninck, Sophie; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] Univ Libre Brussels, Dept Pathol, Erasme Hosp, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] CMMI, DIAPATH, B-6041 Gosselies, Belgium; [Brohee, Sylvain; Appelstein, Ornella] Univ Libre Brussels, Dept Comp Sci, B-1050 Brussels, Belgium; [Van de Sande, Bram; Aerts, Stein] Katholieke Univ Leuven, Lab Computat Biol, Ctr Human Genet, B-3000 Louvain, Belgium; [Berthe, Jean-Valery] Univ Libre Brussels, Dept Plast Surg, Erasme Hosp, B-1070 Brussels, Belgium; [del Marmol, Veronique] Erasme Univ Hosp, Dept Dermatol, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Brussels, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles; KU Leuven; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Brussels, IRIBHM, 808 Route Lennik, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Sukumaran, Vijayakumar/K-8523-2015; Aerts, Stein/A-1100-2009; Blanpain, Cedric/ABD-8392-2021; del marmol, veronique/AAZ-8117-2020; Youssef, Khalil Kass/AAB-6528-2021	Sukumaran, Vijayakumar/0000-0002-2686-7329; Aerts, Stein/0000-0002-8006-0315; Youssef, Khalil Kass/0000-0002-4572-3160; Van de Sande, Bram/0000-0001-5122-4061	TELE VIE; FNRS; program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; Fondation ULB; Fond Yvonne Boel; Fond Gaston Ithier; European Research Council (ERC); EMBO Young Investigator Program	TELE VIE; FNRS(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; Fondation ULB; Fond Yvonne Boel; Fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	We would like to thank those who provided us with reagents and who are acknowledged in the text. C.B. is an investigator of WELBIO. C.B. is a chercheur qualifie, S.B. is a charge de recherche and G.L. is a collaborateur scientifique of the FRS/FNRS; K.K.Y. is supported by TELE VIE. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the Fondation ULB, the Fond Yvonne Boel and the Fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; Crowson AN, 2006, MODERN PATHOL, V19, pS127, DOI 10.1038/modpathol.3800512; DasGupta R, 1999, DEVELOPMENT, V126, P4557; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; El-Bahrawy M, 2003, BRIT J DERMATOL, V148, P964, DOI 10.1046/j.1365-2133.2003.05240.x; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Enshell-Seijffers D, 2010, P NATL ACAD SCI USA, V107, P21564, DOI 10.1073/pnas.1007326107; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Krahl D, 2010, BRIT J DERMATOL, V162, P1294, DOI 10.1111/j.1365-2133.2010.09630.x; Kriegl L, 2009, BRIT J DERMATOL, V160, P1353, DOI 10.1111/j.1365-2133.2009.09144.x; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; MARKEY AC, 1992, BRIT J DERMATOL, V126, P154, DOI 10.1111/j.1365-2133.1992.tb07813.x; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Osorio KM, 2011, J CELL BIOL, V193, P235, DOI 10.1083/jcb.201006068; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Shirahama S, 1996, J DERMATOL SCI, V13, P30, DOI 10.1016/0923-1811(95)00493-9; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong SY, 2011, P NATL ACAD SCI USA, V108, P4093, DOI 10.1073/pnas.1013098108; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Yoshikawa K, 1998, J DERMATOL SCI, V17, P15, DOI 10.1016/S0923-1811(97)00065-0; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459	52	97	99	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2012	14	12					1282	+		10.1038/ncb2628	http://dx.doi.org/10.1038/ncb2628			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	048DL	23178882				2022-12-25	WOS:000311890300010
J	Harris, E; Ennis, FA; Diamond, MS				Harris, Eva; Ennis, Francis A.; Diamond, Michael S.			Defeating dengue: a challenge for a vaccine	NATURE MEDICINE			English	Editorial Material							VIRUS-INFECTIONS; DISEASE SEVERITY; NEUTRALIZATION	Dengue poses a substantial clinical problem, with the four serotypes of dengue viruses infecting 50-100 million people per year and approximately half the world's population estimated to be at risk. As there is no specific treatment for dengue, the development of an effective vaccine will be an important measure for controlling this disease. A phase 2b trial testing a recombinant live, attenuated tetravalent dengue-yellow fever chimeric virus vaccine in Thai schoolchildren of 4-11 years of age has recently been reported(1). The vaccine showed an overall efficacy of 30.2%, and one or more doses of the vaccine reduced the incidence of disease caused by the DENV3 and DENV4 dengue virus serotypes by 80-90%, with less reduction of disease caused by DENV1; however, there was no efficacy against DENV2. We asked three experts to comment on the results of this trial and how they might influence the landscape of dengue vaccine development.	[Harris, Eva] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Harris, Eva] Univ Calif Berkeley, Ctr Global Publ Hlth, Sch Publ Hlth, Berkeley, CA 94720 USA; [Ennis, Francis A.] Univ Massachusetts, Sch Med, Worcester, MA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester	Harris, E (corresponding author), Univ Calif Berkeley, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.		Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165				Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x	10	8	9	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1622	1623		10.1038/nm.2997	http://dx.doi.org/10.1038/nm.2997			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135514	Bronze			2022-12-25	WOS:000310837000019
J	Molenaar, JJ; Domingo-Fernandez, R; Ebus, ME; Lindner, S; Koster, J; Drabek, K; Mestdagh, P; van Sluis, P; Valentijn, LJ; van Nes, J; Broekmans, M; Haneveld, F; Volckmann, R; Bray, I; Heukamp, L; Sprussel, A; Thor, T; Kieckbusch, K; Klein-Hitpass, L; Fischer, M; Vandesompele, J; Schramm, A; van Noesel, MM; Varesio, L; Speleman, F; Eggert, A; Stallings, RL; Caron, HN; Versteeg, R; Schulte, JH				Molenaar, Jan J.; Domingo-Fernandez, Raquel; Ebus, Marli E.; Lindner, Sven; Koster, Jan; Drabek, Ksenija; Mestdagh, Pieter; van Sluis, Peter; Valentijn, Linda J.; van Nes, Johan; Broekmans, Marloes; Haneveld, Franciska; Volckmann, Richard; Bray, Isabella; Heukamp, Lukas; Spruessel, Annika; Thor, Theresa; Kieckbusch, Kristina; Klein-Hitpass, Ludger; Fischer, Matthias; Vandesompele, Jo; Schramm, Alexander; van Noesel, Max M.; Varesio, Luigi; Speleman, Frank; Eggert, Angelika; Stallings, Raymond L.; Caron, Huib N.; Versteeg, Rogier; Schulte, Johannes H.			LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression	NATURE GENETICS			English	Article							COPY NUMBER DEFECTS; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; PROMOTES TRANSFORMATION; RISK STRATIFICATION; MIRNA EXPRESSION; MESSENGER-RNA; IN-VIVO; N-MYC; MICRORNA	LIN28B regulates developmental processes by modulating microRNAs (miRNAs) of the let-7 family. A role for LIN28B in cancer has been proposed but has not been established in vivo. Here, we report that LIN28B showed genomic aberrations and extensive overexpression in high-risk neuroblastoma compared to several other tumor entities and normal tissues. High LIN28B expression was an independent risk factor for adverse outcome in neuroblastoma. LIN28B signaled through repression of the let-7 miRNAs and consequently resulted in elevated MYCN protein expression in neuroblastoma cells. LIN28B-let-7-MYCN signaling blocked differentiation of normal neuroblasts and neuroblastoma cells. These findings were fully recapitulated in a mouse model in which LIN28B expression in the sympathetic adrenergic lineage induced development of neuroblastomas marked by low let-7 miRNA levels and high MYCN protein expression. Interference with this pathway might offer therapeutic perspectives.	[Molenaar, Jan J.; Ebus, Marli E.; Koster, Jan; Drabek, Ksenija; van Sluis, Peter; Valentijn, Linda J.; van Nes, Johan; Broekmans, Marloes; Haneveld, Franciska; Volckmann, Richard; Caron, Huib N.; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Domingo-Fernandez, Raquel; Bray, Isabella; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Domingo-Fernandez, Raquel; Bray, Isabella; Stallings, Raymond L.] Natl Childrens Res Ctr, Dublin, Ireland; [Lindner, Sven; Spruessel, Annika; Thor, Theresa; Kieckbusch, Kristina; Schramm, Alexander; Eggert, Angelika; Schulte, Johannes H.] Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Essen, Germany; [Mestdagh, Pieter; Vandesompele, Jo; Speleman, Frank] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Heukamp, Lukas] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Klein-Hitpass, Ludger] Univ Hosp Essen, Inst Cell Biol, Essen, Germany; [Fischer, Matthias] Univ Cologne, Childrens Hosp, Dept Pediat Oncol & Hematol, D-50931 Cologne, Germany; [van Noesel, Max M.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Varesio, Luigi] Gaslini Inst, Mol Biol Lab, Genoa, Italy	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Trinity College Dublin; Ghent University; University of Cologne; University of Duisburg Essen; University of Cologne; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini	Molenaar, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.molenaar@amc.uva.nl	Heukamp, Lukas C/A-8338-2013; Schulte, Johannes H./V-2474-2018; Stallings, Raymond/A-7213-2008; speleman, frank/AAR-5184-2020; Schulte, Johannes H/G-3981-2010; Vandesompele, Jo/W-3411-2018; Koster, Jan/C-5934-2008; varesio, luigi/J-8261-2016; Versteeg, Rogier/AAQ-1765-2020; Schramm, Alexander/G-5688-2010; Eggert, Angelika/AAE-6907-2022; Heukamp, Lukas/G-9967-2012	speleman, frank/0000-0002-6628-8559; Vandesompele, Jo/0000-0001-6274-0184; Koster, Jan/0000-0002-0890-7585; varesio, luigi/0000-0001-5659-2218; Schramm, Alexander/0000-0001-7670-7529; Eggert, Angelika/0000-0003-3476-8184; Versteeg, Rogier/0000-0001-7172-0388; Heukamp, Lukas/0000-0002-3388-3482; Schulte, Johannes Hubertus/0000-0003-0671-1201; Mestdagh, Pieter/0000-0001-7821-9684; van Nes, Johan/0000-0001-7691-1431	Villa Joep Foundation; Kinderen Kankervrij (KiKa); Toni Voute Fund; Netherlands Cancer Foundation; Science Foundation Ireland [07/IN.1/B1776]; Children's Medical and Research Foundation; US National Institutes of Health [5R01CA127496]; European Union (ENCCA: EU Seventh Framework Programme, Network of Excellence) [261474]; European Union (ASSET: EU Seventh Framework Programme) [CP 259348]; National Genome Research Network (NGFNplus (Germany)) [PKN-01GS0894-6]; German Cancer Aid [108941]; NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	Villa Joep Foundation; Kinderen Kankervrij (KiKa); Toni Voute Fund; Netherlands Cancer Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union (ENCCA: EU Seventh Framework Programme, Network of Excellence); European Union (ASSET: EU Seventh Framework Programme); National Genome Research Network (NGFNplus (Germany)); German Cancer Aid(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We kindly thank A. Odersky, L. Schild, I. van der Ploeg, E. Dolman, T Eleveld and L. Bate Eya for excellent technical assistance. The research reported in this Manuscript was supported by grants from the Villa Joep Foundation, Kinderen Kankervrij (KiKa), the Toni Voute Fund and the Netherlands Cancer Foundation. R.L.S. was a recipient of grants from the Science Foundation Ireland (07/IN.1/B1776), the Children's Medical and Research Foundation and the US National Institutes of Health (5R01CA127496). A.E. is funded by the European Union (ENCCA: EU Seventh Framework Programme, Network of Excellence 261474; ASSET: EU Seventh Framework Programme, CP 259348). Support was also provided by the National Genome Research Network (NGFNplus (Germany); PKN-01GS0894-6 to J.H.S., A.E. and A.S.) and the German Cancer Aid (grant 108941 to J.H.S. and A.E.).	Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; De Preter K, 2011, CLIN CANCER RES, V17, P7684, DOI 10.1158/1078-0432.CCR-11-0610; Eda A, 2009, BIOCHEM BIOPH RES CO, V388, P648, DOI 10.1016/j.bbrc.2009.08.040; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Olsson-Carter K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001054; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Ora I, 2011, SEMIN CANCER BIOL, V21, P217, DOI 10.1016/j.semcancer.2011.07.002; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Stanke M, 2006, DEVELOPMENT, V133, P141, DOI 10.1242/dev.02189; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang J, 2012, STEM CELLS DEV, V21, P1524, DOI 10.1089/scd.2011.0350; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	56	261	267	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1199	1206		10.1038/ng.2436	http://dx.doi.org/10.1038/ng.2436			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23042116				2022-12-25	WOS:000310495800010
J	Pillay, N; Plagnol, V; Tarpey, PS; Lobo, SB; Presneau, N; Szuhai, K; Halai, D; Berisha, F; Cannon, SR; Mead, S; Kasperaviciute, D; Palmen, J; Talmud, PJ; Kindblom, LG; Amary, MF; Tirabosco, R; Flanagan, AM				Pillay, Nischalan; Plagnol, Vincent; Tarpey, Patrick S.; Lobo, Samira B.; Presneau, Nadege; Szuhai, Karoly; Halai, Dina; Berisha, Fitim; Cannon, Stephen R.; Mead, Simon; Kasperaviciute, Dalia; Palmen, Jutta; Talmud, Philippa J.; Kindblom, Lars-Gunnar; Amary, M. Fernanda; Tirabosco, Roberto; Flanagan, Adrienne M.			A common single-nucleotide variant in T is strongly associated with chordoma	NATURE GENETICS			English	Article							BRACHYURY; EXPRESSION; CANCER; GENE	Chordoma is a rare malignant bone tumor that expresses the transcription factor T. We conducted an association study of 40 individuals with chordoma and 358 ancestry-matched controls, with replication in an independent cohort. Whole-exome and Sanger sequencing of T exons showed strong association of the common nonsynonymous SNP rs2305089 with chordoma risk (allelic odds ratio (OR) = 6.1, 95% confidence interval (Cl) = 3.1-12.1; P = 4.4 x 10(-9)), a finding that is exceptional in cancers with a non-Mendelian mode of inheritance.	[Pillay, Nischalan; Presneau, Nadege; Flanagan, Adrienne M.] UCL, Inst Canc, London, England; [Cannon, Stephen R.] Royal Natl Orthopaed Hosp, Bone Tumour Unit, Stanmore HA7 4LP, Middx, England; [Plagnol, Vincent] UCL, UCL Genet Inst, London, England; [Tarpey, Patrick S.] Wellcome Trust Sanger Inst, Cambridge, England; [Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Mead, Simon] UCL, Inst Neurol, Prion Unit, MRC, London, England; [Kasperaviciute, Dalia] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Palmen, Jutta; Talmud, Philippa J.] UCL, Inst Cardiovasc Sci, London, England; [Kindblom, Lars-Gunnar] Royal Orthopaed Hosp, Dept Histopathol, Birmingham B31 2AP, W Midlands, England	University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Wellcome Trust Sanger Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; University of London; University College London; University of London; University College London; Royal Orthopaedic Hospital	Flanagan, AM (corresponding author), UCL, Inst Canc, London, England.	a.flanagan@ucl.ac.uk	Szuhai, Karoly/A-1100-2008; Amary, Fernanda/AAI-7339-2020; Mead, Simon/E-9414-2011	Szuhai, Karoly/0000-0002-1228-4245; Mead, Simon/0000-0002-4326-1468; Plagnol, Vincent/0000-0002-5597-9215; Pillay, Nischalan/0000-0003-0579-4105; Flanagan, Adrienne/0000-0002-2832-1303; Talmud, Philippa/0000-0002-5560-1933	Skeletal Cancer Action Trust (SCAT), UK; Pathological Society; Chordoma Foundation; Rosetrees Foundation; Wellcome Trust Sanger Institute [98051]; UCL Experimental Cancer Centre; Medical Research Council [MC_U123160651] Funding Source: researchfish; MRC [MC_U123160651] Funding Source: UKRI	Skeletal Cancer Action Trust (SCAT), UK; Pathological Society; Chordoma Foundation; Rosetrees Foundation(Rosetrees Trust); Wellcome Trust Sanger Institute(Wellcome Trust); UCL Experimental Cancer Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the study subjects for participating in the research and to the clinicians and support staff in the London Sarcoma Service involved in their care. We thank S. McLaren, C. Latimer, K. Raine and A. Butler at the The Wellcome Trust Sanger Institute for assistance with the exome sequencing. We are also grateful to L. Game (Head of Genomics Laboratory, MRC Clinical Sciences Centre) for assistance with aCGH scanning. We are particularly grateful to B. Liegl (Medical University of Graz) for providing us with the chordoma cell line, MUG-Chor1. The research was funded by the Skeletal Cancer Action Trust (SCAT), UK, The Pathological Society (N. Pillay), The Chordoma Foundation, The Rosetrees Foundation and the Wellcome Trust Sanger Institute (grant 98051). The research was part of the RNOH Musculoskeletal Research Programme and Biobank and the UCL Hospital (UCLH)/UCL Comprehensive Biomedical Research Programme and was supported by the UCL Experimental Cancer Centre.	Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Papapetrou C, 1997, FEBS LETT, V409, P201, DOI 10.1016/S0014-5793(97)00506-1; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tirabosco R, 2008, AM J SURG PATHOL, V32, P572, DOI 10.1097/PAS.0b013e31815b693a; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454	15	86	87	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1185	1187		10.1038/ng.2419	http://dx.doi.org/10.1038/ng.2419			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23064415				2022-12-25	WOS:000310495800007
J	Xu, JF; Mo, ZN; Ye, DW; Wang, ML; Liu, F; Jin, GF; Xu, CL; Wang, X; Shao, Q; Chen, ZW; Tao, ZH; Qi, J; Zhou, FJ; Wang, Z; Fu, YW; He, DL; Wei, Q; Guo, JM; Wu, DL; Gao, X; Yuan, JL; Wang, GX; Xu, Y; Wang, GZ; Yao, HJ; Dong, P; Jiao, Y; Shen, M; Yang, J; Jun, OY; Jiang, HW; Zhu, Y; Ren, SC; Zhang, ZD; Yin, CJ; Gao, X; Dai, B; Hu, ZB; Yang, YJ; Wu, QJ; Chen, HY; Peng, P; Zheng, Y; Zheng, XD; Xiang, YB; Long, JR; Gong, J; Na, R; Lin, XL; Yu, HJ; Wang, Z; Tao, S; Feng, JJ; Sun, JS; Liu, WN; Hsing, A; Rao, JY; Ding, Q; Wiklund, F; Gronberg, H; Shu, XO; Zheng, W; Shen, HB; Jin, L; Shi, R; Lu, DR; Zhang, XJ; Sun, JL; Zheng, SL; Sun, YH				Xu, Jianfeng; Mo, Zengnan; Ye, Dingwei; Wang, Meilin; Liu, Fang; Jin, Guangfu; Xu, Chuanliang; Wang, Xiang; Shao, Qiang; Chen, Zhiwen; Tao, Zhihua; Qi, Jun; Zhou, Fangjian; Wang, Zhong; Fu, Yaowen; He, Dalin; Wei, Qiang; Guo, Jianming; Wu, Denglong; Gao, Xin; Yuan, Jianlin; Wang, Gongxian; Xu, Yong; Wang, Guozeng; Yao, Haijun; Dong, Pei; Jiao, Yang; Shen, Mo; Yang, Jin; Jun Ou-Yang; Jiang, Haowen; Zhu, Yao; Ren, Shancheng; Zhang, Zhengdong; Yin, Changjun; Gao, Xu; Dai, Bo; Hu, Zhibin; Yang, Yajun; Wu, Qijun; Chen, Hongyan; Peng, Peng; Zheng, Ying; Zheng, Xiaodong; Xiang, Yongbing; Long, Jirong; Gong, Jian; Na, Rong; Lin, Xiaoling; Yu, Hongjie; Wang, Zhong; Tao, Sha; Feng, Junjie; Sun, Jishan; Liu, Wennuan; Hsing, Ann; Rao, Jianyu; Ding, Qiang; Wiklund, Fredirik; Gronberg, Henrik; Shu, Xiao-Ou; Zheng, Wei; Shen, Hongbing; Jin, Li; Shi, Rong; Lu, Daru; Zhang, Xuejun; Sun, Jielin; Zheng, S. Lilly; Sun, Yinghao			Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS; GENE-CLUSTER; CLASS-I; VARIANTS; RECEPTORS	Prostate cancer risk-associated variants have been reported in populations of European descent, African-Americans and Japanese using genome-wide association studies (GWAS). To systematically investigate prostate cancer risk-associated variants in Chinese men, we performed the first GWAS in Han Chinese. In addition to confirming several associations reported in other ancestry groups, this study identified two new risk-associated loci for prostate cancer on chromosomes 9q31.2 (rs817826, P = 5.45 x 10(-14)) and 19q13.4 (rs103294, P = 5.34 x 10(-16)) in 4,484 prostate cancer cases and 8,934 controls. The rs103294 marker at 19q13.4 is in strong linkage equilibrium with a 6.7-kb germline deletion that removes the first six of seven exons in LILRA3, a gene regulating inflammatory response, and was significantly associated with the mRNA expression of LILRA3 in T cells (P < 1 x 10(-4)). These findings may advance the understanding of genetic susceptibility to prostate cancer.	[Xu, Chuanliang; Ren, Shancheng; Gao, Xu; Sun, Yinghao] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Xu, Jianfeng; Liu, Fang; Wang, Xiang; Jiang, Haowen; Gong, Jian; Na, Rong; Lin, Xiaoling] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Liu, Fang; Chen, Hongyan; Lin, Xiaoling; Yu, Hongjie; Lu, Daru; Sun, Jielin; Zheng, S. Lilly] Fudan Univ, Sch Life Sci, Fudan Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Chen, Hongyan; Yu, Hongjie; Lu, Daru] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Jin, Guangfu; Wang, Zhong; Tao, Sha; Feng, Junjie; Sun, Jishan; Liu, Wennuan; Ding, Qiang; Sun, Jielin; Zheng, S. Lilly] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China; [Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol, Nanning, Peoples R China; [Ye, Dingwei; Zhu, Yao; Dai, Bo] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China; [Ye, Dingwei; Zhu, Yao; Dai, Bo] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Dept Mol & Genet Toxicol,Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Jin, Guangfu; Zhang, Zhengdong; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Shao, Qiang] Suzhou Municipal Hosp, Dept Urol, Suzhou, Peoples R China; [Chen, Zhiwen] Third Mil Med Univ, Southwest Hosp, Urol Inst Peoples Liberat Army PLA, Chongqing, Peoples R China; [Tao, Zhihua] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Lab Med, Hangzhou 310003, Zhejiang, Peoples R China; [Qi, Jun; Jiao, Yang] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Urol, Shanghai 200030, Peoples R China; [Zhou, Fangjian; Dong, Pei] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Zhou, Fangjian; Dong, Pei] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Zhong; Yao, Haijun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol, Shanghai 200030, Peoples R China; [Fu, Yaowen] Jilin Univ, Hosp 1, Dept Urol, Changchun 130023, Peoples R China; [He, Dalin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Urol, Xian 710049, Peoples R China; [Wei, Qiang] Sichuan Univ, W China Hosp, Dept Urol, Chengdu 610064, Peoples R China; [Guo, Jianming] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Wu, Denglong] Tongji Univ, Tongji Hosp, Dept Urol, Shanghai 200092, Peoples R China; [Gao, Xin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Yuan, Jianlin] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Wang, Gongxian] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China; [Xu, Yong] TianJin Med Univ, TianJin Inst Urol, Hosp 2, Dept Urol, Tianjin, Peoples R China; [Wang, Guozeng] Pudong Gongli Hosp, Dept Urol, Shanghai, Peoples R China; [Shen, Mo] Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China; [Yang, Jin] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [Jun Ou-Yang] Suzhou Univ, Peoples Hosp 1, Dept Urol, Suzhou 215006, Peoples R China; [Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Yang, Yajun; Jin, Li; Lu, Daru] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Yang, Yajun; Jin, Li; Lu, Daru] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yang, Yajun; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Peoples R China; [Wu, Qijun] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogene & Related Genes,Sch Med, Shanghai 200030, Peoples R China; [Peng, Peng; Zheng, Ying] Shanghai Municipal Ctr Dis Control & Prevent, Dept Canc Prevent & Control, Shanghai, Peoples R China; [Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Peoples R China; [Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Peoples R China; [Zheng, Xiaodong; Zhang, Xuejun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Peoples R China; [Xiang, Yongbing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Long, Jirong; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr,Div Epidemiol, Nashville, TN 37212 USA; [Hsing, Ann] Canc Prevent Inst Calif, Fremont, CA USA; [Rao, Jianyu] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Wiklund, Fredirik; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Shi, Rong] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China	Naval Medical University; Fudan University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center; Guangxi Medical University; Guangxi Medical University; Fudan University; Fudan University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Army Medical University; Zhejiang University; Shanghai Jiao Tong University; Sun Yat Sen University; Shanghai Jiao Tong University; Jilin University; Xi'an Jiaotong University; Sichuan University; Fudan University; Tongji University; Sun Yat Sen University; Air Force Military Medical University; Nanchang University; Tianjin Medical University; Wenzhou Medical University; Army Medical University; Soochow University - China; Nanjing Medical University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention; Anhui Medical University; Anhui Medical University; Shanghai Jiao Tong University; Vanderbilt University; Cancer Prevention Institute of California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Karolinska Institutet; Shanghai Jiao Tong University	Sun, YH (corresponding author), Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China.	sunyh@medmail.com.cn	Chen, Zhiwen/I-1153-2013; Zheng, Wei/O-3351-2013; Chen, Gang/G-2722-2010; Yu, Hongjie/GZK-5351-2022; zhang, weihua/GXV-1334-2022; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; zhang, zheng/HCH-9684-2022	Zheng, Wei/0000-0003-1226-070X; Jin, Li/0000-0002-4546-2415; mo, zengnan/0000-0002-3047-3138; Na, Rong/0000-0001-7470-5108; Qi, Jun/0000-0003-0970-8462; Long, Jirong/0000-0002-7433-9766; Shen, Hongbing/0000-0002-2581-5906; Jin, Guangfu/0000-0003-0249-5337	National Key Basic Research Program [2012CB518300, 2012CB518301]; National Natural Science Foundation of China [81130047, 30945204, 30973009]; Fudan University; Huashan Hospital; US National Institutes of Health [NCI CA129684]; Ministry of Health [201002007]; National Science & Technology Pillar Program [2011BAI09B00]; NATIONAL CANCER INSTITUTE [R01CA129684] Funding Source: NIH RePORTER	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University; Huashan Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health; National Science & Technology Pillar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all of the subjects included in this study. This work was partially funded by the National Key Basic Research Program grant 973 (2012CB518300 to Y.S and 2012CB518301 to J.X.), the Key Project of the National Natural Science Foundation of China (81130047 to J.X.), intramural grants from the Fudan University Thousand Talents Program and Huashan Hospital (to J.X.), the US National Institutes of Health (NCI CA129684 to J.X.), the National Natural Science Foundation of China (30945204 to Z.M and 30973009 to D.Y.), the Ministry of Health Special Research Fund for Public Interests (201002007 to L.J.) and the National Science & Technology Pillar Program (2011BAI09B00 to L.J.).	Akamatsu S, 2012, NAT GENET, V44, P426, DOI 10.1038/ng.1104; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Borges L, 1997, J IMMUNOL, V159, P5192; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	26	137	143	1	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1231	1235		10.1038/ng.2424	http://dx.doi.org/10.1038/ng.2424			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23023329	Green Accepted			2022-12-25	WOS:000310495800015
J	Hook, AL; Chang, CY; Yang, J; Luckett, J; Cockayne, A; Atkinson, S; Mei, Y; Bayston, R; Irvine, DJ; Langer, R; Anderson, DG; Williams, P; Davies, MC; Alexander, MR				Hook, Andrew L.; Chang, Chien-Yi; Yang, Jing; Luckett, Jeni; Cockayne, Alan; Atkinson, Steve; Mei, Ying; Bayston, Roger; Irvine, Derek J.; Langer, Robert; Anderson, Daniel G.; Williams, Paul; Davies, Martyn C.; Alexander, Morgan R.			Combinatorial discovery of polymers resistant to bacterial attachment	NATURE BIOTECHNOLOGY			English	Article							CENTRAL VENOUS CATHETERS; THROUGHPUT SURFACE CHARACTERIZATION; BIOFILM FORMATION; BIOMATERIALS; PREVENTION; GROWTH; CHLORHEXIDINE; INFECTIONS; INHIBITION; EXPRESSION	Bacterial attachment and subsequent biofilm formation pose key challenges to the optimal performance of medical devices. In this study, we determined the attachment of selected bacterial species to hundreds of polymeric materials in a high-throughput microarray format. Using this method, we identified a group of structurally related materials comprising ester and cyclic hydrocarbon moieties that substantially reduced the attachment of pathogenic bacteria (Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli). Coating silicone with these 'hit' materials achieved up to a 30-fold (96.7%) reduction in the surface area covered by bacteria compared with a commercial silver hydrogel coating in vitro, and the same material coatings were effective at reducing bacterial attachment in vivo in a mouse implant infection model. These polymers represent a class of materials that reduce the attachment of bacteria that could not have been predicted to have this property from the current understanding of bacteria-surface interactions.	[Hook, Andrew L.; Yang, Jing; Davies, Martyn C.; Alexander, Morgan R.] Univ Nottingham, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England; [Chang, Chien-Yi; Luckett, Jeni; Cockayne, Alan; Atkinson, Steve; Williams, Paul] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Mei, Ying; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Bayston, Roger] Univ Nottingham, Queens Med Ctr, Sch Clin Sci, Nottingham NG7 2RD, England; [Irvine, Derek J.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; [Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	University of Nottingham; University of Nottingham; Massachusetts Institute of Technology (MIT); University of Nottingham; University of Nottingham; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Alexander, MR (corresponding author), Univ Nottingham, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.	morgan.alexander@nottingham.ac.uk	Chang, Chien-Yi/E-1338-2012; Bayston, Roger/E-7699-2019; Williams, Paul/A-5629-2011; Chang, Chien-Yi/ABH-6848-2020; yang, jing/L-6313-2015; Alexander, Morgan R/C-2506-2009; Bayston, Roger/AAD-5427-2019; Williams, Paul/P-5224-2019; Hook, Andrew L/K-6924-2012	Chang, Chien-Yi/0000-0003-3570-4019; Chang, Chien-Yi/0000-0003-3570-4019; yang, jing/0000-0002-8822-7124; Alexander, Morgan R/0000-0001-5182-493X; Bayston, Roger/0000-0002-8312-3844; Williams, Paul/0000-0002-1920-5036; Hook, Andrew L/0000-0001-7756-8444; Irvine, Derek/0000-0003-1461-9851; Davies, Martyn/0000-0001-7695-0596; Mei, Ying/0000-0002-8508-4076; Atkinson, Steve/0000-0002-5705-8727	Wellcome Trust [085245]; Medical Research Council UK [G0802525]; Royal Society; Medical Research Council [MC_G0802525, G9219778] Funding Source: researchfish; MRC [G9219778, MC_G0802525] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding from the Wellcome Trust (grant no. 085245 and support from N. Shepherd) and the Medical Research Council UK (for the in vivo work; grant no. G0802525) is gratefully acknowledged. M. Alexander gratefully acknowledges the Royal Society for the provision of his Wolfson Research Merit Award. Assistance with ToF-SIMS measurements from D. Scurr is kindly acknowledged. Assistance with the preparation of polymer for in vivo studies by E. Eaves, N. Nguyen and J. Li is kindly acknowledged.	Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; BERGER H, 1982, J BACTERIOL, V152, P1241; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Caillier L, 2009, EUR J MED CHEM, V44, P3201, DOI 10.1016/j.ejmech.2009.03.031; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dalton H.M., 2000, HDB BACTERIAL ADHESI, P43; Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8; Darouiche RO, 2008, J ANTIMICROB CHEMOTH, V61, P651, DOI 10.1093/jac/dkn006; Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies MC, 2010, J DRUG TARGET, V18, P741, DOI 10.3109/1061186X.2010.521941; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; GREENFELD JI, 1995, CRIT CARE MED, V23, P894, DOI 10.1097/00003246-199505000-00018; Guay DR, 2001, DRUGS, V61, P353, DOI 10.2165/00003495-200161030-00004; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Holmes PF, 2009, J BIOMED MATER RES A, V91A, P824, DOI 10.1002/jbm.a.32285; Hook AL, 2011, SOFT MATTER, V7, P7194, DOI 10.1039/c1sm06063e; Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037; Jaeger K, 2001, CHEMOTHERAPY, V47, P50, DOI 10.1159/000048501; Johansson EMV, 2008, CHEM BIOL, V15, P1249, DOI 10.1016/j.chembiol.2008.10.009; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Krol JE, 2011, APPL ENVIRON MICROB, V77, P5079, DOI 10.1128/AEM.00090-11; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]; Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]; Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184; Messina M., 2010, THESIS U NOTTINGHAM; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e; Pernagallo S, 2011, J MATER CHEM, V21, P96, DOI 10.1039/c0jm01987a; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002; Schumm K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004013.pub3; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Taylor M, 2007, LANGMUIR, V23, P6875, DOI 10.1021/la070100j; Taylor M, 2009, SURF INTERFACE ANAL, V41, P127, DOI 10.1002/sia.2969; Urquhart AJ, 2008, ANAL CHEM, V80, P135, DOI 10.1021/ac071560k; Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028; Yorganci K, 2002, INTENS CARE MED, V28, P438, DOI 10.1007/s00134-002-1243-4	50	255	260	5	353	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					868	U99		10.1038/nbt.2316	http://dx.doi.org/10.1038/nbt.2316			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22885723	Green Accepted, Green Published			2022-12-25	WOS:000308705700021
J	Perrault, I; Hanein, S; Zanlonghi, X; Serre, V; Nicouleau, M; Defoort-Delhemmes, S; Delphin, N; Fares-Taie, L; Gerber, S; Xerri, O; Edelson, C; Goldenberg, A; Duncombe, A; Le Meur, G; Hamel, C; Silva, E; Nitschke, P; Calvas, P; Munnich, A; Roche, O; Dollfus, H; Kaplan, J; Rozet, JM				Perrault, Isabelle; Hanein, Sylvain; Zanlonghi, Xavier; Serre, Valerie; Nicouleau, Michael; Defoort-Delhemmes, Sabine; Delphin, Nathalie; Fares-Taie, Lucas; Gerber, Sylvie; Xerri, Olivia; Edelson, Catherine; Goldenberg, Alice; Duncombe, Alice; Le Meur, Gylene; Hamel, Christian; Silva, Eduardo; Nitschke, Patrick; Calvas, Patrick; Munnich, Arnold; Roche, Olivier; Dollfus, Helene; Kaplan, Josseline; Rozet, Jean-Michel			Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy	NATURE GENETICS			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; WALLERIAN DEGENERATION; ENZYMATIC-ACTIVITY; WLD(S)	In addition to its activity in nicotinamide adenine dinucleotide (NAD(+)) synthesis, the nuclear nicotinamide mononucleotide adenyltransferase NMNAT1 acts as a chaperone that protects against neuronal activity-induced degeneration. Here we report that compound heterozygous and homozygous NMNAT1 mutations cause severe neonatal neurodegeneration of the central retina and early-onset optic atrophy in 22 unrelated individuals. Their clinical presentation is consistent with Leber congenital amaurosis and suggests that the mutations affect neuroprotection of photoreceptor cells.	[Perrault, Isabelle; Hanein, Sylvain; Serre, Valerie; Nicouleau, Michael; Delphin, Nathalie; Fares-Taie, Lucas; Gerber, Sylvie; Xerri, Olivia; Munnich, Arnold; Kaplan, Josseline; Rozet, Jean-Michel] Univ Paris Descartes Sorbonne Paris Cite, Imagine Inst, INSERM, Dept Genet,U781, Paris, France; [Zanlonghi, Xavier] Clin Sourdille, Dept Vis Funct Explorat, Nantes, France; [Defoort-Delhemmes, Sabine] Ctr Hosp Univ Reg, Hop Roger Salengro, Dept Explorat Vis & Neuroophthalmol, Lille, France; [Edelson, Catherine] Fdn Ophtalmol Adolphe Rothschild, Dept Ophthalmol, Paris, France; [Goldenberg, Alice; Duncombe, Alice] Ctr Hosp Univ, Dept Genet, Rouen, France; [Le Meur, Gylene] CHU Nantes, Dept Ophthalmol, F-44035 Nantes 01, France; [Hamel, Christian] Hop St Eloi, Inst Neurosci, Montpellier, France; [Silva, Eduardo] Coimbra Univ Hosp, Dept Ophthalmol, Coimbra, Portugal; [Calvas, Patrick] Ctr Hosp Univ, Purpan Hosp, Dept Med Genet, Toulouse, France; [Roche, Olivier] Univ Paris Descartes Sorbonne Paris Cite, Dept Ophthalmol, Paris, France; [Dollfus, Helene] Strasbourg Univ Hosp, Dept Clin Genet, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Fondation Adolphe de Rothschild; CHU de Rouen; Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Montpellier; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); CHU de Toulouse; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kaplan, J (corresponding author), Univ Paris Descartes Sorbonne Paris Cite, Imagine Inst, INSERM, Dept Genet,U781, Paris, France.	josseline.kaplan@inserm.fr; jean-michel.rozet@inserm.fr	ROZET, Jean-Michel/E-5737-2016; hanein, sylvain/AAG-4933-2019; FARES TAIE, Lucas/H-2940-2017; perrault, isabelle/H-3047-2017; KAPLAN, Josseline/I-2622-2017	ROZET, Jean-Michel/0000-0001-7951-7886; hanein, sylvain/0000-0001-5817-6330; Silva, Eduardo/0000-0002-2739-9854; GERBER, Sylvie/0000-0002-6827-1769; FARES TAIE, Lucas/0000-0002-4613-0711; Nicouleau, Michael/0000-0001-9319-3355; perrault, isabelle/0000-0002-8560-1379; Dollfus, Helene/0000-0002-2249-895X; KAPLAN, Josseline/0000-0002-1849-8658	Association Retina France; Assistance Publique-Hopitaux de Paris (AP-HP); PHRC National AOM [09058/P081257]	Association Retina France; Assistance Publique-Hopitaux de Paris (AP-HP); PHRC National AOM	We are grateful to the individuals with Leber congenital amaurosis and their families for their participation in this study. We thank P. Debruyne for making available the fundus pictures of subject P4. This research was supported by the Association Retina France (grant to J.-M.R.) and the Assistance Publique-Hopitaux de Paris (AP-HP; grant PHRC National-2009 AOM 09058/P081257 to J.K.). We also thank the Association Retina France for supporting the 100 Exomes project of the French Research Network aiming to speed the genetic analysis of inherited retinal diseases through whole-exome resequencing. Written consent was obtained from participants or legally authorized representatives. The study was conducted in strict adherence to the tenets of the Declaration of Helsinki and was approved by the Comite de Protection des Personnes Ile-de-France II.	Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	15	98	100	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2012	44	9					975	977		10.1038/ng.2357	http://dx.doi.org/10.1038/ng.2357			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22842229				2022-12-25	WOS:000308491200007
J	Turchin, MC; Chiang, CWK; Palmer, CD; Sankararaman, S; Reich, D; Hirschhorn, JN				Turchin, Michael C.; Chiang, Charleston W. K.; Palmer, Cameron D.; Sankararaman, Sriram; Reich, David; Hirschhorn, Joel N.		Genetic Invest ANthropometric	Evidence of widespread selection on standing variation in Europe at height-associated SNPs	NATURE GENETICS			English	Article							NATURAL-SELECTION; POSITIVE SELECTION; SOFT SWEEPS; ADAPTATION; POPULATION; GENETICS; STRATIFICATION; SIGNATURE	Strong signatures of positive selection at newly arising genetic variants are well documented in humans(1-8), but this form of selection may not be widespread in recent human evolution(9). Because many human traits are highly polygenic and partly determined by common, ancient genetic variation, an alternative model for rapid genetic adaptation has been proposed: weak selection acting on many pre-existing (standing) genetic variants, or polygenic adaptation(10-12). By studying height, a classic polygenic trait, we demonstrate the first human signature of widespread selection on standing variation. We show that frequencies of alleles associated with increased height, both at known loci and genome wide, are systematically elevated in Northern Europeans compared with Southern Europeans (P < 4.3 x 10(-4)). This pattern mirrors intra-European height differences and is not confounded by ancestry or other ascertainment biases. The systematic frequency differences are consistent with the presence of widespread weak selection (selection coefficients similar to 10(-3)-10(-5) per allele) rather than genetic drift alone (P < 10(-15)).	[Turchin, Michael C.; Chiang, Charleston W. K.; Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA; [Turchin, Michael C.; Chiang, Charleston W. K.; Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA; [Turchin, Michael C.; Chiang, Charleston W. K.; Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Program Genom, Boston, MA USA; [Turchin, Michael C.; Chiang, Charleston W. K.; Palmer, Cameron D.; Hirschhorn, Joel N.] Broad Inst, Metab Initiat, Cambridge, MA USA; [Turchin, Michael C.; Chiang, Charleston W. K.; Palmer, Cameron D.; Sankararaman, Sriram; Reich, David; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Chiang, Charleston W. K.; Sankararaman, Sriram; Reich, David; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Hirschhorn, JN (corresponding author), Childrens Hosp Boston, Div Genet, Boston, MA 02115 USA.	joelh@broadinstitute.org	Chiang, Charleston W. K./H-3169-2019	Chiang, Charleston W. K./0000-0002-0668-7865; Turchin, Michael/0000-0003-3569-1529	National Heart, Lung and Blood Institute's FHS [N01-HC-25195]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; graduate research fellowship from the National Science Foundation; March of Dimes [6-FY09-507]; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK075787]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute's FHS; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; graduate research fellowship from the National Science Foundation; March of Dimes(March of Dimes); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank E.L. Altmaier, K.E. Samocha, S.R. Grossman, G. Coop, other attendees of the Biology of Genomes 2011 conference, B.F. Voight, M. McCarthy, P. Visscher and other members of the Reich and Hirschhorn labs for their discussions and helpful comments. We gratefully thank the GIANT consortium and particularly the members of the height working group for making unpublished association data available. We thank the MIGen consortium for making allele frequency data available. This research was conducted using data and resources from the FHS of the National Heart, Lung, and Blood Institute of the US National Institutes of Health and Boston University School of Medicine based on analyses by FHS investigators participating in the SNP Health Association Resource project. This work was supported by the National Heart, Lung and Blood Institute's FHS (contract no. N01-HC-25195) and its contract with Affymetrix, Inc., for genotyping services (contract no. N02-HL-6-4278). A portion of this research used the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. This work was also supported by a graduate research fellowship from the National Science Foundation (to C.W.K.C.), the March of Dimes (6-FY09-507 to J.N.H.) and the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK075787 to J.N.H.).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEWONTIN RC, 1970, SCI PUBLIC AFF, V26, P2; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Orr HA, 1998, GENETICS, V149, P2099; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	32	211	213	0	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1015	+		10.1038/ng.2368	http://dx.doi.org/10.1038/ng.2368			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22902787	Green Accepted, Green Submitted			2022-12-25	WOS:000308491200012
J	Holmfeldt, L; Wei, L; Diaz-Flores, E; Walsh, M; Zhang, JH; Ding, L; Payne-Turner, D; Churchman, M; Andersson, A; Chen, SC; McCastlain, K; Becksfort, J; Ma, J; Wu, G; Patel, SN; Heatley, SL; Phillips, LA; Song, GC; Easton, J; Parker, M; Chen, X; Rusch, M; Boggs, K; Vadodaria, B; Hedlund, E; Drenberg, C; Baker, S; Pei, DQ; Cheng, C; Huether, R; Lu, C; Fulton, RS; Fulton, LL; Tabib, Y; Dooling, DJ; Ochoa, K; Minden, M; Lewis, ID; To, LB; Marlton, P; Roberts, AW; Raca, G; Stock, W; Neale, G; Drexler, HG; Dickins, RA; Ellison, DW; Shurtleff, SA; Pui, CH; Ribeiro, RC; Devidas, M; Carroll, AJ; Heerema, NA; Wood, B; Borowitz, MJ; Gastier-Foster, JM; Raimondi, SC; Mardis, ER; Wilson, RK; Downing, JR; Hunger, SP; Loh, ML; Mullighan, CG				Holmfeldt, Linda; Wei, Lei; Diaz-Flores, Ernesto; Walsh, Michael; Zhang, Jinghui; Ding, Li; Payne-Turner, Debbie; Churchman, Michelle; Andersson, Anna; Chen, Shann-Ching; McCastlain, Kelly; Becksfort, Jared; Ma, Jing; Wu, Gang; Patel, Samir N.; Heatley, Susan L.; Phillips, Letha A.; Song, Guangchun; Easton, John; Parker, Matthew; Chen, Xiang; Rusch, Michael; Boggs, Kristy; Vadodaria, Bhavin; Hedlund, Erin; Drenberg, Christina; Baker, Sharyn; Pei, Deqing; Cheng, Cheng; Huether, Robert; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Tabib, Yashodhan; Dooling, David J.; Ochoa, Kerri; Minden, Mark; Lewis, Ian D.; To, L. Bik; Marlton, Paula; Roberts, Andrew W.; Raca, Gordana; Stock, Wendy; Neale, Geoffrey; Drexler, Hans G.; Dickins, Ross A.; Ellison, David W.; Shurtleff, Sheila A.; Pui, Ching-Hon; Ribeiro, Raul C.; Devidas, Meenakshi; Carroll, Andrew J.; Heerema, Nyla A.; Wood, Brent; Borowitz, Michael J.; Gastier-Foster, Julie M.; Raimondi, Susana C.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Hunger, Stephen P.; Loh, Mignon L.; Mullighan, Charles G.			The genomic landscape of hypodiploid acute lymphoblastic leukemia	NATURE GENETICS			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; NEUROFIBROMATOSIS TYPE-1 GENE; REGULATORY T-CELLS; TRANSMEMBRANE ADAPTER; HEMATOLOGIC MALIGNANCIES; P53 MUTATIONS; HUMAN CANCERS; MUTANT P53; IKAROS; CHILDHOOD	The genetic basis of hypodiploid acute lymphoblastic leukemia (ALL), a subtype of ALL characterized by aneuploidy and poor outcome, is unknown. Genomic profiling of 124 hypodiploid ALL cases, including whole-genome and exome sequencing of 40 cases, identified two subtypes that differ in the severity of aneuploidy, transcriptional profiles and submicroscopic genetic alterations. Near-haploid ALL with 24-31 chromosomes harbor alterations targeting receptor tyrosine kinase signaling and Ras signaling (71%) and the lymphoid transcription factor gene IKZF3 (encoding AIOLOS; 13%). In contrast, low-hypodiploid ALL with 32-39 chromosomes are characterized by alterations in TP53 (91.2%) that are commonly present in nontumor cells, IKZF2 (encoding HELIOS; 53%) and RB1 (41%). Both near-haploid and low-hypodiploid leukemic cells show activation of Ras-signaling and phosphoinositide 3-kinase (PI3K)-signaling pathways and are sensitive to PI3K inhibitors, indicating that these drugs should be explored as a new therapeutic strategy for this aggressive form of leukemia.	[Holmfeldt, Linda; Wei, Lei; Payne-Turner, Debbie; Churchman, Michelle; Andersson, Anna; Chen, Shann-Ching; McCastlain, Kelly; Ma, Jing; Patel, Samir N.; Heatley, Susan L.; Phillips, Letha A.; Song, Guangchun; Ellison, David W.; Shurtleff, Sheila A.; Raimondi, Susana C.; Downing, James R.; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Diaz-Flores, Ernesto; Loh, Mignon L.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Walsh, Michael; Pui, Ching-Hon; Ribeiro, Raul C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Zhang, Jinghui; Becksfort, Jared; Wu, Gang; Parker, Matthew; Chen, Xiang; Rusch, Michael; Hedlund, Erin; Huether, Robert; Mardis, Elaine R.; Wilson, Richard K.] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Ding, Li; Lu, Charles; Fulton, Robert S.; Fulton, Lucinda L.; Tabib, Yashodhan; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Andersson, Anna] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Easton, John; Boggs, Kristy; Vadodaria, Bhavin] St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Drenberg, Christina; Baker, Sharyn] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Pei, Deqing; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Minden, Mark] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5S 1A1, Canada; [Lewis, Ian D.; To, L. Bik] Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia; [Marlton, Paula] Princess Alexandra Hosp, Oncol Haematol Unit, Woolloongabba, Qld 4102, Australia; [Roberts, Andrew W.] Royal Melbourne Hosp, Dept Clin Haematol & Bone Marrow Transplant, Melbourne, Vic, Australia; [Raca, Gordana; Stock, Wendy] Univ Chicago Med, Sect Hematol Oncol, Chicago, IL USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Drexler, Hans G.] Deutsch Sammlung Mikroorganismen & Zellkulturen, Dept Human & Anim Cell Cultures, Braunschweig, Germany; [Dickins, Ross A.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Med Div, Parkville, Vic 3050, Australia; [Devidas, Meenakshi] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA; [Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Heerema, Nyla A.] Ohio State Univ, Ctr Comprehens Canc, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Wood, Brent] Seattle Childrens Hosp, Dept Lab Med, Seattle, WA USA; [Borowitz, Michael J.] Johns Hopkins Univ Hosp, Div Hematol Pathol, Baltimore, MD 21287 USA; [Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp Colorado, Sect Pediat Hematol Oncol Bone Marrow Transplanta, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA	St Jude Children's Research Hospital; University of California System; University of California San Francisco; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); Lund University; Skane University Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Institute Medical & Veterinary Science Australia; Royal Melbourne Hospital; St Jude Children's Research Hospital; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Royal Melbourne Hospital; Walter & Eliza Hall Institute; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Seattle Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Siteman Cancer Center; Washington University (WUSTL); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Chen, Xiang/N-2524-2018; Heatley, Susan/AGP-2179-2022; Raimondi, Susana C/N-8166-2018; Rusch, Michael/AAG-1998-2019; McCastlain, Kelly/O-3366-2018; Roberts, Andrew W./C-6736-2012; Zhang, Jing/GWZ-7332-2022; Wilson, Richard K./AAF-4139-2019; Cheng, Cheng/N-8075-2018; Dickins, Ross A/K-2852-2012; Downing, James R./N-8102-2018; Marlton, Paula/F-3026-2011; Mardis, Elaine/W-2202-2019; Pui, Ching-Hon/N-8076-2018; Huether, Robert/E-9638-2012; Mullighan, Charles/H-3253-2011; Wu, Gang/M-8012-2014; Devidas, Meenakshi/H-1170-2019; Ellison, David/N-4806-2018	Chen, Xiang/0000-0002-2499-8261; Rusch, Michael/0000-0002-5363-1848; McCastlain, Kelly/0000-0001-7868-3049; Roberts, Andrew W./0000-0002-7341-5720; Wilson, Richard K./0000-0002-1992-1358; Dickins, Ross A/0000-0003-4112-5304; Pui, Ching-Hon/0000-0003-0303-5658; Huether, Robert/0000-0001-7077-7470; Mullighan, Charles/0000-0002-1871-1850; Wu, Gang/0000-0002-1678-5864; Devidas, Meenakshi/0000-0002-1099-3478; Parker, Matthew/0000-0003-2999-3870; Baker, Sharyn/0000-0003-3062-3252; Heatley, Susan/0000-0001-7497-6477; Guttke, Christina/0000-0001-7759-8213; Loh, Mignon/0000-0003-4099-4700; Holmfeldt, Linda/0000-0003-4140-3423; Hagstrom-Andersson, Anna/0000-0002-2904-1311; Easton, John/0000-0003-4503-6608	The Henry Schueler 419 Foundation; Partnership for Cures; St. Baldrick's Foundation; US National Cancer Institute (NCI) [RC4CA156329]; US National Institutes of Health (NIH) [CA21765, U01 GM92666]; American Association for Cancer Research (AACR) Gertrude B. Elion Cancer Research Award; American Lebanese and Syrian Associated Charities (ALSAC) of SJCRH; NCI [CA98543, CA98413, CA114766, 5R25CA023944]; Swedish Research Council; Frank A. Campini Foundation; Team Connor Foundation; NATIONAL CANCER INSTITUTE [P30CA021765, U10CA098543, RC4CA156329, U24CA114766, U10CA098413, U24CA196173, R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	The Henry Schueler 419 Foundation; Partnership for Cures; St. Baldrick's Foundation; US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research (AACR) Gertrude B. Elion Cancer Research Award; American Lebanese and Syrian Associated Charities (ALSAC) of SJCRH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Frank A. Campini Foundation; Team Connor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Morris, E. Walker and A. Merriman for performing SNP and gene expression microarrays and G. Zambetti and P. Brindle for insightful discussions of TP53 and CREBBP mutational data, respectively. We also thank H. Mulder, R. Collins, M. Barbato, E. Stonerock, E. Pinto and M. Ellis for technical assistance, the Tissue Resources Core facility and the Flow Cytometry and Cell Sorting Core facility of the St. Jude Children's Research Hospital (SJCRH). This work was supported by The Henry Schueler 41&9 Foundation in conjunction with Partnership for Cures, the St. Baldrick's Foundation, US National Cancer Institute (NCI) grant RC4CA156329, US National Institutes of Health (NIH) grants CA21765 and U01 GM92666, the American Association for Cancer Research (AACR) Gertrude B. Elion Cancer Research Award and the American Lebanese and Syrian Associated Charities (ALSAC) of SJCRH. Support was also provided by NCI grants to the Children's Oncology Group, including CA98543, CA98413 and CA114766. L.H. was supported by the Swedish Research Council. S.P.H. is the Ergen Family Chair in Pediatric Cancer. M.L.L. is a Clinical Scholar in the Leukemia Lymphoma Society and supported by the Frank A. Campini Foundation. C.G.M. is a Pew Scholar in the Biomedical Sciences and a St. Baldrick's Scholar. M.L.L. and E.D.-F. were supported by the Team Connor Foundation, and S.N.P. was supported by 5R25CA023944 from NCI. This paper is dedicated to Henry 'Hank' Schueler who died from complications of hypodiploid ALL and whose Foundation is dedicated to finding a cure for hypodiploid ALL in his memory and to James B. Nachman who was instrumental in the genesis of this project and who recently passed away.	[Anonymous], BLOOD; Balgobind BV, 2008, BLOOD, V111, P4322, DOI 10.1182/blood-2007-06-095075; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; De Filippi P, 2009, BRIT J HAEMATOL, V147, P706, DOI 10.1111/j.1365-2141.2009.07894.x; Deshpande A, 2006, CURR MOL MED, V6, P809; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Goodman RH, 2000, GENE DEV, V14, P1553; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Harrison CJ, 2004, BRIT J HAEMATOL, V125, P552, DOI 10.1111/j.1365-2141.2004.04948.x; Heerema NA, 1999, BLOOD, V94, P4036; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; IMAMURA J, 1994, BLOOD, V84, P2412, DOI 10.1182/blood.V84.8.2412.bloodjournal8482412; Kalland ME, 2012, EXP CELL RES, V318, P1611, DOI 10.1016/j.yexcr.2012.05.014; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Klopfenstein KJ, 1999, J PEDIAT HEMATOL ONC, V21, P158, DOI 10.1097/00043426-199903000-00014; KOHNO S, 1980, J NATL CANCER I, V64, P485; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Lohmann D, 2010, ADV EXP MED BIOL, V685, P220; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Messiaen L, 2011, HUM MUTAT, V32, P213, DOI 10.1002/humu.21418; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nachman JB, 2007, BLOOD, V110, P1112, DOI 10.1182/blood-2006-07-038299; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Raimondi SC, 2003, CANCER-AM CANCER SOC, V98, P2715, DOI 10.1002/cncr.11841; Raimondi SC, 2012, CHILDHOOD LEUKEMIAS, 3RD EDITION, P135; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Romero F, 1999, EMBO J, V18, P3419, DOI 10.1093/emboj/18.12.3419; ROVINSKI B, 1988, ONCOGENE, V2, P445; Side LE, 1998, BLOOD, V92, P267, DOI 10.1182/blood.V92.1.267.413a31_267_272; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; STILLER CA, 1994, BRIT J CANCER, V70, P969, DOI 10.1038/bjc.1994.431; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	68	427	431	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					242	252		10.1038/ng.2532	http://dx.doi.org/10.1038/ng.2532			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23334668	Green Accepted			2022-12-25	WOS:000315664800007
J	Alonso, PL; Tanner, M				Alonso, Pedro L.; Tanner, Marcel			Public health challenges and prospects for malaria control and elimination	NATURE MEDICINE			English	Article							VACCINE; COMBINATION; MOZAMBIQUE; RESISTANCE; MORTALITY; DECLINE; BURDEN; SAFETY	The past decade witnessed unprecedented efforts to control malaria, including renewed political and financial commitment and increased availability of both old and new strategies and tools. However, malaria still represents a major health burden, particularly in Africa. Important challenges such as the fragility of many health systems, the rise of insecticide and drug resistance, and particularly the expected decline both in funding and in the coverage of key interventions if they are not replaced as needed, urgently need to be addressed. Further research and development is also becoming increasingly crucial. Among other needs, common methodologies for estimating and tracking the malaria burden, new strategies to measure transmission, better understanding of immunity, and increased knowledge of the mechanisms and effects of resistance to drugs and insecticides stand out. The ongoing efforts in research and development for new antimalarial drugs, more sensitive point-of-care rapid diagnostic tests and new insecticides need further innovation and substantial strengthening. Clearly, efforts should focus not only on Plasmodium falciparum but also and increasingly on Plasmodium vivax, the neglected human malaria parasite. Addressing these challenges in a comprehensive and timely way will allow us to sustain the gains made so far and make further progress in control and progressive elimination.	[Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, E-08007 Barcelona, Spain; [Alonso, Pedro L.] Manhica Hlth Res Ctr, Manhica, Mozambique; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tanner, Marcel] Univ Basel, Fac Sci Infect Biol & Epidemiol, CH-4003 Basel, Switzerland	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Alonso, PL (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, E-08007 Barcelona, Spain.	pedro.alonso@isglobal.org	Alonso, Pedro L/AAZ-3645-2020	Alonso, Pedro L/0000-0003-3292-3443				Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aide P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013838; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2011, GLOB PLAN ART RES CO; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Cech PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022273; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; GREENWOOD BM, 1988, LANCET, V1, P1121; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; *MALERA CONS GROUP, 2011, PLOS MED, V0008; *MALERA CONS GROUP, 2011, PLOS MED, V0008; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moran M., 2011, POLICY CURES; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Roll Back Malaria Partnership, 2011, REF UPD GMAP OBJ TAR; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO Global Malaria Programme, 2012, WHO POL REC SEAS MAL; WHO/GMP, 2011, REP TECHN CONS SEAS; World Health Organization, 2012, WHO GLOB MAL PROGR G	40	89	93	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					150	155		10.1038/nm.3077	http://dx.doi.org/10.1038/nm.3077			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389615				2022-12-25	WOS:000314675900023
J	Sausen, M; Leary, RJ; Jones, S; Wu, J; Reynolds, CP; Liu, XY; Blackford, A; Parmigiani, G; Diaz, LA; Papadopoulos, N; Vogelstein, B; Kinzler, KW; Velculescu, VE; Hogarty, MD				Sausen, Mark; Leary, Rebecca J.; Jones, Sian; Wu, Jian; Reynolds, C. Patrick; Liu, Xueyuan; Blackford, Amanda; Parmigiani, Giovanni; Diaz, Luis A., Jr.; Papadopoulos, Nickolas; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Hogarty, Michael D.			Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma	NATURE GENETICS			English	Article							CHROMATIN REMODELING GENES; CELL CARCINOMA; INACTIVATING MUTATIONS; ACTIVATING MUTATIONS; RECURRENT MUTATIONS; THERAPEUTIC TARGET; FREQUENT MUTATIONS; LUNG-CANCER; ALK KINASE; DNA	Neuroblastomas are tumors of peripheral sympathetic neurons and are the most common solid tumor in children. To determine the genetic basis for neuroblastoma, we performed whole-genome sequencing (6 cases), exome sequencing (16 cases), genome-wide rearrangement analyses (32 cases) and targeted analyses of specific genomic loci (40 cases) using massively parallel sequencing. On average, each tumor had 19 somatic alterations in coding genes (range of 3-70). Among genes not previously known to be involved in neuroblastoma, chromosomal deletions and sequence alterations of the chromatin-remodeling genes ARID1A and ARID1B were identified in 8 of 71 tumors (11%) and were associated with early treatment failure and decreased survival. Using tumor-specific structural alterations, we developed an approach to identify rearranged DNA fragments in sera, providing personalized biomarkers for minimal residual disease detection and monitoring. These results highlight the dysregulation of chromatin remodeling in pediatric tumorigenesis and provide new approaches for the management of patients with neuroblastoma.	[Sausen, Mark; Leary, Rebecca J.; Jones, Sian; Wu, Jian; Diaz, Luis A., Jr.; Papadopoulos, Nickolas; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Reynolds, C. Patrick] Texas Tech Univ Hlth Sci Ctr, Ctr Canc, Lubbock, TX USA; [Liu, Xueyuan; Hogarty, Michael D.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Parmigiani, Giovanni] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Baltimore, MD USA; [Parmigiani, Giovanni] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vogelstein, Bert] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD USA; [Hogarty, Michael D.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Texas Tech University System; Texas Tech University Health Science Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine	Velculescu, VE (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA.	velculescu@jhmi.edu; hogartym@email.chop.edu	Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Reynolds, C. Patrick/0000-0002-2827-8536; Sausen, Mark/0000-0002-2916-5269; Diaz, Luis/0000-0002-7079-8914	US National Institutes of Health (NIH) [CA121113]; NATIONAL CANCER INSTITUTE [R01CA121113, R37CA043460, R37CA057345] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the families and children with neuroblastoma who contributed to this work. We thank J. Maris for valuable input to this work, J. Ptak, N. Silliman, L. Dobbyn, M. Whalen, J. Schaefer and T. Mosbruger for technical assistance with sequencing analyses, L. Kann and S. Angiuoli of Personal Genome Diagnostics for targeted sequence analyses, the Children's Oncology Group (COG), W. B. London and the COG Statistics and Data Center, J. Gastier-Foster and the Neuroblastoma Reference Laboratory, N. Ramirez and the Biopathology Center, C. Winter and the Children's Hospital of Philadelphia (CHOP) Nucleic Acids Bank, and T. Woodburn and the COG Cell Line Repository. This work was generously supported by the St. Baldrick's Foundation for childhood cancer research, the Virginia and D. K. Ludwig Fund for Cancer Research, Swim Across America, an American Association for Cancer Research (AACR) Stand Up To Cancer-Dream Team Translational Cancer Research Grant and US National Institutes of Health (NIH) grant CA121113.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; BRODEUR GM, 1986, CANCER GENET CYTOGEN, V19, P101, DOI 10.1016/0165-4608(86)90377-8; Capasso M, 2010, CANCER TREAT RES, V155, P65, DOI 10.1007/978-1-4419-6033-7_4; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Combaret V, 2002, CANCER RES, V62, P3646; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KNUDSON AG, 1976, NEW ENGL J MED, V295, P1120, DOI 10.1056/NEJM197611112952007; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mueller S, 2009, CURR ONCOL REP, V11, P431, DOI 10.1007/s11912-009-0059-6; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Ries L.A.G., 1999, CANC INCIDENCE SURVI; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	53	296	332	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2013	45	1					12	U31		10.1038/ng.2493	http://dx.doi.org/10.1038/ng.2493			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202128	Green Submitted, Green Accepted			2022-12-25	WOS:000312838800007
J	Lawo, S; Hasegan, M; Gupta, GD; Pelletier, L				Lawo, Steffen; Hasegan, Monica; Gupta, Gagan D.; Pelletier, Laurence			Subdiffraction imaging of centrosomes reveals higher-order organizational features of pericentriolar material	NATURE CELL BIOLOGY			English	Article							STRUCTURED ILLUMINATION MICROSCOPY; GAMMA-TUBULIN COMPLEXES; TISSUE-CULTURE CELLS; POLO-LIKE KINASES; CAENORHABDITIS-ELEGANS; MICROTUBULE NUCLEATION; CENTRIOLE DUPLICATION; PROTEIN COMPLEX; RING COMPLEX; FLUORESCENCE MICROSCOPY	The centrosome is the main microtubule organization centre of animal cells. It is composed of a centriole pair surrounded by pericentriolar material (PCM). Traditionally described as amorphous, the architecture of the PCM is not known, although its intricate mode of assembly alludes to the presence of a functional, hierarchical structure. Here we used subdiffraction imaging to reveal organizational features of the PCM. Interphase PCM components adopt a concentric toroidal distribution of discrete diameter around centrioles. Positional mapping of multiple non-overlapping epitopes revealed that pericentrin (PCNT) is an elongated molecule extending away from the centriole. We find that PCM components occupy separable spatial domains within mitotic PCM that are maintained in the absence of microtubule nucleation complexes and further implicate PCNT and CDK5RAP2 in the organization and assembly of PCM. Globally, this work highlights the role of higher-order PCM organization in the regulation of centrosome assembly and function.	[Lawo, Steffen; Hasegan, Monica; Gupta, Gagan D.; Pelletier, Laurence] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Lawo, Steffen; Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Pelletier, L (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pelletier@lunenfeld.ca	Pelletier, Laurence/F-8858-2013	Gupta, Gagan/0000-0002-1089-965X; Lawo, Steffen/0000-0002-9659-7416	Canadian Cancer Society [019562]; Natural Sciences and Engineering Research Council of Canada [RGPIN-355644-2008]; Krembil Foundation	Canadian Cancer Society(Canadian Cancer Society (CCS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Krembil Foundation	We would like to thank members of the Pelletier laboratory for stimulating discussions during the course of this work, especially C. Yeh and J. Goncalves for their critical reading of the manuscript, C. Holley for esiRNA production, and M. Bashkurov for help with super-resolution imaging. Furthermore, we are grateful to D. Drechsel (MPI-CBG, Dresden, Germany), S. Doxsey (University of Massachusetts Medical School, Worcester, USA), M. Gomez-Ferreria (CRG, Barcelona, Spain), J. Luders (IRB, Barcelona, Spain), K. Rhee (Seoul National University, Korea), J. Salisbury (Mayo Clinic, Minnesota, USA) and L-H. Tsai (MIT, Cambridge, USA) for providing key reagents and Applied Precision/GE Healthcare for excellent technical support with the OMX microscope. This work was financially supported by the Canadian Cancer Society (019562), the Natural Sciences and Engineering Research Council of Canada (RGPIN-355644-2008) and a grant-in-aid from the Krembil Foundation. L.P. holds a Canada Research Chair (Tier 2) in Centrosome Biogenesis and Function. S.L. is a Vanier Canada Graduate Scholar (CIHR).	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bucciarelli E, 2009, CURR BIOL, V19, P1839, DOI 10.1016/j.cub.2009.09.043; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Dobbie Ian M, 2011, Cold Spring Harb Protoc, V2011, P899, DOI 10.1101/pdb.top121; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gillingham AK, 2000, EMBO REP, V1, P524; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gomez-Ferreria M., 2012, J CELL SCI; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kim T, 2011, CELL CYCLE, V10, P1010, DOI 10.4161/cc.10.6.15121; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lampert F, 2011, NAT REV MOL CELL BIO, V12, P407, DOI 10.1038/nrm3133; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Ou Y, 2004, INT REV CYTOL, V238, P119, DOI 10.1016/S0074-7696(04)38003-4; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Sonnen K. F., 2012, BIOL OPEN; SZOLLOSI A, 1986, EUR J CELL BIOL, V40, P100; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	69	265	270	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1148	+		10.1038/ncb2591	http://dx.doi.org/10.1038/ncb2591			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23086237				2022-12-25	WOS:000310778100008
J	Lou, CB; Stanton, B; Chen, YJ; Munsky, B; Voigt, CA				Lou, Chunbo; Stanton, Brynne; Chen, Ying-Ja; Munsky, Brian; Voigt, Christopher A.			Ribozyme-based insulator parts buffer synthetic circuits from genetic context	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; NOISE-PROPAGATION; SELF-CLEAVAGE; RNA; CONSTRUCTION; SATELLITE; SEQUENCE; NETWORK; DESIGN	Synthetic genetic programs are built from circuits that integrate sensors and implement temporal control of gene expression(1-4). Transcriptional circuits are layered by using promoters to carry the signal between circuits. In other words, the output promoter of one circuit serves as the input promoter to the next. Thus, connecting circuits requires physically connecting a promoter to the next circuit. We show that the sequence at the junction between the input promoter and circuit can affect the input-output response (transfer function) of the circuit(5-9). A library of putative sequences that might reduce (or buffer) such context effects, which we refer to as 'insulator parts', is screened in Escherichia coli. We find that ribozymes that cleave the 5' untranslated region (5'-UTR) of the mRNA are effective insulators. They generate quantitatively identical transfer functions, irrespective of the identity of the input promoter. When these insulators are used to join synthetic gene circuits, the behavior of layered circuits can be predicted using a mathematical model. The inclusion of insulators will be critical in reliably permuting circuits to build different programs.	[Lou, Chunbo; Stanton, Brynne; Chen, Ying-Ja; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Munsky, Brian] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM USA; [Munsky, Brian] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com	Munsky, Brian/A-1947-2016	Munsky, Brian/0000-0001-6147-7329; hong, xizhi/0000-0001-6029-6761; Lou, Chunbo/0000-0002-7941-6038	Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO) [N66001-12-C-4018]; Office of Naval Research [N00014-10-1-0245]; National Science Foundation (NSF) [CCF-0943385]; National Institutes of Health [AI067699]; NSF Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067699, R56AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology Engineering Research Center (SynBERC); Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.A.V. is supported by Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO, N66001-12-C-4018), Office of Naval Research (N00014-10-1-0245), National Science Foundation (NSF) (CCF-0943385), National Institutes of Health (AI067699) and the NSF Synthetic Biology Engineering Research Center (SynBERC, SA5284-11210).	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Arkin A, 1998, GENETICS, V149, P1633; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; BUZAYAN JM, 1986, P NATL ACAD SCI USA, V83, P8859, DOI 10.1073/pnas.83.23.8859; Carrier TA, 1997, BIOTECHNOL BIOENG, V55, P577, DOI 10.1002/(SICI)1097-0290(19970805)55:3<577::AID-BIT16>3.3.CO;2-6; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DiSerio F, 1997, J VIROL, V71, P6603, DOI 10.1128/JVI.71.9.6603-6610.1997; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Galdzicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2663, DOI 10.1093/nar/gkq139; HERNANDEZ C, 1992, P NATL ACAD SCI USA, V89, P3711, DOI 10.1073/pnas.89.9.3711; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; KAPER JM, 1988, BIOCHEM BIOPH RES CO, V154, P318, DOI 10.1016/0006-291X(88)90687-0; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kim PM, 2003, GENOME RES, V13, P2391, DOI 10.1101/gr.1207003; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Nelson JA, 2005, BIOCHEMISTRY-US, V44, P14577, DOI 10.1021/bi051130t; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Rhodius VA, 2012, NUCLEIC ACIDS RES, V40, P2907, DOI 10.1093/nar/gkr1190; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; ROOSSINCK MJ, 1992, MICROBIOL REV, V56, P265, DOI 10.1128/MMBR.56.2.265-279.1992; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Walczak AM, 2009, P NATL ACAD SCI USA, V106, P6529, DOI 10.1073/pnas.0811999106; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	48	233	240	4	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1137	+		10.1038/nbt.2401	http://dx.doi.org/10.1038/nbt.2401			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23034349	Green Accepted, Green Published			2022-12-25	WOS:000311087500034
J	Wu, C; Kraft, P; Zhai, K; Chang, J; Wang, ZM; Li, Y; Hu, ZB; He, ZH; Jia, WH; Abnet, CC; Liang, LM; Hu, N; Miao, XP; Zhou, YF; Liu, ZH; Zhan, QM; Liu, Y; Qiao, Y; Zhou, YL; Jin, GF; Guo, CH; Lu, CD; Yang, HJ; Fu, JH; Yu, DK; Freedman, ND; Ding, T; Tan, W; Goldstein, AM; Wu, TC; Shen, HB; Ke, Y; Zeng, YX; Chanock, SJ; Taylor, PR; Lin, DX				Wu, Chen; Kraft, Peter; Zhai, Kan; Chang, Jiang; Wang, Zhaoming; Li, Yun; Hu, Zhibin; He, Zhonghu; Jia, Weihua; Abnet, Christian C.; Liang, Liming; Hu, Nan; Miao, Xiaoping; Zhou, Yifeng; Liu, Zhihua; Zhan, Qimin; Liu, Yu; Qiao, Yan; Zhou, Yuling; Jin, Guangfu; Guo, Chuanhai; Lu, Changdong; Yang, Haijun; Fu, Jianhua; Yu, Dianke; Freedman, Neal D.; Ding, Ti; Tan, Wen; Goldstein, Alisa M.; Wu, Tangchun; Shen, Hongbing; Ke, Yang; Zeng, Yixin; Chanock, Stephen J.; Taylor, Philip R.; Lin, Dongxin			Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions	NATURE GENETICS			English	Article							RISK-FACTORS; MESSENGER-RNA; COLON-CANCER; MOUSE MODEL; ALCOHOL; EXPRESSION; CATENIN; POLYMORPHISMS; INVOLVEMENT; ACTIVATION	We conducted a genome-wide association study (GWAS) and a genome-wide gene-environment interaction analysis of esophageal squamous-cell carcinoma (ESCC) in 2,031 affected individuals (cases) and 2,044 controls with independent validation in 8,092 cases and 8,620 controls. We identified nine new ESCC susceptibility loci, of which seven, at chromosomes 4q23, 16q12.1, 17q21, 22q12, 3q27, 17p13 and 18p11, had a significant marginal effect (P = 1.78 x 10(-39) to P = 2.49 x 10(-11)) and two of which, at 2q22 and 13q33, had a significant association only in the gene-alcohol drinking interaction (gene-environment interaction P (P-G x E) = 4.39 x 10(-11) and P-G x E = 4.80 x 10(-8), respectively). Variants at the 4q23 locus, which includes the ADH cluster, each had a significant interaction with alcohol drinking in their association with ESCC risk (P-G x E = 2.54 x 10(-7) to P-G x E = 3.23 x 10(-2)). We confirmed the known association of the ALDH2 locus on 12q24 to ESCC, and a joint analysis showed that drinkers with both of the ADH1B and ALDH2 risk alleles had a fourfold increased risk for ESCC compared to drinkers without these risk alleles. Our results underscore the direct genetic contribution to ESCC risk, as well as the genetic contribution to ESCC through interaction with alcohol consumption.	[Wu, Chen; Zhai, Kan; Chang, Jiang; Liu, Zhihua; Zhan, Qimin; Liu, Yu; Qiao, Yan; Zhou, Yuling; Lu, Changdong; Yu, Dianke; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wu, Chen; Zhai, Kan; Chang, Jiang; Liu, Zhihua; Zhan, Qimin; Liu, Yu; Qiao, Yan; Zhou, Yuling; Yu, Dianke; Tan, Wen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Chen; Kraft, Peter; Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Zhaoming; Abnet, Christian C.; Hu, Nan; Freedman, Neal D.; Goldstein, Alisa M.; Chanock, Stephen J.; Taylor, Philip R.] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Wang, Zhaoming; Chanock, Stephen J.] NCI, Core Genotyping Facil, SAIC Frederick, Frederick, MD 21701 USA; [Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Hu, Zhibin; Jin, Guangfu; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [He, Zhonghu; Guo, Chuanhai; Ke, Yang] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China; [Jia, Weihua; Fu, Jianhua; Zeng, Yixin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Miao, Xiaoping; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Key Lab Environm & Hlth, Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Zhou, Yifeng] Soochow Univ, Lab Canc Mol Genet, Coll Med, Suzhou, Jiangsu, Peoples R China; [Lu, Changdong; Yang, Haijun] Anyang Canc Hosp, Anyang, Henan, Peoples R China; [Ding, Ti] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of North Carolina; University of North Carolina Chapel Hill; Nanjing Medical University; Peking University; Sun Yat Sen University; Huazhong University of Science & Technology; Soochow University - China	Lin, DX (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China.	lindx72@cicams.ac.cn	miao, xiaoping/C-4336-2011; Abnet, Christian C/C-4111-2015; Chang, Jiang/AAP-6156-2020; Wang, Zhaoming/R-5527-2018; Freedman, Neal David/B-9741-2015	miao, xiaoping/0000-0002-6818-9722; Abnet, Christian C/0000-0002-3008-7843; Wang, Zhaoming/0000-0001-7556-3869; Freedman, Neal David/0000-0003-0074-1098; Lin, Dongxin/0000-0002-8723-8868; Zhai, Kan/0000-0002-6495-3690; Shen, Hongbing/0000-0002-2581-5906; Jin, Guangfu/0000-0003-0249-5337; Wu, Chen/0000-0003-4954-1011; Jacobs, Kevin/0000-0002-4657-6473	National High-Tech Research and Development Program of China [2009AA022706]; National Basic Research Program of China [2011CB504303]; National Natural Science Foundation of China [30721001]; Intramural Research Program of the US National Institutes of Health, NCI; Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA055069, R35CA053890, R01CA082729, R01CA080205] Funding Source: NIH RePORTER	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Intramural Research Program of the US National Institutes of Health, NCI; Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National High-Tech Research and Development Program of China (2009AA022706 to D.L.), the National Basic Research Program of China (2011CB504303 to D.L. and W.T.), the National Natural Science Foundation of China (30721001 to D.L., Q.Z. and Z.L.) and the Intramural Research Program of the US National Institutes of Health, NCI and the Division of Cancer Epidemiology and Genetics.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Akbari MR, 2009, CANCER RES, V69, P7994, DOI 10.1158/0008-5472.CAN-09-1149; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bullions Linda C., 1998, Current Opinion in Oncology, V10, P81, DOI 10.1097/00001622-199801000-00013; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Dall'Olio F, 1999, INT J CANCER, V81, P243, DOI 10.1002/(SICI)1097-0215(19990412)81:2<243::AID-IJC13>3.0.CO;2-O; DeZwaan DC, 2009, P NATL ACAD SCI USA, V106, P17337, DOI 10.1073/pnas.0905703106; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Fatayerji N, 1996, ALCOHOL CLIN EXP RES, V20, P94, DOI 10.1111/j.1530-0277.1996.tb01051.x; Gao Y, 2011, CANCER EPIDEMIOL, V35, pE91, DOI 10.1016/j.canep.2011.06.006; Gao Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-269; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; He Z, 2010, BRIT J CANCER, V103, P1085, DOI 10.1038/sj.bjc.6605843; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Hoeflich A, 2001, CANCER RES, V61, P8601; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Islami F, 2011, INT J CANCER, V129, P2473, DOI 10.1002/ijc.25885; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kolligs FT, 2000, GENE DEV, V14, P1319; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LU SH, 1986, J CELL PHYSIOL, P51; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pousset D, 1997, CANCER RES, V57, P4249; Recchi MA, 1998, CANCER RES, V58, P4066; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Simcha I, 1996, J CELL BIOL, V133, P199, DOI 10.1083/jcb.133.1.199; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	46	191	207	6	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1090	+		10.1038/ng.2411	http://dx.doi.org/10.1038/ng.2411			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22960999				2022-12-25	WOS:000309550200007
J	Ricciardi, S; Ungaro, F; Hambrock, M; Rademacher, N; Stefanelli, G; Brambilla, D; Sessa, A; Magagnotti, C; Bachi, A; Giarda, E; Verpelli, C; Kilstrup-Nielsen, C; Sala, C; Kalscheuer, VM; Broccoli, V				Ricciardi, Sara; Ungaro, Federica; Hambrock, Melanie; Rademacher, Nils; Stefanelli, Gilda; Brambilla, Dario; Sessa, Alessandro; Magagnotti, Cinzia; Bachi, Angela; Giarda, Elisa; Verpelli, Chiara; Kilstrup-Nielsen, Charlotte; Sala, Carlo; Kalscheuer, Vera M.; Broccoli, Vania			CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons	NATURE CELL BIOLOGY			English	Article							RETT-SYNDROME; INFANTILE SPASMS; MENTAL-RETARDATION; EPILEPTIC ENCEPHALOPATHY; INTERSTITIAL DELETION; ADHESION MOLECULES; MUTATIONS; GENE; PROTEIN; PHOSPHORYLATION	Mutations of the cyclin-dependent kinase-like 5 (CDKL5) and netrin-G1 (NTNG1) genes cause a severe neurodevelopmental disorder with clinical features that are closely related to Rett syndrome, including intellectual disability, early-onset intractable epilepsy and autism.We report here that CDKL5 is localized at excitatory synapses and contributes to correct dendritic spine structure and synapse activity. To exert this role, CDKL5 binds and phosphorylates the cell adhesion molecule NGL-1. This phosphorylation event ensures a stable association between NGL-1 and PSD95. Accordingly, phospho-mutant NGL-1 is unable to induce synaptic contacts whereas its phospho-mimetic form binds PSD95 more efficiently and partially rescues the CDKL5-specific spine defects. Interestingly, similarly to rodent neurons, iPSC-derived neurons from patients with CDKL5 mutations exhibit aberrant dendritic spines, thus suggesting a common function of CDKL5 in mice and humans.	[Hambrock, Melanie; Rademacher, Nils; Kalscheuer, Vera M.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Ricciardi, Sara; Ungaro, Federica; Stefanelli, Gilda; Sessa, Alessandro; Broccoli, Vania] Ist Sci San Raffaele, Stem Cell & Neurogenesis Unit, Div Neurosci, I-20132 Milan, Italy; [Brambilla, Dario] Univ Milan, Sch Med, Dept Human Physiol, I-20133 Milan, Italy; [Magagnotti, Cinzia; Bachi, Angela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Giarda, Elisa; Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Struct & Funct Biol, Lab Genet & Epigenet Control Gene Express, I-21052 Busto Arsizio, VA, Italy; [Verpelli, Chiara; Sala, Carlo] Consiglio Nazl Ric Neurosci Inst, I-20129 Milan, Italy	Max Planck Society; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Insubria	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kalscheu@molgen.mpg.de; broccoli.vania@hsr.it	Ricciardi, Sara/I-6308-2018; Magagnotti, Cinzia/AAN-6575-2020; Kilstrup-Nielsen, Charlotte/A-6348-2014; Verpelli, Chiara/K-6673-2016; Verpelli, Chiara/AAH-1140-2020; Broccoli, Vania/K-3464-2016; Sala, Carlo/A-2493-2009; Ungaro, Federica/J-6047-2018; bachi, angela/B-3527-2015; Sessa, Alessandro/AAB-8777-2019	Ricciardi, Sara/0000-0001-8124-432X; Magagnotti, Cinzia/0000-0001-9077-2757; Verpelli, Chiara/0000-0003-2949-9725; Verpelli, Chiara/0000-0003-2949-9725; Broccoli, Vania/0000-0003-4050-0926; Sala, Carlo/0000-0003-0662-9523; Ungaro, Federica/0000-0001-5395-7795; bachi, angela/0000-0003-4842-6556; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; stefanelli, gilda/0000-0001-7034-8174; Kalscheuer, Vera/0000-0001-6898-3259; Brambilla, Dario/0000-0002-4838-482X; Sessa, Alessandro/0000-0003-3611-5056; Rademacher, Nils/0000-0003-0625-6798	Telethon Foundation; Ministry of Health; IIT-SEED project; EuroRETT network; EU-FP7 project GENCODYS [241995]	Telethon Foundation(Fondazione Telethon); Ministry of Health; IIT-SEED project; EuroRETT network; EU-FP7 project GENCODYS	We gratefully acknowledge T. Bienvenu for providing primary fibroblasts from CDKL5 patients, H. Van Esch and H. Archer for providing DNA samples from patients, S. Freier, A. Walther, A. Grimme, U. Fischer and B. Moser for their excellent technical assistance, and L. Musante for helpful discussions. L. Pecciarini is acknowledged for karyotype analysis of the iPSC lines. This study was supported by the Telethon Foundation, Ministry of Health, IIT-SEED project, EuroRETT network to V.B. and the EU-FP7 project GENCODYS (241995) to V.M.K.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Archer HL, 2006, J MED GENET, V43, P729, DOI 10.1136/jmg.2006.041467; Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Borg I, 2005, EUR J HUM GENET, V13, P921, DOI 10.1038/sj.ejhg.5201429; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Colleoni S, 2010, EXP CELL RES, V316, P1148, DOI 10.1016/j.yexcr.2010.02.013; Cordova-Fletes C., 2010, CLIN GENET, V77, P92; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Francke U, 2006, NAT CLIN PRACT NEURO, V2, P212, DOI 10.1038/ncpneuro0148; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kim EE, 2009, CURR MED IMAGING REV, V5, P1, DOI 10.2174/157340509787354688; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Liang JS, 2011, EPILEPSIA, V52, P1835, DOI 10.1111/j.1528-1167.2011.03174.x; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Mei D, 2010, EPILEPSIA, V51, P647, DOI 10.1111/j.1528-1167.2009.02308.x; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ohtsuki T, 2008, NEUROSCI LETT, V435, P194, DOI 10.1016/j.neulet.2008.02.053; Rademacher N, 2011, NEUROGENETICS, V12, P165, DOI 10.1007/s10048-011-0277-6; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Rosas-Vargas H, 2008, J MED GENET, V45, P172, DOI 10.1136/jmg.2007.053504; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Rusconi L, 2011, J BIOL CHEM, V286, P36550, DOI 10.1074/jbc.M111.235630; Scala E, 2005, J MED GENET, V42, P103, DOI 10.1136/jmg.2004.026237; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Van Esch H, 2007, AM J MED GENET A, V143A, P364, DOI 10.1002/ajmg.a.31572; van Kuilenburg ABP, 2009, HUM GENET, V125, P581, DOI 10.1007/s00439-009-0653-6; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Woo J, 2009, MOL CELL NEUROSCI, V42, P1, DOI 10.1016/j.mcn.2009.05.008; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279	45	183	189	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2012	14	9					911	+		10.1038/ncb2566	http://dx.doi.org/10.1038/ncb2566			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	004GJ	22922712	Green Published, Green Accepted			2022-12-25	WOS:000308668600007
J	Rosenbloom, DIS; Hill, AL; Rabi, SA; Siliciano, RF; Nowak, MA				Rosenbloom, Daniel I. S.; Hill, Alison L.; Rabi, S. Alireza; Siliciano, Robert F.; Nowak, Martin A.			Antiretroviral dynamics determines HIV evolution and predicts therapy outcome	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MUTANT SELECTION WINDOW; REVERSE-TRANSCRIPTASE INHIBITORS; RESPONSE CURVE SLOPE; DRUG-RESISTANCE; HIV-1-INFECTED PATIENTS; VIROLOGICAL FAILURE; ANTIVIRAL THERAPY; ADHERENCE; PROTEASE	Despite the high inhibition of viral replication achieved by current anti-HIV drugs, many patients fail treatment, often with emergence of drug-resistant virus. Clinical observations show that the relationship between adherence and likelihood of resistance differs dramatically among drug classes. We developed a mathematical model that explains these observations and predicts treatment outcomes. Our model incorporates drug properties, fitness differences between susceptible and resistant strains, mutations and adherence. We show that antiviral activity falls quickly for drugs with sharp dose-response curves and short half-lives, such as boosted protease inhibitors, limiting the time during which resistance can be selected for. We find that poor adherence to such drugs causes treatment failure via growth of susceptible virus, explaining puzzling clinical observations. Furthermore, our model predicts that certain single-pill combination therapies can prevent resistance regardless of patient adherence. Our approach represents a first step for simulating clinical trials of untested anti-HIV regimens and may help in the selection of new drug regimens for investigation.	[Rabi, S. Alireza; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Rosenbloom, Daniel I. S.; Hill, Alison L.; Nowak, Martin A.] Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Hill, Alison L.] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Hill, Alison L.] Harvard Univ, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02138 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Harvard University; Harvard University; Harvard University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu; martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008; Hill, Alison Lynn/W-7839-2019	Hill, Alison Lynn/0000-0002-6583-3623	US National Institutes of Health [R01 MH054907, R01 AI081600, R01 GM078986]; Research Computing Group of Harvard University; Bill & Melinda Gates Foundation; Cancer Research Institute Fellowship; US National Science Foundation; Howard Hughes Medical Institute; Canadian Natural Sciences and Engineering Research Council; John Templeton Foundation; J. Epstein; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081600, T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Computing Group of Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Cancer Research Institute Fellowship; US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); John Templeton Foundation; J. Epstein; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Antal, I. Bozic, F. Fu, M. Sampah and L. Shen for discussion during the conception of this work, and we thank J. Gallant, J.-B. Michel and P. Pennings for their comments on the manuscript. We thank D. Bangsberg of Massachusetts General Hospital for supplying adherence data from the REACH study (supported by US National Institutes of Health grant R01 MH054907). Simulations were run on the Odyssey cluster supported by the Research Computing Group of Harvard University. We are grateful for support from the US National Institutes of Health (R01 AI081600 (R.F.S., S.A.R.), R01 GM078986 (M.A.N., A.L.H.)), the Bill & Melinda Gates Foundation (M.A.N., A.L.H.), a Cancer Research Institute Fellowship (S.A.R.), a US National Science Foundation Graduate Research Fellowship (D.I.S.R.), the Howard Hughes Medical Institute (R.F.S., S.A.R.), a Canadian Natural Sciences and Engineering Research Council Post-Graduate Scholarship (A.L.H.), the John Templeton Foundation (M.A.N.) and J. Epstein (M.A.N.).	Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Best BM, 2011, J ANTIMICROB CHEMOTH, V66, P354, DOI 10.1093/jac/dkq434; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631; CHEESEMAN SH, 1995, J ACQ IMMUN DEF SYND, V8, P141; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; Condra JH, 1998, HAEMOPHILIA, V4, P610, DOI 10.1046/j.1365-2516.1998.440610.x; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Gardner EA, 2008, AIDS, V22, P75, DOI 10.1097/QAD.0b013e3282f366ff; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gupta RK, 2010, AIDS, V24, P1651, DOI 10.1097/QAD.0b013e3283398216; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hill AL, 2012, J MOL MED, V90, P543, DOI 10.1007/s00109-012-0892-1; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Jourdain G, 2010, CLIN INFECT DIS, V50, P1397, DOI 10.1086/652148; Kastrissios H, 1998, AIDS, V12, P2295, DOI 10.1097/00002030-199817000-00011; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Liu HH, 2007, STAT MED, V26, P991, DOI 10.1002/sim.2592; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Nowak M. A., 2000, VIRUS DYNAMICS MATH; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Parienti JJ, 2010, CLIN INFECT DIS, V50, P1192, DOI 10.1086/651419; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; Perez-Valero I, 2011, CURR OPIN INFECT DIS, V24, P7, DOI 10.1097/QCO.0b013e3283422cdf; Pulido F, 2012, AIDS RES HUM RETROV, V28, P1167, DOI 10.1089/aid.2011.0256; Ribeiro RM, 1998, AIDS, V12, P461, DOI 10.1097/00002030-199805000-00006; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rong LB, 2007, B MATH BIOL, V69, P2027, DOI 10.1007/s11538-007-9203-3; Ruxrungtham K, 2008, HIV MED, V9, P883, DOI 10.1111/j.1468-1293.2008.00644.x; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002304; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Smith RJ, 2006, P ROY SOC B-BIOL SCI, V273, P617, DOI 10.1098/rspb.2005.3352; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; Vanhove GF, 1996, JAMA-J AM MED ASSOC, V276, P1955, DOI 10.1001/jama.276.24.1955; Wahl LM, 2000, P ROY SOC B-BIOL SCI, V267, P835, DOI 10.1098/rspb.2000.1079; Wu HL, 2005, JAIDS-J ACQ IMM DEF, V39, P272, DOI 10.1097/01.qai.0000165907.04710.da; Zhao XL, 2002, J INFECT DIS, V185, P561, DOI 10.1086/338571	65	113	114	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1378	+		10.1038/nm.2892	http://dx.doi.org/10.1038/nm.2892			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22941277	Green Accepted, Green Submitted			2022-12-25	WOS:000308472300033
J	Peng, ZH; Lu, Y; Li, LB; Zhao, Q; Feng, Q; Gao, ZM; Lu, HY; Hu, T; Yao, N; Liu, KY; Li, Y; Fan, DL; Guo, YL; Li, WJ; Lu, YQ; Weng, QJ; Zhou, CC; Zhang, L; Huang, T; Zhao, Y; Zhu, CR; Liu, XG; Yang, XW; Wang, T; Miao, K; Zhuang, CY; Cao, XL; Tang, WL; Liu, GS; Liu, YL; Chen, J; Liu, ZJ; Yuan, LC; Liu, ZH; Huang, XH; Lu, TT; Fei, BH; Ning, ZM; Han, B; Jiang, ZH				Peng, Zhenhua; Lu, Ying; Li, Lubin; Zhao, Qiang; Feng, Qi; Gao, Zhimin; Lu, Hengyun; Hu, Tao; Yao, Na; Liu, Kunyan; Li, Yan; Fan, Danlin; Guo, Yunli; Li, Wenjun; Lu, Yiqi; Weng, Qijun; Zhou, CongCong; Zhang, Lei; Huang, Tao; Zhao, Yan; Zhu, Chuanrang; Liu, Xinge; Yang, Xuewen; Wang, Tao; Miao, Kun; Zhuang, Caiyun; Cao, Xiaolu; Tang, Wenli; Liu, Guanshui; Liu, Yingli; Chen, Jie; Liu, Zhenjing; Yuan, Licai; Liu, Zhenhua; Huang, Xuehui; Lu, Tingting; Fei, Benhua; Ning, Zemin; Han, Bin; Jiang, Zehui			The draft genome of the fast-growing non-timber forest species moso bamboo (Phyllostachys heterocycla)	NATURE GENETICS			English	Article							POPULUS-TRICHOCARPA; ORYZA-SATIVA; RICE; GENE; SEQUENCE; GRASSES; DIVERSIFICATION; EXPRESSION; DIVERSITY; POACEAE	Bamboo represents the only major lineage of grasses that is native to forests and is one of the most important non-timber forest products in the world. However, no species in the Bambusoideae subfamily has been sequenced. Here, we report a high-quality draft genome sequence of moso bamboo (P. heterocycla var. pubescens). The 2.05-Gb assembly covers 95% of the genomic region. Gene prediction modeling identified 31,987 genes, most of which are supported by cDNA and deep RNA sequencing data. Analyses of clustered gene families and gene collinearity show that bamboo underwent whole-genome duplication 7-12 million years ago. Identification of gene families that are key in cell wall biosynthesis suggests that the whole-genome duplication event generated more gene duplicates involved in bamboo shoot development. RNA sequencing analysis of bamboo flowering tissues suggests a potential connection between drought-responsive and flowering genes.	[Peng, Zhenhua; Li, Lubin; Yao, Na; Wang, Tao; Miao, Kun; Zhuang, Caiyun; Cao, Xiaolu; Chen, Jie; Liu, Zhenjing; Liu, Zhenhua; Jiang, Zehui] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China; [Lu, Ying; Zhao, Qiang; Feng, Qi; Lu, Hengyun; Liu, Kunyan; Li, Yan; Fan, Danlin; Guo, Yunli; Li, Wenjun; Lu, Yiqi; Weng, Qijun; Zhou, CongCong; Zhang, Lei; Huang, Tao; Zhao, Yan; Zhu, Chuanrang; Huang, Xuehui; Lu, Tingting; Ning, Zemin; Han, Bin] Chinese Acad Sci, Natl Ctr Gene Res, Shanghai Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Gao, Zhimin; Hu, Tao; Liu, Xinge; Yang, Xuewen; Tang, Wenli; Liu, Guanshui; Liu, Yingli; Yuan, Licai; Fei, Benhua; Jiang, Zehui] Int Ctr Bamboo & Rattan, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; International Centre for Bamboo & Rattan	Han, B (corresponding author), Chinese Acad Sci, Natl Ctr Gene Res, Shanghai Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	bhan@ncgr.ac.cn; jiangzehui@icbr.ac.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022; yao, na/HDL-8772-2022; Ning, Zemin/D-2411-2013	wang, tao/0000-0002-8592-9083; Yao, Na/0000-0001-8394-4143; Hu, Tao/0000-0002-1430-3112; Lu, Ying/0000-0002-2509-9209; Ning, Zemin/0000-0003-4359-776X	Forestry Project of the Ministry of Science and Technology of the People's Republic of China [200704001]; Chinese Academy of Sciences [KSCX2-YW-G-034]	Forestry Project of the Ministry of Science and Technology of the People's Republic of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank C. Xu for her technological support in cytogenetic analysis. This work was supported by the Forestry Project of the Ministry of Science and Technology of the People's Republic of China (grant 200704001 to Z.J.) and the Chinese Academy of Sciences (KSCX2-YW-G-034 to B.H.).	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Chen RY, 2003, 8 C ACAD C CHINESE S; Cui K, 2012, J PROTEOME RES, V11, P2492, DOI 10.1021/pr2011878; Das M, 2005, ANN BOT-LONDON, V95, P835, DOI 10.1093/aob/mci088; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Fornara Fabio, 2010, Cell, V141, DOI 10.1016/j.cell.2010.04.024; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gui YJ, 2010, J INTEGR PLANT BIOL, V52, P1008, DOI 10.1111/j.1744-7909.2010.00965.x; Gui YJ, 2007, SCI CHINA SER C, V50, P700, DOI 10.1007/s11427-007-0081-6; Guyot R, 2004, GENOME, V47, P610, DOI 10.1139/G04-016; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Humphreys JM, 2002, CURR OPIN PLANT BIOL, V5, P224, DOI 10.1016/S1369-5266(02)00257-1; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kellogg EA, 1998, P NATL ACAD SCI USA, V95, P2005, DOI 10.1073/pnas.95.5.2005; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sharma RK, 2008, GENOME, V51, P91, DOI 10.1139/g07-101; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	37	330	432	12	147	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					456	461		10.1038/ng.2569	http://dx.doi.org/10.1038/ng.2569			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435089	hybrid			2022-12-25	WOS:000316840600019
J	Reilly, SM; Chiang, SH; Decker, SJ; Chang, L; Uhm, M; Larsen, MJ; Rubin, JR; Mowers, J; White, NM; Hochberg, I; Downes, M; Yu, RT; Liddle, C; Evans, RM; Oh, D; Li, PP; Olefsky, JM; Saltiel, AR				Reilly, Shannon M.; Chiang, Shian-Huey; Decker, Stuart J.; Chang, Louise; Uhm, Maeran; Larsen, Martha J.; Rubin, John R.; Mowers, Jonathan; White, Nicole M.; Hochberg, Irit; Downes, Michael; Yu, Ruth T.; Liddle, Christopher; Evans, Ronald M.; Oh, Dayoung; Li, Pingping; Olefsky, Jerrold M.; Saltiel, Alan R.			An inhibitor of the protein kinases TBK1 and IKK-epsilon improves obesity-related metabolic dysfunctions in mice	NATURE MEDICINE			English	Article							DIET-INDUCED OBESITY; NF-KAPPA-B; INSULIN-RESISTANCE; T-CELLS; MAST-CELLS; CROSS-TALK; FAT; INFLAMMATION; LINKS; ACTIVATION	Emerging evidence suggests that inflammation provides a link between obesity and insulin resistance. The noncanonical I kappa B kinases IKK-epsilon and TANK-binding kinase 1 (TBK1) are induced in liver and fat by NF-kappa B activation upon high-fat diet feeding and in turn initiate a program of counterinflammation that preserves energy storage. Here we report that amlexanox, an approved small-molecule therapeutic presently used in the clinic to treat aphthous ulcers and asthma, is an inhibitor of these kinases. Treatment of obese mice with amlexanox elevates energy expenditure through increased thermogenesis, producing weight loss, improved insulin sensitivity and decreased steatosis. Because of its record of safety in patients, amlexanox may be an interesting candidate for clinical evaluation in the treatment of obesity and related disorders.	[Reilly, Shannon M.; Chiang, Shian-Huey; Decker, Stuart J.; Chang, Louise; Uhm, Maeran; Larsen, Martha J.; Rubin, John R.; Mowers, Jonathan; White, Nicole M.; Hochberg, Irit; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Uhm, Maeran; Mowers, Jonathan; Saltiel, Alan R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Uhm, Maeran; Mowers, Jonathan; Saltiel, Alan R.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Downes, Michael; Yu, Ruth T.; Liddle, Christopher; Evans, Ronald M.] Salk Inst Biol Sci, Gene Express Lab, La Jolla, CA USA; [Liddle, Christopher] Westmead Millennlum Inst, Storr Liver Unit, Westmead, NSW, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Sci, Howard Hughes Med Inst, La Jolla, CA USA; [Oh, Dayoung; Li, Pingping; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Salk Institute; University of Sydney; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@umich.edu	Reilly, Shannon Marie/ABB-6473-2021; Saltiel, Alan/L-3632-2019; Li, Pingping/F-1109-2019; Evans, Ronald/AAF-4001-2019	Reilly, Shannon Marie/0000-0003-0412-2446; Li, Pingping/0000-0003-0679-270X; Evans, Ronald/0000-0002-9986-5965; Hochberg, Irit/0000-0002-4232-5191; Yu, Ruth/0000-0002-9527-9627; White, Nicole/0000-0003-3928-9502; Chang, Louise/0000-0001-5501-4774; Saltiel, Alan/0000-0002-9726-9828	US National Institutes of Health [DK60597, 60591, F32DK09685101, F30DK089687, R24DK090962]; Leona M. and Harry B. Helmsley Charitable Trust; Michigan Diabetes Research and Training Center [DK020572]; Michigan Institute for Clinical and Health Research [UL1-RR024986]; Nathan Shock Center; Michigan Metabolic Phenotyping Core; Michigan Nutritional Obesity Research Center [DK089503]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090962, R01DK060591, F30DK089687, F32DK096851, R01DK060597, P60DK020572, P30DK089503, R01DK061618, P30DK020572, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Michigan Diabetes Research and Training Center; Michigan Institute for Clinical and Health Research; Nathan Shock Center; Michigan Metabolic Phenotyping Core; Michigan Nutritional Obesity Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hung and X. Peng for excellent technical assistance and members of the Saltiel laboratory for helpful discussions. This work was supported by US National Institutes of Health grants DK60597 and 60591 to A.R.S., F32DK09685101 to S.M.R., F30DK089687 to J.M. and R24DK090962 to A.R.S., J.M.O. and R.M.E. R.M.E., M.D. and R.T.Y. are supported by the Leona M. and Harry B. Helmsley Charitable Trust. We thank S. Akira (Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan) for providing MEFs. We also acknowledge support from the Michigan Diabetes Research and Training Center (DK020572), Michigan Institute for Clinical and Health Research (UL1-RR024986), Nathan Shock Center, Michigan Metabolic Phenotyping Core and Michigan Nutritional Obesity Research Center (DK089503).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bamborough P, 2006, BIOORG MED CHEM LETT, V16, P6236, DOI 10.1016/j.bmcl.2006.09.018; Bell J, 2005, CLIN DRUG INVEST, V25, P555, DOI 10.2165/00044011-200525090-00001; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Blackburn P, 2006, OBESITY, V14, P1747, DOI 10.1038/oby.2006.201; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; MAKINO H, 1987, INT ARCH ALLER A IMM, V82, P66, DOI 10.1159/000234292; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Reaven GM, 2005, CELL METAB, V1, P9, DOI 10.1016/j.cmet.2004.12.001; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shigeharu, 1985, JPN PHARMACOL THER, V13, P4933; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	60	302	321	4	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					313	321		10.1038/nm.3082	http://dx.doi.org/10.1038/nm.3082			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396211	Green Accepted			2022-12-25	WOS:000316040700024
J	Morgan, B; Ezerina, D; Amoako, TNE; Riemer, J; Seedorf, M; Dick, TP				Morgan, Bruce; Ezerina, Daria; Amoako, Theresa N. E.; Riemer, Jan; Seedorf, Matthias; Dick, Tobias P.			Multiple glutathione disulfide removal pathways mediate cytosolic redox homeostasis	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDIZED GLUTATHIONE; THIOREDOXIN SYSTEM; OXIDATIVE STRESS; IN-VIVO; REDUCTASE; RESISTANCE; TRANSPORTER; METABOLISM; BIOLOGY	Glutathione is central to cellular redox chemistry. The majority of glutathione redox research has been based on the chemical analysis of whole-cell extracts, which unavoidably destroy subcellular compartment-specific information. Compartment-specific real-time measurements based on genetically encoded fluorescent probes now suggest that the cytosolic glutathione redox potential is about 100 mV more reducing than previously thought. Using these probes in yeast, we show that even during severe oxidative stress, the cytosolic glutathione disulfide (GSSG) concentration is much more tightly regulated than expected and provide a mechanistic explanation for the discrepancy with conventional measurements. GSSG that is not immediately reduced in the cytosol is rapidly transported into the vacuole by the ABC-C transporter Ycf1. The amount of whole-cell GSSG is entirely dependent on Ycf1 and uninformative about the cytosolic glutathione pool. Applying these insights, we identify Trx2 and Grx2 as efficient backup systems to glutathione reductase for cytosolic GSSG reduction.	[Morgan, Bruce; Ezerina, Daria; Amoako, Theresa N. E.; Dick, Tobias P.] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, Heidelberg, Germany; [Riemer, Jan] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [Seedorf, Matthias] Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Kaiserslautern; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Dick, TP (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, Heidelberg, Germany.	t.dick@dkfz.de	Ezeriņa, Daria/GXM-5832-2022; Ezerina, Daria/ABH-9010-2020; Riemer, Jan/AAC-1072-2021	Ezeriņa, Daria/0000-0002-3104-7093; Ezerina, Daria/0000-0002-3104-7093; Morgan, Bruce/0000-0001-9393-1071; Riemer, Jan/0000-0002-7574-8457	European Molecular Biology Organization [313-2009]; DKFZ; Chica and Heinz Schaller Foundation	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); DKFZ(Helmholtz Association); Chica and Heinz Schaller Foundation	B.M. was funded by a European Molecular Biology Organization short-term fellowship (313-2009) and a DKFZ visiting scientist fellowship. Support by the Chica and Heinz Schaller Foundation is gratefully acknowledged. We thank B. Schwappach for critical reading of the manuscript.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Aw TY, 2003, NEWS PHYSIOL SCI, V18, P201, DOI 10.1152/nips.01448.2003; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Bonilla M, 2011, J BIOL CHEM, V286, P4959, DOI 10.1074/jbc.M110.170761; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Brechbuhl HM, 2010, J BIOL CHEM, V285, P16582, DOI 10.1074/jbc.M109.090506; BULGER JE, 1971, J BIOL CHEM, V246, P5570; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dardalhon M, 2012, FREE RADICAL BIO MED, V52, P2254, DOI 10.1016/j.freeradbiomed.2012.04.004; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Knollema S, 1996, J COMP NEUROL, V373, P157, DOI 10.1002/(SICI)1096-9861(19960916)373:2<157::AID-CNE1>3.0.CO;2-2; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lazard M, 2011, FEBS J, V278, P4112, DOI 10.1111/j.1742-4658.2011.08318.x; Lee ME, 2011, GENETICS, V188, P859, DOI 10.1534/genetics.111.130724; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Lopez-Mirabal HR, 2007, FEMS YEAST RES, V7, P391, DOI 10.1111/j.1567-1364.2006.00202.x; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Paumi CM, 2012, FEBS LETT, V586, P847, DOI 10.1016/j.febslet.2012.02.010; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4; Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844	38	206	209	0	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					119	125		10.1038/NCHEMBIO.1142	http://dx.doi.org/10.1038/NCHEMBIO.1142			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23242256				2022-12-25	WOS:000314083200011
J	Souers, AJ; Leverson, JD; Boghaert, ER; Ackler, SL; Catron, ND; Chen, J; Dayton, BD; Ding, H; Enschede, SH; Fairbrother, WJ; Huang, DCS; Hymowitz, SG; Jin, S; Khaw, SL; Kovar, PJ; Lam, LT; Lee, J; Maecker, HL; Marsh, KC; Mason, KD; Mitten, MJ; Nimmer, PM; Oleksijew, A; Park, CH; Park, CM; Phillips, DC; Roberts, AW; Sampath, D; Seymour, JF; Smith, ML; Sullivan, GM; Tahir, SK; Tse, C; Wendt, MD; Xiao, Y; Xue, JC; Zhang, HC; Humerickhouse, RA; Rosenberg, SH; Elmore, SW				Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.			ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets	NATURE MEDICINE			English	Article							B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMA; FAMILY INHIBITOR; INDUCE APOPTOSIS; HIGH-AFFINITY; IN-VIVO; EXPRESSION; CANCER	Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process. This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis. The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-X-L), which has shown clinical efficacy in some BCL-2-dependent hematological cancers. However, concomitant on-target thrombocytopenia caused by BCL-X-L inhibition limits the efficacy achievable with this agent. Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199. This compound inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets. A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h. These data indicate that selective pharmacological inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematological cancers.	[Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Jin, Sha; Kovar, Peter J.; Lam, Lloyd T.; Marsh, Kennan C.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.] AbbVie Inc, N Chicago, IL USA; [Fairbrother, Wayne J.; Hymowitz, Sarah G.; Lee, Jackie; Maecker, Heather L.; Sampath, Deepak] Genentech Inc, San Francisco, CA 94080 USA; [Huang, David C. S.; Khaw, Seong Lin; Mason, Kylie D.; Roberts, Andrew W.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Huang, David C. S.; Khaw, Seong Lin; Mason, Kylie D.; Roberts, Andrew W.; Seymour, John F.] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Mason, Kylie D.; Roberts, Andrew W.] Royal Melbourne Hosp, Dept Clin Hematol & Bone Marrow Transplant, Parkville, Vic 3050, Australia; [Seymour, John F.] Peter MacCallum Canc Ctr, Dept Hematol, Melbourne, Vic, Australia	AbbVie; Roche Holding; Genentech; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Royal Melbourne Hospital; Peter Maccallum Cancer Center	Souers, AJ (corresponding author), AbbVie Inc, N Chicago, IL USA.	andrew.souers@abbvie.com	Seymour, John/K-7326-2019; Park, Cheol-Min/G-2688-2010; Jones, Jeffrey A/E-9827-2013; Huang, David C. S./C-7586-2013; Roberts, Andrew W./C-6736-2012	Seymour, John/0000-0003-2188-6835; Huang, David C. S./0000-0002-3101-4873; Roberts, Andrew W./0000-0002-7341-5720; Mason, Kylie/0000-0002-6238-4092; Maecker, Heather/0000-0002-5378-1141	Australian National Health and Medical Research Council (NHMRC); Australian Cancer Research Foundation; Leukaemia Foundation of Australia; Cancer Council of Victoria; Victorian Cancer Agency; Victorian State Government Operational Infrastructure Support; Leukemia Lymphoma Society	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Leukaemia Foundation of Australia; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Cancer Agency; Victorian State Government Operational Infrastructure Support; Leukemia Lymphoma Society(Leukemia and Lymphoma Society)	We thank M. Bruncko, E. Fry, L. Hasvold, L. Hexamer, A. Kunzer, A. Petros, X. Song, Z. Tao, L. Wang and X. Wang for contributions to the generation of ABT-199 and related analogs and J. Bouska, and D. Osterling for analytical support. The authors acknowledge G. Chiang and A. Vasudevan for critical reading of this manuscript, L. Belmont, I. Wertz, J. Adams, S. Cory, P. Colman, P. Czabotar and G. Lessene for useful discussions and K. Lowes, E. Litvinovich and L. Roberts for technical analysis. Research performed at the Walter and Eliza Hall Institute (WEHI) was supported by grants and fellowships from the Australian National Health and Medical Research Council (NHMRC, including an Independent Research Institutes Infrastructure Support Scheme (IRIISS) grant), the Australian Cancer Research Foundation, the Leukaemia Foundation of Australia, the Cancer Council of Victoria, the Victorian Cancer Agency, the Victorian State Government Operational Infrastructure Support and the Leukemia Lymphoma Society. The authors acknowledge L.M. Staudt (US National Institutes of Health) for DLBCL cell lines.	Ackler S, 2012, BRIT J PHARMACOL, V167, P881, DOI 10.1111/j.1476-5381.2012.02048.x; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; American Cancer Society, 2011, CANC FACTS FIG 2011; Amundson SA, 2000, CANCER RES, V60, P6101; Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Campas C, 2006, EXP HEMATOL, V34, P1663, DOI 10.1016/j.exphem.2006.07.008; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CoustanSmith E, 1996, BLOOD, V87, P1140, DOI 10.1182/blood.V87.3.1140.bloodjournal8731140; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Huang JZ, 2002, BLOOD, V99, P2285, DOI 10.1182/blood.V99.7.2285; Iqbal J, 2006, J CLIN ONCOL, V24, P961, DOI 10.1200/JCO.2005.03.4264; Irish JM, 2007, BLOOD, V109, P2589, DOI 10.1182/blood-2006-02-004234; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Marschitz I, 2000, AM J CLIN PATHOL, V113, P219, DOI 10.1309/491W-L1TN-UFQX-T61B; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Matsumura N, 2010, FASEB J, V24, P2201, DOI 10.1096/fj.09-143008; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rampello E, 2006, NAT CLIN PRACT ONCOL, V3, P438, DOI 10.1038/ncponc0581; Roberts A.W., 2012, EUR HEM ASS 2012 AMS; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Samuel S, 2010, MOL THER, V18, P2094, DOI 10.1038/mt.2010.188; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sawas A, 2011, CURR OPIN HEMATOL, V18, P280, DOI 10.1097/MOH.0b013e328347786d; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Singh RR, 2010, LEUKEMIA, V24, P1025, DOI 10.1038/leu.2010.35; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wendt MD, 2006, J MED CHEM, V49, P1165, DOI 10.1021/jm050754u; Wendt MD, 2008, EXPERT OPIN DRUG DIS, V3, P1123, DOI 10.1517/17460441.3.9.1123; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081	46	1915	2001	32	427	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					202	208		10.1038/nm.3048	http://dx.doi.org/10.1038/nm.3048			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23291630				2022-12-25	WOS:000314675900028
J	Wang, GL; Wang, XM; Yu, H; Wei, SG; Williams, N; Holmes, DL; Halfmann, R; Naidoo, J; Wang, L; Li, L; Chen, S; Harran, P; Lei, XG; Wang, XD				Wang, Gelin; Wang, Xiaoming; Yu, Hong; Wei, Shuguang; Williams, Noelle; Holmes, Daniel L.; Halfmann, Randal; Naidoo, Jacinth; Wang, Lai; Li, Lin; Chen, She; Harran, Patrick; Lei, Xiaoguang; Wang, Xiaodong			Small-molecule activation of the TRAIL receptor DR5 in human cancer cells	NATURE CHEMICAL BIOLOGY			English	Article							APOPTOSIS-INDUCING LIGAND; DEATH RECEPTORS; CYTOCHROME-C; CASPASE-8; PATHWAYS; PROTEINS	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) activates apoptosis through the death receptors DR4 and DR5. Because of its superior safety profile and high tumor specificity compared to other TNF family members, recombinant soluble TRAIL and agonistic antibodies against its receptors are actively being developed for clinical cancer therapy. Here, we describe the identification and characterization of the small molecules that directly target DR5 to initiate apoptosis in human cancer cells. The activity was initially discovered through a high-throughput chemical screen for compounds that promote cell death in synergy with a small-molecule mimetic of Smac, the antagonist for inhibitor of apoptosis protein. Structure-activity relationship studies yielded a more potent analog called bioymifi, which can act as a single agent to induce DR5 clustering and aggregation, leading to apoptosis. Thus, this study identified potential lead compounds for the development of small-molecule TRAIL mimics targeting DR5 for cancer therapy.	[Wang, Gelin; Yu, Hong; Wei, Shuguang; Williams, Noelle; Holmes, Daniel L.; Halfmann, Randal; Naidoo, Jacinth] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wang, Xiaoming; Lei, Xiaoguang] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Wang, Lai; Li, Lin] Joyant Pharmaceut, Dallas, TX USA; [Chen, She; Lei, Xiaoguang; Wang, Xiaodong] Natl Inst Biol Sci, Beijing, Peoples R China; [Harran, Patrick] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Tianjin University; National Institute of Biological Sciences, Beijing; University of California System; University of California Los Angeles	Wang, GL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	gelin.wang@utsouthwestern.edu; leixiaoguang@nibs.ac.cn; wangxiaodong@nibs.ac.cn		Wang, Xiaodong/0000-0001-9885-356X; Holmes, Daniel/0000-0002-0489-4043; Halfmann, Randal/0000-0002-6592-1471	US National Cancer Institute [2P01 CA095471-06]; National Natural Science Foundation of China [21072150, 21222209]; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009152] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Zhao for NMR and HPLC/MS analysis; S.L. Petersen for reagents and discussions; L. Zhao for the toxicological experiments; S.L. McKnight for helpful suggestions; M. Roth for proposing the chemical library screen; D. Frantz, J. Ready and A. Wang for synthesis of initial hits; Y. Liu, Z. Zhang, Q. Liu and L. Shang for comments of the manuscript; S.-C. Tso and T. Scheuermann for detecting the interaction between DR5 and bioymifi; and K. Phelps and A. Budge for the cell imaging. This work is supported by a program project grant from the US National Cancer Institute (2P01 CA095471-06 to Xiaodong Wang and G.W.) and the National Natural Science Foundation of China (21072150 and 21222209 to X.L.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	28	82	96	4	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					84	89		10.1038/NCHEMBIO.1153	http://dx.doi.org/10.1038/NCHEMBIO.1153			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23292651				2022-12-25	WOS:000314083200006
J	Li, H; Peng, ZY; Yang, XH; Wang, WD; Fu, JJ; Wang, JH; Han, YJ; Chai, YC; Guo, TT; Yang, N; Liu, J; Warburton, ML; Cheng, YB; Hao, XM; Zhang, P; Zhao, JY; Liu, YJ; Wang, GY; Li, JS; Yan, JB				Li, Hui; Peng, Zhiyu; Yang, Xiaohong; Wang, Weidong; Fu, Junjie; Wang, Jianhua; Han, Yingjia; Chai, Yuchao; Guo, Tingting; Yang, Ning; Liu, Jie; Warburton, Marilyn L.; Cheng, Yanbing; Hao, Xiaomin; Zhang, Pan; Zhao, Jinyang; Liu, Yunjun; Wang, Guoying; Li, Jiansheng; Yan, Jianbing			Genome-wide association study dissects the genetic architecture of oil biosynthesis in maize kernels	NATURE GENETICS			English	Article							ACYL-CARRIER PROTEIN; FATTY-ACID; BRASSICA-NAPUS; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; QUANTITATIVE RESISTANCE; LEAF-BLIGHT; MIXED-MODEL; SELECTION; ENCODES; FAD2	Maize kernel oil is a valuable source of nutrition. Here we extensively examine the genetic architecture of maize oil biosynthesis in a genome-wide association study using 1.03 million SNPs characterized in 368 maize inbred lines, including 'high-oil' lines. We identified 74 loci significantly associated with kernel oil concentration and fatty acid composition (P < 1.8 x 10(-6)), which we subsequently examined using expression quantitative trait loci (QTL) mapping, linkage mapping and coexpression analysis. More than half of the identified loci localized in mapped QTL intervals, and one-third of the candidate genes were annotated as enzymes in the oil metabolic pathway. The 26 loci associated with oil concentration could explain up to 83% of the phenotypic variation using a simple additive model. Our results provide insights into the genetic basis of oil biosynthesis in maize kernels and may facilitate marker-based breeding for oil quantity and quality.	[Li, Hui; Yang, Xiaohong; Wang, Weidong; Wang, Jianhua; Han, Yingjia; Chai, Yuchao; Guo, Tingting; Hao, Xiaomin; Zhang, Pan; Li, Jiansheng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China; [Peng, Zhiyu; Cheng, Yanbing; Zhao, Jinyang] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Fu, Junjie; Liu, Yunjun; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Yang, Ning; Liu, Jie; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Warburton, Marilyn L.] ARS, Corn Host Plant Resistance Res Unit, USDA, Starkville, MS USA	China Agricultural University; Beijing Genomics Institute (BGI); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Huazhong Agricultural University; United States Department of Agriculture (USDA)	Yan, JB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	gywang@caas.net.cn; lijiansheng@cau.edu.cn; yjianbing@mail.hzau.edu.cn	Peng, Zhiyu/GXV-5301-2022; Fu, Junjie/F-5921-2010; Warburton, Marilyn/J-2250-2017	Yang, Ning/0000-0002-6354-3534; Peng, Zhiyu/0000-0003-2349-750X; Fu, Junjie/0000-0002-4702-2392; Warburton, Marilyn/0000-0002-9542-9912; Guo, Tingting/0000-0002-6647-6998; Liu, Jie/0000-0002-1129-9584	National Hi-Tech Research and Development Program of China [2012AA10A307]; National Natural Science Foundation of China [31101156, 31123009]; National Basic Research Program of China [2009CB118404]; Ministry of Agriculture of China [2011ZX08009-001]; National Gene Bank Project of China	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Gene Bank Project of China	We appreciated the helpful comments on the manuscript from A. Rafalski, J. Dudley, T. Setter and B. Shen. This research was supported by the National Hi-Tech Research and Development Program of China (2012AA10A307), the National Natural Science Foundation of China (31101156, 31123009), the National Basic Research Program of China (2009CB118404), the Ministry of Agriculture of China (2011ZX08009-001) and the National Gene Bank Project of China.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Benveniste I, 1998, BIOCHEM BIOPH RES CO, V243, P688, DOI 10.1006/bbrc.1998.8156; Bouvier-Nave P, 2011, FEBS J, V267, P85; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Branen JK, 2001, PLANT PHYSIOL, V127, P222, DOI 10.1104/pp.127.1.222; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chai YC, 2012, MOL BREEDING, V29, P939, DOI 10.1007/s11032-011-9644-0; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Dyer JM, 2001, FEBS LETT, V494, P44, DOI 10.1016/S0014-5793(01)02315-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EVANS DE, 1992, PLANTA, V186, P343, DOI 10.1007/BF00195314; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; Gupta S, 2005, PLANT MOL BIOL, V57, P115, DOI 10.1007/s11103-004-6636-z; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hellyer SA, 1999, BBA-MOL CELL BIOL L, V1440, P215, DOI 10.1016/S1388-1981(99)00125-0; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lal SK, 2003, PLANT CELL, V15, P381, DOI 10.1105/tpc.008375; Lambert R. J., 2004, Plant Breeding Reviews, V24, P153; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024699; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036807; Li-Beisson Y.H, 2010, ARABIDOPSIS BOOK, V1; Lincoln S.E, 1992, CONSTRUCTION GENETIC; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Mikkilineni V, 2003, THEOR APPL GENET, V106, P1326, DOI 10.1007/s00122-003-1190-7; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; Murata N, 1997, BBA-LIPID LIPID MET, V1348, P10, DOI 10.1016/S0005-2760(97)00115-X; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nawrath C, 2010, ARABIDOPSIS BOOK, V2; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Nickel W, 1998, SEMIN CELL DEV BIOL, V9, P493, DOI 10.1006/scdb.1998.0256; Oakes J, 2011, PLANT PHYSIOL, V155, P1146, DOI 10.1104/pp.110.167676; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Palocci C, 2003, PLANT SCI, V165, P577, DOI 10.1016/S0168-9452(03)00223-1; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Pouvreau B, 2011, PLANT PHYSIOL, V156, P674, DOI 10.1104/pp.111.173641; ROSNITSCHEK I, 1980, PLANTA, V148, P193, DOI 10.1007/BF00380026; SAFFORD R, 1988, EUR J BIOCHEM, V174, P287, DOI 10.1111/j.1432-1033.1988.tb14096.x; Sanchez J, 1984, STRUCTURE FUNCTION M; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; SHINTANI DK, 1994, PLANT PHYSIOL, V104, P1221, DOI 10.1104/pp.104.4.1221; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song TM, 2004, MAYDICA, V49, P9; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Song XF, 2004, MAYDICA, V49, P41; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Wang S, 2005, WINDOWS QTL CARTOGRA; Wassom JJ, 2008, CROP SCI, V48, P69, DOI 10.2135/cropsci2007.04.0208; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2008, EUPHYTICA, V162, P335, DOI 10.1007/s10681-007-9500-9; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhang ZW, 2009, BRIEF BIOINFORM, V10, P664, DOI 10.1093/bib/bbp050; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85; Zhou LL, 2011, CELL RES, V21, P1267, DOI 10.1038/cr.2011.104	84	503	567	19	378	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					43	U72		10.1038/ng.2484	http://dx.doi.org/10.1038/ng.2484			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23242369				2022-12-25	WOS:000312838800011
J	Wehr, MC; Holder, MV; Gailite, I; Saunders, RE; Maile, TM; Ciirdaeva, E; Instrell, R; Jiang, M; Howell, M; Rossner, MJ; Tapon, N				Wehr, Michael C.; Holder, Maxine V.; Gailite, Ieva; Saunders, Rebecca E.; Maile, Tobias M.; Ciirdaeva, Elena; Instrell, Rachael; Jiang, Ming; Howell, Michael; Rossner, Moritz J.; Tapon, Nicolas			Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila	NATURE CELL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; TUMOR-SUPPRESSOR PATHWAY; CONTROLS TISSUE-GROWTH; CELL-CYCLE EXIT; PROLIFERATION ARREST; PROMOTES APOPTOSIS; NEGATIVE REGULATOR; EXPANDED FUNCTION; TEAD/TEF FAMILY; BANTAM MICRORNA	The specification of tissue size during development involves the coordinated action of many signalling pathways responding to organ-intrinsic signals, such as morphogen gradients, and systemic cues, such as nutrient status. The conserved Hippo (Hpo) pathway, which promotes both cell-cycle exit and apoptosis, is a major determinant of size control. The pathway core is a kinase cassette, comprising the kinases Hpo and Warts (Wts) and the scaffold proteins Salvador (Say) and Mats, which inactivates the pro-growth transcriptional co-activator Yorkie (Yki). We performed a split-TEV-based genome-wide RNAi screen for modulators of Hpo signalling. We characterize the Drosophila salt-inducible kinases (Sik2 and Sik3) as negative regulators of Hpo signalling. Activated Sik kinases increase Yki target expression and promote tissue overgrowth through phosphorylation of Say at Ser 413. As Sik kinases have been implicated in nutrient sensing, this suggests a link between the Hpo pathway and systemic growth control.	[Wehr, Michael C.; Holder, Maxine V.; Gailite, Ieva; Maile, Tobias M.; Tapon, Nicolas] Canc Res UK, Apoptosis & Proliferat Control Lab, London Res Inst, London WC2A 3LY, England; [Saunders, Rebecca E.; Instrell, Rachael; Jiang, Ming; Howell, Michael] Canc Res UK, London Res Inst, High Throughput Screening Lab, London WC2A 3LY, England; [Wehr, Michael C.; Ciirdaeva, Elena; Rossner, Moritz J.] Max Planck Inst Expt Med, Res Grp Gene Express, D-37075 Gottingen, Germany	Cancer Research UK; Cancer Research UK; Max Planck Society	Tapon, N (corresponding author), Canc Res UK, Apoptosis & Proliferat Control Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	nicolas.tapon@cancer.org.uk	Wehr, Michael/J-7989-2019; Maile, Tobias M/A-7805-2016	Wehr, Michael/0000-0003-1770-8323; Maile, Tobias M/0000-0003-0376-8683; Tapon, Nicolas/0000-0001-5267-6510; Holder, Maxine/0000-0002-4613-2194; Howell, Michael/0000-0003-0912-0079; Rossner, Moritz/0000-0002-0667-3420	Bundesministerium fur Wirtschaft und Forschung [03EFT6N1, 16V0008]; EMBO Long Term Fellowship; Cancer Research UK; Cancer Research UK [17064] Funding Source: researchfish	Bundesministerium fur Wirtschaft und Forschung; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank A. Kerai for help with re screening candidates; T. Gilbank, S. Maloney and F. Earl for maintaining flies; L. Muthusamy for sequencing and helping with plating RNAi libraries; the Vienna Drosophila RNAi Centre for fly stocks; and O. Shaham and B. Thompson for comments on the manuscript. We are very grateful to P. Gaspar for help with fly genetics; F. Josue and P. Langton for advice; and A. Teleman and A. Celik for sharing reagents and exchanging unpublished data before publication. We thank K-A. Nave (Gottingen) for ongoing support. M.C.W. and M.J.R. acknowledge the support by the Bundesministerium fur Wirtschaft und Forschung (grants 03EFT6N1 and 16V0008). M.C.W. was supported by an EMBO Long Term Fellowship. The Tapon laboratory is supported by Cancer Research UK.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Charoenfuprasert S, 2011, ONCOGENE, V30, P3570, DOI 10.1038/onc.2011.77; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Choi S, 2011, J BIOL CHEM, V286, P2658, DOI 10.1074/jbc.C110.119222; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; McCartney BM, 2000, DEVELOPMENT, V127, P1315; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nguyen H.B., 2012, ONCOGENE; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Wehr MC, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-55; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	80	78	82	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2013	15	1					61	U132		10.1038/ncb2658	http://dx.doi.org/10.1038/ncb2658			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	061II	23263283	Green Accepted			2022-12-25	WOS:000312841300010
J	Tiels, P; Baranova, E; Piens, K; De Visscher, C; Pynaert, G; Nerinckx, W; Stout, J; Fudalej, F; Hulpiau, P; Tannler, S; Geysens, S; Van Hecke, A; Valevska, A; Vervecken, W; Remaut, H; Callewaert, N				Tiels, Petra; Baranova, Ekaterina; Piens, Kathleen; De Visscher, Charlotte; Pynaert, Gwenda; Nerinckx, Wim; Stout, Jan; Fudalej, Franck; Hulpiau, Paco; Tannler, Simon; Geysens, Steven; Van Hecke, Annelies; Valevska, Albena; Vervecken, Wouter; Remaut, Han; Callewaert, Nico			A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes	NATURE BIOTECHNOLOGY			English	Article							ACID ALPHA-GLUCOSIDASE; MANNOSE 6-PHOSPHATE RECEPTORS; MOUSE MODEL; N-GLYCANS; PHOSPHORYLATION; REPLACEMENT; STORAGE; TRANSPORT; IDENTIFICATION; THERAPIES	Lysosomal storage diseases are treated with human lysosomal enzymes produced in mammalian cells. Such enzyme therapeutics contain relatively low levels of mannose-6-phosphate, which is required to target them to the lysosomes of patient cells. Here we describe a method for increasing mannose-6-phosphate modification of lysosomal enzymes produced in yeast. We identified a glycosidase from C. cellulans that 'uncaps' N-glycans modified by yeast-type mannose-Pi-6-mannose to generate mammalian-type N-glycans with a mannose-6-phosphate substitution. Determination of the crystal structure of this glycosidase provided insight into its substrate specificity. We used this uncapping enzyme together with alpha-mannosidase to produce in yeast a form of the Pompe disease enzyme alpha-glucosidase rich in mannose-6-phosphate. Compared with the currently used therapeutic version, this form of alpha-glucosidase was more efficiently taken up by fibroblasts from Pompe disease patients, and it more effectively reduced cardiac muscular glycogen storage in a mouse model of the disease.	[Tiels, Petra; De Visscher, Charlotte; Nerinckx, Wim; Van Hecke, Annelies; Callewaert, Nico] VIB, Unit Med Biotechnol, Dept Mol Biomed Res, Ghent, Belgium; [Tiels, Petra; De Visscher, Charlotte; Nerinckx, Wim; Van Hecke, Annelies; Callewaert, Nico] Univ Ghent, Lab Prot Biochem & Biomol Engn, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Baranova, Ekaterina; Remaut, Han] VIB, Dept Biol Struct, Brussels, Belgium; [Baranova, Ekaterina; Remaut, Han] Vrije Univ Brussel, Brussels, Belgium; [Piens, Kathleen; Pynaert, Gwenda; Stout, Jan; Fudalej, Franck; Tannler, Simon; Geysens, Steven; Valevska, Albena; Vervecken, Wouter] Oxyrane, Ghent, Belgium; [Hulpiau, Paco] VIB, Bio IT Core Facil, Dept Mol Biomed Res, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Callewaert, N (corresponding author), VIB, Unit Med Biotechnol, Dept Mol Biomed Res, Ghent, Belgium.	wvervecken@oxyrane.com; han.remaut@vib-vub.be; nico.callewaert@dmbr.vib-ugent.be	Hulpiau, Paco/C-3215-2009	Hulpiau, Paco/0000-0002-6692-2150; Van Hecke, Annelies/0000-0002-3010-8034; Baranova, Ekaterina/0000-0003-3211-7134; Remaut, Han/0000-0002-9775-4102; Callewaert, Nico/0000-0003-2069-6917	IWT-Flanders [080775, 110379]; Marie Curie Excellence Grant under EU Framework Program 6 [MEXT-014292]; FWO-Vlaanderen [G.0.327.11.N.10]; Institute for the Advancement of Scientific and Technological Research in Industry (IWT); VIB grant [PRJ9]; Odysseus program of the FWO-Vlaanderen	IWT-Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Marie Curie Excellence Grant under EU Framework Program 6; FWO-Vlaanderen(FWO); Institute for the Advancement of Scientific and Technological Research in Industry (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); VIB grant; Odysseus program of the FWO-Vlaanderen	This work was supported by an R&D grant from IWT-Flanders (projects 080775 and 110379), the Marie Curie Excellence Grant MEXT-014292 under EU Framework Program 6 and by grant G.0.327.11.N.10 of FWO-Vlaanderen.; P.T. holds a doctor-assistant position at Ghent University. C. D. V. holds a fellowship of the Institute for the Advancement of Scientific and Technological Research in Industry (IWT). H. R. is supported by VIB grant PRJ9 and the Odysseus program of the FWO-Vlaanderen. We thank J.-M. Nicaud (CNRS-INRA-INAPG UMR2585, France) for donating Y. lipolytica Po1d lnuga, A. Reuser for providing GAA KO mice and TNO Triskelion for executing the in vivo part of the mouse studies. We acknowledge M. Zawisza, D. Bracke, T. Herman, H. Van Put, S. Poiz and I. Dewerte for their excellent technical assistance during the project and thank the Protein Service Facility (Y. Leoen and J. Haustraete) for their assistance, as well as Y.-C. Lin for handling the genome sequencing data. We dedicate this paper to the memory of the late Prof. Dr. Yoshifumi Jigami, one of the pioneers in glyco-engineering of yeasts.	Akeboshi H, 2009, GLYCOBIOLOGY, V19, P1002, DOI 10.1093/glycob/cwp080; BALLOU DL, 1975, J BACTERIOL, V123, P616, DOI 10.1128/JB.123.2.616-619.1975; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Bijvoet AGA, 1998, HUM MOL GENET, V7, P53, DOI 10.1093/hmg/7.1.53; BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; Breuer P, 1997, MOL BIOL CELL, V8, P567, DOI 10.1091/mbc.8.4.567; Chiba Y, 2002, GLYCOBIOLOGY, V12, P821, DOI 10.1093/glycob/cwf096; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; De Pourcq K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-53; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fickers P, 2005, FUNGAL GENET BIOL, V42, P264, DOI 10.1016/j.fgb.2004.12.003; Fickers P, 2003, J MICROBIOL METH, V55, P727, DOI 10.1016/j.mimet.2003.07.003; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; METCALFE G, 1957, J GEN MICROBIOL, V17, P567, DOI 10.1099/00221287-17-3-567; Miura M, 2004, GENE, V324, P129, DOI 10.1016/j.gene.2003.09.023; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odani T, 1996, GLYCOBIOLOGY, V6, P805, DOI 10.1093/glycob/6.8.805; Pohl S, 2009, BIOL CHEM, V390, P521, DOI 10.1515/BC.2009.076; REUSER AJJ, 1984, EXP CELL RES, V155, P178, DOI 10.1016/0014-4827(84)90779-1; Schumann P, 2001, INT J SYST EVOL MICR, V51, P1007, DOI 10.1099/00207713-51-3-1007; Schwientek P, 2011, J BIOTECHNOL, V155, P68, DOI 10.1016/j.jbiotec.2011.04.010; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Takashiba M, 2006, ANAL CHEM, V78, P5208, DOI 10.1021/ac060072u; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364	41	74	80	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1225	+		10.1038/nbt.2427	http://dx.doi.org/10.1038/nbt.2427			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159880				2022-12-25	WOS:000312092400026
J	Dumelin, CE; Chen, YY; Leconte, AM; Chen, YG; Liu, DR				Dumelin, Christoph E.; Chen, Yiyun; Leconte, Aaron M.; Chen, Y. Grace; Liu, David R.			Discovery and biological characterization of geranylated RNA in bacteria	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; MODIFIED NUCLEOSIDE; TRANSLATION; BIOSYNTHESIS; SEQUENCES; GENE; CODON; EXPRESSION; ANTICODON; DIVERSITY	A general MS-based screen for unusually hydrophobic cellular small molecule-RNA conjugates revealed geranylated RNA in Escherichia coli, Enterobacter aerogenes, Pseudomonas aeruginosa and Salmonella enterica var. Typhimurium. The geranyl group is conjugated to the sulfur atom in two 5-methylaminomethyl-2-thiouridine nucleotides. These geranylated nucleotides occur in the first anticodon position of tRNA(UUC)(Glu), tRNA(UUU)(Lys) and tRNA(UUG)(Gln) at a frequency of up to 6.7% (similar to 400 geranylated nucleotides per cell). RNA geranylation can be increased or abolished by mutation or deletion of the selU (ybbB) gene in E. coli, and purified SelU protein in the presence of geranyl pyrophosphate and tRNA can produce geranylated tRNA. The presence or absence of the geranyl group in tRNA(UUC)(Glu), tRNA(UUU)(Lys) and tRNA(UUG)(Gln) affects codon bias and frameshifting during translation. These RNAs represent the first reported examples of oligoisoprenylated cellular nucleic acids.	[Dumelin, Christoph E.; Chen, Yiyun; Leconte, Aaron M.; Chen, Y. Grace; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Dumelin, Christoph E.; Chen, Yiyun; Leconte, Aaron M.; Chen, Y. Grace; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Dumelin, CE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Chen, Yiyun/Q-9895-2016; Liu, David R./HCH-3132-2022	Chen, Yiyun/0000-0003-0916-0994; 	US National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS) [R01GM065865]; Novartis Foundation; NIH National Research Service Award Postdoctoral Fellowship [F32GM095028]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865, F32GM095028] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS); Novartis Foundation(Novartis); NIH National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute and the US National Institutes of Health (NIH)-National Institute of General Medical Sciences (NIGMS) (R01GM065865). C. E. D. acknowledges fellowship from the Novartis Foundation. A. M. L. was supported by a NIH National Research Service Award Postdoctoral Fellowship (F32GM095028). We thank S.-L. Zheng for his help with X-ray diffraction and structural determination of synthetic geranyl-2-thiouracil. We thank A. Saghatelian (Harvard University) for providing P. aeruginosa and I. Chen (Harvard University) for providing S. Typhimurium and BL2 facilities. We are also grateful to J. Carlson for his assistance and M. Ibba for helpful discussions.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Chen YG, 2009, NAT CHEM BIOL, V5, P879, DOI 10.1038/nchembio.235; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; JAKUBOWSKI H, 1984, J BACTERIOL, V158, P769, DOI 10.1128/JB.158.3.769-776.1984; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Keller KC, 2011, CURR OPIN MICROBIOL, V14, P155, DOI 10.1016/j.mib.2011.01.009; Kowtoniuk WE, 2009, P NATL ACAD SCI USA, V106, P7768, DOI 10.1073/pnas.0900528106; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Lane BG, 1998, MODIFICATION EDITING, P1; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; LINDSLEY D, 1993, P NATL ACAD SCI USA, V90, P5469, DOI 10.1073/pnas.90.12.5469; LOOMAN AC, 1987, EMBO J, V6, P2489, DOI 10.1002/j.1460-2075.1987.tb02530.x; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nicolas EC, 1998, J PHARMACEUT BIOMED, V16, P825, DOI 10.1016/S0731-7085(97)00132-5; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Scott AI, 1997, TETRAHEDRON LETT, V38, P4961, DOI 10.1016/S0040-4039(97)01143-X; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; TSUCHIHASHI Z, 1992, GENE DEV, V6, P511, DOI 10.1101/gad.6.3.511; VOLKIN E, 1953, J BIOL CHEM, V205, P767; WITTWER A J, 1989, Biofactors, V2, P27; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; YANIV M, 1975, J BIOL CHEM, V250, P3243; Yarian C, 2000, BIOCHEMISTRY-US, V39, P13390, DOI 10.1021/bi001302g; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	45	81	82	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					913	919		10.1038/NCHEMBIO.1070	http://dx.doi.org/10.1038/NCHEMBIO.1070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	22983156	Green Accepted, Green Submitted			2022-12-25	WOS:000310052100010
J	Manjarrez-Orduno, N; Marasco, E; Chung, SA; Katz, MS; Kiridly, JF; Simpfendorfer, KR; Freudenberg, J; Ballard, DH; Nashi, E; Hopkins, TJ; Graham, DSC; Lee, AT; Coenen, MJH; Franke, B; Swinkels, DW; Graham, RR; Kimberly, RP; Gaffney, PM; Vyse, TJ; Behrens, TW; Criswell, LA; Diamond, B; Gregersen, PK				Manjarrez-Orduno, Nataly; Marasco, Emiliano; Chung, Sharon A.; Katz, Matthew S.; Kiridly, Jenna F.; Simpfendorfer, Kim R.; Freudenberg, Jan; Ballard, David H.; Nashi, Emil; Hopkins, Thomas J.; Graham, Deborah S. Cunninghame; Lee, Annette T.; Coenen, Marieke J. H.; Franke, Barbara; Swinkels, Dorine W.; Graham, Robert R.; Kimberly, Robert P.; Gaffney, Patrick M.; Vyse, Timothy J.; Behrens, Timothy W.; Criswell, Lindsey A.; Diamond, Betty; Gregersen, Peter K.			CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation	NATURE GENETICS			English	Article							VARIANT; PTPN22; AUTOIMMUNITY; THRESHOLDS; TOLERANCE; ALLELE; ITGAM; LYN	The c-Src tyrosine kinase, Csk, physically interacts with the intracellular phosphatase Lyp (encoded by PTPN22) and can modify the activation state of downstream Src kinases, such as Lyn, in lymphocytes. We identified an association of CSK with systemic lupus erythematosus (SLE) and refined its location to the intronic polymorphism rs34933034 (odds ratio (OR) = 1.32; P = 1.04 x 10(-9)). The risk allele at this SNP is associated with increased CSK expression and augments inhibitory phosphorylation of Lyn. In carriers of the risk allele, there is increased B-cell receptor (BCR)-mediated activation of mature B cells, as well as higher concentrations of plasma immunoglobulin M (IgM), relative to individuals with the non-risk haplotype. Moreover, the fraction of transitional B cells is doubled in the cord blood of carriers of the risk allele, due to an expansion of late transitional cells in a stage targeted by selection mechanisms. This suggests that the Lyp-Csk complex increases susceptibility to lupus at multiple maturation and activation points in B cells.	[Manjarrez-Orduno, Nataly; Marasco, Emiliano; Nashi, Emil; Diamond, Betty] N Shore Long Isl Jewish LIJ, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Disorders, Manhasset, NY USA; [Manjarrez-Orduno, Nataly; Katz, Matthew S.; Kiridly, Jenna F.; Simpfendorfer, Kim R.; Freudenberg, Jan; Ballard, David H.; Hopkins, Thomas J.; Lee, Annette T.; Gregersen, Peter K.] N Shore LIJ, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Chung, Sharon A.; Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; [Graham, Deborah S. Cunninghame; Vyse, Timothy J.] Kings Coll London, Sch Med, Div Genet & Mol Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Coenen, Marieke J. H.; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Kimberly, Robert P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Graham, Robert R.; Behrens, Timothy W.] Genentech Inc, Dept Human Genet, San Francisco, CA 94080 USA; [Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthrit & Immunol Res Program, Oklahoma City, OK 73104 USA	Northwell Health; Northwell Health; University of California System; University of California San Francisco; University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; University of Alabama System; University of Alabama Birmingham; Roche Holding; Genentech; Oklahoma Medical Research Foundation	Diamond, B (corresponding author), N Shore Long Isl Jewish LIJ, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Disorders, Manhasset, NY USA.	bdiamond@nshs.edu; pgregers@nshs.edu	Simpfendorfer, Kim R/AAG-1940-2019; Marasco, Emiliano/J-3627-2016; Franke, Barbara/D-4836-2009; Coenen, Marieke/A-2159-2010; Swinkels, Dorine W./H-8098-2014	Simpfendorfer, Kim R/0000-0002-1906-2899; Marasco, Emiliano/0000-0001-5346-3357; Franke, Barbara/0000-0003-4375-6572; Coenen, Marieke/0000-0001-8796-2031; Swinkels, Dorine W./0000-0002-1040-9446; Kimberly, Robert/0000-0002-5330-3086; Manjarrez Orduno, Nataly/0000-0002-7569-1673; Gaffney, Patrick/0000-0002-1580-869X; Ballard, David/0000-0002-2587-4818	US National Institutes of Health (NIH) [RC2AR059092]; Alliance for Lupus Research; Kirkland Scholar Award; NIH/National Center for Research Resources (NCRR) [5 M01 RR-00079, P01 AR49084, UL1 TR000165]; NIH/National Center for Advancing Translational Sciences [KL2TR000143]; American College of Rheumatology;  [N01AR62277]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143, UL1TR000165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049084, P60AR053308, RC2AR059092, RC2AR058959, N01AR62277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Kirkland Scholar Award; NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/National Center for Advancing Translational Sciences; American College of Rheumatology(General Electric); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the volunteers who participated in this study; the Genotype and Phenotype (GaP) registry; M. Keogh, M. DeFranco, C. Mason, C. Metz and the Biorepository at the Feinstein Institute for Medical Research (FIMR) for recruiting subjects and collecting samples; H. Borrero for technical assistance; and the Biostatistics Unit of the FIMR and M. Akerman for assistance. This work was supported by US National Institutes of Health (NIH) grant RC2AR059092; The Alliance for Lupus Research, a Kirkland Scholar Award and NIH/National Center for Research Resources (NCRR) grant 5 M01 RR-00079 (L.A.C.); P01 AR49084 and UL1 TR000165 (R.P.K.); and NIH/National Center for Advancing Translational Sciences grant KL2TR000143 and an American College of Rheumatology Physician Scientist Development Award (S.A.C.). The principal investigators of the Nijmegen Biomedical Study are L.A.L.M. Kiemeney, M. den Heijer, A.L.M. Verbeek, D.W. Swinkels and B. Franke. We thank the Lupus Family Registry and Repository (LFRR) investigators, J.B. Harley, K.L. Moser Sivils, M.H. Weisman and D.J. Wallace, funded by N01AR62277 (K.L.M.S. and J.B.H.).	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Hasegawa M, 2001, J IMMUNOL, V167, P2469, DOI 10.4049/jimmunol.167.5.2469; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Liston A, 2005, IMMUNOL REV, V204, P87, DOI 10.1111/j.0105-2896.2005.00253.x; Lu R, 2009, GENES IMMUN, V10, P397, DOI 10.1038/gene.2009.19; Martin JE, 2012, HUM MOL GENET, V21, P2825, DOI 10.1093/hmg/dds099; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	18	84	85	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1227	1230		10.1038/ng.2439	http://dx.doi.org/10.1038/ng.2439			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23042117	Green Accepted, Green Submitted			2022-12-25	WOS:000310495800014
J	Mochida, GH; Ganesh, VS; de Michelena, MI; Dias, H; Atabay, KD; Kathrein, KL; Huang, HT; Hill, RS; Felie, JM; Rakiec, D; Gleason, D; Hill, AD; Malik, AN; Barry, BJ; Partlow, JN; Tan, WH; Glader, LJ; Barkovich, AJ; Dobyns, WB; Zon, LI; Walsh, CA				Mochida, Ganeshwaran H.; Ganesh, Vijay S.; de Michelena, Maria I.; Dias, Hugo; Atabay, Kutay D.; Kathrein, Katie L.; Huang, Hsuan-Ting; Hill, R. Sean; Felie, Jillian M.; Rakiec, Daniel; Gleason, Danielle; Hill, Anthony D.; Malik, Athar N.; Barry, Brenda J.; Partlow, Jennifer N.; Tan, Wen-Hann; Glader, Laurie J.; Barkovich, A. James; Dobyns, William B.; Zon, Leonard I.; Walsh, Christopher A.			CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development	NATURE GENETICS			English	Article							CELL; BMI1	Charged multivesicular body protein 1A (CHMP1A; also known as chromatin-modifying protein 1A) is a member of the ESCRT-III (endosomal sorting complex required for transport-III) complex(1,2) but is also suggested to localize to the nuclear matrix and regulate chromatin structure(3). Here, we show that loss-of-function mutations in human CHMP1A cause reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral cortical size (microcephaly). CHMP1A-mutant cells show impaired proliferation, with increased expression of INK4A, a negative regulator of stem cell proliferation. Chromatin immunoprecipitation suggests loss of the normal INK4A repression by BMI in these cells. Morpholino-based knockdown of zebrafish chmp1a resulted in brain defects resembling those seen after bmi1a and bmi1b knockdown, which were partially rescued by INK4A ortholog knockdown, further supporting links between CHMP1A and BMI1-mediated regulation of INK4A. Our results suggest that CHMP1A serves as a critical link between cytoplasmic signals and BMI1-mediated chromatin modifications that regulate proliferation of central nervous system progenitor cells.	[Mochida, Ganeshwaran H.; Ganesh, Vijay S.; Atabay, Kutay D.; Hill, R. Sean; Felie, Jillian M.; Rakiec, Daniel; Gleason, Danielle; Barry, Brenda J.; Partlow, Jennifer N.; Tan, Wen-Hann; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Dept Med, Boston, MA USA; [Mochida, Ganeshwaran H.; Ganesh, Vijay S.; Atabay, Kutay D.; Hill, R. Sean; Felie, Jillian M.; Rakiec, Daniel; Gleason, Danielle; Barry, Brenda J.; Partlow, Jennifer N.; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Mochida, Ganeshwaran H.; Ganesh, Vijay S.; Atabay, Kutay D.; Kathrein, Katie L.; Huang, Hsuan-Ting; Hill, R. Sean; Felie, Jillian M.; Rakiec, Daniel; Gleason, Danielle; Barry, Brenda J.; Partlow, Jennifer N.; Zon, Leonard I.; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA; [Mochida, Ganeshwaran H.; Tan, Wen-Hann; Glader, Laurie J.; Zon, Leonard I.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA; [Ganesh, Vijay S.; Malik, Athar N.] Harvard Massachusetts Inst Technol MIT Div Hlth S, Cambridge, MA USA; [de Michelena, Maria I.] Cayetano Heredia Univ, Dept Morphol Sci, Lima, Peru; [Dias, Hugo] Inst Child Dev ARIE, Lima, Peru; [Kathrein, Katie L.; Huang, Hsuan-Ting; Zon, Leonard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Kathrein, Katie L.; Huang, Hsuan-Ting; Zon, Leonard I.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Kathrein, Katie L.; Huang, Hsuan-Ting; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Hill, Anthony D.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Glader, Laurie J.] Boston Childrens Hosp, Div Gen Pediat, Complex Care Serv, Boston, MA USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Dobyns, William B.] Univ Washington, Ctr Integrat Brain Res, Seattle, WA 98195 USA; [Zon, Leonard I.] Harvard Stem Cell Inst, Cambridge, MA USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Universidad Peruana Cayetano Heredia; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Harvard University; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Boston Childrens Hosp, Div Genet, Dept Med, Boston, MA USA.	christopher.walsh@childrens.harvard.edu	Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020	Dobyns, William/0000-0002-7681-2844; HILL, ANTHONY/0000-0003-2179-6493; Walsh, Christopher/0000-0002-0156-2238; Mochida, Ganeshwaran/0000-0001-7912-4097; Tan, Wen-Hann/0000-0002-1593-6149	US National Institute of Neurological Disorders and Stroke (NINDS) [R01NS035129]; Fogarty International Center [R21TW008223]; Dubai Harvard Foundation for Medical Research; Simons Foundation; Manton Center for Orphan Disease Research; National Alliance for Research on Schizophrenia and Depression (NARSAD); Harvard Medical School; US National institute of General Medical Sciences (NIGMS); FOGARTY INTERNATIONAL CENTER [R21TW008223] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Dubai Harvard Foundation for Medical Research; Simons Foundation; Manton Center for Orphan Disease Research; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Harvard Medical School; US National institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals and their families reported herein for their participation in this research. We thank M. van Lohuizen (Netherlands Cancer Institute) for providing the Bmi1-knockout mice, A. Wagers for help with breeding the Bmi1-knockout mice and P. Baas for sharing human DNA samples. This research was supported by grants from the US National Institute of Neurological Disorders and Stroke (NINDS; R01NS035129) and the Fogarty International Center (R21TW008223) to C.A.W, the Dubai Harvard Foundation for Medical Research, the Simons Foundation and the Manton Center for Orphan Disease Research. G.H.M. was supported by the Young Investigator Award of the National Alliance for Research on Schizophrenia and Depression (NARSAD) as a NARSAD Lieber Investigator. V.S.G. is supported by the Medical Scientist Training Program of Harvard Medical School, with financial support from the US National institute of General Medical Sciences (NIGMS). C.A.W and L.I.Z. are investigators of the Howard Hughes Medical Institute. Microscopy and image analyses were performed with support from the Cellular Imaging Core of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Garel C, 2011, J CHILD NEUROL, V26, P1483, DOI 10.1177/0883073811420148; Howard TL, 2001, J CELL SCI, V114, P2395; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Stauffer DR, 2001, J CELL SCI, V114, P2383; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	12	62	67	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1260	1264		10.1038/ng.2425	http://dx.doi.org/10.1038/ng.2425			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23023333	Green Submitted, Green Accepted			2022-12-25	WOS:000310495800020
J	Reitman, ZJ; Choi, BD; Spasojevic, I; Bigner, DD; Sampson, JH; Yan, H				Reitman, Zachary J.; Choi, Bryan D.; Spasojevic, Ivan; Bigner, Darell D.; Sampson, John H.; Yan, Hai			Enzyme redesign guided by cancer-derived IDH1 mutations	NATURE CHEMICAL BIOLOGY			English	Article							HOMOISOCITRATE DEHYDROGENASE; ADIPIC ACID; ISOCITRATE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; MECHANISM; SUBSTRATE	Mutations in an enzyme can result in a neomorphic catalytic activity in cancers. We applied cancer-associated mutations from isocitrate dehydrogenases to homologous residues in the active sites of homoisocitrate dehydrogenases to derive enzymes that catalyze the conversion of 2-oxoadipate to (R)-2-hydroxyadipate, a critical step for adipic acid production. Thus, we provide a prototypic example of how insights from cancer genome sequencing and functional studies can aid in enzyme redesign.	[Reitman, Zachary J.; Choi, Bryan D.; Bigner, Darell D.; Sampson, John H.; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Duke Canc Inst, Bioanalyt Core Lab, Durham, NC 27710 USA	Duke University; Duke University	Reitman, ZJ (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	hai.yan@dm.duke.edu		Sampson, John/0000-0002-0104-7658; Reitman, Zachary/0000-0002-9122-9550	US National Institutes of Health [R01 CA1403160]; NATIONAL CANCER INSTITUTE [R01CA140310, R01CA140316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by US National Institutes of Health grant R01 CA1403160 (H.Y.). We thank P. F. Cook at the University of Oklahoma for an HIDH expression plasmid, E. Spana at Duke University for S. cerevisiae genomic DNA, P. Fan for technical assistance and I. Fridovich and I. Batinic-Haberle for feedback on the manuscript.	Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; Bulfer SL, 2012, PROTEINS, V80, P661, DOI 10.1002/prot.23231; Burgard AP, 2010, Google Patents, Patent No. [US 2010/0330626 A1, 20100330626]; Chen RD, 2000, PROTEIN SCI, V9, P2344, DOI 10.1110/ps.9.12.2344; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Lin Y, 2008, BIOCHEMISTRY-US, V47, P4169, DOI 10.1021/bi702361j; Lin Y, 2007, BIOCHEMISTRY-US, V46, P890, DOI 10.1021/bi062067q; Lin Y, 2009, BIOCHEMISTRY-US, V48, P7305, DOI 10.1021/bi900175z; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Niu W, 2002, BIOTECHNOL PROGR, V18, P201, DOI 10.1021/bp010179x; Noack H, 2011, INORG CHEM, V50, P1194, DOI 10.1021/ic101405u; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Sato K, 1998, SCIENCE, V281, P1646, DOI 10.1126/science.281.5383.1646; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; UHR ML, 1974, J BIOL CHEM, V249, P2920; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	23	16	19	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					887	889		10.1038/NCHEMBIO.1065	http://dx.doi.org/10.1038/NCHEMBIO.1065			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23001033	Green Accepted			2022-12-25	WOS:000310052100006
J	Sundaresan, NR; Vasudevan, P; Zhong, L; Kim, G; Samant, S; Parekh, V; Pillai, VB; Ravindra, PV; Gupta, M; Jeevanandam, V; Cunningham, JM; Deng, CX; Lombard, DB; Mostoslavsky, R; Gupta, MP				Sundaresan, Nagalingam R.; Vasudevan, Prabhakaran; Zhong, Lei; Kim, Gene; Samant, Sadhana; Parekh, Vishwas; Pillai, Vinodkumar B.; Ravindra, P. V.; Gupta, Madhu; Jeevanandam, Valluvan; Cunningham, John M.; Deng, Chu-Xia; Lombard, David B.; Mostoslavsky, Raul; Gupta, Mahesh P.			The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun	NATURE MEDICINE			English	Article							FOCAL ADHESION KINASE; REGULATES LIFE-SPAN; CALORIE RESTRICTION; HISTONE DEACETYLASE; GENE-EXPRESSION; HEART; ACTIVATION; AP-1; INDUCTION; RECEPTOR	Abnormal activation of insulin-like growth factor (IGF)-Akt signaling is implicated in the development of various diseases, including heart failure. However, the molecular mechanisms that regulate activation of this signaling pathway are not completely understood. Here we show that sirtuin 6 (SIRT6), a nuclear histone deacetylase, functions at the level of chromatin to directly attenuate IGF-Akt signaling. SIRT6-deficient mice developed cardiac hypertrophy and heart failure, whereas SIRT6 transgenic mice were protected from hypertrophic stimuli, indicating that SIRT6 acts as a negative regulator of cardiac hypertrophy. SIRT6-deficient mouse hearts showed hyperactivation of IGF signaling-related genes and their downstream targets. Mechanistically, SIRT6 binds to and suppresses the promoter of IGF signaling-related genes by interacting with c-Jun and deacetylating histone 3 at Lys9 (H3K9). We also found reduced SIRT6 expression in human failing hearts. These findings disclose a new link between SIRT6 and IGF-Akt signaling and implicate SIRT6 in the development of cardiac hypertrophy and failure.	[Sundaresan, Nagalingam R.; Samant, Sadhana; Pillai, Vinodkumar B.; Ravindra, P. V.; Jeevanandam, Valluvan; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Comm Cellular & Mol Physiol, Chicago, IL 60637 USA; [Vasudevan, Prabhakaran; Parekh, Vishwas; Cunningham, John M.] Univ Chicago, Dept Pediat, Comm Dev Biol, Chicago, IL 60637 USA; [Zhong, Lei; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Kim, Gene] Univ Chicago, Cardiol Sect, Dept Med, Chicago, IL 60637 USA; [Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Deng, Chu-Xia] NIDDKD, US NIH, Bethesda, MD 20892 USA; [Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Chicago; University of Chicago; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, Comm Cellular & Mol Physiol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu	deng, chuxia/N-6713-2016; Parekh, Vishwas/B-7162-2014	Parekh, Vishwas/0000-0003-3131-2958; Kim, Gene/0000-0001-6461-1992; Lombard, David/0000-0002-4292-0185; Veeranna, Ravindra/0000-0003-4228-1843	US National Institutes of Health [RO1 HL-117041, HL-83423, 111455]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117041, R01HL111455, R01HL077788, R01HL083423] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. Alt, Harvard Medical School, for providing SIRT6 knockout mice, E. Verdin, University of California, San Francisco, for providing Flag-SIRT6 wild-type and mutant plasmids, F. VanGool, Institut de Biologie, Universite Libre de Bruxelles, Gosselies, Belgium, for providing mouse-SIRT6 expression plasmid and K. Chua, Stanford University, for providing SIRT6 retroviral vectors and SIRT6 knockout MEFs. The alpha-MHC promoter vector used to make cardiac-specific SIRT6 transgenic mice was provided by J. Robbins, University of Cincinnati. This study was supported by US National Institutes of Health grants RO1 HL-117041, HL-83423 and 111455 to M. P. G. N.R.S. was supported by a postdoctoral fellowship from the American Heart Association.	Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Freire G, 2007, J MOL CELL CARDIOL, V43, P465, DOI 10.1016/j.yjmcc.2007.07.046; Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gatenby VK, 2010, EXPERT OPIN THER TAR, V14, P1333, DOI 10.1517/14728222.2010.528930; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haq S, 2001, CIRCULATION, V103, P670; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; KAHN AJ, 1972, AM J CLIN NUTR, V25, P822; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kostin S, 2000, Heart Fail Rev, V5, P271; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Pillai JB, 2008, AM J PHYSIOL-HEART C, V294, pH1388, DOI 10.1152/ajpheart.01339.2007; REISS K, 1993, AM J PHYSIOL, V264, pH760, DOI 10.1152/ajpheart.1993.264.3.H760; SCHUNKERT H, 1991, P NATL ACAD SCI USA, V88, P11480, DOI 10.1073/pnas.88.24.11480; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Takemoto Y, 1999, J MOL CELL CARDIOL, V31, P2017, DOI 10.1006/jmcc.1999.1033; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zaina S, 2003, ENDOCRINOLOGY, V144, P2695, DOI 10.1210/en.2002-220944; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	46	332	341	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1643	+		10.1038/nm.2961	http://dx.doi.org/10.1038/nm.2961			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086477	Green Accepted			2022-12-25	WOS:000310837000024
J	Peifer, M; Fernandez-Cuesta, L; Sos, ML; George, J; Seidel, D; Kasper, LH; Plenker, D; Leenders, F; Sun, RP; Zander, T; Menon, R; Koker, M; Dahmen, I; Muller, C; Di Cerbo, V; Schildhaus, HU; Altmuller, J; Baessmann, I; Becker, C; de Wilde, B; Vandesompele, J; Bohm, D; Ansen, S; Gabler, F; Wilkening, I; Heynck, S; Heuckmann, JM; Lu, X; Carter, SL; Cibulskis, K; Banerji, S; Getz, G; Park, KS; Rauh, D; Grutter, C; Fischer, M; Pasqualucci, L; Wright, G; Wainer, Z; Russell, P; Petersen, I; Chen, Y; Stoelben, E; Ludwig, C; Schnabel, P; Hoffmann, H; Muley, T; Brockmann, M; Engel-Riedel, W; Muscarella, LA; Fazio, VM; Groen, H; Timens, W; Sietsma, H; Thunnissen, E; Smit, E; Heideman, DAM; Snijders, PJF; Cappuzzo, F; Ligorio, C; Damiani, S; Field, J; Solberg, S; Brustugun, OT; Lund-Iversen, M; Sanger, J; Clement, JH; Soltermann, A; Moch, H; Weder, W; Solomon, B; Soria, JC; Validire, P; Besse, B; Brambilla, E; Brambilla, C; Lantuejoul, S; Lorimier, P; Schneider, PM; Hallek, M; Pao, W; Meyerson, M; Sage, J; Shendure, J; Schneider, R; Buttner, R; Wolf, J; Nurnberg, P; Perner, S; Heukamp, LC; Brindle, PK; Haas, S; Thomas, RK				Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Kasper, Lawryn H.; Plenker, Dennis; Leenders, Frauke; Sun, Ruping; Zander, Thomas; Menon, Roopika; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Di Cerbo, Vincenzo; Schildhaus, Hans-Ulrich; Altmueller, Janine; Baessmann, Ingelore; Becker, Christian; de Wilde, Bram; Vandesompele, Jo; Boehm, Diana; Ansen, Sascha; Gabler, Franziska; Wilkening, Ines; Heynck, Stefanie; Heuckmann, Johannes M.; Lu, Xin; Carter, Scott L.; Cibulskis, Kristian; Banerji, Shantanu; Getz, Gad; Park, Kwon-Sik; Rauh, Daniel; Gruetter, Christian; Fischer, Matthias; Pasqualucci, Laura; Wright, Gavin; Wainer, Zoe; Russell, Prudence; Petersen, Iver; Chen, Yuan; Stoelben, Erich; Ludwig, Corinna; Schnabel, Philipp; Hoffmann, Hans; Muley, Thomas; Brockmann, Michael; Engel-Riedel, Walburga; Muscarella, Lucia A.; Fazio, Vito M.; Groen, Harry; Timens, Wim; Sietsma, Hannie; Thunnissen, Erik; Smit, Egbert; Heideman, Danielle A. M.; Snijders, Peter J. F.; Cappuzzo, Federico; Ligorio, Claudia; Damiani, Stefania; Field, John; Solberg, Steinar; Brustugun, Odd Terje; Lund-Iversen, Marius; Saenger, Joerg; Clement, Joachim H.; Soltermann, Alex; Moch, Holger; Weder, Walter; Solomon, Benjamin; Soria, Jean-Charles; Validire, Pierre; Besse, Benjamin; Brambilla, Elisabeth; Brambilla, Christian; Lantuejoul, Sylvie; Lorimier, Philippe; Schneider, Peter M.; Hallek, Michael; Pao, William; Meyerson, Matthew; Sage, Julien; Shendure, Jay; Schneider, Robert; Buettner, Reinhard; Wolf, Juergen; Nuernberg, Peter; Perner, Sven; Heukamp, Lukas C.; Brindle, Paul K.; Haas, Stefan; Thomas, Roman K.			Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer	NATURE GENETICS			English	Article							FREQUENT MUTATION; EGFR MUTATIONS; MOUSE MODEL; E-CADHERIN; GENE; P53; CBP; ACETYLATION; SIGNATURES; FUSIONS	Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis(1-3). We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an extremely high mutation rate of 7.4 +/- 1 protein-changing mutations per million base pairs. Therefore, we conducted integrated analyses of the various data sets to identify pathogenetically relevant mutated genes. In all cases, we found evidence for inactivation of TP53 and RB1 and identified recurrent mutations in the CREBBP, EP300 and MLL genes that encode histone modifiers. Furthermore, we observed mutations in PTEN, SLIT2 and EPHA7, as well as focal amplifications of the FGFR1 tyrosine kinase gene. Finally, we detected many of the alterations found in humans in SCLC tumors from Tp53 and Rb1 double knockout mice(4). Our study implicates histone modification as a major feature of SCLC, reveals potentially therapeutically tractable genomic alterations and provides a generalizable framework for the identification of biologically relevant genes in the context of high mutational background.	[Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Plenker, Dennis; Leenders, Frauke; Zander, Thomas; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Heuckmann, Johannes M.; Lu, Xin; Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Plenker, Dennis; Leenders, Frauke; Zander, Thomas; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Gabler, Franziska; Wilkening, Ines; Heynck, Stefanie; Heuckmann, Johannes M.; Lu, Xin; Thomas, Roman K.] Univ Cologne, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, Max Planck Soc, D-50931 Cologne, Germany; [Peifer, Martin; Fernandez-Cuesta, Lynnette; Sos, Martin L.; George, Julie; Seidel, Danila; Plenker, Dennis; Leenders, Frauke; Zander, Thomas; Koker, Mirjam; Dahmen, Ilona; Mueller, Christian; Gabler, Franziska; Wilkening, Ines; Heynck, Stefanie; Heuckmann, Johannes M.; Lu, Xin; Thomas, Roman K.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Sos, Martin L.; Zander, Thomas; Ansen, Sascha; Hallek, Michael; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Sos, Martin L.; Zander, Thomas; Ansen, Sascha; Hallek, Michael; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, D-50931 Cologne, Germany; [Seidel, Danila; Leenders, Frauke; Hallek, Michael; Buettner, Reinhard; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Lab Translat Canc Genom, Ctr Integrated Oncol Kolm Bonn, D-50931 Cologne, Germany; [Kasper, Lawryn H.; Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Sun, Ruping; Haas, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Menon, Roopika; Boehm, Diana; Perner, Sven] Univ Hosp Bonn, Inst Prostate Canc Res, Inst Pathol, Bonn, Germany; [Di Cerbo, Vincenzo; Schneider, Robert] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Schildhaus, Hans-Ulrich; Buettner, Reinhard; Heukamp, Lukas C.; Thomas, Roman K.] Univ Cologne, Dept Pathol, Cologne, Germany; [Altmueller, Janine; Baessmann, Ingelore; Becker, Christian; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [de Wilde, Bram; Vandesompele, Jo] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Carter, Scott L.; Cibulskis, Kristian; Banerji, Shantanu; Getz, Gad; Meyerson, Matthew] Broad Inst Harvard & MIT, Cambridge, MA USA; [Park, Kwon-Sik; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Park, Kwon-Sik; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Rauh, Daniel; Gruetter, Christian] Tech Univ Dortmund, Dept Chem Biol, Dortmund, Germany; [Fischer, Matthias] Univ Childrens Hosp Cologne, Dept Pediat Oncol & Hematol, Cologne, Germany; [Fischer, Matthias; Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, New York, NY USA; [Pasqualucci, Laura] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Wright, Gavin; Wainer, Zoe] Univ Melbourne, Dept Surg, St Vincents Hosp, Melbourne, Vic, Australia; [Russell, Prudence] St Vincents Hosp, Dept Pathol, Melbourne, Vic, Australia; [Petersen, Iver; Chen, Yuan] Univ Jena, Jena Univ Hosp, Inst Pathol, Jena, Germany; [Stoelben, Erich; Ludwig, Corinna; Engel-Riedel, Walburga] Kliniken Stadt Koln, Lungenklin Merheim, Dept Thorac Surg, Cologne, Germany; [Schnabel, Philipp] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Hoffmann, Hans; Muley, Thomas] Thoraxklin Heidelberg, Dept Thorac Surg, Heidelberg, Germany; [Brockmann, Michael] Hosp Merheim, Dept Pathol, Kliniken Stadt Koln, Cologne, Germany; [Muscarella, Lucia A.; Fazio, Vito M.] Ist Ricovero & Cura Carattere Sci IRCCS Casa Soll, Lab Oncol, San Giovanni Rotondo, Italy; [Groen, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, NL-9713 AV Groningen, Netherlands; [Timens, Wim; Sietsma, Hannie] Univ Med Ctr Groningen, Dept Pathol, NL-9713 AV Groningen, Netherlands; [Thunnissen, Erik; Heideman, Danielle A. M.; Snijders, Peter J. F.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Smit, Egbert] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands; [Cappuzzo, Federico] Osped Civile, Dept Med Oncol, Livorno, Italy; [Ligorio, Claudia; Damiani, Stefania] Univ Hosp Bologna, Dept Haematol & Oncol Sci, Bologna, Italy; [Field, John] Univ Liverpool, Roy Castle Lung Canc Res Programme, Canc Res Ctr, Liverpool L69 3BX, Merseyside, England; [Solberg, Steinar] Oslo Univ Hosp, Rikshosp, Dept Thorac Surg, Oslo, Norway; [Brustugun, Odd Terje] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Brustugun, Odd Terje] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Lund-Iversen, Marius] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Saenger, Joerg] Inst Pathol Bad Berka, Bad Berka, Germany; [Clement, Joachim H.] Univ Jena, Dept Internal Med 2, Jena Univ Hosp, Jena, Germany; [Soltermann, Alex; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Weder, Walter] Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland; [Solomon, Benjamin] Peter MacCallum Canc Ctr, Dept Haematol & Med Oncol, Melbourne, Vic, Australia; [Soria, Jean-Charles; Besse, Benjamin] Inst Gustave Roussy, Dept Med, Phase Unit 1, Villejuif, France; [Validire, Pierre] Inst Mutualiste Montsouris, France Serv Anat Pathol, Paris, France; [Brambilla, Elisabeth; Brambilla, Christian; Lantuejoul, Sylvie; Lorimier, Philippe] Univ Grenoble 1, Dept Pathol, Grenoble, France; [Brambilla, Elisabeth; Brambilla, Christian; Lantuejoul, Sylvie] Univ Grenoble 1, Inst Albert Bonniot, INSERM U823, Grenoble, France; [Schneider, Peter M.] Univ Cologne, Inst Legal Med, D-50931 Cologne, Germany; [Pao, William] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schneider, Robert] Univ Strasbourg, CNRS UMR 7104, INSERM U964, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cologne; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; St Jude Children's Research Hospital; Max Planck Society; University of Bonn; Max Planck Society; University of Cologne; University of Cologne; Ghent University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Stanford University; Dortmund University of Technology; University of Cologne; University of Cologne; Columbia University; Columbia University; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Cologne; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Liverpool; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; Friedrich Schiller University of Jena; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Peter Maccallum Cancer Center; UNICANCER; Gustave Roussy; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Cologne; Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Cologne	Thomas, RK (corresponding author), Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany.	roman.thomas@uni-koeln.de	Groen, Harry/AAP-2242-2021; Hallek, Michael/Y-3191-2019; Field, John K./AAD-5674-2020; Fernandez-Cuesta, Lynnette/O-2415-2017; Seidel, Danila/Y-6795-2018; Brambilla, Elisabeth MP/L-8796-2013; Muley, Thomas/AAY-9200-2020; Besse, Benjamin/V-1523-2019; Di Cerbo, Vincenzo/AAR-2818-2021; Cibulskis, Kristian/AAC-7380-2019; Vandesompele, Jo/W-3411-2018; Timens, Wim/K-5570-2013; Cappuzzo, federico/R-2827-2016; lantuejoul, sylvie/N-9315-2017; Lantuejoul, Sylvie/N-4671-2013; Schildhaus, Hans-Ulrich/J-3094-2012; Sos, Martin L/I-1852-2014; Soltermann, Alex/AAE-3012-2020; Soria, Jean-Charles/F-3619-2014; Kasper, Lawryn/GWV-5700-2022; Fernandez-Cuesta, Lynnette/Z-1875-2019; Rauh, Daniel/G-1595-2013; Fazio, Vito Michele VMF/H-3007-2016; Shendure, Jay/AAU-3684-2021; Heukamp, Lukas C/A-8338-2013; Muscarella, Lucia Anna/K-5979-2016; Heukamp, Lukas/G-9967-2012	Hallek, Michael/0000-0002-7425-4455; Field, John K./0000-0003-3951-6365; Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; Seidel, Danila/0000-0003-4388-3117; Besse, Benjamin/0000-0001-5090-8189; Vandesompele, Jo/0000-0001-6274-0184; Timens, Wim/0000-0002-4146-6363; Cappuzzo, federico/0000-0002-6295-6767; lantuejoul, sylvie/0000-0003-4310-6975; Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; Fazio, Vito Michele VMF/0000-0002-7751-1867; Muscarella, Lucia Anna/0000-0002-1866-8151; Di Cerbo, Vincenzo/0000-0002-2920-1274; Wright, Gavin/0000-0002-7000-9305; Smit, Egbert/0000-0002-7329-6995; Schneider, Peter M./0000-0003-0744-2349; Park, Kwon-Sik/0000-0003-3346-9086; Groen, Harry J.M./0000-0002-2978-5265; Shendure, Jay/0000-0002-1516-1865; Peifer, Martin/0000-0002-5243-5503; DAMIANI, STEFANIA/0000-0002-2757-5985; De Wilde, Bram/0000-0003-0213-1322; Thunnissen, Erik/0000-0001-5355-8508; Solomon, Benjamin/0000-0003-3059-5730; Clement, Joachim H./0000-0002-6601-2456; Brindle, Paul/0000-0001-7172-8478; Heukamp, Lukas/0000-0002-3388-3482; Cibulskis, Kristian/0000-0003-1343-1582; Haas, Stefan/0000-0003-3418-3688; Rauh, Daniel/0000-0002-1970-7642; Altmuller, Janine/0000-0003-4372-1521; Soltermann, Alex/0000-0001-9509-6938; Meyerson, Matthew/0000-0002-9133-8108	German Ministry of Science and Education (BMBF) as part of the NGFNplus program [01GS08100, 01GS08101]; Max Planck Society [M.I..F.A.NEUR8061]; Deutsche Forschungsgemeinschaft (DFG) [SFB832, TP6, TP5, Z1, TH1386/3-1]; European Union's Framework Programme CURELUNG [HEALTH-F2-2010-258677]; Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant [SU2C-AACR-IR60109]; Behrens-Weise Foundation; US National Institutes of Health (NIH) Cancer Center [P30 CA021765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; Associazione Italiana Ricerca sul Cancro (AIRC) [IG 9425]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	German Ministry of Science and Education (BMBF) as part of the NGFNplus program(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union's Framework Programme CURELUNG; Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant; Behrens-Weise Foundation; US National Institutes of Health (NIH) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to the individuals donating their tumor specimens as part of the Clinical Lung Cancer Genome Project initiative. Additional biospecimens for this study were obtained from the Victorian Cancer Biobank (Melbourne, Australia). The Institutional Review Board (IRB) of each participating institution approved collection and use of all specimens in this study. We also thank our colleagues at The Cancer Genome Atlas Research Network (TCGA) and A.L. Kung for invaluable discussion and many helpful comments. This work was supported by the German Ministry of Science and Education (BMBF) as part of the NGFNplus program (grant 01GS08100 to R.K.T. and 01GS08101 to J.W. and P.N.), by the Max Planck Society (M.I..F.A.NEUR8061 to R.K.T.), by the Deutsche Forschungsgemeinschaft (DFG) through SFB832 (TP6 to R.K.T. and TP5 and Z1 to L.C.H. and R.B.) and TH1386/3-1 (to R.K.T. and M.L.S.), by the European Union's Framework Programme CURELUNG (HEALTH-F2-2010-258677 to R.K.T., J.F., E.B., C. Brambilla, S.L., B.B. and J.W.), by Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (SU2C-AACR-IR60109 to R.K.T. and W.P.), by the Behrens-Weise Foundation (to R.K.T.) and by an anonymous foundation to R.K.T. M.L.S. is a fellow of the International Association for the Study of Lung Cancer (IASLC). P.K.B. and L.H.K. thank the St. Jude Cell and Tissue Imaging facility and acknowledge support from the US National Institutes of Health (NIH) Cancer Center (grant P30 CA021765) and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. F.C. was supported by Associazione Italiana Ricerca sul Cancro (AIRC, grant IG 9425).	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; GAZZERI S, 1991, CANCER RES, V51, P2566; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gustafsson BI, 2008, CANCER-AM CANCER SOC, V113, P5, DOI 10.1002/cncr.23542; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Han SY, 2000, CANCER RES, V60, P3147; Hassan MI, 2010, J CANCER RES CLIN, V136, P333, DOI 10.1007/s00432-009-0751-9; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inthal A, 2012, LEUKEMIA, V26, P1797, DOI 10.1038/leu.2012.60; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Karro JE, 2008, MOL BIOL EVOL, V25, P362, DOI 10.1093/molbev/msm261; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; MORI N, 1990, ONCOGENE, V5, P1713; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Muraoka M, 1996, ONCOGENE, V12, P1565; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Querings S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019601; Rodin SN, 2005, SEMIN CANCER BIOL, V15, P103, DOI 10.1016/j.semcancer.2004.08.005; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Scheble VJ, 2010, MODERN PATHOL, V23, P1061, DOI 10.1038/modpathol.2010.87; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Tillinghast GW, 2003, GENE CHROMOSOME CANC, V37, P121, DOI 10.1002/gcc.10195; Tiseo M, 2007, J THORAC ONCOL, V2, P764, DOI 10.1097/JTO.0b013e3180986262; Travis W.D., 2004, PATHOLOGY GENETICS T, P344; Travis William D, 2009, Eur J Cancer, V45 Suppl 1, P251, DOI 10.1016/S0959-8049(09)70040-1; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Voortman J, 2010, P NATL ACAD SCI USA, V107, P13040, DOI 10.1073/pnas.1008132107; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17	90	919	953	3	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1104	+		10.1038/ng.2396	http://dx.doi.org/10.1038/ng.2396			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22941188	Green Accepted, Green Published			2022-12-25	WOS:000309550200009
J	Gildersleeve, JC				Gildersleeve, Jeffrey C.			GLYCOSYLTRANSFERASES Carb loading strategy is spot on	NATURE CHEMICAL BIOLOGY			English	News Item							MICROARRAYS; SPECIFICITIES; GLYCANS		NCI, Biol Chem Lab, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gildersleeve, JC (corresponding author), NCI, Biol Chem Lab, Frederick, MD 21701 USA.	gildersj@mail.nih.gov	Gildersleeve, Jeffrey/N-3392-2014	Gildersleeve, Jeffrey/0000-0002-3744-6423				Ban L, 2012, NAT CHEM BIOL, V8, P769, DOI [10.1038/NCHEMBIO.1022, 10.1038/nchembio.1022]; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Laurent N, 2008, CHEMBIOCHEM, V9, P883, DOI 10.1002/cbic.200700692; Muthana SM, 2012, ACS CHEM BIOL, V7, P31, DOI 10.1021/cb2004466; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Park S, 2007, ORG LETT, V9, P1675, DOI 10.1021/ol070250l; Sanchez-Ruiz A, 2011, ANGEW CHEM INT EDIT, V50, P1801, DOI 10.1002/anie.201006304; Seibel J, 2006, CHEMBIOCHEM, V7, P310, DOI 10.1002/cbic.200500350; Su J, 2002, ANGEW CHEM INT EDIT, V41, P4715, DOI 10.1002/anie.200290026	10	2	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2012	8	9					741	742		10.1038/nchembio.1049	http://dx.doi.org/10.1038/nchembio.1049			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996IH	22907089				2022-12-25	WOS:000308077600002
J	Sun, Y; Campisi, J; Higano, C; Beer, TM; Porter, P; Coleman, I; True, L; Nelson, PS				Sun, Yu; Campisi, Judith; Higano, Celestia; Beer, Tomasz M.; Porter, Peggy; Coleman, Ilsa; True, Lawrence; Nelson, Peter S.			Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B	NATURE MEDICINE			English	Article							CELL-CYCLE ARREST; DRUG-RESISTANCE; BREAST-CANCER; SENESCENCE; MECHANISMS; CHEMOTHERAPY; MITOXANTRONE; PROGRESSION; CHEMORESISTANCE; INHIBITION	Acquired resistance to anticancer treatments is a substantial barrier to reducing the morbidity and mortality that is attributable to malignant tumors. Components of tissue microenvironments are recognized to profoundly influence cellular phenotypes, including susceptibilities to toxic insults. Using a genome-wide analysis of transcriptional responses to genotoxic stress induced by cancer therapeutics, we identified a spectrum of secreted proteins derived from the tumor microenvironment that includes the Wnt family member wingless-type MMTV integration site family member 16B (WNT16B). We determined that WNT16B expression is regulated by nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kappa B) after DNA damage and subsequently signals in a paracrine manner to activate the canonical Wnt program in tumor cells. The expression of WNT16B in the prostate tumor microenvironment attenuated the effects of cytotoxic chemotherapy in vivo, promoting tumor cell survival and disease progression. These results delineate a mechanism by which genotoxic therapies given in a cyclical manner can enhance subsequent treatment resistance through cell nonautonomous effects that are contributed by the tumor microenvironment.	[Sun, Yu; Porter, Peggy; Coleman, Ilsa; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Campisi, Judith] Buck Inst Res Aging, Novato, CA USA; [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Higano, Celestia; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Higano, Celestia; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA USA; [Beer, Tomasz M.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Beer, Tomasz M.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [True, Lawrence; Nelson, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle	Nelson, PS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	pnelson@fhcrc.org		sun, yu/0000-0001-7121-9112	POCRC SPORE grant [P50CA83636]; Department of Defense [PC073217, R01CA119125]; National Cancer Institute Tumor Microenvironment Network [U54126540]; Pacific Northwest Prostate Cancer SPORE [P50CA097186]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA083636, P50CA138293, P50CA097186, R01CA119125, U54CA126540, U01CA164188] Funding Source: NIH RePORTER	POCRC SPORE grant; Department of Defense(United States Department of Defense); National Cancer Institute Tumor Microenvironment Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Dean and D. Bianchi-Frias for helpful comments, A. Moreno for administrative assistance and N. Clegg for bioinformatics support. S. Hayward, Vanderbilt University, and J. Ware, Medical College of Virginia, provided BPH1 and M12 cells, respectively. Primary human prostate (PSC27), ovarian (OVF28901) and breast (HBF1203) fibroblasts were provided by B. Knudsen, Cedars Sinai Medical Center, E. Swisher, University of Washington, and P. Porter through the Seattle Breast SPORE (P50 CA138293), Fred Hutchinson Cancer Research Center, respectively. B. Torok-Strorb, Fred Hutchinson Cancer Research Center, provided HS5 and HS27A HPV E6/E7 immortalized human bone marrow stromal cells. We thank the clinicians who participated in the trials of neoadjuvant chemotherapy: M. Garzotto, T. Takayama, P. Lange, W. Ellis, S. Lieberman and B. A. Lowe. We are also grateful for the participation of the patients and their families in these studies. Breast cancer specimens were obtained from the Fred Hutchinson Cancer Research Center/University of Washington Medical Center Breast Specimen Repository. We thank N. Urban, Fred Hutchinson Cancer Research Center, for providing ovarian cancer biospecimens funded through the POCRC SPORE grant P50CA83636. This work was supported by a fellowship from the Department of Defense (PC073217), R01CA119125, the National Cancer Institute Tumor Microenvironment Network U54126540, the Pacific Northwest Prostate Cancer SPORE P50CA097186 and the Prostate Cancer Foundation.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ALDERTON PM, 1992, CANCER RES, V52, P194; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beer TM, 2004, CLIN CANCER RES, V10, P1306, DOI 10.1158/1078-0432.CCR-1021-03; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davis A J, 2000, Lancet Oncol, V1, P86, DOI 10.1016/S1470-2045(00)00019-X; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; Garzotto M, 2006, UROL ONCOL-SEMIN ORI, V24, P254, DOI 10.1016/j.urolonc.2005.11.034; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Helmrich A, 2005, ONCOGENE, V24, P4174, DOI 10.1038/sj.onc.1208600; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kerbel RS, 2001, CANCER METAST REV, V20, P1, DOI 10.1023/A:1013129128673; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lee S, 2003, CURR OPIN GENET DEV, V13, P90, DOI 10.1016/S0959-437X(02)00014-X; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Samson DJ, 2004, J CLIN ONCOL, V22, P3618, DOI 10.1200/JCO.2004.04.077; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; StCroix B, 1996, JNCI-J NATL CANCER I, V88, P1285, DOI 10.1093/jnci/88.18.1285; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	46	538	560	7	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1359	+		10.1038/nm.2890	http://dx.doi.org/10.1038/nm.2890			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22863786	Green Accepted			2022-12-25	WOS:000308472300031
J	Tachibana, SI; Sullivan, SA; Kawai, S; Nakamura, S; Kim, HR; Goto, N; Arisue, N; Palacpac, NMQ; Honma, H; Yagi, M; Tougan, T; Katakai, Y; Kaneko, O; Mita, T; Kita, K; Yasutomi, Y; Sutton, PL; Shakhbatyan, R; Horii, T; Yasunaga, T; Barnwell, JW; Escalante, AA; Carlton, JM; Tanabe, K				Tachibana, Shin-Ichiro; Sullivan, Steven A.; Kawai, Satoru; Nakamura, Shota; Kim, Hyunjae R.; Goto, Naohisa; Arisue, Nobuko; Palacpac, Nirianne M. Q.; Honma, Hajime; Yagi, Masanori; Tougan, Takahiro; Katakai, Yuko; Kaneko, Osamu; Mita, Toshihiro; Kita, Kiyoshi; Yasutomi, Yasuhiro; Sutton, Patrick L.; Shakhbatyan, Rimma; Horii, Toshihiro; Yasunaga, Teruo; Barnwell, John W.; Escalante, Ananias A.; Carlton, Jane M.; Tanabe, Kazuyuki			Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade	NATURE GENETICS			English	Article							ALIGNMENT; PARASITE; EVOLUTIONARY; PROTEIN; ORIGIN; TALE	P. cynomolgi, a malaria-causing parasite of Asian Old World monkeys, is the sister taxon of P. vivax, the most prevalent malaria-causing species in humans outside of Africa. Because P. cynomolgi shares many phenotypic, biological and genetic characteristics with P. vivax, we generated draft genome sequences for three P. cynomolgi strains and performed genomic analysis comparing them with the P. vivax genome, as well as with the genome of a third previously sequenced simian parasite, Plasmodium knowlesi. Here, we show that genomes of the monkey malaria clade can be characterized by copy-number variants (CNVs) in multigene families involved in evasion of the human immune system and invasion of host erythrocytes. We identify genome-wide SNPs, microsatellites and CNVs in the P. cynomolgi genome, providing a map of genetic variation that can be used to map parasite traits and study parasite populations. The sequencing of the P. cynomolgi genome is a critical step in developing a model system for P. vivax research and in counteracting the neglect of P. vivax.	[Tachibana, Shin-Ichiro; Honma, Hajime; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Suita, Osaka 565, Japan; [Sullivan, Steven A.; Kim, Hyunjae R.; Sutton, Patrick L.; Shakhbatyan, Rimma; Carlton, Jane M.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Kawai, Satoru] Dokkyo Med Univ, Inst Int Educ & Res, Lab Trop Med & Parasitol, Shimotsuga, Japan; [Nakamura, Shota; Goto, Naohisa; Yasunaga, Teruo] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Suita, Osaka 565, Japan; [Arisue, Nobuko; Palacpac, Nirianne M. Q.; Honma, Hajime; Yagi, Masanori; Tougan, Takahiro; Horii, Toshihiro; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Katakai, Yuko] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki, Japan; [Kaneko, Osamu] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan; [Kaneko, Osamu] Nagasaki Univ, Global COE Ctr Excellence Program, Nagasaki 852, Japan; [Mita, Toshihiro] Juntendo Univ, Grad Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan; [Yasutomi, Yasuhiro] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan; [Barnwell, John W.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Atlanta, GA USA; [Escalante, Ananias A.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA	Osaka University; New York University; Dokkyo Medical University; Osaka University; Osaka University; Nagasaki University; Nagasaki University; Juntendo University; University of Tokyo; National Institute of Health Sciences - Japan; Centers for Disease Control & Prevention - USA; Arizona State University; Arizona State University-Tempe	Tanabe, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Suita, Osaka 565, Japan.	jane.carlton@nyu.edu; kztanabe@biken.osaka-u.ac.jp	Kim, Hyunjae/J-5811-2015; Tougan, Takahiro/AAP-5129-2020; Nakamura, Shota/E-3033-2010; Mita, Toshihiro/U-4126-2019; , 美田敏宏/D-8494-2015	Kim, Hyunjae/0000-0002-1869-0412; Nakamura, Shota/0000-0003-2058-5942; , 美田敏宏/0000-0001-8180-2344; Horii, Toshihiro/0000-0002-3000-2045; Palacpac, Nirianne Marie/0000-0003-4098-3972; Escalante, Ananias/0000-0002-1532-3430; Kita, Kiyoshi/0000-0002-0426-4308	US National Institutes of Health (NIH) [S10 RR026950]; Ministry of Education, Culture, Sports, Science and Technology of Japan [18073013, 18GS03140013, 20390120, 22406012]; NIH [R01 GM080586]; Burroughs Wellcome Fund [1007398]; NIH International Centers of Excellence for Malaria Research grant [U19 AI089676-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070793, R01GM080586] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22700455] Funding Source: KAKEN	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH International Centers of Excellence for Malaria Research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sawai for suggestions on genome analysis, D. Fisher for help with genome-wide evolutionary analyses and the NYU Langone Medical Center Genome Technology Core for access to Roche 454 sequencing equipment (funded by grant S10 RR026950 to J.M.C. from the US National Institutes of Health (NIH)). Genome and phylogenetic analyses used the Genome Information Research Center in the Research Institute of Microbial Diseases at Osaka University. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18073013, 18GS03140013, 20390120 and 22406012) to K.T., an NIH grant (R01 GM080586) to A.A.E. and a Burroughs Wellcome Fund grant (1007398) and an NIH International Centers of Excellence for Malaria Research grant (U19 AI089676-01) to J.M.C. The content is soley the responsibility of the authors and does not necessarily represent the official views of the NIH.	Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001160; COATNEY GR, 1971, PRIMATE MALARIAS; Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; Doi M, 2011, VACCINE, V29, P4308, DOI 10.1016/j.vaccine.2011.04.028; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; EYLES DE, 1960, SCIENCE, V131, P1812, DOI 10.1126/science.131.3416.1812; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Okenu DMN, 1997, MOL BIOCHEM PARASIT, V89, P301, DOI 10.1016/S0166-6851(97)00118-7; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Popendorf K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012651; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Saxena AK, 2007, EUKARYOT CELL, V6, P1260, DOI 10.1128/EC.00060-07; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	135	138	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1051	+		10.1038/ng.2375	http://dx.doi.org/10.1038/ng.2375			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22863735	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-25	WOS:000308491200019
J	Zeybel, M; Hardy, T; Wong, YK; Mathers, JC; Fox, CR; Gackowska, A; Oakley, F; Burt, AD; Wilson, CL; Anstee, QM; Barter, MJ; Masson, S; Elsharkawy, AM; Mann, DA; Mann, J				Zeybel, Muejdat; Hardy, Timothy; Wong, Yi K.; Mathers, John C.; Fox, Christopher R.; Gackowska, Agata; Oakley, Fiona; Burt, Alastair D.; Wilson, Caroline L.; Anstee, Quentin M.; Barter, Matt J.; Masson, Steven; Elsharkawy, Ahmed M.; Mann, Derek A.; Mann, Jelena			Multigenerational epigenetic adaptation of the hepatic wound-healing response	NATURE MEDICINE			English	Article							STELLATE CELL ACTIVATION; DNA METHYLATION; CHROMATIN-STRUCTURE; GENE-EXPRESSION; NONCODING RNAS; LIVER FIBROSIS; FATTY LIVER; TGF-BETA; HISTONE; PROGRESSION	We investigated whether ancestral liver damage leads to heritable reprogramming of hepatic wound healing in male rats. We found that a history of liver damage corresponds with transmission of an epigenetic suppressive adaptation of the fibrogenic component of wound healing to the male F-1 and F-2 generations. Underlying this adaptation was less generation of liver myofibroblasts, higher hepatic expression of the antifibrogenic factor peroxisome proliferator-activated receptor gamma (PPAR-gamma) and lower expression of the profibrogenic factor transforming growth factor beta 1 (TGF-beta 1) compared to rats without this adaptation. Remodeling of DNA methylation and histone acetylation underpinned these alterations in gene expression. Sperm from rats with liver fibrosis were enriched for the histone variant H2A.Z and trimethylation of histone H3 at Lys27 (H3K27me3) at PPAR-gamma chromatin. These modifications to the sperm chromatin were transmittable by adaptive serum transfer from fibrotic rats to naive rats and similar modifications were induced in mesenchymal stem cells exposed to conditioned media from cultured rat or human myofibroblasts. Thus, it is probable that a myofibroblast-secreted soluble factor stimulates heritable epigenetic signatures in sperm so that the resulting offspring better adapt to future fibrogenic hepatic insults. Adding possible relevance to humans, we found that people with mild liver fibrosis have hypomethylation of the PPARG promoter compared to others with severe fibrosis.	[Zeybel, Muejdat; Hardy, Timothy; Fox, Christopher R.; Gackowska, Agata; Oakley, Fiona; Burt, Alastair D.; Wilson, Caroline L.; Anstee, Quentin M.; Barter, Matt J.; Masson, Steven; Elsharkawy, Ahmed M.; Mann, Derek A.; Mann, Jelena] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wong, Yi K.; Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Ctr Brain Ageing & Vital, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Mann, DA (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	derek.mann@ncl.ac.uk; jelena.mann@ncl.ac.uk	Anstee, Quentin M./L-2981-2013; Burt, Alastair D/D-3634-2013	Anstee, Quentin M./0000-0002-9518-0088; Burt, Alastair D/0000-0002-3011-7774; Zeybel, Mujdat/0000-0002-1542-117X; , Caroline/0000-0002-9016-6025; Elsharkawy, Ahmed Mohamed/0000-0001-5369-3734; Oakley, Fiona/0000-0001-8692-1836; Mathers, John/0000-0003-3406-3002; Mann, Derek/0000-0003-0950-243X; Hardy, Timothy/0000-0001-9777-9134; Masson, Steven/0000-0003-1041-9844	US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism [1U01AA018663-01, R21AA016682]; Wellcome Trust [WT086755MA, WT074472MA]; Newcastle Biomedical Research Centre; Lifelong Health and Wellbeing cross council initiative by the Medical Research Council; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Turkish Association For The Study Of The Liver; National Institute for Health Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016682, U01AA018663] Funding Source: NIH RePORTER; MRC [G0900686, G0900535, G0700890] Funding Source: UKRI; Medical Research Council [G0700718B, G0900535, G0700890, G0900686] Funding Source: researchfish; National Institute for Health Research [ACF-2010-01-007] Funding Source: researchfish	US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism; Wellcome Trust(Wellcome TrustEuropean Commission); Newcastle Biomedical Research Centre; Lifelong Health and Wellbeing cross council initiative by the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Turkish Association For The Study Of The Liver; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank A. Cheshire for technical assistance and N. Perkins for helpful suggestions with writing the manuscript, M. Bashton for bioinformatic support with microarray analysis and R. Kendall for assistance with rat studies. We also thank J. Kirby and J. Brain for their help with obtaining ethical approval for the retrospective patient study. This work was supported by grants from US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism (to J.M. and D.A.M.) grant numbers 1U01AA018663-01 and R21AA016682; Wellcome Trust grant numbers WT086755MA (to D.A.M.) and WT074472MA (to A.M.E.) and Newcastle Biomedical Research Centre and National Institute for Health Research (to J.M.). The Centre for Brain Ageing and Vitality is funded through the Lifelong Health and Wellbeing cross council initiative by the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council and the Economic and Social Research Council (to J.C.M.) and the Turkish Association For The Study Of The Liver (to M.Z.).	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; BURD DAR, 1990, J PEDIATR SURG, V25, P898, DOI 10.1016/0022-3468(90)90199-J; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chou S T, 1971, J Pathol, V103, P163, DOI 10.1002/path.1711030305; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; GATEWOOD JM, 1990, J BIOL CHEM, V265, P20662; Ghosh S, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12228; Gieling RG, 2010, HEPATOLOGY, V51, P922, DOI 10.1002/hep.23385; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; HARRISON MR, 1991, ANN SURG, V213, P279, DOI 10.1097/00000658-199104000-00002; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia CK, 2011, EXPERT REV GASTROENT, V5, P105, DOI [10.1586/egh.10.87, 10.1586/EGH.10.87]; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kobor MS, 2009, TRENDS BIOCHEM SCI, V34, P158, DOI 10.1016/j.tibs.2008.12.006; Lavrov SA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1422, DOI 10.1134/S0006297907130020; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; McKay JA, 2011, MOL NUTR FOOD RES, V55, P1717, DOI 10.1002/mnfr.201100150; McKay JA, 2011, MOL NUTR FOOD RES, V55, P1026, DOI 10.1002/mnfr.201100008; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Nagase H, 2008, FEBS J, V275, P1617, DOI 10.1111/j.1742-4658.2008.06330.x; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; RAUCY JL, 1993, CRIT REV TOXICOL, V23, P1, DOI 10.3109/10408449309104072; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	54	193	203	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1369	+		10.1038/nm.2893	http://dx.doi.org/10.1038/nm.2893			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22941276	Green Accepted			2022-12-25	WOS:000308472300032
J	Plotkin, SA; Robinson, HL; Davenport, MP				Plotkin, Stanley A.; Robinson, Harriet L.; Davenport, Miles P.			Mining the mechanisms of an HIV vaccine	NATURE MEDICINE			English	Editorial Material							PROTECTION; ANTIBODIES; INFECTION; TRIAL	Despite the existence of antiretroviral drugs that can combat HIV, it is thought that the development of an effective vaccine will be required to control the spread of this deadly virus. In 2009, the results from a phase 3 trial (RV144) of a vaccine consisting of a combination of a canarypox vector expressing HIV-1 immunogens and a recombinant HIV-1 envelope protein offered some hope, as the vaccine showed modest efficacy in preventing HIV-1 infection (31.2%) in a Thai population. Barton Haynes et al.(1) have now performed a case-control analysis to investigate the immune correlates of protection provided by this vaccine. They found that IgG antibody binding of the variable regions 1 and 2 (V1 and V2) of the HIV-1 envelope (Env) glycoprotein 120 inversely correlated with the rate of HIV-1 infection, and plasma IgA antibody binding to Env directly correlated with the rate of infection. We asked three experts to comment on how these results affect our understanding of immune-mediated protection from HIV and how they might be used to design future vaccine strategies against this virus. [GRAPHICS] .						Davenport, Miles/0000-0002-4751-1831				Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Doria-Rose NA, 2012, J VIROL, V86, P3393, DOI 10.1128/JVI.06745-11; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012	10	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1020	1021		10.1038/nm.2858	http://dx.doi.org/10.1038/nm.2858			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772554				2022-12-25	WOS:000306121600026
J	Hughes, T; Coit, P; Adler, A; Yilmaz, V; Aksu, K; Duzgun, N; Keser, G; Cefle, A; Yazici, A; Ergen, A; Alpsoy, E; Salvarani, C; Casali, B; Kotter, I; Gutierrez-Achury, J; Wijmenga, C; Direskeneli, H; Saruhan-Direskeneli, G; Sawalha, AH				Hughes, Travis; Coit, Patrick; Adler, Adam; Yilmaz, Vuslat; Aksu, Kenan; Duzgun, Nursen; Keser, Gokhan; Cefle, Ayse; Yazici, Ayten; Ergen, Andac; Alpsoy, Erkan; Salvarani, Carlo; Casali, Bruno; Koetter, Ina; Gutierrez-Achury, Javier; Wijmenga, Cisca; Direskeneli, Haner; Saruhan-Direskeneli, Guher; Sawalha, Amr H.			Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GENOME-WIDE ASSOCIATION; CLASS-I; GENETIC ASSOCIATION; IL23R-IL12RB2; ALLELES; IL10; MHC	Behcet's disease is an inflammatory disease characterized by recurrent oral and genital ulcers and significant organ involvement. Localizing the genetic association between HLA-B*51 and Behcet's disease and exploring additional susceptibility loci in the human leukocyte antigen (HLA) region are complicated by the strong linkage disequilibrium in this region. We genotyped 8,572 variants in the extended HLA locus and carried out imputation and meta-analysis of 24,834 variants in 2 independent Behcet's disease cohorts from 2 ancestry groups. Genotyped SNPs were used to infer classical HLA alleles in the HLA-A, HLA-B, HLA-C, HLA-DQA1, HLA-DQB1 and HLA-DRB1 loci. Our data suggest that the robust HLA-B*51 association in Behcet's disease is explained by a variant located between the HLA-B and MICA genes (rs116799036: odds ratio (OR) = 3.88, P = 9.42 x 10(-5)). Three additional independent genetic associations within PSORS1C1 (rs12525170: OR = 3.01, P = 3.01 x 10(-26)), upstream of HLA-F-AS1 (rs114854070: OR = 1.95, P = 7.84 x 10(-14)) and with HLA-Cw*1602 (OR = 5.38, P = 6.07 x 10(-18)) were also identified and replicated.	[Hughes, Travis; Coit, Patrick; Sawalha, Amr H.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Adler, Adam] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Yilmaz, Vuslat; Saruhan-Direskeneli, Guher] Istanbul Univ, Istanbul Sch Med, Dept Physiol, Istanbul, Turkey; [Aksu, Kenan; Keser, Gokhan] Ege Univ, Sch Med, Dept Rheumatol, Izmir, Turkey; [Duzgun, Nursen] Ankara Univ, Fac Med, Dept Rheumatol, TR-06100 Ankara, Turkey; [Cefle, Ayse; Yazici, Ayten] Kocaeli Univ, Sch Med, Dept Rheumatol, Kocaeli, Turkey; [Ergen, Andac] Okmeydani Res & Educ Hosp, Ophthalmol Clin, Istanbul, Turkey; [Alpsoy, Erkan] Akdeniz Univ, Sch Med, Dept Dermatol, TR-07058 Antalya, Turkey; [Salvarani, Carlo] Azienda Osped Arcispedale Santa Maria Nuova, Ist Ricovero & Cura Carattere Sci, Dept Internal Med, Rheumatol Unit, Reggio Emilia, Italy; [Casali, Bruno] Azienda Osped Arcispedale Santa Maria Nuova, Ist Ricovero & Cura Carattere Sci, Mol Biol Lab, Reggio Emilia, Italy; [Koetter, Ina] Univ Tubingen Hosp, Dept Internal Med 2, Tubingen, Germany; [Gutierrez-Achury, Javier; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Direskeneli, Haner] Marmara Univ, Sch Med, Dept Rheumatol, Istanbul, Turkey	University of Michigan System; University of Michigan; Oklahoma Medical Research Foundation; Istanbul University; Ege University; Ankara University; Kocaeli University; Istanbul Okmeydani Training & Research Hospital; Akdeniz University; IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Groningen; Marmara University	Sawalha, AH (corresponding author), Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA.	asawalha@umich.edu	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Direskeneli, Haner/AAS-5508-2020; Keser, Gokhan/I-4282-2019; Koetter, Ina/O-3121-2019; Cefle, Ayse/AAT-3653-2020; Yazıcı, Ayten/AAT-3636-2020; ALPSOY, ERKAN/C-1183-2016; zhang, jun/D-7782-2015; YILMAZ, VUSLAT/AAB-9205-2020; Salvarani, Carlo/K-2431-2018	Wijmenga, Cisca/0000-0002-5635-1614; Koetter, Ina/0000-0002-9262-005X; Yazıcı, Ayten/0000-0003-2167-4509; ALPSOY, ERKAN/0000-0001-7049-0170; Coit, Patrick/0000-0003-0660-764X; Gutierrez-Achury, Javier/0000-0002-4971-1474; aksu, kenan/0000-0001-8889-2688; Salvarani, Carlo/0000-0001-5426-5133	Rheumatology Research Foundation's Rheumatology Investigator award; Celiac Disease Consortium; Dutch government [BSIK03009]; Netherlands Organization for Scientific Research (NWO-VICI grant) [918.66.620]	Rheumatology Research Foundation's Rheumatology Investigator award; Celiac Disease Consortium; Dutch government; Netherlands Organization for Scientific Research (NWO-VICI grant)(Netherlands Organization for Scientific Research (NWO))	Funding for this project was provided by the Rheumatology Research Foundation's Rheumatology Investigator award to A.H.S. Genotyping of the Italian controls has been made possible by grants from the Celiac Disease Consortium (an innovative cluster approved by the Netherlands Genomics Initiative and partly funded by the Dutch government, grant BSIK03009 to C.W.) and the Netherlands Organization for Scientific Research (NWO-VICI grant 918.66.620 to C.W.).	Bettencourt A, 2008, TISSUE ANTIGENS, V72, P379, DOI 10.1111/j.1399-0039.2008.01087.x; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Kaburaki T, 2010, CLIN EXP RHEUMATOL, V28, pS39; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mizuki N, 2000, INVEST OPHTH VIS SCI, V41, P3702; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Mizuki N, 2007, JPN J OPHTHALMOL, V51, P431, DOI 10.1007/s10384-007-0473-y; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Ota M, 1999, AM J HUM GENET, V64, P1406, DOI 10.1086/302364; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sanz L, 1998, TISSUE ANTIGENS, V51, P111, DOI 10.1111/j.1399-0039.1998.tb02955.x; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998	14	106	108	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					319	324		10.1038/ng.2551	http://dx.doi.org/10.1038/ng.2551			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23396137				2022-12-25	WOS:000315664800019
J	Reynolds, A; Qiao, HY; Yang, Y; Chen, JK; Jackson, N; Biswas, K; Holloway, JK; Baudat, F; de Massy, B; Wang, J; Hoog, C; Cohen, PE; Hunter, N				Reynolds, April; Qiao, Huanyu; Yang, Ye; Chen, Jefferson K.; Jackson, Neil; Biswas, Kajal; Holloway, J. Kim; Baudat, Frederic; de Massy, Bernard; Wang, Jeremy; Hoog, Christer; Cohen, Paula E.; Hunter, Neil			RNF212 is a dosage-sensitive regulator of crossing-over during mammalian meiosis	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; SYNAPTONEMAL COMPLEX-FORMATION; MEIOTIC RECOMBINATION; CHROMOSOME SYNAPSIS; MOUSE SPERMATOCYTES; HOLLIDAY JUNCTIONS; HUMAN ANEUPLOIDY; MICE LACKING; FEMALE MICE; CROSSOVER	Crossing-over ensures accurate chromosome segregation during meiosis, and every pair of chromosomes obtains at least one crossover, even though the majority of recombination sites yield non-crossovers. A putative regulator of crossing-over is RNF212, which is associated with variation in crossover rates in humans. We show that mouse RNF212 is essential for crossing-over, functioning to couple chromosome synapsis to the formation of crossover-specific recombination complexes. Selective localization of RNF212 to a subset of recombination sites is shown to be a key early step in the crossover designation process. RNF212 acts at these sites to stabilize meiosis-specific recombination factors, including the MutS gamma complex (MSH4-MSH5). We infer that selective stabilization of key recombination proteins is a fundamental feature of meiotic crossover control. Haploinsufficiency indicates that RNF212 is a limiting factor for crossover control and raises the possibility that human alleles may alter the amount or stability of RNF212 and be risk factors for aneuploid conditions.	[Reynolds, April; Qiao, Huanyu; Yang, Ye; Chen, Jefferson K.; Jackson, Neil; Biswas, Kajal; Hunter, Neil] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA; [Reynolds, April; Qiao, Huanyu; Yang, Ye; Chen, Jefferson K.; Jackson, Neil; Biswas, Kajal; Hunter, Neil] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Holloway, J. Kim; Cohen, Paula E.] Cornell Univ, Dept Biomed Sci, Ctr Reprod Genom, Ithaca, NY USA; [Baudat, Frederic; de Massy, Bernard] CNRS, Inst Genet Humaine, Montpellier, France; [Wang, Jeremy] Univ Penn, Dept Anim Biol, Ctr Anim Transgenesis & Germ Cell Res, Philadelphia, PA 19104 USA; [Hoog, Christer] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Hunter, Neil] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of California System; University of California Davis; University of California System; University of California Davis; Cornell University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Pennsylvania; Karolinska Institutet; University of California System; University of California Davis; University of California System; University of California Davis	Hunter, N (corresponding author), Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA.	nhunter@ucdavis.edu	Yang, Ye/C-8397-2011	Biswas, Kajal/0000-0003-2645-9349; Qiao, Huanyu/0000-0003-0966-8077; Baudat, Frederic/0000-0003-2415-8366	CNRS; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche [ANR-09-BLAN-0269-01]; US National Institutes of Health (NIH) [R01GM084955]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041012] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD041012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084955] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Heyting (Wageningen University) for antibodies to SYCP1 and SYCP3, S. Keeney and M. Jasin (Memorial Sloan-Kettering Cancer Center) for Spo11 knockout mice, M. Paddy for help with SIM imaging, J. Trimmer for help with imaging tissue sections and G. Coop for discussions. Knockout mice were generated in collaboration with the University of California, Davis, Mouse Biology Program (MBP). B.d.M. is supported by grants from the CNRS, Association pour la Recherche sur le Cancer and Agence Nationale de la Recherche (ANR-09-BLAN-0269-01). This work was supported by US National Institutes of Health (NIH) grant R01GM084955 to N.H. N.H. is an Early Career Scientist of the Howard Hughes Medical Institute.	Adelman CA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000042; Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 2005, CYTOGENET GENOME RES, V109, P198, DOI 10.1159/000082400; Anderson LK, 1999, GENETICS, V151, P1569; Ashley T, 2001, J CELL SCI, V114, P685; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bhalla N, 2008, ANNU REV CELL DEV BI, V24, P397, DOI 10.1146/annurev.cellbio.23.090506.123245; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9; Chelysheva L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002799; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Cobb J, 1999, DEV BIOL, V205, P49, DOI 10.1006/dbio.1998.9101; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hirose Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001329; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jantsch V, 2004, MOL CELL BIOL, V24, P7998, DOI 10.1128/MCB.24.18.7998-8006.2004; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kan R, 2008, BIOL REPROD, V78, P462, DOI 10.1095/biolreprod.107.065771; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; MacQueen AJ, 2009, CURR BIOL, V19, P1519, DOI 10.1016/j.cub.2009.08.048; Marcon E, 2003, GENETICS, V165, P2283; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; Moens PB, 2007, J CELL SCI, V120, P1017, DOI 10.1242/jcs.03394; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nabeshima K, 2005, J CELL BIOL, V168, P683, DOI 10.1083/jcb.200410144; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Otto SP, 2011, TRENDS GENET, V27, P358, DOI 10.1016/j.tig.2011.05.001; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sakuno T, 2011, DEV CELL, V21, P534, DOI 10.1016/j.devcel.2011.08.012; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Singh MK, 2007, ONCOGENE, V26, P4825, DOI 10.1038/sj.onc.1210282; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Strong ER, 2010, GENES-BASEL, V1, P440, DOI 10.3390/genes1030440; Terribas E, 2010, J ANDROL, V31, P346, DOI 10.2164/jandrol.109.008805; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Xu KQ, 2010, CLIN CHIM ACTA, V411, P49, DOI 10.1016/j.cca.2009.09.038; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	81	148	151	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					269	278		10.1038/ng.2541	http://dx.doi.org/10.1038/ng.2541			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23396135	Green Accepted			2022-12-25	WOS:000315664800010
J	Dendrou, CA; Bell, JI; Fugger, L				Dendrou, Calliope A.; Bell, John I.; Fugger, Lars			Weighing in on autoimmune disease	NATURE MEDICINE			English	Editorial Material							ANKYLOSING-SPONDYLITIS; SUSCEPTIBILITY LOCI; PSORIASIS	Modern medicine keeps unraveling new ways to investigate autoimmunity, leading to the production of boundless amounts of genetic, cellular and imaging data. Although the precision with which this information can define the etiology and mechanisms of a particular autoimmune disease is encouraging, much work lies ahead until all the knowledge acquired can be translated into the clinic. In 'Bedside to Bench', Calliope A. Dendrou, John I. Bell and Lars Fugger discuss the promises and limitations of genome-wide and next-generation genetic studies to provide further understanding of mechanisms driving autoimmune disorders and the role of experimental medicine in the new era of integrative clinical practice and personalized medicine. In 'Bench to Bedside', Lawrence Steinman argues the concept of a 'hub and spoke' pattern of T cell activation and organ targeting in multiple sclerosis, inflammatory bowel disease and type 1 diabetes. This paradigm suggests new ways to develop drugs to keep autoreactive T cells in the organ where activation occurs and preclude them from reaching the target organ and cause disease.	[Dendrou, Calliope A.; Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford, England; [Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council,Human Immunol Unit, Oxford OX3 9DU, England; [Fugger, Lars] Skejby Sygehus, Aarhus Univ Hosp, Inst Clin, DK-8200 Aarhus, Denmark	University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; Aarhus University	Dendrou, CA (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	lars.fugger@imm.ox.ac.uk		Dendrou, Calliope/0000-0003-1179-4021	Medical Research Council [G1000800i] Funding Source: researchfish; Medical Research Council [G1000800I] Funding Source: Medline; Wellcome Trust [100308] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Cortes A, 2012, ARTHRITIS RHEUM-US, V64, pS1053; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Klareskog L, 2010, ANN RHEUM DIS, V69, P2062, DOI 10.1136/ard.2010.142109; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lewis T., 1944, LANCET, V243, P649; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	12	7	7	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					138	139		10.1038/nm.3087	http://dx.doi.org/10.1038/nm.3087			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389608				2022-12-25	WOS:000314675900020
J	Khan, LA; Zhang, HJ; Abraham, N; Sun, L; Fleming, JT; Buechner, M; Hall, DH; Gobel, V				Khan, Liakot A.; Zhang, Hongjie; Abraham, Nessy; Sun, Lei; Fleming, John T.; Buechner, Matthew; Hall, David H.; Gobel, Verena			Intracellular lumen extension requires ERM-1-dependent apical membrane expansion and AQP-8-mediated flux	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; EXCRETORY CELL; WATER CHANNEL; ERM PROTEINS; C. ELEGANS; IN-VIVO; EZRIN; AQUAPORINS; MORPHOGENESIS; GENE	Many unicellular tubes such as capillaries form lumens intracellularly, a process that is not well understood. Here we show that the cortical membrane organizer ERM-1 is required to expand the intracellular apical/lumenal membrane and its actin undercoat during single-cell Caenorhabditis elegans excretory canal morphogenesis. We characterize AQP-8, identified in an ERM-1-overexpression (ERM-1[++]) suppressor screen, as a canalicular aquaporin that interacts with ERM-1 in lumen extension in a mercury-sensitive manner, implicating water-channel activity. AQP-8 is transiently recruited to the lumen by ERM-1, co-localizing in peri-lumenal cuffs interspaced along expanding canals. An ERM-1[++]-mediated increase in the number of lumen-associated canaliculi is reversed by AQP-8 depletion. We propose that the ERM-1/AQP-8 interaction propels lumen extension by translumenal flux, suggesting a direct morphogenetic effect of water-channel-regulated fluid pressure.	[Khan, Liakot A.; Zhang, Hongjie; Abraham, Nessy; Fleming, John T.; Gobel, Verena] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Khan, Liakot A.; Zhang, Hongjie; Abraham, Nessy; Fleming, John T.; Gobel, Verena] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Buechner, Matthew] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Sun, Lei; Hall, David H.] Albert Einstein Coll Med, Ctr C Elegans Anat, Dept Neurosci, Bronx, NY 10461 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Kansas; Yeshiva University; Albert Einstein College of Medicine	Gobel, V (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.	gobel@helix.mgh.harvard.edu		Zhang, Hongjie/0000-0002-1474-5658	NIH [GM078653]; Mattina R. Proctor Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078653] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mattina R. Proctor Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Bailie (Simon Fraser University, Burnaby, British Columbia, Canada), M. Futai (Osaka University, Osaka, Japan), M. Labouesse (IGBMC, France), K. Nehrke (University of Rochester Medical Center, Rochester New York, USA) and J. Simske (Case Western Reserve University School of Medicine, Cleveland, Ohio, USA), and the following C. elegans resource centres: J. Kohara (National Institute of Genetics, Mishima, Japan), S. Mitani (National Bioresource Project, Tokyo Women's Medical University, Tokyo, Japan), the International C. elegans Gene Knockout Consortium and the Caenorhabditis elegans genetic centre (NIH Center for Research Resources) for providing plasmids and strains. We thank E. Membreno and D. Fernandez for technical support, A. Sengupta for three-dimensional graphics, A. Kim for image editing, F. Solomon for critical reading of the manuscript, and H. Weinstein and A. Walker for ongoing support. This work was supported by NIH grant GM078653 and a Mattina R. Proctor Award to V.G.	Abdus-Saboor I, 2011, DEVELOPMENT, V138, P3545, DOI 10.1242/dev.068148; Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Bagnat M, 2010, CURR BIOL, V20, P1840, DOI 10.1016/j.cub.2010.09.012; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chen Y, 2012, J AM SOC NEPHROL, V23, P1506, DOI 10.1681/ASN.2012010079; Cheong HI, 2005, J KOREAN MED SCI, V20, P1076, DOI 10.3346/jkms.2005.20.6.1076; Chirivino D, 2011, MOL BIOL CELL, V22, P375, DOI 10.1091/mbc.E10-09-0796; Cho SJ, 2002, P NATL ACAD SCI USA, V99, P4720, DOI 10.1073/pnas.072083499; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Deretic D, 2004, MOL BIOL CELL, V15, P359, DOI 10.1091/mbc.E03-04-0203; DESMOND ME, 1977, DEV BIOL, V57, P188, DOI 10.1016/0012-1606(77)90364-5; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Fujita M, 2003, DEV BIOL, V256, P290, DOI 10.1016/S0012-1606(03)00040-X; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Hachez C, 2010, ADV EXP MED BIOL, V679, P1; Hahn-Windgassen A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000553; Hall DH., 2008, C ELEGANS ATLAS; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; JONES SJM, 1995, MOL GEN GENET, V248, P719, DOI 10.1007/BF02191712; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kerman BE, 2008, DEV BIOL, V320, P278, DOI 10.1016/j.ydbio.2008.05.541; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kolotuev I., 2013, NAT CELL BIOL; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Krupinski T, 2009, PHYSIOLOGY, V24, P192, DOI 10.1152/physiol.00008.2009; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Liu JL, 2011, J CELL SCI, V124, P198, DOI 10.1242/jcs.072652; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; Mah AK, 2007, J BIOL CHEM, V282, P28074, DOI 10.1074/jbc.M703305200; Mattingly BC, 2011, DEV BIOL, V359, P59, DOI 10.1016/j.ydbio.2011.08.011; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Nozaki K, 2008, PFLUG ARCH EUR J PHY, V456, P701, DOI 10.1007/s00424-007-0373-5; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schottenfeld-Roames J, 2012, NAT CELL BIOL, V14, P386, DOI 10.1038/ncb2454; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Sugiya H, 2008, J CELL MOL MED, V12, P1486, DOI 10.1111/j.1582-4934.2008.00239.x; Suzuki N, 2001, EMBO REP, V2, P530, DOI 10.1093/embo-reports/kve110; Tamma G, 2005, J CELL SCI, V118, P3623, DOI 10.1242/jcs.02495; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Tatsumi K, 2009, FEBS LETT, V583, P2077, DOI 10.1016/j.febslet.2009.05.035; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Tung JJ, 2009, ANGIOGENESIS, V12, P209, DOI 10.1007/s10456-009-9139-3; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Wang Z, 2011, INVEST OPHTH VIS SCI, V52, P5079, DOI 10.1167/iovs.10-6998; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200; Zhu LX, 2010, AM J PHYSIOL-CELL PH, V299, pC431, DOI 10.1152/ajpcell.00090.2010	65	61	63	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2013	15	2					143	156		10.1038/ncb2656	http://dx.doi.org/10.1038/ncb2656			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	088SF	23334498	Green Submitted, Green Accepted			2022-12-25	WOS:000314856700006
J	Xue, B; Krishnamurthy, K; Allred, DC; Muthuswamy, SK				Xue, Bin; Krishnamurthy, Kannan; Allred, D. Craig; Muthuswamy, Senthil K.			Loss of Par3 promotes breast cancer metastasis by cornpromising cell-cell cohesion	NATURE CELL BIOLOGY			English	Article							POLARITY PROTEIN PAR-3; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; TIGHT JUNCTION; EXCHANGE FACTOR; RHO-GTPASE; RAC; ACTIN; ADHESION; ESTABLISHMENT	The mechanisms by which tumour cells metastasize and the role that cell polarity proteins play in this process are not well understood. We report that partitioning defective protein 3 (Par3) is dysregulated in metastasis in human breast cancer, and is associated with a higher tumour grade and ErbB2-positive status. Downregulation of Par3 cooperated with ErbB2 to induce cell invasion and metastasis in vivo. Interestingly, the metastatic behaviour was not associated with an overt mesenchymal phenotype. However, loss of Par3 inhibited E-cadherin junction stability, disrupted membrane and actin dynamics at cell-cell junctions and decreased cell-cell cohesion in a manner dependent on the Tiam1/Rac-GTP pathway. Inhibition of this pathway restored E-cadherin junction stability and blocked invasive behaviour of cells lacking Par3, suggesting that loss of Par3 promotes metastatic behaviour of ErbB2-induced tumour epithelial cells by decreasing cell-cell cohesion.	[Xue, Bin; Krishnamurthy, Kannan; Muthuswamy, Senthil K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Xue, Bin; Muthuswamy, Senthil K.] SUNY Stony Brook, Dept Mol & Cellular Biol, Stony Brook, NY 11974 USA; [Allred, D. Craig] Washington Univ Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Muthuswamy, Senthil K.] Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Muthuswamy, SK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	s.muthuswamy@utoronto.ca	Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634; Xue, Bin/0000-0002-5472-1300	DOD [CA098830, BC075024]; Rita Allen Foundation; Ontario Ministry of Health and Long Term Care; Campbell Family Institute for Breast cancer research; NATIONAL CANCER INSTITUTE [R56CA098830, R01CA098830] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Rita Allen Foundation; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Campbell Family Institute for Breast cancer research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank W. J. Muller (McGill University, Canada) for the NDL transgenic mice, I. Macara (Univ of Virginia, USA) for the Tiam1 cDNA, M. Matsuda (Kyoto University, Japan) for the Raichu-Rac plasmid and D. Barber (UCSF, USA) for sharing the anti-ARPC2 antibody. We thank J. Haynes for critical reading of the manuscript and M. Egeblad and R. Sordella for helpful comments. We thank S. Hearn for assistance with microscopy and C. Camaxcla for assistance with the graphic abstract. We thank members of the Muthuswamy laboratory for critical comments on the manuscripts and insightful discussions. This work was supported by CA098830, BC075024, Era of Hope Scholar award from DOD Breast Cancer Research Program; Rita Allen Foundation, Lee K Margaret Lau Chair for breast cancer research and Campbell Family Institute for Breast cancer research to S.K.M. This was also financially supported in part by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC.	Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Benard V, 2002, METHOD ENZYMOL, V345, P349; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; DSOUZA B, 1994, P NATL ACAD SCI USA, V91, P7202, DOI 10.1073/pnas.91.15.7202; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gomes JE, 2002, CURR BIOL, V12, pR444, DOI 10.1016/S0960-9822(02)00939-9; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Iwaya K, 2007, MODERN PATHOL, V20, P339, DOI 10.1038/modpathol.3800741; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; KIRBY C, 1990, DEV BIOL, V142, P203, DOI 10.1016/0012-1606(90)90164-E; Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006; LAMPKIN SR, 1990, J HISTOTECHNOL, V13, P121, DOI 10.1179/his.1990.13.2.121; Ling C, 2010, GENE DEV, V24, P947, DOI 10.1101/gad.1896810; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Mizutani K, 2002, CANCER RES, V62, P669; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020	58	121	125	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2013	15	2					189	200		10.1038/ncb2663	http://dx.doi.org/10.1038/ncb2663			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	088SF	23263278	Green Accepted			2022-12-25	WOS:000314856700010
J	Jiang, DK; Sun, JL; Cao, GW; Liu, Y; Lin, DX; Gao, YZ; Ren, WH; Long, XD; Zhang, HX; Ma, XP; Wang, Z; Jiang, W; Chen, TY; Gao, Y; Sun, LD; Long, JR; Huang, HX; Wang, D; Yu, HJ; Zhang, PY; Tang, LS; Peng, B; Cai, H; Liu, TT; Zhou, P; Liu, F; Lin, XL; Tao, S; Wan, B; Sai-Yin, HXG; Qin, LX; Yin, JH; Liu, L; Wu, C; Pei, Y; Zhou, YF; Zhai, Y; Lu, PX; Tan, AH; Zuo, XB; Fan, J; Chang, J; Gu, XL; Wang, NJ; Li, Y; Liu, YK; Zhai, K; Zhang, HW; Hu, ZB; Liu, J; Yi, Q; Xiang, YB; Shi, R; Ding, Q; Zheng, W; Shu, XO; Mo, ZN; Shugart, YY; Zhang, XJ; Zhou, GQ; Shen, HB; Zheng, SL; Xu, JF; Yu, L				Jiang, De-Ke; Sun, Jielin; Cao, Guangwen; Liu, Yao; Lin, Dongxin; Gao, Yu-Zhen; Ren, Wei-Hua; Long, Xi-Dai; Zhang, Hongxing; Ma, Xiao-Pin; Wang, Zhong; Jiang, Wei; Chen, Tao-Yang; Gao, Yong; Sun, Liang-Dan; Long, Ji-Rong; Huang, Hui-Xing; Wang, Dan; Yu, Hongjie; Zhang, Pengyin; Tang, Li-Sha; Peng, Bo; Cai, Hao; Liu, Ting-Ting; Zhou, Ping; Liu, Fang; Lin, Xiaoling; Tao, Sha; Wan, Bo; Sai-Yin, He-Xi Ge; Qin, Lun-Xiu; Yin, Jianhua; Liu, Li; Wu, Chen; Pei, Yan; Zhou, Yuan-Feng; Zhai, Yun; Lu, Pei-Xin; Tan, Aihua; Zuo, Xian-Bo; Fan, Jia; Chang, Jiang; Gu, Xiaoli; Wang, Neng-Jin; Li, Yang; Liu, Yin-Kun; Zhai, Kan; Zhang, Hongwei; Hu, Zhibin; Liu, Jun; Yi, Qing; Xiang, Yongbing; Shi, Rong; Ding, Qiang; Zheng, Wei; Shu, Xiao-Ou; Mo, Zengnan; Shugart, Yin Yao; Zhang, Xue-Jun; Zhou, Gangqiao; Shen, Hongbing; Zheng, S. Lilly; Xu, Jianfeng; Yu, Long			Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY BILIARY-CIRRHOSIS; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCUS; INTERFERON-GAMMA; VIRAL-INFECTION; POPULATION; ALLELES; CHINESE	To identify genetic susceptibility loci for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in the Chinese population, we carried out a genome-wide association study (GWAS) in 2,514 chronic HBV carriers (1,161 HCC cases and 1,353 controls) followed by a 2-stage validation among 6 independent populations of chronic HBV carriers (4,319 cases and 4,966 controls). The joint analyses showed that HCC risk was significantly associated with two independent loci: rs7574865 at STAT4, P-meta = 2.48 x 10(-10), odds ratio (OR) = 1.21; and rs9275319 at HLA-DQ, P-meta = 2.72 x 10(-17), OR = 1.49. The risk allele G at rs7574865 was significantly associated with lower mRNA levels of STAT4 in both the HCC tissues and nontumor tissues of 155 individuals with HBV-related HCC (P-trend = 0.0008 and 0.0002, respectively). We also found significantly lower mRNA expression of STAT4 in HCC tumor tissues compared with paired adjacent nontumor tissues (P = 2.33 x 10(-14)).	[Jiang, De-Ke; Ren, Wei-Hua; Ma, Xiao-Pin; Jiang, Wei; Huang, Hui-Xing; Wang, Dan; Tang, Li-Sha; Peng, Bo; Cai, Hao; Liu, Ting-Ting; Zhou, Ping; Wan, Bo; Sai-Yin, He-Xi Ge; Liu, Jun; Yi, Qing] Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China; [Sun, Jielin; Wang, Zhong; Tao, Sha; Zheng, S. Lilly; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Cao, Guangwen; Yin, Jianhua; Zhang, Hongwei] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Liu, Yao; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Peoples R China; [Liu, Yao; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China; [Liu, Yao; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Sch Publ Hlth, Nanjing, Peoples R China; [Lin, Dongxin; Wu, Chen; Chang, Jiang; Zhai, Kan] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Lin, Dongxin; Wu, Chen; Chang, Jiang; Zhai, Kan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gao, Yu-Zhen] Soochow Univ, Dept Forens Med, Coll Med, Suzhou, Peoples R China; [Ren, Wei-Hua; Pei, Yan] Henan Univ Sci & Technol, Dept Surg, Affiliated Hosp 1, Luoyang, Peoples R China; [Long, Xi-Dai; Zhou, Yuan-Feng] Youjiang Med Coll Nationalities, Dept Pathol, Baise, Peoples R China; [Zhang, Hongxing; Zhai, Yun; Gu, Xiaoli; Zhou, Gangqiao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Chen, Tao-Yang; Lu, Pei-Xin; Wang, Neng-Jin] Qidong Liver Canc Inst, Qidong, Peoples R China; [Gao, Yong; Tan, Aihua; Mo, Zengnan] Guangxi Med Univ, Inst Urol & Nephrol, Affiliated Hosp 1, Nanning, Peoples R China; [Gao, Yong; Tan, Aihua; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China; [Gao, Yong; Yu, Hongjie; Zhang, Pengyin; Liu, Fang; Lin, Xiaoling; Xu, Jianfeng] Fudan Univ, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Sun, Liang-Dan; Zuo, Xian-Bo; Li, Yang; Zhang, Xue-Jun] Anhui Med Univ, Inst Dermatol, Hefei, Peoples R China; [Sun, Liang-Dan; Zuo, Xian-Bo; Li, Yang; Zhang, Xue-Jun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei, Peoples R China; [Sun, Liang-Dan; Zuo, Xian-Bo; Li, Yang; Zhang, Xue-Jun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Peoples R China; [Long, Ji-Rong] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Epidemiol Ctr,Vanderbilt Ingram Canc C, Nashville, TN 37212 USA; [Qin, Lun-Xiu; Fan, Jia; Liu, Yin-Kun] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Qin, Lun-Xiu; Fan, Jia; Liu, Yin-Kun] Fudan Univ, Dept Liver Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Liu, Li] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Peoples R China; [Liu, Jun] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yi, Qing] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Yi, Qing] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Yi, Qing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Xiang, Yongbing] Shanghai Canc Inst, Shanghai, Peoples R China; [Shi, Rong] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Ding, Qiang] Fudan Univ, Fudan Inst Urol, Huashan Hosp, Shanghai 200433, Peoples R China; [Shugart, Yin Yao] NIMH, Unit Stat Genom, Div Intramural Res Program, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Wake Forest University; Wake Forest Baptist Medical Center; Naval Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Soochow University - China; Henan University of Science & Technology; Youjiang Medical University for Nationalities; Academy of Military Medical Sciences - China; Guangxi Medical University; Guangxi Medical University; Fudan University; Anhui Medical University; Anhui Medical University; Vanderbilt University; Fudan University; Fudan University; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Fudan University	Yu, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China.	jxu@wfubmc.edu; longyu@fudan.edu.cn	Wan, Bo/AAE-6352-2021; zhang, weihua/GXV-1334-2022; Yu, Hongjie/GZK-5351-2022; Fan, Jia/C-6689-2017; Jiang, Deke/M-6945-2013; Zheng, Wei/O-3351-2013; Chen, Gang/G-2722-2010	Zheng, Wei/0000-0003-1226-070X; Cao, Guangwen/0000-0002-8094-1278; YAO, YIN/0000-0003-3053-8429; Long, Jirong/0000-0002-7433-9766; Saiyin, Hexige/0000-0003-2993-6817; Wu, Chen/0000-0003-4954-1011; mo, zengnan/0000-0002-3047-3138; Zhou, Ping/0000-0002-5792-6790; Lin, Dongxin/0000-0002-8723-8868; Wan, Bo/0000-0002-6724-4718; Shen, Hongbing/0000-0002-2581-5906; Jiang, Deke/0000-0002-7888-2344	National Natural Science Foundation of China for Creative Research Groups [30024001]; National Key Sci-Tech Special Project of China [2013ZX10002010, 2008ZX10002-020]; Shanghai Municipal Science and Technology Commission; National Natural Science Foundation of China [31071193, 31100895, 30800946]; Director Foundation of the State Key Laboratory of Genetic Engineering; Fund from X.-J. Qu and Chang-An Capital of Beijing; Fund from S.-J. Yan and Tianying S. T. Group of Jiangsu; MOE Foundation of Cheung Kong Scholars Program; Huashan Hospital, Fudan University; Fudan-VARI Center for Genetic Epidemiology, Fudan University; Foundation for the Author of National Excellent Doctoral Dissertation [201081]; Program for New Century Excellent Talents in University [NCET-10-0178]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE [R37CA070867, R01CA082729] Funding Source: NIH RePORTER	National Natural Science Foundation of China for Creative Research Groups(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Director Foundation of the State Key Laboratory of Genetic Engineering; Fund from X.-J. Qu and Chang-An Capital of Beijing; Fund from S.-J. Yan and Tianying S. T. Group of Jiangsu; MOE Foundation of Cheung Kong Scholars Program; Huashan Hospital, Fudan University; Fudan-VARI Center for Genetic Epidemiology, Fudan University; Foundation for the Author of National Excellent Doctoral Dissertation(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the subjects who participated in this study. We also thank Y. Shi and L. He from Bio-X Institutes of Shanghai Jiao Tong University for helping with data analysis of typical Chinese population control subjects, and L. Jin, Y. Zhong, H.-H. Wang and W.-Y. Yan from the School of Life Sciences of Fudan University and H.-B. Shu from College of Life Sciences of Wuhan University for suggestions on this study. The study is supported by the National Natural Science Foundation of China for Creative Research Groups (30024001 to L. Y.), the National Key Sci-Tech Special Project of China (2013ZX10002010 and 2008ZX10002-020 to L. Y.), the Project of the Shanghai Municipal Science and Technology Commission (to L. Y.), the National Natural Science Foundation of China (31071193 to L. Y. and 31100895 to D.-K.J.), Director Foundation of the State Key Laboratory of Genetic Engineering (to L. Y.), the Fund from X.-J. Qu and Chang-An Capital of Beijing (to L. Y.), the Fund from S.-J. Yan and Tianying S. T. Group of Jiangsu (to L. Y.), MOE Foundation of Cheung Kong Scholars Program (to J.L. and Q. Y.), an intramural research grant from Huashan Hospital, Fudan University (to J.X.) and an intramural research grant from Fudan-VARI Center for Genetic Epidemiology, Fudan University (to J.X.). This work is partly funded by the National Natural Science Foundation of China (30800946 to H. S.), Foundation for the Author of National Excellent Doctoral Dissertation (201081 to H. S.), the Program for New Century Excellent Talents in University (NCET-10-0178 to H. S.), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (to H.S.).	Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Budhu A, 2011, J HEPATOL, V54, P823, DOI 10.1016/j.jhep.2010.10.035; Casper Markus, 2011, Hepatology, V53, P1390, DOI 10.1002/hep.24241; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Chen JS, 2007, J CLIN VIROL, V38, P238, DOI 10.1016/j.jcv.2006.12.007; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Li J, 2011, TISSUE ANTIGENS, V78, P267, DOI 10.1111/j.1399-0039.2011.01731.x; Liu C, 2007, INT J IMMUNOGENET, V34, P373, DOI 10.1111/j.1744-313X.2007.00702.x; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Long XD, 2010, HEPATOLOGY, V52, P1301, DOI 10.1002/hep.23807; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Schwarting A, 1999, J IMMUNOL, V163, P6884; SHEN FM, 1991, AM J HUM GENET, V49, P88; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Xin YN, 2011, WORLD J GASTROENTERO, V17, P2248, DOI 10.3748/wjg.v17.i17.2248; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	45	228	248	2	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					72	U105		10.1038/ng.2483	http://dx.doi.org/10.1038/ng.2483			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23242368	Green Accepted			2022-12-25	WOS:000312838800015
J	Eyre, S; Bowes, J; Diogo, D; Lee, A; Barton, A; Martin, P; Zhernakova, A; Stahl, E; Viatte, S; McAllister, K; Amos, CI; Padyukov, L; Toes, REM; Huizinga, TWJ; Wijmenga, C; Trynka, G; Franke, L; Westra, HJ; Alfredsson, L; Hu, XL; Sandor, C; de Bakker, PIW; Davila, S; Khor, CC; Heng, KK; Andrews, R; Edkins, S; Hunt, SE; Langford, C; Symmons, D; Concannon, P; Onengut-Gumuscu, S; Rich, SS; Deloukas, P; Gonzalez-Gay, MA; Rodriguez-Rodriguez, L; Arlsetig, L; Martin, J; Rantapaa-Dahlqvist, S; Plenge, RM; Raychaudhuri, S; Klareskog, L; Gregersen, PK; Worthington, J				Eyre, Steve; Bowes, John; Diogo, Dorothee; Lee, Annette; Barton, Anne; Martin, Paul; Zhernakova, Alexandra; Stahl, Eli; Viatte, Sebastien; McAllister, Kate; Amos, Christopher I.; Padyukov, Leonid; Toes, Rene E. M.; Huizinga, Tom W. J.; Wijmenga, Cisca; Trynka, Gosia; Franke, Lude; Westra, Harm-Jan; Alfredsson, Lars; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Davila, Sonia; Khor, Chiea Chuen; Heng, Khai Koon; Andrews, Robert; Edkins, Sarah; Hunt, Sarah E.; Langford, Cordelia; Symmons, Deborah; Concannon, Pat; Onengut-Gumuscu, Suna; Rich, Stephen S.; Deloukas, Panos; Gonzalez-Gay, Miguel A.; Rodriguez-Rodriguez, Luis; Arlsetig, Lisbeth; Martin, Javier; Rantapaa-Dahlqvist, Solbritt; Plenge, Robert M.; Raychaudhuri, Soumya; Klareskog, Lars; Gregersen, Peter K.; Worthington, Jane		Biol Rheumatoid Arthrit Genetics G; Wellcome Trust Case Control Consor	High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis	NATURE GENETICS			English	Article							RISK LOCI; METAANALYSIS; ASSOCIATION; EXPRESSION	Using the Immunochip custom SNP array, which was designed for dense genotyping of 186 loci identified through genome-wide association studies (GWAS), we analyzed 11,475 individuals with rheumatoid arthritis (cases) of European ancestry and 15,870 controls for 129,464 markers. We combined these data in a meta-analysis with GWAS data from additional independent cases (n = 2,363) and controls (n = 17,872). We identified 14 new susceptibility loci, 9 of which were associated with rheumatoid arthritis overall and five of which were specifically associated with disease that was positive for anticitrullinated peptide antibodies, bringing the number of confirmed rheumatoid arthritis risk loci in individuals of European ancestry to 46. We refined the peak of association to a single gene for 19 loci, identified secondary independent effects at 6 loci and identified association to low-frequency variants at 4 loci. Bioinformatic analyses generated strong hypotheses for the causal SNP at seven loci. This study illustrates the advantages of dense SNP mapping analysis to inform subsequent functional investigations.	[Eyre, Steve; Bowes, John; Barton, Anne; Martin, Paul; Viatte, Sebastien; McAllister, Kate; Symmons, Deborah; Raychaudhuri, Soumya; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Diogo, Dorothee; Stahl, Eli; Trynka, Gosia; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Plenge, Robert M.; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Diogo, Dorothee; Stahl, Eli; Trynka, Gosia; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Plenge, Robert M.; Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Lee, Annette; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Zhernakova, Alexandra; Wijmenga, Cisca; Trynka, Gosia; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Zhernakova, Alexandra; Wijmenga, Cisca; Trynka, Gosia; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ, Hosp Solna, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Dept Environm Med, Stockholm, Sweden; [Hu, Xinli] Harvard Massachusetts Inst Technol Div Hlth Sci &, Boston, MA USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Davila, Sonia; Khor, Chiea Chuen; Heng, Khai Koon] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Andrews, Robert; Edkins, Sarah; Hunt, Sarah E.; Langford, Cordelia; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Concannon, Pat; Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Gonzalez-Gay, Miguel A.] Hosp Marques de Valdecilla, Inst Fdn Invest Marques de Valdecilla, Dept Rheumatol, Santander, Spain; [Arlsetig, Lisbeth; Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Arlsetig, Lisbeth; Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Rheumatol, Umea, Sweden; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Eyre, Steve; Bowes, John; Barton, Anne; Martin, Paul; Viatte, Sebastien; McAllister, Kate; Symmons, Deborah; Raychaudhuri, Soumya; Worthington, Jane] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester Musculoskeletal Biomed Res Unit, Natl Inst Hlth Res, Manchester, Lancs, England; [Diogo, Dorothee; Stahl, Eli; Trynka, Gosia; Hu, Xinli; Sandor, Cynthia; de Bakker, Paul I. W.; Plenge, Robert M.; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Zhernakova, Alexandra; Toes, Rene E. M.; Huizinga, Tom W. J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands	University of Manchester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northwell Health; University of Groningen; University of Groningen; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Wellcome Trust Sanger Institute; University of Virginia; Hospital Universitario Marques de Valdecilla (HUMV); Umea University; Umea University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Manchester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Worthington, J (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England.	jane.worthington@manchester.ac.uk	Wijmenga, Cisca/D-2173-2009; Attrill, Lauren/V-1688-2018; Martín, María/HDL-9512-2022; Newhouse, Stephen J/C-9330-2011; Worthington, Jane/M-9770-2014; Raza, Karim/AAN-3089-2021; Barton, Anne/N-2053-2014; González-Gay, Miguel A./B-2306-2008; eyre, stephen/K-3776-2017; Zhernakova, Alexandra/ABA-9372-2020; Franke, Lude/P-7036-2016; Timpson, Nicholas John/O-7548-2015; Martín, Javier/AAV-5209-2021; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Martin, Javier/B-8141-2008; Bowes, John/B-3472-2015; Viatte, Sebastien/B-4253-2015; Deloukas, Panos/B-2922-2013; Wijmenga, Cisca/AAE-7719-2019; Collier, David A/D-1649-2011; Alfredsson, Lars/AAC-9007-2019; Rodriguez-Rodriguez, Luis/H-5880-2013; Breen, Gerome/Y-2706-2019; Dominiczak, Anna F/P-9390-2017; de Bakker, Paul IW/B-8730-2009; Brown, Matthew A/E-5749-2010; Breen, Gerome D/A-5540-2010; O'Donovan, Michael C/P-7005-2018; McCarthy, Mark/M-3763-2015; Ng, Wan-Fai/R-8083-2016; Padyukov, Leonid/A-4890-2009; Prescott, Natalie/F-6490-2011; dobson, richard/C-9269-2011	Newhouse, Stephen J/0000-0002-1843-9842; Worthington, Jane/0000-0003-0544-042X; Raza, Karim/0000-0003-1570-1232; Barton, Anne/0000-0003-3316-2527; González-Gay, Miguel A./0000-0002-7924-7406; eyre, stephen/0000-0002-1251-6974; Franke, Lude/0000-0002-5159-8802; Timpson, Nicholas John/0000-0002-7141-9189; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Martin, Javier/0000-0002-2202-0622; Bowes, John/0000-0003-4659-031X; Viatte, Sebastien/0000-0001-6471-3358; Deloukas, Panos/0000-0001-9251-070X; Wijmenga, Cisca/0000-0002-5635-1614; Collier, David A/0000-0003-4087-1559; Alfredsson, Lars/0000-0003-1688-6697; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Breen, Gerome/0000-0003-2053-1792; Dominiczak, Anna F/0000-0003-4913-3608; de Bakker, Paul IW/0000-0001-7735-7858; Brown, Matthew A/0000-0003-0538-8211; Breen, Gerome D/0000-0003-2053-1792; O'Donovan, Michael C/0000-0001-7073-2379; Ouwehand, Willem/0000-0002-7744-1790; Weedon, Michael/0000-0002-6174-6135; Raychaudhuri, Soumya/0000-0002-1901-8265; Young-Min, Steven/0000-0001-8270-6207; Lango Allen, Hana/0000-0002-7803-8688; Martin, Paul/0000-0002-1016-6851; MacGregor, Alex/0000-0003-2163-2325; Symmons, Deborah/0000-0002-8625-1200; Cooper, Cyrus/0000-0003-3510-0709; DIOGO, DOROTHEE/0000-0003-2913-5913; Caulfield, Mark/0000-0001-9295-3594; Dunger, Professor David/0000-0002-2566-9304; Conaghan, Philip/0000-0002-3478-5665; Morgan, Ann/0000-0003-1109-624X; Bukhari, Marwan/0000-0003-4311-5222; Birrell, Fraser/0000-0002-6163-6155; Wallace, Chris/0000-0001-9755-1703; Hunt, Sarah/0000-0002-8350-1235; McCarthy, Mark/0000-0002-4393-0510; Duffus, Kate/0000-0002-8925-1863; Zhernakova, Alexandra/0000-0002-4574-0841; Grozeva, Detelina/0000-0003-3239-8415; Lindgren, Cecilia/0000-0002-4903-9374; Isaacs, John/0000-0002-6103-7056; Young, Allan/0000-0003-2291-6952; Packham, Jon/0000-0001-5531-1680; Forbes, Alastair/0000-0001-7416-9843; Toes, Rene/0000-0002-9618-6414; Trynka, Gosia/0000-0002-6955-9529; Khor, Chiea Chuen/0000-0002-1128-4729; Ng, Wan-Fai/0000-0002-5539-388X; Newport, Melanie/0000-0002-8946-7525; Dennison, Elaine/0000-0002-3048-4961; Padyukov, Leonid/0000-0003-2950-5670; Prescott, Natalie/0000-0002-5901-7371; Hall, Alistair/0000-0003-0306-7887; Parkes, Miles/0000-0002-6467-0631; dobson, richard/0000-0003-4224-9245; Klareskog, Lars/0000-0001-9601-6186; Concannon, Patrick/0000-0002-5801-1859; Munroe, Patricia/0000-0002-4176-2947; Hattersley, Andrew/0000-0001-5620-473X; Rich, Stephen/0000-0003-3872-7793; Zeggini, Eleftheria/0000-0003-4238-659X; Bruce, Ian/0000-0003-3047-500X; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Jones, Lisa/0000-0002-5122-8334; Bishop, Tim/0000-0002-8752-8785; Tobin, Martin/0000-0002-3596-7874; Lees, Charlie/0000-0002-0732-8215; Iles, Mark/0000-0002-2603-6509; Hyrich, Kimme/0000-0001-8242-9262	Arthritis Research UK [17552]; Manchester Biomedical Research Centre; Arthritis Foundation; Uppsala University; Uppsala University Hospital; Science for Life Laboratory-Uppsala; Swedish Research Council [80576801, 70374401]; Redes Tematicas de Investigacion Cooperative en Salud (RETICS) Program, Instituto de Salud Carlos III, Spain [RD08/0075]; Wellcome Trust [076113/C/04/Z, 068545/Z/02]; US National Institutes for Health research program [RP-PG-0310-1002]; UK Medical Research Council [G0000934]; US National Institutes of Health [K08AR055688, 1R01AR062886-01, RO1-AR-4-4422, NO1-AR-2-2263, NO1-AR1-2256, RO1 AI068759, RC2AR059092-01, R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; Eileen Ludwig Greenland Center for Rheumatoid Arthritis; family of Robert S. Boas; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059648, K08AR055688, RC2AR059092, R01AR057108, N01AR012256, R01AR044422, R01AR062886, N01AR022263, R01AR056768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; MRC [G0800759, MC_U147585819, G0400491, G0800675, G0600329, G0000934, MC_U147585827] Funding Source: UKRI; Medical Research Council [U1475000001, MC_U147585819, G0600329, MC_U147585827, MC_U147585824, G0800675, MC_UP_A620_1014, G0400491, G0800759, G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10335, NF-SI-0508-10082, NF-SI-0508-10299, NF-SI-0611-10219] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75, ETM/137] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Arthritis Foundation; Uppsala University; Uppsala University Hospital; Science for Life Laboratory-Uppsala; Swedish Research Council(Swedish Research CouncilEuropean Commission); Redes Tematicas de Investigacion Cooperative en Salud (RETICS) Program, Instituto de Salud Carlos III, Spain; Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes for Health research program; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eileen Ludwig Greenland Center for Rheumatoid Arthritis; family of Robert S. Boas; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); Chief Scientist Office	We thank). Barrett and C. Wallace for the SNP selection. We thank the Wellcome Trust Sanger Institute Genotyping Facility, and, in particular, E. Gray, S. Bumpstead, D. Simpkin and H. Blackburn. Genotyping of the UK Rheumatoid Arthritis Genetics samples was supported by the Arthritis Research UK grant reference number 17552 and the Manchester Biomedical Research Centre. This work was made possible by funds from the Arthritis Foundation (S.R., principal investigator) and the US National Institutes Health (K08AR055688 to S.R. and 1R01AR062886-01 to P.I.W.d.B). P. Gilbert prepared the UK samples. Genotyping of the Swedish Umea samples was performed by the SNP&SEQ Technology Platform in Uppsala, which is supported by Uppsala University, Uppsala University Hospital, Science for Life Laboratory-Uppsala and the Swedish Research Council (contracts 80576801 and 70374401). This work was partially supported by the Redes Tematicas de Investigacion Cooperative en Salud (RETICS) Program, RD08/0075 (RIER), from the Instituto de Salud Carlos III, Spain. We acknowledge use of DNA from the UK Blood Services collection of Common Controls (UKBS-CC collection), which is funded by Wellcome Trust grant 076113/C/04/Z and by the US National Institutes for Health research program grant to the National Health Service Blood and Transplant (RP-PG-0310-1002). We acknowledge the use of DNA from the British 1958 Birth Cohort collection, which is funded by the UK Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. The North American Rheumatoid Arthritis Consortium and analysis of other US patient and control collections at the Feinstein Institute were supported by the US National Institutes of Health RO1-AR-4-4422, NO1-AR-2-2263; NO1-AR1-2256, RO1 AI068759 and RC2AR059092-01, with additional support from the Eileen Ludwig Greenland Center for Rheumatoid Arthritis and the family of Robert S. Boas. R.M.P. is supported by grants from the US National Institutes of Health (R01-AR057108, R01-AR056768, U01-GM092691 and R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stevens L, 2006, EUR J IMMUNOL, V36, P3305, DOI 10.1002/eji.200636400; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	17	439	462	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1336	1340		10.1038/ng.2462	http://dx.doi.org/10.1038/ng.2462			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143596	Green Accepted, Green Submitted			2022-12-25	WOS:000311713200012
J	Mulleder, M; Capuano, F; Pir, P; Christen, S; Sauer, U; Oliver, SG; Ralser, M				Muelleder, Michael; Capuano, Floriana; Pir, Pinar; Christen, Stefan; Sauer, Uwe; Oliver, Stephen G.; Ralser, Markus			A prototrophic deletion mutant collection for yeast metabolomics and systems biology	NATURE BIOTECHNOLOGY			English	Letter							SACCHAROMYCES-CEREVISIAE; STRAINS; LONGEVITY; NETWORK		[Muelleder, Michael; Capuano, Floriana; Pir, Pinar; Oliver, Stephen G.; Ralser, Markus] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Muelleder, Michael; Capuano, Floriana; Pir, Pinar; Oliver, Stephen G.; Ralser, Markus] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Christen, Stefan; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland	University of Cambridge; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mulleder, M (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	mr559@cam.ac.uk	Pir, Pinar/AAA-5103-2022; Sauer, Uwe/Y-3556-2019; Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; Mulleder, Michael/0000-0001-9792-3861; Ralser, Markus/0000-0001-9535-7413; Pir, Pinar/0000-0002-0078-4904	Biotechnology and Biological Sciences Research Council [BB/C505140/2, BB/C505140/1] Funding Source: Medline; European Research Council [260809] Funding Source: Medline; Wellcome Trust [093735] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Gruning NM, 2010, TRENDS BIOCHEM SCI, V35, P220, DOI 10.1016/j.tibs.2009.12.001; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Li LH, 2009, MOL BIOL CELL, V20, P3851, DOI 10.1091/mbc.E09-04-0347; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; SIKORSKI RS, 1989, GENETICS, V122, P19; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	9	67	67	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1176	1178		10.1038/nbt.2442	http://dx.doi.org/10.1038/nbt.2442			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222782	Green Accepted			2022-12-25	WOS:000312092400015
J	Vanderschuren, H				Vanderschuren, Herve			Strengthening African R&D through effective transfer of tropical crop biotech to African institutions	NATURE BIOTECHNOLOGY			English	Letter							AGROBACTERIUM-MEDIATED TRANSFORMATION; TRANSGENIC CASSAVA; MAIZE		Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	ETH Zurich	Vanderschuren, H (corresponding author), Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.	hvanderschuren@ethz.ch	Vanderschuren, Hervé/AAF-5118-2021	Vanderschuren, Herve/0000-0003-2102-9737				Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Bull SE, 2011, PLANT CELL REP, V30, P779, DOI 10.1007/s00299-010-0986-6; Chetty CC, 2013, NEW BIOTECHNOL, V30, P136, DOI 10.1016/j.nbt.2012.04.006; Ezezika OC, 2012, NAT BIOTECHNOL, V30, P38, DOI 10.1038/nbt.2088; Juma C, 2011, SCIENCE, V334, P1323, DOI 10.1126/science.1217148; Shepherd DN, 2007, PLANT BIOTECHNOL J, V5, P759, DOI 10.1111/j.1467-7652.2007.00279.x; Tripathi L, 2010, MOL PLANT PATHOL, V11, P721, DOI 10.1111/j.1364-3703.2010.00639.x; Turok N, 2011, NATURE, V474, P567, DOI 10.1038/474567a; Vanderschuren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045277; Vasil IK, 1996, NAT BIOTECHNOL, V14, P702, DOI 10.1038/nbt0696-702	10	10	10	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1170	1172		10.1038/nbt.2405	http://dx.doi.org/10.1038/nbt.2405			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222780				2022-12-25	WOS:000312092400013
J	Knutson, SK; Wigle, TJ; Warholic, NM; Sneeringer, CJ; Allain, CJ; Klaus, CR; Sacks, JD; Raimondi, A; Majer, CR; Song, J; Scott, MP; Jin, L; Smith, JJ; Olhava, EJ; Chesworth, R; Moyer, MP; Richon, VM; Copeland, RA; Keilhack, H; Pollock, RM; Kuntz, KW				Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.			A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells	NATURE CHEMICAL BIOLOGY			English	Article							METHYLTRANSFERASE GENE EZH2; NON-HODGKIN-LYMPHOMA; HISTONE H3; SOMATIC MUTATIONS; LYSINE 27; PROTEIN METHYLTRANSFERASES; HUMAN CANCER; DISCOVERY; COMPLEX; JMJD3	EZH2 catalyzes trimethylation of histone H3 lysine 27 (H3K27). Point mutations of EZH2 at Tyr641 and Ala677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive H3K27 hypertrimethylation. Here we report the discovery of EPZ005687, a potent inhibitor of EZH2 (K-i of 24 nM). EPZ005687 has greater than 500-fold selectivity against 15 other protein methyltransferases and has 50-fold selectivity against the closely related enzyme EZH1. The compound reduces H3K27 methylation in various lymphoma cells; this translates into apoptotic cell killing in heterozygous Tyr641 or Ala677 mutant cells, with minimal effects on the proliferation of wild-type cells. These data suggest that genetic alteration of EZH2 (for example, mutations at Tyr641 or Ala677) results in a critical dependency on enzymatic activity for proliferation (that is, the equivalent of oncogene addiction), thus portending the clinical use of EZH2 inhibitors for cancers in which EZH2 is genetically altered.	[Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.] Epizyme Inc, Cambridge, MA USA		Knutson, SK (corresponding author), Epizyme Inc, Cambridge, MA USA.	kkuntz@epizyme.com	Suarez, Joelle S/H-9582-2014	Suarez, Joelle S/0000-0003-1528-2701				Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Burgess J. L., 2012, Patent No. [WO2012005805, 2012005805]; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Copeland R. A., 2005, EVALUATION ENZYME IN; Copeland RA, 2012, DRUG DISCOV TODAY TH, V9, pe83, DOI DOI 10.1016/J.DDSTR.2011.08.001; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dornan D, 2009, BLOOD, V114, P2721, DOI 10.1182/blood-2009-02-205500; Duquenne C., 2011, Indazoles, Patent No. 2011140325; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Kaelin WG, 1999, J CLIN INVEST, V104, P1503, DOI 10.1172/JCI8888; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li R., 2009, KINASE INHIBITOR DRU; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; YONETANI T, 1964, ARCH BIOCHEM BIOPHYS, V106, P243, DOI 10.1016/0003-9861(64)90184-5	47	593	638	3	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2012	8	11					890	896		10.1038/NCHEMBIO.1084	http://dx.doi.org/10.1038/NCHEMBIO.1084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	023RJ	23023262				2022-12-25	WOS:000310052100007
J	Martell, JD; Deerinck, TJ; Sancak, Y; Poulos, TL; Mootha, VK; Sosinsky, GE; Ellisman, MH; Ting, AY				Martell, Jeffrey D.; Deerinck, Thomas J.; Sancak, Yasemin; Poulos, Thomas L.; Mootha, Vamsi K.; Sosinsky, Gina E.; Ellisman, Mark H.; Ting, Alice Y.			Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy	NATURE BIOTECHNOLOGY			English	Article							HORSERADISH-PEROXIDASE; CRYSTAL-STRUCTURE; CORRELATED LIGHT; PROTEIN; LOCALIZATION; FLUORESCENCE; MEMBRANE; COMPLEX; MARKER; ENZYME	Electron microscopy (EM) is the standard method for imaging cellular structures with nanometer resolution, but existing genetic tags are inactive in most cellular compartments(1) or require light and can be difficult to use(2). Here we report the development of 'APEX', a genetically encodable EM tag that is active in all cellular compartments and does not require light. APEX is a monomeric 28-kDa peroxidase that withstands strong EM fixation to give excellent ultrastructural preservation. We demonstrate the utility of APEX for high-resolution EM imaging of a variety of mammalian organelles and specific proteins using a simple and robust labeling procedure. We also fused APEX to the N or C terminus of the mitochondrial calcium uniporter (MCU), a recently identified channel whose topology is disputed(3,4). These fusions give EM contrast exclusively in the mitochondrial matrix, suggesting that both the N and C termini of MCU face the matrix. Because APEX staining is not dependent on light activation, APEX should make EM imaging of any cellular protein straightforward, regardless of the size or thickness of the specimen.	[Martell, Jeffrey D.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Deerinck, Thomas J.; Sosinsky, Gina E.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Sancak, Yasemin; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Sancak, Yasemin; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sancak, Yasemin; Mootha, Vamsi K.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sancak, Yasemin; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA; [Sosinsky, Gina E.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	ating@mit.edu		Ting, Alice/0000-0002-8277-5226	US National Institutes of Health [DP1 OD003961, P41RR004050, P41GM103412, GM065937, GM072881, GM077465, GM42614]; National Science Foundation Graduate Research Fellowship; National Defense Science and Engineering Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250, P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465, P41GM103412, R01GM072881, R01GM065937, R01GM042614] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003961] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Keating for use of her gel filtration chromatography system and A. Thor, A. Cone and M. Terada for assistance with electron tomography. The IMS-APEX EM data were obtained by H.-W. Rhee, P. Zou, J.D.M. and E. Vasile (Microscopy and Imaging Core Facility, Koch Institute at MIT). C. Uttamapinant (MIT) and H. Fraser (Stanford) provided helpful feedback on the manuscript. Funding was provided by US National Institutes of Health grants DP1 OD003961 (A.Y.T.), P41RR004050 (M.H.E.), P41GM103412 (M.H.E.), GM065937 (G. E. S.), GM072881 (G.E.S.), GM077465 (V.K.M.) and GM42614 (T.L.P.). J.D.M. was supported by a National Science Foundation Graduate Research Fellowship and a National Defense Science and Engineering Graduate Fellowship.	Barrows TP, 2005, BIOCHEMISTRY-US, V44, P14062, DOI 10.1021/bi0507128; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Cheek J, 1999, J BIOL INORG CHEM, V4, P64, DOI 10.1007/s007750050290; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; DEMEY J, 1981, CELL BIOL INT REP, V5, P889, DOI 10.1016/0309-1651(81)90204-6; Ellisman MH, 2012, METHOD CELL BIOL, V111, P139, DOI 10.1016/B978-0-12-416026-2.00008-X; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; HENDERSON D, 1979, EXP CELL RES, V124, P301, DOI 10.1016/0014-4827(79)90206-4; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hopkins C, 2000, METHOD ENZYMOL, V327, P35, DOI 10.1016/S0076-6879(00)27265-0; Kirmse R, 2010, METHOD CELL BIOL, V96, P565, DOI 10.1016/S0091-679X(10)96023-8; KOSHIBA T, 1993, PLANT CELL PHYSIOL, V34, P713, DOI 10.1093/oxfordjournals.pcp.a078474; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012; Li JL, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.006.2010; Mandelman D, 1998, PROTEIN SCI, V7, P2089, DOI 10.1002/pro.5560071005; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4331, DOI 10.1021/bi00013a023; PORSTMANN B, 1985, J IMMUNOL METHODS, V79, P27, DOI 10.1016/0022-1759(85)90388-6; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; RICHARDS MK, 1994, BIOCHEMISTRY-US, V33, P14723, DOI 10.1021/bi00253a010; Ryan BJ, 2006, TRENDS BIOTECHNOL, V24, P355, DOI 10.1016/j.tibtech.2006.06.007; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Sharp KH, 2004, BIOCHEMISTRY-US, V43, P8644, DOI 10.1021/bi049343q; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sosinsky GE, 2003, CELL COMMUN ADHES, V10, P181, DOI 10.1080/714040424; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107	38	411	427	6	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1143	+		10.1038/nbt.2375	http://dx.doi.org/10.1038/nbt.2375			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23086203	Green Accepted, Green Submitted			2022-12-25	WOS:000311087500035
J	Gao, X; Haynes, SW; Ames, BD; Wang, P; Vien, LP; Walsh, CT; Tang, Y				Gao, Xue; Haynes, Stuart W.; Ames, Brian D.; Wang, Peng; Vien, Linda P.; Walsh, Christopher T.; Tang, Yi			Cyclization of fungal nonribosomal peptides by a terminal condensation-like domain	NATURE CHEMICAL BIOLOGY			English	Article							BIOSYNTHETIC GENE-CLUSTER; IN-VITRO; FUNCTIONAL-CHARACTERIZATION; ALKALOID BIOSYNTHESIS; ASPERGILLUS-FUMIGATUS; MOLECULAR-MECHANISMS; POLYKETIDE SYNTHASE; MUTATIONAL ANALYSIS; CYCLOSPORINE-A; SYNTHETASE	Cyclization of linear peptidyl precursors produced by nonribosomal peptide synthetases (NRPSs) is an important step in the biosynthesis of bioactive cyclic peptides. Whereas bacterial NRPSs use thioesterase domains to perform the cyclization, fungal NRPSs have apparently evolved to use a different enzymatic route. In verified fungal NRPSs that produce macrocyclic peptides, each megasynthetase terminates with a condensation-like (C-T) domain that may perform the macrocyclization reaction. To probe the role of such a C-T domain, we reconstituted the activities of the Penicillium aethiopicum trimodular NPRS TqaA in Saccharomyces cerevisiae and in vitro. Together with the reconstituted bimodular NRPS AnaPS, we dissected the cyclization steps of TqaA in transforming the linear anthranilate-(D)-tryptophan-(L)-alanyl tripeptide into fumiquinazoline F. Extensive biochemical and mutational studies confirmed the essential role of the C-T domain in catalyzing cyclization in a thiolation domain-dependent fashion. Our work provides evidence of a likely universal macrocyclization strategy used by fungal NRPSs.	[Gao, Xue; Wang, Peng; Vien, Linda P.; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA; [Haynes, Stuart W.; Ames, Brian D.; Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles	Gao, X (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA.	christopher_walsh@hms.harvard.edu; yitang@ucla.edu	WANG, Peng/GSN-5263-2022; gao, xue/J-7037-2016	gao, xue/0000-0003-3213-9704	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020011, R01GM020011, F32GM090475, R01GM092217, DP1GM106413, F32GM020011] Funding Source: NIH RePORTER; NIGMS NIH HHS [DP1 GM106413, F32GM090475, GM20011, 1R01GM092217, F32 GM020011, R01 GM092217, R01 GM020011, F32 GM090475] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames BD, 2011, BIOCHEMISTRY-US, V50, P8756, DOI 10.1021/bi201302w; Ames BD, 2010, BIOCHEMISTRY-US, V49, P8564, DOI 10.1021/bi1012029; Ames BD, 2010, BIOCHEMISTRY-US, V49, P3351, DOI 10.1021/bi100198y; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Chen SCA, 2011, DRUGS, V71, P11, DOI 10.2165/11585270-000000000-00000; Daniel JFD, 2007, NAT PROD REP, V24, P1128, DOI 10.1039/b618086h; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Eisfeld K., 2009, PHYSL GENETICS, V15, P315; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gao X, 2011, J AM CHEM SOC, V133, P2729, DOI 10.1021/ja1101085; Gatto GJ, 2005, BIOCHEMISTRY-US, V44, P5993, DOI 10.1021/bi050230w; Grindberg RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018565; Jin JM, 2010, MOL MICROBIOL, V76, P456, DOI 10.1111/j.1365-2958.2010.07109.x; Keating TA, 2000, BIOCHEMISTRY-US, V39, P4729, DOI 10.1021/bi992923g; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; LAWEN A, 1990, J BIOL CHEM, V265, P11355; Lee JH, 2009, BIOCHEMISTRY-US, V48, P5054, DOI 10.1021/bi900164d; Linne U, 2000, BIOCHEMISTRY-US, V39, P10439, DOI 10.1021/bi000768w; Liu XY, 2009, BIOCHEMISTRY-US, V48, P8746, DOI 10.1021/bi901123r; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; RUSNAK F, 1991, BIOCHEMISTRY-US, V30, P2916, DOI 10.1021/bi00225a027; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sieber SA, 2004, ANGEW CHEM INT EDIT, V43, P493, DOI 10.1002/anie.200352787; Sieber SA, 2003, J AM CHEM SOC, V125, P10862, DOI 10.1021/ja0361852; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Sims JW, 2008, J AM CHEM SOC, V130, P11149, DOI 10.1021/ja803078z; Slightom JL, 2009, GENE, V431, P67, DOI 10.1016/j.gene.2008.11.011; Stachelhaus T, 2000, BIOCHEMISTRY-US, V39, P5775, DOI 10.1021/bi9929002; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g; Xu W, 2010, J AM CHEM SOC, V132, P13604, DOI 10.1021/ja107084d; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200; ZOCHER R, 1986, BIOCHEMISTRY-US, V25, P550, DOI 10.1021/bi00351a005	44	116	120	4	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					823	830		10.1038/NCHEMBIO.1047	http://dx.doi.org/10.1038/NCHEMBIO.1047			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22902615	Green Accepted, Green Submitted			2022-12-25	WOS:000309056200007
J	Kelso, A; Hurt, AC				Kelso, Anne; Hurt, Aeron C.			Drug-resistant influenza viruses: why fitness matters	NATURE MEDICINE			English	Editorial Material							OSELTAMIVIR-RESISTANT; TRANSMISSION; H1N1		[Kelso, Anne; Hurt, Aeron C.] WHO, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	World Health Organization	Kelso, A (corresponding author), WHO, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia.	Anne.Kelso@influenzacentre.org		Kelso, Anne/0000-0002-3166-3267; Hurt, Aeron/0000-0003-1826-4314				Bloom JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022201; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Lackenby A, 2011, EUROSURVEILLANCE, V16, P10; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Storms AD, 2012, EMERG INFECT DIS, V18, P308, DOI 10.3201/eid1802.111466; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132	14	28	30	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1470	1471		10.1038/nm.2954	http://dx.doi.org/10.1038/nm.2954			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042350				2022-12-25	WOS:000309587500019
J	Komori, J; Boone, L; DeWard, A; Hoppo, T; Lagasse, E				Komori, Junji; Boone, Lindsey; DeWard, Aaron; Hoppo, Toshitaka; Lagasse, Eric			The mouse lymph node as an ectopic transplantation site for multiple tissues	NATURE BIOTECHNOLOGY			English	Article							HUMAN HEPATOCYTE TRANSPLANTATION; FIBROBLASTIC RETICULAR CELLS; STEM-CELLS; REJECTION; MODEL; FLOW	Cell-based therapy has been viewed as a promising alternative to organ transplantation, but cell transplantation aimed at organ repair is not always possible. Here we show that the mouse lymph node can support the engraftment and growth of healthy cells from multiple tissues. Direct injection of hepatocytes into a single mouse lymph node generated enough ectopic liver mass to rescue the survival of mice with lethal metabolic disease. Furthermore, thymuses transplanted into single lymph nodes of athymic nude mice generated functional immune systems that were capable of rejecting allogeneic and xenogeneic grafts. Additionally, pancreatic islets injected into the lymph nodes of diabetic mice restored normal glucose control. Collectively, these results suggest the practical approach of targeting lymph nodes to restore, maintain or improve tissue and organ functions.	[Komori, Junji; Boone, Lindsey; DeWard, Aaron; Hoppo, Toshitaka; Lagasse, Eric] Univ Pittsburgh, Sch Med, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lagasse, E (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	lagasse@pitt.edu			US National Institutes of Health [R01 DK085711];  [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085711] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank S. Thorne and R. Sikorski for the in vivo imaging and the luciferase C57BL/6 transgenic mice. 129sv and 129sv Fah<SUP>-/-</SUP> mice were a kind gift from M. Grompe (Oregon Health and Sciences University). CTLA4-Ig and MR1 antibodies were a kind gift from F. Lakkis (University of Pittsburgh). This project used University of Pittsburgh Cancer Institute shared resources that are supported in part by award P30CA047904. This work was supported by the US National Institutes of Health grant R01 DK085711 (J.K., L.B., A.D. and E.L.).	Bumgardner GL, 1998, TRANSPLANTATION, V66, P1841, DOI 10.1097/00007890-199812270-00047; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Gao DH, 2000, HEPATOLOGY, V32, P1018, DOI 10.1053/jhep.2000.19325; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Gordon R D, 1988, Clin Transpl, P5; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hoppo T, 2011, GASTROENTEROLOGY, V140, P656, DOI 10.1053/j.gastro.2010.11.006; Jiang JF, 1999, MICROSURG, V19, P56, DOI 10.1002/(SICI)1098-2752(1999)19:2<56::AID-MICR3>3.0.CO;2-F; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kim M, 2011, VET RADIOL ULTRASOUN, V52, P302, DOI 10.1111/j.1740-8261.2010.01794.x; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Notenboom RGE, 1996, DEVELOPMENT, V122, P321; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Ohashi K, 2005, HEPATOLOGY, V41, P132, DOI 10.1002/hep.20484; Overturf K, 1997, AM J PATHOL, V151, P1273; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Rice HE, 2004, J PEDIATR SURG, V39, P1607, DOI 10.1016/j.jpedsurg.2004.07.020; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rodeck B, 1999, Pediatr Transplant, V3, P328, DOI 10.1034/j.1399-3046.1999.00060.x; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; SIEGLER EL, 1979, IMMUNOGENETICS, V9, P207, DOI 10.1007/BF01570415; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; STAMPFL DA, 1990, GASTROENTEROLOGY, V99, P1834, DOI 10.1016/0016-5085(90)90497-O; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	48	68	73	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					976	+		10.1038/nbt.2379	http://dx.doi.org/10.1038/nbt.2379			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23000933	Green Accepted			2022-12-25	WOS:000309965500024
J	Skokowa, J; Klimiankou, M; Klimenkova, O; Lan, D; Gupta, K; Hussein, K; Carrizosa, E; Kusnetsova, I; Li, ZX; Sustmann, C; Ganser, A; Zeidler, C; Kreipe, HH; Burkhardt, J; Grosschedl, R; Welte, K				Skokowa, Julia; Klimiankou, Maxim; Klimenkova, Olga; Lan, Dan; Gupta, Kshama; Hussein, Kais; Carrizosa, Esteban; Kusnetsova, Inna; Li, Zhixiong; Sustmann, Claudio; Ganser, Arnold; Zeidler, Cornelia; Kreipe, Hans-Heinrich; Burkhardt, Janis; Grosschedl, Rudolf; Welte, Karl			Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOBLASTIC-LEUKEMIA; CELL-SPECIFIC PROTEIN-1; INDUCED TYROSINE PHOSPHORYLATION; ENHANCER FACTOR-I; FACTOR-RECEPTOR; HEMATOPOIETIC LINEAGE; HS1 PROTEIN; PROXIMITY LIGATION	We found that hematopoietic cell-specific Lyn substrate 1 (HCLS1 or HS1) is highly expressed in human myeloid cells and that stimulation with granulocyte colony-stimulating factor (G-CSF) leads to HCLS1 phosphorylation. HCLS1 binds the transcription factor lymphoid-enhancer binding factor 1 (LEF-1), transporting LEF-1 into the nucleus upon G-CSF stimulation and inducing LEF-1 autoregulation. In patients with severe congenital neutropenia, inherited mutations in the gene encoding HCLS1-associated protein X-1 (HAX1) lead to profound defects in G-CSF-triggered phosphorylation of HCLS1 and subsequently to reduced autoregulation and expression of LEF-1. Consistent with these results, HCLS1-deficient mice are neutropenic. In bone marrow biopsies of the majority of tested patients with acute myeloid leukemia, HCLS1 protein expression is substantially elevated, associated with high levels of G-CSF synthesis and, in some individuals, a four-residue insertion in a proline-rich region of HCLS1 protein known to accelerate intracellular signaling. These data demonstrate the importance of HCLS1 in myelopoiesis in vitro and in vivo.	[Skokowa, Julia; Klimiankou, Maxim; Klimenkova, Olga; Lan, Dan; Gupta, Kshama; Kusnetsova, Inna; Zeidler, Cornelia; Welte, Karl] Hannover Med Sch, Dept Mol Hematopoiesis, D-3000 Hannover, Germany; [Lan, Dan] GuangXi Med Univ, Affiliated Hosp 1, Dept Pediat, Nanning, Peoples R China; [Hussein, Kais; Kreipe, Hans-Heinrich] Hannover Med Sch, Dept Pathol, D-3000 Hannover, Germany; [Carrizosa, Esteban; Burkhardt, Janis] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Carrizosa, Esteban; Burkhardt, Janis] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Li, Zhixiong] Hannover Med Sch, Inst Expt Hematol, D-3000 Hannover, Germany; [Ganser, Arnold] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany; [Sustmann, Claudio; Grosschedl, Rudolf] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, Freiburg, Germany	Hannover Medical School; Guangxi Medical University; Hannover Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Hannover Medical School; Hannover Medical School; Max Planck Society	Skokowa, J (corresponding author), Hannover Med Sch, Dept Mol Hematopoiesis, D-3000 Hannover, Germany.	skokowa.julia@mh-hannover.de; Welte.Karl.H@mh-hannover.de	Skokowa, Julia/AAU-3622-2021; Gupta, Kshama/GRS-8778-2022	Skokowa, Julia/0000-0002-4399-2324; Burkhardt, Janis/0000-0002-8176-1375	German Jose Carreras Leukemia Foundation; REBIRTH Cluster of Excellence of the Hannover Medical School; Madeleine Schickedanz-KinderKrebs-Stiftung; Deutsche Forschungsgemeinschaft (DFG) [Li 1608/2-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088376] Funding Source: NIH RePORTER	German Jose Carreras Leukemia Foundation; REBIRTH Cluster of Excellence of the Hannover Medical School; Madeleine Schickedanz-KinderKrebs-Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Gigina, K. Cherkaoui, A. Muller Brechlin, M. Reuter and A.-L. Hagemann for technical assistance. We thank J. Klupp for assistance in generation of LEF-1 Ala16 mutant; D. D. Billadeau (Department of Immunology, Schulze Center for Novel Therapeutics, College of Medicine, Mayo Clinic) for providing us with the rabbit polyclonal HCLS1-specific antibody; L. Naldini (San Raffaele Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Gene Therapy and Stem Cells, San Raffaele Institute) for pRRL.PPT.PGK.GFPpre vector; A. Schambach (Department of Experimental Hematology, Hannover Medical School) for VSVg envelope plasmid; Thomas J. Hope (University of Illinois at Chicago) for pRSV-Rev plasmid; and O. Tetsu (Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco) for the CCND1 reporter construct. We also thank the physicians within the Severe Chronic Neutropenia International Registry for providing patient material. We thank study subjects for their cooperation. This work was partially supported by German Jose Carreras Leukemia Foundation (J. S., M. K.), by REBIRTH Cluster of Excellence of the Hannover Medical School (J. S.), by Madeleine Schickedanz-KinderKrebs-Stiftung (J. S.), and by the Deutsche Forschungsgemeinschaft (Z.L.; DFG grant Li 1608/2-1).	Akbarzadeh S, 2002, BLOOD, V99, P879, DOI 10.1182/blood.V99.3.879; Al-Maghrebi M, 2002, NUCLEIC ACIDS RES, V30, P5017, DOI 10.1093/nar/gkf656; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Basu S, 2002, INT J MOL MED, V10, P3; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Brunati AM, 2005, J BIOL CHEM, V280, P21029, DOI 10.1074/jbc.M412634200; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Corey SJ, 1998, J BIOL CHEM, V273, P3230, DOI 10.1074/jbc.273.6.3230; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; Coyle-Rink J, 2002, CANCER BIOL THER, V1, P640, DOI 10.4161/cbt.313; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; ELSNER J, 1993, EXP HEMATOL, V21, P38; ERNST TJ, 1989, LEUKEMIA, V3, P620; Fonseca AV, 2010, J BIOL CHEM, V285, P31661, DOI 10.1074/jbc.M110.145037; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hagiwara S, 1998, INT J HEMATOL, V68, P387; Hao JJ, 2004, J BIOL CHEM, V279, P33413, DOI 10.1074/jbc.M313564200; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ingley E, 2000, J BIOL CHEM, V275, P7887, DOI 10.1074/jbc.275.11.7887; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Kendrick TS, 2007, FRONT BIOSCI-LANDMRK, V12, P591, DOI 10.2741/2085; KITAMURA D, 1989, NUCLEIC ACIDS RES, V17, P9367; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Luderer HF, 2011, J BIOL CHEM, V286, P18444, DOI 10.1074/jbc.M110.188219; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Otsuka J, 2004, ARTHRITIS RHEUM-US, V50, P871, DOI 10.1002/art.20192; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Prieve MG, 1996, J BIOL CHEM, V271, P7654, DOI 10.1074/jbc.271.13.7654; Prieve MG, 1998, MOL CELL BIOL, V18, P4819, DOI 10.1128/MCB.18.8.4819; Scielzo C, 2005, J CLIN INVEST, V115, P1644, DOI 10.1172/JCI24276; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Takemoto Y, 1998, J IMMUNOL, V161, P625; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; Timm A, 2005, CURR TOP MICROBIOL, V290, P225; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; van Rossum AGSH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-15; Ward AC, 1998, BBA-MOL CELL RES, V1448, P70, DOI 10.1016/S0167-4889(98)00120-7; Ward AC, 2000, LEUKEMIA, V14, P1284, DOI 10.1038/sj.leu.2401822; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; YOUNG DC, 1987, J CLIN INVEST, V79, P100, DOI 10.1172/JCI112769; YOUNG DC, 1988, EXP HEMATOL, V16, P378; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612; Zhu QS, 2004, BLOOD, V103, P3305, DOI 10.1182/blood-2003-06-1861	59	58	62	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1550	U157		10.1038/nm.2958	http://dx.doi.org/10.1038/nm.2958			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23001182	Green Accepted			2022-12-25	WOS:000309587500034
J	Su, Z; Gay, LJ; Strange, A; Palles, C; Band, G; Whiteman, DC; Lescai, F; Langford, C; Nanji, M; Edkins, S; van der Winkel, A; Levine, D; Sasieni, P; Bellenguez, C; Howarth, K; Freeman, C; Trudgill, N; Tucker, AT; Pirinen, M; Peppelenbosch, MP; van der Laan, LJW; Kuipers, EJ; Drenth, JPH; Peters, WH; Reynolds, JV; Kelleher, DP; McManus, R; Grabsch, H; Prenen, H; Bisschops, R; Krishnadath, K; Siersema, PD; van Baal, JWPM; Middleton, M; Petty, R; Gillies, R; Burch, N; Bhandari, P; Paterson, S; Edwards, C; Penman, I; Vaidya, K; Ang, Y; Murray, I; Patel, P; Ye, WM; Mullins, P; Wu, AH; Bird, NC; Dallal, H; Shaheen, NJ; Murray, LJ; Koss, K; Bernstein, L; Romero, Y; Hardie, LJ; Zhang, R; Winter, H; Corley, DA; Panter, S; Risch, HA; Reid, BJ; Sargeant, I; Gammon, MD; Smart, H; Dhar, A; McMurtry, H; Ali, H; Liu, G; Casson, AG; Chow, WH; Rutter, M; Tawil, A; Morris, D; Nwokolo, C; Isaacs, P; Rodgers, C; Ragunath, K; MacDonald, C; Haigh, C; Monk, D; Davies, G; Wajed, S; Johnston, D; Gibbons, M; Cullen, S; Church, N; Langley, R; Griffin, M; Alderson, D; Deloukas, P; Hunt, SE; Gray, E; Dronov, S; Potter, SC; Tashakkori-Ghanbaria, A; Anderson, M; Brooks, C; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Duncanson, A; Markus, HS; Mathew, CG; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Trembath, RC; Viswanathan, AC; Wood, N; Trynka, G; Wijmenga, C; Cazier, JB; Atherfold, P; Nicholson, AM; Gellatly, NL; Glancy, D; Cooper, SC; Cunningham, D; Lind, T; Hapeshi, J; Ferry, D; Rathbone, B; Brown, J; Love, S; Attwood, S; MacGregor, S; Watson, P; Sanders, S; Ek, W; Harrison, RF; Moayyedi, P; de Caestecker, J; Barr, H; Stupka, E; Vaughan, TL; Peltonen, L; Spencer, CCA; Tomlinson, I; Donnelly, P; Jankowski, JAZ				Su, Zhan; Gay, Laura J.; Strange, Amy; Palles, Claire; Band, Gavin; Whiteman, David C.; Lescai, Francesco; Langford, Cordelia; Nanji, Manoj; Edkins, Sarah; van der Winkel, Anouk; Levine, David; Sasieni, Peter; Bellenguez, Celine; Howarth, Kimberley; Freeman, Colin; Trudgill, Nigel; Tucker, Art T.; Pirinen, Matti; Peppelenbosch, Maikel P.; van der Laan, Luc J. W.; Kuipers, Ernst J.; Drenth, Joost P. H.; Peters, Wilbert H.; Reynolds, John V.; Kelleher, Dermot P.; McManus, Ross; Grabsch, Heike; Prenen, Hans; Bisschops, Raf; Krishnadath, Kausila; Siersema, Peter D.; van Baal, Jantine W. P. M.; Middleton, Mark; Petty, Russell; Gillies, Richard; Burch, Nicola; Bhandari, Pradeep; Paterson, Stuart; Edwards, Cathryn; Penman, Ian; Vaidya, Kishor; Ang, Yeng; Murray, Iain; Patel, Praful; Ye, Weimin; Mullins, Paul; Wu, Anna H.; Bird, Nigel C.; Dallal, Helen; Shaheen, Nicholas J.; Murray, Liam J.; Koss, Konrad; Bernstein, Leslie; Romero, Yvonne; Hardie, Laura J.; Zhang, Rui; Winter, Helen; Corley, Douglas A.; Panter, Simon; Risch, Harvey A.; Reid, Brian J.; Sargeant, Ian; Gammon, Marilie D.; Smart, Howard; Dhar, Anjan; McMurtry, Hugh; Ali, Haythem; Liu, Geoffrey; Casson, Alan G.; Chow, Wong-Ho; Rutter, Matt; Tawil, Ashref; Morris, Danielle; Nwokolo, Chuka; Isaacs, Peter; Rodgers, Colin; Ragunath, Krish; MacDonald, Chris; Haigh, Chris; Monk, David; Davies, Gareth; Wajed, Saj; Johnston, David; Gibbons, Michael; Cullen, Sue; Church, Nicholas; Langley, Ruth; Griffin, Michael; Alderson, Derek; Deloukas, Panos; Hunt, Sarah E.; Gray, Emma; Dronov, Serge; Potter, Simon C.; Tashakkori-Ghanbaria, Avazeh; Anderson, Mark; Brooks, Claire; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Duncanson, Audrey; Markus, Hugh S.; Mathew, Christopher G.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas; Trynka, Gosia; Wijmenga, Cisca; Cazier, Jean-Baptiste; Atherfold, Paul; Nicholson, Anna M.; Gellatly, Nichola L.; Glancy, Deborah; Cooper, Sheldon C.; Cunningham, David; Lind, Tore; Hapeshi, Julie; Ferry, David; Rathbone, Barrie; Brown, Julia; Love, Sharon; Attwood, Stephen; MacGregor, Stuart; Watson, Peter; Sanders, Scott; Ek, Weronica; Harrison, Rebecca F.; Moayyedi, Paul; de Caestecker, John; Barr, Hugh; Stupka, Elia; Vaughan, Thomas L.; Peltonen, Leena; Spencer, Chris C. A.; Tomlinson, Ian; Donnelly, Peter; Jankowski, Janusz A. Z.		Esophageal Adenocarcinoma Genetics; Wellcome Trust Case Control Consor	Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus	NATURE GENETICS			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK-FACTORS; ADENOCARCINOMA; CANCER; MANAGEMENT; MORTALITY; DIAGNOSIS; GENETICS	Barrett's esophagus is an increasingly common disease that is strongly associated with reflux of stomach acid and usually a hiatus hernia, and it strongly predisposes to esophageal adenocarcinoma (EAC), a tumor with a very poor prognosis. We report the first genome-wide association study on Barrett's esophagus, comprising 1,852 UK cases and 5,172 UK controls in the discovery stage and 5,986 cases and 12,825 controls in the replication stage. Variants at two loci were associated with disease risk: chromosome 6p21, rs9257809 (P-combined = 4.09 x 10(-9); odds ratio (OR) = 1.21, 95% confidence interval (CI) = 1.13-1.28), within the major histocompatibility complex locus, and chromosome 16q24, rs9936833 (P-combined = 2.74 x 10(-10); OR = 1.14, 95% CI = 1.10-1.19), for which the closest protein-coding gene is FOXF1, which is implicated in esophageal development and structure. We found evidence that many common variants of small effect contribute to genetic susceptibility to Barrett's esophagus and that SNP alleles predisposing to obesity also increase risk for Barrett's esophagus.	[Gay, Laura J.; Nanji, Manoj; Nicholson, Anna M.; Gellatly, Nichola L.; Stupka, Elia; Jankowski, Janusz A. Z.] Queen Mary Univ London, Ctr Digest Dis, Blizard Inst, London, England; [Su, Zhan; Strange, Amy; Palles, Claire; Band, Gavin; Bellenguez, Celine; Howarth, Kimberley; Freeman, Colin; Pirinen, Matti; Rautanen, Anna; Cazier, Jean-Baptiste; Spencer, Chris C. A.; Tomlinson, Ian; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford, England; [Palles, Claire; Tomlinson, Ian] Oxford Natl Inst Hlth Res, Comprehens Biomed Res Ctr, Oxford, England; [Whiteman, David C.; MacGregor, Stuart; Ek, Weronica] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Lescai, Francesco; Stupka, Elia] UCL, Inst Canc, London, England; [Langford, Cordelia; Edkins, Sarah; Deloukas, Panos; Hunt, Sarah E.; Gray, Emma; Dronov, Serge; Potter, Simon C.; Tashakkori-Ghanbaria, Avazeh] Wellcome Trust Sanger Inst, Cambridge, England; [van der Winkel, Anouk; Peppelenbosch, Maikel P.; Kuipers, Ernst J.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Levine, David; Zhang, Rui] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Sasieni, Peter] Barts & London Queen Marys Sch Med & Dent, Ctr Canc Prevent, Wolfson Inst Prevent Med, London, England; [Trudgill, Nigel; Cooper, Sheldon C.] Sandwell Gen Hosp, Dept Gastroenterol, Lyndon, England; [Tucker, Art T.] Queen Mary Univ London, Ctr Clin Pharmacol, William Harvey Res Inst, London, England; [van der Laan, Luc J. W.] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands; [Drenth, Joost P. H.; Peters, Wilbert H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Reynolds, John V.] St James Hosp, Dept Surg, Inst Mol Med, Dublin 8, Ireland; [Reynolds, John V.; Kelleher, Dermot P.; McManus, Ross] Trinity Coll Dublin, Dublin, Ireland; [Kelleher, Dermot P.; McManus, Ross] St James Hosp, Inst Mol Med, Dept Clin Med, Dublin 8, Ireland; [Grabsch, Heike] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Pathol & Tumour Biol, Leeds, W Yorkshire, England; [Prenen, Hans; Bisschops, Raf] Univ Hosp Gasthuisberg, Dept Digest Oncol, B-3000 Louvain, Belgium; [Krishnadath, Kausila] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Siersema, Peter D.; van Baal, Jantine W. P. M.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Middleton, Mark; Gillies, Richard; Jankowski, Janusz A. Z.] Univ Oxford, Dept Med Oncol, Churchill Hosp, Oxford, England; [Petty, Russell] Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen, Scotland; [Burch, Nicola; Glancy, Deborah; Rathbone, Barrie; Jankowski, Janusz A. Z.] Leicester Royal Infirm, Ctr Digest Dis, Leicester, Leics, England; [Bhandari, Pradeep] Queen Alexandra Hosp, Gastroenterol & Hepatol Serv, Portsmouth, Hants, England; [Paterson, Stuart] Forth Valley Royal Hosp, Dept Gastroenterol, Larbert, England; [Edwards, Cathryn] Torbay Hosp, Dept Gastroenterol, Torquay, England; [Penman, Ian] Western Gen Hosp, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Penman, Ian] Royal Infirm Edinburgh NHS Trust, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Vaidya, Kishor] Victoria Hosp, Gastrointestinal Unit, Kirkcaldy, England; [Ang, Yeng] Natl Hlth Serv NHS Trust, Dept Gastroenterol, Royal Albert Edward Infirm, Wigan, England; [Murray, Iain] Royal Cornwall Hosp, Dept Gastroenterol, Truro, England; [Patel, Praful] Southampton Univ Hosp, NHS Trust, Dept Gastroenterol, Southampton, Hants, England; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mullins, Paul] NHS Trust Royal Blackburn Hosp, E Lancashire Hosp, Dept Gastroenterol, Blackburn, Lancs, England; [Wu, Anna H.] Univ So Calif, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Bird, Nigel C.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Dallal, Helen] S Tees NHS Fdn Trust, Middlesbrough, Cleveland, England; [Shaheen, Nicholas J.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Murray, Liam J.] Queens Univ, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Koss, Konrad] Macclesfield Gen Hosp, Dept Gastroenterol, Macclesfield, Cheshire, England; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Romero, Yvonne] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Hardie, Laura J.] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England; [Winter, Helen] Great Western Hosp, Dept Oncol, Swindon, Wilts, England; [Corley, Douglas A.] Kaiser Permanente, Oakland Med Ctr, Div Res, Oakland, CA USA; [Panter, Simon] S Tyneside Dist Hosp, Dept Gastroenterol, S Shields, England; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Sargeant, Ian] Lister Hosp, Gastroenterol & Hepatol Serv, London, England; [Gammon, Marilie D.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Smart, Howard] Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool, Merseyside, England; [Smart, Howard] Royal Liverpool Univ Hosp, Dept Hepatol, Liverpool, Merseyside, England; [Dhar, Anjan] Cty Durham & Darlington NHS Fdn Trust, Darlington, Durham, England; [McMurtry, Hugh] Lancashire Teaching Hosp NHS Fdn Trust, Chorley, England; [Ali, Haythem] Maidstone Hlth Author, Dept Surg, Maidstone, Kent, England; [Liu, Geoffrey] Univ Toronto, Dept Med, Princess Margaret Hosp, Univ Hlth Network,Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Liu, Geoffrey] Univ Toronto, Dept Med Biophys, Princess Margaret Hosp, Univ Hlth Network,Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Liu, Geoffrey] Univ Toronto, Div Epidemiol, Princess Margaret Hosp, Univ Hlth Network,Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Chow, Wong-Ho] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Rutter, Matt] Univ Hosp N Tees, Dept Gastroenterol, Stockton On Tees, England; [Tawil, Ashref] N Devon Dist Hosp, Gastroenterol & Hepatol Serv, Barnstaple, England; [Morris, Danielle] E&N Herts NHS Trust, Queen Elizabeth Hosp, Dept Gastroenterol, Welwyn Garden City, Herts, England; [Nwokolo, Chuka] Univ Hosp Coventry, Dept Gastroenterol, Coventry, W Midlands, England; [Isaacs, Peter] Blackpool Victoria Hosp, Gastroenterol & Hepatol Serv, Blackpool, England; [Rodgers, Colin] Antrim & Whiteabbey United Hosp, Dept Gastroenterol, Whiteabbey, Antrim, North Ireland; [Ragunath, Krish] Queens Med Ctr, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England; [MacDonald, Chris] Cumberland Infirm, Gastroenterol Clin, Carlisle, England; [Haigh, Chris] Wansbeck Gen Hosp, Dept Gastroenterol, Ashington, England; [Monk, David] Countess Chester Hosp, Dept Gen Surg, Chester, Cheshire, England; [Davies, Gareth] Harrogate Dist Hosp, Gastroenterol & Hepatol Serv, Harrogate, England; [Wajed, Saj] Royal Devon & Exeter NHS Fdn Trust, Dept Thorac & Upper Gastrointestinal Surg, Exeter, Devon, England; [Johnston, David] Ninewells Hosp, Dept Gastroenterol, Dundee DD1 9SY, Scotland; [Gibbons, Michael] Craigavon Area Hosp, Dept Gastroenterol, Craigavon, England; [Cullen, Sue] Wycombe Hosp, Dept Gastroenterol, High Wycombe, Bucks, England; [Church, Nicholas] Royal Edinburgh Infirm, Ctr Liver & Digest Dis, Edinburgh, Midlothian, Scotland; [Langley, Ruth] MRC, Clin Trials Unit, London, England; [Griffin, Michael] Royal Victoria Infirm, No Osophago Gastirc Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Alderson, Derek] Univ Birmingham, Queen Elizabeth Hosp, Acad Dept Surg, Sch Canc Sci,Coll Med & Dent Sci, Birmingham B15 2TH, W Midlands, England; [Anderson, Mark] City Hosp Birmingham, Gastrointestinal Unit, Birmingham, W Midlands, England; [Brooks, Claire] Univ Oxford, Dept Oncol, Oncol Clin Trials Off, Oxford, England; [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Bramon, Elvira] Kings Coll London, Dept Psychoisis Studies, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth,Inst Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London, England; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Inst Mol Med, Dublin, Ireland; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Markus, Hugh S.] St Georges Univ London, Ctr Clin Neurosci, London, England; [Mathew, Christopher G.; Trembath, Richard C.] Guys Hosp, Dept Med & Mol Genet, Kings Coll London, London SE1 9RT, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Trynka, Gosia; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Trynka, Gosia; Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Atherfold, Paul] UCB Pharma, Slough, Berks, England; [Atherfold, Paul] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Cunningham, David] Royal Marsden Hosp, Gastrointestinal Unit, London SW3 6JJ, England; [Lind, Tore] AstraZeneca, Res & Dev, Lund, Sweden; [Hapeshi, Julie] Gloucestershire Royal Hosp, Gloucestershire Res & Dev Support Unit, Gloucester GL1 3NN, England; [Ferry, David] Royal Wolverhampton Hosp NHS Trust, New Cross Hosp, Dept Oncol, Wolverhampton, W Midlands, England; [Brown, Julia] Leeds Inst Mol Med, Clin Trial Res Unit, Leeds, W Yorkshire, England; [Love, Sharon] Ctr Stat Med, Oxford Clin Trials Res Unit, Oxford, England; [Sanders, Scott] Warwick Hosp, Dept Cellular Pathol, Warwick, England; [Harrison, Rebecca F.] Leicester Royal Infirm, Dept Pathol, Leicester LE2 7LX, Leics, England; [Moayyedi, Paul] McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada; [de Caestecker, John] Leicester Gen Hosp, Dept Gastroenterol, Leicester LE5 4PW, Leics, England; [Barr, Hugh] Gloucestershire Royal Hosp, Dept Upper Gastrointestinal Surg, Gloucester GL1 3NN, England; [Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Jankowski, Janusz A. Z.] Univ Oxford, Gastrointestinal Canc Grp, Oxford, England	University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; QIMR Berghofer Medical Research Institute; University of London; University College London; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of London; Queen Mary University London; University of London; Queen Mary University London; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Saint James's University Hospital; University of Leeds; KU Leuven; University Hospital Leuven; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Aberdeen; University of Leicester; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Royal Cornwall Hospital; University of Southampton; Karolinska Institutet; University of Southern California; University of Sheffield; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Queens University Belfast; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Mayo Clinic; University of Leeds; Kaiser Permanente; Yale University; Fred Hutchinson Cancer Center; Lister Hospital; University of North Carolina; University of North Carolina Chapel Hill; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University Hospital of North Tees; University of Warwick; University of Nottingham; University of Exeter; University of Dundee; Royal Infirmary of Edinburgh; Medical Research Council Clinical Trials Unit; Newcastle University - UK; University of Birmingham; University of Oxford; Telethon Kids Institute; University of Western Australia; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust; University of Queensland; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Trinity College Dublin; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Groningen; University of Groningen; UCB Pharma SA; University of Oxford; Royal Marsden NHS Foundation Trust; AstraZeneca; Gloucestershire Royal Hospital; New Cross Hospital; University of Leeds; University of Oxford; University of Leicester; McMaster University; University Hospitals of Leicester NHS Trust; Leicester General Hospital; Gloucestershire Royal Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fred Hutchinson Cancer Center; University of Oxford; University of Oxford	Jankowski, JAZ (corresponding author), Queen Mary Univ London, Ctr Digest Dis, Blizard Inst, London, England.	iant@well.ox.ac.uk; donnelly@well.ox.ac.uk; j.a.jankowski@qmul.ac.uk	Drenth, Joost/V-7436-2019; Shaheen, Nicholas J/A-1898-2013; Peters, W.H.M./L-4572-2015; Bramon, Elvira/A-9463-2011; Cazier, Jean-Baptiste/F-2369-2010; Moayyedi, Paul/M-6178-2014; Bramon, Elvira/HHC-3809-2022; Rutter, Michael/C-8570-2013; Kuipers, Ernst J/H-3293-2019; Drenth, J.P.H./H-8025-2014; Macgregor, Stuart/C-6442-2009; Barr, Hugh/G-4673-2014; Cazier, Jean-Baptiste/GLR-2949-2022; Mathew, Christopher G/G-3434-2015; van der Laan, Luc/M-5495-2019; Hardie, Laura/AAY-6724-2020; Jankowski, Janusz/H-2706-2012; Belllenguez, Céline/Y-3183-2018; Bellenguez, Céline/X-4004-2019; Wijmenga, Cisca/AAE-7719-2019; Reid, Brian John/AFT-8587-2022; Liu, Geoffrey/N-4421-2016; McManus, Ross/AAE-9236-2020; Brown, Matthew A/E-5749-2010; Wijmenga, Cisca/D-2173-2009; Deloukas, Panos/B-2922-2013; Blackwell, Jenefer M/H-3015-2015; Siersema, Peter/V-1636-2019; Peppelenbosch, Maikel P./U-5304-2019; Palmer, Colin NA/C-7053-2008; Whiteman, David C/P-2728-2014; Wood, Nicholas/C-2505-2009	Cazier, Jean-Baptiste/0000-0001-7581-9051; Moayyedi, Paul/0000-0002-3616-9292; Bramon, Elvira/0000-0003-1369-5983; Kuipers, Ernst J/0000-0002-0633-3098; Macgregor, Stuart/0000-0001-6731-8142; Barr, Hugh/0000-0002-2919-5660; Cazier, Jean-Baptiste/0000-0001-7581-9051; Mathew, Christopher G/0000-0003-4178-1838; van der Laan, Luc/0000-0002-0651-5334; Hardie, Laura/0000-0001-5039-2100; Jankowski, Janusz/0000-0003-2130-9181; Belllenguez, Céline/0000-0002-1240-7874; Bellenguez, Céline/0000-0002-1240-7874; Wijmenga, Cisca/0000-0002-5635-1614; Reid, Brian John/0000-0002-9613-979X; Brown, Matthew A/0000-0003-0538-8211; Deloukas, Panos/0000-0001-9251-070X; Palmer, Colin NA/0000-0002-6415-6560; Whiteman, David C/0000-0003-2563-9559; Reynolds, John V/0000-0002-5501-9521; Cooper, Sheldon/0000-0003-3621-4345; Walters, James/0000-0002-6980-4053; Pirinen, Matti/0000-0002-1664-1350; Liu, Geoffrey/0000-0002-2603-7296; Wajed, Shahjehan/0000-0002-8767-0490; Ang, Yeng/0000-0003-0496-6710; Peppelenbosch, Maikel/0000-0001-9112-6028; Lescai, Francesco/0000-0002-6399-9101; Hunt, Sarah/0000-0002-8350-1235; Palles, Claire/0000-0002-9670-2263; McManus, Ross/0000-0002-0529-9617; Love, Sharon/0000-0002-6695-5390; Wood, Nicholas/0000-0002-9500-3348; bhandari, pradeep/0000-0002-1241-2083; Stupka, Elia/0000-0003-3154-4011; Prenen, Hans/0000-0001-8802-7352; Ghanbarian, Avazeh/0000-0003-3920-5807; Ragunath, Krish/0000-0001-6571-5435; Cunningham, David/0000-0001-5158-1069; de Caestecker, John/0000-0001-5526-8176; Murray, Iain/0000-0002-1795-3647; Corvin, Aiden/0000-0001-6717-4089; Sasieni, Peter/0000-0003-1509-8744; Trynka, Gosia/0000-0002-6955-9529; Donnelly, Peter/0000-0001-9495-3408; Plomin, Robert/0000-0002-0756-3629; Bisschops, Raf/0000-0002-9994-8226; Trembath, Richard/0000-0003-0550-3400	WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; Wellcome Trust [072894/Z/03/Z, 090532/Z/09/Z, 075491/Z/04/B, 068545/Z/02]; Wolfson-Royal Society Merit Award; Australian Research Council; Australian National Health & Medical Research Council (NHMRC) Career Development Award; Wellcome Trust Fellowship [097364/Z/11/Z]; UK Medical Research Council [G0000934]; UK National Blood Service controls; Esophageal Adenocarcinoma GenE Consortia incorporating the ChOPIN project [C548/A5675]; AspECT [HDRMJQ0]; BOSS clinical trials project [MGAG1G7R]; Cancer Research UK (AspECT) [C548/A4584, D9612L00090]; Histological AssessmeNt Determining EpitheliaL Response (HANDEL) [C548/A9085]; AstraZeneca UK educational grant; University Hospitals of Leicester R and D grant; US National Institutes of Health [R01CA13672501]; Health Research Board and the Wellcome Trust; Science Foundation Ireland [09/IN.1/B2640]; MRC [G0000934, G0901310] Funding Source: UKRI; Medical Research Council [G0901310, G0000934] Funding Source: researchfish; National Institute for Health Research [05/12/01, NF-SI-0507-10379, PDA/02/06/016, NF-SI-0611-10065] Funding Source: researchfish; Chief Scientist Office [ETM/116, CZB/4/747] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA091955, R01CA072866, P30CA015704, R01CA136725, K05CA124911] Funding Source: NIH RePORTER	WTCCC2 project; Wellcome Trust(Wellcome TrustEuropean Commission); Wolfson-Royal Society Merit Award(Royal Society of London); Australian Research Council(Australian Research Council); Australian National Health & Medical Research Council (NHMRC) Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Fellowship(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Blood Service controls; Esophageal Adenocarcinoma GenE Consortia incorporating the ChOPIN project; AspECT; BOSS clinical trials project; Cancer Research UK (AspECT); Histological AssessmeNt Determining EpitheliaL Response (HANDEL); AstraZeneca UK educational grant(AstraZeneca); University Hospitals of Leicester R and D grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Board and the Wellcome Trust; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the individuals with Barrett's esophagus who participated in the study and the physicians who helped in recruitment. We thank the many research nurses who also helped recruit, including S. Prew. We thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, A. Wilk, C. R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We also thank J. Barrett for design of the Immunochip array. Funding for this study was provided by the WTCCC2 project (085475/B/08/Z and 085475/Z/08/Z) and the Wellcome Trust (072894/Z/03/Z, 090532/Z/09/Z and 075491/Z/04/B). P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. D.C.W. is supported by a Future Fellowship from the Australian Research Council. S.M. is supported by an Australian National Health & Medical Research Council (NHMRC) Career Development Award. C.C.A.S. was supported by a Wellcome Trust Fellowship (097364/Z/11/Z). We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the UK Medical Research Council (grant G0000934) and the Wellcome Trust (grant 068545/Z/02), the UK National Blood Service controls, funded by the Wellcome Trust, and the People of the British Isles collection, funded by the Wellcome Trust. This work was also supported by the Esophageal Adenocarcinoma GenE Consortia incorporating the ChOPIN project (grant C548/A5675) and Inherited Predisposition of neoplasia analysis of genomic DNA (IPOD) from AspECT and BOSS clinical trials project (grant MGAG1G7R); Cancer Research UK (AspECT, grants C548/A4584 and D9612L00090, and Histological AssessmeNt Determining EpitheliaL Response (HANDEL), grant C548/A9085); AstraZeneca UK educational grant; University Hospitals of Leicester R and D grant; and AspECT (T91 5211 University of Oxford grant HDRMJQ0). The Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS) within the BEACON Consortium was supported by US National Institutes of Health grant R01CA13672501. We acknowledge the Dublin Centre for Clinical Research (funded by the Health Research Board and the Wellcome Trust) for support in sample collection and the Irish Blood Transfusion Service and TCD DNA Biobank for provision of control samples. R.M. is supported by the Science Foundation Ireland grant 09/IN.1/B2640.	Akiyama T, 2011, DIGESTION, V83, P142, DOI 10.1159/000321810; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Chak A, 2002, GUT, V51, P323, DOI 10.1136/gut.51.3.323; Chak A, 2006, CANCER EPIDEM BIOMAR, V15, P1668, DOI 10.1158/1055-9965.EPI-06-0293; Corley DA, 2001, INT J EPIDEMIOL, V30, P1415, DOI 10.1093/ije/30.6.1415; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Drovdlic CM, 2003, J MED GENET, V40, P651, DOI 10.1136/jmg.40.9.651; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000694; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jankowski J, 2006, BRIT MED J, V332, P1512, DOI 10.1136/bmj.332.7556.1512; Jankowski JA, 2000, LANCET, V356, P2079, DOI 10.1016/S0140-6736(00)03411-5; Jankowski JA, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31599; Jankowski J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4551; Koek GH, 2008, GUT, V57, P1056, DOI 10.1136/gut.2006.119206; Kulig M, 2004, J CLIN EPIDEMIOL, V57, P580, DOI 10.1016/j.jclinepi.2003.10.010; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Martin V, 2010, PEDIATR SURG INT, V26, P769, DOI 10.1007/s00383-010-2622-5; Moayyedi P, 2008, ALIMENT PHARM THERAP, V27, P316, DOI 10.1111/j.1365-2036.2007.03582.x; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Robertson EV, 2008, AM J GASTROENTEROL, V103, P443, DOI 10.1111/j.1572-0241.2007.01574.x; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shalauta MD, 2004, AM FAM PHYSICIAN, V69, P2113; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Shepherd N.A., 2005, REPORT WORKING PARTY, P1; Sikkema M, 2010, CLIN GASTROENTEROL H, V8, P235, DOI 10.1016/j.cgh.2009.10.010; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Sun XQ, 2010, CANCER EPIDEM BIOMAR, V19, P666, DOI 10.1158/1055-9965.EPI-09-1136; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Thomas T, 2007, ALIMENT PHARM THER, V26, P1465, DOI 10.1111/j.1365-2036.2007.03528.x; Trudgill NJ, 1999, AM J GASTROENTEROL, V94, P1172, DOI 10.1016/S0002-9270(99)00116-1; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Winberg H, 2012, SCAND J GASTROENTERO, V47, P397, DOI 10.3109/00365521.2012.667145; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127	47	127	128	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1131	+		10.1038/ng.2408	http://dx.doi.org/10.1038/ng.2408			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22961001	Green Accepted, Green Submitted			2022-12-25	WOS:000309550200014
J	Granier, S; Kobilka, B				Granier, Sebastien; Kobilka, Brian			A new era of GPCR structural and chemical biology	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; OPIOID RECEPTOR; COMPLEX; ANTAGONIST; INSIGHTS; RHODOPSIN	G protein-coupled receptors (GPCRs) are versatile molecular machines that regulate the majority of physiological responses to chemically diverse hormones and neurotransmitters. Recent breakthroughs in structural studies have advanced our understanding of GPCR signaling, particularly the selectivity of ligand recognition and receptor activation of G proteins.	[Granier, Sebastien; Kobilka, Brian] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Granier, S (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu	Granier, Sebastien/J-1089-2016; Centeno, Patricia Pacios/O-8368-2016	Kobilka, Brian/0000-0001-5958-3990	NINDS NIH HHS [R01 NS028471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schertler GFX, 1998, EYE, V12, P504, DOI 10.1038/eye.1998.138; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	25	152	156	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					670	673		10.1038/nchembio.1025	http://dx.doi.org/10.1038/nchembio.1025			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22810761	Green Accepted			2022-12-25	WOS:000306527600002
J	Okuno, Y; Nakamura-Ishizu, A; Otsu, K; Suda, T; Kubota, Y				Okuno, Yuji; Nakamura-Ishizu, Ayako; Otsu, Kinya; Suda, Toshio; Kubota, Yoshiaki			Pathological neoangiogenesis depends on oxidative stress regulation by ATM	NATURE MEDICINE			English	Article							OXYGEN-INDUCED RETINOPATHY; ATAXIA-TELANGIECTASIA; PROTEIN-KINASE; DNA-DAMAGE; TUMOR ANGIOGENESIS; HISTONE H2AX; MOUSE MODEL; MECHANISMS; CELLS; VEGF	The ataxia telangiectasia mutated (ATM) kinase, a master regulator of the DNA damage response (DDR), acts as a barrier to cellular senescence and tumorigenesis. Aside from DDR signaling, ATM also functions in oxidative defense. Here we show that Atm in mice is activated specifically in immature vessels in response to the accumulation of reactive oxygen species (ROS). Global or endothelial-specific Atm deficiency in mice blocked pathological neoangiogenesis in the retina. This block resulted from increased amounts of ROS and excessive activation of the mitogen activated kinase p38 alpha rather than from defects in the canonical DDR pathway. Atm deficiency also lowered tumor angiogenesis and enhanced the antiangiogenic action of vascular endothelial growth factor (Vegf) blockade. These data suggest that pathological neoangiogenesis requires ATM-mediated oxidative defense and that agents that promote excessive ROS generation may have beneficial effects in the treatment of neovascular disease.	[Okuno, Yuji; Kubota, Yoshiaki] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Nakamura-Ishizu, Ayako; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab, Dept Cell Differentiat, Tokyo, Japan; [Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan	Keio University; Keio University; Osaka University	Kubota, Y (corresponding author), Kings Coll London, Div Cardiovasc, London WC2R 2LS, England.	ykubo33@a3.keio.jp	Kubota, Yoshiaki/L-2231-2013; Suda, Toshio/H-6761-2013	Suda, Toshio/0000-0001-7540-1771; Okuno, Yuji/0000-0001-7345-4618	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; AstraZeneca Virtual Research Institute Research Grant; Keio Kanrinmaru Project	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); AstraZeneca Virtual Research Institute Research Grant; Keio Kanrinmaru Project	We thank S. Kobayashi for outstanding technical support. We also thank F.W. Alt (Howard Hughes Medical Institute, Children's Hospital, Immune Disease Institute and Harvard Medical School) for providing Atm<SUP>flox/flox</SUP> mice, P.J. McKinnon (St. Jude Children's Research Hospital) for providing Atm<SUP>-/-</SUP> mice and H. Saya (Division of Gene Regulation, Keio University) for providing p53<SUP>-/-</SUP> mice. This work was supported by Grants-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by a research grant from Takeda Science Foundation, by the AstraZeneca Virtual Research Institute Research Grant and by the Keio Kanrinmaru Project.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BODER E, 1958, PEDIATRICS, V21, P526; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hida K, 2005, CANCER RES, V65, P2507, DOI 10.1158/0008-5472.CAN-05-0002; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P1205, DOI 10.1007/s00417-009-1116-4; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Pan H, 2004, INVEST OPHTH VIS SCI, V45, P2413, DOI 10.1167/iovs.03-1001; Ratner M, 2004, NAT BIOTECHNOL, V22, P1198, DOI 10.1038/nbt1004-1198; Raz-Prag D, 2011, AM J PATHOL, V179, P1533, DOI 10.1016/j.ajpath.2011.05.026; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Zha S, 2011, P NATL ACAD SCI USA, V108, P2028, DOI 10.1073/pnas.1019293108; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153	46	111	113	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1208	+		10.1038/nm.2846	http://dx.doi.org/10.1038/nm.2846			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22797809				2022-12-25	WOS:000307469300026
J	Onaran, HO; Costa, T				Onaran, H. Ongun; Costa, Tommaso			Where have all the active receptor states gone?	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; TERNARY COMPLEX MODEL; 7-TRANSMEMBRANE RECEPTORS; ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; PLAUSIBLE MODEL; BINDING; AGONIST; ADRENOCEPTOR; ALLOSTERY	Defining G protein-coupled receptor ligand efficacy and biased agonism in precise chemical terms is one challenge posed by the current structural data that exists for this receptor family. Concepts classically used for understanding enzymes and other nonreceptor proteins may lead us in the right direction.	[Onaran, H. Ongun] Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey; [Costa, Tommaso] Ist Super Sanita, Dipartimento Farmaco, I-00161 Rome, Italy	Ankara University; Istituto Superiore di Sanita (ISS)	Onaran, HO (corresponding author), Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey.	ongun.onaran@medicine.ankara.edu.tr; tommaso.costa@iss.it	costa, tommaso/AAD-3714-2019; Onaran, Ongun/AAI-5348-2020	costa, tommaso/0000-0002-8729-3357; Onaran, Ongun/0000-0001-6766-4774				COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Freire E, 2000, P NATL ACAD SCI USA, V97, P11680, DOI 10.1073/pnas.97.22.11680; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Onaran HO, 2009, CURR PROTEIN PEPT SC, V10, P110, DOI 10.2174/138920309787847644; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; WYMAN J, 1965, J MOL BIOL, V11, P631, DOI 10.1016/S0022-2836(65)80017-1; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	25	26	26	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	AUG	2012	8	8					674	677		10.1038/nchembio.1024	http://dx.doi.org/10.1038/nchembio.1024			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975RC	22810762				2022-12-25	WOS:000306527600003
J	Pal, D; Dasgupta, S; Kundu, R; Maitra, S; Das, G; Mukhopadhyay, S; Ray, S; Majumdar, SS; Bhattacharya, S				Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Maitra, Sudipta; Das, Gobardhan; Mukhopadhyay, Satinath; Ray, Sukanta; Majumdar, Subeer S.; Bhattacharya, Samir			Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance	NATURE MEDICINE			English	Article							SATURATED FATTY-ACIDS; FACTOR-KAPPA-B; ADIPOSE-TISSUE; OBESITY; EXPRESSION; INFLAMMATION; ADIPOCYTES; ADIPONECTIN; MECHANISMS; PATHWAY	Toll-like receptor 4 (TLR4) has a key role in innate immunity by activating an inflammatory signaling pathway. Free fatty acids (FFAs) stimulate adipose tissue inflammation through the TLR4 pathway, resulting in insulin resistance(1-7). However, current evidence suggests that FFAs do not directly bind to TLR4(8,9), but an endogenous ligand for TLR4 remains to be identified. Here we show that fetuin-A (FetA) could be this endogenous ligand and that it has a crucial role in regulating insulin sensitivity via Tlr4 signaling in mice. FetA (officially known as Ahsg) knockdown in mice with insulin resistance caused by a high-fat diet (HFD) resulted in downregulation of Tlr4-mediated inflammatory signaling in adipose tissue, whereas selective administration of FetA induced inflammatory signaling and insulin resistance. FFA-induced proinflammatory cytokine expression in adipocytes occurred only in the presence of both FetA and Tlr4; removing either of them prevented FFA-induced insulin resistance. We further found that FetA, through its terminal galactoside moiety, directly binds the residues of Leu100-Gly123 and Thr493-Thr516 in Tlr4. FFAs did not produce insulin resistance in adipocytes with mutated Tlr4 or galactoside-cleaved FetA. Taken together, our results suggest that FetA fulfills the requirement of an endogenous ligand for TLR4 through which lipids induce insulin resistance. This may position FetA as a new therapeutic target for managing insulin resistance and type 2 diabetes.	[Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Maitra, Sudipta; Bhattacharya, Samir] Visva Bharati, Sch Life Sci, Ctr Adv Studies Zool, Cellular & Mol Endocrinol Lab, Santini Ketan, W Bengal, India; [Dasgupta, Suman; Bhattacharya, Samir] NEIST, CSIR, Jorhat, Assam, India; [Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Mukhopadhyay, Satinath] Seth Sukhlal Karnani Mem Hosp IPGME&R SSKM Hosp, Postgrad Inst Med Educ & Res, Dept Endocrinol & Metab, Kolkata, India; [Ray, Sukanta] IPGME&R SSKM Hosp, Div Surg Gastroenterol, Kolkata, India; [Majumdar, Subeer S.] Natl Inst Immunol, Div Cellular Endocrinol, New Delhi 110067, India	Visva Bharati University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bhattacharya, S (corresponding author), Visva Bharati, Sch Life Sci, Ctr Adv Studies Zool, Cellular & Mol Endocrinol Lab, Santini Ketan, W Bengal, India.	bhattacharyasa@gmail.com	MAITRA, SUDIPTA/P-3858-2017; Kundu, Rakesh Kundu/AAC-3543-2019; Dasgupta, Suman/B-8808-2013; Kundu, Rakesh/AAG-2582-2021; Kundu, Rakesh/ABE-3083-2021	MAITRA, SUDIPTA/0000-0002-1167-9333; Kundu, Rakesh Kundu/0000-0001-8871-0565; Dasgupta, Suman/0000-0003-2599-2299; Mukhopadhyay, Satinath/0000-0001-8033-5748; Majumdar, Subeer/0000-0003-1724-7483	CSIR; Department of Science and Technology, Ministry of Science and Technology, New Delhi; CSIR, New Delhi; University Grants Commission (UGC), New Delhi; CSIR-NEIST	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi(University Grants Commission, India); CSIR-NEIST	This research was financially supported by a grant from the CSIR and Department of Science and Technology, Ministry of Science and Technology, New Delhi. We thank the National Centre for Cell Science, Pune, India, for providing the 3T3L1 cell line; A. Bandyopadhyay and S. Roy of the Indian Institute of Chemical Biology, Kolkata for their help in the confocal and SPR work, respectively. D.P. is thankful to CSIR, New Delhi, for the award of Senior Research Fellowship. S.D. thanks the University Grants Commission (UGC), New Delhi, for the award of a UGC-Dr. D.S. Kothari postdoctoral fellowship and CSIR-NEIST for a Quick Hire Fellowship. S.B. thanks the Indian National Science Academy for his Senior Scientist position. G.D. gratefully acknowledges the gift of Tlr4<SUP>-/-</SUP> mice from R. Medzhitov, Yale School of Medicine. The authors appreciate the use of facilities as extended to us by the head of the Department of Zoology, Visva-Bharati University, Santiniketan; the director of IICB, director of IPGME&R-SSKM Hospital, Kolkata; the director of the National Institute of Immunology, director of ICGEB, New Delhi and the director of NEIST, Jorhat, India.	Barata TS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002095; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; CAYATTE AJ, 1990, J BIOL CHEM, V265, P5883; Dasgupta S, 2011, BBA-MOL BASIS DIS, V1812, P495, DOI 10.1016/j.bbadis.2011.01.001; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; de Luca C, 2006, NAT MED, V12, P41, DOI 10.1038/nm0106-41; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mellgren RL, 2007, J BIOL CHEM, V282, P35868, DOI 10.1074/jbc.M706929200; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Suganami T, 2017, BIOCH BIOPHYS RES CO, V354, P45; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	42	586	610	0	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1279	+		10.1038/nm.2851	http://dx.doi.org/10.1038/nm.2851			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22842477				2022-12-25	WOS:000307469300035
J	Shi, LH; Cui, SY; Engel, JD; Tanabe, O				Shi, Lihong; Cui, Shuaiying; Engel, James D.; Tanabe, Osamu			Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction	NATURE MEDICINE			English	Article							NUCLEAR RECEPTORS; GLOBIN; MICE; TR2	Enhanced fetal gamma-globin synthesis alleviates symptoms of beta-globinopathies such as sickle cell disease and beta-thalassemia, but current gamma-globin-inducing drugs offer limited beneficial effects. We show here that lysine-specific demethylase 1 (LSD1) inhibition by RNAi in human erythroid cells or by the monoamine oxidase inhibitor tranylcypromine in human erythroid cells or beta-type globin-transgenic mice enhances gamma-globin expression. LSD1 is thus a promising therapeutic target for gamma-globin induction, and tranylcypromine may serve as a lead compound for the development of a new gamma-globin inducer.	[Shi, Lihong; Cui, Shuaiying; Engel, James D.; Tanabe, Osamu] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Tanabe, Osamu] Tohoku Univ, Tohoku Med Megabank, Dept Integrat Genom, Sendai, Miyagi 980, Japan	University of Michigan System; University of Michigan; Tohoku University	Engel, JD (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	engel@umich.edu; otanabe@umich.edu	Cui, Shuaiying/C-1154-2011	xing zhi, shi zhi/0000-0003-3289-5681	US National Institutes of Health [DK086956, HL24415]; American Heart Association postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants DK086956 (to O.T. and J.D.E.) and HL24415 (to J.D.E.) and an American Heart Association postdoctoral fellowship to L.S. We thank D. Giacherio and D. Harro for hemoglobin HPLC analysis; C. Yu, A.D. Campbell, K.C. Lim, T. Hosoya, B. Godfrey and M. Sierant for discussions, comments and technical assistance; and D. Lavelle and J. DeSimone for discussions regarding the inductive properties of decitabine. Lentiviruses were produced by the University of Michigan Vector Core. Microarray analysis was performed at the University of Michigan Microarray Core.	Banzon V, 2011, EXP HEMATOL, V39, P26, DOI 10.1016/j.exphem.2010.10.003; Buller AM, 1999, BLOOD CELL MOL DIS, V25, P255, DOI 10.1006/bcmd.1999.0252; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; Eyer F, 2008, CLIN TOXICOL, V46, P261, DOI 10.1080/15563650601118085; Frieling H, 2006, EUR ARCH PSY CLIN N, V256, P268, DOI 10.1007/s00406-006-0660-8; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; MALLINGER AG, 1991, PSYCHOPHARMACOL BULL, V27, P493; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Parseval LAM, 2008, J CLIN INVEST, V118, P248, DOI 10.1172/JCI32322; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Testa U, 2009, ANN HEMATOL, V88, P505, DOI 10.1007/s00277-008-0637-y; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053	20	125	149	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					291	294		10.1038/nm.3101	http://dx.doi.org/10.1038/nm.3101			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23416702	Green Accepted			2022-12-25	WOS:000316040700021
J	Kaylor, JJ; Yuan, Q; Cook, J; Sarfare, S; Makshanoff, J; Miu, A; Kim, A; Kim, P; Habib, S; Roybal, CN; Xu, TZ; Nusinowitz, S; Travis, GH				Kaylor, Joanna J.; Yuan, Quan; Cook, Jeremy; Sarfare, Shanta; Makshanoff, Jacob; Miu, Anh; Kim, Anita; Kim, Paul; Habib, Samer; Roybal, C. Nathaniel; Xu, Tongzhou; Nusinowitz, Steven; Travis, Gabriel H.			Identification of DES1 as a vitamin A isomerase in Muller glial cells of the retina	NATURE CHEMICAL BIOLOGY			English	Article							RETINALDEHYDE-BINDING PROTEIN; ALL-TRANS-RETINOL; DIHYDROCERAMIDE DESATURASE; PIGMENT REGENERATION; RPE65; LOCALIZATION; RODS; ISOMEROHYDROLASE; DEHYDROGENASE; SENSITIVITY	Absorption of a light particle by an opsin-pigment causes photoisomerization of its retinaldehyde chromophore. Restoration of light sensitivity to the resulting apo-opsin requires chemical re-isomerization of the photobleached chromophore. This is carried out by a multistep enzyme pathway called the visual cycle. Accumulating evidence suggests the existence of an alternative visual cycle for regenerating opsins in daylight. Here we identified dihydroceramide desaturase-1 (DES1) as a retinol isomerase and an excellent candidate for isomerase-2 in this alternative pathway. DES1 is expressed in retinal Muller cells, where it coimmuno-precipitates with cellular retinaldehyde binding protein (CRALBP). Adenoviral gene therapy with DES1 partially rescued the biochemical and physiological phenotypes in Rpe65(-/-) mice lacking isomerohydrolase (isomerase-1). Knockdown of DES1 expression by RNA interference concordantly reduced isomerase-2 activity in cultured Muller cells. Purified DES1 had very high isomerase-2 activity in the presence of appropriate cofactors, suggesting that DES1 by itself is sufficient for isomerase activity.	[Kaylor, Joanna J.; Yuan, Quan; Cook, Jeremy; Sarfare, Shanta; Makshanoff, Jacob; Miu, Anh; Kim, Anita; Kim, Paul; Habib, Samer; Roybal, C. Nathaniel; Xu, Tongzhou; Nusinowitz, Steven; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaylor, JJ (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	travis@jsei.ucla.edu	yuan, quan/GZM-5597-2022; Kaylor, Joanna/Y-5184-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493	US National Eye Institute [R01-EY11713]; NATIONAL EYE INSTITUTE [R01EY011713, P30EY000331] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank R. Radu for insightful suggestions throughout this project and valuable comments on the manuscript, J. Hu and D. Bok for assistance with immunocytochemistry, M. Redmond (National Eye Institute) for providing Rpe65<SUP>-/-</SUP> mice, and R. Crouch (Medical University of South Carolina) for the gift of 11-cis-RAL. This work was supported by a grant to G.H.T. from the US National Eye Institute (R01-EY11713). G.H.T. is the Charles Kenneth Feldman Professor of Ophthalmology.	BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Beauchamp E, 2007, BIOCHIMIE, V89, P1553, DOI 10.1016/j.biochi.2007.07.001; Beauchamp E, 2009, BIOCHIMIE, V91, P1411, DOI 10.1016/j.biochi.2009.07.014; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Caruso RC, 2010, INVEST OPHTH VIS SCI, V51, P5304, DOI 10.1167/iovs.10-5559; Causeret C, 2000, LIPIDS, V35, P1117, DOI 10.1007/s11745-000-0627-6; CROUCH R, 1975, P NATL ACAD SCI USA, V72, P1538, DOI 10.1073/pnas.72.4.1538; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; EISENFELD AJ, 1985, EXP EYE RES, V41, P299, DOI 10.1016/S0014-4835(85)80020-8; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Farjo KM, 2009, INVEST OPHTH VIS SCI, V50, P5089, DOI 10.1167/iovs.09-3797; GOLDSTEI.EB, 1970, VISION RES, V10, P1065, DOI 10.1016/0042-6989(70)90082-9; Golovleva I, 2003, J BIOL CHEM, V278, P12397, DOI 10.1074/jbc.M207300200; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; HSU SC, 1994, J BIOL CHEM, V269, P17954; HUBBARD R, 1958, J GEN PHYSIOL, V42, P259, DOI 10.1085/jgp.42.2.259; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Mata NL, 2005, BIOCHEMISTRY-US, V44, P11715, DOI 10.1021/bi050942m; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Muniz A, 2009, BIOCHEMISTRY-US, V48, P6854, DOI 10.1021/bi9002937; Nusinowitz S, 2007, EXP EYE RES, V84, P1104, DOI 10.1016/j.exer.2007.02.009; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; RANDO RR, 1992, PHOTOCHEM PHOTOBIOL, V56, P1145, DOI 10.1111/j.1751-1097.1992.tb09739.x; RANDO RR, 1983, J AM CHEM SOC, V105, P2879, DOI 10.1021/ja00347a058; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rioux V, 2011, BBA-MOL CELL BIOL L, V1811, P1, DOI 10.1016/j.bbalip.2010.09.005; Rohrer B, 2003, INVEST OPHTH VIS SCI, V44, P310, DOI 10.1167/iovs.02-0567; SAARI JC, 1987, J BIOL CHEM, V262, P7618; Saari JC, 2009, MOL VIS, V15, P844; Savile CK, 2001, J AM CHEM SOC, V123, P4382, DOI 10.1021/ja010088w; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Trevino SG, 2005, J EXP BIOL, V208, P4151, DOI 10.1242/jeb.01881; Triola G, 2003, J ORG CHEM, V68, P9924, DOI 10.1021/jo030141u; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	48	79	81	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2013	9	1					30	+		10.1038/NCHEMBIO.1114	http://dx.doi.org/10.1038/NCHEMBIO.1114			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056JI	23143414	Green Submitted, Green Accepted			2022-12-25	WOS:000312484200009
J	Nesbit, MA; Hannan, FM; Howles, SA; Reed, AAC; Cranston, T; Thakker, CE; Gregory, L; Rimmer, AJ; Rust, N; Graham, U; Morrison, PJ; Hunter, SJ; Whyte, MP; McVean, G; Buck, D; Thakker, RV				Nesbit, M. Andrew; Hannan, Fadil M.; Howles, Sarah A.; Reed, Anita A. C.; Cranston, Treena; Thakker, Clare E.; Gregory, Lorna; Rimmer, Andrew J.; Rust, Nigel; Graham, Una; Morrison, Patrick J.; Hunter, Steven J.; Whyte, Michael P.; McVean, Gil; Buck, David; Thakker, Rajesh V.			Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3	NATURE GENETICS			English	Article							SENSING RECEPTOR MUTATIONS; CA2+-SENSING RECEPTOR; EXTRACELLULAR DOMAIN; BENIGN HYPERCALCEMIA; ADAPTER PROTEIN-2; CALCIUM; CLATHRIN; IDENTIFICATION; BINDING; LOCALIZATION	Adaptor protein-2 (AP2), a central component of clathrin-coated vesicles (CCVs), is pivotal in clathrin-mediated endocytosis, which internalizes plasma membrane constituents such as G protein-coupled receptors (GPCRs)(1-3). AP2, a heterotetramer of alpha, beta, mu and sigma subunits, links clathrin to vesicle membranes and binds to tyrosine-and dileucine-based motifs of membrane-associated cargo proteins(1,4). Here we show that missense mutations of AP2 s subunit (AP2S1) affecting Arg15, which forms key contacts with dileucine-based motifs of CCV cargo proteins(4), result in familial hypocalciuric hypercalcemia type 3 (FHH3), an extracellular calcium homeostasis disorder affecting the parathyroids, kidneys and bone(5-7). We found AP2S1 mutations in > 20% of cases of FHH without mutations in calcium-sensing GPCR (CASR)(8-12), which cause FHH1. AP2S1 mutations decreased the sensitivity of CaSR-expressing cells to extracellular calcium and reduced CaSR endocytosis, probably through loss of interaction with a C-terminal CaSR dileucine-based motif, whose disruption also decreased intracellular signaling. Thus, our results identify a new role for AP2 in extracellular calcium homeostasis.	[Nesbit, M. Andrew; Hannan, Fadil M.; Howles, Sarah A.; Reed, Anita A. C.; Thakker, Clare E.; Thakker, Rajesh V.] Univ Oxford, Acad Endocrine Unit, Nuffield Dept Clin Med, Oxford, England; [Cranston, Treena] Churchill Hosp, Oxford Mol Genet Lab, Oxford OX3 7LJ, England; [Gregory, Lorna; Rimmer, Andrew J.; McVean, Gil; Buck, David] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Rust, Nigel] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Graham, Una; Hunter, Steven J.] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland; [Morrison, Patrick J.] Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland; [Whyte, Michael P.] Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO USA	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Queens University Belfast	Thakker, RV (corresponding author), Univ Oxford, Acad Endocrine Unit, Nuffield Dept Clin Med, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Centeno, Patricia Pacios/O-8368-2016	Hannan, Fadil/0000-0002-2975-5170; Thakker, Rajesh/0000-0002-1438-3220; Howles, Sarah/0000-0001-6342-0895	UK Medical Research Council (MRC) [G9825289, G1000467]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; High-Throughput Genomics Group, Wellcome Trust Centre for Human Genetics (Wellcome Trust) [090532/Z/09/Z]; High-Throughput Genomics Group, Wellcome Trust Centre for Human Genetics (MRC Hub) [G0900747 91070]; Research and Development Office, Northern Ireland; Shriners Hospitals for Children [15958]; MRC [G1000467, G9825289] Funding Source: UKRI; Medical Research Council [G9825289, G1000467] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); High-Throughput Genomics Group, Wellcome Trust Centre for Human Genetics (Wellcome Trust); High-Throughput Genomics Group, Wellcome Trust Centre for Human Genetics (MRC Hub); Research and Development Office, Northern Ireland; Shriners Hospitals for Children; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MRC) programme grants G9825289 and G1000467 (to M.A.N., F. M. H., A. A. C. R., C. E. T. and R. V. T.); the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (to M.A.N. and R. V. T.); the High-Throughput Genomics Group, Wellcome Trust Centre for Human Genetics (Wellcome Trust grant reference 090532/Z/09/Z and MRC Hub grant G0900747 91070); the Research and Development Office, Northern Ireland (to U. G., S.J.H. and P.J.M.); and the Shriners Hospitals for Children (grant 15958) (to M. P. W.). S. A. H. is a Wellcome Trust Clinical Research Training Fellow.	Bataille S, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-57; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Fang Y, 1999, METHOD ENZYMOL, V302, P207, DOI 10.1016/S0076-6879(99)02020-0; Gaynor KU, 2009, J CLIN ENDOCR METAB, V94, P3897, DOI 10.1210/jc.2009-0717; Goldsmith PK, 1997, J BONE MINER RES, V12, P1780, DOI 10.1359/jbmr.1997.12.11.1780; Grant MP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002208; Guarnieri V, 2010, J CLIN ENDOCR METAB, V95, P1819, DOI 10.1210/jc.2008-2430; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hannan S, 2011, J BIOL CHEM, V286, P24324, DOI 10.1074/jbc.M110.220814; HEATH H, 1993, AM J HUM GENET, V53, P193; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; KIRCHHAUSEN T, 1991, J BIOL CHEM, V266, P11153; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd SE, 1999, AM J HUM GENET, V64, P189, DOI 10.1086/302202; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MCMURTRY CT, 1992, AM J MED, V93, P247, DOI 10.1016/0002-9343(92)90229-5; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Nesbit MA, 2010, J CLIN ENDOCR METAB, V95, P1947, DOI 10.1210/jc.2009-2152; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ohno H, 2006, J BIOCHEM, V139, P943, DOI 10.1093/jb/mvj120; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x	37	171	178	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					93	U135		10.1038/ng.2492	http://dx.doi.org/10.1038/ng.2492			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23222959	Green Accepted			2022-12-25	WOS:000312838800019
J	Huang, J; Nguyen-McCarty, M; Hexner, EO; Danet-Desnoyers, G; Klein, PS				Huang, Jian; Nguyen-McCarty, Michelle; Hexner, Elizabeth O.; Danet-Desnoyers, Gwenn; Klein, Peter S.			Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways	NATURE MEDICINE			English	Article							EX-VIVO EXPANSION; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; SELF-RENEWAL; WNT/BETA-CATENIN; PROGENITOR CELLS; QUIESCENCE; RECEPTOR; DEFECTS; REGENERATION	Hematopoietic stem cell (HSC) self renewal and lineage commitment depend on complex interactions with the microenvironment. The ability to maintain or expand HSCs for clinical applications or basic research has been substantially limited because these interactions are not well defined. Recent evidence suggests that HSCs reside in a low-perfusion, reduced-nutrient niche and that nutrient-sensing pathways contribute to HSC homeostasis. Here we report that suppression of the mTOR pathway, an established nutrient sensor, combined with activation of canonical Wnt-beta-catenin signaling, allows for the ex vivo maintenance of human and mouse long-term HSCs under cytokine-free conditions. We also show that the combination of two clinically approved medications that together activate Wnt-beta-catenin and inhibit mTOR signaling increases the number (but not the proportion) of long-term HSCs in vivo.	[Huang, Jian; Hexner, Elizabeth O.; Danet-Desnoyers, Gwenn; Klein, Peter S.] Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA; [Nguyen-McCarty, Michelle; Klein, Peter S.] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Hexner, Elizabeth O.] Univ Penn, Abramson Canc Ctr, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA.	pklein@mail.med.upenn.edu	Hexner, Elizabeth/AAC-1442-2020	Hexner, Elizabeth/0000-0002-1125-4060	Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; US National Institutes of Health [1R21HL107968-01, 1R01HL110806-01, K99, 1K99HL10774701, 1-K23-HL-093366-01A1]; Leukemia and Lymphoma Society; University of Pennsylvania; Human Hematopoietic Stem Cell Center of Excellence at the Children's Hospital of Philadelphia [5P30DK090969-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093366, R01HL110806, R21HL107968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090969] Funding Source: NIH RePORTER	Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of Pennsylvania; Human Hematopoietic Stem Cell Center of Excellence at the Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Tong, N. Speck, A. Bhandoola, A. Chi and H.-C. Huang for insightful comments and discussion. We also thank A. Bhandoola (University of Pennsylvania) for providing OP9 and OP9-DL1 cells. We thank J. Garskof, A. Christian and A. Mezochow for technical help and all members of the Klein lab for help and discussions. We specially thank A. Secreto and C. Keefer of the Stem Cell and Xenograft Core and Flow Cytometry and Cell Sorting Facility at the University of Pennsylvania for technical support. This study was supported by a grant from the Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania and by grants from the US National Institutes of Health to P.S.K. (1R21HL107968-01 and 1R01HL110806-01). J.H. was supported by a Leukemia and Lymphoma Society Career Development Award and a K99 award from the US National Institutes of Health (1K99HL10774701). E.O.H. was supported by a grant from the US National Institutes of Health (1-K23-HL-093366-01A1). We also appreciate support from the Human Hematopoietic Stem Cell Center of Excellence (5P30DK090969-02) at the Children's Hospital of Philadelphia and the University of Pennsylvania.	Ballin A, 1998, BRIT J HAEMATOL, V100, P219, DOI 10.1046/j.1365-2141.1998.00537.x; BOGGS DR, 1983, SEMIN HEMATOL, V20, P129; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bowman Teresa V, 2009, Drug Discov Today Ther Strateg, V6, P135, DOI 10.1016/j.ddstr.2009.06.003; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chou S, 2010, CELL STEM CELL, V7, P427, DOI 10.1016/j.stem.2010.09.001; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000302; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Holmes Roxanne, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5156; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; KODAMA H, 1994, EXP HEMATOL, V22, P979; Krock B, 2011, CELL METAB, V13, P8, DOI 10.1016/j.cmet.2010.12.015; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Polakis P, 2000, GENE DEV, V14, P1837; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	60	159	171	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1778	+		10.1038/nm.2984	http://dx.doi.org/10.1038/nm.2984			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142822	Green Accepted			2022-12-25	WOS:000311999800025
J	Richter, J; Schlesner, M; Hoffmann, S; Kreuz, M; Leich, E; Burkhardt, B; Rosolowski, M; Ammerpohl, O; Wagener, R; Bernhart, SH; Lenze, D; Szczepanowski, M; Paulsen, M; Lipinski, S; Russell, RB; Adam-Klages, S; Apic, G; Claviez, A; Hasenclever, D; Hovestadt, V; Hornig, N; Korbel, JO; Kube, D; Langenberger, D; Lawerenz, C; Lisfeld, J; Meyer, K; Picelli, S; Pischimarov, J; Radlwimmer, B; Rausch, T; Rohde, M; Schilhabel, M; Scholtysik, R; Spang, R; Trautmann, H; Zenz, T; Borkhardt, A; Drexler, HG; Moller, P; MacLeod, RAF; Pott, C; Schreiber, S; Trumper, L; Loeffler, M; Stadler, PF; Lichter, P; Eils, R; Kuppers, R; Hummel, M; Klapper, W; Rosenstiel, P; Rosenwald, A; Brors, B; Siebert, R				Richter, Julia; Schlesner, Matthias; Hoffmann, Steve; Kreuz, Markus; Leich, Ellen; Burkhardt, Birgit; Rosolowski, Maciej; Ammerpohl, Ole; Wagener, Rabea; Bernhart, Stephan H.; Lenze, Dido; Szczepanowski, Monika; Paulsen, Maren; Lipinski, Simone; Russell, Robert B.; Adam-Klages, Sabine; Apic, Gordana; Claviez, Alexander; Hasenclever, Dirk; Hovestadt, Volker; Hornig, Nadine; Korbel, Jan O.; Kube, Dieter; Langenberger, David; Lawerenz, Chris; Lisfeld, Jasmin; Meyer, Katharina; Picelli, Simone; Pischimarov, Jordan; Radlwimmer, Bernhard; Rausch, Tobias; Rohde, Marius; Schilhabel, Markus; Scholtysik, Rene; Spang, Rainer; Trautmann, Heiko; Zenz, Thorsten; Borkhardt, Arndt; Drexler, Hans G.; Moeller, Peter; MacLeod, Roderick A. F.; Pott, Christiane; Schreiber, Stefan; Truemper, Lorenz; Loeffler, Markus; Stadler, Peter F.; Lichter, Peter; Eils, Roland; Kueppers, Ralf; Hummel, Michael; Klapper, Wolfram; Rosenstiel, Philip; Rosenwald, Andreas; Brors, Benedikt; Siebert, Reiner		ICGC MMML-Seq Project	Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing	NATURE GENETICS			English	Article							B-CELL LYMPHOMA; MYC; INACTIVATION; DIAGNOSIS; PROTEINS	Burkitt lymphoma is a mature aggressive B-cell lymphoma derived from germinal center B cells(1). Its cytogenetic hallmark is the Burkitt translocation t(8;14)(q24;q32) and its variants, which juxtapose the MYC oncogene with one of the three immunoglobulin loci(2). Consequently, MYC is deregulated, resulting in massive perturbation of gene expression(3). Nevertheless, MYC deregulation alone seems not to be sufficient to drive Burkitt lymphomagenesis. By whole-genome, whole-exome and transcriptome sequencing of four prototypical Burkitt lymphomas with immunoglobulin gene (IG)-MYC translocation, we identified seven recurrently mutated genes. One of these genes, ID3, mapped to a region of focal homozygous loss in Burkitt lymphoma(4). In an extended cohort, 36 of 53 molecularly defined Burkitt lymphomas (68%) carried potentially damaging mutations of ID3. These were strongly enriched at somatic hypermutation motifs. Only 6 of 47 other B-cell lymphomas with the IG-MYC translocation (13%) carried ID3 mutations. These findings suggest that cooperation between ID3 inactivation and IG-MYC translocation is a hallmark of Burkitt lymphomagenesis.	[Richter, Julia; Ammerpohl, Ole; Wagener, Rabea; Hornig, Nadine; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Schlesner, Matthias; Lawerenz, Chris; Eils, Roland; Brors, Benedikt] Deutsch Krebsforschungszentrum Heidelberg DKFZ, Div Theoret Bioinformat, Heidelberg, Germany; [Hoffmann, Steve; Bernhart, Stephan H.; Langenberger, David] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany; [Kreuz, Markus; Rosolowski, Maciej; Hasenclever, Dirk; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Leich, Ellen; Pischimarov, Jordan; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Burkhardt, Birgit] Univ Hosp Muenster, Munster, Germany; [Burkhardt, Birgit; Lisfeld, Jasmin; Rohde, Marius] Univ Hosp Giessen, Giessen, Germany; [Lenze, Dido; Hummel, Michael] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany; [Szczepanowski, Monika; Klapper, Wolfram] Univ Kiel, Hematopathol Sect, Kiel, Germany; [Paulsen, Maren; Lipinski, Simone; Schilhabel, Markus; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Russell, Robert B.; Apic, Gordana] Heidelberg Univ, Cell Networks, Bioquant, Heidelberg, Germany; [Adam-Klages, Sabine] Univ Kiel, Inst Immunol, Kiel, Germany; [Claviez, Alexander] Univ Hosp Schleswig Holstein, Dept Pediat, Kiel, Germany; [Hovestadt, Volker; Picelli, Simone; Radlwimmer, Bernhard; Lichter, Peter] DKFZ, Div Mol Genet, Heidelberg, Germany; [Korbel, Jan O.; Rausch, Tobias] EMBL, Genome Biol Res Unit, Heidelberg, Germany; [Kube, Dieter; Truemper, Lorenz] Univ Gottingen, Dept Hematol & Oncol, Gottingen, Germany; [Meyer, Katharina; Spang, Rainer] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Scholtysik, Rene; Kueppers, Ralf] Univ Duisburg Essen, Sch Med, Inst Cell Biol Canc Res, Essen, Germany; [Trautmann, Heiko; Pott, Christiane] Univ Med Ctr, Dept Internal Med Hematol & Oncol 2, Kiel, Germany; [Zenz, Thorsten] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Zenz, Thorsten] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Zenz, Thorsten] Univ Ulm, Dept Med 3, Ulm, Germany; [Borkhardt, Arndt] Univ Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Drexler, Hans G.; MacLeod, Roderick A. F.] German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Cultures, Braunschweig, Germany; [Moeller, Peter] Univ Ulm, Fac Med, Inst Pathol, Ulm, Germany; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany; [Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Bioquant, Heidelberg, Germany	University of Kiel; Helmholtz Association; German Cancer Research Center (DKFZ); Leipzig University; Leipzig University; University of Wurzburg; University of Munster; University Hospital of Giessen & Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; University of Kiel; Ruprecht Karls University Heidelberg; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); University of Gottingen; University of Regensburg; University of Duisburg Essen; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ulm University; Heinrich Heine University Dusseldorf; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Ulm University; University of Kiel; Leipzig University; Leipzig University; Ruprecht Karls University Heidelberg	Siebert, R (corresponding author), Univ Kiel, Inst Human Genet, Kiel, Germany.	rsiebert@medgen.uni-kiel.de	Brors, Benedikt/E-5620-2013; Ammerpohl, Ole/G-2691-2010; Hoell, Jessica/J-8136-2016; Burkhardt, Birgit/AAS-9678-2021; Lipinski, Simone/L-9818-2017; Russell, Robert/GWU-6389-2022; Eils, Roland/B-6121-2009; Klapper, Wolfram/S-6314-2016; Esser, Daniela/ABB-9383-2020; Radlwimmer, Bernhard F/I-3229-2013; Paulsen, Maren D/K-4684-2013; Adam-Klages, Sabine/E-9761-2010; Schlesner, Matthias/I-4030-2013; Rosenstiel, Philip/A-5137-2009; Russell, Rob/AAH-9145-2019; Siebert, Reiner/A-8049-2010; Korbel, Jan O/G-6470-2012; Langenberger, David/AAF-3313-2020; Rausch, Tobias/H-6511-2019; Lipinski, Simone/HHY-9238-2022; Stadler, Peter F. F/L-7857-2015; Hornig, Nadine/AAO-2648-2021; Langenberger, David/D-4155-2013; Hoffmann, Steve/E-1438-2013	Brors, Benedikt/0000-0001-5940-3101; Hoell, Jessica/0000-0002-5532-9845; Burkhardt, Birgit/0000-0002-1151-829X; Lipinski, Simone/0000-0002-9322-7372; Russell, Robert/0000-0002-7213-1398; Eils, Roland/0000-0002-0034-4036; Radlwimmer, Bernhard F/0000-0002-4553-7800; Paulsen, Maren D/0000-0003-4454-3632; Schlesner, Matthias/0000-0002-5896-4086; Rosenstiel, Philip/0000-0002-9692-8828; Russell, Rob/0000-0002-1905-4717; Korbel, Jan O/0000-0002-2798-3794; Rausch, Tobias/0000-0001-5773-5620; Stadler, Peter F. F/0000-0002-5016-5191; Langenberger, David/0000-0001-9424-9701; Kuppers, Ralf/0000-0002-6691-7191; Claviez, Alexander/0000-0002-1561-5185; Hovestadt, Volker/0000-0002-3480-6649; Hummel, Michael/0000-0001-6717-605X; Spang, Rainer/0000-0002-1326-4297; , Stephan/0000-0002-5928-9449; Kreuz, Markus/0000-0002-0520-8391	Federal Ministry of Education and Research in Germany (BMBF) [01KU1002A, 01KU1002B, 01KU1002C, 01KU1002D, 01KU1002E, 01KU1002F, 01KU1002G, 01KU1002H, 01KU1002I, 01KU1002J]; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft (DFG); KinderKrebsInitiative Buchholz/Holm-Seppensen	Federal Ministry of Education and Research in Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); KinderKrebsInitiative Buchholz/Holm-Seppensen	This manuscript is dedicated to the memory of Karl Lennert, the founder of the Kiel classification of lymphoma, who died during the preparation of the manuscript. The authors thank O. Batic, C. Becher, C. Botz-von Drathen, A. Dietsch, J. Eils, M. Friskovec, K. Gobel, T. Grieb, S. Hengst, U. Jacobsen, T. Kaacksteen, H. Lammert, C. von der Lancken, H.-H. Muller, S. Radomski, J. Schieferstein, M. Schlapkohl, D. Schuster, S. Olmez and L. Valles for their excellent technical support. We are grateful to G. Richter for excellent work in the coordination of the ICGC MMML-Scq Consortium and to the members of the MMML Consortium for providing extensive data of the sample analyzed within that project. We are also very grateful to all individuals who participate in this study. The project was funded by the Federal Ministry of Education and Research in Germany (BMBF) within the Program for Medical Genuine Research (01KU1002A to 01KU1002J). The authors are responsible for the content of this publication. The MMML Consortium was funded by the Deutsche Krebshilfe from 2003 to 2011. Support of sequencing infrastructure by the Deutsche Forschungsgemeinschaft (DFG) and the KinderKrebsInitiative Buchholz/Holm-Seppensen is gratefully acknowledged. R.W. is the recipient of a Christoph-Schubert-Award from the KinderKrebsInitiative Buchholz/Holm-Seppensen.	Boerma EG, 2009, LEUKEMIA, V23, P225, DOI 10.1038/leu.2008.281; Casellas R, 2009, IMMUNOLOGY, V126, P316, DOI 10.1111/j.1365-2567.2008.03050.x; Choi YJ, 2012, J CELL BIOCHEM, V113, P985, DOI 10.1002/jcb.23428; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dominguez-Sola D, 2012, CANCER CELL, V22, P141, DOI 10.1016/j.ccr.2012.07.018; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; JOHNSTON JM, 1992, LEUKEMIA LYMPHOMA, V8, P431, DOI 10.3109/10428199209051025; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klapper W, 2008, BLOOD, V112, P1374, DOI 10.1182/blood-2008-01-136465; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Li J, 2010, BLOOD, V116, P5615, DOI 10.1182/blood-2010-03-274506; Love C. L., 2011, BLOOD, V118, P433; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Salaverria I, 2011, J CLIN ONCOL, V29, P1835, DOI 10.1200/JCO.2010.32.8385; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schmitz R, 2011, BLOOD, V118, P200, DOI 10.1182/blood.V118.21.435.435; Scholtysik R, 2010, HAEMATOL-HEMATOL J, V95, P2047, DOI 10.3324/haematol.2010.026831; Seitz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026837; Swerdlow SH, 2008, WHO CLASSIFICATION T, P179; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070	28	289	297	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1316	1320		10.1038/ng.2469	http://dx.doi.org/10.1038/ng.2469			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143595	Green Published			2022-12-25	WOS:000311713200008
J	Luders, J				Lueders, Jens			The amorphous pericentriolar cloud takes shape	NATURE CELL BIOLOGY			English	Editorial Material							CENTROSOME; TUBULIN; RINGS	The pericentriolar material (PCM), the microtubule-organizing component of the centrosome, contains a multitude of proteins and is commonly described as an amorphous cloud surrounding the centrioles. However, the days of the PCM as an unstructured matrix are numbered. Using super-resolution microscopy, several reports have now revealed remarkable domain organization within the PCM.	Inst Res Biomed, Cell & Dev Biol Programme, Barcelona 08028, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Luders, J (corresponding author), Inst Res Biomed, Cell & Dev Biol Programme, Baldiri & Reixac 10, Barcelona 08028, Spain.	jens.luders@irbbarcelona.org	Lüders, Jens/H-2812-2015	Lüders, Jens/0000-0002-9018-7977				Boveri T, 1900, ZELLEN STUDIEN, V4; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Fu JY, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120104; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Ou YC, 2000, CELL MOTIL CYTOSKEL, V47, P13, DOI 10.1002/1097-0169(200009)47:1<13::AID-CM2>3.0.CO;2-C; Ou YY, 2003, CELL MOTIL CYTOSKEL, V55, P125, DOI 10.1002/cm.10115; Schnackenberg BJ, 1998, P NATL ACAD SCI USA, V95, P9295, DOI 10.1073/pnas.95.16.9295; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Vogel JM, 1997, J CELL BIOL, V137, P193, DOI 10.1083/jcb.137.1.193	13	23	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2012	14	11					1126	1128		10.1038/ncb2617	http://dx.doi.org/10.1038/ncb2617			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	033EX	23131920				2022-12-25	WOS:000310778100005
J	Wilson, RH; Maruoka, S; Whitehead, GS; Foley, JF; Flake, GP; Sever, ML; Zeldin, DC; Kraft, M; Garantziotis, S; Nakano, H; Cook, DN				Wilson, Rhonda H.; Maruoka, Shuichiro; Whitehead, Gregory S.; Foley, Julie F.; Flake, Gordon P.; Sever, Michelle L.; Zeldin, Darryl C.; Kraft, Monica; Garantziotis, Stavros; Nakano, Hideki; Cook, Donald N.			The Toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergens	NATURE MEDICINE			English	Article							ENDOTOXIN EXPOSURE; IMMUNE-RESPONSES; AIRWAY HYPERRESPONSIVENESS; BACTERIAL FLAGELLIN; INNATE; SALMONELLA; INTERLEUKIN-1-BETA; RADIORESISTANT; SENSITIZATION; INFLAMMATION	Allergic asthma is a complex disease characterized by eosinophilic pulmonary inflammation, mucus production and reversible airway obstruction(1). Exposure to indoor allergens is a risk factor for asthma, but this disease is also associated with high household levels of total and particularly Gram-negative bacteria(2). The ability of bacterial products to act as adjuvants(3) suggests they might promote asthma by priming allergic sensitization to inhaled allergens. In support of this idea, house dust extracts (HDEs) can activate antigen-presenting dendritic cells (DCs) in vitro and promote allergic sensitization to inhaled innocuous proteins in vivo(4). It is unknown which microbial products provide most of the adjuvant activity in HDEs. A screen for adjuvant activity of microbial products revealed that the bacterial protein flagellin (FLA) stimulated strong allergic airway responses to an innocuous inhaled protein, ovalbumin (OVA). Moreover, Toll-like receptor 5 (TLR5), the mammalian receptor for FLA(5,6), was required for priming strong allergic responses to natural indoor allergens present in HDEs. In addition, individuals with asthma have higher serum levels of FLA-specific antibodies as compared to nonasthmatic individuals. Together, these findings suggest that household FLA promotes the development of allergic asthma by TLR5-dependent priming of allergic responses to indoor allergens.	[Wilson, Rhonda H.; Maruoka, Shuichiro; Whitehead, Gregory S.; Foley, Julie F.; Flake, Gordon P.; Sever, Michelle L.; Zeldin, Darryl C.; Garantziotis, Stavros; Nakano, Hideki; Cook, Donald N.] NIEHS, Biol Res Lab, NIH, Res Triangle Pk, NC 27709 USA; [Maruoka, Shuichiro] Nihon Univ, Sch Med, Div Resp Med, Tokyo, Japan; [Kraft, Monica] Duke Univ, Med Ctr, Duke Asthma Allergy & Airway Ctr, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Nihon University; Duke University	Cook, DN (corresponding author), NIEHS, Biol Res Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	cookd@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018; Garantziotis, Stavros/A-6903-2009; Cook, Donald/E-5079-2019	Zeldin, Darryl C/0000-0002-2087-7307; Garantziotis, Stavros/0000-0003-4007-375X; Cook, Donald/0000-0002-0052-3755; Sever, Michelle/0000-0002-2435-1214	Intramural Research Program of the US National Institutes of Health NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIDES102465, ZIAES102605, ZIAES025041, ZICES102546, ZIAES102025] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the US National Institutes of Health NIEHS. We thank the human subjects for their blood donations and B. Yingling, J. Marshburn and A. Rice of the NIEHS Clinical Research Unit and D. Beaver of Duke University for assistance with patient recruitment and serum isolation. J. Hollingsworth (Duke University) with permission from R. Medzhitov (Yale University) provided CD11c-Myd88 transgenic mice on a Myd88<SUP>-/-</SUP> background. S. Akira (Osaka University) provided Tlr2<SUP>-/-</SUP>, Tlr4<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice and J. Ting (University of North Carolina) provided Nlrc4<SUP>-/-</SUP> mice. D. Wozniak (Ohio State University) provided both strains of P. aeruginosa, F.-S. Shu (Wayne State University) provided purified FLA from P. aeruginosa and A. Gewirtz (Emory University) provided FLA from Escherichia coli. We also thank NIEHS members K. Nakano for genotyping, L. Perrow for mouse colony management, N. Flagler for histology, J. Aloor for measuring endotoxin levels in HDEs, M. Sifre and C. Bortner for help with FACS-based cell sorting, J. Ciencewicki for advice on airway epithelial cell culture and M. Fessler and S. London for suggestions on the manuscript.	Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Bolte G, 2003, CLIN EXP ALLERGY, V33, P770, DOI 10.1046/j.1365-2222.2003.01665.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127, P390, DOI 10.1016/j.jaci.2010.10.050; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; El-Sharif N, 2006, J ASTHMA, V43, P241, DOI 10.1080/02770900600567122; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gehring U, 2004, ALLERGY, V59, P946, DOI 10.1111/j.1398-9995.2004.00551.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Janot L, 2009, EUR J IMMUNOL, V39, P1587, DOI 10.1002/eji.200838907; Karp CL, 2010, J ALLERGY CLIN IMMUN, V125, P955, DOI 10.1016/j.jaci.2010.03.002; Lam D, 2008, J IMMUNOL, V181, P2925, DOI 10.4049/jimmunol.181.4.2925; MCDONOUGH MW, 1976, MICROBIOS, V16, P49; Mckinley L, 2004, CLIN EXP IMMUNOL, V136, P224, DOI 10.1111/j.1365-2249.2004.02461.x; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Merx Sabine, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9409; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mijares LA, 2011, J IMMUNOL, V186, P7080, DOI 10.4049/jimmunol.1003687; Ng N, 2006, J ALLERGY CLIN IMMUN, V117, P1074, DOI 10.1016/j.jaci.2006.03.025; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Ross MA, 2000, ALLERGY, V55, P705, DOI 10.1034/j.1398-9995.2000.00551.x; Sanders CJ, 2008, J IMMUNOL, V180, P7184, DOI 10.4049/jimmunol.180.11.7184; Schulke S, 2011, J ALLERGY CLIN IMMUN, V128, P1340, DOI 10.1016/j.jaci.2011.07.036; Sever ML, 2007, J ALLERGY CLIN IMMUN, V120, P849, DOI 10.1016/j.jaci.2007.07.003; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Strindelius L, 2004, VACCINE, V22, P3797, DOI 10.1016/j.vaccine.2003.12.035; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	41	89	111	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1705	+		10.1038/nm.2920	http://dx.doi.org/10.1038/nm.2920			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23064463	Green Accepted			2022-12-25	WOS:000310837000033
J	Krishnamoorthy, N; Khare, A; Oriss, TB; Raundhal, M; Morse, C; Yarlagadda, M; Wenzel, SE; Moore, ML; Peebles, RS; Ray, A; Ray, P				Krishnamoorthy, Nandini; Khare, Anupriya; Oriss, Timothy B.; Raundhal, Mahesh; Morse, Christina; Yarlagadda, Manohar; Wenzel, Sally E.; Moore, Martin L.; Peebles, R. Stokes, Jr.; Ray, Anuradha; Ray, Prabir			Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR GATA-3; MEDIATED DISEASE; BREAST-MILK; TH2 CELLS; EXPRESSION; DIFFERENTIATION; RESPONSES; IMMUNITY; INFANCY; ANTIGEN	Immune tolerance is instituted early in life, during which time regulatory T (T-reg) cells have an important role. Recurrent infections with respiratory syncytial virus (RSV) in early life increase the risk for asthma in adult life. Repeated infection of infant mice tolerized to ovalbumin (OVA) through their mother's milk with RSV induced allergic airway disease in response to OVA sensitization and challenge, including airway inflammation, hyper-reactivity and higher OVA-specific IgE, as compared to uninfected tolerized control mice. Virus infection induced GATA-3 expression and T helper type 2 (T(H)2) cytokine production in forkhead box P3 (FOXP3)(+) T-reg cells and compromised the suppressive function of pulmonary T-reg cells in a manner that was dependent on interleukin-4 receptor alpha (IL-4R alpha) expression in the host. Thus, by promoting a T(H)2-type inflammatory response in the lung, RSV induced a T(H)2-like effector phenotype in T-reg cells and attenuated tolerance to an unrelated antigen (allergen). Our findings highlight a mechanism by which viral infection targets a host-protective mechanism in early life and increases susceptibility to allergic disease.	[Krishnamoorthy, Nandini; Khare, Anupriya; Oriss, Timothy B.; Raundhal, Mahesh; Morse, Christina; Yarlagadda, Manohar; Wenzel, Sally E.; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Raundhal, Mahesh; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Moore, Martin L.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Children's Healthcare of Atlanta (CHOA); Vanderbilt University	Ray, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	raya@pitt.edu; rayp@pitt.edu		Wenzel, Sally/0000-0002-4242-0164	NIH [HL060207, AI093116, HL 077430, AI048927, U19 AI095227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077430, R01HL060207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100012, R01AI048927, R01AI087798, R21AI093116, U19AI095227] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Shevach and G. Chattopadhyay (Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH)) for providing spleens of OT-II x FOXP3-eGFP knock-in mice and J. Zhu (Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH) for his efforts in identifying the source of these mice. DO11.10 transgenic mice were originally provided by K. Murphy (Washington University, St. Louis). This work was supported by NIH grants HL060207 and AI093116 (to P. R.), HL 077430 and AI048927 (to A. R.) and U19 AI095227 (to R.S.P.).	Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Domachowske JB, 1998, BIOTECHNIQUES, V25, P644, DOI 10.2144/98254dt01; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Moore ML, 2007, J IMMUNOL, V178, P2651, DOI 10.4049/jimmunol.178.5.2651; Moore ML, 2009, J IMMUNOL, V183, P2016, DOI 10.4049/jimmunol.0803167; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Noble V, 1997, ARCH DIS CHILD, V76, P315, DOI 10.1136/adc.76.4.315; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Ostroukhova TY, 2006, B EXP BIOL MED+, V141, P364, DOI 10.1007/s10517-006-0172-6; Polte T, 2008, CLIN EXP ALLERGY, V38, P1950, DOI 10.1111/j.1365-2222.2008.03096.x; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003; Sly PD, 2010, J ALLERGY CLIN IMMUN, V125, P1202, DOI 10.1016/j.jaci.2010.01.024; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Xu H, 2008, P NATL ACAD SCI USA, V105, P6690, DOI 10.1073/pnas.0708809105; Yung RL, 2008, AUTOIMMUNITY, V41, P329, DOI 10.1080/08916930802024889; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	52	172	180	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1525	U121		10.1038/nm.2896	http://dx.doi.org/10.1038/nm.2896			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22961107	Green Accepted			2022-12-25	WOS:000309587500031
J	McCurley, A; Pires, PW; Bender, SB; Aronovitz, M; Zhao, MJ; Metzger, D; Chambon, P; Hill, MA; Dorrance, AM; Mendelsohn, ME; Jaffe, IZ				McCurley, Amy; Pires, Paulo W.; Bender, Shawn B.; Aronovitz, Mark; Zhao, Michelle J.; Metzger, Daniel; Chambon, Pierre; Hill, Michael A.; Dorrance, Anne M.; Mendelsohn, Michael E.; Jaffe, Iris Z.			Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors	NATURE MEDICINE			English	Article							ANGIOTENSIN-II; GENE-TRANSCRIPTION; VASCULAR FUNCTION; MICE DEFICIENT; KNOCKOUT MICE; ALDOSTERONE; HYPERTENSION; TONE; SPIRONOLACTONE; DYSFUNCTION	Hypertension is a cardiovascular risk factor present in over two-thirds of people over age 60 in North America; elevated blood pressure correlates with increased risk of heart attack, stroke and progression to heart and kidney failure. Current therapies are insufficient to control blood pressure in almost half of these patients(1,2). The mineralocorticoid receptor (MR), acting in the kidney, is known to regulate blood pressure through aldosterone binding and stimulation of sodium retention(3). However, recent studies support the concept that the MR also has extrarenal actions(4-7) and that defects in sodium handling alone do not fully explain the development of hypertension and associated cardiovascular mortality(8,9). We and others have identified functional MR in human vascular smooth muscle cells (SMCs)(10,11), suggesting that vascular MR might directly regulate blood pressure. Here we show that mice with SMC-specific deficiency of the MR have decreased blood pressure as they age without defects in renal sodium handling or vascular structure. Aged mice lacking MR in SMCs (SMC-MR) have reduced vascular myogenic tone, agonist-dependent contraction and expression and activity of L-type calcium channels. Moreover, SMC-MR contributes to angiotensin II-induced vascular oxidative stress, vascular contraction and hypertension. This study identifies a new role for vascular MR in blood pressure control and in vascular aging and supports the emerging hypothesis that vascular tone contributes directly to systemic blood pressure.	[McCurley, Amy; Aronovitz, Mark; Mendelsohn, Michael E.; Jaffe, Iris Z.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Pires, Paulo W.; Dorrance, Anne M.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Bender, Shawn B.] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO USA; [Zhao, Michelle J.] Nova SE Univ, Coll Med Sci, Ft Lauderdale, FL 33314 USA; [Metzger, Daniel; Chambon, Pierre] Univ Strasbourg, Coll France, Inst Natl Sante & Rech Med, Inst Genet & Biol Mol & Cellulaire,Ctr Natl Rech, Illkirch Graffenstaden, France; [Hill, Michael A.] Univ Missouri, Sch Med, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Hill, Michael A.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Mendelsohn, Michael E.] Merck Res Labs, Rahway, NJ USA	Tufts Medical Center; Michigan State University; University of Missouri System; University of Missouri Columbia; Nova Southeastern University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Merck & Company	Jaffe, IZ (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA.	ijaffe@tuftsmedicalcenter.org	Hill, Michael/AAV-5350-2020; Pires, Paulo Wagner/I-8542-2014	Pires, Paulo Wagner/0000-0001-5972-4554; Metzger, Daniel/0000-0002-5555-046X; Hill, Michael/0000-0002-4455-2072; Dorrance, Anne/0000-0001-6573-2729	US National Institutes of Health [HL095590, HL092241, T32 HL069770]; American Heart Association [11GRNT7240000, 11POST7590096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069770, R01HL095590] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Mouse Clinical Institute (Illkirch) for help in generating MR<SUP>f/f</SUP> mice, Y. Yang, A. Stupica and Z. Nourian for technical assistance, and J.D. Jaffe for assistance with figures. This work was supported by grants from the US National Institutes of Health (HL095590 to I.Z.J., HL092241 to M.A.H. and T32 HL069770) and the American Heart Association (11GRNT7240000 to I.Z.J. and 11POST7590096 to A.M.).	Ambroisine ML, 2007, CIRCULATION, V116, P2435, DOI 10.1161/CIRCULATIONAHA.107.722009; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Berger S, 2000, KIDNEY INT, V57, P1295, DOI 10.1046/j.1523-1755.2000.00965.x; Bhargava A, 2004, MOL CELL ENDOCRINOL, V217, P189, DOI 10.1016/j.mce.2003.10.020; Cassis P, 2010, PFLUG ARCH EUR J PHY, V459, P325, DOI 10.1007/s00424-009-0725-4; Cat AND, 2010, FASEB J, V24, P2454, DOI 10.1096/fj.09-147926; Funder JW, 2009, MOL CELL ENDOCRINOL, V301, P2, DOI 10.1016/j.mce.2008.10.029; FUNDER JW, 1989, ENDOCRINOLOGY, V125, P2224, DOI 10.1210/endo-125-4-2224; Gradman AH, 2009, DRUG AGING, V26, P751, DOI 10.2165/11316790-000000000-00000; Id D, 2010, J CARDIOVASC SURG, V51, P721; Jaffe IZ, 2010, J CLIN INVEST, V120, P3891, DOI 10.1172/JCI40205; Jaffe IZ, 2005, CIRC RES, V96, P643, DOI 10.1161/01.RES.0000159937.05502.d1; Krug AW, 2010, HYPERTENSION, V55, P1476, DOI 10.1161/HYPERTENSIONAHA.109.148783; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Levy DG, 2004, J CLIN ENDOCR METAB, V89, P2736, DOI 10.1210/jc.2003-032149; Logan AG, 2011, EXPERT REV CARDIOVAS, V9, P113, DOI 10.1586/ERC.10.171; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Newfell BG, 2011, ARTERIOSCL THROM VAS, V31, P1871, DOI 10.1161/ATVBAHA.111.229070; Pires PW, 2011, AM J PHYSIOL-HEART C, V301, pH87, DOI 10.1152/ajpheart.01206.2010; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poulsen CB, 2011, KIDNEY INT, V79, P443, DOI 10.1038/ki.2010.429; Rautureau Y, 2011, STEROIDS, V76, P834, DOI 10.1016/j.steroids.2011.02.015; Rigsby CS, 2007, MICROVASC RES, V73, P198, DOI 10.1016/j.mvr.2006.12.001; Rogerson FM, 2000, STEROIDS, V65, P61, DOI 10.1016/S0039-128X(99)00087-2; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Ronzaud C, 2011, AM J PHYSIOL-RENAL, V300, pF756, DOI 10.1152/ajprenal.00728.2009; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Wang WZ, 2011, J VASC RES, V48, P67, DOI 10.1159/000318776; Wendling O, 2009, GENESIS, V47, P14, DOI 10.1002/dvg.20448; Xue BJ, 2005, AM J PHYSIOL-HEART C, V288, pH2177, DOI 10.1152/ajpheart.00969.2004; Yang Y, 2009, J PHYSIOL-LONDON, V587, P3025, DOI 10.1113/jphysiol.2009.169920; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	40	233	236	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1429	+		10.1038/nm.2891	http://dx.doi.org/10.1038/nm.2891			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922412	Green Accepted			2022-12-25	WOS:000308472300041
J	Purwar, R; Schlapbach, C; Xiao, S; Kang, HS; Elyaman, W; Jiang, XD; Jetten, AM; Khoury, SJ; Fuhlbrigge, RC; Kuchroo, VK; Clark, RA; Kupper, TS				Purwar, Rahul; Schlapbach, Christoph; Xiao, Sheng; Kang, Hong Soon; Elyaman, Wassim; Jiang, Xiaodong; Jetten, Anton M.; Khoury, Samia J.; Fuhlbrigge, Robert C.; Kuchroo, Vijay K.; Clark, Rachael A.; Kupper, Thomas S.			Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells	NATURE MEDICINE			English	Article							IN-VIVO; IL-9 PRODUCTION; T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; RECEPTOR; CANCER; LUNG; IMMUNOTHERAPY; THERAPY	Interleukin-9 (IL-9) is a T cell cytokine that acts through a gamma C-family receptor on target cells and is associated with inflammation and allergy. We determined that T cells from mice deficient in the T helper type 17 (T(H)17) pathway genes encoding retinoid-related orphan receptor gamma (ROR-gamma) and IL-23 receptor (IL-23R) produced abundant IL-9, and we found substantial growth inhibition of B16F10 melanoma in these mice. IL-9-blocking antibodies reversed this tumor growth inhibition and enhanced tumor growth in wild-type (WT) mice. Il9r(-/-) mice showed accelerated tumor growth, and administration of recombinant IL-9 (rIL-9) to tumor-bearing WT and Rag1(-/-) mice inhibited melanoma as well as lung carcinoma growth. Adoptive transfer of tumor-antigen-specific T(H)9 cells into both WT and Rag1(-/-) mice suppressed melanoma growth; this effect was abrogated by treatment with neutralizing antibodies to IL-9. Exogenous rIL-9 inhibited tumor growth in Rag1(-/-) mice but not in mast-cell-deficient mice, suggesting that the targets of IL-9 in this setting include mast cells but not T or B cells. In addition, we found higher numbers of T(H)9 cells in normal human skin and blood compared to metastatic lesions of subjects with progressive stage IV melanoma. These results suggest a role for IL-9 in tumor immunity and offer insight into potential therapeutic strategies.	[Purwar, Rahul; Schlapbach, Christoph; Jiang, Xiaodong; Fuhlbrigge, Robert C.; Clark, Rachael A.; Kupper, Thomas S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Xiao, Sheng; Elyaman, Wassim; Khoury, Samia J.; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Kang, Hong Soon; Jetten, Anton M.] NIEHS, Cell Biol Sect, NIH, Res Triangle Pk, NC 27709 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kupper, TS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA.	tkupper@partners.org	Schlapbach, Christoph/I-4608-2019; Jetten, Anton/C-3736-2019; Kupper, Thomas/O-4962-2019; Elyaman, Wassim/AAJ-1562-2021	Schlapbach, Christoph/0000-0003-0258-1243; Jetten, Anton/0000-0003-0954-4445; khoury, samia/0000-0003-3198-6063; Elyaman, Wassim/0000-0001-7238-374X	US National Institutes of Health [R01 AI-041707, R01 AI-097128, P50 CA-093683, R01-AR-056720, R03-MH-095529, Z01-ES-101586]; Skin Cancer Foundation; Swiss National Science Foundation; Foundation Rene Touraine; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058680, R01AI097128, R01AI067472, R01AI041707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056720, R01AR065807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101586, ZIAES101586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH095529] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skin Cancer Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Rene Touraine; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from US National Institutes of Health to T.S.K. (R01 AI-041707, R01 AI-097128 and P50 CA-093683), R.A.C. (R01-AR-056720 and R03-MH-095529) and A.M.J. (Z01-ES-101586). R.P. received a Research Grant Award from The Skin Cancer Foundation. The authors thank K. Gerrish (US National Institutes of Health) with his help with the microarray analysis. J.-C. Renauld<SUP>39</SUP> (Ludwig Institute, Belgium) provided Il9r<SUP>-/-</SUP> mice and the corresponding control mice (Il9r<SUP>+/-</SUP>). Neutralizing antibodies to IL-9 (MM9C1) were a kind gift from J.v. Snick (Ludwig Institute, Belgium). Salary support for C.S. was provided by the Swiss National Science Foundation and the Foundation Rene Touraine and for R.A.C. from a Damon Runyon Clinical Investigator Award.	Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Ma HL, 2003, J IMMUNOL, V171, P608, DOI 10.4049/jimmunol.171.2.608; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Oldford SA, 2010, J IMMUNOL, V185, P7067, DOI 10.4049/jimmunol.1001137; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schumacher TNM, 2009, CURR OPIN IMMUNOL, V21, P187, DOI 10.1016/j.coi.2009.03.006; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Tilley SL, 2007, J IMMUNOL, V178, P3208, DOI 10.4049/jimmunol.178.5.3208; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yang XR, 2009, INT J CANCER, V125, P2912, DOI 10.1002/ijc.24622; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	39	289	317	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1248	+		10.1038/nm.2856	http://dx.doi.org/10.1038/nm.2856			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22772464	Green Accepted			2022-12-25	WOS:000307469300031
J	Bradley, E				Bradley, Edward			Incorporating biomarkers into clinical trial designs: points to consider	NATURE BIOTECHNOLOGY			English	Letter								In an environment where the regulatory and reimbursement authorities continue to raise the bar for new oncology therapies, how are sponsors adapting clinical trial designs?	MedImmune, Clin Dev, Oncol, Gaithersburg, MD USA	AstraZeneca; Medimmune	Bradley, E (corresponding author), MedImmune, Clin Dev, Oncol, Gaithersburg, MD USA.	bradleyed@Medimmune.com						[Anonymous], 2010, BIOCENTURY, V39, pA1; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Beckman RA, 2011, NAT REV DRUG DISCOV, V10, P735, DOI 10.1038/nrd3550; Chen K, 2008, CONTEMP CLIN TRIALS, V29, P32, DOI 10.1016/j.cct.2007.04.008; D'Agostino RB, 2011, NEW ENGL J MED, V365, DOI [10.1056/nejmp1106984, 10.1056/NEJMp1106984]; Fleming TR, 2004, J INFECT DIS, V190, P666, DOI 10.1086/422603; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Jallal B., 2011, EURO PHARM REV, V16, P29; LaVallee T., 2011, ONC NEWS, V6, P52; Maitland ML, 2011, J CLIN ONCOL, V29, P3109, DOI 10.1200/JCO.2011.36.3887; Patlak M., 2011, NATL CANC POLICY SUM; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sikorski R, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000287; Thall P.F, 2007, DEP BIOSTATISTICS WO; Vickers AJ, 2007, CLIN CANCER RES, V13, P972, DOI 10.1158/1078-0432.CCR-06-0909	16	14	14	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					596	599		10.1038/nbt.2296	http://dx.doi.org/10.1038/nbt.2296			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781677				2022-12-25	WOS:000306293400013
J	Scheuermann, TH; Li, QM; Ma, HW; Key, J; Zhang, L; Chen, R; Garcia, JA; Naidoo, J; Longgood, J; Frantz, DE; Tambar, UK; Gardner, KH; Bruick, RK				Scheuermann, Thomas H.; Li, Qiming; Ma, He-Wen; Key, Jason; Zhang, Lei; Chen, Rui; Garcia, Joseph A.; Naidoo, Jacinth; Longgood, Jamie; Frantz, Doug E.; Tambar, Uttam K.; Gardner, Kevin H.; Bruick, Richard K.			Allosteric inhibition of hypoxia inducible factor-2 with small molecules	NATURE CHEMICAL BIOLOGY			English	Article							LIGAND-BINDING; STRUCTURAL BASIS; HIF-BINDING; PAS DOMAIN; HIF-2-ALPHA; HIF-1-ALPHA; NEUROBLASTOMA; HYDROXYLATION; RECRUITMENT; HIF1-ALPHA	Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in many cancers where they frequently promote the expression of protumorigenic pathways. Though transcription factors are typically considered 'undruggable', the PAS-B domain of the HIF-2 alpha subunit contains a large cavity within its hydrophobic core that offers a unique foothold for small-molecule regulation. Here we identify artificial ligands that bind within this pocket and characterize the resulting structural and functional changes caused by binding. Notably, these ligands antagonize HIF-2 heterodimerization and DNA-binding activity in vitro and in cultured cells, reducing HIF-2 target gene expression. Despite the high sequence identity between HIF-2 alpha and HIF-1 alpha, these ligands are highly selective and do not affect HIF-1 function. These chemical tools establish the molecular basis for selective regulation of HIF-2, providing potential therapeutic opportunities to intervene in HIF-2-driven tumors, such as renal cell carcinomas.	[Scheuermann, Thomas H.; Li, Qiming; Ma, He-Wen; Key, Jason; Zhang, Lei; Naidoo, Jacinth; Longgood, Jamie; Frantz, Doug E.; Tambar, Uttam K.; Gardner, Kevin H.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Scheuermann, Thomas H.; Key, Jason; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Chen, Rui; Garcia, Joseph A.] Vet Affairs North Texas Hlth Care Syst, Dept Med, Dallas, TX USA; [Chen, Rui; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Kevin.Gardner@utsouthwestern.edu; Richard.Bruick@utsouthwestern.edu	Gardner, Kevin/K-5493-2019; Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556; Garcia, Joseph/0000-0002-5621-7538; Key, Jason/0000-0001-6002-2111	US National Institutes of Health [P01 CA095471, P30 CA142543]; Cancer Prevention Research Institute of Texas [RP-100846]; Burroughs Wellcome Fund; Department of Veterans Affairs; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Center for Research Resources, US National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA095471, P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Department of Veterans Affairs(US Department of Veterans Affairs); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank S. Wang and members of the University of Texas Southwestern High-Throughput Screening Core Facility, D. Tomchick, C. Brautigam, J. MacMillan, N. Williams and members of our laboratories for their help. This work was funded by grants from the US National Institutes of Health (P01 CA095471, P30 CA142543) and the Cancer Prevention Research Institute of Texas (RP-100846). R.K.B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; K.H.G. is the Virginia Lazenby O'Hara Chair in Biochemistry and W.W. Caruth Scholar in Biomedical Research; and U.K.T. is a W.W. Caruth Jr. Scholar in Biomedical Research. J.A.G. was supported by funds provided by the Department of Veterans Affairs. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (grant no. C06 RR 15437-01) from the National Center for Research Resources, US National Institutes of Health.	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Key J, 2009, J AM CHEM SOC, V131, P17647, DOI 10.1021/ja9073062; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Morris MR, 2009, ANTICANCER RES, V29, P4337; Park EJ, 2006, CELL CYCLE, V5, P1847, DOI 10.4161/cc.5.16.3019; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200	42	193	208	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2013	9	4					271	276		10.1038/NCHEMBIO.1185	http://dx.doi.org/10.1038/NCHEMBIO.1185			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	118LA	23434853	Green Published, Green Accepted			2022-12-25	WOS:000317025800018
J	Chatterjee, SS; Joo, HS; Duong, AC; Dieringer, TD; Tan, VY; Song, Y; Fischer, ER; Cheung, GYC; Li, M; Otto, M				Chatterjee, Som S.; Joo, Hwang-Soo; Duong, Anthony C.; Dieringer, Thomas D.; Tan, Vee Y.; Song, Yan; Fischer, Elizabeth R.; Cheung, Gordon Y. C.; Li, Min; Otto, Michael			Essential Staphylococcus aureus toxin export system	NATURE MEDICINE			English	Article							PHENOL-SOLUBLE MODULINS; VIRULENCE DETERMINANTS; BACTERIAL VIRULENCE; EPIDERMIDIS; PEPTIDES; INACTIVATION; EXPRESSION; BIOFILMS; TARGET; AGR	Widespread antibiotic resistance among important bacterial pathogens such as Staphylococcus aureus(1) calls for alternative routes of drug development. Interfering with crucial virulence determinants is considered a promising new approach to control bacterial infection(2). Phenol-soluble modulins (PSMs) are peptide toxins with multiple key roles in pathogenesis(3-5) and have a major impact on the ability of highly virulent S. aureus to cause disease(3,6). However, targeting PSMs for therapeutic intervention is hampered by their multitude and diversity. Here we report that an ATP-binding cassette transporter with previously unknown function is responsible for the export of all PSMs, thus representing a single target for complete obstruction of PSM production. The transporter had a strong effect on virulence phenotypes, such as neutrophil lysis, and the extent of its effect on the development of S. aureus infection was similar to that of the sum of all PSMs. Notably, the transporter was essential for bacterial growth. Furthermore, it contributed to producer immunity toward secreted PSMs and defense against PSM-mediated bacterial interference. Our study reveals a noncanonical, dedicated secretion mechanism for an important class of toxins and identifies this mechanism as a comprehensive potential target for the development of drugs to efficiently inhibit the growth and virulence of pathogenic staphylococci.	[Chatterjee, Som S.; Joo, Hwang-Soo; Duong, Anthony C.; Dieringer, Thomas D.; Tan, Vee Y.; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Song, Yan; Li, Min] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Fischer, Elizabeth R.] NIAID, Microscopy Unit, Rocky Mt Labs, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	motto@niaid.nih.gov		JOO, HWANG-SOO/0000-0003-4668-3225; Otto, Michael/0000-0002-2222-4115	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); US National Institutes of Health (NIH) [ZIA AI000904-10]; National Natural Science Foundation of China [30900026, 81171623, 81261120387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000904] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), US National Institutes of Health (NIH) (grant ZIA AI000904-10) to M.O. and the National Natural Science Foundation of China (grants 30900026, 81171623 and 81261120387) to M.L. We thank J. Kok (University of Groningen), F. Lowy (Columbia University) and G. Dunny (University of Minnesota) for lactococcal strains and plasmids and A. Peschel for critically reading the manuscript.	Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Forsman H, 2012, INFECT IMMUN, V80, P1987, DOI 10.1128/IAI.05906-11; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945; Zolnerciks JK, 2011, ESSAYS BIOCHEM, V50, P43, DOI [10.1042/bse0500043, 10.1042/BSE0500043]	29	118	120	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					364	367		10.1038/nm.3047	http://dx.doi.org/10.1038/nm.3047			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396209	Green Accepted			2022-12-25	WOS:000316040700031
J	Hwang, WY; Fu, YF; Reyon, D; Maeder, ML; Tsai, SQ; Sander, JD; Peterson, RT; Yeh, JRJ; Joung, JK				Hwang, Woong Y.; Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Tsai, Shengdar Q.; Sander, Jeffry D.; Peterson, Randall T.; Yeh, J-R Joanna; Joung, J. Keith			Efficient genome editing in zebrafish using a CRISPR-Cas system	NATURE BIOTECHNOLOGY			English	Article								In bacteria, foreign nucleic acids are silenced by clustered, regularly interspaced, short palindromic repeats (CRISPR) CRISPR-associated (Gas) systems. Bacterial type II CRISPR systems have been adapted to create guide RNAs that direct site-specific DNA cleavage by the Cas9 endonuclease in cultured cells. Here we show that the CRISPR-Cas system functions in vivo to induce targeted genetic modifications in zebrafish embryos with efficiencies similar to those obtained using zinc finger nucleases and transcription activator like effector nucleases.	[Hwang, Woong Y.; Peterson, Randall T.; Yeh, J-R Joanna] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Fu, Yanfang; Reyon, Deepak; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Maeder, Morgan L.; Joung, J. Keith] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Peterson, Randall T.; Yeh, J-R Joanna] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yeh, J-R Joanna] Broad Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA.	jyeh1@partners.org; jjoung@partners.org	Reyon, Deepak/HCH-3183-2022; Tsai, Shengdar Q./G-4600-2012; Wilson, Matthew H/K-3193-2013	Tsai, Shengdar Q./0000-0001-9161-3993; Peterson, Randall/0000-0003-0727-3469; Hwang, Woong/0000-0002-0575-0033; Yeh, Jing-Ruey Joanna/0000-0002-7768-4901	US National Institutes of Health (NIH) [DP1 GM105378]; NIH [R01 GM088040, P50 HG005550, K01 AG031300]; Jim and Ann Orr Research Scholar Award; Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [R01CA140188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105189, DP1GM105378, R01GM088040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031300] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Research Scholar Award; Massachusetts General Hospital(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a US National Institutes of Health (NIH) Director's Pioneer Award DP1 GM105378 (J.K.J.), NIH R01 GM088040 (J.K.J. & R.T.P.), NIH P50 HG005550 (J.K.J.), the Jim and Ann Orr Research Scholar Award (J.K.J.), NIH K01 AG031300 (J.-R.J.Y.) and a Massachusetts General Hospital Claflin award (J.-R.J.Y.). We thank G. Church, J. Aach and P. Mali for sharing unpublished results and helpful discussions.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	1988	2376	34	1226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					227	229		10.1038/nbt.2501	http://dx.doi.org/10.1038/nbt.2501			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23360964	Green Accepted, Green Submitted			2022-12-25	WOS:000316439500016
J	Meyer, JA; Wang, JH; Hogan, LE; Yang, JJ; Dandekar, S; Patel, JP; Tang, ZJ; Zumbo, P; Li, S; Zavadil, J; Levine, RL; Cardozo, T; Hunger, SP; Raetz, EA; Evans, WE; Morrison, DJ; Mason, CE; Carroll, WL				Meyer, Julia A.; Wang, Jinhua; Hogan, Laura E.; Yang, Jun J.; Dandekar, Smita; Patel, Jay P.; Tang, Zuojian; Zumbo, Paul; Li, Sheng; Zavadil, Jiri; Levine, Ross L.; Cardozo, Timothy; Hunger, Stephen P.; Raetz, Elizabeth A.; Evans, William E.; Morrison, Debra J.; Mason, Christopher E.; Carroll, William L.			Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia	NATURE GENETICS			English	Article							CHILDRENS-ONCOLOGY-GROUP; HIGH KM 5'-NUCLEOTIDASE; DRUG-RESISTANCE; MARROW RELAPSE; CANCER; TRANSPLANTATION; CHEMOTHERAPY; ADOLESCENTS; EXPRESSION; INHIBITORS	Relapsed childhood acute lymphoblastic leukemia (ALL) carries a poor prognosis, despite intensive retreatment, owing to intrinsic drug resistance(1,2). The biological pathways that mediate resistance are unknown. Here, we report the transcriptome profiles of matched diagnosis and relapse bone marrow specimens from ten individuals with pediatric B-lymphoblastic leukemia using RNA sequencing. Transcriptome sequencing identified 20 newly acquired, novel nonsynonymous mutations not present at initial diagnosis, with 2 individuals harboring relapse-specific mutations in the same gene, NT5C2, encoding a 5'-nucleotidase. Full-exon sequencing of NT5C2 was completed in 61 further relapse specimens, identifying additional mutations in 5 cases. Enzymatic analysis of mutant proteins showed that base substitutions conferred increased enzymatic activity and resistance to treatment with nucleoside analog therapies. Clinically, all individuals who harbored NT5C2 mutations relapsed early, within 36 months of initial diagnosis (P = 0.03). These results suggest that mutations in NT5C2 are associated with the outgrowth of drug-resistant clones in ALL.	[Meyer, Julia A.; Wang, Jinhua; Hogan, Laura E.; Dandekar, Smita; Zavadil, Jiri; Raetz, Elizabeth A.; Morrison, Debra J.; Carroll, William L.] NYU, Langone Med Ctr, Inst Canc, New York, NY 10012 USA; [Meyer, Julia A.; Carroll, William L.] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Wang, Jinhua; Tang, Zuojian; Zavadil, Jiri] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Hogan, Laura E.; Dandekar, Smita; Raetz, Elizabeth A.; Morrison, Debra J.; Carroll, William L.] NYU, Dept Pediat, Langone Med Ctr, New York, NY 10016 USA; [Yang, Jun J.; Evans, William E.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Patel, Jay P.; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Zumbo, Paul; Li, Sheng; Mason, Christopher E.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Zumbo, Paul; Li, Sheng; Mason, Christopher E.] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10021 USA; [Cardozo, Timothy] NYU, Dept Pharmacol, Langone Med Ctr, New York, NY 10016 USA; [Hunger, Stephen P.] Univ Colorado, Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp Colorado, Aurora, CO USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; New York University; NYU Langone Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Carroll, WL (corresponding author), NYU, Langone Med Ctr, Inst Canc, New York, NY 10012 USA.	william.carroll@nyumc.org	Evans, William E./C-2069-2012; Yang, Jun J./ABG-5646-2020; Yang, Jun/B-6976-2008; Meyer, Julia/ABD-4452-2021; levine, ross/AAE-7658-2019; Li, Sheng/A-1964-2014; Zavadil, Jiri/ABG-1780-2020; Mason, Christopher/HCH-3977-2022; Patel, Jay/HDM-6251-2022	Evans, William E./0000-0002-9333-5322; Yang, Jun J./0000-0002-0770-9659; Yang, Jun/0000-0002-0770-9659; Zavadil, Jiri/0000-0003-0640-5562; Morrison, Debra/0000-0002-8265-5910	US National Institutes of Health/National Center for Research Resources (NIH/NCRR) grant [S10 RR026950-01]; US NIH [R01 CA140729, R21 CA152838-02]; New York University Cancer Center Support Grant [5 P30 CA16087-30]; New York University Genome Technology Center; National Cancer Institute [U10 CA98543, U10 CA98413, U24 CA114766]; NIH grant [T32 CA009161]; American Society of Hematology; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, U10CA098413, P30CA016087, R01CA140729, U24CA114766, R21CA152838, U10CA098543, T32CA009161, R37CA036401] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026950] Funding Source: NIH RePORTER	US National Institutes of Health/National Center for Research Resources (NIH/NCRR) grant; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Cancer Center Support Grant; New York University Genome Technology Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We would like to thank the members of the Carroll laboratory as well as L.B. Gardner, M. Karajannis and I. Osman for their critical review of the manuscript. We gratefully acknowledge the Children's Oncology Group (COG) for patient specimens, the New York University Genome Technology Center for expert assistance with Illumina (B. Baysa) and Roche 454 (E. Venturini) deep-sequencing experiments (supported in part by US National Institutes of Health/National Center for Research Resources (NIH/NCRR) grant S10 RR026950-01), P. Grace, J.D. Ernst and M.R. Phillips (New York University School of Medicine) for expression and lentiviral vectors and F. Tsai, M.R. Phillips and S.M. Brown for technical guidance. This work was supported by US NIH grants R01 CA140729 and R21 CA152838-02 to W.L.C. and New York University Cancer Center Support Grant 5 P30 CA16087-30 in collaboration with the New York University Genome Technology Center. Additional support was provided by grants from the National Cancer Institute to COG, including U10 CA98543 (COG Chair's grant), U10 CA98413 (COG Statistical Center) and U24 CA114766 (COG Specimen Banking). J.A.M. is supported by NIH grant T32 CA009161. L.E.H. was supported by the American Society of Hematology and St. Baldrick's Foundation. S.P.H. is the Ergen Family Chair in Pediatric Cancer.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Chessells JM, 2003, BRIT J HAEMATOL, V123, P396, DOI 10.1046/j.1365-2141.2003.04584.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Eapen M, 2006, BLOOD, V107, P4961, DOI 10.1182/blood-2005-12-4942; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gallier F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002295; Galmarini CM, 2003, BRIT J HAEMATOL, V122, P53, DOI 10.1046/j.1365-2141.2003.04386.x; Galmarini CM, 2001, BLOOD, V98, P1922, DOI 10.1182/blood.V98.6.1922; Gaynon PS, 2006, J CLIN ONCOL, V24, P3150, DOI 10.1200/JCO.2005.04.5856; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Jordheim LP, 2013, BIOCHEM PHARMACOL, V85, P497, DOI 10.1016/j.bcp.2012.11.024; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Li J, 2008, PEDIATRICS, V121, pE1470, DOI 10.1542/peds.2007-2964; Mazzon C, 2003, BIOCHEM PHARMACOL, V66, P471, DOI 10.1016/S0006-2952(03)00290-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; PIETERS R, 1992, LEUKEMIA RES, V16, P873, DOI 10.1016/0145-2126(92)90033-4; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Raetz EA, 2008, J CLIN ONCOL, V26, P3971, DOI 10.1200/JCO.2008.16.1414; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Spychala J, 1999, EUR J BIOCHEM, V259, P851, DOI 10.1046/j.1432-1327.1999.00099.x; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; TOZZI MG, 1991, ARCH BIOCHEM BIOPHYS, V291, P212, DOI 10.1016/0003-9861(91)90125-3; TOZZI MG, 1991, ADV EXP MED BIOL, V309, P173; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027	33	205	214	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					290	294		10.1038/ng.2558	http://dx.doi.org/10.1038/ng.2558			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23377183	Green Accepted			2022-12-25	WOS:000315664800013
J	Chao, FA; Morelli, A; Haugner, JC; Churchfield, L; Hagmann, LN; Shi, L; Masterson, LR; Sarangi, R; Veglia, G; Seelig, B				Chao, Fa-An; Morelli, Aleardo; Haugner, John C., III; Churchfield, Lewis; Hagmann, Leonardo N.; Shi, Lei; Masterson, Larry R.; Sarangi, Ritimukta; Veglia, Gianluigi; Seelig, Burckhard			Structure and dynamics of a primordial catalytic fold generated by in vitro evolution	NATURE CHEMICAL BIOLOGY			English	Article							PROTEINS; BINDING; SELECTION; ENZYMES; DOMAIN	Engineering functional protein scaffolds capable of carrying out chemical catalysis is a major challenge in enzyme design. Starting from a noncatalytic protein scaffold, we recently generated a new RNA ligase by in vitro directed evolution. This artificial enzyme lost its original fold and adopted an entirely new structure with substantially enhanced conformational dynamics, demonstrating that a primordial fold with suitable flexibility is sufficient to carry out enzymatic function.	[Chao, Fa-An; Morelli, Aleardo; Haugner, John C., III; Churchfield, Lewis; Hagmann, Leonardo N.; Masterson, Larry R.; Veglia, Gianluigi; Seelig, Burckhard] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Morelli, Aleardo; Haugner, John C., III; Churchfield, Lewis; Hagmann, Leonardo N.; Seelig, Burckhard] Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA; [Shi, Lei; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Sarangi, Ritimukta] Stanford Synchrotron Radiat Lightsource, SLAC Natl Accelerator Lab, Menlo Pk, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Seelig, B (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	seelig@umn.edu	Seelig, Burckhard/D-1042-2013	Seelig, Burckhard/0000-0001-8598-0586; Chao, Fa-An/0000-0001-5215-8545	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center [NNX09AH70A]; Minnesota Medical Foundation; US National Institutes of Health (NIH) [T32 GM08347, T32 DE007288, GM100310, P41 RR001209]; US Department of Energy (DOE)-Basic Energy Sciences; NIH-National Center for Research Resources; DOE-Biological Environmental Resarch; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347, R01GM100310, R01GM081388] Funding Source: NIH RePORTER	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center; Minnesota Medical Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy (DOE)-Basic Energy Sciences(United States Department of Energy (DOE)); NIH-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE-Biological Environmental Resarch; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Golynskiy and A. Pohorille for helpful discussions; Z. Sachs, F.P. Seebeck, J.W. Szostak and F. Hollfelder for comments on the manuscript; and R. Majerle for isothermal titration calorimetry instrument use. This work was supported by the US National Aeronautics and Space Administration (NASA) Agreement no. NNX09AH70A through the NASA Astrobiology Institute-Ames Research Center (to F.-A.C., A.M., L.C. and B.S.); the Minnesota Medical Foundation (to B.S.) and the US National Institutes of Health (NIH) (T32 GM08347 to J.C.H., T32 DE007288 to L.R.M., GM100310 to G.V. and P41 RR001209). Stanford Synchrotron Radiation Lightsource (SSRL) operations are funded by the US Department of Energy (DOE)-Basic Energy Sciences. The SSRL Structural Molecular Biology program is supported by NIH-National Center for Research Resources and DOE-Biological Environmental Resarch.	Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Cho GS, 2006, CHEM BIOL, V13, P139, DOI 10.1016/j.chembiol.2005.10.015; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cordes MHJ, 1999, SCIENCE, V284, P325, DOI 10.1126/science.284.5412.325; Golynskiy MV, 2010, TRENDS BIOTECHNOL, V28, P340, DOI 10.1016/j.tibtech.2010.04.003; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Holmbeck SMA, 1998, J MOL BIOL, V281, P271, DOI 10.1006/jmbi.1998.1908; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Mansy SS, 2007, J MOL BIOL, V371, P501, DOI 10.1016/j.jmb.2007.05.062; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; OHNO S, 1971, EVOLUTION GENE DUPLI; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Seelig B, 2011, NAT PROTOC, V6, P540, DOI 10.1038/nprot.2011.312; Smith BA, 2011, CURR OPIN CHEM BIOL, V15, P421, DOI 10.1016/j.cbpa.2011.03.006; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; van Tilborg PJA, 2000, BIOCHEMISTRY-US, V39, P8747, DOI 10.1021/bi991550g; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhao Q, 2000, J MOL BIOL, V296, P509, DOI 10.1006/jmbi.1999.3457	25	44	44	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					81	83		10.1038/NCHEMBIO.1138	http://dx.doi.org/10.1038/NCHEMBIO.1138			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23222886	Green Accepted			2022-12-25	WOS:000314083200005
J	Wang, AM; Miyata, Y; Klinedinst, S; Peng, HM; Chua, JP; Komiyama, T; Li, XK; Morishima, Y; Merry, DE; Pratt, WB; Osawa, Y; Collins, CA; Gestwicki, JE; Lieberman, AP				Wang, Adrienne M.; Miyata, Yoshinari; Klinedinst, Susan; Peng, Hwei-Ming; Chua, Jason P.; Komiyama, Tomoko; Li, Xiaokai; Morishima, Yoshihiro; Merry, Diane E.; Pratt, William B.; Osawa, Yoichi; Collins, Catherine A.; Gestwicki, Jason E.; Lieberman, Andrew P.			Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation	NATURE CHEMICAL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; BULBAR MUSCULAR-ATROPHY; ANDROGEN RECEPTOR PROTEIN; AMELIORATES PHENOTYPES; CHAPERONE MACHINERY; BINDING; HSP90; CHIP; MUTANT; CELLS	We sought new strategies to reduce amounts of the polyglutamine androgen receptor (polyQ AR) and achieve benefits in models of spinobulbar muscular atrophy, a protein aggregation neurodegenerative disorder. Proteostasis of the polyQ AR is controlled by the heat shock protein 90 (Hsp90)- and Hsp70-based chaperone machinery, but mechanisms regulating the protein's turnover are incompletely understood. We demonstrate that overexpression of Hsp70 interacting protein (Hip), a co-chaperone that enhances binding of Hsp70 to its substrates, promotes client protein ubiquitination and polyQ AR clearance. Furthermore, we identify a small molecule that acts similarly to Hip by allosterically promoting Hsp70 binding to unfolded substrates. Like Hip, this synthetic co-chaperone enhances client protein ubiquitination and polyQ AR degradation. Both genetic and pharmacologic approaches targeting Hsp70 alleviate toxicity in a Drosophila model of spinobulbar muscular atrophy. These findings highlight the therapeutic potential of allosteric regulators of Hsp70 and provide new insights into the role of the chaperone machinery in protein quality control.	[Wang, Adrienne M.; Miyata, Yoshinari; Chua, Jason P.; Komiyama, Tomoko; Li, Xiaokai; Gestwicki, Jason E.; Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Wang, Adrienne M.; Chua, Jason P.; Lieberman, Andrew P.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Miyata, Yoshinari; Komiyama, Tomoko; Li, Xiaokai; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Klinedinst, Susan; Collins, Catherine A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Peng, Hwei-Ming; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chua, Jason P.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Merry, Diane E.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jefferson University	Lieberman, AP (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	gestwick@umich.edu; liebermn@umich.edu	Li, Xiaokai/D-2680-2014; Li, Xiaokai/A-7162-2012	Collins, Catherine/0000-0002-1608-6692	McKnight Foundation; US National Institutes of Health [NS055746, NS055746-04S1, NS059690, GM077430, NS069844, NS32214, NS076189]; Muscular Dystrophy Association [MDA238924]; US National Science Foundation [IOS-0842701]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401, R01NS059690, R01NS032214, R01NS069844, R56NS032214, F31NS076189, R01NS055746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007281] Funding Source: NIH RePORTER	McKnight Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Reddy, J. Diep and T. Washington for technical assistance and K. Takeyama (University of Tokyo) and the Bloomington Stock Center for fly strains. This work was initiated under a grant from the McKnight Foundation (to A.P.L.) and was supported by the US National Institutes of Health (NS055746, NS055746-04S1 to A.P.L.; NS059690 to J.E.G.; GM077430 to Y.O.; NS069844 to C.A.C.; NS32214 to D.E.M.; NS076189 to J.P.C.), the Muscular Dystrophy Association (MDA238924 to A.P.L.) and the US National Science Foundation (IOS-0842701 to C.A.C.).	Adachi H, 2003, J NEUROSCI, V23, P2203; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Clapp KM, 2010, J BIOL CHEM, V285, P33642, DOI 10.1074/jbc.M110.159178; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; HOHFELD J, 1995, CELL, V83, P589; Howarth JL, 2009, J NEUROCHEM, V108, P945, DOI [10.1111/j.1471-4159.2008.05847.x, 10.1111/j.0022-3042.2008.05847.x]; Kemp MQ, 2011, HUM MOL GENET, V20, P4475, DOI 10.1093/hmg/ddr380; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Lieberman AP, 2002, HUM MOL GENET, V11, P1967, DOI 10.1093/hmg/11.17.1967; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Morishima Y, 2011, BIOCHEMISTRY-US, V50, P7146, DOI 10.1021/bi200751t; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2012, J BIOL CHEM, V287, P1556, DOI 10.1074/jbc.M111.323295; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tikoo A, 2000, CANCER J, V6, P162; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Wadhwa R, 2000, CANCER RES, V60, P6818; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yu ZG, 2009, DIS MODEL MECH, V2, P500, DOI 10.1242/dmm.003301; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	42	129	132	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2013	9	2					112	118		10.1038/NCHEMBIO.1140	http://dx.doi.org/10.1038/NCHEMBIO.1140			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	078FE	23222885	Green Accepted, Green Submitted			2022-12-25	WOS:000314083200010
J	Graham, RL; Becker, MM; Eckerle, LD; Bolles, M; Denison, MR; Baric, RS				Graham, Rachel L.; Becker, Michelle M.; Eckerle, Lance D.; Bolles, Meagan; Denison, Mark R.; Baric, Ralph S.			A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease	NATURE MEDICINE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MURINE HEPATITIS-VIRUS; REPLICATION FIDELITY; SARS-CORONAVIRUS; EXORIBONUCLEASE; RECOMBINATION; PATHOGENESIS; EXONUCLEASE; SITES; MICE	Live, attenuated RNA virus vaccines are efficacious but subject to reversion to virulence. Among RNA viruses, replication fidelity is recognized as a key determinant of virulence and escape from antiviral therapy; increased fidelity is attenuating for some viruses. Coronavirus (CoV) replication fidelity is approximately 20-fold greater than that of other RNA viruses and is mediated by a 3'-> 5' exonuclease (ExoN) activity that probably functions in RNA proofreading. In this study we demonstrate that engineered inactivation of severe acute respiratory syndrome (SARS)-CoV ExoN activity results in a stable mutator phenotype with profoundly decreased fidelity in vivo and attenuation of pathogenesis in young, aged and immunocompromised mice. The ExoN inactivation genotype and mutator phenotype are stable and do not revert to virulence, even after serial passage or long-term persistent infection in vivo. ExoN inactivation has potential for broad applications in the stable attenuation of CoVs and, perhaps, other RNA viruses.	[Graham, Rachel L.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Becker, Michelle M.; Eckerle, Lance D.; Denison, Mark R.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Bolles, Meagan; Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Denison, Mark R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN USA	University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University	Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	rbaric@email.unc.edu	Graham, Rachel/AAM-9048-2020; Deming, Meagan/AEX-6400-2022; Denison, Mark R/O-7258-2018	Graham, Rachel/0000-0002-3143-6515; Deming, Meagan/0000-0003-2574-0542; Denison, Mark R/0000-0003-2655-0900	US National Institutes of Health [U54-AI057157, AI075297, 5F32AI080148, HHSN272200900007C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075297, F32AI080148, U54AI057157] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank R. Halpin, C. Town (US National Institutes of Health Microbial Genome Sequencing Contract HHSN272200900007C) and X. Lu for their assistance in sequencing in vitro isolates. This work was funded by US National Institutes of Health grants U54-AI057157 (SERCEB; R.S.B. and M.R.D.), AI075297 (R.S.B.) and 5F32AI080148 (R.L.G.).	Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Chey S, 2010, J CELL BIOCHEM, V110, P118, DOI 10.1002/jcb.22518; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Frieman MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000849; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Sessa R, 1999, PANMINERVA MED, V41, P78; Sheahan T, 2011, J VIROL, V85, P217, DOI 10.1128/JVI.01805-10; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yount B, 2006, P NATL ACAD SCI USA, V103, P12546, DOI 10.1073/pnas.0605438103; Zhao JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000636	42	166	173	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1820	+		10.1038/nm.2972	http://dx.doi.org/10.1038/nm.2972			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142821	Green Published, Bronze, Green Accepted			2022-12-25	WOS:000311999800030
J	Krueger, JG				Krueger, James G.			A welcome surprise in psoriasis	NATURE MEDICINE			English	Editorial Material							INFLAMMATION; ANTIBODY; CYTOKINE; T(H)17; SKIN		Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA	Rockefeller University	Krueger, JG (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	jgk@mail.rockefeller.edu						Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Ding HS, 2012, MOL BIOL REP, V39, P7473, DOI 10.1007/s11033-012-1580-5; Farley E, 2011, GIORN ITAL DERMAT V, V146, P9; Johnson-Huang LM, 2012, DIS MODEL MECH, V5, P423, DOI 10.1242/dmm.009092; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	12	38	55	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1750	1751		10.1038/nm.3025	http://dx.doi.org/10.1038/nm.3025			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223064				2022-12-25	WOS:000311999800022
J	Kitazawa, T; Igawa, T; Sampei, Z; Muto, A; Kojima, T; Soeda, T; Yoshihashi, K; Okuyama-Nishida, Y; Saito, H; Tsunoda, H; Suzuki, T; Adachi, H; Miyazaki, T; Ishii, S; Kamata-Sakurai, M; Iida, T; Harada, A; Esaki, K; Funaki, M; Moriyama, C; Tanaka, E; Kikuchi, Y; Wakabayashi, T; Wada, M; Goto, M; Toyoda, T; Ueyama, A; Suzuki, S; Haraya, K; Tachibana, T; Kawabe, Y; Shima, M; Yoshioka, A; Hattori, K				Kitazawa, Takehisa; Igawa, Tomoyuki; Sampei, Zenjiro; Muto, Atsushi; Kojima, Tetsuo; Soeda, Tetsuhiro; Yoshihashi, Kazutaka; Okuyama-Nishida, Yukiko; Saito, Hiroyuki; Tsunoda, Hiroyuki; Suzuki, Tsukasa; Adachi, Hideki; Miyazaki, Taro; Ishii, Shinya; Kamata-Sakurai, Mika; Iida, Takeo; Harada, Aya; Esaki, Keiko; Funaki, Miho; Moriyama, Chifumi; Tanaka, Eriko; Kikuchi, Yasufumi; Wakabayashi, Tetsuya; Wada, Manabu; Goto, Masaaki; Toyoda, Takeshi; Ueyama, Atsunori; Suzuki, Sachiyo; Haraya, Kenta; Tachibana, Tatsuhiko; Kawabe, Yoshiki; Shima, Midori; Yoshioka, Akira; Hattori, Kunihiro			A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model	NATURE MEDICINE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; RECOMBINANT FACTOR-VIII; THERAPEUTIC ANTIBODIES; INHIBITOR DEVELOPMENT; VARIABLE REGION; IGG ANTIBODIES; BINDING-SITE; FULLY HUMAN; PHARMACOKINETICS; PHARMACODYNAMICS	Hemophilia A is a bleeding disorder resulting from coagulation factor VIII (FVIII) deficiency. Exogenously provided FVIII effectively reduces bleeding complications in patients with severe hemophilia A. In approximately 30% of such patients, however, the 'foreignness' of the FVIII molecule causes them to develop inhibitory antibodies against FVIII (inhibitors), precluding FVIII treatment in this set of patients(1-3). Moreover, the poor pharmacokinetics of FVIII, attributed to low subcutaneous bioavailability and a short half-life of 0.5 d, necessitates frequent intravenous injections(3-5). To overcome these drawbacks, we generated a humanized bispecific antibody to factor IXa (FIXa) and factor X (FX), termed hBS23, that places these two factors into spatially appropriate positions and mimics the cofactor function of FVIII. hBS23 exerted coagulation activity in FVIII-deficient plasma, even in the presence of inhibitors, and showed in vivo hemostatic activity in a nonhuman primate model of acquired hemophilia A. Notably, hBS23 had high subcutaneous bioavailability and a 2-week half-life and would not be expected to elicit the development of FVIII-specific inhibitory antibodies, as its molecular structure, and hence antigenicity, differs from that of FVIII. A long-acting, subcutaneously injectable agent that is unaffected by the presence of inhibitors could markedly reduce the burden of care for the treatment of hemophilia A.	[Kitazawa, Takehisa; Igawa, Tomoyuki; Sampei, Zenjiro; Muto, Atsushi; Kojima, Tetsuo; Soeda, Tetsuhiro; Yoshihashi, Kazutaka; Okuyama-Nishida, Yukiko; Saito, Hiroyuki; Tsunoda, Hiroyuki; Suzuki, Tsukasa; Adachi, Hideki; Miyazaki, Taro; Ishii, Shinya; Kamata-Sakurai, Mika; Iida, Takeo; Harada, Aya; Esaki, Keiko; Funaki, Miho; Moriyama, Chifumi; Tanaka, Eriko; Kikuchi, Yasufumi; Wakabayashi, Tetsuya; Wada, Manabu; Goto, Masaaki; Toyoda, Takeshi; Ueyama, Atsunori; Suzuki, Sachiyo; Haraya, Kenta; Tachibana, Tatsuhiko; Kawabe, Yoshiki; Hattori, Kunihiro] Chugai Pharmaceut, Fuji Gotemba Res Labs, Shizuoka, Japan; [Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Nara Medical University	Kitazawa, T (corresponding author), Chugai Pharmaceut, Fuji Gotemba Res Labs, Shizuoka, Japan.	kitazawatkh@chugai-pharm.co.jp	HARAYA, KENTA/AAW-4267-2020	HARAYA, KENTA/0000-0002-9142-5607; Sampei, Zenjiro/0000-0001-5343-4468; Tachibana, Tatsuhiko/0000-0001-8339-3986; Kawabe, Yoshiki/0000-0002-6465-7146				Astermark J, 2007, BLOOD, V109, P546, DOI 10.1182/blood-2006-04-017988; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Benincosa LJ, 2000, J PHARMACOL EXP THER, V292, P810; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; Bjorkman S, 2012, BLOOD, V119, P612, DOI 10.1182/blood-2011-07-360594; Bloom JW, 1997, PROTEIN SCI, V6, P407; Deng R, 2011, MABS-AUSTIN, V3, P61, DOI 10.4161/mabs.3.1.13799; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fischer K, 2012, HAEMOPHILIA, V18, pe241, DOI 10.1111/j.1365-2516.2011.02687.x; Geraghty S, 2006, HAEMOPHILIA, V12, P75, DOI 10.1111/j.1365-2516.2006.01189.x; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; Healey JF, 1996, BLOOD, V88, P4209; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; High KA, 2011, J THROMB HAEMOST, V9, P2, DOI 10.1111/j.1538-7836.2011.04369.x; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Leissinger C, 2011, NEW ENGL J MED, V365, P1684, DOI 10.1056/NEJMoa1104435; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lillicrap D, 2010, CURR OPIN HEMATOL, V17, P393, DOI 10.1097/MOH.0b013e32833c06c6; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Mayorov AV, 2008, P NATL ACAD SCI USA, V105, P17487, DOI 10.1073/pnas.0711808105; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Okuda M, 2004, CLIN LAB HAEMATOL, V26, P215, DOI 10.1111/j.1365-2257.2004.00605.x; Oldenburg J, 2002, HAEMOPHILIA, V8, P23, DOI 10.1046/j.1351-8216.2001.00134.x; Powell JS, 2012, BLOOD, V119, P3031, DOI 10.1182/blood-2011-09-382846; Ragni MV, 2012, HAEMOPHILIA, V18, P63, DOI 10.1111/j.1365-2516.2011.02554.x; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Shetty S, 2011, AUTOIMMUN REV, V10, P311, DOI 10.1016/j.autrev.2010.11.005; Shi Q, 2012, HAEMOPHILIA, V18, P639, DOI 10.1111/j.1365-2516.2011.02735.x; Shima M, 2008, HAEMOPHILIA, V14, P83, DOI 10.1111/j.1365-2516.2008.01737.x; Stonebraker JS, 2010, HAEMOPHILIA, V16, P20, DOI 10.1111/j.1365-2516.2009.02127.x; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; YONEMURA H, 1993, PROTEIN ENG, V6, P669, DOI 10.1093/protein/6.6.669; Young G, 2011, HAEMOPHILIA, V17, pE849, DOI 10.1111/j.1365-2516.2011.02494.x	46	296	327	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1570	U177		10.1038/nm.2942	http://dx.doi.org/10.1038/nm.2942			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23023498				2022-12-25	WOS:000309587500036
J	Sentelle, RD; Senkal, CE; Jiang, WH; Ponnusamy, S; Gencer, S; Selvam, SP; Ramshesh, VK; Peterson, YK; Lemasters, JJ; Szulc, ZM; Bielawski, J; Ogretmen, B				Sentelle, R. David; Senkal, Can E.; Jiang, Wenhui; Ponnusamy, Suriyan; Gencer, Salih; Selvam, Shanmugam Panneer; Ramshesh, Venkat K.; Peterson, Yuri K.; Lemasters, John J.; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim			Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy	NATURE CHEMICAL BIOLOGY			English	Article							LONGEVITY ASSURANCE GENE-1; SQUAMOUS-CELL CARCINOMAS; HUMAN HEAD; IN-VITRO; (DIHYDRO)CERAMIDE SYNTHASE; NONVESICULAR TRAFFICKING; PROTEIN-KINASE; ER STRESS; C-ELEGANS; DEATH	Mechanisms by which autophagy promotes cell survival or death are unclear. We provide evidence that C-18-pyridinium ceramide treatment or endogenous C-18-ceramide generation by ceramide synthase 1 (CerS1) expression mediates autophagic cell death, independent of apoptosis in human cancer cells. C-18-ceramide-induced lethal autophagy was regulated via microtubule-associated protein 1 light chain 3 beta-lipidation, forming LC3B-II, and selective targeting of mitochondria by LC3B-II-containing autophagolysosomes (mitophagy) through direct interaction between ceramide and LC3B-II upon Drp1-dependent mitochondrial fission, leading to inhibition of mitochondrial function and oxygen consumption. Accordingly, expression of mutant LC3B with impaired ceramide binding, as predicted by molecular modeling, prevented CerS1-mediated mitochondrial targeting, recovering oxygen consumption. Moreover, knockdown of CerS1 abrogated sodium selenite-induced mitophagy, and stable LC3B knockdown protected against CerS1- and C-18-ceramide-dependent mitophagy and blocked tumor suppression in vivo. Thus, these data suggest a new receptor function of ceramide for anchoring LC3B-II autophagolysosomes to mitochondrial membranes, defining a key mechanism for the induction of lethal mitophagy.	[Sentelle, R. David; Senkal, Can E.; Jiang, Wenhui; Ponnusamy, Suriyan; Gencer, Salih; Selvam, Shanmugam Panneer; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Sentelle, R. David; Senkal, Can E.; Jiang, Wenhui; Ponnusamy, Suriyan; Gencer, Salih; Selvam, Shanmugam Panneer; Ramshesh, Venkat K.; Peterson, Yuri K.; Lemasters, John J.; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Ramshesh, Venkat K.; Peterson, Yuri K.; Lemasters, John J.] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Sentelle, RD (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	ogretmen@musc.edu	jiang, wen/GYI-9662-2022; Gencer, Salih/B-6436-2012; Gencer, Salih/AAL-5502-2020; Panneer Selvam, Shanmugam/K-4759-2016	Panneer Selvam, Shanmugam/0000-0002-3290-8844; Szulc, Zdzislaw M./0000-0003-1756-9028	US National Institutes of Health (NIH) [CA088932, DE016572, CA097165]; NIH [C06 RR015455, 5-P30-DK34987, 1-P50-AA11605, P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA088932, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011605] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank J.G. Schnellmann for her editorial review. We also thank D.J. Hazen-Martin and her group for TEM preparations. This work was supported by research grants obtained from the US National Institutes of Health (NIH; CA088932, DE016572 and CA097165 to B.O.). The core facilities used for animal studies, lipidomics and imaging were constructed using support from NIH (C06 RR015455, 5-P30-DK34987, 1-P50-AA11605 and P30 CA138313).	Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Kim EH, 2008, AUTOPHAGY, V4, P76, DOI 10.4161/auto.5119; Kim I, 2011, AM J PHYSIOL-CELL PH, V300, pC308, DOI 10.1152/ajpcell.00056.2010; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Masud A, 2007, J BIOL CHEM, V282, P14132, DOI 10.1074/jbc.M700077200; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Saddoughi SA, 2011, CLIN CANCER RES, V17, P6097, DOI 10.1158/1078-0432.CCR-11-0930; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	43	315	322	8	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2012	8	10					831	838		10.1038/NCHEMBIO.1059	http://dx.doi.org/10.1038/NCHEMBIO.1059			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009WN	22922758	Green Accepted			2022-12-25	WOS:000309056200008
J	Urano, D; Phan, N; Jones, JC; Yang, J; Huang, JR; Grigston, J; Taylor, JP; Jones, AM				Urano, Daisuke; Nguyen Phan; Jones, Janice C.; Yang, Jing; Huang, Jirong; Grigston, Jeffrey; Taylor, J. Philip; Jones, Alan M.			Endocytosis of the seven-transmembrane RGS1 protein activates G-protein-coupled signalling in Arabidopsis	NATURE CELL BIOLOGY			English	Article							HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; FLOWERING TIME; CELL-DIVISION; BETA-SUBUNIT; GENE FAMILY; GLUCOSE; YEAST; TRAFFICKING; EXPRESSION	Signal transduction typically begins by ligand-dependent activation of a concomitant partner that is otherwise in its resting state. However, in cases where signal activation is constitutive by default, the mechanism of regulation is unknown. The Arabidopsis thaliana heterotrimeric G alpha protein self-activates without accessory proteins, and is kept in its resting state by the negative regulator, AtRGS1 (regulator of G-protein signalling 1), which is the prototype of a seven-transmembrane receptor fused with an RGS domain. Endocytosis of AtRGS1 by ligand-dependent endocytosis physically uncouples the GTPase-accelerating activity of AtRGS1 from the G alpha protein, permitting sustained activation. Phosphorylation of AtRGS1 by AtWNK8 kinase causes AtRGS1 endocytosis, required for both G-protein-mediated sugar signalling and cell proliferation. In animals, receptor endocytosis results in signal desensitization, whereas in plants, endocytosis results in signal activation. These findings reveal how different organisms rearrange a regulatory system to result in opposite outcomes using similar phosphorylation-dependent endocytosis mechanisms.	[Urano, Daisuke; Nguyen Phan; Yang, Jing; Huang, Jirong; Grigston, Jeffrey; Taylor, J. Philip; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Janice C.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Grigston, Jeffrey/E-9012-2013; Phan, Nguyen/I-3381-2013	Grigston, Jeffrey/0000-0002-8428-4180; Phan, Nguyen/0000-0001-7662-9014; Urano, Daisuke/0000-0003-4541-1076	NIGMS [R01GM065989]; NSF [MCB-0723515, MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-05er15671]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Smalley for determining the phosphorylation sites of AtRGS1, N. Nakamichi, T. Eulgem and H. Ma (Pennsylvania State University, USA) for supplying experimental materials, K. Williamson and M. Mathew for assistance in protein purification and gene cloning, A. Urano for assisting in experiments and H. Dohlman for helpful discussions. This work was supported by grants from the NIGMS (R01GM065989) and NSF (MCB-0723515 and MCB-0718202) to A.M.J. The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy through grant DE-FG02-05er15671 to A.M.J. financially supported the genotyping of the materials in this study.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; An SW, 2011, CURR BIOL, V21, P1979, DOI 10.1016/j.cub.2011.11.002; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; Booker KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012833; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen ZY, 2009, PLANT CELL, V21, P1972, DOI 10.1105/tpc.108.062653; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; Day PW, 2004, METHOD ENZYMOL, V390, P295; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Grigston JC, 2008, FEBS LETT, V582, P3577, DOI 10.1016/j.febslet.2008.08.038; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hislop J. N., 2005, REGULATED MEMBRANE T, P95; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Huang CL, 2008, CURR OPIN NEPHROL HY, V17, P519, DOI 10.1097/MNH.0b013e32830dd580; Huang CL, 2007, EXP MOL MED, V39, P565, DOI 10.1038/emm.2007.62; ISSHIKI T, 1992, GENE DEV, V6, P2455, DOI 10.1101/gad.6.12b.2455; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kumar K, 2011, TLS-TIMES LIT SUPPL, P6; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lalonde S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00024; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Murakami-Kojima M, 2002, PLANT CELL PHYSIOL, V43, P675, DOI 10.1093/pcp/pcf084; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Park HY, 2011, PLANT CELL PHYSIOL, V52, P1376, DOI 10.1093/pcp/pcr084; Pego JV, 2000, TRENDS PLANT SCI, V5, P531, DOI 10.1016/S1360-1385(00)01783-0; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stubbs MD, 2001, BBA-PROTEIN STRUCT M, V1550, P52, DOI 10.1016/S0167-4838(01)00267-9; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Wang Y., 2011, J PLANT PHYSL	55	122	130	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2012	14	10					1079	+		10.1038/ncb2568	http://dx.doi.org/10.1038/ncb2568			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	016UA	22940907	Green Accepted, Green Submitted			2022-12-25	WOS:000309543800016
J	Wang, KB; Wang, ZW; Li, FG; Ye, WW; Wang, JY; Song, GL; Yue, Z; Cong, L; Shang, HH; Zhu, SL; Zou, CS; Li, Q; Yuan, YL; Lu, CR; Wei, HL; Gou, CY; Zheng, ZQ; Yin, Y; Zhang, XY; Liu, K; Wang, B; Song, C; Shi, N; Kohel, RJ; Percy, RG; Yu, JZ; Zhu, YX; Wang, J; Yu, SX				Wang, Kunbo; Wang, Zhiwen; Li, Fuguang; Ye, Wuwei; Wang, Junyi; Song, Guoli; Yue, Zhen; Cong, Lin; Shang, Haihong; Zhu, Shilin; Zou, Changsong; Li, Qin; Yuan, Youlu; Lu, Cairui; Wei, Hengling; Gou, Caiyun; Zheng, Zequn; Yin, Ye; Zhang, Xueyan; Liu, Kun; Wang, Bo; Song, Chi; Shi, Nan; Kohel, Russell J.; Percy, Richard G.; Yu, John Z.; Zhu, Yu-Xian; Wang, Jun; Yu, Shuxun			The draft genome of a diploid cotton Gossypium raimondii	NATURE GENETICS			English	Article							(+)-DELTA-CADINENE SYNTHASE; FIBER; SEQUENCE; EXPRESSION; MAP; ORGANIZATION; POLYPLOIDY; ELONGATION; EVOLUTION; ETHYLENE	We have sequenced and assembled a draft genome of G. raimondii, whose progenitor is the putative contributor of the D subgenome to the economically important fiber-producing cotton species Gossypium hirsutum and Gossypium barbadense. Over 73% of the assembled sequences were anchored on 13 G. raimondii chromosomes. The genome contains 40,976 protein-coding genes, with 92.2% of these further confirmed by transcriptome data. Evidence of the hexaploidization event shared by the eudicots as well as of a cotton-specific whole-genome duplication approximately 13-20 million years ago was observed. We identified 2,355 syntenic blocks in the G. raimondii genome, and we found that approximately 40% of the paralogous genes were present in more than 1 block, which suggests that this genome has undergone substantial chromosome rearrangement during its evolution. Cotton, and probably Theobroma cacao, are the only sequenced plant species that possess an authentic CDN1 gene family for gossypol biosynthesis, as revealed by phylogenetic analysis.	[Wang, Kunbo; Li, Fuguang; Ye, Wuwei; Song, Guoli; Shang, Haihong; Zou, Changsong; Yuan, Youlu; Lu, Cairui; Wei, Hengling; Zhang, Xueyan; Liu, Kun; Yu, Shuxun] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Cotton Res Inst, Anyang, Peoples R China; [Wang, Zhiwen; Wang, Junyi; Yue, Zhen; Cong, Lin; Zhu, Shilin; Gou, Caiyun; Zheng, Zequn; Yin, Ye; Wang, Bo; Song, Chi; Shi, Nan; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Qin; Zhu, Yu-Xian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Kohel, Russell J.; Percy, Richard G.; Yu, John Z.] USDA ARS, Crop Germplasm Res Unit, So Plains Agr Res Ctr, College Stn, TX USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Beijing Genomics Institute (BGI); Peking University; United States Department of Agriculture (USDA); University of Copenhagen	Yu, SX (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Cotton Res Inst, Anyang, Peoples R China.	zhuyx2@pku.edu.cn; wangj@genomics.org.cn; yu@cricaas.com.cn	Li, Qin/AAP-9448-2020; wang, junyi/GYA-3213-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Li, Qin/0000-0002-8948-2717; Wang, Jun/0000-0002-2113-5874; yu, shuxun/0000-0002-9715-3462; Wang, Jun/0000-0002-8540-8931; Zhu, Yuxian/0000-0003-2371-5933	China National Basic Research Program [2010CB126000]; National Natural Science Foundation of China [90717009]	China National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank X.-Y. Chen for his valuable criticisms and suggestions to the manuscript. This work was supported by a grant from the China National Basic Research Program (grant 2010CB126000) and by the National Natural Science Foundation of China (grant 90717009).	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen XY, 1996, J NAT PROD, V59, P944, DOI 10.1021/np960344w; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Desai A, 2006, GENOME, V49, P336, DOI 10.1139/G05-116; ESSENBERG M, 1990, PHYTOCHEMISTRY, V29, P3107, DOI 10.1016/0031-9422(90)80166-E; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Gennadios HA, 2009, BIOCHEMISTRY-US, V48, P6175, DOI 10.1021/bi900483b; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jia S., 2006, TRANSGENIC COTTON; LARKIN JC, 1994, PLANT CELL, V6, P1065, DOI 10.1105/tpc.6.8.1065; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin LF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-395; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; REINISCH AJ, 1994, GENETICS, V138, P829; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu J.Z., 2004, PLANT BREEDING NEWS	44	664	790	10	234	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1098	+		10.1038/ng.2371	http://dx.doi.org/10.1038/ng.2371			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922876				2022-12-25	WOS:000309550200008
J	Yoshioka, K; Yoshida, K; Cui, H; Wakayama, T; Takuwa, N; Okamoto, Y; Du, W; Qi, X; Asanuma, K; Sugihara, K; Aki, S; Miyazawa, H; Biswas, K; Nagakura, C; Ueno, M; Iseki, S; Schwartz, RJ; Okamoto, H; Sasaki, T; Matsui, O; Asano, M; Adams, RH; Takakura, N; Takuwa, Y				Yoshioka, Kazuaki; Yoshida, Kotaro; Cui, Hong; Wakayama, Tomohiko; Takuwa, Noriko; Okamoto, Yasuo; Du, Wa; Qi, Xun; Asanuma, Ken; Sugihara, Kazushi; Aki, Sho; Miyazawa, Hidekazu; Biswas, Kuntal; Nagakura, Chisa; Ueno, Masaya; Iseki, Shoichi; Schwartz, Robert J.; Okamoto, Hiroshi; Sasaki, Takehiko; Matsui, Osamu; Asano, Masahide; Adams, Ralf H.; Takakura, Nobuyuki; Takuwa, Yoh			Endothelial PI3K-C2 alpha, a class II PI3K, has an essential role in angiogenesis and vascular barrier function	NATURE MEDICINE			English	Article							3-KINASE ALPHA-ISOFORM; PHOSPHOINOSITIDE 3-KINASE; MYOSIN PHOSPHATASE; RHO-KINASE; IN-VIVO; MEMBRANE; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; RECEPTOR; GROWTH	The class II alpha-isoform of phosphatidylinositol 3-kinase (PI3K-C2 alpha) is localized in endosomes, the trans-Golgi network and clathrin-coated vesicles; however, its functional role is not well understood. Global or endothelial-cell-specific deficiency of PI3K-C2 alpha resulted in embryonic lethality caused by defects in sprouting angiogenesis and vascular maturation. PI3K-C2 alpha knockdown in endothelial cells resulted in a decrease in the number of PI3-phosphate-enriched endosomes, impaired endosomal trafficking, defective delivery of VE-cadherin to endothelial cell junctions and defective junction assembly. PI3K-C2 alpha knockdown also impaired endothelial cell signaling, including vascular endothelial growth factor receptor internalization and endosomal RhoA activation. Together, the effects of PI3K-C2 alpha knockdown led to defective endothelial cell migration, proliferation, tube formation and barrier integrity. Endothelial PI3K-C2 alpha deficiency in vivo suppressed postischemic and tumor angiogenesis and diminished vascular barrier function with a greatly augmented susceptibility to anaphylaxis and a higher incidence of dissecting aortic aneurysm formation in response to angiotensin II infusion. Thus, PI3K-C2 alpha has a crucial role in vascular formation and barrier integrity and represents a new therapeutic target for vascular disease.	[Yoshioka, Kazuaki; Yoshida, Kotaro; Cui, Hong; Takuwa, Noriko; Okamoto, Yasuo; Du, Wa; Qi, Xun; Aki, Sho; Miyazawa, Hidekazu; Biswas, Kuntal; Nagakura, Chisa; Takuwa, Yoh] Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 920, Japan; [Yoshida, Kotaro; Matsui, Osamu] Kanazawa Univ, Sch Med, Dept Radiol, Kanazawa, Ishikawa 920, Japan; [Wakayama, Tomohiko; Iseki, Shoichi] Kanazawa Univ, Sch Med, Dept Histol & Embryol, Kanazawa, Ishikawa 920, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa, Japan; [Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 010, Japan; [Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa, Japan; [Ueno, Masaya; Takakura, Nobuyuki] Osaka Univ, Dept Signal Transduct, Microbial Dis Res Inst, Osaka, Japan; [Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Okamoto, Hiroshi] Tohoku Univ, Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Sasaki, Takehiko] Akita Univ, Res Ctr Biosignal, Akita 010, Japan; [Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, Munster, Germany	Kanazawa University; Kanazawa University; Kanazawa University; Akita University; Kanazawa University; Osaka University; University of Houston System; University of Houston; Tohoku University; Akita University; Max Planck Society; University of Munster	Takuwa, Y (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 920, Japan.	ytakuwa@med.kanazawa-u.ac.jp	OKAMOTO, Yasuo/J-8438-2015; Adams, Ralf H/AAE-9274-2019; Yoshioka, Kazuaki/G-1038-2013; Du, Wa/I-8453-2019; UENO, Masaya/D-8464-2015	Yoshioka, Kazuaki/0000-0002-8631-3846; Du, Wa/0000-0002-1518-7301; UENO, Masaya/0000-0001-9177-8640; TAKUWA, Noriko/0000-0002-4278-2704; Sasaki, Takehiko/0000-0003-1837-3748	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research [23590257, 23500493] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Mitsumori for comments on the histological study. We thank N. Mochizuki and K. Ando for assistance with the FRET imaging analysis. We thank N. Furusawa, K. Sunagawa and E. Kaneko for assistance with live-cell imaging using a Yokogawa confocal microscope system. We also thank Y. Ohta and T. Murakawa for technical assistance and T. Hirose for administrative assistance. C2 alpha complementary DNA was obtained from J. Domin (Imperial College London). GFP-2 x FYVE and mRFP-2 x FYVE expression vectors were obtained from H. Stenmark (Oslo University Hospital) and Y. Ohsumi (Tokyo Institute of Technology), respectively. VE-cadherin-GFP expression vectors were obtained from N. Mochizuki (National Cerebral and Cardiovascular Center). The pRaichu-RhoA probe was obtained from M. Matsuda (Kyoto University). GFP-RhoA<SUP>Asn19</SUP> and GFP-RhoA<SUP>Val14</SUP> expression vectors were obtained from F. Valderrama (King's College London). This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Society for the Promotion of Science (to K. Yoshioka, N. Takuwa, Y.O. and Y. T.), the Honjin Foundation, the Mitsubishi Pharma Research Foundation and the SENSIN Medical Research Foundation (to K. Yoshioka).	Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; Di Gennaro A, 2010, P NATL ACAD SCI USA, V107, P21093, DOI 10.1073/pnas.1015166107; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; El Sheikh Soha Salama, 2003, BMC Clin Pathol, V3, P4, DOI 10.1186/1472-6890-3-4; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Harris DP, 2011, MOL CELL BIOL, V31, P63, DOI 10.1128/MCB.00468-10; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Linassier C, 1997, BIOCHEM J, V321, P849, DOI 10.1042/bj3210849; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Traer Colin J, 2006, Bull Cancer, V93, pE53; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wheeler M, 2006, J CELL PHYSIOL, V206, P586, DOI 10.1002/jcp.20507; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yoshioka K, 2007, MOL PHARMACOL, V71, P912, DOI 10.1124/mol.106.032599; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	61	144	153	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1560	U170		10.1038/nm.2928	http://dx.doi.org/10.1038/nm.2928			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22983395	Green Submitted			2022-12-25	WOS:000309587500035
J	Zhang, SQ; Jiang, T; Li, M; Zhang, X; Ren, YQ; Wei, SC; Sun, LD; Cheng, H; Li, Y; Yin, XY; Hu, ZM; Wang, ZY; Liu, Y; Guo, BR; Tang, HY; Tang, XF; Ding, YT; Wang, JB; Li, P; Wu, BY; Wang, W; Yuan, XF; Hou, JS; Ha, WW; Wang, WJ; Zhai, YJ; Wang, J; Qian, FF; Zhou, FS; Chen, G; Zuo, XB; Zheng, XD; Sheng, YJ; Gao, JP; Liang, B; Li, P; Zhu, J; Xiao, FL; Wang, PG; Cui, Y; Li, H; Liu, SX; Gao, M; Fan, X; Shen, SK; Zeng, M; Sun, GQ; Xu, Y; Hu, JC; He, TT; Li, YR; Yang, HM; Wang, J; Yu, ZY; Zhang, HF; Hu, X; Yang, K; Wang, J; Zhao, SX; Zhou, YW; Liu, JJ; Du, WD; Zhang, L; Xia, K; Yang, S; Wang, J; Zhang, XJ				Zhang, Sheng-Quan; Jiang, Tao; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Hu, Zheng-Mao; Wang, Zhen-Ying; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Zhou, Fu-Sheng; Chen, Gang; Zuo, Xian-Bo; Zheng, Xiao-Dong; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Sun, Guang-Qing; Xu, Yu; Hu, Jing-Chu; He, Ting-Ting; Li, Ying-Rui; Yang, Huan-Ming; Wang, Jian; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Zhang, Li; Xia, Kun; Yang, Sen; Wang, Jun; Zhang, Xue-Jun			Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis	NATURE GENETICS			English	Article							MEVALONATE KINASE-DEFICIENCY; PERIODIC FEVER SYNDROME; SHORT READ ALIGNMENT; HYPERIMMUNOGLOBULINEMIA-D; GENETIC-ASPECTS; LOCUS; 12Q23.2-24.1; SPECTRUM; DISEASE	Disseminated superficial actinic porokeratosis (DSAP) is an autosomal dominantly inherited epidermal keratinization disorder whose etiology remains unclear. We performed exome sequencing in one unaffected and two affected individuals from a DSAP family. The mevalonate kinase gene (MVK) emerged as the only candidate gene located in previously defined linkage regions after filtering against existing SNP databases, eight HapMap exomes and 1000 Genomes Project data and taking into consideration the functional implications of the mutations. Sanger sequencing in 57 individuals with familial DSAP and 25 individuals with sporadic DSAP identified MVK mutations in 33% and 16% of these individuals (cases), respectively. All 14 MVK mutations identified in our study were absent in 676 individuals without DSAP. Our functional studies in cultured primary keratinocytes suggest that MVK has a role in regulating calcium-induced keratinocyte differentiation and could protect keratinocytes from apoptosis induced by type A ultraviolet radiation. Our results should help advance the understanding of DSAP pathogenesis.	[Zhang, Sheng-Quan; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Yang, Sen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Zhang, Sheng-Quan; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Yang, Sen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Zhang, Sheng-Quan; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Zhou, Fu-Sheng; Chen, Gang; Zuo, Xian-Bo; Zheng, Xiao-Dong; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Yang, Sen; Zhang, Xue-Jun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Jiang, Tao; Sun, Guang-Qing; Xu, Yu; Hu, Jing-Chu; He, Ting-Ting; Li, Ying-Rui; Yang, Huan-Ming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Hu, Zheng-Mao; Xia, Kun] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Wang, Zhen-Ying; Zhang, Li] Shandong Univ, Prov Hosp, Dept Dermatol, Jinan, Shandong, Peoples R China; [Liu, Jian-Jun] Anhui Med Univ, Inst Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Xue-Jun] Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Beijing Genomics Institute (BGI); Central South University; Shandong University; Anhui Medical University; Anhui Medical University	Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.	wangj@genomics.org.cn; ayzxj@vip.sina.com	Cui, Yong/AAF-9300-2020; Wang, Jun/A-7261-2013; SHENG, Yu/GXZ-8269-2022; Liu, Jianjun/AAK-4989-2020; Chen, Gang/G-2722-2010; XIA, KUN/AAO-3525-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Liu, Jianjun/0000-0002-3255-3019; Hu, Jingchu/0000-0001-6144-7226; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Ministry of Education of China [IRT-1046]	Ministry of Education of China(Ministry of Education, China)	We thank the individuals and their families who participated in this project. This study was funded by Ministry of Education of China (IRT-1046).	ANDERSON DE, 1969, ARCH DERMATOL, V99, P408, DOI 10.1001/archderm.99.4.408; Bader-Meunier B, 2011, PEDIATRICS, V128, pE152, DOI 10.1542/peds.2010-3639; Bouwstra JA, 2006, BBA-BIOMEMBRANES, V1758, P2080, DOI 10.1016/j.bbamem.2006.06.021; CHERNOSKY ME, 1986, ARCH DERMATOL, V122, P869, DOI 10.1001/archderm.122.8.869; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; Edmondson SR, 2001, J INVEST DERMATOL, V116, P491, DOI 10.1046/j.0022-202x.2001.temp.doc.x; Frank J, 2007, HUM MUTAT, V28, P1241, DOI 10.1002/humu.20587; Frank J, 2007, J INVEST DERMATOL, V127, P2058, DOI 10.1038/sj.jid.5700783; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; GOERTTLER EA, 1975, HUMANGENETIK, V26, P291; Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13; Houten SM, 2000, BBA-MOL CELL BIOL L, V1529, P19, DOI 10.1016/S1388-1981(00)00135-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu P, 2008, HUM GENET, V123, P507, DOI 10.1007/s00439-008-0504-x; Luan J, 2011, HUM GENET, V129, P329, DOI 10.1007/s00439-010-0929-x; Mandey SHL, 2006, HUM MUTAT, V27, P796, DOI 10.1002/humu.20361; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; OTSUKA F, 1991, J CANCER RES CLIN, V117, P55, DOI 10.1007/BF01613197; Sasson M, 1996, DERMATOL SURG, V22, P339, DOI 10.1111/j.1524-4725.1996.tb00327.x; Shen CS, 2002, BRIT J DERMATOL, V147, P498, DOI 10.1046/j.1365-2133.2002.04853.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu LQ, 2004, BRIT J DERMATOL, V150, P999, DOI 10.1111/j.1365-2133.2004.05912.x; Xia JH, 2000, J INVEST DERMATOL, V114, P1071, DOI 10.1046/j.1523-1747.2000.00978.x; Xia K, 2002, BRIT J DERMATOL, V147, P650, DOI 10.1046/j.1365-2133.2002.05058.x; Zhang ZH, 2005, BRIT J DERMATOL, V152, P658, DOI 10.1111/j.1365-2133.2005.06443.x; Zhang Zhenghua, 2004, Hum Mutat, V24, P438, DOI 10.1002/humu.9283; Zhao YW, 2011, J INVEST DERMATOL, V131, P1045, DOI 10.1038/jid.2011.41	34	84	99	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1156	+		10.1038/ng.2409	http://dx.doi.org/10.1038/ng.2409			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22983302				2022-12-25	WOS:000309550200019
J	Bodenmiller, B; Zunder, ER; Finck, R; Chen, TJ; Savig, ES; Bruggner, RV; Simonds, EF; Bendall, SC; Sachs, K; Krutzik, PO; Nolan, GP				Bodenmiller, Bernd; Zunder, Eli R.; Finck, Rachel; Chen, Tiffany J.; Savig, Erica S.; Bruggner, Robert V.; Simonds, Erin F.; Bendall, Sean C.; Sachs, Karen; Krutzik, Peter O.; Nolan, Garry P.			Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators	NATURE BIOTECHNOLOGY			English	Article							KINASE INHIBITOR SELECTIVITY; POLYCHROMATIC FLOW-CYTOMETRY; FUNCTIONAL GENOMICS; DRUG DISCOVERY; IMMUNE-SYSTEM; CANCER; CELLS; PROTEOMICS; RESPONSES; POPULATIONS	Mass cytometry facilitates high-dimensional, quantitative analysis of the effects of bioactive molecules on human samples at single-cell resolution, but instruments process only one sample at a time. Here we describe mass-tag cellular barcoding (MCB), which increases mass cytometry throughput by using n metal ion tags to multiplex up to 2(n) samples. We used seven tags to multiplex an entire 96-well plate, and applied MCB to characterize human peripheral blood mononuclear cell (PBMC) signaling dynamics and cell-to-cell communication, signaling variability between PBMCs from eight human donors, and the effects of 27 inhibitors on this system. For each inhibitor, we measured 14 phosphorylation sites in 14 PBMC types at 96 conditions, resulting in 18,816 quantified phosphorylation levels from each multiplexed sample. This high-dimensional, systems-level inquiry allowed analysis across cell-type and signaling space, reclassified inhibitors and revealed off-target effects. High-content, high-throughput screening with MCB should be useful for drug discovery, preclinical testing and mechanistic investigation of human disease.	[Bodenmiller, Bernd; Zunder, Eli R.; Finck, Rachel; Chen, Tiffany J.; Savig, Erica S.; Bruggner, Robert V.; Simonds, Erin F.; Bendall, Sean C.; Sachs, Karen; Krutzik, Peter O.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Chen, Tiffany J.; Bruggner, Robert V.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Chen, Tiffany J.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Savig, Erica S.] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Zunder, Eli/0000-0002-0356-1685; Simonds, Erin/0000-0002-3497-4861; Nolan, Garry/0000-0002-8862-9043; Bendall, Sean/0000-0003-1341-2453	Swiss National Science Foundation (SNF); European Molecular Biology Organization (EMBO); Marie Curie IOF; National Institute of General Medical Sciences [F32GM093508]; Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Stanford Graduate Fellowship in Science and Engineering; Damon Runyon Cancer Research Foundation Fellowship [DRG-2017-09]; Rachford and Carlota A. Harris Endowed Professorship; European Commission [HEALTH.2010.1.2-1]; Bill and Melinda Gates Foundation [GF12141-137101];  [U19 AI057229];  [P01 CA034233];  [HHSN272200700038C];  [1R01CA130826];  [CIRM DR1-01477];  [RB2-01592];  [NCI RFA CA 09-011];  [NHLBI-HV-10-05(2)]; NATIONAL CANCER INSTITUTE [R01CA130826, U54CA149145, T32CA009302, P01CA034233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, U19AI100627, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093508] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie IOF(European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Stanford Graduate Fellowship in Science and Engineering; Damon Runyon Cancer Research Foundation Fellowship; Rachford and Carlota A. Harris Endowed Professorship; European Commission(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank A. Trejo, M. Clutter, K. Gibbs and G. Behbahani for their experimental support and discussions, and D. Pe'er and El-ad D. Amir for their feedback on data analysis. B. B. was supported by fellowships of the Swiss National Science Foundation (SNF), the European Molecular Biology Organization (EMBO), and the Marie Curie IOF. E.R.Z. is supported by a fellowship from National Institute of General Medical Sciences (F32GM093508). T.J.C. is supported by the Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program, and the Stanford Graduate Fellowship in Science and Engineering. S. C. B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). G.P.N. is supported by the Rachford and Carlota A. Harris Endowed Professorship and grants from U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, CIRM DR1-01477 and RB2-01592, NCI RFA CA 09-011, NHLBI-HV-10-05(2), European Commission HEALTH.2010.1.2-1, and the Bill and Melinda Gates Foundation (GF12141-137101).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; ANDERSSON U, 1989, EUR J IMMUNOL, V19, P1157, DOI 10.1002/eji.1830190629; Arrell DK, 2010, CLIN PHARMACOL THER, V88, P120, DOI 10.1038/clpt.2010.91; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2009, DRUG DISCOV TODAY, V14, P1021, DOI 10.1016/j.drudis.2009.07.001; Bartsch JW, 2004, ANAL CHEM, V76, P3810, DOI 10.1021/ac049870f; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deisseroth A, 2012, CLIN CANCER RES, V18, P3212, DOI 10.1158/1078-0432.CCR-12-0653; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; Kramer R, 2004, NAT REV DRUG DISCOV, V3, P965, DOI 10.1038/nrd1552; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; LOWN JW, 1983, MOL CELL BIOCHEM, V55, P17, DOI 10.1007/BF00229240; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Nolan GP, 2007, NAT CHEM BIOL, V3, P187, DOI 10.1038/nchembio0407-187; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Perez-Oliva AB, 2011, GLYCOBIOLOGY, V21, P757, DOI 10.1093/glycob/cwq220; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Young SM, 2005, J BIOMOL SCREEN, V10, P374, DOI 10.1177/1087057105274532; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	50	363	377	5	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					858	U89		10.1038/nbt.2317	http://dx.doi.org/10.1038/nbt.2317			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22902532	Green Accepted			2022-12-25	WOS:000308705700020
J	Rader, DJ; Tall, AR				Rader, Daniel J.; Tall, Alan R.			The not-so-simple HDL story Is it time to revise the HDL cholesterol hypothesis?	NATURE MEDICINE			English	Editorial Material							HIGH-DENSITY-LIPOPROTEIN; TRANSPORT IN-VIVO; ACCELERATES ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM; NIACIN; TRIAL; ABCA1; ABCG1; MICE	Formation of plaques in artery walls, or atherogenesis, is known to lead to cardiovascular disease risk and heart disease. Low-density lipoproteins (LDLs), which deliver cholesterol to inflammatory cells in blood vessels, are linked to disease, which is commonly managed using cholesterol-lowering therapies. Whether increasing levels of high-density lipoproteins (HDLs), which remove cholesterol from the circulation, can be cardioprotective has not been clear, despite early clinical studies showing evidence for a positive effect in cardiovascular disease. In 'Bench to Bedside', Daniel J. Rader and Alan R. Tall discuss how the field should focus on promoting reverse cholesterol transport that would result in cholesterol efflux from macrophages to biliary excretion rather than simply trying to increase HDL cholesterol levels. Understanding how different molecular mechanisms operate in this 'HDL flux hypothesis' will uncover ways to develop HDL-targeted therapeutics that will protect from cardiovascular and heart disease. In 'Bedside to Bench', Jay W. Heinecke peruses clinical studies to propose better and simpler ways to measure reverse cholesterol transport in the clinic. Genetic alterations and factors involved in HDL functionality may be useful for quantifying HDL function and finding effective drugs to lower cardiovascular disease risk.	[Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Columbia University	Rader, DJ (corresponding author), Univ Penn, Cardiovasc Inst, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu; art1@columbia.edu	Tall, Alan/AAT-8528-2021					Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Schwartz GG, 2009, AM HEART J, V158, P896, DOI 10.1016/j.ahj.2009.09.017; Steinberg D, 2006, J LIPID RES, V47, P1339, DOI 10.1194/jlr.R600009-JLR200; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	18	211	215	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1344	1346		10.1038/nm.2937	http://dx.doi.org/10.1038/nm.2937			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22961164				2022-12-25	WOS:000308472300028
J	Yipp, BG; Petri, B; Salina, D; Jenne, CN; Scott, BNV; Zbytnuik, LD; Pittman, K; Asaduzzaman, M; Wu, KY; Meijndert, HC; Malawista, SE; Chevance, AD; Zhang, KY; Conly, J; Kubes, P				Yipp, Bryan G.; Petri, Bjoern; Salina, Davide; Jenne, Craig N.; Scott, Brittney N. V.; Zbytnuik, Lori D.; Pittman, Keir; Asaduzzaman, Muhammad; Wu, Kaiyu; Meijndert, H. Christopher; Malawista, Stephen E.; Chevance, Anne de Boisfleury; Zhang, Kunyan; Conly, John; Kubes, Paul			Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo	NATURE MEDICINE			English	Article							BLOOD POLYMORPHONUCLEAR LEUKOCYTES; RESISTANT STAPHYLOCOCCUS-AUREUS; GROUP-A STREPTOCOCCUS; EXTRACELLULAR TRAPS; MITOCHONDRIAL-DNA; UNITED-STATES; CYTOPLASTS; KILL; EPIDEMIOLOGY; MECHANISMS	Neutrophil extracellular traps (NETs) are released as neutrophils die in vitro in a process requiring hours, leaving a temporal gap that invasive microbes may exploit. Neutrophils capable of migration and phagocytosis while undergoing NETosis have not been documented. During Gram-positive skin infections, we directly visualized live polymorphonuclear cells (PMNs) in vivo rapidly releasing NETs, which prevented systemic bacterial dissemination. NETosis occurred during crawling, thereby casting large areas of NETs. NET-releasing PMNs developed diffuse decondensed nuclei, ultimately becoming devoid of DNA. Cells with abnormal nuclei showed unusual crawling behavior highlighted by erratic pseudopods and hyperpolarization consistent with the nucleus being a fulcrum for crawling. A requirement for both Toll-like receptor 2 and complement-mediated opsonization tightly regulated NET release. Additionally, live human PMNs injected into mouse skin developed decondensed nuclei and formed NETS in vivo, and intact anuclear neutrophils were abundant in Gram-positive human abscesses. Therefore early in infection NETosis involves neutrophils that do not undergo lysis and retain the ability to multitask.	[Yipp, Bryan G.; Jenne, Craig N.; Scott, Brittney N. V.; Kubes, Paul] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Yipp, Bryan G.; Petri, Bjoern; Jenne, Craig N.; Scott, Brittney N. V.; Zbytnuik, Lori D.; Pittman, Keir; Meijndert, H. Christopher; Zhang, Kunyan; Conly, John; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Petri, Bjoern; Wu, Kaiyu; Zhang, Kunyan; Conly, John] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Salina, Davide; Wu, Kaiyu; Zhang, Kunyan; Conly, John] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Scott, Brittney N. V.; Zbytnuik, Lori D.; Pittman, Keir; Asaduzzaman, Muhammad; Kubes, Paul] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada; [Malawista, Stephen E.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Chevance, Anne de Boisfleury] Hop La Pitie Salpetriere, Ctr Ecol Cellulaire, Paris, France; [Zhang, Kunyan; Conly, John; Kubes, Paul] Univ Calgary, Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	pkubes@ucalgary.ca	Jenne, Craig/HCH-3413-2022	Zhang, Kunyan/0000-0003-1078-6011; Yipp, Bryan/0000-0002-5887-9551	Canada Foundation for Innovation; Canadian Institute of Health Research (CIHR); AIHS postdoctoral fellowship; Rockefeller University from the National Center for Research Resources (NCRR) [UL1RR024143]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); AIHS postdoctoral fellowship; Rockefeller University from the National Center for Research Resources (NCRR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The pBT2 was a gift from R. Bruckner (University of Kaiserslautern). Myd88<SUP>-/-</SUP> and Tlr2<SUP>-/-</SUP> mice were provided by S. Akira (Osaka University). T. Graf (Barcelona, Spain) provided the Tg(LysMeGFP). We thank D. Knight and C. Baddick for technical assistance and ongoing support. We acknowledge P. Colarusso and the support staff of the Snyder Institute Live Cell Imaging Facility for assisting in the image capturing and analysis (Canada Foundation for Innovation funded). We also thank the University of Calgary Flow Cytometry Facility and L. Kennedy for their assistance. We are grateful to P. Forsyth for use of the IVIS 200. We thank the physicians, nurses and support staff in the Division of Infectious Diseases in the Department of Medicine, Alberta Health Services-Calgary and Area for assistance in obtaining clinical samples. We thank E. Yung, C. Horn, K. Nelson and K. Headley from Calgary Lab Services for assistance with the electron microscopy experiments. The Canadian Institute of Health Research (CIHR) provided the operating grants to support this work. P. K. is an Alberta Innovates-Health Solutions (AIHS) Scientist, Canada Research Chair and the Snyder Chair in Critical Care Medicine. B. Petri received an AIHS postdoctoral fellowship. B. Yipp is a Clinical Scholar (Department of Critical Care Medicine, Calgary), an AIHS clinical fellow and a CIHR fellow. During a portion of this study he received salary support from the Rockefeller University by Grant Award Number UL1RR024143 from the National Center for Research Resources (NCRR), a component of the US National Institutes of Health (NIH) and NIH Roadmap for Medical Research. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or the NIH.	Amulic B, 2011, CURR BIOL, V21, pR297, DOI 10.1016/j.cub.2011.03.021; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Dahl KN, 2010, J BIOMECH, V43, P2, DOI 10.1016/j.jbiomech.2009.09.002; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Ji P, 2011, TRENDS CELL BIOL, V21, P409, DOI 10.1016/j.tcb.2011.04.003; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kollef MH, 2006, CURR OPIN INFECT DIS, V19, P161, DOI 10.1097/01.qco.0000216627.13445.e2; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; MALAWISTA SE, 1989, J CLIN INVEST, V83, P728, DOI 10.1172/JCI113939; MALAWISTA SE, 1986, BLOOD CELLS, V12, P167; MALAWISTA SE, 1992, J CLIN INVEST, V90, P631, DOI 10.1172/JCI115903; MALAWISTA SE, 1987, P NATL ACAD SCI USA, V84, P454, DOI 10.1073/pnas.84.2.454; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Skrupky LP, 2009, CRIT CARE, V13, DOI 10.1186/cc8028; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wu K, 2010, CLIN MICROBIOL INFEC, V16, P245, DOI 10.1111/j.1469-0691.2009.02765.x; Yan J, 2012, J IMMUNOL, V188, P2316, DOI 10.4049/jimmunol.1102683; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	48	672	697	9	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1386	+		10.1038/nm.2847	http://dx.doi.org/10.1038/nm.2847			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922410	Green Accepted			2022-12-25	WOS:000308472300034
J	Stock, K; Kumar, J; Synowitz, M; Petrosino, S; Imperatore, R; Smith, ES; Wend, P; Purfurst, B; Nuber, UA; Gurok, U; Matyash, V; Walzlein, JH; Chirasani, SR; Dittmar, G; Cravatt, BF; Momma, S; Lewin, GR; Ligresti, A; De Petrocellis, L; Cristino, L; Di Marzo, V; Kettenmann, H; Glass, R				Stock, Kristin; Kumar, Jitender; Synowitz, Michael; Petrosino, Stefania; Imperatore, Roberta; Smith, Ewan St J.; Wend, Peter; Purfuerst, Bettina; Nuber, Ulrike A.; Gurok, Ulf; Matyash, Vitali; Waelzlein, Joo-Hee; Chirasani, Sridhar R.; Dittmar, Gunnar; Cravatt, Benjamin F.; Momma, Stefan; Lewin, Gary R.; Ligresti, Alessia; De Petrocellis, Luciano; Cristino, Luigia; Di Marzo, Vincenzo; Kettenmann, Helmut; Glass, Rainer			Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; STEM-CELLS; VANILLOID RECEPTORS; GLIAL PROGENITORS; MICE LACKING; ANANDAMIDE; GLIOBLASTOMA; BRAIN; MECHANISMS; NEUROGENESIS	Primary astrocytomas of grade 3 or 4 according to the classification system of the World Health Organization (high-grade astrocytomas or HGAs) are preponderant among adults and are almost invariably fatal despite the use of multimodal therapy. Here we show that the juvenile brain has an endogenous defense mechanism against HGAs. Neural precursor cells (NPCs) migrate to HGAs, reduce glioma expansion and prolong survival time by releasing endovanilloids that activate the vanilloid receptor (transient receptor potential vanilloid subfamily member-1 or TRPV1) on HGA cells. TRPV1 is highly expressed in tumor and weakly expressed in tumor-free brain. TRPV1 stimulation triggers tumor cell death through the branch of the endoplasmic reticulum stress pathway that is controlled by activating transcription factor-3 (ATF3). The antitumorigenic response of NPCs is lost with aging. NPC-mediated tumor suppression can be mimicked in the adult brain by systemic administration of the synthetic vanilloid arvanil, suggesting that TRPV1 agonists have potential as new HGA therapeutics.	[Stock, Kristin; Kumar, Jitender; Synowitz, Michael; Matyash, Vitali; Waelzlein, Joo-Hee; Chirasani, Sridhar R.; Kettenmann, Helmut; Glass, Rainer] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Synowitz, Michael] Univ Med Berlin, Charite, Dept Neurosurg, Berlin, Germany; [Petrosino, Stefania; Ligresti, Alessia; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy; [Imperatore, Roberta; De Petrocellis, Luciano; Cristino, Luigia] CNR, Inst Cybernet, Endocannabinoid Res Grp, Pozzuoli, Italy; [Purfuerst, Bettina] MDC, Cent Facil Electron Microscopy, Berlin, Germany; [Smith, Ewan St J.] NYU, Langone Med Ctr, Skirball Inst Biomol Med, New York, NY USA; [Nuber, Ulrike A.] Lund Univ, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Gurok, Ulf] Max Planck Inst Mol Genet, Berlin, Germany; [Dittmar, Gunnar] MDC, Cent Facil Mass Spectrometry, Berlin, Germany; [Cravatt, Benjamin F.] Scripps Res Inst, La Jolla, CA 92037 USA; [Momma, Stefan] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Glass, Rainer] Univ Munich, Clin Neurosurg, Munich, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); New York University; NYU Langone Medical Center; Lund University; Max Planck Society; Scripps Research Institute; Goethe University Frankfurt; University of Munich	Glass, R (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	rainer.glass@med.uni-muenchen.de	Glass, Rainer/GMW-7952-2022; Cristino, Luigia/AAE-3934-2020; Ligresti, Alessia/B-7564-2015; St. John Smith, Ewan/G-1776-2011; Di Marzo, Vincenzo/AAD-7742-2019; Kettenmann, Helmut/AAJ-5142-2021; Synowitz, Michael/G-2596-2012; Lewin, Gary R/B-8028-2011; Dittmar, Gunnar/B-6383-2016; Dittmar, Gunnar/C-6333-2019	Cristino, Luigia/0000-0002-0182-4699; Ligresti, Alessia/0000-0003-1787-3900; St. John Smith, Ewan/0000-0002-2699-1979; Di Marzo, Vincenzo/0000-0002-1490-3070; Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Lewin, Gary/0000-0002-2890-6352; Kettenmann, Helmut/0000-0001-8208-0291; IMPERATORE, Roberta/0000-0003-3609-2771	Helios Clinics [HeFoFo-ID1148]; US National Institutes of Health [DA-009789]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	Helios Clinics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Gargiulo, O. Daumke and J. Kurreck for discussion of the manuscript, S. Kitajima (Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan) for ATF3 constructs and L. Kaczmarek and M. Szymanska (Nencki Institute, Warsaw, Poland) for providing Ccnd2<SUP>-/-</SUP> mice. We acknowledge funding from the Helios Clinics (HeFoFo-ID1148) and the US National Institutes of Health (DA-009789 to V.D.M.).	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Bode AM, 2009, CANCER RES, V69, P905, DOI 10.1158/0008-5472.CAN-08-3263; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Chirasani SR, 2010, BRAIN, V133, P1961, DOI 10.1093/brain/awq128; Conover JC, 2011, AGING DIS, V2, P49; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P594, DOI 10.1016/j.tips.2008.09.004; Fisher T, 2007, CANCER J, V13, P335, DOI 10.1097/PPO.0b013e318157053f; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409; Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Izzo AA, 2008, J MOL MED, V86, P89, DOI 10.1007/s00109-007-0248-4; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Khan MA, 2011, AGING-US, V3, P182, DOI 10.18632/aging.100297; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Lambert DM, 1999, CURR MED CHEM, V6, P757; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Melck D, 1999, BIOCHEM BIOPH RES CO, V262, P275, DOI 10.1006/bbrc.1999.1105; Morelli MB, 2012, INT J CANCER, V131, pE1067, DOI 10.1002/ijc.27588; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Okano H, 2002, J CELL SCI, V115, P1355; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Reimer TA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-47; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Staflin K, 2004, CANCER RES, V64, P5347, DOI 10.1158/0008-5472.CAN-03-1246; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Sturzebecher AS, 2010, J PHYSIOL-LONDON, V588, P1695, DOI 10.1113/jphysiol.2010.187112; Suzuki T, 2005, J NEURO-ONCOL, V74, P233, DOI 10.1007/s11060-004-7118-5; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; Ueda N, 2000, CHEM PHYS LIPIDS, V108, P107, DOI 10.1016/S0009-3084(00)00190-0; Veldhuis WB, 2003, J NEUROSCI, V23, P4127; Visnyei K, 2011, MOL CANCER THER, V10, P1818, DOI 10.1158/1535-7163.MCT-11-0268; Walzlein JH, 2008, STEM CELLS, V26, P2945, DOI 10.1634/stemcells.2008-0307; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	54	125	128	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1232	+		10.1038/nm.2827	http://dx.doi.org/10.1038/nm.2827			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820645	Green Accepted			2022-12-25	WOS:000307469300029
J	Lowy, DR; Kim, J; Smith-McCune, KK; Melief, CJM				Lowy, Douglas R.; Kim, Jane; Smith-McCune, Karen K.; Melief, Cornelis J. M.			The value of HPV vaccination	NATURE MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS INFECTION; IMMUNOGENICITY; IMPACT		[Lowy, Douglas R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Lowy, Douglas R.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Lowy, DR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.			Chun, Hyung/0000-0003-3508-2678	Howard Hughes Medical Institute Funding Source: Medline; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NHLBI NIH HHS [R37 HL060917, P30 HL101284, HL101284, HL093362, R01 HL113005, R01 HL069170, HL113005, K08 HL095654, K08 HL093362, HL069170, HL095654, U10 HL109250] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Barr E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.001; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Hoy T, 2009, CURR MED RES OPIN, V25, P2343, DOI 10.1185/03007990903136378; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lowy DR, 2008, CANCER-AM CANCER SOC, V113, P1980, DOI 10.1002/cncr.23704; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	14	35	39	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					28	29						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227663				2022-12-25	WOS:000299018600021
